data_6sgo_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6sgo _Structure_validation_residue.Date_analyzed 2019-12-13 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 t70 . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 121.033 0.444 . . . . 73.340000000000003 110.8 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.31 -38.46 90.26 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 107.582 -1.266 . . . . 73.409999999999997 107.582 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -71.31 -35.02 71.11 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.543 -0.753 . . . . 72.340000000000003 110.028 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.491 HG13 ' SG ' ' A' ' 132' ' ' CYS . 90.2 t -62.65 -55.9 20.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.868 -0.605 . . . . 74.450000000000003 110.696 176.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -25.65 62.12 Favored 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 120.431 -0.508 . . . . 74.239999999999995 111.633 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.48 -42.17 89.43 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.198 -1.161 . . . . 65.120000000000005 110.198 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.88 -53.49 49.63 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 123.658 0.783 . . . . 65.349999999999994 109.786 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.19 -44.89 88.87 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 115.427 -0.806 . . . . 75.450000000000003 112.536 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -66.46 -40.1 89.21 Favored 'General case' 0 C--O 1.206 -1.192 0 CA-C-O 119.423 -0.323 . . . . 75.129999999999995 111.549 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.6 -40.41 92.63 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.483 0.659 . . . . 61.219999999999999 110.102 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.493 ' CE2' HD13 ' A' ' 45' ' ' LEU . 13.6 t80 -61.79 -53.52 54.81 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.414 -1.266 . . . . 73.319999999999993 109.783 176.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.4 mm -64.17 -35.89 75.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 116.328 -0.396 . . . . 73.340000000000003 111.502 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.73 -52.36 66.03 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.28 0.632 . . . . 74.420000000000002 110.109 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.5 pp -67.73 -29.32 68.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 120.58 -0.448 . . . . 75.099999999999994 111.338 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.17 -31.84 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.119 0.485 . . . . 73.109999999999999 110.602 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 p -108.09 17.17 22.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.668 0.747 . . . . 73.219999999999999 110.466 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.415 ' HB2' ' HA ' ' A' ' 31' ' ' LEU . 8.3 tptm -74.04 171.26 13.82 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-N 114.523 -1.217 . . . . 73.450000000000003 111.708 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.5 m -43.94 138.56 3.23 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.357 1.863 . . . . 72.200000000000003 113.768 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.16 -7.18 16.12 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.794 2.329 . . . . 74.319999999999993 109.889 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.21 -28.02 68.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.04 -1.436 . . . . 73.420000000000002 110.736 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.7 p -94.3 158.23 15.67 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.872 -0.604 . . . . 74.230000000000004 110.089 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.489 HG21 ' OD1' ' A' ' 40' ' ' ASN . 9.2 p -50.55 -53.02 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 114.77 1.396 . . . . 62.219999999999999 114.77 -172.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.489 ' OD1' HG21 ' A' ' 39' ' ' VAL . 14.5 m120 -159.21 135.55 9.1 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 118.184 0.447 . . . . 73.129999999999995 110.548 -176.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.0 m -66.19 -31.28 72.02 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.667 -1.234 . . . . 73.439999999999998 107.667 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.456 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 1.8 mp0 -63.4 -25.61 68.37 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.731 -1.577 . . . . 74.439999999999998 109.624 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -71.02 -46.17 62.63 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.489 -0.93 . . . . 75.049999999999997 108.489 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -67.57 -31.66 71.89 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.016 -0.993 . . . . 71.109999999999999 109.424 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.493 HD13 ' CE2' ' A' ' 28' ' ' PHE . 42.6 tp -68.2 -45.06 74.39 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.763 -0.653 . . . . 75.340000000000003 110.358 177.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.37 -36.62 78.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.831 0.824 . . . . 70.450000000000003 109.844 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -75.62 -27.72 58.56 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.499 -1.228 . . . . 74.310000000000002 110.384 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -74.72 -44.59 49.19 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.477 -0.564 . . . . 74.430000000000007 109.477 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 3.9 pp -79.59 -2.62 43.3 Favored 'General case' 0 C--O 1.199 -1.562 0 CA-C-N 115.824 -0.626 . . . . 65.230000000000004 112.422 -174.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -51.89 -61.77 6.2 Favored Glycine 0 CA--C 1.544 1.853 0 C-N-CA 121.494 -0.384 . . . . 63.100000000000001 112.235 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -77.04 -5.42 15.83 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.236 2.624 . . . . 71.310000000000002 112.178 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.458 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 55.8 m-70 -119.0 29.5 7.67 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.837 -0.801 . . . . 64.319999999999993 108.837 -175.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -55.91 107.67 0.96 Allowed Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 124.859 1.264 . . . . 71.239999999999995 112.871 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HB3' ' HB3' ' A' ' 134' ' ' LEU . 75.0 Cg_endo -98.93 -173.81 0.15 Allowed 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 123.273 2.649 . . . . 75.450000000000003 111.13 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -86.08 101.98 13.43 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 107.306 -1.368 . . . . 73.200000000000003 107.306 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.42 HD12 ' HB2' ' A' ' 68' ' ' PHE . 65.1 mt -87.15 105.69 15.35 Favored 'Isoleucine or valine' 0 C--O 1.172 -3.007 0 N-CA-C 109.251 -0.648 . . . . 75.349999999999994 109.251 -175.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -94.02 106.88 18.84 Favored 'General case' 0 C--N 1.276 -2.61 0 O-C-N 121.314 -0.866 . . . . 75.230000000000004 111.459 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.2 t -108.45 113.19 43.29 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.939 0 N-CA-C 108.23 -1.026 . . . . 74.219999999999999 108.23 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 62.04 21.28 12.24 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.96 -1.473 . . . . 74.420000000000002 110.599 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.47 2.98 56.52 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.564 -0.744 . . . . 61.420000000000002 113.357 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -112.85 135.21 53.87 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 117.758 0.779 . . . . 75.299999999999997 110.509 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.01 126.35 34.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.949 0.88 . . . . 74.329999999999998 109.376 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.419 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 59.0 mm-40 -126.13 149.45 48.94 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.164 -1.421 . . . . 75.129999999999995 107.164 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.8 t -97.95 173.56 7.01 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.355 -0.98 . . . . 73.450000000000003 108.355 173.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.6 t -42.25 -42.89 3.22 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.144 1.378 . . . . 74.530000000000001 112.479 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.5 m -69.35 -42.36 75.37 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.377 -0.374 . . . . 62.420000000000002 111.978 -176.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.419 ' HB1' ' HB3' ' A' ' 63' ' ' GLN . . . -65.08 -45.99 82.98 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.656 -0.498 . . . . 73.340000000000003 109.656 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.42 ' HB2' HD12 ' A' ' 56' ' ' ILE . 41.2 t80 -52.75 -55.21 24.46 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 109.108 -0.701 . . . . 73.400000000000006 109.108 174.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -48.34 -44.19 34.07 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.3 -1.318 . . . . 75.219999999999999 110.963 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 45.2 mt-30 -61.55 -46.49 89.7 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 112.029 0.381 . . . . 63.030000000000001 112.029 177.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.504 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 57.6 m-85 -68.62 -36.25 78.41 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.421 0.629 . . . . 71.209999999999994 109.315 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -57.99 -51.57 69.1 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.621 -0.718 . . . . 73.209999999999994 111.084 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 34.1 ptt180 -66.85 -30.93 71.24 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.705 -0.48 . . . . 75.129999999999995 109.705 -176.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -74.86 -10.09 59.17 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.779 -0.646 . . . . 72.010000000000005 112.212 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.36 6.84 47.17 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 114.77 0.668 . . . . 61.25 114.77 174.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.446 ' HB3' ' SD ' ' A' ' 141' ' ' MET . 3.5 mm? -68.15 -48.77 64.44 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.659 0.614 . . . . 71.430000000000007 112.659 -176.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.504 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 45.5 m-85 -90.8 12.74 18.34 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 113.273 0.842 . . . . 73.530000000000001 113.273 -173.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 51.7 mtmt -66.97 -14.22 62.64 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.634 0.605 . . . . 74.439999999999998 112.634 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -79.96 -13.01 59.67 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 123.218 0.607 . . . . 72.299999999999997 110.695 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.5 tt -60.78 -28.17 68.54 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.583 0.586 . . . . 72.310000000000002 112.583 -174.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.13 4.57 46.93 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 117.623 -1.631 . . . . 74.230000000000004 111.409 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -105.85 10.07 32.64 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.265 -1.384 . . . . 74.140000000000001 107.265 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 105' ' ' SER . . . -91.71 153.08 19.89 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 113.805 -1.543 . . . . 74.409999999999997 113.15 -174.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 104' ' ' LYS . 13.6 pt-20 -95.09 133.23 39.13 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.64 -1.164 . . . . 73.340000000000003 110.143 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.61 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 43.2 p90 . . . . . 0 C--N 1.31 -1.113 0 N-CA-C 108.763 -0.829 . . . . 70.25 108.763 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 . . . . . 0 CA--C 1.508 -0.659 0 CA-C-O 121.602 0.715 . . . . 70.430000000000007 112.842 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -150.75 138.76 6.83 Favored Glycine 0 N--CA 1.414 -2.768 0 N-CA-C 109.695 -1.362 . . . . 71.540000000000006 109.695 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -123.63 143.63 50.11 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.687 -1.598 . . . . 74.140000000000001 106.687 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 19.6 pttp -136.02 98.98 4.02 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-O 122.104 0.954 . . . . 71.120000000000005 109.257 173.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.88 125.43 34.0 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.349 -1.296 . . . . 74.549999999999997 108.253 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 10.0 p -117.11 136.74 53.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 C-N-CA 119.866 -0.734 . . . . 62.439999999999998 111.414 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.61 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 27.0 m-90 -115.58 140.29 49.31 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.506 -1.225 . . . . 71.209999999999994 107.711 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 97.4 mttt -116.87 120.99 40.19 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.985 -1.487 . . . . 74.409999999999997 106.985 172.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 46.3 m . . . . . 0 C--N 1.306 -1.311 0 N-CA-C 108.218 -1.03 . . . . 73.129999999999995 108.218 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 21.7 p90 . . . . . 0 N--CA 1.445 -0.693 0 N-CA-C 108.938 -0.764 . . . . 74.25 108.938 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -118.59 138.39 52.6 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 105.651 -1.981 . . . . 62.32 105.651 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.406 ' HB2' HG13 ' A' ' 140' ' ' ILE . 47.6 mt-10 -114.57 142.08 46.91 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.722 -0.791 . . . . 75.010000000000005 110.533 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -133.9 117.15 16.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.739 -0.664 . . . . 73.219999999999999 110.042 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -116.45 110.89 19.23 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 122.94 0.496 . . . . 74.540000000000006 110.366 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -97.74 113.75 25.59 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 110.152 -0.314 . . . . 74.310000000000002 110.152 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -97.84 119.8 37.09 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.455 -0.942 . . . . 74.510000000000005 108.455 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.444 HG12 HD13 ' A' ' 134' ' ' LEU . 59.6 mt -118.54 144.88 25.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 106.953 -1.499 . . . . 73.510000000000005 106.953 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.496 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.6 OUTLIER -119.97 146.0 46.24 Favored 'General case' 0 C--O 1.267 2.008 0 C-N-CA 118.485 -1.286 . . . . 65.200000000000003 107.604 174.307 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -93.0 106.02 18.04 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 106.607 -1.627 . . . . 75.239999999999995 106.607 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -58.44 145.69 37.71 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 113.67 -1.605 . . . . 75.209999999999994 108.195 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -61.51 -18.21 58.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.694 0.759 . . . . 72.140000000000001 110.8 -177.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -65.07 -17.86 64.82 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.562 1.145 . . . . 74.340000000000003 110.953 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.92 -16.66 36.18 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 121.38 -0.438 . . . . 64.030000000000001 112.677 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.0 p -92.8 176.98 6.24 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 109.51 -0.552 . . . . 65.450000000000003 109.51 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.491 ' SG ' HG13 ' A' ' 21' ' ' VAL . 30.4 p -131.16 143.7 50.82 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 109.705 -0.48 . . . . 72.140000000000001 109.705 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.496 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 2.0 t90 -139.27 155.01 48.04 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.809 -0.811 . . . . 65.530000000000001 108.809 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.444 HD13 HG12 ' A' ' 124' ' ' ILE . 2.7 mm? -67.89 111.35 4.3 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.071 -0.968 . . . . 74.239999999999995 108.676 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -76.44 -60.41 2.35 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.718 -1.215 . . . . 74.549999999999997 107.718 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.8 m -161.31 150.5 16.43 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.136 -1.801 . . . . 73.010000000000005 106.136 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.0 m -133.35 135.83 55.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 107.001 -1.481 . . . . 71.140000000000001 107.001 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -115.79 131.29 56.98 Favored 'General case' 0 C--N 1.274 -2.716 0 CA-C-O 120.644 0.259 . . . . 75.439999999999998 110.8 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -119.66 126.23 50.64 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.915 -1.143 . . . . 71.530000000000001 107.915 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.406 HG13 ' HB2' ' A' ' 119' ' ' GLU . 3.8 pt -126.29 98.65 5.02 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 N-CA-C 107.94 -1.133 . . . . 63.439999999999998 107.94 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.446 ' SD ' ' HB3' ' A' ' 76' ' ' LEU . 63.1 mtm -87.91 127.98 35.36 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.01 -1.45 . . . . 71.150000000000006 112.039 -171.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.1 m 64.19 77.33 0.32 Allowed 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 113.332 -1.758 . . . . 62.539999999999999 112.654 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt . . . . . 0 N--CA 1.418 -2.068 0 CA-C-N 112.981 -1.918 . . . . 71.349999999999994 108.566 177.69 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 27.7 t70 . . . . . 0 C--O 1.241 0.612 0 CA-C-O 121.811 0.815 . . . . 74.239999999999995 109.403 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.2 -35.82 80.41 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.141 -0.936 . . . . 75.299999999999997 108.946 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -64.34 -49.25 72.45 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.725 -0.67 . . . . 71.409999999999997 110.052 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.71 -45.55 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.038 -0.528 . . . . 74.349999999999994 112.341 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 18.3 ptpt -72.27 -26.09 61.85 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 118.632 -1.227 . . . . 72.540000000000006 111.128 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.64 -55.1 12.45 Favored Glycine 0 C--O 1.262 1.876 0 N-CA-C 111.386 -0.685 . . . . 65.230000000000004 111.386 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 pp -66.75 -38.98 87.7 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 108.518 -0.919 . . . . 74.140000000000001 108.518 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.12 -42.84 99.92 Favored Glycine 0 CA--C 1.497 -1.074 0 CA-C-N 116.025 -0.534 . . . . 72.209999999999994 111.986 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -64.62 -45.77 85.46 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-O 119.533 -0.27 . . . . 75.140000000000001 110.424 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.18 -38.61 88.45 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 120.456 -0.498 . . . . 75.230000000000004 110.771 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.488 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 24.7 t80 -62.48 -54.62 37.31 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.522 1.129 . . . . 73.219999999999999 110.123 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.6 mm -65.58 -33.14 61.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 116.358 -0.383 . . . . 65.099999999999994 111.134 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.76 -49.11 77.68 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.109 -0.496 . . . . 75.329999999999998 110.774 175.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.5 pp -67.76 -31.22 70.98 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 120.671 -0.412 . . . . 74.049999999999997 110.836 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.5 t -69.97 -21.87 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-O 121.308 0.575 . . . . 63.210000000000001 110.651 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.7 p -110.51 13.06 22.77 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.754 -0.591 . . . . 75.329999999999998 111.334 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -62.91 144.24 56.91 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.615 -0.721 . . . . 74.329999999999998 112.167 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.3 m -66.05 155.14 88.03 Favored Pre-proline 0 C--N 1.299 -1.594 0 CA-C-N 114.86 -1.064 . . . . 50.549999999999997 110.971 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.97 -6.49 4.92 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 124.389 3.393 . . . . 74.310000000000002 113.259 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.8 -27.84 68.56 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.884 -0.598 . . . . 74.219999999999999 110.193 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.6 m -72.46 158.8 35.05 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.431 -0.951 . . . . 62.450000000000003 108.431 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.534 HG21 ' OD1' ' A' ' 40' ' ' ASN . 32.0 m -63.89 -37.6 80.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 C-N-CA 119.503 -0.879 . . . . 74.329999999999998 110.634 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.624 ' HB2' ' OE1' ' A' ' 42' ' ' GLU . 12.1 p-10 178.92 137.94 0.09 Allowed 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.563 1.145 . . . . 65.25 110.661 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.3 m -63.55 -37.37 87.07 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-O 122.34 1.067 . . . . 74.400000000000006 109.639 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.624 ' OE1' ' HB2' ' A' ' 40' ' ' ASN . 1.2 pm0 -67.58 -20.5 65.39 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 114.317 -1.31 . . . . 75.519999999999996 112.191 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.551 ' HB2' ' OD1' ' A' ' 40' ' ' ASN . 54.8 t-80 -67.43 -49.03 65.52 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 108.877 -0.786 . . . . 64.430000000000007 108.877 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -66.99 -33.84 76.45 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.317 -1.311 . . . . 72.239999999999995 109.058 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.411 HD11 ' CE1' ' A' ' 28' ' ' PHE . 51.8 tp -66.56 -46.42 76.09 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 116.281 -0.418 . . . . 71.519999999999996 110.708 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.73 -35.32 76.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.188 0.518 . . . . 74.450000000000003 110.418 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -76.95 -29.97 55.84 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.436 -0.802 . . . . 72.349999999999994 109.699 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -68.27 -42.96 78.79 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 123.248 0.619 . . . . 73.0 110.019 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 pp -85.44 0.72 51.41 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.821 -0.627 . . . . 75.109999999999999 111.323 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -52.61 -57.95 12.6 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-N 116.383 -0.372 . . . . 74.409999999999997 112.423 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -76.85 -4.1 14.54 Favored 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.438 2.759 . . . . 72.239999999999995 112.525 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -125.13 45.07 2.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.372 -0.376 . . . . 75.340000000000003 110.006 -173.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -54.97 104.98 0.46 Allowed Pre-proline 0 N--CA 1.492 1.666 0 C-N-CA 124.833 1.253 . . . . 75.450000000000003 113.179 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -97.9 177.16 0.47 Allowed 'Trans proline' 0 N--CA 1.431 -2.164 0 C-N-CA 123.13 2.553 . . . . 71.340000000000003 110.268 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.92 105.34 11.13 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.919 -1.141 . . . . 73.340000000000003 107.919 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.452 HD12 ' CB ' ' A' ' 68' ' ' PHE . 68.9 mt -93.06 106.54 18.05 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.404 0 N-CA-C 108.879 -0.786 . . . . 74.319999999999993 108.879 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -95.82 112.9 24.52 Favored 'General case' 0 C--N 1.265 -3.092 0 O-C-N 121.718 -0.614 . . . . 72.129999999999995 110.398 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 3.6 p -108.57 118.49 56.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 C-N-CA 118.81 -1.156 . . . . 73.319999999999993 108.129 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 59.74 20.34 9.1 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.643 -1.162 . . . . 75.450000000000003 111.106 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.53 7.84 53.29 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 115.158 -0.928 . . . . 73.310000000000002 114.144 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -116.64 132.94 56.55 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 117.666 0.733 . . . . 72.430000000000007 110.862 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.1 127.05 36.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 121.481 0.658 . . . . 73.239999999999995 110.222 -176.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -126.95 151.17 48.87 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.793 -1.188 . . . . 74.439999999999998 107.793 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.6 t -93.77 173.11 7.84 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.457 -0.942 . . . . 75.409999999999997 108.457 174.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.0 t -49.22 -39.45 30.02 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 124.605 1.162 . . . . 74.239999999999995 111.64 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.2 m -65.21 -47.86 75.4 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 122.918 0.487 . . . . 74.200000000000003 111.108 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.6 78.28 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 122.745 0.418 . . . . 72.030000000000001 110.129 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.452 ' CB ' HD12 ' A' ' 56' ' ' ILE . 51.4 t80 -52.81 -55.17 24.89 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 116.177 -0.465 . . . . 74.209999999999994 110.271 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -51.35 -42.09 61.05 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.042 -0.981 . . . . 62.439999999999998 110.857 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -62.66 -49.7 74.12 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 116.299 -0.41 . . . . 75.530000000000001 111.683 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.4 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 24.8 m-85 -65.82 -33.4 75.78 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.794 0.807 . . . . 73.219999999999999 109.27 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.511 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 4.1 t80 -57.85 -53.18 61.13 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.02 -0.991 . . . . 73.099999999999994 110.841 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -74.73 -20.63 59.76 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.15 0.5 . . . . 75.120000000000005 110.671 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -76.18 -8.25 56.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.901 -0.591 . . . . 74.430000000000007 111.051 173.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.16 10.07 57.6 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 120.539 -0.838 . . . . 74.129999999999995 114.266 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.32 -50.53 52.83 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 116.868 0.334 . . . . 73.129999999999995 110.442 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 36.5 m-85 -99.31 10.08 42.12 Favored 'General case' 0 C--O 1.204 -1.326 0 N-CA-C 112.819 0.674 . . . . 75.099999999999994 112.819 -173.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.301 62.8 pttt -70.48 -10.62 59.65 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 114.221 1.193 . . . . 74.349999999999994 114.221 -176.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -83.33 -10.55 58.42 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.196 -0.456 . . . . 75.349999999999994 110.485 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.44 -15.93 63.71 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 112.578 0.584 . . . . 64.400000000000006 112.578 -172.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -11.16 40.54 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.931 -0.481 . . . . 63.119999999999997 112.122 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -99.76 14.06 31.55 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 122.65 0.38 . . . . 73.319999999999993 111.23 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 103' ' ' TRP . . . -58.71 129.22 41.06 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.008 0.744 . . . . 65.019999999999996 113.008 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -100.67 127.01 47.23 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.497 -1.668 . . . . 72.049999999999997 106.497 173.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 73.7 t80 . . . . . 0 C--N 1.304 -1.403 0 C-N-CA 120.749 -0.38 . . . . 75.150000000000006 110.526 -178.371 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 . . . . . 0 C--O 1.247 0.93 0 CA-C-O 121.009 0.433 . . . . 73.450000000000003 111.058 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.54 138.35 14.91 Favored Glycine 0 N--CA 1.423 -2.226 0 N-CA-C 108.628 -1.789 . . . . 74.530000000000001 108.628 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -112.67 146.3 38.93 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 117.11 0.455 . . . . 74.519999999999996 109.931 -176.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -124.89 97.59 5.33 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.164 -1.421 . . . . 75.329999999999998 107.164 172.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.64 107.99 20.53 Favored 'General case' 0 C--N 1.259 -3.363 0 N-CA-C 106.383 -1.71 . . . . 73.409999999999997 106.383 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.2 p -115.89 135.27 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 CA-C-O 121.897 0.856 . . . . 73.340000000000003 112.258 -174.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 30.5 m-90 -119.28 155.43 31.81 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.285 -1.325 . . . . 73.439999999999998 109.94 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -129.03 125.25 36.91 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 104.485 -2.413 . . . . 73.129999999999995 104.485 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 80.6 p . . . . . 0 C--N 1.3 -1.576 0 CA-C-N 118.296 0.498 . . . . 73.510000000000005 110.644 -178.164 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.464 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 22.1 p90 . . . . . 0 C--O 1.2 -1.536 0 N-CA-C 106.822 -1.548 . . . . 75.329999999999998 106.822 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -116.28 141.3 48.34 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 106.332 -1.729 . . . . 74.200000000000003 106.332 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.464 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 42.4 mt-10 -115.33 147.04 40.94 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 119.701 -0.8 . . . . 65.030000000000001 112.567 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -139.37 117.88 12.16 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.169 -0.923 . . . . 71.530000000000001 110.185 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.57 109.57 17.98 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.697 -0.853 . . . . 74.439999999999998 108.697 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.65 123.02 37.84 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 109.527 -0.546 . . . . 74.319999999999993 109.527 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -103.31 112.18 24.94 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.764 -1.199 . . . . 75.329999999999998 107.764 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.4 mt -117.3 150.92 19.24 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 N-CA-C 106.744 -1.576 . . . . 72.109999999999999 106.744 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -136.16 143.06 44.26 Favored 'General case' 0 C--O 1.275 2.414 0 N-CA-C 108.226 -1.028 . . . . 73.230000000000004 108.226 172.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -91.53 100.98 13.63 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 106.793 -1.558 . . . . 72.010000000000005 106.793 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -68.03 132.89 48.08 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 114.765 -1.107 . . . . 75.219999999999999 109.258 -171.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -66.16 -10.57 42.46 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 123.75 0.82 . . . . 74.420000000000002 111.417 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -74.6 -8.0 54.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.055 -0.52 . . . . 73.049999999999997 111.023 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.22 -8.78 28.95 Favored Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.707 -0.759 . . . . 75.030000000000001 113.932 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.9 m -104.16 138.78 40.15 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.414 -0.587 . . . . 72.010000000000005 109.414 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 44.7 t -98.33 132.65 43.63 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 107.037 -1.468 . . . . 74.310000000000002 107.037 170.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -146.0 154.78 42.27 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 118.389 -1.324 . . . . 73.439999999999998 110.642 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.22 125.67 29.59 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.99 -1.115 . . . . 74.310000000000002 107.99 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -80.79 -53.99 6.0 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.408 -0.96 . . . . 64.209999999999994 108.408 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.4 m -162.48 158.48 23.76 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 105.266 -2.124 . . . . 73.25 105.266 -175.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.7 m -143.06 138.4 27.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 107.296 -1.372 . . . . 75.129999999999995 107.296 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -112.82 136.33 52.57 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 109.786 -0.45 . . . . 71.5 109.786 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 71.8 m-85 -125.04 122.94 38.69 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 107.72 -1.215 . . . . 61.340000000000003 107.72 175.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.2 pt -127.14 98.81 4.9 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 N-CA-C 107.946 -1.131 . . . . 74.439999999999998 107.946 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 23.4 ptm -86.63 143.09 27.8 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.481 -1.236 . . . . 74.329999999999998 110.564 -173.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.8 m 67.62 35.23 4.17 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.569 1.168 . . . . 74.150000000000006 109.287 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 26.1 tptp . . . . . 0 N--CA 1.408 -2.54 0 CA-C-N 113.082 -1.872 . . . . 74.409999999999997 109.258 179.075 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 . . . . . 0 CA--C 1.507 -0.695 0 CA-C-O 121.007 0.432 . . . . 73.040000000000006 110.178 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.99 -43.86 97.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.559 -0.746 . . . . 75.120000000000005 109.434 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.04 -42.93 99.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.843 -0.617 . . . . 63.0 111.622 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.6 m -74.46 -39.79 48.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 119.352 -0.939 . . . . 73.409999999999997 112.698 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -72.38 -28.03 62.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 119.052 -1.059 . . . . 75.310000000000002 109.787 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.03 -42.55 43.94 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 110.533 -1.027 . . . . 60.409999999999997 110.533 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.546 HD23 ' SG ' ' A' ' 132' ' ' CYS . 17.9 tp -64.84 -50.37 66.94 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.025 -0.731 . . . . 73.349999999999994 109.025 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.59 -39.05 94.58 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.347 -0.842 . . . . 71.400000000000006 112.232 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -68.63 -42.13 78.49 Favored 'General case' 0 C--O 1.204 -1.292 0 C-N-CA 121.051 -0.26 . . . . 75.230000000000004 110.565 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.454 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 7.9 t70 -63.56 -41.46 98.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.777 0.799 . . . . 74.549999999999997 109.234 -176.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.433 ' CE1' HD11 ' A' ' 45' ' ' LEU . 33.4 t80 -63.88 -55.03 25.76 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.362 -1.744 . . . . 70.420000000000002 110.163 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.9 mm -64.41 -32.89 59.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 111.693 0.257 . . . . 71.5 111.693 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.41 -52.8 63.06 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 122.786 0.434 . . . . 75.329999999999998 110.192 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 27' ' ' ASP . 3.7 pp -71.97 -24.4 61.59 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 119.629 -0.828 . . . . 72.329999999999998 112.162 -176.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.2 t -71.08 -25.31 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.094 0.473 . . . . 73.340000000000003 109.972 174.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.6 p -108.17 13.38 25.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.251 0.548 . . . . 73.239999999999995 110.281 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -62.67 148.35 46.71 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 115.423 -0.808 . . . . 72.010000000000005 110.834 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.6 m -51.37 143.11 19.36 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 125.763 1.625 . . . . 64.510000000000005 114.175 -175.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.39 -6.39 17.41 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 124.452 3.434 . . . . 60.009999999999998 113.338 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -62.99 -25.84 68.58 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.643 0.735 . . . . 64.409999999999997 110.134 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 t -81.46 172.18 13.83 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.233 -1.025 . . . . 75.530000000000001 108.233 175.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -56.52 -45.65 82.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 C-N-CA 122.51 0.324 . . . . 74.409999999999997 110.776 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.564 ' ND2' ' HB3' ' A' ' 42' ' ' GLU . 39.2 t30 178.16 139.06 0.09 Allowed 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.873 -1.158 . . . . 74.299999999999997 107.873 -177.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 m -61.85 -26.66 68.27 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 122.571 1.177 . . . . 62.5 110.688 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.592 ' OE2' ' HA ' ' A' ' 78' ' ' LYS . 38.1 tt0 -64.67 -23.48 67.27 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 125.099 1.36 . . . . 55.439999999999998 109.897 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.409 ' HA ' ' CZ ' ' A' ' 72' ' ' PHE . 48.2 t-80 -65.05 -46.12 82.54 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.264 -0.643 . . . . 73.219999999999999 109.264 176.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -70.58 -31.46 68.49 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 108.292 -1.003 . . . . 73.340000000000003 108.292 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.433 HD11 ' CE1' ' A' ' 28' ' ' PHE . 48.4 tp -66.82 -46.88 73.76 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.936 -0.575 . . . . 74.129999999999995 111.052 176.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.62 -34.33 75.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.359 0.6 . . . . 55.140000000000001 110.094 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -73.16 -34.82 66.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.366 -0.834 . . . . 74.420000000000002 109.632 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 41.8 t80 -66.28 -48.52 70.13 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.864 0.865 . . . . 75.340000000000003 110.231 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 pp -80.44 -3.07 48.43 Favored 'General case' 0 C--O 1.198 -1.616 0 CA-C-N 115.275 -0.875 . . . . 73.019999999999996 111.774 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -42.45 -60.82 2.66 Favored Glycine 0 CA--C 1.537 1.432 0 O-C-N 123.792 0.682 . . . . 75.430000000000007 113.573 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.45 -5.76 13.48 Favored 'Trans proline' 0 CA--C 1.551 1.328 0 C-N-CA 122.452 2.101 . . . . 74.439999999999998 112.998 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -116.51 22.47 12.75 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.128 -0.358 . . . . 74.099999999999994 110.454 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.679 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 18.4 t70 -65.9 120.07 66.13 Favored Pre-proline 0 C--O 1.256 1.434 0 N-CA-C 112.943 0.72 . . . . 74.209999999999994 112.943 -172.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -104.92 -148.8 0.02 OUTLIER 'Trans proline' 0 CA--C 1.554 1.524 0 C-N-CA 124.252 3.301 . . . . 73.129999999999995 112.22 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -86.85 126.12 34.43 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 107.888 -1.152 . . . . 71.299999999999997 107.888 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.531 HD11 ' CB ' ' A' ' 68' ' ' PHE . 48.2 mt -107.34 113.1 42.71 Favored 'Isoleucine or valine' 0 C--O 1.172 -3.012 0 N-CA-C 106.86 -1.533 . . . . 73.219999999999999 106.86 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -99.2 135.18 40.98 Favored 'General case' 0 C--N 1.266 -3.051 0 O-C-N 121.669 -0.644 . . . . 74.430000000000007 109.703 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 74.9 t -133.54 113.61 19.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 108.714 -0.847 . . . . 75.019999999999996 108.714 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 61.32 25.18 15.19 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 125.377 1.471 . . . . 72.219999999999999 111.695 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.8 2.12 58.53 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.856 -0.688 . . . . 62.310000000000002 112.627 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -113.4 135.49 53.81 Favored 'General case' 0 CA--C 1.492 -1.278 0 O-C-N 122.31 -0.524 . . . . 75.420000000000002 110.713 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.21 128.49 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 108.903 -0.777 . . . . 73.25 108.903 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -122.52 143.6 49.61 Favored 'General case' 0 C--O 1.282 2.766 0 N-CA-C 107.161 -1.422 . . . . 74.099999999999994 107.161 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.1 t -91.91 173.14 8.01 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.923 -1.14 . . . . 72.310000000000002 107.923 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.679 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 13.6 t -58.4 -32.46 68.64 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.698 0.399 . . . . 75.230000000000004 111.637 -176.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.5 m -60.82 -51.56 68.81 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.869 -0.605 . . . . 74.239999999999995 110.105 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.64 -49.36 75.49 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.532 -0.758 . . . . 75.430000000000007 110.441 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.531 ' CB ' HD11 ' A' ' 56' ' ' ILE . 56.9 t80 -52.9 -54.91 27.88 Favored 'General case' 0 CA--C 1.501 -0.939 0 O-C-N 123.676 0.61 . . . . 73.349999999999994 110.926 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.2 tp -53.06 -44.85 67.78 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 124.094 0.871 . . . . 72.209999999999994 111.782 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.538 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 76.3 mt-30 -58.07 -51.81 68.14 Favored 'General case' 0 N--CA 1.439 -1.014 0 O-C-N 123.257 0.348 . . . . 74.510000000000005 111.025 175.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -62.47 -40.72 97.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.217 0.532 . . . . 74.450000000000003 110.735 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.409 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 2.6 t80 -57.86 -52.1 66.87 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.593 0.757 . . . . 71.230000000000004 110.309 177.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -73.23 -18.28 61.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.149 -0.478 . . . . 72.209999999999994 111.397 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 46.8 mt-30 -87.22 -11.5 49.59 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 120.167 -0.613 . . . . 75.400000000000006 111.773 175.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.52 42.14 6.62 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.509 -0.853 . . . . 74.420000000000002 112.821 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.03 -35.37 17.59 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 122.79 -0.241 . . . . 71.209999999999994 111.206 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -108.08 -2.81 19.23 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.219 -0.593 . . . . 74.439999999999998 112.297 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.592 ' HA ' ' OE2' ' A' ' 42' ' ' GLU 0.372 0.0 OUTLIER -60.19 -13.65 13.44 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 115.894 1.813 . . . . 75.150000000000006 115.894 -165.783 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.22 -12.91 62.08 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 116.113 -0.494 . . . . 74.430000000000007 111.169 174.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.7 tt -61.46 -27.09 68.32 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.438 1.095 . . . . 75.099999999999994 110.657 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.469 ' HB2' ' OD1' ' A' ' 40' ' ' ASN . 27.4 ttpp -55.02 -33.51 62.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.328 0.585 . . . . 75.340000000000003 111.321 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -105.33 14.56 28.69 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.443 -0.798 . . . . 75.140000000000001 111.032 -173.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.06 153.81 23.59 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.308 0.575 . . . . 64.040000000000006 112.433 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 103' ' ' TRP . 10.2 pt-20 -89.31 149.82 22.87 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.213 -1.402 . . . . 75.109999999999999 107.213 175.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.5 p90 . . . . . 0 C--N 1.316 -0.869 0 CA-C-N 118.972 0.805 . . . . 73.299999999999997 112.002 -177.335 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 97' ' ' GLU . 1.1 mp0 . . . . . 0 C--O 1.247 0.974 0 CA-C-O 120.974 0.416 . . . . 73.510000000000005 110.641 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.59 144.5 18.28 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 110.852 -0.899 . . . . 73.239999999999995 110.852 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -109.99 140.4 44.05 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.628 -1.249 . . . . 75.430000000000007 107.628 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -131.59 101.19 5.4 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.769 -0.826 . . . . 73.310000000000002 108.769 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 83.4 mt -107.96 112.22 24.7 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.967 -0.753 . . . . 74.230000000000004 108.967 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.6 p -114.03 129.2 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-O 121.484 0.659 . . . . 73.010000000000005 111.996 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.59 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 31.4 m-90 -101.82 141.6 34.43 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.604 -1.18 . . . . 75.219999999999999 109.217 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.405 ' HB2' ' CG ' ' A' ' 84' ' ' GLU . 36.3 mtpt -118.56 125.46 49.87 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 107.549 -1.278 . . . . 73.099999999999994 107.549 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.8 t . . . . . 0 C--N 1.27 -2.862 0 CA-C-N 114.917 -1.038 . . . . 61.340000000000003 110.311 -177.511 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.445 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 46.5 p90 . . . . . 0 N--CA 1.42 -1.945 0 N-CA-C 107.536 -1.283 . . . . 75.140000000000001 107.536 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -116.18 138.95 50.84 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 106.056 -1.831 . . . . 73.010000000000005 106.056 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.445 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 38.4 mt-10 -118.31 144.3 45.95 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.001 -0.68 . . . . 75.129999999999995 111.225 176.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -132.51 116.74 17.13 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.861 -1.163 . . . . 44.340000000000003 107.861 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -125.68 113.26 17.11 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 121.68 0.752 . . . . 72.120000000000005 111.987 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.86 128.65 41.77 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.791 -1.095 . . . . 72.439999999999998 110.036 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -109.55 117.93 35.27 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.316 -0.994 . . . . 75.230000000000004 108.316 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.5 mt -115.59 151.17 17.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 106.435 -1.691 . . . . 71.329999999999998 106.435 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -136.02 150.17 49.1 Favored 'General case' 0 C--O 1.27 2.144 0 C-N-CA 118.984 -1.086 . . . . 73.109999999999999 109.231 175.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -76.07 113.04 13.14 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 108.145 -1.057 . . . . 75.239999999999995 108.145 172.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -73.41 133.06 43.65 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 113.906 -1.497 . . . . 65.340000000000003 107.566 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -62.53 -15.46 50.73 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.152 0.581 . . . . 64.430000000000007 112.192 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -64.94 -16.8 63.75 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 124.001 0.921 . . . . 73.019999999999996 110.988 173.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.34 -6.35 30.24 Favored Glycine 0 CA--C 1.501 -0.791 0 N-CA-C 111.215 -0.754 . . . . 71.519999999999996 111.215 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.9 p -100.01 -172.34 2.21 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 123.33 0.652 . . . . 71.230000000000004 110.6 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.546 ' SG ' HD23 ' A' ' 24' ' ' LEU . 15.0 p -134.61 144.57 47.98 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.601 -1.259 . . . . 75.510000000000005 107.601 174.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -155.23 155.2 33.41 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 119.292 -0.963 . . . . 74.439999999999998 108.889 -176.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.88 128.47 36.48 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.153 0.501 . . . . 64.430000000000007 109.652 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -87.12 -46.77 9.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.047 -0.723 . . . . 75.219999999999999 109.047 -176.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.9 p -175.01 152.4 1.48 Allowed 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 107.805 -1.183 . . . . 75.329999999999998 107.805 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.41 150.55 32.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.385 -1.339 . . . . 72.040000000000006 107.385 175.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -130.09 133.29 46.58 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 110.266 -0.272 . . . . 73.299999999999997 110.266 -177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 67.0 m-85 -117.57 127.26 53.8 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.609 -1.256 . . . . 75.230000000000004 107.609 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.0 pt -128.45 98.76 4.49 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.42 0 CA-C-O 122.395 1.093 . . . . 71.450000000000003 108.896 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 22.6 ptp -89.73 126.94 35.85 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.163 -1.381 . . . . 73.409999999999997 109.87 -175.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.2 t 73.74 73.97 0.12 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.42 -1.264 . . . . 65.5 110.593 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 85.6 tttt . . . . . 0 C--N 1.294 -1.838 0 CA-C-N 114.19 -1.368 . . . . 73.019999999999996 107.451 177.388 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 C--O 1.236 0.347 0 CA-C-O 121.24 0.543 . . . . 73.340000000000003 111.413 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.69 -36.83 84.76 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.222 -1.029 . . . . 75.230000000000004 108.222 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -69.91 -38.23 76.2 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.372 -0.831 . . . . 74.540000000000006 109.853 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 89.3 t -59.16 -56.66 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 115.218 -0.901 . . . . 75.209999999999994 110.437 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.404 ' HB3' ' HZ3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -66.14 -25.9 67.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.354 -0.384 . . . . 75.420000000000002 110.545 -179.025 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.59 -50.44 48.91 Favored Glycine 0 C--O 1.25 1.128 0 N-CA-C 111.659 -0.576 . . . . 71.120000000000005 111.659 175.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.77 -37.74 76.48 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 108.613 -0.884 . . . . 75.430000000000007 108.613 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.58 -40.63 99.38 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.704 -0.68 . . . . 73.310000000000002 111.851 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -67.77 -46.03 73.22 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 120.457 -0.497 . . . . 71.310000000000002 110.409 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.23 -39.82 95.7 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 120.567 -0.453 . . . . 74.420000000000002 110.644 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -61.57 -52.54 64.01 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.604 0.762 . . . . 72.219999999999999 109.902 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 29' ' ' ILE . 7.4 mm -67.52 -35.09 72.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 120.906 -0.318 . . . . 75.439999999999998 111.675 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -63.2 -46.24 87.94 Favored 'General case' 0 CA--C 1.495 -1.141 0 C-N-CA 122.425 0.29 . . . . 61.539999999999999 110.487 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.509 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 4.1 pp -69.65 -28.76 66.16 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 119.736 -0.786 . . . . 71.340000000000003 111.249 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.412 ' N ' HD11 ' A' ' 31' ' ' LEU . 52.9 t -71.76 -24.33 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-O 121.456 0.646 . . . . 74.310000000000002 110.084 174.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.9 p -107.23 19.29 20.56 Favored 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 121.598 -0.689 . . . . 73.099999999999994 111.261 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 64.7 mmtt -53.24 138.64 31.55 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 116.051 -0.522 . . . . 74.510000000000005 111.057 175.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -64.28 159.23 59.79 Favored Pre-proline 0 N--CA 1.435 -1.222 0 CA-C-N 115.003 -0.999 . . . . 74.310000000000002 109.675 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.5 -11.04 18.16 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 123.349 2.699 . . . . 73.340000000000003 111.502 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -68.0 -26.05 65.71 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.607 -1.179 . . . . 74.299999999999997 110.872 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.9 t -82.67 172.26 13.11 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.442 -1.318 . . . . 71.019999999999996 107.442 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.7 t -74.77 -54.29 14.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.485 -0.486 . . . . 74.450000000000003 111.131 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.484 ' O ' ' HB3' ' A' ' 43' ' ' HIS . 23.8 t30 -170.84 126.61 0.72 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.211 -0.45 . . . . 71.219999999999999 110.355 -173.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 p -61.0 -39.3 89.15 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 123.358 0.663 . . . . 71.430000000000007 111.624 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.44 -21.6 66.21 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.962 -0.563 . . . . 61.5 110.483 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.484 ' HB3' ' O ' ' A' ' 40' ' ' ASN . 42.7 t-80 -72.91 -48.87 33.41 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.354 -0.98 . . . . 74.299999999999997 108.354 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -64.19 -35.0 79.37 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.587 -1.188 . . . . 75.400000000000006 109.541 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.0 tp -66.88 -42.37 85.69 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 116.292 -0.413 . . . . 70.299999999999997 110.466 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.32 -32.13 73.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.455 0.645 . . . . 74.239999999999995 110.319 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -74.83 -35.75 62.4 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.536 -0.757 . . . . 71.209999999999994 110.25 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -68.37 -41.69 80.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.364 0.666 . . . . 72.049999999999997 110.718 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 pp -79.02 -8.44 58.94 Favored 'General case' 0 C--O 1.194 -1.838 0 CA-C-N 115.746 -0.661 . . . . 72.540000000000006 111.814 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -46.9 -55.67 8.2 Favored Glycine 0 CA--C 1.546 1.993 0 O-C-N 123.454 0.472 . . . . 54.130000000000003 114.017 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -78.0 -3.81 13.82 Favored 'Trans proline' 0 CA--C 1.55 1.32 0 C-N-CA 122.993 2.462 . . . . 64.109999999999999 112.474 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -129.46 28.31 5.21 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.984 -0.448 . . . . 75.219999999999999 110.21 -168.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -55.98 115.68 10.33 Favored Pre-proline 0 N--CA 1.475 0.818 0 O-C-N 124.042 0.839 . . . . 74.239999999999995 111.451 -175.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -108.96 -158.15 0.02 OUTLIER 'Trans proline' 0 CA--C 1.557 1.636 0 C-N-CA 123.721 2.947 . . . . 75.530000000000001 111.546 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -86.85 126.12 34.44 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.08 -1.081 . . . . 71.430000000000007 108.08 175.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.513 HD12 ' CB ' ' A' ' 68' ' ' PHE . 36.7 mt -112.18 107.06 22.0 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.412 0 N-CA-C 108.98 -0.748 . . . . 73.140000000000001 108.98 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -89.84 135.64 33.51 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 109.753 -0.462 . . . . 72.420000000000002 109.753 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 3.8 p -126.03 117.88 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 N-CA-C 107.371 -1.344 . . . . 74.200000000000003 107.371 174.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 62.77 20.8 12.38 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 123.956 0.902 . . . . 63.229999999999997 110.709 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.38 -5.34 58.82 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.38 -0.827 . . . . 71.430000000000007 112.489 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -99.82 126.18 45.87 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 109.026 -0.731 . . . . 74.329999999999998 109.026 -178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -70.88 126.41 31.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-O 121.54 0.686 . . . . 75.120000000000005 109.427 -176.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 63.1 mm-40 -122.33 152.45 40.11 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.077 -0.712 . . . . 74.219999999999999 109.077 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.6 t -87.64 169.15 12.39 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.327 -0.99 . . . . 74.549999999999997 108.327 175.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.404 ' HA ' HD13 ' A' ' 56' ' ' ILE . 13.2 t -58.03 -34.18 69.77 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.379 0.672 . . . . 73.120000000000005 111.33 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.0 m -61.58 -49.46 76.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.25 0.548 . . . . 73.340000000000003 109.784 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 63' ' ' GLN . . . -60.83 -49.78 76.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.281 -0.872 . . . . 74.439999999999998 110.391 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CB ' HD12 ' A' ' 56' ' ' ILE . 44.3 t80 -51.49 -56.07 15.38 Favored 'General case' 0 CA--C 1.5 -0.943 0 O-C-N 123.778 0.674 . . . . 74.329999999999998 110.415 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.5 mt -49.77 -47.54 50.97 Favored 'General case' 0 CA--C 1.491 -1.3 0 O-C-N 124.079 0.862 . . . . 62.5 112.94 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -55.54 -51.42 67.12 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 123.703 0.627 . . . . 64.129999999999995 111.773 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -65.63 -37.3 86.18 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.555 0.693 . . . . 75.510000000000005 110.463 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.47 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 3.4 t80 -61.83 -53.6 53.69 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.183 -0.917 . . . . 72.319999999999993 111.197 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -74.62 -18.17 60.6 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 123.333 0.396 . . . . 75.150000000000006 111.123 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -75.3 -14.51 60.5 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.033 0.444 . . . . 72.519999999999996 111.285 171.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.43 18.01 29.66 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 120.749 -0.739 . . . . 60.43 113.577 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.6 mt -76.84 -44.65 31.46 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.469 -0.892 . . . . 75.340000000000003 112.019 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -89.3 -5.77 57.29 Favored 'General case' 0 C--O 1.203 -1.358 0 N-CA-C 113.384 0.883 . . . . 75.519999999999996 113.384 -174.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.286 0.0 OUTLIER -64.09 -12.4 38.9 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.727 1.38 . . . . 72.319999999999993 114.727 -175.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -80.81 -10.68 59.7 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.112 -0.495 . . . . 72.510000000000005 111.176 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.49 -15.56 60.39 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 122.76 0.424 . . . . 74.299999999999997 111.864 -176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -53.44 -30.42 40.4 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.265 0.555 . . . . 73.239999999999995 111.838 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -99.4 8.56 44.51 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 122.016 -0.427 . . . . 72.25 111.735 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.36 147.76 47.68 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.584 0.707 . . . . 72.299999999999997 111.675 -176.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -88.14 116.14 26.11 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.26 -0.882 . . . . 71.120000000000005 112.202 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.57 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 55.7 p90 . . . . . 0 C--N 1.302 -1.467 0 N-CA-C 106.216 -1.772 . . . . 74.200000000000003 106.216 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.453 ' CG ' ' HB3' ' A' ' 126' ' ' ARG . 9.9 pt-20 . . . . . 0 C--O 1.234 0.283 0 N-CA-C 109.753 -0.462 . . . . 64.420000000000002 109.753 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -118.84 138.67 13.8 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 119.683 -1.246 . . . . 73.420000000000002 112.98 -173.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -108.44 129.83 55.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.281 -1.007 . . . . 70.409999999999997 108.281 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.401 ' HZ3' ' CD ' ' A' ' 121' ' ' GLU . 27.5 mtpp -108.25 98.96 8.43 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.961 -1.126 . . . . 72.439999999999998 107.961 177.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 3.2 mm? -92.8 100.82 13.23 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.853 -1.165 . . . . 75.430000000000007 107.853 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.1 p -116.81 122.18 69.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-O 122.415 1.102 . . . . 75.109999999999999 113.692 -176.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.57 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 29.7 m-90 -102.83 129.99 49.69 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 113.869 -1.514 . . . . 73.109999999999999 107.854 177.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -114.41 125.7 54.14 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.105 -1.072 . . . . 73.430000000000007 108.105 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.9 p . . . . . 0 C--N 1.308 -1.213 0 C-N-CA 120.236 -0.586 . . . . 71.049999999999997 110.621 -179.132 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.8 p90 . . . . . 0 N--CA 1.436 -1.127 0 N-CA-C 106.793 -1.558 . . . . 74.200000000000003 106.793 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -116.49 138.75 51.14 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.004 -1.85 . . . . 60.210000000000001 106.004 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.475 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 45.7 mt-10 -117.23 141.1 48.71 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 119.803 -0.759 . . . . 75.310000000000002 110.988 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -127.52 116.71 20.8 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.808 -1.182 . . . . 54.509999999999998 107.808 177.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 41.8 tt0 -125.5 114.94 19.45 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 121.162 0.506 . . . . 75.120000000000005 110.861 -177.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.98 134.3 39.16 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.732 -0.667 . . . . 72.340000000000003 109.49 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -111.28 118.57 36.25 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 123.396 0.679 . . . . 62.229999999999997 109.345 -175.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.2 mt -120.91 150.27 23.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.174 -1.417 . . . . 72.209999999999994 107.174 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -134.63 145.04 48.22 Favored 'General case' 0 C--O 1.266 1.924 0 C-N-CA 118.998 -1.081 . . . . 74.400000000000006 110.292 173.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.507 ' HB2' ' SG ' ' A' ' 132' ' ' CYS . 10.6 ttp180 -91.42 113.66 25.99 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 114.731 -1.122 . . . . 74.510000000000005 108.25 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 131' ' ' SER . 62.9 mtm180 -70.46 158.43 36.06 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.31 -1.314 . . . . 75.310000000000002 110.119 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -69.34 -15.07 63.25 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.875 0.845 . . . . 74.310000000000002 109.004 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -66.57 -17.76 64.99 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.068 -1.424 . . . . 63.009999999999998 108.918 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.72 -23.74 35.06 Favored Glycine 0 CA--C 1.504 -0.628 0 N-CA-C 111.315 -0.714 . . . . 54.509999999999998 111.315 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 36.6 t -88.49 133.82 34.03 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 115.07 -0.565 . . . . 75.129999999999995 110.33 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 126' ' ' ARG . 95.2 m -90.67 150.48 21.66 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 115.504 -0.771 . . . . 54.219999999999999 109.861 175.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 21.1 t90 -151.09 155.84 39.79 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.172 -1.047 . . . . 74.150000000000006 108.172 177.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.1 mt -65.85 117.62 8.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.196 -1.039 . . . . 73.329999999999998 108.196 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -75.37 -56.59 4.56 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.826 -1.546 . . . . 73.409999999999997 106.826 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 52.2 m -167.14 175.35 7.54 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.988 -1.486 . . . . 75.409999999999997 106.988 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.7 t -142.57 145.51 23.28 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 105.939 -1.874 . . . . 74.239999999999995 105.939 175.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -130.56 130.72 44.45 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-O 121.057 0.456 . . . . 72.239999999999995 109.773 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 82.9 m-85 -115.58 126.97 54.89 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.985 -1.487 . . . . 73.439999999999998 106.985 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.7 pt -127.68 98.44 4.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 CA-C-O 122.304 1.049 . . . . 74.430000000000007 108.471 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 19.2 ptm -93.0 124.96 37.35 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 114.496 -1.229 . . . . 71.219999999999999 109.256 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.5 t 79.27 63.87 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.906 -1.497 . . . . 74.319999999999993 109.924 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.475 ' HG2' ' OE1' ' A' ' 119' ' ' GLU . 23.4 tptm . . . . . 0 C--N 1.295 -1.778 0 N-CA-C 106.139 -1.8 . . . . 74.049999999999997 106.139 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.0 t70 . . . . . 0 CA--C 1.506 -0.747 0 CA-C-O 121.109 0.48 . . . . 73.140000000000001 110.298 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.62 -38.13 89.96 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-N 115.002 -0.999 . . . . 74.540000000000006 109.65 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.28 -47.69 63.85 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.346 -0.843 . . . . 74.530000000000001 109.816 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 m -71.95 -32.2 43.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 112.545 0.572 . . . . 75.409999999999997 112.545 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -72.0 -33.47 68.1 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.588 -0.893 . . . . 63.420000000000002 108.588 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.8 -37.59 92.43 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 110.823 -0.911 . . . . 72.129999999999995 110.823 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.5 tp -66.63 -50.1 64.09 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 124.544 1.138 . . . . 74.340000000000003 109.968 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.75 -44.3 98.11 Favored Glycine 0 C--O 1.245 0.841 0 N-CA-C 111.76 -0.536 . . . . 72.549999999999997 111.76 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -63.49 -42.61 98.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.692 -0.254 . . . . 73.549999999999997 110.46 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.72 -41.83 98.01 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 123.248 0.343 . . . . 72.329999999999998 110.806 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 33.5 t80 -62.05 -54.08 46.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.353 -0.84 . . . . 73.430000000000007 110.053 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 29' ' ' ILE . 9.8 mm -62.94 -39.37 84.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.406 -0.361 . . . . 73.230000000000004 111.774 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.29 -48.62 80.56 Favored 'General case' 0 C--O 1.198 -1.608 0 O-C-N 123.436 0.46 . . . . 73.150000000000006 110.782 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.514 ' O ' ' HB3' ' A' ' 41' ' ' SER . 4.0 pp -70.59 -25.0 62.86 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 119.734 -0.786 . . . . 74.349999999999994 112.055 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.7 t -70.9 -26.04 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.348 0.594 . . . . 73.349999999999994 109.896 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.5 p -119.77 28.16 8.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 122.156 0.979 . . . . 74.120000000000005 108.639 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.2 tptt -60.96 156.65 17.14 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.051 -1.431 . . . . 73.400000000000006 112.266 -175.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 p -52.62 141.75 34.13 Favored Pre-proline 0 N--CA 1.432 -1.328 0 C-N-CA 125.096 1.358 . . . . 54.420000000000002 112.307 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -56.11 -18.7 24.09 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.825 3.017 . . . . 75.109999999999999 112.464 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -55.27 -27.83 49.26 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.604 -0.725 . . . . 73.319999999999993 110.158 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.2 p -111.24 102.77 11.16 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.862 -1.162 . . . . 71.109999999999999 107.862 174.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.3 -42.74 96.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 74.439999999999998 111.86 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -106.61 86.05 2.27 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 122.474 1.13 . . . . 74.310000000000002 110.504 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 36.8 m -68.6 -23.67 64.49 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.264 -1.335 . . . . 60.240000000000002 108.544 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 2.0 mp0 -61.38 -26.49 67.87 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 113.909 -1.496 . . . . 72.150000000000006 109.583 177.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -68.68 -42.43 77.85 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.443 -0.577 . . . . 73.439999999999998 109.443 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -69.07 -34.72 75.6 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 108.025 -1.102 . . . . 74.239999999999995 108.025 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.591 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 52.1 tp -66.22 -45.67 79.88 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 115.627 -0.715 . . . . 71.239999999999995 110.274 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.39 74.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.057 0.456 . . . . 72.099999999999994 110.949 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -75.24 -33.58 61.34 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 109.747 -0.464 . . . . 75.349999999999994 109.747 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 57.2 t80 -70.31 -46.31 64.49 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 123.286 0.634 . . . . 75.409999999999997 109.952 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 3.6 pp -84.24 -8.03 59.17 Favored 'General case' 0 C--O 1.194 -1.864 0 CA-C-N 115.654 -0.703 . . . . 75.010000000000005 112.146 -177.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -41.83 -57.49 3.42 Favored Glycine 0 CA--C 1.541 1.708 0 O-C-N 123.543 0.527 . . . . 70.439999999999998 113.574 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -85.48 -5.91 9.1 Favored 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 123.068 2.512 . . . . 72.340000000000003 112.768 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 16.0 m-70 -115.77 22.27 13.21 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.998 -0.439 . . . . 75.420000000000002 111.128 -172.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.507 ' CG ' ' HB ' ' A' ' 65' ' ' THR . 13.3 t70 -76.3 119.67 78.31 Favored Pre-proline 0 C--N 1.309 -1.173 0 O-C-N 123.337 0.398 . . . . 73.230000000000004 110.745 -174.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -101.77 -150.33 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.431 0 C-N-CA 123.506 2.804 . . . . 62.310000000000002 111.993 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.67 118.64 24.52 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 107.711 -1.218 . . . . 72.150000000000006 107.711 172.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 52.9 mt -100.55 113.4 36.23 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.104 0 N-CA-C 107.753 -1.203 . . . . 75.340000000000003 107.753 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -100.34 112.37 24.71 Favored 'General case' 0 C--N 1.278 -2.534 0 O-C-N 121.048 -1.033 . . . . 74.120000000000005 111.578 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.43 HG23 ' HB2' ' A' ' 139' ' ' PHE . 70.4 t -115.11 117.69 56.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 108.793 -0.818 . . . . 73.030000000000001 108.793 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 60.34 21.7 11.22 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.503 1.127 . . . . 72.25 111.455 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.54 6.17 61.2 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.267 -0.878 . . . . 52.109999999999999 112.545 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -112.1 133.46 54.24 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.558 -0.534 . . . . 72.200000000000003 109.558 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.09 124.51 30.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 122.501 1.143 . . . . 72.25 109.392 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -117.92 136.96 53.14 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.589 -1.187 . . . . 63.219999999999999 107.966 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 t -93.43 174.78 7.03 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.266 -1.013 . . . . 71.140000000000001 108.266 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.507 ' HB ' ' CG ' ' A' ' 53' ' ' ASP . 8.8 t -51.24 -37.54 47.58 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 125.114 1.366 . . . . 74.209999999999994 111.529 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.4 m -62.84 -49.92 72.98 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.34 0.591 . . . . 75.230000000000004 110.135 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.48 -51.28 69.34 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.482 -0.781 . . . . 71.439999999999998 111.617 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -54.36 -55.45 28.41 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 123.22 0.325 . . . . 71.329999999999998 110.33 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -50.06 -44.62 51.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.852 -1.067 . . . . 74.349999999999994 110.737 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -58.23 -48.84 79.13 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.883 0.327 . . . . 75.540000000000006 111.883 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.455 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 33.1 m-85 -66.05 -37.89 86.98 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.615 0.722 . . . . 72.349999999999994 109.721 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -56.73 -54.16 49.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 123.965 0.906 . . . . 75.439999999999998 110.831 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -72.21 -22.02 61.32 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.317 -0.401 . . . . 74.420000000000002 111.608 -176.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -77.06 -16.44 59.25 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 112.457 0.54 . . . . 71.209999999999994 112.457 172.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.55 21.28 12.97 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.37 -0.919 . . . . 72.319999999999993 114.155 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.66 -54.76 6.23 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.504 0.668 . . . . 73.25 110.123 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 46.3 m-85 -83.22 5.7 22.03 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 115.898 -0.592 . . . . 64.230000000000004 112.057 -174.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 96.8 mttt -73.93 -14.11 61.0 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.843 0.83 . . . . 75.340000000000003 111.201 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -86.09 -19.08 30.74 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.095 -0.957 . . . . 73.150000000000006 108.705 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 80' ' ' LEU . 9.5 tt -77.76 -12.21 59.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.354 -0.839 . . . . 74.120000000000005 111.563 -171.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -74.1 -23.49 59.33 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.88 0.847 . . . . 71.299999999999997 109.182 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -96.5 13.61 27.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.857 -1.065 . . . . 70.150000000000006 110.131 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.48 147.27 29.8 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.736 -0.665 . . . . 65.140000000000001 111.563 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 103' ' ' TRP . 8.0 pt-20 -92.64 142.05 27.8 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.473 -0.785 . . . . 75.420000000000002 108.898 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.488 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 43.3 p90 . . . . . 0 C--N 1.307 -1.269 0 C-N-CA 120.422 -0.511 . . . . 74.530000000000001 111.735 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.515 ' OE2' ' HD3' ' A' ' 126' ' ' ARG . 1.2 pm0 . . . . . 0 CA--C 1.504 -0.805 0 N-CA-C 113.767 1.025 . . . . 64.409999999999997 113.767 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -120.74 137.12 11.79 Favored Glycine 0 N--CA 1.411 -3.018 0 N-CA-C 109.475 -1.45 . . . . 74.439999999999998 109.475 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -108.06 140.36 41.35 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.747 -1.205 . . . . 75.439999999999998 107.747 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 33.1 mtmt -125.05 99.08 5.95 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.91 -1.515 . . . . 65.109999999999999 106.91 174.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.5 mt -102.51 134.68 45.45 Favored 'General case' 0 C--N 1.274 -2.706 0 N-CA-C 107.984 -1.117 . . . . 74.349999999999994 107.984 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 9.8 p -123.89 125.23 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 119.414 -0.914 . . . . 75.319999999999993 112.861 -175.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.55 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 15.4 m-90 -101.06 148.8 24.64 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.629 -1.168 . . . . 74.109999999999999 109.6 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -118.61 120.9 38.83 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.415 -1.328 . . . . 75.340000000000003 107.415 172.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 C--N 1.298 -1.667 0 O-C-N 123.977 0.798 . . . . 72.140000000000001 111.007 -176.579 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 43.9 p90 . . . . . 0 N--CA 1.413 -2.293 0 CA-C-O 121.464 0.649 . . . . 71.439999999999998 110.051 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.62 136.9 41.6 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 106.206 -1.776 . . . . 64.109999999999999 106.206 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -114.21 141.14 47.91 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.487 -0.885 . . . . 71.519999999999996 108.974 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.645 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -123.2 117.49 25.46 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 115.472 -0.785 . . . . 75.420000000000002 111.307 -173.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -111.13 109.39 19.43 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.095 -1.076 . . . . 72.409999999999997 108.095 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -99.03 126.36 44.73 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 122.484 0.314 . . . . 70.329999999999998 110.48 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -103.69 119.3 38.62 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.584 -1.265 . . . . 74.409999999999997 107.584 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.428 HG22 ' SG ' ' A' ' 132' ' ' CYS . 50.2 mt -128.94 139.72 51.16 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 N-CA-C 106.315 -1.735 . . . . 75.219999999999999 106.315 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -130.21 152.09 50.03 Favored 'General case' 0 C--O 1.256 1.428 0 C-N-CA 118.96 -1.096 . . . . 75.349999999999994 110.674 -177.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.515 ' HD3' ' OE2' ' A' ' 97' ' ' GLU . 45.6 ttp180 -74.81 114.49 13.31 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 105.965 -1.865 . . . . 75.519999999999996 105.965 174.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -81.43 145.48 30.75 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 108.271 -1.011 . . . . 75.0 108.271 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -66.4 -10.79 47.07 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 122.345 1.069 . . . . 75.349999999999994 110.12 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.78 -16.63 63.85 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.645 -1.161 . . . . 70.409999999999997 110.412 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.29 -23.43 20.68 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 111.482 -0.647 . . . . 72.099999999999994 111.482 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.0 t -100.47 -173.24 2.36 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.758 -0.83 . . . . 73.439999999999998 108.758 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.428 ' SG ' HG22 ' A' ' 124' ' ' ILE . 27.8 t -122.6 143.06 49.99 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.049 -1.834 . . . . 74.129999999999995 106.049 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -150.45 155.44 39.55 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 108.955 -0.757 . . . . 75.099999999999994 108.955 -172.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.59 130.75 42.64 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.938 0.399 . . . . 75.209999999999994 110.359 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -92.42 -43.29 9.29 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.746 -0.661 . . . . 71.430000000000007 109.646 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.5 t -179.41 151.33 0.47 Allowed 'General case' 0 C--O 1.194 -1.85 0 N-CA-C 106.582 -1.636 . . . . 71.230000000000004 106.582 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.2 m -134.95 152.37 32.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.832 -1.173 . . . . 74.510000000000005 107.832 173.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -128.64 133.64 48.31 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 122.72 0.408 . . . . 73.420000000000002 109.9 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.43 ' HB2' HG23 ' A' ' 58' ' ' VAL . 44.0 m-85 -121.98 112.4 18.24 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.185 -1.043 . . . . 71.430000000000007 108.185 176.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 17.2 pt -112.65 99.21 8.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 121.604 0.716 . . . . 63.140000000000001 111.926 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 52.2 mtt -86.78 94.65 9.59 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 106.415 -1.698 . . . . 74.510000000000005 106.415 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.5 m -162.74 -56.86 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.368 0.877 . . . . 75.430000000000007 113.368 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 N--CA 1.471 0.603 0 C-N-CA 124.328 1.051 . . . . 73.349999999999994 112.744 -171.101 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 121.663 0.744 . . . . 74.510000000000005 109.579 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.41 -37.12 84.49 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.265 -1.334 . . . . 71.209999999999994 108.182 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -73.12 -31.35 64.25 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.599 -0.728 . . . . 73.209999999999994 110.278 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.541 ' HA ' ' SG ' ' A' ' 132' ' ' CYS . 90.8 t -63.93 -50.19 78.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 109.688 -0.486 . . . . 71.25 109.688 175.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -30.21 66.71 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.398 -0.521 . . . . 73.530000000000001 110.438 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.43 -41.66 90.43 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 111.054 -0.818 . . . . 72.219999999999999 111.054 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 tp -63.04 -48.17 79.89 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 123.75 0.82 . . . . 75.340000000000003 109.146 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.95 -42.88 97.03 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.462 -0.79 . . . . 72.409999999999997 111.759 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -64.89 -44.33 89.98 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-O 119.773 -0.156 . . . . 74.450000000000003 111.194 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.35 -43.78 96.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.88 0.371 . . . . 71.409999999999997 110.251 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.45 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 26.7 t80 -62.39 -54.85 34.3 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 124.961 1.304 . . . . 73.439999999999998 110.113 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.2 mm -66.1 -34.06 67.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 112.24 0.459 . . . . 71.25 112.24 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.83 -39.15 73.16 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.572 -0.451 . . . . 71.450000000000003 110.043 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.547 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 4.1 pp -69.29 -30.25 68.3 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 119.556 -0.857 . . . . 75.340000000000003 110.846 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.7 t -72.08 -21.87 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 115.819 -0.628 . . . . 74.109999999999999 110.213 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.2 p -110.4 19.45 18.78 Favored 'General case' 0 C--O 1.248 0.991 0 O-C-N 121.455 -0.778 . . . . 74.299999999999997 111.887 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.547 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 70.6 mmtt -58.2 158.02 7.6 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-N 115.854 -0.612 . . . . 75.140000000000001 111.389 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.3 t -74.67 148.18 85.07 Favored Pre-proline 0 C--N 1.287 -2.11 0 N-CA-C 108.377 -0.971 . . . . 74.109999999999999 108.377 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -59.87 -6.03 4.28 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 123.858 3.039 . . . . 73.25 111.731 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.4 -27.48 67.48 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.009 0.924 . . . . 64.310000000000002 108.641 171.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.1 m -92.35 152.71 19.62 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 105.963 -1.866 . . . . 73.510000000000005 105.963 172.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.1 t -62.23 -53.21 50.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 113.208 0.818 . . . . 74.019999999999996 113.208 -174.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' ' 42' ' ' GLU . 28.2 t-20 -158.08 125.4 5.07 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 119.618 -0.833 . . . . 72.329999999999998 112.204 -172.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -32.47 74.03 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 123.609 0.763 . . . . 75.530000000000001 112.14 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.424 ' HB2' ' OD1' ' A' ' 40' ' ' ASN . 1.7 mp0 -72.04 -21.73 61.49 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.993 -0.549 . . . . 75.109999999999999 109.532 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -71.84 -42.35 67.05 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 107.42 -1.326 . . . . 73.329999999999998 107.42 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -66.16 -33.92 76.86 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.054 -0.976 . . . . 74.510000000000005 109.124 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.431 HD11 ' CE1' ' A' ' 28' ' ' PHE . 39.5 tp -69.91 -40.83 75.36 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.95 -0.568 . . . . 75.109999999999999 110.459 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.36 79.7 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.416 0.627 . . . . 73.209999999999994 109.915 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -69.59 -38.24 77.24 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.666 -1.152 . . . . 75.409999999999997 109.26 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.501 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 43.8 t80 -66.45 -45.31 80.21 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.353 -0.84 . . . . 71.420000000000002 110.308 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.423 HD21 ' CE2' ' A' ' 68' ' ' PHE . 4.3 pp -80.19 2.58 23.73 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.046 0.388 . . . . 75.400000000000006 112.046 -176.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -47.87 -62.52 4.09 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 111.729 -0.549 . . . . 71.420000000000002 111.729 173.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 48' ' ' PHE . 66.0 Cg_endo -79.99 -6.5 14.11 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.244 1.963 . . . . 72.299999999999997 112.363 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 92.4 m-70 -114.38 33.61 5.2 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 109.292 -0.632 . . . . 74.230000000000004 109.292 -176.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.442 ' CG ' HG22 ' A' ' 65' ' ' THR 0.267 13.5 t70 -53.76 99.03 0.19 Allowed Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 128.818 2.847 . . . . 74.010000000000005 111.516 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -113.06 -156.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 123.97 3.114 . . . . 74.129999999999995 113.089 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -92.75 127.87 38.41 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 107.608 -1.256 . . . . 75.310000000000002 107.608 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 65' ' ' THR . 43.2 mt -116.48 109.04 26.65 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 N-CA-C 109.046 -0.724 . . . . 71.109999999999999 109.046 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -91.18 138.89 31.24 Favored 'General case' 0 C--N 1.274 -2.698 0 O-C-N 122.176 -0.327 . . . . 64.310000000000002 110.487 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.76 120.07 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 N-CA-C 107.428 -1.323 . . . . 62.409999999999997 107.428 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 61.74 20.22 11.2 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.983 0.913 . . . . 73.5 110.636 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.41 3.67 58.55 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 115.922 -0.581 . . . . 73.549999999999997 113.208 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -111.67 132.39 54.64 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.021 -0.733 . . . . 74.540000000000006 109.021 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.77 126.15 34.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.689 0.757 . . . . 74.340000000000003 110.387 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -121.82 146.56 46.96 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.127 -1.434 . . . . 72.319999999999993 107.127 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -81.33 174.53 11.41 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.204 -0.598 . . . . 73.040000000000006 109.567 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.489 ' HA ' HD12 ' A' ' 56' ' ' ILE . 50.5 p -65.48 -33.92 77.07 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.528 1.131 . . . . 74.310000000000002 110.45 -176.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.452 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 25.0 m -62.53 -51.53 67.03 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.694 -1.139 . . . . 55.399999999999999 109.641 174.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.84 -48.51 79.56 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 123.628 0.771 . . . . 71.400000000000006 110.416 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.483 ' CG ' HD11 ' A' ' 56' ' ' ILE . 31.6 t80 -49.87 -56.5 10.24 Favored 'General case' 0 CA--C 1.501 -0.931 0 O-C-N 123.751 0.657 . . . . 71.310000000000002 110.491 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -53.34 -42.95 67.29 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 124.517 1.135 . . . . 75.329999999999998 110.589 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.7 mm100 -61.75 -48.64 79.76 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 123.275 0.63 . . . . 74.540000000000006 111.234 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.433 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 34.3 m-85 -67.22 -40.27 86.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.314 0.578 . . . . 74.200000000000003 109.461 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -56.21 -51.31 68.55 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.765 -0.652 . . . . 74.409999999999997 110.653 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -72.05 -21.39 61.53 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 116.22 -0.446 . . . . 75.540000000000006 111.291 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -83.25 -2.5 55.76 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 120.793 -0.363 . . . . 75.519999999999996 111.889 173.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.09 12.09 50.48 Favored Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 120.632 -0.794 . . . . 45.009999999999998 114.136 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.83 -45.5 50.86 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 122.104 -0.645 . . . . 74.450000000000003 111.751 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 32.6 m-85 -97.08 0.83 49.25 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 113.819 1.044 . . . . 75.129999999999995 113.819 -175.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -67.74 -13.61 62.26 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.596 0.712 . . . . 74.519999999999996 111.374 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.495 ' HZ2' ' HB3' ' A' ' 79' ' ' LYS . 8.4 mtpm? -72.25 -10.94 60.44 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.898 -0.592 . . . . 74.140000000000001 111.72 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.69 -7.28 59.58 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 121.067 0.461 . . . . 72.439999999999998 111.086 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.13 -26.39 64.87 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.469 0.652 . . . . 73.439999999999998 109.273 172.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -96.07 13.6 26.61 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.051 -0.522 . . . . 73.340000000000003 109.952 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.71 145.83 24.12 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.738 1.014 . . . . 65.230000000000004 113.738 -173.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -100.49 139.98 35.4 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.024 -1.843 . . . . 75.340000000000003 106.024 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.431 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 48.2 p90 . . . . . 0 C--N 1.308 -1.223 0 CA-C-O 121.497 0.665 . . . . 70.099999999999994 112.222 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 N--CA 1.444 -0.771 0 CA-C-O 121.584 0.707 . . . . 72.439999999999998 111.235 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.28 148.79 17.52 Favored Glycine 0 N--CA 1.412 -2.935 0 CA-C-N 115.167 -0.924 . . . . 54.5 111.433 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -115.79 121.76 43.39 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.755 -1.202 . . . . 75.219999999999999 107.755 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.409 ' HE3' ' CD1' ' A' ' 123' ' ' TYR . 14.3 mptt -102.77 103.24 13.44 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 123.98 0.8 . . . . 74.129999999999995 108.952 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.25 125.1 48.86 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.161 -1.422 . . . . 64.239999999999995 107.161 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 15.3 t -124.4 134.64 66.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 119.796 -0.762 . . . . 75.5 110.492 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.431 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 18.8 m-90 -114.9 139.83 49.48 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.445 -0.946 . . . . 74.25 108.445 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -118.99 120.84 38.44 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.022 -1.103 . . . . 73.329999999999998 108.022 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 C--N 1.308 -1.239 0 N-CA-C 108.454 -0.943 . . . . 73.409999999999997 108.454 179.264 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.468 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 44.8 p90 . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 108.764 -0.828 . . . . 64.349999999999994 108.764 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -114.51 144.16 43.79 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.333 -1.358 . . . . 65.329999999999998 107.333 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.468 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 31.9 mt-10 -120.56 153.89 36.14 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 113.01 0.745 . . . . 72.329999999999998 113.01 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -137.07 120.93 17.52 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.731 -1.122 . . . . 75.099999999999994 108.939 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -121.58 110.16 15.66 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.779 -0.823 . . . . 75.219999999999999 108.779 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.57 133.94 41.45 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 122.933 0.493 . . . . 55.310000000000002 110.337 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.409 ' CD1' ' HE3' ' A' ' 100' ' ' LYS . 24.8 m-85 -113.53 116.85 30.19 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.703 -0.851 . . . . 75.349999999999994 108.703 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.9 mt -119.17 149.47 21.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.494 -1.669 . . . . 75.040000000000006 106.494 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -133.71 143.3 48.41 Favored 'General case' 0 C--O 1.265 1.898 0 C-N-CA 119.232 -0.987 . . . . 73.319999999999993 109.296 174.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -90.17 131.55 35.94 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 106.239 -1.763 . . . . 75.420000000000002 106.239 173.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.501 ' HD3' ' OG ' ' A' ' 131' ' ' SER . 54.4 mtp180 -85.39 144.58 27.94 Favored 'General case' 0 C--N 1.261 -3.242 0 N-CA-C 106.716 -1.587 . . . . 74.420000000000002 106.716 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -63.75 -10.57 20.42 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 114.651 1.352 . . . . 75.010000000000005 114.651 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -79.98 -14.17 58.78 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.726 -0.472 . . . . 73.349999999999994 109.726 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.88 -11.54 27.31 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.629 -0.796 . . . . 74.140000000000001 113.652 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.501 ' OG ' ' HD3' ' A' ' 127' ' ' ARG . 61.3 p -84.68 170.12 13.63 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 117.805 0.803 . . . . 73.040000000000006 109.72 175.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' A' ' 21' ' ' VAL . 13.7 p -138.02 142.3 40.39 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 108.395 -0.965 . . . . 64.129999999999995 108.395 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -150.08 155.66 40.27 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.291 -1.003 . . . . 73.209999999999994 108.291 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.9 mp -72.05 123.26 22.43 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.81 -0.441 . . . . 72.329999999999998 109.81 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -74.62 -52.91 10.44 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.149 -0.932 . . . . 74.319999999999993 109.009 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.4 t 179.52 156.91 0.58 Allowed 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 106.637 -1.616 . . . . 74.409999999999997 106.637 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.8 m -133.68 147.33 30.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 107.536 -1.283 . . . . 70.319999999999993 107.536 173.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.495 ' HZ3' ' HB3' ' A' ' 138' ' ' LYS . 7.5 ttpm? -125.67 130.91 52.52 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-O 120.994 0.426 . . . . 70.439999999999998 109.979 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -110.23 135.85 50.34 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 107.878 -1.156 . . . . 72.219999999999999 107.878 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.52 ' HB ' ' CE ' ' A' ' 143' ' ' LYS . 12.3 pt -132.86 102.41 5.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 108.863 -0.792 . . . . 73.030000000000001 108.863 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 23.3 ptp -91.75 138.13 31.8 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.89 -0.724 . . . . 73.019999999999996 112.416 -173.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 35.3 m 59.34 77.97 0.29 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 113.456 -1.702 . . . . 74.329999999999998 114.08 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.52 ' CE ' ' HB ' ' A' ' 140' ' ' ILE . 5.9 mptp? . . . . . 0 C--N 1.3 -1.57 0 CA-C-N 114.477 -1.238 . . . . 74.439999999999998 108.509 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 C--O 1.24 0.588 0 N-CA-C 108.351 -0.981 . . . . 71.519999999999996 108.351 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.91 -34.74 78.45 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.132 -1.394 . . . . 73.549999999999997 107.498 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.25 -43.28 98.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.433 -0.803 . . . . 74.5 109.669 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.04 -56.7 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 O-C-N 123.837 0.711 . . . . 74.299999999999997 111.077 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -64.14 -34.3 77.74 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.326 -0.55 . . . . 72.239999999999995 110.797 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.523 ' HA2' ' CE1' ' A' ' 26' ' ' TYR . . . -62.22 -51.45 56.55 Favored Glycine 0 C--O 1.256 1.519 0 CA-C-N 115.887 -0.597 . . . . 65.25 112.303 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 pp -70.63 -30.38 67.01 Favored 'General case' 0 C--O 1.21 -0.999 0 N-CA-C 108.48 -0.933 . . . . 74.409999999999997 108.48 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.14 -44.43 76.54 Favored Glycine 0 N--CA 1.424 -2.107 0 CA-C-N 115.729 -0.669 . . . . 52.409999999999997 111.849 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.523 ' CE1' ' HA2' ' A' ' 23' ' ' GLY . 2.9 p90 -74.59 -35.23 62.99 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 119.272 -0.971 . . . . 73.129999999999995 110.459 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -63.63 -46.76 84.22 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.351 -0.611 . . . . 72.209999999999994 109.351 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -61.58 -52.7 63.35 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 115.35 -0.841 . . . . 74.310000000000002 110.554 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.3 mm -61.14 -39.03 81.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 112.643 0.609 . . . . 74.519999999999996 112.643 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -68.15 -40.21 82.45 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 119.697 -0.801 . . . . 75.200000000000003 110.365 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.532 ' HA ' ' HD3' ' A' ' 34' ' ' LYS . 4.0 pp -71.59 -26.77 62.74 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 119.134 -1.026 . . . . 75.340000000000003 112.311 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.2 t -70.72 -25.74 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 109.363 -0.606 . . . . 72.319999999999993 109.363 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.4 p -107.94 19.31 20.2 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.308 0.575 . . . . 73.510000000000005 110.226 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.532 ' HD3' ' HA ' ' A' ' 31' ' ' LEU . 17.8 tptt -61.83 143.21 56.68 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-N 115.196 -0.911 . . . . 72.400000000000006 109.446 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.6 m -55.53 141.58 63.37 Favored Pre-proline 0 C--N 1.309 -1.159 0 O-C-N 123.78 0.675 . . . . 74.549999999999997 112.216 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.53 -7.44 20.33 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.332 2.688 . . . . 74.200000000000003 112.883 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -79.63 -26.53 41.1 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.944 -0.571 . . . . 64.109999999999999 109.954 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.3 m -70.46 172.87 7.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.816 -0.809 . . . . 73.329999999999998 108.816 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.2 t -52.54 -53.69 18.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 112.255 0.465 . . . . 75.310000000000002 112.255 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.521 ' ND2' ' HB3' ' A' ' 42' ' ' GLU . 33.4 t30 173.43 134.81 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.836 0.71 . . . . 74.129999999999995 109.243 -175.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.7 m -58.11 -38.92 77.39 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.24 0.543 . . . . 74.040000000000006 110.283 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.521 ' HB3' ' ND2' ' A' ' 40' ' ' ASN . 8.7 tp10 -68.43 -20.85 64.67 Favored 'General case' 0 C--O 1.204 -1.292 0 CA-C-N 115.153 -0.93 . . . . 72.040000000000006 110.135 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -67.16 -47.23 71.65 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.412 -0.959 . . . . 71.420000000000002 108.412 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -71.04 -34.38 71.2 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 114.744 -1.116 . . . . 73.409999999999997 109.52 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.1 tp -66.16 -45.87 79.43 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 120.961 -0.296 . . . . 74.510000000000005 110.656 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.45 -34.14 73.56 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.57 0.7 . . . . 73.549999999999997 110.661 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -70.67 -39.56 73.49 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.379 -0.828 . . . . 75.420000000000002 109.902 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -68.04 -40.43 82.84 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 124.38 1.072 . . . . 73.230000000000004 110.565 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.49 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.7 pp -83.13 0.94 42.88 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 115.689 -0.687 . . . . 75.25 110.864 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.45 -58.21 4.72 Favored Glycine 0 CA--C 1.536 1.378 0 O-C-N 123.965 0.791 . . . . 71.400000000000006 113.439 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.89 -6.3 12.3 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 121.922 1.748 . . . . 65.010000000000005 112.172 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.49 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 10.9 m170 -108.82 32.22 5.06 Favored 'General case' 0 C--O 1.213 -0.862 0 C-N-CA 123.417 0.687 . . . . 75.340000000000003 109.807 -175.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.409 ' CG ' HG22 ' A' ' 65' ' ' THR . 13.0 t70 -53.57 98.58 0.17 Allowed Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 127.515 2.326 . . . . 63.530000000000001 110.633 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -114.54 -147.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 124.48 3.453 . . . . 74.129999999999995 113.188 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -102.71 128.77 49.28 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 108.717 -0.846 . . . . 74.439999999999998 108.717 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.415 HD13 ' CB ' ' A' ' 68' ' ' PHE . 3.4 mp -107.91 111.71 37.06 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.369 0 N-CA-C 108.862 -0.792 . . . . 75.540000000000006 108.862 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -95.97 109.57 21.93 Favored 'General case' 0 C--O 1.18 -2.553 0 O-C-N 121.742 -0.599 . . . . 73.319999999999993 111.334 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' A' ' 139' ' ' PHE . 70.6 t -109.14 114.34 46.64 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.539 0 N-CA-C 108.392 -0.966 . . . . 74.219999999999999 108.392 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 63.93 20.83 12.39 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.524 1.13 . . . . 75.420000000000002 110.311 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.93 -10.08 62.0 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 114.961 -1.018 . . . . 61.329999999999998 112.022 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -93.59 130.51 39.46 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 110.069 -0.345 . . . . 74.099999999999994 110.069 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.68 121.07 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-O 122.611 1.196 . . . . 74.549999999999997 109.163 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -115.22 137.88 51.55 Favored 'General case' 0 C--N 1.271 -2.811 0 N-CA-C 106.451 -1.685 . . . . 74.230000000000004 106.451 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.2 t -77.1 168.21 20.46 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 108.606 -0.887 . . . . 72.340000000000003 108.606 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.409 HG22 ' CG ' ' A' ' 53' ' ' ASP . 46.9 p -63.76 -32.83 74.45 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 123.981 0.912 . . . . 75.540000000000006 110.472 -176.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -62.65 -46.84 86.37 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.221 -1.354 . . . . 73.430000000000007 109.888 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.96 -44.9 87.89 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 123.549 0.74 . . . . 72.239999999999995 110.469 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.415 ' CB ' HD13 ' A' ' 56' ' ' ILE . 37.9 t80 -53.58 -54.35 38.68 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 123.477 0.486 . . . . 74.209999999999994 110.137 174.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -52.15 -41.42 62.55 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 124.306 1.003 . . . . 72.219999999999999 110.643 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.477 ' HG2' ' NH2' ' A' ' 73' ' ' ARG . 46.2 mt-30 -60.26 -51.47 69.39 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.279 -0.419 . . . . 74.400000000000006 111.556 175.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -63.33 -32.98 74.55 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.981 0.896 . . . . 74.409999999999997 110.393 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -62.07 -53.51 54.52 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.419 -1.264 . . . . 74.209999999999994 111.169 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.477 ' NH2' ' HG2' ' A' ' 70' ' ' GLN . 26.1 ptt180 -71.29 -20.7 62.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.96 0.409 . . . . 73.450000000000003 110.561 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 56.3 mt-30 -76.88 -9.2 58.52 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.229 -0.442 . . . . 71.409999999999997 110.941 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.57 7.48 64.92 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.941 -0.647 . . . . 73.010000000000005 114.024 174.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.2 mt -65.92 -28.81 69.2 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 117.161 0.481 . . . . 75.400000000000006 112.273 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -99.18 12.63 35.6 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.529 -0.469 . . . . 74.200000000000003 111.912 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 30.1 mmmt -70.78 -17.34 62.78 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.388 0.613 . . . . 74.319999999999993 110.434 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -83.27 -22.51 33.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.83 -0.623 . . . . 74.109999999999999 110.001 175.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.0 tp -76.68 -6.72 53.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.854 -0.612 . . . . 73.230000000000004 111.453 -172.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 1.6 pptp? -76.76 -3.65 39.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.618 0.723 . . . . 75.310000000000002 110.687 177.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -100.93 10.83 40.65 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 115.295 -0.866 . . . . 75.430000000000007 110.147 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 103' ' ' TRP . . . -76.14 130.07 37.74 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-O 121.406 0.622 . . . . 74.140000000000001 112.301 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -112.6 150.02 31.97 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.855 -1.066 . . . . 75.040000000000006 109.871 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.6 t80 . . . . . 0 C--N 1.307 -1.278 0 O-C-N 123.774 0.671 . . . . 74.129999999999995 111.041 -174.991 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 . . . . . 0 N--CA 1.437 -1.079 0 N-CA-C 108.842 -0.799 . . . . 73.209999999999994 108.842 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -165.25 -167.53 25.99 Favored Glycine 0 N--CA 1.417 -2.569 0 C-N-CA 119.718 -1.23 . . . . 62.130000000000003 112.568 -176.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.08 157.42 41.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 109.033 -0.729 . . . . 70.239999999999995 109.033 -174.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 57.9 tttm -147.41 100.13 3.22 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.93 -1.137 . . . . 74.540000000000006 107.93 174.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -110.31 158.88 17.94 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.766 -0.827 . . . . 74.030000000000001 108.766 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.2 p -134.51 140.56 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 121.667 0.746 . . . . 63.329999999999998 111.838 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 24.1 m-90 -116.15 127.69 55.03 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.689 -1.141 . . . . 75.329999999999998 108.172 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.405 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 66.3 mttm -105.9 131.96 52.58 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.147 -0.686 . . . . 75.450000000000003 109.147 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 C--N 1.299 -1.615 0 N-CA-C 108.506 -0.924 . . . . 74.420000000000002 108.506 176.412 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 2.8 p90 . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 108.772 -0.825 . . . . 73.109999999999999 108.772 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -110.5 135.56 50.98 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.963 -1.495 . . . . 74.329999999999998 106.963 176.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.41 ' HB2' HG13 ' A' ' 140' ' ' ILE . 46.0 mt-10 -116.83 156.53 27.11 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.919 -0.713 . . . . 62.240000000000002 111.89 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -135.87 117.53 14.97 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.923 -1.035 . . . . 71.310000000000002 108.415 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -112.79 112.31 23.71 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.845 -0.798 . . . . 75.519999999999996 108.845 -175.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -98.16 131.76 44.26 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.402 -0.519 . . . . 74.129999999999995 110.716 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -108.77 121.81 45.84 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 114.478 -1.237 . . . . 74.430000000000007 108.206 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.8 mt -124.3 137.12 58.26 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 N-CA-C 107.53 -1.285 . . . . 72.430000000000007 107.53 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -114.37 150.31 34.78 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.298 -1.742 . . . . 74.349999999999994 106.298 176.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -111.67 136.56 50.73 Favored 'General case' 0 N--CA 1.403 -2.817 0 C-N-CA 118.293 -1.363 . . . . 73.340000000000003 110.385 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -88.83 154.82 19.95 Favored 'General case' 0 C--N 1.258 -3.389 0 CA-C-N 112.912 -1.949 . . . . 74.219999999999999 109.366 -170.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -59.78 -26.62 65.87 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.466 0.706 . . . . 74.340000000000003 110.91 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -67.01 -16.22 64.23 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.43 -0.805 . . . . 72.25 110.773 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.62 -23.64 29.26 Favored Glycine 0 C--O 1.221 -0.683 0 O-C-N 121.921 -0.487 . . . . 74.409999999999997 112.111 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.9 t -73.0 140.47 47.35 Favored 'General case' 0 N--CA 1.42 -1.933 0 C-N-CA 123.483 0.713 . . . . 74.150000000000006 109.532 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 81.3 m -104.57 141.92 35.56 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.195 -1.039 . . . . 75.099999999999994 108.195 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -140.54 154.56 46.58 Favored 'General case' 0 N--CA 1.408 -2.56 0 N-CA-C 107.941 -1.133 . . . . 73.230000000000004 107.941 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.9 mt -67.9 116.14 8.21 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.25 -0.648 . . . . 74.329999999999998 109.25 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -80.84 -46.41 15.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 106.921 -1.511 . . . . 74.409999999999997 106.921 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.8 p -174.75 172.97 2.88 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.002 -0.999 . . . . 71.099999999999994 108.74 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.6 t -144.05 141.12 24.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 106.596 -1.631 . . . . 74.209999999999994 106.596 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -119.08 132.37 56.01 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 109.5 -0.555 . . . . 74.409999999999997 109.5 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.411 ' HB2' HG21 ' A' ' 58' ' ' VAL . 64.4 m-85 -115.28 131.72 56.84 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.604 -1.258 . . . . 64.409999999999997 107.604 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.41 HG13 ' HB2' ' A' ' 119' ' ' GLU . 4.5 pt -132.12 99.04 3.4 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 CA-C-O 121.71 0.767 . . . . 74.140000000000001 110.811 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 21.6 ptp -85.07 126.22 33.4 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.843 -1.071 . . . . 71.340000000000003 109.805 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.7 t 77.42 74.32 0.07 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.548 1.139 . . . . 75.409999999999997 112.016 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt . . . . . 0 CA--C 1.47 -2.109 0 N-CA-C 107.167 -1.42 . . . . 74.329999999999998 107.167 171.459 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 17.2 t70 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 122.083 0.944 . . . . 73.549999999999997 111.028 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.36 -33.83 67.54 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.865 -1.061 . . . . 75.510000000000005 108.39 -177.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -65.45 -47.43 76.18 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 124.751 1.22 . . . . 64.239999999999995 109.982 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.516 ' HA ' ' CD2' ' A' ' 24' ' ' LEU . 6.3 p -65.85 -43.06 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 112.327 0.491 . . . . 74.409999999999997 112.327 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 13.4 ptpt -71.25 -24.51 62.19 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 118.659 -1.216 . . . . 75.319999999999993 111.23 177.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.33 -56.49 10.09 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.782 -0.645 . . . . 71.439999999999998 112.323 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.516 ' CD2' ' HA ' ' A' ' 21' ' ' VAL . 1.7 pt? -70.09 -30.65 67.92 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 118.965 -1.094 . . . . 75.200000000000003 109.629 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.9 -42.17 98.47 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.664 -0.698 . . . . 72.239999999999995 111.92 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -69.03 -43.67 74.25 Favored 'General case' 0 C--O 1.208 -1.084 0 C-N-CA 119.795 -0.762 . . . . 75.329999999999998 110.759 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -57.75 -43.9 85.71 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.154 0.502 . . . . 73.099999999999994 110.1 -177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.495 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 26.5 t80 -62.3 -54.23 43.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.725 -1.125 . . . . 72.219999999999999 110.149 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 29' ' ' ILE . 11.6 mm -63.42 -33.96 64.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 112.296 0.48 . . . . 74.230000000000004 112.296 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -68.82 -43.73 74.94 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 110.181 -0.303 . . . . 63.340000000000003 110.181 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.6 pp -68.19 -31.18 70.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.979 -0.688 . . . . 73.239999999999995 110.562 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.72 -27.49 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 116.06 -0.518 . . . . 72.439999999999998 110.103 175.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.8 p -107.51 19.83 19.7 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.485 0.659 . . . . 73.030000000000001 110.299 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -77.26 158.14 30.41 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.749 -0.66 . . . . 74.310000000000002 109.62 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 m -56.39 131.3 76.25 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.474 0.71 . . . . 64.019999999999996 111.521 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.31 -7.11 20.04 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.614 2.876 . . . . 72.310000000000002 111.544 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.73 -19.58 65.78 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.26 1.424 . . . . 72.329999999999998 110.58 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -76.08 -176.56 3.55 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 107.92 -1.141 . . . . 71.450000000000003 107.92 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.64 -50.01 82.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 118.341 0.519 . . . . 74.549999999999997 111.575 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.3 t30 177.2 131.07 0.05 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.566 -0.531 . . . . 71.140000000000001 109.566 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.3 m -60.86 -35.19 75.94 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-O 121.44 0.638 . . . . 74.030000000000001 110.384 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -66.66 -20.75 66.06 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.923 -1.035 . . . . 74.400000000000006 110.946 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -67.68 -47.35 69.69 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 108.944 -0.761 . . . . 70.430000000000007 108.944 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -68.23 -34.32 76.02 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.084 -0.962 . . . . 73.349999999999994 108.741 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.1 tp -66.47 -44.68 82.06 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 116.129 -0.487 . . . . 64.019999999999996 110.42 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.77 -33.12 73.51 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.431 0.634 . . . . 71.310000000000002 110.408 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -77.12 -32.36 56.39 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.203 -0.908 . . . . 63.43 109.756 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -68.9 -47.31 66.11 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.772 -0.455 . . . . 73.219999999999999 109.772 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.6 pp -73.33 -2.56 22.6 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.766 -0.652 . . . . 71.450000000000003 112.363 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -39.24 -67.44 0.59 Allowed Glycine 0 CA--C 1.538 1.487 0 O-C-N 123.908 0.755 . . . . 70.310000000000002 113.123 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -78.78 -6.4 15.19 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.823 2.348 . . . . 72.439999999999998 113.002 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -110.5 24.73 12.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.704 -0.48 . . . . 75.200000000000003 109.704 -172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.42 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 8.3 t70 -55.91 109.47 1.67 Allowed Pre-proline 0 C--O 1.244 0.811 0 C-N-CA 124.654 1.181 . . . . 75.310000000000002 111.965 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -112.98 -149.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 124.257 3.304 . . . . 73.319999999999993 110.577 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -92.12 119.16 31.52 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 107.986 -1.116 . . . . 74.430000000000007 107.986 172.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.471 HD12 ' CB ' ' A' ' 68' ' ' PHE . 67.5 mt -101.16 112.71 34.99 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.683 0 N-CA-C 106.552 -1.647 . . . . 74.530000000000001 106.552 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -98.09 133.24 42.81 Favored 'General case' 0 C--N 1.259 -3.357 0 C-N-CA 119.891 -0.724 . . . . 65.439999999999998 109.298 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.3 t -128.28 114.68 35.21 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 107.31 -1.367 . . . . 75.319999999999993 107.31 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 63.53 20.57 12.31 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.947 1.299 . . . . 75.239999999999995 110.473 -176.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.55 -3.24 65.59 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.672 -0.694 . . . . 45.409999999999997 112.286 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -98.48 133.14 43.28 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.934 -0.765 . . . . 74.439999999999998 108.934 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -73.63 125.41 32.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 122.152 0.977 . . . . 71.129999999999995 109.81 -175.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.404 ' N ' HD12 ' A' ' 62' ' ' ILE . 58.9 mm-40 -124.65 148.02 48.18 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 115.044 -0.98 . . . . 75.519999999999996 108.727 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 t -95.14 172.21 8.26 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.517 -1.29 . . . . 74.450000000000003 107.517 173.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.42 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 9.1 t -54.06 -34.92 61.36 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 112.731 0.641 . . . . 73.519999999999996 112.731 -177.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.525 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 73.0 m -65.43 -48.31 73.2 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 120.869 -0.332 . . . . 74.140000000000001 110.696 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.12 -45.71 90.2 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 122.668 0.387 . . . . 75.5 110.16 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.471 ' CB ' HD12 ' A' ' 56' ' ' ILE . 56.7 t80 -54.21 -55.82 24.3 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 123.441 0.463 . . . . 75.540000000000006 110.032 174.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.86 -39.88 59.65 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.767 -1.106 . . . . 72.450000000000003 110.885 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.9 mm100 -63.81 -47.6 80.2 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 123.048 0.539 . . . . 64.400000000000006 111.375 177.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.403 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 31.7 m-85 -66.35 -32.67 74.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.816 0.817 . . . . 64.200000000000003 109.684 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -61.93 -56.02 23.54 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.008 -0.996 . . . . 73.450000000000003 110.617 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -69.16 -22.81 63.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.465 -0.334 . . . . 74.200000000000003 111.777 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 53.1 mt-30 -74.43 -16.1 60.88 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.164 0.507 . . . . 64.230000000000004 110.905 174.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.24 7.4 52.19 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.245 -0.978 . . . . 62.409999999999997 113.635 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.0 mt -70.72 -43.31 69.2 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.08 0.467 . . . . 72.030000000000001 110.641 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.403 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 32.3 m-85 -83.9 -4.45 58.7 Favored 'General case' 0 C--O 1.211 -0.945 0 C-N-CA 120.303 -0.559 . . . . 73.129999999999995 111.066 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.01 -14.44 61.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.673 0.749 . . . . 74.129999999999995 109.462 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -84.81 -29.02 25.73 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.58 -0.896 . . . . 74.549999999999997 108.58 175.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HA ' ' OG ' ' A' ' 105' ' ' SER . 8.6 tt -84.45 -6.62 59.39 Favored 'General case' 0 C--O 1.2 -1.517 0 CA-C-N 114.835 -1.075 . . . . 74.430000000000007 110.919 -172.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -66.57 -10.96 50.65 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.608 0.718 . . . . 74.349999999999994 112.296 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -98.35 14.33 28.37 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.684 -0.689 . . . . 62.520000000000003 109.359 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 104' ' ' LYS . . . -69.81 130.55 42.6 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 113.799 1.037 . . . . 65.310000000000002 113.799 -176.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -104.3 139.86 38.69 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.237 -1.347 . . . . 61.240000000000002 107.575 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.429 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 44.2 p90 . . . . . 0 C--N 1.309 -1.185 0 C-N-CA 119.99 -0.684 . . . . 75.409999999999997 111.77 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 N--CA 1.434 -1.226 0 N-CA-C 107.861 -1.163 . . . . 74.439999999999998 107.861 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -104.31 148.95 16.94 Favored Glycine 0 N--CA 1.427 -1.938 0 C-N-CA 120.242 -0.98 . . . . 74.219999999999999 112.524 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -106.87 145.32 32.31 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.142 -1.058 . . . . 72.129999999999995 108.142 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.12 100.24 6.86 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.875 -1.528 . . . . 70.239999999999995 106.875 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.6 mt -108.83 127.48 54.06 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 108.204 -1.036 . . . . 70.450000000000003 108.204 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 18.8 t -123.44 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 120.262 -0.575 . . . . 73.400000000000006 110.736 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.429 ' NE1' ' HB3' ' A' ' 85' ' ' PHE . 19.3 m-90 -111.06 145.15 39.02 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.402 -0.817 . . . . 71.299999999999997 109.093 176.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 83' ' ' ALA . 51.1 mttm -119.31 120.36 36.73 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.593 -0.892 . . . . 71.329999999999998 108.593 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.515 ' OG ' ' HA ' ' A' ' 80' ' ' LEU . 29.1 t . . . . . 0 C--N 1.298 -1.654 0 C-N-CA 124.215 1.006 . . . . 74.319999999999993 111.399 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 36.9 p90 . . . . . 0 N--CA 1.408 -2.565 0 N-CA-C 108.699 -0.852 . . . . 75.450000000000003 108.699 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -112.08 136.8 50.98 Favored 'General case' 0 C--N 1.259 -3.339 0 N-CA-C 105.872 -1.899 . . . . 65.25 105.872 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.401 ' CD ' ' HD3' ' A' ' 143' ' ' LYS . 86.9 mt-10 -114.7 145.29 42.22 Favored 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 119.411 -0.915 . . . . 73.310000000000002 110.119 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -126.32 117.24 22.59 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 115.123 -0.944 . . . . 73.430000000000007 109.424 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -110.64 110.04 20.56 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.731 -0.84 . . . . 75.349999999999994 108.731 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.65 125.06 42.2 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 109.315 -0.624 . . . . 70.230000000000004 109.315 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -106.89 112.48 25.46 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.946 -1.131 . . . . 62.109999999999999 107.946 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 54.6 mt -110.74 146.84 15.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.283 0 N-CA-C 107.348 -1.353 . . . . 70.120000000000005 107.348 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.419 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.3 OUTLIER -129.24 150.5 50.59 Favored 'General case' 0 C--O 1.262 1.75 0 N-CA-C 108.028 -1.101 . . . . 72.209999999999994 108.028 177.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 40.3 ttp85 -85.45 112.57 21.01 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.408 -1.33 . . . . 73.519999999999996 107.408 176.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -67.41 150.43 48.94 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.852 -1.067 . . . . 75.25 109.132 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -57.82 -15.7 9.19 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.855 1.262 . . . . 74.329999999999998 111.411 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -81.06 -6.38 58.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.828 -0.624 . . . . 75.420000000000002 111.411 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.4 -25.25 15.97 Favored Glycine 0 CA--C 1.504 -0.597 0 N-CA-C 114.816 0.687 . . . . 72.140000000000001 114.816 172.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.5 m -103.79 166.56 10.34 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 109.399 -0.593 . . . . 73.230000000000004 109.399 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 63.9 m -98.66 154.7 17.76 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.866 -0.42 . . . . 74.209999999999994 109.866 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.419 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 25.0 t-105 -150.09 155.13 39.3 Favored 'General case' 0 N--CA 1.412 -2.368 0 N-CA-C 106.681 -1.6 . . . . 74.140000000000001 106.681 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.03 119.71 10.0 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.682 -0.488 . . . . 73.019999999999996 109.682 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -83.72 -53.8 5.37 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.693 -1.225 . . . . 73.239999999999995 107.693 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.6 m -164.62 157.42 16.85 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 106.396 -1.705 . . . . 71.340000000000003 106.396 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.95 154.8 31.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 107.472 -1.307 . . . . 73.329999999999998 107.472 173.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -130.55 137.35 49.65 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 110.112 -0.329 . . . . 72.310000000000002 110.112 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -120.63 118.02 29.05 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.873 -1.158 . . . . 74.239999999999995 107.873 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.5 pt -116.03 102.78 14.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-O 121.504 0.669 . . . . 73.510000000000005 110.851 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.8 mtp -96.33 92.45 6.34 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.802 -1.555 . . . . 71.230000000000004 106.802 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.4 m -177.23 -49.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 112.754 0.65 . . . . 73.340000000000003 112.754 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.401 ' HD3' ' CD ' ' A' ' 119' ' ' GLU . 86.6 tttt . . . . . 0 N--CA 1.485 1.313 0 C-N-CA 123.986 0.914 . . . . 72.120000000000005 112.994 -172.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.4 t70 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 121.57 0.7 . . . . 65.230000000000004 110.489 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.55 -38.31 71.03 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.539 -0.911 . . . . 74.430000000000007 108.539 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.23 -45.37 69.96 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.372 -0.831 . . . . 74.349999999999994 111.259 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.3 m -70.39 -34.69 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 112.109 0.411 . . . . 61.509999999999998 112.109 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.477 ' HZ2' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -69.7 -35.47 75.11 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 118.638 -1.225 . . . . 74.420000000000002 109.078 176.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.07 -40.79 83.05 Favored Glycine 0 C--O 1.216 -1.02 0 N-CA-C 111.327 -0.709 . . . . 74.400000000000006 111.327 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 tp -68.21 -47.98 66.42 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 123.465 0.706 . . . . 75.409999999999997 109.705 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.79 -41.04 99.01 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 115.645 -0.707 . . . . 72.409999999999997 111.718 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -67.82 -43.5 79.44 Favored 'General case' 0 C--O 1.198 -1.644 0 CA-C-O 118.879 -0.581 . . . . 74.540000000000006 111.085 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -57.96 -44.31 86.96 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 120.837 0.351 . . . . 72.319999999999993 110.082 -176.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -61.73 -54.56 40.9 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.633 -1.167 . . . . 75.200000000000003 110.438 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 29' ' ' ILE . 9.6 mm -60.6 -35.84 66.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 112.49 0.552 . . . . 71.239999999999995 112.49 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.93 -47.76 73.66 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.102 -0.703 . . . . 71.040000000000006 109.102 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.523 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 4.1 pp -73.59 -19.13 60.96 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 119.985 -0.686 . . . . 72.439999999999998 112.099 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.1 t -74.86 -28.17 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.462 0.649 . . . . 72.329999999999998 109.527 173.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.8 p -106.13 14.32 27.85 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.829 0.823 . . . . 73.5 109.18 -176.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 21.5 tptp -39.66 124.25 1.65 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 127.163 2.185 . . . . 74.0 112.879 -176.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 m -53.49 146.91 22.21 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.707 1.203 . . . . 75.209999999999994 112.048 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.14 -7.76 16.47 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 123.598 2.865 . . . . 73.409999999999997 112.614 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.93 -26.95 68.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.321 -0.854 . . . . 75.349999999999994 110.276 175.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 p -101.81 167.79 9.85 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.861 -0.609 . . . . 72.109999999999999 110.675 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.4 t -62.96 -54.95 26.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 114.034 1.124 . . . . 74.430000000000007 114.034 -172.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -171.11 139.84 1.43 Allowed 'General case' 0 C--O 1.245 0.836 0 C-N-CA 119.195 -1.002 . . . . 64.310000000000002 110.654 -172.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.7 m -63.22 -42.94 99.34 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.004 0.521 . . . . 74.109999999999999 111.724 -172.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.3 -20.6 65.62 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.031 -0.531 . . . . 72.400000000000006 111.466 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -69.86 -46.97 64.39 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.868 -0.79 . . . . 73.25 108.868 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -71.0 -31.95 68.62 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.87 -1.159 . . . . 73.430000000000007 107.87 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 54.3 tp -65.4 -46.59 79.42 Favored 'General case' 0 C--O 1.191 -2.012 0 CA-C-N 115.584 -0.735 . . . . 75.549999999999997 110.095 176.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 49' ' ' LEU . . . -62.37 -30.97 71.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.838 0.828 . . . . 65.420000000000002 110.494 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -73.25 -34.81 66.05 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.555 -1.202 . . . . 74.219999999999999 110.489 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -80.48 -26.92 37.96 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.458 1.123 . . . . 73.109999999999999 108.475 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 39.9 tp -69.79 -29.8 67.19 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 127.323 2.249 . . . . 73.439999999999998 111.509 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -38.47 -56.17 2.0 Allowed Glycine 0 CA--C 1.545 1.929 0 N-CA-C 115.628 1.011 . . . . 71.329999999999998 115.628 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -77.81 -5.83 15.6 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.153 1.902 . . . . 64.239999999999995 113.585 177.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -133.21 24.9 4.19 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.685 -0.634 . . . . 75.430000000000007 111.654 -169.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -56.17 107.32 0.86 Allowed Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 123.067 0.547 . . . . 75.329999999999998 111.823 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -109.51 -159.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 123.84 3.027 . . . . 74.319999999999993 112.228 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -86.73 131.16 34.21 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.226 -1.027 . . . . 63.329999999999998 108.226 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mp -108.86 112.75 41.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.763 -1.199 . . . . 75.340000000000003 107.763 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 138' ' ' LYS . 80.2 m-85 -92.88 133.7 35.82 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 108.502 -0.925 . . . . 75.530000000000001 108.502 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.3 t -131.84 117.09 32.81 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 108.101 -1.074 . . . . 71.109999999999999 108.101 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 60.78 29.44 19.01 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.373 1.045 . . . . 74.310000000000002 110.765 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.75 5.94 80.68 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.906 -1.043 . . . . 62.119999999999997 112.839 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -113.85 134.33 54.87 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 109.723 -0.473 . . . . 75.099999999999994 109.723 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.417 HD11 ' N ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -75.06 128.22 36.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.885 0.85 . . . . 75.409999999999997 110.284 -175.355 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.417 ' N ' HD11 ' A' ' 62' ' ' ILE . 50.8 mm-40 -126.37 144.32 50.86 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 106.921 -1.511 . . . . 65.239999999999995 106.921 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -87.08 174.3 8.74 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.281 -0.637 . . . . 74.140000000000001 109.281 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.7 t -56.7 -33.47 66.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.256 0.622 . . . . 74.530000000000001 111.378 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.419 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 60.9 m -67.21 -42.52 83.95 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.091 -0.504 . . . . 75.129999999999995 110.469 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.86 -47.92 76.15 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 122.766 0.426 . . . . 64.129999999999995 109.984 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -52.97 -53.56 48.04 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 123.552 0.533 . . . . 71.310000000000002 110.114 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.0 tp -49.72 -46.43 50.21 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 124.167 0.917 . . . . 70.25 111.537 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 66' ' ' THR . 49.0 mt-30 -59.46 -48.1 82.95 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 116.201 -0.454 . . . . 64.510000000000005 111.306 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -66.87 -35.28 79.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.243 0.544 . . . . 74.329999999999998 110.532 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -60.17 -51.91 67.57 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.554 -0.748 . . . . 75.510000000000005 110.649 175.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -75.33 -13.19 60.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.874 0.368 . . . . 75.239999999999995 111.372 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 27.9 mm-40 -82.1 -8.99 59.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.977 0.417 . . . . 71.340000000000003 111.412 170.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.82 26.31 50.19 Favored Glycine 0 N--CA 1.427 -1.903 0 CA-C-N 116.147 -0.479 . . . . 70.140000000000001 112.349 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.8 mt -78.36 -37.24 44.75 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.034 -0.667 . . . . 74.530000000000001 112.001 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -97.36 1.3 49.21 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.963 -0.695 . . . . 74.319999999999993 112.655 -175.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.301 0.0 OUTLIER -70.4 -16.88 63.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.177 1.177 . . . . 73.439999999999998 114.177 -173.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -89.53 -15.78 32.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.362 0.601 . . . . 74.409999999999997 111.543 171.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.3 tt -84.84 -14.82 46.76 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.568 -0.742 . . . . 72.540000000000006 110.262 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.84 -8.72 57.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.365 0.602 . . . . 74.409999999999997 111.748 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -92.72 13.52 19.91 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.616 -0.72 . . . . 72.430000000000007 109.524 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 105' ' ' SER . . . -79.99 154.44 28.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.282 -0.872 . . . . 71.230000000000004 113.352 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -107.79 143.79 35.87 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.523 -1.217 . . . . 72.230000000000004 109.256 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.0 p90 . . . . . 0 C--N 1.298 -1.643 0 CA-C-O 121.236 0.541 . . . . 73.230000000000004 109.578 176.286 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 . . . . . 0 N--CA 1.432 -1.34 0 N-CA-C 109.511 -0.551 . . . . 74.129999999999995 109.511 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.46 -164.64 33.94 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 110.261 -1.136 . . . . 72.200000000000003 110.261 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -128.55 136.3 50.55 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.454 -0.573 . . . . 73.450000000000003 109.454 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -122.71 98.9 6.12 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.008 -1.849 . . . . 75.340000000000003 106.008 170.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 mt -109.62 124.42 51.12 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 123.775 0.672 . . . . 74.219999999999999 109.889 -172.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 10.9 p -114.77 122.42 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-O 122.331 1.062 . . . . 55.119999999999997 112.474 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 -96.07 145.1 25.75 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.025 -1.443 . . . . 75.340000000000003 108.522 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -128.5 121.12 28.15 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.19 -1.411 . . . . 73.299999999999997 107.19 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 42.5 m . . . . . 0 C--O 1.253 1.282 0 C-N-CA 122.973 0.509 . . . . 73.25 112.018 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 8.4 p90 . . . . . 0 N--CA 1.436 -1.143 0 N-CA-C 107.696 -1.224 . . . . 73.129999999999995 107.696 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -107.23 139.17 42.11 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.843 -1.169 . . . . 72.420000000000002 107.843 175.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -119.21 151.55 38.17 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 120.446 -0.502 . . . . 65.299999999999997 110.125 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -137.31 123.15 20.06 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 116.079 -0.51 . . . . 64.420000000000002 110.079 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -114.78 110.33 19.55 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.16 -0.682 . . . . 72.239999999999995 109.16 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.02 130.39 44.35 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 109.031 -0.729 . . . . 74.230000000000004 109.031 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -110.31 110.67 21.56 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.213 -1.032 . . . . 72.530000000000001 108.213 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.453 HG12 HD13 ' A' ' 134' ' ' LEU . 61.4 mt -115.28 137.16 49.7 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.674 0 N-CA-C 107.511 -1.292 . . . . 75.030000000000001 107.511 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.505 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.2 OUTLIER -122.27 147.95 45.6 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.007 -1.849 . . . . 71.120000000000005 106.007 177.335 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -117.06 133.53 55.88 Favored 'General case' 0 N--CA 1.398 -3.028 0 C-N-CA 117.553 -1.659 . . . . 75.120000000000005 109.725 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -82.56 144.69 30.19 Favored 'General case' 0 C--N 1.255 -3.533 0 CA-C-N 113.044 -1.889 . . . . 72.109999999999999 109.789 -172.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -49.4 -31.8 10.33 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.853 1.261 . . . . 75.030000000000001 112.423 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -76.69 0.93 18.57 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.515 -0.766 . . . . 74.400000000000006 111.667 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.95 -1.48 56.54 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.335 -0.46 . . . . 73.129999999999995 112.619 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.4 m -85.5 101.46 12.67 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 122.623 -0.339 . . . . 74.510000000000005 111.521 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 42.0 t -80.78 120.74 25.05 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 105.57 -2.011 . . . . 74.030000000000001 105.57 173.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.505 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 5.9 t-105 -140.22 150.56 44.29 Favored 'General case' 0 N--CA 1.394 -3.245 0 C-N-CA 119.163 -1.015 . . . . 75.310000000000002 111.301 -170.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.453 HD13 HG12 ' A' ' 124' ' ' ILE . 3.4 mm? -68.75 116.6 9.44 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.053 -0.976 . . . . 73.019999999999996 109.057 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -83.72 -56.61 3.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.975 -0.75 . . . . 75.319999999999993 108.975 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.0 m -164.45 156.55 16.36 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 106.291 -1.744 . . . . 73.239999999999995 106.291 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.8 m -131.03 162.34 39.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.384 -1.339 . . . . 75.030000000000001 107.384 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 57' ' ' TYR . 78.7 tttt -142.28 136.97 30.3 Favored 'General case' 0 C--N 1.275 -2.641 0 C-N-CA 122.718 0.407 . . . . 64.420000000000002 110.071 -173.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -123.04 141.01 52.43 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.821 -0.807 . . . . 74.349999999999994 108.821 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.9 pt -132.18 98.36 3.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.788 -1.19 . . . . 73.239999999999995 107.788 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 68.8 mtm -89.55 130.38 35.88 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.213 -1.358 . . . . 74.319999999999993 111.138 -171.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.4 t 71.47 24.46 3.63 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 124.468 1.105 . . . . 71.329999999999998 110.303 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? . . . . . 0 N--CA 1.426 -1.641 0 CA-C-N 114.891 -1.05 . . . . 74.140000000000001 108.381 178.732 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 . . . . . 0 CA--C 1.507 -0.676 0 CA-C-O 120.969 0.414 . . . . 75.129999999999995 110.815 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.96 -40.43 96.4 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.68 -0.691 . . . . 72.049999999999997 109.454 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.15 -43.6 81.9 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.021 -0.536 . . . . 73.209999999999994 110.517 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.435 HG13 ' SG ' ' A' ' 132' ' ' CYS . 11.3 m -70.39 -38.73 75.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 120.334 -0.547 . . . . 75.409999999999997 112.104 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -28.0 50.37 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.662 -0.815 . . . . 71.150000000000006 110.581 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.75 -41.43 49.99 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 110.066 -1.214 . . . . 62.450000000000003 110.066 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.3 tp -68.12 -49.78 58.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.889 -0.782 . . . . 62.140000000000001 108.889 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.26 -38.72 95.0 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.516 -0.765 . . . . 43.43 112.447 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -71.95 -40.85 68.39 Favored 'General case' 0 C--O 1.195 -1.792 0 C-N-CA 120.426 -0.51 . . . . 72.200000000000003 110.571 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -62.32 -43.1 99.61 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.622 0.725 . . . . 73.430000000000007 110.049 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.425 ' CZ ' ' HH2' ' A' ' 103' ' ' TRP . 27.7 t80 -64.63 -54.63 28.78 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 113.946 -1.479 . . . . 74.420000000000002 110.157 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.8 mm -65.49 -33.52 64.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 120.882 -0.327 . . . . 72.340000000000003 111.838 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -63.41 -48.82 76.24 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 110.067 -0.346 . . . . 64.319999999999993 110.067 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.415 HD11 ' N ' ' A' ' 32' ' ' VAL . 4.4 pp -68.55 -30.28 69.03 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.088 -0.645 . . . . 63.329999999999998 110.94 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.415 ' N ' HD11 ' A' ' 31' ' ' LEU . 66.0 t -70.58 -25.09 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 CA-C-O 121.201 0.524 . . . . 71.540000000000006 110.492 175.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.5 p -110.33 19.3 18.98 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.565 0.698 . . . . 74.109999999999999 110.226 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -55.78 142.86 33.14 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.949 -1.023 . . . . 74.310000000000002 110.328 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 m -62.92 153.99 78.1 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-N 115.435 -0.802 . . . . 65.209999999999994 110.694 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.16 -5.65 3.11 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 125.03 3.82 . . . . 71.329999999999998 113.043 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.6 -27.22 68.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.498 -0.774 . . . . 73.540000000000006 109.17 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -94.97 142.2 27.76 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 105.788 -1.93 . . . . 74.219999999999999 105.788 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.7 t -68.96 -46.07 79.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 120.606 -0.438 . . . . 74.120000000000005 111.927 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -145.01 119.29 9.54 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 119.406 -0.918 . . . . 74.25 112.552 -174.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.9 m -64.13 -35.96 82.49 Favored 'General case' 0 C--O 1.251 1.165 0 C-N-CA 123.714 0.806 . . . . 74.099999999999994 110.768 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.724 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 1.3 mp0 -65.8 -21.2 66.47 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.156 -0.929 . . . . 75.299999999999997 110.466 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -68.69 -43.02 76.94 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.607 -1.257 . . . . 75.140000000000001 107.607 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.43 -32.12 69.59 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.552 -1.204 . . . . 74.150000000000006 109.43 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.5 tp -67.78 -40.87 83.95 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 116.017 -0.538 . . . . 63.420000000000002 110.7 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.11 -36.62 84.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.622 0.725 . . . . 74.310000000000002 109.921 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -69.47 -37.6 77.35 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.985 -1.007 . . . . 75.140000000000001 109.44 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -65.55 -43.24 90.51 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.218 1.007 . . . . 74.120000000000005 110.727 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.42 ' C ' HD13 ' A' ' 49' ' ' LEU . 4.4 pp -80.45 -2.49 46.02 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.822 -0.626 . . . . 74.340000000000003 111.214 -177.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.2 -62.47 5.02 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 111.888 -0.485 . . . . 73.420000000000002 111.888 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -77.15 -5.57 15.88 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.45 2.1 . . . . 73.109999999999999 112.235 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -124.46 38.08 4.27 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.798 -0.445 . . . . 72.420000000000002 109.798 -172.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.535 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 34.4 t70 -54.52 106.03 0.61 Allowed Pre-proline 0 C--O 1.245 0.848 0 C-N-CA 125.23 1.412 . . . . 63.229999999999997 113.22 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -107.92 -157.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.101 0 C-N-CA 123.798 2.999 . . . . 74.530000000000001 110.548 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -98.97 123.66 43.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.665 -0.865 . . . . 72.319999999999993 108.665 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.441 HD11 ' CG ' ' A' ' 68' ' ' PHE . 46.6 mt -105.25 107.92 23.74 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.606 0 N-CA-C 107.868 -1.16 . . . . 74.099999999999994 107.868 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -96.75 138.82 33.73 Favored 'General case' 0 C--N 1.27 -2.888 0 O-C-N 121.737 -0.602 . . . . 75.230000000000004 110.26 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 p -128.24 117.92 46.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 107.16 -1.422 . . . . 74.099999999999994 107.16 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 60.8 20.82 10.95 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.705 -0.68 . . . . 74.400000000000006 111.571 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.27 1.17 56.89 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.817 -0.629 . . . . 75.030000000000001 112.866 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -108.74 130.84 55.37 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 117.397 0.598 . . . . 75.219999999999999 110.438 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.58 125.25 33.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 122.055 0.931 . . . . 74.409999999999997 110.256 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -120.56 140.53 51.36 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.44 -1.318 . . . . 72.129999999999995 107.44 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.0 t -85.66 173.52 10.06 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.701 -0.852 . . . . 71.420000000000002 108.701 176.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.535 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 9.7 t -52.62 -37.52 58.52 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.405 0.682 . . . . 64.519999999999996 111.57 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -70.03 -41.1 74.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.336 -0.393 . . . . 73.129999999999995 111.855 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.54 -47.34 76.19 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.229 -0.656 . . . . 74.420000000000002 109.229 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.441 ' CG ' HD11 ' A' ' 56' ' ' ILE . 55.3 t80 -53.18 -54.33 37.57 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 115.667 -0.697 . . . . 71.230000000000004 110.118 174.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -50.13 -44.31 52.33 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 124.206 0.941 . . . . 64.049999999999997 110.867 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -60.41 -48.84 80.03 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 122.853 0.461 . . . . 71.150000000000006 111.531 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.443 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 32.6 m-85 -68.4 -36.78 79.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.678 0.752 . . . . 60.009999999999998 109.398 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -58.46 -54.56 45.7 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.102 -0.954 . . . . 73.200000000000003 110.948 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -66.07 -29.74 70.14 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.582 -0.281 . . . . 74.340000000000003 110.557 -176.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.403 HE21 ' HA ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -77.71 -8.78 58.44 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 113.373 0.879 . . . . 72.230000000000004 113.373 178.007 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.13 11.35 42.84 Favored Glycine 0 C--N 1.315 -0.63 0 C-N-CA 120.31 -0.947 . . . . 73.150000000000006 114.944 173.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.14 -53.85 22.22 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 120.878 0.371 . . . . 74.209999999999994 111.974 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.443 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 40.5 m-85 -89.72 6.17 42.7 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 112.781 0.66 . . . . 74.349999999999994 112.781 -172.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.724 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 41.9 mtmt -66.16 -12.47 56.03 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.492 0.923 . . . . 75.340000000000003 113.492 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -77.64 -10.67 59.64 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.363 -0.835 . . . . 71.049999999999997 111.2 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.3 tp -68.3 -28.86 67.55 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.488 -0.56 . . . . 74.319999999999993 109.488 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.536 ' HB2' ' OE2' ' A' ' 42' ' ' GLU . 0.8 OUTLIER -65.83 -28.67 69.16 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.581 -0.736 . . . . 74.099999999999994 110.127 176.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -98.82 7.07 46.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.656 -0.702 . . . . 74.519999999999996 110.348 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.48 150.82 22.3 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.967 0.413 . . . . 54.420000000000002 110.612 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.09 134.11 47.9 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.674 -0.862 . . . . 70.109999999999999 108.674 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 48.7 p90 . . . . . 0 C--N 1.302 -1.479 0 N-CA-C 113.55 0.944 . . . . 75.329999999999998 113.55 -174.013 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 . . . . . 0 C--O 1.256 1.44 0 N-CA-C 109.803 -0.443 . . . . 73.109999999999999 109.803 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -105.41 146.49 16.08 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 110.979 -0.848 . . . . 75.530000000000001 110.979 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -110.99 133.91 53.01 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.0 -1.111 . . . . 72.439999999999998 108.0 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -113.45 109.82 19.29 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 123.583 0.552 . . . . 74.349999999999994 109.872 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -97.42 108.73 21.51 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 105.675 -1.972 . . . . 70.230000000000004 105.675 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 3.9 t -115.11 150.24 17.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 119.776 -0.77 . . . . 75.030000000000001 110.187 -174.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.425 ' HH2' ' CZ ' ' A' ' 28' ' ' PHE . 25.2 m-90 -132.35 151.19 51.96 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.556 -0.905 . . . . 74.230000000000004 108.556 175.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.435 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 67.3 mttm -126.34 130.85 51.62 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.684 -1.599 . . . . 75.209999999999994 106.684 174.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.1 p . . . . . 0 C--N 1.3 -1.577 0 N-CA-C 110.288 -0.264 . . . . 63.210000000000001 110.288 -179.616 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.423 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 1.6 p90 . . . . . 0 N--CA 1.422 -1.83 0 N-CA-C 107.147 -1.427 . . . . 74.209999999999994 107.147 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -113.02 135.33 53.9 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 106.022 -1.844 . . . . 63.32 106.022 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.435 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 44.0 mt-10 -115.07 148.77 38.49 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-O 121.69 0.757 . . . . 75.439999999999998 112.159 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -132.97 117.75 18.02 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-N 114.414 -1.266 . . . . 63.340000000000003 108.562 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -121.38 110.91 16.67 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 109.1 -0.704 . . . . 75.340000000000003 109.1 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -98.16 133.76 42.16 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.118 -0.492 . . . . 73.450000000000003 109.847 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -114.76 121.11 42.31 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 123.188 0.595 . . . . 72.530000000000001 110.198 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.5 mt -123.41 149.64 27.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.07 -1.826 . . . . 73.349999999999994 106.07 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.4 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.7 OUTLIER -132.19 145.21 51.19 Favored 'General case' 0 C--O 1.272 2.259 0 C-N-CA 119.066 -1.054 . . . . 73.329999999999998 109.157 173.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -83.66 119.9 25.33 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.473 -1.306 . . . . 74.209999999999994 107.473 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -89.59 133.06 34.79 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.481 -1.674 . . . . 65.329999999999998 106.481 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.29 -12.58 30.49 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.664 0.745 . . . . 75.239999999999995 111.228 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.8 -11.0 60.69 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.215 -0.902 . . . . 72.420000000000002 111.095 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.17 -12.9 28.79 Favored Glycine 0 CA--C 1.509 -0.344 0 C-N-CA 121.066 -0.588 . . . . 61.439999999999998 112.986 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.3 m -104.56 164.93 11.41 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 109.798 -0.445 . . . . 61.119999999999997 109.798 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.435 ' SG ' HG13 ' A' ' 21' ' ' VAL . 25.3 p -127.12 143.27 51.31 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.101 -1.444 . . . . 74.349999999999994 107.101 172.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.4 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 1.7 t90 -143.41 155.56 44.43 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.173 -1.011 . . . . 74.319999999999993 109.435 -176.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.7 mp -70.37 119.35 14.41 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 109.447 -0.575 . . . . 72.040000000000006 109.447 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -72.04 -50.5 27.97 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.562 -1.273 . . . . 74.430000000000007 107.562 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.8 p -177.19 177.42 1.23 Allowed 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.334 -1.303 . . . . 74.540000000000006 108.634 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.9 t -144.78 138.72 22.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 105.015 -2.217 . . . . 72.540000000000006 105.015 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -129.31 130.26 45.9 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-O 121.462 0.649 . . . . 74.420000000000002 109.847 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -110.42 133.57 53.15 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 107.791 -1.189 . . . . 71.430000000000007 107.791 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 10.1 pt -131.88 98.36 3.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 CA-C-O 122.078 0.942 . . . . 74.030000000000001 108.772 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 90.5 mtp -88.97 138.92 30.97 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.828 -1.078 . . . . 75.439999999999998 110.6 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.0 m 70.79 29.64 3.11 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 124.881 1.363 . . . . 73.340000000000003 112.795 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.1 mptt . . . . . 0 C--N 1.306 -1.305 0 N-CA-C 109.365 -0.606 . . . . 74.140000000000001 109.365 177.452 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 10.6 t70 . . . . . 0 C--O 1.242 0.667 0 N-CA-C 108.217 -1.031 . . . . 71.209999999999994 108.217 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.92 -36.69 84.06 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.784 -1.098 . . . . 73.239999999999995 110.027 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.36 -42.6 87.83 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.228 -0.442 . . . . 73.239999999999995 110.466 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 m -71.75 -41.88 70.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 112.387 0.514 . . . . 74.439999999999998 112.387 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -68.73 -31.41 70.46 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.622 -0.831 . . . . 74.109999999999999 110.161 178.503 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.01 -57.32 8.8 Favored Glycine 0 N--CA 1.437 -1.263 0 O-C-N 123.805 0.69 . . . . 71.409999999999997 111.939 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.68 -33.08 73.36 Favored 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.086 -1.046 . . . . 74.540000000000006 110.231 -177.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.06 -39.68 96.51 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 120.925 -0.655 . . . . 70.230000000000004 111.971 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -67.15 -47.56 70.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.655 -0.498 . . . . 75.040000000000006 109.655 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.6 -41.93 98.14 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.558 -0.746 . . . . 75.530000000000001 110.28 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.513 ' CE2' HD12 ' A' ' 45' ' ' LEU . 23.9 t80 -61.46 -53.15 60.2 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 124.912 1.285 . . . . 71.239999999999995 109.985 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 29' ' ' ILE . 9.8 mm -65.76 -32.66 59.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 112.152 0.427 . . . . 72.129999999999995 112.152 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.23 -47.0 72.1 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.371 -0.532 . . . . 72.409999999999997 110.622 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.77 -26.21 64.18 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.02 -0.672 . . . . 74.140000000000001 111.925 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 28' ' ' PHE . 63.2 t -71.68 -24.42 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 CA-C-O 121.552 0.691 . . . . 72.129999999999995 110.538 174.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.6 p -107.31 9.83 29.88 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 121.618 -0.676 . . . . 74.109999999999999 110.595 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -69.63 156.95 38.15 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.161 -0.927 . . . . 74.230000000000004 112.474 -174.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.0 m -63.31 154.31 78.95 Favored Pre-proline 0 N--CA 1.424 -1.765 0 CA-C-N 113.711 -1.586 . . . . 73.450000000000003 113.04 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -59.18 -5.17 2.69 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 125.182 3.921 . . . . 72.209999999999994 112.785 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -54.31 -26.8 31.49 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.93 0.892 . . . . 75.329999999999998 110.785 173.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.1 t -101.14 156.81 17.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 105.158 -2.164 . . . . 72.0 105.158 168.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -50.24 -41.63 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.831 0.741 . . . . 75.109999999999999 111.987 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -167.04 151.08 6.82 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.966 -1.124 . . . . 73.010000000000005 107.966 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.7 m -60.71 -32.16 71.41 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-O 121.461 0.648 . . . . 74.040000000000006 110.648 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -64.55 -22.75 67.05 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.201 -0.909 . . . . 73.219999999999999 110.151 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -67.06 -45.78 76.35 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.78 0.8 . . . . 72.450000000000003 108.915 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -71.49 -33.49 69.3 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.409 -1.269 . . . . 74.049999999999997 109.151 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.513 HD12 ' CE2' ' A' ' 28' ' ' PHE . 34.4 tp -68.74 -43.88 74.97 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 116.17 -0.468 . . . . 75.219999999999999 110.37 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.51 -37.02 77.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.476 0.655 . . . . 74.340000000000003 110.195 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -69.49 -36.08 76.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.124 -0.944 . . . . 72.219999999999999 110.176 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -67.26 -46.56 73.32 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.667 -0.697 . . . . 75.329999999999998 110.285 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.413 ' C ' HD13 ' A' ' 49' ' ' LEU . 4.2 pp -82.23 -2.39 52.28 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.356 -0.838 . . . . 71.340000000000003 111.338 -176.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.69 -62.5 4.82 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 112.306 -0.318 . . . . 75.340000000000003 112.306 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -79.47 -7.23 14.83 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 121.842 1.694 . . . . 74.209999999999994 112.151 176.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -114.17 35.19 4.26 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.041 -0.725 . . . . 72.120000000000005 109.041 -175.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.6 106.26 0.64 Allowed Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 125.28 1.432 . . . . 53.509999999999998 112.356 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -101.69 -164.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 123.243 2.629 . . . . 73.129999999999995 110.928 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -90.34 108.07 19.54 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 107.545 -1.28 . . . . 75.109999999999999 107.545 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.462 HD11 ' CB ' ' A' ' 68' ' ' PHE . 73.4 mt -92.48 107.91 19.58 Favored 'Isoleucine or valine' 0 C--O 1.162 -3.515 0 N-CA-C 108.744 -0.836 . . . . 74.439999999999998 108.744 -176.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -95.55 128.15 42.18 Favored 'General case' 0 C--N 1.268 -2.975 0 O-C-N 121.12 -0.988 . . . . 74.549999999999997 109.127 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.0 t -124.97 114.44 40.4 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 N-CA-C 107.959 -1.126 . . . . 74.540000000000006 107.959 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 62.01 20.94 11.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.56 -1.2 . . . . 74.329999999999998 110.591 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.63 -4.89 58.21 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 114.72 -1.127 . . . . 73.219999999999999 113.165 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -101.01 132.72 46.29 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 117.714 0.757 . . . . 72.439999999999998 109.376 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.59 129.25 36.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.874 0.845 . . . . 74.129999999999995 109.676 -177.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -126.9 152.83 46.56 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 124.78 1.232 . . . . 65.409999999999997 108.295 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.9 t -97.71 170.24 9.13 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.341 -0.985 . . . . 74.209999999999994 108.341 175.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.8 t -52.14 -38.43 57.52 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.285 0.634 . . . . 75.109999999999999 111.231 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -62.0 -49.2 76.99 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.175 0.59 . . . . 70.019999999999996 111.105 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.44 84.49 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.095 0.558 . . . . 73.25 110.314 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.462 ' CB ' HD11 ' A' ' 56' ' ' ILE . 56.6 t80 -53.68 -55.65 24.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.907 -0.588 . . . . 74.120000000000005 110.413 175.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -50.87 -42.44 58.92 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.07 -0.968 . . . . 73.319999999999993 110.572 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -60.28 -47.43 86.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 112.014 0.375 . . . . 73.230000000000004 112.014 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -66.78 -32.7 74.16 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.495 0.664 . . . . 73.219999999999999 109.976 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -61.77 -52.61 63.53 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.47 -0.786 . . . . 75.099999999999994 110.91 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -71.17 -21.28 62.19 Favored 'General case' 0 C--O 1.224 -0.271 0 O-C-N 123.27 0.356 . . . . 74.439999999999998 110.904 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -71.57 -19.95 62.08 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.351 0.596 . . . . 65.120000000000005 110.108 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.94 13.79 33.14 Favored Glycine 0 N--CA 1.422 -2.235 0 CA-C-N 115.492 -0.776 . . . . 63.039999999999999 113.299 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.0 mt -74.55 -44.56 50.48 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 117.427 0.614 . . . . 65.230000000000004 111.365 -177.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -88.8 -4.58 58.46 Favored 'General case' 0 C--O 1.214 -0.814 0 N-CA-C 112.662 0.615 . . . . 74.109999999999999 112.662 -176.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -15.57 62.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 119.392 -0.923 . . . . 74.049999999999997 112.304 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -86.61 -21.57 26.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.631 -0.713 . . . . 75.310000000000002 110.281 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.1 tp -74.54 -14.76 60.84 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.915 0.864 . . . . 72.239999999999995 109.684 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -57.66 -25.65 60.53 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.598 -1.183 . . . . 72.239999999999995 112.295 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -92.95 11.94 25.58 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 111.997 0.369 . . . . 64.019999999999996 111.997 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.73 150.24 28.06 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.096 0.474 . . . . 74.549999999999997 111.627 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -99.5 132.41 44.86 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.504 -0.924 . . . . 64.430000000000007 108.504 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.55 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 51.1 p90 . . . . . 0 C--N 1.319 -0.759 0 C-N-CA 119.924 -0.711 . . . . 74.150000000000006 112.311 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.435 -1.184 0 N-CA-C 110.184 -0.302 . . . . 71.239999999999995 110.184 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -153.88 141.67 8.48 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 108.853 -1.699 . . . . 75.310000000000002 108.853 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -108.56 150.99 26.72 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.459 -1.312 . . . . 72.230000000000004 107.459 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.623 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 39.4 ttpt -150.05 107.83 3.69 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-O 121.745 0.783 . . . . 74.319999999999993 109.41 176.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 72.8 mt -101.99 134.35 45.35 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 114.146 -1.388 . . . . 73.430000000000007 107.935 -177.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 6.1 t -120.01 128.97 75.97 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.182 0 C-N-CA 120.685 -0.406 . . . . 64.319999999999993 110.397 -176.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 18.8 m-90 -99.95 127.44 46.14 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 107.317 -1.364 . . . . 75.549999999999997 107.317 173.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -112.36 120.12 40.61 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 107.696 -1.224 . . . . 71.099999999999994 107.696 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 C--N 1.301 -1.54 0 CA-C-N 115.194 -0.912 . . . . 75.299999999999997 110.483 -176.057 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.525 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 43.2 p90 . . . . . 0 C--O 1.211 -0.936 0 N-CA-C 108.146 -1.057 . . . . 72.120000000000005 108.146 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -112.88 140.53 47.61 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.947 -1.501 . . . . 62.43 106.947 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.525 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 40.7 mt-10 -123.32 155.14 37.84 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 121.183 0.516 . . . . 64.099999999999994 111.031 175.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -141.61 117.29 10.35 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.771 -1.104 . . . . 62.409999999999997 108.039 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 7.9 pt-20 -125.23 111.99 15.89 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-O 121.718 0.771 . . . . 64.099999999999994 112.193 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.623 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -93.91 124.61 38.03 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.427 -1.261 . . . . 75.239999999999995 110.005 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.454 ' CE2' ' HD3' ' A' ' 100' ' ' LYS . 8.7 m-85 -103.07 129.34 49.85 Favored 'General case' 0 C--O 1.249 1.069 0 C-N-CA 124.622 1.169 . . . . 74.400000000000006 108.171 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 53.8 mt -131.46 144.28 38.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.697 -0.853 . . . . 75.319999999999993 108.697 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.415 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.5 OUTLIER -137.73 151.51 48.27 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 108.117 -1.068 . . . . 73.129999999999995 108.117 176.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -107.04 150.64 26.31 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.421 -0.912 . . . . 74.25 110.995 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.478 ' HB2' ' OD1' ' A' ' 129' ' ' ASP . 50.4 mtt180 -99.47 168.91 9.68 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.017 -0.992 . . . . 75.140000000000001 109.643 -172.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -80.97 -10.3 59.73 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.849 0.357 . . . . 74.040000000000006 110.617 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.478 ' OD1' ' HB2' ' A' ' 127' ' ' ARG . 11.4 p-10 -74.27 -16.04 60.96 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.058 0.456 . . . . 75.230000000000004 110.943 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.08 -11.95 26.78 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 120.834 -0.698 . . . . 61.409999999999997 112.055 178.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.4 m -105.08 -177.33 3.33 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.687 0.756 . . . . 74.329999999999998 110.208 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 28.8 p -143.62 169.4 17.8 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 106.69 -1.596 . . . . 54.530000000000001 106.69 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.415 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 0.0 OUTLIER -159.28 155.81 27.61 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.125 -0.694 . . . . 73.230000000000004 109.125 -178.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.4 mp -70.07 123.38 21.42 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.555 -0.906 . . . . 72.540000000000006 108.555 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -72.71 -54.47 8.88 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.741 -1.207 . . . . 75.239999999999995 107.741 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.4 m -168.4 165.89 12.54 Favored 'General case' 0 C--O 1.201 -1.472 0 N-CA-C 106.066 -1.827 . . . . 71.329999999999998 106.066 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.5 m -142.12 142.61 27.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 105.46 -2.052 . . . . 70.310000000000002 105.46 171.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -127.93 130.54 48.63 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 118.206 0.457 . . . . 75.340000000000003 110.439 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -115.25 128.91 56.45 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.901 -1.148 . . . . 74.200000000000003 107.901 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.6 pt -128.64 98.31 4.19 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.6 0 N-CA-C 108.07 -1.085 . . . . 74.200000000000003 108.07 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 74.7 mtm -87.27 128.36 35.17 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.631 -1.168 . . . . 74.549999999999997 111.71 -174.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.5 m 61.52 55.09 2.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 113.935 -1.484 . . . . 64.519999999999996 111.339 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 37.3 tptt . . . . . 0 N--CA 1.412 -2.343 0 N-CA-C 106.194 -1.78 . . . . 72.420000000000002 106.194 179.362 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.4 t70 . . . . . 0 C--O 1.242 0.707 0 CA-C-O 121.454 0.645 . . . . 73.319999999999993 111.387 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.52 -37.09 79.73 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.648 -0.871 . . . . 75.299999999999997 108.648 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -68.71 -42.41 77.73 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 115.873 -0.603 . . . . 71.450000000000003 110.627 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.695 HG13 ' SG ' ' A' ' 132' ' ' CYS . 13.2 m -69.92 -41.28 79.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.027 -0.533 . . . . 75.129999999999995 111.617 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.54 ' HB3' ' HZ1' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -77.33 -24.94 50.73 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 118.907 -1.117 . . . . 75.040000000000006 110.018 -178.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.07 -55.16 11.04 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 121.017 -0.611 . . . . 73.530000000000001 111.583 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.36 -35.26 71.07 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.244 -1.021 . . . . 75.349999999999994 108.244 -178.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.7 -43.57 97.69 Favored Glycine 0 N--CA 1.432 -1.583 0 O-C-N 123.936 0.772 . . . . 75.439999999999998 112.003 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -69.41 -42.07 75.57 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 120.841 -0.344 . . . . 75.450000000000003 110.82 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -63.16 -46.11 88.69 Favored 'General case' 0 C--O 1.253 1.262 0 N-CA-C 109.671 -0.492 . . . . 74.200000000000003 109.671 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.498 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 30.4 t80 -62.64 -53.12 59.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.923 -1.035 . . . . 74.420000000000002 110.61 177.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 29' ' ' ILE . 6.8 mm -61.2 -38.86 80.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 111.974 0.361 . . . . 72.109999999999999 111.974 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.39 -49.76 76.3 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 123.155 0.284 . . . . 73.230000000000004 110.307 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.3 pp -67.99 -29.6 68.66 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 120.562 -0.455 . . . . 75.120000000000005 111.121 -176.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.2 t -72.53 -27.71 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.401 0.62 . . . . 70.409999999999997 110.264 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.6 p -111.05 22.56 15.14 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.701 0.763 . . . . 72.230000000000004 109.115 -177.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -63.4 136.51 57.68 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.27 -1.332 . . . . 74.340000000000003 109.116 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -57.59 153.91 27.54 Favored Pre-proline 0 N--CA 1.435 -1.177 0 O-C-N 124.14 0.9 . . . . 74.109999999999999 110.72 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.79 -7.32 4.29 Favored 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 124.239 3.293 . . . . 74.239999999999995 113.093 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.73 -27.54 68.79 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.346 -0.843 . . . . 75.340000000000003 109.04 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.2 t -94.86 123.25 38.22 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 105.387 -2.079 . . . . 74.030000000000001 105.387 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.8 t -57.92 -48.06 84.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 123.566 0.541 . . . . 71.310000000000002 112.299 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -141.12 114.53 8.77 Favored 'General case' 0 N--CA 1.417 -2.106 0 C-N-CA 118.12 -1.432 . . . . 73.319999999999993 111.785 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.0 m -60.53 -32.64 71.66 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 123.203 0.601 . . . . 72.219999999999999 110.686 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -24.24 67.38 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.105 0.962 . . . . 74.120000000000005 110.791 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -70.62 -42.84 70.38 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 108.425 -0.954 . . . . 73.109999999999999 108.425 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -71.79 -30.57 65.68 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 114.535 -1.211 . . . . 55.530000000000001 108.841 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.6 tp -70.13 -41.51 73.82 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.631 -0.713 . . . . 75.349999999999994 110.091 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.56 -34.76 77.58 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.607 0.718 . . . . 63.5 109.694 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -68.72 -39.25 80.5 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.885 -1.052 . . . . 75.329999999999998 109.675 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -67.78 -41.45 83.2 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.773 -0.649 . . . . 75.200000000000003 111.238 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.4 pp -82.06 -4.16 56.22 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.074 -0.512 . . . . 74.5 111.254 -177.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -47.07 -58.21 6.47 Favored Glycine 0 C--O 1.213 -1.189 0 O-C-N 123.742 0.652 . . . . 64.209999999999994 112.863 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.79 -3.35 9.03 Favored 'Trans proline' 0 CA--C 1.556 1.6 0 C-N-CA 123.811 3.007 . . . . 71.0 113.074 172.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 69.1 m-70 -125.5 38.11 4.24 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 122.878 0.471 . . . . 64.420000000000002 109.837 -167.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.428 ' CB ' HG22 ' A' ' 65' ' ' THR . 7.1 m-20 -53.65 107.46 0.86 Allowed Pre-proline 0 C--N 1.321 -0.673 0 C-N-CA 126.25 1.82 . . . . 71.519999999999996 112.806 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -100.66 -164.96 0.06 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 123.118 2.545 . . . . 71.129999999999995 111.054 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -98.69 119.52 37.57 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 107.302 -1.37 . . . . 73.310000000000002 107.302 174.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.45 HD11 ' HA ' ' A' ' 65' ' ' THR . 72.1 mt -100.04 112.29 32.15 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.627 0 N-CA-C 109.102 -0.703 . . . . 72.109999999999999 109.102 -174.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -97.7 106.22 18.5 Favored 'General case' 0 C--N 1.283 -2.322 0 O-C-N 121.855 -0.528 . . . . 75.120000000000005 111.722 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.423 HG22 HG23 ' A' ' 56' ' ' ILE . 73.2 t -116.81 124.21 72.62 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 108.131 -1.063 . . . . 63.520000000000003 108.131 -175.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.0 m120 66.13 19.61 11.13 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 124.563 1.164 . . . . 72.510000000000005 109.291 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.81 11.85 78.56 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.567 -0.742 . . . . 74.409999999999997 111.291 -176.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -113.69 139.94 48.65 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 122.869 0.468 . . . . 74.340000000000003 110.196 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.21 125.5 35.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.997 0.903 . . . . 74.409999999999997 109.054 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -124.05 142.98 50.72 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.224 -1.028 . . . . 75.5 108.224 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 t -82.05 170.09 15.95 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.156 -1.053 . . . . 71.129999999999995 108.156 173.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.45 ' HA ' HD11 ' A' ' 56' ' ' ILE . 64.3 p -65.64 -34.08 77.38 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 123.843 0.857 . . . . 73.140000000000001 110.357 -176.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.9 m -65.05 -40.57 94.96 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.428 -1.26 . . . . 71.450000000000003 110.307 175.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.42 -46.49 79.74 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 116.169 -0.469 . . . . 71.150000000000006 109.809 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.416 ' CB ' HD13 ' A' ' 56' ' ' ILE . 48.9 t80 -52.06 -54.86 25.15 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 123.459 0.474 . . . . 73.299999999999997 109.963 174.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -50.82 -41.5 57.51 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.412 1.07 . . . . 73.340000000000003 110.774 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.455 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 45.8 mt-30 -63.08 -48.16 79.83 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 116.311 -0.404 . . . . 63.420000000000002 111.82 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.445 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 40.0 m-85 -69.33 -30.17 68.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.831 0.824 . . . . 75.010000000000005 109.739 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -61.32 -51.84 67.16 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.883 -1.053 . . . . 75.420000000000002 110.432 175.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 12.4 ptm180 -71.56 -21.7 61.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.128 0.489 . . . . 74.549999999999997 110.401 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 96.1 mt-30 -77.49 -3.29 39.77 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.041 -0.527 . . . . 74.0 111.538 173.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.05 22.37 63.55 Favored Glycine 0 N--CA 1.438 -1.215 0 CA-C-N 116.315 -0.402 . . . . 73.430000000000007 113.262 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.2 mt -83.51 -41.4 18.02 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.02 -0.672 . . . . 62.140000000000001 111.066 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.445 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 22.9 m-85 -100.91 -6.88 24.04 Favored 'General case' 0 C--O 1.185 -2.335 0 C-N-CA 119.845 -0.742 . . . . 75.340000000000003 112.838 -178.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -12.72 36.42 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 122.009 0.909 . . . . 74.140000000000001 112.847 -175.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HZ3' ' CG ' ' A' ' 118' ' ' ASP . 17.3 pttp -82.2 -9.6 59.45 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.229 -0.896 . . . . 75.239999999999995 112.536 176.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.498 HD13 ' O ' ' A' ' 80' ' ' LEU . 3.2 tm? -77.9 -14.96 59.38 Favored 'General case' 0 C--O 1.208 -1.113 0 C-N-CA 123.26 0.624 . . . . 73.409999999999997 110.906 -175.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -53.31 -19.05 2.9 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 114.39 1.255 . . . . 75.230000000000004 114.39 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -100.01 10.86 40.61 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 120.977 0.418 . . . . 73.349999999999994 110.682 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 104' ' ' LYS . . . -68.87 146.06 53.16 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.343 0.868 . . . . 64.439999999999998 113.343 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -114.41 156.72 23.97 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.484 -1.235 . . . . 64.549999999999997 107.71 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.53 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 38.0 p90 . . . . . 0 C--N 1.309 -1.194 0 N-CA-C 113.202 0.816 . . . . 75.129999999999995 113.202 -173.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 . . . . . 0 CA--C 1.482 -1.649 0 CA-C-O 121.361 0.6 . . . . 73.450000000000003 111.787 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -158.99 161.57 32.04 Favored Glycine 1 N--CA 1.391 -4.32 0 CA-C-N 114.638 -1.165 . . . . 54.130000000000003 110.381 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -107.22 123.23 47.99 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.234 -1.024 . . . . 75.219999999999999 108.234 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -117.86 103.4 9.93 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.22 -1.03 . . . . 75.319999999999993 108.22 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 87.2 mt -124.63 158.16 33.75 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 110.092 -0.336 . . . . 75.540000000000006 110.092 -177.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 8.3 p -133.68 134.51 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.439 0.638 . . . . 71.310000000000002 111.954 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.53 ' NE1' ' HB3' ' A' ' 85' ' ' PHE . 14.6 m-90 -106.82 147.66 29.45 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 124.318 1.047 . . . . 74.510000000000005 109.5 177.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 83' ' ' ALA . 62.6 mttm -127.91 126.49 41.6 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.016 -0.735 . . . . 74.329999999999998 109.016 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.6 t . . . . . 0 CA--C 1.553 1.081 0 N-CA-C 109.945 -0.391 . . . . 73.209999999999994 109.945 178.322 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 46.8 p90 . . . . . 0 N--CA 1.43 -1.436 0 N-CA-C 108.551 -0.907 . . . . 75.129999999999995 108.551 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.48 ' CG ' ' HZ3' ' A' ' 79' ' ' LYS . 7.1 m-20 -114.13 138.29 50.62 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.922 -1.51 . . . . 70.299999999999997 106.922 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.579 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 44.7 mt-10 -115.16 143.49 45.14 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.143 0.497 . . . . 75.319999999999993 109.927 175.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -129.43 120.94 26.33 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.724 -0.671 . . . . 74.450000000000003 110.877 -174.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 35.0 mt-10 -111.18 110.06 20.4 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.66 -0.496 . . . . 75.209999999999994 109.66 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.44 134.27 38.46 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 120.841 0.353 . . . . 74.049999999999997 110.401 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -118.5 120.17 36.72 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.437 1.095 . . . . 74.519999999999996 108.661 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.79 148.79 21.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 106.131 -1.803 . . . . 74.400000000000006 106.131 175.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -128.49 146.9 50.68 Favored 'General case' 0 C--O 1.262 1.742 0 C-N-CA 119.109 -1.036 . . . . 74.430000000000007 110.095 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -81.02 112.82 18.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.689 -1.226 . . . . 75.349999999999994 107.689 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.1 136.32 33.61 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 105.835 -1.913 . . . . 73.299999999999997 105.835 -175.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.98 -10.55 14.2 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-O 121.531 0.682 . . . . 73.25 111.889 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -72.01 -16.04 62.05 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.552 0.692 . . . . 74.230000000000004 109.644 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.68 -11.7 27.75 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.599 -0.81 . . . . 73.319999999999993 113.493 175.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 24.4 t -105.18 169.39 8.47 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 107.254 -1.387 . . . . 73.349999999999994 107.254 176.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.695 ' SG ' HG13 ' A' ' 21' ' ' VAL . 14.9 p -119.19 145.22 46.2 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 107.634 -1.247 . . . . 72.150000000000006 107.634 173.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -140.66 155.68 46.44 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.738 -0.838 . . . . 73.329999999999998 108.738 -176.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.11 125.11 25.81 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.54 0.686 . . . . 65.329999999999998 110.256 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -81.04 -57.39 3.55 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.701 -1.136 . . . . 74.430000000000007 108.034 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.8 m -166.16 157.13 13.11 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.237 -1.394 . . . . 55.229999999999997 107.237 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.6 135.98 43.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 106.862 -1.532 . . . . 71.310000000000002 106.862 171.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -108.99 136.12 49.04 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 122.731 0.412 . . . . 72.030000000000001 110.136 -174.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.415 ' HB2' HG23 ' A' ' 58' ' ' VAL . 62.6 m-85 -120.95 113.98 20.88 Favored 'General case' 0 C--O 1.255 1.352 0 CA-C-O 121.344 0.593 . . . . 74.420000000000002 109.671 176.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 13.9 pt -110.7 97.79 6.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-O 122.532 1.158 . . . . 74.150000000000006 109.248 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 19.8 ptm -101.31 93.77 5.59 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.163 -1.38 . . . . 73.230000000000004 110.164 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.0 m 160.8 19.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 127.004 2.122 . . . . 64.219999999999999 111.65 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.579 ' HG2' ' OE1' ' A' ' 119' ' ' GLU . 50.3 tptt . . . . . 0 C--N 1.319 -0.753 0 N-CA-C 107.079 -1.452 . . . . 74.150000000000006 107.079 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 t70 . . . . . 0 CA--C 1.511 -0.528 0 CA-C-O 121.162 0.506 . . . . 73.120000000000005 110.019 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.96 -39.55 94.99 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.138 -1.06 . . . . 64.310000000000002 108.138 175.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.35 -42.11 84.06 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.146 -0.934 . . . . 73.430000000000007 109.893 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.22 -45.1 94.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.514 -0.766 . . . . 72.340000000000003 111.082 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -70.89 -25.95 63.01 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.732 -0.387 . . . . 71.239999999999995 110.28 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.83 -45.41 58.02 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.214 -1.154 . . . . 62.350000000000001 110.214 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.4 tp -62.89 -50.15 72.0 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 124.579 1.152 . . . . 73.430000000000007 109.791 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.23 -43.24 98.68 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.656 -0.702 . . . . 72.439999999999998 112.017 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -66.17 -39.6 89.86 Favored 'General case' 0 C--O 1.211 -0.928 0 CA-C-O 119.22 -0.419 . . . . 73.239999999999995 111.218 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -60.62 -46.41 90.39 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.829 -0.804 . . . . 75.510000000000005 108.829 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.487 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 38.5 t80 -61.64 -53.74 52.18 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 114.377 -1.283 . . . . 73.219999999999999 110.424 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.9 mm -62.02 -36.17 72.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 112.464 0.542 . . . . 72.209999999999994 112.464 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.35 -41.16 81.08 Favored 'General case' 0 CA--C 1.491 -1.306 0 C-N-CA 120.333 -0.547 . . . . 73.209999999999994 109.864 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.543 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.8 pp -70.44 -28.03 64.72 Favored 'General case' 0 N--CA 1.421 -1.876 0 C-N-CA 119.498 -0.881 . . . . 74.340000000000003 111.761 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.1 t -70.62 -24.58 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 121.315 0.579 . . . . 73.150000000000006 109.653 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.5 p -115.18 21.85 13.83 Favored 'General case' 0 C--O 1.244 0.773 0 O-C-N 122.071 -0.393 . . . . 74.340000000000003 111.296 -176.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.543 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 53.2 mmtt -44.24 149.34 0.37 Allowed 'General case' 0 C--O 1.245 0.843 0 N-CA-C 115.808 1.781 . . . . 74.099999999999994 115.808 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 m -60.7 154.23 58.32 Favored Pre-proline 0 N--CA 1.423 -1.782 0 CA-C-N 112.981 -1.918 . . . . 70.129999999999995 108.191 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.04 -8.9 8.84 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 123.5 2.8 . . . . 71.150000000000006 112.941 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.8 -27.35 64.82 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.567 0.699 . . . . 73.549999999999997 109.878 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.7 m -118.21 81.43 1.68 Allowed 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 107.817 -1.179 . . . . 72.040000000000006 107.817 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -81.21 -5.3 8.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-O 122.258 1.028 . . . . 64.0 110.091 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -115.67 78.14 1.15 Allowed 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 107.414 -1.328 . . . . 74.439999999999998 107.414 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.6 m -66.43 -25.54 66.79 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 113.979 -1.464 . . . . 74.439999999999998 110.906 -173.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 6.5 pm0 -68.5 -22.98 64.51 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.616 -0.72 . . . . 73.129999999999995 110.533 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -63.94 -49.87 70.91 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.573 -0.899 . . . . 73.129999999999995 108.573 176.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -65.26 -38.24 89.69 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.439 -1.255 . . . . 73.239999999999995 109.96 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.6 tp -65.25 -42.96 92.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 116.429 -0.351 . . . . 74.340000000000003 110.73 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.13 -32.33 73.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.296 0.569 . . . . 75.340000000000003 110.435 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -74.2 -36.78 64.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.439 -0.8 . . . . 71.420000000000002 109.496 178.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 68.4 t80 -67.97 -42.95 80.09 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.189 0.996 . . . . 75.310000000000002 111.04 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 pp -81.3 -5.34 57.7 Favored 'General case' 0 C--O 1.204 -1.316 0 CA-C-N 115.907 -0.588 . . . . 72.120000000000005 111.138 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.54 -54.4 6.54 Favored Glycine 0 CA--C 1.545 1.92 0 CA-C-N 115.895 -0.593 . . . . 63.340000000000003 113.781 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -85.41 -3.56 9.34 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 123.356 2.704 . . . . 61.240000000000002 112.941 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -128.75 31.53 4.94 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.992 -0.443 . . . . 55.0 110.595 -168.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -56.0 111.91 3.72 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.132 0.973 . . . . 71.310000000000002 112.559 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -105.57 -159.68 0.03 OUTLIER 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 123.631 2.888 . . . . 72.129999999999995 111.367 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -89.16 124.11 34.04 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 108.189 -1.041 . . . . 74.519999999999996 108.189 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.45 HD13 ' CB ' ' A' ' 68' ' ' PHE . 59.6 mt -107.0 112.48 40.12 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.179 0 N-CA-C 107.447 -1.316 . . . . 74.129999999999995 107.447 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -98.18 136.14 38.82 Favored 'General case' 0 C--N 1.263 -3.166 0 O-C-N 121.468 -0.77 . . . . 74.099999999999994 109.108 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.0 t -132.38 117.34 31.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 107.286 -1.375 . . . . 74.109999999999999 107.286 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 65.47 20.99 11.8 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.5 1.12 . . . . 74.430000000000007 109.893 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.59 3.25 84.09 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.903 -1.044 . . . . 75.310000000000002 111.454 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -99.97 130.91 46.19 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 108.14 -1.059 . . . . 72.519999999999996 108.14 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.4 HD13 ' N ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -68.51 124.28 23.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 122.325 1.06 . . . . 74.219999999999999 110.549 -176.37 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.4 ' N ' HD13 ' A' ' 62' ' ' ILE . 61.7 mm-40 -123.55 143.06 50.43 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 107.315 -1.365 . . . . 73.409999999999997 107.315 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.1 t -87.42 171.3 10.66 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 109.023 -0.732 . . . . 74.310000000000002 109.023 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.3 t -53.83 -36.21 62.29 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.107 0.963 . . . . 74.439999999999998 111.426 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.493 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 16.4 m -61.91 -50.45 72.14 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 122.971 0.509 . . . . 75.340000000000003 110.35 178.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.37 -47.79 82.68 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 123.598 0.759 . . . . 73.209999999999994 110.744 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CB ' HD13 ' A' ' 56' ' ' ILE . 60.5 t80 -54.38 -55.31 29.92 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 123.755 0.659 . . . . 74.549999999999997 110.267 176.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -51.98 -40.76 61.44 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.187 0.929 . . . . 73.239999999999995 110.512 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 66' ' ' THR . 44.9 mt-30 -62.19 -49.07 77.28 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 116.577 -0.283 . . . . 74.129999999999995 111.118 176.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.0 -36.56 84.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.649 0.738 . . . . 71.329999999999998 110.092 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -59.2 -54.65 44.5 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 124.303 1.041 . . . . 74.299999999999997 110.971 176.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 7.8 ptm180 -68.76 -24.5 64.45 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.371 -0.377 . . . . 75.129999999999995 110.58 -176.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -86.38 -0.48 56.03 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.304 0.483 . . . . 71.040000000000006 112.304 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.72 13.29 61.29 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 115.391 0.916 . . . . 52.310000000000002 115.391 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.77 -39.69 94.03 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 112.701 0.63 . . . . 74.150000000000006 112.701 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -89.75 -2.02 58.15 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.537 0.569 . . . . 72.030000000000001 112.537 -174.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.49 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 98.9 mttt -65.78 -14.62 61.72 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.732 0.641 . . . . 75.129999999999995 112.732 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -76.79 -37.66 55.4 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.373 0.606 . . . . 74.420000000000002 110.029 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.503 HD23 ' O ' ' A' ' 80' ' ' LEU . 3.6 tt -88.88 5.56 43.3 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.031 -0.986 . . . . 74.230000000000004 110.85 -168.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -12.17 52.54 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.303 0.853 . . . . 75.109999999999999 113.303 -176.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.67 -36.51 51.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.574 0.702 . . . . 73.040000000000006 109.341 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 34.81 114.59 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 118.67 2.841 . . . . 74.0 118.67 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -113.77 123.39 49.72 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 113.847 -1.524 . . . . 74.409999999999997 107.537 173.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.8 p90 . . . . . 0 C--N 1.296 -1.736 0 C-N-CA 119.252 -0.979 . . . . 75.540000000000006 112.301 -176.759 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 N--CA 1.442 -0.855 0 N-CA-C 107.176 -1.416 . . . . 74.150000000000006 107.176 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 125' ' ' TRP . . . -80.93 152.78 33.54 Favored Glycine 0 N--CA 1.425 -2.034 0 C-N-CA 120.266 -0.969 . . . . 65.340000000000003 112.752 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -106.95 134.95 49.32 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.309 -1.367 . . . . 65.319999999999993 107.309 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 100' ' ' LYS . 7.7 mptt -124.21 102.59 7.78 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.433 -1.321 . . . . 74.310000000000002 107.433 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 96.0 mt -119.22 141.02 49.27 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 120.457 -0.497 . . . . 74.109999999999999 109.978 -176.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 121' ' ' GLU . 20.3 t -122.9 135.39 63.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.941 -0.392 . . . . 74.409999999999997 109.941 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -120.38 141.42 50.11 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.38 -0.97 . . . . 75.409999999999997 108.38 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -114.96 144.33 43.75 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 109.304 -0.628 . . . . 73.140000000000001 109.304 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.293 -1.869 0 C-N-CA 124.165 0.986 . . . . 74.040000000000006 108.625 174.816 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 46.2 p90 . . . . . 0 N--CA 1.425 -1.709 0 N-CA-C 108.633 -0.877 . . . . 74.239999999999995 108.633 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -102.55 141.14 35.87 Favored 'General case' 0 C--N 1.264 -3.15 0 N-CA-C 106.653 -1.61 . . . . 65.540000000000006 106.653 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.495 ' CD ' ' HG3' ' A' ' 143' ' ' LYS . 93.5 mt-10 -114.94 141.39 48.02 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.484 -0.486 . . . . 74.329999999999998 110.005 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.72 121.77 31.19 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.838 -0.619 . . . . 71.510000000000005 109.565 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.429 ' HB3' HG21 ' A' ' 102' ' ' VAL . 14.5 pt-20 -123.77 115.33 21.2 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-O 121.626 0.726 . . . . 63.350000000000001 111.784 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.31 135.7 35.43 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.891 -1.049 . . . . 72.420000000000002 109.891 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -117.28 117.47 29.64 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.431 -0.951 . . . . 74.5 108.431 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.525 HG22 ' SG ' ' A' ' 132' ' ' CYS . 54.4 mt -119.76 128.87 75.92 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 N-CA-C 105.533 -2.025 . . . . 75.219999999999999 105.533 176.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.45 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 0.2 OUTLIER -110.89 145.18 38.74 Favored 'General case' 0 N--CA 1.425 -1.723 0 C-N-CA 117.373 -1.731 . . . . 74.420000000000002 110.536 -177.223 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -103.84 118.26 36.27 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 107.711 -1.218 . . . . 75.010000000000005 107.711 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -75.9 155.67 35.0 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.205 -1.361 . . . . 75.049999999999997 109.422 -174.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -60.12 -22.57 62.97 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.011 0.91 . . . . 74.510000000000005 110.106 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.69 -13.37 54.12 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.703 1.201 . . . . 72.310000000000002 111.336 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.77 -23.71 34.68 Favored Glycine 0 CA--C 1.498 -1.001 0 N-CA-C 111.22 -0.752 . . . . 54.25 111.22 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.0 p -78.37 159.58 28.28 Favored 'General case' 0 N--CA 1.408 -2.565 0 C-N-CA 124.06 0.944 . . . . 74.430000000000007 110.392 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.525 ' SG ' HG22 ' A' ' 124' ' ' ILE . 7.7 t -135.49 143.7 45.96 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 108.889 -0.782 . . . . 75.209999999999994 108.889 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -153.85 156.17 37.11 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.966 -1.124 . . . . 72.209999999999994 107.966 -176.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.0 mp -68.81 127.9 34.74 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.834 -0.432 . . . . 74.329999999999998 109.834 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -87.02 -52.26 5.54 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.902 0.858 . . . . 72.140000000000001 108.767 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.8 p -174.93 162.02 3.07 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.324 -1.307 . . . . 63.030000000000001 108.131 -175.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.6 m -137.08 144.44 32.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 N-CA-C 106.342 -1.725 . . . . 73.209999999999994 106.342 172.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -124.65 130.6 52.73 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 120.674 -0.41 . . . . 72.120000000000005 110.78 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -109.97 127.75 54.98 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.573 -1.269 . . . . 64.030000000000001 107.573 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.7 pt -126.82 99.01 5.12 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-O 121.932 0.872 . . . . 73.239999999999995 111.803 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -86.05 92.25 8.65 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 105.402 -2.073 . . . . 75.109999999999999 105.402 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.7 m -165.66 3.35 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.277 -0.42 . . . . 64.310000000000002 112.01 -176.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.495 ' HG3' ' CD ' ' A' ' 119' ' ' GLU . 28.1 mmtp . . . . . 0 CA--C 1.489 -1.383 0 C-N-CA 119.57 -0.852 . . . . 73.409999999999997 111.935 -176.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 t70 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 121.726 0.774 . . . . 73.209999999999994 110.964 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.36 -33.32 72.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.918 -1.142 . . . . 73.219999999999999 107.918 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -69.98 -38.95 76.18 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.185 -0.916 . . . . 75.030000000000001 109.728 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.578 HG23 ' SG ' ' A' ' 132' ' ' CYS . 61.9 t -58.32 -53.89 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 123.507 0.504 . . . . 75.340000000000003 110.011 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.06 -32.78 74.2 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.874 -0.731 . . . . 72.340000000000003 111.413 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.86 -37.24 83.6 Favored Glycine 0 C--O 1.229 -0.161 0 N-CA-C 111.465 -0.654 . . . . 64.340000000000003 111.465 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.7 tp -65.45 -46.48 79.68 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 124.102 0.961 . . . . 74.430000000000007 108.663 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.46 -41.27 99.79 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.167 -0.924 . . . . 74.230000000000004 111.577 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -61.71 -42.28 98.74 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 122.731 0.412 . . . . 70.310000000000002 110.737 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -64.55 -47.71 77.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.356 0.598 . . . . 64.310000000000002 109.407 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -61.43 -51.59 68.09 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.309 -1.314 . . . . 61.240000000000002 110.42 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 29' ' ' ILE . 15.3 mm -64.82 -32.28 57.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 116.24 -0.436 . . . . 53.509999999999998 111.687 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.31 -43.0 71.23 Favored 'General case' 0 CA--C 1.479 -1.784 0 C-N-CA 119.761 -0.775 . . . . 73.400000000000006 109.99 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.674 ' O ' ' HB3' ' A' ' 41' ' ' SER . 4.1 pp -70.53 -26.03 63.38 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 119.912 -0.715 . . . . 73.129999999999995 112.045 -178.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.0 t -70.25 -28.02 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 121.453 0.644 . . . . 64.420000000000002 109.777 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.9 p -114.21 23.66 12.67 Favored 'General case' 0 C--O 1.25 1.111 0 N-CA-C 109.148 -0.686 . . . . 73.299999999999997 109.148 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.496 ' HD3' ' HA ' ' A' ' 31' ' ' LEU . 27.4 tptt -52.8 137.56 31.48 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.342 -1.299 . . . . 73.219999999999999 111.684 -173.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.0 p -40.72 138.89 1.22 Allowed Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 125.411 1.484 . . . . 72.450000000000003 112.576 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -57.3 -15.22 18.06 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 123.545 2.83 . . . . 62.530000000000001 113.209 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.52 -27.94 68.96 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.921 0.867 . . . . 71.230000000000004 109.114 174.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.7 p -119.26 96.48 5.24 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 114.667 -1.151 . . . . 62.43 108.179 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.6 t -66.32 -50.03 71.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 113.348 0.87 . . . . 74.340000000000003 113.348 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.437 ' OD1' ' HB2' ' A' ' 43' ' ' HIS . 17.6 t-20 -89.72 80.76 6.51 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 123.111 1.434 . . . . 71.349999999999994 112.023 -171.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.674 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 15.8 m -67.2 -27.48 67.3 Favored 'General case' 0 C--O 1.255 1.374 0 CA-C-N 113.008 -1.906 . . . . 64.430000000000007 109.632 -175.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -68.52 -20.34 64.56 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 114.318 -1.31 . . . . 74.409999999999997 112.619 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.437 ' HB2' ' OD1' ' A' ' 40' ' ' ASN . 13.2 t60 -70.49 -38.46 74.35 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.19 -1.041 . . . . 72.209999999999994 108.19 175.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -66.57 -36.65 83.17 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.377 -0.972 . . . . 75.329999999999998 108.377 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.64 -43.18 97.54 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.671 -0.695 . . . . 74.450000000000003 110.722 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.01 79.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.31 0.576 . . . . 71.239999999999995 110.469 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -68.47 -39.12 81.52 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.443 -0.799 . . . . 73.030000000000001 109.698 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -69.4 -41.21 76.73 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 123.624 0.769 . . . . 73.310000000000002 111.084 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.438 HD12 ' C ' ' A' ' 49' ' ' LEU . 4.3 pp -79.52 -7.98 58.84 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-N 116.02 -0.536 . . . . 72.430000000000007 112.143 -176.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.05 -61.61 5.22 Favored Glycine 0 CA--C 1.541 1.687 0 C-N-CA 121.231 -0.509 . . . . 72.219999999999999 112.788 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -76.48 -4.92 15.61 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.118 2.545 . . . . 72.319999999999993 112.47 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -122.61 29.95 6.68 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.889 -0.507 . . . . 74.030000000000001 110.646 -173.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.556 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 6.2 t70 -55.83 106.8 0.72 Allowed Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 125.207 1.403 . . . . 72.150000000000006 113.274 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -107.33 -165.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 123.894 3.063 . . . . 64.329999999999998 112.803 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -87.85 115.58 25.41 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.077 -1.082 . . . . 72.510000000000005 108.077 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 53.4 mt -101.27 108.77 24.11 Favored 'Isoleucine or valine' 0 C--O 1.168 -3.217 0 N-CA-C 108.398 -0.964 . . . . 74.530000000000001 108.398 -176.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -93.55 135.91 34.35 Favored 'General case' 0 C--N 1.272 -2.788 0 O-C-N 121.397 -0.814 . . . . 74.140000000000001 108.998 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 55.7 t -133.49 116.93 25.95 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.951 -1.129 . . . . 74.140000000000001 107.951 177.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 61.89 20.5 11.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.126 1.37 . . . . 74.430000000000007 110.931 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.6 4.72 60.51 Favored Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.26 -0.882 . . . . 75.230000000000004 112.822 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -107.45 134.77 49.99 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 108.096 -1.076 . . . . 71.340000000000003 108.096 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.11 127.88 38.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.523 0.678 . . . . 75.439999999999998 109.247 -178.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -122.01 150.12 42.53 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.005 -1.109 . . . . 73.409999999999997 108.005 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 t -97.86 174.09 6.76 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.414 -0.958 . . . . 75.239999999999995 108.414 176.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.556 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 8.9 t -53.77 -35.22 61.08 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 122.816 0.446 . . . . 75.319999999999993 111.058 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.518 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 10.7 m -58.73 -56.0 27.86 Favored 'General case' 0 C--O 1.212 -0.897 0 O-C-N 123.5 0.5 . . . . 63.530000000000001 110.014 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.96 -48.03 82.99 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 123.493 0.496 . . . . 74.439999999999998 111.014 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -52.95 -56.86 12.85 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.464 0.478 . . . . 74.349999999999994 110.012 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -52.11 -42.87 63.63 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.716 -1.129 . . . . 73.140000000000001 110.857 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.8 mm100 -60.49 -48.77 80.32 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 122.797 0.439 . . . . 73.230000000000004 111.343 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.5 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 23.3 m-85 -66.41 -37.5 85.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.937 -0.764 . . . . 65.129999999999995 108.937 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -57.45 -53.37 58.89 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 123.762 0.825 . . . . 75.239999999999995 110.911 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -70.95 -19.2 62.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.118 0.485 . . . . 74.230000000000004 111.42 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -84.21 -9.91 58.14 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 112.972 0.731 . . . . 74.040000000000006 112.972 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.76 21.36 16.47 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 119.975 -1.107 . . . . 73.510000000000005 113.612 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.18 -49.7 9.19 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 122.255 -0.556 . . . . 74.329999999999998 110.78 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 62.4 m-85 -92.1 11.18 26.29 Favored 'General case' 0 C--O 1.193 -1.876 0 N-CA-C 113.333 0.864 . . . . 75.109999999999999 113.333 -175.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -12.35 59.96 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.391 0.885 . . . . 71.430000000000007 113.391 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -87.46 -10.05 52.92 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.648 -1.16 . . . . 74.409999999999997 111.779 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.7 tt -65.05 -26.24 68.17 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 122.505 0.322 . . . . 74.340000000000003 110.955 -173.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -60.86 -24.46 65.93 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.16 0.43 . . . . 75.010000000000005 112.16 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -105.16 13.65 30.35 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 112.108 0.41 . . . . 73.450000000000003 112.108 -178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 103' ' ' TRP . . . -70.17 126.46 29.75 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.414 0.626 . . . . 45.210000000000001 111.224 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -86.61 123.81 32.2 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.087 -0.96 . . . . 73.510000000000005 109.458 -177.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.457 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 39.7 p90 . . . . . 0 C--N 1.294 -1.827 0 CA-C-O 121.238 0.542 . . . . 74.040000000000006 111.833 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 110.145 -0.317 . . . . 64.099999999999994 110.145 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 125' ' ' TRP . . . -100.0 148.89 18.63 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.649 -0.786 . . . . 70.430000000000007 113.214 -176.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -107.04 135.2 49.0 Favored 'General case' 0 C--O 1.25 1.111 0 N-CA-C 106.679 -1.6 . . . . 71.239999999999995 106.679 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -126.67 107.8 10.51 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.933 -0.766 . . . . 74.540000000000006 108.933 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.3 mt -114.57 138.14 51.0 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.082 -1.081 . . . . 73.400000000000006 108.082 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 11.8 p -127.26 137.69 57.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.572 0.701 . . . . 73.109999999999999 111.715 -177.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.457 ' NE1' ' HB3' ' A' ' 85' ' ' PHE . 17.4 m-90 -118.49 157.18 27.74 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.833 -1.076 . . . . 73.340000000000003 109.622 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.12 121.35 40.33 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.884 -1.895 . . . . 63.420000000000002 105.884 170.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.4 t . . . . . 0 C--N 1.279 -2.483 0 CA-C-N 115.777 -0.647 . . . . 70.030000000000001 110.917 -174.6 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 41.2 p90 . . . . . 0 N--CA 1.416 -2.165 0 N-CA-C 108.757 -0.831 . . . . 74.420000000000002 108.757 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.477 ' HB3' ' HA ' ' A' ' 141' ' ' MET . 2.7 p-10 -124.37 146.38 48.89 Favored 'General case' 0 C--N 1.249 -3.774 0 N-CA-C 108.82 -0.808 . . . . 74.219999999999999 108.82 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -113.78 147.88 37.53 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 119.725 -0.79 . . . . 75.310000000000002 109.786 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -131.45 120.22 22.71 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.345 -0.843 . . . . 74.409999999999997 111.274 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -110.83 118.1 35.22 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 108.207 -1.035 . . . . 74.430000000000007 108.207 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -106.15 134.66 48.94 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.664 -0.648 . . . . 74.230000000000004 110.146 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -119.82 118.75 31.62 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.171 -0.922 . . . . 73.409999999999997 110.818 -174.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.33 145.37 26.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 106.331 -1.729 . . . . 60.439999999999998 106.331 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.467 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.4 OUTLIER -123.58 140.06 53.38 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 117.751 -1.58 . . . . 75.109999999999999 108.924 174.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -85.19 120.05 26.25 Favored 'General case' 0 N--CA 1.403 -2.811 0 N-CA-C 106.165 -1.791 . . . . 74.019999999999996 106.165 172.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.41 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 76.6 ttt180 -69.82 149.33 48.03 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.116 -1.438 . . . . 73.530000000000001 107.116 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.24 -20.35 58.53 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.697 0.76 . . . . 74.140000000000001 111.03 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.41 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 11.5 t70 -64.8 -18.13 64.83 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.507 1.123 . . . . 72.200000000000003 111.245 175.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.19 -21.28 33.72 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.192 -0.763 . . . . 74.129999999999995 111.192 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.0 m -78.2 171.33 15.2 Favored 'General case' 0 N--CA 1.419 -2.013 0 C-N-CA 123.562 0.745 . . . . 75.25 109.153 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.578 ' SG ' HG23 ' A' ' 21' ' ' VAL . 28.3 p -140.52 151.25 44.62 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 109.486 -0.561 . . . . 73.340000000000003 109.486 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.467 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 1.8 t90 -152.07 155.29 37.63 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.537 -1.283 . . . . 75.310000000000002 107.537 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.3 mp -68.82 123.87 22.14 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.349 0.595 . . . . 74.450000000000003 110.287 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -83.68 -50.6 8.02 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.135 -0.938 . . . . 74.409999999999997 108.563 -176.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 26.6 p -170.2 166.09 8.96 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 108.294 -1.002 . . . . 74.109999999999999 108.294 -177.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.2 t -143.52 143.37 24.45 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 N-CA-C 104.683 -2.34 . . . . 73.129999999999995 104.683 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -131.48 131.13 43.25 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 117.721 0.237 . . . . 74.400000000000006 110.866 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 62.7 m-85 -118.17 130.54 56.16 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.147 -1.057 . . . . 64.530000000000001 108.147 177.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.5 pt -125.97 103.84 12.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-O 121.352 0.596 . . . . 75.209999999999994 111.438 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.477 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 52.8 mtt -95.85 94.85 7.88 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.064 -0.516 . . . . 64.439999999999998 109.611 -178.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.2 m -164.25 -46.38 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.018 -0.537 . . . . 75.209999999999994 110.672 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.9 tptm . . . . . 0 N--CA 1.475 0.787 0 C-N-CA 125.644 1.578 . . . . 73.420000000000002 113.363 -173.182 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.0 t70 . . . . . 0 N--CA 1.444 -0.759 0 CA-C-O 121.134 0.492 . . . . 73.310000000000002 110.758 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.76 -37.34 81.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.518 -0.765 . . . . 75.530000000000001 108.941 178.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -66.65 -53.45 33.83 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 115.199 -0.91 . . . . 63.149999999999999 109.931 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.8 p -66.32 -32.99 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 116.033 -0.53 . . . . 71.109999999999999 112.39 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HZ3' ' HB3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -74.52 -33.89 62.88 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 119.045 -1.062 . . . . 73.540000000000006 110.045 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.29 -41.36 68.7 Favored Glycine 0 CA--C 1.496 -1.1 0 N-CA-C 110.605 -0.998 . . . . 53.030000000000001 110.605 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.7 tp -65.15 -50.8 64.59 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 123.778 0.831 . . . . 73.510000000000005 109.698 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.33 -42.18 97.26 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.61 -0.723 . . . . 72.129999999999995 112.258 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -74.02 -32.52 63.4 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 120.159 -0.616 . . . . 75.530000000000001 111.559 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.86 -44.04 97.19 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.069 -0.715 . . . . 71.310000000000002 109.069 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 23.0 t80 -62.08 -53.73 51.3 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.08 -1.418 . . . . 74.209999999999994 110.31 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.6 mm -61.09 -40.53 86.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.606 0.595 . . . . 73.239999999999995 112.606 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.5 -40.49 85.19 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 120.521 -0.471 . . . . 75.420000000000002 110.136 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.543 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.8 pp -71.54 -27.51 63.24 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 118.801 -1.16 . . . . 72.519999999999996 112.054 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.5 t -71.07 -21.65 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 121.27 0.557 . . . . 73.329999999999998 109.527 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.0 p -115.09 22.31 13.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 122.115 -0.366 . . . . 75.409999999999997 111.915 -177.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.543 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 61.0 mmtt -49.82 133.71 21.59 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 113.544 0.942 . . . . 74.120000000000005 113.544 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.5 m -55.21 150.39 21.88 Favored Pre-proline 0 C--N 1.302 -1.496 0 C-N-CA 125.537 1.535 . . . . 74.420000000000002 110.487 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -59.18 -12.77 17.05 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.658 2.905 . . . . 62.530000000000001 112.857 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.52 -27.42 69.14 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.072 0.939 . . . . 63.25 109.1 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.4 p -109.99 99.17 8.32 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 106.354 -1.721 . . . . 71.340000000000003 106.354 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.8 p -49.61 -37.88 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 116.657 2.095 . . . . 71.120000000000005 116.657 -168.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -132.49 110.54 10.57 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 118.153 -1.419 . . . . 73.0 113.149 -174.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.8 m -65.89 -35.77 81.56 Favored 'General case' 0 C--O 1.256 1.412 0 CA-C-O 121.823 0.821 . . . . 73.540000000000006 110.331 -175.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.564 ' OE2' ' HA ' ' A' ' 78' ' ' LYS . 1.5 mp0 -66.6 -21.3 66.13 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.243 -0.889 . . . . 75.140000000000001 110.586 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -68.62 -42.23 78.39 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 108.533 -0.914 . . . . 74.030000000000001 108.533 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -69.76 -35.01 74.57 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 108.098 -1.075 . . . . 72.340000000000003 108.098 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.0 tp -66.97 -42.97 84.25 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.896 -0.593 . . . . 70.209999999999994 110.801 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.99 -34.39 76.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.624 0.726 . . . . 70.530000000000001 110.366 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -76.35 -32.72 58.82 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.197 -0.91 . . . . 64.140000000000001 109.98 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.484 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 59.9 t80 -67.28 -47.7 69.86 Favored 'General case' 0 C--O 1.215 -0.744 0 C-N-CA 123.48 0.712 . . . . 73.409999999999997 109.991 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.465 ' C ' HD13 ' A' ' 49' ' ' LEU . 4.5 pp -75.03 -4.14 36.65 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.766 -0.652 . . . . 74.549999999999997 111.107 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.61 -61.13 5.36 Favored Glycine 0 CA--C 1.526 0.755 0 O-C-N 123.644 0.59 . . . . 74.109999999999999 112.371 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.484 ' HD2' ' O ' ' A' ' 48' ' ' PHE . 93.5 Cg_endo -85.18 -6.5 9.3 Favored 'Trans proline' 0 CA--C 1.549 1.264 0 C-N-CA 122.214 1.942 . . . . 74.329999999999998 112.672 173.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.45 ' HD2' ' O ' ' A' ' 48' ' ' PHE . 91.3 m-70 -111.41 31.35 6.18 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.726 -0.472 . . . . 72.450000000000003 109.726 -175.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -54.68 107.82 0.97 Allowed Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 124.679 1.192 . . . . 75.519999999999996 112.505 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -108.7 -154.45 0.02 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.294 0 C-N-CA 123.602 2.868 . . . . 74.400000000000006 110.485 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -93.63 120.13 33.52 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 107.195 -1.409 . . . . 74.239999999999995 107.195 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.438 HD12 ' CB ' ' A' ' 68' ' ' PHE . 64.7 mt -101.56 110.38 28.25 Favored 'Isoleucine or valine' 0 C--O 1.168 -3.19 0 N-CA-C 108.038 -1.097 . . . . 74.129999999999995 108.038 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -96.77 138.62 34.05 Favored 'General case' 0 C--N 1.271 -2.839 0 O-C-N 121.304 -0.873 . . . . 75.329999999999998 109.304 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.5 t -133.07 114.44 21.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 107.502 -1.296 . . . . 74.329999999999998 107.502 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 63.19 21.02 12.63 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 124.794 1.237 . . . . 73.319999999999993 111.073 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.92 -1.16 59.41 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.329 -0.851 . . . . 71.420000000000002 112.39 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -103.96 135.27 45.79 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.417 -0.586 . . . . 73.340000000000003 109.417 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -76.97 129.2 37.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.671 0.748 . . . . 74.310000000000002 109.265 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -126.21 147.55 49.64 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 124.642 1.177 . . . . 73.430000000000007 108.227 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 t -92.63 174.56 7.2 Favored 'General case' 0 C--O 1.254 1.341 0 N-CA-C 108.232 -1.025 . . . . 75.200000000000003 108.232 175.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.8 t -54.8 -36.17 64.65 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.028 0.531 . . . . 71.239999999999995 111.058 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.425 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 35.8 m -65.92 -46.42 78.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 122.729 0.412 . . . . 74.140000000000001 111.194 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.88 -46.19 86.01 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.91 -0.404 . . . . 62.0 109.91 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.438 ' CB ' HD12 ' A' ' 56' ' ' ILE . 48.9 t80 -54.28 -54.94 33.41 Favored 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 123.656 0.597 . . . . 74.219999999999999 109.723 174.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.465 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 2.2 tm? -50.39 -44.36 54.87 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 124.424 1.078 . . . . 73.040000000000006 110.54 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 26.8 mt-30 -56.91 -52.11 66.45 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 123.101 0.56 . . . . 73.239999999999995 111.929 174.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -64.87 -36.53 84.66 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.704 0.764 . . . . 74.109999999999999 109.817 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -57.7 -55.99 27.72 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 124.612 1.165 . . . . 71.349999999999994 110.472 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 48.9 ptt85 -68.87 -23.93 64.28 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.358 -0.383 . . . . 74.510000000000005 111.597 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 54.8 mt-30 -78.99 -15.31 58.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 120.432 -0.507 . . . . 74.019999999999996 111.459 176.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.47 14.33 30.41 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.677 -0.773 . . . . 72.200000000000003 114.622 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.16 -42.54 79.91 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.437 0.532 . . . . 74.120000000000005 112.437 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -92.48 6.89 45.42 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.587 0.588 . . . . 75.200000000000003 112.587 -173.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.564 ' HA ' ' OE2' ' A' ' 42' ' ' GLU . 99.4 mttt -67.06 -13.96 62.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.222 0.534 . . . . 75.219999999999999 112.233 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -77.57 -27.24 51.39 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.083 -0.71 . . . . 75.530000000000001 109.083 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.453 ' O ' HD22 ' A' ' 80' ' ' LEU . 7.1 tt -71.63 -17.51 62.26 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.077 0.951 . . . . 75.129999999999995 109.662 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -68.04 -22.04 64.97 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.105 -0.498 . . . . 75.099999999999994 109.879 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -101.13 4.76 42.4 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.379 -0.601 . . . . 73.310000000000002 109.379 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 105' ' ' SER . . . -75.73 143.17 42.2 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.525 0.935 . . . . 60.119999999999997 113.525 -173.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.14 139.37 30.54 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.12 -0.945 . . . . 74.5 109.175 175.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.5 t80 . . . . . 0 N--CA 1.43 -1.469 0 N-CA-C 104.465 -2.42 . . . . 65.340000000000003 104.465 167.953 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 . . . . . 0 CA--C 1.508 -0.643 0 N-CA-C 113.508 0.929 . . . . 64.010000000000005 113.508 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.83 138.12 13.73 Favored Glycine 0 N--CA 1.406 -3.33 0 N-CA-C 107.556 -2.218 . . . . 51.43 107.556 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -111.14 127.0 55.43 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.583 -0.895 . . . . 72.329999999999998 108.583 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -123.2 98.63 5.96 Favored 'General case' 0 C--N 1.273 -2.736 0 N-CA-C 105.44 -2.059 . . . . 72.230000000000004 105.44 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 75.2 mt -109.75 138.84 45.53 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.034 -0.985 . . . . 74.409999999999997 108.897 -173.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 12.1 p -133.43 138.2 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-O 121.729 0.776 . . . . 72.329999999999998 111.839 -178.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 23.3 m-90 -113.77 143.71 44.19 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.392 -1.277 . . . . 74.109999999999999 107.661 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -126.01 124.24 40.26 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.092 -1.447 . . . . 75.209999999999994 107.092 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 40.0 m . . . . . 0 C--N 1.281 -2.407 0 O-C-N 123.397 0.436 . . . . 75.109999999999999 111.012 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.412 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 10.2 p90 . . . . . 0 N--CA 1.439 -1.017 0 N-CA-C 108.918 -0.771 . . . . 73.549999999999997 108.918 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.407 ' CB ' ' HA ' ' A' ' 141' ' ' MET . 4.7 p-10 -113.01 134.65 54.41 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-O 121.199 0.523 . . . . 74.530000000000001 110.07 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.412 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 37.2 mt-10 -117.16 154.62 30.78 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.783 -1.099 . . . . 73.519999999999996 112.015 178.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -135.79 118.48 16.05 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.042 -0.981 . . . . 61.299999999999997 109.284 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 37.2 mt-10 -116.4 110.54 18.8 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.624 -0.51 . . . . 74.319999999999993 109.624 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.21 130.65 41.87 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 109.057 -0.72 . . . . 73.120000000000005 109.057 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -113.84 118.52 34.48 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.964 -0.754 . . . . 73.040000000000006 108.964 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.3 mt -118.95 152.69 21.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.388 -1.338 . . . . 74.510000000000005 107.388 178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -137.53 148.55 46.06 Favored 'General case' 0 C--O 1.275 2.417 0 C-N-CA 119.715 -0.794 . . . . 74.430000000000007 109.922 175.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -88.11 129.37 35.32 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.116 -0.947 . . . . 74.409999999999997 108.691 170.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.41 ' HD3' ' OG ' ' A' ' 131' ' ' SER . 47.8 ttt180 -87.86 147.29 25.18 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-N 113.983 -1.462 . . . . 75.530000000000001 108.075 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -58.21 -28.27 64.66 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.855 0.462 . . . . 75.329999999999998 112.065 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.84 -16.87 63.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.148 -0.933 . . . . 74.519999999999996 111.702 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.6 6.8 56.24 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 119.849 -1.167 . . . . 63.109999999999999 111.283 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.41 ' OG ' ' HD3' ' A' ' 127' ' ' ARG . 0.4 OUTLIER -96.89 162.37 13.44 Favored 'General case' 0 N--CA 1.396 -3.151 0 N-CA-C 108.438 -0.949 . . . . 72.219999999999999 108.438 175.711 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 28.8 p -133.22 144.99 50.15 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 107.967 -1.123 . . . . 63.210000000000001 107.967 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -159.06 156.05 28.5 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 120.088 -0.645 . . . . 75.109999999999999 109.797 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.6 mp -69.23 127.01 31.54 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.268 0.556 . . . . 65.519999999999996 109.773 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -80.89 -56.12 4.34 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.806 -1.183 . . . . 75.430000000000007 107.806 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 10.9 m -166.5 162.27 16.67 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 105.931 -1.877 . . . . 65.299999999999997 105.931 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.7 m -137.55 149.84 25.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 106.394 -1.706 . . . . 74.230000000000004 106.394 171.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -134.4 130.71 37.26 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 117.686 0.221 . . . . 71.400000000000006 110.414 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -112.63 129.05 56.52 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 107.312 -1.366 . . . . 74.049999999999997 107.312 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 8.4 pt -129.0 98.3 4.08 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 CA-C-O 122.129 0.966 . . . . 75.299999999999997 109.048 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.407 ' HA ' ' CB ' ' A' ' 118' ' ' ASP . 23.3 ptp -92.83 138.31 31.6 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.013 -0.994 . . . . 72.239999999999995 110.205 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.5 t 81.26 29.02 0.17 Allowed 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.264 0.977 . . . . 74.230000000000004 109.812 176.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 80.4 tttt . . . . . 0 N--CA 1.439 -1.009 0 N-CA-C 106.282 -1.747 . . . . 75.099999999999994 106.282 173.557 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 9.6 m-20 . . . . . 0 CA--C 1.508 -0.664 0 CA-C-O 120.533 0.206 . . . . 71.129999999999995 111.21 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.4 -42.95 87.12 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.873 -0.788 . . . . 75.510000000000005 108.873 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.17 -48.81 78.4 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 115.86 -0.609 . . . . 73.340000000000003 111.411 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.0 p -69.38 -38.83 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 112.552 0.575 . . . . 74.450000000000003 112.552 -176.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 22.5 ptmt -75.76 -25.96 56.96 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 119.076 -1.05 . . . . 73.329999999999998 110.187 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.56 -57.74 5.82 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 120.64 -0.791 . . . . 74.040000000000006 111.262 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 pp -68.45 -35.91 78.26 Favored 'General case' 0 C--O 1.199 -1.559 0 N-CA-C 108.947 -0.76 . . . . 65.129999999999995 108.947 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.23 -43.67 96.69 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 116.231 -0.44 . . . . 70.340000000000003 112.036 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -63.83 -46.85 83.2 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.76 -0.459 . . . . 73.319999999999993 109.76 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -65.16 -41.27 94.85 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 116.051 -0.522 . . . . 71.239999999999995 110.247 -177.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -63.05 -53.59 51.39 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.418 -0.81 . . . . 74.420000000000002 110.481 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.5 mm -64.23 -34.81 71.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.613 -0.267 . . . . 74.430000000000007 111.666 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -63.3 -48.59 77.43 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 116.34 -0.391 . . . . 72.239999999999995 110.144 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 pp -68.57 -29.35 67.88 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.288 -0.565 . . . . 75.219999999999999 111.84 -177.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.45 -28.54 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-O 121.471 0.653 . . . . 71.400000000000006 110.326 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.7 p -110.17 13.29 23.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.34 0.59 . . . . 54.210000000000001 110.566 -175.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 tptt -57.0 140.39 49.14 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.638 1.175 . . . . 74.310000000000002 111.928 -175.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.6 m -57.63 155.26 21.75 Favored Pre-proline 0 C--O 1.248 1.014 0 C-N-CA 124.183 0.993 . . . . 64.010000000000005 111.259 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.83 -5.99 5.39 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 124.82 3.68 . . . . 73.340000000000003 112.146 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -59.7 -26.42 65.59 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.463 -1.244 . . . . 64.439999999999998 110.589 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.2 p -92.43 167.72 11.78 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 107.358 -1.349 . . . . 73.109999999999999 107.358 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.62 -46.93 67.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 118.884 -1.126 . . . . 74.530000000000001 111.13 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -168.09 141.64 3.28 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.331 -0.989 . . . . 73.510000000000005 108.331 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.8 m -56.62 -41.29 76.84 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 123.186 0.594 . . . . 72.450000000000003 111.067 -177.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -67.83 -20.06 65.12 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.947 -1.024 . . . . 74.450000000000003 111.383 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -69.99 -48.26 58.91 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 108.26 -1.015 . . . . 72.299999999999997 108.26 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -69.32 -32.07 70.96 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 114.2 -1.364 . . . . 74.519999999999996 108.518 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.4 tp -67.04 -45.06 78.6 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.526 -0.761 . . . . 73.439999999999998 110.117 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.85 -34.94 75.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.293 0.568 . . . . 73.519999999999996 110.214 177.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -69.14 -40.29 78.33 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.103 -0.953 . . . . 70.25 109.215 177.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -68.48 -42.58 78.47 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 123.498 0.719 . . . . 64.209999999999994 110.594 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.438 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 3.3 pp -84.41 0.66 48.64 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.877 -0.601 . . . . 64.230000000000004 110.964 -176.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.32 -61.59 7.05 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 111.303 -0.719 . . . . 63.100000000000001 111.303 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -77.2 -5.09 15.47 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.868 2.379 . . . . 75.109999999999999 112.034 175.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 62.9 m-70 -121.47 36.55 4.58 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.698 -0.482 . . . . 64.120000000000005 109.698 -174.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -55.7 106.56 0.69 Allowed Pre-proline 0 N--CA 1.48 1.051 0 O-C-N 124.706 1.254 . . . . 72.140000000000001 111.892 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -99.95 -177.37 0.19 Allowed 'Trans proline' 0 N--CA 1.422 -2.697 0 C-N-CA 122.661 2.241 . . . . 72.530000000000001 109.979 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -84.22 107.46 16.54 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 107.254 -1.388 . . . . 72.540000000000006 107.254 174.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.472 HD13 ' HB2' ' A' ' 68' ' ' PHE . 71.7 mt -92.41 105.95 17.27 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.161 0 N-CA-C 107.39 -1.337 . . . . 74.5 107.39 -175.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -98.9 105.9 18.09 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 122.029 -0.42 . . . . 72.120000000000005 111.312 -175.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 70.3 t -107.97 113.1 42.89 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.649 0 N-CA-C 108.02 -1.104 . . . . 73.010000000000005 108.02 -177.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 56.63 26.3 11.02 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 124.536 1.148 . . . . 71.430000000000007 111.034 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.75 14.3 61.42 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.438 -0.801 . . . . 75.540000000000006 112.614 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -112.3 130.35 55.97 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.519 -0.919 . . . . 75.319999999999993 108.519 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.88 125.97 38.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 121.833 0.825 . . . . 74.319999999999993 109.183 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.418 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 47.9 mm-40 -124.44 147.84 48.03 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.719 -1.215 . . . . 75.430000000000007 107.719 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.1 t -101.24 173.73 6.32 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.793 -1.188 . . . . 65.430000000000007 107.793 174.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -46.23 -39.88 10.55 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.809 1.244 . . . . 70.340000000000003 112.09 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 27.6 m -64.43 -52.74 56.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 122.651 0.38 . . . . 75.340000000000003 110.489 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.95 -45.82 93.2 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.036 -0.529 . . . . 72.329999999999998 110.809 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.472 ' HB2' HD13 ' A' ' 56' ' ' ILE . 46.5 t80 -52.22 -56.4 14.89 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.232 0.539 . . . . 75.439999999999998 109.796 175.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -49.77 -43.3 48.09 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 114.194 -1.367 . . . . 75.439999999999998 111.12 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.464 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 15.7 mm100 -62.75 -46.68 86.94 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 122.892 0.477 . . . . 71.0 111.222 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.468 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 51.6 m-85 -66.45 -37.58 85.46 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.332 0.587 . . . . 75.230000000000004 109.664 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.19 -51.83 67.77 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.022 -0.536 . . . . 74.409999999999997 110.96 175.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 12.8 ptm180 -69.47 -23.33 63.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.334 0.588 . . . . 75.409999999999997 110.68 -176.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -81.01 -6.12 58.4 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.653 0.612 . . . . 72.049999999999997 112.653 175.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.8 17.37 30.67 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.175 -0.536 . . . . 53.210000000000001 114.032 175.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.45 -60.29 2.42 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 122.47 -0.429 . . . . 73.530000000000001 111.874 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 56.5 m-85 -83.31 -7.43 59.59 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 113.455 0.909 . . . . 74.540000000000006 113.455 -171.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -15.81 63.82 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.469 -0.892 . . . . 73.340000000000003 111.561 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -88.37 -17.01 31.46 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.123 0.487 . . . . 75.209999999999994 109.689 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 80' ' ' LEU . 3.3 tm? -84.59 -17.36 38.99 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 115.64 -0.709 . . . . 73.420000000000002 109.381 -174.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.47 3.27 13.83 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.721 0.772 . . . . 75.450000000000003 111.086 -176.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -104.64 2.93 31.08 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.422 -0.955 . . . . 65.299999999999997 108.422 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.56 153.13 39.17 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.126 -0.943 . . . . 64.430000000000007 113.248 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -99.48 135.45 40.87 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.382 -1.281 . . . . 75.349999999999994 108.385 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 25.2 p90 . . . . . 0 C--N 1.307 -1.252 0 N-CA-C 109.506 -0.553 . . . . 75.409999999999997 109.506 177.188 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 CA--C 1.509 -0.627 0 CA-C-O 121.022 0.439 . . . . 64.549999999999997 111.265 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -138.74 156.41 24.21 Favored Glycine 0 N--CA 1.409 -3.116 0 C-N-CA 120.412 -0.899 . . . . 73.540000000000006 111.587 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -116.7 157.0 26.14 Favored 'General case' 0 C--O 1.261 1.671 0 N-CA-C 108.119 -1.067 . . . . 74.450000000000003 108.119 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -125.46 101.8 7.1 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 105.833 -1.914 . . . . 73.310000000000002 105.833 171.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.2 mt -99.16 112.43 24.58 Favored 'General case' 0 C--N 1.261 -3.253 0 N-CA-C 106.923 -1.51 . . . . 73.420000000000002 106.923 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 8.5 p -115.6 132.0 66.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.486 0.66 . . . . 75.439999999999998 112.035 -174.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -106.34 140.86 38.6 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.051 -0.977 . . . . 75.420000000000002 109.245 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -118.63 121.24 39.71 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.063 -1.088 . . . . 74.319999999999993 108.063 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.1 t . . . . . 0 C--N 1.292 -1.931 0 CA-C-N 115.313 -0.858 . . . . 75.140000000000001 110.827 -177.846 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 39.1 p90 . . . . . 0 N--CA 1.418 -2.069 0 N-CA-C 108.019 -1.104 . . . . 75.510000000000005 108.019 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -106.55 134.19 50.06 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 105.57 -2.011 . . . . 72.219999999999999 105.57 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -114.87 154.12 29.23 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 119.482 -0.887 . . . . 75.439999999999998 111.727 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -139.32 116.85 11.36 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.878 -1.055 . . . . 71.140000000000001 108.999 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -111.98 109.66 19.54 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.058 -0.719 . . . . 75.519999999999996 109.058 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.54 118.25 33.62 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 121.136 0.493 . . . . 44.420000000000002 109.751 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -100.82 113.55 26.57 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.198 -1.408 . . . . 74.209999999999994 107.198 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 54.4 mt -118.31 143.62 28.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.42 -1.326 . . . . 70.010000000000005 107.42 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.25 147.57 51.1 Favored 'General case' 0 C--O 1.262 1.725 0 C-N-CA 119.098 -1.041 . . . . 75.150000000000006 110.752 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.573 ' HG2' ' SG ' ' A' ' 132' ' ' CYS . 29.1 mtp180 -89.91 116.86 28.29 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.073 -1.421 . . . . 73.219999999999999 109.17 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -80.96 145.21 31.35 Favored 'General case' 0 C--N 1.273 -2.725 0 CA-C-N 113.79 -1.55 . . . . 74.209999999999994 111.049 -170.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -72.59 -10.71 60.13 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 107.813 -1.18 . . . . 71.310000000000002 107.813 174.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.95 -17.72 64.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.006 -0.997 . . . . 72.0 109.589 173.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 101.89 -6.67 54.54 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.508 -0.637 . . . . 42.409999999999997 111.508 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.9 m -103.88 -179.62 4.0 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.141 -0.688 . . . . 72.299999999999997 109.141 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.573 ' SG ' ' HG2' ' A' ' 126' ' ' ARG . 74.0 m -131.49 142.14 49.91 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.611 -1.255 . . . . 74.109999999999999 107.611 175.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -149.78 154.89 39.19 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 119.718 -0.793 . . . . 74.519999999999996 109.879 -176.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.23 122.35 22.68 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.861 -0.792 . . . . 73.230000000000004 108.861 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -76.34 -52.8 9.2 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.209 -1.034 . . . . 75.109999999999999 108.209 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.7 m -167.88 154.53 7.86 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.479 -1.674 . . . . 75.450000000000003 106.479 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.39 139.41 41.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.469 -1.308 . . . . 62.439999999999998 107.469 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -114.39 139.19 49.69 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 109.965 -0.383 . . . . 72.239999999999995 109.965 -175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 66.2 m-85 -125.4 121.44 33.85 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.78 -1.192 . . . . 72.109999999999999 107.78 174.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.501 ' HB ' ' CD ' ' A' ' 143' ' ' LYS . 9.5 pt -128.83 97.61 3.75 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 CA-C-O 122.16 0.981 . . . . 73.129999999999995 109.109 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -87.95 137.04 32.68 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.925 -1.034 . . . . 72.219999999999999 111.33 -177.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.473 ' O ' ' HE3' ' A' ' 143' ' ' LYS . 41.4 t 71.27 49.19 0.33 Allowed 'General case' 0 C--N 1.321 -0.668 0 O-C-N 124.657 1.223 . . . . 75.409999999999997 111.403 175.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.501 ' CD ' ' HB ' ' A' ' 140' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.623 0 N-CA-C 108.422 -0.955 . . . . 72.299999999999997 108.422 175.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 t70 . . . . . 0 C--O 1.244 0.804 0 CA-C-O 121.94 0.876 . . . . 74.129999999999995 109.104 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -70.41 -39.49 74.43 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.864 -1.062 . . . . 74.430000000000007 108.901 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.57 -45.01 84.94 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.859 -0.61 . . . . 72.540000000000006 109.916 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.521 HG12 ' SG ' ' A' ' 132' ' ' CYS . 17.9 m -69.49 -37.89 75.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.167 -0.47 . . . . 71.140000000000001 112.015 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.551 ' HZ2' ' HB3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -72.5 -33.5 66.99 Favored 'General case' 0 C--O 1.211 -0.954 0 C-N-CA 118.629 -1.228 . . . . 74.239999999999995 109.961 178.519 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.83 -41.93 61.96 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.241 -0.743 . . . . 72.219999999999999 111.241 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.0 tp -69.65 -50.4 44.55 Favored 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 124.047 0.939 . . . . 73.340000000000003 109.173 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.05 -42.22 99.72 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.967 -0.56 . . . . 71.140000000000001 111.872 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -65.32 -44.2 88.61 Favored 'General case' 0 C--O 1.187 -2.218 0 CA-C-O 118.791 -0.623 . . . . 72.129999999999995 110.872 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.02 -38.63 91.95 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.116 0.96 . . . . 74.409999999999997 110.252 -174.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.567 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 24.1 t80 -64.45 -55.18 22.52 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.698 -1.592 . . . . 75.019999999999996 110.081 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.0 mm -67.03 -30.56 49.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.074 -0.512 . . . . 71.420000000000002 111.007 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.34 -48.44 77.96 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.596 0.758 . . . . 73.140000000000001 110.142 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.4 pp -69.14 -28.49 66.49 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 119.944 -0.702 . . . . 72.340000000000003 110.048 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 68.8 t -73.21 -22.19 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 CA-C-O 121.219 0.533 . . . . 72.230000000000004 110.929 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.4 p -107.5 15.69 24.57 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.415 -0.803 . . . . 74.439999999999998 111.858 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 32.4 mmmt -57.05 162.22 2.64 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 113.543 0.942 . . . . 75.129999999999995 113.543 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.408 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 12.2 p -70.33 169.54 13.35 Favored Pre-proline 0 N--CA 1.435 -1.197 0 C-N-CA 125.469 1.508 . . . . 64.209999999999994 111.8 -177.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 35' ' ' SER . 19.0 Cg_endo -64.42 -7.46 14.27 Favored 'Trans proline' 0 C--N 1.363 1.317 0 C-N-CA 123.09 2.527 . . . . 75.340000000000003 112.09 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -73.92 -27.32 60.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.662 -0.699 . . . . 64.519999999999996 109.886 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.6 m -82.73 113.08 20.15 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.62 -0.718 . . . . 74.519999999999996 109.312 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.1 -32.91 56.04 Favored 'Isoleucine or valine' 0 C--O 1.25 1.124 0 N-CA-C 113.331 0.863 . . . . 71.140000000000001 113.331 -174.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -151.06 94.04 2.0 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.428 -0.909 . . . . 74.540000000000006 109.921 -174.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.3 m -67.35 -30.17 69.91 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.699 0.762 . . . . 75.319999999999993 109.766 -175.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -71.84 -20.03 61.88 Favored 'General case' 0 N--CA 1.414 -2.269 0 CA-C-N 115.15 -0.932 . . . . 75.150000000000006 112.008 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -69.76 -45.37 68.21 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.692 -1.225 . . . . 73.439999999999998 107.692 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.13 -26.82 65.08 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.004 -0.998 . . . . 65.25 110.177 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.552 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 51.2 tp -70.18 -47.09 63.09 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.554 -0.748 . . . . 73.219999999999999 109.636 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.48 -27.01 68.99 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 121.528 0.68 . . . . 61.130000000000003 110.083 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -73.95 -38.8 64.13 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.878 -1.055 . . . . 74.510000000000005 109.64 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -70.11 -51.64 29.98 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.562 -0.745 . . . . 71.340000000000003 110.419 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 4.0 pp -82.12 -8.03 59.64 Favored 'General case' 0 C--O 1.196 -1.754 0 CA-C-N 115.382 -0.826 . . . . 72.540000000000006 111.824 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -43.64 -60.19 3.4 Favored Glycine 0 N--CA 1.477 1.374 0 O-C-N 123.672 0.607 . . . . 71.230000000000004 114.264 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.11 -6.3 16.49 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.506 2.137 . . . . 75.120000000000005 112.04 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -110.42 19.78 18.43 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.008 -0.738 . . . . 73.439999999999998 109.008 -175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.651 ' CG ' ' HB ' ' A' ' 65' ' ' THR . 27.2 t70 -56.7 109.94 2.04 Favored Pre-proline 0 C--O 1.245 0.857 0 C-N-CA 125.163 1.385 . . . . 71.040000000000006 113.744 -176.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -106.54 -152.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.637 0 C-N-CA 123.929 3.086 . . . . 74.549999999999997 110.502 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -81.99 124.03 29.41 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.551 -0.907 . . . . 72.530000000000001 108.551 176.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.49 HD11 ' CB ' ' A' ' 68' ' ' PHE . 39.7 mt -108.22 109.2 27.38 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.396 0 N-CA-C 107.219 -1.4 . . . . 75.420000000000002 107.219 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -96.07 138.88 33.05 Favored 'General case' 0 C--N 1.263 -3.182 0 O-C-N 121.601 -0.687 . . . . 75.409999999999997 109.678 -177.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 3.6 p -133.29 122.76 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 N-CA-C 107.298 -1.371 . . . . 71.030000000000001 107.298 174.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 62.69 20.72 12.27 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.612 0.72 . . . . 74.239999999999995 110.865 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.59 7.38 64.98 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.652 -0.704 . . . . 64.019999999999996 112.572 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -113.78 135.52 53.86 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.908 -0.405 . . . . 75.329999999999998 109.908 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.53 126.52 37.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-O 121.708 0.766 . . . . 73.540000000000006 110.187 -175.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.425 ' NE2' HG13 ' A' ' 58' ' ' VAL . 51.9 mm-40 -122.68 148.19 45.58 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.46 -0.941 . . . . 73.530000000000001 108.46 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.2 t -100.43 175.71 5.6 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.953 -1.128 . . . . 61.039999999999999 107.953 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.651 ' HB ' ' CG ' ' A' ' 53' ' ' ASP . 9.3 t -52.17 -34.05 43.33 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 123.28 0.632 . . . . 72.439999999999998 112.261 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 m -59.41 -54.15 49.95 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-O 121.123 0.487 . . . . 71.420000000000002 109.946 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.45 -47.51 75.91 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-N 115.005 -0.998 . . . . 61.32 110.967 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.49 ' CB ' HD11 ' A' ' 56' ' ' ILE . 51.0 t80 -54.46 -54.29 42.83 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.661 0.384 . . . . 73.439999999999998 111.169 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.454 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 2.8 tm? -54.16 -42.49 69.67 Favored 'General case' 0 C--O 1.244 0.801 0 O-C-N 124.206 0.941 . . . . 73.519999999999996 110.384 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.431 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 73.3 mt-30 -57.93 -53.61 56.3 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 116.552 -0.294 . . . . 70.540000000000006 111.115 174.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.459 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 28.5 m-85 -63.05 -32.54 73.93 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.657 0.742 . . . . 75.040000000000006 110.723 -176.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -61.64 -55.27 32.42 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.204 -0.907 . . . . 73.319999999999993 110.354 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 12.4 ptp180 -70.64 -22.52 62.5 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 120.798 0.332 . . . . 73.340000000000003 111.391 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 54.4 mt-30 -71.39 -20.12 62.18 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.161 -0.472 . . . . 75.430000000000007 110.807 174.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.62 24.96 12.56 Favored Glycine 0 N--CA 1.415 -2.758 0 C-N-CA 120.103 -1.046 . . . . 70.530000000000001 113.278 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.6 mt -88.44 -46.75 8.88 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.692 -0.803 . . . . 74.329999999999998 110.593 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.459 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 22.1 m-85 -89.87 10.86 22.14 Favored 'General case' 0 C--O 1.21 -0.99 0 O-C-N 121.913 -0.492 . . . . 64.549999999999997 112.258 -177.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -71.67 -11.71 60.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.754 1.02 . . . . 71.209999999999994 113.754 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -82.47 -10.17 59.13 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 122.056 -0.403 . . . . 73.040000000000006 111.012 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 80' ' ' LEU . 3.3 tm? -59.32 -29.59 67.74 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.515 0.509 . . . . 71.219999999999999 110.602 -174.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.483 ' HD3' ' C ' ' A' ' 81' ' ' LYS . 12.1 tmtt? -58.97 -41.72 88.2 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.442 -0.345 . . . . 74.209999999999994 111.445 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -98.68 13.15 33.16 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 120.802 0.334 . . . . 60.140000000000001 111.856 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.02 131.66 35.32 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.101 -1.074 . . . . 65.400000000000006 108.101 175.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -104.12 130.72 51.84 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.593 -0.443 . . . . 72.420000000000002 110.305 -174.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 103' ' ' TRP . 50.8 p90 . . . . . 0 N--CA 1.439 -1.009 0 CA-C-O 121.619 0.724 . . . . 63.409999999999997 112.028 -177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 . . . . . 0 C--O 1.249 1.061 0 N-CA-C 108.509 -0.923 . . . . 73.129999999999995 108.509 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -149.22 141.08 8.6 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.468 -1.053 . . . . 54.119999999999997 110.468 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -121.03 136.52 54.97 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.3 -0.63 . . . . 75.310000000000002 109.3 -177.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -124.97 107.55 10.96 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.869 0.731 . . . . 74.450000000000003 109.155 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -106.48 117.14 33.28 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.713 -1.217 . . . . 73.400000000000006 107.713 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 8.2 p -120.35 125.07 73.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 122.037 0.923 . . . . 65.540000000000006 112.522 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 25.8 m-90 -105.73 147.23 28.8 Favored 'General case' 0 CA--C 1.472 -2.034 0 CA-C-N 114.613 -1.176 . . . . 75.120000000000005 109.356 178.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -121.64 123.66 42.45 Favored 'General case' 0 N--CA 1.403 -2.82 0 N-CA-C 105.713 -1.958 . . . . 74.319999999999993 105.713 172.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.2 m . . . . . 0 C--N 1.292 -1.896 0 CA-C-N 115.897 -0.592 . . . . 50.030000000000001 110.082 -177.998 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 16.4 p90 . . . . . 0 N--CA 1.434 -1.242 0 N-CA-C 106.978 -1.49 . . . . 74.349999999999994 106.978 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -107.71 141.28 39.48 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 106.384 -1.71 . . . . 64.519999999999996 106.384 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -114.97 144.55 43.41 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 119.784 -0.766 . . . . 74.310000000000002 110.485 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -133.76 117.26 16.71 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.537 -0.756 . . . . 73.120000000000005 109.109 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -115.9 110.3 18.81 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 109.281 -0.637 . . . . 75.239999999999995 109.281 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.12 125.5 46.24 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.377 -0.601 . . . . 73.329999999999998 109.377 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -111.45 121.08 44.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.75 -0.833 . . . . 74.420000000000002 108.75 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.2 mt -120.42 153.32 23.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 108.537 -0.912 . . . . 72.409999999999997 108.537 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -141.25 152.12 44.28 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 108.553 -0.906 . . . . 74.140000000000001 108.553 174.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -80.8 115.29 20.22 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.605 -0.887 . . . . 74.310000000000002 108.605 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -79.05 140.87 37.81 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.803 -1.925 . . . . 74.519999999999996 105.803 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -64.83 -14.71 60.23 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.327 0.584 . . . . 73.420000000000002 111.874 -170.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.8 -16.46 63.1 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 124.557 1.143 . . . . 74.340000000000003 111.314 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.67 -8.86 43.87 Favored Glycine 0 CA--C 1.5 -0.851 0 C-N-CA 121.073 -0.584 . . . . 74.340000000000003 111.805 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.9 t -104.7 130.14 52.79 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 106.547 -1.649 . . . . 73.349999999999994 106.547 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.521 ' SG ' HG12 ' A' ' 21' ' ' VAL . 12.0 t -83.79 134.81 34.71 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.522 -1.288 . . . . 73.400000000000006 107.522 177.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -133.12 154.53 50.51 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.093 -0.706 . . . . 73.219999999999999 109.093 -173.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.0 mp -75.14 128.82 36.38 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 120.875 0.369 . . . . 74.109999999999999 110.472 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -72.46 -56.39 5.48 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.068 -1.086 . . . . 73.209999999999994 108.068 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.7 m -172.62 157.73 3.93 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.799 -1.556 . . . . 73.109999999999999 106.799 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.7 m -131.73 149.3 32.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 107.543 -1.281 . . . . 61.32 107.543 172.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -131.61 131.96 43.66 Favored 'General case' 0 C--N 1.266 -3.046 0 C-N-CA 123.107 0.563 . . . . 74.409999999999997 110.121 -172.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 72.8 m-85 -121.93 129.02 52.18 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.348 -0.982 . . . . 74.099999999999994 108.348 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.0 pt -131.74 99.12 3.59 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-O 122.162 0.982 . . . . 73.420000000000002 109.142 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 58.4 mtm -85.44 133.64 34.1 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.653 -1.158 . . . . 73.420000000000002 110.836 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . 0.267 51.3 p 62.61 73.15 0.47 Allowed 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 125.953 1.701 . . . . 74.439999999999998 113.222 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 47.1 tttm . . . . . 0 N--CA 1.423 -1.801 0 CA-C-N 114.433 -1.258 . . . . 74.230000000000004 108.106 177.333 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 120.907 0.384 . . . . 70.140000000000001 111.827 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.51 -38.21 77.49 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.241 -0.652 . . . . 74.140000000000001 109.241 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.96 -45.51 74.02 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.715 -0.675 . . . . 74.409999999999997 110.214 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.526 ' HB ' ' SG ' ' A' ' 132' ' ' CYS . 14.6 p -65.84 -42.74 92.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 112.25 0.463 . . . . 75.439999999999998 112.25 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 -28.61 60.73 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 118.673 -1.211 . . . . 71.430000000000007 110.772 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.24 -44.84 63.92 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.415 -0.811 . . . . 54.219999999999999 111.874 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.46 -34.85 70.58 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 108.905 -0.776 . . . . 71.239999999999995 108.905 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.98 -40.94 99.92 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 111.244 -0.742 . . . . 54.119999999999997 111.244 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -69.62 -44.98 69.57 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 120.991 -0.284 . . . . 74.109999999999999 110.259 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.42 -42.6 99.0 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.687 0.395 . . . . 74.239999999999995 110.539 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.431 ' CE1' HD12 ' A' ' 45' ' ' LEU . 18.0 t80 -62.46 -54.59 37.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.238 -0.892 . . . . 73.540000000000006 110.016 177.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 29' ' ' ILE . 8.3 mm -63.31 -35.78 73.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 112.149 0.426 . . . . 74.030000000000001 112.149 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -62.85 -48.95 76.81 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 119.409 -0.329 . . . . 71.510000000000005 110.568 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 pp -67.6 -30.79 70.48 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.348 -0.541 . . . . 73.140000000000001 111.315 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.34 -24.01 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-O 121.484 0.659 . . . . 75.340000000000003 110.912 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.5 p -115.5 14.22 16.59 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 121.504 -0.748 . . . . 64.019999999999996 110.59 -176.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -81.54 145.3 30.75 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.762 -0.654 . . . . 74.409999999999997 111.861 -173.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.5 m -51.2 160.36 0.91 Allowed Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 126.421 1.889 . . . . 62.240000000000002 113.113 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.06 -6.83 6.88 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 124.289 3.326 . . . . 65.310000000000002 112.897 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -61.46 -27.03 68.28 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.277 -1.009 . . . . 72.409999999999997 108.277 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.4 m -96.7 123.31 40.34 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 103.778 -2.675 . . . . 74.540000000000006 103.778 168.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.7 t -49.92 -53.07 11.75 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 113.301 0.852 . . . . 74.409999999999997 113.301 -170.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -147.64 127.82 13.81 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.29 -1.004 . . . . 72.319999999999993 108.29 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.3 m -59.47 -36.51 76.13 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.602 0.564 . . . . 64.420000000000002 109.848 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -73.83 -21.17 60.22 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.153 -0.93 . . . . 72.310000000000002 110.268 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -76.77 -43.33 37.37 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.483 -1.303 . . . . 64.329999999999998 107.483 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -63.07 -35.34 79.91 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.597 -0.89 . . . . 75.430000000000007 108.597 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.431 HD12 ' CE1' ' A' ' 28' ' ' PHE . 35.2 tp -68.2 -44.34 76.04 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.639 -0.71 . . . . 75.420000000000002 110.097 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.83 -31.5 71.75 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.355 0.598 . . . . 64.319999999999993 110.529 177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -71.72 -40.52 69.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.909 -1.041 . . . . 72.530000000000001 109.627 177.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -69.3 -44.32 72.0 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.028 -0.533 . . . . 74.420000000000002 110.511 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.404 HD12 ' C ' ' A' ' 49' ' ' LEU . 4.1 pp -80.75 -2.03 45.3 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.95 -0.568 . . . . 75.209999999999994 111.052 -177.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.26 -60.47 6.69 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 119.926 -0.374 . . . . 74.239999999999995 112.906 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.51 -6.4 12.67 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.114 1.876 . . . . 74.420000000000002 111.904 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -118.52 38.26 3.8 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.773 -0.454 . . . . 72.319999999999993 109.773 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -55.78 105.89 0.59 Allowed Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 124.627 1.171 . . . . 73.409999999999997 112.815 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -98.89 -168.93 0.1 Allowed 'Trans proline' 0 N--CA 1.43 -2.216 0 C-N-CA 122.825 2.35 . . . . 73.450000000000003 111.177 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -91.66 104.74 17.17 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.782 -1.192 . . . . 74.329999999999998 107.782 176.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.6 mt -89.65 106.85 17.49 Favored 'Isoleucine or valine' 0 C--O 1.18 -2.59 0 CA-C-N 115.391 -0.822 . . . . 74.209999999999994 109.054 -175.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -96.23 107.68 20.05 Favored 'General case' 0 C--N 1.276 -2.608 0 O-C-N 121.55 -0.719 . . . . 72.0 111.815 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.418 HG22 ' HB2' ' A' ' 139' ' ' PHE . 70.0 t -108.3 111.59 36.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 108.398 -0.964 . . . . 73.319999999999993 108.398 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 63.25 21.15 12.68 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.624 -1.171 . . . . 71.329999999999998 110.329 -177.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.49 -5.45 62.54 Favored Glycine 0 N--CA 1.437 -1.237 0 CA-C-N 114.87 -1.059 . . . . 64.430000000000007 111.967 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -95.7 125.68 40.45 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 109.592 -0.521 . . . . 75.129999999999995 109.592 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.2 127.21 35.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.643 0.735 . . . . 73.510000000000005 109.54 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -128.41 150.94 49.9 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.949 -1.13 . . . . 73.140000000000001 107.949 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -101.57 172.9 6.68 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.283 -1.006 . . . . 73.540000000000006 108.283 172.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -45.53 -40.46 8.62 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 125.179 1.392 . . . . 65.239999999999995 112.231 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.6 m -65.4 -44.67 86.71 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.124 0.487 . . . . 53.25 111.358 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.64 -44.94 76.73 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.697 -0.483 . . . . 74.129999999999995 109.697 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -53.62 -56.2 19.3 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.206 0.602 . . . . 73.200000000000003 109.863 175.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -49.95 -43.8 50.21 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.276 -1.329 . . . . 71.530000000000001 110.765 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -60.22 -47.5 85.69 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 111.9 0.333 . . . . 70.239999999999995 111.9 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.451 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 33.7 m-85 -66.94 -36.37 82.08 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.514 0.674 . . . . 65.200000000000003 110.008 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -57.85 -54.8 42.87 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.543 -0.753 . . . . 72.510000000000005 110.637 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -66.83 -29.67 69.66 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.519 -0.31 . . . . 75.519999999999996 110.69 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -73.67 -15.35 61.24 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 112.273 0.472 . . . . 71.439999999999998 112.273 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.48 13.78 25.42 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 119.931 -1.128 . . . . 73.200000000000003 114.544 175.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.38 -56.56 4.89 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.183 0.516 . . . . 71.409999999999997 110.96 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.451 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 43.1 m-85 -83.52 -5.31 59.13 Favored 'General case' 0 C--O 1.21 -0.995 0 N-CA-C 112.911 0.708 . . . . 73.230000000000004 112.911 -172.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -14.19 61.8 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.095 -1.042 . . . . 73.530000000000001 111.795 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -85.33 -16.59 39.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.169 0.509 . . . . 72.5 110.377 175.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.481 ' O ' HD11 ' A' ' 80' ' ' LEU . 3.2 tm? -89.32 -15.73 32.74 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 108.109 -1.071 . . . . 73.109999999999999 108.109 -178.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.501 ' C ' ' HD3' ' A' ' 81' ' ' LYS . 11.2 tmtt? -52.18 -41.74 62.89 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.969 0.908 . . . . 75.120000000000005 111.963 -177.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -88.46 14.61 9.36 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.561 0.696 . . . . 74.349999999999994 111.686 -174.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.52 150.92 47.57 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.989 0.737 . . . . 64.239999999999995 112.989 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -106.26 136.14 46.51 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.524 -1.287 . . . . 64.540000000000006 107.524 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.634 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 53.0 p90 . . . . . 0 C--N 1.315 -0.925 0 N-CA-C 113.545 0.943 . . . . 62.329999999999998 113.545 -175.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 C--O 1.247 0.95 0 N-CA-C 109.753 -0.462 . . . . 72.549999999999997 109.753 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -116.7 139.56 15.27 Favored Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 109.456 -1.458 . . . . 73.400000000000006 109.456 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -106.34 150.43 25.99 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.2 -1.778 . . . . 73.219999999999999 106.2 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HE2' ' CE2' ' A' ' 123' ' ' TYR . 35.9 ttmt -136.23 129.79 32.11 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.465 -0.568 . . . . 74.140000000000001 109.465 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.5 mt -126.79 127.1 44.49 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.259 -1.386 . . . . 73.519999999999996 107.259 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.5 p -125.64 127.03 71.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 113.302 0.852 . . . . 72.519999999999996 113.302 -174.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.634 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 20.4 m-90 -104.16 151.03 23.81 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.642 -1.163 . . . . 75.5 108.523 178.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.508 ' HZ2' ' HB2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -135.79 133.54 38.01 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.908 -2.256 . . . . 75.430000000000007 104.908 176.175 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.7 p . . . . . 0 C--N 1.306 -1.317 0 CA-C-N 118.09 0.405 . . . . 74.040000000000006 110.346 179.016 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 6.4 p90 . . . . . 0 N--CA 1.442 -0.863 0 N-CA-C 108.223 -1.029 . . . . 74.340000000000003 108.223 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -113.14 137.61 51.18 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.153 -1.795 . . . . 75.519999999999996 106.153 176.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -115.01 151.92 33.35 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 119.947 -0.701 . . . . 74.230000000000004 111.71 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -139.6 117.49 11.7 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.03 -0.986 . . . . 75.439999999999998 108.52 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -123.98 112.35 17.08 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.572 0.701 . . . . 75.420000000000002 110.324 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -93.78 133.38 37.22 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.372 -0.831 . . . . 75.439999999999998 109.925 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.461 ' CE2' ' HE2' ' A' ' 100' ' ' LYS . 35.9 m-85 -115.9 122.82 46.46 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 124.153 0.908 . . . . 64.319999999999993 108.617 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.5 mt -120.84 141.59 40.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.281 -1.748 . . . . 75.420000000000002 106.281 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -130.17 150.8 51.26 Favored 'General case' 0 C--O 1.268 2.045 0 C-N-CA 117.417 -1.713 . . . . 72.209999999999994 112.853 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.423 ' HD3' ' SG ' ' A' ' 132' ' ' CYS . 4.6 tpp180 -75.28 104.67 5.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 104.633 -2.358 . . . . 74.329999999999998 104.633 174.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 131' ' ' SER . 57.0 ttt180 -85.45 139.73 31.28 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.417 -0.81 . . . . 71.310000000000002 110.69 -168.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -59.77 -10.41 3.78 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.961 1.304 . . . . 74.209999999999994 112.641 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -78.41 -16.39 57.67 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 123.882 0.873 . . . . 74.129999999999995 110.604 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.06 -5.85 50.44 Favored Glycine 0 C--O 1.24 0.525 0 N-CA-C 111.042 -0.823 . . . . 72.030000000000001 111.042 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' A' ' 127' ' ' ARG . 12.0 p -103.86 169.85 8.27 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 109.66 -0.496 . . . . 74.430000000000007 109.66 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.526 ' SG ' ' HB ' ' A' ' 21' ' ' VAL . 68.8 m -121.67 125.27 46.27 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 106.891 -1.522 . . . . 72.430000000000007 106.891 174.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -140.82 155.39 46.38 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.516 -0.873 . . . . 71.099999999999994 109.533 -169.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.0 mp -67.55 125.95 27.79 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 109.093 -0.706 . . . . 73.109999999999999 109.093 176.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -83.34 -53.65 5.58 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 108.897 -0.779 . . . . 74.400000000000006 108.897 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.0 m -166.71 161.45 15.64 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.874 -1.528 . . . . 73.230000000000004 106.874 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.1 m -141.28 139.59 32.68 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 105.751 -1.944 . . . . 54.219999999999999 105.751 172.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -115.15 132.12 56.71 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 110.196 -0.298 . . . . 74.040000000000006 110.196 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.418 ' HB2' HG22 ' A' ' 58' ' ' VAL . 64.7 m-85 -118.53 122.42 42.63 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 107.517 -1.29 . . . . 73.230000000000004 107.517 175.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.3 pt -126.24 98.57 4.98 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.551 0 CA-C-O 122.079 0.943 . . . . 75.150000000000006 109.112 -178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.4 mtm -85.89 127.47 34.6 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.293 -1.321 . . . . 71.420000000000002 111.213 -174.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 70.7 m 71.64 75.43 0.17 Allowed 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 113.794 -1.548 . . . . 74.200000000000003 114.145 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? . . . . . 0 C--N 1.301 -1.515 0 CA-C-N 114.249 -1.341 . . . . 72.510000000000005 107.547 172.896 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.537 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 8.4 m-20 . . . . . 0 CA--C 1.518 -0.282 0 CA-C-O 121.131 0.491 . . . . 75.129999999999995 111.901 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.38 -40.61 73.86 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.934 -1.136 . . . . 64.519999999999996 107.934 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -61.66 -51.63 67.63 Favored 'General case' 0 CA--C 1.496 -1.132 0 C-N-CA 124.159 0.984 . . . . 74.519999999999996 109.982 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.45 HG11 ' NH2' ' A' ' 126' ' ' ARG . 7.3 p -64.88 -42.74 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.358 -0.837 . . . . 74.319999999999993 112.893 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 17.3 ptpt -74.48 -24.73 59.06 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 118.622 -1.231 . . . . 75.140000000000001 111.745 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.47 -54.45 12.89 Favored Glycine 0 N--CA 1.428 -1.867 0 C-N-CA 120.633 -0.794 . . . . 71.219999999999999 111.166 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.79 -36.04 72.84 Favored 'General case' 0 C--O 1.213 -0.864 0 N-CA-C 109.159 -0.682 . . . . 54.549999999999997 109.159 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.52 -43.08 98.63 Favored Glycine 0 C--O 1.254 1.359 0 CA-C-N 116.213 -0.448 . . . . 75.230000000000004 112.57 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -73.32 -39.5 65.23 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 119.56 -0.856 . . . . 74.540000000000006 109.8 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.51 -39.32 94.11 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.028 0.442 . . . . 75.120000000000005 110.334 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.407 ' CE2' HD12 ' A' ' 45' ' ' LEU . 31.7 t80 -61.31 -53.17 60.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.293 -0.867 . . . . 73.439999999999998 109.623 176.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 29' ' ' ILE . 7.7 mm -64.43 -33.76 64.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 112.202 0.445 . . . . 65.219999999999999 112.202 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.86 -52.12 66.4 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 122.588 0.355 . . . . 61.009999999999998 110.614 175.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.81 -26.32 64.2 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 120.347 -0.541 . . . . 75.430000000000007 111.538 -176.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.7 t -70.75 -26.08 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 CA-C-O 120.983 0.421 . . . . 74.420000000000002 110.698 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.4 p -109.75 14.99 23.05 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.855 0.836 . . . . 71.019999999999996 109.895 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -62.29 147.95 46.52 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 114.306 -1.316 . . . . 74.140000000000001 111.203 -176.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.7 p -54.64 158.35 4.38 Favored Pre-proline 0 C--N 1.313 -0.983 0 C-N-CA 125.196 1.398 . . . . 75.420000000000002 113.282 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.38 -7.01 18.95 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.917 2.411 . . . . 73.299999999999997 111.13 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.33 -27.67 67.54 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.317 -0.856 . . . . 71.25 109.777 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 p -100.78 143.39 31.0 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.536 -1.283 . . . . 74.109999999999999 107.536 173.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.9 p -51.32 -52.58 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.887 1.069 . . . . 71.519999999999996 113.887 -173.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -150.82 136.73 18.25 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 122.381 0.272 . . . . 64.019999999999996 110.454 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.6 m -67.98 -33.66 75.06 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 122.337 1.065 . . . . 72.430000000000007 108.778 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -70.06 -20.32 63.23 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.427 -1.26 . . . . 74.200000000000003 111.408 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -69.95 -46.75 64.61 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 107.646 -1.242 . . . . 73.230000000000004 107.646 177.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.29 -34.15 77.35 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.818 -1.083 . . . . 75.510000000000005 109.076 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.407 HD12 ' CE2' ' A' ' 28' ' ' PHE . 44.1 tp -66.28 -41.73 89.44 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.808 -0.633 . . . . 73.120000000000005 110.651 177.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.53 -35.9 80.9 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.326 0.584 . . . . 51.32 110.437 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -72.99 -35.94 66.97 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.939 -1.028 . . . . 72.430000000000007 110.157 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -68.5 -43.03 77.71 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 116.045 -0.525 . . . . 75.239999999999995 109.846 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.2 pp -77.79 -2.11 34.78 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.942 -0.572 . . . . 73.010000000000005 111.281 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.71 -63.84 2.35 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 123.746 0.654 . . . . 70.319999999999993 112.766 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -82.73 -8.56 11.25 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.849 1.699 . . . . 75.129999999999995 111.935 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 45.8 m-70 -100.45 27.94 5.4 Favored 'General case' 0 C--O 1.213 -0.863 0 N-CA-C 109.014 -0.736 . . . . 73.340000000000003 109.014 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.457 ' CG ' HG22 ' A' ' 65' ' ' THR . 10.2 t70 -52.44 100.77 0.24 Allowed Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 127.844 2.457 . . . . 74.409999999999997 111.661 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -114.17 -154.91 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 124.22 3.28 . . . . 73.439999999999998 112.131 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -94.06 123.74 37.63 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.149 -1.056 . . . . 73.219999999999999 108.149 176.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.45 HD12 ' CB ' ' A' ' 68' ' ' PHE . 74.3 mt -109.46 112.97 42.82 Favored 'Isoleucine or valine' 0 C--O 1.177 -2.711 0 N-CA-C 108.734 -0.839 . . . . 74.109999999999999 108.734 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.54 138.52 33.1 Favored 'General case' 0 C--N 1.269 -2.924 0 N-CA-C 108.825 -0.805 . . . . 75.510000000000005 108.825 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.4 t -132.58 112.69 19.4 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 107.906 -1.146 . . . . 72.519999999999996 107.906 176.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 63.7 20.39 12.2 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.914 1.285 . . . . 73.450000000000003 111.068 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.11 2.25 58.13 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.748 -0.66 . . . . 74.400000000000006 112.222 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -108.17 132.76 53.29 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.896 -0.779 . . . . 73.5 108.896 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.412 HD11 ' N ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -78.77 127.9 38.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 121.699 0.761 . . . . 74.040000000000006 109.658 -175.354 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.412 ' N ' HD11 ' A' ' 62' ' ' ILE . 50.3 mm-40 -126.81 149.19 49.81 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.388 -1.338 . . . . 71.400000000000006 107.388 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.1 t -87.38 173.52 9.09 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.313 -0.625 . . . . 75.510000000000005 109.313 174.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.457 HG22 ' CG ' ' A' ' 53' ' ' ASP . 18.5 p -61.4 -38.31 86.63 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 125.361 1.464 . . . . 75.310000000000002 110.543 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 m -59.62 -46.65 88.36 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.518 -1.219 . . . . 63.329999999999998 110.584 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.24 -47.26 83.17 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.066 0.546 . . . . 73.120000000000005 109.994 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CB ' HD12 ' A' ' 56' ' ' ILE . 38.4 t80 -51.24 -55.95 15.43 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 123.759 0.662 . . . . 75.019999999999996 110.371 174.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -51.07 -45.34 61.37 Favored 'General case' 0 C--O 1.245 0.834 0 O-C-N 124.315 1.01 . . . . 74.040000000000006 110.826 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 46.7 mt-30 -58.75 -50.9 72.21 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 116.133 -0.485 . . . . 72.519999999999996 111.861 175.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.444 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 38.4 m-85 -65.76 -35.53 80.98 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.495 0.664 . . . . 73.439999999999998 109.989 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -57.23 -53.34 59.24 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.55 -0.75 . . . . 74.319999999999993 110.748 176.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -72.13 -22.0 61.39 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 120.832 0.348 . . . . 72.340000000000003 111.293 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 16.5 mm100 -76.29 -11.21 59.87 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 116.226 -0.443 . . . . 63.210000000000001 112.133 174.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.21 27.23 11.07 Favored Glycine 0 N--CA 1.428 -1.837 0 C-N-CA 120.209 -0.996 . . . . 72.450000000000003 113.081 177.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.67 -53.02 5.41 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.108 0.48 . . . . 75.400000000000006 110.654 177.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 35.1 m-85 -91.72 6.51 45.64 Favored 'General case' 0 C--O 1.208 -1.086 0 N-CA-C 113.167 0.803 . . . . 74.230000000000004 113.167 -173.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -11.97 30.04 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.262 0.838 . . . . 72.510000000000005 113.262 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -75.48 -11.28 60.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.081 -0.509 . . . . 74.019999999999996 111.232 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 tt -69.63 -25.6 64.02 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.585 0.707 . . . . 75.310000000000002 109.296 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.2 tmtp? -62.71 -32.84 74.02 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 124.559 1.143 . . . . 72.319999999999993 109.481 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -105.79 4.62 30.06 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.633 0.73 . . . . 73.230000000000004 110.457 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.36 146.09 33.05 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.66 0.615 . . . . 73.329999999999998 112.66 -173.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -102.53 133.81 46.9 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.741 -0.663 . . . . 73.120000000000005 109.29 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 47.5 p90 . . . . . 0 C--N 1.311 -1.106 0 N-CA-C 113.288 0.848 . . . . 74.299999999999997 113.288 -173.546 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 . . . . . 0 N--CA 1.443 -0.788 0 N-CA-C 109.678 -0.49 . . . . 75.140000000000001 109.678 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -149.77 138.65 6.9 Favored Glycine 0 N--CA 1.412 -2.921 0 N-CA-C 109.836 -1.305 . . . . 72.200000000000003 109.836 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -114.52 124.18 51.25 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.096 -1.446 . . . . 75.340000000000003 107.096 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -117.82 101.6 8.43 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 107.705 -1.221 . . . . 75.409999999999997 107.705 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -109.87 133.27 53.34 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.657 -1.156 . . . . 75.349999999999994 108.171 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 12.9 p -126.9 135.69 62.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-O 121.324 0.583 . . . . 74.140000000000001 110.771 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 27.9 m-90 -108.88 132.03 54.44 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.456 -0.942 . . . . 73.019999999999996 108.456 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -109.09 121.37 45.0 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.62 -1.252 . . . . 72.150000000000006 107.62 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.7 t . . . . . 0 C--N 1.299 -1.59 0 CA-C-N 115.368 -0.833 . . . . 75.540000000000006 111.368 -176.491 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 40.1 p90 . . . . . 0 N--CA 1.43 -1.45 0 N-CA-C 108.79 -0.818 . . . . 74.040000000000006 108.79 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -132.53 147.0 52.35 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 105.59 -2.004 . . . . 72.540000000000006 105.59 176.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -125.27 155.26 40.42 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-O 121.138 0.495 . . . . 71.109999999999999 112.028 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -134.68 117.55 16.18 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.529 -0.76 . . . . 75.349999999999994 109.351 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -111.36 110.82 21.46 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 123.357 0.663 . . . . 75.420000000000002 109.842 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.14 131.48 45.15 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 109.039 -0.726 . . . . 73.0 109.039 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -115.93 114.65 24.94 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.568 -0.901 . . . . 73.040000000000006 108.568 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 59.0 mt -112.83 143.71 21.97 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.694 0 N-CA-C 106.643 -1.614 . . . . 74.219999999999999 106.643 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -127.43 148.41 50.29 Favored 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 118.668 -1.213 . . . . 71.319999999999993 109.006 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.45 ' NH2' HG11 ' A' ' 21' ' ' VAL . 19.4 ttm180 -90.09 115.01 27.03 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 106.007 -1.849 . . . . 74.349999999999994 106.007 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 23.2 ttp85 -67.55 144.26 55.71 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.484 -1.302 . . . . 74.200000000000003 107.484 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -63.54 -10.31 17.45 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.139 0.792 . . . . 71.439999999999998 113.139 -172.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -71.33 -16.82 62.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.115 -0.493 . . . . 73.219999999999999 110.269 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.37 -19.24 27.03 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 115.874 -0.603 . . . . 73.430000000000007 112.54 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.0 m -91.51 152.23 20.42 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 106.897 -1.52 . . . . 71.439999999999998 106.897 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 22.4 t -111.03 153.26 25.86 Favored 'General case' 0 C--N 1.271 -2.834 0 C-N-CA 121.11 -0.236 . . . . 71.140000000000001 110.411 -174.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -157.72 155.92 30.76 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.429 -0.952 . . . . 75.329999999999998 108.429 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.7 mp -67.18 130.31 42.7 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 110.193 -0.299 . . . . 74.239999999999995 110.193 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -82.27 -59.94 2.38 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.286 -1.376 . . . . 75.540000000000006 107.286 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.6 m -167.62 160.82 13.19 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.358 -1.719 . . . . 74.120000000000005 106.358 -176.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.51 152.19 34.73 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 N-CA-C 106.42 -1.696 . . . . 74.349999999999994 106.42 171.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -136.96 130.38 31.44 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-O 120.954 0.406 . . . . 72.540000000000006 109.932 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -110.78 143.17 41.74 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.362 -0.977 . . . . 71.109999999999999 108.362 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.4 pt -138.25 98.28 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-O 121.774 0.797 . . . . 75.299999999999997 109.341 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 22.1 ptp -93.14 136.89 32.99 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-N 115.095 -0.957 . . . . 73.030000000000001 108.742 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.1 t 81.39 73.92 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 O-C-N 125.017 1.448 . . . . 73.209999999999994 110.536 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt . . . . . 0 N--CA 1.415 -2.204 0 CA-C-N 114.39 -1.277 . . . . 71.319999999999993 109.125 175.206 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 C--O 1.252 1.234 0 CA-C-O 122.326 1.06 . . . . 74.120000000000005 108.713 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.58 -34.21 71.94 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.1 -1.409 . . . . 74.299999999999997 107.481 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.01 -49.96 70.39 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 114.759 -1.11 . . . . 72.510000000000005 110.559 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.62 -43.08 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 112.216 0.45 . . . . 72.140000000000001 112.216 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -70.47 -31.76 69.03 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 118.069 -1.452 . . . . 73.120000000000005 111.512 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.91 -37.13 83.25 Favored Glycine 0 C--O 1.218 -0.861 0 N-CA-C 110.641 -0.984 . . . . 62.210000000000001 110.641 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp -65.53 -50.02 66.78 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 124.348 1.059 . . . . 74.400000000000006 109.165 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.85 -36.82 93.91 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.475 -0.784 . . . . 72.329999999999998 112.228 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -69.98 -41.18 74.78 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 110.665 -0.124 . . . . 74.25 110.665 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.75 -40.2 96.5 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.81 0.814 . . . . 74.099999999999994 109.555 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.476 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 14.0 t80 -62.11 -55.32 30.12 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.068 -1.424 . . . . 73.439999999999998 109.705 176.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' A' ' 29' ' ' ILE . 12.3 mm -63.43 -35.19 71.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.98 -0.555 . . . . 73.329999999999998 111.89 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.29 -44.77 86.91 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 121.109 -0.236 . . . . 74.25 111.011 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.3 pp -70.63 -27.58 64.17 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.378 -0.929 . . . . 74.430000000000007 110.567 -178.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 79.1 t -73.6 -21.03 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 CA-C-O 121.173 0.511 . . . . 74.409999999999997 110.411 176.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.5 p -114.46 18.15 16.99 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.619 0.723 . . . . 73.530000000000001 110.131 -177.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -72.31 161.78 30.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.13 -0.941 . . . . 74.450000000000003 110.252 -176.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 m -48.06 144.94 5.38 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 124.463 1.105 . . . . 74.140000000000001 113.317 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.81 -7.74 15.77 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.56 2.84 . . . . 71.120000000000005 112.962 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -66.98 -26.57 66.87 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.163 0.506 . . . . 73.409999999999997 109.91 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.2 m -75.53 106.25 6.99 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.898 -1.149 . . . . 74.219999999999999 107.898 176.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.6 t -53.98 -52.7 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.097 -0.956 . . . . 75.340000000000003 113.075 -173.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -129.05 105.36 8.14 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.923 -0.711 . . . . 72.129999999999995 110.668 -175.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.1 t -65.92 -33.31 75.54 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 115.776 -0.647 . . . . 75.299999999999997 109.728 -175.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.29 -23.35 67.01 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.414 -0.812 . . . . 61.030000000000001 110.131 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 72' ' ' PHE . 52.8 t-80 -71.68 -45.48 61.78 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 109.84 -0.43 . . . . 73.129999999999995 109.84 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -69.72 -31.79 69.99 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.22 -1.03 . . . . 74.049999999999997 108.22 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.404 HD12 ' CE2' ' A' ' 28' ' ' PHE . 45.1 tp -67.1 -45.03 78.49 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.273 -0.876 . . . . 71.329999999999998 110.595 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.58 -32.0 73.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.244 0.545 . . . . 65.109999999999999 110.613 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -72.77 -37.05 67.76 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.901 -0.778 . . . . 74.030000000000001 108.901 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -63.41 -44.29 95.06 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.827 0.851 . . . . 75.439999999999998 111.073 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 pp -84.69 6.78 22.82 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 115.873 -0.603 . . . . 73.319999999999993 111.846 -177.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -47.73 -57.28 7.73 Favored Glycine 0 CA--C 1.548 2.139 0 CA-C-N 116.254 -0.43 . . . . 70.510000000000005 112.792 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -76.98 -3.43 13.76 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 123.101 2.534 . . . . 75.019999999999996 112.645 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -125.86 28.35 6.17 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.197 -0.314 . . . . 74.120000000000005 111.469 -169.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.453 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 25.4 m-20 -56.58 113.73 6.52 Favored Pre-proline 0 C--O 1.24 0.588 0 O-C-N 123.771 0.669 . . . . 71.319999999999993 111.544 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.451 ' HB2' ' HA ' ' A' ' 136' ' ' SER . 45.5 Cg_endo -101.45 -164.59 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 123.011 2.474 . . . . 70.109999999999999 112.058 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -90.8 125.06 35.6 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 106.986 -1.487 . . . . 72.400000000000006 106.986 173.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 mp -103.41 114.3 42.63 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.173 0 C-N-CA 119.024 -1.07 . . . . 74.129999999999995 109.298 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -96.83 132.03 42.97 Favored 'General case' 0 C--N 1.271 -2.812 0 N-CA-C 108.981 -0.748 . . . . 72.040000000000006 108.981 177.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 53.7 t -129.53 112.95 25.94 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 107.691 -1.226 . . . . 64.439999999999998 107.691 176.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 62.61 22.22 13.18 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.111 -0.95 . . . . 73.230000000000004 110.867 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.01 -2.41 66.08 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.076 -0.965 . . . . 72.510000000000005 112.185 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -98.37 126.87 44.05 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.292 -1.003 . . . . 74.120000000000005 108.292 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.413 HD11 ' N ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -76.81 127.83 37.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.924 0.868 . . . . 75.329999999999998 108.89 -177.335 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.413 ' N ' HD11 ' A' ' 62' ' ' ILE . 63.4 mm-40 -117.6 137.67 52.46 Favored 'General case' 0 C--O 1.284 2.881 0 N-CA-C 106.752 -1.573 . . . . 74.450000000000003 106.752 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -75.3 174.62 9.28 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 115.895 -0.593 . . . . 73.310000000000002 109.407 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.453 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 78.6 p -60.68 -40.67 93.02 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 124.14 0.976 . . . . 71.109999999999999 109.807 -175.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 91.3 m -65.48 -45.03 85.22 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 114.563 -1.198 . . . . 65.420000000000002 110.696 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.06 -48.33 82.0 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 122.753 0.421 . . . . 75.349999999999994 110.389 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -52.66 -54.17 37.04 Favored 'General case' 0 CA--C 1.498 -1.045 0 O-C-N 123.445 0.466 . . . . 74.109999999999999 109.913 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.1 tp -51.43 -42.65 61.65 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.958 -1.019 . . . . 74.219999999999999 112.152 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.2 mm100 -63.55 -49.19 74.41 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 116.122 -0.49 . . . . 64.25 111.413 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -65.17 -34.13 77.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.535 0.683 . . . . 73.310000000000002 109.94 -178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.421 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 2.7 t80 -59.41 -53.78 54.21 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.379 -0.828 . . . . 75.510000000000005 110.474 175.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -73.89 -15.24 61.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.86 0.362 . . . . 73.120000000000005 111.629 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 55.3 mt-30 -87.8 -5.08 58.8 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 116.197 -0.456 . . . . 75.040000000000006 112.144 175.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.53 28.39 27.23 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.485 -0.864 . . . . 53.210000000000001 113.589 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.84 -45.34 18.87 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 117.286 0.543 . . . . 72.129999999999995 111.462 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -94.46 5.58 51.38 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.796 0.665 . . . . 70.400000000000006 112.796 -171.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -14.77 63.15 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.046 0.758 . . . . 64.209999999999994 113.046 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -78.12 -29.08 48.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.325 0.583 . . . . 74.329999999999998 110.112 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.1 mt -78.11 -8.21 57.96 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.399 -0.818 . . . . 71.239999999999995 111.378 -174.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -68.2 -31.6 71.24 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.483 0.659 . . . . 75.219999999999999 109.344 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -98.81 13.87 30.85 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.858 0.837 . . . . 71.519999999999996 110.286 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.31 148.97 31.91 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.869 -0.605 . . . . 73.129999999999995 110.763 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -100.6 138.62 37.42 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.344 -0.613 . . . . 74.099999999999994 109.344 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 45.4 p90 . . . . . 0 C--N 1.299 -1.601 0 CA-C-O 121.185 0.516 . . . . 75.010000000000005 111.139 179.296 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 C--O 1.246 0.886 0 N-CA-C 112.638 0.607 . . . . 74.439999999999998 112.638 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -133.91 138.17 9.88 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 108.72 -1.752 . . . . 74.120000000000005 108.72 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.411 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 21.8 m-85 -120.06 129.4 54.2 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.347 -0.983 . . . . 71.140000000000001 108.347 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.411 ' HD2' ' C ' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -119.39 103.77 9.77 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.121 -0.696 . . . . 74.230000000000004 109.121 179.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.33 121.26 43.52 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.04 -1.096 . . . . 74.209999999999994 108.04 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 10.0 p -120.16 132.5 69.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.665 0.745 . . . . 71.329999999999998 112.269 -177.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 30.5 m-90 -109.82 130.47 55.52 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.677 -1.147 . . . . 73.230000000000004 107.946 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -115.87 128.65 55.97 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.042 -0.725 . . . . 73.510000000000005 109.042 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 C--N 1.286 -2.157 0 CA-C-N 115.217 -0.901 . . . . 73.530000000000001 109.594 -178.253 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 17.9 p90 . . . . . 0 C--O 1.208 -1.098 0 N-CA-C 108.24 -1.022 . . . . 64.209999999999994 108.24 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -102.83 133.18 48.32 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 107.83 -1.174 . . . . 62.140000000000001 107.83 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -115.51 141.73 47.67 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 120.582 -0.447 . . . . 72.25 110.277 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -127.25 116.74 21.04 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.504 -1.295 . . . . 73.209999999999994 107.504 176.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -123.16 111.39 16.46 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.27 -0.641 . . . . 74.439999999999998 109.27 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.6 133.86 36.49 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 123.119 0.567 . . . . 75.109999999999999 109.642 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -111.96 115.33 28.78 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.189 -1.041 . . . . 75.319999999999993 108.189 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.4 mt -113.9 147.04 17.7 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.497 0 N-CA-C 106.994 -1.484 . . . . 75.519999999999996 106.994 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.433 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -131.73 150.37 52.18 Favored 'General case' 0 C--O 1.266 1.945 0 C-N-CA 118.722 -1.191 . . . . 75.219999999999999 109.333 176.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -100.92 116.58 33.11 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 106.219 -1.771 . . . . 73.209999999999994 106.219 174.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -69.3 155.15 40.89 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.389 -0.823 . . . . 71.409999999999997 109.455 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -51.85 -31.53 28.13 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.638 0.775 . . . . 70.409999999999997 111.552 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.42 -5.63 34.21 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 124.512 1.125 . . . . 64.420000000000002 111.271 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 94.07 -23.95 29.03 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.46 -0.656 . . . . 74.299999999999997 111.46 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.4 m -65.73 124.56 22.76 Favored 'General case' 0 N--CA 1.425 -1.675 0 C-N-CA 124.014 0.925 . . . . 71.519999999999996 109.868 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 7.1 t -103.26 142.24 34.52 Favored 'General case' 0 C--N 1.27 -2.864 0 N-CA-C 108.666 -0.864 . . . . 64.510000000000005 108.666 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.433 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 2.1 t90 -156.53 155.61 32.24 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.8 -1.185 . . . . 73.430000000000007 107.8 -173.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.37 127.55 33.11 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.577 -0.527 . . . . 74.019999999999996 109.577 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -83.28 -55.57 4.26 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.006 -1.109 . . . . 73.129999999999995 108.006 -176.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.451 ' HA ' ' HB2' ' A' ' 54' ' ' PRO . 34.0 m -167.08 164.72 15.86 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.698 -1.593 . . . . 52.119999999999997 106.698 -177.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.95 149.49 22.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 106.263 -1.754 . . . . 71.319999999999993 106.263 172.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -129.51 130.79 46.25 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 120.843 0.354 . . . . 74.439999999999998 110.414 -177.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 53.7 m-85 -113.43 127.24 56.04 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.535 -1.283 . . . . 72.430000000000007 107.535 177.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.9 pt -129.58 98.72 4.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-O 122.273 1.035 . . . . 74.510000000000005 109.427 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 74.8 mtm -84.46 131.7 34.64 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.529 -1.214 . . . . 72.310000000000002 110.762 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 74.5 m 68.84 37.79 2.26 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.512 1.133 . . . . 70.420000000000002 111.943 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? . . . . . 0 N--CA 1.436 -1.137 0 N-CA-C 103.314 -2.847 . . . . 72.519999999999996 103.314 173.102 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.5 t70 . . . . . 0 CA--C 1.497 -1.079 0 N-CA-C 106.735 -1.58 . . . . 64.049999999999997 106.735 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.9 mtt -75.88 78.04 2.79 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.228 0.537 . . . . 74.400000000000006 111.177 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.4 m -88.09 -178.25 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.158 -0.928 . . . . 75.230000000000004 109.369 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.505 ' O ' HG22 ' A' ' 21' ' ' VAL . 16.7 p -60.41 -47.79 84.56 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 113.46 0.911 . . . . 74.040000000000006 113.46 -176.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.11 -34.14 77.38 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.033 0.444 . . . . 73.340000000000003 110.8 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.31 -38.46 90.26 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 107.582 -1.266 . . . . 73.409999999999997 107.582 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -71.31 -35.02 71.11 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.543 -0.753 . . . . 72.340000000000003 110.028 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 17' ' ' THR . 90.2 t -62.65 -55.9 20.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.868 -0.605 . . . . 74.450000000000003 110.696 176.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -25.65 62.12 Favored 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 120.431 -0.508 . . . . 74.239999999999995 111.633 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.48 -42.17 89.43 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.198 -1.161 . . . . 65.120000000000005 110.198 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.88 -53.49 49.63 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 123.658 0.783 . . . . 65.349999999999994 109.786 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.19 -44.89 88.87 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 115.427 -0.806 . . . . 75.450000000000003 112.536 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -66.46 -40.1 89.21 Favored 'General case' 0 C--O 1.206 -1.192 0 CA-C-O 119.423 -0.323 . . . . 75.129999999999995 111.549 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.6 -40.41 92.63 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.483 0.659 . . . . 61.219999999999999 110.102 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.493 ' CE2' HD13 ' A' ' 45' ' ' LEU . 13.6 t80 -61.79 -53.52 54.81 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.414 -1.266 . . . . 73.319999999999993 109.783 176.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.4 mm -64.17 -35.89 75.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 116.328 -0.396 . . . . 73.340000000000003 111.502 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.73 -52.36 66.03 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.28 0.632 . . . . 74.420000000000002 110.109 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.5 pp -67.73 -29.32 68.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 120.58 -0.448 . . . . 75.099999999999994 111.338 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.17 -31.84 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.119 0.485 . . . . 73.109999999999999 110.602 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 p -108.09 17.17 22.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.668 0.747 . . . . 73.219999999999999 110.466 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.415 ' HB2' ' HA ' ' A' ' 31' ' ' LEU . 8.3 tptm -74.04 171.26 13.82 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-N 114.523 -1.217 . . . . 73.450000000000003 111.708 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.5 m -43.94 138.56 3.23 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.357 1.863 . . . . 72.200000000000003 113.768 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.16 -7.18 16.12 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.794 2.329 . . . . 74.319999999999993 109.889 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.21 -28.02 68.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.04 -1.436 . . . . 73.420000000000002 110.736 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.7 p -94.3 158.23 15.67 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.872 -0.604 . . . . 74.230000000000004 110.089 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.489 HG21 ' OD1' ' A' ' 40' ' ' ASN . 9.2 p -50.55 -53.02 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 114.77 1.396 . . . . 62.219999999999999 114.77 -172.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.489 ' OD1' HG21 ' A' ' 39' ' ' VAL . 14.5 m120 -159.21 135.55 9.1 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 118.184 0.447 . . . . 73.129999999999995 110.548 -176.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.0 m -66.19 -31.28 72.02 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.667 -1.234 . . . . 73.439999999999998 107.667 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.456 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 1.8 mp0 -63.4 -25.61 68.37 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.731 -1.577 . . . . 74.439999999999998 109.624 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -71.02 -46.17 62.63 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.489 -0.93 . . . . 75.049999999999997 108.489 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -67.57 -31.66 71.89 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.016 -0.993 . . . . 71.109999999999999 109.424 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.493 HD13 ' CE2' ' A' ' 28' ' ' PHE . 42.6 tp -68.2 -45.06 74.39 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.763 -0.653 . . . . 75.340000000000003 110.358 177.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.37 -36.62 78.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.831 0.824 . . . . 70.450000000000003 109.844 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -75.62 -27.72 58.56 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.499 -1.228 . . . . 74.310000000000002 110.384 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -74.72 -44.59 49.19 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.477 -0.564 . . . . 74.430000000000007 109.477 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 3.9 pp -79.59 -2.62 43.3 Favored 'General case' 0 C--O 1.199 -1.562 0 CA-C-N 115.824 -0.626 . . . . 65.230000000000004 112.422 -174.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -51.89 -61.77 6.2 Favored Glycine 0 CA--C 1.544 1.853 0 C-N-CA 121.494 -0.384 . . . . 63.100000000000001 112.235 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -77.04 -5.42 15.83 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.236 2.624 . . . . 71.310000000000002 112.178 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.458 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 55.8 m-70 -119.0 29.5 7.67 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.837 -0.801 . . . . 64.319999999999993 108.837 -175.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -55.91 107.67 0.96 Allowed Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 124.859 1.264 . . . . 71.239999999999995 112.871 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HB3' ' HB3' ' A' ' 134' ' ' LEU . 75.0 Cg_endo -98.93 -173.81 0.15 Allowed 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 123.273 2.649 . . . . 75.450000000000003 111.13 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -86.08 101.98 13.43 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 107.306 -1.368 . . . . 73.200000000000003 107.306 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.42 HD12 ' HB2' ' A' ' 68' ' ' PHE . 65.1 mt -87.15 105.69 15.35 Favored 'Isoleucine or valine' 0 C--O 1.172 -3.007 0 N-CA-C 109.251 -0.648 . . . . 75.349999999999994 109.251 -175.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -94.02 106.88 18.84 Favored 'General case' 0 C--N 1.276 -2.61 0 O-C-N 121.314 -0.866 . . . . 75.230000000000004 111.459 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.2 t -108.45 113.19 43.29 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.939 0 N-CA-C 108.23 -1.026 . . . . 74.219999999999999 108.23 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 62.04 21.28 12.24 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.96 -1.473 . . . . 74.420000000000002 110.599 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.47 2.98 56.52 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.564 -0.744 . . . . 61.420000000000002 113.357 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -112.85 135.21 53.87 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 117.758 0.779 . . . . 75.299999999999997 110.509 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.01 126.35 34.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.949 0.88 . . . . 74.329999999999998 109.376 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.419 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 59.0 mm-40 -126.13 149.45 48.94 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.164 -1.421 . . . . 75.129999999999995 107.164 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.8 t -97.95 173.56 7.01 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.355 -0.98 . . . . 73.450000000000003 108.355 173.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.6 t -42.25 -42.89 3.22 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.144 1.378 . . . . 74.530000000000001 112.479 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.5 m -69.35 -42.36 75.37 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.377 -0.374 . . . . 62.420000000000002 111.978 -176.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.419 ' HB1' ' HB3' ' A' ' 63' ' ' GLN . . . -65.08 -45.99 82.98 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.656 -0.498 . . . . 73.340000000000003 109.656 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.42 ' HB2' HD12 ' A' ' 56' ' ' ILE . 41.2 t80 -52.75 -55.21 24.46 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 109.108 -0.701 . . . . 73.400000000000006 109.108 174.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -48.34 -44.19 34.07 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.3 -1.318 . . . . 75.219999999999999 110.963 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 45.2 mt-30 -61.55 -46.49 89.7 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 112.029 0.381 . . . . 63.030000000000001 112.029 177.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.504 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 57.6 m-85 -68.62 -36.25 78.41 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.421 0.629 . . . . 71.209999999999994 109.315 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -57.99 -51.57 69.1 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.621 -0.718 . . . . 73.209999999999994 111.084 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 34.1 ptt180 -66.85 -30.93 71.24 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.705 -0.48 . . . . 75.129999999999995 109.705 -176.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -74.86 -10.09 59.17 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.779 -0.646 . . . . 72.010000000000005 112.212 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.36 6.84 47.17 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 114.77 0.668 . . . . 61.25 114.77 174.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.446 ' HB3' ' SD ' ' A' ' 141' ' ' MET . 3.5 mm? -68.15 -48.77 64.44 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.659 0.614 . . . . 71.430000000000007 112.659 -176.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.504 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 45.5 m-85 -90.8 12.74 18.34 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 113.273 0.842 . . . . 73.530000000000001 113.273 -173.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 51.7 mtmt -66.97 -14.22 62.64 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.634 0.605 . . . . 74.439999999999998 112.634 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -79.96 -13.01 59.67 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 123.218 0.607 . . . . 72.299999999999997 110.695 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.5 tt -60.78 -28.17 68.54 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.583 0.586 . . . . 72.310000000000002 112.583 -174.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.13 4.57 46.93 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 117.623 -1.631 . . . . 74.230000000000004 111.409 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -105.85 10.07 32.64 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.265 -1.384 . . . . 74.140000000000001 107.265 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 105' ' ' SER . . . -91.71 153.08 19.89 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 113.805 -1.543 . . . . 74.409999999999997 113.15 -174.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 104' ' ' LYS . 13.6 pt-20 -95.09 133.23 39.13 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.64 -1.164 . . . . 73.340000000000003 110.143 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.61 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 43.2 p90 -130.7 156.0 45.67 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.763 -0.829 . . . . 70.25 108.763 176.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -146.7 -178.15 6.03 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.673 -0.862 . . . . 62.420000000000002 108.673 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.2 tp -77.75 113.66 17.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.249 0.547 . . . . 74.430000000000007 109.671 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -86.3 158.55 19.65 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 122.157 -0.339 . . . . 71.150000000000006 110.259 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.35 133.82 31.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.624 0.726 . . . . 51.100000000000001 112.444 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.5 m -154.31 21.71 0.49 Allowed 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.047 0.939 . . . . 73.349999999999994 108.476 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.77 -38.39 42.53 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.786 -0.643 . . . . 65.109999999999999 113.389 -174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -85.41 89.44 7.68 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 120.551 -0.46 . . . . 64.439999999999998 110.625 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.4 ' HA ' ' OE2' ' A' ' 97' ' ' GLU . 46.3 t -85.39 114.97 26.24 Favored 'Isoleucine or valine' 0 C--O 1.248 1.015 0 N-CA-C 108.368 -0.975 . . . . 75.409999999999997 108.368 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.49 ' HG3' ' H ' ' A' ' 95' ' ' GLU . 44.3 pttt -103.36 -73.51 0.66 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 113.757 1.021 . . . . 72.010000000000005 113.757 -172.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.49 ' H ' ' HG3' ' A' ' 94' ' ' LYS . 34.8 tt0 170.22 102.85 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 126.503 1.921 . . . . 75.219999999999999 106.394 -172.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.82 74.81 1.11 Allowed Glycine 0 C--O 1.242 0.642 0 N-CA-C 108.594 -1.803 . . . . 74.299999999999997 108.594 -174.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.4 ' OE2' ' HA ' ' A' ' 93' ' ' VAL . 22.0 mm-40 -76.89 171.46 14.72 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.602 0.715 . . . . 70.430000000000007 112.842 -171.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -150.75 138.76 6.83 Favored Glycine 0 N--CA 1.414 -2.768 0 N-CA-C 109.695 -1.362 . . . . 71.540000000000006 109.695 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -123.63 143.63 50.11 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.687 -1.598 . . . . 74.140000000000001 106.687 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 19.6 pttp -136.02 98.98 4.02 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-O 122.104 0.954 . . . . 71.120000000000005 109.257 173.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.88 125.43 34.0 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.349 -1.296 . . . . 74.549999999999997 108.253 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 10.0 p -117.11 136.74 53.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 C-N-CA 119.866 -0.734 . . . . 62.439999999999998 111.414 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.61 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 27.0 m-90 -115.58 140.29 49.31 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.506 -1.225 . . . . 71.209999999999994 107.711 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 97.4 mttt -116.87 120.99 40.19 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.985 -1.487 . . . . 74.409999999999997 106.985 172.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 46.3 m -64.18 150.71 45.21 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.218 -1.03 . . . . 73.129999999999995 108.218 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.39 119.62 5.88 Favored 'General case' 0 CA--C 1.49 -1.351 0 O-C-N 123.892 0.745 . . . . 70.109999999999999 111.018 -174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.451 ' HB3' ' CG2' ' A' ' 115' ' ' ILE . . . -64.09 130.89 45.77 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 113.487 -1.688 . . . . 62.530000000000001 109.862 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -113.52 137.53 51.43 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.963 -0.562 . . . . 71.299999999999997 109.834 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -58.44 117.97 5.06 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 122.095 0.95 . . . . 73.439999999999998 111.666 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 114' ' ' LYS . 19.8 m -109.96 -165.26 0.99 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.068 -0.969 . . . . 74.409999999999997 111.448 -174.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -84.42 -59.6 2.33 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 114.373 1.249 . . . . 74.129999999999995 114.373 -171.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -86.44 36.75 0.71 Allowed 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 114.18 1.178 . . . . 54.340000000000003 114.18 -165.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 67.43 10.53 7.81 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 122.567 1.175 . . . . 73.439999999999998 111.36 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 110' ' ' SER . 20.3 pttp -115.91 167.91 10.53 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.135 -1.431 . . . . 71.209999999999994 107.135 173.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.451 ' CG2' ' HB3' ' A' ' 107' ' ' ALA . 0.7 OUTLIER -120.88 149.71 23.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 C-N-CA 120.056 -0.658 . . . . 74.310000000000002 109.382 -169.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -98.84 131.16 45.16 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.975 -0.75 . . . . 73.349999999999994 108.975 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 21.7 p90 -147.08 170.05 17.98 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.938 -0.764 . . . . 74.25 108.938 176.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -118.59 138.39 52.6 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 105.651 -1.981 . . . . 62.32 105.651 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.406 ' HB2' HG13 ' A' ' 140' ' ' ILE . 47.6 mt-10 -114.57 142.08 46.91 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.722 -0.791 . . . . 75.010000000000005 110.533 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -133.9 117.15 16.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.739 -0.664 . . . . 73.219999999999999 110.042 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -116.45 110.89 19.23 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 122.94 0.496 . . . . 74.540000000000006 110.366 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -97.74 113.75 25.59 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 110.152 -0.314 . . . . 74.310000000000002 110.152 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -97.84 119.8 37.09 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.455 -0.942 . . . . 74.510000000000005 108.455 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.444 HG12 HD13 ' A' ' 134' ' ' LEU . 59.6 mt -118.54 144.88 25.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 106.953 -1.499 . . . . 73.510000000000005 106.953 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.496 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.6 OUTLIER -119.97 146.0 46.24 Favored 'General case' 0 C--O 1.267 2.008 0 C-N-CA 118.485 -1.286 . . . . 65.200000000000003 107.604 174.307 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -93.0 106.02 18.04 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 106.607 -1.627 . . . . 75.239999999999995 106.607 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -58.44 145.69 37.71 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 113.67 -1.605 . . . . 75.209999999999994 108.195 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -61.51 -18.21 58.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.694 0.759 . . . . 72.140000000000001 110.8 -177.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -65.07 -17.86 64.82 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.562 1.145 . . . . 74.340000000000003 110.953 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.92 -16.66 36.18 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 121.38 -0.438 . . . . 64.030000000000001 112.677 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.0 p -92.8 176.98 6.24 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 109.51 -0.552 . . . . 65.450000000000003 109.51 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.491 ' SG ' HG13 ' A' ' 21' ' ' VAL . 30.4 p -131.16 143.7 50.82 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 109.705 -0.48 . . . . 72.140000000000001 109.705 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.496 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 2.0 t90 -139.27 155.01 48.04 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.809 -0.811 . . . . 65.530000000000001 108.809 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.444 HD13 HG12 ' A' ' 124' ' ' ILE . 2.7 mm? -67.89 111.35 4.3 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.071 -0.968 . . . . 74.239999999999995 108.676 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -76.44 -60.41 2.35 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.718 -1.215 . . . . 74.549999999999997 107.718 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.8 m -161.31 150.5 16.43 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.136 -1.801 . . . . 73.010000000000005 106.136 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.0 m -133.35 135.83 55.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 107.001 -1.481 . . . . 71.140000000000001 107.001 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -115.79 131.29 56.98 Favored 'General case' 0 C--N 1.274 -2.716 0 CA-C-O 120.644 0.259 . . . . 75.439999999999998 110.8 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -119.66 126.23 50.64 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.915 -1.143 . . . . 71.530000000000001 107.915 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.406 HG13 ' HB2' ' A' ' 119' ' ' GLU . 3.8 pt -126.29 98.65 5.02 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 N-CA-C 107.94 -1.133 . . . . 63.439999999999998 107.94 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.446 ' SD ' ' HB3' ' A' ' 76' ' ' LEU . 63.1 mtm -87.91 127.98 35.36 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.01 -1.45 . . . . 71.150000000000006 112.039 -171.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.1 m 64.19 77.33 0.32 Allowed 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 113.332 -1.758 . . . . 62.539999999999999 112.654 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -118.85 177.01 5.01 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 112.981 -1.918 . . . . 71.349999999999994 108.566 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -160.55 175.2 12.98 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 106.84 -1.541 . . . . 72.310000000000002 106.84 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -135.9 147.07 59.52 Favored Pre-proline 0 C--N 1.288 -2.073 0 N-CA-C 106.537 -1.653 . . . . 74.239999999999995 106.537 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -61.13 129.62 29.28 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.028 1.818 . . . . 74.530000000000001 109.946 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -81.26 146.75 30.27 Favored 'General case' 0 N--CA 1.413 -2.301 0 N-CA-C 108.863 -0.791 . . . . 74.219999999999999 108.863 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 19.1 m -87.59 120.82 37.35 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-O 121.112 0.482 . . . . 70.420000000000002 110.767 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.806 0 N-CA-C 108.435 -0.95 . . . . 72.109999999999999 108.435 177.927 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.0 t70 . . . . . 0 N--CA 1.464 0.227 0 N-CA-C 107.37 -1.344 . . . . 73.109999999999999 107.37 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.2 mmt -80.95 92.13 6.12 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.38 -0.6 . . . . 75.420000000000002 109.38 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.9 m -61.77 -30.89 49.39 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.048 0 CA-C-N 115.55 -0.75 . . . . 75.439999999999998 110.562 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.4 m -67.32 -38.04 84.28 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 123.746 0.818 . . . . 73.430000000000007 110.254 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 27.7 t70 -75.8 -39.01 57.66 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.272 -0.877 . . . . 74.239999999999995 109.403 -177.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.2 -35.82 80.41 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.141 -0.936 . . . . 75.299999999999997 108.946 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -64.34 -49.25 72.45 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.725 -0.67 . . . . 71.409999999999997 110.052 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.71 -45.55 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.038 -0.528 . . . . 74.349999999999994 112.341 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 18.3 ptpt -72.27 -26.09 61.85 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 118.632 -1.227 . . . . 72.540000000000006 111.128 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.64 -55.1 12.45 Favored Glycine 0 C--O 1.262 1.876 0 N-CA-C 111.386 -0.685 . . . . 65.230000000000004 111.386 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 pp -66.75 -38.98 87.7 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 108.518 -0.919 . . . . 74.140000000000001 108.518 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.12 -42.84 99.92 Favored Glycine 0 CA--C 1.497 -1.074 0 CA-C-N 116.025 -0.534 . . . . 72.209999999999994 111.986 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -64.62 -45.77 85.46 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-O 119.533 -0.27 . . . . 75.140000000000001 110.424 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.18 -38.61 88.45 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 120.456 -0.498 . . . . 75.230000000000004 110.771 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.488 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 24.7 t80 -62.48 -54.62 37.31 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.522 1.129 . . . . 73.219999999999999 110.123 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.6 mm -65.58 -33.14 61.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 116.358 -0.383 . . . . 65.099999999999994 111.134 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.76 -49.11 77.68 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.109 -0.496 . . . . 75.329999999999998 110.774 175.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.5 pp -67.76 -31.22 70.98 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 120.671 -0.412 . . . . 74.049999999999997 110.836 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.5 t -69.97 -21.87 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-O 121.308 0.575 . . . . 63.210000000000001 110.651 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.7 p -110.51 13.06 22.77 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.754 -0.591 . . . . 75.329999999999998 111.334 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -62.91 144.24 56.91 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.615 -0.721 . . . . 74.329999999999998 112.167 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.3 m -66.05 155.14 88.03 Favored Pre-proline 0 C--N 1.299 -1.594 0 CA-C-N 114.86 -1.064 . . . . 50.549999999999997 110.971 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.97 -6.49 4.92 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 124.389 3.393 . . . . 74.310000000000002 113.259 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.8 -27.84 68.56 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.884 -0.598 . . . . 74.219999999999999 110.193 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.6 m -72.46 158.8 35.05 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.431 -0.951 . . . . 62.450000000000003 108.431 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.534 HG21 ' OD1' ' A' ' 40' ' ' ASN . 32.0 m -63.89 -37.6 80.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 C-N-CA 119.503 -0.879 . . . . 74.329999999999998 110.634 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.624 ' HB2' ' OE1' ' A' ' 42' ' ' GLU . 12.1 p-10 178.92 137.94 0.09 Allowed 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.563 1.145 . . . . 65.25 110.661 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.3 m -63.55 -37.37 87.07 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-O 122.34 1.067 . . . . 74.400000000000006 109.639 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.624 ' OE1' ' HB2' ' A' ' 40' ' ' ASN . 1.2 pm0 -67.58 -20.5 65.39 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 114.317 -1.31 . . . . 75.519999999999996 112.191 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.551 ' HB2' ' OD1' ' A' ' 40' ' ' ASN . 54.8 t-80 -67.43 -49.03 65.52 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 108.877 -0.786 . . . . 64.430000000000007 108.877 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -66.99 -33.84 76.45 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.317 -1.311 . . . . 72.239999999999995 109.058 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.411 HD11 ' CE1' ' A' ' 28' ' ' PHE . 51.8 tp -66.56 -46.42 76.09 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 116.281 -0.418 . . . . 71.519999999999996 110.708 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.73 -35.32 76.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.188 0.518 . . . . 74.450000000000003 110.418 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -76.95 -29.97 55.84 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.436 -0.802 . . . . 72.349999999999994 109.699 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -68.27 -42.96 78.79 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 123.248 0.619 . . . . 73.0 110.019 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 pp -85.44 0.72 51.41 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.821 -0.627 . . . . 75.109999999999999 111.323 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -52.61 -57.95 12.6 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-N 116.383 -0.372 . . . . 74.409999999999997 112.423 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -76.85 -4.1 14.54 Favored 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.438 2.759 . . . . 72.239999999999995 112.525 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -125.13 45.07 2.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.372 -0.376 . . . . 75.340000000000003 110.006 -173.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -54.97 104.98 0.46 Allowed Pre-proline 0 N--CA 1.492 1.666 0 C-N-CA 124.833 1.253 . . . . 75.450000000000003 113.179 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -97.9 177.16 0.47 Allowed 'Trans proline' 0 N--CA 1.431 -2.164 0 C-N-CA 123.13 2.553 . . . . 71.340000000000003 110.268 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.92 105.34 11.13 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.919 -1.141 . . . . 73.340000000000003 107.919 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.452 HD12 ' CB ' ' A' ' 68' ' ' PHE . 68.9 mt -93.06 106.54 18.05 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.404 0 N-CA-C 108.879 -0.786 . . . . 74.319999999999993 108.879 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -95.82 112.9 24.52 Favored 'General case' 0 C--N 1.265 -3.092 0 O-C-N 121.718 -0.614 . . . . 72.129999999999995 110.398 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 3.6 p -108.57 118.49 56.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 C-N-CA 118.81 -1.156 . . . . 73.319999999999993 108.129 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 59.74 20.34 9.1 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.643 -1.162 . . . . 75.450000000000003 111.106 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.53 7.84 53.29 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 115.158 -0.928 . . . . 73.310000000000002 114.144 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -116.64 132.94 56.55 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 117.666 0.733 . . . . 72.430000000000007 110.862 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.1 127.05 36.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 121.481 0.658 . . . . 73.239999999999995 110.222 -176.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -126.95 151.17 48.87 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.793 -1.188 . . . . 74.439999999999998 107.793 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.6 t -93.77 173.11 7.84 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.457 -0.942 . . . . 75.409999999999997 108.457 174.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.0 t -49.22 -39.45 30.02 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 124.605 1.162 . . . . 74.239999999999995 111.64 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.2 m -65.21 -47.86 75.4 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 122.918 0.487 . . . . 74.200000000000003 111.108 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.6 78.28 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 122.745 0.418 . . . . 72.030000000000001 110.129 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.452 ' CB ' HD12 ' A' ' 56' ' ' ILE . 51.4 t80 -52.81 -55.17 24.89 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 116.177 -0.465 . . . . 74.209999999999994 110.271 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -51.35 -42.09 61.05 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.042 -0.981 . . . . 62.439999999999998 110.857 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -62.66 -49.7 74.12 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 116.299 -0.41 . . . . 75.530000000000001 111.683 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.4 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 24.8 m-85 -65.82 -33.4 75.78 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.794 0.807 . . . . 73.219999999999999 109.27 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.511 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 4.1 t80 -57.85 -53.18 61.13 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.02 -0.991 . . . . 73.099999999999994 110.841 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -74.73 -20.63 59.76 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.15 0.5 . . . . 75.120000000000005 110.671 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -76.18 -8.25 56.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.901 -0.591 . . . . 74.430000000000007 111.051 173.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.16 10.07 57.6 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 120.539 -0.838 . . . . 74.129999999999995 114.266 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.32 -50.53 52.83 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 116.868 0.334 . . . . 73.129999999999995 110.442 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 36.5 m-85 -99.31 10.08 42.12 Favored 'General case' 0 C--O 1.204 -1.326 0 N-CA-C 112.819 0.674 . . . . 75.099999999999994 112.819 -173.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.301 62.8 pttt -70.48 -10.62 59.65 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 114.221 1.193 . . . . 74.349999999999994 114.221 -176.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -83.33 -10.55 58.42 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.196 -0.456 . . . . 75.349999999999994 110.485 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.44 -15.93 63.71 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 112.578 0.584 . . . . 64.400000000000006 112.578 -172.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -11.16 40.54 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.931 -0.481 . . . . 63.119999999999997 112.122 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -99.76 14.06 31.55 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 122.65 0.38 . . . . 73.319999999999993 111.23 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 103' ' ' TRP . . . -58.71 129.22 41.06 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.008 0.744 . . . . 65.019999999999996 113.008 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -100.67 127.01 47.23 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.497 -1.668 . . . . 72.049999999999997 106.497 173.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -82.2 125.12 30.55 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 120.749 -0.38 . . . . 75.150000000000006 110.526 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.42 ' HB3' HG12 ' A' ' 102' ' ' VAL . . . -88.94 113.5 24.54 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.167 -1.42 . . . . 62.329999999999998 107.167 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.2 tt -47.74 107.75 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 114.337 1.236 . . . . 74.519999999999996 114.337 -173.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -87.58 117.71 26.57 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 106.507 -1.664 . . . . 63.439999999999998 106.507 173.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.45 97.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.855 0.836 . . . . 65.120000000000005 109.993 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p -113.09 6.05 17.4 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 114.757 -1.111 . . . . 74.239999999999995 110.375 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.34 85.55 0.72 Allowed Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 114.715 -1.13 . . . . 62.299999999999997 110.661 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -173.3 172.36 3.81 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 124.441 1.096 . . . . 63.049999999999997 108.44 -175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.06 118.18 28.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.053 -1.092 . . . . 71.120000000000005 108.053 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -116.68 123.74 48.0 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.622 -0.717 . . . . 72.430000000000007 109.556 -174.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.432 ' HA ' ' NH2' ' A' ' 126' ' ' ARG . 10.0 pt-20 -116.13 -44.07 2.93 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.376 -0.53 . . . . 75.239999999999995 110.316 173.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -145.61 61.81 0.47 Allowed Glycine 0 C--N 1.308 -0.986 0 N-CA-C 110.176 -1.17 . . . . 70.129999999999995 110.176 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -96.65 163.53 12.98 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 121.009 0.433 . . . . 73.450000000000003 111.058 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.54 138.35 14.91 Favored Glycine 0 N--CA 1.423 -2.226 0 N-CA-C 108.628 -1.789 . . . . 74.530000000000001 108.628 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -112.67 146.3 38.93 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 117.11 0.455 . . . . 74.519999999999996 109.931 -176.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -124.89 97.59 5.33 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.164 -1.421 . . . . 75.329999999999998 107.164 172.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.64 107.99 20.53 Favored 'General case' 0 C--N 1.259 -3.363 0 N-CA-C 106.383 -1.71 . . . . 73.409999999999997 106.383 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.2 p -115.89 135.27 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 CA-C-O 121.897 0.856 . . . . 73.340000000000003 112.258 -174.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 30.5 m-90 -119.28 155.43 31.81 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.285 -1.325 . . . . 73.439999999999998 109.94 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -129.03 125.25 36.91 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 104.485 -2.413 . . . . 73.129999999999995 104.485 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 80.6 p -75.65 -170.47 1.29 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 118.296 0.498 . . . . 73.510000000000005 110.644 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.32 117.33 5.96 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.438 0.637 . . . . 72.219999999999999 109.894 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.68 139.79 32.56 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.327 -1.306 . . . . 73.310000000000002 109.189 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -126.55 114.76 18.53 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.312 -0.625 . . . . 73.019999999999996 109.312 -176.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -66.35 133.45 50.53 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 120.169 -0.612 . . . . 75.0 109.412 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.9 m -104.88 164.57 11.68 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.137 -0.938 . . . . 74.439999999999998 109.386 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -68.06 -19.79 64.91 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.334 0.588 . . . . 74.239999999999995 111.012 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.76 -1.03 29.3 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.902 -0.59 . . . . 73.519999999999996 109.917 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 75.37 10.56 3.54 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.318 1.447 . . . . 75.129999999999995 109.355 -176.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -92.14 164.6 13.52 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.859 -1.534 . . . . 73.120000000000005 106.859 174.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.1 mp -127.38 137.84 56.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 106.506 -1.664 . . . . 74.409999999999997 106.506 175.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -115.64 137.84 51.67 Favored 'General case' 0 C--N 1.292 -1.925 0 O-C-N 123.411 0.444 . . . . 74.430000000000007 110.331 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.464 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 22.1 p90 -149.41 174.6 12.28 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.822 -1.548 . . . . 75.329999999999998 106.822 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -116.28 141.3 48.34 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 106.332 -1.729 . . . . 74.200000000000003 106.332 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.464 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 42.4 mt-10 -115.33 147.04 40.94 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 119.701 -0.8 . . . . 65.030000000000001 112.567 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -139.37 117.88 12.16 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.169 -0.923 . . . . 71.530000000000001 110.185 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.57 109.57 17.98 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.697 -0.853 . . . . 74.439999999999998 108.697 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.65 123.02 37.84 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 109.527 -0.546 . . . . 74.319999999999993 109.527 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -103.31 112.18 24.94 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.764 -1.199 . . . . 75.329999999999998 107.764 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.4 mt -117.3 150.92 19.24 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 N-CA-C 106.744 -1.576 . . . . 72.109999999999999 106.744 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -136.16 143.06 44.26 Favored 'General case' 0 C--O 1.275 2.414 0 N-CA-C 108.226 -1.028 . . . . 73.230000000000004 108.226 172.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.432 ' NH2' ' HA ' ' A' ' 95' ' ' GLU . 19.9 ttp180 -91.53 100.98 13.63 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 106.793 -1.558 . . . . 72.010000000000005 106.793 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -68.03 132.89 48.08 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 114.765 -1.107 . . . . 75.219999999999999 109.258 -171.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -66.16 -10.57 42.46 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 123.75 0.82 . . . . 74.420000000000002 111.417 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -74.6 -8.0 54.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.055 -0.52 . . . . 73.049999999999997 111.023 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.22 -8.78 28.95 Favored Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.707 -0.759 . . . . 75.030000000000001 113.932 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.9 m -104.16 138.78 40.15 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.414 -0.587 . . . . 72.010000000000005 109.414 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 44.7 t -98.33 132.65 43.63 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 107.037 -1.468 . . . . 74.310000000000002 107.037 170.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -146.0 154.78 42.27 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 118.389 -1.324 . . . . 73.439999999999998 110.642 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.22 125.67 29.59 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.99 -1.115 . . . . 74.310000000000002 107.99 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -80.79 -53.99 6.0 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.408 -0.96 . . . . 64.209999999999994 108.408 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.4 m -162.48 158.48 23.76 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 105.266 -2.124 . . . . 73.25 105.266 -175.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.7 m -143.06 138.4 27.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 107.296 -1.372 . . . . 75.129999999999995 107.296 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -112.82 136.33 52.57 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 109.786 -0.45 . . . . 71.5 109.786 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 71.8 m-85 -125.04 122.94 38.69 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 107.72 -1.215 . . . . 61.340000000000003 107.72 175.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.2 pt -127.14 98.81 4.9 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 N-CA-C 107.946 -1.131 . . . . 74.439999999999998 107.946 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 23.4 ptm -86.63 143.09 27.8 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.481 -1.236 . . . . 74.329999999999998 110.564 -173.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.8 m 67.62 35.23 4.17 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.569 1.168 . . . . 74.150000000000006 109.287 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -71.07 127.69 33.44 Favored 'General case' 0 N--CA 1.408 -2.54 0 CA-C-N 113.082 -1.872 . . . . 74.409999999999997 109.258 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -147.44 168.78 21.0 Favored 'General case' 0 C--N 1.268 -2.966 0 CA-C-N 114.313 -1.312 . . . . 55.439999999999998 108.578 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -123.03 158.86 56.38 Favored Pre-proline 0 C--N 1.279 -2.47 0 N-CA-C 106.247 -1.76 . . . . 71.340000000000003 106.247 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.81 130.9 42.84 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.809 1.673 . . . . 73.540000000000006 109.246 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -61.65 139.14 58.32 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.326 0.584 . . . . 75.420000000000002 111.45 -174.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.8 m -90.11 151.04 3.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 108.414 -0.958 . . . . 73.319999999999993 108.414 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.654 0 N-CA-C 108.762 -0.829 . . . . 62.310000000000002 108.762 -179.189 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 120.826 0.346 . . . . 64.150000000000006 111.436 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -75.24 8.89 2.35 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 112.615 0.598 . . . . 70.200000000000003 112.615 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.7 m -65.43 -40.15 87.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 110.194 -0.298 . . . . 74.209999999999994 110.194 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.4 m -72.13 -29.18 63.81 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.405 0.622 . . . . 73.439999999999998 109.507 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -69.76 -46.43 65.83 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 116.153 -0.476 . . . . 73.040000000000006 110.178 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.99 -43.86 97.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.559 -0.746 . . . . 75.120000000000005 109.434 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.04 -42.93 99.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.843 -0.617 . . . . 63.0 111.622 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.6 m -74.46 -39.79 48.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 119.352 -0.939 . . . . 73.409999999999997 112.698 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -72.38 -28.03 62.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 119.052 -1.059 . . . . 75.310000000000002 109.787 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.03 -42.55 43.94 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 110.533 -1.027 . . . . 60.409999999999997 110.533 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.546 HD23 ' SG ' ' A' ' 132' ' ' CYS . 17.9 tp -64.84 -50.37 66.94 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.025 -0.731 . . . . 73.349999999999994 109.025 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.59 -39.05 94.58 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.347 -0.842 . . . . 71.400000000000006 112.232 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -68.63 -42.13 78.49 Favored 'General case' 0 C--O 1.204 -1.292 0 C-N-CA 121.051 -0.26 . . . . 75.230000000000004 110.565 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.454 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 7.9 t70 -63.56 -41.46 98.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.777 0.799 . . . . 74.549999999999997 109.234 -176.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.433 ' CE1' HD11 ' A' ' 45' ' ' LEU . 33.4 t80 -63.88 -55.03 25.76 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.362 -1.744 . . . . 70.420000000000002 110.163 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.9 mm -64.41 -32.89 59.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 111.693 0.257 . . . . 71.5 111.693 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.41 -52.8 63.06 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 122.786 0.434 . . . . 75.329999999999998 110.192 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 27' ' ' ASP . 3.7 pp -71.97 -24.4 61.59 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 119.629 -0.828 . . . . 72.329999999999998 112.162 -176.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.2 t -71.08 -25.31 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.094 0.473 . . . . 73.340000000000003 109.972 174.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.6 p -108.17 13.38 25.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.251 0.548 . . . . 73.239999999999995 110.281 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -62.67 148.35 46.71 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 115.423 -0.808 . . . . 72.010000000000005 110.834 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.6 m -51.37 143.11 19.36 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 125.763 1.625 . . . . 64.510000000000005 114.175 -175.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.39 -6.39 17.41 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 124.452 3.434 . . . . 60.009999999999998 113.338 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -62.99 -25.84 68.58 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.643 0.735 . . . . 64.409999999999997 110.134 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 t -81.46 172.18 13.83 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.233 -1.025 . . . . 75.530000000000001 108.233 175.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -56.52 -45.65 82.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 C-N-CA 122.51 0.324 . . . . 74.409999999999997 110.776 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.564 ' ND2' ' HB3' ' A' ' 42' ' ' GLU . 39.2 t30 178.16 139.06 0.09 Allowed 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.873 -1.158 . . . . 74.299999999999997 107.873 -177.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 m -61.85 -26.66 68.27 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 122.571 1.177 . . . . 62.5 110.688 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.592 ' OE2' ' HA ' ' A' ' 78' ' ' LYS . 38.1 tt0 -64.67 -23.48 67.27 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 125.099 1.36 . . . . 55.439999999999998 109.897 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.409 ' HA ' ' CZ ' ' A' ' 72' ' ' PHE . 48.2 t-80 -65.05 -46.12 82.54 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.264 -0.643 . . . . 73.219999999999999 109.264 176.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -70.58 -31.46 68.49 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 108.292 -1.003 . . . . 73.340000000000003 108.292 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.433 HD11 ' CE1' ' A' ' 28' ' ' PHE . 48.4 tp -66.82 -46.88 73.76 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.936 -0.575 . . . . 74.129999999999995 111.052 176.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.62 -34.33 75.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.359 0.6 . . . . 55.140000000000001 110.094 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -73.16 -34.82 66.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.366 -0.834 . . . . 74.420000000000002 109.632 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 41.8 t80 -66.28 -48.52 70.13 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.864 0.865 . . . . 75.340000000000003 110.231 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 pp -80.44 -3.07 48.43 Favored 'General case' 0 C--O 1.198 -1.616 0 CA-C-N 115.275 -0.875 . . . . 73.019999999999996 111.774 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -42.45 -60.82 2.66 Favored Glycine 0 CA--C 1.537 1.432 0 O-C-N 123.792 0.682 . . . . 75.430000000000007 113.573 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.45 -5.76 13.48 Favored 'Trans proline' 0 CA--C 1.551 1.328 0 C-N-CA 122.452 2.101 . . . . 74.439999999999998 112.998 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -116.51 22.47 12.75 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.128 -0.358 . . . . 74.099999999999994 110.454 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.679 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 18.4 t70 -65.9 120.07 66.13 Favored Pre-proline 0 C--O 1.256 1.434 0 N-CA-C 112.943 0.72 . . . . 74.209999999999994 112.943 -172.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -104.92 -148.8 0.02 OUTLIER 'Trans proline' 0 CA--C 1.554 1.524 0 C-N-CA 124.252 3.301 . . . . 73.129999999999995 112.22 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -86.85 126.12 34.43 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 107.888 -1.152 . . . . 71.299999999999997 107.888 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.531 HD11 ' CB ' ' A' ' 68' ' ' PHE . 48.2 mt -107.34 113.1 42.71 Favored 'Isoleucine or valine' 0 C--O 1.172 -3.012 0 N-CA-C 106.86 -1.533 . . . . 73.219999999999999 106.86 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -99.2 135.18 40.98 Favored 'General case' 0 C--N 1.266 -3.051 0 O-C-N 121.669 -0.644 . . . . 74.430000000000007 109.703 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 74.9 t -133.54 113.61 19.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 108.714 -0.847 . . . . 75.019999999999996 108.714 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 61.32 25.18 15.19 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 125.377 1.471 . . . . 72.219999999999999 111.695 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.8 2.12 58.53 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.856 -0.688 . . . . 62.310000000000002 112.627 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -113.4 135.49 53.81 Favored 'General case' 0 CA--C 1.492 -1.278 0 O-C-N 122.31 -0.524 . . . . 75.420000000000002 110.713 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.21 128.49 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 108.903 -0.777 . . . . 73.25 108.903 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -122.52 143.6 49.61 Favored 'General case' 0 C--O 1.282 2.766 0 N-CA-C 107.161 -1.422 . . . . 74.099999999999994 107.161 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.1 t -91.91 173.14 8.01 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.923 -1.14 . . . . 72.310000000000002 107.923 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.679 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 13.6 t -58.4 -32.46 68.64 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.698 0.399 . . . . 75.230000000000004 111.637 -176.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.5 m -60.82 -51.56 68.81 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.869 -0.605 . . . . 74.239999999999995 110.105 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.64 -49.36 75.49 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.532 -0.758 . . . . 75.430000000000007 110.441 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.531 ' CB ' HD11 ' A' ' 56' ' ' ILE . 56.9 t80 -52.9 -54.91 27.88 Favored 'General case' 0 CA--C 1.501 -0.939 0 O-C-N 123.676 0.61 . . . . 73.349999999999994 110.926 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.2 tp -53.06 -44.85 67.78 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 124.094 0.871 . . . . 72.209999999999994 111.782 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.538 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 76.3 mt-30 -58.07 -51.81 68.14 Favored 'General case' 0 N--CA 1.439 -1.014 0 O-C-N 123.257 0.348 . . . . 74.510000000000005 111.025 175.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -62.47 -40.72 97.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.217 0.532 . . . . 74.450000000000003 110.735 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.409 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 2.6 t80 -57.86 -52.1 66.87 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.593 0.757 . . . . 71.230000000000004 110.309 177.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -73.23 -18.28 61.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.149 -0.478 . . . . 72.209999999999994 111.397 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 46.8 mt-30 -87.22 -11.5 49.59 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 120.167 -0.613 . . . . 75.400000000000006 111.773 175.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.52 42.14 6.62 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.509 -0.853 . . . . 74.420000000000002 112.821 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.03 -35.37 17.59 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 122.79 -0.241 . . . . 71.209999999999994 111.206 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -108.08 -2.81 19.23 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.219 -0.593 . . . . 74.439999999999998 112.297 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.592 ' HA ' ' OE2' ' A' ' 42' ' ' GLU 0.372 0.0 OUTLIER -60.19 -13.65 13.44 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 115.894 1.813 . . . . 75.150000000000006 115.894 -165.783 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.22 -12.91 62.08 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 116.113 -0.494 . . . . 74.430000000000007 111.169 174.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.7 tt -61.46 -27.09 68.32 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.438 1.095 . . . . 75.099999999999994 110.657 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.469 ' HB2' ' OD1' ' A' ' 40' ' ' ASN . 27.4 ttpp -55.02 -33.51 62.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.328 0.585 . . . . 75.340000000000003 111.321 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -105.33 14.56 28.69 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.443 -0.798 . . . . 75.140000000000001 111.032 -173.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.06 153.81 23.59 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.308 0.575 . . . . 64.040000000000006 112.433 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 103' ' ' TRP . 10.2 pt-20 -89.31 149.82 22.87 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.213 -1.402 . . . . 75.109999999999999 107.213 175.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -117.91 136.14 53.66 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 118.972 0.805 . . . . 73.299999999999997 112.002 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.86 110.22 21.89 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.827 -0.805 . . . . 71.439999999999998 108.827 174.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.4 tt -82.87 103.0 9.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.545 0.688 . . . . 63.420000000000002 111.703 -177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -116.33 89.68 3.16 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.691 -0.686 . . . . 64.129999999999995 109.806 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.8 t -104.0 149.28 7.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 107.71 -1.218 . . . . 63.329999999999998 107.71 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.8 p -65.28 -55.34 18.92 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.087 0.47 . . . . 60.43 110.811 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.47 -136.94 7.97 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 109.509 -1.437 . . . . 61.439999999999998 109.509 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -102.42 12.16 36.93 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.687 0.756 . . . . 64.219999999999999 110.324 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.1 t -82.28 139.68 17.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.454 -1.313 . . . . 73.430000000000007 107.454 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.408 ' HA ' ' NH1' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -130.9 102.54 6.1 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.127 -1.064 . . . . 72.540000000000006 108.127 177.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -136.5 -31.7 0.86 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.078 0.466 . . . . 75.040000000000006 111.547 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 129.53 47.03 0.16 Allowed Glycine 0 C--N 1.299 -1.476 0 N-CA-C 109.669 -1.373 . . . . 61.240000000000002 109.669 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 97' ' ' GLU . 1.1 mp0 -82.09 175.65 10.16 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 123.237 0.615 . . . . 73.510000000000005 110.641 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.59 144.5 18.28 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 110.852 -0.899 . . . . 73.239999999999995 110.852 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -109.99 140.4 44.05 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.628 -1.249 . . . . 75.430000000000007 107.628 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -131.59 101.19 5.4 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.769 -0.826 . . . . 73.310000000000002 108.769 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 83.4 mt -107.96 112.22 24.7 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.967 -0.753 . . . . 74.230000000000004 108.967 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.6 p -114.03 129.2 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-O 121.484 0.659 . . . . 73.010000000000005 111.996 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.59 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 31.4 m-90 -101.82 141.6 34.43 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.604 -1.18 . . . . 75.219999999999999 109.217 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.405 ' HB2' ' CG ' ' A' ' 84' ' ' GLU . 36.3 mtpt -118.56 125.46 49.87 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 107.549 -1.278 . . . . 73.099999999999994 107.549 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.8 t -79.33 -164.28 0.61 Allowed 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.917 -1.038 . . . . 61.340000000000003 110.311 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.52 151.98 40.82 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 112.862 0.689 . . . . 74.420000000000002 112.862 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.5 108.84 10.96 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.278 -1.379 . . . . 71.420000000000002 107.278 173.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -95.98 140.4 30.77 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 115.822 -0.626 . . . . 72.519999999999996 110.858 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -59.78 120.08 8.87 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 116.24 1.941 . . . . 75.129999999999995 116.24 -166.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 114' ' ' LYS . 18.7 t -154.0 105.82 2.77 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 104.881 -2.266 . . . . 74.129999999999995 104.881 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -76.31 12.64 1.14 Allowed 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 114.487 1.291 . . . . 72.420000000000002 114.487 -169.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -93.02 16.45 12.74 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.779 -0.575 . . . . 75.340000000000003 112.143 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 113' ' ' GLN . 9.1 tt0 72.08 14.08 5.75 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 122.711 1.243 . . . . 73.450000000000003 109.614 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 110' ' ' SER . 2.8 pptp? -133.12 118.74 19.07 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 107.208 -1.404 . . . . 74.329999999999998 107.208 173.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.1 pt -93.59 168.55 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-N 115.553 -0.749 . . . . 73.310000000000002 109.131 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.403 ' HD2' ' OG ' ' A' ' 142' ' ' SER . 18.0 ptt180 -125.28 136.73 53.81 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 107.864 -1.162 . . . . 73.200000000000003 107.864 174.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.445 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 46.5 p90 -134.74 173.33 11.81 Favored 'General case' 0 C--N 1.269 -2.923 0 N-CA-C 107.536 -1.283 . . . . 75.140000000000001 107.536 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -116.18 138.95 50.84 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 106.056 -1.831 . . . . 73.010000000000005 106.056 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.445 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 38.4 mt-10 -118.31 144.3 45.95 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.001 -0.68 . . . . 75.129999999999995 111.225 176.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -132.51 116.74 17.13 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.861 -1.163 . . . . 44.340000000000003 107.861 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -125.68 113.26 17.11 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 121.68 0.752 . . . . 72.120000000000005 111.987 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.86 128.65 41.77 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.791 -1.095 . . . . 72.439999999999998 110.036 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -109.55 117.93 35.27 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.316 -0.994 . . . . 75.230000000000004 108.316 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.5 mt -115.59 151.17 17.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 106.435 -1.691 . . . . 71.329999999999998 106.435 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -136.02 150.17 49.1 Favored 'General case' 0 C--O 1.27 2.144 0 C-N-CA 118.984 -1.086 . . . . 73.109999999999999 109.231 175.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.408 ' NH1' ' HA ' ' A' ' 94' ' ' LYS . 61.7 mtt180 -76.07 113.04 13.14 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 108.145 -1.057 . . . . 75.239999999999995 108.145 172.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -73.41 133.06 43.65 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 113.906 -1.497 . . . . 65.340000000000003 107.566 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -62.53 -15.46 50.73 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.152 0.581 . . . . 64.430000000000007 112.192 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -64.94 -16.8 63.75 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 124.001 0.921 . . . . 73.019999999999996 110.988 173.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.34 -6.35 30.24 Favored Glycine 0 CA--C 1.501 -0.791 0 N-CA-C 111.215 -0.754 . . . . 71.519999999999996 111.215 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.9 p -100.01 -172.34 2.21 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 123.33 0.652 . . . . 71.230000000000004 110.6 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.546 ' SG ' HD23 ' A' ' 24' ' ' LEU . 15.0 p -134.61 144.57 47.98 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.601 -1.259 . . . . 75.510000000000005 107.601 174.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -155.23 155.2 33.41 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 119.292 -0.963 . . . . 74.439999999999998 108.889 -176.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.88 128.47 36.48 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.153 0.501 . . . . 64.430000000000007 109.652 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -87.12 -46.77 9.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.047 -0.723 . . . . 75.219999999999999 109.047 -176.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.9 p -175.01 152.4 1.48 Allowed 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 107.805 -1.183 . . . . 75.329999999999998 107.805 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.41 150.55 32.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.385 -1.339 . . . . 72.040000000000006 107.385 175.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -130.09 133.29 46.58 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 110.266 -0.272 . . . . 73.299999999999997 110.266 -177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 67.0 m-85 -117.57 127.26 53.8 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.609 -1.256 . . . . 75.230000000000004 107.609 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.0 pt -128.45 98.76 4.49 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.42 0 CA-C-O 122.395 1.093 . . . . 71.450000000000003 108.896 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 22.6 ptp -89.73 126.94 35.85 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.163 -1.381 . . . . 73.409999999999997 109.87 -175.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.403 ' OG ' ' HD2' ' A' ' 116' ' ' ARG . 32.2 t 73.74 73.97 0.12 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.42 -1.264 . . . . 65.5 110.593 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -113.78 135.96 53.38 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.19 -1.368 . . . . 73.019999999999996 107.451 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -134.69 143.1 47.02 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 109.715 -0.476 . . . . 65.319999999999993 109.715 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.83 130.53 24.31 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 109.107 -0.701 . . . . 61.32 109.107 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.94 132.28 44.05 Favored 'Trans proline' 0 C--O 1.246 0.924 0 C-N-CA 122.66 2.24 . . . . 74.120000000000005 111.094 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -93.61 168.06 11.27 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 108.164 -1.05 . . . . 73.209999999999994 108.164 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 38.5 t -135.23 98.98 2.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.505 -0.924 . . . . 73.310000000000002 108.505 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.888 0 CA-C-N 115.321 -0.854 . . . . 73.420000000000002 108.717 -179.013 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 112.565 0.58 . . . . 75.129999999999995 112.565 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 92.6 mtp -66.55 162.32 21.11 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.751 0.705 . . . . 65.439999999999998 110.764 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.11 -42.68 96.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.162 -0.681 . . . . 72.549999999999997 109.162 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.608 ' O ' HG22 ' A' ' 21' ' ' VAL . 8.5 p -62.39 -43.15 99.51 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.32 -0.855 . . . . 63.43 109.842 177.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -66.67 -34.9 78.9 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.018 -0.992 . . . . 73.340000000000003 111.413 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.69 -36.83 84.76 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.222 -1.029 . . . . 75.230000000000004 108.222 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -69.91 -38.23 76.2 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.372 -0.831 . . . . 74.540000000000006 109.853 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 17' ' ' THR . 89.3 t -59.16 -56.66 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 115.218 -0.901 . . . . 75.209999999999994 110.437 176.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.404 ' HB3' ' HZ3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -66.14 -25.9 67.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.354 -0.384 . . . . 75.420000000000002 110.545 -179.025 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.59 -50.44 48.91 Favored Glycine 0 C--O 1.25 1.128 0 N-CA-C 111.659 -0.576 . . . . 71.120000000000005 111.659 175.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.77 -37.74 76.48 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 108.613 -0.884 . . . . 75.430000000000007 108.613 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.58 -40.63 99.38 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.704 -0.68 . . . . 73.310000000000002 111.851 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -67.77 -46.03 73.22 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 120.457 -0.497 . . . . 71.310000000000002 110.409 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.23 -39.82 95.7 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 120.567 -0.453 . . . . 74.420000000000002 110.644 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -61.57 -52.54 64.01 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.604 0.762 . . . . 72.219999999999999 109.902 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 29' ' ' ILE . 7.4 mm -67.52 -35.09 72.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 120.906 -0.318 . . . . 75.439999999999998 111.675 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -63.2 -46.24 87.94 Favored 'General case' 0 CA--C 1.495 -1.141 0 C-N-CA 122.425 0.29 . . . . 61.539999999999999 110.487 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.509 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 4.1 pp -69.65 -28.76 66.16 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 119.736 -0.786 . . . . 71.340000000000003 111.249 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.412 ' N ' HD11 ' A' ' 31' ' ' LEU . 52.9 t -71.76 -24.33 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-O 121.456 0.646 . . . . 74.310000000000002 110.084 174.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.9 p -107.23 19.29 20.56 Favored 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 121.598 -0.689 . . . . 73.099999999999994 111.261 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 64.7 mmtt -53.24 138.64 31.55 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 116.051 -0.522 . . . . 74.510000000000005 111.057 175.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -64.28 159.23 59.79 Favored Pre-proline 0 N--CA 1.435 -1.222 0 CA-C-N 115.003 -0.999 . . . . 74.310000000000002 109.675 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.5 -11.04 18.16 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 123.349 2.699 . . . . 73.340000000000003 111.502 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -68.0 -26.05 65.71 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.607 -1.179 . . . . 74.299999999999997 110.872 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.9 t -82.67 172.26 13.11 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.442 -1.318 . . . . 71.019999999999996 107.442 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.7 t -74.77 -54.29 14.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.485 -0.486 . . . . 74.450000000000003 111.131 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.484 ' O ' ' HB3' ' A' ' 43' ' ' HIS . 23.8 t30 -170.84 126.61 0.72 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.211 -0.45 . . . . 71.219999999999999 110.355 -173.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 p -61.0 -39.3 89.15 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 123.358 0.663 . . . . 71.430000000000007 111.624 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.44 -21.6 66.21 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.962 -0.563 . . . . 61.5 110.483 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.484 ' HB3' ' O ' ' A' ' 40' ' ' ASN . 42.7 t-80 -72.91 -48.87 33.41 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.354 -0.98 . . . . 74.299999999999997 108.354 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -64.19 -35.0 79.37 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.587 -1.188 . . . . 75.400000000000006 109.541 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.0 tp -66.88 -42.37 85.69 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 116.292 -0.413 . . . . 70.299999999999997 110.466 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.32 -32.13 73.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.455 0.645 . . . . 74.239999999999995 110.319 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -74.83 -35.75 62.4 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.536 -0.757 . . . . 71.209999999999994 110.25 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -68.37 -41.69 80.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.364 0.666 . . . . 72.049999999999997 110.718 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 pp -79.02 -8.44 58.94 Favored 'General case' 0 C--O 1.194 -1.838 0 CA-C-N 115.746 -0.661 . . . . 72.540000000000006 111.814 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -46.9 -55.67 8.2 Favored Glycine 0 CA--C 1.546 1.993 0 O-C-N 123.454 0.472 . . . . 54.130000000000003 114.017 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -78.0 -3.81 13.82 Favored 'Trans proline' 0 CA--C 1.55 1.32 0 C-N-CA 122.993 2.462 . . . . 64.109999999999999 112.474 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -129.46 28.31 5.21 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.984 -0.448 . . . . 75.219999999999999 110.21 -168.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -55.98 115.68 10.33 Favored Pre-proline 0 N--CA 1.475 0.818 0 O-C-N 124.042 0.839 . . . . 74.239999999999995 111.451 -175.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -108.96 -158.15 0.02 OUTLIER 'Trans proline' 0 CA--C 1.557 1.636 0 C-N-CA 123.721 2.947 . . . . 75.530000000000001 111.546 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -86.85 126.12 34.44 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.08 -1.081 . . . . 71.430000000000007 108.08 175.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.513 HD12 ' CB ' ' A' ' 68' ' ' PHE . 36.7 mt -112.18 107.06 22.0 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.412 0 N-CA-C 108.98 -0.748 . . . . 73.140000000000001 108.98 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -89.84 135.64 33.51 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 109.753 -0.462 . . . . 72.420000000000002 109.753 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 3.8 p -126.03 117.88 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 N-CA-C 107.371 -1.344 . . . . 74.200000000000003 107.371 174.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 62.77 20.8 12.38 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 123.956 0.902 . . . . 63.229999999999997 110.709 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.38 -5.34 58.82 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.38 -0.827 . . . . 71.430000000000007 112.489 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -99.82 126.18 45.87 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 109.026 -0.731 . . . . 74.329999999999998 109.026 -178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -70.88 126.41 31.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-O 121.54 0.686 . . . . 75.120000000000005 109.427 -176.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 63.1 mm-40 -122.33 152.45 40.11 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.077 -0.712 . . . . 74.219999999999999 109.077 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.6 t -87.64 169.15 12.39 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.327 -0.99 . . . . 74.549999999999997 108.327 175.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.404 ' HA ' HD13 ' A' ' 56' ' ' ILE . 13.2 t -58.03 -34.18 69.77 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.379 0.672 . . . . 73.120000000000005 111.33 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.0 m -61.58 -49.46 76.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.25 0.548 . . . . 73.340000000000003 109.784 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 63' ' ' GLN . . . -60.83 -49.78 76.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.281 -0.872 . . . . 74.439999999999998 110.391 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CB ' HD12 ' A' ' 56' ' ' ILE . 44.3 t80 -51.49 -56.07 15.38 Favored 'General case' 0 CA--C 1.5 -0.943 0 O-C-N 123.778 0.674 . . . . 74.329999999999998 110.415 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.5 mt -49.77 -47.54 50.97 Favored 'General case' 0 CA--C 1.491 -1.3 0 O-C-N 124.079 0.862 . . . . 62.5 112.94 176.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -55.54 -51.42 67.12 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 123.703 0.627 . . . . 64.129999999999995 111.773 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -65.63 -37.3 86.18 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.555 0.693 . . . . 75.510000000000005 110.463 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.47 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 3.4 t80 -61.83 -53.6 53.69 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.183 -0.917 . . . . 72.319999999999993 111.197 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -74.62 -18.17 60.6 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 123.333 0.396 . . . . 75.150000000000006 111.123 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -75.3 -14.51 60.5 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.033 0.444 . . . . 72.519999999999996 111.285 171.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.43 18.01 29.66 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 120.749 -0.739 . . . . 60.43 113.577 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.6 mt -76.84 -44.65 31.46 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.469 -0.892 . . . . 75.340000000000003 112.019 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -89.3 -5.77 57.29 Favored 'General case' 0 C--O 1.203 -1.358 0 N-CA-C 113.384 0.883 . . . . 75.519999999999996 113.384 -174.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.286 0.0 OUTLIER -64.09 -12.4 38.9 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.727 1.38 . . . . 72.319999999999993 114.727 -175.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -80.81 -10.68 59.7 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.112 -0.495 . . . . 72.510000000000005 111.176 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.49 -15.56 60.39 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 122.76 0.424 . . . . 74.299999999999997 111.864 -176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -53.44 -30.42 40.4 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.265 0.555 . . . . 73.239999999999995 111.838 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -99.4 8.56 44.51 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 122.016 -0.427 . . . . 72.25 111.735 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.36 147.76 47.68 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.584 0.707 . . . . 72.299999999999997 111.675 -176.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -88.14 116.14 26.11 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.26 -0.882 . . . . 71.120000000000005 112.202 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.57 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 55.7 p90 -102.64 158.8 15.98 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.216 -1.772 . . . . 74.200000000000003 106.216 169.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -161.62 -151.28 0.21 Allowed 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.979 -1.489 . . . . 64.310000000000002 106.979 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.34 90.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-O 122.314 1.054 . . . . 74.329999999999998 108.969 174.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -79.62 125.14 29.24 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.609 -1.178 . . . . 74.409999999999997 108.533 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.9 m -78.71 139.5 18.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-O 121.762 0.792 . . . . 74.310000000000002 111.708 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 98' ' ' GLY . 48.6 m -150.61 -176.81 5.65 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.307 -1.368 . . . . 63.310000000000002 107.307 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -149.57 144.54 12.16 Favored Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 119.128 -1.511 . . . . 74.329999999999998 112.413 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -95.83 123.6 39.48 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.835 0.826 . . . . 71.209999999999994 110.892 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.412 HG11 ' H ' ' A' ' 95' ' ' GLU . 25.0 t -110.81 152.05 12.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 106.476 -1.676 . . . . 74.239999999999995 106.476 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -68.82 -11.58 60.59 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.223 0.535 . . . . 70.510000000000005 110.877 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' H ' HG11 ' A' ' 93' ' ' VAL . 37.7 tt0 -137.37 91.89 2.65 Favored 'General case' 0 N--CA 1.422 -1.875 0 CA-C-N 116.065 -0.516 . . . . 64.319999999999993 109.986 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 126' ' ' ARG . . . 75.34 70.1 1.31 Allowed Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 115.53 -0.759 . . . . 73.310000000000002 113.055 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.453 ' CG ' ' HB3' ' A' ' 126' ' ' ARG . 9.9 pt-20 -64.24 140.25 58.85 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.753 -0.462 . . . . 64.420000000000002 109.753 176.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 90' ' ' SER . . . -118.84 138.67 13.8 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 119.683 -1.246 . . . . 73.420000000000002 112.98 -173.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -108.44 129.83 55.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.281 -1.007 . . . . 70.409999999999997 108.281 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.401 ' HZ3' ' CD ' ' A' ' 121' ' ' GLU . 27.5 mtpp -108.25 98.96 8.43 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.961 -1.126 . . . . 72.439999999999998 107.961 177.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 3.2 mm? -92.8 100.82 13.23 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.853 -1.165 . . . . 75.430000000000007 107.853 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.1 p -116.81 122.18 69.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-O 122.415 1.102 . . . . 75.109999999999999 113.692 -176.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.57 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 29.7 m-90 -102.83 129.99 49.69 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 113.869 -1.514 . . . . 73.109999999999999 107.854 177.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -114.41 125.7 54.14 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.105 -1.072 . . . . 73.430000000000007 108.105 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.9 p -79.08 -178.57 6.2 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.236 -0.586 . . . . 71.049999999999997 110.621 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.39 145.16 28.21 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 122.869 0.468 . . . . 74.239999999999995 111.111 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.72 127.4 42.67 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.879 -0.6 . . . . 73.420000000000002 110.007 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -114.56 127.42 55.78 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 109.146 -0.687 . . . . 75.129999999999995 109.146 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -82.8 106.13 14.39 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.732 -0.667 . . . . 73.349999999999994 110.432 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 51.1 m -75.6 155.02 36.32 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 115.027 -0.988 . . . . 75.239999999999995 109.17 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -65.54 -7.14 13.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 113.639 0.977 . . . . 65.299999999999997 113.639 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -87.15 -0.03 56.03 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.411 -0.589 . . . . 73.319999999999993 109.411 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 77.62 11.14 2.16 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.082 1.353 . . . . 74.040000000000006 108.922 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -98.03 158.82 15.32 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.692 -1.595 . . . . 75.129999999999995 106.692 175.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.6 mp -120.59 139.3 48.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 108.164 -1.05 . . . . 74.040000000000006 108.164 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.54 146.84 44.25 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 123.29 0.369 . . . . 73.450000000000003 110.759 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.8 p90 -152.62 174.35 14.07 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.793 -1.558 . . . . 74.200000000000003 106.793 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -116.49 138.75 51.14 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.004 -1.85 . . . . 60.210000000000001 106.004 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.475 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 45.7 mt-10 -117.23 141.1 48.71 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 119.803 -0.759 . . . . 75.310000000000002 110.988 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -127.52 116.71 20.8 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.808 -1.182 . . . . 54.509999999999998 107.808 177.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 41.8 tt0 -125.5 114.94 19.45 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 121.162 0.506 . . . . 75.120000000000005 110.861 -177.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.98 134.3 39.16 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.732 -0.667 . . . . 72.340000000000003 109.49 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -111.28 118.57 36.25 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 123.396 0.679 . . . . 62.229999999999997 109.345 -175.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.2 mt -120.91 150.27 23.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.174 -1.417 . . . . 72.209999999999994 107.174 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -134.63 145.04 48.22 Favored 'General case' 0 C--O 1.266 1.924 0 C-N-CA 118.998 -1.081 . . . . 74.400000000000006 110.292 173.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.507 ' HB2' ' SG ' ' A' ' 132' ' ' CYS . 10.6 ttp180 -91.42 113.66 25.99 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 114.731 -1.122 . . . . 74.510000000000005 108.25 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 131' ' ' SER . 62.9 mtm180 -70.46 158.43 36.06 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.31 -1.314 . . . . 75.310000000000002 110.119 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -69.34 -15.07 63.25 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.875 0.845 . . . . 74.310000000000002 109.004 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -66.57 -17.76 64.99 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.068 -1.424 . . . . 63.009999999999998 108.918 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.72 -23.74 35.06 Favored Glycine 0 CA--C 1.504 -0.628 0 N-CA-C 111.315 -0.714 . . . . 54.509999999999998 111.315 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 36.6 t -88.49 133.82 34.03 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 115.07 -0.565 . . . . 75.129999999999995 110.33 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 126' ' ' ARG . 95.2 m -90.67 150.48 21.66 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 115.504 -0.771 . . . . 54.219999999999999 109.861 175.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 21.1 t90 -151.09 155.84 39.79 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.172 -1.047 . . . . 74.150000000000006 108.172 177.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.1 mt -65.85 117.62 8.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.196 -1.039 . . . . 73.329999999999998 108.196 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -75.37 -56.59 4.56 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.826 -1.546 . . . . 73.409999999999997 106.826 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 52.2 m -167.14 175.35 7.54 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.988 -1.486 . . . . 75.409999999999997 106.988 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.7 t -142.57 145.51 23.28 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 105.939 -1.874 . . . . 74.239999999999995 105.939 175.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -130.56 130.72 44.45 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-O 121.057 0.456 . . . . 72.239999999999995 109.773 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 82.9 m-85 -115.58 126.97 54.89 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.985 -1.487 . . . . 73.439999999999998 106.985 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.7 pt -127.68 98.44 4.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 CA-C-O 122.304 1.049 . . . . 74.430000000000007 108.471 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 19.2 ptm -93.0 124.96 37.35 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 114.496 -1.229 . . . . 71.219999999999999 109.256 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.5 t 79.27 63.87 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.906 -1.497 . . . . 74.319999999999993 109.924 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.475 ' HG2' ' OE1' ' A' ' 119' ' ' GLU . 23.4 tptm -98.31 136.47 38.44 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.139 -1.8 . . . . 74.049999999999997 106.139 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -136.46 143.94 44.12 Favored 'General case' 0 C--N 1.278 -2.513 0 C-N-CA 120.123 -0.631 . . . . 73.019999999999996 111.567 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.73 120.55 58.62 Favored Pre-proline 0 N--CA 1.424 -1.75 0 N-CA-C 106.819 -1.549 . . . . 73.400000000000006 106.819 173.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -56.04 141.21 87.07 Favored 'Trans proline' 0 C--O 1.257 1.429 0 C-N-CA 122.749 2.299 . . . . 63.149999999999999 111.38 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -62.16 145.11 54.34 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.633 -0.712 . . . . 74.129999999999995 110.141 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 31.0 m -80.82 128.62 38.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-O 120.996 0.427 . . . . 72.109999999999999 110.344 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.693 0 N-CA-C 107.611 -1.255 . . . . 53.229999999999997 107.611 177.781 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 . . . . . 0 CA--C 1.505 -0.757 0 N-CA-C 108.145 -1.058 . . . . 64.109999999999999 108.145 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.3 ttt -115.0 118.67 34.07 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.933 -1.136 . . . . 65.150000000000006 107.933 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.09 -44.43 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 113.47 0.915 . . . . 74.239999999999995 113.47 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.9 p -66.0 -40.63 91.33 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.154 0.502 . . . . 73.129999999999995 110.602 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.24 -44.95 96.43 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.238 -0.892 . . . . 73.140000000000001 110.298 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.62 -38.13 89.96 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-N 115.002 -0.999 . . . . 74.540000000000006 109.65 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.28 -47.69 63.85 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.346 -0.843 . . . . 74.530000000000001 109.816 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 m -71.95 -32.2 43.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 112.545 0.572 . . . . 75.409999999999997 112.545 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -72.0 -33.47 68.1 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.588 -0.893 . . . . 63.420000000000002 108.588 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.8 -37.59 92.43 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 110.823 -0.911 . . . . 72.129999999999995 110.823 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.5 tp -66.63 -50.1 64.09 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 124.544 1.138 . . . . 74.340000000000003 109.968 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.75 -44.3 98.11 Favored Glycine 0 C--O 1.245 0.841 0 N-CA-C 111.76 -0.536 . . . . 72.549999999999997 111.76 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -63.49 -42.61 98.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.692 -0.254 . . . . 73.549999999999997 110.46 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.72 -41.83 98.01 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 123.248 0.343 . . . . 72.329999999999998 110.806 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 33.5 t80 -62.05 -54.08 46.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.353 -0.84 . . . . 73.430000000000007 110.053 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 29' ' ' ILE . 9.8 mm -62.94 -39.37 84.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.406 -0.361 . . . . 73.230000000000004 111.774 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.29 -48.62 80.56 Favored 'General case' 0 C--O 1.198 -1.608 0 O-C-N 123.436 0.46 . . . . 73.150000000000006 110.782 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.514 ' O ' ' HB3' ' A' ' 41' ' ' SER . 4.0 pp -70.59 -25.0 62.86 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 119.734 -0.786 . . . . 74.349999999999994 112.055 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.7 t -70.9 -26.04 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.348 0.594 . . . . 73.349999999999994 109.896 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.5 p -119.77 28.16 8.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 122.156 0.979 . . . . 74.120000000000005 108.639 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.2 tptt -60.96 156.65 17.14 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.051 -1.431 . . . . 73.400000000000006 112.266 -175.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 p -52.62 141.75 34.13 Favored Pre-proline 0 N--CA 1.432 -1.328 0 C-N-CA 125.096 1.358 . . . . 54.420000000000002 112.307 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -56.11 -18.7 24.09 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.825 3.017 . . . . 75.109999999999999 112.464 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -55.27 -27.83 49.26 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.604 -0.725 . . . . 73.319999999999993 110.158 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.2 p -111.24 102.77 11.16 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.862 -1.162 . . . . 71.109999999999999 107.862 174.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.3 -42.74 96.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 74.439999999999998 111.86 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -106.61 86.05 2.27 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 122.474 1.13 . . . . 74.310000000000002 110.504 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 36.8 m -68.6 -23.67 64.49 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.264 -1.335 . . . . 60.240000000000002 108.544 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 2.0 mp0 -61.38 -26.49 67.87 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 113.909 -1.496 . . . . 72.150000000000006 109.583 177.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -68.68 -42.43 77.85 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.443 -0.577 . . . . 73.439999999999998 109.443 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -69.07 -34.72 75.6 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 108.025 -1.102 . . . . 74.239999999999995 108.025 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.591 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 52.1 tp -66.22 -45.67 79.88 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 115.627 -0.715 . . . . 71.239999999999995 110.274 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.39 74.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.057 0.456 . . . . 72.099999999999994 110.949 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -75.24 -33.58 61.34 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 109.747 -0.464 . . . . 75.349999999999994 109.747 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 57.2 t80 -70.31 -46.31 64.49 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 123.286 0.634 . . . . 75.409999999999997 109.952 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 3.6 pp -84.24 -8.03 59.17 Favored 'General case' 0 C--O 1.194 -1.864 0 CA-C-N 115.654 -0.703 . . . . 75.010000000000005 112.146 -177.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -41.83 -57.49 3.42 Favored Glycine 0 CA--C 1.541 1.708 0 O-C-N 123.543 0.527 . . . . 70.439999999999998 113.574 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -85.48 -5.91 9.1 Favored 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 123.068 2.512 . . . . 72.340000000000003 112.768 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 16.0 m-70 -115.77 22.27 13.21 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.998 -0.439 . . . . 75.420000000000002 111.128 -172.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.507 ' CG ' ' HB ' ' A' ' 65' ' ' THR . 13.3 t70 -76.3 119.67 78.31 Favored Pre-proline 0 C--N 1.309 -1.173 0 O-C-N 123.337 0.398 . . . . 73.230000000000004 110.745 -174.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -101.77 -150.33 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.431 0 C-N-CA 123.506 2.804 . . . . 62.310000000000002 111.993 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.67 118.64 24.52 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 107.711 -1.218 . . . . 72.150000000000006 107.711 172.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 52.9 mt -100.55 113.4 36.23 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.104 0 N-CA-C 107.753 -1.203 . . . . 75.340000000000003 107.753 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -100.34 112.37 24.71 Favored 'General case' 0 C--N 1.278 -2.534 0 O-C-N 121.048 -1.033 . . . . 74.120000000000005 111.578 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.43 HG23 ' HB2' ' A' ' 139' ' ' PHE . 70.4 t -115.11 117.69 56.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 108.793 -0.818 . . . . 73.030000000000001 108.793 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 60.34 21.7 11.22 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.503 1.127 . . . . 72.25 111.455 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.54 6.17 61.2 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.267 -0.878 . . . . 52.109999999999999 112.545 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -112.1 133.46 54.24 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.558 -0.534 . . . . 72.200000000000003 109.558 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.09 124.51 30.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 122.501 1.143 . . . . 72.25 109.392 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -117.92 136.96 53.14 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.589 -1.187 . . . . 63.219999999999999 107.966 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 t -93.43 174.78 7.03 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.266 -1.013 . . . . 71.140000000000001 108.266 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.507 ' HB ' ' CG ' ' A' ' 53' ' ' ASP . 8.8 t -51.24 -37.54 47.58 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 125.114 1.366 . . . . 74.209999999999994 111.529 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.4 m -62.84 -49.92 72.98 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.34 0.591 . . . . 75.230000000000004 110.135 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.48 -51.28 69.34 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.482 -0.781 . . . . 71.439999999999998 111.617 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -54.36 -55.45 28.41 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 123.22 0.325 . . . . 71.329999999999998 110.33 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -50.06 -44.62 51.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.852 -1.067 . . . . 74.349999999999994 110.737 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -58.23 -48.84 79.13 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.883 0.327 . . . . 75.540000000000006 111.883 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.455 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 33.1 m-85 -66.05 -37.89 86.98 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.615 0.722 . . . . 72.349999999999994 109.721 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -56.73 -54.16 49.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 123.965 0.906 . . . . 75.439999999999998 110.831 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -72.21 -22.02 61.32 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.317 -0.401 . . . . 74.420000000000002 111.608 -176.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -77.06 -16.44 59.25 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 112.457 0.54 . . . . 71.209999999999994 112.457 172.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.55 21.28 12.97 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.37 -0.919 . . . . 72.319999999999993 114.155 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.66 -54.76 6.23 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.504 0.668 . . . . 73.25 110.123 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 46.3 m-85 -83.22 5.7 22.03 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 115.898 -0.592 . . . . 64.230000000000004 112.057 -174.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 96.8 mttt -73.93 -14.11 61.0 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.843 0.83 . . . . 75.340000000000003 111.201 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -86.09 -19.08 30.74 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.095 -0.957 . . . . 73.150000000000006 108.705 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 80' ' ' LEU . 9.5 tt -77.76 -12.21 59.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.354 -0.839 . . . . 74.120000000000005 111.563 -171.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -74.1 -23.49 59.33 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.88 0.847 . . . . 71.299999999999997 109.182 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -96.5 13.61 27.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.857 -1.065 . . . . 70.150000000000006 110.131 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.48 147.27 29.8 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.736 -0.665 . . . . 65.140000000000001 111.563 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 103' ' ' TRP . 8.0 pt-20 -92.64 142.05 27.8 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.473 -0.785 . . . . 75.420000000000002 108.898 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.488 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 43.3 p90 -105.2 139.27 40.11 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.422 -0.511 . . . . 74.530000000000001 111.735 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -132.78 148.21 52.32 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.232 -0.895 . . . . 64.439999999999998 108.708 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.0 mm -89.78 118.43 35.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.019 -1.104 . . . . 73.099999999999994 108.019 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -86.61 153.73 21.56 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.753 -1.202 . . . . 62.43 107.753 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.6 m -70.17 80.4 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 122.592 1.186 . . . . 73.450000000000003 113.686 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.0 m -158.94 158.55 33.53 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.578 -1.638 . . . . 73.540000000000006 106.578 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 160.19 -99.21 0.18 Allowed Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 119.255 -1.45 . . . . 71.230000000000004 113.779 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -66.65 111.62 3.75 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 114.904 1.446 . . . . 74.340000000000003 114.904 -170.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.0 m -136.7 138.27 46.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 107.171 -1.418 . . . . 74.340000000000003 107.171 169.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -73.8 -7.24 51.42 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.607 0.965 . . . . 63.240000000000002 113.607 -172.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -87.8 -3.71 58.92 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.485 0.66 . . . . 72.430000000000007 110.217 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.74 100.24 1.13 Allowed Glycine 0 CA--C 1.487 -1.683 0 N-CA-C 107.844 -2.102 . . . . 70.299999999999997 107.844 -176.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.515 ' OE2' ' HD3' ' A' ' 126' ' ' ARG . 1.2 pm0 -60.17 141.38 56.03 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 113.767 1.025 . . . . 64.409999999999997 113.767 -173.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -120.74 137.12 11.79 Favored Glycine 0 N--CA 1.411 -3.018 0 N-CA-C 109.475 -1.45 . . . . 74.439999999999998 109.475 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -108.06 140.36 41.35 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.747 -1.205 . . . . 75.439999999999998 107.747 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 33.1 mtmt -125.05 99.08 5.95 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.91 -1.515 . . . . 65.109999999999999 106.91 174.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.5 mt -102.51 134.68 45.45 Favored 'General case' 0 C--N 1.274 -2.706 0 N-CA-C 107.984 -1.117 . . . . 74.349999999999994 107.984 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 9.8 p -123.89 125.23 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 119.414 -0.914 . . . . 75.319999999999993 112.861 -175.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.55 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 15.4 m-90 -101.06 148.8 24.64 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.629 -1.168 . . . . 74.109999999999999 109.6 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -118.61 120.9 38.83 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.415 -1.328 . . . . 75.340000000000003 107.415 172.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.2 t -72.32 176.78 4.98 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 123.977 0.798 . . . . 72.140000000000001 111.007 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.29 162.02 23.68 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.905 -0.589 . . . . 75.239999999999995 110.435 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.46 108.84 4.47 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.739 0.78 . . . . 65.140000000000001 110.398 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -92.58 101.68 14.1 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.504 -1.295 . . . . 74.439999999999998 107.504 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.447 ' HD3' ' H ' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -59.14 119.46 7.36 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.498 -0.774 . . . . 73.25 110.345 176.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.8 t -103.03 161.29 13.89 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.115 -0.948 . . . . 72.340000000000003 109.822 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -61.57 -6.32 2.38 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.647 1.579 . . . . 75.219999999999999 114.3 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.489 ' HB2' ' HG2' ' A' ' 114' ' ' LYS . 0.5 OUTLIER -92.68 -4.66 52.89 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.6 -0.889 . . . . 75.120000000000005 108.6 179.297 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 68.69 42.07 1.52 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.454 1.121 . . . . 73.439999999999998 110.228 -171.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.489 ' HG2' ' HB2' ' A' ' 112' ' ' ASP . 18.2 pttp -129.22 158.0 40.27 Favored 'General case' 0 CA--C 1.487 -1.464 0 CA-C-N 113.912 -1.494 . . . . 74.420000000000002 107.369 173.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 26.1 pt -102.24 128.97 54.39 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.475 0 CA-C-O 121.113 0.482 . . . . 73.150000000000006 109.771 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.91 159.77 20.31 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 106.406 -1.702 . . . . 73.5 106.406 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 43.9 p90 -145.46 163.36 34.9 Favored 'General case' 0 C--N 1.265 -3.066 0 CA-C-O 121.464 0.649 . . . . 71.439999999999998 110.051 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.62 136.9 41.6 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 106.206 -1.776 . . . . 64.109999999999999 106.206 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -114.21 141.14 47.91 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.487 -0.885 . . . . 71.519999999999996 108.974 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.645 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -123.2 117.49 25.46 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 115.472 -0.785 . . . . 75.420000000000002 111.307 -173.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -111.13 109.39 19.43 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.095 -1.076 . . . . 72.409999999999997 108.095 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -99.03 126.36 44.73 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 122.484 0.314 . . . . 70.329999999999998 110.48 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -103.69 119.3 38.62 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.584 -1.265 . . . . 74.409999999999997 107.584 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.428 HG22 ' SG ' ' A' ' 132' ' ' CYS . 50.2 mt -128.94 139.72 51.16 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 N-CA-C 106.315 -1.735 . . . . 75.219999999999999 106.315 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -130.21 152.09 50.03 Favored 'General case' 0 C--O 1.256 1.428 0 C-N-CA 118.96 -1.096 . . . . 75.349999999999994 110.674 -177.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.515 ' HD3' ' OE2' ' A' ' 97' ' ' GLU . 45.6 ttp180 -74.81 114.49 13.31 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 105.965 -1.865 . . . . 75.519999999999996 105.965 174.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -81.43 145.48 30.75 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 108.271 -1.011 . . . . 75.0 108.271 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -66.4 -10.79 47.07 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 122.345 1.069 . . . . 75.349999999999994 110.12 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.78 -16.63 63.85 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.645 -1.161 . . . . 70.409999999999997 110.412 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.29 -23.43 20.68 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 111.482 -0.647 . . . . 72.099999999999994 111.482 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.0 t -100.47 -173.24 2.36 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.758 -0.83 . . . . 73.439999999999998 108.758 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.428 ' SG ' HG22 ' A' ' 124' ' ' ILE . 27.8 t -122.6 143.06 49.99 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.049 -1.834 . . . . 74.129999999999995 106.049 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -150.45 155.44 39.55 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 108.955 -0.757 . . . . 75.099999999999994 108.955 -172.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.59 130.75 42.64 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.938 0.399 . . . . 75.209999999999994 110.359 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -92.42 -43.29 9.29 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.746 -0.661 . . . . 71.430000000000007 109.646 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.5 t -179.41 151.33 0.47 Allowed 'General case' 0 C--O 1.194 -1.85 0 N-CA-C 106.582 -1.636 . . . . 71.230000000000004 106.582 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.2 m -134.95 152.37 32.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.832 -1.173 . . . . 74.510000000000005 107.832 173.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -128.64 133.64 48.31 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 122.72 0.408 . . . . 73.420000000000002 109.9 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.43 ' HB2' HG23 ' A' ' 58' ' ' VAL . 44.0 m-85 -121.98 112.4 18.24 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.185 -1.043 . . . . 71.430000000000007 108.185 176.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 17.2 pt -112.65 99.21 8.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 121.604 0.716 . . . . 63.140000000000001 111.926 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 52.2 mtt -86.78 94.65 9.59 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 106.415 -1.698 . . . . 74.510000000000005 106.415 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.5 m -162.74 -56.86 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.368 0.877 . . . . 75.430000000000007 113.368 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -52.87 132.51 37.11 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.328 1.051 . . . . 73.349999999999994 112.744 -171.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -152.75 142.28 21.77 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.351 -0.841 . . . . 74.140000000000001 111.001 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.03 161.01 74.95 Favored Pre-proline 0 C--N 1.3 -1.571 0 O-C-N 124.036 0.835 . . . . 53.439999999999998 108.832 172.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.19 147.98 51.98 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.764 2.309 . . . . 72.140000000000001 111.712 176.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 114' ' ' LYS . 6.1 p90 -61.87 160.12 12.67 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 113.089 0.774 . . . . 74.230000000000004 113.089 -176.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.5 p -101.93 148.74 7.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 108.242 -1.021 . . . . 75.109999999999999 108.242 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.962 0 N-CA-C 108.094 -1.076 . . . . 62.109999999999999 108.094 178.206 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 108.444 -0.947 . . . . 74.519999999999996 108.444 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.99 29.48 6.45 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.063 0.458 . . . . 70.530000000000001 111.284 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.78 -28.88 45.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 116.482 -0.326 . . . . 74.219999999999999 110.543 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.587 ' O ' HG21 ' A' ' 21' ' ' VAL . 1.4 p -63.87 -42.63 97.46 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.297 -0.41 . . . . 74.219999999999999 110.553 175.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.68 -38.49 91.17 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.841 0.856 . . . . 74.510000000000005 109.579 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.41 -37.12 84.49 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.265 -1.334 . . . . 71.209999999999994 108.182 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -73.12 -31.35 64.25 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.599 -0.728 . . . . 73.209999999999994 110.278 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.587 HG21 ' O ' ' A' ' 17' ' ' THR . 90.8 t -63.93 -50.19 78.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 109.688 -0.486 . . . . 71.25 109.688 175.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -30.21 66.71 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.398 -0.521 . . . . 73.530000000000001 110.438 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.43 -41.66 90.43 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 111.054 -0.818 . . . . 72.219999999999999 111.054 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 tp -63.04 -48.17 79.89 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 123.75 0.82 . . . . 75.340000000000003 109.146 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.95 -42.88 97.03 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.462 -0.79 . . . . 72.409999999999997 111.759 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -64.89 -44.33 89.98 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-O 119.773 -0.156 . . . . 74.450000000000003 111.194 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.35 -43.78 96.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.88 0.371 . . . . 71.409999999999997 110.251 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.45 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 26.7 t80 -62.39 -54.85 34.3 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 124.961 1.304 . . . . 73.439999999999998 110.113 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.2 mm -66.1 -34.06 67.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 112.24 0.459 . . . . 71.25 112.24 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.83 -39.15 73.16 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.572 -0.451 . . . . 71.450000000000003 110.043 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.547 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 4.1 pp -69.29 -30.25 68.3 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 119.556 -0.857 . . . . 75.340000000000003 110.846 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.7 t -72.08 -21.87 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 115.819 -0.628 . . . . 74.109999999999999 110.213 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.2 p -110.4 19.45 18.78 Favored 'General case' 0 C--O 1.248 0.991 0 O-C-N 121.455 -0.778 . . . . 74.299999999999997 111.887 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.547 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 70.6 mmtt -58.2 158.02 7.6 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-N 115.854 -0.612 . . . . 75.140000000000001 111.389 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.3 t -74.67 148.18 85.07 Favored Pre-proline 0 C--N 1.287 -2.11 0 N-CA-C 108.377 -0.971 . . . . 74.109999999999999 108.377 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -59.87 -6.03 4.28 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 123.858 3.039 . . . . 73.25 111.731 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.4 -27.48 67.48 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.009 0.924 . . . . 64.310000000000002 108.641 171.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.1 m -92.35 152.71 19.62 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 105.963 -1.866 . . . . 73.510000000000005 105.963 172.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.1 t -62.23 -53.21 50.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 113.208 0.818 . . . . 74.019999999999996 113.208 -174.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' ' 42' ' ' GLU . 28.2 t-20 -158.08 125.4 5.07 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 119.618 -0.833 . . . . 72.329999999999998 112.204 -172.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -32.47 74.03 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 123.609 0.763 . . . . 75.530000000000001 112.14 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.424 ' HB2' ' OD1' ' A' ' 40' ' ' ASN . 1.7 mp0 -72.04 -21.73 61.49 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.993 -0.549 . . . . 75.109999999999999 109.532 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -71.84 -42.35 67.05 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 107.42 -1.326 . . . . 73.329999999999998 107.42 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -66.16 -33.92 76.86 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.054 -0.976 . . . . 74.510000000000005 109.124 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.431 HD11 ' CE1' ' A' ' 28' ' ' PHE . 39.5 tp -69.91 -40.83 75.36 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.95 -0.568 . . . . 75.109999999999999 110.459 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.36 79.7 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.416 0.627 . . . . 73.209999999999994 109.915 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -69.59 -38.24 77.24 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.666 -1.152 . . . . 75.409999999999997 109.26 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.501 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 43.8 t80 -66.45 -45.31 80.21 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.353 -0.84 . . . . 71.420000000000002 110.308 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.423 HD21 ' CE2' ' A' ' 68' ' ' PHE . 4.3 pp -80.19 2.58 23.73 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.046 0.388 . . . . 75.400000000000006 112.046 -176.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -47.87 -62.52 4.09 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 111.729 -0.549 . . . . 71.420000000000002 111.729 173.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 48' ' ' PHE . 66.0 Cg_endo -79.99 -6.5 14.11 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.244 1.963 . . . . 72.299999999999997 112.363 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 92.4 m-70 -114.38 33.61 5.2 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 109.292 -0.632 . . . . 74.230000000000004 109.292 -176.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.442 ' CG ' HG22 ' A' ' 65' ' ' THR 0.267 13.5 t70 -53.76 99.03 0.19 Allowed Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 128.818 2.847 . . . . 74.010000000000005 111.516 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -113.06 -156.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 123.97 3.114 . . . . 74.129999999999995 113.089 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -92.75 127.87 38.41 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 107.608 -1.256 . . . . 75.310000000000002 107.608 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 65' ' ' THR . 43.2 mt -116.48 109.04 26.65 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 N-CA-C 109.046 -0.724 . . . . 71.109999999999999 109.046 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -91.18 138.89 31.24 Favored 'General case' 0 C--N 1.274 -2.698 0 O-C-N 122.176 -0.327 . . . . 64.310000000000002 110.487 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.76 120.07 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 N-CA-C 107.428 -1.323 . . . . 62.409999999999997 107.428 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 61.74 20.22 11.2 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.983 0.913 . . . . 73.5 110.636 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.41 3.67 58.55 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 115.922 -0.581 . . . . 73.549999999999997 113.208 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -111.67 132.39 54.64 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.021 -0.733 . . . . 74.540000000000006 109.021 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.77 126.15 34.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.689 0.757 . . . . 74.340000000000003 110.387 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -121.82 146.56 46.96 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.127 -1.434 . . . . 72.319999999999993 107.127 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -81.33 174.53 11.41 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.204 -0.598 . . . . 73.040000000000006 109.567 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.489 ' HA ' HD12 ' A' ' 56' ' ' ILE . 50.5 p -65.48 -33.92 77.07 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.528 1.131 . . . . 74.310000000000002 110.45 -176.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.452 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 25.0 m -62.53 -51.53 67.03 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.694 -1.139 . . . . 55.399999999999999 109.641 174.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.84 -48.51 79.56 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 123.628 0.771 . . . . 71.400000000000006 110.416 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.483 ' CG ' HD11 ' A' ' 56' ' ' ILE . 31.6 t80 -49.87 -56.5 10.24 Favored 'General case' 0 CA--C 1.501 -0.931 0 O-C-N 123.751 0.657 . . . . 71.310000000000002 110.491 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -53.34 -42.95 67.29 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 124.517 1.135 . . . . 75.329999999999998 110.589 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.7 mm100 -61.75 -48.64 79.76 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 123.275 0.63 . . . . 74.540000000000006 111.234 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.433 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 34.3 m-85 -67.22 -40.27 86.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.314 0.578 . . . . 74.200000000000003 109.461 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -56.21 -51.31 68.55 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.765 -0.652 . . . . 74.409999999999997 110.653 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -72.05 -21.39 61.53 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 116.22 -0.446 . . . . 75.540000000000006 111.291 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -83.25 -2.5 55.76 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 120.793 -0.363 . . . . 75.519999999999996 111.889 173.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.09 12.09 50.48 Favored Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 120.632 -0.794 . . . . 45.009999999999998 114.136 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.83 -45.5 50.86 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 122.104 -0.645 . . . . 74.450000000000003 111.751 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 32.6 m-85 -97.08 0.83 49.25 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 113.819 1.044 . . . . 75.129999999999995 113.819 -175.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -67.74 -13.61 62.26 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.596 0.712 . . . . 74.519999999999996 111.374 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.495 ' HZ2' ' HB3' ' A' ' 79' ' ' LYS . 8.4 mtpm? -72.25 -10.94 60.44 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.898 -0.592 . . . . 74.140000000000001 111.72 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.69 -7.28 59.58 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 121.067 0.461 . . . . 72.439999999999998 111.086 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.13 -26.39 64.87 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.469 0.652 . . . . 73.439999999999998 109.273 172.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -96.07 13.6 26.61 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.051 -0.522 . . . . 73.340000000000003 109.952 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.71 145.83 24.12 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.738 1.014 . . . . 65.230000000000004 113.738 -173.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -100.49 139.98 35.4 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.024 -1.843 . . . . 75.340000000000003 106.024 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.431 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 48.2 p90 -95.59 129.61 42.72 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.497 0.665 . . . . 70.099999999999994 112.222 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.61 103.33 14.15 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.184 -0.916 . . . . 73.340000000000003 108.612 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.3 tp -91.28 98.3 8.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 122.027 0.918 . . . . 73.430000000000007 110.226 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -90.05 170.34 10.42 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.731 -1.122 . . . . 64.519999999999996 109.228 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.7 p -70.49 106.31 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 121.631 0.729 . . . . 74.510000000000005 112.2 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.1 m -148.88 132.6 16.91 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.276 -0.875 . . . . 61.329999999999998 109.682 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 142.06 -47.12 0.84 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.143 -1.027 . . . . 73.219999999999999 113.318 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -83.38 83.8 7.74 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 113.878 1.066 . . . . 75.409999999999997 113.878 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.6 m -136.63 176.65 7.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.355 -1.72 . . . . 63.149999999999999 106.355 171.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -82.31 -59.43 2.55 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 113.09 0.774 . . . . 74.519999999999996 113.09 -176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -129.73 139.44 51.32 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.672 -0.492 . . . . 74.219999999999999 109.672 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.13 50.12 11.21 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 111.017 -0.833 . . . . 64.239999999999995 111.017 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -67.76 119.7 12.9 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.584 0.707 . . . . 72.439999999999998 111.235 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.28 148.79 17.52 Favored Glycine 0 N--CA 1.412 -2.935 0 CA-C-N 115.167 -0.924 . . . . 54.5 111.433 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -115.79 121.76 43.39 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.755 -1.202 . . . . 75.219999999999999 107.755 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.409 ' HE3' ' CD1' ' A' ' 123' ' ' TYR . 14.3 mptt -102.77 103.24 13.44 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 123.98 0.8 . . . . 74.129999999999995 108.952 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.25 125.1 48.86 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.161 -1.422 . . . . 64.239999999999995 107.161 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 15.3 t -124.4 134.64 66.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 119.796 -0.762 . . . . 75.5 110.492 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.431 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 18.8 m-90 -114.9 139.83 49.48 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.445 -0.946 . . . . 74.25 108.445 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -118.99 120.84 38.44 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.022 -1.103 . . . . 73.329999999999998 108.022 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.2 t -70.46 165.56 22.29 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.454 -0.943 . . . . 73.409999999999997 108.454 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.76 131.87 50.51 Favored 'General case' 0 C--O 1.239 0.515 0 O-C-N 123.249 0.343 . . . . 62.100000000000001 111.021 -176.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.88 129.75 36.64 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.094 0.473 . . . . 73.519999999999996 110.032 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -108.03 150.17 27.48 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.823 -1.547 . . . . 74.329999999999998 106.823 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -78.88 136.23 37.24 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 108.441 -0.948 . . . . 74.239999999999995 108.441 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.8 t -98.13 160.44 14.29 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.729 -0.841 . . . . 72.420000000000002 108.729 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -73.6 -14.11 61.13 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.69 0.757 . . . . 75.450000000000003 109.231 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -87.82 14.94 7.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.722 -0.672 . . . . 73.030000000000001 111.664 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 66.58 21.73 10.65 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.049 0.939 . . . . 74.239999999999995 111.8 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -114.53 -176.03 2.81 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.542 -1.281 . . . . 74.430000000000007 107.542 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 15.7 pt -121.55 153.04 25.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.832 -0.803 . . . . 75.019999999999996 108.832 172.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -133.92 142.61 47.8 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 123.23 0.612 . . . . 73.310000000000002 109.762 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.468 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 44.8 p90 -153.37 173.63 15.39 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.764 -0.828 . . . . 64.349999999999994 108.764 -176.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -114.51 144.16 43.79 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.333 -1.358 . . . . 65.329999999999998 107.333 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.468 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 31.9 mt-10 -120.56 153.89 36.14 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 113.01 0.745 . . . . 72.329999999999998 113.01 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -137.07 120.93 17.52 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.731 -1.122 . . . . 75.099999999999994 108.939 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -121.58 110.16 15.66 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.779 -0.823 . . . . 75.219999999999999 108.779 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.57 133.94 41.45 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 122.933 0.493 . . . . 55.310000000000002 110.337 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.409 ' CD1' ' HE3' ' A' ' 100' ' ' LYS . 24.8 m-85 -113.53 116.85 30.19 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.703 -0.851 . . . . 75.349999999999994 108.703 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.9 mt -119.17 149.47 21.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.494 -1.669 . . . . 75.040000000000006 106.494 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -133.71 143.3 48.41 Favored 'General case' 0 C--O 1.265 1.898 0 C-N-CA 119.232 -0.987 . . . . 73.319999999999993 109.296 174.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -90.17 131.55 35.94 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 106.239 -1.763 . . . . 75.420000000000002 106.239 173.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.501 ' HD3' ' OG ' ' A' ' 131' ' ' SER . 54.4 mtp180 -85.39 144.58 27.94 Favored 'General case' 0 C--N 1.261 -3.242 0 N-CA-C 106.716 -1.587 . . . . 74.420000000000002 106.716 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -63.75 -10.57 20.42 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 114.651 1.352 . . . . 75.010000000000005 114.651 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -79.98 -14.17 58.78 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.726 -0.472 . . . . 73.349999999999994 109.726 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.88 -11.54 27.31 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.629 -0.796 . . . . 74.140000000000001 113.652 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.501 ' OG ' ' HD3' ' A' ' 127' ' ' ARG . 61.3 p -84.68 170.12 13.63 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 117.805 0.803 . . . . 73.040000000000006 109.72 175.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' A' ' 21' ' ' VAL . 13.7 p -138.02 142.3 40.39 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 108.395 -0.965 . . . . 64.129999999999995 108.395 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -150.08 155.66 40.27 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.291 -1.003 . . . . 73.209999999999994 108.291 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.9 mp -72.05 123.26 22.43 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.81 -0.441 . . . . 72.329999999999998 109.81 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -74.62 -52.91 10.44 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.149 -0.932 . . . . 74.319999999999993 109.009 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.4 t 179.52 156.91 0.58 Allowed 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 106.637 -1.616 . . . . 74.409999999999997 106.637 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.8 m -133.68 147.33 30.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 107.536 -1.283 . . . . 70.319999999999993 107.536 173.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.495 ' HZ3' ' HB3' ' A' ' 138' ' ' LYS . 7.5 ttpm? -125.67 130.91 52.52 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-O 120.994 0.426 . . . . 70.439999999999998 109.979 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -110.23 135.85 50.34 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 107.878 -1.156 . . . . 72.219999999999999 107.878 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.52 ' HB ' ' CE ' ' A' ' 143' ' ' LYS . 12.3 pt -132.86 102.41 5.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 108.863 -0.792 . . . . 73.030000000000001 108.863 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 23.3 ptp -91.75 138.13 31.8 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.89 -0.724 . . . . 73.019999999999996 112.416 -173.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 35.3 m 59.34 77.97 0.29 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 113.456 -1.702 . . . . 74.329999999999998 114.08 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.52 ' CE ' ' HB ' ' A' ' 140' ' ' ILE . 5.9 mptp? -110.56 141.11 44.18 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.477 -1.238 . . . . 74.439999999999998 108.509 173.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -135.34 109.07 8.02 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.181 0.515 . . . . 74.340000000000003 109.997 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.77 159.09 34.11 Favored Pre-proline 0 C--N 1.294 -1.843 0 N-CA-C 109.208 -0.664 . . . . 75.019999999999996 109.208 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.81 129.79 35.85 Favored 'Trans proline' 0 CA--C 1.504 -0.982 0 C-N-CA 122.242 1.962 . . . . 75.019999999999996 111.102 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -139.32 131.15 27.59 Favored 'General case' 0 N--CA 1.392 -3.33 0 N-CA-C 107.847 -1.168 . . . . 73.409999999999997 107.847 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.4 m -92.28 122.45 43.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.544 0.687 . . . . 65.310000000000002 110.588 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.729 0 N-CA-C 107.633 -1.247 . . . . 74.340000000000003 107.633 178.94 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.491 -1.308 0 CA-C-O 121.137 0.494 . . . . 63.409999999999997 110.961 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.2 ttt -84.33 126.5 33.26 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 105.255 -2.128 . . . . 75.230000000000004 105.255 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.9 m -56.44 -26.39 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.454 0.909 . . . . 72.219999999999999 113.454 -173.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.629 ' O ' HG23 ' A' ' 21' ' ' VAL . 15.8 p -75.16 -22.77 57.87 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 112.195 0.443 . . . . 73.400000000000006 112.195 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.55 -35.55 60.64 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.351 -0.981 . . . . 71.519999999999996 108.351 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.91 -34.74 78.45 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.132 -1.394 . . . . 73.549999999999997 107.498 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 17' ' ' THR . 25.6 t70 -63.25 -43.28 98.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.433 -0.803 . . . . 74.5 109.669 177.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 17' ' ' THR . 57.7 t -61.04 -56.7 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 O-C-N 123.837 0.711 . . . . 74.299999999999997 111.077 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -64.14 -34.3 77.74 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.326 -0.55 . . . . 72.239999999999995 110.797 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.523 ' HA2' ' CE1' ' A' ' 26' ' ' TYR . . . -62.22 -51.45 56.55 Favored Glycine 0 C--O 1.256 1.519 0 CA-C-N 115.887 -0.597 . . . . 65.25 112.303 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 pp -70.63 -30.38 67.01 Favored 'General case' 0 C--O 1.21 -0.999 0 N-CA-C 108.48 -0.933 . . . . 74.409999999999997 108.48 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.14 -44.43 76.54 Favored Glycine 0 N--CA 1.424 -2.107 0 CA-C-N 115.729 -0.669 . . . . 52.409999999999997 111.849 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.523 ' CE1' ' HA2' ' A' ' 23' ' ' GLY . 2.9 p90 -74.59 -35.23 62.99 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 119.272 -0.971 . . . . 73.129999999999995 110.459 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -63.63 -46.76 84.22 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.351 -0.611 . . . . 72.209999999999994 109.351 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -61.58 -52.7 63.35 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 115.35 -0.841 . . . . 74.310000000000002 110.554 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.3 mm -61.14 -39.03 81.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 112.643 0.609 . . . . 74.519999999999996 112.643 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -68.15 -40.21 82.45 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 119.697 -0.801 . . . . 75.200000000000003 110.365 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.532 ' HA ' ' HD3' ' A' ' 34' ' ' LYS . 4.0 pp -71.59 -26.77 62.74 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 119.134 -1.026 . . . . 75.340000000000003 112.311 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.2 t -70.72 -25.74 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 109.363 -0.606 . . . . 72.319999999999993 109.363 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.4 p -107.94 19.31 20.2 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.308 0.575 . . . . 73.510000000000005 110.226 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.532 ' HD3' ' HA ' ' A' ' 31' ' ' LEU . 17.8 tptt -61.83 143.21 56.68 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-N 115.196 -0.911 . . . . 72.400000000000006 109.446 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.6 m -55.53 141.58 63.37 Favored Pre-proline 0 C--N 1.309 -1.159 0 O-C-N 123.78 0.675 . . . . 74.549999999999997 112.216 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.53 -7.44 20.33 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.332 2.688 . . . . 74.200000000000003 112.883 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -79.63 -26.53 41.1 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.944 -0.571 . . . . 64.109999999999999 109.954 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.3 m -70.46 172.87 7.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.816 -0.809 . . . . 73.329999999999998 108.816 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.2 t -52.54 -53.69 18.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 112.255 0.465 . . . . 75.310000000000002 112.255 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.521 ' ND2' ' HB3' ' A' ' 42' ' ' GLU . 33.4 t30 173.43 134.81 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.836 0.71 . . . . 74.129999999999995 109.243 -175.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.7 m -58.11 -38.92 77.39 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.24 0.543 . . . . 74.040000000000006 110.283 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.521 ' HB3' ' ND2' ' A' ' 40' ' ' ASN . 8.7 tp10 -68.43 -20.85 64.67 Favored 'General case' 0 C--O 1.204 -1.292 0 CA-C-N 115.153 -0.93 . . . . 72.040000000000006 110.135 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -67.16 -47.23 71.65 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.412 -0.959 . . . . 71.420000000000002 108.412 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -71.04 -34.38 71.2 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 114.744 -1.116 . . . . 73.409999999999997 109.52 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.1 tp -66.16 -45.87 79.43 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 120.961 -0.296 . . . . 74.510000000000005 110.656 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.45 -34.14 73.56 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.57 0.7 . . . . 73.549999999999997 110.661 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -70.67 -39.56 73.49 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.379 -0.828 . . . . 75.420000000000002 109.902 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -68.04 -40.43 82.84 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 124.38 1.072 . . . . 73.230000000000004 110.565 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.49 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.7 pp -83.13 0.94 42.88 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 115.689 -0.687 . . . . 75.25 110.864 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.45 -58.21 4.72 Favored Glycine 0 CA--C 1.536 1.378 0 O-C-N 123.965 0.791 . . . . 71.400000000000006 113.439 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.89 -6.3 12.3 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 121.922 1.748 . . . . 65.010000000000005 112.172 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.49 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 10.9 m170 -108.82 32.22 5.06 Favored 'General case' 0 C--O 1.213 -0.862 0 C-N-CA 123.417 0.687 . . . . 75.340000000000003 109.807 -175.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.409 ' CG ' HG22 ' A' ' 65' ' ' THR . 13.0 t70 -53.57 98.58 0.17 Allowed Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 127.515 2.326 . . . . 63.530000000000001 110.633 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -114.54 -147.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 124.48 3.453 . . . . 74.129999999999995 113.188 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -102.71 128.77 49.28 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 108.717 -0.846 . . . . 74.439999999999998 108.717 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.415 HD13 ' CB ' ' A' ' 68' ' ' PHE . 3.4 mp -107.91 111.71 37.06 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.369 0 N-CA-C 108.862 -0.792 . . . . 75.540000000000006 108.862 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -95.97 109.57 21.93 Favored 'General case' 0 C--O 1.18 -2.553 0 O-C-N 121.742 -0.599 . . . . 73.319999999999993 111.334 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' A' ' 139' ' ' PHE . 70.6 t -109.14 114.34 46.64 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.539 0 N-CA-C 108.392 -0.966 . . . . 74.219999999999999 108.392 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 63.93 20.83 12.39 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.524 1.13 . . . . 75.420000000000002 110.311 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.93 -10.08 62.0 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 114.961 -1.018 . . . . 61.329999999999998 112.022 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -93.59 130.51 39.46 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 110.069 -0.345 . . . . 74.099999999999994 110.069 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.68 121.07 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-O 122.611 1.196 . . . . 74.549999999999997 109.163 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -115.22 137.88 51.55 Favored 'General case' 0 C--N 1.271 -2.811 0 N-CA-C 106.451 -1.685 . . . . 74.230000000000004 106.451 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.2 t -77.1 168.21 20.46 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 108.606 -0.887 . . . . 72.340000000000003 108.606 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.409 HG22 ' CG ' ' A' ' 53' ' ' ASP . 46.9 p -63.76 -32.83 74.45 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 123.981 0.912 . . . . 75.540000000000006 110.472 -176.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -62.65 -46.84 86.37 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.221 -1.354 . . . . 73.430000000000007 109.888 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.96 -44.9 87.89 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 123.549 0.74 . . . . 72.239999999999995 110.469 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.415 ' CB ' HD13 ' A' ' 56' ' ' ILE . 37.9 t80 -53.58 -54.35 38.68 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 123.477 0.486 . . . . 74.209999999999994 110.137 174.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -52.15 -41.42 62.55 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 124.306 1.003 . . . . 72.219999999999999 110.643 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.477 ' HG2' ' NH2' ' A' ' 73' ' ' ARG . 46.2 mt-30 -60.26 -51.47 69.39 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.279 -0.419 . . . . 74.400000000000006 111.556 175.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -63.33 -32.98 74.55 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.981 0.896 . . . . 74.409999999999997 110.393 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -62.07 -53.51 54.52 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.419 -1.264 . . . . 74.209999999999994 111.169 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.477 ' NH2' ' HG2' ' A' ' 70' ' ' GLN . 26.1 ptt180 -71.29 -20.7 62.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.96 0.409 . . . . 73.450000000000003 110.561 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 56.3 mt-30 -76.88 -9.2 58.52 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.229 -0.442 . . . . 71.409999999999997 110.941 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.57 7.48 64.92 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.941 -0.647 . . . . 73.010000000000005 114.024 174.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.2 mt -65.92 -28.81 69.2 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 117.161 0.481 . . . . 75.400000000000006 112.273 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -99.18 12.63 35.6 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.529 -0.469 . . . . 74.200000000000003 111.912 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 30.1 mmmt -70.78 -17.34 62.78 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.388 0.613 . . . . 74.319999999999993 110.434 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -83.27 -22.51 33.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.83 -0.623 . . . . 74.109999999999999 110.001 175.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.0 tp -76.68 -6.72 53.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.854 -0.612 . . . . 73.230000000000004 111.453 -172.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 1.6 pptp? -76.76 -3.65 39.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.618 0.723 . . . . 75.310000000000002 110.687 177.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -100.93 10.83 40.65 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 115.295 -0.866 . . . . 75.430000000000007 110.147 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 103' ' ' TRP . . . -76.14 130.07 37.74 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-O 121.406 0.622 . . . . 74.140000000000001 112.301 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -112.6 150.02 31.97 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.855 -1.066 . . . . 75.040000000000006 109.871 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -72.44 128.5 35.79 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 123.774 0.671 . . . . 74.129999999999995 111.041 -174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -129.86 137.99 50.73 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 116.148 -0.478 . . . . 75.319999999999993 110.01 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.8 pt -93.04 78.07 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.935 0.874 . . . . 75.310000000000002 113.158 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -97.08 160.65 14.22 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.548 -1.278 . . . . 74.549999999999997 107.548 175.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.5 m -62.75 139.14 21.62 Favored 'Isoleucine or valine' 0 C--O 1.25 1.112 0 N-CA-C 113.248 0.833 . . . . 74.409999999999997 113.248 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.9 m -81.59 -43.07 19.16 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.049 -0.978 . . . . 74.340000000000003 109.03 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.54 44.29 90.34 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.546 -0.752 . . . . 74.450000000000003 113.058 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -89.59 89.32 7.77 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.997 -0.372 . . . . 75.409999999999997 109.997 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.54 -52.15 17.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.835 -0.802 . . . . 74.430000000000007 108.835 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -157.71 133.89 9.5 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.228 -0.896 . . . . 72.25 108.698 175.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -179.15 -61.31 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.648 -1.612 . . . . 74.340000000000003 106.648 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.38 165.71 32.48 Favored Glycine 0 C--N 1.279 -2.633 0 N-CA-C 106.587 -2.605 . . . . 53.310000000000002 106.587 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -76.23 119.91 20.78 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 118.285 1.043 . . . . 73.209999999999994 108.842 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -165.25 -167.53 25.99 Favored Glycine 0 N--CA 1.417 -2.569 0 C-N-CA 119.718 -1.23 . . . . 62.130000000000003 112.568 -176.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.08 157.42 41.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 109.033 -0.729 . . . . 70.239999999999995 109.033 -174.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 57.9 tttm -147.41 100.13 3.22 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.93 -1.137 . . . . 74.540000000000006 107.93 174.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -110.31 158.88 17.94 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.766 -0.827 . . . . 74.030000000000001 108.766 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.2 p -134.51 140.56 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 121.667 0.746 . . . . 63.329999999999998 111.838 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 83' ' ' ALA . 24.1 m-90 -116.15 127.69 55.03 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.689 -1.141 . . . . 75.329999999999998 108.172 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.405 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 66.3 mttm -105.9 131.96 52.58 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.147 -0.686 . . . . 75.450000000000003 109.147 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.2 t -75.01 -174.63 2.31 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.506 -0.924 . . . . 74.420000000000002 108.506 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.23 153.16 38.9 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.307 -0.627 . . . . 73.549999999999997 109.307 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.11 129.63 42.13 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 108.999 -0.741 . . . . 72.409999999999997 108.999 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -112.35 137.43 50.53 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.184 -1.043 . . . . 71.430000000000007 108.184 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -75.95 132.17 40.07 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.396 0.617 . . . . 73.430000000000007 110.91 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.7 t -92.04 161.77 14.64 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.099 -0.955 . . . . 72.239999999999995 109.183 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -60.69 -28.13 68.38 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.244 1.018 . . . . 73.010000000000005 111.224 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.445 ' OD2' ' HG2' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -88.77 15.76 7.82 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.378 -0.828 . . . . 64.239999999999995 112.856 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 73.0 10.07 5.34 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.032 0.933 . . . . 73.049999999999997 112.608 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.445 ' HG2' ' OD2' ' A' ' 112' ' ' ASP . 26.3 pttm -103.72 172.7 6.66 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.844 -1.169 . . . . 73.25 107.844 174.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 16.1 pt -114.44 140.37 35.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.733 -0.787 . . . . 71.319999999999993 111.765 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.41 HH22 ' CG ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -121.61 133.15 54.99 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.982 -1.008 . . . . 75.549999999999997 109.083 179.033 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 2.8 p90 -129.15 174.06 9.91 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 108.772 -0.825 . . . . 73.109999999999999 108.772 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.41 ' CG ' HH22 ' A' ' 116' ' ' ARG . 5.0 m-20 -110.5 135.56 50.98 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.963 -1.495 . . . . 74.329999999999998 106.963 176.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.41 ' HB2' HG13 ' A' ' 140' ' ' ILE . 46.0 mt-10 -116.83 156.53 27.11 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.919 -0.713 . . . . 62.240000000000002 111.89 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -135.87 117.53 14.97 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.923 -1.035 . . . . 71.310000000000002 108.415 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -112.79 112.31 23.71 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.845 -0.798 . . . . 75.519999999999996 108.845 -175.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -98.16 131.76 44.26 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.402 -0.519 . . . . 74.129999999999995 110.716 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -108.77 121.81 45.84 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 114.478 -1.237 . . . . 74.430000000000007 108.206 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.8 mt -124.3 137.12 58.26 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 N-CA-C 107.53 -1.285 . . . . 72.430000000000007 107.53 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -114.37 150.31 34.78 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.298 -1.742 . . . . 74.349999999999994 106.298 176.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -111.67 136.56 50.73 Favored 'General case' 0 N--CA 1.403 -2.817 0 C-N-CA 118.293 -1.363 . . . . 73.340000000000003 110.385 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -88.83 154.82 19.95 Favored 'General case' 0 C--N 1.258 -3.389 0 CA-C-N 112.912 -1.949 . . . . 74.219999999999999 109.366 -170.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -59.78 -26.62 65.87 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.466 0.706 . . . . 74.340000000000003 110.91 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -67.01 -16.22 64.23 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.43 -0.805 . . . . 72.25 110.773 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.62 -23.64 29.26 Favored Glycine 0 C--O 1.221 -0.683 0 O-C-N 121.921 -0.487 . . . . 74.409999999999997 112.111 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.9 t -73.0 140.47 47.35 Favored 'General case' 0 N--CA 1.42 -1.933 0 C-N-CA 123.483 0.713 . . . . 74.150000000000006 109.532 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 81.3 m -104.57 141.92 35.56 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.195 -1.039 . . . . 75.099999999999994 108.195 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -140.54 154.56 46.58 Favored 'General case' 0 N--CA 1.408 -2.56 0 N-CA-C 107.941 -1.133 . . . . 73.230000000000004 107.941 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.9 mt -67.9 116.14 8.21 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.25 -0.648 . . . . 74.329999999999998 109.25 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -80.84 -46.41 15.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 106.921 -1.511 . . . . 74.409999999999997 106.921 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.8 p -174.75 172.97 2.88 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.002 -0.999 . . . . 71.099999999999994 108.74 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.6 t -144.05 141.12 24.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 106.596 -1.631 . . . . 74.209999999999994 106.596 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -119.08 132.37 56.01 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 109.5 -0.555 . . . . 74.409999999999997 109.5 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.411 ' HB2' HG21 ' A' ' 58' ' ' VAL . 64.4 m-85 -115.28 131.72 56.84 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.604 -1.258 . . . . 64.409999999999997 107.604 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.41 HG13 ' HB2' ' A' ' 119' ' ' GLU . 4.5 pt -132.12 99.04 3.4 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 CA-C-O 121.71 0.767 . . . . 74.140000000000001 110.811 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 21.6 ptp -85.07 126.22 33.4 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.843 -1.071 . . . . 71.340000000000003 109.805 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.7 t 77.42 74.32 0.07 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.548 1.139 . . . . 75.409999999999997 112.016 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -113.12 128.7 56.56 Favored 'General case' 0 CA--C 1.47 -2.109 0 N-CA-C 107.167 -1.42 . . . . 74.329999999999998 107.167 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -119.3 128.06 53.79 Favored 'General case' 0 C--N 1.259 -3.349 0 CA-C-N 115.029 -0.987 . . . . 61.149999999999999 112.826 -171.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.75 133.03 33.21 Favored Pre-proline 0 N--CA 1.426 -1.654 0 N-CA-C 107.79 -1.189 . . . . 72.510000000000005 107.79 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.43 147.11 82.16 Favored 'Trans proline' 0 C--O 1.246 0.891 0 C-N-CA 122.23 1.953 . . . . 63.130000000000003 111.108 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -80.72 147.49 30.55 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 107.63 -1.248 . . . . 74.310000000000002 107.63 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.6 106.18 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 122.283 1.04 . . . . 75.209999999999994 112.554 -174.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.656 0 CA-C-N 114.589 -1.187 . . . . 72.239999999999995 108.709 -179.851 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 CA--C 1.5 -0.98 0 N-CA-C 109.763 -0.458 . . . . 74.230000000000004 109.763 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 52.5 ttm 62.61 17.78 9.97 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.558 1.143 . . . . 74.120000000000005 110.715 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.3 t -73.04 148.01 9.37 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.882 0 N-CA-C 105.344 -2.095 . . . . 75.129999999999995 105.344 175.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.4 p -45.59 -47.07 14.64 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.298 0.954 . . . . 74.5 113.431 -177.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 17.2 t70 -59.89 -45.45 92.46 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-O 122.083 0.944 . . . . 73.549999999999997 111.028 177.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.36 -33.83 67.54 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.865 -1.061 . . . . 75.510000000000005 108.39 -177.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -65.45 -47.43 76.18 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 124.751 1.22 . . . . 64.239999999999995 109.982 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.516 ' HA ' ' CD2' ' A' ' 24' ' ' LEU . 6.3 p -65.85 -43.06 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 112.327 0.491 . . . . 74.409999999999997 112.327 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 13.4 ptpt -71.25 -24.51 62.19 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 118.659 -1.216 . . . . 75.319999999999993 111.23 177.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.33 -56.49 10.09 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.782 -0.645 . . . . 71.439999999999998 112.323 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.516 ' CD2' ' HA ' ' A' ' 21' ' ' VAL . 1.7 pt? -70.09 -30.65 67.92 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 118.965 -1.094 . . . . 75.200000000000003 109.629 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.9 -42.17 98.47 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.664 -0.698 . . . . 72.239999999999995 111.92 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -69.03 -43.67 74.25 Favored 'General case' 0 C--O 1.208 -1.084 0 C-N-CA 119.795 -0.762 . . . . 75.329999999999998 110.759 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -57.75 -43.9 85.71 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.154 0.502 . . . . 73.099999999999994 110.1 -177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.495 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 26.5 t80 -62.3 -54.23 43.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.725 -1.125 . . . . 72.219999999999999 110.149 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 29' ' ' ILE . 11.6 mm -63.42 -33.96 64.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 112.296 0.48 . . . . 74.230000000000004 112.296 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -68.82 -43.73 74.94 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 110.181 -0.303 . . . . 63.340000000000003 110.181 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.6 pp -68.19 -31.18 70.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.979 -0.688 . . . . 73.239999999999995 110.562 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.72 -27.49 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 116.06 -0.518 . . . . 72.439999999999998 110.103 175.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.8 p -107.51 19.83 19.7 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.485 0.659 . . . . 73.030000000000001 110.299 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -77.26 158.14 30.41 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.749 -0.66 . . . . 74.310000000000002 109.62 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 m -56.39 131.3 76.25 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.474 0.71 . . . . 64.019999999999996 111.521 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.31 -7.11 20.04 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.614 2.876 . . . . 72.310000000000002 111.544 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.73 -19.58 65.78 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.26 1.424 . . . . 72.329999999999998 110.58 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -76.08 -176.56 3.55 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 107.92 -1.141 . . . . 71.450000000000003 107.92 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.64 -50.01 82.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 118.341 0.519 . . . . 74.549999999999997 111.575 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.3 t30 177.2 131.07 0.05 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.566 -0.531 . . . . 71.140000000000001 109.566 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.3 m -60.86 -35.19 75.94 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-O 121.44 0.638 . . . . 74.030000000000001 110.384 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -66.66 -20.75 66.06 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.923 -1.035 . . . . 74.400000000000006 110.946 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -67.68 -47.35 69.69 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 108.944 -0.761 . . . . 70.430000000000007 108.944 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -68.23 -34.32 76.02 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.084 -0.962 . . . . 73.349999999999994 108.741 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.1 tp -66.47 -44.68 82.06 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 116.129 -0.487 . . . . 64.019999999999996 110.42 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.77 -33.12 73.51 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.431 0.634 . . . . 71.310000000000002 110.408 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -77.12 -32.36 56.39 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.203 -0.908 . . . . 63.43 109.756 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -68.9 -47.31 66.11 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.772 -0.455 . . . . 73.219999999999999 109.772 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.6 pp -73.33 -2.56 22.6 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.766 -0.652 . . . . 71.450000000000003 112.363 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -39.24 -67.44 0.59 Allowed Glycine 0 CA--C 1.538 1.487 0 O-C-N 123.908 0.755 . . . . 70.310000000000002 113.123 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -78.78 -6.4 15.19 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.823 2.348 . . . . 72.439999999999998 113.002 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -110.5 24.73 12.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.704 -0.48 . . . . 75.200000000000003 109.704 -172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.42 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 8.3 t70 -55.91 109.47 1.67 Allowed Pre-proline 0 C--O 1.244 0.811 0 C-N-CA 124.654 1.181 . . . . 75.310000000000002 111.965 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -112.98 -149.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 124.257 3.304 . . . . 73.319999999999993 110.577 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -92.12 119.16 31.52 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 107.986 -1.116 . . . . 74.430000000000007 107.986 172.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.471 HD12 ' CB ' ' A' ' 68' ' ' PHE . 67.5 mt -101.16 112.71 34.99 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.683 0 N-CA-C 106.552 -1.647 . . . . 74.530000000000001 106.552 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -98.09 133.24 42.81 Favored 'General case' 0 C--N 1.259 -3.357 0 C-N-CA 119.891 -0.724 . . . . 65.439999999999998 109.298 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.3 t -128.28 114.68 35.21 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 107.31 -1.367 . . . . 75.319999999999993 107.31 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 63.53 20.57 12.31 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.947 1.299 . . . . 75.239999999999995 110.473 -176.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.55 -3.24 65.59 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.672 -0.694 . . . . 45.409999999999997 112.286 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -98.48 133.14 43.28 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.934 -0.765 . . . . 74.439999999999998 108.934 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -73.63 125.41 32.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 122.152 0.977 . . . . 71.129999999999995 109.81 -175.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.404 ' N ' HD12 ' A' ' 62' ' ' ILE . 58.9 mm-40 -124.65 148.02 48.18 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 115.044 -0.98 . . . . 75.519999999999996 108.727 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 t -95.14 172.21 8.26 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.517 -1.29 . . . . 74.450000000000003 107.517 173.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.42 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 9.1 t -54.06 -34.92 61.36 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 112.731 0.641 . . . . 73.519999999999996 112.731 -177.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.525 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 73.0 m -65.43 -48.31 73.2 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 120.869 -0.332 . . . . 74.140000000000001 110.696 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.12 -45.71 90.2 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 122.668 0.387 . . . . 75.5 110.16 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.471 ' CB ' HD12 ' A' ' 56' ' ' ILE . 56.7 t80 -54.21 -55.82 24.3 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 123.441 0.463 . . . . 75.540000000000006 110.032 174.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.86 -39.88 59.65 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.767 -1.106 . . . . 72.450000000000003 110.885 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.9 mm100 -63.81 -47.6 80.2 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 123.048 0.539 . . . . 64.400000000000006 111.375 177.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.403 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 31.7 m-85 -66.35 -32.67 74.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.816 0.817 . . . . 64.200000000000003 109.684 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -61.93 -56.02 23.54 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.008 -0.996 . . . . 73.450000000000003 110.617 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -69.16 -22.81 63.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.465 -0.334 . . . . 74.200000000000003 111.777 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 53.1 mt-30 -74.43 -16.1 60.88 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.164 0.507 . . . . 64.230000000000004 110.905 174.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.24 7.4 52.19 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.245 -0.978 . . . . 62.409999999999997 113.635 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.0 mt -70.72 -43.31 69.2 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.08 0.467 . . . . 72.030000000000001 110.641 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.403 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 32.3 m-85 -83.9 -4.45 58.7 Favored 'General case' 0 C--O 1.211 -0.945 0 C-N-CA 120.303 -0.559 . . . . 73.129999999999995 111.066 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.01 -14.44 61.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.673 0.749 . . . . 74.129999999999995 109.462 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -84.81 -29.02 25.73 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.58 -0.896 . . . . 74.549999999999997 108.58 175.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HA ' ' OG ' ' A' ' 105' ' ' SER . 8.6 tt -84.45 -6.62 59.39 Favored 'General case' 0 C--O 1.2 -1.517 0 CA-C-N 114.835 -1.075 . . . . 74.430000000000007 110.919 -172.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -66.57 -10.96 50.65 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.608 0.718 . . . . 74.349999999999994 112.296 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -98.35 14.33 28.37 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.684 -0.689 . . . . 62.520000000000003 109.359 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 104' ' ' LYS . . . -69.81 130.55 42.6 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 113.799 1.037 . . . . 65.310000000000002 113.799 -176.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -104.3 139.86 38.69 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.237 -1.347 . . . . 61.240000000000002 107.575 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.429 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 44.2 p90 -81.98 142.43 32.4 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.99 -0.684 . . . . 75.409999999999997 111.77 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.35 149.05 28.27 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 115.057 -0.974 . . . . 65.540000000000006 108.524 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 51.1 mm -79.23 124.49 37.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.433 -0.951 . . . . 74.400000000000006 108.433 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -146.8 140.9 26.15 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 106.027 -1.842 . . . . 74.25 106.027 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.303 28.0 m 45.79 96.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.794 1.638 . . . . 73.019999999999996 115.045 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.0 m -78.75 89.12 4.61 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 114.83 -1.077 . . . . 74.109999999999999 108.871 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.42 147.16 19.06 Favored Glycine 0 N--CA 1.424 -2.137 0 N-CA-C 110.344 -1.102 . . . . 43.450000000000003 110.344 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -113.07 -177.67 3.19 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.319 -0.552 . . . . 72.099999999999994 111.756 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.8 m -85.66 22.05 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 123.596 0.758 . . . . 75.25 112.052 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -51.49 16.11 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.825 0.676 . . . . 74.310000000000002 112.825 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -120.84 163.97 17.36 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.913 -0.403 . . . . 73.450000000000003 109.913 -175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.405 ' HA2' ' HE ' ' A' ' 126' ' ' ARG . . . -79.49 91.97 1.29 Allowed Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 112.054 -0.418 . . . . 72.030000000000001 112.054 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -136.05 175.21 9.81 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.861 -1.163 . . . . 74.439999999999998 107.861 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -104.31 148.95 16.94 Favored Glycine 0 N--CA 1.427 -1.938 0 C-N-CA 120.242 -0.98 . . . . 74.219999999999999 112.524 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -106.87 145.32 32.31 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.142 -1.058 . . . . 72.129999999999995 108.142 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.12 100.24 6.86 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.875 -1.528 . . . . 70.239999999999995 106.875 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.6 mt -108.83 127.48 54.06 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 108.204 -1.036 . . . . 70.450000000000003 108.204 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 18.8 t -123.44 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 120.262 -0.575 . . . . 73.400000000000006 110.736 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.429 ' NE1' ' HB3' ' A' ' 85' ' ' PHE . 19.3 m-90 -111.06 145.15 39.02 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.402 -0.817 . . . . 71.299999999999997 109.093 176.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 83' ' ' ALA . 51.1 mttm -119.31 120.36 36.73 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.593 -0.892 . . . . 71.329999999999998 108.593 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.515 ' OG ' ' HA ' ' A' ' 80' ' ' LEU . 29.1 t -75.08 177.48 6.37 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 124.215 1.006 . . . . 74.319999999999993 111.399 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.0 139.31 54.99 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.879 -0.601 . . . . 63.409999999999997 109.608 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -82.74 120.92 26.21 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-N 115.922 -0.581 . . . . 74.5 109.696 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -107.11 141.1 38.89 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.101 -1.074 . . . . 75.439999999999998 108.101 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.4 ttm-85 -78.35 118.12 20.23 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.547 -0.909 . . . . 73.400000000000006 108.547 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 99.3 p -91.31 -174.88 4.08 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.113 -0.949 . . . . 74.109999999999999 110.795 -173.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -82.94 -13.14 56.6 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.097 0.475 . . . . 75.25 110.344 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -90.0 9.79 26.56 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.62 -0.718 . . . . 62.399999999999999 110.723 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 69.86 12.88 7.99 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.319 1.048 . . . . 74.430000000000007 112.152 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -111.57 165.45 12.0 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.034 -0.728 . . . . 75.310000000000002 109.034 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 21.2 pt -107.35 127.52 63.11 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 108.751 -0.833 . . . . 75.120000000000005 108.751 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 41.6 ptt85 -112.62 159.31 19.0 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.237 -0.653 . . . . 74.430000000000007 109.237 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 36.9 p90 -136.13 173.97 11.13 Favored 'General case' 0 C--N 1.272 -2.784 0 N-CA-C 108.699 -0.852 . . . . 75.450000000000003 108.699 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -112.08 136.8 50.98 Favored 'General case' 0 C--N 1.259 -3.339 0 N-CA-C 105.872 -1.899 . . . . 65.25 105.872 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.401 ' CD ' ' HD3' ' A' ' 143' ' ' LYS . 86.9 mt-10 -114.7 145.29 42.22 Favored 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 119.411 -0.915 . . . . 73.310000000000002 110.119 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -126.32 117.24 22.59 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 115.123 -0.944 . . . . 73.430000000000007 109.424 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -110.64 110.04 20.56 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.731 -0.84 . . . . 75.349999999999994 108.731 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.65 125.06 42.2 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 109.315 -0.624 . . . . 70.230000000000004 109.315 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -106.89 112.48 25.46 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.946 -1.131 . . . . 62.109999999999999 107.946 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 54.6 mt -110.74 146.84 15.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.283 0 N-CA-C 107.348 -1.353 . . . . 70.120000000000005 107.348 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.419 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.3 OUTLIER -129.24 150.5 50.59 Favored 'General case' 0 C--O 1.262 1.75 0 N-CA-C 108.028 -1.101 . . . . 72.209999999999994 108.028 177.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 40.3 ttp85 -85.45 112.57 21.01 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.408 -1.33 . . . . 73.519999999999996 107.408 176.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -67.41 150.43 48.94 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.852 -1.067 . . . . 75.25 109.132 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -57.82 -15.7 9.19 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.855 1.262 . . . . 74.329999999999998 111.411 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -81.06 -6.38 58.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.828 -0.624 . . . . 75.420000000000002 111.411 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.4 -25.25 15.97 Favored Glycine 0 CA--C 1.504 -0.597 0 N-CA-C 114.816 0.687 . . . . 72.140000000000001 114.816 172.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.5 m -103.79 166.56 10.34 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 109.399 -0.593 . . . . 73.230000000000004 109.399 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 63.9 m -98.66 154.7 17.76 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.866 -0.42 . . . . 74.209999999999994 109.866 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.419 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 25.0 t-105 -150.09 155.13 39.3 Favored 'General case' 0 N--CA 1.412 -2.368 0 N-CA-C 106.681 -1.6 . . . . 74.140000000000001 106.681 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.03 119.71 10.0 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.682 -0.488 . . . . 73.019999999999996 109.682 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -83.72 -53.8 5.37 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.693 -1.225 . . . . 73.239999999999995 107.693 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.6 m -164.62 157.42 16.85 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 106.396 -1.705 . . . . 71.340000000000003 106.396 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.95 154.8 31.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 107.472 -1.307 . . . . 73.329999999999998 107.472 173.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -130.55 137.35 49.65 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 110.112 -0.329 . . . . 72.310000000000002 110.112 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -120.63 118.02 29.05 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.873 -1.158 . . . . 74.239999999999995 107.873 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.5 pt -116.03 102.78 14.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-O 121.504 0.669 . . . . 73.510000000000005 110.851 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.8 mtp -96.33 92.45 6.34 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.802 -1.555 . . . . 71.230000000000004 106.802 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.4 m -177.23 -49.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 112.754 0.65 . . . . 73.340000000000003 112.754 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.401 ' HD3' ' CD ' ' A' ' 119' ' ' GLU . 86.6 tttt -50.09 137.79 16.94 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.986 0.914 . . . . 72.120000000000005 112.994 -172.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -152.91 161.75 42.15 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 112.516 0.561 . . . . 75.349999999999994 112.516 -173.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.73 156.95 67.6 Favored Pre-proline 0 C--N 1.312 -1.029 0 CA-C-N 114.591 -1.186 . . . . 74.420000000000002 107.915 170.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -55.7 147.41 60.48 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.869 2.379 . . . . 75.099999999999994 112.342 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -63.06 152.8 36.04 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 121.213 0.53 . . . . 72.049999999999997 111.403 -175.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.2 p -115.0 142.58 27.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.751 -0.659 . . . . 72.349999999999994 109.415 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.789 0 N-CA-C 107.227 -1.398 . . . . 74.040000000000006 107.227 176.55 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.5 -0.947 0 N-CA-C 108.327 -0.99 . . . . 74.540000000000006 108.327 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 55.3 ttm -91.11 -21.59 21.12 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.11 0.957 . . . . 55.009999999999998 109.718 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.1 m -85.2 67.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 114.235 -1.348 . . . . 73.010000000000005 109.364 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.0 p -64.44 -37.65 88.28 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.565 -1.198 . . . . 64.120000000000005 113.025 -171.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -63.03 -40.88 99.06 Favored 'General case' 0 C--O 1.249 1.071 0 CA-C-O 121.57 0.7 . . . . 65.230000000000004 110.489 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.55 -38.31 71.03 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.539 -0.911 . . . . 74.430000000000007 108.539 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.23 -45.37 69.96 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.372 -0.831 . . . . 74.349999999999994 111.259 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.3 m -70.39 -34.69 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 112.109 0.411 . . . . 61.509999999999998 112.109 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.477 ' HZ2' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -69.7 -35.47 75.11 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 118.638 -1.225 . . . . 74.420000000000002 109.078 176.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.07 -40.79 83.05 Favored Glycine 0 C--O 1.216 -1.02 0 N-CA-C 111.327 -0.709 . . . . 74.400000000000006 111.327 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 tp -68.21 -47.98 66.42 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 123.465 0.706 . . . . 75.409999999999997 109.705 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.79 -41.04 99.01 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 115.645 -0.707 . . . . 72.409999999999997 111.718 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -67.82 -43.5 79.44 Favored 'General case' 0 C--O 1.198 -1.644 0 CA-C-O 118.879 -0.581 . . . . 74.540000000000006 111.085 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -57.96 -44.31 86.96 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 120.837 0.351 . . . . 72.319999999999993 110.082 -176.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -61.73 -54.56 40.9 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.633 -1.167 . . . . 75.200000000000003 110.438 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 29' ' ' ILE . 9.6 mm -60.6 -35.84 66.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 112.49 0.552 . . . . 71.239999999999995 112.49 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.93 -47.76 73.66 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.102 -0.703 . . . . 71.040000000000006 109.102 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.523 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 4.1 pp -73.59 -19.13 60.96 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 119.985 -0.686 . . . . 72.439999999999998 112.099 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.1 t -74.86 -28.17 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.462 0.649 . . . . 72.329999999999998 109.527 173.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.8 p -106.13 14.32 27.85 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.829 0.823 . . . . 73.5 109.18 -176.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 21.5 tptp -39.66 124.25 1.65 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 127.163 2.185 . . . . 74.0 112.879 -176.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 m -53.49 146.91 22.21 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.707 1.203 . . . . 75.209999999999994 112.048 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.14 -7.76 16.47 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 123.598 2.865 . . . . 73.409999999999997 112.614 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.93 -26.95 68.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.321 -0.854 . . . . 75.349999999999994 110.276 175.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 p -101.81 167.79 9.85 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.861 -0.609 . . . . 72.109999999999999 110.675 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.4 t -62.96 -54.95 26.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 114.034 1.124 . . . . 74.430000000000007 114.034 -172.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -171.11 139.84 1.43 Allowed 'General case' 0 C--O 1.245 0.836 0 C-N-CA 119.195 -1.002 . . . . 64.310000000000002 110.654 -172.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.7 m -63.22 -42.94 99.34 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.004 0.521 . . . . 74.109999999999999 111.724 -172.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.3 -20.6 65.62 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.031 -0.531 . . . . 72.400000000000006 111.466 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -69.86 -46.97 64.39 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.868 -0.79 . . . . 73.25 108.868 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -71.0 -31.95 68.62 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.87 -1.159 . . . . 73.430000000000007 107.87 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 54.3 tp -65.4 -46.59 79.42 Favored 'General case' 0 C--O 1.191 -2.012 0 CA-C-N 115.584 -0.735 . . . . 75.549999999999997 110.095 176.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 49' ' ' LEU . . . -62.37 -30.97 71.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.838 0.828 . . . . 65.420000000000002 110.494 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -73.25 -34.81 66.05 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.555 -1.202 . . . . 74.219999999999999 110.489 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -80.48 -26.92 37.96 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.458 1.123 . . . . 73.109999999999999 108.475 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 39.9 tp -69.79 -29.8 67.19 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 127.323 2.249 . . . . 73.439999999999998 111.509 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -38.47 -56.17 2.0 Allowed Glycine 0 CA--C 1.545 1.929 0 N-CA-C 115.628 1.011 . . . . 71.329999999999998 115.628 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -77.81 -5.83 15.6 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.153 1.902 . . . . 64.239999999999995 113.585 177.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -133.21 24.9 4.19 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.685 -0.634 . . . . 75.430000000000007 111.654 -169.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -56.17 107.32 0.86 Allowed Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 123.067 0.547 . . . . 75.329999999999998 111.823 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -109.51 -159.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 123.84 3.027 . . . . 74.319999999999993 112.228 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -86.73 131.16 34.21 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.226 -1.027 . . . . 63.329999999999998 108.226 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mp -108.86 112.75 41.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.763 -1.199 . . . . 75.340000000000003 107.763 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 138' ' ' LYS . 80.2 m-85 -92.88 133.7 35.82 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 108.502 -0.925 . . . . 75.530000000000001 108.502 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.3 t -131.84 117.09 32.81 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 108.101 -1.074 . . . . 71.109999999999999 108.101 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 60.78 29.44 19.01 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.373 1.045 . . . . 74.310000000000002 110.765 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.75 5.94 80.68 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.906 -1.043 . . . . 62.119999999999997 112.839 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -113.85 134.33 54.87 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 109.723 -0.473 . . . . 75.099999999999994 109.723 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.417 HD11 ' N ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -75.06 128.22 36.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.885 0.85 . . . . 75.409999999999997 110.284 -175.355 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.417 ' N ' HD11 ' A' ' 62' ' ' ILE . 50.8 mm-40 -126.37 144.32 50.86 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 106.921 -1.511 . . . . 65.239999999999995 106.921 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -87.08 174.3 8.74 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.281 -0.637 . . . . 74.140000000000001 109.281 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.7 t -56.7 -33.47 66.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.256 0.622 . . . . 74.530000000000001 111.378 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.419 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 60.9 m -67.21 -42.52 83.95 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.091 -0.504 . . . . 75.129999999999995 110.469 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.86 -47.92 76.15 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 122.766 0.426 . . . . 64.129999999999995 109.984 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -52.97 -53.56 48.04 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 123.552 0.533 . . . . 71.310000000000002 110.114 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.0 tp -49.72 -46.43 50.21 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 124.167 0.917 . . . . 70.25 111.537 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 66' ' ' THR . 49.0 mt-30 -59.46 -48.1 82.95 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 116.201 -0.454 . . . . 64.510000000000005 111.306 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -66.87 -35.28 79.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.243 0.544 . . . . 74.329999999999998 110.532 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -60.17 -51.91 67.57 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.554 -0.748 . . . . 75.510000000000005 110.649 175.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -75.33 -13.19 60.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.874 0.368 . . . . 75.239999999999995 111.372 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 27.9 mm-40 -82.1 -8.99 59.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.977 0.417 . . . . 71.340000000000003 111.412 170.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.82 26.31 50.19 Favored Glycine 0 N--CA 1.427 -1.903 0 CA-C-N 116.147 -0.479 . . . . 70.140000000000001 112.349 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.8 mt -78.36 -37.24 44.75 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.034 -0.667 . . . . 74.530000000000001 112.001 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -97.36 1.3 49.21 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.963 -0.695 . . . . 74.319999999999993 112.655 -175.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.301 0.0 OUTLIER -70.4 -16.88 63.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.177 1.177 . . . . 73.439999999999998 114.177 -173.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -89.53 -15.78 32.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.362 0.601 . . . . 74.409999999999997 111.543 171.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.3 tt -84.84 -14.82 46.76 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.568 -0.742 . . . . 72.540000000000006 110.262 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.84 -8.72 57.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.365 0.602 . . . . 74.409999999999997 111.748 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -92.72 13.52 19.91 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.616 -0.72 . . . . 72.430000000000007 109.524 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 105' ' ' SER . . . -79.99 154.44 28.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.282 -0.872 . . . . 71.230000000000004 113.352 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -107.79 143.79 35.87 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.523 -1.217 . . . . 72.230000000000004 109.256 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -95.58 120.11 35.25 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.236 0.541 . . . . 73.230000000000004 109.578 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.49 -179.94 4.17 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.915 -0.584 . . . . 72.140000000000001 109.943 -176.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.2 pp -61.26 130.7 25.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 CA-C-O 121.707 0.765 . . . . 73.25 112.621 177.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -106.27 81.82 1.67 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.382 -0.826 . . . . 74.430000000000007 109.151 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.0 t -75.49 -39.18 40.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.576 -0.898 . . . . 73.409999999999997 108.576 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.1 m -77.5 -5.61 50.62 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.973 -1.012 . . . . 63.119999999999997 111.259 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.04 64.49 4.22 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.819 -0.512 . . . . 63.340000000000003 111.819 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -112.18 111.15 21.83 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.421 0.629 . . . . 74.219999999999999 110.549 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.1 99.62 9.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.755 -0.832 . . . . 75.109999999999999 108.755 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -84.68 -26.88 27.45 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.547 0.689 . . . . 72.540000000000006 109.711 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -75.79 9.57 2.27 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.232 -0.895 . . . . 74.340000000000003 112.629 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.86 -125.35 1.73 Allowed Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.242 -1.543 . . . . 51.509999999999998 109.242 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -148.95 139.57 22.64 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.511 -0.551 . . . . 74.129999999999995 109.511 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.46 -164.64 33.94 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 110.261 -1.136 . . . . 72.200000000000003 110.261 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -128.55 136.3 50.55 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.454 -0.573 . . . . 73.450000000000003 109.454 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -122.71 98.9 6.12 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.008 -1.849 . . . . 75.340000000000003 106.008 170.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 mt -109.62 124.42 51.12 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 123.775 0.672 . . . . 74.219999999999999 109.889 -172.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 10.9 p -114.77 122.42 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-O 122.331 1.062 . . . . 55.119999999999997 112.474 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 -96.07 145.1 25.75 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.025 -1.443 . . . . 75.340000000000003 108.522 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -128.5 121.12 28.15 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.19 -1.411 . . . . 73.299999999999997 107.19 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 42.5 m -73.46 -174.29 1.63 Allowed 'General case' 0 C--O 1.253 1.282 0 C-N-CA 122.973 0.509 . . . . 73.25 112.018 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.9 161.11 19.06 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.713 -0.847 . . . . 72.140000000000001 108.713 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.434 ' HB3' ' CG2' ' A' ' 115' ' ' ILE . . . -100.08 136.67 39.62 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 120.83 -0.348 . . . . 74.349999999999994 111.832 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -113.56 112.46 23.59 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.542 -0.91 . . . . 65.140000000000001 108.542 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -77.46 108.63 10.76 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.637 -0.875 . . . . 71.040000000000006 108.637 176.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.2 t -93.22 154.63 17.92 Favored 'General case' 0 N--CA 1.414 -2.271 0 N-CA-C 108.183 -1.043 . . . . 74.230000000000004 108.183 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -71.83 0.37 9.24 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.346 0.594 . . . . 72.549999999999997 112.252 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -75.15 -4.7 40.28 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.101 0.96 . . . . 63.420000000000002 109.181 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 77.12 11.04 2.41 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 125.583 1.553 . . . . 74.409999999999997 111.68 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.415 ' HB3' ' CD1' ' A' ' 147' ' ' TYR . 25.0 pttm -125.96 157.85 36.74 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 115.521 -0.763 . . . . 73.319999999999993 109.039 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.434 ' CG2' ' HB3' ' A' ' 107' ' ' ALA . 2.0 mp -100.51 137.44 28.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 N-CA-C 107.891 -1.151 . . . . 71.030000000000001 107.891 -175.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -114.61 154.82 27.66 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.032 -0.729 . . . . 73.299999999999997 109.032 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 8.4 p90 -163.79 173.75 12.42 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.696 -1.224 . . . . 73.129999999999995 107.696 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -107.23 139.17 42.11 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.843 -1.169 . . . . 72.420000000000002 107.843 175.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -119.21 151.55 38.17 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 120.446 -0.502 . . . . 65.299999999999997 110.125 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -137.31 123.15 20.06 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 116.079 -0.51 . . . . 64.420000000000002 110.079 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -114.78 110.33 19.55 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.16 -0.682 . . . . 72.239999999999995 109.16 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.02 130.39 44.35 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 109.031 -0.729 . . . . 74.230000000000004 109.031 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -110.31 110.67 21.56 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.213 -1.032 . . . . 72.530000000000001 108.213 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.453 HG12 HD13 ' A' ' 134' ' ' LEU . 61.4 mt -115.28 137.16 49.7 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.674 0 N-CA-C 107.511 -1.292 . . . . 75.030000000000001 107.511 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.505 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.2 OUTLIER -122.27 147.95 45.6 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.007 -1.849 . . . . 71.120000000000005 106.007 177.335 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -117.06 133.53 55.88 Favored 'General case' 0 N--CA 1.398 -3.028 0 C-N-CA 117.553 -1.659 . . . . 75.120000000000005 109.725 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -82.56 144.69 30.19 Favored 'General case' 0 C--N 1.255 -3.533 0 CA-C-N 113.044 -1.889 . . . . 72.109999999999999 109.789 -172.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -49.4 -31.8 10.33 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.853 1.261 . . . . 75.030000000000001 112.423 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -76.69 0.93 18.57 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.515 -0.766 . . . . 74.400000000000006 111.667 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.95 -1.48 56.54 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.335 -0.46 . . . . 73.129999999999995 112.619 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.4 m -85.5 101.46 12.67 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 122.623 -0.339 . . . . 74.510000000000005 111.521 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 42.0 t -80.78 120.74 25.05 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 105.57 -2.011 . . . . 74.030000000000001 105.57 173.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.505 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 5.9 t-105 -140.22 150.56 44.29 Favored 'General case' 0 N--CA 1.394 -3.245 0 C-N-CA 119.163 -1.015 . . . . 75.310000000000002 111.301 -170.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.453 HD13 HG12 ' A' ' 124' ' ' ILE . 3.4 mm? -68.75 116.6 9.44 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.053 -0.976 . . . . 73.019999999999996 109.057 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -83.72 -56.61 3.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.975 -0.75 . . . . 75.319999999999993 108.975 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.0 m -164.45 156.55 16.36 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 106.291 -1.744 . . . . 73.239999999999995 106.291 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.8 m -131.03 162.34 39.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.384 -1.339 . . . . 75.030000000000001 107.384 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 57' ' ' TYR . 78.7 tttt -142.28 136.97 30.3 Favored 'General case' 0 C--N 1.275 -2.641 0 C-N-CA 122.718 0.407 . . . . 64.420000000000002 110.071 -173.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -123.04 141.01 52.43 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.821 -0.807 . . . . 74.349999999999994 108.821 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.9 pt -132.18 98.36 3.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.788 -1.19 . . . . 73.239999999999995 107.788 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 68.8 mtm -89.55 130.38 35.88 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.213 -1.358 . . . . 74.319999999999993 111.138 -171.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.4 t 71.47 24.46 3.63 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 124.468 1.105 . . . . 71.329999999999998 110.303 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -75.26 144.72 42.39 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.891 -1.05 . . . . 74.140000000000001 108.381 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -127.03 175.09 8.37 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 121.373 0.606 . . . . 73.109999999999999 111.185 -175.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -112.89 129.31 24.61 Favored Pre-proline 0 C--N 1.289 -2.033 0 N-CA-C 107.258 -1.386 . . . . 51.200000000000003 107.258 175.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.42 129.15 22.17 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.736 2.291 . . . . 73.120000000000005 110.06 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.415 ' CD1' ' HB3' ' A' ' 114' ' ' LYS . 39.3 p90 -97.2 168.77 10.23 Favored 'General case' 0 N--CA 1.413 -2.289 0 CA-C-O 121.705 0.764 . . . . 74.230000000000004 112.088 -172.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.2 p -134.0 109.76 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.485 0 CA-C-N 114.569 -1.196 . . . . 73.150000000000006 108.689 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.289 -2.023 0 CA-C-N 114.99 -1.004 . . . . 44.240000000000002 108.728 -178.785 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 . . . . . 0 CA--C 1.484 -1.571 0 N-CA-C 108.909 -0.774 . . . . 74.030000000000001 108.909 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.7 ptp -80.86 91.86 6.03 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.289 1.042 . . . . 71.329999999999998 110.646 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.3 t -81.68 147.48 6.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 105.516 -2.031 . . . . 65.439999999999998 105.516 173.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.439 ' O ' HG12 ' A' ' 21' ' ' VAL . 6.7 m -56.63 -40.42 75.36 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 118.356 0.525 . . . . 73.329999999999998 109.782 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -64.66 -42.1 95.64 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 115.625 -0.716 . . . . 75.129999999999995 110.815 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.96 -40.43 96.4 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.68 -0.691 . . . . 72.049999999999997 109.454 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.15 -43.6 81.9 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.021 -0.536 . . . . 73.209999999999994 110.517 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 17' ' ' THR . 11.3 m -70.39 -38.73 75.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 120.334 -0.547 . . . . 75.409999999999997 112.104 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -28.0 50.37 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.662 -0.815 . . . . 71.150000000000006 110.581 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.75 -41.43 49.99 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 110.066 -1.214 . . . . 62.450000000000003 110.066 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.3 tp -68.12 -49.78 58.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.889 -0.782 . . . . 62.140000000000001 108.889 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.26 -38.72 95.0 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.516 -0.765 . . . . 43.43 112.447 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -71.95 -40.85 68.39 Favored 'General case' 0 C--O 1.195 -1.792 0 C-N-CA 120.426 -0.51 . . . . 72.200000000000003 110.571 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -62.32 -43.1 99.61 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.622 0.725 . . . . 73.430000000000007 110.049 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.425 ' CZ ' ' HH2' ' A' ' 103' ' ' TRP . 27.7 t80 -64.63 -54.63 28.78 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 113.946 -1.479 . . . . 74.420000000000002 110.157 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.8 mm -65.49 -33.52 64.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 120.882 -0.327 . . . . 72.340000000000003 111.838 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -63.41 -48.82 76.24 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 110.067 -0.346 . . . . 64.319999999999993 110.067 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.415 HD11 ' N ' ' A' ' 32' ' ' VAL . 4.4 pp -68.55 -30.28 69.03 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.088 -0.645 . . . . 63.329999999999998 110.94 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.415 ' N ' HD11 ' A' ' 31' ' ' LEU . 66.0 t -70.58 -25.09 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 CA-C-O 121.201 0.524 . . . . 71.540000000000006 110.492 175.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.5 p -110.33 19.3 18.98 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.565 0.698 . . . . 74.109999999999999 110.226 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -55.78 142.86 33.14 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.949 -1.023 . . . . 74.310000000000002 110.328 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 m -62.92 153.99 78.1 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-N 115.435 -0.802 . . . . 65.209999999999994 110.694 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.16 -5.65 3.11 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 125.03 3.82 . . . . 71.329999999999998 113.043 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.6 -27.22 68.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.498 -0.774 . . . . 73.540000000000006 109.17 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -94.97 142.2 27.76 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 105.788 -1.93 . . . . 74.219999999999999 105.788 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.7 t -68.96 -46.07 79.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 120.606 -0.438 . . . . 74.120000000000005 111.927 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -145.01 119.29 9.54 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 119.406 -0.918 . . . . 74.25 112.552 -174.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.9 m -64.13 -35.96 82.49 Favored 'General case' 0 C--O 1.251 1.165 0 C-N-CA 123.714 0.806 . . . . 74.099999999999994 110.768 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.724 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 1.3 mp0 -65.8 -21.2 66.47 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.156 -0.929 . . . . 75.299999999999997 110.466 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -68.69 -43.02 76.94 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.607 -1.257 . . . . 75.140000000000001 107.607 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.43 -32.12 69.59 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.552 -1.204 . . . . 74.150000000000006 109.43 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.5 tp -67.78 -40.87 83.95 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 116.017 -0.538 . . . . 63.420000000000002 110.7 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.11 -36.62 84.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.622 0.725 . . . . 74.310000000000002 109.921 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -69.47 -37.6 77.35 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.985 -1.007 . . . . 75.140000000000001 109.44 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -65.55 -43.24 90.51 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.218 1.007 . . . . 74.120000000000005 110.727 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.42 ' C ' HD13 ' A' ' 49' ' ' LEU . 4.4 pp -80.45 -2.49 46.02 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.822 -0.626 . . . . 74.340000000000003 111.214 -177.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.2 -62.47 5.02 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 111.888 -0.485 . . . . 73.420000000000002 111.888 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -77.15 -5.57 15.88 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.45 2.1 . . . . 73.109999999999999 112.235 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -124.46 38.08 4.27 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.798 -0.445 . . . . 72.420000000000002 109.798 -172.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.535 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 34.4 t70 -54.52 106.03 0.61 Allowed Pre-proline 0 C--O 1.245 0.848 0 C-N-CA 125.23 1.412 . . . . 63.229999999999997 113.22 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -107.92 -157.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.101 0 C-N-CA 123.798 2.999 . . . . 74.530000000000001 110.548 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -98.97 123.66 43.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.665 -0.865 . . . . 72.319999999999993 108.665 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.441 HD11 ' CG ' ' A' ' 68' ' ' PHE . 46.6 mt -105.25 107.92 23.74 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.606 0 N-CA-C 107.868 -1.16 . . . . 74.099999999999994 107.868 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -96.75 138.82 33.73 Favored 'General case' 0 C--N 1.27 -2.888 0 O-C-N 121.737 -0.602 . . . . 75.230000000000004 110.26 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 p -128.24 117.92 46.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 107.16 -1.422 . . . . 74.099999999999994 107.16 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 60.8 20.82 10.95 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.705 -0.68 . . . . 74.400000000000006 111.571 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.27 1.17 56.89 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.817 -0.629 . . . . 75.030000000000001 112.866 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -108.74 130.84 55.37 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 117.397 0.598 . . . . 75.219999999999999 110.438 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.58 125.25 33.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 122.055 0.931 . . . . 74.409999999999997 110.256 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -120.56 140.53 51.36 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.44 -1.318 . . . . 72.129999999999995 107.44 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.0 t -85.66 173.52 10.06 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.701 -0.852 . . . . 71.420000000000002 108.701 176.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.535 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 9.7 t -52.62 -37.52 58.52 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.405 0.682 . . . . 64.519999999999996 111.57 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -70.03 -41.1 74.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.336 -0.393 . . . . 73.129999999999995 111.855 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.54 -47.34 76.19 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.229 -0.656 . . . . 74.420000000000002 109.229 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.441 ' CG ' HD11 ' A' ' 56' ' ' ILE . 55.3 t80 -53.18 -54.33 37.57 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 115.667 -0.697 . . . . 71.230000000000004 110.118 174.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -50.13 -44.31 52.33 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 124.206 0.941 . . . . 64.049999999999997 110.867 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -60.41 -48.84 80.03 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 122.853 0.461 . . . . 71.150000000000006 111.531 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.443 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 32.6 m-85 -68.4 -36.78 79.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.678 0.752 . . . . 60.009999999999998 109.398 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -58.46 -54.56 45.7 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.102 -0.954 . . . . 73.200000000000003 110.948 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -66.07 -29.74 70.14 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.582 -0.281 . . . . 74.340000000000003 110.557 -176.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.403 HE21 ' HA ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -77.71 -8.78 58.44 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 113.373 0.879 . . . . 72.230000000000004 113.373 178.007 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.13 11.35 42.84 Favored Glycine 0 C--N 1.315 -0.63 0 C-N-CA 120.31 -0.947 . . . . 73.150000000000006 114.944 173.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.14 -53.85 22.22 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 120.878 0.371 . . . . 74.209999999999994 111.974 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.443 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 40.5 m-85 -89.72 6.17 42.7 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 112.781 0.66 . . . . 74.349999999999994 112.781 -172.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.724 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 41.9 mtmt -66.16 -12.47 56.03 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.492 0.923 . . . . 75.340000000000003 113.492 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -77.64 -10.67 59.64 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.363 -0.835 . . . . 71.049999999999997 111.2 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.3 tp -68.3 -28.86 67.55 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.488 -0.56 . . . . 74.319999999999993 109.488 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.536 ' HB2' ' OE2' ' A' ' 42' ' ' GLU . 0.8 OUTLIER -65.83 -28.67 69.16 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.581 -0.736 . . . . 74.099999999999994 110.127 176.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -98.82 7.07 46.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.656 -0.702 . . . . 74.519999999999996 110.348 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.48 150.82 22.3 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.967 0.413 . . . . 54.420000000000002 110.612 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.09 134.11 47.9 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.674 -0.862 . . . . 70.109999999999999 108.674 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -85.71 144.25 27.9 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 113.55 0.944 . . . . 75.329999999999998 113.55 -174.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.74 95.13 3.08 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 105.545 -2.02 . . . . 72.0 105.545 173.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.7 pp -84.51 140.74 15.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 112.687 0.625 . . . . 74.409999999999997 112.687 -174.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -131.63 93.94 3.43 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.893 0.854 . . . . 64.319999999999993 109.862 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -100.0 135.04 37.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 115.017 -0.992 . . . . 71.040000000000006 108.57 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.2 m -76.57 80.77 3.25 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.697 0.284 . . . . 74.409999999999997 111.069 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.48 -15.91 1.44 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 115.962 1.145 . . . . 71.420000000000002 115.962 174.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 86.9 tttt 64.03 44.12 4.81 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 106.321 -1.733 . . . . 75.219999999999999 106.321 -173.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.551 ' HB ' ' OE2' ' A' ' 95' ' ' GLU . 31.1 m -82.01 168.77 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 113.217 -1.811 . . . . 75.420000000000002 111.232 -176.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -95.38 -9.04 33.95 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 113.441 0.904 . . . . 74.120000000000005 113.441 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.551 ' OE2' ' HB ' ' A' ' 93' ' ' VAL . 2.4 pm0 -87.44 -176.12 5.49 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.03 -0.668 . . . . 75.299999999999997 111.324 177.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -83.01 72.47 2.84 Favored Glycine 0 N--CA 1.419 -2.491 0 N-CA-C 115.266 0.866 . . . . 74.430000000000007 115.266 -174.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -100.67 167.6 10.22 Favored 'General case' 0 C--O 1.256 1.44 0 N-CA-C 109.803 -0.443 . . . . 73.109999999999999 109.803 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -105.41 146.49 16.08 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 110.979 -0.848 . . . . 75.530000000000001 110.979 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -110.99 133.91 53.01 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.0 -1.111 . . . . 72.439999999999998 108.0 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -113.45 109.82 19.29 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 123.583 0.552 . . . . 74.349999999999994 109.872 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -97.42 108.73 21.51 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 105.675 -1.972 . . . . 70.230000000000004 105.675 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 3.9 t -115.11 150.24 17.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 119.776 -0.77 . . . . 75.030000000000001 110.187 -174.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.425 ' HH2' ' CZ ' ' A' ' 28' ' ' PHE . 25.2 m-90 -132.35 151.19 51.96 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.556 -0.905 . . . . 74.230000000000004 108.556 175.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.435 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 67.3 mttm -126.34 130.85 51.62 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.684 -1.599 . . . . 75.209999999999994 106.684 174.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.1 p -85.35 -166.83 1.62 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 110.288 -0.264 . . . . 63.210000000000001 110.288 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.41 128.46 36.77 Favored 'General case' 0 C--O 1.256 1.411 0 CA-C-O 121.223 0.535 . . . . 73.239999999999995 110.604 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -101.96 142.67 32.89 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.182 -0.917 . . . . 71.319999999999993 110.859 -177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -139.99 142.86 36.28 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.633 -1.617 . . . . 74.230000000000004 106.633 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.416 ' HG2' HG13 ' A' ' 115' ' ' ILE . 45.9 mtt180 -76.85 131.57 38.69 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-O 121.94 0.876 . . . . 73.439999999999998 112.4 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.4 m -95.49 169.18 10.23 Favored 'General case' 0 N--CA 1.405 -2.691 0 CA-C-N 113.816 -1.538 . . . . 62.420000000000002 109.292 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -72.61 -18.8 61.56 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.17 0.588 . . . . 72.200000000000003 111.461 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.406 ' HB2' ' HG2' ' A' ' 114' ' ' LYS . 24.9 m-20 -79.4 7.71 7.49 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.538 -0.301 . . . . 74.340000000000003 110.999 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 70.25 18.81 6.77 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.381 1.472 . . . . 75.439999999999998 109.451 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.406 ' HG2' ' HB2' ' A' ' 112' ' ' ASP . 65.2 pttt -108.84 173.31 6.38 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.586 -1.264 . . . . 74.439999999999998 107.586 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.416 HG13 ' HG2' ' A' ' 109' ' ' ARG . 1.1 mp -120.45 126.16 74.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 107.924 -1.139 . . . . 71.340000000000003 107.924 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.46 ' NH2' ' HA ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -97.38 142.03 29.74 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 120.397 -0.521 . . . . 72.450000000000003 110.51 -179.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.46 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 1.6 p90 -153.85 173.29 16.1 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 107.147 -1.427 . . . . 74.209999999999994 107.147 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -113.02 135.33 53.9 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 106.022 -1.844 . . . . 63.32 106.022 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.435 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 44.0 mt-10 -115.07 148.77 38.49 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-O 121.69 0.757 . . . . 75.439999999999998 112.159 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -132.97 117.75 18.02 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-N 114.414 -1.266 . . . . 63.340000000000003 108.562 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -121.38 110.91 16.67 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 109.1 -0.704 . . . . 75.340000000000003 109.1 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -98.16 133.76 42.16 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.118 -0.492 . . . . 73.450000000000003 109.847 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -114.76 121.11 42.31 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 123.188 0.595 . . . . 72.530000000000001 110.198 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.5 mt -123.41 149.64 27.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.07 -1.826 . . . . 73.349999999999994 106.07 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.4 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.7 OUTLIER -132.19 145.21 51.19 Favored 'General case' 0 C--O 1.272 2.259 0 C-N-CA 119.066 -1.054 . . . . 73.329999999999998 109.157 173.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -83.66 119.9 25.33 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.473 -1.306 . . . . 74.209999999999994 107.473 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -89.59 133.06 34.79 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.481 -1.674 . . . . 65.329999999999998 106.481 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.29 -12.58 30.49 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.664 0.745 . . . . 75.239999999999995 111.228 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.8 -11.0 60.69 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.215 -0.902 . . . . 72.420000000000002 111.095 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.17 -12.9 28.79 Favored Glycine 0 CA--C 1.509 -0.344 0 C-N-CA 121.066 -0.588 . . . . 61.439999999999998 112.986 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.3 m -104.56 164.93 11.41 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 109.798 -0.445 . . . . 61.119999999999997 109.798 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.435 ' SG ' HG13 ' A' ' 21' ' ' VAL . 25.3 p -127.12 143.27 51.31 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.101 -1.444 . . . . 74.349999999999994 107.101 172.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.4 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 1.7 t90 -143.41 155.56 44.43 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.173 -1.011 . . . . 74.319999999999993 109.435 -176.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.7 mp -70.37 119.35 14.41 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 109.447 -0.575 . . . . 72.040000000000006 109.447 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -72.04 -50.5 27.97 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.562 -1.273 . . . . 74.430000000000007 107.562 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.8 p -177.19 177.42 1.23 Allowed 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.334 -1.303 . . . . 74.540000000000006 108.634 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.9 t -144.78 138.72 22.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 105.015 -2.217 . . . . 72.540000000000006 105.015 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -129.31 130.26 45.9 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-O 121.462 0.649 . . . . 74.420000000000002 109.847 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -110.42 133.57 53.15 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 107.791 -1.189 . . . . 71.430000000000007 107.791 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 10.1 pt -131.88 98.36 3.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 CA-C-O 122.078 0.942 . . . . 74.030000000000001 108.772 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 90.5 mtp -88.97 138.92 30.97 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.828 -1.078 . . . . 75.439999999999998 110.6 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.0 m 70.79 29.64 3.11 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 124.881 1.363 . . . . 73.340000000000003 112.795 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -87.04 170.0 11.92 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.365 -0.606 . . . . 74.140000000000001 109.365 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -154.14 159.9 41.66 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.247 -0.981 . . . . 75.099999999999994 111.849 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.24 126.79 28.21 Favored Pre-proline 0 C--N 1.296 -1.743 0 N-CA-C 106.736 -1.579 . . . . 75.319999999999993 106.736 173.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.08 158.4 41.9 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.819 1.679 . . . . 75.349999999999994 111.946 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -70.5 146.81 49.99 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.222 -1.029 . . . . 73.409999999999997 108.222 177.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.9 m -77.94 111.22 14.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.422 0.629 . . . . 75.239999999999995 110.271 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.519 0 N-CA-C 108.114 -1.069 . . . . 52.039999999999999 108.114 179.836 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 121.064 0.459 . . . . 44.340000000000003 111.078 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -108.41 121.92 45.94 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.428 -0.582 . . . . 70.450000000000003 109.428 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.7 p -60.07 -41.69 87.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 113.45 0.908 . . . . 72.299999999999997 113.45 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.436 ' OG1' ' HA2' ' A' ' 130' ' ' GLY . 1.7 m -76.87 -35.23 57.59 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.489 -0.485 . . . . 74.420000000000002 110.757 -176.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 10.6 t70 -62.67 -46.74 86.78 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.217 -1.031 . . . . 71.209999999999994 108.217 177.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.92 -36.69 84.06 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.784 -1.098 . . . . 73.239999999999995 110.027 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.36 -42.6 87.83 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.228 -0.442 . . . . 73.239999999999995 110.466 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 m -71.75 -41.88 70.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 112.387 0.514 . . . . 74.439999999999998 112.387 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -68.73 -31.41 70.46 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.622 -0.831 . . . . 74.109999999999999 110.161 178.503 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.01 -57.32 8.8 Favored Glycine 0 N--CA 1.437 -1.263 0 O-C-N 123.805 0.69 . . . . 71.409999999999997 111.939 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.68 -33.08 73.36 Favored 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.086 -1.046 . . . . 74.540000000000006 110.231 -177.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.06 -39.68 96.51 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 120.925 -0.655 . . . . 70.230000000000004 111.971 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -67.15 -47.56 70.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.655 -0.498 . . . . 75.040000000000006 109.655 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.6 -41.93 98.14 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.558 -0.746 . . . . 75.530000000000001 110.28 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.513 ' CE2' HD12 ' A' ' 45' ' ' LEU . 23.9 t80 -61.46 -53.15 60.2 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 124.912 1.285 . . . . 71.239999999999995 109.985 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 29' ' ' ILE . 9.8 mm -65.76 -32.66 59.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 112.152 0.427 . . . . 72.129999999999995 112.152 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.23 -47.0 72.1 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.371 -0.532 . . . . 72.409999999999997 110.622 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.77 -26.21 64.18 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.02 -0.672 . . . . 74.140000000000001 111.925 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 28' ' ' PHE . 63.2 t -71.68 -24.42 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 CA-C-O 121.552 0.691 . . . . 72.129999999999995 110.538 174.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.6 p -107.31 9.83 29.88 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 121.618 -0.676 . . . . 74.109999999999999 110.595 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -69.63 156.95 38.15 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.161 -0.927 . . . . 74.230000000000004 112.474 -174.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.0 m -63.31 154.31 78.95 Favored Pre-proline 0 N--CA 1.424 -1.765 0 CA-C-N 113.711 -1.586 . . . . 73.450000000000003 113.04 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -59.18 -5.17 2.69 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 125.182 3.921 . . . . 72.209999999999994 112.785 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -54.31 -26.8 31.49 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.93 0.892 . . . . 75.329999999999998 110.785 173.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.1 t -101.14 156.81 17.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 105.158 -2.164 . . . . 72.0 105.158 168.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -50.24 -41.63 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.831 0.741 . . . . 75.109999999999999 111.987 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -167.04 151.08 6.82 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.966 -1.124 . . . . 73.010000000000005 107.966 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.7 m -60.71 -32.16 71.41 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-O 121.461 0.648 . . . . 74.040000000000006 110.648 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -64.55 -22.75 67.05 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.201 -0.909 . . . . 73.219999999999999 110.151 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -67.06 -45.78 76.35 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.78 0.8 . . . . 72.450000000000003 108.915 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -71.49 -33.49 69.3 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.409 -1.269 . . . . 74.049999999999997 109.151 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.513 HD12 ' CE2' ' A' ' 28' ' ' PHE . 34.4 tp -68.74 -43.88 74.97 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 116.17 -0.468 . . . . 75.219999999999999 110.37 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.51 -37.02 77.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.476 0.655 . . . . 74.340000000000003 110.195 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -69.49 -36.08 76.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.124 -0.944 . . . . 72.219999999999999 110.176 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -67.26 -46.56 73.32 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.667 -0.697 . . . . 75.329999999999998 110.285 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.413 ' C ' HD13 ' A' ' 49' ' ' LEU . 4.2 pp -82.23 -2.39 52.28 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.356 -0.838 . . . . 71.340000000000003 111.338 -176.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.69 -62.5 4.82 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 112.306 -0.318 . . . . 75.340000000000003 112.306 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -79.47 -7.23 14.83 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 121.842 1.694 . . . . 74.209999999999994 112.151 176.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -114.17 35.19 4.26 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.041 -0.725 . . . . 72.120000000000005 109.041 -175.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.6 106.26 0.64 Allowed Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 125.28 1.432 . . . . 53.509999999999998 112.356 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -101.69 -164.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 123.243 2.629 . . . . 73.129999999999995 110.928 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -90.34 108.07 19.54 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 107.545 -1.28 . . . . 75.109999999999999 107.545 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.462 HD11 ' CB ' ' A' ' 68' ' ' PHE . 73.4 mt -92.48 107.91 19.58 Favored 'Isoleucine or valine' 0 C--O 1.162 -3.515 0 N-CA-C 108.744 -0.836 . . . . 74.439999999999998 108.744 -176.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -95.55 128.15 42.18 Favored 'General case' 0 C--N 1.268 -2.975 0 O-C-N 121.12 -0.988 . . . . 74.549999999999997 109.127 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.0 t -124.97 114.44 40.4 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 N-CA-C 107.959 -1.126 . . . . 74.540000000000006 107.959 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 62.01 20.94 11.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.56 -1.2 . . . . 74.329999999999998 110.591 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.63 -4.89 58.21 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 114.72 -1.127 . . . . 73.219999999999999 113.165 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -101.01 132.72 46.29 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 117.714 0.757 . . . . 72.439999999999998 109.376 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.59 129.25 36.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.874 0.845 . . . . 74.129999999999995 109.676 -177.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -126.9 152.83 46.56 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 124.78 1.232 . . . . 65.409999999999997 108.295 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.9 t -97.71 170.24 9.13 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.341 -0.985 . . . . 74.209999999999994 108.341 175.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.8 t -52.14 -38.43 57.52 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.285 0.634 . . . . 75.109999999999999 111.231 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -62.0 -49.2 76.99 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.175 0.59 . . . . 70.019999999999996 111.105 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.44 84.49 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.095 0.558 . . . . 73.25 110.314 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.462 ' CB ' HD11 ' A' ' 56' ' ' ILE . 56.6 t80 -53.68 -55.65 24.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.907 -0.588 . . . . 74.120000000000005 110.413 175.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -50.87 -42.44 58.92 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.07 -0.968 . . . . 73.319999999999993 110.572 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -60.28 -47.43 86.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 112.014 0.375 . . . . 73.230000000000004 112.014 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -66.78 -32.7 74.16 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.495 0.664 . . . . 73.219999999999999 109.976 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -61.77 -52.61 63.53 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.47 -0.786 . . . . 75.099999999999994 110.91 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -71.17 -21.28 62.19 Favored 'General case' 0 C--O 1.224 -0.271 0 O-C-N 123.27 0.356 . . . . 74.439999999999998 110.904 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -71.57 -19.95 62.08 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.351 0.596 . . . . 65.120000000000005 110.108 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.94 13.79 33.14 Favored Glycine 0 N--CA 1.422 -2.235 0 CA-C-N 115.492 -0.776 . . . . 63.039999999999999 113.299 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.0 mt -74.55 -44.56 50.48 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 117.427 0.614 . . . . 65.230000000000004 111.365 -177.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -88.8 -4.58 58.46 Favored 'General case' 0 C--O 1.214 -0.814 0 N-CA-C 112.662 0.615 . . . . 74.109999999999999 112.662 -176.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -15.57 62.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 119.392 -0.923 . . . . 74.049999999999997 112.304 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -86.61 -21.57 26.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.631 -0.713 . . . . 75.310000000000002 110.281 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.1 tp -74.54 -14.76 60.84 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.915 0.864 . . . . 72.239999999999995 109.684 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -57.66 -25.65 60.53 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.598 -1.183 . . . . 72.239999999999995 112.295 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -92.95 11.94 25.58 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 111.997 0.369 . . . . 64.019999999999996 111.997 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.73 150.24 28.06 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.096 0.474 . . . . 74.549999999999997 111.627 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -99.5 132.41 44.86 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.504 -0.924 . . . . 64.430000000000007 108.504 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.55 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 51.1 p90 -95.25 143.94 26.24 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.924 -0.711 . . . . 74.150000000000006 112.311 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.89 163.37 34.31 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.694 -1.225 . . . . 71.230000000000004 107.694 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.6 pp -82.13 142.98 12.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 120.794 -0.363 . . . . 74.409999999999997 110.841 177.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.51 ' HB2' ' CG2' ' A' ' 102' ' ' VAL . 23.7 t-20 -90.79 153.43 20.25 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.653 -0.869 . . . . 72.140000000000001 108.653 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 p -51.43 -44.04 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 124.202 0.939 . . . . 74.120000000000005 110.745 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 m 50.76 42.65 27.79 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.238 1.015 . . . . 60.520000000000003 111.627 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -82.78 48.6 4.04 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.538 -0.755 . . . . 75.409999999999997 113.818 -174.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -101.34 167.8 9.94 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 106.908 -1.515 . . . . 63.420000000000002 106.908 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.3 m -78.38 95.38 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 121.818 0.818 . . . . 75.510000000000005 111.629 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.06 116.58 29.06 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.842 -0.743 . . . . 73.409999999999997 110.868 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.49 -28.7 69.39 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.547 -1.206 . . . . 74.319999999999993 111.694 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -124.39 -88.03 0.78 Allowed Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 108.843 -1.703 . . . . 64.519999999999996 108.843 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -167.13 154.06 8.62 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 123.138 0.575 . . . . 71.239999999999995 110.184 175.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -153.88 141.67 8.48 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 108.853 -1.699 . . . . 75.310000000000002 108.853 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -108.56 150.99 26.72 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.459 -1.312 . . . . 72.230000000000004 107.459 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.623 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 39.4 ttpt -150.05 107.83 3.69 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-O 121.745 0.783 . . . . 74.319999999999993 109.41 176.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 72.8 mt -101.99 134.35 45.35 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 114.146 -1.388 . . . . 73.430000000000007 107.935 -177.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 6.1 t -120.01 128.97 75.97 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.182 0 C-N-CA 120.685 -0.406 . . . . 64.319999999999993 110.397 -176.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 18.8 m-90 -99.95 127.44 46.14 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 107.317 -1.364 . . . . 75.549999999999997 107.317 173.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -112.36 120.12 40.61 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 107.696 -1.224 . . . . 71.099999999999994 107.696 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.6 t -85.82 -176.29 5.95 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.194 -0.912 . . . . 75.299999999999997 110.483 -176.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.54 125.66 26.45 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 115.532 -0.758 . . . . 72.430000000000007 111.178 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.19 116.66 22.47 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.704 -1.135 . . . . 73.400000000000006 109.142 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -94.36 145.58 24.65 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.768 -0.827 . . . . 63.210000000000001 108.768 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -74.4 158.74 33.37 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.016 0.436 . . . . 74.430000000000007 111.491 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.3 t -142.12 147.46 36.75 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 106.292 -1.744 . . . . 65.109999999999999 106.292 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -71.85 -10.7 60.15 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.727 0.775 . . . . 75.150000000000006 111.872 -172.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.34 16.88 10.72 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.507 -0.77 . . . . 72.200000000000003 111.698 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 72.09 10.02 6.03 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.34 1.456 . . . . 74.200000000000003 113.158 173.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -108.6 178.82 4.37 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.88 -0.785 . . . . 73.129999999999995 108.88 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 9.5 pt -129.43 145.67 35.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 120.855 0.36 . . . . 73.340000000000003 111.633 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -105.68 109.5 21.48 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 124.464 1.105 . . . . 74.030000000000001 108.823 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.525 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 43.2 p90 -121.65 165.61 15.49 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.146 -1.057 . . . . 72.120000000000005 108.146 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -112.88 140.53 47.61 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.947 -1.501 . . . . 62.43 106.947 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.525 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 40.7 mt-10 -123.32 155.14 37.84 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 121.183 0.516 . . . . 64.099999999999994 111.031 175.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -141.61 117.29 10.35 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.771 -1.104 . . . . 62.409999999999997 108.039 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 7.9 pt-20 -125.23 111.99 15.89 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-O 121.718 0.771 . . . . 64.099999999999994 112.193 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.623 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -93.91 124.61 38.03 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.427 -1.261 . . . . 75.239999999999995 110.005 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.454 ' CE2' ' HD3' ' A' ' 100' ' ' LYS . 8.7 m-85 -103.07 129.34 49.85 Favored 'General case' 0 C--O 1.249 1.069 0 C-N-CA 124.622 1.169 . . . . 74.400000000000006 108.171 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 53.8 mt -131.46 144.28 38.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.697 -0.853 . . . . 75.319999999999993 108.697 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.415 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.5 OUTLIER -137.73 151.51 48.27 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 108.117 -1.068 . . . . 73.129999999999995 108.117 176.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -107.04 150.64 26.31 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.421 -0.912 . . . . 74.25 110.995 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.478 ' HB2' ' OD1' ' A' ' 129' ' ' ASP . 50.4 mtt180 -99.47 168.91 9.68 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.017 -0.992 . . . . 75.140000000000001 109.643 -172.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -80.97 -10.3 59.73 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.849 0.357 . . . . 74.040000000000006 110.617 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.478 ' OD1' ' HB2' ' A' ' 127' ' ' ARG . 11.4 p-10 -74.27 -16.04 60.96 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.058 0.456 . . . . 75.230000000000004 110.943 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.436 ' HA2' ' OG1' ' A' ' 17' ' ' THR . . . 112.08 -11.95 26.78 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 120.834 -0.698 . . . . 61.409999999999997 112.055 178.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.4 m -105.08 -177.33 3.33 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.687 0.756 . . . . 74.329999999999998 110.208 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 28.8 p -143.62 169.4 17.8 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 106.69 -1.596 . . . . 54.530000000000001 106.69 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.415 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 0.0 OUTLIER -159.28 155.81 27.61 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.125 -0.694 . . . . 73.230000000000004 109.125 -178.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.4 mp -70.07 123.38 21.42 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.555 -0.906 . . . . 72.540000000000006 108.555 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -72.71 -54.47 8.88 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.741 -1.207 . . . . 75.239999999999995 107.741 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.4 m -168.4 165.89 12.54 Favored 'General case' 0 C--O 1.201 -1.472 0 N-CA-C 106.066 -1.827 . . . . 71.329999999999998 106.066 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.5 m -142.12 142.61 27.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 105.46 -2.052 . . . . 70.310000000000002 105.46 171.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -127.93 130.54 48.63 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 118.206 0.457 . . . . 75.340000000000003 110.439 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -115.25 128.91 56.45 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.901 -1.148 . . . . 74.200000000000003 107.901 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.6 pt -128.64 98.31 4.19 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.6 0 N-CA-C 108.07 -1.085 . . . . 74.200000000000003 108.07 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 74.7 mtm -87.27 128.36 35.17 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.631 -1.168 . . . . 74.549999999999997 111.71 -174.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.5 m 61.52 55.09 2.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 113.935 -1.484 . . . . 64.519999999999996 111.339 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -91.39 145.37 24.69 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 106.194 -1.78 . . . . 72.420000000000002 106.194 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.13 145.81 42.07 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 120.595 -0.442 . . . . 62.25 109.947 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.52 134.14 23.77 Favored Pre-proline 0 N--CA 1.414 -2.239 0 N-CA-C 105.436 -2.061 . . . . 74.450000000000003 105.436 172.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -58.04 152.84 48.86 Favored 'Trans proline' 0 C--O 1.254 1.322 0 C-N-CA 122.041 1.827 . . . . 71.219999999999999 110.54 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -61.74 144.38 54.77 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 109.571 -0.529 . . . . 75.430000000000007 109.571 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.3 p -91.52 136.26 24.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 C-N-CA 120.348 -0.541 . . . . 62.100000000000001 110.114 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.5 0 N-CA-C 108.118 -1.068 . . . . 73.329999999999998 108.118 177.309 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 120.573 0.225 . . . . 60.100000000000001 110.525 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.7 mtt -92.32 155.76 17.72 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.306 -0.627 . . . . 75.120000000000005 109.306 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.6 t -78.32 136.22 24.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.492 -0.929 . . . . 74.019999999999996 108.492 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.444 ' O ' HG12 ' A' ' 21' ' ' VAL . 19.4 m -56.82 -39.36 74.05 Favored 'General case' 0 C--O 1.215 -0.751 0 C-N-CA 123.141 0.576 . . . . 71.099999999999994 110.9 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.52 -40.15 93.58 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.454 0.645 . . . . 73.319999999999993 111.387 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.52 -37.09 79.73 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.648 -0.871 . . . . 75.299999999999997 108.648 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -68.71 -42.41 77.73 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 115.873 -0.603 . . . . 71.450000000000003 110.627 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.695 HG13 ' SG ' ' A' ' 132' ' ' CYS . 13.2 m -69.92 -41.28 79.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.027 -0.533 . . . . 75.129999999999995 111.617 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.54 ' HZ1' ' HB3' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -77.33 -24.94 50.73 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 118.907 -1.117 . . . . 75.040000000000006 110.018 -178.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.07 -55.16 11.04 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 121.017 -0.611 . . . . 73.530000000000001 111.583 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.36 -35.26 71.07 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.244 -1.021 . . . . 75.349999999999994 108.244 -178.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.7 -43.57 97.69 Favored Glycine 0 N--CA 1.432 -1.583 0 O-C-N 123.936 0.772 . . . . 75.439999999999998 112.003 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -69.41 -42.07 75.57 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 120.841 -0.344 . . . . 75.450000000000003 110.82 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -63.16 -46.11 88.69 Favored 'General case' 0 C--O 1.253 1.262 0 N-CA-C 109.671 -0.492 . . . . 74.200000000000003 109.671 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.498 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 30.4 t80 -62.64 -53.12 59.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.923 -1.035 . . . . 74.420000000000002 110.61 177.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 29' ' ' ILE . 6.8 mm -61.2 -38.86 80.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 111.974 0.361 . . . . 72.109999999999999 111.974 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.39 -49.76 76.3 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 123.155 0.284 . . . . 73.230000000000004 110.307 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.3 pp -67.99 -29.6 68.66 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 120.562 -0.455 . . . . 75.120000000000005 111.121 -176.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.2 t -72.53 -27.71 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.401 0.62 . . . . 70.409999999999997 110.264 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.6 p -111.05 22.56 15.14 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.701 0.763 . . . . 72.230000000000004 109.115 -177.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -63.4 136.51 57.68 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.27 -1.332 . . . . 74.340000000000003 109.116 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -57.59 153.91 27.54 Favored Pre-proline 0 N--CA 1.435 -1.177 0 O-C-N 124.14 0.9 . . . . 74.109999999999999 110.72 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.79 -7.32 4.29 Favored 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 124.239 3.293 . . . . 74.239999999999995 113.093 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.73 -27.54 68.79 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.346 -0.843 . . . . 75.340000000000003 109.04 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.2 t -94.86 123.25 38.22 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 105.387 -2.079 . . . . 74.030000000000001 105.387 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.8 t -57.92 -48.06 84.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 123.566 0.541 . . . . 71.310000000000002 112.299 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -141.12 114.53 8.77 Favored 'General case' 0 N--CA 1.417 -2.106 0 C-N-CA 118.12 -1.432 . . . . 73.319999999999993 111.785 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.0 m -60.53 -32.64 71.66 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 123.203 0.601 . . . . 72.219999999999999 110.686 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -24.24 67.38 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.105 0.962 . . . . 74.120000000000005 110.791 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -70.62 -42.84 70.38 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 108.425 -0.954 . . . . 73.109999999999999 108.425 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -71.79 -30.57 65.68 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 114.535 -1.211 . . . . 55.530000000000001 108.841 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.6 tp -70.13 -41.51 73.82 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.631 -0.713 . . . . 75.349999999999994 110.091 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.56 -34.76 77.58 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.607 0.718 . . . . 63.5 109.694 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -68.72 -39.25 80.5 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.885 -1.052 . . . . 75.329999999999998 109.675 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -67.78 -41.45 83.2 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.773 -0.649 . . . . 75.200000000000003 111.238 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.4 pp -82.06 -4.16 56.22 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.074 -0.512 . . . . 74.5 111.254 -177.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -47.07 -58.21 6.47 Favored Glycine 0 C--O 1.213 -1.189 0 O-C-N 123.742 0.652 . . . . 64.209999999999994 112.863 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.79 -3.35 9.03 Favored 'Trans proline' 0 CA--C 1.556 1.6 0 C-N-CA 123.811 3.007 . . . . 71.0 113.074 172.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 69.1 m-70 -125.5 38.11 4.24 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 122.878 0.471 . . . . 64.420000000000002 109.837 -167.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.428 ' CB ' HG22 ' A' ' 65' ' ' THR . 7.1 m-20 -53.65 107.46 0.86 Allowed Pre-proline 0 C--N 1.321 -0.673 0 C-N-CA 126.25 1.82 . . . . 71.519999999999996 112.806 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -100.66 -164.96 0.06 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 123.118 2.545 . . . . 71.129999999999995 111.054 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -98.69 119.52 37.57 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 107.302 -1.37 . . . . 73.310000000000002 107.302 174.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.45 HD11 ' HA ' ' A' ' 65' ' ' THR . 72.1 mt -100.04 112.29 32.15 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.627 0 N-CA-C 109.102 -0.703 . . . . 72.109999999999999 109.102 -174.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -97.7 106.22 18.5 Favored 'General case' 0 C--N 1.283 -2.322 0 O-C-N 121.855 -0.528 . . . . 75.120000000000005 111.722 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.423 HG22 HG23 ' A' ' 56' ' ' ILE . 73.2 t -116.81 124.21 72.62 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 108.131 -1.063 . . . . 63.520000000000003 108.131 -175.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.0 m120 66.13 19.61 11.13 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 124.563 1.164 . . . . 72.510000000000005 109.291 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.81 11.85 78.56 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.567 -0.742 . . . . 74.409999999999997 111.291 -176.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -113.69 139.94 48.65 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 122.869 0.468 . . . . 74.340000000000003 110.196 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.21 125.5 35.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.997 0.903 . . . . 74.409999999999997 109.054 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -124.05 142.98 50.72 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.224 -1.028 . . . . 75.5 108.224 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 t -82.05 170.09 15.95 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.156 -1.053 . . . . 71.129999999999995 108.156 173.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.45 ' HA ' HD11 ' A' ' 56' ' ' ILE . 64.3 p -65.64 -34.08 77.38 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 123.843 0.857 . . . . 73.140000000000001 110.357 -176.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.9 m -65.05 -40.57 94.96 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.428 -1.26 . . . . 71.450000000000003 110.307 175.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.42 -46.49 79.74 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 116.169 -0.469 . . . . 71.150000000000006 109.809 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.416 ' CB ' HD13 ' A' ' 56' ' ' ILE . 48.9 t80 -52.06 -54.86 25.15 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 123.459 0.474 . . . . 73.299999999999997 109.963 174.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -50.82 -41.5 57.51 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.412 1.07 . . . . 73.340000000000003 110.774 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.455 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 45.8 mt-30 -63.08 -48.16 79.83 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 116.311 -0.404 . . . . 63.420000000000002 111.82 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.445 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 40.0 m-85 -69.33 -30.17 68.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.831 0.824 . . . . 75.010000000000005 109.739 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -61.32 -51.84 67.16 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.883 -1.053 . . . . 75.420000000000002 110.432 175.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 12.4 ptm180 -71.56 -21.7 61.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.128 0.489 . . . . 74.549999999999997 110.401 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 96.1 mt-30 -77.49 -3.29 39.77 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.041 -0.527 . . . . 74.0 111.538 173.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.05 22.37 63.55 Favored Glycine 0 N--CA 1.438 -1.215 0 CA-C-N 116.315 -0.402 . . . . 73.430000000000007 113.262 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.2 mt -83.51 -41.4 18.02 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.02 -0.672 . . . . 62.140000000000001 111.066 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.445 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 22.9 m-85 -100.91 -6.88 24.04 Favored 'General case' 0 C--O 1.185 -2.335 0 C-N-CA 119.845 -0.742 . . . . 75.340000000000003 112.838 -178.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -12.72 36.42 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 122.009 0.909 . . . . 74.140000000000001 112.847 -175.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HZ3' ' CG ' ' A' ' 118' ' ' ASP . 17.3 pttp -82.2 -9.6 59.45 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.229 -0.896 . . . . 75.239999999999995 112.536 176.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.498 HD13 ' O ' ' A' ' 80' ' ' LEU . 3.2 tm? -77.9 -14.96 59.38 Favored 'General case' 0 C--O 1.208 -1.113 0 C-N-CA 123.26 0.624 . . . . 73.409999999999997 110.906 -175.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -53.31 -19.05 2.9 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 114.39 1.255 . . . . 75.230000000000004 114.39 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -100.01 10.86 40.61 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 120.977 0.418 . . . . 73.349999999999994 110.682 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 104' ' ' LYS . . . -68.87 146.06 53.16 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.343 0.868 . . . . 64.439999999999998 113.343 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -114.41 156.72 23.97 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.484 -1.235 . . . . 64.549999999999997 107.71 178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.53 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 38.0 p90 -107.26 132.34 53.2 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.202 0.816 . . . . 75.129999999999995 113.202 -173.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.89 119.18 38.39 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.634 -1.247 . . . . 62.200000000000003 107.634 175.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.8 pt -82.83 113.53 22.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-O 121.898 0.856 . . . . 73.25 112.033 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -83.07 139.51 33.19 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.547 -0.908 . . . . 71.430000000000007 108.547 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 m -86.17 166.22 2.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 109.762 -0.458 . . . . 62.439999999999998 109.762 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -76.29 -36.34 58.41 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 120.761 0.315 . . . . 71.239999999999995 110.814 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.69 -65.25 3.73 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 116.006 -0.543 . . . . 51.520000000000003 112.145 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.29 132.07 21.31 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 106.992 -1.484 . . . . 74.349999999999994 106.992 -178.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.59 117.82 5.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 121.47 0.652 . . . . 75.219999999999999 110.05 175.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -126.77 141.12 51.92 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.577 -1.268 . . . . 75.299999999999997 107.577 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -69.87 136.01 50.2 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.276 -0.638 . . . . 71.519999999999996 109.276 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.48 54.3 0.58 Allowed Glycine 0 N--CA 1.427 -1.924 0 N-CA-C 106.952 -2.459 . . . . 64.209999999999994 106.952 -171.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -64.38 124.93 23.04 Favored 'General case' 0 CA--C 1.482 -1.649 0 CA-C-N 114.183 -1.009 . . . . 73.450000000000003 111.787 -173.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -158.99 161.57 32.04 Favored Glycine 1 N--CA 1.391 -4.32 0 CA-C-N 114.638 -1.165 . . . . 54.130000000000003 110.381 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -107.22 123.23 47.99 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.234 -1.024 . . . . 75.219999999999999 108.234 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -117.86 103.4 9.93 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.22 -1.03 . . . . 75.319999999999993 108.22 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 87.2 mt -124.63 158.16 33.75 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 110.092 -0.336 . . . . 75.540000000000006 110.092 -177.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 8.3 p -133.68 134.51 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.439 0.638 . . . . 71.310000000000002 111.954 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.53 ' NE1' ' HB3' ' A' ' 85' ' ' PHE . 14.6 m-90 -106.82 147.66 29.45 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 124.318 1.047 . . . . 74.510000000000005 109.5 177.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 83' ' ' ALA . 62.6 mttm -127.91 126.49 41.6 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.016 -0.735 . . . . 74.329999999999998 109.016 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.6 t -75.81 179.29 5.56 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 109.945 -0.391 . . . . 73.209999999999994 109.945 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.62 167.43 19.24 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 122.655 0.382 . . . . 52.219999999999999 110.21 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.26 110.86 1.76 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.474 0.654 . . . . 71.430000000000007 110.647 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -93.89 127.4 39.63 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.925 -1.139 . . . . 65.099999999999994 107.925 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -72.12 141.08 49.16 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.732 -0.667 . . . . 74.329999999999998 111.134 -177.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.2 m -131.96 150.11 52.25 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.522 -0.918 . . . . 70.510000000000005 108.522 -176.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -66.7 -9.35 35.45 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.548 0.689 . . . . 72.420000000000002 111.919 -176.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -92.25 -1.74 56.91 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.066 -0.97 . . . . 73.319999999999993 110.446 -178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 70.12 15.68 7.58 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.741 1.258 . . . . 74.129999999999995 110.264 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 0.1 OUTLIER -96.41 159.03 15.16 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 107.508 -1.293 . . . . 74.099999999999994 107.508 174.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 22.3 pt -109.16 130.77 61.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 109.019 -0.734 . . . . 73.219999999999999 109.019 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 47.8 mtm180 -121.6 171.3 8.93 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.383 -0.969 . . . . 74.230000000000004 108.383 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -163.08 173.58 13.34 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.551 -0.907 . . . . 75.129999999999995 108.551 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.48 ' CG ' ' HZ3' ' A' ' 79' ' ' LYS . 7.1 m-20 -114.13 138.29 50.62 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.922 -1.51 . . . . 70.299999999999997 106.922 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.579 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 44.7 mt-10 -115.16 143.49 45.14 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.143 0.497 . . . . 75.319999999999993 109.927 175.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -129.43 120.94 26.33 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.724 -0.671 . . . . 74.450000000000003 110.877 -174.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 35.0 mt-10 -111.18 110.06 20.4 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.66 -0.496 . . . . 75.209999999999994 109.66 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.44 134.27 38.46 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 120.841 0.353 . . . . 74.049999999999997 110.401 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -118.5 120.17 36.72 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.437 1.095 . . . . 74.519999999999996 108.661 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.79 148.79 21.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 106.131 -1.803 . . . . 74.400000000000006 106.131 175.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -128.49 146.9 50.68 Favored 'General case' 0 C--O 1.262 1.742 0 C-N-CA 119.109 -1.036 . . . . 74.430000000000007 110.095 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -81.02 112.82 18.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.689 -1.226 . . . . 75.349999999999994 107.689 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.1 136.32 33.61 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 105.835 -1.913 . . . . 73.299999999999997 105.835 -175.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.98 -10.55 14.2 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-O 121.531 0.682 . . . . 73.25 111.889 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -72.01 -16.04 62.05 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.552 0.692 . . . . 74.230000000000004 109.644 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.68 -11.7 27.75 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.599 -0.81 . . . . 73.319999999999993 113.493 175.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 24.4 t -105.18 169.39 8.47 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 107.254 -1.387 . . . . 73.349999999999994 107.254 176.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.695 ' SG ' HG13 ' A' ' 21' ' ' VAL . 14.9 p -119.19 145.22 46.2 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 107.634 -1.247 . . . . 72.150000000000006 107.634 173.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -140.66 155.68 46.44 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.738 -0.838 . . . . 73.329999999999998 108.738 -176.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.11 125.11 25.81 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.54 0.686 . . . . 65.329999999999998 110.256 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -81.04 -57.39 3.55 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.701 -1.136 . . . . 74.430000000000007 108.034 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.8 m -166.16 157.13 13.11 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.237 -1.394 . . . . 55.229999999999997 107.237 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.6 135.98 43.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 106.862 -1.532 . . . . 71.310000000000002 106.862 171.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -108.99 136.12 49.04 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 122.731 0.412 . . . . 72.030000000000001 110.136 -174.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.415 ' HB2' HG23 ' A' ' 58' ' ' VAL . 62.6 m-85 -120.95 113.98 20.88 Favored 'General case' 0 C--O 1.255 1.352 0 CA-C-O 121.344 0.593 . . . . 74.420000000000002 109.671 176.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 13.9 pt -110.7 97.79 6.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-O 122.532 1.158 . . . . 74.150000000000006 109.248 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 19.8 ptm -101.31 93.77 5.59 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.163 -1.38 . . . . 73.230000000000004 110.164 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.0 m 160.8 19.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 127.004 2.122 . . . . 64.219999999999999 111.65 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.579 ' HG2' ' OE1' ' A' ' 119' ' ' GLU . 50.3 tptt -80.67 136.1 36.14 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.079 -1.452 . . . . 74.150000000000006 107.079 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -155.55 142.28 18.87 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 112.714 0.635 . . . . 73.299999999999997 112.714 -174.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.67 158.87 32.91 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 107.593 -1.262 . . . . 61.43 107.593 172.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -49.42 135.32 32.59 Favored 'Trans proline' 0 C--N 1.358 1.026 0 C-N-CA 123.274 2.65 . . . . 74.329999999999998 112.626 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.407 ' HB3' ' HB3' ' A' ' 114' ' ' LYS . 50.0 p90 -61.5 155.61 21.52 Favored 'General case' 0 C--O 1.251 1.146 0 C-N-CA 123.697 0.799 . . . . 75.030000000000001 112.046 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 29.7 m -80.22 129.87 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 CA-C-N 115.738 -0.665 . . . . 61.549999999999997 109.32 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.284 -2.271 0 N-CA-C 106.287 -1.746 . . . . 51.219999999999999 106.287 177.748 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 CA--C 1.509 -0.622 0 N-CA-C 110.06 -0.348 . . . . 61.299999999999997 110.06 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 51.6 ttm -73.63 -27.29 61.19 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.623 0.725 . . . . 74.120000000000005 111.154 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.9 p -61.51 -33.2 56.01 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-N 114.571 -1.195 . . . . 74.120000000000005 110.663 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.2 m -68.02 -39.59 83.13 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.381 -0.6 . . . . 73.510000000000005 109.381 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.42 -35.22 73.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.916 -0.584 . . . . 73.120000000000005 110.019 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.96 -39.55 94.99 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.138 -1.06 . . . . 64.310000000000002 108.138 175.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.35 -42.11 84.06 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.146 -0.934 . . . . 73.430000000000007 109.893 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 17' ' ' THR . 58.8 t -65.22 -45.1 94.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.514 -0.766 . . . . 72.340000000000003 111.082 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -70.89 -25.95 63.01 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.732 -0.387 . . . . 71.239999999999995 110.28 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.83 -45.41 58.02 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.214 -1.154 . . . . 62.350000000000001 110.214 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.4 tp -62.89 -50.15 72.0 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 124.579 1.152 . . . . 73.430000000000007 109.791 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.23 -43.24 98.68 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.656 -0.702 . . . . 72.439999999999998 112.017 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -66.17 -39.6 89.86 Favored 'General case' 0 C--O 1.211 -0.928 0 CA-C-O 119.22 -0.419 . . . . 73.239999999999995 111.218 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -60.62 -46.41 90.39 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.829 -0.804 . . . . 75.510000000000005 108.829 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.487 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 38.5 t80 -61.64 -53.74 52.18 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 114.377 -1.283 . . . . 73.219999999999999 110.424 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.9 mm -62.02 -36.17 72.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 112.464 0.542 . . . . 72.209999999999994 112.464 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.35 -41.16 81.08 Favored 'General case' 0 CA--C 1.491 -1.306 0 C-N-CA 120.333 -0.547 . . . . 73.209999999999994 109.864 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.543 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.8 pp -70.44 -28.03 64.72 Favored 'General case' 0 N--CA 1.421 -1.876 0 C-N-CA 119.498 -0.881 . . . . 74.340000000000003 111.761 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.1 t -70.62 -24.58 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 121.315 0.579 . . . . 73.150000000000006 109.653 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.5 p -115.18 21.85 13.83 Favored 'General case' 0 C--O 1.244 0.773 0 O-C-N 122.071 -0.393 . . . . 74.340000000000003 111.296 -176.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.543 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 53.2 mmtt -44.24 149.34 0.37 Allowed 'General case' 0 C--O 1.245 0.843 0 N-CA-C 115.808 1.781 . . . . 74.099999999999994 115.808 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 m -60.7 154.23 58.32 Favored Pre-proline 0 N--CA 1.423 -1.782 0 CA-C-N 112.981 -1.918 . . . . 70.129999999999995 108.191 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.04 -8.9 8.84 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 123.5 2.8 . . . . 71.150000000000006 112.941 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.8 -27.35 64.82 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.567 0.699 . . . . 73.549999999999997 109.878 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.7 m -118.21 81.43 1.68 Allowed 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 107.817 -1.179 . . . . 72.040000000000006 107.817 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -81.21 -5.3 8.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-O 122.258 1.028 . . . . 64.0 110.091 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -115.67 78.14 1.15 Allowed 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 107.414 -1.328 . . . . 74.439999999999998 107.414 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.6 m -66.43 -25.54 66.79 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 113.979 -1.464 . . . . 74.439999999999998 110.906 -173.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 6.5 pm0 -68.5 -22.98 64.51 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.616 -0.72 . . . . 73.129999999999995 110.533 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -63.94 -49.87 70.91 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.573 -0.899 . . . . 73.129999999999995 108.573 176.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -65.26 -38.24 89.69 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.439 -1.255 . . . . 73.239999999999995 109.96 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.6 tp -65.25 -42.96 92.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 116.429 -0.351 . . . . 74.340000000000003 110.73 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.13 -32.33 73.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.296 0.569 . . . . 75.340000000000003 110.435 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -74.2 -36.78 64.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.439 -0.8 . . . . 71.420000000000002 109.496 178.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 68.4 t80 -67.97 -42.95 80.09 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.189 0.996 . . . . 75.310000000000002 111.04 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 pp -81.3 -5.34 57.7 Favored 'General case' 0 C--O 1.204 -1.316 0 CA-C-N 115.907 -0.588 . . . . 72.120000000000005 111.138 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.54 -54.4 6.54 Favored Glycine 0 CA--C 1.545 1.92 0 CA-C-N 115.895 -0.593 . . . . 63.340000000000003 113.781 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -85.41 -3.56 9.34 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 123.356 2.704 . . . . 61.240000000000002 112.941 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -128.75 31.53 4.94 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.992 -0.443 . . . . 55.0 110.595 -168.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -56.0 111.91 3.72 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.132 0.973 . . . . 71.310000000000002 112.559 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -105.57 -159.68 0.03 OUTLIER 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 123.631 2.888 . . . . 72.129999999999995 111.367 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -89.16 124.11 34.04 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 108.189 -1.041 . . . . 74.519999999999996 108.189 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.45 HD13 ' CB ' ' A' ' 68' ' ' PHE . 59.6 mt -107.0 112.48 40.12 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.179 0 N-CA-C 107.447 -1.316 . . . . 74.129999999999995 107.447 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -98.18 136.14 38.82 Favored 'General case' 0 C--N 1.263 -3.166 0 O-C-N 121.468 -0.77 . . . . 74.099999999999994 109.108 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.0 t -132.38 117.34 31.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 107.286 -1.375 . . . . 74.109999999999999 107.286 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 65.47 20.99 11.8 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.5 1.12 . . . . 74.430000000000007 109.893 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.59 3.25 84.09 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.903 -1.044 . . . . 75.310000000000002 111.454 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -99.97 130.91 46.19 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 108.14 -1.059 . . . . 72.519999999999996 108.14 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.4 HD13 ' N ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -68.51 124.28 23.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 122.325 1.06 . . . . 74.219999999999999 110.549 -176.37 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.4 ' N ' HD13 ' A' ' 62' ' ' ILE . 61.7 mm-40 -123.55 143.06 50.43 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 107.315 -1.365 . . . . 73.409999999999997 107.315 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.1 t -87.42 171.3 10.66 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 109.023 -0.732 . . . . 74.310000000000002 109.023 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.3 t -53.83 -36.21 62.29 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.107 0.963 . . . . 74.439999999999998 111.426 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.493 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 16.4 m -61.91 -50.45 72.14 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 122.971 0.509 . . . . 75.340000000000003 110.35 178.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.37 -47.79 82.68 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 123.598 0.759 . . . . 73.209999999999994 110.744 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CB ' HD13 ' A' ' 56' ' ' ILE . 60.5 t80 -54.38 -55.31 29.92 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 123.755 0.659 . . . . 74.549999999999997 110.267 176.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -51.98 -40.76 61.44 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.187 0.929 . . . . 73.239999999999995 110.512 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 66' ' ' THR . 44.9 mt-30 -62.19 -49.07 77.28 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 116.577 -0.283 . . . . 74.129999999999995 111.118 176.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.0 -36.56 84.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.649 0.738 . . . . 71.329999999999998 110.092 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -59.2 -54.65 44.5 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 124.303 1.041 . . . . 74.299999999999997 110.971 176.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 7.8 ptm180 -68.76 -24.5 64.45 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.371 -0.377 . . . . 75.129999999999995 110.58 -176.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -86.38 -0.48 56.03 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.304 0.483 . . . . 71.040000000000006 112.304 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.72 13.29 61.29 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 115.391 0.916 . . . . 52.310000000000002 115.391 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.77 -39.69 94.03 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 112.701 0.63 . . . . 74.150000000000006 112.701 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -89.75 -2.02 58.15 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.537 0.569 . . . . 72.030000000000001 112.537 -174.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.49 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 98.9 mttt -65.78 -14.62 61.72 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.732 0.641 . . . . 75.129999999999995 112.732 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -76.79 -37.66 55.4 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.373 0.606 . . . . 74.420000000000002 110.029 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.503 HD23 ' O ' ' A' ' 80' ' ' LEU . 3.6 tt -88.88 5.56 43.3 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.031 -0.986 . . . . 74.230000000000004 110.85 -168.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -12.17 52.54 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.303 0.853 . . . . 75.109999999999999 113.303 -176.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.67 -36.51 51.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.574 0.702 . . . . 73.040000000000006 109.341 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 34.81 114.59 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 118.67 2.841 . . . . 74.0 118.67 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -113.77 123.39 49.72 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 113.847 -1.524 . . . . 74.409999999999997 107.537 173.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -83.61 138.04 33.54 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.252 -0.979 . . . . 75.540000000000006 112.301 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.11 115.37 30.15 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 106.737 -1.579 . . . . 74.239999999999995 106.737 175.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.1 pt -69.78 113.86 6.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-O 122.526 1.155 . . . . 73.439999999999998 113.949 -173.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -118.32 136.62 53.61 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 104.814 -2.291 . . . . 74.349999999999994 104.814 174.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.7 m -94.41 146.05 7.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 115.312 1.597 . . . . 74.409999999999997 115.312 -166.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.9 t -143.65 122.14 12.45 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 103.568 -2.753 . . . . 71.230000000000004 103.568 173.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.02 158.8 48.62 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 121.168 -0.539 . . . . 70.349999999999994 111.754 -176.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -81.77 45.08 0.87 Allowed 'General case' 0 C--O 1.253 1.259 0 CA-C-O 121.26 0.552 . . . . 72.299999999999997 110.075 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.69 124.73 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 CA-C-N 115.351 -0.841 . . . . 74.310000000000002 109.666 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -64.11 -22.88 67.11 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.449 -0.796 . . . . 71.450000000000003 111.44 -174.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -76.51 -25.97 54.75 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.019 0.438 . . . . 75.409999999999997 110.703 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.96 140.84 8.37 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.795 -0.639 . . . . 71.310000000000002 113.069 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -147.87 177.4 9.37 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.176 -1.416 . . . . 74.150000000000006 107.176 175.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 125' ' ' TRP . . . -80.93 152.78 33.54 Favored Glycine 0 N--CA 1.425 -2.034 0 C-N-CA 120.266 -0.969 . . . . 65.340000000000003 112.752 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -106.95 134.95 49.32 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.309 -1.367 . . . . 65.319999999999993 107.309 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 100' ' ' LYS . 7.7 mptt -124.21 102.59 7.78 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.433 -1.321 . . . . 74.310000000000002 107.433 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 96.0 mt -119.22 141.02 49.27 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 120.457 -0.497 . . . . 74.109999999999999 109.978 -176.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 121' ' ' GLU . 20.3 t -122.9 135.39 63.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.941 -0.392 . . . . 74.409999999999997 109.941 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -120.38 141.42 50.11 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.38 -0.97 . . . . 75.409999999999997 108.38 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -114.96 144.33 43.75 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 109.304 -0.628 . . . . 73.140000000000001 109.304 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.9 t -68.96 166.23 18.37 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 124.165 0.986 . . . . 74.040000000000006 108.625 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.68 150.64 47.7 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.638 -0.875 . . . . 70.019999999999996 108.638 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.09 108.89 3.27 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.554 -0.535 . . . . 75.310000000000002 109.554 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -94.22 135.15 35.93 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.606 -0.725 . . . . 75.209999999999994 109.103 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -68.11 119.71 13.15 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 123.547 0.53 . . . . 71.420000000000002 109.895 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.1 t -96.19 162.45 13.52 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.05 -1.093 . . . . 74.120000000000005 108.05 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -62.57 -27.69 69.36 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.05 0.54 . . . . 74.519999999999996 111.716 -176.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.74 5.39 18.68 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.056 0.542 . . . . 64.409999999999997 110.615 -175.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 76.63 9.9 2.89 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.866 1.266 . . . . 74.239999999999995 109.953 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -96.69 174.7 6.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 109.045 -0.724 . . . . 72.230000000000004 109.045 177.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.96 133.54 59.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 109.547 -0.538 . . . . 74.200000000000003 109.547 178.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -115.01 155.44 26.96 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.688 -0.856 . . . . 75.519999999999996 108.688 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 46.2 p90 -156.04 149.38 24.63 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.633 -0.877 . . . . 74.239999999999995 108.633 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -102.55 141.14 35.87 Favored 'General case' 0 C--N 1.264 -3.15 0 N-CA-C 106.653 -1.61 . . . . 65.540000000000006 106.653 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.495 ' CD ' ' HG3' ' A' ' 143' ' ' LYS . 93.5 mt-10 -114.94 141.39 48.02 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.484 -0.486 . . . . 74.329999999999998 110.005 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.72 121.77 31.19 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.838 -0.619 . . . . 71.510000000000005 109.565 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.429 ' HB3' HG21 ' A' ' 102' ' ' VAL . 14.5 pt-20 -123.77 115.33 21.2 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-O 121.626 0.726 . . . . 63.350000000000001 111.784 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.31 135.7 35.43 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.891 -1.049 . . . . 72.420000000000002 109.891 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -117.28 117.47 29.64 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.431 -0.951 . . . . 74.5 108.431 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.525 HG22 ' SG ' ' A' ' 132' ' ' CYS . 54.4 mt -119.76 128.87 75.92 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 N-CA-C 105.533 -2.025 . . . . 75.219999999999999 105.533 176.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.45 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 0.2 OUTLIER -110.89 145.18 38.74 Favored 'General case' 0 N--CA 1.425 -1.723 0 C-N-CA 117.373 -1.731 . . . . 74.420000000000002 110.536 -177.223 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -103.84 118.26 36.27 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 107.711 -1.218 . . . . 75.010000000000005 107.711 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -75.9 155.67 35.0 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.205 -1.361 . . . . 75.049999999999997 109.422 -174.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -60.12 -22.57 62.97 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.011 0.91 . . . . 74.510000000000005 110.106 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.69 -13.37 54.12 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.703 1.201 . . . . 72.310000000000002 111.336 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.77 -23.71 34.68 Favored Glycine 0 CA--C 1.498 -1.001 0 N-CA-C 111.22 -0.752 . . . . 54.25 111.22 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.0 p -78.37 159.58 28.28 Favored 'General case' 0 N--CA 1.408 -2.565 0 C-N-CA 124.06 0.944 . . . . 74.430000000000007 110.392 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.525 ' SG ' HG22 ' A' ' 124' ' ' ILE . 7.7 t -135.49 143.7 45.96 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 108.889 -0.782 . . . . 75.209999999999994 108.889 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -153.85 156.17 37.11 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.966 -1.124 . . . . 72.209999999999994 107.966 -176.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.0 mp -68.81 127.9 34.74 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.834 -0.432 . . . . 74.329999999999998 109.834 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -87.02 -52.26 5.54 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.902 0.858 . . . . 72.140000000000001 108.767 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.8 p -174.93 162.02 3.07 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.324 -1.307 . . . . 63.030000000000001 108.131 -175.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.6 m -137.08 144.44 32.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 N-CA-C 106.342 -1.725 . . . . 73.209999999999994 106.342 172.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -124.65 130.6 52.73 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 120.674 -0.41 . . . . 72.120000000000005 110.78 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -109.97 127.75 54.98 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.573 -1.269 . . . . 64.030000000000001 107.573 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.7 pt -126.82 99.01 5.12 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-O 121.932 0.872 . . . . 73.239999999999995 111.803 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -86.05 92.25 8.65 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 105.402 -2.073 . . . . 75.109999999999999 105.402 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.7 m -165.66 3.35 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.277 -0.42 . . . . 64.310000000000002 112.01 -176.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.495 ' HG3' ' CD ' ' A' ' 119' ' ' GLU . 28.1 mmtp -96.21 129.15 43.59 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 119.57 -0.852 . . . . 73.409999999999997 111.935 -176.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.18 109.03 0.29 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.448 -1.251 . . . . 74.219999999999999 109.476 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.36 138.47 81.2 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 109.045 -0.724 . . . . 74.349999999999994 109.045 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.24 140.56 71.97 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.591 2.194 . . . . 65.310000000000002 110.468 176.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -70.57 161.29 30.95 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.586 0.707 . . . . 74.120000000000005 111.559 -176.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.92 155.95 15.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 107.593 -1.262 . . . . 75.049999999999997 107.593 173.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.757 0 N-CA-C 108.623 -0.881 . . . . 75.200000000000003 108.623 -179.835 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 t70 . . . . . 0 CA--C 1.505 -0.788 0 CA-C-O 120.678 0.275 . . . . 64.439999999999998 110.457 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.5 mtt -95.17 107.69 19.79 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.873 -0.788 . . . . 74.310000000000002 108.873 175.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.9 t -76.16 140.2 17.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 105.569 -2.011 . . . . 74.120000000000005 105.569 173.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.607 ' O ' HG22 ' A' ' 21' ' ' VAL . 9.4 p -55.45 -42.97 74.97 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 118.594 0.634 . . . . 72.230000000000004 111.366 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.15 -37.91 89.17 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-O 121.726 0.774 . . . . 73.209999999999994 110.964 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.36 -33.32 72.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.918 -1.142 . . . . 73.219999999999999 107.918 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -69.98 -38.95 76.18 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.185 -0.916 . . . . 75.030000000000001 109.728 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 17' ' ' THR . 61.9 t -58.32 -53.89 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 123.507 0.504 . . . . 75.340000000000003 110.011 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.06 -32.78 74.2 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.874 -0.731 . . . . 72.340000000000003 111.413 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.86 -37.24 83.6 Favored Glycine 0 C--O 1.229 -0.161 0 N-CA-C 111.465 -0.654 . . . . 64.340000000000003 111.465 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.7 tp -65.45 -46.48 79.68 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 124.102 0.961 . . . . 74.430000000000007 108.663 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.46 -41.27 99.79 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.167 -0.924 . . . . 74.230000000000004 111.577 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -61.71 -42.28 98.74 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 122.731 0.412 . . . . 70.310000000000002 110.737 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -64.55 -47.71 77.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.356 0.598 . . . . 64.310000000000002 109.407 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -61.43 -51.59 68.09 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.309 -1.314 . . . . 61.240000000000002 110.42 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 29' ' ' ILE . 15.3 mm -64.82 -32.28 57.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 116.24 -0.436 . . . . 53.509999999999998 111.687 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.31 -43.0 71.23 Favored 'General case' 0 CA--C 1.479 -1.784 0 C-N-CA 119.761 -0.775 . . . . 73.400000000000006 109.99 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.674 ' O ' ' HB3' ' A' ' 41' ' ' SER . 4.1 pp -70.53 -26.03 63.38 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 119.912 -0.715 . . . . 73.129999999999995 112.045 -178.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.0 t -70.25 -28.02 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 121.453 0.644 . . . . 64.420000000000002 109.777 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.9 p -114.21 23.66 12.67 Favored 'General case' 0 C--O 1.25 1.111 0 N-CA-C 109.148 -0.686 . . . . 73.299999999999997 109.148 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.496 ' HD3' ' HA ' ' A' ' 31' ' ' LEU . 27.4 tptt -52.8 137.56 31.48 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.342 -1.299 . . . . 73.219999999999999 111.684 -173.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.0 p -40.72 138.89 1.22 Allowed Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 125.411 1.484 . . . . 72.450000000000003 112.576 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -57.3 -15.22 18.06 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 123.545 2.83 . . . . 62.530000000000001 113.209 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.52 -27.94 68.96 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.921 0.867 . . . . 71.230000000000004 109.114 174.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.7 p -119.26 96.48 5.24 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 114.667 -1.151 . . . . 62.43 108.179 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.6 t -66.32 -50.03 71.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 113.348 0.87 . . . . 74.340000000000003 113.348 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.437 ' OD1' ' HB2' ' A' ' 43' ' ' HIS . 17.6 t-20 -89.72 80.76 6.51 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 123.111 1.434 . . . . 71.349999999999994 112.023 -171.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.674 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 15.8 m -67.2 -27.48 67.3 Favored 'General case' 0 C--O 1.255 1.374 0 CA-C-N 113.008 -1.906 . . . . 64.430000000000007 109.632 -175.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -68.52 -20.34 64.56 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 114.318 -1.31 . . . . 74.409999999999997 112.619 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.437 ' HB2' ' OD1' ' A' ' 40' ' ' ASN . 13.2 t60 -70.49 -38.46 74.35 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.19 -1.041 . . . . 72.209999999999994 108.19 175.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -66.57 -36.65 83.17 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.377 -0.972 . . . . 75.329999999999998 108.377 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.64 -43.18 97.54 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.671 -0.695 . . . . 74.450000000000003 110.722 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.01 79.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.31 0.576 . . . . 71.239999999999995 110.469 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -68.47 -39.12 81.52 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.443 -0.799 . . . . 73.030000000000001 109.698 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -69.4 -41.21 76.73 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 123.624 0.769 . . . . 73.310000000000002 111.084 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 49' ' ' LEU . 4.3 pp -79.52 -7.98 58.84 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-N 116.02 -0.536 . . . . 72.430000000000007 112.143 -176.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.05 -61.61 5.22 Favored Glycine 0 CA--C 1.541 1.687 0 C-N-CA 121.231 -0.509 . . . . 72.219999999999999 112.788 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -76.48 -4.92 15.61 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.118 2.545 . . . . 72.319999999999993 112.47 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -122.61 29.95 6.68 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.889 -0.507 . . . . 74.030000000000001 110.646 -173.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.556 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 6.2 t70 -55.83 106.8 0.72 Allowed Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 125.207 1.403 . . . . 72.150000000000006 113.274 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -107.33 -165.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 123.894 3.063 . . . . 64.329999999999998 112.803 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -87.85 115.58 25.41 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.077 -1.082 . . . . 72.510000000000005 108.077 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 53.4 mt -101.27 108.77 24.11 Favored 'Isoleucine or valine' 0 C--O 1.168 -3.217 0 N-CA-C 108.398 -0.964 . . . . 74.530000000000001 108.398 -176.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -93.55 135.91 34.35 Favored 'General case' 0 C--N 1.272 -2.788 0 O-C-N 121.397 -0.814 . . . . 74.140000000000001 108.998 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 55.7 t -133.49 116.93 25.95 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.951 -1.129 . . . . 74.140000000000001 107.951 177.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 61.89 20.5 11.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.126 1.37 . . . . 74.430000000000007 110.931 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.6 4.72 60.51 Favored Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.26 -0.882 . . . . 75.230000000000004 112.822 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -107.45 134.77 49.99 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 108.096 -1.076 . . . . 71.340000000000003 108.096 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.11 127.88 38.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.523 0.678 . . . . 75.439999999999998 109.247 -178.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -122.01 150.12 42.53 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.005 -1.109 . . . . 73.409999999999997 108.005 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 t -97.86 174.09 6.76 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.414 -0.958 . . . . 75.239999999999995 108.414 176.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.556 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 8.9 t -53.77 -35.22 61.08 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 122.816 0.446 . . . . 75.319999999999993 111.058 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.518 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 10.7 m -58.73 -56.0 27.86 Favored 'General case' 0 C--O 1.212 -0.897 0 O-C-N 123.5 0.5 . . . . 63.530000000000001 110.014 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.96 -48.03 82.99 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 123.493 0.496 . . . . 74.439999999999998 111.014 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -52.95 -56.86 12.85 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.464 0.478 . . . . 74.349999999999994 110.012 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -52.11 -42.87 63.63 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.716 -1.129 . . . . 73.140000000000001 110.857 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.8 mm100 -60.49 -48.77 80.32 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 122.797 0.439 . . . . 73.230000000000004 111.343 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.5 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 23.3 m-85 -66.41 -37.5 85.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.937 -0.764 . . . . 65.129999999999995 108.937 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -57.45 -53.37 58.89 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 123.762 0.825 . . . . 75.239999999999995 110.911 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -70.95 -19.2 62.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.118 0.485 . . . . 74.230000000000004 111.42 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -84.21 -9.91 58.14 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 112.972 0.731 . . . . 74.040000000000006 112.972 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.76 21.36 16.47 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 119.975 -1.107 . . . . 73.510000000000005 113.612 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.18 -49.7 9.19 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 122.255 -0.556 . . . . 74.329999999999998 110.78 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 62.4 m-85 -92.1 11.18 26.29 Favored 'General case' 0 C--O 1.193 -1.876 0 N-CA-C 113.333 0.864 . . . . 75.109999999999999 113.333 -175.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -12.35 59.96 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.391 0.885 . . . . 71.430000000000007 113.391 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -87.46 -10.05 52.92 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.648 -1.16 . . . . 74.409999999999997 111.779 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.7 tt -65.05 -26.24 68.17 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 122.505 0.322 . . . . 74.340000000000003 110.955 -173.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -60.86 -24.46 65.93 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.16 0.43 . . . . 75.010000000000005 112.16 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -105.16 13.65 30.35 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 112.108 0.41 . . . . 73.450000000000003 112.108 -178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 103' ' ' TRP . . . -70.17 126.46 29.75 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.414 0.626 . . . . 45.210000000000001 111.224 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -86.61 123.81 32.2 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.087 -0.96 . . . . 73.510000000000005 109.458 -177.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.457 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 39.7 p90 -87.45 135.31 33.39 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.238 0.542 . . . . 74.040000000000006 111.833 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.39 132.45 33.95 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 105.851 -1.907 . . . . 72.319999999999993 105.851 172.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.8 tp -83.79 74.32 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 122.706 1.241 . . . . 71.140000000000001 113.071 -173.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -89.27 99.95 12.84 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 104.406 -2.442 . . . . 73.230000000000004 104.406 170.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.3 p -112.98 97.46 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 113.912 1.079 . . . . 74.430000000000007 113.912 -173.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.0 m -83.37 -37.92 22.69 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 105.632 -1.988 . . . . 73.519999999999996 105.632 166.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.93 -115.76 4.82 Favored Glycine 0 CA--C 1.5 -0.849 0 CA-C-N 114.29 -1.323 . . . . 64.140000000000001 113.996 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -78.8 79.95 5.18 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.233 0.539 . . . . 72.439999999999998 111.807 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.8 m -120.07 110.69 29.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.04 -0.982 . . . . 70.099999999999994 108.484 173.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -91.84 79.71 5.3 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.106 -0.952 . . . . 72.120000000000005 109.49 -174.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.407 ' O ' ' HD2' ' A' ' 126' ' ' ARG . 8.7 tp10 -157.83 155.56 29.91 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.477 -1.238 . . . . 74.140000000000001 107.789 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.92 70.53 3.11 Favored Glycine 0 N--CA 1.429 -1.791 0 N-CA-C 110.718 -0.953 . . . . 72.109999999999999 110.718 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -127.43 177.03 7.01 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 122.549 0.34 . . . . 64.099999999999994 110.145 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 125' ' ' TRP . . . -100.0 148.89 18.63 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.649 -0.786 . . . . 70.430000000000007 113.214 -176.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -107.04 135.2 49.0 Favored 'General case' 0 C--O 1.25 1.111 0 N-CA-C 106.679 -1.6 . . . . 71.239999999999995 106.679 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -126.67 107.8 10.51 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.933 -0.766 . . . . 74.540000000000006 108.933 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.3 mt -114.57 138.14 51.0 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.082 -1.081 . . . . 73.400000000000006 108.082 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 11.8 p -127.26 137.69 57.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.572 0.701 . . . . 73.109999999999999 111.715 -177.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.457 ' NE1' ' HB3' ' A' ' 85' ' ' PHE . 17.4 m-90 -118.49 157.18 27.74 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.833 -1.076 . . . . 73.340000000000003 109.622 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.12 121.35 40.33 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.884 -1.895 . . . . 63.420000000000002 105.884 170.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.4 t -75.2 -166.91 0.55 Allowed 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 115.777 -0.647 . . . . 70.030000000000001 110.917 -174.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.41 124.1 19.31 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.979 -0.555 . . . . 75.120000000000005 112.359 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.77 124.42 28.59 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.396 -1.335 . . . . 74.519999999999996 107.396 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -131.26 136.19 47.98 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.934 -0.575 . . . . 74.420000000000002 110.233 -171.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.5 mtp85 -80.52 111.49 16.99 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.853 -0.795 . . . . 75.209999999999994 108.853 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.6 t -84.44 170.73 13.24 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.169 -0.923 . . . . 72.329999999999998 110.509 -174.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -67.73 -13.68 62.31 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.057 0.943 . . . . 72.530000000000001 110.489 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.47 ' HB2' ' HG2' ' A' ' 114' ' ' LYS . 6.0 m-20 -78.83 -5.94 54.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.041 -0.981 . . . . 73.430000000000007 110.285 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 69.44 19.22 7.66 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.898 1.279 . . . . 74.109999999999999 109.431 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.47 ' HB3' ' CB ' ' A' ' 147' ' ' TYR . 24.3 pttm -116.11 155.55 28.0 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.479 -0.934 . . . . 73.219999999999999 108.479 173.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 19.0 mt -90.8 132.92 34.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.22 -1.4 . . . . 72.010000000000005 107.22 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 56.6 ttm-85 -123.23 143.72 49.85 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.376 -0.972 . . . . 73.340000000000003 108.376 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 41.2 p90 -140.85 173.45 11.47 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.757 -0.831 . . . . 74.420000000000002 108.757 176.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.477 ' HB3' ' HA ' ' A' ' 141' ' ' MET . 2.7 p-10 -124.37 146.38 48.89 Favored 'General case' 0 C--N 1.249 -3.774 0 N-CA-C 108.82 -0.808 . . . . 74.219999999999999 108.82 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -113.78 147.88 37.53 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 119.725 -0.79 . . . . 75.310000000000002 109.786 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -131.45 120.22 22.71 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.345 -0.843 . . . . 74.409999999999997 111.274 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -110.83 118.1 35.22 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 108.207 -1.035 . . . . 74.430000000000007 108.207 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -106.15 134.66 48.94 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.664 -0.648 . . . . 74.230000000000004 110.146 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -119.82 118.75 31.62 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.171 -0.922 . . . . 73.409999999999997 110.818 -174.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.33 145.37 26.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 106.331 -1.729 . . . . 60.439999999999998 106.331 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.467 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.4 OUTLIER -123.58 140.06 53.38 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 117.751 -1.58 . . . . 75.109999999999999 108.924 174.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.407 ' HD2' ' O ' ' A' ' 95' ' ' GLU . 18.7 ttm180 -85.19 120.05 26.25 Favored 'General case' 0 N--CA 1.403 -2.811 0 N-CA-C 106.165 -1.791 . . . . 74.019999999999996 106.165 172.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.41 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 76.6 ttt180 -69.82 149.33 48.03 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.116 -1.438 . . . . 73.530000000000001 107.116 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.24 -20.35 58.53 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.697 0.76 . . . . 74.140000000000001 111.03 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.41 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 11.5 t70 -64.8 -18.13 64.83 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.507 1.123 . . . . 72.200000000000003 111.245 175.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.19 -21.28 33.72 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.192 -0.763 . . . . 74.129999999999995 111.192 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.0 m -78.2 171.33 15.2 Favored 'General case' 0 N--CA 1.419 -2.013 0 C-N-CA 123.562 0.745 . . . . 75.25 109.153 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.578 ' SG ' HG23 ' A' ' 21' ' ' VAL . 28.3 p -140.52 151.25 44.62 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 109.486 -0.561 . . . . 73.340000000000003 109.486 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.467 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 1.8 t90 -152.07 155.29 37.63 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.537 -1.283 . . . . 75.310000000000002 107.537 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.3 mp -68.82 123.87 22.14 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.349 0.595 . . . . 74.450000000000003 110.287 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -83.68 -50.6 8.02 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.135 -0.938 . . . . 74.409999999999997 108.563 -176.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 26.6 p -170.2 166.09 8.96 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 108.294 -1.002 . . . . 74.109999999999999 108.294 -177.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.2 t -143.52 143.37 24.45 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 N-CA-C 104.683 -2.34 . . . . 73.129999999999995 104.683 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -131.48 131.13 43.25 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 117.721 0.237 . . . . 74.400000000000006 110.866 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 62.7 m-85 -118.17 130.54 56.16 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.147 -1.057 . . . . 64.530000000000001 108.147 177.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.5 pt -125.97 103.84 12.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-O 121.352 0.596 . . . . 75.209999999999994 111.438 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.477 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 52.8 mtt -95.85 94.85 7.88 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.064 -0.516 . . . . 64.439999999999998 109.611 -178.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.2 m -164.25 -46.38 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.018 -0.537 . . . . 75.209999999999994 110.672 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -45.44 131.58 8.32 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.644 1.578 . . . . 73.420000000000002 113.363 -173.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -159.52 157.49 30.07 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.393 -0.821 . . . . 63.32 109.788 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.59 159.2 53.11 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 108.274 -1.009 . . . . 70.439999999999998 108.274 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.05 147.73 32.93 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.994 2.463 . . . . 73.239999999999995 111.268 176.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.47 ' CB ' ' HB3' ' A' ' 114' ' ' LYS . 29.8 p90 -80.57 148.23 30.44 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-O 121.416 0.627 . . . . 74.209999999999994 112.143 -175.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.5 m -92.28 150.3 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 CA-C-N 114.978 -1.01 . . . . 75.239999999999995 108.336 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.466 0 N-CA-C 108.861 -0.792 . . . . 74.200000000000003 108.861 -179.91 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 CA--C 1.507 -0.682 0 N-CA-C 110.051 -0.352 . . . . 73.420000000000002 110.051 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.4 ttt 74.08 11.07 4.4 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 125.345 1.458 . . . . 75.25 110.683 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.1 p -64.62 -31.58 54.26 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.247 0 CA-C-N 115.209 -0.905 . . . . 74.230000000000004 109.764 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.5 m -57.9 -46.71 84.52 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-O 121.46 0.648 . . . . 72.150000000000006 110.829 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -76.5 -35.35 58.4 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.541 -0.754 . . . . 73.310000000000002 110.758 -175.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.76 -37.34 81.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.518 -0.765 . . . . 75.530000000000001 108.941 178.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -66.65 -53.45 33.83 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 115.199 -0.91 . . . . 63.149999999999999 109.931 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.8 p -66.32 -32.99 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 116.033 -0.53 . . . . 71.109999999999999 112.39 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HB3' ' HZ3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -74.52 -33.89 62.88 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 119.045 -1.062 . . . . 73.540000000000006 110.045 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.29 -41.36 68.7 Favored Glycine 0 CA--C 1.496 -1.1 0 N-CA-C 110.605 -0.998 . . . . 53.030000000000001 110.605 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.7 tp -65.15 -50.8 64.59 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 123.778 0.831 . . . . 73.510000000000005 109.698 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.33 -42.18 97.26 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.61 -0.723 . . . . 72.129999999999995 112.258 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -74.02 -32.52 63.4 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 120.159 -0.616 . . . . 75.530000000000001 111.559 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.86 -44.04 97.19 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.069 -0.715 . . . . 71.310000000000002 109.069 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 23.0 t80 -62.08 -53.73 51.3 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.08 -1.418 . . . . 74.209999999999994 110.31 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.6 mm -61.09 -40.53 86.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.606 0.595 . . . . 73.239999999999995 112.606 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.5 -40.49 85.19 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 120.521 -0.471 . . . . 75.420000000000002 110.136 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.543 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.8 pp -71.54 -27.51 63.24 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 118.801 -1.16 . . . . 72.519999999999996 112.054 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.5 t -71.07 -21.65 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 121.27 0.557 . . . . 73.329999999999998 109.527 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.0 p -115.09 22.31 13.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 122.115 -0.366 . . . . 75.409999999999997 111.915 -177.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.543 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 61.0 mmtt -49.82 133.71 21.59 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 113.544 0.942 . . . . 74.120000000000005 113.544 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.5 m -55.21 150.39 21.88 Favored Pre-proline 0 C--N 1.302 -1.496 0 C-N-CA 125.537 1.535 . . . . 74.420000000000002 110.487 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -59.18 -12.77 17.05 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.658 2.905 . . . . 62.530000000000001 112.857 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.52 -27.42 69.14 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.072 0.939 . . . . 63.25 109.1 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.4 p -109.99 99.17 8.32 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 106.354 -1.721 . . . . 71.340000000000003 106.354 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.8 p -49.61 -37.88 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 116.657 2.095 . . . . 71.120000000000005 116.657 -168.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -132.49 110.54 10.57 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 118.153 -1.419 . . . . 73.0 113.149 -174.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.8 m -65.89 -35.77 81.56 Favored 'General case' 0 C--O 1.256 1.412 0 CA-C-O 121.823 0.821 . . . . 73.540000000000006 110.331 -175.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.564 ' OE2' ' HA ' ' A' ' 78' ' ' LYS . 1.5 mp0 -66.6 -21.3 66.13 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.243 -0.889 . . . . 75.140000000000001 110.586 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -68.62 -42.23 78.39 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 108.533 -0.914 . . . . 74.030000000000001 108.533 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -69.76 -35.01 74.57 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 108.098 -1.075 . . . . 72.340000000000003 108.098 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.0 tp -66.97 -42.97 84.25 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.896 -0.593 . . . . 70.209999999999994 110.801 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.99 -34.39 76.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.624 0.726 . . . . 70.530000000000001 110.366 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -76.35 -32.72 58.82 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.197 -0.91 . . . . 64.140000000000001 109.98 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.484 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 59.9 t80 -67.28 -47.7 69.86 Favored 'General case' 0 C--O 1.215 -0.744 0 C-N-CA 123.48 0.712 . . . . 73.409999999999997 109.991 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.465 HD13 ' C ' ' A' ' 49' ' ' LEU . 4.5 pp -75.03 -4.14 36.65 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.766 -0.652 . . . . 74.549999999999997 111.107 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.61 -61.13 5.36 Favored Glycine 0 CA--C 1.526 0.755 0 O-C-N 123.644 0.59 . . . . 74.109999999999999 112.371 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.484 ' HD2' ' O ' ' A' ' 48' ' ' PHE . 93.5 Cg_endo -85.18 -6.5 9.3 Favored 'Trans proline' 0 CA--C 1.549 1.264 0 C-N-CA 122.214 1.942 . . . . 74.329999999999998 112.672 173.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.45 ' HD2' ' O ' ' A' ' 48' ' ' PHE . 91.3 m-70 -111.41 31.35 6.18 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.726 -0.472 . . . . 72.450000000000003 109.726 -175.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -54.68 107.82 0.97 Allowed Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 124.679 1.192 . . . . 75.519999999999996 112.505 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -108.7 -154.45 0.02 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.294 0 C-N-CA 123.602 2.868 . . . . 74.400000000000006 110.485 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -93.63 120.13 33.52 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 107.195 -1.409 . . . . 74.239999999999995 107.195 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.438 HD12 ' CB ' ' A' ' 68' ' ' PHE . 64.7 mt -101.56 110.38 28.25 Favored 'Isoleucine or valine' 0 C--O 1.168 -3.19 0 N-CA-C 108.038 -1.097 . . . . 74.129999999999995 108.038 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -96.77 138.62 34.05 Favored 'General case' 0 C--N 1.271 -2.839 0 O-C-N 121.304 -0.873 . . . . 75.329999999999998 109.304 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.5 t -133.07 114.44 21.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 107.502 -1.296 . . . . 74.329999999999998 107.502 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 63.19 21.02 12.63 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 124.794 1.237 . . . . 73.319999999999993 111.073 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.92 -1.16 59.41 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.329 -0.851 . . . . 71.420000000000002 112.39 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -103.96 135.27 45.79 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.417 -0.586 . . . . 73.340000000000003 109.417 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -76.97 129.2 37.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.671 0.748 . . . . 74.310000000000002 109.265 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -126.21 147.55 49.64 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 124.642 1.177 . . . . 73.430000000000007 108.227 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 t -92.63 174.56 7.2 Favored 'General case' 0 C--O 1.254 1.341 0 N-CA-C 108.232 -1.025 . . . . 75.200000000000003 108.232 175.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.8 t -54.8 -36.17 64.65 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.028 0.531 . . . . 71.239999999999995 111.058 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.425 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 35.8 m -65.92 -46.42 78.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 122.729 0.412 . . . . 74.140000000000001 111.194 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.88 -46.19 86.01 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.91 -0.404 . . . . 62.0 109.91 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.438 ' CB ' HD12 ' A' ' 56' ' ' ILE . 48.9 t80 -54.28 -54.94 33.41 Favored 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 123.656 0.597 . . . . 74.219999999999999 109.723 174.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.465 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 2.2 tm? -50.39 -44.36 54.87 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 124.424 1.078 . . . . 73.040000000000006 110.54 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 26.8 mt-30 -56.91 -52.11 66.45 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 123.101 0.56 . . . . 73.239999999999995 111.929 174.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -64.87 -36.53 84.66 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.704 0.764 . . . . 74.109999999999999 109.817 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -57.7 -55.99 27.72 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 124.612 1.165 . . . . 71.349999999999994 110.472 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 48.9 ptt85 -68.87 -23.93 64.28 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.358 -0.383 . . . . 74.510000000000005 111.597 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 54.8 mt-30 -78.99 -15.31 58.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 120.432 -0.507 . . . . 74.019999999999996 111.459 176.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.47 14.33 30.41 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.677 -0.773 . . . . 72.200000000000003 114.622 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.16 -42.54 79.91 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.437 0.532 . . . . 74.120000000000005 112.437 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -92.48 6.89 45.42 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.587 0.588 . . . . 75.200000000000003 112.587 -173.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.564 ' HA ' ' OE2' ' A' ' 42' ' ' GLU . 99.4 mttt -67.06 -13.96 62.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.222 0.534 . . . . 75.219999999999999 112.233 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -77.57 -27.24 51.39 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.083 -0.71 . . . . 75.530000000000001 109.083 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.453 HD22 ' O ' ' A' ' 80' ' ' LEU . 7.1 tt -71.63 -17.51 62.26 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.077 0.951 . . . . 75.129999999999995 109.662 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -68.04 -22.04 64.97 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.105 -0.498 . . . . 75.099999999999994 109.879 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -101.13 4.76 42.4 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.379 -0.601 . . . . 73.310000000000002 109.379 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 105' ' ' SER . . . -75.73 143.17 42.2 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.525 0.935 . . . . 60.119999999999997 113.525 -173.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.14 139.37 30.54 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.12 -0.945 . . . . 74.5 109.175 175.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -76.25 106.04 7.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 104.465 -2.42 . . . . 65.340000000000003 104.465 167.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.68 101.12 4.52 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.448 0.642 . . . . 71.299999999999997 111.25 -173.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.6 mm -97.5 128.64 48.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 107.405 -1.331 . . . . 74.140000000000001 107.405 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -69.04 -46.66 67.34 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.221 -1.029 . . . . 61.200000000000003 108.221 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.9 p -167.74 136.02 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 107.718 -1.216 . . . . 74.439999999999998 107.718 176.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 m -87.64 -38.85 15.54 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.713 -0.847 . . . . 72.129999999999995 108.713 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.39 -145.74 37.95 Favored Glycine 0 N--CA 1.428 -1.846 0 CA-C-N 114.795 -1.093 . . . . 60.340000000000003 110.496 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -133.89 129.62 36.63 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 120.85 0.357 . . . . 75.420000000000002 110.147 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.7 t -89.44 118.01 33.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 106.143 -1.799 . . . . 64.400000000000006 106.143 174.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -73.28 -36.82 66.37 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 112.959 0.726 . . . . 75.109999999999999 112.959 -171.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -149.93 115.47 5.53 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.541 -0.463 . . . . 71.209999999999994 110.217 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.41 91.81 0.47 Allowed Glycine 0 CA--C 1.5 -0.875 0 N-CA-C 110.825 -0.91 . . . . 61.119999999999997 110.825 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -58.67 119.77 7.71 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 113.508 0.929 . . . . 64.010000000000005 113.508 -174.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.83 138.12 13.73 Favored Glycine 0 N--CA 1.406 -3.33 0 N-CA-C 107.556 -2.218 . . . . 51.43 107.556 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -111.14 127.0 55.43 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.583 -0.895 . . . . 72.329999999999998 108.583 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -123.2 98.63 5.96 Favored 'General case' 0 C--N 1.273 -2.736 0 N-CA-C 105.44 -2.059 . . . . 72.230000000000004 105.44 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 75.2 mt -109.75 138.84 45.53 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.034 -0.985 . . . . 74.409999999999997 108.897 -173.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 12.1 p -133.43 138.2 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-O 121.729 0.776 . . . . 72.329999999999998 111.839 -178.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 23.3 m-90 -113.77 143.71 44.19 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.392 -1.277 . . . . 74.109999999999999 107.661 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -126.01 124.24 40.26 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.092 -1.447 . . . . 75.209999999999994 107.092 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 40.0 m -82.22 177.78 8.61 Favored 'General case' 0 C--N 1.281 -2.407 0 O-C-N 123.397 0.436 . . . . 75.109999999999999 111.012 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.34 126.22 25.35 Favored 'General case' 0 C--O 1.24 0.571 0 O-C-N 123.485 0.491 . . . . 74.420000000000002 110.787 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 117' ' ' TRP . . . -76.99 142.89 39.77 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.035 -0.984 . . . . 72.319999999999993 110.375 -177.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -124.78 120.69 32.47 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.87 -1.159 . . . . 73.340000000000003 107.87 -176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -75.87 109.08 9.2 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.631 -0.877 . . . . 74.109999999999999 108.631 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 t -82.96 157.35 23.02 Favored 'General case' 0 N--CA 1.408 -2.532 0 CA-C-N 114.615 -1.175 . . . . 42.439999999999998 107.937 -172.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -76.74 3.69 11.2 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.859 0.838 . . . . 64.329999999999998 110.012 -177.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -87.86 5.56 39.72 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 124.952 1.301 . . . . 75.319999999999993 109.848 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 74.2 10.91 4.33 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.847 1.259 . . . . 74.219999999999999 110.698 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -129.02 165.44 21.15 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.308 -0.997 . . . . 75.109999999999999 108.308 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.1 mp -104.91 136.2 39.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 108.193 -1.04 . . . . 75.239999999999995 108.193 -176.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.448 ' HG2' ' HB3' ' A' ' 144' ' ' ALA . 53.0 mtm180 -115.46 151.13 35.35 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.499 -0.556 . . . . 64.120000000000005 109.499 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.442 ' HB3' ' HA ' ' A' ' 107' ' ' ALA . 10.2 p90 -160.49 174.06 14.63 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.918 -0.771 . . . . 73.549999999999997 108.918 177.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.407 ' CB ' ' HA ' ' A' ' 141' ' ' MET . 4.7 p-10 -113.01 134.65 54.41 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-O 121.199 0.523 . . . . 74.530000000000001 110.07 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.412 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 37.2 mt-10 -117.16 154.62 30.78 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.783 -1.099 . . . . 73.519999999999996 112.015 178.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -135.79 118.48 16.05 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.042 -0.981 . . . . 61.299999999999997 109.284 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 37.2 mt-10 -116.4 110.54 18.8 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.624 -0.51 . . . . 74.319999999999993 109.624 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.21 130.65 41.87 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 109.057 -0.72 . . . . 73.120000000000005 109.057 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -113.84 118.52 34.48 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.964 -0.754 . . . . 73.040000000000006 108.964 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.3 mt -118.95 152.69 21.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.388 -1.338 . . . . 74.510000000000005 107.388 178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -137.53 148.55 46.06 Favored 'General case' 0 C--O 1.275 2.417 0 C-N-CA 119.715 -0.794 . . . . 74.430000000000007 109.922 175.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -88.11 129.37 35.32 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.116 -0.947 . . . . 74.409999999999997 108.691 170.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.41 ' HD3' ' OG ' ' A' ' 131' ' ' SER . 47.8 ttt180 -87.86 147.29 25.18 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-N 113.983 -1.462 . . . . 75.530000000000001 108.075 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -58.21 -28.27 64.66 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.855 0.462 . . . . 75.329999999999998 112.065 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.84 -16.87 63.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.148 -0.933 . . . . 74.519999999999996 111.702 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.6 6.8 56.24 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 119.849 -1.167 . . . . 63.109999999999999 111.283 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.41 ' OG ' ' HD3' ' A' ' 127' ' ' ARG . 0.4 OUTLIER -96.89 162.37 13.44 Favored 'General case' 0 N--CA 1.396 -3.151 0 N-CA-C 108.438 -0.949 . . . . 72.219999999999999 108.438 175.711 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 28.8 p -133.22 144.99 50.15 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 107.967 -1.123 . . . . 63.210000000000001 107.967 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -159.06 156.05 28.5 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 120.088 -0.645 . . . . 75.109999999999999 109.797 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.6 mp -69.23 127.01 31.54 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.268 0.556 . . . . 65.519999999999996 109.773 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -80.89 -56.12 4.34 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.806 -1.183 . . . . 75.430000000000007 107.806 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 10.9 m -166.5 162.27 16.67 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 105.931 -1.877 . . . . 65.299999999999997 105.931 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.7 m -137.55 149.84 25.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 106.394 -1.706 . . . . 74.230000000000004 106.394 171.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -134.4 130.71 37.26 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 117.686 0.221 . . . . 71.400000000000006 110.414 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -112.63 129.05 56.52 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 107.312 -1.366 . . . . 74.049999999999997 107.312 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 8.4 pt -129.0 98.3 4.08 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 CA-C-O 122.129 0.966 . . . . 75.299999999999997 109.048 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.407 ' HA ' ' CB ' ' A' ' 118' ' ' ASP . 23.3 ptp -92.83 138.31 31.6 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.013 -0.994 . . . . 72.239999999999995 110.205 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.5 t 81.26 29.02 0.17 Allowed 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.264 0.977 . . . . 74.230000000000004 109.812 176.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -73.42 146.03 45.35 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.282 -1.747 . . . . 75.099999999999994 106.282 173.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.448 ' HB3' ' HG2' ' A' ' 116' ' ' ARG . . . -135.38 150.37 49.9 Favored 'General case' 0 N--CA 1.418 -2.047 0 C-N-CA 120.221 -0.592 . . . . 73.510000000000005 111.688 -175.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.06 109.14 35.46 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 106.277 -1.749 . . . . 75.340000000000003 106.277 169.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.74 144.33 97.03 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.71 2.273 . . . . 71.019999999999996 111.898 -176.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -79.85 151.09 30.42 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 108.893 -0.78 . . . . 64.530000000000001 108.893 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 31.1 m -77.66 115.29 19.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-O 121.668 0.747 . . . . 74.340000000000003 111.328 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.644 0 N-CA-C 107.845 -1.168 . . . . 70.120000000000005 107.845 178.904 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 CA--C 1.504 -0.807 0 N-CA-C 111.921 0.341 . . . . 75.549999999999997 111.921 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.55 1.38 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 116.907 2.188 . . . . 72.150000000000006 116.907 -170.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.1 m -71.19 -43.48 74.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 118.772 0.715 . . . . 75.450000000000003 110.88 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.2 p -67.9 -41.54 82.55 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.38 -0.6 . . . . 74.239999999999995 109.38 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 9.6 m-20 -60.23 -43.46 96.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.488 -1.233 . . . . 71.129999999999995 111.21 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.4 -42.95 87.12 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.873 -0.788 . . . . 75.510000000000005 108.873 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.17 -48.81 78.4 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 115.86 -0.609 . . . . 73.340000000000003 111.411 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.0 p -69.38 -38.83 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 112.552 0.575 . . . . 74.450000000000003 112.552 -176.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 22.5 ptmt -75.76 -25.96 56.96 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 119.076 -1.05 . . . . 73.329999999999998 110.187 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.56 -57.74 5.82 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 120.64 -0.791 . . . . 74.040000000000006 111.262 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 pp -68.45 -35.91 78.26 Favored 'General case' 0 C--O 1.199 -1.559 0 N-CA-C 108.947 -0.76 . . . . 65.129999999999995 108.947 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.23 -43.67 96.69 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 116.231 -0.44 . . . . 70.340000000000003 112.036 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -63.83 -46.85 83.2 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.76 -0.459 . . . . 73.319999999999993 109.76 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -65.16 -41.27 94.85 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 116.051 -0.522 . . . . 71.239999999999995 110.247 -177.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -63.05 -53.59 51.39 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.418 -0.81 . . . . 74.420000000000002 110.481 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.5 mm -64.23 -34.81 71.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.613 -0.267 . . . . 74.430000000000007 111.666 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -63.3 -48.59 77.43 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 116.34 -0.391 . . . . 72.239999999999995 110.144 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 pp -68.57 -29.35 67.88 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.288 -0.565 . . . . 75.219999999999999 111.84 -177.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.45 -28.54 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-O 121.471 0.653 . . . . 71.400000000000006 110.326 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.7 p -110.17 13.29 23.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.34 0.59 . . . . 54.210000000000001 110.566 -175.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 tptt -57.0 140.39 49.14 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.638 1.175 . . . . 74.310000000000002 111.928 -175.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.6 m -57.63 155.26 21.75 Favored Pre-proline 0 C--O 1.248 1.014 0 C-N-CA 124.183 0.993 . . . . 64.010000000000005 111.259 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.83 -5.99 5.39 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 124.82 3.68 . . . . 73.340000000000003 112.146 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -59.7 -26.42 65.59 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.463 -1.244 . . . . 64.439999999999998 110.589 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.2 p -92.43 167.72 11.78 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 107.358 -1.349 . . . . 73.109999999999999 107.358 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.62 -46.93 67.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 118.884 -1.126 . . . . 74.530000000000001 111.13 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -168.09 141.64 3.28 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.331 -0.989 . . . . 73.510000000000005 108.331 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.8 m -56.62 -41.29 76.84 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 123.186 0.594 . . . . 72.450000000000003 111.067 -177.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -67.83 -20.06 65.12 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.947 -1.024 . . . . 74.450000000000003 111.383 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -69.99 -48.26 58.91 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 108.26 -1.015 . . . . 72.299999999999997 108.26 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -69.32 -32.07 70.96 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 114.2 -1.364 . . . . 74.519999999999996 108.518 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.4 tp -67.04 -45.06 78.6 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.526 -0.761 . . . . 73.439999999999998 110.117 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.85 -34.94 75.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.293 0.568 . . . . 73.519999999999996 110.214 177.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -69.14 -40.29 78.33 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.103 -0.953 . . . . 70.25 109.215 177.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -68.48 -42.58 78.47 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 123.498 0.719 . . . . 64.209999999999994 110.594 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.438 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 3.3 pp -84.41 0.66 48.64 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.877 -0.601 . . . . 64.230000000000004 110.964 -176.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.32 -61.59 7.05 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 111.303 -0.719 . . . . 63.100000000000001 111.303 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -77.2 -5.09 15.47 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.868 2.379 . . . . 75.109999999999999 112.034 175.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 62.9 m-70 -121.47 36.55 4.58 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.698 -0.482 . . . . 64.120000000000005 109.698 -174.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -55.7 106.56 0.69 Allowed Pre-proline 0 N--CA 1.48 1.051 0 O-C-N 124.706 1.254 . . . . 72.140000000000001 111.892 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -99.95 -177.37 0.19 Allowed 'Trans proline' 0 N--CA 1.422 -2.697 0 C-N-CA 122.661 2.241 . . . . 72.530000000000001 109.979 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -84.22 107.46 16.54 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 107.254 -1.388 . . . . 72.540000000000006 107.254 174.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.472 HD13 ' HB2' ' A' ' 68' ' ' PHE . 71.7 mt -92.41 105.95 17.27 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.161 0 N-CA-C 107.39 -1.337 . . . . 74.5 107.39 -175.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -98.9 105.9 18.09 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 122.029 -0.42 . . . . 72.120000000000005 111.312 -175.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 70.3 t -107.97 113.1 42.89 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.649 0 N-CA-C 108.02 -1.104 . . . . 73.010000000000005 108.02 -177.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 56.63 26.3 11.02 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 124.536 1.148 . . . . 71.430000000000007 111.034 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.75 14.3 61.42 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.438 -0.801 . . . . 75.540000000000006 112.614 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -112.3 130.35 55.97 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.519 -0.919 . . . . 75.319999999999993 108.519 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.88 125.97 38.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 121.833 0.825 . . . . 74.319999999999993 109.183 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.418 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 47.9 mm-40 -124.44 147.84 48.03 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.719 -1.215 . . . . 75.430000000000007 107.719 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.1 t -101.24 173.73 6.32 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.793 -1.188 . . . . 65.430000000000007 107.793 174.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -46.23 -39.88 10.55 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.809 1.244 . . . . 70.340000000000003 112.09 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 27.6 m -64.43 -52.74 56.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 122.651 0.38 . . . . 75.340000000000003 110.489 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.95 -45.82 93.2 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.036 -0.529 . . . . 72.329999999999998 110.809 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.472 ' HB2' HD13 ' A' ' 56' ' ' ILE . 46.5 t80 -52.22 -56.4 14.89 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.232 0.539 . . . . 75.439999999999998 109.796 175.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -49.77 -43.3 48.09 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 114.194 -1.367 . . . . 75.439999999999998 111.12 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.464 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 15.7 mm100 -62.75 -46.68 86.94 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 122.892 0.477 . . . . 71.0 111.222 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.468 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 51.6 m-85 -66.45 -37.58 85.46 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.332 0.587 . . . . 75.230000000000004 109.664 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.19 -51.83 67.77 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.022 -0.536 . . . . 74.409999999999997 110.96 175.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 12.8 ptm180 -69.47 -23.33 63.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.334 0.588 . . . . 75.409999999999997 110.68 -176.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -81.01 -6.12 58.4 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.653 0.612 . . . . 72.049999999999997 112.653 175.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.8 17.37 30.67 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.175 -0.536 . . . . 53.210000000000001 114.032 175.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.45 -60.29 2.42 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 122.47 -0.429 . . . . 73.530000000000001 111.874 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 56.5 m-85 -83.31 -7.43 59.59 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 113.455 0.909 . . . . 74.540000000000006 113.455 -171.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -15.81 63.82 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.469 -0.892 . . . . 73.340000000000003 111.561 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -88.37 -17.01 31.46 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.123 0.487 . . . . 75.209999999999994 109.689 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 80' ' ' LEU . 3.3 tm? -84.59 -17.36 38.99 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 115.64 -0.709 . . . . 73.420000000000002 109.381 -174.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.47 3.27 13.83 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.721 0.772 . . . . 75.450000000000003 111.086 -176.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -104.64 2.93 31.08 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.422 -0.955 . . . . 65.299999999999997 108.422 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.56 153.13 39.17 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.126 -0.943 . . . . 64.430000000000007 113.248 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -99.48 135.45 40.87 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.382 -1.281 . . . . 75.349999999999994 108.385 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -76.93 118.83 19.91 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.506 -0.553 . . . . 75.409999999999997 109.506 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.22 161.37 15.05 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.587 0.708 . . . . 75.129999999999995 110.77 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.6 tp -108.53 141.34 24.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.378 -0.971 . . . . 72.420000000000002 108.378 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -125.02 103.3 7.94 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.49 -0.93 . . . . 70.040000000000006 108.49 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.5 p -68.9 -21.07 25.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.295 0.569 . . . . 74.329999999999998 111.237 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 t -96.97 20.38 11.26 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 122.142 0.972 . . . . 74.430000000000007 108.664 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.45 157.7 52.86 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 110.477 -1.049 . . . . 72.420000000000002 110.477 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -95.46 143.18 27.01 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.508 -0.477 . . . . 73.25 111.381 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.2 m -126.4 156.49 37.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.294 -1.373 . . . . 73.409999999999997 107.294 174.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.09 172.86 16.85 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.82 -0.437 . . . . 62.399999999999999 109.82 -171.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -54.03 -34.36 59.77 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.431 0.692 . . . . 75.230000000000004 112.563 -177.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.14 102.84 2.95 Favored Glycine 0 N--CA 1.425 -2.089 0 N-CA-C 106.126 -2.79 . . . . 73.329999999999998 106.126 170.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -58.76 119.86 7.91 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.022 0.439 . . . . 64.549999999999997 111.265 -172.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -138.74 156.41 24.21 Favored Glycine 0 N--CA 1.409 -3.116 0 C-N-CA 120.412 -0.899 . . . . 73.540000000000006 111.587 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -116.7 157.0 26.14 Favored 'General case' 0 C--O 1.261 1.671 0 N-CA-C 108.119 -1.067 . . . . 74.450000000000003 108.119 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -125.46 101.8 7.1 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 105.833 -1.914 . . . . 73.310000000000002 105.833 171.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.2 mt -99.16 112.43 24.58 Favored 'General case' 0 C--N 1.261 -3.253 0 N-CA-C 106.923 -1.51 . . . . 73.420000000000002 106.923 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 8.5 p -115.6 132.0 66.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.486 0.66 . . . . 75.439999999999998 112.035 -174.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -106.34 140.86 38.6 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.051 -0.977 . . . . 75.420000000000002 109.245 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -118.63 121.24 39.71 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.063 -1.088 . . . . 74.319999999999993 108.063 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.1 t -80.26 -168.13 1.57 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.313 -0.858 . . . . 75.140000000000001 110.827 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.26 141.72 53.68 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 113.426 0.899 . . . . 74.519999999999996 113.426 -174.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.07 98.47 9.32 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.863 -1.162 . . . . 61.43 107.863 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -93.42 110.41 21.97 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 114.098 -1.41 . . . . 73.5 107.561 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -64.03 132.41 50.52 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 114.948 1.462 . . . . 75.239999999999995 114.948 -172.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.7 t -113.98 132.99 55.78 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 106.382 -1.71 . . . . 74.319999999999993 106.382 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -69.89 6.73 1.1 Allowed 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 113.005 0.743 . . . . 71.299999999999997 113.005 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -96.13 25.56 4.78 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 122.158 -0.339 . . . . 74.230000000000004 110.454 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 70.54 23.23 4.83 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.236 1.014 . . . . 71.319999999999993 111.12 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 20.8 pttp -137.03 171.11 14.99 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.238 0.542 . . . . 72.019999999999996 111.462 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.54 151.4 34.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.135 -1.431 . . . . 72.530000000000001 107.135 176.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -114.83 158.33 22.07 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 106.528 -1.656 . . . . 74.400000000000006 106.528 176.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 39.1 p90 -148.76 164.88 33.09 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 108.019 -1.104 . . . . 75.510000000000005 108.019 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -106.55 134.19 50.06 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 105.57 -2.011 . . . . 72.219999999999999 105.57 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -114.87 154.12 29.23 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 119.482 -0.887 . . . . 75.439999999999998 111.727 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -139.32 116.85 11.36 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.878 -1.055 . . . . 71.140000000000001 108.999 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -111.98 109.66 19.54 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.058 -0.719 . . . . 75.519999999999996 109.058 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.54 118.25 33.62 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 121.136 0.493 . . . . 44.420000000000002 109.751 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -100.82 113.55 26.57 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.198 -1.408 . . . . 74.209999999999994 107.198 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 54.4 mt -118.31 143.62 28.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.42 -1.326 . . . . 70.010000000000005 107.42 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.25 147.57 51.1 Favored 'General case' 0 C--O 1.262 1.725 0 C-N-CA 119.098 -1.041 . . . . 75.150000000000006 110.752 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.573 ' HG2' ' SG ' ' A' ' 132' ' ' CYS . 29.1 mtp180 -89.91 116.86 28.29 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.073 -1.421 . . . . 73.219999999999999 109.17 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -80.96 145.21 31.35 Favored 'General case' 0 C--N 1.273 -2.725 0 CA-C-N 113.79 -1.55 . . . . 74.209999999999994 111.049 -170.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -72.59 -10.71 60.13 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 107.813 -1.18 . . . . 71.310000000000002 107.813 174.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.95 -17.72 64.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.006 -0.997 . . . . 72.0 109.589 173.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 101.89 -6.67 54.54 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.508 -0.637 . . . . 42.409999999999997 111.508 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.9 m -103.88 -179.62 4.0 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.141 -0.688 . . . . 72.299999999999997 109.141 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.573 ' SG ' ' HG2' ' A' ' 126' ' ' ARG . 74.0 m -131.49 142.14 49.91 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.611 -1.255 . . . . 74.109999999999999 107.611 175.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -149.78 154.89 39.19 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 119.718 -0.793 . . . . 74.519999999999996 109.879 -176.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.23 122.35 22.68 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.861 -0.792 . . . . 73.230000000000004 108.861 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -76.34 -52.8 9.2 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.209 -1.034 . . . . 75.109999999999999 108.209 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.7 m -167.88 154.53 7.86 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.479 -1.674 . . . . 75.450000000000003 106.479 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.39 139.41 41.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.469 -1.308 . . . . 62.439999999999998 107.469 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -114.39 139.19 49.69 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 109.965 -0.383 . . . . 72.239999999999995 109.965 -175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 66.2 m-85 -125.4 121.44 33.85 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.78 -1.192 . . . . 72.109999999999999 107.78 174.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.501 ' HB ' ' CD ' ' A' ' 143' ' ' LYS . 9.5 pt -128.83 97.61 3.75 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 CA-C-O 122.16 0.981 . . . . 73.129999999999995 109.109 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -87.95 137.04 32.68 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.925 -1.034 . . . . 72.219999999999999 111.33 -177.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.473 ' O ' ' HE3' ' A' ' 143' ' ' LYS . 41.4 t 71.27 49.19 0.33 Allowed 'General case' 0 C--N 1.321 -0.668 0 O-C-N 124.657 1.223 . . . . 75.409999999999997 111.403 175.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.501 ' CD ' ' HB ' ' A' ' 140' ' ' ILE . 0.3 OUTLIER -101.86 145.81 28.69 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.422 -0.955 . . . . 72.299999999999997 108.422 175.436 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -149.84 139.07 21.28 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.308 -0.627 . . . . 74.209999999999994 109.308 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.92 153.16 49.34 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 109.062 -0.718 . . . . 74.430000000000007 109.062 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.62 132.49 52.45 Favored 'Trans proline' 0 C--O 1.247 0.963 0 C-N-CA 122.519 2.146 . . . . 74.409999999999997 109.997 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.424 ' HB3' ' HB3' ' A' ' 114' ' ' LYS . 54.9 p90 -67.71 153.92 42.64 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 121.201 0.524 . . . . 75.540000000000006 112.01 -173.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.73 127.1 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 CA-C-N 115.575 -0.739 . . . . 74.530000000000001 110.273 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.465 0 N-CA-C 107.78 -1.192 . . . . 70.409999999999997 107.78 178.412 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.501 -0.905 0 N-CA-C 109.029 -0.73 . . . . 61.329999999999998 109.029 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.9 ttt -94.56 -6.82 42.76 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.673 0.749 . . . . 72.5 111.21 -174.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.2 p -65.92 -20.32 27.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 114.965 -1.016 . . . . 75.150000000000006 110.326 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.431 ' O ' HG11 ' A' ' 21' ' ' VAL . 18.9 p -64.57 -39.69 94.19 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.351 -0.84 . . . . 74.430000000000007 111.288 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -68.21 -34.94 77.19 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.94 0.876 . . . . 74.129999999999995 109.104 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -70.41 -39.49 74.43 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.864 -1.062 . . . . 74.430000000000007 108.901 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.57 -45.01 84.94 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.859 -0.61 . . . . 72.540000000000006 109.916 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.521 HG12 ' SG ' ' A' ' 132' ' ' CYS . 17.9 m -69.49 -37.89 75.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.167 -0.47 . . . . 71.140000000000001 112.015 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.551 ' HZ2' ' HB3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -72.5 -33.5 66.99 Favored 'General case' 0 C--O 1.211 -0.954 0 C-N-CA 118.629 -1.228 . . . . 74.239999999999995 109.961 178.519 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.83 -41.93 61.96 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.241 -0.743 . . . . 72.219999999999999 111.241 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.0 tp -69.65 -50.4 44.55 Favored 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 124.047 0.939 . . . . 73.340000000000003 109.173 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.05 -42.22 99.72 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.967 -0.56 . . . . 71.140000000000001 111.872 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -65.32 -44.2 88.61 Favored 'General case' 0 C--O 1.187 -2.218 0 CA-C-O 118.791 -0.623 . . . . 72.129999999999995 110.872 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.02 -38.63 91.95 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.116 0.96 . . . . 74.409999999999997 110.252 -174.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.567 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 24.1 t80 -64.45 -55.18 22.52 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.698 -1.592 . . . . 75.019999999999996 110.081 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.0 mm -67.03 -30.56 49.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.074 -0.512 . . . . 71.420000000000002 111.007 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.34 -48.44 77.96 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.596 0.758 . . . . 73.140000000000001 110.142 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.4 pp -69.14 -28.49 66.49 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 119.944 -0.702 . . . . 72.340000000000003 110.048 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 68.8 t -73.21 -22.19 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 CA-C-O 121.219 0.533 . . . . 72.230000000000004 110.929 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.4 p -107.5 15.69 24.57 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.415 -0.803 . . . . 74.439999999999998 111.858 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 32.4 mmmt -57.05 162.22 2.64 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 113.543 0.942 . . . . 75.129999999999995 113.543 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.408 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 12.2 p -70.33 169.54 13.35 Favored Pre-proline 0 N--CA 1.435 -1.197 0 C-N-CA 125.469 1.508 . . . . 64.209999999999994 111.8 -177.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 35' ' ' SER . 19.0 Cg_endo -64.42 -7.46 14.27 Favored 'Trans proline' 0 C--N 1.363 1.317 0 C-N-CA 123.09 2.527 . . . . 75.340000000000003 112.09 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -73.92 -27.32 60.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.662 -0.699 . . . . 64.519999999999996 109.886 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.6 m -82.73 113.08 20.15 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.62 -0.718 . . . . 74.519999999999996 109.312 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.1 -32.91 56.04 Favored 'Isoleucine or valine' 0 C--O 1.25 1.124 0 N-CA-C 113.331 0.863 . . . . 71.140000000000001 113.331 -174.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -151.06 94.04 2.0 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.428 -0.909 . . . . 74.540000000000006 109.921 -174.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.3 m -67.35 -30.17 69.91 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.699 0.762 . . . . 75.319999999999993 109.766 -175.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -71.84 -20.03 61.88 Favored 'General case' 0 N--CA 1.414 -2.269 0 CA-C-N 115.15 -0.932 . . . . 75.150000000000006 112.008 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -69.76 -45.37 68.21 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.692 -1.225 . . . . 73.439999999999998 107.692 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.13 -26.82 65.08 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.004 -0.998 . . . . 65.25 110.177 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.552 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 51.2 tp -70.18 -47.09 63.09 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.554 -0.748 . . . . 73.219999999999999 109.636 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.48 -27.01 68.99 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 121.528 0.68 . . . . 61.130000000000003 110.083 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -73.95 -38.8 64.13 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.878 -1.055 . . . . 74.510000000000005 109.64 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -70.11 -51.64 29.98 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.562 -0.745 . . . . 71.340000000000003 110.419 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 4.0 pp -82.12 -8.03 59.64 Favored 'General case' 0 C--O 1.196 -1.754 0 CA-C-N 115.382 -0.826 . . . . 72.540000000000006 111.824 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -43.64 -60.19 3.4 Favored Glycine 0 N--CA 1.477 1.374 0 O-C-N 123.672 0.607 . . . . 71.230000000000004 114.264 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.11 -6.3 16.49 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.506 2.137 . . . . 75.120000000000005 112.04 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -110.42 19.78 18.43 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.008 -0.738 . . . . 73.439999999999998 109.008 -175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.651 ' CG ' ' HB ' ' A' ' 65' ' ' THR . 27.2 t70 -56.7 109.94 2.04 Favored Pre-proline 0 C--O 1.245 0.857 0 C-N-CA 125.163 1.385 . . . . 71.040000000000006 113.744 -176.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -106.54 -152.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.637 0 C-N-CA 123.929 3.086 . . . . 74.549999999999997 110.502 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -81.99 124.03 29.41 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.551 -0.907 . . . . 72.530000000000001 108.551 176.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.49 HD11 ' CB ' ' A' ' 68' ' ' PHE . 39.7 mt -108.22 109.2 27.38 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.396 0 N-CA-C 107.219 -1.4 . . . . 75.420000000000002 107.219 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -96.07 138.88 33.05 Favored 'General case' 0 C--N 1.263 -3.182 0 O-C-N 121.601 -0.687 . . . . 75.409999999999997 109.678 -177.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 3.6 p -133.29 122.76 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 N-CA-C 107.298 -1.371 . . . . 71.030000000000001 107.298 174.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 62.69 20.72 12.27 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.612 0.72 . . . . 74.239999999999995 110.865 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.59 7.38 64.98 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.652 -0.704 . . . . 64.019999999999996 112.572 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -113.78 135.52 53.86 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.908 -0.405 . . . . 75.329999999999998 109.908 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.53 126.52 37.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-O 121.708 0.766 . . . . 73.540000000000006 110.187 -175.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.425 ' NE2' HG13 ' A' ' 58' ' ' VAL . 51.9 mm-40 -122.68 148.19 45.58 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.46 -0.941 . . . . 73.530000000000001 108.46 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.2 t -100.43 175.71 5.6 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.953 -1.128 . . . . 61.039999999999999 107.953 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.651 ' HB ' ' CG ' ' A' ' 53' ' ' ASP . 9.3 t -52.17 -34.05 43.33 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 123.28 0.632 . . . . 72.439999999999998 112.261 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 m -59.41 -54.15 49.95 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-O 121.123 0.487 . . . . 71.420000000000002 109.946 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.45 -47.51 75.91 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-N 115.005 -0.998 . . . . 61.32 110.967 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.49 ' CB ' HD11 ' A' ' 56' ' ' ILE . 51.0 t80 -54.46 -54.29 42.83 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.661 0.384 . . . . 73.439999999999998 111.169 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.454 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 2.8 tm? -54.16 -42.49 69.67 Favored 'General case' 0 C--O 1.244 0.801 0 O-C-N 124.206 0.941 . . . . 73.519999999999996 110.384 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.431 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 73.3 mt-30 -57.93 -53.61 56.3 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 116.552 -0.294 . . . . 70.540000000000006 111.115 174.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.459 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 28.5 m-85 -63.05 -32.54 73.93 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.657 0.742 . . . . 75.040000000000006 110.723 -176.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -61.64 -55.27 32.42 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.204 -0.907 . . . . 73.319999999999993 110.354 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 12.4 ptp180 -70.64 -22.52 62.5 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 120.798 0.332 . . . . 73.340000000000003 111.391 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 54.4 mt-30 -71.39 -20.12 62.18 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.161 -0.472 . . . . 75.430000000000007 110.807 174.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.62 24.96 12.56 Favored Glycine 0 N--CA 1.415 -2.758 0 C-N-CA 120.103 -1.046 . . . . 70.530000000000001 113.278 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.6 mt -88.44 -46.75 8.88 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.692 -0.803 . . . . 74.329999999999998 110.593 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.459 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 22.1 m-85 -89.87 10.86 22.14 Favored 'General case' 0 C--O 1.21 -0.99 0 O-C-N 121.913 -0.492 . . . . 64.549999999999997 112.258 -177.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -71.67 -11.71 60.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.754 1.02 . . . . 71.209999999999994 113.754 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -82.47 -10.17 59.13 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 122.056 -0.403 . . . . 73.040000000000006 111.012 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 80' ' ' LEU . 3.3 tm? -59.32 -29.59 67.74 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.515 0.509 . . . . 71.219999999999999 110.602 -174.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.483 ' HD3' ' C ' ' A' ' 81' ' ' LYS . 12.1 tmtt? -58.97 -41.72 88.2 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.442 -0.345 . . . . 74.209999999999994 111.445 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -98.68 13.15 33.16 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 120.802 0.334 . . . . 60.140000000000001 111.856 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.02 131.66 35.32 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.101 -1.074 . . . . 65.400000000000006 108.101 175.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -104.12 130.72 51.84 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.593 -0.443 . . . . 72.420000000000002 110.305 -174.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 103' ' ' TRP . 50.8 p90 -70.52 122.29 19.42 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.619 0.724 . . . . 63.409999999999997 112.028 -177.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.47 95.89 7.96 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 107.044 -1.465 . . . . 72.140000000000001 107.044 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.1 tp -72.66 84.14 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 122.615 1.198 . . . . 73.109999999999999 111.233 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -88.39 -43.71 11.29 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.159 -1.382 . . . . 74.129999999999995 107.481 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 91' ' ' GLY . 13.2 p -152.22 147.82 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.083 -1.821 . . . . 61.539999999999999 106.083 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.4 m -90.31 -19.3 24.22 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.525 0.679 . . . . 74.540000000000006 110.006 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.448 ' H ' HG23 ' A' ' 89' ' ' VAL . . . 140.83 -122.41 2.12 Favored Glycine 0 N--CA 1.424 -2.103 0 N-CA-C 110.795 -0.922 . . . . 72.040000000000006 110.795 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -150.45 147.8 27.97 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.545 -0.539 . . . . 73.209999999999994 109.545 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.426 HG21 ' H ' ' A' ' 94' ' ' LYS . 10.7 p -146.51 -179.25 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 104.222 -2.511 . . . . 72.519999999999996 104.222 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.426 ' H ' HG21 ' A' ' 93' ' ' VAL . 59.4 tttp 78.92 -44.3 0.35 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.405 1.082 . . . . 70.540000000000006 111.199 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -141.14 92.92 2.53 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 107.986 -1.116 . . . . 73.409999999999997 107.986 176.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.56 107.25 0.7 Allowed Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 111.254 -0.739 . . . . 61.340000000000003 111.254 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -75.84 118.54 18.74 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 108.509 -0.923 . . . . 73.129999999999995 108.509 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -149.22 141.08 8.6 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.468 -1.053 . . . . 54.119999999999997 110.468 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -121.03 136.52 54.97 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.3 -0.63 . . . . 75.310000000000002 109.3 -177.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.41 ' HD3' ' HA2' ' A' ' 91' ' ' GLY . 13.5 mptt -124.97 107.55 10.96 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.869 0.731 . . . . 74.450000000000003 109.155 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -106.48 117.14 33.28 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.713 -1.217 . . . . 73.400000000000006 107.713 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 8.2 p -120.35 125.07 73.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 122.037 0.923 . . . . 65.540000000000006 112.522 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 25.8 m-90 -105.73 147.23 28.8 Favored 'General case' 0 CA--C 1.472 -2.034 0 CA-C-N 114.613 -1.176 . . . . 75.120000000000005 109.356 178.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -121.64 123.66 42.45 Favored 'General case' 0 N--CA 1.403 -2.82 0 N-CA-C 105.713 -1.958 . . . . 74.319999999999993 105.713 172.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.2 m -71.95 177.95 4.01 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.897 -0.592 . . . . 50.030000000000001 110.082 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.86 120.85 8.61 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-O 121.1 0.476 . . . . 70.209999999999994 110.97 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.2 135.47 38.5 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 114.51 -1.223 . . . . 75.319999999999993 110.749 -176.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -124.64 123.46 40.09 Favored 'General case' 0 C--O 1.255 1.348 0 N-CA-C 108.494 -0.928 . . . . 74.239999999999995 108.494 -175.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -72.55 158.35 35.85 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 123.989 0.915 . . . . 72.409999999999997 111.463 -173.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.7 t -137.86 154.84 49.44 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.579 -0.897 . . . . 72.409999999999997 108.579 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -66.73 -14.81 62.99 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.694 0.627 . . . . 74.420000000000002 112.694 -174.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -80.38 -0.26 36.17 Favored 'General case' 0 C--O 1.2 -1.5 0 CA-C-O 119.478 -0.296 . . . . 75.239999999999995 111.282 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 75.82 10.48 3.28 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.415 1.086 . . . . 73.129999999999995 109.533 -173.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -95.11 162.62 13.64 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.914 -1.513 . . . . 75.109999999999999 106.914 176.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.4 mp -133.14 140.15 47.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 N-CA-C 106.216 -1.772 . . . . 74.25 106.216 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.96 143.84 49.23 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.379 -0.528 . . . . 64.200000000000003 111.79 177.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -144.95 173.92 11.47 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 106.978 -1.49 . . . . 74.349999999999994 106.978 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -107.71 141.28 39.48 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 106.384 -1.71 . . . . 64.519999999999996 106.384 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -114.97 144.55 43.41 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 119.784 -0.766 . . . . 74.310000000000002 110.485 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -133.76 117.26 16.71 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.537 -0.756 . . . . 73.120000000000005 109.109 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -115.9 110.3 18.81 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 109.281 -0.637 . . . . 75.239999999999995 109.281 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.12 125.5 46.24 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.377 -0.601 . . . . 73.329999999999998 109.377 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -111.45 121.08 44.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.75 -0.833 . . . . 74.420000000000002 108.75 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.2 mt -120.42 153.32 23.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 108.537 -0.912 . . . . 72.409999999999997 108.537 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -141.25 152.12 44.28 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 108.553 -0.906 . . . . 74.140000000000001 108.553 174.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -80.8 115.29 20.22 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.605 -0.887 . . . . 74.310000000000002 108.605 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -79.05 140.87 37.81 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.803 -1.925 . . . . 74.519999999999996 105.803 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -64.83 -14.71 60.23 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.327 0.584 . . . . 73.420000000000002 111.874 -170.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.8 -16.46 63.1 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 124.557 1.143 . . . . 74.340000000000003 111.314 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.67 -8.86 43.87 Favored Glycine 0 CA--C 1.5 -0.851 0 C-N-CA 121.073 -0.584 . . . . 74.340000000000003 111.805 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.9 t -104.7 130.14 52.79 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 106.547 -1.649 . . . . 73.349999999999994 106.547 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.521 ' SG ' HG12 ' A' ' 21' ' ' VAL . 12.0 t -83.79 134.81 34.71 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.522 -1.288 . . . . 73.400000000000006 107.522 177.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -133.12 154.53 50.51 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.093 -0.706 . . . . 73.219999999999999 109.093 -173.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.0 mp -75.14 128.82 36.38 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 120.875 0.369 . . . . 74.109999999999999 110.472 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -72.46 -56.39 5.48 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.068 -1.086 . . . . 73.209999999999994 108.068 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.7 m -172.62 157.73 3.93 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.799 -1.556 . . . . 73.109999999999999 106.799 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.7 m -131.73 149.3 32.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 107.543 -1.281 . . . . 61.32 107.543 172.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -131.61 131.96 43.66 Favored 'General case' 0 C--N 1.266 -3.046 0 C-N-CA 123.107 0.563 . . . . 74.409999999999997 110.121 -172.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 72.8 m-85 -121.93 129.02 52.18 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.348 -0.982 . . . . 74.099999999999994 108.348 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.0 pt -131.74 99.12 3.59 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-O 122.162 0.982 . . . . 73.420000000000002 109.142 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 58.4 mtm -85.44 133.64 34.1 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.653 -1.158 . . . . 73.420000000000002 110.836 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . 0.267 51.3 p 62.61 73.15 0.47 Allowed 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 125.953 1.701 . . . . 74.439999999999998 113.222 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -113.83 131.26 56.31 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 114.433 -1.258 . . . . 74.230000000000004 108.106 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -112.11 149.69 31.79 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.752 -0.658 . . . . 54.420000000000002 112.508 -173.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.58 105.85 52.0 Favored Pre-proline 0 N--CA 1.429 -1.486 0 N-CA-C 107.057 -1.46 . . . . 74.549999999999997 107.057 169.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.51 147.83 77.63 Favored 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 122.609 2.206 . . . . 74.439999999999998 111.302 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -70.77 156.03 40.03 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 116.287 -0.415 . . . . 71.430000000000007 110.54 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 28.7 m -93.64 135.09 29.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.95 -0.568 . . . . 75.439999999999998 109.99 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.43 0 N-CA-C 108.728 -0.842 . . . . 73.510000000000005 108.728 179.966 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 CA--C 1.507 -0.676 0 N-CA-C 109.431 -0.581 . . . . 74.0 109.431 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.6 ttt 69.02 15.83 8.77 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.576 1.15 . . . . 75.140000000000001 110.2 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.5 t -73.45 129.78 36.07 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 N-CA-C 107.308 -1.367 . . . . 71.109999999999999 107.308 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.6 m -33.23 -63.95 0.22 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 126.0 1.72 . . . . 73.010000000000005 115.632 -170.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -72.75 -40.4 66.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.907 0.384 . . . . 70.140000000000001 111.827 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.51 -38.21 77.49 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.241 -0.652 . . . . 74.140000000000001 109.241 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.96 -45.51 74.02 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.715 -0.675 . . . . 74.409999999999997 110.214 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.526 ' HB ' ' SG ' ' A' ' 132' ' ' CYS . 14.6 p -65.84 -42.74 92.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 112.25 0.463 . . . . 75.439999999999998 112.25 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 -28.61 60.73 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 118.673 -1.211 . . . . 71.430000000000007 110.772 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.24 -44.84 63.92 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.415 -0.811 . . . . 54.219999999999999 111.874 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.46 -34.85 70.58 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 108.905 -0.776 . . . . 71.239999999999995 108.905 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.98 -40.94 99.92 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 111.244 -0.742 . . . . 54.119999999999997 111.244 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -69.62 -44.98 69.57 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 120.991 -0.284 . . . . 74.109999999999999 110.259 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.42 -42.6 99.0 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.687 0.395 . . . . 74.239999999999995 110.539 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.431 ' CE1' HD12 ' A' ' 45' ' ' LEU . 18.0 t80 -62.46 -54.59 37.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.238 -0.892 . . . . 73.540000000000006 110.016 177.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 29' ' ' ILE . 8.3 mm -63.31 -35.78 73.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 112.149 0.426 . . . . 74.030000000000001 112.149 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -62.85 -48.95 76.81 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 119.409 -0.329 . . . . 71.510000000000005 110.568 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 pp -67.6 -30.79 70.48 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.348 -0.541 . . . . 73.140000000000001 111.315 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.34 -24.01 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-O 121.484 0.659 . . . . 75.340000000000003 110.912 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.5 p -115.5 14.22 16.59 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 121.504 -0.748 . . . . 64.019999999999996 110.59 -176.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -81.54 145.3 30.75 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.762 -0.654 . . . . 74.409999999999997 111.861 -173.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.5 m -51.2 160.36 0.91 Allowed Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 126.421 1.889 . . . . 62.240000000000002 113.113 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.06 -6.83 6.88 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 124.289 3.326 . . . . 65.310000000000002 112.897 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -61.46 -27.03 68.28 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.277 -1.009 . . . . 72.409999999999997 108.277 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.4 m -96.7 123.31 40.34 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 103.778 -2.675 . . . . 74.540000000000006 103.778 168.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.7 t -49.92 -53.07 11.75 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 113.301 0.852 . . . . 74.409999999999997 113.301 -170.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -147.64 127.82 13.81 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.29 -1.004 . . . . 72.319999999999993 108.29 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.3 m -59.47 -36.51 76.13 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.602 0.564 . . . . 64.420000000000002 109.848 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -73.83 -21.17 60.22 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.153 -0.93 . . . . 72.310000000000002 110.268 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -76.77 -43.33 37.37 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.483 -1.303 . . . . 64.329999999999998 107.483 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -63.07 -35.34 79.91 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.597 -0.89 . . . . 75.430000000000007 108.597 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.431 HD12 ' CE1' ' A' ' 28' ' ' PHE . 35.2 tp -68.2 -44.34 76.04 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.639 -0.71 . . . . 75.420000000000002 110.097 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.83 -31.5 71.75 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.355 0.598 . . . . 64.319999999999993 110.529 177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -71.72 -40.52 69.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.909 -1.041 . . . . 72.530000000000001 109.627 177.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -69.3 -44.32 72.0 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.028 -0.533 . . . . 74.420000000000002 110.511 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.404 ' C ' HD12 ' A' ' 49' ' ' LEU . 4.1 pp -80.75 -2.03 45.3 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.95 -0.568 . . . . 75.209999999999994 111.052 -177.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.26 -60.47 6.69 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 119.926 -0.374 . . . . 74.239999999999995 112.906 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.51 -6.4 12.67 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.114 1.876 . . . . 74.420000000000002 111.904 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -118.52 38.26 3.8 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.773 -0.454 . . . . 72.319999999999993 109.773 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -55.78 105.89 0.59 Allowed Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 124.627 1.171 . . . . 73.409999999999997 112.815 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -98.89 -168.93 0.1 Allowed 'Trans proline' 0 N--CA 1.43 -2.216 0 C-N-CA 122.825 2.35 . . . . 73.450000000000003 111.177 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -91.66 104.74 17.17 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.782 -1.192 . . . . 74.329999999999998 107.782 176.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.6 mt -89.65 106.85 17.49 Favored 'Isoleucine or valine' 0 C--O 1.18 -2.59 0 CA-C-N 115.391 -0.822 . . . . 74.209999999999994 109.054 -175.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -96.23 107.68 20.05 Favored 'General case' 0 C--N 1.276 -2.608 0 O-C-N 121.55 -0.719 . . . . 72.0 111.815 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.418 HG22 ' HB2' ' A' ' 139' ' ' PHE . 70.0 t -108.3 111.59 36.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 108.398 -0.964 . . . . 73.319999999999993 108.398 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 63.25 21.15 12.68 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.624 -1.171 . . . . 71.329999999999998 110.329 -177.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.49 -5.45 62.54 Favored Glycine 0 N--CA 1.437 -1.237 0 CA-C-N 114.87 -1.059 . . . . 64.430000000000007 111.967 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -95.7 125.68 40.45 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 109.592 -0.521 . . . . 75.129999999999995 109.592 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.2 127.21 35.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.643 0.735 . . . . 73.510000000000005 109.54 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -128.41 150.94 49.9 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.949 -1.13 . . . . 73.140000000000001 107.949 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -101.57 172.9 6.68 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.283 -1.006 . . . . 73.540000000000006 108.283 172.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -45.53 -40.46 8.62 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 125.179 1.392 . . . . 65.239999999999995 112.231 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.6 m -65.4 -44.67 86.71 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.124 0.487 . . . . 53.25 111.358 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.64 -44.94 76.73 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.697 -0.483 . . . . 74.129999999999995 109.697 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -53.62 -56.2 19.3 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.206 0.602 . . . . 73.200000000000003 109.863 175.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -49.95 -43.8 50.21 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.276 -1.329 . . . . 71.530000000000001 110.765 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -60.22 -47.5 85.69 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 111.9 0.333 . . . . 70.239999999999995 111.9 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.451 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 33.7 m-85 -66.94 -36.37 82.08 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.514 0.674 . . . . 65.200000000000003 110.008 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -57.85 -54.8 42.87 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.543 -0.753 . . . . 72.510000000000005 110.637 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -66.83 -29.67 69.66 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.519 -0.31 . . . . 75.519999999999996 110.69 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -73.67 -15.35 61.24 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 112.273 0.472 . . . . 71.439999999999998 112.273 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.48 13.78 25.42 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 119.931 -1.128 . . . . 73.200000000000003 114.544 175.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.38 -56.56 4.89 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.183 0.516 . . . . 71.409999999999997 110.96 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.451 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 43.1 m-85 -83.52 -5.31 59.13 Favored 'General case' 0 C--O 1.21 -0.995 0 N-CA-C 112.911 0.708 . . . . 73.230000000000004 112.911 -172.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -14.19 61.8 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.095 -1.042 . . . . 73.530000000000001 111.795 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -85.33 -16.59 39.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.169 0.509 . . . . 72.5 110.377 175.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.481 HD11 ' O ' ' A' ' 80' ' ' LEU . 3.2 tm? -89.32 -15.73 32.74 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 108.109 -1.071 . . . . 73.109999999999999 108.109 -178.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.501 ' HD3' ' C ' ' A' ' 81' ' ' LYS . 11.2 tmtt? -52.18 -41.74 62.89 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.969 0.908 . . . . 75.120000000000005 111.963 -177.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -88.46 14.61 9.36 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.561 0.696 . . . . 74.349999999999994 111.686 -174.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.52 150.92 47.57 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.989 0.737 . . . . 64.239999999999995 112.989 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -106.26 136.14 46.51 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.524 -1.287 . . . . 64.540000000000006 107.524 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.634 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 53.0 p90 -99.15 140.33 33.48 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.545 0.943 . . . . 62.329999999999998 113.545 -175.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.03 124.18 45.12 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 106.914 -1.513 . . . . 72.230000000000004 106.914 175.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.5 tt -77.13 98.51 2.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 122.184 0.992 . . . . 74.310000000000002 111.136 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -82.65 127.3 33.26 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.605 -1.628 . . . . 74.150000000000006 106.605 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.8 106.98 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.2 0.524 . . . . 73.129999999999995 112.124 -173.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 m -90.12 170.05 10.64 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.926 -1.139 . . . . 72.430000000000007 107.926 176.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.486 ' HA3' ' OE1' ' A' ' 97' ' ' GLU . . . -79.65 139.12 21.18 Favored Glycine 0 N--CA 1.428 -1.872 0 C-N-CA 120.249 -0.977 . . . . 74.219999999999999 111.705 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -74.54 -50.52 17.77 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.595 -0.52 . . . . 71.099999999999994 109.595 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.1 t -138.82 93.3 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-N 116.21 -0.45 . . . . 75.299999999999997 110.915 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -139.6 134.22 31.8 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.012 -0.736 . . . . 74.299999999999997 109.012 170.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.72 -0.73 19.08 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 112.873 0.694 . . . . 71.319999999999993 112.873 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.7 98.01 0.14 Allowed Glycine 0 N--CA 1.428 -1.879 0 C-N-CA 120.449 -0.881 . . . . 71.420000000000002 111.656 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.486 ' OE1' ' HA3' ' A' ' 91' ' ' GLY . 10.0 pt-20 -156.53 175.25 14.28 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.753 -0.462 . . . . 72.549999999999997 109.753 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -116.7 139.56 15.27 Favored Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 109.456 -1.458 . . . . 73.400000000000006 109.456 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -106.34 150.43 25.99 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.2 -1.778 . . . . 73.219999999999999 106.2 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HE2' ' CE2' ' A' ' 123' ' ' TYR . 35.9 ttmt -136.23 129.79 32.11 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.465 -0.568 . . . . 74.140000000000001 109.465 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.5 mt -126.79 127.1 44.49 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.259 -1.386 . . . . 73.519999999999996 107.259 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.5 p -125.64 127.03 71.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 113.302 0.852 . . . . 72.519999999999996 113.302 -174.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.634 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 20.4 m-90 -104.16 151.03 23.81 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.642 -1.163 . . . . 75.5 108.523 178.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.508 ' HB2' ' HZ2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -135.79 133.54 38.01 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.908 -2.256 . . . . 75.430000000000007 104.908 176.175 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.7 p -68.62 171.78 7.17 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 118.09 0.405 . . . . 74.040000000000006 110.346 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.72 121.03 10.04 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.827 -0.434 . . . . 64.540000000000006 109.827 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.29 135.12 52.83 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 124.045 0.841 . . . . 71.340000000000003 111.063 -174.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -131.08 136.02 48.05 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.906 -1.146 . . . . 71.140000000000001 107.906 -175.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -84.6 130.15 34.76 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.575 -0.85 . . . . 73.430000000000007 110.711 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.464 ' HB3' ' OD2' ' A' ' 112' ' ' ASP . 38.5 t -88.5 177.42 6.8 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.373 -0.83 . . . . 72.140000000000001 111.088 -174.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -77.08 -15.31 59.62 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 122.142 0.972 . . . . 71.040000000000006 110.648 -175.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.64 ' OD2' ' HG2' ' A' ' 114' ' ' LYS . 1.1 p30 -87.87 1.17 54.69 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.299 -1.319 . . . . 75.439999999999998 110.537 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 78.44 9.88 1.98 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.287 1.835 . . . . 73.329999999999998 112.493 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.64 ' HG2' ' OD2' ' A' ' 112' ' ' ASP . 57.3 pttt -108.33 173.89 6.12 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.354 -0.841 . . . . 72.439999999999998 109.26 175.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.02 132.65 53.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.92 -0.771 . . . . 74.329999999999998 108.92 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.08 154.77 29.35 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 109.171 -0.677 . . . . 73.209999999999994 109.171 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 6.4 p90 -161.17 173.89 14.45 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 124.572 1.149 . . . . 74.340000000000003 108.223 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -113.14 137.61 51.18 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.153 -1.795 . . . . 75.519999999999996 106.153 176.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -115.01 151.92 33.35 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 119.947 -0.701 . . . . 74.230000000000004 111.71 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -139.6 117.49 11.7 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.03 -0.986 . . . . 75.439999999999998 108.52 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -123.98 112.35 17.08 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.572 0.701 . . . . 75.420000000000002 110.324 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -93.78 133.38 37.22 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.372 -0.831 . . . . 75.439999999999998 109.925 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.461 ' CE2' ' HE2' ' A' ' 100' ' ' LYS . 35.9 m-85 -115.9 122.82 46.46 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 124.153 0.908 . . . . 64.319999999999993 108.617 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.5 mt -120.84 141.59 40.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.281 -1.748 . . . . 75.420000000000002 106.281 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -130.17 150.8 51.26 Favored 'General case' 0 C--O 1.268 2.045 0 C-N-CA 117.417 -1.713 . . . . 72.209999999999994 112.853 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.423 ' HD3' ' SG ' ' A' ' 132' ' ' CYS . 4.6 tpp180 -75.28 104.67 5.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 104.633 -2.358 . . . . 74.329999999999998 104.633 174.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 131' ' ' SER . 57.0 ttt180 -85.45 139.73 31.28 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.417 -0.81 . . . . 71.310000000000002 110.69 -168.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -59.77 -10.41 3.78 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.961 1.304 . . . . 74.209999999999994 112.641 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -78.41 -16.39 57.67 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 123.882 0.873 . . . . 74.129999999999995 110.604 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.06 -5.85 50.44 Favored Glycine 0 C--O 1.24 0.525 0 N-CA-C 111.042 -0.823 . . . . 72.030000000000001 111.042 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' A' ' 127' ' ' ARG . 12.0 p -103.86 169.85 8.27 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 109.66 -0.496 . . . . 74.430000000000007 109.66 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.526 ' SG ' ' HB ' ' A' ' 21' ' ' VAL . 68.8 m -121.67 125.27 46.27 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 106.891 -1.522 . . . . 72.430000000000007 106.891 174.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -140.82 155.39 46.38 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.516 -0.873 . . . . 71.099999999999994 109.533 -169.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.0 mp -67.55 125.95 27.79 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 109.093 -0.706 . . . . 73.109999999999999 109.093 176.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -83.34 -53.65 5.58 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 108.897 -0.779 . . . . 74.400000000000006 108.897 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.0 m -166.71 161.45 15.64 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.874 -1.528 . . . . 73.230000000000004 106.874 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.1 m -141.28 139.59 32.68 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 105.751 -1.944 . . . . 54.219999999999999 105.751 172.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -115.15 132.12 56.71 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 110.196 -0.298 . . . . 74.040000000000006 110.196 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.418 ' HB2' HG22 ' A' ' 58' ' ' VAL . 64.7 m-85 -118.53 122.42 42.63 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 107.517 -1.29 . . . . 73.230000000000004 107.517 175.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.3 pt -126.24 98.57 4.98 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.551 0 CA-C-O 122.079 0.943 . . . . 75.150000000000006 109.112 -178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.4 mtm -85.89 127.47 34.6 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.293 -1.321 . . . . 71.420000000000002 111.213 -174.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 70.7 m 71.64 75.43 0.17 Allowed 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 113.794 -1.548 . . . . 74.200000000000003 114.145 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -116.13 152.66 33.22 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.249 -1.341 . . . . 72.510000000000005 107.547 172.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -136.4 158.65 43.94 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 120.775 -0.37 . . . . 73.219999999999999 110.488 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 114' ' ' LYS . . . -107.96 130.06 23.3 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 108.299 -1.0 . . . . 73.230000000000004 108.299 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.3 133.17 47.84 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.935 2.423 . . . . 71.120000000000005 112.43 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -87.25 169.82 11.98 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.49 -0.777 . . . . 75.409999999999997 109.41 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.0 p -125.18 139.03 52.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.981 -0.748 . . . . 74.430000000000007 108.981 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.28 0 N-CA-C 108.3 -1.0 . . . . 73.209999999999994 108.3 177.848 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 . . . . . 0 CA--C 1.509 -0.613 0 CA-C-O 120.462 0.172 . . . . 73.129999999999995 111.198 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.0 mtt -127.22 102.03 6.75 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.298 0.571 . . . . 60.450000000000003 111.474 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 t -89.68 165.85 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 106.492 -1.67 . . . . 64.239999999999995 106.492 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.3 p -40.09 -66.56 0.3 Allowed 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 115.226 1.565 . . . . 73.120000000000005 115.226 -173.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.537 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 8.4 m-20 -68.91 -27.27 65.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.131 0.491 . . . . 75.129999999999995 111.901 -176.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.38 -40.61 73.86 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.934 -1.136 . . . . 64.519999999999996 107.934 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -61.66 -51.63 67.63 Favored 'General case' 0 CA--C 1.496 -1.132 0 C-N-CA 124.159 0.984 . . . . 74.519999999999996 109.982 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.45 HG11 ' NH2' ' A' ' 126' ' ' ARG . 7.3 p -64.88 -42.74 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.358 -0.837 . . . . 74.319999999999993 112.893 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 17.3 ptpt -74.48 -24.73 59.06 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 118.622 -1.231 . . . . 75.140000000000001 111.745 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.47 -54.45 12.89 Favored Glycine 0 N--CA 1.428 -1.867 0 C-N-CA 120.633 -0.794 . . . . 71.219999999999999 111.166 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.79 -36.04 72.84 Favored 'General case' 0 C--O 1.213 -0.864 0 N-CA-C 109.159 -0.682 . . . . 54.549999999999997 109.159 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.52 -43.08 98.63 Favored Glycine 0 C--O 1.254 1.359 0 CA-C-N 116.213 -0.448 . . . . 75.230000000000004 112.57 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -73.32 -39.5 65.23 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 119.56 -0.856 . . . . 74.540000000000006 109.8 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.51 -39.32 94.11 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.028 0.442 . . . . 75.120000000000005 110.334 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.407 ' CE2' HD12 ' A' ' 45' ' ' LEU . 31.7 t80 -61.31 -53.17 60.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.293 -0.867 . . . . 73.439999999999998 109.623 176.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 29' ' ' ILE . 7.7 mm -64.43 -33.76 64.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 112.202 0.445 . . . . 65.219999999999999 112.202 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.86 -52.12 66.4 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 122.588 0.355 . . . . 61.009999999999998 110.614 175.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.81 -26.32 64.2 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 120.347 -0.541 . . . . 75.430000000000007 111.538 -176.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.7 t -70.75 -26.08 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 CA-C-O 120.983 0.421 . . . . 74.420000000000002 110.698 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.4 p -109.75 14.99 23.05 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.855 0.836 . . . . 71.019999999999996 109.895 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -62.29 147.95 46.52 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 114.306 -1.316 . . . . 74.140000000000001 111.203 -176.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.7 p -54.64 158.35 4.38 Favored Pre-proline 0 C--N 1.313 -0.983 0 C-N-CA 125.196 1.398 . . . . 75.420000000000002 113.282 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.38 -7.01 18.95 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.917 2.411 . . . . 73.299999999999997 111.13 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.33 -27.67 67.54 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.317 -0.856 . . . . 71.25 109.777 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 p -100.78 143.39 31.0 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.536 -1.283 . . . . 74.109999999999999 107.536 173.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.9 p -51.32 -52.58 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.887 1.069 . . . . 71.519999999999996 113.887 -173.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -150.82 136.73 18.25 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 122.381 0.272 . . . . 64.019999999999996 110.454 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.6 m -67.98 -33.66 75.06 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 122.337 1.065 . . . . 72.430000000000007 108.778 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -70.06 -20.32 63.23 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.427 -1.26 . . . . 74.200000000000003 111.408 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -69.95 -46.75 64.61 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 107.646 -1.242 . . . . 73.230000000000004 107.646 177.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.29 -34.15 77.35 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.818 -1.083 . . . . 75.510000000000005 109.076 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.407 HD12 ' CE2' ' A' ' 28' ' ' PHE . 44.1 tp -66.28 -41.73 89.44 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.808 -0.633 . . . . 73.120000000000005 110.651 177.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.53 -35.9 80.9 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.326 0.584 . . . . 51.32 110.437 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -72.99 -35.94 66.97 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.939 -1.028 . . . . 72.430000000000007 110.157 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -68.5 -43.03 77.71 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 116.045 -0.525 . . . . 75.239999999999995 109.846 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.2 pp -77.79 -2.11 34.78 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.942 -0.572 . . . . 73.010000000000005 111.281 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.71 -63.84 2.35 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 123.746 0.654 . . . . 70.319999999999993 112.766 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -82.73 -8.56 11.25 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.849 1.699 . . . . 75.129999999999995 111.935 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 45.8 m-70 -100.45 27.94 5.4 Favored 'General case' 0 C--O 1.213 -0.863 0 N-CA-C 109.014 -0.736 . . . . 73.340000000000003 109.014 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.457 ' CG ' HG22 ' A' ' 65' ' ' THR . 10.2 t70 -52.44 100.77 0.24 Allowed Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 127.844 2.457 . . . . 74.409999999999997 111.661 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -114.17 -154.91 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 124.22 3.28 . . . . 73.439999999999998 112.131 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -94.06 123.74 37.63 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.149 -1.056 . . . . 73.219999999999999 108.149 176.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.45 HD12 ' CB ' ' A' ' 68' ' ' PHE . 74.3 mt -109.46 112.97 42.82 Favored 'Isoleucine or valine' 0 C--O 1.177 -2.711 0 N-CA-C 108.734 -0.839 . . . . 74.109999999999999 108.734 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.54 138.52 33.1 Favored 'General case' 0 C--N 1.269 -2.924 0 N-CA-C 108.825 -0.805 . . . . 75.510000000000005 108.825 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.4 t -132.58 112.69 19.4 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 107.906 -1.146 . . . . 72.519999999999996 107.906 176.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 63.7 20.39 12.2 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.914 1.285 . . . . 73.450000000000003 111.068 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.11 2.25 58.13 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.748 -0.66 . . . . 74.400000000000006 112.222 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -108.17 132.76 53.29 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.896 -0.779 . . . . 73.5 108.896 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.412 HD11 ' N ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -78.77 127.9 38.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 121.699 0.761 . . . . 74.040000000000006 109.658 -175.354 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.412 ' N ' HD11 ' A' ' 62' ' ' ILE . 50.3 mm-40 -126.81 149.19 49.81 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.388 -1.338 . . . . 71.400000000000006 107.388 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.1 t -87.38 173.52 9.09 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.313 -0.625 . . . . 75.510000000000005 109.313 174.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.457 HG22 ' CG ' ' A' ' 53' ' ' ASP . 18.5 p -61.4 -38.31 86.63 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 125.361 1.464 . . . . 75.310000000000002 110.543 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 m -59.62 -46.65 88.36 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.518 -1.219 . . . . 63.329999999999998 110.584 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.24 -47.26 83.17 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.066 0.546 . . . . 73.120000000000005 109.994 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CB ' HD12 ' A' ' 56' ' ' ILE . 38.4 t80 -51.24 -55.95 15.43 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 123.759 0.662 . . . . 75.019999999999996 110.371 174.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -51.07 -45.34 61.37 Favored 'General case' 0 C--O 1.245 0.834 0 O-C-N 124.315 1.01 . . . . 74.040000000000006 110.826 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 46.7 mt-30 -58.75 -50.9 72.21 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 116.133 -0.485 . . . . 72.519999999999996 111.861 175.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.444 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 38.4 m-85 -65.76 -35.53 80.98 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.495 0.664 . . . . 73.439999999999998 109.989 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -57.23 -53.34 59.24 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.55 -0.75 . . . . 74.319999999999993 110.748 176.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -72.13 -22.0 61.39 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 120.832 0.348 . . . . 72.340000000000003 111.293 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 16.5 mm100 -76.29 -11.21 59.87 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 116.226 -0.443 . . . . 63.210000000000001 112.133 174.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.21 27.23 11.07 Favored Glycine 0 N--CA 1.428 -1.837 0 C-N-CA 120.209 -0.996 . . . . 72.450000000000003 113.081 177.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.67 -53.02 5.41 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.108 0.48 . . . . 75.400000000000006 110.654 177.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 35.1 m-85 -91.72 6.51 45.64 Favored 'General case' 0 C--O 1.208 -1.086 0 N-CA-C 113.167 0.803 . . . . 74.230000000000004 113.167 -173.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -11.97 30.04 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.262 0.838 . . . . 72.510000000000005 113.262 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -75.48 -11.28 60.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.081 -0.509 . . . . 74.019999999999996 111.232 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 tt -69.63 -25.6 64.02 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.585 0.707 . . . . 75.310000000000002 109.296 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.2 tmtp? -62.71 -32.84 74.02 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 124.559 1.143 . . . . 72.319999999999993 109.481 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -105.79 4.62 30.06 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.633 0.73 . . . . 73.230000000000004 110.457 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.36 146.09 33.05 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.66 0.615 . . . . 73.329999999999998 112.66 -173.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -102.53 133.81 46.9 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.741 -0.663 . . . . 73.120000000000005 109.29 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -89.38 151.84 21.83 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 113.288 0.848 . . . . 74.299999999999997 113.288 -173.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -142.05 134.9 28.62 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.018 -1.104 . . . . 73.120000000000005 108.018 174.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.2 tt -101.54 133.12 45.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 109.347 -0.612 . . . . 74.540000000000006 109.347 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -99.83 87.72 3.6 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.944 -0.703 . . . . 74.329999999999998 111.181 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.8 m -77.61 148.47 6.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.018 -0.992 . . . . 74.319999999999993 109.234 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.5 t 69.24 16.78 8.42 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.159 0.984 . . . . 63.43 108.627 -176.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.74 -34.16 77.36 Favored Glycine 0 C--N 1.344 0.979 0 CA-C-N 115.219 -0.901 . . . . 73.040000000000006 111.596 -178.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 96' ' ' GLY . 46.2 tptt -140.82 115.57 9.62 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.466 -1.309 . . . . 65.329999999999998 107.466 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.6 m -104.66 2.88 10.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-O 121.105 0.479 . . . . 74.510000000000005 111.458 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -95.06 -178.57 4.52 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.976 -0.556 . . . . 74.299999999999997 110.694 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.28 -20.27 65.32 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.628 1.171 . . . . 72.319999999999993 112.84 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.441 ' O ' ' HG2' ' A' ' 92' ' ' LYS . . . -73.96 87.91 0.66 Allowed Glycine 0 N--CA 1.428 -1.856 0 N-CA-C 111.446 -0.661 . . . . 74.329999999999998 111.446 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -58.92 118.55 5.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.678 -0.49 . . . . 75.140000000000001 109.678 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -149.77 138.65 6.9 Favored Glycine 0 N--CA 1.412 -2.921 0 N-CA-C 109.836 -1.305 . . . . 72.200000000000003 109.836 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -114.52 124.18 51.25 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.096 -1.446 . . . . 75.340000000000003 107.096 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -117.82 101.6 8.43 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 107.705 -1.221 . . . . 75.409999999999997 107.705 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -109.87 133.27 53.34 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.657 -1.156 . . . . 75.349999999999994 108.171 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 12.9 p -126.9 135.69 62.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-O 121.324 0.583 . . . . 74.140000000000001 110.771 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 27.9 m-90 -108.88 132.03 54.44 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.456 -0.942 . . . . 73.019999999999996 108.456 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -109.09 121.37 45.0 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.62 -1.252 . . . . 72.150000000000006 107.62 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.7 t -70.92 -171.75 0.58 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.368 -0.833 . . . . 75.540000000000006 111.368 -176.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.63 134.6 43.69 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.681 -0.69 . . . . 70.099999999999994 109.306 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -87.7 125.95 34.69 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 115.628 -0.715 . . . . 73.420000000000002 109.496 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -102.7 142.38 33.95 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 106.928 -1.508 . . . . 73.340000000000003 106.928 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -84.04 130.81 34.86 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.321 -0.552 . . . . 72.140000000000001 111.447 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.6 t -106.79 161.17 14.92 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.745 -0.835 . . . . 74.120000000000005 108.745 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -80.86 11.93 3.6 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.559 0.695 . . . . 74.439999999999998 112.365 -175.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -110.03 13.44 23.31 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 122.144 0.974 . . . . 75.439999999999998 109.011 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 68.17 10.46 7.84 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.148 1.379 . . . . 74.430000000000007 112.207 -178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 25.4 pttm -110.36 174.56 5.81 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.623 -0.88 . . . . 74.409999999999997 108.623 174.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.454 HG13 ' CE3' ' A' ' 117' ' ' TRP . 13.8 pt -113.22 157.04 14.04 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 CA-C-O 121.721 0.772 . . . . 71.0 111.483 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -108.04 118.16 36.02 Favored 'General case' 0 C--N 1.28 -2.428 0 C-N-CA 125.121 1.369 . . . . 75.239999999999995 107.943 176.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.454 ' CE3' HG13 ' A' ' 115' ' ' ILE . 40.1 p90 -133.46 174.29 10.57 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.79 -0.818 . . . . 74.040000000000006 108.79 176.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -132.53 147.0 52.35 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 105.59 -2.004 . . . . 72.540000000000006 105.59 176.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -125.27 155.26 40.42 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-O 121.138 0.495 . . . . 71.109999999999999 112.028 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -134.68 117.55 16.18 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.529 -0.76 . . . . 75.349999999999994 109.351 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -111.36 110.82 21.46 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 123.357 0.663 . . . . 75.420000000000002 109.842 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.14 131.48 45.15 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 109.039 -0.726 . . . . 73.0 109.039 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -115.93 114.65 24.94 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.568 -0.901 . . . . 73.040000000000006 108.568 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 59.0 mt -112.83 143.71 21.97 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.694 0 N-CA-C 106.643 -1.614 . . . . 74.219999999999999 106.643 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -127.43 148.41 50.29 Favored 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 118.668 -1.213 . . . . 71.319999999999993 109.006 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.45 ' NH2' HG11 ' A' ' 21' ' ' VAL . 19.4 ttm180 -90.09 115.01 27.03 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 106.007 -1.849 . . . . 74.349999999999994 106.007 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 23.2 ttp85 -67.55 144.26 55.71 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.484 -1.302 . . . . 74.200000000000003 107.484 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -63.54 -10.31 17.45 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.139 0.792 . . . . 71.439999999999998 113.139 -172.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -71.33 -16.82 62.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.115 -0.493 . . . . 73.219999999999999 110.269 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.37 -19.24 27.03 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 115.874 -0.603 . . . . 73.430000000000007 112.54 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.0 m -91.51 152.23 20.42 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 106.897 -1.52 . . . . 71.439999999999998 106.897 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 22.4 t -111.03 153.26 25.86 Favored 'General case' 0 C--N 1.271 -2.834 0 C-N-CA 121.11 -0.236 . . . . 71.140000000000001 110.411 -174.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -157.72 155.92 30.76 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.429 -0.952 . . . . 75.329999999999998 108.429 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.7 mp -67.18 130.31 42.7 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 110.193 -0.299 . . . . 74.239999999999995 110.193 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -82.27 -59.94 2.38 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.286 -1.376 . . . . 75.540000000000006 107.286 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.6 m -167.62 160.82 13.19 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.358 -1.719 . . . . 74.120000000000005 106.358 -176.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.51 152.19 34.73 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 N-CA-C 106.42 -1.696 . . . . 74.349999999999994 106.42 171.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -136.96 130.38 31.44 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-O 120.954 0.406 . . . . 72.540000000000006 109.932 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -110.78 143.17 41.74 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.362 -0.977 . . . . 71.109999999999999 108.362 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.4 pt -138.25 98.28 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-O 121.774 0.797 . . . . 75.299999999999997 109.341 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 22.1 ptp -93.14 136.89 32.99 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-N 115.095 -0.957 . . . . 73.030000000000001 108.742 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.1 t 81.39 73.92 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 O-C-N 125.017 1.448 . . . . 73.209999999999994 110.536 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -112.98 138.45 49.83 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 114.39 -1.277 . . . . 71.319999999999993 109.125 175.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -152.53 152.82 32.35 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.533 -1.212 . . . . 72.450000000000003 108.154 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.69 158.28 68.44 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 107.413 -1.328 . . . . 72.219999999999999 107.413 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -49.64 129.35 23.38 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 122.413 2.076 . . . . 73.430000000000007 110.366 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.41 ' HB3' ' HB3' ' A' ' 114' ' ' LYS . 6.6 p90 -63.54 156.26 26.96 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 113.159 0.799 . . . . 74.319999999999993 113.159 -171.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 19.7 m -129.09 150.51 34.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 115.063 -0.972 . . . . 74.299999999999997 108.584 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.286 -2.156 0 N-CA-C 108.14 -1.059 . . . . 70.530000000000001 108.14 178.381 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 109.388 -0.597 . . . . 75.430000000000007 109.388 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.1 mtt -91.57 119.32 31.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.414 -0.958 . . . . 73.230000000000004 108.414 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.32 -40.49 81.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 121.724 0.774 . . . . 73.430000000000007 109.767 -177.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 130' ' ' GLY . 18.0 p -73.38 -25.79 60.72 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.463 -1.244 . . . . 64.420000000000002 112.645 -176.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -77.62 -39.67 44.55 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-O 122.326 1.06 . . . . 74.120000000000005 108.713 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.58 -34.21 71.94 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.1 -1.409 . . . . 74.299999999999997 107.481 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.01 -49.96 70.39 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 114.759 -1.11 . . . . 72.510000000000005 110.559 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.62 -43.08 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 112.216 0.45 . . . . 72.140000000000001 112.216 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -70.47 -31.76 69.03 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 118.069 -1.452 . . . . 73.120000000000005 111.512 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.91 -37.13 83.25 Favored Glycine 0 C--O 1.218 -0.861 0 N-CA-C 110.641 -0.984 . . . . 62.210000000000001 110.641 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp -65.53 -50.02 66.78 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 124.348 1.059 . . . . 74.400000000000006 109.165 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.85 -36.82 93.91 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.475 -0.784 . . . . 72.329999999999998 112.228 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -69.98 -41.18 74.78 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 110.665 -0.124 . . . . 74.25 110.665 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.75 -40.2 96.5 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.81 0.814 . . . . 74.099999999999994 109.555 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.476 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 14.0 t80 -62.11 -55.32 30.12 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.068 -1.424 . . . . 73.439999999999998 109.705 176.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' A' ' 29' ' ' ILE . 12.3 mm -63.43 -35.19 71.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.98 -0.555 . . . . 73.329999999999998 111.89 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.29 -44.77 86.91 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 121.109 -0.236 . . . . 74.25 111.011 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.3 pp -70.63 -27.58 64.17 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.378 -0.929 . . . . 74.430000000000007 110.567 -178.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 79.1 t -73.6 -21.03 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 CA-C-O 121.173 0.511 . . . . 74.409999999999997 110.411 176.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.5 p -114.46 18.15 16.99 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.619 0.723 . . . . 73.530000000000001 110.131 -177.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -72.31 161.78 30.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.13 -0.941 . . . . 74.450000000000003 110.252 -176.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 m -48.06 144.94 5.38 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 124.463 1.105 . . . . 74.140000000000001 113.317 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.81 -7.74 15.77 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.56 2.84 . . . . 71.120000000000005 112.962 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -66.98 -26.57 66.87 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.163 0.506 . . . . 73.409999999999997 109.91 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.2 m -75.53 106.25 6.99 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.898 -1.149 . . . . 74.219999999999999 107.898 176.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.6 t -53.98 -52.7 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.097 -0.956 . . . . 75.340000000000003 113.075 -173.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -129.05 105.36 8.14 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.923 -0.711 . . . . 72.129999999999995 110.668 -175.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.1 t -65.92 -33.31 75.54 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 115.776 -0.647 . . . . 75.299999999999997 109.728 -175.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.29 -23.35 67.01 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.414 -0.812 . . . . 61.030000000000001 110.131 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 72' ' ' PHE . 52.8 t-80 -71.68 -45.48 61.78 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 109.84 -0.43 . . . . 73.129999999999995 109.84 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -69.72 -31.79 69.99 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.22 -1.03 . . . . 74.049999999999997 108.22 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.404 HD12 ' CE2' ' A' ' 28' ' ' PHE . 45.1 tp -67.1 -45.03 78.49 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.273 -0.876 . . . . 71.329999999999998 110.595 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.58 -32.0 73.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.244 0.545 . . . . 65.109999999999999 110.613 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -72.77 -37.05 67.76 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.901 -0.778 . . . . 74.030000000000001 108.901 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -63.41 -44.29 95.06 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.827 0.851 . . . . 75.439999999999998 111.073 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 pp -84.69 6.78 22.82 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 115.873 -0.603 . . . . 73.319999999999993 111.846 -177.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -47.73 -57.28 7.73 Favored Glycine 0 CA--C 1.548 2.139 0 CA-C-N 116.254 -0.43 . . . . 70.510000000000005 112.792 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -76.98 -3.43 13.76 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 123.101 2.534 . . . . 75.019999999999996 112.645 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -125.86 28.35 6.17 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.197 -0.314 . . . . 74.120000000000005 111.469 -169.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.453 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 25.4 m-20 -56.58 113.73 6.52 Favored Pre-proline 0 C--O 1.24 0.588 0 O-C-N 123.771 0.669 . . . . 71.319999999999993 111.544 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.451 ' HB2' ' HA ' ' A' ' 136' ' ' SER . 45.5 Cg_endo -101.45 -164.59 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 123.011 2.474 . . . . 70.109999999999999 112.058 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -90.8 125.06 35.6 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 106.986 -1.487 . . . . 72.400000000000006 106.986 173.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 mp -103.41 114.3 42.63 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.173 0 C-N-CA 119.024 -1.07 . . . . 74.129999999999995 109.298 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -96.83 132.03 42.97 Favored 'General case' 0 C--N 1.271 -2.812 0 N-CA-C 108.981 -0.748 . . . . 72.040000000000006 108.981 177.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 53.7 t -129.53 112.95 25.94 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 107.691 -1.226 . . . . 64.439999999999998 107.691 176.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 62.61 22.22 13.18 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.111 -0.95 . . . . 73.230000000000004 110.867 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.01 -2.41 66.08 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.076 -0.965 . . . . 72.510000000000005 112.185 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -98.37 126.87 44.05 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.292 -1.003 . . . . 74.120000000000005 108.292 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.413 HD11 ' N ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -76.81 127.83 37.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.924 0.868 . . . . 75.329999999999998 108.89 -177.335 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.413 ' N ' HD11 ' A' ' 62' ' ' ILE . 63.4 mm-40 -117.6 137.67 52.46 Favored 'General case' 0 C--O 1.284 2.881 0 N-CA-C 106.752 -1.573 . . . . 74.450000000000003 106.752 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -75.3 174.62 9.28 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 115.895 -0.593 . . . . 73.310000000000002 109.407 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.453 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 78.6 p -60.68 -40.67 93.02 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 124.14 0.976 . . . . 71.109999999999999 109.807 -175.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 91.3 m -65.48 -45.03 85.22 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 114.563 -1.198 . . . . 65.420000000000002 110.696 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.06 -48.33 82.0 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 122.753 0.421 . . . . 75.349999999999994 110.389 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -52.66 -54.17 37.04 Favored 'General case' 0 CA--C 1.498 -1.045 0 O-C-N 123.445 0.466 . . . . 74.109999999999999 109.913 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.1 tp -51.43 -42.65 61.65 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.958 -1.019 . . . . 74.219999999999999 112.152 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.2 mm100 -63.55 -49.19 74.41 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 116.122 -0.49 . . . . 64.25 111.413 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -65.17 -34.13 77.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.535 0.683 . . . . 73.310000000000002 109.94 -178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.421 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 2.7 t80 -59.41 -53.78 54.21 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.379 -0.828 . . . . 75.510000000000005 110.474 175.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -73.89 -15.24 61.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.86 0.362 . . . . 73.120000000000005 111.629 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 55.3 mt-30 -87.8 -5.08 58.8 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 116.197 -0.456 . . . . 75.040000000000006 112.144 175.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.53 28.39 27.23 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.485 -0.864 . . . . 53.210000000000001 113.589 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.84 -45.34 18.87 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 117.286 0.543 . . . . 72.129999999999995 111.462 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -94.46 5.58 51.38 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.796 0.665 . . . . 70.400000000000006 112.796 -171.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -14.77 63.15 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.046 0.758 . . . . 64.209999999999994 113.046 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -78.12 -29.08 48.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.325 0.583 . . . . 74.329999999999998 110.112 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.1 mt -78.11 -8.21 57.96 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.399 -0.818 . . . . 71.239999999999995 111.378 -174.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -68.2 -31.6 71.24 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.483 0.659 . . . . 75.219999999999999 109.344 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -98.81 13.87 30.85 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.858 0.837 . . . . 71.519999999999996 110.286 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.31 148.97 31.91 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.869 -0.605 . . . . 73.129999999999995 110.763 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -100.6 138.62 37.42 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.344 -0.613 . . . . 74.099999999999994 109.344 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -75.3 135.7 40.9 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.185 0.516 . . . . 75.010000000000005 111.139 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -117.18 92.85 3.97 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.611 -0.885 . . . . 72.129999999999995 108.611 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.3 pt -87.63 87.05 2.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-O 122.262 1.03 . . . . 71.540000000000006 112.064 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -80.32 -84.87 0.09 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.732 -1.122 . . . . 62.439999999999998 109.696 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.66 86.35 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 105.344 -2.095 . . . . 74.510000000000005 105.344 171.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.5 m -67.35 -48.67 66.8 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.215 -1.357 . . . . 73.120000000000005 111.344 -175.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -108.93 115.1 4.23 Favored Glycine 0 N--CA 1.424 -2.143 0 C-N-CA 120.032 -1.08 . . . . 71.230000000000004 111.972 -176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -80.79 101.95 9.67 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.389 -0.597 . . . . 74.420000000000002 109.389 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.9 102.22 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-O 122.025 0.917 . . . . 73.549999999999997 110.632 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -160.16 167.92 26.61 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.642 -1.985 . . . . 63.409999999999997 105.642 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -71.4 114.51 9.54 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.544 -1.65 . . . . 72.219999999999999 106.544 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.64 78.35 1.38 Allowed Glycine 0 N--CA 1.421 -2.344 0 N-CA-C 107.399 -2.28 . . . . 60.43 107.399 -170.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.23 136.6 48.09 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 112.638 0.607 . . . . 74.439999999999998 112.638 -174.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -133.91 138.17 9.88 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 108.72 -1.752 . . . . 74.120000000000005 108.72 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.411 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 21.8 m-85 -120.06 129.4 54.2 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.347 -0.983 . . . . 71.140000000000001 108.347 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.411 ' HD2' ' C ' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -119.39 103.77 9.77 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.121 -0.696 . . . . 74.230000000000004 109.121 179.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.33 121.26 43.52 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.04 -1.096 . . . . 74.209999999999994 108.04 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 10.0 p -120.16 132.5 69.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.665 0.745 . . . . 71.329999999999998 112.269 -177.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 30.5 m-90 -109.82 130.47 55.52 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.677 -1.147 . . . . 73.230000000000004 107.946 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -115.87 128.65 55.97 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.042 -0.725 . . . . 73.510000000000005 109.042 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.6 t -81.51 174.74 11.14 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.217 -0.901 . . . . 73.530000000000001 109.594 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.99 136.71 58.17 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 123.623 0.577 . . . . 75.109999999999999 110.624 -178.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.27 136.13 47.79 Favored 'General case' 0 N--CA 1.435 -1.183 0 O-C-N 123.799 0.687 . . . . 74.010000000000005 109.623 178.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -114.8 134.87 54.77 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.453 -0.573 . . . . 64.109999999999999 109.453 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -74.41 106.82 6.2 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.884 -1.154 . . . . 74.409999999999997 107.884 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.4 t -96.39 133.09 41.22 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 107.67 -1.233 . . . . 75.319999999999993 107.67 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -74.87 11.59 1.04 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 114.595 1.332 . . . . 65.120000000000005 114.595 -174.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.71 -1.58 57.35 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 106.297 -1.742 . . . . 75.329999999999998 106.297 172.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.502 ' O ' ' HB3' ' A' ' 147' ' ' TYR . 23.8 tt0 79.34 17.96 0.82 Allowed 'General case' 0 C--N 1.347 0.459 0 C-N-CA 126.797 2.039 . . . . 75.150000000000006 110.156 -176.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 22.8 pttm -109.88 179.04 4.23 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.014 -1.106 . . . . 73.340000000000003 108.014 174.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 27.2 mt -122.45 134.95 64.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.22 -1.03 . . . . 74.530000000000001 108.22 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -114.08 140.46 48.46 Favored 'General case' 0 C--O 1.2 -1.516 0 N-CA-C 109.325 -0.62 . . . . 74.120000000000005 109.325 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 17.9 p90 -147.47 160.26 42.79 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.24 -1.022 . . . . 64.209999999999994 108.24 174.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -102.83 133.18 48.32 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 107.83 -1.174 . . . . 62.140000000000001 107.83 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -115.51 141.73 47.67 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 120.582 -0.447 . . . . 72.25 110.277 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -127.25 116.74 21.04 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.504 -1.295 . . . . 73.209999999999994 107.504 176.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -123.16 111.39 16.46 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.27 -0.641 . . . . 74.439999999999998 109.27 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.6 133.86 36.49 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 123.119 0.567 . . . . 75.109999999999999 109.642 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -111.96 115.33 28.78 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.189 -1.041 . . . . 75.319999999999993 108.189 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.4 mt -113.9 147.04 17.7 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.497 0 N-CA-C 106.994 -1.484 . . . . 75.519999999999996 106.994 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.433 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -131.73 150.37 52.18 Favored 'General case' 0 C--O 1.266 1.945 0 C-N-CA 118.722 -1.191 . . . . 75.219999999999999 109.333 176.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -100.92 116.58 33.11 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 106.219 -1.771 . . . . 73.209999999999994 106.219 174.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -69.3 155.15 40.89 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.389 -0.823 . . . . 71.409999999999997 109.455 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -51.85 -31.53 28.13 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.638 0.775 . . . . 70.409999999999997 111.552 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.42 -5.63 34.21 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 124.512 1.125 . . . . 64.420000000000002 111.271 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.485 ' O ' ' HB ' ' A' ' 17' ' ' THR . . . 94.07 -23.95 29.03 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.46 -0.656 . . . . 74.299999999999997 111.46 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.4 m -65.73 124.56 22.76 Favored 'General case' 0 N--CA 1.425 -1.675 0 C-N-CA 124.014 0.925 . . . . 71.519999999999996 109.868 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 7.1 t -103.26 142.24 34.52 Favored 'General case' 0 C--N 1.27 -2.864 0 N-CA-C 108.666 -0.864 . . . . 64.510000000000005 108.666 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.433 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 2.1 t90 -156.53 155.61 32.24 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.8 -1.185 . . . . 73.430000000000007 107.8 -173.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.37 127.55 33.11 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.577 -0.527 . . . . 74.019999999999996 109.577 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -83.28 -55.57 4.26 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.006 -1.109 . . . . 73.129999999999995 108.006 -176.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.451 ' HA ' ' HB2' ' A' ' 54' ' ' PRO . 34.0 m -167.08 164.72 15.86 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.698 -1.593 . . . . 52.119999999999997 106.698 -177.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.95 149.49 22.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 106.263 -1.754 . . . . 71.319999999999993 106.263 172.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -129.51 130.79 46.25 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 120.843 0.354 . . . . 74.439999999999998 110.414 -177.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 53.7 m-85 -113.43 127.24 56.04 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.535 -1.283 . . . . 72.430000000000007 107.535 177.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.9 pt -129.58 98.72 4.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-O 122.273 1.035 . . . . 74.510000000000005 109.427 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 74.8 mtm -84.46 131.7 34.64 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.529 -1.214 . . . . 72.310000000000002 110.762 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 74.5 m 68.84 37.79 2.26 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.512 1.133 . . . . 70.420000000000002 111.943 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -66.31 130.24 42.55 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 103.314 -2.847 . . . . 72.519999999999996 103.314 173.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -134.44 145.74 49.15 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 114.732 1.382 . . . . 72.209999999999994 114.732 -167.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 114' ' ' LYS . . . -101.62 126.1 35.26 Favored Pre-proline 0 N--CA 1.43 -1.441 0 N-CA-C 107.052 -1.462 . . . . 71.239999999999995 107.052 172.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -72.82 160.35 46.34 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.565 2.177 . . . . 73.239999999999995 111.948 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.502 ' HB3' ' O ' ' A' ' 113' ' ' GLN . 37.2 p90 -68.06 159.88 29.97 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.793 -0.639 . . . . 71.239999999999995 110.326 177.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.4 m -97.89 96.78 5.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 122.165 0.983 . . . . 74.219999999999999 112.18 -177.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.958 0 N-CA-C 108.355 -0.979 . . . . 51.149999999999999 108.355 179.181 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 t70 . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 121.033 0.444 . . . . 72.33 110.8 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.433 HD22 ' HD2' ' A' ' 22' ' ' LYS . 3.1 tm? -65.31 -38.46 90.26 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 107.582 -1.266 . . . . 73.41 107.582 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -71.31 -35.02 71.11 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.543 -0.753 . . . . 72.34 110.028 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.495 HG13 ' SG ' ' A' ' 132' ' ' CYS . 90.2 t -62.65 -55.9 20.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.868 -0.605 . . . . 74.45 110.696 176.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.433 ' HD2' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -71.76 -25.65 62.12 Favored 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 120.431 -0.508 . . . . 74.24 111.633 -178.324 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.48 -42.17 89.43 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.198 -1.161 . . . . 65.12 110.198 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.88 -53.49 49.63 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 123.658 0.783 . . . . 65.35 109.786 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.19 -44.89 88.87 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 115.427 -0.806 . . . . 75.45 112.536 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -66.46 -40.1 89.21 Favored 'General case' 0 C--O 1.206 -1.192 0 CA-C-O 119.423 -0.323 . . . . 75.13 111.549 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.6 -40.41 92.63 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.483 0.659 . . . . 54.21 110.102 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.501 ' CE2' HD11 ' A' ' 45' ' ' LEU . 13.6 t80 -61.79 -53.52 54.81 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.414 -1.266 . . . . 70.34 109.783 176.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 29' ' ' ILE . 14.4 mm -64.17 -35.89 75.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 116.328 -0.396 . . . . 64.41 111.502 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.73 -52.36 66.03 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.28 0.632 . . . . 53.13 110.109 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.5 pp -67.73 -29.32 68.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 120.58 -0.448 . . . . 75.1 111.338 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.17 -31.84 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.119 0.485 . . . . 63.22 110.602 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 p -108.09 17.17 22.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.668 0.747 . . . . 73.22 110.466 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.427 ' HB2' ' HA ' ' A' ' 31' ' ' LEU . 8.3 tptm -74.04 171.26 13.82 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-N 114.523 -1.217 . . . . 61.15 111.708 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.5 m -43.94 138.56 3.23 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.357 1.863 . . . . 72.12 113.768 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.16 -7.18 16.12 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.794 2.329 . . . . 74.32 109.889 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.21 -28.02 68.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.04 -1.436 . . . . 73.42 110.736 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.7 p -94.3 158.23 15.67 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.872 -0.604 . . . . 74.23 110.089 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.5 HG22 ' OD1' ' A' ' 40' ' ' ASN . 9.2 p -50.55 -53.02 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 114.77 1.396 . . . . 45.31 114.77 -172.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.5 ' OD1' HG22 ' A' ' 39' ' ' VAL . 14.5 m120 -159.21 135.55 9.1 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 118.184 0.447 . . . . 73.13 110.548 -176.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.0 m -66.19 -31.28 72.02 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.667 -1.234 . . . . 73.13 107.667 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.471 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 1.8 mp0 -63.4 -25.61 68.37 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.731 -1.577 . . . . 74.44 109.624 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -71.02 -46.17 62.63 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.489 -0.93 . . . . 73.02 108.489 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -67.57 -31.66 71.89 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.016 -0.993 . . . . 71.11 109.424 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.501 HD11 ' CE2' ' A' ' 28' ' ' PHE . 42.6 tp -68.2 -45.06 74.39 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.763 -0.653 . . . . 74.54 110.358 177.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.37 -36.62 78.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.831 0.824 . . . . 70.45 109.844 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -75.62 -27.72 58.56 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.499 -1.228 . . . . 74.31 110.384 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -74.72 -44.59 49.19 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.477 -0.564 . . . . 74.43 109.477 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 3.9 pp -79.59 -2.62 43.3 Favored 'General case' 0 C--O 1.199 -1.562 0 CA-C-N 115.824 -0.626 . . . . 61.24 112.422 -174.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -51.89 -61.77 6.2 Favored Glycine 0 CA--C 1.544 1.853 0 C-N-CA 121.494 -0.384 . . . . 63.1 112.235 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -77.04 -5.42 15.83 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.236 2.624 . . . . 70.41 112.178 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.497 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 55.8 m-70 -119.0 29.5 7.67 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.837 -0.801 . . . . 54.24 108.837 -175.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -55.91 107.67 0.96 Allowed Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 124.859 1.264 . . . . 71.24 112.871 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.508 ' HB3' ' HB3' ' A' ' 134' ' ' LEU . 75.0 Cg_endo -98.93 -173.81 0.15 Allowed 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 123.273 2.649 . . . . 73.3 111.13 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -86.08 101.98 13.43 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 107.306 -1.368 . . . . 73.2 107.306 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 68' ' ' PHE . 65.1 mt -87.15 105.69 15.35 Favored 'Isoleucine or valine' 0 C--O 1.172 -3.007 0 N-CA-C 109.251 -0.648 . . . . 75.35 109.251 -175.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -94.02 106.88 18.84 Favored 'General case' 0 C--N 1.276 -2.61 0 O-C-N 121.314 -0.866 . . . . 64.03 111.459 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.454 HG23 HG22 ' A' ' 56' ' ' ILE . 54.2 t -108.45 113.19 43.29 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.939 0 N-CA-C 108.23 -1.026 . . . . 51.22 108.23 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 62.04 21.28 12.24 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.96 -1.473 . . . . 52.32 110.599 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.47 2.98 56.52 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.564 -0.744 . . . . 61.42 113.357 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -112.85 135.21 53.87 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 117.758 0.779 . . . . 74.44 110.509 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.01 126.35 34.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.949 0.88 . . . . 64.52 109.376 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.535 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 59.0 mm-40 -126.13 149.45 48.94 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.164 -1.421 . . . . 75.13 107.164 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.8 t -97.95 173.56 7.01 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.355 -0.98 . . . . 71.22 108.355 173.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.6 t -42.25 -42.89 3.22 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.144 1.378 . . . . 62.25 112.479 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.5 m -69.35 -42.36 75.37 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.377 -0.374 . . . . 54.23 111.978 -176.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -65.08 -45.99 82.98 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.656 -0.498 . . . . 63.25 109.656 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' HB2' HD13 ' A' ' 56' ' ' ILE . 41.2 t80 -52.75 -55.21 24.46 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 109.108 -0.701 . . . . 73.4 109.108 174.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -48.34 -44.19 34.07 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.3 -1.318 . . . . 73.15 110.963 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 50.0 mt-30 -61.55 -46.49 89.7 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 112.029 0.381 . . . . 63.03 112.029 177.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.528 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 57.6 m-85 -68.62 -36.25 78.41 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.421 0.629 . . . . 71.21 109.315 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -57.99 -51.57 69.1 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.621 -0.718 . . . . 55.43 111.084 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 34.1 ptt180 -66.85 -30.93 71.24 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.705 -0.48 . . . . 72.14 109.705 -176.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -74.86 -10.09 59.17 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.779 -0.646 . . . . 72.01 112.212 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.36 6.84 47.17 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 114.77 0.668 . . . . 54.43 114.77 174.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.457 ' HB3' ' SD ' ' A' ' 141' ' ' MET . 3.5 mm? -68.15 -48.77 64.44 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.659 0.614 . . . . 34.24 112.659 -176.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.528 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 45.5 m-85 -90.8 12.74 18.34 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 113.273 0.842 . . . . 73.53 113.273 -173.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.471 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 51.7 mtmt -66.97 -14.22 62.64 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.634 0.605 . . . . 74.44 112.634 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -79.96 -13.01 59.67 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 123.218 0.607 . . . . 54.21 110.695 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.5 tt -60.78 -28.17 68.54 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.583 0.586 . . . . 72.31 112.583 -174.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.13 4.57 46.93 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 117.623 -1.631 . . . . 74.23 111.409 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -105.85 10.07 32.64 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.265 -1.384 . . . . 55.44 107.265 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -91.71 153.08 19.89 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 113.805 -1.543 . . . . 74.41 113.15 -174.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 104' ' ' LYS . 13.6 pt-20 -95.09 133.23 39.13 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.64 -1.164 . . . . 73.34 110.143 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.619 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 43.2 p90 . . . . . 0 C--N 1.31 -1.113 0 N-CA-C 108.763 -0.829 . . . . 62.34 108.763 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 . . . . . 0 CA--C 1.508 -0.659 0 CA-C-O 121.602 0.715 . . . . 70.32 112.842 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -150.75 138.76 6.83 Favored Glycine 0 N--CA 1.414 -2.768 0 N-CA-C 109.695 -1.362 . . . . 55.52 109.695 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -123.63 143.63 50.11 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.687 -1.598 . . . . 72.52 106.687 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 19.6 pttp -136.02 98.98 4.02 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-O 122.104 0.954 . . . . 71.12 109.257 173.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.88 125.43 34.0 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.349 -1.296 . . . . 63.52 108.253 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 10.0 p -117.11 136.74 53.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 C-N-CA 119.866 -0.734 . . . . 61.23 111.414 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.619 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 27.0 m-90 -115.58 140.29 49.31 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.506 -1.225 . . . . 71.21 107.711 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 97.4 mttt -116.87 120.99 40.19 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.985 -1.487 . . . . 74.24 106.985 172.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.429 ' HB2' ' H ' ' A' ' 118' ' ' ASP . 46.3 m . . . . . 0 C--N 1.306 -1.311 0 N-CA-C 108.218 -1.03 . . . . 73.13 108.218 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 21.7 p90 . . . . . 0 N--CA 1.445 -0.693 0 N-CA-C 108.938 -0.764 . . . . 73.12 108.938 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.429 ' H ' ' HB2' ' A' ' 105' ' ' SER . 5.6 m-20 -118.59 138.39 52.6 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 105.651 -1.981 . . . . 62.32 105.651 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.454 ' HB2' HG13 ' A' ' 140' ' ' ILE . 47.6 mt-10 -114.57 142.08 46.91 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.722 -0.791 . . . . 75.01 110.533 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -133.9 117.15 16.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.739 -0.664 . . . . 73.22 110.042 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -116.45 110.89 19.23 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 122.94 0.496 . . . . 71.03 110.366 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -97.74 113.75 25.59 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 110.152 -0.314 . . . . 74.31 110.152 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -97.84 119.8 37.09 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.455 -0.942 . . . . 74.51 108.455 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.499 HG12 HD13 ' A' ' 134' ' ' LEU . 59.6 mt -118.54 144.88 25.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 106.953 -1.499 . . . . 41.0 106.953 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.503 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.6 OUTLIER -119.97 146.0 46.24 Favored 'General case' 0 C--O 1.267 2.008 0 C-N-CA 118.485 -1.286 . . . . 63.33 107.604 174.307 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -93.0 106.02 18.04 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 106.607 -1.627 . . . . 75.24 106.607 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.449 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 65.1 ttt180 -58.44 145.69 37.71 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 113.67 -1.605 . . . . 72.32 108.195 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 128' ' ' LYS . 37.5 ttmt -61.51 -18.21 58.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.694 0.759 . . . . 65.42 110.8 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.449 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 7.4 t70 -65.07 -17.86 64.82 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.562 1.145 . . . . 74.34 110.953 173.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.92 -16.66 36.18 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 121.38 -0.438 . . . . 64.03 112.677 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.0 p -92.8 176.98 6.24 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 109.51 -0.552 . . . . 42.41 109.51 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.495 ' SG ' HG13 ' A' ' 21' ' ' VAL . 30.4 p -131.16 143.7 50.82 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 109.705 -0.48 . . . . 54.33 109.705 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.503 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 2.0 t90 -139.27 155.01 48.04 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.809 -0.811 . . . . 65.53 108.809 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 2.7 mm? -67.89 111.35 4.3 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.071 -0.968 . . . . 71.54 108.676 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -76.44 -60.41 2.35 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.718 -1.215 . . . . 62.03 107.718 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.8 m -161.31 150.5 16.43 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.136 -1.801 . . . . 73.01 106.136 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.0 m -133.35 135.83 55.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 107.001 -1.481 . . . . 71.14 107.001 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -115.79 131.29 56.98 Favored 'General case' 0 C--N 1.274 -2.716 0 CA-C-O 120.644 0.259 . . . . 73.41 110.8 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.416 ' HB2' HG22 ' A' ' 58' ' ' VAL . 78.2 m-85 -119.66 126.23 50.64 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.915 -1.143 . . . . 71.53 107.915 176.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.454 HG13 ' HB2' ' A' ' 119' ' ' GLU . 3.8 pt -126.29 98.65 5.02 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 N-CA-C 107.94 -1.133 . . . . 63.44 107.94 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.457 ' SD ' ' HB3' ' A' ' 76' ' ' LEU . 63.1 mtm -87.91 127.98 35.36 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.01 -1.45 . . . . 71.15 112.039 -171.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.1 m 64.19 77.33 0.32 Allowed 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 113.332 -1.758 . . . . 41.01 112.654 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt . . . . . 0 N--CA 1.418 -2.068 0 CA-C-N 112.981 -1.918 . . . . 60.44 108.566 177.69 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 27.7 t70 . . . . . 0 C--O 1.241 0.612 0 CA-C-O 121.811 0.815 . . . . 74.24 109.403 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.2 -35.82 80.41 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.141 -0.936 . . . . 71.53 108.946 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -64.34 -49.25 72.45 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.725 -0.67 . . . . 71.21 110.052 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.71 -45.55 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.038 -0.528 . . . . 74.35 112.341 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 18.3 ptpt -72.27 -26.09 61.85 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 118.632 -1.227 . . . . 72.54 111.128 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.64 -55.1 12.45 Favored Glycine 0 C--O 1.262 1.876 0 N-CA-C 111.386 -0.685 . . . . 65.23 111.386 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 pp -66.75 -38.98 87.7 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 108.518 -0.919 . . . . 74.14 108.518 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.12 -42.84 99.92 Favored Glycine 0 CA--C 1.497 -1.074 0 CA-C-N 116.025 -0.534 . . . . 72.21 111.986 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -64.62 -45.77 85.46 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-O 119.533 -0.27 . . . . 75.14 110.424 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.18 -38.61 88.45 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 120.456 -0.498 . . . . 75.23 110.771 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.49 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 24.7 t80 -62.48 -54.62 37.31 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.522 1.129 . . . . 70.01 110.123 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 29' ' ' ILE . 12.6 mm -65.58 -33.14 61.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 116.358 -0.383 . . . . 25.4 111.134 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.76 -49.11 77.68 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.109 -0.496 . . . . 74.04 110.774 175.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.5 pp -67.76 -31.22 70.98 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 120.671 -0.412 . . . . 74.05 110.836 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.5 t -69.97 -21.87 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-O 121.308 0.575 . . . . 62.21 110.651 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.7 p -110.51 13.06 22.77 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.754 -0.591 . . . . 73.11 111.334 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -62.91 144.24 56.91 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.615 -0.721 . . . . 61.5 112.167 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.3 m -66.05 155.14 88.03 Favored Pre-proline 0 C--N 1.299 -1.594 0 CA-C-N 114.86 -1.064 . . . . 50.55 110.971 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.97 -6.49 4.92 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 124.389 3.393 . . . . 74.31 113.259 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.8 -27.84 68.56 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.884 -0.598 . . . . 71.5 110.193 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.6 m -72.46 158.8 35.05 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.431 -0.951 . . . . 62.45 108.431 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.544 HG23 ' OD1' ' A' ' 40' ' ' ASN . 32.0 m -63.89 -37.6 80.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 C-N-CA 119.503 -0.879 . . . . 61.31 110.634 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.636 ' HB2' ' OE1' ' A' ' 42' ' ' GLU . 12.1 p-10 178.92 137.94 0.09 Allowed 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.563 1.145 . . . . 63.14 110.661 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.3 m -63.55 -37.37 87.07 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-O 122.34 1.067 . . . . 74.4 109.639 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.636 ' OE1' ' HB2' ' A' ' 40' ' ' ASN . 1.2 pm0 -67.58 -20.5 65.39 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 114.317 -1.31 . . . . 65.14 112.191 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.561 ' HB2' ' OD1' ' A' ' 40' ' ' ASN . 54.8 t-80 -67.43 -49.03 65.52 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 108.877 -0.786 . . . . 51.24 108.877 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -66.99 -33.84 76.45 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.317 -1.311 . . . . 63.43 109.058 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.423 HD11 ' CE1' ' A' ' 28' ' ' PHE . 51.8 tp -66.56 -46.42 76.09 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 116.281 -0.418 . . . . 71.52 110.708 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.73 -35.32 76.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.188 0.518 . . . . 74.45 110.418 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -76.95 -29.97 55.84 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.436 -0.802 . . . . 72.35 109.699 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -68.27 -42.96 78.79 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 123.248 0.619 . . . . 73.0 110.019 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 pp -85.44 0.72 51.41 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.821 -0.627 . . . . 72.33 111.323 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -52.61 -57.95 12.6 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-N 116.383 -0.372 . . . . 74.41 112.423 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -76.85 -4.1 14.54 Favored 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.438 2.759 . . . . 72.24 112.525 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.413 ' HA ' ' HE1' ' A' ' 133' ' ' TRP . 71.1 m-70 -125.13 45.07 2.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.372 -0.376 . . . . 75.34 110.006 -173.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -54.97 104.98 0.46 Allowed Pre-proline 0 N--CA 1.492 1.666 0 C-N-CA 124.833 1.253 . . . . 75.45 113.179 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -97.9 177.16 0.47 Allowed 'Trans proline' 0 N--CA 1.431 -2.164 0 C-N-CA 123.13 2.553 . . . . 71.34 110.268 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.92 105.34 11.13 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.919 -1.141 . . . . 73.34 107.919 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.467 HD13 ' CB ' ' A' ' 68' ' ' PHE . 68.9 mt -93.06 106.54 18.05 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.404 0 N-CA-C 108.879 -0.786 . . . . 62.42 108.879 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -95.82 112.9 24.52 Favored 'General case' 0 C--N 1.265 -3.092 0 O-C-N 121.718 -0.614 . . . . 62.3 110.398 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 3.6 p -108.57 118.49 56.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 C-N-CA 118.81 -1.156 . . . . 64.43 108.129 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.408 ' HA ' HG22 ' A' ' 140' ' ' ILE . 63.9 m-20 59.74 20.34 9.1 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.643 -1.162 . . . . 75.45 111.106 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.53 7.84 53.29 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 115.158 -0.928 . . . . 25.54 114.144 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -116.64 132.94 56.55 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 117.666 0.733 . . . . 62.44 110.862 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.1 127.05 36.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 121.481 0.658 . . . . 73.24 110.222 -176.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.466 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 9.4 mm100 -126.95 151.17 48.87 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.793 -1.188 . . . . 74.44 107.793 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.6 t -93.77 173.11 7.84 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.457 -0.942 . . . . 75.41 108.457 174.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.0 t -49.22 -39.45 30.02 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 124.605 1.162 . . . . 52.4 111.64 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.2 m -65.21 -47.86 75.4 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 122.918 0.487 . . . . 74.2 111.108 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.466 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -64.51 -47.6 78.28 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 122.745 0.418 . . . . 34.12 110.129 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.467 ' CB ' HD13 ' A' ' 56' ' ' ILE . 51.4 t80 -52.81 -55.17 24.89 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 116.177 -0.465 . . . . 74.21 110.271 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -51.35 -42.09 61.05 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.042 -0.981 . . . . 62.44 110.857 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -62.66 -49.7 74.12 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 116.299 -0.41 . . . . 75.53 111.683 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.434 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 24.8 m-85 -65.82 -33.4 75.78 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.794 0.807 . . . . 71.52 109.27 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.546 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 4.1 t80 -57.85 -53.18 61.13 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.02 -0.991 . . . . 63.03 110.841 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -74.73 -20.63 59.76 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.15 0.5 . . . . 75.12 110.671 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.424 ' HB2' HD23 ' A' ' 76' ' ' LEU . 55.3 mt-30 -76.18 -8.25 56.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.901 -0.591 . . . . 70.42 111.051 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.16 10.07 57.6 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 120.539 -0.838 . . . . 74.13 114.266 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 74' ' ' GLN . 3.5 mm? -68.32 -50.53 52.83 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 116.868 0.334 . . . . 62.13 110.442 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.434 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 36.5 m-85 -99.31 10.08 42.12 Favored 'General case' 0 C--O 1.204 -1.326 0 N-CA-C 112.819 0.674 . . . . 73.44 112.819 -173.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.301 62.8 pttt -70.48 -10.62 59.65 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 114.221 1.193 . . . . 74.35 114.221 -176.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -83.33 -10.55 58.42 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.196 -0.456 . . . . 75.35 110.485 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.44 -15.93 63.71 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 112.578 0.584 . . . . 60.11 112.578 -172.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -11.16 40.54 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.931 -0.481 . . . . 61.42 112.122 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -99.76 14.06 31.55 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 122.65 0.38 . . . . 73.32 111.23 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.505 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -58.71 129.22 41.06 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.008 0.744 . . . . 65.02 113.008 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -100.67 127.01 47.23 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.497 -1.668 . . . . 72.05 106.497 173.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 73.7 t80 . . . . . 0 C--N 1.304 -1.403 0 C-N-CA 120.749 -0.38 . . . . 75.15 110.526 -178.371 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 . . . . . 0 C--O 1.247 0.93 0 CA-C-O 121.009 0.433 . . . . 73.45 111.058 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.54 138.35 14.91 Favored Glycine 0 N--CA 1.423 -2.226 0 N-CA-C 108.628 -1.789 . . . . 71.21 108.628 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -112.67 146.3 38.93 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 117.11 0.455 . . . . 74.52 109.931 -176.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -124.89 97.59 5.33 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.164 -1.421 . . . . 64.22 107.164 172.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.64 107.99 20.53 Favored 'General case' 0 C--N 1.259 -3.363 0 N-CA-C 106.383 -1.71 . . . . 73.41 106.383 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.2 p -115.89 135.27 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 CA-C-O 121.897 0.856 . . . . 73.34 112.258 -174.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.505 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 30.5 m-90 -119.28 155.43 31.81 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.285 -1.325 . . . . 72.34 109.94 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -129.03 125.25 36.91 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 104.485 -2.413 . . . . 73.13 104.485 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 80.6 p . . . . . 0 C--N 1.3 -1.576 0 CA-C-N 118.296 0.498 . . . . 65.33 110.644 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.505 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 22.1 p90 . . . . . 0 C--O 1.2 -1.536 0 N-CA-C 106.822 -1.548 . . . . 65.31 106.822 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -116.28 141.3 48.34 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 106.332 -1.729 . . . . 74.2 106.332 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.505 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 42.4 mt-10 -115.33 147.04 40.94 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 119.701 -0.8 . . . . 65.03 112.567 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.604 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -139.37 117.88 12.16 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.169 -0.923 . . . . 63.41 110.185 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.57 109.57 17.98 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.697 -0.853 . . . . 72.02 108.697 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.65 123.02 37.84 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 109.527 -0.546 . . . . 74.32 109.527 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -103.31 112.18 24.94 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.764 -1.199 . . . . 75.33 107.764 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.4 mt -117.3 150.92 19.24 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 N-CA-C 106.744 -1.576 . . . . 60.23 106.744 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -136.16 143.06 44.26 Favored 'General case' 0 C--O 1.275 2.414 0 N-CA-C 108.226 -1.028 . . . . 73.23 108.226 172.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -91.53 100.98 13.63 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 106.793 -1.558 . . . . 72.01 106.793 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -68.03 132.89 48.08 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 114.765 -1.107 . . . . 75.22 109.258 -171.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -66.16 -10.57 42.46 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 123.75 0.82 . . . . 74.42 111.417 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -74.6 -8.0 54.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.055 -0.52 . . . . 72.24 111.023 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.22 -8.78 28.95 Favored Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.707 -0.759 . . . . 72.51 113.932 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.9 m -104.16 138.78 40.15 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.414 -0.587 . . . . 70.13 109.414 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 44.7 t -98.33 132.65 43.63 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 107.037 -1.468 . . . . 74.31 107.037 170.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.413 ' HE1' ' HA ' ' A' ' 52' ' ' HIS . 1.6 t90 -146.0 154.78 42.27 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 118.389 -1.324 . . . . 73.44 110.642 -176.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.22 125.67 29.59 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.99 -1.115 . . . . 74.31 107.99 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -80.79 -53.99 6.0 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.408 -0.96 . . . . 64.21 108.408 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.4 m -162.48 158.48 23.76 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 105.266 -2.124 . . . . 70.34 105.266 -175.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.7 m -143.06 138.4 27.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 107.296 -1.372 . . . . 52.51 107.296 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -112.82 136.33 52.57 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 109.786 -0.45 . . . . 65.31 109.786 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 71.8 m-85 -125.04 122.94 38.69 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 107.72 -1.215 . . . . 61.34 107.72 175.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.408 HG22 ' HA ' ' A' ' 59' ' ' ASN . 5.2 pt -127.14 98.81 4.9 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 N-CA-C 107.946 -1.131 . . . . 74.44 107.946 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 23.4 ptm -86.63 143.09 27.8 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.481 -1.236 . . . . 74.33 110.564 -173.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.8 m 67.62 35.23 4.17 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.569 1.168 . . . . 74.15 109.287 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 26.1 tptp . . . . . 0 N--CA 1.408 -2.54 0 CA-C-N 113.082 -1.872 . . . . 71.31 109.258 179.075 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 . . . . . 0 CA--C 1.507 -0.695 0 CA-C-O 121.007 0.432 . . . . 73.04 110.178 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.99 -43.86 97.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.559 -0.746 . . . . 64.23 109.434 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.04 -42.93 99.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.843 -0.617 . . . . 54.3 111.622 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.543 HG11 ' HE ' ' A' ' 126' ' ' ARG . 26.6 m -74.46 -39.79 48.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 119.352 -0.939 . . . . 71.44 112.698 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -72.38 -28.03 62.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 119.052 -1.059 . . . . 75.31 109.787 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.03 -42.55 43.94 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 110.533 -1.027 . . . . 52.13 110.533 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.551 HD22 ' SG ' ' A' ' 132' ' ' CYS . 17.9 tp -64.84 -50.37 66.94 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.025 -0.731 . . . . 73.35 109.025 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.59 -39.05 94.58 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.347 -0.842 . . . . 71.4 112.232 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -68.63 -42.13 78.49 Favored 'General case' 0 C--O 1.204 -1.292 0 C-N-CA 121.051 -0.26 . . . . 75.23 110.565 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.461 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 7.9 t70 -63.56 -41.46 98.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.777 0.799 . . . . 74.0 109.234 -176.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.434 ' CE1' HD11 ' A' ' 45' ' ' LEU . 33.4 t80 -63.88 -55.03 25.76 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.362 -1.744 . . . . 64.14 110.163 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 29' ' ' ILE . 11.9 mm -64.41 -32.89 59.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 111.693 0.257 . . . . 71.05 111.693 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.41 -52.8 63.06 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 122.786 0.434 . . . . 75.33 110.192 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 27' ' ' ASP . 3.7 pp -71.97 -24.4 61.59 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 119.629 -0.828 . . . . 72.33 112.162 -176.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.2 t -71.08 -25.31 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.094 0.473 . . . . 73.34 109.972 174.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.6 p -108.17 13.38 25.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.251 0.548 . . . . 73.24 110.281 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -62.67 148.35 46.71 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 115.423 -0.808 . . . . 72.01 110.834 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.6 m -51.37 143.11 19.36 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 125.763 1.625 . . . . 64.51 114.175 -175.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.39 -6.39 17.41 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 124.452 3.434 . . . . 53.1 113.338 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -62.99 -25.84 68.58 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.643 0.735 . . . . 52.31 110.134 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 t -81.46 172.18 13.83 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.233 -1.025 . . . . 75.53 108.233 175.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -56.52 -45.65 82.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 C-N-CA 122.51 0.324 . . . . 74.41 110.776 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.568 ' ND2' ' HB3' ' A' ' 42' ' ' GLU . 39.2 t30 178.16 139.06 0.09 Allowed 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.873 -1.158 . . . . 73.4 107.873 -177.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 m -61.85 -26.66 68.27 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 122.571 1.177 . . . . 62.5 110.688 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.568 ' HB3' ' ND2' ' A' ' 40' ' ' ASN . 38.1 tt0 -64.67 -23.48 67.27 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 125.099 1.36 . . . . 55.44 109.897 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 72' ' ' PHE . 48.2 t-80 -65.05 -46.12 82.54 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.264 -0.643 . . . . 71.43 109.264 176.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -70.58 -31.46 68.49 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 108.292 -1.003 . . . . 73.34 108.292 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.434 HD11 ' CE1' ' A' ' 28' ' ' PHE . 48.4 tp -66.82 -46.88 73.76 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.936 -0.575 . . . . 74.13 111.052 176.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.62 -34.33 75.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.359 0.6 . . . . 55.14 110.094 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -73.16 -34.82 66.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.366 -0.834 . . . . 72.05 109.632 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 41.8 t80 -66.28 -48.52 70.13 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.864 0.865 . . . . 75.34 110.231 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 pp -80.44 -3.07 48.43 Favored 'General case' 0 C--O 1.198 -1.616 0 CA-C-N 115.275 -0.875 . . . . 60.11 111.774 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -42.45 -60.82 2.66 Favored Glycine 0 CA--C 1.537 1.432 0 O-C-N 123.792 0.682 . . . . 64.14 113.573 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.45 -5.76 13.48 Favored 'Trans proline' 0 CA--C 1.551 1.328 0 C-N-CA 122.452 2.101 . . . . 74.13 112.998 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -116.51 22.47 12.75 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.128 -0.358 . . . . 64.42 110.454 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.67 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 18.4 t70 -65.9 120.07 66.13 Favored Pre-proline 0 C--O 1.256 1.434 0 N-CA-C 112.943 0.72 . . . . 74.21 112.943 -172.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 3.8 Cg_endo -104.92 -148.8 0.02 OUTLIER 'Trans proline' 0 CA--C 1.554 1.524 0 C-N-CA 124.252 3.301 . . . . 73.13 112.22 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -86.85 126.12 34.43 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 107.888 -1.152 . . . . 64.24 107.888 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.55 HD13 ' CB ' ' A' ' 68' ' ' PHE . 48.2 mt -107.34 113.1 42.71 Favored 'Isoleucine or valine' 0 C--O 1.172 -3.012 0 N-CA-C 106.86 -1.533 . . . . 72.45 106.86 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -99.2 135.18 40.98 Favored 'General case' 0 C--N 1.266 -3.051 0 O-C-N 121.669 -0.644 . . . . 74.43 109.703 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 74.9 t -133.54 113.61 19.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 108.714 -0.847 . . . . 74.43 108.714 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.414 ' OD1' ' HG2' ' A' ' 141' ' ' MET . 72.5 m-20 61.32 25.18 15.19 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 125.377 1.471 . . . . 72.22 111.695 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.8 2.12 58.53 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.856 -0.688 . . . . 43.54 112.627 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -113.4 135.49 53.81 Favored 'General case' 0 CA--C 1.492 -1.278 0 O-C-N 122.31 -0.524 . . . . 70.22 110.713 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.21 128.49 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 108.903 -0.777 . . . . 63.23 108.903 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -122.52 143.6 49.61 Favored 'General case' 0 C--O 1.282 2.766 0 N-CA-C 107.161 -1.422 . . . . 74.1 107.161 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.1 t -91.91 173.14 8.01 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.923 -1.14 . . . . 72.31 107.923 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.67 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 13.6 t -58.4 -32.46 68.64 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.698 0.399 . . . . 65.51 111.637 -176.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.5 m -60.82 -51.56 68.81 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.869 -0.605 . . . . 74.24 110.105 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.64 -49.36 75.49 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.532 -0.758 . . . . 61.54 110.441 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.55 ' CB ' HD13 ' A' ' 56' ' ' ILE . 56.9 t80 -52.9 -54.91 27.88 Favored 'General case' 0 CA--C 1.501 -0.939 0 O-C-N 123.676 0.61 . . . . 70.54 110.926 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.2 tp -53.06 -44.85 67.78 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 124.094 0.871 . . . . 72.21 111.782 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.528 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 76.3 mt-30 -58.07 -51.81 68.14 Favored 'General case' 0 N--CA 1.439 -1.014 0 O-C-N 123.257 0.348 . . . . 74.51 111.025 175.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.425 ' HB3' ' HB2' ' A' ' 76' ' ' LEU . 27.3 m-85 -62.47 -40.72 97.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.217 0.532 . . . . 71.31 110.735 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 2.6 t80 -57.86 -52.1 66.87 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.593 0.757 . . . . 71.23 110.309 177.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -73.23 -18.28 61.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.149 -0.478 . . . . 64.04 111.397 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 46.8 mt-30 -87.22 -11.5 49.59 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 120.167 -0.613 . . . . 75.4 111.773 175.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.52 42.14 6.62 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.509 -0.853 . . . . 74.42 112.821 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.442 HD23 ' HB2' ' A' ' 74' ' ' GLN . 4.3 mm? -88.03 -35.37 17.59 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 122.79 -0.241 . . . . 71.21 111.206 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -108.08 -2.81 19.23 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.219 -0.593 . . . . 74.44 112.297 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.565 ' HA ' ' OE2' ' A' ' 42' ' ' GLU 0.372 0.0 OUTLIER -60.19 -13.65 13.44 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 115.894 1.813 . . . . 72.41 115.894 -165.783 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.22 -12.91 62.08 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 116.113 -0.494 . . . . 71.33 111.169 174.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.7 tt -61.46 -27.09 68.32 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.438 1.095 . . . . 74.42 110.657 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.477 ' HB2' ' OD1' ' A' ' 40' ' ' ASN . 27.4 ttpp -55.02 -33.51 62.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.328 0.585 . . . . 75.34 111.321 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -105.33 14.56 28.69 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.443 -0.798 . . . . 73.12 111.032 -173.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -84.06 153.81 23.59 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.308 0.575 . . . . 61.12 112.433 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 103' ' ' TRP . 10.2 pt-20 -89.31 149.82 22.87 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.213 -1.402 . . . . 75.11 107.213 175.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.5 p90 . . . . . 0 C--N 1.316 -0.869 0 CA-C-N 118.972 0.805 . . . . 73.3 112.002 -177.335 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--O 1.247 0.974 0 CA-C-O 120.974 0.416 . . . . 73.51 110.641 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.59 144.5 18.28 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 110.852 -0.899 . . . . 73.24 110.852 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -109.99 140.4 44.05 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.628 -1.249 . . . . 75.43 107.628 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -131.59 101.19 5.4 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.769 -0.826 . . . . 73.11 108.769 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 83.4 mt -107.96 112.22 24.7 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.967 -0.753 . . . . 72.12 108.967 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.6 p -114.03 129.2 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-O 121.484 0.659 . . . . 62.04 111.996 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.579 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 31.4 m-90 -101.82 141.6 34.43 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.604 -1.18 . . . . 75.22 109.217 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.413 ' HB2' ' CG ' ' A' ' 84' ' ' GLU . 36.3 mtpt -118.56 125.46 49.87 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 107.549 -1.278 . . . . 73.1 107.549 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 42.8 t . . . . . 0 C--N 1.27 -2.862 0 CA-C-N 114.917 -1.038 . . . . 53.12 110.311 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.475 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 46.5 p90 . . . . . 0 N--CA 1.42 -1.945 0 N-CA-C 107.536 -1.283 . . . . 74.42 107.536 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.435 ' H ' ' HB3' ' A' ' 105' ' ' SER . 2.1 m-20 -116.18 138.95 50.84 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 106.056 -1.831 . . . . 73.01 106.056 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.475 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 38.4 mt-10 -118.31 144.3 45.95 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.001 -0.68 . . . . 75.13 111.225 176.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -132.51 116.74 17.13 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.861 -1.163 . . . . 44.34 107.861 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -125.68 113.26 17.11 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 121.68 0.752 . . . . 72.12 111.987 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.86 128.65 41.77 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.791 -1.095 . . . . 72.44 110.036 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -109.55 117.93 35.27 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.316 -0.994 . . . . 63.4 108.316 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.5 mt -115.59 151.17 17.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 106.435 -1.691 . . . . 61.13 106.435 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.406 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -136.02 150.17 49.1 Favored 'General case' 0 C--O 1.27 2.144 0 C-N-CA 118.984 -1.086 . . . . 73.11 109.231 175.546 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.543 ' HE ' HG11 ' A' ' 21' ' ' VAL . 61.7 mtt180 -76.07 113.04 13.14 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 108.145 -1.057 . . . . 71.23 108.145 172.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -73.41 133.06 43.65 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 113.906 -1.497 . . . . 64.52 107.566 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -62.53 -15.46 50.73 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.152 0.581 . . . . 61.33 112.192 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -64.94 -16.8 63.75 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 124.001 0.921 . . . . 73.02 110.988 173.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.34 -6.35 30.24 Favored Glycine 0 CA--C 1.501 -0.791 0 N-CA-C 111.215 -0.754 . . . . 71.52 111.215 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.9 p -100.01 -172.34 2.21 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 123.33 0.652 . . . . 71.23 110.6 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.551 ' SG ' HD22 ' A' ' 24' ' ' LEU . 15.0 p -134.61 144.57 47.98 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.601 -1.259 . . . . 73.41 107.601 174.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.406 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 0.2 OUTLIER -155.23 155.2 33.41 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 119.292 -0.963 . . . . 71.42 108.889 -176.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.88 128.47 36.48 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.153 0.501 . . . . 64.43 109.652 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -87.12 -46.77 9.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.047 -0.723 . . . . 65.22 109.047 -176.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.9 p -175.01 152.4 1.48 Allowed 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 107.805 -1.183 . . . . 75.33 107.805 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.41 150.55 32.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.385 -1.339 . . . . 72.04 107.385 175.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -130.09 133.29 46.58 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 110.266 -0.272 . . . . 73.3 110.266 -177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 67.0 m-85 -117.57 127.26 53.8 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.609 -1.256 . . . . 75.23 107.609 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.418 HD12 ' HD2' ' A' ' 143' ' ' LYS . 6.0 pt -128.45 98.76 4.49 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.42 0 CA-C-O 122.395 1.093 . . . . 71.31 108.896 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.414 ' HG2' ' OD1' ' A' ' 59' ' ' ASN . 22.6 ptp -89.73 126.94 35.85 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.163 -1.381 . . . . 73.41 109.87 -175.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.2 t 73.74 73.97 0.12 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.42 -1.264 . . . . 65.5 110.593 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.418 ' HD2' HD12 ' A' ' 140' ' ' ILE . 85.6 tttt . . . . . 0 C--N 1.294 -1.838 0 CA-C-N 114.19 -1.368 . . . . 61.42 107.451 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 C--O 1.236 0.347 0 CA-C-O 121.24 0.543 . . . . 53.44 111.413 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.69 -36.83 84.76 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.222 -1.029 . . . . 75.23 108.222 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -69.91 -38.23 76.2 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.372 -0.831 . . . . 74.54 109.853 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 89.3 t -59.16 -56.66 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 115.218 -0.901 . . . . 74.14 110.437 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -25.9 67.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.354 -0.384 . . . . 72.13 110.545 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.59 -50.44 48.91 Favored Glycine 0 C--O 1.25 1.128 0 N-CA-C 111.659 -0.576 . . . . 70.44 111.659 175.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.77 -37.74 76.48 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 108.613 -0.884 . . . . 52.21 108.613 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.58 -40.63 99.38 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.704 -0.68 . . . . 50.32 111.851 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -67.77 -46.03 73.22 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 120.457 -0.497 . . . . 60.31 110.409 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.23 -39.82 95.7 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 120.567 -0.453 . . . . 74.42 110.644 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -61.57 -52.54 64.01 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.604 0.762 . . . . 72.22 109.902 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.421 ' HA ' HD13 ' A' ' 29' ' ' ILE . 7.4 mm -67.52 -35.09 72.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 120.906 -0.318 . . . . 75.44 111.675 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -63.2 -46.24 87.94 Favored 'General case' 0 CA--C 1.495 -1.141 0 C-N-CA 122.425 0.29 . . . . 61.54 110.487 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.586 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 4.1 pp -69.65 -28.76 66.16 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 119.736 -0.786 . . . . 64.31 111.249 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.409 ' N ' HD12 ' A' ' 31' ' ' LEU . 52.9 t -71.76 -24.33 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-O 121.456 0.646 . . . . 74.31 110.084 174.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.9 p -107.23 19.29 20.56 Favored 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 121.598 -0.689 . . . . 73.1 111.261 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.586 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 64.7 mmtt -53.24 138.64 31.55 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 116.051 -0.522 . . . . 52.11 111.057 175.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -64.28 159.23 59.79 Favored Pre-proline 0 N--CA 1.435 -1.222 0 CA-C-N 115.003 -0.999 . . . . 74.31 109.675 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.5 -11.04 18.16 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 123.349 2.699 . . . . 73.34 111.502 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -68.0 -26.05 65.71 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.607 -1.179 . . . . 74.3 110.872 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.9 t -82.67 172.26 13.11 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.442 -1.318 . . . . 51.14 107.442 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.7 t -74.77 -54.29 14.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.485 -0.486 . . . . 54.45 111.131 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.498 ' O ' ' HB3' ' A' ' 43' ' ' HIS . 23.8 t30 -170.84 126.61 0.72 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.211 -0.45 . . . . 71.22 110.355 -173.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 p -61.0 -39.3 89.15 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 123.358 0.663 . . . . 71.43 111.624 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.44 -21.6 66.21 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.962 -0.563 . . . . 61.45 110.483 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.498 ' HB3' ' O ' ' A' ' 40' ' ' ASN . 42.7 t-80 -72.91 -48.87 33.41 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.354 -0.98 . . . . 74.3 108.354 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -64.19 -35.0 79.37 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.587 -1.188 . . . . 63.1 109.541 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.0 tp -66.88 -42.37 85.69 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 116.292 -0.413 . . . . 70.3 110.466 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.32 -32.13 73.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.455 0.645 . . . . 74.24 110.319 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -74.83 -35.75 62.4 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.536 -0.757 . . . . 71.21 110.25 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -68.37 -41.69 80.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.364 0.666 . . . . 72.05 110.718 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 pp -79.02 -8.44 58.94 Favored 'General case' 0 C--O 1.194 -1.838 0 CA-C-N 115.746 -0.661 . . . . 70.22 111.814 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -46.9 -55.67 8.2 Favored Glycine 0 CA--C 1.546 1.993 0 O-C-N 123.454 0.472 . . . . 53.31 114.017 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -78.0 -3.81 13.82 Favored 'Trans proline' 0 CA--C 1.55 1.32 0 C-N-CA 122.993 2.462 . . . . 64.11 112.474 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -129.46 28.31 5.21 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.984 -0.448 . . . . 74.14 110.21 -168.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -55.98 115.68 10.33 Favored Pre-proline 0 N--CA 1.475 0.818 0 O-C-N 124.042 0.839 . . . . 74.24 111.451 -175.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -108.96 -158.15 0.02 OUTLIER 'Trans proline' 0 CA--C 1.557 1.636 0 C-N-CA 123.721 2.947 . . . . 75.53 111.546 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -86.85 126.12 34.44 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.08 -1.081 . . . . 63.32 108.08 175.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.48 HD13 ' CB ' ' A' ' 68' ' ' PHE . 36.7 mt -112.18 107.06 22.0 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.412 0 N-CA-C 108.98 -0.748 . . . . 73.14 108.98 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -89.84 135.64 33.51 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 109.753 -0.462 . . . . 72.42 109.753 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.8 p -126.03 117.88 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 N-CA-C 107.371 -1.344 . . . . 64.04 107.371 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 62.77 20.8 12.38 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 123.956 0.902 . . . . 63.23 110.709 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.38 -5.34 58.82 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.38 -0.827 . . . . 63.55 112.489 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -99.82 126.18 45.87 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 109.026 -0.731 . . . . 73.42 109.026 -178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.88 126.41 31.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-O 121.54 0.686 . . . . 71.12 109.427 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.483 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 12.5 mm100 -122.33 152.45 40.11 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.077 -0.712 . . . . 71.3 109.077 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.6 t -87.64 169.15 12.39 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.327 -0.99 . . . . 74.55 108.327 175.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.426 ' HA ' HD12 ' A' ' 56' ' ' ILE . 13.2 t -58.03 -34.18 69.77 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.379 0.672 . . . . 73.12 111.33 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.0 m -61.58 -49.46 76.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.25 0.548 . . . . 73.34 109.784 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -60.83 -49.78 76.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.281 -0.872 . . . . 71.42 110.391 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.48 ' CB ' HD13 ' A' ' 56' ' ' ILE . 44.3 t80 -51.49 -56.07 15.38 Favored 'General case' 0 CA--C 1.5 -0.943 0 O-C-N 123.778 0.674 . . . . 74.33 110.415 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 69' ' ' LEU . 13.5 mt -49.77 -47.54 50.97 Favored 'General case' 0 CA--C 1.491 -1.3 0 O-C-N 124.079 0.862 . . . . 54.33 112.94 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -55.54 -51.42 67.12 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 123.703 0.627 . . . . 64.13 111.773 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -65.63 -37.3 86.18 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.555 0.693 . . . . 70.23 110.463 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 3.4 t80 -61.83 -53.6 53.69 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.183 -0.917 . . . . 64.12 111.197 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -74.62 -18.17 60.6 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 123.333 0.396 . . . . 64.21 111.123 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -75.3 -14.51 60.5 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.033 0.444 . . . . 63.53 111.285 171.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.43 18.01 29.66 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 120.749 -0.739 . . . . 60.43 113.577 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.6 mt -76.84 -44.65 31.46 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.469 -0.892 . . . . 75.34 112.019 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -89.3 -5.77 57.29 Favored 'General case' 0 C--O 1.203 -1.358 0 N-CA-C 113.384 0.883 . . . . 75.52 113.384 -174.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.286 0.0 OUTLIER -64.09 -12.4 38.9 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.727 1.38 . . . . 71.34 114.727 -175.277 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -80.81 -10.68 59.7 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.112 -0.495 . . . . 64.55 111.176 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.49 -15.56 60.39 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 122.76 0.424 . . . . 74.3 111.864 -176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -53.44 -30.42 40.4 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.265 0.555 . . . . 72.34 111.838 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -99.4 8.56 44.51 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 122.016 -0.427 . . . . 72.25 111.735 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.36 147.76 47.68 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.584 0.707 . . . . 50.32 111.675 -176.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -88.14 116.14 26.11 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.26 -0.882 . . . . 71.12 112.202 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.579 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 55.7 p90 . . . . . 0 C--N 1.302 -1.467 0 N-CA-C 106.216 -1.772 . . . . 74.2 106.216 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.476 ' CG ' ' HB3' ' A' ' 126' ' ' ARG . 9.9 pt-20 . . . . . 0 C--O 1.234 0.283 0 N-CA-C 109.753 -0.462 . . . . 64.42 109.753 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -118.84 138.67 13.8 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 119.683 -1.246 . . . . 73.42 112.98 -173.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -108.44 129.83 55.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.281 -1.007 . . . . 70.41 108.281 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -108.25 98.96 8.43 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.961 -1.126 . . . . 72.44 107.961 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 3.2 mm? -92.8 100.82 13.23 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.853 -1.165 . . . . 71.32 107.853 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.1 p -116.81 122.18 69.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-O 122.415 1.102 . . . . 75.11 113.692 -176.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.579 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 29.7 m-90 -102.83 129.99 49.69 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 113.869 -1.514 . . . . 73.11 107.854 177.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.423 ' HG3' ' HG2' ' A' ' 119' ' ' GLU . 3.1 mppt? -114.41 125.7 54.14 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.105 -1.072 . . . . 65.21 108.105 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.9 p . . . . . 0 C--N 1.308 -1.213 0 C-N-CA 120.236 -0.586 . . . . 63.44 110.621 -179.132 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.8 p90 . . . . . 0 N--CA 1.436 -1.127 0 N-CA-C 106.793 -1.558 . . . . 74.2 106.793 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -116.49 138.75 51.14 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.004 -1.85 . . . . 60.21 106.004 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.495 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 45.7 mt-10 -117.23 141.1 48.71 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 119.803 -0.759 . . . . 75.31 110.988 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -127.52 116.71 20.8 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.808 -1.182 . . . . 54.51 107.808 177.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 41.8 tt0 -125.5 114.94 19.45 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 121.162 0.506 . . . . 75.12 110.861 -177.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.98 134.3 39.16 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.732 -0.667 . . . . 55.22 109.49 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -111.28 118.57 36.25 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 123.396 0.679 . . . . 62.23 109.345 -175.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.2 mt -120.91 150.27 23.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.174 -1.417 . . . . 65.1 107.174 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -134.63 145.04 48.22 Favored 'General case' 0 C--O 1.266 1.924 0 C-N-CA 118.998 -1.081 . . . . 74.4 110.292 173.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.509 ' HB2' ' SG ' ' A' ' 132' ' ' CYS . 10.6 ttp180 -91.42 113.66 25.99 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 114.731 -1.122 . . . . 62.42 108.25 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 131' ' ' SER . 62.9 mtm180 -70.46 158.43 36.06 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.31 -1.314 . . . . 75.31 110.119 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -69.34 -15.07 63.25 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.875 0.845 . . . . 70.52 109.004 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -66.57 -17.76 64.99 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.068 -1.424 . . . . 63.01 108.918 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.72 -23.74 35.06 Favored Glycine 0 CA--C 1.504 -0.628 0 N-CA-C 111.315 -0.714 . . . . 54.51 111.315 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 36.6 t -88.49 133.82 34.03 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 115.07 -0.565 . . . . 72.22 110.33 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 126' ' ' ARG . 95.2 m -90.67 150.48 21.66 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 115.504 -0.771 . . . . 51.21 109.861 175.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 21.1 t90 -151.09 155.84 39.79 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.172 -1.047 . . . . 72.34 108.172 177.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.1 mt -65.85 117.62 8.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.196 -1.039 . . . . 73.33 108.196 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -75.37 -56.59 4.56 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.826 -1.546 . . . . 73.41 106.826 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 52.2 m -167.14 175.35 7.54 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.988 -1.486 . . . . 75.41 106.988 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.7 t -142.57 145.51 23.28 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 105.939 -1.874 . . . . 74.24 105.939 175.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -130.56 130.72 44.45 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-O 121.057 0.456 . . . . 71.21 109.773 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -115.58 126.97 54.89 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.985 -1.487 . . . . 73.44 106.985 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.7 pt -127.68 98.44 4.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 CA-C-O 122.304 1.049 . . . . 74.43 108.471 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 19.2 ptm -93.0 124.96 37.35 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 114.496 -1.229 . . . . 71.22 109.256 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.5 t 79.27 63.87 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.906 -1.497 . . . . 74.32 109.924 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.495 ' HG2' ' OE1' ' A' ' 119' ' ' GLU . 23.4 tptm . . . . . 0 C--N 1.295 -1.778 0 N-CA-C 106.139 -1.8 . . . . 71.21 106.139 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.0 t70 . . . . . 0 CA--C 1.506 -0.747 0 CA-C-O 121.109 0.48 . . . . 73.14 110.298 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.62 -38.13 89.96 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-N 115.002 -0.999 . . . . 73.41 109.65 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.28 -47.69 63.85 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.346 -0.843 . . . . 74.53 109.816 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 m -71.95 -32.2 43.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 112.545 0.572 . . . . 72.25 112.545 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -72.0 -33.47 68.1 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.588 -0.893 . . . . 63.42 108.588 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.8 -37.59 92.43 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 110.823 -0.911 . . . . 72.13 110.823 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.5 tp -66.63 -50.1 64.09 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 124.544 1.138 . . . . 74.34 109.968 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.75 -44.3 98.11 Favored Glycine 0 C--O 1.245 0.841 0 N-CA-C 111.76 -0.536 . . . . 72.55 111.76 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -63.49 -42.61 98.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.692 -0.254 . . . . 73.55 110.46 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.72 -41.83 98.01 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 123.248 0.343 . . . . 72.14 110.806 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 33.5 t80 -62.05 -54.08 46.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.353 -0.84 . . . . 64.31 110.053 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 29' ' ' ILE . 9.8 mm -62.94 -39.37 84.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.406 -0.361 . . . . 55.32 111.774 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.29 -48.62 80.56 Favored 'General case' 0 C--O 1.198 -1.608 0 O-C-N 123.436 0.46 . . . . 73.15 110.782 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 41' ' ' SER . 4.0 pp -70.59 -25.0 62.86 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 119.734 -0.786 . . . . 74.35 112.055 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.7 t -70.9 -26.04 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.348 0.594 . . . . 70.35 109.896 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.5 p -119.77 28.16 8.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 122.156 0.979 . . . . 71.42 108.639 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.435 ' HB2' ' HA ' ' A' ' 31' ' ' LEU . 38.2 tptt -60.96 156.65 17.14 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.051 -1.431 . . . . 72.33 112.266 -175.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 5.2 p -52.62 141.75 34.13 Favored Pre-proline 0 N--CA 1.432 -1.328 0 C-N-CA 125.096 1.358 . . . . 52.15 112.307 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 35' ' ' SER . 31.4 Cg_exo -56.11 -18.7 24.09 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.825 3.017 . . . . 75.11 112.464 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -55.27 -27.83 49.26 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.604 -0.725 . . . . 70.25 110.158 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.2 p -111.24 102.77 11.16 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.862 -1.162 . . . . 71.11 107.862 174.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.3 -42.74 96.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 72.53 111.86 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -106.61 86.05 2.27 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 122.474 1.13 . . . . 74.31 110.504 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 36.8 m -68.6 -23.67 64.49 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.264 -1.335 . . . . 60.24 108.544 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.449 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 2.0 mp0 -61.38 -26.49 67.87 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 113.909 -1.496 . . . . 72.15 109.583 177.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -68.68 -42.43 77.85 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.443 -0.577 . . . . 73.44 109.443 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -69.07 -34.72 75.6 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 108.025 -1.102 . . . . 73.22 108.025 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 52.1 tp -66.22 -45.67 79.88 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 115.627 -0.715 . . . . 71.24 110.274 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.39 74.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.057 0.456 . . . . 72.1 110.949 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -75.24 -33.58 61.34 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 109.747 -0.464 . . . . 72.14 109.747 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 57.2 t80 -70.31 -46.31 64.49 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 123.286 0.634 . . . . 71.4 109.952 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 3.6 pp -84.24 -8.03 59.17 Favored 'General case' 0 C--O 1.194 -1.864 0 CA-C-N 115.654 -0.703 . . . . 73.42 112.146 -177.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -41.83 -57.49 3.42 Favored Glycine 0 CA--C 1.541 1.708 0 O-C-N 123.543 0.527 . . . . 70.44 113.574 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -85.48 -5.91 9.1 Favored 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 123.068 2.512 . . . . 72.34 112.768 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.481 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 16.0 m-70 -115.77 22.27 13.21 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.998 -0.439 . . . . 75.25 111.128 -172.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.502 ' CG ' ' HB ' ' A' ' 65' ' ' THR . 13.3 t70 -76.3 119.67 78.31 Favored Pre-proline 0 C--N 1.309 -1.173 0 O-C-N 123.337 0.398 . . . . 73.23 110.745 -174.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 9.9 Cg_endo -101.77 -150.33 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.431 0 C-N-CA 123.506 2.804 . . . . 62.31 111.993 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.67 118.64 24.52 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 107.711 -1.218 . . . . 72.15 107.711 172.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.484 HD13 ' HB2' ' A' ' 68' ' ' PHE . 52.9 mt -100.55 113.4 36.23 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.104 0 N-CA-C 107.753 -1.203 . . . . 64.13 107.753 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -100.34 112.37 24.71 Favored 'General case' 0 C--N 1.278 -2.534 0 O-C-N 121.048 -1.033 . . . . 74.12 111.578 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.453 HG22 ' HB2' ' A' ' 139' ' ' PHE . 70.4 t -115.11 117.69 56.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 108.793 -0.818 . . . . 73.03 108.793 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 60.34 21.7 11.22 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.503 1.127 . . . . 72.25 111.455 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.54 6.17 61.2 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.267 -0.878 . . . . 52.11 112.545 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -112.1 133.46 54.24 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.558 -0.534 . . . . 72.2 109.558 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.09 124.51 30.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 122.501 1.143 . . . . 72.25 109.392 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.401 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 66.6 mm-40 -117.92 136.96 53.14 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.589 -1.187 . . . . 54.32 107.966 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 t -93.43 174.78 7.03 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.266 -1.013 . . . . 71.14 108.266 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.502 ' HB ' ' CG ' ' A' ' 53' ' ' ASP . 8.8 t -51.24 -37.54 47.58 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 125.114 1.366 . . . . 60.34 111.529 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.4 m -62.84 -49.92 72.98 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.34 0.591 . . . . 75.23 110.135 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.48 -51.28 69.34 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.482 -0.781 . . . . 61.5 111.617 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.484 ' HB2' HD13 ' A' ' 56' ' ' ILE . 39.5 t80 -54.36 -55.45 28.41 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 123.22 0.325 . . . . 63.32 110.33 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -50.06 -44.62 51.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.852 -1.067 . . . . 71.22 110.737 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -58.23 -48.84 79.13 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.883 0.327 . . . . 72.04 111.883 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.485 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 33.1 m-85 -66.05 -37.89 86.98 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.615 0.722 . . . . 72.35 109.721 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -56.73 -54.16 49.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 123.965 0.906 . . . . 75.44 110.831 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -72.21 -22.02 61.32 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.317 -0.401 . . . . 74.42 111.608 -176.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -77.06 -16.44 59.25 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 112.457 0.54 . . . . 71.21 112.457 172.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.55 21.28 12.97 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.37 -0.919 . . . . 34.25 114.155 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.66 -54.76 6.23 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.504 0.668 . . . . 73.25 110.123 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.485 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 46.3 m-85 -83.22 5.7 22.03 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 115.898 -0.592 . . . . 64.23 112.057 -174.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.449 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 96.8 mttt -73.93 -14.11 61.0 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.843 0.83 . . . . 73.52 111.201 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -86.09 -19.08 30.74 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.095 -0.957 . . . . 55.52 108.705 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 80' ' ' LEU . 9.5 tt -77.76 -12.21 59.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.354 -0.839 . . . . 71.24 111.563 -171.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -74.1 -23.49 59.33 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.88 0.847 . . . . 71.3 109.182 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -96.5 13.61 27.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.857 -1.065 . . . . 70.15 110.131 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -81.48 147.27 29.8 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.736 -0.665 . . . . 65.14 111.563 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 103' ' ' TRP . 8.0 pt-20 -92.64 142.05 27.8 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.473 -0.785 . . . . 74.34 108.898 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.498 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 43.3 p90 . . . . . 0 C--N 1.307 -1.269 0 C-N-CA 120.422 -0.511 . . . . 73.42 111.735 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.514 ' OE2' ' HD3' ' A' ' 126' ' ' ARG . 1.2 pm0 . . . . . 0 CA--C 1.504 -0.805 0 N-CA-C 113.767 1.025 . . . . 64.41 113.767 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 125' ' ' TRP . . . -120.74 137.12 11.79 Favored Glycine 0 N--CA 1.411 -3.018 0 N-CA-C 109.475 -1.45 . . . . 62.31 109.475 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -108.06 140.36 41.35 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.747 -1.205 . . . . 72.14 107.747 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -125.05 99.08 5.95 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.91 -1.515 . . . . 54.41 106.91 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.5 mt -102.51 134.68 45.45 Favored 'General case' 0 C--N 1.274 -2.706 0 N-CA-C 107.984 -1.117 . . . . 74.35 107.984 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 9.8 p -123.89 125.23 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 119.414 -0.914 . . . . 65.2 112.861 -175.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.532 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 15.4 m-90 -101.06 148.8 24.64 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.629 -1.168 . . . . 74.11 109.6 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -118.61 120.9 38.83 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.415 -1.328 . . . . 75.34 107.415 172.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.447 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 35.2 t . . . . . 0 C--N 1.298 -1.667 0 O-C-N 123.977 0.798 . . . . 72.14 111.007 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 43.9 p90 . . . . . 0 N--CA 1.413 -2.293 0 CA-C-O 121.464 0.649 . . . . 62.22 110.051 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 105' ' ' SER . 0.4 OUTLIER -102.62 136.9 41.6 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 106.206 -1.776 . . . . 64.11 106.206 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -114.21 141.14 47.91 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.487 -0.885 . . . . 70.41 108.974 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.66 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -123.2 117.49 25.46 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 115.472 -0.785 . . . . 62.34 111.307 -173.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -111.13 109.39 19.43 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.095 -1.076 . . . . 72.41 108.095 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.03 126.36 44.73 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 122.484 0.314 . . . . 70.33 110.48 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -103.69 119.3 38.62 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.584 -1.265 . . . . 74.41 107.584 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.438 HG22 ' SG ' ' A' ' 132' ' ' CYS . 50.2 mt -128.94 139.72 51.16 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 N-CA-C 106.315 -1.735 . . . . 75.22 106.315 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.429 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 0.2 OUTLIER -130.21 152.09 50.03 Favored 'General case' 0 C--O 1.256 1.428 0 C-N-CA 118.96 -1.096 . . . . 73.31 110.674 -177.733 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.514 ' HD3' ' OE2' ' A' ' 97' ' ' GLU . 45.6 ttp180 -74.81 114.49 13.31 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 105.965 -1.865 . . . . 61.43 105.965 174.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -81.43 145.48 30.75 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 108.271 -1.011 . . . . 75.0 108.271 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -66.4 -10.79 47.07 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 122.345 1.069 . . . . 75.35 110.12 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.78 -16.63 63.85 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.645 -1.161 . . . . 60.53 110.412 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.29 -23.43 20.68 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 111.482 -0.647 . . . . 72.1 111.482 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.0 t -100.47 -173.24 2.36 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.758 -0.83 . . . . 63.11 108.758 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.438 ' SG ' HG22 ' A' ' 124' ' ' ILE . 27.8 t -122.6 143.06 49.99 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.049 -1.834 . . . . 74.13 106.049 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.411 ' HE1' ' HA ' ' A' ' 52' ' ' HIS . 6.4 t90 -150.45 155.44 39.55 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 108.955 -0.757 . . . . 70.41 108.955 -172.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.59 130.75 42.64 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.938 0.399 . . . . 72.35 110.359 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -92.42 -43.29 9.29 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.746 -0.661 . . . . 71.01 109.646 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.5 t -179.41 151.33 0.47 Allowed 'General case' 0 C--O 1.194 -1.85 0 N-CA-C 106.582 -1.636 . . . . 71.23 106.582 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.2 m -134.95 152.37 32.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.832 -1.173 . . . . 74.51 107.832 173.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -128.64 133.64 48.31 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 122.72 0.408 . . . . 54.43 109.9 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.453 ' HB2' HG22 ' A' ' 58' ' ' VAL . 44.0 m-85 -121.98 112.4 18.24 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.185 -1.043 . . . . 71.22 108.185 176.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 17.2 pt -112.65 99.21 8.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 121.604 0.716 . . . . 60.51 111.926 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 52.2 mtt -86.78 94.65 9.59 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 106.415 -1.698 . . . . 74.51 106.415 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.5 m -162.74 -56.86 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.368 0.877 . . . . 75.43 113.368 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 N--CA 1.471 0.603 0 C-N-CA 124.328 1.051 . . . . 72.24 112.744 -171.101 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 121.663 0.744 . . . . 73.03 109.579 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.41 -37.12 84.49 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.265 -1.334 . . . . 71.21 108.182 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -73.12 -31.35 64.25 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.599 -0.728 . . . . 73.21 110.278 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.564 ' HA ' ' SG ' ' A' ' 132' ' ' CYS . 90.8 t -63.93 -50.19 78.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 109.688 -0.486 . . . . 71.2 109.688 175.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -30.21 66.71 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.398 -0.521 . . . . 64.24 110.438 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.43 -41.66 90.43 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 111.054 -0.818 . . . . 72.22 111.054 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 tp -63.04 -48.17 79.89 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 123.75 0.82 . . . . 74.44 109.146 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.95 -42.88 97.03 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.462 -0.79 . . . . 72.41 111.759 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -64.89 -44.33 89.98 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-O 119.773 -0.156 . . . . 74.45 111.194 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.35 -43.78 96.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.88 0.371 . . . . 61.12 110.251 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.463 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 26.7 t80 -62.39 -54.85 34.3 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 124.961 1.304 . . . . 73.44 110.113 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.2 mm -66.1 -34.06 67.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 112.24 0.459 . . . . 65.12 112.24 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.83 -39.15 73.16 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.572 -0.451 . . . . 71.45 110.043 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.63 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 4.1 pp -69.29 -30.25 68.3 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 119.556 -0.857 . . . . 65.14 110.846 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.7 t -72.08 -21.87 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 115.819 -0.628 . . . . 73.54 110.213 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.2 p -110.4 19.45 18.78 Favored 'General case' 0 C--O 1.248 0.991 0 O-C-N 121.455 -0.778 . . . . 74.3 111.887 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.63 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 70.6 mmtt -58.2 158.02 7.6 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-N 115.854 -0.612 . . . . 61.32 111.389 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.3 t -74.67 148.18 85.07 Favored Pre-proline 0 C--N 1.287 -2.11 0 N-CA-C 108.377 -0.971 . . . . 51.0 108.377 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -59.87 -6.03 4.28 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 123.858 3.039 . . . . 71.11 111.731 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.4 -27.48 67.48 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.009 0.924 . . . . 64.31 108.641 171.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.1 m -92.35 152.71 19.62 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 105.963 -1.866 . . . . 54.52 105.963 172.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.1 t -62.23 -53.21 50.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 113.208 0.818 . . . . 55.43 113.208 -174.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -158.08 125.4 5.07 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 119.618 -0.833 . . . . 72.33 112.204 -172.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -32.47 74.03 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 123.609 0.763 . . . . 75.32 112.14 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.04 -21.73 61.49 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.993 -0.549 . . . . 75.11 109.532 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -71.84 -42.35 67.05 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 107.42 -1.326 . . . . 71.51 107.42 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -66.16 -33.92 76.86 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.054 -0.976 . . . . 73.11 109.124 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.439 HD11 ' CE1' ' A' ' 28' ' ' PHE . 39.5 tp -69.91 -40.83 75.36 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.95 -0.568 . . . . 61.22 110.459 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.36 79.7 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.416 0.627 . . . . 73.21 109.915 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -69.59 -38.24 77.24 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.666 -1.152 . . . . 64.44 109.26 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.507 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 43.8 t80 -66.45 -45.31 80.21 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.353 -0.84 . . . . 71.42 110.308 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.3 pp -80.19 2.58 23.73 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.046 0.388 . . . . 71.33 112.046 -176.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -47.87 -62.52 4.09 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 111.729 -0.549 . . . . 42.35 111.729 173.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.507 ' HD2' ' O ' ' A' ' 48' ' ' PHE . 66.0 Cg_endo -79.99 -6.5 14.11 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.244 1.963 . . . . 72.3 112.363 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 92.4 m-70 -114.38 33.61 5.2 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 109.292 -0.632 . . . . 74.2 109.292 -176.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.436 ' CG ' HG21 ' A' ' 65' ' ' THR 0.267 13.5 t70 -53.76 99.03 0.19 Allowed Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 128.818 2.847 . . . . 74.01 111.516 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -113.06 -156.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 123.97 3.114 . . . . 74.13 113.089 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -92.75 127.87 38.41 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 107.608 -1.256 . . . . 74.33 107.608 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 65' ' ' THR . 43.2 mt -116.48 109.04 26.65 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 N-CA-C 109.046 -0.724 . . . . 61.24 109.046 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -91.18 138.89 31.24 Favored 'General case' 0 C--N 1.274 -2.698 0 O-C-N 122.176 -0.327 . . . . 64.31 110.487 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.76 120.07 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 N-CA-C 107.428 -1.323 . . . . 62.41 107.428 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 61.74 20.22 11.2 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.983 0.913 . . . . 72.43 110.636 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.41 3.67 58.55 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 115.922 -0.581 . . . . 73.55 113.208 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -111.67 132.39 54.64 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.021 -0.733 . . . . 72.13 109.021 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.77 126.15 34.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.689 0.757 . . . . 74.34 110.387 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -121.82 146.56 46.96 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.127 -1.434 . . . . 72.32 107.127 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -81.33 174.53 11.41 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.204 -0.598 . . . . 73.04 109.567 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.532 ' HA ' HD12 ' A' ' 56' ' ' ILE . 50.5 p -65.48 -33.92 77.07 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.528 1.131 . . . . 73.44 110.45 -176.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.526 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 25.0 m -62.53 -51.53 67.03 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.694 -1.139 . . . . 54.21 109.641 174.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.84 -48.51 79.56 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 123.628 0.771 . . . . 53.14 110.416 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CG ' HD13 ' A' ' 56' ' ' ILE . 31.6 t80 -49.87 -56.5 10.24 Favored 'General case' 0 CA--C 1.501 -0.931 0 O-C-N 123.751 0.657 . . . . 71.31 110.491 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -53.34 -42.95 67.29 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 124.517 1.135 . . . . 75.33 110.589 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.7 mm100 -61.75 -48.64 79.76 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 123.275 0.63 . . . . 73.12 111.234 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.462 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 34.3 m-85 -67.22 -40.27 86.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.314 0.578 . . . . 74.2 109.461 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -56.21 -51.31 68.55 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.765 -0.652 . . . . 72.43 110.653 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -72.05 -21.39 61.53 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 116.22 -0.446 . . . . 74.23 111.291 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -83.25 -2.5 55.76 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 120.793 -0.363 . . . . 75.52 111.889 173.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.09 12.09 50.48 Favored Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 120.632 -0.794 . . . . 34.44 114.136 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.83 -45.5 50.86 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 122.104 -0.645 . . . . 74.45 111.751 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 32.6 m-85 -97.08 0.83 49.25 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 113.819 1.044 . . . . 75.13 113.819 -175.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -67.74 -13.61 62.26 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.596 0.712 . . . . 64.33 111.374 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.424 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 8.4 mtpm? -72.25 -10.94 60.44 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.898 -0.592 . . . . 71.32 111.72 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.69 -7.28 59.58 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 121.067 0.461 . . . . 72.03 111.086 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.13 -26.39 64.87 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.469 0.652 . . . . 73.44 109.273 172.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -96.07 13.6 26.61 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.051 -0.522 . . . . 50.2 109.952 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -92.71 145.83 24.12 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.738 1.014 . . . . 64.23 113.738 -173.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -100.49 139.98 35.4 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.024 -1.843 . . . . 75.34 106.024 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.443 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 48.2 p90 . . . . . 0 C--N 1.308 -1.223 0 CA-C-O 121.497 0.665 . . . . 70.1 112.222 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 N--CA 1.444 -0.771 0 CA-C-O 121.584 0.707 . . . . 72.44 111.235 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.28 148.79 17.52 Favored Glycine 0 N--CA 1.412 -2.935 0 CA-C-N 115.167 -0.924 . . . . 54.5 111.433 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -115.79 121.76 43.39 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.755 -1.202 . . . . 75.22 107.755 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.419 ' HE3' ' CD1' ' A' ' 123' ' ' TYR . 14.3 mptt -102.77 103.24 13.44 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 123.98 0.8 . . . . 74.13 108.952 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.25 125.1 48.86 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.161 -1.422 . . . . 64.24 107.161 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 15.3 t -124.4 134.64 66.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 119.796 -0.762 . . . . 71.24 110.492 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.443 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 18.8 m-90 -114.9 139.83 49.48 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.445 -0.946 . . . . 73.51 108.445 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.403 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 64.5 mttm -118.99 120.84 38.44 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.022 -1.103 . . . . 73.33 108.022 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 20.2 t . . . . . 0 C--N 1.308 -1.239 0 N-CA-C 108.454 -0.943 . . . . 52.12 108.454 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.498 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 44.8 p90 . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 108.764 -0.828 . . . . 62.14 108.764 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.4 ' H ' ' HB3' ' A' ' 105' ' ' SER . 8.1 m-20 -114.51 144.16 43.79 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.333 -1.358 . . . . 65.33 107.333 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.498 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 31.9 mt-10 -120.56 153.89 36.14 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 113.01 0.745 . . . . 72.33 113.01 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -137.07 120.93 17.52 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.731 -1.122 . . . . 75.1 108.939 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.418 ' HG3' HG22 ' A' ' 102' ' ' VAL . 88.6 tt0 -121.58 110.16 15.66 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.779 -0.823 . . . . 60.33 108.779 -176.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.57 133.94 41.45 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 122.933 0.493 . . . . 45.33 110.337 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.419 ' CD1' ' HE3' ' A' ' 100' ' ' LYS . 24.8 m-85 -113.53 116.85 30.19 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.703 -0.851 . . . . 75.35 108.703 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.9 mt -119.17 149.47 21.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.494 -1.669 . . . . 72.3 106.494 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -133.71 143.3 48.41 Favored 'General case' 0 C--O 1.265 1.898 0 C-N-CA 119.232 -0.987 . . . . 73.32 109.296 174.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -90.17 131.55 35.94 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 106.239 -1.763 . . . . 75.42 106.239 173.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.508 ' HD3' ' OG ' ' A' ' 131' ' ' SER . 54.4 mtp180 -85.39 144.58 27.94 Favored 'General case' 0 C--N 1.261 -3.242 0 N-CA-C 106.716 -1.587 . . . . 74.42 106.716 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -63.75 -10.57 20.42 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 114.651 1.352 . . . . 75.01 114.651 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -79.98 -14.17 58.78 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.726 -0.472 . . . . 73.35 109.726 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.88 -11.54 27.31 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.629 -0.796 . . . . 71.51 113.652 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.508 ' OG ' ' HD3' ' A' ' 127' ' ' ARG . 61.3 p -84.68 170.12 13.63 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 117.805 0.803 . . . . 73.04 109.72 175.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.564 ' SG ' ' HA ' ' A' ' 21' ' ' VAL . 13.7 p -138.02 142.3 40.39 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 108.395 -0.965 . . . . 62.21 108.395 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -150.08 155.66 40.27 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.291 -1.003 . . . . 73.21 108.291 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.9 mp -72.05 123.26 22.43 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.81 -0.441 . . . . 63.11 109.81 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -74.62 -52.91 10.44 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.149 -0.932 . . . . 74.32 109.009 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.4 t 179.52 156.91 0.58 Allowed 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 106.637 -1.616 . . . . 72.35 106.637 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.8 m -133.68 147.33 30.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 107.536 -1.283 . . . . 70.32 107.536 173.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -125.67 130.91 52.52 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-O 120.994 0.426 . . . . 65.05 109.979 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -110.23 135.85 50.34 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 107.878 -1.156 . . . . 72.22 107.878 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.528 ' HB ' ' CE ' ' A' ' 143' ' ' LYS . 12.3 pt -132.86 102.41 5.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 108.863 -0.792 . . . . 72.24 108.863 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 23.3 ptp -91.75 138.13 31.8 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.89 -0.724 . . . . 72.31 112.416 -173.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 35.3 m 59.34 77.97 0.29 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 113.456 -1.702 . . . . 74.33 114.08 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.528 ' CE ' ' HB ' ' A' ' 140' ' ' ILE . 5.9 mptp? . . . . . 0 C--N 1.3 -1.57 0 CA-C-N 114.477 -1.238 . . . . 74.34 108.509 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 C--O 1.24 0.588 0 N-CA-C 108.351 -0.981 . . . . 71.52 108.351 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.91 -34.74 78.45 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.132 -1.394 . . . . 73.55 107.498 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.25 -43.28 98.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.433 -0.803 . . . . 74.5 109.669 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.04 -56.7 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 O-C-N 123.837 0.711 . . . . 64.21 111.077 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -64.14 -34.3 77.74 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.326 -0.55 . . . . 71.0 110.797 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.53 ' HA2' ' CE1' ' A' ' 26' ' ' TYR . . . -62.22 -51.45 56.55 Favored Glycine 0 C--O 1.256 1.519 0 CA-C-N 115.887 -0.597 . . . . 65.25 112.303 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 pp -70.63 -30.38 67.01 Favored 'General case' 0 C--O 1.21 -0.999 0 N-CA-C 108.48 -0.933 . . . . 70.43 108.48 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.14 -44.43 76.54 Favored Glycine 0 N--CA 1.424 -2.107 0 CA-C-N 115.729 -0.669 . . . . 51.54 111.849 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.53 ' CE1' ' HA2' ' A' ' 23' ' ' GLY . 2.9 p90 -74.59 -35.23 62.99 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 119.272 -0.971 . . . . 73.13 110.459 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -63.63 -46.76 84.22 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.351 -0.611 . . . . 52.22 109.351 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 33.0 t80 -61.58 -52.7 63.35 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 115.35 -0.841 . . . . 74.2 110.554 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 29' ' ' ILE . 9.3 mm -61.14 -39.03 81.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 112.643 0.609 . . . . 65.3 112.643 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -68.15 -40.21 82.45 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 119.697 -0.801 . . . . 74.43 110.365 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.615 ' HA ' ' HD3' ' A' ' 34' ' ' LYS . 4.0 pp -71.59 -26.77 62.74 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 119.134 -1.026 . . . . 73.42 112.311 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.2 t -70.72 -25.74 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 109.363 -0.606 . . . . 42.32 109.363 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.4 p -107.94 19.31 20.2 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.308 0.575 . . . . 73.51 110.226 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.615 ' HD3' ' HA ' ' A' ' 31' ' ' LEU . 17.8 tptt -61.83 143.21 56.68 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-N 115.196 -0.911 . . . . 72.4 109.446 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.6 m -55.53 141.58 63.37 Favored Pre-proline 0 C--N 1.309 -1.159 0 O-C-N 123.78 0.675 . . . . 74.55 112.216 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.53 -7.44 20.33 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.332 2.688 . . . . 74.01 112.883 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -79.63 -26.53 41.1 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.944 -0.571 . . . . 55.43 109.954 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.3 m -70.46 172.87 7.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.816 -0.809 . . . . 73.33 108.816 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.2 t -52.54 -53.69 18.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 112.255 0.465 . . . . 73.35 112.255 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 173.43 134.81 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.836 0.71 . . . . 74.13 109.243 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.7 m -58.11 -38.92 77.39 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.24 0.543 . . . . 73.31 110.283 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -68.43 -20.85 64.67 Favored 'General case' 0 C--O 1.204 -1.292 0 CA-C-N 115.153 -0.93 . . . . 64.5 110.135 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -67.16 -47.23 71.65 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.412 -0.959 . . . . 52.45 108.412 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 18.3 mm-40 -71.04 -34.38 71.2 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 114.744 -1.116 . . . . 52.22 109.52 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.1 tp -66.16 -45.87 79.43 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 120.961 -0.296 . . . . 74.31 110.656 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.401 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . . . -60.45 -34.14 73.56 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.57 0.7 . . . . 73.55 110.661 176.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -70.67 -39.56 73.49 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.379 -0.828 . . . . 75.2 109.902 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 62.4 t80 -68.04 -40.43 82.84 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 124.38 1.072 . . . . 73.23 110.565 -178.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.7 pp -83.13 0.94 42.88 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 115.689 -0.687 . . . . 72.35 110.864 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.45 -58.21 4.72 Favored Glycine 0 CA--C 1.536 1.378 0 O-C-N 123.965 0.791 . . . . 71.4 113.439 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.89 -6.3 12.3 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 121.922 1.748 . . . . 62.11 112.172 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 10.9 m170 -108.82 32.22 5.06 Favored 'General case' 0 C--O 1.213 -0.862 0 C-N-CA 123.417 0.687 . . . . 73.13 109.807 -175.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.421 ' CG ' HG21 ' A' ' 65' ' ' THR . 13.0 t70 -53.57 98.58 0.17 Allowed Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 127.515 2.326 . . . . 63.53 110.633 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -114.54 -147.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 124.48 3.453 . . . . 65.31 113.188 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -102.71 128.77 49.28 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 108.717 -0.846 . . . . 74.44 108.717 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.433 HG22 HG23 ' A' ' 58' ' ' VAL . 3.4 mp -107.91 111.71 37.06 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.369 0 N-CA-C 108.862 -0.792 . . . . 74.54 108.862 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -95.97 109.57 21.93 Favored 'General case' 0 C--O 1.18 -2.553 0 O-C-N 121.742 -0.599 . . . . 73.32 111.334 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 56' ' ' ILE . 70.6 t -109.14 114.34 46.64 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.539 0 N-CA-C 108.392 -0.966 . . . . 74.22 108.392 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 63.93 20.83 12.39 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.524 1.13 . . . . 75.42 110.311 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.93 -10.08 62.0 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 114.961 -1.018 . . . . 61.33 112.022 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -93.59 130.51 39.46 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 110.069 -0.345 . . . . 74.1 110.069 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.68 121.07 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-O 122.611 1.196 . . . . 73.34 109.163 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -115.22 137.88 51.55 Favored 'General case' 0 C--N 1.271 -2.811 0 N-CA-C 106.451 -1.685 . . . . 74.23 106.451 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 67' ' ' ALA . 15.2 t -77.1 168.21 20.46 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 108.606 -0.887 . . . . 41.32 108.606 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.421 HG21 ' CG ' ' A' ' 53' ' ' ASP . 46.9 p -63.76 -32.83 74.45 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 123.981 0.912 . . . . 75.54 110.472 -176.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -62.65 -46.84 86.37 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.221 -1.354 . . . . 73.43 109.888 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.451 ' H ' HG23 ' A' ' 64' ' ' THR . . . -64.96 -44.9 87.89 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 123.549 0.74 . . . . 64.43 110.469 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -53.58 -54.35 38.68 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 123.477 0.486 . . . . 74.21 110.137 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -52.15 -41.42 62.55 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 124.306 1.003 . . . . 54.41 110.643 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.491 ' HG2' ' NH2' ' A' ' 73' ' ' ARG . 48.5 mt-30 -60.26 -51.47 69.39 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.279 -0.419 . . . . 74.4 111.556 175.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -63.33 -32.98 74.55 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.981 0.896 . . . . 74.41 110.393 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -62.07 -53.51 54.52 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.419 -1.264 . . . . 62.24 111.169 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.491 ' NH2' ' HG2' ' A' ' 70' ' ' GLN . 26.1 ptt180 -71.29 -20.7 62.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.96 0.409 . . . . 73.45 110.561 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 56.3 mt-30 -76.88 -9.2 58.52 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.229 -0.442 . . . . 71.41 110.941 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.57 7.48 64.92 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.941 -0.647 . . . . 70.43 114.024 174.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.2 mt -65.92 -28.81 69.2 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 117.161 0.481 . . . . 75.4 112.273 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -99.18 12.63 35.6 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.529 -0.469 . . . . 74.2 111.912 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.435 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 30.1 mmmt -70.78 -17.34 62.78 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.388 0.613 . . . . 72.12 110.434 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -83.27 -22.51 33.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.83 -0.623 . . . . 34.01 110.001 175.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.0 tp -76.68 -6.72 53.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.854 -0.612 . . . . 73.23 111.453 -172.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 1.6 pptp? -76.76 -3.65 39.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.618 0.723 . . . . 75.31 110.687 177.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -100.93 10.83 40.65 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 115.295 -0.866 . . . . 75.43 110.147 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.714 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -76.14 130.07 37.74 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-O 121.406 0.622 . . . . 74.14 112.301 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -112.6 150.02 31.97 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.855 -1.066 . . . . 75.04 109.871 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.6 t80 . . . . . 0 C--N 1.307 -1.278 0 O-C-N 123.774 0.671 . . . . 72.15 111.041 -174.991 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 . . . . . 0 N--CA 1.437 -1.079 0 N-CA-C 108.842 -0.799 . . . . 73.21 108.842 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -165.25 -167.53 25.99 Favored Glycine 0 N--CA 1.417 -2.569 0 C-N-CA 119.718 -1.23 . . . . 62.13 112.568 -176.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.08 157.42 41.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 109.033 -0.729 . . . . 64.34 109.033 -174.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 57.9 tttm -147.41 100.13 3.22 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.93 -1.137 . . . . 74.54 107.93 174.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -110.31 158.88 17.94 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.766 -0.827 . . . . 54.0 108.766 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.2 p -134.51 140.56 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 121.667 0.746 . . . . 63.33 111.838 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.714 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 24.1 m-90 -116.15 127.69 55.03 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.689 -1.141 . . . . 74.25 108.172 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.431 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 66.3 mttm -105.9 131.96 52.58 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.147 -0.686 . . . . 74.22 109.147 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 C--N 1.299 -1.615 0 N-CA-C 108.506 -0.924 . . . . 63.21 108.506 176.412 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 2.8 p90 . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 108.772 -0.825 . . . . 73.11 108.772 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -110.5 135.56 50.98 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.963 -1.495 . . . . 74.33 106.963 176.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.468 ' HB2' HG13 ' A' ' 140' ' ' ILE . 46.0 mt-10 -116.83 156.53 27.11 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.919 -0.713 . . . . 52.13 111.89 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -135.87 117.53 14.97 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.923 -1.035 . . . . 71.31 108.415 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -112.79 112.31 23.71 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.845 -0.798 . . . . 75.52 108.845 -175.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -98.16 131.76 44.26 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.402 -0.519 . . . . 54.31 110.716 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -108.77 121.81 45.84 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 114.478 -1.237 . . . . 74.41 108.206 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.425 HG12 HD23 ' A' ' 134' ' ' LEU . 50.8 mt -124.3 137.12 58.26 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 N-CA-C 107.53 -1.285 . . . . 72.43 107.53 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -114.37 150.31 34.78 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.298 -1.742 . . . . 74.35 106.298 176.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -111.67 136.56 50.73 Favored 'General case' 0 N--CA 1.403 -2.817 0 C-N-CA 118.293 -1.363 . . . . 73.34 110.385 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.403 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 61.4 ttt180 -88.83 154.82 19.95 Favored 'General case' 0 C--N 1.258 -3.389 0 CA-C-N 112.912 -1.949 . . . . 74.22 109.366 -170.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -59.78 -26.62 65.87 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.466 0.706 . . . . 52.33 110.91 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.403 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 31.1 t70 -67.01 -16.22 64.23 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.43 -0.805 . . . . 72.25 110.773 175.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.62 -23.64 29.26 Favored Glycine 0 C--O 1.221 -0.683 0 O-C-N 121.921 -0.487 . . . . 74.41 112.111 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.9 t -73.0 140.47 47.35 Favored 'General case' 0 N--CA 1.42 -1.933 0 C-N-CA 123.483 0.713 . . . . 74.15 109.532 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 81.3 m -104.57 141.92 35.56 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.195 -1.039 . . . . 74.15 108.195 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -140.54 154.56 46.58 Favored 'General case' 0 N--CA 1.408 -2.56 0 N-CA-C 107.941 -1.133 . . . . 62.31 107.941 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.425 HD23 HG12 ' A' ' 124' ' ' ILE . 78.9 mt -67.9 116.14 8.21 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.25 -0.648 . . . . 60.25 109.25 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -80.84 -46.41 15.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 106.921 -1.511 . . . . 74.41 106.921 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.8 p -174.75 172.97 2.88 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.002 -0.999 . . . . 71.1 108.74 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.6 t -144.05 141.12 24.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 106.596 -1.631 . . . . 74.21 106.596 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -119.08 132.37 56.01 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 109.5 -0.555 . . . . 70.33 109.5 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.425 ' HB2' HG22 ' A' ' 58' ' ' VAL . 64.4 m-85 -115.28 131.72 56.84 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.604 -1.258 . . . . 64.41 107.604 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.468 HG13 ' HB2' ' A' ' 119' ' ' GLU . 4.5 pt -132.12 99.04 3.4 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 CA-C-O 121.71 0.767 . . . . 62.51 110.811 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 21.6 ptp -85.07 126.22 33.4 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.843 -1.071 . . . . 50.21 109.805 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.7 t 77.42 74.32 0.07 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.548 1.139 . . . . 61.24 112.016 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt . . . . . 0 CA--C 1.47 -2.109 0 N-CA-C 107.167 -1.42 . . . . 74.33 107.167 171.459 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 17.2 t70 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 122.083 0.944 . . . . 62.42 111.028 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.36 -33.83 67.54 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.865 -1.061 . . . . 72.11 108.39 -177.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -65.45 -47.43 76.18 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 124.751 1.22 . . . . 64.24 109.982 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.507 ' HA ' ' CD2' ' A' ' 24' ' ' LEU . 6.3 p -65.85 -43.06 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 112.327 0.491 . . . . 73.41 112.327 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 13.4 ptpt -71.25 -24.51 62.19 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 118.659 -1.216 . . . . 75.32 111.23 177.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.33 -56.49 10.09 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.782 -0.645 . . . . 71.44 112.323 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.507 ' CD2' ' HA ' ' A' ' 21' ' ' VAL . 1.7 pt? -70.09 -30.65 67.92 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 118.965 -1.094 . . . . 74.12 109.629 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.9 -42.17 98.47 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.664 -0.698 . . . . 51.1 111.92 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -69.03 -43.67 74.25 Favored 'General case' 0 C--O 1.208 -1.084 0 C-N-CA 119.795 -0.762 . . . . 75.33 110.759 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -57.75 -43.9 85.71 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.154 0.502 . . . . 70.3 110.1 -177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.501 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 26.5 t80 -62.3 -54.23 43.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.725 -1.125 . . . . 72.22 110.149 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.6 mm -63.42 -33.96 64.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 112.296 0.48 . . . . 65.13 112.296 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -68.82 -43.73 74.94 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 110.181 -0.303 . . . . 54.24 110.181 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.6 pp -68.19 -31.18 70.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.979 -0.688 . . . . 73.24 110.562 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.72 -27.49 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 116.06 -0.518 . . . . 62.43 110.103 175.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.8 p -107.51 19.83 19.7 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.485 0.659 . . . . 53.14 110.299 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 34' ' ' LYS . 20.5 tptt -77.26 158.14 30.41 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.749 -0.66 . . . . 65.13 109.62 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 m -56.39 131.3 76.25 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.474 0.71 . . . . 64.02 111.521 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.31 -7.11 20.04 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.614 2.876 . . . . 70.02 111.544 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.73 -19.58 65.78 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.26 1.424 . . . . 72.33 110.58 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -76.08 -176.56 3.55 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 107.92 -1.141 . . . . 71.45 107.92 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.64 -50.01 82.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 118.341 0.519 . . . . 74.55 111.575 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.3 t30 177.2 131.07 0.05 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.566 -0.531 . . . . 63.15 109.566 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.3 m -60.86 -35.19 75.94 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-O 121.44 0.638 . . . . 74.03 110.384 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -66.66 -20.75 66.06 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.923 -1.035 . . . . 74.4 110.946 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -67.68 -47.35 69.69 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 108.944 -0.761 . . . . 70.43 108.944 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -68.23 -34.32 76.02 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.084 -0.962 . . . . 73.35 108.741 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.4 HD11 ' CE2' ' A' ' 28' ' ' PHE . 36.1 tp -66.47 -44.68 82.06 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 116.129 -0.487 . . . . 54.12 110.42 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.77 -33.12 73.51 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.431 0.634 . . . . 32.24 110.408 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -77.12 -32.36 56.39 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.203 -0.908 . . . . 53.02 109.756 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -68.9 -47.31 66.11 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.772 -0.455 . . . . 73.22 109.772 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.6 pp -73.33 -2.56 22.6 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.766 -0.652 . . . . 65.13 112.363 -176.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -39.24 -67.44 0.59 Allowed Glycine 0 CA--C 1.538 1.487 0 O-C-N 123.908 0.755 . . . . 70.31 113.123 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.402 ' O ' ' HZ2' ' A' ' 133' ' ' TRP . 7.8 Cg_exo -78.78 -6.4 15.19 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.823 2.348 . . . . 64.53 113.002 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 70.1 m80 -110.5 24.73 12.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.704 -0.48 . . . . 75.2 109.704 -172.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.446 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 8.3 t70 -55.91 109.47 1.67 Allowed Pre-proline 0 C--O 1.244 0.811 0 C-N-CA 124.654 1.181 . . . . 75.31 111.965 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -112.98 -149.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 124.257 3.304 . . . . 73.32 110.577 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -92.12 119.16 31.52 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 107.986 -1.116 . . . . 74.43 107.986 172.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.475 HD13 ' CB ' ' A' ' 68' ' ' PHE . 67.5 mt -101.16 112.71 34.99 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.683 0 N-CA-C 106.552 -1.647 . . . . 74.53 106.552 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -98.09 133.24 42.81 Favored 'General case' 0 C--N 1.259 -3.357 0 C-N-CA 119.891 -0.724 . . . . 65.44 109.298 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.3 t -128.28 114.68 35.21 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 107.31 -1.367 . . . . 75.32 107.31 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 63.53 20.57 12.31 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.947 1.299 . . . . 75.24 110.473 -176.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.55 -3.24 65.59 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.672 -0.694 . . . . 43.01 112.286 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -98.48 133.14 43.28 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.934 -0.765 . . . . 64.44 108.934 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.401 HD13 ' N ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -73.63 125.41 32.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 122.152 0.977 . . . . 70.42 109.81 -175.863 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 58.9 mm-40 -124.65 148.02 48.18 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 115.044 -0.98 . . . . 63.3 108.727 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 t -95.14 172.21 8.26 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.517 -1.29 . . . . 74.45 107.517 173.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.446 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 9.1 t -54.06 -34.92 61.36 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 112.731 0.641 . . . . 73.52 112.731 -177.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.538 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 73.0 m -65.43 -48.31 73.2 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 120.869 -0.332 . . . . 74.14 110.696 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -59.12 -45.71 90.2 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 122.668 0.387 . . . . 75.5 110.16 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.475 ' CB ' HD13 ' A' ' 56' ' ' ILE . 56.7 t80 -54.21 -55.82 24.3 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 123.441 0.463 . . . . 75.54 110.032 174.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.86 -39.88 59.65 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.767 -1.106 . . . . 71.33 110.885 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.9 mm100 -63.81 -47.6 80.2 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 123.048 0.539 . . . . 64.4 111.375 177.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.43 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 31.7 m-85 -66.35 -32.67 74.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.816 0.817 . . . . 64.0 109.684 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -61.93 -56.02 23.54 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.008 -0.996 . . . . 52.33 110.617 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -69.16 -22.81 63.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.465 -0.334 . . . . 63.23 111.777 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 53.1 mt-30 -74.43 -16.1 60.88 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.164 0.507 . . . . 64.23 110.905 174.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.24 7.4 52.19 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.245 -0.978 . . . . 62.41 113.635 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.0 mt -70.72 -43.31 69.2 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.08 0.467 . . . . 72.03 110.641 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 32.3 m-85 -83.9 -4.45 58.7 Favored 'General case' 0 C--O 1.211 -0.945 0 C-N-CA 120.303 -0.559 . . . . 73.13 111.066 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.01 -14.44 61.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.673 0.749 . . . . 63.25 109.462 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -84.81 -29.02 25.73 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.58 -0.896 . . . . 74.55 108.58 175.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.519 ' HA ' ' OG ' ' A' ' 105' ' ' SER . 8.6 tt -84.45 -6.62 59.39 Favored 'General case' 0 C--O 1.2 -1.517 0 CA-C-N 114.835 -1.075 . . . . 73.3 110.919 -172.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -66.57 -10.96 50.65 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.608 0.718 . . . . 74.35 112.296 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -98.35 14.33 28.37 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.684 -0.689 . . . . 54.24 109.359 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.713 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -69.81 130.55 42.6 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 113.799 1.037 . . . . 65.31 113.799 -176.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -104.3 139.86 38.69 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.237 -1.347 . . . . 61.24 107.575 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.44 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 44.2 p90 . . . . . 0 C--N 1.309 -1.185 0 C-N-CA 119.99 -0.684 . . . . 75.41 111.77 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 N--CA 1.434 -1.226 0 N-CA-C 107.861 -1.163 . . . . 74.44 107.861 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -104.31 148.95 16.94 Favored Glycine 0 N--CA 1.427 -1.938 0 C-N-CA 120.242 -0.98 . . . . 54.41 112.524 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -106.87 145.32 32.31 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.142 -1.058 . . . . 63.31 108.142 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.12 100.24 6.86 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.875 -1.528 . . . . 70.24 106.875 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.6 mt -108.83 127.48 54.06 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 108.204 -1.036 . . . . 70.45 108.204 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 18.8 t -123.44 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 120.262 -0.575 . . . . 64.52 110.736 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.713 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 19.3 m-90 -111.06 145.15 39.02 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.402 -0.817 . . . . 71.3 109.093 176.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 83' ' ' ALA . 51.1 mttm -119.31 120.36 36.73 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.593 -0.892 . . . . 71.33 108.593 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.519 ' OG ' ' HA ' ' A' ' 80' ' ' LEU . 29.1 t . . . . . 0 C--N 1.298 -1.654 0 C-N-CA 124.215 1.006 . . . . 64.04 111.399 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 36.9 p90 . . . . . 0 N--CA 1.408 -2.565 0 N-CA-C 108.699 -0.852 . . . . 75.45 108.699 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.51 ' H ' ' HB3' ' A' ' 105' ' ' SER . 2.4 m-20 -112.08 136.8 50.98 Favored 'General case' 0 C--N 1.259 -3.339 0 N-CA-C 105.872 -1.899 . . . . 65.25 105.872 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.414 ' CD ' ' HD3' ' A' ' 143' ' ' LYS . 86.9 mt-10 -114.7 145.29 42.22 Favored 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 119.411 -0.915 . . . . 73.22 110.119 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -126.32 117.24 22.59 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 115.123 -0.944 . . . . 71.54 109.424 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -110.64 110.04 20.56 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.731 -0.84 . . . . 75.35 108.731 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.65 125.06 42.2 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 109.315 -0.624 . . . . 61.41 109.315 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -106.89 112.48 25.46 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.946 -1.131 . . . . 62.11 107.946 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 54.6 mt -110.74 146.84 15.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.283 0 N-CA-C 107.348 -1.353 . . . . 63.31 107.348 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.427 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.3 OUTLIER -129.24 150.5 50.59 Favored 'General case' 0 C--O 1.262 1.75 0 N-CA-C 108.028 -1.101 . . . . 72.21 108.028 177.016 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 40.3 ttp85 -85.45 112.57 21.01 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.408 -1.33 . . . . 73.52 107.408 176.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -67.41 150.43 48.94 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.852 -1.067 . . . . 73.41 109.132 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -57.82 -15.7 9.19 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.855 1.262 . . . . 71.4 111.411 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -81.06 -6.38 58.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.828 -0.624 . . . . 75.42 111.411 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.4 -25.25 15.97 Favored Glycine 0 CA--C 1.504 -0.597 0 N-CA-C 114.816 0.687 . . . . 52.34 114.816 172.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.5 m -103.79 166.56 10.34 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 109.399 -0.593 . . . . 73.23 109.399 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 63.9 m -98.66 154.7 17.76 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.866 -0.42 . . . . 52.23 109.866 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.427 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 25.0 t-105 -150.09 155.13 39.3 Favored 'General case' 0 N--CA 1.412 -2.368 0 N-CA-C 106.681 -1.6 . . . . 74.14 106.681 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.03 119.71 10.0 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.682 -0.488 . . . . 64.04 109.682 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -83.72 -53.8 5.37 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.693 -1.225 . . . . 71.51 107.693 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.6 m -164.62 157.42 16.85 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 106.396 -1.705 . . . . 71.34 106.396 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.95 154.8 31.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 107.472 -1.307 . . . . 72.1 107.472 173.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -130.55 137.35 49.65 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 110.112 -0.329 . . . . 71.31 110.112 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -120.63 118.02 29.05 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.873 -1.158 . . . . 61.53 107.873 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.5 pt -116.03 102.78 14.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-O 121.504 0.669 . . . . 73.51 110.851 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.8 mtp -96.33 92.45 6.34 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.802 -1.555 . . . . 64.31 106.802 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.4 m -177.23 -49.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 112.754 0.65 . . . . 70.53 112.754 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.414 ' HD3' ' CD ' ' A' ' 119' ' ' GLU . 86.6 tttt . . . . . 0 N--CA 1.485 1.313 0 C-N-CA 123.986 0.914 . . . . 72.11 112.994 -172.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.4 t70 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 121.57 0.7 . . . . 62.53 110.489 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.55 -38.31 71.03 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.539 -0.911 . . . . 73.23 108.539 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.23 -45.37 69.96 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.372 -0.831 . . . . 74.35 111.259 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.3 m -70.39 -34.69 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 112.109 0.411 . . . . 52.15 112.109 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.537 ' HZ3' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -69.7 -35.47 75.11 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 118.638 -1.225 . . . . 74.42 109.078 176.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.07 -40.79 83.05 Favored Glycine 0 C--O 1.216 -1.02 0 N-CA-C 111.327 -0.709 . . . . 74.4 111.327 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 tp -68.21 -47.98 66.42 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 123.465 0.706 . . . . 63.02 109.705 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.79 -41.04 99.01 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 115.645 -0.707 . . . . 72.41 111.718 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -67.82 -43.5 79.44 Favored 'General case' 0 C--O 1.198 -1.644 0 CA-C-O 118.879 -0.581 . . . . 74.45 111.085 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -57.96 -44.31 86.96 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 120.837 0.351 . . . . 72.32 110.082 -176.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -61.73 -54.56 40.9 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.633 -1.167 . . . . 74.25 110.438 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.6 mm -60.6 -35.84 66.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 112.49 0.552 . . . . 42.44 112.49 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.93 -47.76 73.66 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.102 -0.703 . . . . 71.04 109.102 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.536 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 4.1 pp -73.59 -19.13 60.96 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 119.985 -0.686 . . . . 63.22 112.099 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.1 t -74.86 -28.17 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.462 0.649 . . . . 71.01 109.527 173.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.8 p -106.13 14.32 27.85 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.829 0.823 . . . . 73.41 109.18 -176.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 21.5 tptp -39.66 124.25 1.65 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 127.163 2.185 . . . . 74.0 112.879 -176.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 m -53.49 146.91 22.21 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.707 1.203 . . . . 64.43 112.048 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.14 -7.76 16.47 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 123.598 2.865 . . . . 73.41 112.614 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.93 -26.95 68.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.321 -0.854 . . . . 75.35 110.276 175.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 p -101.81 167.79 9.85 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.861 -0.609 . . . . 72.11 110.675 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.4 t -62.96 -54.95 26.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 114.034 1.124 . . . . 71.35 114.034 -172.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -171.11 139.84 1.43 Allowed 'General case' 0 C--O 1.245 0.836 0 C-N-CA 119.195 -1.002 . . . . 64.1 110.654 -172.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.7 m -63.22 -42.94 99.34 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.004 0.521 . . . . 70.13 111.724 -172.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.453 ' HB2' ' CD2' ' A' ' 72' ' ' PHE . 1.6 mp0 -63.3 -20.6 65.62 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.031 -0.531 . . . . 61.03 111.466 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -69.86 -46.97 64.39 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.868 -0.79 . . . . 73.25 108.868 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -71.0 -31.95 68.62 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.87 -1.159 . . . . 73.13 107.87 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 54.3 tp -65.4 -46.59 79.42 Favored 'General case' 0 C--O 1.191 -2.012 0 CA-C-N 115.584 -0.735 . . . . 75.55 110.095 176.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 49' ' ' LEU . . . -62.37 -30.97 71.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.838 0.828 . . . . 65.42 110.494 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -73.25 -34.81 66.05 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.555 -1.202 . . . . 74.22 110.489 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.429 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 61.3 t80 -80.48 -26.92 37.96 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.458 1.123 . . . . 71.4 108.475 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.481 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 39.9 tp -69.79 -29.8 67.19 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 127.323 2.249 . . . . 53.11 111.509 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -38.47 -56.17 2.0 Allowed Glycine 0 CA--C 1.545 1.929 0 N-CA-C 115.628 1.011 . . . . 45.42 115.628 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 48' ' ' PHE . 8.2 Cg_exo -77.81 -5.83 15.6 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.153 1.902 . . . . 54.23 113.585 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -133.21 24.9 4.19 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.685 -0.634 . . . . 72.53 111.654 -169.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -56.17 107.32 0.86 Allowed Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 123.067 0.547 . . . . 73.44 111.823 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.424 ' HB2' ' HA ' ' A' ' 136' ' ' SER . 6.7 Cg_endo -109.51 -159.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 123.84 3.027 . . . . 72.23 112.228 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -86.73 131.16 34.21 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.226 -1.027 . . . . 44.43 108.226 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mp -108.86 112.75 41.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.763 -1.199 . . . . 75.34 107.763 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 138' ' ' LYS . 80.2 m-85 -92.88 133.7 35.82 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 108.502 -0.925 . . . . 75.53 108.502 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.3 t -131.84 117.09 32.81 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 108.101 -1.074 . . . . 62.5 108.101 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 60.78 29.44 19.01 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.373 1.045 . . . . 64.21 110.765 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.75 5.94 80.68 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.906 -1.043 . . . . 62.12 112.839 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -113.85 134.33 54.87 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 109.723 -0.473 . . . . 75.1 109.723 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.411 HD13 ' N ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -75.06 128.22 36.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.885 0.85 . . . . 75.41 110.284 -175.355 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.411 ' N ' HD13 ' A' ' 62' ' ' ILE . 50.8 mm-40 -126.37 144.32 50.86 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 106.921 -1.511 . . . . 63.2 106.921 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -87.08 174.3 8.74 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.281 -0.637 . . . . 74.14 109.281 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.7 t -56.7 -33.47 66.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.256 0.622 . . . . 70.1 111.378 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 60.9 m -67.21 -42.52 83.95 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.091 -0.504 . . . . 72.34 110.469 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -64.86 -47.92 76.15 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 122.766 0.426 . . . . 62.32 109.984 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -52.97 -53.56 48.04 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 123.552 0.533 . . . . 54.43 110.114 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.0 tp -49.72 -46.43 50.21 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 124.167 0.917 . . . . 70.25 111.537 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 66' ' ' THR . 54.6 mt-30 -59.46 -48.1 82.95 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 116.201 -0.454 . . . . 61.45 111.306 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -66.87 -35.28 79.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.243 0.544 . . . . 74.33 110.532 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.453 ' CD2' ' HB2' ' A' ' 42' ' ' GLU . 3.5 t80 -60.17 -51.91 67.57 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.554 -0.748 . . . . 75.51 110.649 175.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -75.33 -13.19 60.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.874 0.368 . . . . 70.22 111.372 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 27.9 mm-40 -82.1 -8.99 59.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.977 0.417 . . . . 71.34 111.412 170.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.82 26.31 50.19 Favored Glycine 0 N--CA 1.427 -1.903 0 CA-C-N 116.147 -0.479 . . . . 70.14 112.349 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.8 mt -78.36 -37.24 44.75 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.034 -0.667 . . . . 73.41 112.001 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -97.36 1.3 49.21 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.963 -0.695 . . . . 53.22 112.655 -175.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.301 0.0 OUTLIER -70.4 -16.88 63.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.177 1.177 . . . . 71.4 114.177 -173.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -89.53 -15.78 32.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.362 0.601 . . . . 74.41 111.543 171.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.3 tt -84.84 -14.82 46.76 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.568 -0.742 . . . . 62.02 110.262 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.84 -8.72 57.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.365 0.602 . . . . 64.44 111.748 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -92.72 13.52 19.91 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.616 -0.72 . . . . 62.51 109.524 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 105' ' ' SER . . . -79.99 154.44 28.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.282 -0.872 . . . . 71.23 113.352 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -107.79 143.79 35.87 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.523 -1.217 . . . . 72.23 109.256 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.0 p90 . . . . . 0 C--N 1.298 -1.643 0 CA-C-O 121.236 0.541 . . . . 73.21 109.578 176.286 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 . . . . . 0 N--CA 1.432 -1.34 0 N-CA-C 109.511 -0.551 . . . . 74.13 109.511 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.46 -164.64 33.94 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 110.261 -1.136 . . . . 70.33 110.261 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -128.55 136.3 50.55 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.454 -0.573 . . . . 73.45 109.454 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -122.71 98.9 6.12 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.008 -1.849 . . . . 75.34 106.008 170.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 mt -109.62 124.42 51.12 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 123.775 0.672 . . . . 74.22 109.889 -172.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 10.9 p -114.77 122.42 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-O 122.331 1.062 . . . . 55.12 112.474 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 -96.07 145.1 25.75 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.025 -1.443 . . . . 75.34 108.522 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -128.5 121.12 28.15 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.19 -1.411 . . . . 72.31 107.19 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 42.5 m . . . . . 0 C--O 1.253 1.282 0 C-N-CA 122.973 0.509 . . . . 73.25 112.018 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.438 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 8.4 p90 . . . . . 0 N--CA 1.436 -1.143 0 N-CA-C 107.696 -1.224 . . . . 65.25 107.696 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -107.23 139.17 42.11 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.843 -1.169 . . . . 72.42 107.843 175.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.438 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 46.2 mt-10 -119.21 151.55 38.17 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 120.446 -0.502 . . . . 65.3 110.125 174.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -137.31 123.15 20.06 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 116.079 -0.51 . . . . 40.53 110.079 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -114.78 110.33 19.55 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.16 -0.682 . . . . 72.24 109.16 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.02 130.39 44.35 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 109.031 -0.729 . . . . 70.3 109.031 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -110.31 110.67 21.56 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.213 -1.032 . . . . 72.53 108.213 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.484 HG12 HD13 ' A' ' 134' ' ' LEU . 61.4 mt -115.28 137.16 49.7 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.674 0 N-CA-C 107.511 -1.292 . . . . 73.3 107.511 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.507 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.2 OUTLIER -122.27 147.95 45.6 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.007 -1.849 . . . . 71.12 106.007 177.335 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -117.06 133.53 55.88 Favored 'General case' 0 N--CA 1.398 -3.028 0 C-N-CA 117.553 -1.659 . . . . 74.44 109.725 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.465 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 73.4 ttt180 -82.56 144.69 30.19 Favored 'General case' 0 C--N 1.255 -3.533 0 CA-C-N 113.044 -1.889 . . . . 72.11 109.789 -172.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -49.4 -31.8 10.33 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.853 1.261 . . . . 74.12 112.423 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.465 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 6.9 m-20 -76.69 0.93 18.57 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.515 -0.766 . . . . 74.4 111.667 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.95 -1.48 56.54 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.335 -0.46 . . . . 45.02 112.619 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.4 m -85.5 101.46 12.67 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 122.623 -0.339 . . . . 74.51 111.521 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 42.0 t -80.78 120.74 25.05 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 105.57 -2.011 . . . . 74.03 105.57 173.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.507 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 5.9 t-105 -140.22 150.56 44.29 Favored 'General case' 0 N--CA 1.394 -3.245 0 C-N-CA 119.163 -1.015 . . . . 72.13 111.301 -170.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.484 HD13 HG12 ' A' ' 124' ' ' ILE . 3.4 mm? -68.75 116.6 9.44 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.053 -0.976 . . . . 72.4 109.057 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -83.72 -56.61 3.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.975 -0.75 . . . . 74.01 108.975 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.424 ' HA ' ' HB2' ' A' ' 54' ' ' PRO . 14.0 m -164.45 156.55 16.36 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 106.291 -1.744 . . . . 43.22 106.291 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.8 m -131.03 162.34 39.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.384 -1.339 . . . . 75.03 107.384 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 57' ' ' TYR . 78.7 tttt -142.28 136.97 30.3 Favored 'General case' 0 C--N 1.275 -2.641 0 C-N-CA 122.718 0.407 . . . . 35.02 110.071 -173.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -123.04 141.01 52.43 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.821 -0.807 . . . . 74.35 108.821 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.9 pt -132.18 98.36 3.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.788 -1.19 . . . . 72.2 107.788 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 68.8 mtm -89.55 130.38 35.88 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.213 -1.358 . . . . 74.32 111.138 -171.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.4 t 71.47 24.46 3.63 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 124.468 1.105 . . . . 71.33 110.303 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? . . . . . 0 N--CA 1.426 -1.641 0 CA-C-N 114.891 -1.05 . . . . 54.32 108.381 178.732 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 . . . . . 0 CA--C 1.507 -0.676 0 CA-C-O 120.969 0.414 . . . . 75.12 110.815 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.96 -40.43 96.4 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.68 -0.691 . . . . 52.31 109.454 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.15 -43.6 81.9 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.021 -0.536 . . . . 73.21 110.517 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.434 HG12 ' HB3' ' A' ' 132' ' ' CYS . 11.3 m -70.39 -38.73 75.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 120.334 -0.547 . . . . 75.41 112.104 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -28.0 50.37 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.662 -0.815 . . . . 71.15 110.581 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.75 -41.43 49.99 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 110.066 -1.214 . . . . 42.1 110.066 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.3 tp -68.12 -49.78 58.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.889 -0.782 . . . . 61.41 108.889 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.26 -38.72 95.0 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.516 -0.765 . . . . 33.21 112.447 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -71.95 -40.85 68.39 Favored 'General case' 0 C--O 1.195 -1.792 0 C-N-CA 120.426 -0.51 . . . . 72.2 110.571 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -62.32 -43.1 99.61 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.622 0.725 . . . . 73.43 110.049 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.427 ' CZ ' ' HH2' ' A' ' 103' ' ' TRP . 27.7 t80 -64.63 -54.63 28.78 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 113.946 -1.479 . . . . 74.42 110.157 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 29' ' ' ILE . 9.8 mm -65.49 -33.52 64.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 120.882 -0.327 . . . . 55.44 111.838 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -63.41 -48.82 76.24 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 110.067 -0.346 . . . . 64.32 110.067 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 32' ' ' VAL . 4.4 pp -68.55 -30.28 69.03 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.088 -0.645 . . . . 43.15 110.94 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.414 ' N ' HD12 ' A' ' 31' ' ' LEU . 66.0 t -70.58 -25.09 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 CA-C-O 121.201 0.524 . . . . 71.54 110.492 175.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.5 p -110.33 19.3 18.98 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.565 0.698 . . . . 74.11 110.226 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -55.78 142.86 33.14 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.949 -1.023 . . . . 74.31 110.328 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 m -62.92 153.99 78.1 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-N 115.435 -0.802 . . . . 63.23 110.694 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.16 -5.65 3.11 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 125.03 3.82 . . . . 64.25 113.043 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.6 -27.22 68.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.498 -0.774 . . . . 73.54 109.17 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -94.97 142.2 27.76 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 105.788 -1.93 . . . . 74.22 105.788 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.7 t -68.96 -46.07 79.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 120.606 -0.438 . . . . 44.11 111.927 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -145.01 119.29 9.54 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 119.406 -0.918 . . . . 64.34 112.552 -174.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.9 m -64.13 -35.96 82.49 Favored 'General case' 0 C--O 1.251 1.165 0 C-N-CA 123.714 0.806 . . . . 74.1 110.768 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.724 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 1.3 mp0 -65.8 -21.2 66.47 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.156 -0.929 . . . . 75.3 110.466 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -68.69 -43.02 76.94 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.607 -1.257 . . . . 72.22 107.607 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.43 -32.12 69.59 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.552 -1.204 . . . . 74.15 109.43 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.5 tp -67.78 -40.87 83.95 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 116.017 -0.538 . . . . 63.42 110.7 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.11 -36.62 84.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.622 0.725 . . . . 74.31 109.921 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -69.47 -37.6 77.35 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.985 -1.007 . . . . 72.32 109.44 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -65.55 -43.24 90.51 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.218 1.007 . . . . 74.12 110.727 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 pp -80.45 -2.49 46.02 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.822 -0.626 . . . . 61.52 111.214 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.2 -62.47 5.02 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 111.888 -0.485 . . . . 73.42 111.888 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -77.15 -5.57 15.88 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.45 2.1 . . . . 73.11 112.235 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -124.46 38.08 4.27 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.798 -0.445 . . . . 60.52 109.798 -172.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.553 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 34.4 t70 -54.52 106.03 0.61 Allowed Pre-proline 0 C--O 1.245 0.848 0 C-N-CA 125.23 1.412 . . . . 63.23 113.22 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -107.92 -157.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.101 0 C-N-CA 123.798 2.999 . . . . 74.53 110.548 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -98.97 123.66 43.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.665 -0.865 . . . . 52.53 108.665 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.445 HD13 ' CB ' ' A' ' 68' ' ' PHE . 46.6 mt -105.25 107.92 23.74 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.606 0 N-CA-C 107.868 -1.16 . . . . 61.22 107.868 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -96.75 138.82 33.73 Favored 'General case' 0 C--N 1.27 -2.888 0 O-C-N 121.737 -0.602 . . . . 75.23 110.26 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 p -128.24 117.92 46.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 107.16 -1.422 . . . . 74.1 107.16 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 60.8 20.82 10.95 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.705 -0.68 . . . . 74.1 111.571 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.27 1.17 56.89 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.817 -0.629 . . . . 61.04 112.866 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -108.74 130.84 55.37 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 117.397 0.598 . . . . 63.13 110.438 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.58 125.25 33.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 122.055 0.931 . . . . 74.41 110.256 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -120.56 140.53 51.36 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.44 -1.318 . . . . 70.21 107.44 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.0 t -85.66 173.52 10.06 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.701 -0.852 . . . . 71.42 108.701 176.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.553 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 9.7 t -52.62 -37.52 58.52 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.405 0.682 . . . . 64.52 111.57 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -70.03 -41.1 74.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.336 -0.393 . . . . 73.13 111.855 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.54 -47.34 76.19 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.229 -0.656 . . . . 44.31 109.229 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CB ' HD13 ' A' ' 56' ' ' ILE . 55.3 t80 -53.18 -54.33 37.57 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 115.667 -0.697 . . . . 71.23 110.118 174.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -50.13 -44.31 52.33 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 124.206 0.941 . . . . 33.23 110.867 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -60.41 -48.84 80.03 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 122.853 0.461 . . . . 62.13 111.531 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.47 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 32.6 m-85 -68.4 -36.78 79.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.678 0.752 . . . . 60.01 109.398 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -58.46 -54.56 45.7 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.102 -0.954 . . . . 73.2 110.948 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -66.07 -29.74 70.14 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.582 -0.281 . . . . 74.34 110.557 -176.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -77.71 -8.78 58.44 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 113.373 0.879 . . . . 44.42 113.373 178.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.419 ' HA2' ' HG3' ' A' ' 78' ' ' LYS . . . 100.13 11.35 42.84 Favored Glycine 0 C--N 1.315 -0.63 0 C-N-CA 120.31 -0.947 . . . . 60.31 114.944 173.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.14 -53.85 22.22 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 120.878 0.371 . . . . 73.14 111.974 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.47 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 40.5 m-85 -89.72 6.17 42.7 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 112.781 0.66 . . . . 74.35 112.781 -172.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.724 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 41.9 mtmt -66.16 -12.47 56.03 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.492 0.923 . . . . 75.34 113.492 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -77.64 -10.67 59.64 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.363 -0.835 . . . . 71.05 111.2 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.3 tp -68.3 -28.86 67.55 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.488 -0.56 . . . . 71.22 109.488 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.55 ' HB2' ' OE2' ' A' ' 42' ' ' GLU . 0.8 OUTLIER -65.83 -28.67 69.16 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.581 -0.736 . . . . 63.23 110.127 176.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -98.82 7.07 46.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.656 -0.702 . . . . 60.11 110.348 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.48 150.82 22.3 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.967 0.413 . . . . 45.51 110.612 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.09 134.11 47.9 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.674 -0.862 . . . . 70.11 108.674 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 48.7 p90 . . . . . 0 C--N 1.302 -1.479 0 N-CA-C 113.55 0.944 . . . . 75.33 113.55 -174.013 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 . . . . . 0 C--O 1.256 1.44 0 N-CA-C 109.803 -0.443 . . . . 73.11 109.803 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -105.41 146.49 16.08 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 110.979 -0.848 . . . . 75.53 110.979 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -110.99 133.91 53.01 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.0 -1.111 . . . . 72.44 108.0 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -113.45 109.82 19.29 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 123.583 0.552 . . . . 74.35 109.872 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -97.42 108.73 21.51 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 105.675 -1.972 . . . . 61.44 105.675 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 3.9 t -115.11 150.24 17.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 119.776 -0.77 . . . . 75.03 110.187 -174.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.427 ' HH2' ' CZ ' ' A' ' 28' ' ' PHE . 25.2 m-90 -132.35 151.19 51.96 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.556 -0.905 . . . . 74.23 108.556 175.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.461 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 67.3 mttm -126.34 130.85 51.62 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.684 -1.599 . . . . 53.45 106.684 174.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.1 p . . . . . 0 C--N 1.3 -1.577 0 N-CA-C 110.288 -0.264 . . . . 63.21 110.288 -179.616 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.456 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 1.6 p90 . . . . . 0 N--CA 1.422 -1.83 0 N-CA-C 107.147 -1.427 . . . . 74.21 107.147 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -113.02 135.33 53.9 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 106.022 -1.844 . . . . 63.32 106.022 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.461 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 44.0 mt-10 -115.07 148.77 38.49 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-O 121.69 0.757 . . . . 75.44 112.159 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -132.97 117.75 18.02 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-N 114.414 -1.266 . . . . 53.25 108.562 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.421 ' HG3' HG22 ' A' ' 102' ' ' VAL . 40.5 tt0 -121.38 110.91 16.67 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 109.1 -0.704 . . . . 75.34 109.1 -176.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -98.16 133.76 42.16 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.118 -0.492 . . . . 73.45 109.847 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -114.76 121.11 42.31 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 123.188 0.595 . . . . 72.53 110.198 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.5 mt -123.41 149.64 27.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.07 -1.826 . . . . 73.35 106.07 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.409 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.7 OUTLIER -132.19 145.21 51.19 Favored 'General case' 0 C--O 1.272 2.259 0 C-N-CA 119.066 -1.054 . . . . 73.33 109.157 173.492 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -83.66 119.9 25.33 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.473 -1.306 . . . . 65.54 107.473 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -89.59 133.06 34.79 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.481 -1.674 . . . . 64.23 106.481 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.29 -12.58 30.49 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.664 0.745 . . . . 75.15 111.228 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.8 -11.0 60.69 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.215 -0.902 . . . . 72.42 111.095 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.17 -12.9 28.79 Favored Glycine 0 CA--C 1.509 -0.344 0 C-N-CA 121.066 -0.588 . . . . 55.0 112.986 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.3 m -104.56 164.93 11.41 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 109.798 -0.445 . . . . 61.12 109.798 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.434 ' HB3' HG12 ' A' ' 21' ' ' VAL . 25.3 p -127.12 143.27 51.31 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.101 -1.444 . . . . 74.35 107.101 172.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.409 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 1.7 t90 -143.41 155.56 44.43 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.173 -1.011 . . . . 74.32 109.435 -176.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.7 mp -70.37 119.35 14.41 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 109.447 -0.575 . . . . 64.22 109.447 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -72.04 -50.5 27.97 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.562 -1.273 . . . . 62.21 107.562 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.8 p -177.19 177.42 1.23 Allowed 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.334 -1.303 . . . . 61.52 108.634 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.9 t -144.78 138.72 22.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 105.015 -2.217 . . . . 60.41 105.015 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -129.31 130.26 45.9 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-O 121.462 0.649 . . . . 74.42 109.847 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -110.42 133.57 53.15 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 107.791 -1.189 . . . . 71.43 107.791 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 10.1 pt -131.88 98.36 3.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 CA-C-O 122.078 0.942 . . . . 74.03 108.772 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 90.5 mtp -88.97 138.92 30.97 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.828 -1.078 . . . . 64.51 110.6 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.0 m 70.79 29.64 3.11 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 124.881 1.363 . . . . 73.34 112.795 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.1 mptt . . . . . 0 C--N 1.306 -1.305 0 N-CA-C 109.365 -0.606 . . . . 73.24 109.365 177.452 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 C--O 1.242 0.667 0 N-CA-C 108.217 -1.031 . . . . 71.21 108.217 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.92 -36.69 84.06 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.784 -1.098 . . . . 64.0 110.027 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.36 -42.6 87.83 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.228 -0.442 . . . . 73.24 110.466 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 m -71.75 -41.88 70.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 112.387 0.514 . . . . 74.0 112.387 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -31.41 70.46 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.622 -0.831 . . . . 55.44 110.161 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.01 -57.32 8.8 Favored Glycine 0 N--CA 1.437 -1.263 0 O-C-N 123.805 0.69 . . . . 50.31 111.939 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.68 -33.08 73.36 Favored 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.086 -1.046 . . . . 71.4 110.231 -177.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.06 -39.68 96.51 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 120.925 -0.655 . . . . 70.23 111.971 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -67.15 -47.56 70.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.655 -0.498 . . . . 75.04 109.655 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.6 -41.93 98.14 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.558 -0.746 . . . . 75.53 110.28 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 45' ' ' LEU . 23.9 t80 -61.46 -53.15 60.2 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 124.912 1.285 . . . . 71.24 109.985 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 29' ' ' ILE . 9.8 mm -65.76 -32.66 59.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 112.152 0.427 . . . . 53.52 112.152 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.23 -47.0 72.1 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.371 -0.532 . . . . 51.41 110.622 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.77 -26.21 64.18 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.02 -0.672 . . . . 74.05 111.925 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.2 t -71.68 -24.42 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 CA-C-O 121.552 0.691 . . . . 52.11 110.538 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.6 p -107.31 9.83 29.88 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 121.618 -0.676 . . . . 73.03 110.595 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 34' ' ' LYS . 24.7 tptt -69.63 156.95 38.15 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.161 -0.927 . . . . 74.23 112.474 -174.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.0 m -63.31 154.31 78.95 Favored Pre-proline 0 N--CA 1.424 -1.765 0 CA-C-N 113.711 -1.586 . . . . 71.24 113.04 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -59.18 -5.17 2.69 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 125.182 3.921 . . . . 71.12 112.785 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -54.31 -26.8 31.49 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.93 0.892 . . . . 74.52 110.785 173.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.1 t -101.14 156.81 17.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 105.158 -2.164 . . . . 72.0 105.158 168.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -50.24 -41.63 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.831 0.741 . . . . 75.11 111.987 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -167.04 151.08 6.82 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.966 -1.124 . . . . 54.52 107.966 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.7 m -60.71 -32.16 71.41 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-O 121.461 0.648 . . . . 74.04 110.648 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' OE1' HD23 ' A' ' 45' ' ' LEU . 8.5 tp10 -64.55 -22.75 67.05 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.201 -0.909 . . . . 73.22 110.151 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -67.06 -45.78 76.35 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.78 0.8 . . . . 54.44 108.915 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -71.49 -33.49 69.3 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.409 -1.269 . . . . 74.05 109.151 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.513 HD11 ' CE2' ' A' ' 28' ' ' PHE . 34.4 tp -68.74 -43.88 74.97 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 116.17 -0.468 . . . . 72.13 110.37 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.51 -37.02 77.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.476 0.655 . . . . 74.34 110.195 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -69.49 -36.08 76.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.124 -0.944 . . . . 72.22 110.176 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -67.26 -46.56 73.32 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.667 -0.697 . . . . 75.33 110.285 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.2 pp -82.23 -2.39 52.28 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.356 -0.838 . . . . 60.55 111.338 -176.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.69 -62.5 4.82 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 112.306 -0.318 . . . . 75.34 112.306 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -79.47 -7.23 14.83 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 121.842 1.694 . . . . 74.21 112.151 176.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 77.3 m80 -114.17 35.19 4.26 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.041 -0.725 . . . . 72.12 109.041 -175.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.6 106.26 0.64 Allowed Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 125.28 1.432 . . . . 53.51 112.356 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -101.69 -164.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 123.243 2.629 . . . . 65.31 110.928 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -90.34 108.07 19.54 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 107.545 -1.28 . . . . 72.32 107.545 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.469 HD13 ' CB ' ' A' ' 68' ' ' PHE . 73.4 mt -92.48 107.91 19.58 Favored 'Isoleucine or valine' 0 C--O 1.162 -3.515 0 N-CA-C 108.744 -0.836 . . . . 73.03 108.744 -176.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -95.55 128.15 42.18 Favored 'General case' 0 C--N 1.268 -2.975 0 O-C-N 121.12 -0.988 . . . . 74.55 109.127 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.0 t -124.97 114.44 40.4 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 N-CA-C 107.959 -1.126 . . . . 74.54 107.959 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 62.01 20.94 11.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.56 -1.2 . . . . 74.33 110.591 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.63 -4.89 58.21 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 114.72 -1.127 . . . . 32.03 113.165 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -101.01 132.72 46.29 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 117.714 0.757 . . . . 72.44 109.376 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.59 129.25 36.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.874 0.845 . . . . 73.33 109.676 -177.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -126.9 152.83 46.56 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 124.78 1.232 . . . . 65.41 108.295 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.9 t -97.71 170.24 9.13 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.341 -0.985 . . . . 74.21 108.341 175.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.8 t -52.14 -38.43 57.52 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.285 0.634 . . . . 61.31 111.231 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -62.0 -49.2 76.99 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.175 0.59 . . . . 65.53 111.105 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.44 84.49 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.095 0.558 . . . . 73.25 110.314 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.469 ' CB ' HD13 ' A' ' 56' ' ' ILE . 56.6 t80 -53.68 -55.65 24.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.907 -0.588 . . . . 64.14 110.413 175.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -50.87 -42.44 58.92 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.07 -0.968 . . . . 61.34 110.572 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -60.28 -47.43 86.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 112.014 0.375 . . . . 73.23 112.014 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.427 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 39.8 m-85 -66.78 -32.7 74.16 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.495 0.664 . . . . 73.22 109.976 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -61.77 -52.61 63.53 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.47 -0.786 . . . . 62.23 110.91 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -71.17 -21.28 62.19 Favored 'General case' 0 C--O 1.224 -0.271 0 O-C-N 123.27 0.356 . . . . 74.41 110.904 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -71.57 -19.95 62.08 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.351 0.596 . . . . 62.53 110.108 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 78' ' ' LYS . . . 100.94 13.79 33.14 Favored Glycine 0 N--CA 1.422 -2.235 0 CA-C-N 115.492 -0.776 . . . . 63.04 113.299 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.0 mt -74.55 -44.56 50.48 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 117.427 0.614 . . . . 64.02 111.365 -177.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 45.0 m-85 -88.8 -4.58 58.46 Favored 'General case' 0 C--O 1.214 -0.814 0 N-CA-C 112.662 0.615 . . . . 74.11 112.662 -176.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -70.98 -15.57 62.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 119.392 -0.923 . . . . 70.23 112.304 -177.881 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -86.61 -21.57 26.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.631 -0.713 . . . . 75.31 110.281 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.1 tp -74.54 -14.76 60.84 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.915 0.864 . . . . 72.24 109.684 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -57.66 -25.65 60.53 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.598 -1.183 . . . . 52.45 112.295 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -92.95 11.94 25.58 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 111.997 0.369 . . . . 34.12 111.997 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.73 150.24 28.06 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.096 0.474 . . . . 74.55 111.627 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -99.5 132.41 44.86 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.504 -0.924 . . . . 64.33 108.504 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.56 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 51.1 p90 . . . . . 0 C--N 1.319 -0.759 0 C-N-CA 119.924 -0.711 . . . . 74.15 112.311 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.435 -1.184 0 N-CA-C 110.184 -0.302 . . . . 71.24 110.184 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -153.88 141.67 8.48 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 108.853 -1.699 . . . . 75.31 108.853 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -108.56 150.99 26.72 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.459 -1.312 . . . . 70.13 107.459 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 39.4 ttpt -150.05 107.83 3.69 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-O 121.745 0.783 . . . . 54.11 109.41 176.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 72.8 mt -101.99 134.35 45.35 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 114.146 -1.388 . . . . 73.43 107.935 -177.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 6.1 t -120.01 128.97 75.97 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.182 0 C-N-CA 120.685 -0.406 . . . . 64.32 110.397 -176.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.56 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 18.8 m-90 -99.95 127.44 46.14 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 107.317 -1.364 . . . . 75.55 107.317 173.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -112.36 120.12 40.61 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 107.696 -1.224 . . . . 64.11 107.696 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 C--N 1.301 -1.54 0 CA-C-N 115.194 -0.912 . . . . 75.3 110.483 -176.057 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.565 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 43.2 p90 . . . . . 0 C--O 1.211 -0.936 0 N-CA-C 108.146 -1.057 . . . . 72.12 108.146 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -112.88 140.53 47.61 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.947 -1.501 . . . . 62.43 106.947 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.565 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 40.7 mt-10 -123.32 155.14 37.84 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 121.183 0.516 . . . . 52.15 111.031 175.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -141.61 117.29 10.35 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.771 -1.104 . . . . 62.41 108.039 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 7.9 pt-20 -125.23 111.99 15.89 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-O 121.718 0.771 . . . . 64.1 112.193 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.624 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -93.91 124.61 38.03 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.427 -1.261 . . . . 75.24 110.005 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.473 ' CE2' ' HD3' ' A' ' 100' ' ' LYS . 8.7 m-85 -103.07 129.34 49.85 Favored 'General case' 0 C--O 1.249 1.069 0 C-N-CA 124.622 1.169 . . . . 61.31 108.171 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 53.8 mt -131.46 144.28 38.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.697 -0.853 . . . . 63.35 108.697 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.427 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.5 OUTLIER -137.73 151.51 48.27 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 108.117 -1.068 . . . . 73.13 108.117 176.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 17.4 ptt180 -107.04 150.64 26.31 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.421 -0.912 . . . . 70.14 110.995 177.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.536 ' HB2' ' OD1' ' A' ' 129' ' ' ASP . 50.4 mtt180 -99.47 168.91 9.68 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.017 -0.992 . . . . 75.14 109.643 -172.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -80.97 -10.3 59.73 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.849 0.357 . . . . 64.25 110.617 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.536 ' OD1' ' HB2' ' A' ' 127' ' ' ARG . 11.4 p-10 -74.27 -16.04 60.96 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.058 0.456 . . . . 75.23 110.943 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.08 -11.95 26.78 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 120.834 -0.698 . . . . 61.41 112.055 178.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.4 m -105.08 -177.33 3.33 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.687 0.756 . . . . 74.33 110.208 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 28.8 p -143.62 169.4 17.8 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 106.69 -1.596 . . . . 52.24 106.69 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.427 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 0.0 OUTLIER -159.28 155.81 27.61 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.125 -0.694 . . . . 72.25 109.125 -178.662 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.4 mp -70.07 123.38 21.42 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.555 -0.906 . . . . 65.23 108.555 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -72.71 -54.47 8.88 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.741 -1.207 . . . . 73.31 107.741 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.4 m -168.4 165.89 12.54 Favored 'General case' 0 C--O 1.201 -1.472 0 N-CA-C 106.066 -1.827 . . . . 71.33 106.066 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 122' ' ' ALA . 7.5 m -142.12 142.61 27.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 105.46 -2.052 . . . . 61.02 105.46 171.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -127.93 130.54 48.63 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 118.206 0.457 . . . . 75.34 110.439 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -115.25 128.91 56.45 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.901 -1.148 . . . . 74.2 107.901 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.6 pt -128.64 98.31 4.19 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.6 0 N-CA-C 108.07 -1.085 . . . . 72.41 108.07 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 74.7 mtm -87.27 128.36 35.17 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.631 -1.168 . . . . 64.44 111.71 -174.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.5 m 61.52 55.09 2.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 113.935 -1.484 . . . . 64.24 111.339 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 37.3 tptt . . . . . 0 N--CA 1.412 -2.343 0 N-CA-C 106.194 -1.78 . . . . 63.25 106.194 179.362 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.4 t70 . . . . . 0 C--O 1.242 0.707 0 CA-C-O 121.454 0.645 . . . . 73.32 111.387 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.52 -37.09 79.73 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.648 -0.871 . . . . 75.3 108.648 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -68.71 -42.41 77.73 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 115.873 -0.603 . . . . 61.31 110.627 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.699 HG12 ' SG ' ' A' ' 132' ' ' CYS . 13.2 m -69.92 -41.28 79.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.027 -0.533 . . . . 61.04 111.617 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.33 -24.94 50.73 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 118.907 -1.117 . . . . 53.44 110.018 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.07 -55.16 11.04 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 121.017 -0.611 . . . . 73.53 111.583 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.36 -35.26 71.07 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.244 -1.021 . . . . 75.35 108.244 -178.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.7 -43.57 97.69 Favored Glycine 0 N--CA 1.432 -1.583 0 O-C-N 123.936 0.772 . . . . 74.11 112.003 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -69.41 -42.07 75.57 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 120.841 -0.344 . . . . 71.43 110.82 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -63.16 -46.11 88.69 Favored 'General case' 0 C--O 1.253 1.262 0 N-CA-C 109.671 -0.492 . . . . 74.2 109.671 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.504 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 30.4 t80 -62.64 -53.12 59.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.923 -1.035 . . . . 64.34 110.61 177.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.476 HD13 ' HA ' ' A' ' 29' ' ' ILE . 6.8 mm -61.2 -38.86 80.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 111.974 0.361 . . . . 63.23 111.974 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.39 -49.76 76.3 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 123.155 0.284 . . . . 73.23 110.307 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.3 pp -67.99 -29.6 68.66 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 120.562 -0.455 . . . . 75.12 111.121 -176.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.2 t -72.53 -27.71 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.401 0.62 . . . . 61.25 110.264 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.6 p -111.05 22.56 15.14 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.701 0.763 . . . . 72.23 109.115 -177.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -63.4 136.51 57.68 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.27 -1.332 . . . . 74.24 109.116 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -57.59 153.91 27.54 Favored Pre-proline 0 N--CA 1.435 -1.177 0 O-C-N 124.14 0.9 . . . . 51.21 110.72 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.79 -7.32 4.29 Favored 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 124.239 3.293 . . . . 74.24 113.093 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.73 -27.54 68.79 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.346 -0.843 . . . . 75.34 109.04 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.2 t -94.86 123.25 38.22 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 105.387 -2.079 . . . . 74.03 105.387 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.8 t -57.92 -48.06 84.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 123.566 0.541 . . . . 71.31 112.299 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -141.12 114.53 8.77 Favored 'General case' 0 N--CA 1.417 -2.106 0 C-N-CA 118.12 -1.432 . . . . 73.32 111.785 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.0 m -60.53 -32.64 71.66 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 123.203 0.601 . . . . 72.22 110.686 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -24.24 67.38 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.105 0.962 . . . . 63.0 110.791 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -70.62 -42.84 70.38 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 108.425 -0.954 . . . . 73.11 108.425 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -71.79 -30.57 65.68 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 114.535 -1.211 . . . . 55.53 108.841 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.6 tp -70.13 -41.51 73.82 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.631 -0.713 . . . . 70.25 110.091 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.56 -34.76 77.58 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.607 0.718 . . . . 63.5 109.694 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -68.72 -39.25 80.5 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.885 -1.052 . . . . 75.33 109.675 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -67.78 -41.45 83.2 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.773 -0.649 . . . . 75.2 111.238 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.4 pp -82.06 -4.16 56.22 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.074 -0.512 . . . . 74.5 111.254 -177.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -47.07 -58.21 6.47 Favored Glycine 0 C--O 1.213 -1.189 0 O-C-N 123.742 0.652 . . . . 64.21 112.863 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.79 -3.35 9.03 Favored 'Trans proline' 0 CA--C 1.556 1.6 0 C-N-CA 123.811 3.007 . . . . 60.54 113.074 172.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 69.1 m-70 -125.5 38.11 4.24 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 122.878 0.471 . . . . 64.42 109.837 -167.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.412 ' CB ' HG21 ' A' ' 65' ' ' THR . 7.1 m-20 -53.65 107.46 0.86 Allowed Pre-proline 0 C--N 1.321 -0.673 0 C-N-CA 126.25 1.82 . . . . 62.44 112.806 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -100.66 -164.96 0.06 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 123.118 2.545 . . . . 64.51 111.054 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -98.69 119.52 37.57 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 107.302 -1.37 . . . . 70.42 107.302 174.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 65' ' ' THR . 72.1 mt -100.04 112.29 32.15 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.627 0 N-CA-C 109.102 -0.703 . . . . 72.11 109.102 -174.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -97.7 106.22 18.5 Favored 'General case' 0 C--N 1.283 -2.322 0 O-C-N 121.855 -0.528 . . . . 75.12 111.722 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.535 HG23 HG22 ' A' ' 56' ' ' ILE . 73.2 t -116.81 124.21 72.62 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 108.131 -1.063 . . . . 60.42 108.131 -175.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.0 m120 66.13 19.61 11.13 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 124.563 1.164 . . . . 72.51 109.291 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.81 11.85 78.56 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.567 -0.742 . . . . 74.41 111.291 -176.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -113.69 139.94 48.65 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 122.869 0.468 . . . . 71.41 110.196 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.21 125.5 35.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.997 0.903 . . . . 74.41 109.054 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -124.05 142.98 50.72 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.224 -1.028 . . . . 70.42 108.224 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 67' ' ' ALA . 4.9 t -82.05 170.09 15.95 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.156 -1.053 . . . . 64.42 108.156 173.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.541 ' HA ' HD12 ' A' ' 56' ' ' ILE . 64.3 p -65.64 -34.08 77.38 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 123.843 0.857 . . . . 73.14 110.357 -176.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.9 m -65.05 -40.57 94.96 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.428 -1.26 . . . . 60.02 110.307 175.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.449 ' H ' HG23 ' A' ' 64' ' ' THR . . . -65.42 -46.49 79.74 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 116.169 -0.469 . . . . 51.52 109.809 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.488 ' HB2' HD13 ' A' ' 56' ' ' ILE . 48.9 t80 -52.06 -54.86 25.15 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 123.459 0.474 . . . . 73.3 109.963 174.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -50.82 -41.5 57.51 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.412 1.07 . . . . 73.34 110.774 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 50.4 mt-30 -63.08 -48.16 79.83 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 116.311 -0.404 . . . . 63.42 111.82 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.484 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 40.0 m-85 -69.33 -30.17 68.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.831 0.824 . . . . 75.01 109.739 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -61.32 -51.84 67.16 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.883 -1.053 . . . . 75.42 110.432 175.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 12.4 ptm180 -71.56 -21.7 61.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.128 0.489 . . . . 52.14 110.401 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 96.1 mt-30 -77.49 -3.29 39.77 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.041 -0.527 . . . . 72.23 111.538 173.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.05 22.37 63.55 Favored Glycine 0 N--CA 1.438 -1.215 0 CA-C-N 116.315 -0.402 . . . . 73.43 113.262 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.2 mt -83.51 -41.4 18.02 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.02 -0.672 . . . . 61.21 111.066 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 22.9 m-85 -100.91 -6.88 24.04 Favored 'General case' 0 C--O 1.185 -2.335 0 C-N-CA 119.845 -0.742 . . . . 75.34 112.838 -178.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -12.72 36.42 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 122.009 0.909 . . . . 70.05 112.847 -175.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -82.2 -9.6 59.45 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.229 -0.896 . . . . 64.3 112.536 176.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 80' ' ' LEU . 3.2 tm? -77.9 -14.96 59.38 Favored 'General case' 0 C--O 1.208 -1.113 0 C-N-CA 123.26 0.624 . . . . 62.01 110.906 -175.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -53.31 -19.05 2.9 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 114.39 1.255 . . . . 75.23 114.39 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -100.01 10.86 40.61 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 120.977 0.418 . . . . 73.35 110.682 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.435 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -68.87 146.06 53.16 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.343 0.868 . . . . 53.2 113.343 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 103' ' ' TRP . 37.6 mt-10 -114.41 156.72 23.97 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.484 -1.235 . . . . 63.44 107.71 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.541 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 38.0 p90 . . . . . 0 C--N 1.309 -1.194 0 N-CA-C 113.202 0.816 . . . . 71.11 113.202 -173.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 . . . . . 0 CA--C 1.482 -1.649 0 CA-C-O 121.361 0.6 . . . . 73.45 111.787 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -158.99 161.57 32.04 Favored Glycine 1 N--CA 1.391 -4.32 0 CA-C-N 114.638 -1.165 . . . . 44.22 110.381 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -107.22 123.23 47.99 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.234 -1.024 . . . . 75.22 108.234 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -117.86 103.4 9.93 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.22 -1.03 . . . . 72.43 108.22 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 87.2 mt -124.63 158.16 33.75 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 110.092 -0.336 . . . . 75.54 110.092 -177.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 8.3 p -133.68 134.51 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.439 0.638 . . . . 62.4 111.954 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.541 ' NE1' ' HB3' ' A' ' 85' ' ' PHE . 14.6 m-90 -106.82 147.66 29.45 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 124.318 1.047 . . . . 74.33 109.5 177.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 83' ' ' ALA . 62.6 mttm -127.91 126.49 41.6 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.016 -0.735 . . . . 73.31 109.016 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.409 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 25.6 t . . . . . 0 CA--C 1.553 1.081 0 N-CA-C 109.945 -0.391 . . . . 65.54 109.945 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 46.8 p90 . . . . . 0 N--CA 1.43 -1.436 0 N-CA-C 108.551 -0.907 . . . . 75.13 108.551 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.409 ' H ' ' HB3' ' A' ' 105' ' ' SER . 7.1 m-20 -114.13 138.29 50.62 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.922 -1.51 . . . . 70.3 106.922 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.593 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 44.7 mt-10 -115.16 143.49 45.14 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.143 0.497 . . . . 75.32 109.927 175.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -129.43 120.94 26.33 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.724 -0.671 . . . . 74.45 110.877 -174.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 35.0 mt-10 -111.18 110.06 20.4 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.66 -0.496 . . . . 74.4 109.66 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.44 134.27 38.46 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 120.841 0.353 . . . . 62.41 110.401 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -118.5 120.17 36.72 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.437 1.095 . . . . 64.11 108.661 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.79 148.79 21.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 106.131 -1.803 . . . . 74.4 106.131 175.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -128.49 146.9 50.68 Favored 'General case' 0 C--O 1.262 1.742 0 C-N-CA 119.109 -1.036 . . . . 72.32 110.095 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -81.02 112.82 18.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.689 -1.226 . . . . 75.35 107.689 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.433 ' HD2' ' H ' ' A' ' 129' ' ' ASP . 0.4 OUTLIER -85.1 136.32 33.61 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 105.835 -1.913 . . . . 70.2 105.835 -175.863 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.98 -10.55 14.2 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-O 121.531 0.682 . . . . 63.42 111.889 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.433 ' H ' ' HD2' ' A' ' 127' ' ' ARG . 28.7 t70 -72.01 -16.04 62.05 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.552 0.692 . . . . 54.12 109.644 178.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.68 -11.7 27.75 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.599 -0.81 . . . . 64.04 113.493 175.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 24.4 t -105.18 169.39 8.47 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 107.254 -1.387 . . . . 65.22 107.254 176.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.699 ' SG ' HG12 ' A' ' 21' ' ' VAL . 14.9 p -119.19 145.22 46.2 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 107.634 -1.247 . . . . 72.15 107.634 173.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -140.66 155.68 46.44 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.738 -0.838 . . . . 72.32 108.738 -176.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.11 125.11 25.81 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.54 0.686 . . . . 62.31 110.256 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -81.04 -57.39 3.55 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.701 -1.136 . . . . 64.1 108.034 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.8 m -166.16 157.13 13.11 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.237 -1.394 . . . . 42.31 107.237 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.6 135.98 43.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 106.862 -1.532 . . . . 71.31 106.862 171.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -108.99 136.12 49.04 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 122.731 0.412 . . . . 62.23 110.136 -174.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.484 ' HB2' HG22 ' A' ' 58' ' ' VAL . 62.6 m-85 -120.95 113.98 20.88 Favored 'General case' 0 C--O 1.255 1.352 0 CA-C-O 121.344 0.593 . . . . 63.53 109.671 176.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 13.9 pt -110.7 97.79 6.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-O 122.532 1.158 . . . . 55.44 109.248 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 19.8 ptm -101.31 93.77 5.59 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.163 -1.38 . . . . 52.44 110.164 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.0 m 160.8 19.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 127.004 2.122 . . . . 52.44 111.65 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.593 ' HG2' ' OE1' ' A' ' 119' ' ' GLU . 50.3 tptt . . . . . 0 C--N 1.319 -0.753 0 N-CA-C 107.079 -1.452 . . . . 72.51 107.079 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 t70 . . . . . 0 CA--C 1.511 -0.528 0 CA-C-O 121.162 0.506 . . . . 73.12 110.019 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.96 -39.55 94.99 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.138 -1.06 . . . . 50.22 108.138 175.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.35 -42.11 84.06 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.146 -0.934 . . . . 73.43 109.893 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.22 -45.1 94.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.514 -0.766 . . . . 63.52 111.082 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -70.89 -25.95 63.01 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.732 -0.387 . . . . 71.24 110.28 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.83 -45.41 58.02 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.214 -1.154 . . . . 45.22 110.214 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.4 tp -62.89 -50.15 72.0 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 124.579 1.152 . . . . 71.4 109.791 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.23 -43.24 98.68 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.656 -0.702 . . . . 61.54 112.017 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -66.17 -39.6 89.86 Favored 'General case' 0 C--O 1.211 -0.928 0 CA-C-O 119.22 -0.419 . . . . 71.24 111.218 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -60.62 -46.41 90.39 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.829 -0.804 . . . . 45.11 108.829 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.497 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 38.5 t80 -61.64 -53.74 52.18 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 114.377 -1.283 . . . . 73.22 110.424 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 29' ' ' ILE . 12.9 mm -62.02 -36.17 72.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 112.464 0.542 . . . . 54.4 112.464 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.35 -41.16 81.08 Favored 'General case' 0 CA--C 1.491 -1.306 0 C-N-CA 120.333 -0.547 . . . . 73.21 109.864 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.673 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.8 pp -70.44 -28.03 64.72 Favored 'General case' 0 N--CA 1.421 -1.876 0 C-N-CA 119.498 -0.881 . . . . 74.34 111.761 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 28' ' ' PHE . 65.1 t -70.62 -24.58 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 121.315 0.579 . . . . 73.15 109.653 175.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.5 p -115.18 21.85 13.83 Favored 'General case' 0 C--O 1.244 0.773 0 O-C-N 122.071 -0.393 . . . . 71.25 111.296 -176.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.673 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 53.2 mmtt -44.24 149.34 0.37 Allowed 'General case' 0 C--O 1.245 0.843 0 N-CA-C 115.808 1.781 . . . . 64.11 115.808 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 m -60.7 154.23 58.32 Favored Pre-proline 0 N--CA 1.423 -1.782 0 CA-C-N 112.981 -1.918 . . . . 70.13 108.191 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.04 -8.9 8.84 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 123.5 2.8 . . . . 63.21 112.941 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.8 -27.35 64.82 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.567 0.699 . . . . 73.14 109.878 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.7 m -118.21 81.43 1.68 Allowed 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 107.817 -1.179 . . . . 72.04 107.817 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -81.21 -5.3 8.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-O 122.258 1.028 . . . . 61.54 110.091 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -115.67 78.14 1.15 Allowed 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 107.414 -1.328 . . . . 74.44 107.414 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.6 m -66.43 -25.54 66.79 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 113.979 -1.464 . . . . 74.44 110.906 -173.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.497 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 6.5 pm0 -68.5 -22.98 64.51 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.616 -0.72 . . . . 61.4 110.533 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -63.94 -49.87 70.91 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.573 -0.899 . . . . 73.13 108.573 176.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -65.26 -38.24 89.69 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.439 -1.255 . . . . 73.24 109.96 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.6 tp -65.25 -42.96 92.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 116.429 -0.351 . . . . 70.45 110.73 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.13 -32.33 73.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.296 0.569 . . . . 75.34 110.435 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -74.2 -36.78 64.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.439 -0.8 . . . . 43.45 109.496 178.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 68.4 t80 -67.97 -42.95 80.09 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.189 0.996 . . . . 75.31 111.04 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 pp -81.3 -5.34 57.7 Favored 'General case' 0 C--O 1.204 -1.316 0 CA-C-N 115.907 -0.588 . . . . 72.12 111.138 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.54 -54.4 6.54 Favored Glycine 0 CA--C 1.545 1.92 0 CA-C-N 115.895 -0.593 . . . . 53.14 113.781 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -85.41 -3.56 9.34 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 123.356 2.704 . . . . 50.31 112.941 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.414 ' HA ' ' HE1' ' A' ' 133' ' ' TRP . 92.0 m-70 -128.75 31.53 4.94 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.992 -0.443 . . . . 54.51 110.595 -168.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -56.0 111.91 3.72 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.132 0.973 . . . . 71.31 112.559 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -105.57 -159.68 0.03 OUTLIER 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 123.631 2.888 . . . . 65.21 111.367 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -89.16 124.11 34.04 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 108.189 -1.041 . . . . 74.52 108.189 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.483 HD13 ' CB ' ' A' ' 68' ' ' PHE . 59.6 mt -107.0 112.48 40.12 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.179 0 N-CA-C 107.447 -1.316 . . . . 52.41 107.447 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -98.18 136.14 38.82 Favored 'General case' 0 C--N 1.263 -3.166 0 O-C-N 121.468 -0.77 . . . . 70.11 109.108 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.0 t -132.38 117.34 31.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 107.286 -1.375 . . . . 62.33 107.286 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.5 m120 65.47 20.99 11.8 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.5 1.12 . . . . 74.43 109.893 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.59 3.25 84.09 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.903 -1.044 . . . . 75.22 111.454 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -99.97 130.91 46.19 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 108.14 -1.059 . . . . 72.52 108.14 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.51 124.28 23.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 122.325 1.06 . . . . 71.4 110.549 -176.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 61.7 mm-40 -123.55 143.06 50.43 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 107.315 -1.365 . . . . 43.41 107.315 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.1 t -87.42 171.3 10.66 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 109.023 -0.732 . . . . 61.55 109.023 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.409 ' HA ' HD12 ' A' ' 56' ' ' ILE . 5.3 t -53.83 -36.21 62.29 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.107 0.963 . . . . 74.44 111.426 177.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.497 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 16.4 m -61.91 -50.45 72.14 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 122.971 0.509 . . . . 75.34 110.35 178.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -58.37 -47.79 82.68 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 123.598 0.759 . . . . 61.15 110.744 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.483 ' CB ' HD13 ' A' ' 56' ' ' ILE . 60.5 t80 -54.38 -55.31 29.92 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 123.755 0.659 . . . . 73.34 110.267 176.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -51.98 -40.76 61.44 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.187 0.929 . . . . 71.4 110.512 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 66' ' ' THR . 48.1 mt-30 -62.19 -49.07 77.28 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 116.577 -0.283 . . . . 73.41 111.118 176.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.0 -36.56 84.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.649 0.738 . . . . 71.33 110.092 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -59.2 -54.65 44.5 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 124.303 1.041 . . . . 64.44 110.971 176.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 7.8 ptm180 -68.76 -24.5 64.45 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.371 -0.377 . . . . 71.03 110.58 -176.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -86.38 -0.48 56.03 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.304 0.483 . . . . 63.31 112.304 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.72 13.29 61.29 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 115.391 0.916 . . . . 52.31 115.391 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.77 -39.69 94.03 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 112.701 0.63 . . . . 74.15 112.701 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -89.75 -2.02 58.15 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.537 0.569 . . . . 72.03 112.537 -174.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.497 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 98.9 mttt -65.78 -14.62 61.72 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.732 0.641 . . . . 74.34 112.732 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -76.79 -37.66 55.4 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.373 0.606 . . . . 74.42 110.029 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.507 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.6 tt -88.88 5.56 43.3 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.031 -0.986 . . . . 74.23 110.85 -168.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -12.17 52.54 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.303 0.853 . . . . 75.11 113.303 -176.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.67 -36.51 51.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.574 0.702 . . . . 73.04 109.341 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 34.81 114.59 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 118.67 2.841 . . . . 60.12 118.67 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -113.77 123.39 49.72 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 113.847 -1.524 . . . . 74.41 107.537 173.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.8 p90 . . . . . 0 C--N 1.296 -1.736 0 C-N-CA 119.252 -0.979 . . . . 75.54 112.301 -176.759 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 N--CA 1.442 -0.855 0 N-CA-C 107.176 -1.416 . . . . 74.15 107.176 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 125' ' ' TRP . . . -80.93 152.78 33.54 Favored Glycine 0 N--CA 1.425 -2.034 0 C-N-CA 120.266 -0.969 . . . . 65.34 112.752 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -106.95 134.95 49.32 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.309 -1.367 . . . . 63.25 107.309 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.404 ' N ' ' HD2' ' A' ' 100' ' ' LYS . 7.7 mptt -124.21 102.59 7.78 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.433 -1.321 . . . . 70.34 107.433 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 96.0 mt -119.22 141.02 49.27 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 120.457 -0.497 . . . . 74.11 109.978 -176.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.537 HG22 ' HB3' ' A' ' 121' ' ' GLU . 20.3 t -122.9 135.39 63.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.941 -0.392 . . . . 73.13 109.941 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -120.38 141.42 50.11 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.38 -0.97 . . . . 75.41 108.38 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -114.96 144.33 43.75 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 109.304 -0.628 . . . . 73.14 109.304 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.508 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 22.9 t . . . . . 0 C--N 1.293 -1.869 0 C-N-CA 124.165 0.986 . . . . 74.04 108.625 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 46.2 p90 . . . . . 0 N--CA 1.425 -1.709 0 N-CA-C 108.633 -0.877 . . . . 74.24 108.633 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.508 ' H ' ' HB3' ' A' ' 105' ' ' SER . 3.5 m-20 -102.55 141.14 35.87 Favored 'General case' 0 C--N 1.264 -3.15 0 N-CA-C 106.653 -1.61 . . . . 65.54 106.653 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.507 ' CD ' ' HG3' ' A' ' 143' ' ' LYS . 93.5 mt-10 -114.94 141.39 48.02 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.484 -0.486 . . . . 65.13 110.005 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.72 121.77 31.19 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.838 -0.619 . . . . 71.51 109.565 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.537 ' HB3' HG22 ' A' ' 102' ' ' VAL . 14.5 pt-20 -123.77 115.33 21.2 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-O 121.626 0.726 . . . . 63.13 111.784 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.31 135.7 35.43 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.891 -1.049 . . . . 65.12 109.891 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -117.28 117.47 29.64 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.431 -0.951 . . . . 74.5 108.431 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.53 HG22 ' SG ' ' A' ' 132' ' ' CYS . 54.4 mt -119.76 128.87 75.92 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 N-CA-C 105.533 -2.025 . . . . 75.22 105.533 176.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.535 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 0.2 OUTLIER -110.89 145.18 38.74 Favored 'General case' 0 N--CA 1.425 -1.723 0 C-N-CA 117.373 -1.731 . . . . 74.42 110.536 -177.223 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -103.84 118.26 36.27 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 107.711 -1.218 . . . . 73.31 107.711 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -75.9 155.67 35.0 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.205 -1.361 . . . . 60.42 109.422 -174.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -60.12 -22.57 62.97 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.011 0.91 . . . . 72.22 110.106 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.69 -13.37 54.12 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.703 1.201 . . . . 72.1 111.336 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.77 -23.71 34.68 Favored Glycine 0 CA--C 1.498 -1.001 0 N-CA-C 111.22 -0.752 . . . . 54.25 111.22 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.0 p -78.37 159.58 28.28 Favored 'General case' 0 N--CA 1.408 -2.565 0 C-N-CA 124.06 0.944 . . . . 74.43 110.392 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.53 ' SG ' HG22 ' A' ' 124' ' ' ILE . 7.7 t -135.49 143.7 45.96 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 108.889 -0.782 . . . . 75.21 108.889 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.414 ' HE1' ' HA ' ' A' ' 52' ' ' HIS . 11.6 t90 -153.85 156.17 37.11 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.966 -1.124 . . . . 72.21 107.966 -176.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.0 mp -68.81 127.9 34.74 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.834 -0.432 . . . . 72.41 109.834 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -87.02 -52.26 5.54 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.902 0.858 . . . . 72.14 108.767 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.8 p -174.93 162.02 3.07 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.324 -1.307 . . . . 43.54 108.131 -175.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.6 m -137.08 144.44 32.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 N-CA-C 106.342 -1.725 . . . . 72.32 106.342 172.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -124.65 130.6 52.73 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 120.674 -0.41 . . . . 70.33 110.78 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -109.97 127.75 54.98 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.573 -1.269 . . . . 64.03 107.573 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.7 pt -126.82 99.01 5.12 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-O 121.932 0.872 . . . . 73.24 111.803 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -86.05 92.25 8.65 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 105.402 -2.073 . . . . 75.11 105.402 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.7 m -165.66 3.35 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.277 -0.42 . . . . 62.33 112.01 -176.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.507 ' HG3' ' CD ' ' A' ' 119' ' ' GLU . 28.1 mmtp . . . . . 0 CA--C 1.489 -1.383 0 C-N-CA 119.57 -0.852 . . . . 73.41 111.935 -176.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 t70 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 121.726 0.774 . . . . 73.21 110.964 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.36 -33.32 72.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.918 -1.142 . . . . 73.22 107.918 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -69.98 -38.95 76.18 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.185 -0.916 . . . . 75.03 109.728 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.585 HG22 ' SG ' ' A' ' 132' ' ' CYS . 61.9 t -58.32 -53.89 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 123.507 0.504 . . . . 71.13 110.011 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.06 -32.78 74.2 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.874 -0.731 . . . . 64.32 111.413 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.86 -37.24 83.6 Favored Glycine 0 C--O 1.229 -0.161 0 N-CA-C 111.465 -0.654 . . . . 63.5 111.465 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.7 tp -65.45 -46.48 79.68 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 124.102 0.961 . . . . 71.12 108.663 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.46 -41.27 99.79 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.167 -0.924 . . . . 74.23 111.577 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -61.71 -42.28 98.74 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 122.731 0.412 . . . . 53.01 110.737 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -64.55 -47.71 77.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.356 0.598 . . . . 63.22 109.407 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 30.2 t80 -61.43 -51.59 68.09 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.309 -1.314 . . . . 61.24 110.42 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.3 mm -64.82 -32.28 57.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 116.24 -0.436 . . . . 52.14 111.687 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.31 -43.0 71.23 Favored 'General case' 0 CA--C 1.479 -1.784 0 C-N-CA 119.761 -0.775 . . . . 73.4 109.99 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 41' ' ' SER . 4.1 pp -70.53 -26.03 63.38 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 119.912 -0.715 . . . . 73.13 112.045 -178.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.0 t -70.25 -28.02 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 121.453 0.644 . . . . 52.32 109.777 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.9 p -114.21 23.66 12.67 Favored 'General case' 0 C--O 1.25 1.111 0 N-CA-C 109.148 -0.686 . . . . 54.02 109.148 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.617 ' HD3' ' HA ' ' A' ' 31' ' ' LEU . 27.4 tptt -52.8 137.56 31.48 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.342 -1.299 . . . . 72.1 111.684 -173.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.0 p -40.72 138.89 1.22 Allowed Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 125.411 1.484 . . . . 72.45 112.576 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -57.3 -15.22 18.06 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 123.545 2.83 . . . . 60.13 113.209 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.52 -27.94 68.96 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.921 0.867 . . . . 71.23 109.114 174.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.7 p -119.26 96.48 5.24 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 114.667 -1.151 . . . . 62.43 108.179 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.6 t -66.32 -50.03 71.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 113.348 0.87 . . . . 74.34 113.348 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.449 ' OD1' ' HB2' ' A' ' 43' ' ' HIS . 17.6 t-20 -89.72 80.76 6.51 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 123.111 1.434 . . . . 70.12 112.023 -171.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.68 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 15.8 m -67.2 -27.48 67.3 Favored 'General case' 0 C--O 1.255 1.374 0 CA-C-N 113.008 -1.906 . . . . 64.43 109.632 -175.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 42' ' ' GLU . 1.7 pm0 -68.52 -20.34 64.56 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 114.318 -1.31 . . . . 71.11 112.619 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.449 ' HB2' ' OD1' ' A' ' 40' ' ' ASN . 13.2 t60 -70.49 -38.46 74.35 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.19 -1.041 . . . . 72.14 108.19 175.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -66.57 -36.65 83.17 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.377 -0.972 . . . . 75.33 108.377 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.64 -43.18 97.54 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.671 -0.695 . . . . 74.45 110.722 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.01 79.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.31 0.576 . . . . 62.24 110.469 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -68.47 -39.12 81.52 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.443 -0.799 . . . . 63.41 109.698 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 79.7 t80 -69.4 -41.21 76.73 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 123.624 0.769 . . . . 73.31 111.084 -177.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.3 pp -79.52 -7.98 58.84 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-N 116.02 -0.536 . . . . 61.41 112.143 -176.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.05 -61.61 5.22 Favored Glycine 0 CA--C 1.541 1.687 0 C-N-CA 121.231 -0.509 . . . . 72.22 112.788 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -76.48 -4.92 15.61 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.118 2.545 . . . . 72.14 112.47 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.41 ' HB3' HD13 ' A' ' 134' ' ' LEU . 80.1 m-70 -122.61 29.95 6.68 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.889 -0.507 . . . . 74.03 110.646 -173.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.571 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 6.2 t70 -55.83 106.8 0.72 Allowed Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 125.207 1.403 . . . . 72.15 113.274 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 26.2 Cg_endo -107.33 -165.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 123.894 3.063 . . . . 50.21 112.803 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -87.85 115.58 25.41 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.077 -1.082 . . . . 72.51 108.077 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.407 HD13 ' HB2' ' A' ' 68' ' ' PHE . 53.4 mt -101.27 108.77 24.11 Favored 'Isoleucine or valine' 0 C--O 1.168 -3.217 0 N-CA-C 108.398 -0.964 . . . . 72.22 108.398 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -93.55 135.91 34.35 Favored 'General case' 0 C--N 1.272 -2.788 0 O-C-N 121.397 -0.814 . . . . 73.34 108.998 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.7 t -133.49 116.93 25.95 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.951 -1.129 . . . . 71.13 107.951 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 61.89 20.5 11.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.126 1.37 . . . . 61.54 110.931 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.6 4.72 60.51 Favored Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.26 -0.882 . . . . 75.23 112.822 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -107.45 134.77 49.99 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 108.096 -1.076 . . . . 71.34 108.096 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.11 127.88 38.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.523 0.678 . . . . 75.44 109.247 -178.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 61.9 mm-40 -122.01 150.12 42.53 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.005 -1.109 . . . . 73.41 108.005 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 t -97.86 174.09 6.76 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.414 -0.958 . . . . 75.24 108.414 176.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.571 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 8.9 t -53.77 -35.22 61.08 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 122.816 0.446 . . . . 74.41 111.058 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.543 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 10.7 m -58.73 -56.0 27.86 Favored 'General case' 0 C--O 1.212 -0.897 0 O-C-N 123.5 0.5 . . . . 63.53 110.014 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -58.96 -48.03 82.99 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 123.493 0.496 . . . . 74.44 111.014 -178.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.407 ' HB2' HD13 ' A' ' 56' ' ' ILE . 42.7 t80 -52.95 -56.86 12.85 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.464 0.478 . . . . 74.35 110.012 176.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -52.11 -42.87 63.63 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.716 -1.129 . . . . 73.14 110.857 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.8 mm100 -60.49 -48.77 80.32 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 122.797 0.439 . . . . 73.23 111.343 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.523 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 23.3 m-85 -66.41 -37.5 85.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.937 -0.764 . . . . 65.13 108.937 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -57.45 -53.37 58.89 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 123.762 0.825 . . . . 53.03 110.911 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -70.95 -19.2 62.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.118 0.485 . . . . 74.23 111.42 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -84.21 -9.91 58.14 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 112.972 0.731 . . . . 74.04 112.972 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.76 21.36 16.47 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 119.975 -1.107 . . . . 52.23 113.612 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.18 -49.7 9.19 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 122.255 -0.556 . . . . 44.13 110.78 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.523 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 62.4 m-85 -92.1 11.18 26.29 Favored 'General case' 0 C--O 1.193 -1.876 0 N-CA-C 113.333 0.864 . . . . 75.11 113.333 -175.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -12.35 59.96 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.391 0.885 . . . . 70.13 113.391 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -87.46 -10.05 52.92 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.648 -1.16 . . . . 64.11 111.779 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.7 tt -65.05 -26.24 68.17 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 122.505 0.322 . . . . 74.34 110.955 -173.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -60.86 -24.46 65.93 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.16 0.43 . . . . 72.1 112.16 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -105.16 13.65 30.35 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 112.108 0.41 . . . . 73.45 112.108 -178.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -70.17 126.46 29.75 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.414 0.626 . . . . 45.21 111.224 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -86.61 123.81 32.2 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.087 -0.96 . . . . 73.51 109.458 -177.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.468 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 39.7 p90 . . . . . 0 C--N 1.294 -1.827 0 CA-C-O 121.238 0.542 . . . . 62.03 111.833 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 110.145 -0.317 . . . . 63.22 110.145 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 125' ' ' TRP . . . -100.0 148.89 18.63 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.649 -0.786 . . . . 70.43 113.214 -176.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -107.04 135.2 49.0 Favored 'General case' 0 C--O 1.25 1.111 0 N-CA-C 106.679 -1.6 . . . . 71.24 106.679 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -126.67 107.8 10.51 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.933 -0.766 . . . . 43.43 108.933 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.3 mt -114.57 138.14 51.0 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.082 -1.081 . . . . 73.4 108.082 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 11.8 p -127.26 137.69 57.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.572 0.701 . . . . 73.11 111.715 -177.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.576 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 17.4 m-90 -118.49 157.18 27.74 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.833 -1.076 . . . . 73.34 109.622 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.12 121.35 40.33 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.884 -1.895 . . . . 60.22 105.884 170.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.4 t . . . . . 0 C--N 1.279 -2.483 0 CA-C-N 115.777 -0.647 . . . . 53.04 110.917 -174.6 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 41.2 p90 . . . . . 0 N--CA 1.416 -2.165 0 N-CA-C 108.757 -0.831 . . . . 74.42 108.757 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.558 ' HB3' ' HA ' ' A' ' 141' ' ' MET . 2.7 p-10 -124.37 146.38 48.89 Favored 'General case' 0 C--N 1.249 -3.774 0 N-CA-C 108.82 -0.808 . . . . 74.22 108.82 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -113.78 147.88 37.53 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 119.725 -0.79 . . . . 75.31 109.786 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -131.45 120.22 22.71 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.345 -0.843 . . . . 64.45 111.274 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -110.83 118.1 35.22 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 108.207 -1.035 . . . . 74.43 108.207 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -106.15 134.66 48.94 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.664 -0.648 . . . . 55.35 110.146 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -119.82 118.75 31.62 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.171 -0.922 . . . . 63.45 110.818 -174.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.33 145.37 26.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 106.331 -1.729 . . . . 45.3 106.331 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.519 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 0.4 OUTLIER -123.58 140.06 53.38 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 117.751 -1.58 . . . . 75.11 108.924 174.871 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -85.19 120.05 26.25 Favored 'General case' 0 N--CA 1.403 -2.811 0 N-CA-C 106.165 -1.791 . . . . 60.11 106.165 172.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.467 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 76.6 ttt180 -69.82 149.33 48.03 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.116 -1.438 . . . . 73.53 107.116 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.24 -20.35 58.53 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.697 0.76 . . . . 74.14 111.03 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.467 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 11.5 t70 -64.8 -18.13 64.83 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.507 1.123 . . . . 72.2 111.245 175.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.19 -21.28 33.72 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.192 -0.763 . . . . 55.11 111.192 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.0 m -78.2 171.33 15.2 Favored 'General case' 0 N--CA 1.419 -2.013 0 C-N-CA 123.562 0.745 . . . . 75.23 109.153 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.585 ' SG ' HG22 ' A' ' 21' ' ' VAL . 28.3 p -140.52 151.25 44.62 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 109.486 -0.561 . . . . 73.34 109.486 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.475 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 1.8 t90 -152.07 155.29 37.63 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.537 -1.283 . . . . 74.1 107.537 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.41 HD13 ' HB3' ' A' ' 52' ' ' HIS . 10.3 mp -68.82 123.87 22.14 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.349 0.595 . . . . 72.01 110.287 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -83.68 -50.6 8.02 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.135 -0.938 . . . . 74.41 108.563 -176.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 26.6 p -170.2 166.09 8.96 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 108.294 -1.002 . . . . 74.11 108.294 -177.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.2 t -143.52 143.37 24.45 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 N-CA-C 104.683 -2.34 . . . . 73.13 104.683 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -131.48 131.13 43.25 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 117.721 0.237 . . . . 74.4 110.866 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -118.17 130.54 56.16 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.147 -1.057 . . . . 64.53 108.147 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.5 pt -125.97 103.84 12.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-O 121.352 0.596 . . . . 75.21 111.438 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.558 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 52.8 mtt -95.85 94.85 7.88 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.064 -0.516 . . . . 55.24 109.611 -178.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.2 m -164.25 -46.38 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.018 -0.537 . . . . 62.52 110.672 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.9 tptm . . . . . 0 N--CA 1.475 0.787 0 C-N-CA 125.644 1.578 . . . . 53.21 113.363 -173.182 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.0 t70 . . . . . 0 N--CA 1.444 -0.759 0 CA-C-O 121.134 0.492 . . . . 73.31 110.758 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.76 -37.34 81.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.518 -0.765 . . . . 73.34 108.941 178.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -66.65 -53.45 33.83 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 115.199 -0.91 . . . . 63.15 109.931 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.8 p -66.32 -32.99 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 116.033 -0.53 . . . . 65.51 112.39 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -33.89 62.88 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 119.045 -1.062 . . . . 63.0 110.045 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.29 -41.36 68.7 Favored Glycine 0 CA--C 1.496 -1.1 0 N-CA-C 110.605 -0.998 . . . . 41.03 110.605 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.7 tp -65.15 -50.8 64.59 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 123.778 0.831 . . . . 71.2 109.698 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.33 -42.18 97.26 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.61 -0.723 . . . . 61.15 112.258 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -74.02 -32.52 63.4 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 120.159 -0.616 . . . . 75.53 111.559 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.86 -44.04 97.19 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.069 -0.715 . . . . 64.22 109.069 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 23.0 t80 -62.08 -53.73 51.3 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.08 -1.418 . . . . 70.5 110.31 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.6 mm -61.09 -40.53 86.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.606 0.595 . . . . 73.21 112.606 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.5 -40.49 85.19 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 120.521 -0.471 . . . . 60.13 110.136 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.686 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.8 pp -71.54 -27.51 63.24 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 118.801 -1.16 . . . . 71.54 112.054 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.5 t -71.07 -21.65 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 121.27 0.557 . . . . 72.0 109.527 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.0 p -115.09 22.31 13.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 122.115 -0.366 . . . . 50.21 111.915 -177.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.686 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 61.0 mmtt -49.82 133.71 21.59 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 113.544 0.942 . . . . 60.13 113.544 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.5 m -55.21 150.39 21.88 Favored Pre-proline 0 C--N 1.302 -1.496 0 C-N-CA 125.537 1.535 . . . . 74.42 110.487 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -59.18 -12.77 17.05 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.658 2.905 . . . . 60.11 112.857 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.52 -27.42 69.14 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.072 0.939 . . . . 63.25 109.1 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.4 p -109.99 99.17 8.32 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 106.354 -1.721 . . . . 71.34 106.354 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.8 p -49.61 -37.88 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 116.657 2.095 . . . . 71.12 116.657 -168.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -132.49 110.54 10.57 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 118.153 -1.419 . . . . 73.0 113.149 -174.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.8 m -65.89 -35.77 81.56 Favored 'General case' 0 C--O 1.256 1.412 0 CA-C-O 121.823 0.821 . . . . 61.44 110.331 -175.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.568 ' OE2' ' HA ' ' A' ' 78' ' ' LYS . 1.5 mp0 -66.6 -21.3 66.13 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.243 -0.889 . . . . 64.22 110.586 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -68.62 -42.23 78.39 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 108.533 -0.914 . . . . 74.03 108.533 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.469 ' HG3' ' HG3' ' A' ' 34' ' ' LYS . 13.2 mm-40 -69.76 -35.01 74.57 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 108.098 -1.075 . . . . 72.34 108.098 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.0 tp -66.97 -42.97 84.25 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.896 -0.593 . . . . 63.31 110.801 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.99 -34.39 76.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.624 0.726 . . . . 70.53 110.366 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -76.35 -32.72 58.82 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.197 -0.91 . . . . 64.14 109.98 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.487 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 59.9 t80 -67.28 -47.7 69.86 Favored 'General case' 0 C--O 1.215 -0.744 0 C-N-CA 123.48 0.712 . . . . 63.4 109.991 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.443 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.5 pp -75.03 -4.14 36.65 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.766 -0.652 . . . . 74.44 111.107 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.61 -61.13 5.36 Favored Glycine 0 CA--C 1.526 0.755 0 O-C-N 123.644 0.59 . . . . 72.03 112.371 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 48' ' ' PHE . 93.5 Cg_endo -85.18 -6.5 9.3 Favored 'Trans proline' 0 CA--C 1.549 1.264 0 C-N-CA 122.214 1.942 . . . . 74.33 112.672 173.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 75.9 m80 -111.41 31.35 6.18 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.726 -0.472 . . . . 72.45 109.726 -175.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.412 ' OD2' ' HB ' ' A' ' 65' ' ' THR . 13.4 t70 -54.68 107.82 0.97 Allowed Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 124.679 1.192 . . . . 75.52 112.505 -177.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -108.7 -154.45 0.02 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.294 0 C-N-CA 123.602 2.868 . . . . 74.22 110.485 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -93.63 120.13 33.52 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 107.195 -1.409 . . . . 55.21 107.195 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.446 HD13 ' CB ' ' A' ' 68' ' ' PHE . 64.7 mt -101.56 110.38 28.25 Favored 'Isoleucine or valine' 0 C--O 1.168 -3.19 0 N-CA-C 108.038 -1.097 . . . . 74.13 108.038 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -96.77 138.62 34.05 Favored 'General case' 0 C--N 1.271 -2.839 0 O-C-N 121.304 -0.873 . . . . 75.33 109.304 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.5 t -133.07 114.44 21.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 107.502 -1.296 . . . . 74.33 107.502 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 63.19 21.02 12.63 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 124.794 1.237 . . . . 63.32 111.073 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.92 -1.16 59.41 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.329 -0.851 . . . . 71.42 112.39 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -103.96 135.27 45.79 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.417 -0.586 . . . . 61.31 109.417 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -76.97 129.2 37.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.671 0.748 . . . . 62.34 109.265 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.456 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 57.4 mm-40 -126.21 147.55 49.64 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 124.642 1.177 . . . . 73.43 108.227 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 t -92.63 174.56 7.2 Favored 'General case' 0 C--O 1.254 1.341 0 N-CA-C 108.232 -1.025 . . . . 71.42 108.232 175.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.412 ' HB ' ' OD2' ' A' ' 53' ' ' ASP . 8.8 t -54.8 -36.17 64.65 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.028 0.531 . . . . 71.24 111.058 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 35.8 m -65.92 -46.42 78.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 122.729 0.412 . . . . 74.14 111.194 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -63.88 -46.19 86.01 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.91 -0.404 . . . . 62.0 109.91 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.446 ' CB ' HD13 ' A' ' 56' ' ' ILE . 48.9 t80 -54.28 -54.94 33.41 Favored 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 123.656 0.597 . . . . 74.22 109.723 174.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 2.2 tm? -50.39 -44.36 54.87 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 124.424 1.078 . . . . 61.23 110.54 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.431 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 89.4 mt-30 -56.91 -52.11 66.45 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 123.101 0.56 . . . . 73.24 111.929 174.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -64.87 -36.53 84.66 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.704 0.764 . . . . 73.21 109.817 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -57.7 -55.99 27.72 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 124.612 1.165 . . . . 71.35 110.472 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 48.9 ptt85 -68.87 -23.93 64.28 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.358 -0.383 . . . . 74.51 111.597 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 54.8 mt-30 -78.99 -15.31 58.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 120.432 -0.507 . . . . 74.02 111.459 176.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.47 14.33 30.41 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.677 -0.773 . . . . 54.24 114.622 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.16 -42.54 79.91 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.437 0.532 . . . . 74.12 112.437 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -92.48 6.89 45.42 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.587 0.588 . . . . 75.2 112.587 -173.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.568 ' HA ' ' OE2' ' A' ' 42' ' ' GLU . 99.4 mttt -67.06 -13.96 62.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.222 0.534 . . . . 75.22 112.233 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -77.57 -27.24 51.39 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.083 -0.71 . . . . 54.11 109.083 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.461 ' O ' HD23 ' A' ' 80' ' ' LEU . 7.1 tt -71.63 -17.51 62.26 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.077 0.951 . . . . 60.53 109.662 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -68.04 -22.04 64.97 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.105 -0.498 . . . . 75.1 109.879 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -101.13 4.76 42.4 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.379 -0.601 . . . . 73.14 109.379 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 105' ' ' SER . . . -75.73 143.17 42.2 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.525 0.935 . . . . 60.12 113.525 -173.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 103' ' ' TRP . 49.4 mt-10 -89.14 139.37 30.54 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.12 -0.945 . . . . 74.5 109.175 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.5 t80 . . . . . 0 N--CA 1.43 -1.469 0 N-CA-C 104.465 -2.42 . . . . 65.34 104.465 167.953 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 . . . . . 0 CA--C 1.508 -0.643 0 N-CA-C 113.508 0.929 . . . . 64.01 113.508 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.83 138.12 13.73 Favored Glycine 0 N--CA 1.406 -3.33 0 N-CA-C 107.556 -2.218 . . . . 33.33 107.556 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -111.14 127.0 55.43 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.583 -0.895 . . . . 71.41 108.583 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -123.2 98.63 5.96 Favored 'General case' 0 C--N 1.273 -2.736 0 N-CA-C 105.44 -2.059 . . . . 72.23 105.44 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 75.2 mt -109.75 138.84 45.53 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.034 -0.985 . . . . 53.53 108.897 -173.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 12.1 p -133.43 138.2 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-O 121.729 0.776 . . . . 72.33 111.839 -178.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.401 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 23.3 m-90 -113.77 143.71 44.19 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.392 -1.277 . . . . 74.11 107.661 176.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.425 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 21.8 mtpp -126.01 124.24 40.26 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.092 -1.447 . . . . 74.44 107.092 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 40.0 m . . . . . 0 C--N 1.281 -2.407 0 O-C-N 123.397 0.436 . . . . 52.41 111.012 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.428 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 10.2 p90 . . . . . 0 N--CA 1.439 -1.017 0 N-CA-C 108.918 -0.771 . . . . 73.13 108.918 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.437 ' CB ' ' HA ' ' A' ' 141' ' ' MET . 4.7 p-10 -113.01 134.65 54.41 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-O 121.199 0.523 . . . . 74.53 110.07 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.428 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 37.2 mt-10 -117.16 154.62 30.78 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.783 -1.099 . . . . 72.42 112.015 178.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.571 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -135.79 118.48 16.05 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.042 -0.981 . . . . 61.3 109.284 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 37.2 mt-10 -116.4 110.54 18.8 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.624 -0.51 . . . . 74.32 109.624 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.21 130.65 41.87 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 109.057 -0.72 . . . . 72.34 109.057 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -113.84 118.52 34.48 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.964 -0.754 . . . . 73.04 108.964 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.3 mt -118.95 152.69 21.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.388 -1.338 . . . . 74.51 107.388 178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -137.53 148.55 46.06 Favored 'General case' 0 C--O 1.275 2.417 0 C-N-CA 119.715 -0.794 . . . . 72.42 109.922 175.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -88.11 129.37 35.32 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.116 -0.947 . . . . 73.43 108.691 170.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.422 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 47.8 ttt180 -87.86 147.29 25.18 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-N 113.983 -1.462 . . . . 54.43 108.075 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -58.21 -28.27 64.66 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.855 0.462 . . . . 75.33 112.065 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.422 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 9.8 t70 -64.84 -16.87 63.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.148 -0.933 . . . . 74.52 111.702 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.6 6.8 56.24 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 119.849 -1.167 . . . . 63.11 111.283 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.404 ' OG ' ' HD3' ' A' ' 127' ' ' ARG . 0.4 OUTLIER -96.89 162.37 13.44 Favored 'General case' 0 N--CA 1.396 -3.151 0 N-CA-C 108.438 -0.949 . . . . 72.22 108.438 175.711 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 28.8 p -133.22 144.99 50.15 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 107.967 -1.123 . . . . 61.31 107.967 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.41 ' HE1' ' HA ' ' A' ' 52' ' ' HIS . 2.1 t90 -159.06 156.05 28.5 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 120.088 -0.645 . . . . 75.11 109.797 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.6 mp -69.23 127.01 31.54 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.268 0.556 . . . . 65.52 109.773 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -80.89 -56.12 4.34 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.806 -1.183 . . . . 75.43 107.806 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 10.9 m -166.5 162.27 16.67 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 105.931 -1.877 . . . . 65.3 105.931 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.7 m -137.55 149.84 25.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 106.394 -1.706 . . . . 74.23 106.394 171.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -134.4 130.71 37.26 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 117.686 0.221 . . . . 65.43 110.414 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -112.63 129.05 56.52 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 107.312 -1.366 . . . . 74.05 107.312 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 8.4 pt -129.0 98.3 4.08 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 CA-C-O 122.129 0.966 . . . . 60.32 109.048 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.437 ' HA ' ' CB ' ' A' ' 118' ' ' ASP . 23.3 ptp -92.83 138.31 31.6 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.013 -0.994 . . . . 72.24 110.205 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.5 t 81.26 29.02 0.17 Allowed 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.264 0.977 . . . . 72.42 109.812 176.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 80.4 tttt . . . . . 0 N--CA 1.439 -1.009 0 N-CA-C 106.282 -1.747 . . . . 75.1 106.282 173.557 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 9.6 m-20 . . . . . 0 CA--C 1.508 -0.664 0 CA-C-O 120.533 0.206 . . . . 71.13 111.21 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.4 -42.95 87.12 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.873 -0.788 . . . . 75.51 108.873 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.17 -48.81 78.4 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 115.86 -0.609 . . . . 73.34 111.411 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.0 p -69.38 -38.83 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 112.552 0.575 . . . . 64.41 112.552 -176.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 22.5 ptmt -75.76 -25.96 56.96 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 119.076 -1.05 . . . . 65.55 110.187 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.56 -57.74 5.82 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 120.64 -0.791 . . . . 71.11 111.262 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 pp -68.45 -35.91 78.26 Favored 'General case' 0 C--O 1.199 -1.559 0 N-CA-C 108.947 -0.76 . . . . 65.13 108.947 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.23 -43.67 96.69 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 116.231 -0.44 . . . . 70.34 112.036 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -63.83 -46.85 83.2 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.76 -0.459 . . . . 72.31 109.76 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -65.16 -41.27 94.85 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 116.051 -0.522 . . . . 71.24 110.247 -177.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -63.05 -53.59 51.39 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.418 -0.81 . . . . 74.42 110.481 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 29' ' ' ILE . 13.5 mm -64.23 -34.81 71.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.613 -0.267 . . . . 74.43 111.666 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -63.3 -48.59 77.43 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 116.34 -0.391 . . . . 72.24 110.144 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 pp -68.57 -29.35 67.88 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.288 -0.565 . . . . 62.51 111.84 -177.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.45 -28.54 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-O 121.471 0.653 . . . . 71.4 110.326 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.7 p -110.17 13.29 23.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.34 0.59 . . . . 34.34 110.566 -175.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 tptt -57.0 140.39 49.14 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.638 1.175 . . . . 74.31 111.928 -175.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.6 m -57.63 155.26 21.75 Favored Pre-proline 0 C--O 1.248 1.014 0 C-N-CA 124.183 0.993 . . . . 43.55 111.259 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.83 -5.99 5.39 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 124.82 3.68 . . . . 72.11 112.146 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -59.7 -26.42 65.59 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.463 -1.244 . . . . 64.44 110.589 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.2 p -92.43 167.72 11.78 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 107.358 -1.349 . . . . 72.43 107.358 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.62 -46.93 67.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 118.884 -1.126 . . . . 74.53 111.13 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -168.09 141.64 3.28 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.331 -0.989 . . . . 73.51 108.331 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.8 m -56.62 -41.29 76.84 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 123.186 0.594 . . . . 72.45 111.067 -177.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' HB2' ' CD2' ' A' ' 72' ' ' PHE . 6.9 mm-40 -67.83 -20.06 65.12 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.947 -1.024 . . . . 54.3 111.383 -176.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -69.99 -48.26 58.91 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 108.26 -1.015 . . . . 72.3 108.26 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -69.32 -32.07 70.96 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 114.2 -1.364 . . . . 74.52 108.518 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.4 tp -67.04 -45.06 78.6 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.526 -0.761 . . . . 73.14 110.117 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.85 -34.94 75.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.293 0.568 . . . . 50.1 110.214 177.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -69.14 -40.29 78.33 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.103 -0.953 . . . . 70.25 109.215 177.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -68.48 -42.58 78.47 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 123.498 0.719 . . . . 62.14 110.594 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.472 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 3.3 pp -84.41 0.66 48.64 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.877 -0.601 . . . . 63.12 110.964 -176.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.32 -61.59 7.05 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 111.303 -0.719 . . . . 63.1 111.303 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -77.2 -5.09 15.47 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.868 2.379 . . . . 75.11 112.034 175.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 62.9 m-70 -121.47 36.55 4.58 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.698 -0.482 . . . . 61.02 109.698 -174.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -55.7 106.56 0.69 Allowed Pre-proline 0 N--CA 1.48 1.051 0 O-C-N 124.706 1.254 . . . . 64.0 111.892 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -99.95 -177.37 0.19 Allowed 'Trans proline' 0 N--CA 1.422 -2.697 0 C-N-CA 122.661 2.241 . . . . 72.53 109.979 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -84.22 107.46 16.54 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 107.254 -1.388 . . . . 72.54 107.254 174.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.65 HD13 ' HB2' ' A' ' 68' ' ' PHE . 71.7 mt -92.41 105.95 17.27 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.161 0 N-CA-C 107.39 -1.337 . . . . 63.32 107.39 -175.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -98.9 105.9 18.09 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 122.029 -0.42 . . . . 72.12 111.312 -175.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 70.3 t -107.97 113.1 42.89 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.649 0 N-CA-C 108.02 -1.104 . . . . 73.01 108.02 -177.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 56.63 26.3 11.02 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 124.536 1.148 . . . . 71.43 111.034 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.75 14.3 61.42 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.438 -0.801 . . . . 75.54 112.614 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -112.3 130.35 55.97 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.519 -0.919 . . . . 63.12 108.519 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.88 125.97 38.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 121.833 0.825 . . . . 74.32 109.183 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.454 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 47.9 mm-40 -124.44 147.84 48.03 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.719 -1.215 . . . . 75.43 107.719 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.1 t -101.24 173.73 6.32 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.793 -1.188 . . . . 60.12 107.793 174.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -46.23 -39.88 10.55 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.809 1.244 . . . . 62.43 112.09 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.466 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 27.6 m -64.43 -52.74 56.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 122.651 0.38 . . . . 72.42 110.489 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -60.95 -45.82 93.2 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.036 -0.529 . . . . 64.31 110.809 -178.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.65 ' HB2' HD13 ' A' ' 56' ' ' ILE . 46.5 t80 -52.22 -56.4 14.89 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.232 0.539 . . . . 75.44 109.796 175.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -49.77 -43.3 48.09 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 114.194 -1.367 . . . . 64.12 111.12 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.492 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 15.7 mm100 -62.75 -46.68 86.94 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 122.892 0.477 . . . . 71.0 111.222 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.498 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 51.6 m-85 -66.45 -37.58 85.46 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.332 0.587 . . . . 75.23 109.664 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.444 ' CD2' ' HB2' ' A' ' 42' ' ' GLU . 3.9 t80 -57.19 -51.83 67.77 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.022 -0.536 . . . . 70.44 110.96 175.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 12.8 ptm180 -69.47 -23.33 63.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.334 0.588 . . . . 75.35 110.68 -176.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -81.01 -6.12 58.4 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.653 0.612 . . . . 72.05 112.653 175.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.8 17.37 30.67 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.175 -0.536 . . . . 24.11 114.032 175.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.45 -60.29 2.42 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 122.47 -0.429 . . . . 45.22 111.874 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.498 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 56.5 m-85 -83.31 -7.43 59.59 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 113.455 0.909 . . . . 70.33 113.455 -171.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -15.81 63.82 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.469 -0.892 . . . . 62.34 111.561 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -88.37 -17.01 31.46 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.123 0.487 . . . . 75.21 109.689 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 80' ' ' LEU . 3.3 tm? -84.59 -17.36 38.99 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 115.64 -0.709 . . . . 73.35 109.381 -174.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.47 3.27 13.83 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.721 0.772 . . . . 75.45 111.086 -176.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -104.64 2.93 31.08 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.422 -0.955 . . . . 64.14 108.422 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -74.56 153.13 39.17 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.126 -0.943 . . . . 61.12 113.248 -175.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -99.48 135.45 40.87 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.382 -1.281 . . . . 71.12 108.385 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 25.2 p90 . . . . . 0 C--N 1.307 -1.252 0 N-CA-C 109.506 -0.553 . . . . 75.41 109.506 177.188 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 CA--C 1.509 -0.627 0 CA-C-O 121.022 0.439 . . . . 62.04 111.265 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -138.74 156.41 24.21 Favored Glycine 0 N--CA 1.409 -3.116 0 C-N-CA 120.412 -0.899 . . . . 73.54 111.587 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -116.7 157.0 26.14 Favored 'General case' 0 C--O 1.261 1.671 0 N-CA-C 108.119 -1.067 . . . . 74.45 108.119 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -125.46 101.8 7.1 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 105.833 -1.914 . . . . 72.43 105.833 171.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.2 mt -99.16 112.43 24.58 Favored 'General case' 0 C--N 1.261 -3.253 0 N-CA-C 106.923 -1.51 . . . . 72.15 106.923 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 8.5 p -115.6 132.0 66.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.486 0.66 . . . . 75.44 112.035 -174.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.401 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 24.3 m-90 -106.34 140.86 38.6 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.051 -0.977 . . . . 75.42 109.245 176.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -118.63 121.24 39.71 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.063 -1.088 . . . . 74.12 108.063 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.461 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 45.1 t . . . . . 0 C--N 1.292 -1.931 0 CA-C-N 115.313 -0.858 . . . . 43.0 110.827 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.423 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 39.1 p90 . . . . . 0 N--CA 1.418 -2.069 0 N-CA-C 108.019 -1.104 . . . . 75.51 108.019 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.461 ' H ' ' HB3' ' A' ' 105' ' ' SER . 1.5 m-20 -106.55 134.19 50.06 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 105.57 -2.011 . . . . 72.22 105.57 176.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.434 ' HB2' HG13 ' A' ' 140' ' ' ILE . 34.9 mt-10 -114.87 154.12 29.23 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 119.482 -0.887 . . . . 75.44 111.727 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -139.32 116.85 11.36 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.878 -1.055 . . . . 53.22 108.999 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -111.98 109.66 19.54 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.058 -0.719 . . . . 71.53 109.058 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.54 118.25 33.62 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 121.136 0.493 . . . . 32.35 109.751 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -100.82 113.55 26.57 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.198 -1.408 . . . . 70.45 107.198 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 54.4 mt -118.31 143.62 28.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.42 -1.326 . . . . 63.31 107.42 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.25 147.57 51.1 Favored 'General case' 0 C--O 1.262 1.725 0 C-N-CA 119.098 -1.041 . . . . 61.22 110.752 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.577 ' HG2' ' SG ' ' A' ' 132' ' ' CYS . 29.1 mtp180 -89.91 116.86 28.29 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.073 -1.421 . . . . 73.22 109.17 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -80.96 145.21 31.35 Favored 'General case' 0 C--N 1.273 -2.725 0 CA-C-N 113.79 -1.55 . . . . 74.21 111.049 -170.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -72.59 -10.71 60.13 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 107.813 -1.18 . . . . 64.05 107.813 174.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.95 -17.72 64.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.006 -0.997 . . . . 72.0 109.589 173.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 101.89 -6.67 54.54 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.508 -0.637 . . . . 42.41 111.508 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.9 m -103.88 -179.62 4.0 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.141 -0.688 . . . . 65.52 109.141 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.577 ' SG ' ' HG2' ' A' ' 126' ' ' ARG . 74.0 m -131.49 142.14 49.91 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.611 -1.255 . . . . 73.53 107.611 175.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -149.78 154.89 39.19 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 119.718 -0.793 . . . . 74.52 109.879 -176.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.23 122.35 22.68 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.861 -0.792 . . . . 70.43 108.861 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -76.34 -52.8 9.2 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.209 -1.034 . . . . 74.3 108.209 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.7 m -167.88 154.53 7.86 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.479 -1.674 . . . . 64.45 106.479 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.39 139.41 41.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.469 -1.308 . . . . 62.44 107.469 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 33.9 ttmt -114.39 139.19 49.69 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 109.965 -0.383 . . . . 64.34 109.965 -175.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 66.2 m-85 -125.4 121.44 33.85 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.78 -1.192 . . . . 72.11 107.78 174.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.51 ' HB ' ' CD ' ' A' ' 143' ' ' LYS . 9.5 pt -128.83 97.61 3.75 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 CA-C-O 122.16 0.981 . . . . 73.13 109.109 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -87.95 137.04 32.68 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.925 -1.034 . . . . 72.22 111.33 -177.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.482 ' O ' ' HE3' ' A' ' 143' ' ' LYS . 41.4 t 71.27 49.19 0.33 Allowed 'General case' 0 C--N 1.321 -0.668 0 O-C-N 124.657 1.223 . . . . 75.41 111.403 175.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.51 ' CD ' ' HB ' ' A' ' 140' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.623 0 N-CA-C 108.422 -0.955 . . . . 72.3 108.422 175.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 t70 . . . . . 0 C--O 1.244 0.804 0 CA-C-O 121.94 0.876 . . . . 74.13 109.104 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -70.41 -39.49 74.43 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.864 -1.062 . . . . 74.13 108.901 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.57 -45.01 84.94 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.859 -0.61 . . . . 72.54 109.916 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.496 HG12 ' SG ' ' A' ' 132' ' ' CYS . 17.9 m -69.49 -37.89 75.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.167 -0.47 . . . . 43.32 112.015 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HB3' ' HZ3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -72.5 -33.5 66.99 Favored 'General case' 0 C--O 1.211 -0.954 0 C-N-CA 118.629 -1.228 . . . . 74.24 109.961 178.519 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.83 -41.93 61.96 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.241 -0.743 . . . . 72.22 111.241 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.0 tp -69.65 -50.4 44.55 Favored 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 124.047 0.939 . . . . 71.11 109.173 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.05 -42.22 99.72 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.967 -0.56 . . . . 43.12 111.872 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -65.32 -44.2 88.61 Favored 'General case' 0 C--O 1.187 -2.218 0 CA-C-O 118.791 -0.623 . . . . 72.13 110.872 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.02 -38.63 91.95 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.116 0.96 . . . . 63.51 110.252 -174.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.572 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 24.1 t80 -64.45 -55.18 22.52 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.698 -1.592 . . . . 75.02 110.081 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 29' ' ' ILE . 16.0 mm -67.03 -30.56 49.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.074 -0.512 . . . . 71.42 111.007 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.34 -48.44 77.96 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.596 0.758 . . . . 73.14 110.142 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.4 pp -69.14 -28.49 66.49 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 119.944 -0.702 . . . . 64.41 110.048 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 68.8 t -73.21 -22.19 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 CA-C-O 121.219 0.533 . . . . 71.44 110.929 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.4 p -107.5 15.69 24.57 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.415 -0.803 . . . . 74.44 111.858 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.525 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 32.4 mmmt -57.05 162.22 2.64 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 113.543 0.942 . . . . 74.14 113.543 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.442 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 12.2 p -70.33 169.54 13.35 Favored Pre-proline 0 N--CA 1.435 -1.197 0 C-N-CA 125.469 1.508 . . . . 64.21 111.8 -177.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 35' ' ' SER . 19.0 Cg_endo -64.42 -7.46 14.27 Favored 'Trans proline' 0 C--N 1.363 1.317 0 C-N-CA 123.09 2.527 . . . . 75.34 112.09 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -73.92 -27.32 60.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.662 -0.699 . . . . 64.52 109.886 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.6 m -82.73 113.08 20.15 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.62 -0.718 . . . . 74.52 109.312 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.1 -32.91 56.04 Favored 'Isoleucine or valine' 0 C--O 1.25 1.124 0 N-CA-C 113.331 0.863 . . . . 71.14 113.331 -174.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -151.06 94.04 2.0 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.428 -0.909 . . . . 74.21 109.921 -174.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.3 m -67.35 -30.17 69.91 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.699 0.762 . . . . 54.23 109.766 -175.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' ' 42' ' ' GLU . 1.4 pm0 -71.84 -20.03 61.88 Favored 'General case' 0 N--CA 1.414 -2.269 0 CA-C-N 115.15 -0.932 . . . . 75.15 112.008 177.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -69.76 -45.37 68.21 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.692 -1.225 . . . . 73.44 107.692 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.13 -26.82 65.08 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.004 -0.998 . . . . 65.25 110.177 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.559 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 51.2 tp -70.18 -47.09 63.09 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.554 -0.748 . . . . 73.22 109.636 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.48 -27.01 68.99 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 121.528 0.68 . . . . 61.13 110.083 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -73.95 -38.8 64.13 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.878 -1.055 . . . . 72.4 109.64 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -70.11 -51.64 29.98 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.562 -0.745 . . . . 54.24 110.419 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 4.0 pp -82.12 -8.03 59.64 Favored 'General case' 0 C--O 1.196 -1.754 0 CA-C-N 115.382 -0.826 . . . . 72.25 111.824 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -43.64 -60.19 3.4 Favored Glycine 0 N--CA 1.477 1.374 0 O-C-N 123.672 0.607 . . . . 71.23 114.264 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.11 -6.3 16.49 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.506 2.137 . . . . 73.4 112.04 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -110.42 19.78 18.43 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.008 -0.738 . . . . 73.33 109.008 -175.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.663 ' CG ' ' HB ' ' A' ' 65' ' ' THR . 27.2 t70 -56.7 109.94 2.04 Favored Pre-proline 0 C--O 1.245 0.857 0 C-N-CA 125.163 1.385 . . . . 71.04 113.744 -176.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 17.3 Cg_endo -106.54 -152.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.637 0 C-N-CA 123.929 3.086 . . . . 63.11 110.502 178.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -81.99 124.03 29.41 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.551 -0.907 . . . . 72.53 108.551 176.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.51 HD13 ' CB ' ' A' ' 68' ' ' PHE . 39.7 mt -108.22 109.2 27.38 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.396 0 N-CA-C 107.219 -1.4 . . . . 60.42 107.219 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -96.07 138.88 33.05 Favored 'General case' 0 C--N 1.263 -3.182 0 O-C-N 121.601 -0.687 . . . . 75.41 109.678 -177.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 3.6 p -133.29 122.76 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 N-CA-C 107.298 -1.371 . . . . 71.03 107.298 174.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 62.69 20.72 12.27 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.612 0.72 . . . . 74.24 110.865 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.59 7.38 64.98 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.652 -0.704 . . . . 64.02 112.572 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -113.78 135.52 53.86 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.908 -0.405 . . . . 54.03 109.908 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.53 126.52 37.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-O 121.708 0.766 . . . . 73.54 110.187 -175.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.448 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 10.5 mm100 -122.68 148.19 45.58 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.46 -0.941 . . . . 73.13 108.46 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.2 t -100.43 175.71 5.6 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.953 -1.128 . . . . 53.02 107.953 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.663 ' HB ' ' CG ' ' A' ' 53' ' ' ASP . 9.3 t -52.17 -34.05 43.33 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 123.28 0.632 . . . . 72.14 112.261 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 m -59.41 -54.15 49.95 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-O 121.123 0.487 . . . . 71.42 109.946 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -65.45 -47.51 75.91 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-N 115.005 -0.998 . . . . 51.15 110.967 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.51 ' CB ' HD13 ' A' ' 56' ' ' ILE . 51.0 t80 -54.46 -54.29 42.83 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.661 0.384 . . . . 73.44 111.169 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 2.8 tm? -54.16 -42.49 69.67 Favored 'General case' 0 C--O 1.244 0.801 0 O-C-N 124.206 0.941 . . . . 71.51 110.384 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.422 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 73.3 mt-30 -57.93 -53.61 56.3 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 116.552 -0.294 . . . . 65.52 111.115 174.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.499 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 28.5 m-85 -63.05 -32.54 73.93 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.657 0.742 . . . . 75.04 110.723 -176.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -61.64 -55.27 32.42 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.204 -0.907 . . . . 73.32 110.354 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 12.4 ptp180 -70.64 -22.52 62.5 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 120.798 0.332 . . . . 73.34 111.391 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 54.4 mt-30 -71.39 -20.12 62.18 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.161 -0.472 . . . . 53.4 110.807 174.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.62 24.96 12.56 Favored Glycine 0 N--CA 1.415 -2.758 0 C-N-CA 120.103 -1.046 . . . . 60.25 113.278 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.6 mt -88.44 -46.75 8.88 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.692 -0.803 . . . . 74.33 110.593 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 22.1 m-85 -89.87 10.86 22.14 Favored 'General case' 0 C--O 1.21 -0.99 0 O-C-N 121.913 -0.492 . . . . 64.55 112.258 -177.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -71.67 -11.71 60.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.754 1.02 . . . . 71.21 113.754 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -82.47 -10.17 59.13 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 122.056 -0.403 . . . . 71.34 111.012 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 80' ' ' LEU . 3.3 tm? -59.32 -29.59 67.74 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.515 0.509 . . . . 71.22 110.602 -174.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.479 ' C ' ' HD3' ' A' ' 81' ' ' LYS . 12.1 tmtt? -58.97 -41.72 88.2 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.442 -0.345 . . . . 71.34 111.445 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -98.68 13.15 33.16 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 120.802 0.334 . . . . 52.32 111.856 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 105' ' ' SER . . . -81.02 131.66 35.32 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.101 -1.074 . . . . 63.34 108.101 175.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -104.12 130.72 51.84 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.593 -0.443 . . . . 72.42 110.305 -174.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 103' ' ' TRP . 50.8 p90 . . . . . 0 N--CA 1.439 -1.009 0 CA-C-O 121.619 0.724 . . . . 63.41 112.028 -177.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 . . . . . 0 C--O 1.249 1.061 0 N-CA-C 108.509 -0.923 . . . . 64.13 108.509 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -149.22 141.08 8.6 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.468 -1.053 . . . . 54.12 110.468 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -121.03 136.52 54.97 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.3 -0.63 . . . . 75.31 109.3 -177.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -124.97 107.55 10.96 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.869 0.731 . . . . 74.45 109.155 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -106.48 117.14 33.28 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.713 -1.217 . . . . 73.4 107.713 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 8.2 p -120.35 125.07 73.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 122.037 0.923 . . . . 64.03 112.522 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 25.8 m-90 -105.73 147.23 28.8 Favored 'General case' 0 CA--C 1.472 -2.034 0 CA-C-N 114.613 -1.176 . . . . 75.12 109.356 178.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -121.64 123.66 42.45 Favored 'General case' 0 N--CA 1.403 -2.82 0 N-CA-C 105.713 -1.958 . . . . 74.32 105.713 172.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 39.2 m . . . . . 0 C--N 1.292 -1.896 0 CA-C-N 115.897 -0.592 . . . . 50.03 110.082 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 16.4 p90 . . . . . 0 N--CA 1.434 -1.242 0 N-CA-C 106.978 -1.49 . . . . 73.42 106.978 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -107.71 141.28 39.48 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 106.384 -1.71 . . . . 61.42 106.384 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.439 ' HB2' HG13 ' A' ' 140' ' ' ILE . 93.3 mt-10 -114.97 144.55 43.41 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 119.784 -0.766 . . . . 74.31 110.485 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -133.76 117.26 16.71 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.537 -0.756 . . . . 73.12 109.109 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -115.9 110.3 18.81 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 109.281 -0.637 . . . . 62.25 109.281 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.12 125.5 46.24 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.377 -0.601 . . . . 61.23 109.377 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -111.45 121.08 44.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.75 -0.833 . . . . 74.42 108.75 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.2 mt -120.42 153.32 23.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 108.537 -0.912 . . . . 72.41 108.537 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -141.25 152.12 44.28 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 108.553 -0.906 . . . . 74.14 108.553 174.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -80.8 115.29 20.22 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.605 -0.887 . . . . 74.1 108.605 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -79.05 140.87 37.81 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.803 -1.925 . . . . 74.52 105.803 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -64.83 -14.71 60.23 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.327 0.584 . . . . 73.11 111.874 -170.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.8 -16.46 63.1 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 124.557 1.143 . . . . 72.33 111.314 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.67 -8.86 43.87 Favored Glycine 0 CA--C 1.5 -0.851 0 C-N-CA 121.073 -0.584 . . . . 63.4 111.805 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.9 t -104.7 130.14 52.79 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 106.547 -1.649 . . . . 71.14 106.547 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.496 ' SG ' HG12 ' A' ' 21' ' ' VAL . 12.0 t -83.79 134.81 34.71 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.522 -1.288 . . . . 73.33 107.522 177.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -133.12 154.53 50.51 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.093 -0.706 . . . . 73.22 109.093 -173.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.0 mp -75.14 128.82 36.38 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 120.875 0.369 . . . . 74.11 110.472 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -72.46 -56.39 5.48 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.068 -1.086 . . . . 73.21 108.068 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.7 m -172.62 157.73 3.93 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.799 -1.556 . . . . 64.23 106.799 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.7 m -131.73 149.3 32.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 107.543 -1.281 . . . . 54.34 107.543 172.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -131.61 131.96 43.66 Favored 'General case' 0 C--N 1.266 -3.046 0 C-N-CA 123.107 0.563 . . . . 74.41 110.121 -172.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 72.8 m-85 -121.93 129.02 52.18 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.348 -0.982 . . . . 74.1 108.348 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.439 HG13 ' HB2' ' A' ' 119' ' ' GLU . 6.0 pt -131.74 99.12 3.59 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-O 122.162 0.982 . . . . 63.23 109.142 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 58.4 mtm -85.44 133.64 34.1 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.653 -1.158 . . . . 73.42 110.836 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . 0.267 51.3 p 62.61 73.15 0.47 Allowed 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 125.953 1.701 . . . . 74.44 113.222 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 47.1 tttm . . . . . 0 N--CA 1.423 -1.801 0 CA-C-N 114.433 -1.258 . . . . 73.11 108.106 177.333 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 120.907 0.384 . . . . 70.14 111.827 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.51 -38.21 77.49 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.241 -0.652 . . . . 74.14 109.241 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.96 -45.51 74.02 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.715 -0.675 . . . . 74.41 110.214 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.52 ' HB ' ' SG ' ' A' ' 132' ' ' CYS . 14.6 p -65.84 -42.74 92.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 112.25 0.463 . . . . 75.44 112.25 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 -28.61 60.73 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 118.673 -1.211 . . . . 61.12 110.772 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.24 -44.84 63.92 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.415 -0.811 . . . . 54.22 111.874 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.46 -34.85 70.58 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 108.905 -0.776 . . . . 71.24 108.905 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.98 -40.94 99.92 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 111.244 -0.742 . . . . 51.23 111.244 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -69.62 -44.98 69.57 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 120.991 -0.284 . . . . 71.53 110.259 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.42 -42.6 99.0 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.687 0.395 . . . . 73.04 110.539 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.434 ' CE1' HD11 ' A' ' 45' ' ' LEU . 18.0 t80 -62.46 -54.59 37.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.238 -0.892 . . . . 73.54 110.016 177.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.3 mm -63.31 -35.78 73.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 112.149 0.426 . . . . 73.14 112.149 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -62.85 -48.95 76.81 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 119.409 -0.329 . . . . 34.22 110.568 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 pp -67.6 -30.79 70.48 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.348 -0.541 . . . . 71.41 111.315 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.34 -24.01 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-O 121.484 0.659 . . . . 61.43 110.912 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.5 p -115.5 14.22 16.59 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 121.504 -0.748 . . . . 64.02 110.59 -176.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -81.54 145.3 30.75 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.762 -0.654 . . . . 71.41 111.861 -173.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.5 m -51.2 160.36 0.91 Allowed Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 126.421 1.889 . . . . 61.32 113.113 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.06 -6.83 6.88 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 124.289 3.326 . . . . 65.31 112.897 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -61.46 -27.03 68.28 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.277 -1.009 . . . . 72.14 108.277 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.4 m -96.7 123.31 40.34 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 103.778 -2.675 . . . . 73.45 103.778 168.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.7 t -49.92 -53.07 11.75 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 113.301 0.852 . . . . 71.21 113.301 -170.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 43' ' ' HIS . 50.3 t-20 -147.64 127.82 13.81 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.29 -1.004 . . . . 64.3 108.29 -176.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.3 m -59.47 -36.51 76.13 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.602 0.564 . . . . 64.42 109.848 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -73.83 -21.17 60.22 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.153 -0.93 . . . . 72.31 110.268 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 40' ' ' ASN . 10.0 t60 -76.77 -43.33 37.37 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.483 -1.303 . . . . 64.33 107.483 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -63.07 -35.34 79.91 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.597 -0.89 . . . . 75.43 108.597 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.434 HD11 ' CE1' ' A' ' 28' ' ' PHE . 35.2 tp -68.2 -44.34 76.04 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.639 -0.71 . . . . 75.42 110.097 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.83 -31.5 71.75 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.355 0.598 . . . . 64.32 110.529 177.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -71.72 -40.52 69.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.909 -1.041 . . . . 72.53 109.627 177.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -69.3 -44.32 72.0 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.028 -0.533 . . . . 74.15 110.511 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.1 pp -80.75 -2.03 45.3 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.95 -0.568 . . . . 53.32 111.052 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.26 -60.47 6.69 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 119.926 -0.374 . . . . 74.24 112.906 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.51 -6.4 12.67 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.114 1.876 . . . . 74.4 111.904 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -118.52 38.26 3.8 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.773 -0.454 . . . . 72.32 109.773 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -55.78 105.89 0.59 Allowed Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 124.627 1.171 . . . . 73.41 112.815 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -98.89 -168.93 0.1 Allowed 'Trans proline' 0 N--CA 1.43 -2.216 0 C-N-CA 122.825 2.35 . . . . 73.45 111.177 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -91.66 104.74 17.17 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.782 -1.192 . . . . 74.33 107.782 176.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.504 HD13 ' HB2' ' A' ' 68' ' ' PHE . 67.6 mt -89.65 106.85 17.49 Favored 'Isoleucine or valine' 0 C--O 1.18 -2.59 0 CA-C-N 115.391 -0.822 . . . . 72.42 109.054 -175.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -96.23 107.68 20.05 Favored 'General case' 0 C--N 1.276 -2.608 0 O-C-N 121.55 -0.719 . . . . 71.22 111.815 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 139' ' ' PHE . 70.0 t -108.3 111.59 36.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 108.398 -0.964 . . . . 73.32 108.398 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 63.25 21.15 12.68 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.624 -1.171 . . . . 71.33 110.329 -177.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.49 -5.45 62.54 Favored Glycine 0 N--CA 1.437 -1.237 0 CA-C-N 114.87 -1.059 . . . . 64.43 111.967 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -95.7 125.68 40.45 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 109.592 -0.521 . . . . 75.13 109.592 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.2 127.21 35.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.643 0.735 . . . . 64.44 109.54 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.432 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 48.3 mm-40 -128.41 150.94 49.9 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.949 -1.13 . . . . 73.14 107.949 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -101.57 172.9 6.68 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.283 -1.006 . . . . 73.54 108.283 172.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -45.53 -40.46 8.62 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 125.179 1.392 . . . . 51.02 112.231 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.6 m -65.4 -44.67 86.71 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.124 0.487 . . . . 53.25 111.358 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -67.64 -44.94 76.73 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.697 -0.483 . . . . 71.1 109.697 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.504 ' HB2' HD13 ' A' ' 56' ' ' ILE . 48.3 t80 -53.62 -56.2 19.3 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.206 0.602 . . . . 73.2 109.863 175.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -49.95 -43.8 50.21 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.276 -1.329 . . . . 71.53 110.765 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -60.22 -47.5 85.69 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 111.9 0.333 . . . . 70.24 111.9 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.474 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 33.7 m-85 -66.94 -36.37 82.08 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.514 0.674 . . . . 65.2 110.008 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -57.85 -54.8 42.87 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.543 -0.753 . . . . 72.51 110.637 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -66.83 -29.67 69.66 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.519 -0.31 . . . . 75.52 110.69 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -73.67 -15.35 61.24 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 112.273 0.472 . . . . 44.42 112.273 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.48 13.78 25.42 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 119.931 -1.128 . . . . 54.22 114.544 175.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.38 -56.56 4.89 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.183 0.516 . . . . 71.41 110.96 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.474 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 43.1 m-85 -83.52 -5.31 59.13 Favored 'General case' 0 C--O 1.21 -0.995 0 N-CA-C 112.911 0.708 . . . . 73.23 112.911 -172.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -14.19 61.8 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.095 -1.042 . . . . 63.43 111.795 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -85.33 -16.59 39.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.169 0.509 . . . . 62.35 110.377 175.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 80' ' ' LEU . 3.2 tm? -89.32 -15.73 32.74 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 108.109 -1.071 . . . . 73.11 108.109 -178.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.502 ' C ' ' HD3' ' A' ' 81' ' ' LYS . 11.2 tmtt? -52.18 -41.74 62.89 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.969 0.908 . . . . 64.31 111.963 -177.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -88.46 14.61 9.36 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.561 0.696 . . . . 74.35 111.686 -174.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.52 150.92 47.57 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.989 0.737 . . . . 64.24 112.989 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -106.26 136.14 46.51 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.524 -1.287 . . . . 64.54 107.524 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.645 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 53.0 p90 . . . . . 0 C--N 1.315 -0.925 0 N-CA-C 113.545 0.943 . . . . 61.12 113.545 -175.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 C--O 1.247 0.95 0 N-CA-C 109.753 -0.462 . . . . 72.34 109.753 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -116.7 139.56 15.27 Favored Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 109.456 -1.458 . . . . 73.4 109.456 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -106.34 150.43 25.99 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.2 -1.778 . . . . 73.22 106.2 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.476 ' HE2' ' CE2' ' A' ' 123' ' ' TYR . 35.9 ttmt -136.23 129.79 32.11 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.465 -0.568 . . . . 74.11 109.465 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.5 mt -126.79 127.1 44.49 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.259 -1.386 . . . . 61.04 107.259 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.5 p -125.64 127.03 71.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 113.302 0.852 . . . . 62.51 113.302 -174.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.645 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 20.4 m-90 -104.16 151.03 23.81 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.642 -1.163 . . . . 75.43 108.523 178.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -135.79 133.54 38.01 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.908 -2.256 . . . . 75.43 104.908 176.175 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.7 p . . . . . 0 C--N 1.306 -1.317 0 CA-C-N 118.09 0.405 . . . . 73.31 110.346 179.016 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 6.4 p90 . . . . . 0 N--CA 1.442 -0.863 0 N-CA-C 108.223 -1.029 . . . . 73.31 108.223 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -113.14 137.61 51.18 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.153 -1.795 . . . . 75.52 106.153 176.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -115.01 151.92 33.35 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 119.947 -0.701 . . . . 74.23 111.71 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -139.6 117.49 11.7 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.03 -0.986 . . . . 75.44 108.52 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -123.98 112.35 17.08 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.572 0.701 . . . . 75.42 110.324 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -93.78 133.38 37.22 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.372 -0.831 . . . . 75.44 109.925 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.476 ' CE2' ' HE2' ' A' ' 100' ' ' LYS . 35.9 m-85 -115.9 122.82 46.46 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 124.153 0.908 . . . . 64.32 108.617 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.408 HG12 ' HG ' ' A' ' 134' ' ' LEU . 62.5 mt -120.84 141.59 40.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.281 -1.748 . . . . 73.55 106.281 176.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -130.17 150.8 51.26 Favored 'General case' 0 C--O 1.268 2.045 0 C-N-CA 117.417 -1.713 . . . . 71.41 112.853 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.431 ' HD3' ' SG ' ' A' ' 132' ' ' CYS . 4.6 tpp180 -75.28 104.67 5.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 104.633 -2.358 . . . . 74.33 104.633 174.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 131' ' ' SER . 57.0 ttt180 -85.45 139.73 31.28 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.417 -0.81 . . . . 63.45 110.69 -168.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -59.77 -10.41 3.78 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.961 1.304 . . . . 70.31 112.641 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.445 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 10.3 t70 -78.41 -16.39 57.67 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 123.882 0.873 . . . . 74.13 110.604 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.06 -5.85 50.44 Favored Glycine 0 C--O 1.24 0.525 0 N-CA-C 111.042 -0.823 . . . . 63.22 111.042 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 127' ' ' ARG . 12.0 p -103.86 169.85 8.27 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 109.66 -0.496 . . . . 74.43 109.66 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.52 ' SG ' ' HB ' ' A' ' 21' ' ' VAL . 68.8 m -121.67 125.27 46.27 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 106.891 -1.522 . . . . 64.32 106.891 174.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -140.82 155.39 46.38 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.516 -0.873 . . . . 71.1 109.533 -169.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.408 ' HG ' HG12 ' A' ' 124' ' ' ILE . 9.0 mp -67.55 125.95 27.79 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 109.093 -0.706 . . . . 73.11 109.093 176.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -83.34 -53.65 5.58 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 108.897 -0.779 . . . . 74.4 108.897 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.0 m -166.71 161.45 15.64 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.874 -1.528 . . . . 73.23 106.874 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.1 m -141.28 139.59 32.68 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 105.751 -1.944 . . . . 54.22 105.751 172.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 32.4 ttmt -115.15 132.12 56.71 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 110.196 -0.298 . . . . 74.04 110.196 -176.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.455 ' HB2' HG22 ' A' ' 58' ' ' VAL . 64.7 m-85 -118.53 122.42 42.63 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 107.517 -1.29 . . . . 73.23 107.517 175.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.446 ' HB ' ' HD3' ' A' ' 143' ' ' LYS . 9.3 pt -126.24 98.57 4.98 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.551 0 CA-C-O 122.079 0.943 . . . . 75.15 109.112 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.4 mtm -85.89 127.47 34.6 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.293 -1.321 . . . . 71.42 111.213 -174.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 70.7 m 71.64 75.43 0.17 Allowed 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 113.794 -1.548 . . . . 74.2 114.145 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.446 ' HD3' ' HB ' ' A' ' 140' ' ' ILE . 1.5 mptm? . . . . . 0 C--N 1.301 -1.515 0 CA-C-N 114.249 -1.341 . . . . 72.51 107.547 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.53 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 8.4 m-20 . . . . . 0 CA--C 1.518 -0.282 0 CA-C-O 121.131 0.491 . . . . 75.13 111.901 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.38 -40.61 73.86 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.934 -1.136 . . . . 64.52 107.934 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -61.66 -51.63 67.63 Favored 'General case' 0 CA--C 1.496 -1.132 0 C-N-CA 124.159 0.984 . . . . 74.52 109.982 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 18' ' ' ASP . 7.3 p -64.88 -42.74 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.358 -0.837 . . . . 64.24 112.893 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 17.3 ptpt -74.48 -24.73 59.06 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 118.622 -1.231 . . . . 71.35 111.745 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.47 -54.45 12.89 Favored Glycine 0 N--CA 1.428 -1.867 0 C-N-CA 120.633 -0.794 . . . . 62.05 111.166 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.79 -36.04 72.84 Favored 'General case' 0 C--O 1.213 -0.864 0 N-CA-C 109.159 -0.682 . . . . 52.54 109.159 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.52 -43.08 98.63 Favored Glycine 0 C--O 1.254 1.359 0 CA-C-N 116.213 -0.448 . . . . 61.54 112.57 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -73.32 -39.5 65.23 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 119.56 -0.856 . . . . 74.31 109.8 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.51 -39.32 94.11 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.028 0.442 . . . . 75.12 110.334 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.413 ' CE2' HD11 ' A' ' 45' ' ' LEU . 31.7 t80 -61.31 -53.17 60.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.293 -0.867 . . . . 70.05 109.623 176.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.7 mm -64.43 -33.76 64.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 112.202 0.445 . . . . 63.44 112.202 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.86 -52.12 66.4 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 122.588 0.355 . . . . 54.42 110.614 175.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.81 -26.32 64.2 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 120.347 -0.541 . . . . 71.41 111.538 -176.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.7 t -70.75 -26.08 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 CA-C-O 120.983 0.421 . . . . 71.5 110.698 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.4 p -109.75 14.99 23.05 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.855 0.836 . . . . 71.02 109.895 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -62.29 147.95 46.52 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 114.306 -1.316 . . . . 62.44 111.203 -176.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.7 p -54.64 158.35 4.38 Favored Pre-proline 0 C--N 1.313 -0.983 0 C-N-CA 125.196 1.398 . . . . 75.42 113.282 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.38 -7.01 18.95 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.917 2.411 . . . . 73.3 111.13 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.33 -27.67 67.54 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.317 -0.856 . . . . 71.25 109.777 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 p -100.78 143.39 31.0 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.536 -1.283 . . . . 74.11 107.536 173.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.9 p -51.32 -52.58 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.887 1.069 . . . . 71.42 113.887 -173.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -150.82 136.73 18.25 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 122.381 0.272 . . . . 62.12 110.454 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.419 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 19.6 m -67.98 -33.66 75.06 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 122.337 1.065 . . . . 72.43 108.778 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -70.06 -20.32 63.23 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.427 -1.26 . . . . 53.31 111.408 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -69.95 -46.75 64.61 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 107.646 -1.242 . . . . 72.03 107.646 177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.29 -34.15 77.35 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.818 -1.083 . . . . 74.23 109.076 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.413 HD11 ' CE2' ' A' ' 28' ' ' PHE . 44.1 tp -66.28 -41.73 89.44 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.808 -0.633 . . . . 63.3 110.651 177.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.53 -35.9 80.9 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.326 0.584 . . . . 51.32 110.437 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -72.99 -35.94 66.97 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.939 -1.028 . . . . 72.43 110.157 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -68.5 -43.03 77.71 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 116.045 -0.525 . . . . 75.24 109.846 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.2 pp -77.79 -2.11 34.78 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.942 -0.572 . . . . 63.03 111.281 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.71 -63.84 2.35 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 123.746 0.654 . . . . 70.32 112.766 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -82.73 -8.56 11.25 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.849 1.699 . . . . 75.13 111.935 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 45.8 m-70 -100.45 27.94 5.4 Favored 'General case' 0 C--O 1.213 -0.863 0 N-CA-C 109.014 -0.736 . . . . 73.34 109.014 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.473 ' HA ' HG21 ' A' ' 65' ' ' THR . 10.2 t70 -52.44 100.77 0.24 Allowed Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 127.844 2.457 . . . . 61.15 111.661 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -114.17 -154.91 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 124.22 3.28 . . . . 73.44 112.131 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -94.06 123.74 37.63 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.149 -1.056 . . . . 73.22 108.149 176.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 65' ' ' THR . 74.3 mt -109.46 112.97 42.82 Favored 'Isoleucine or valine' 0 C--O 1.177 -2.711 0 N-CA-C 108.734 -0.839 . . . . 71.45 108.734 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.54 138.52 33.1 Favored 'General case' 0 C--N 1.269 -2.924 0 N-CA-C 108.825 -0.805 . . . . 72.11 108.825 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.4 t -132.58 112.69 19.4 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 107.906 -1.146 . . . . 72.52 107.906 176.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 63.7 20.39 12.2 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.914 1.285 . . . . 73.45 111.068 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.11 2.25 58.13 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.748 -0.66 . . . . 25.04 112.222 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -108.17 132.76 53.29 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.896 -0.779 . . . . 73.5 108.896 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.401 HD13 ' N ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -78.77 127.9 38.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 121.699 0.761 . . . . 71.22 109.658 -175.354 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.401 ' N ' HD13 ' A' ' 62' ' ' ILE . 50.3 mm-40 -126.81 149.19 49.81 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.388 -1.338 . . . . 71.4 107.388 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.1 t -87.38 173.52 9.09 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.313 -0.625 . . . . 64.14 109.313 174.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.49 ' HA ' HD12 ' A' ' 56' ' ' ILE . 18.5 p -61.4 -38.31 86.63 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 125.361 1.464 . . . . 72.31 110.543 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 m -59.62 -46.65 88.36 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.518 -1.219 . . . . 53.43 110.584 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.24 -47.26 83.17 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.066 0.546 . . . . 73.12 109.994 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.476 ' CB ' HD13 ' A' ' 56' ' ' ILE . 38.4 t80 -51.24 -55.95 15.43 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 123.759 0.662 . . . . 70.54 110.371 174.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -51.07 -45.34 61.37 Favored 'General case' 0 C--O 1.245 0.834 0 O-C-N 124.315 1.01 . . . . 74.04 110.826 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 46.7 mt-30 -58.75 -50.9 72.21 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 116.133 -0.485 . . . . 71.14 111.861 175.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.477 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 38.4 m-85 -65.76 -35.53 80.98 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.495 0.664 . . . . 73.44 109.989 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -57.23 -53.34 59.24 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.55 -0.75 . . . . 71.32 110.748 176.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -72.13 -22.0 61.39 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 120.832 0.348 . . . . 72.34 111.293 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 92.3 mm-40 -76.29 -11.21 59.87 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 116.226 -0.443 . . . . 63.21 112.133 174.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.21 27.23 11.07 Favored Glycine 0 N--CA 1.428 -1.837 0 C-N-CA 120.209 -0.996 . . . . 65.14 113.081 177.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.402 HD23 ' HB2' ' A' ' 74' ' ' GLN . 3.8 mm? -85.67 -53.02 5.41 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.108 0.48 . . . . 74.3 110.654 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 35.1 m-85 -91.72 6.51 45.64 Favored 'General case' 0 C--O 1.208 -1.086 0 N-CA-C 113.167 0.803 . . . . 74.23 113.167 -173.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -11.97 30.04 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.262 0.838 . . . . 72.51 113.262 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -75.48 -11.28 60.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.081 -0.509 . . . . 65.42 111.232 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 tt -69.63 -25.6 64.02 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.585 0.707 . . . . 72.24 109.296 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.419 ' HG2' ' H ' ' A' ' 41' ' ' SER . 4.2 tmtp? -62.71 -32.84 74.02 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 124.559 1.143 . . . . 70.23 109.481 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -105.79 4.62 30.06 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.633 0.73 . . . . 73.23 110.457 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -79.36 146.09 33.05 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.66 0.615 . . . . 73.33 112.66 -173.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -102.53 133.81 46.9 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.741 -0.663 . . . . 73.12 109.29 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 47.5 p90 . . . . . 0 C--N 1.311 -1.106 0 N-CA-C 113.288 0.848 . . . . 63.31 113.288 -173.546 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 . . . . . 0 N--CA 1.443 -0.788 0 N-CA-C 109.678 -0.49 . . . . 75.14 109.678 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 124' ' ' ILE . . . -149.77 138.65 6.9 Favored Glycine 0 N--CA 1.412 -2.921 0 N-CA-C 109.836 -1.305 . . . . 72.2 109.836 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -114.52 124.18 51.25 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.096 -1.446 . . . . 71.42 107.096 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -117.82 101.6 8.43 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 107.705 -1.221 . . . . 64.4 107.705 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -109.87 133.27 53.34 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.657 -1.156 . . . . 61.13 108.171 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 12.9 p -126.9 135.69 62.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-O 121.324 0.583 . . . . 72.22 110.771 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.414 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 27.9 m-90 -108.88 132.03 54.44 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.456 -0.942 . . . . 73.02 108.456 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -109.09 121.37 45.0 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.62 -1.252 . . . . 72.15 107.62 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.7 t . . . . . 0 C--N 1.299 -1.59 0 CA-C-N 115.368 -0.833 . . . . 72.23 111.368 -176.491 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 40.1 p90 . . . . . 0 N--CA 1.43 -1.45 0 N-CA-C 108.79 -0.818 . . . . 74.04 108.79 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -132.53 147.0 52.35 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 105.59 -2.004 . . . . 72.54 105.59 176.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -125.27 155.26 40.42 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-O 121.138 0.495 . . . . 71.11 112.028 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -134.68 117.55 16.18 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.529 -0.76 . . . . 74.13 109.351 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -111.36 110.82 21.46 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 123.357 0.663 . . . . 75.42 109.842 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.14 131.48 45.15 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 109.039 -0.726 . . . . 73.0 109.039 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -115.93 114.65 24.94 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.568 -0.901 . . . . 73.04 108.568 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.407 ' O ' ' HA2' ' A' ' 98' ' ' GLY . 59.0 mt -112.83 143.71 21.97 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.694 0 N-CA-C 106.643 -1.614 . . . . 50.12 106.643 176.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -127.43 148.41 50.29 Favored 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 118.668 -1.213 . . . . 65.24 109.006 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.468 ' NH2' HG11 ' A' ' 21' ' ' VAL . 19.4 ttm180 -90.09 115.01 27.03 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 106.007 -1.849 . . . . 74.35 106.007 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 23.2 ttp85 -67.55 144.26 55.71 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.484 -1.302 . . . . 74.2 107.484 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -63.54 -10.31 17.45 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.139 0.792 . . . . 71.4 113.139 -172.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -71.33 -16.82 62.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.115 -0.493 . . . . 73.05 110.269 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.37 -19.24 27.03 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 115.874 -0.603 . . . . 73.43 112.54 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.0 m -91.51 152.23 20.42 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 106.897 -1.52 . . . . 50.32 106.897 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.405 ' SG ' HG22 ' A' ' 124' ' ' ILE . 22.4 t -111.03 153.26 25.86 Favored 'General case' 0 C--N 1.271 -2.834 0 C-N-CA 121.11 -0.236 . . . . 62.11 110.411 -174.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -157.72 155.92 30.76 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.429 -0.952 . . . . 73.34 108.429 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.7 mp -67.18 130.31 42.7 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 110.193 -0.299 . . . . 74.24 110.193 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -82.27 -59.94 2.38 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.286 -1.376 . . . . 75.54 107.286 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.6 m -167.62 160.82 13.19 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.358 -1.719 . . . . 73.34 106.358 -176.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.51 152.19 34.73 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 N-CA-C 106.42 -1.696 . . . . 74.35 106.42 171.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -136.96 130.38 31.44 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-O 120.954 0.406 . . . . 72.54 109.932 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -110.78 143.17 41.74 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.362 -0.977 . . . . 71.11 108.362 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.515 HD12 ' HE3' ' A' ' 143' ' ' LYS . 2.4 pt -138.25 98.28 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-O 121.774 0.797 . . . . 73.33 109.341 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 22.1 ptp -93.14 136.89 32.99 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-N 115.095 -0.957 . . . . 71.21 108.742 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.1 t 81.39 73.92 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 O-C-N 125.017 1.448 . . . . 72.33 110.536 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.515 ' HE3' HD12 ' A' ' 140' ' ' ILE . 53.1 mmtt . . . . . 0 N--CA 1.415 -2.204 0 CA-C-N 114.39 -1.277 . . . . 63.3 109.125 175.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 C--O 1.252 1.234 0 CA-C-O 122.326 1.06 . . . . 62.55 108.713 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.58 -34.21 71.94 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.1 -1.409 . . . . 62.21 107.481 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.01 -49.96 70.39 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 114.759 -1.11 . . . . 72.51 110.559 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.62 -43.08 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 112.216 0.45 . . . . 72.14 112.216 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HB2' ' HE3' ' A' ' 22' ' ' LYS . 21.1 ptmt -70.47 -31.76 69.03 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 118.069 -1.452 . . . . 60.22 111.512 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.91 -37.13 83.25 Favored Glycine 0 C--O 1.218 -0.861 0 N-CA-C 110.641 -0.984 . . . . 62.21 110.641 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp -65.53 -50.02 66.78 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 124.348 1.059 . . . . 63.54 109.165 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.85 -36.82 93.91 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.475 -0.784 . . . . 72.33 112.228 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -69.98 -41.18 74.78 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 110.665 -0.124 . . . . 71.44 110.665 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.75 -40.2 96.5 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.81 0.814 . . . . 72.45 109.555 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.484 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 14.0 t80 -62.11 -55.32 30.12 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.068 -1.424 . . . . 73.44 109.705 176.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.3 mm -63.43 -35.19 71.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.98 -0.555 . . . . 73.33 111.89 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.29 -44.77 86.91 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 121.109 -0.236 . . . . 74.25 111.011 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.3 pp -70.63 -27.58 64.17 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.378 -0.929 . . . . 71.05 110.567 -178.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 28' ' ' PHE . 79.1 t -73.6 -21.03 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 CA-C-O 121.173 0.511 . . . . 72.5 110.411 176.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.5 p -114.46 18.15 16.99 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.619 0.723 . . . . 71.24 110.131 -177.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 34' ' ' LYS . 25.1 tptt -72.31 161.78 30.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.13 -0.941 . . . . 65.35 110.252 -176.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 m -48.06 144.94 5.38 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 124.463 1.105 . . . . 74.14 113.317 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.81 -7.74 15.77 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.56 2.84 . . . . 71.12 112.962 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -66.98 -26.57 66.87 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.163 0.506 . . . . 73.41 109.91 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.2 m -75.53 106.25 6.99 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.898 -1.149 . . . . 74.22 107.898 176.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.6 t -53.98 -52.7 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.097 -0.956 . . . . 75.34 113.075 -173.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -129.05 105.36 8.14 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.923 -0.711 . . . . 63.42 110.668 -175.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.1 t -65.92 -33.31 75.54 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 115.776 -0.647 . . . . 54.11 109.728 -175.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.29 -23.35 67.01 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.414 -0.812 . . . . 54.41 110.131 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.43 ' HA ' ' CZ ' ' A' ' 72' ' ' PHE . 52.8 t-80 -71.68 -45.48 61.78 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 109.84 -0.43 . . . . 60.12 109.84 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -69.72 -31.79 69.99 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.22 -1.03 . . . . 73.22 108.22 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.421 HD11 ' CE2' ' A' ' 28' ' ' PHE . 45.1 tp -67.1 -45.03 78.49 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.273 -0.876 . . . . 63.13 110.595 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.58 -32.0 73.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.244 0.545 . . . . 54.35 110.613 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -72.77 -37.05 67.76 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.901 -0.778 . . . . 73.31 108.901 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -63.41 -44.29 95.06 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.827 0.851 . . . . 75.44 111.073 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 pp -84.69 6.78 22.82 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 115.873 -0.603 . . . . 53.45 111.846 -177.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -47.73 -57.28 7.73 Favored Glycine 0 CA--C 1.548 2.139 0 CA-C-N 116.254 -0.43 . . . . 70.51 112.792 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -76.98 -3.43 13.76 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 123.101 2.534 . . . . 70.43 112.645 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -125.86 28.35 6.17 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.197 -0.314 . . . . 74.12 111.469 -169.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.469 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 25.4 m-20 -56.58 113.73 6.52 Favored Pre-proline 0 C--O 1.24 0.588 0 O-C-N 123.771 0.669 . . . . 64.12 111.544 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.463 ' HB2' ' HA ' ' A' ' 136' ' ' SER . 45.5 Cg_endo -101.45 -164.59 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 123.011 2.474 . . . . 70.11 112.058 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -90.8 125.06 35.6 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 106.986 -1.487 . . . . 72.4 106.986 173.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 mp -103.41 114.3 42.63 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.173 0 C-N-CA 119.024 -1.07 . . . . 74.13 109.298 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 138' ' ' LYS . 32.4 m-85 -96.83 132.03 42.97 Favored 'General case' 0 C--N 1.271 -2.812 0 N-CA-C 108.981 -0.748 . . . . 72.04 108.981 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 53.7 t -129.53 112.95 25.94 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 107.691 -1.226 . . . . 63.22 107.691 176.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 62.61 22.22 13.18 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.111 -0.95 . . . . 73.23 110.867 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.01 -2.41 66.08 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.076 -0.965 . . . . 24.23 112.185 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -98.37 126.87 44.05 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.292 -1.003 . . . . 65.15 108.292 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -76.81 127.83 37.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.924 0.868 . . . . 70.4 108.89 -177.335 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.424 ' N ' HD13 ' A' ' 62' ' ' ILE . 63.4 mm-40 -117.6 137.67 52.46 Favored 'General case' 0 C--O 1.284 2.881 0 N-CA-C 106.752 -1.573 . . . . 74.11 106.752 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -75.3 174.62 9.28 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 115.895 -0.593 . . . . 73.31 109.407 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.469 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 78.6 p -60.68 -40.67 93.02 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 124.14 0.976 . . . . 43.43 109.807 -175.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 91.3 m -65.48 -45.03 85.22 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 114.563 -1.198 . . . . 65.42 110.696 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.06 -48.33 82.0 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 122.753 0.421 . . . . 64.24 110.389 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -52.66 -54.17 37.04 Favored 'General case' 0 CA--C 1.498 -1.045 0 O-C-N 123.445 0.466 . . . . 74.11 109.913 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.1 tp -51.43 -42.65 61.65 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.958 -1.019 . . . . 64.11 112.152 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.2 mm100 -63.55 -49.19 74.41 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 116.122 -0.49 . . . . 60.41 111.413 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -65.17 -34.13 77.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.535 0.683 . . . . 62.4 109.94 -178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 2.7 t80 -59.41 -53.78 54.21 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.379 -0.828 . . . . 75.51 110.474 175.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -73.89 -15.24 61.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.86 0.362 . . . . 73.12 111.629 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 55.3 mt-30 -87.8 -5.08 58.8 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 116.197 -0.456 . . . . 75.04 112.144 175.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.53 28.39 27.23 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.485 -0.864 . . . . 53.21 113.589 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.84 -45.34 18.87 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 117.286 0.543 . . . . 63.44 111.462 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -94.46 5.58 51.38 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.796 0.665 . . . . 64.11 112.796 -171.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -14.77 63.15 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.046 0.758 . . . . 63.0 113.046 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -78.12 -29.08 48.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.325 0.583 . . . . 70.44 110.112 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.1 mt -78.11 -8.21 57.96 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.399 -0.818 . . . . 63.23 111.378 -174.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -68.2 -31.6 71.24 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.483 0.659 . . . . 75.22 109.344 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -98.81 13.87 30.85 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.858 0.837 . . . . 71.52 110.286 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.31 148.97 31.91 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.869 -0.605 . . . . 73.13 110.763 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -100.6 138.62 37.42 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.344 -0.613 . . . . 61.52 109.344 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 45.4 p90 . . . . . 0 C--N 1.299 -1.601 0 CA-C-O 121.185 0.516 . . . . 75.01 111.139 179.296 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 C--O 1.246 0.886 0 N-CA-C 112.638 0.607 . . . . 61.12 112.638 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -133.91 138.17 9.88 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 108.72 -1.752 . . . . 52.34 108.72 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.422 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 21.8 m-85 -120.06 129.4 54.2 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.347 -0.983 . . . . 71.14 108.347 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.422 ' HD2' ' C ' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -119.39 103.77 9.77 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.121 -0.696 . . . . 74.23 109.121 179.484 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.33 121.26 43.52 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.04 -1.096 . . . . 62.21 108.04 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 10.0 p -120.16 132.5 69.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.665 0.745 . . . . 71.33 112.269 -177.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 30.5 m-90 -109.82 130.47 55.52 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.677 -1.147 . . . . 72.3 107.946 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -115.87 128.65 55.97 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.042 -0.725 . . . . 73.04 109.042 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.471 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 34.6 t . . . . . 0 C--N 1.286 -2.157 0 CA-C-N 115.217 -0.901 . . . . 73.53 109.594 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 17.9 p90 . . . . . 0 C--O 1.208 -1.098 0 N-CA-C 108.24 -1.022 . . . . 64.21 108.24 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.471 ' H ' ' HB3' ' A' ' 105' ' ' SER . 3.7 m-20 -102.83 133.18 48.32 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 107.83 -1.174 . . . . 62.14 107.83 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.405 ' HB2' HG13 ' A' ' 140' ' ' ILE . 50.0 mt-10 -115.51 141.73 47.67 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 120.582 -0.447 . . . . 65.25 110.277 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -127.25 116.74 21.04 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.504 -1.295 . . . . 72.31 107.504 176.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -123.16 111.39 16.46 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.27 -0.641 . . . . 74.44 109.27 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.6 133.86 36.49 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 123.119 0.567 . . . . 71.42 109.642 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -111.96 115.33 28.78 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.189 -1.041 . . . . 75.32 108.189 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.4 mt -113.9 147.04 17.7 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.497 0 N-CA-C 106.994 -1.484 . . . . 70.2 106.994 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.444 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -131.73 150.37 52.18 Favored 'General case' 0 C--O 1.266 1.945 0 C-N-CA 118.722 -1.191 . . . . 74.34 109.333 176.492 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -100.92 116.58 33.11 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 106.219 -1.771 . . . . 61.33 106.219 174.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.459 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 63.5 ttt180 -69.3 155.15 40.89 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.389 -0.823 . . . . 71.41 109.455 -176.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -51.85 -31.53 28.13 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.638 0.775 . . . . 64.35 111.552 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.459 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 3.9 m-20 -71.42 -5.63 34.21 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 124.512 1.125 . . . . 62.31 111.271 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 94.07 -23.95 29.03 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.46 -0.656 . . . . 62.04 111.46 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.4 m -65.73 124.56 22.76 Favored 'General case' 0 N--CA 1.425 -1.675 0 C-N-CA 124.014 0.925 . . . . 70.14 109.868 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 7.1 t -103.26 142.24 34.52 Favored 'General case' 0 C--N 1.27 -2.864 0 N-CA-C 108.666 -0.864 . . . . 64.51 108.666 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.444 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 2.1 t90 -156.53 155.61 32.24 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.8 -1.185 . . . . 71.44 107.8 -173.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.37 127.55 33.11 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.577 -0.527 . . . . 64.35 109.577 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -83.28 -55.57 4.26 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.006 -1.109 . . . . 63.33 108.006 -176.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.463 ' HA ' ' HB2' ' A' ' 54' ' ' PRO . 34.0 m -167.08 164.72 15.86 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.698 -1.593 . . . . 52.12 106.698 -177.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.95 149.49 22.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 106.263 -1.754 . . . . 70.24 106.263 172.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 57' ' ' TYR . 39.4 ttmt -129.51 130.79 46.25 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 120.843 0.354 . . . . 74.44 110.414 -177.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 53.7 m-85 -113.43 127.24 56.04 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.535 -1.283 . . . . 71.2 107.535 177.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.405 HG13 ' HB2' ' A' ' 119' ' ' GLU . 6.9 pt -129.58 98.72 4.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-O 122.273 1.035 . . . . 74.51 109.427 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 74.8 mtm -84.46 131.7 34.64 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.529 -1.214 . . . . 72.31 110.762 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 74.5 m 68.84 37.79 2.26 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.512 1.133 . . . . 70.42 111.943 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? . . . . . 0 N--CA 1.436 -1.137 0 N-CA-C 103.314 -2.847 . . . . 64.45 103.314 173.102 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.5 t70 . . . . . 0 CA--C 1.497 -1.079 0 N-CA-C 106.735 -1.58 . . . . 64.05 106.735 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.9 mtt -75.88 78.04 2.79 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.228 0.537 . . . . 74.4 111.177 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.4 m -88.09 -178.25 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.158 -0.928 . . . . 75.23 109.369 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 21' ' ' VAL . 16.7 p -60.41 -47.79 84.56 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 113.46 0.911 . . . . 70.15 113.46 -176.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.11 -34.14 77.38 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.033 0.444 . . . . 72.33 110.8 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.433 HD22 ' HD2' ' A' ' 22' ' ' LYS . 3.1 tm? -65.31 -38.46 90.26 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 107.582 -1.266 . . . . 73.41 107.582 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -71.31 -35.02 71.11 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.543 -0.753 . . . . 72.34 110.028 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 17' ' ' THR . 90.2 t -62.65 -55.9 20.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.868 -0.605 . . . . 74.45 110.696 176.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.433 ' HD2' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -71.76 -25.65 62.12 Favored 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 120.431 -0.508 . . . . 74.24 111.633 -178.324 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.48 -42.17 89.43 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.198 -1.161 . . . . 65.12 110.198 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.88 -53.49 49.63 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 123.658 0.783 . . . . 65.35 109.786 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.19 -44.89 88.87 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 115.427 -0.806 . . . . 75.45 112.536 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -66.46 -40.1 89.21 Favored 'General case' 0 C--O 1.206 -1.192 0 CA-C-O 119.423 -0.323 . . . . 75.13 111.549 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.6 -40.41 92.63 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.483 0.659 . . . . 54.21 110.102 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.501 ' CE2' HD11 ' A' ' 45' ' ' LEU . 13.6 t80 -61.79 -53.52 54.81 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.414 -1.266 . . . . 70.34 109.783 176.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 29' ' ' ILE . 14.4 mm -64.17 -35.89 75.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 116.328 -0.396 . . . . 64.41 111.502 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.73 -52.36 66.03 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.28 0.632 . . . . 53.13 110.109 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.5 pp -67.73 -29.32 68.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 120.58 -0.448 . . . . 75.1 111.338 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.17 -31.84 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.119 0.485 . . . . 63.22 110.602 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 p -108.09 17.17 22.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.668 0.747 . . . . 73.22 110.466 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.427 ' HB2' ' HA ' ' A' ' 31' ' ' LEU . 8.3 tptm -74.04 171.26 13.82 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-N 114.523 -1.217 . . . . 61.15 111.708 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.5 m -43.94 138.56 3.23 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.357 1.863 . . . . 72.12 113.768 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.16 -7.18 16.12 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.794 2.329 . . . . 74.32 109.889 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.21 -28.02 68.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.04 -1.436 . . . . 73.42 110.736 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.7 p -94.3 158.23 15.67 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.872 -0.604 . . . . 74.23 110.089 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.5 HG22 ' OD1' ' A' ' 40' ' ' ASN . 9.2 p -50.55 -53.02 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 114.77 1.396 . . . . 45.31 114.77 -172.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.5 ' OD1' HG22 ' A' ' 39' ' ' VAL . 14.5 m120 -159.21 135.55 9.1 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 118.184 0.447 . . . . 73.13 110.548 -176.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.0 m -66.19 -31.28 72.02 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.667 -1.234 . . . . 73.13 107.667 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.471 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 1.8 mp0 -63.4 -25.61 68.37 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.731 -1.577 . . . . 74.44 109.624 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -71.02 -46.17 62.63 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.489 -0.93 . . . . 73.02 108.489 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -67.57 -31.66 71.89 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.016 -0.993 . . . . 71.11 109.424 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.501 HD11 ' CE2' ' A' ' 28' ' ' PHE . 42.6 tp -68.2 -45.06 74.39 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.763 -0.653 . . . . 74.54 110.358 177.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.37 -36.62 78.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.831 0.824 . . . . 70.45 109.844 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -75.62 -27.72 58.56 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.499 -1.228 . . . . 74.31 110.384 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -74.72 -44.59 49.19 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.477 -0.564 . . . . 74.43 109.477 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 3.9 pp -79.59 -2.62 43.3 Favored 'General case' 0 C--O 1.199 -1.562 0 CA-C-N 115.824 -0.626 . . . . 61.24 112.422 -174.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -51.89 -61.77 6.2 Favored Glycine 0 CA--C 1.544 1.853 0 C-N-CA 121.494 -0.384 . . . . 63.1 112.235 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -77.04 -5.42 15.83 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.236 2.624 . . . . 70.41 112.178 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.497 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 55.8 m-70 -119.0 29.5 7.67 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.837 -0.801 . . . . 54.24 108.837 -175.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -55.91 107.67 0.96 Allowed Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 124.859 1.264 . . . . 71.24 112.871 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.508 ' HB3' ' HB3' ' A' ' 134' ' ' LEU . 75.0 Cg_endo -98.93 -173.81 0.15 Allowed 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 123.273 2.649 . . . . 73.3 111.13 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -86.08 101.98 13.43 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 107.306 -1.368 . . . . 73.2 107.306 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 68' ' ' PHE . 65.1 mt -87.15 105.69 15.35 Favored 'Isoleucine or valine' 0 C--O 1.172 -3.007 0 N-CA-C 109.251 -0.648 . . . . 75.35 109.251 -175.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -94.02 106.88 18.84 Favored 'General case' 0 C--N 1.276 -2.61 0 O-C-N 121.314 -0.866 . . . . 64.03 111.459 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.454 HG23 HG22 ' A' ' 56' ' ' ILE . 54.2 t -108.45 113.19 43.29 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.939 0 N-CA-C 108.23 -1.026 . . . . 51.22 108.23 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 62.04 21.28 12.24 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.96 -1.473 . . . . 52.32 110.599 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.47 2.98 56.52 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.564 -0.744 . . . . 61.42 113.357 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -112.85 135.21 53.87 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 117.758 0.779 . . . . 74.44 110.509 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.01 126.35 34.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.949 0.88 . . . . 64.52 109.376 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.535 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 59.0 mm-40 -126.13 149.45 48.94 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.164 -1.421 . . . . 75.13 107.164 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.8 t -97.95 173.56 7.01 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.355 -0.98 . . . . 71.22 108.355 173.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.6 t -42.25 -42.89 3.22 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.144 1.378 . . . . 62.25 112.479 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.5 m -69.35 -42.36 75.37 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.377 -0.374 . . . . 54.23 111.978 -176.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -65.08 -45.99 82.98 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.656 -0.498 . . . . 63.25 109.656 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' HB2' HD13 ' A' ' 56' ' ' ILE . 41.2 t80 -52.75 -55.21 24.46 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 109.108 -0.701 . . . . 73.4 109.108 174.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -48.34 -44.19 34.07 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.3 -1.318 . . . . 73.15 110.963 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 50.0 mt-30 -61.55 -46.49 89.7 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 112.029 0.381 . . . . 63.03 112.029 177.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.528 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 57.6 m-85 -68.62 -36.25 78.41 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.421 0.629 . . . . 71.21 109.315 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -57.99 -51.57 69.1 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.621 -0.718 . . . . 55.43 111.084 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 34.1 ptt180 -66.85 -30.93 71.24 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.705 -0.48 . . . . 72.14 109.705 -176.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -74.86 -10.09 59.17 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.779 -0.646 . . . . 72.01 112.212 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.36 6.84 47.17 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 114.77 0.668 . . . . 54.43 114.77 174.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.457 ' HB3' ' SD ' ' A' ' 141' ' ' MET . 3.5 mm? -68.15 -48.77 64.44 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.659 0.614 . . . . 34.24 112.659 -176.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.528 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 45.5 m-85 -90.8 12.74 18.34 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 113.273 0.842 . . . . 73.53 113.273 -173.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.471 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 51.7 mtmt -66.97 -14.22 62.64 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.634 0.605 . . . . 74.44 112.634 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -79.96 -13.01 59.67 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 123.218 0.607 . . . . 54.21 110.695 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.5 tt -60.78 -28.17 68.54 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.583 0.586 . . . . 72.31 112.583 -174.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.13 4.57 46.93 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 117.623 -1.631 . . . . 74.23 111.409 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -105.85 10.07 32.64 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.265 -1.384 . . . . 55.44 107.265 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -91.71 153.08 19.89 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 113.805 -1.543 . . . . 74.41 113.15 -174.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 104' ' ' LYS . 13.6 pt-20 -95.09 133.23 39.13 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.64 -1.164 . . . . 73.34 110.143 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.619 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 43.2 p90 -130.7 156.0 45.67 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.763 -0.829 . . . . 62.34 108.763 176.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -146.7 -178.15 6.03 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.673 -0.862 . . . . 61.43 108.673 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.2 tp -77.75 113.66 17.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.249 0.547 . . . . 73.34 109.671 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -86.3 158.55 19.65 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 122.157 -0.339 . . . . 63.22 110.259 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.35 133.82 31.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.624 0.726 . . . . 45.2 112.444 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.5 m -154.31 21.71 0.49 Allowed 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.047 0.939 . . . . 73.35 108.476 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.77 -38.39 42.53 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.786 -0.643 . . . . 62.31 113.389 -174.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -85.41 89.44 7.68 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 120.551 -0.46 . . . . 64.44 110.625 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.39 114.97 26.24 Favored 'Isoleucine or valine' 0 C--O 1.248 1.015 0 N-CA-C 108.368 -0.975 . . . . 75.24 108.368 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.574 ' HG3' ' H ' ' A' ' 95' ' ' GLU . 44.3 pttt -103.36 -73.51 0.66 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 113.757 1.021 . . . . 71.55 113.757 -172.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.574 ' H ' ' HG3' ' A' ' 94' ' ' LYS . 34.8 tt0 170.22 102.85 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 126.503 1.921 . . . . 63.13 106.394 -172.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.82 74.81 1.11 Allowed Glycine 0 C--O 1.242 0.642 0 N-CA-C 108.594 -1.803 . . . . 74.23 108.594 -174.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -76.89 171.46 14.72 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.602 0.715 . . . . 70.32 112.842 -171.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -150.75 138.76 6.83 Favored Glycine 0 N--CA 1.414 -2.768 0 N-CA-C 109.695 -1.362 . . . . 55.52 109.695 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -123.63 143.63 50.11 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.687 -1.598 . . . . 72.52 106.687 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 19.6 pttp -136.02 98.98 4.02 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-O 122.104 0.954 . . . . 71.12 109.257 173.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.88 125.43 34.0 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.349 -1.296 . . . . 63.52 108.253 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 10.0 p -117.11 136.74 53.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 C-N-CA 119.866 -0.734 . . . . 61.23 111.414 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.619 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 27.0 m-90 -115.58 140.29 49.31 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.506 -1.225 . . . . 71.21 107.711 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 97.4 mttt -116.87 120.99 40.19 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.985 -1.487 . . . . 74.24 106.985 172.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.429 ' HB2' ' H ' ' A' ' 118' ' ' ASP . 46.3 m -64.18 150.71 45.21 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.218 -1.03 . . . . 73.13 108.218 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.39 119.62 5.88 Favored 'General case' 0 CA--C 1.49 -1.351 0 O-C-N 123.892 0.745 . . . . 70.11 111.018 -174.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.516 ' HB1' ' CG2' ' A' ' 115' ' ' ILE . . . -64.09 130.89 45.77 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 113.487 -1.688 . . . . 53.12 109.862 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -113.52 137.53 51.43 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.963 -0.562 . . . . 71.3 109.834 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -58.44 117.97 5.06 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 122.095 0.95 . . . . 73.44 111.666 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 114' ' ' LYS . 19.8 m -109.96 -165.26 0.99 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.068 -0.969 . . . . 74.41 111.448 -174.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -84.42 -59.6 2.33 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 114.373 1.249 . . . . 62.03 114.373 -171.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -86.44 36.75 0.71 Allowed 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 114.18 1.178 . . . . 54.34 114.18 -165.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 67.43 10.53 7.81 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 122.567 1.175 . . . . 73.44 111.36 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 110' ' ' SER . 20.3 pttp -115.91 167.91 10.53 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.135 -1.431 . . . . 61.23 107.135 173.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.516 ' CG2' ' HB1' ' A' ' 107' ' ' ALA . 0.7 OUTLIER -120.88 149.71 23.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 C-N-CA 120.056 -0.658 . . . . 74.31 109.382 -169.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -98.84 131.16 45.16 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.975 -0.75 . . . . 73.21 108.975 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 21.7 p90 -147.08 170.05 17.98 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.938 -0.764 . . . . 73.12 108.938 176.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.429 ' H ' ' HB2' ' A' ' 105' ' ' SER . 5.6 m-20 -118.59 138.39 52.6 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 105.651 -1.981 . . . . 62.32 105.651 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.454 ' HB2' HG13 ' A' ' 140' ' ' ILE . 47.6 mt-10 -114.57 142.08 46.91 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.722 -0.791 . . . . 75.01 110.533 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -133.9 117.15 16.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.739 -0.664 . . . . 73.22 110.042 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -116.45 110.89 19.23 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 122.94 0.496 . . . . 71.03 110.366 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -97.74 113.75 25.59 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 110.152 -0.314 . . . . 74.31 110.152 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -97.84 119.8 37.09 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.455 -0.942 . . . . 74.51 108.455 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.499 HG12 HD13 ' A' ' 134' ' ' LEU . 59.6 mt -118.54 144.88 25.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 106.953 -1.499 . . . . 41.0 106.953 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.503 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.6 OUTLIER -119.97 146.0 46.24 Favored 'General case' 0 C--O 1.267 2.008 0 C-N-CA 118.485 -1.286 . . . . 63.33 107.604 174.307 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -93.0 106.02 18.04 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 106.607 -1.627 . . . . 75.24 106.607 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.449 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 65.1 ttt180 -58.44 145.69 37.71 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 113.67 -1.605 . . . . 72.32 108.195 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 128' ' ' LYS . 37.5 ttmt -61.51 -18.21 58.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.694 0.759 . . . . 65.42 110.8 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.449 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 7.4 t70 -65.07 -17.86 64.82 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.562 1.145 . . . . 74.34 110.953 173.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.92 -16.66 36.18 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 121.38 -0.438 . . . . 64.03 112.677 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.0 p -92.8 176.98 6.24 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 109.51 -0.552 . . . . 42.41 109.51 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.495 ' SG ' HG13 ' A' ' 21' ' ' VAL . 30.4 p -131.16 143.7 50.82 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 109.705 -0.48 . . . . 54.33 109.705 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.503 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 2.0 t90 -139.27 155.01 48.04 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.809 -0.811 . . . . 65.53 108.809 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 2.7 mm? -67.89 111.35 4.3 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.071 -0.968 . . . . 71.54 108.676 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -76.44 -60.41 2.35 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.718 -1.215 . . . . 62.03 107.718 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.8 m -161.31 150.5 16.43 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.136 -1.801 . . . . 73.01 106.136 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.0 m -133.35 135.83 55.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 107.001 -1.481 . . . . 71.14 107.001 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -115.79 131.29 56.98 Favored 'General case' 0 C--N 1.274 -2.716 0 CA-C-O 120.644 0.259 . . . . 73.41 110.8 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.416 ' HB2' HG22 ' A' ' 58' ' ' VAL . 78.2 m-85 -119.66 126.23 50.64 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.915 -1.143 . . . . 71.53 107.915 176.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.454 HG13 ' HB2' ' A' ' 119' ' ' GLU . 3.8 pt -126.29 98.65 5.02 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 N-CA-C 107.94 -1.133 . . . . 63.44 107.94 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.457 ' SD ' ' HB3' ' A' ' 76' ' ' LEU . 63.1 mtm -87.91 127.98 35.36 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.01 -1.45 . . . . 71.15 112.039 -171.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.1 m 64.19 77.33 0.32 Allowed 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 113.332 -1.758 . . . . 41.01 112.654 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -118.85 177.01 5.01 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 112.981 -1.918 . . . . 60.44 108.566 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -160.55 175.2 12.98 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 106.84 -1.541 . . . . 72.31 106.84 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -135.9 147.07 59.52 Favored Pre-proline 0 C--N 1.288 -2.073 0 N-CA-C 106.537 -1.653 . . . . 74.24 106.537 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -61.13 129.62 29.28 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.028 1.818 . . . . 74.41 109.946 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -81.26 146.75 30.27 Favored 'General case' 0 N--CA 1.413 -2.301 0 N-CA-C 108.863 -0.791 . . . . 74.22 108.863 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 19.1 m -87.59 120.82 37.35 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-O 121.112 0.482 . . . . 70.42 110.767 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.806 0 N-CA-C 108.435 -0.95 . . . . 33.4 108.435 177.927 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.0 t70 . . . . . 0 N--CA 1.464 0.227 0 N-CA-C 107.37 -1.344 . . . . 71.15 107.37 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.2 mmt -80.95 92.13 6.12 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.38 -0.6 . . . . 73.25 109.38 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.9 m -61.77 -30.89 49.39 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.048 0 CA-C-N 115.55 -0.75 . . . . 75.44 110.562 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.4 m -67.32 -38.04 84.28 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 123.746 0.818 . . . . 33.11 110.254 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 27.7 t70 -75.8 -39.01 57.66 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.272 -0.877 . . . . 74.24 109.403 -177.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.2 -35.82 80.41 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.141 -0.936 . . . . 71.53 108.946 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -64.34 -49.25 72.45 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.725 -0.67 . . . . 71.21 110.052 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.71 -45.55 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.038 -0.528 . . . . 74.35 112.341 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 18.3 ptpt -72.27 -26.09 61.85 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 118.632 -1.227 . . . . 72.54 111.128 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.64 -55.1 12.45 Favored Glycine 0 C--O 1.262 1.876 0 N-CA-C 111.386 -0.685 . . . . 65.23 111.386 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 pp -66.75 -38.98 87.7 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 108.518 -0.919 . . . . 74.14 108.518 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.12 -42.84 99.92 Favored Glycine 0 CA--C 1.497 -1.074 0 CA-C-N 116.025 -0.534 . . . . 72.21 111.986 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -64.62 -45.77 85.46 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-O 119.533 -0.27 . . . . 75.14 110.424 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.18 -38.61 88.45 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 120.456 -0.498 . . . . 75.23 110.771 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.49 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 24.7 t80 -62.48 -54.62 37.31 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.522 1.129 . . . . 70.01 110.123 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 29' ' ' ILE . 12.6 mm -65.58 -33.14 61.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 116.358 -0.383 . . . . 25.4 111.134 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.76 -49.11 77.68 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.109 -0.496 . . . . 74.04 110.774 175.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.5 pp -67.76 -31.22 70.98 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 120.671 -0.412 . . . . 74.05 110.836 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.5 t -69.97 -21.87 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-O 121.308 0.575 . . . . 62.21 110.651 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.7 p -110.51 13.06 22.77 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.754 -0.591 . . . . 73.11 111.334 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -62.91 144.24 56.91 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.615 -0.721 . . . . 61.5 112.167 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.3 m -66.05 155.14 88.03 Favored Pre-proline 0 C--N 1.299 -1.594 0 CA-C-N 114.86 -1.064 . . . . 50.55 110.971 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.97 -6.49 4.92 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 124.389 3.393 . . . . 74.31 113.259 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.8 -27.84 68.56 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.884 -0.598 . . . . 71.5 110.193 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.6 m -72.46 158.8 35.05 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.431 -0.951 . . . . 62.45 108.431 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.544 HG23 ' OD1' ' A' ' 40' ' ' ASN . 32.0 m -63.89 -37.6 80.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 C-N-CA 119.503 -0.879 . . . . 61.31 110.634 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.636 ' HB2' ' OE1' ' A' ' 42' ' ' GLU . 12.1 p-10 178.92 137.94 0.09 Allowed 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.563 1.145 . . . . 63.14 110.661 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.3 m -63.55 -37.37 87.07 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-O 122.34 1.067 . . . . 74.4 109.639 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.636 ' OE1' ' HB2' ' A' ' 40' ' ' ASN . 1.2 pm0 -67.58 -20.5 65.39 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 114.317 -1.31 . . . . 65.14 112.191 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.561 ' HB2' ' OD1' ' A' ' 40' ' ' ASN . 54.8 t-80 -67.43 -49.03 65.52 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 108.877 -0.786 . . . . 51.24 108.877 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -66.99 -33.84 76.45 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.317 -1.311 . . . . 63.43 109.058 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.423 HD11 ' CE1' ' A' ' 28' ' ' PHE . 51.8 tp -66.56 -46.42 76.09 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 116.281 -0.418 . . . . 71.52 110.708 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.73 -35.32 76.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.188 0.518 . . . . 74.45 110.418 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -76.95 -29.97 55.84 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.436 -0.802 . . . . 72.35 109.699 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -68.27 -42.96 78.79 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 123.248 0.619 . . . . 73.0 110.019 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 pp -85.44 0.72 51.41 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.821 -0.627 . . . . 72.33 111.323 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -52.61 -57.95 12.6 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-N 116.383 -0.372 . . . . 74.41 112.423 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -76.85 -4.1 14.54 Favored 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.438 2.759 . . . . 72.24 112.525 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.413 ' HA ' ' HE1' ' A' ' 133' ' ' TRP . 71.1 m-70 -125.13 45.07 2.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.372 -0.376 . . . . 75.34 110.006 -173.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -54.97 104.98 0.46 Allowed Pre-proline 0 N--CA 1.492 1.666 0 C-N-CA 124.833 1.253 . . . . 75.45 113.179 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -97.9 177.16 0.47 Allowed 'Trans proline' 0 N--CA 1.431 -2.164 0 C-N-CA 123.13 2.553 . . . . 71.34 110.268 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.92 105.34 11.13 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.919 -1.141 . . . . 73.34 107.919 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.467 HD13 ' CB ' ' A' ' 68' ' ' PHE . 68.9 mt -93.06 106.54 18.05 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.404 0 N-CA-C 108.879 -0.786 . . . . 62.42 108.879 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -95.82 112.9 24.52 Favored 'General case' 0 C--N 1.265 -3.092 0 O-C-N 121.718 -0.614 . . . . 62.3 110.398 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 3.6 p -108.57 118.49 56.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 C-N-CA 118.81 -1.156 . . . . 64.43 108.129 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.408 ' HA ' HG22 ' A' ' 140' ' ' ILE . 63.9 m-20 59.74 20.34 9.1 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.643 -1.162 . . . . 75.45 111.106 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.53 7.84 53.29 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 115.158 -0.928 . . . . 25.54 114.144 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -116.64 132.94 56.55 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 117.666 0.733 . . . . 62.44 110.862 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.1 127.05 36.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 121.481 0.658 . . . . 73.24 110.222 -176.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.466 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 9.4 mm100 -126.95 151.17 48.87 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.793 -1.188 . . . . 74.44 107.793 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.6 t -93.77 173.11 7.84 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.457 -0.942 . . . . 75.41 108.457 174.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.0 t -49.22 -39.45 30.02 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 124.605 1.162 . . . . 52.4 111.64 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.2 m -65.21 -47.86 75.4 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 122.918 0.487 . . . . 74.2 111.108 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.466 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -64.51 -47.6 78.28 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 122.745 0.418 . . . . 34.12 110.129 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.467 ' CB ' HD13 ' A' ' 56' ' ' ILE . 51.4 t80 -52.81 -55.17 24.89 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 116.177 -0.465 . . . . 74.21 110.271 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -51.35 -42.09 61.05 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.042 -0.981 . . . . 62.44 110.857 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -62.66 -49.7 74.12 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 116.299 -0.41 . . . . 75.53 111.683 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.434 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 24.8 m-85 -65.82 -33.4 75.78 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.794 0.807 . . . . 71.52 109.27 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.546 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 4.1 t80 -57.85 -53.18 61.13 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.02 -0.991 . . . . 63.03 110.841 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -74.73 -20.63 59.76 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.15 0.5 . . . . 75.12 110.671 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.424 ' HB2' HD23 ' A' ' 76' ' ' LEU . 55.3 mt-30 -76.18 -8.25 56.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.901 -0.591 . . . . 70.42 111.051 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.16 10.07 57.6 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 120.539 -0.838 . . . . 74.13 114.266 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 74' ' ' GLN . 3.5 mm? -68.32 -50.53 52.83 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 116.868 0.334 . . . . 62.13 110.442 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.434 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 36.5 m-85 -99.31 10.08 42.12 Favored 'General case' 0 C--O 1.204 -1.326 0 N-CA-C 112.819 0.674 . . . . 73.44 112.819 -173.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.301 62.8 pttt -70.48 -10.62 59.65 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 114.221 1.193 . . . . 74.35 114.221 -176.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -83.33 -10.55 58.42 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.196 -0.456 . . . . 75.35 110.485 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.44 -15.93 63.71 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 112.578 0.584 . . . . 60.11 112.578 -172.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -11.16 40.54 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.931 -0.481 . . . . 61.42 112.122 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -99.76 14.06 31.55 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 122.65 0.38 . . . . 73.32 111.23 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.505 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -58.71 129.22 41.06 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.008 0.744 . . . . 65.02 113.008 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -100.67 127.01 47.23 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.497 -1.668 . . . . 72.05 106.497 173.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -82.2 125.12 30.55 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 120.749 -0.38 . . . . 75.15 110.526 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.469 ' HB3' HG13 ' A' ' 102' ' ' VAL . . . -88.94 113.5 24.54 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.167 -1.42 . . . . 60.02 107.167 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.2 tt -47.74 107.75 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 114.337 1.236 . . . . 74.52 114.337 -173.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -87.58 117.71 26.57 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 106.507 -1.664 . . . . 55.04 106.507 173.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.45 97.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.855 0.836 . . . . 53.44 109.993 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p -113.09 6.05 17.4 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 114.757 -1.111 . . . . 34.21 110.375 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.34 85.55 0.72 Allowed Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 114.715 -1.13 . . . . 62.3 110.661 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -173.3 172.36 3.81 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 124.441 1.096 . . . . 63.05 108.44 -175.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.06 118.18 28.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.053 -1.092 . . . . 71.04 108.053 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -116.68 123.74 48.0 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.622 -0.717 . . . . 72.43 109.556 -174.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.4 ' HA ' ' NH2' ' A' ' 126' ' ' ARG . 10.0 pt-20 -116.13 -44.07 2.93 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.376 -0.53 . . . . 75.24 110.316 173.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -145.61 61.81 0.47 Allowed Glycine 0 C--N 1.308 -0.986 0 N-CA-C 110.176 -1.17 . . . . 65.45 110.176 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -96.65 163.53 12.98 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 121.009 0.433 . . . . 73.45 111.058 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.54 138.35 14.91 Favored Glycine 0 N--CA 1.423 -2.226 0 N-CA-C 108.628 -1.789 . . . . 71.21 108.628 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -112.67 146.3 38.93 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 117.11 0.455 . . . . 74.52 109.931 -176.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -124.89 97.59 5.33 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.164 -1.421 . . . . 64.22 107.164 172.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.64 107.99 20.53 Favored 'General case' 0 C--N 1.259 -3.363 0 N-CA-C 106.383 -1.71 . . . . 73.41 106.383 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.2 p -115.89 135.27 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 CA-C-O 121.897 0.856 . . . . 73.34 112.258 -174.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.505 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 30.5 m-90 -119.28 155.43 31.81 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.285 -1.325 . . . . 72.34 109.94 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -129.03 125.25 36.91 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 104.485 -2.413 . . . . 73.13 104.485 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 80.6 p -75.65 -170.47 1.29 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 118.296 0.498 . . . . 65.33 110.644 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.32 117.33 5.96 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.438 0.637 . . . . 64.13 109.894 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.68 139.79 32.56 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.327 -1.306 . . . . 73.31 109.189 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -126.55 114.76 18.53 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.312 -0.625 . . . . 73.02 109.312 -176.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -66.35 133.45 50.53 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 120.169 -0.612 . . . . 75.0 109.412 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.9 m -104.88 164.57 11.68 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.137 -0.938 . . . . 74.44 109.386 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -68.06 -19.79 64.91 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.334 0.588 . . . . 61.53 111.012 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.76 -1.03 29.3 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.902 -0.59 . . . . 73.52 109.917 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 75.37 10.56 3.54 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.318 1.447 . . . . 52.24 109.355 -176.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -92.14 164.6 13.52 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.859 -1.534 . . . . 73.12 106.859 174.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.1 mp -127.38 137.84 56.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 106.506 -1.664 . . . . 74.41 106.506 175.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -115.64 137.84 51.67 Favored 'General case' 0 C--N 1.292 -1.925 0 O-C-N 123.411 0.444 . . . . 74.43 110.331 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.505 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 22.1 p90 -149.41 174.6 12.28 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.822 -1.548 . . . . 65.31 106.822 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -116.28 141.3 48.34 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 106.332 -1.729 . . . . 74.2 106.332 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.505 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 42.4 mt-10 -115.33 147.04 40.94 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 119.701 -0.8 . . . . 65.03 112.567 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.604 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -139.37 117.88 12.16 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.169 -0.923 . . . . 63.41 110.185 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.57 109.57 17.98 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.697 -0.853 . . . . 72.02 108.697 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.65 123.02 37.84 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 109.527 -0.546 . . . . 74.32 109.527 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -103.31 112.18 24.94 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.764 -1.199 . . . . 75.33 107.764 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.4 mt -117.3 150.92 19.24 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 N-CA-C 106.744 -1.576 . . . . 60.23 106.744 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -136.16 143.06 44.26 Favored 'General case' 0 C--O 1.275 2.414 0 N-CA-C 108.226 -1.028 . . . . 73.23 108.226 172.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.4 ' NH2' ' HA ' ' A' ' 95' ' ' GLU . 19.9 ttp180 -91.53 100.98 13.63 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 106.793 -1.558 . . . . 72.01 106.793 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -68.03 132.89 48.08 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 114.765 -1.107 . . . . 75.22 109.258 -171.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -66.16 -10.57 42.46 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 123.75 0.82 . . . . 74.42 111.417 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -74.6 -8.0 54.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.055 -0.52 . . . . 72.24 111.023 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.22 -8.78 28.95 Favored Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.707 -0.759 . . . . 72.51 113.932 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.9 m -104.16 138.78 40.15 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.414 -0.587 . . . . 70.13 109.414 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 44.7 t -98.33 132.65 43.63 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 107.037 -1.468 . . . . 74.31 107.037 170.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.413 ' HE1' ' HA ' ' A' ' 52' ' ' HIS . 1.6 t90 -146.0 154.78 42.27 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 118.389 -1.324 . . . . 73.44 110.642 -176.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.22 125.67 29.59 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.99 -1.115 . . . . 74.31 107.99 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -80.79 -53.99 6.0 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.408 -0.96 . . . . 64.21 108.408 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.4 m -162.48 158.48 23.76 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 105.266 -2.124 . . . . 70.34 105.266 -175.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.7 m -143.06 138.4 27.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 107.296 -1.372 . . . . 52.51 107.296 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -112.82 136.33 52.57 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 109.786 -0.45 . . . . 65.31 109.786 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 71.8 m-85 -125.04 122.94 38.69 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 107.72 -1.215 . . . . 61.34 107.72 175.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.408 HG22 ' HA ' ' A' ' 59' ' ' ASN . 5.2 pt -127.14 98.81 4.9 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 N-CA-C 107.946 -1.131 . . . . 74.44 107.946 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 23.4 ptm -86.63 143.09 27.8 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.481 -1.236 . . . . 74.33 110.564 -173.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.8 m 67.62 35.23 4.17 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.569 1.168 . . . . 74.15 109.287 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -71.07 127.69 33.44 Favored 'General case' 0 N--CA 1.408 -2.54 0 CA-C-N 113.082 -1.872 . . . . 71.31 109.258 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -147.44 168.78 21.0 Favored 'General case' 0 C--N 1.268 -2.966 0 CA-C-N 114.313 -1.312 . . . . 55.44 108.578 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -123.03 158.86 56.38 Favored Pre-proline 0 C--N 1.279 -2.47 0 N-CA-C 106.247 -1.76 . . . . 71.34 106.247 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.81 130.9 42.84 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.809 1.673 . . . . 73.54 109.246 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -61.65 139.14 58.32 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.326 0.584 . . . . 75.42 111.45 -174.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.8 m -90.11 151.04 3.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 108.414 -0.958 . . . . 61.32 108.414 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.654 0 N-CA-C 108.762 -0.829 . . . . 50.11 108.762 -179.189 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 120.826 0.346 . . . . 64.15 111.436 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -75.24 8.89 2.35 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 112.615 0.598 . . . . 51.42 112.615 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.7 m -65.43 -40.15 87.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 110.194 -0.298 . . . . 73.51 110.194 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.4 m -72.13 -29.18 63.81 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.405 0.622 . . . . 73.11 109.507 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -69.76 -46.43 65.83 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 116.153 -0.476 . . . . 73.04 110.178 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.99 -43.86 97.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.559 -0.746 . . . . 64.23 109.434 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.04 -42.93 99.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.843 -0.617 . . . . 54.3 111.622 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.543 HG11 ' HE ' ' A' ' 126' ' ' ARG . 26.6 m -74.46 -39.79 48.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 119.352 -0.939 . . . . 71.44 112.698 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -72.38 -28.03 62.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 119.052 -1.059 . . . . 75.31 109.787 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.03 -42.55 43.94 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 110.533 -1.027 . . . . 52.13 110.533 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.551 HD22 ' SG ' ' A' ' 132' ' ' CYS . 17.9 tp -64.84 -50.37 66.94 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.025 -0.731 . . . . 73.35 109.025 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.59 -39.05 94.58 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.347 -0.842 . . . . 71.4 112.232 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -68.63 -42.13 78.49 Favored 'General case' 0 C--O 1.204 -1.292 0 C-N-CA 121.051 -0.26 . . . . 75.23 110.565 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.461 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 7.9 t70 -63.56 -41.46 98.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.777 0.799 . . . . 74.0 109.234 -176.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.434 ' CE1' HD11 ' A' ' 45' ' ' LEU . 33.4 t80 -63.88 -55.03 25.76 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.362 -1.744 . . . . 64.14 110.163 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 29' ' ' ILE . 11.9 mm -64.41 -32.89 59.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 111.693 0.257 . . . . 71.05 111.693 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.41 -52.8 63.06 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 122.786 0.434 . . . . 75.33 110.192 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 27' ' ' ASP . 3.7 pp -71.97 -24.4 61.59 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 119.629 -0.828 . . . . 72.33 112.162 -176.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.2 t -71.08 -25.31 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.094 0.473 . . . . 73.34 109.972 174.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.6 p -108.17 13.38 25.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.251 0.548 . . . . 73.24 110.281 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -62.67 148.35 46.71 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 115.423 -0.808 . . . . 72.01 110.834 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.6 m -51.37 143.11 19.36 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 125.763 1.625 . . . . 64.51 114.175 -175.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.39 -6.39 17.41 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 124.452 3.434 . . . . 53.1 113.338 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -62.99 -25.84 68.58 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.643 0.735 . . . . 52.31 110.134 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 t -81.46 172.18 13.83 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.233 -1.025 . . . . 75.53 108.233 175.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -56.52 -45.65 82.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 C-N-CA 122.51 0.324 . . . . 74.41 110.776 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.568 ' ND2' ' HB3' ' A' ' 42' ' ' GLU . 39.2 t30 178.16 139.06 0.09 Allowed 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.873 -1.158 . . . . 73.4 107.873 -177.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 m -61.85 -26.66 68.27 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 122.571 1.177 . . . . 62.5 110.688 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.568 ' HB3' ' ND2' ' A' ' 40' ' ' ASN . 38.1 tt0 -64.67 -23.48 67.27 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 125.099 1.36 . . . . 55.44 109.897 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 72' ' ' PHE . 48.2 t-80 -65.05 -46.12 82.54 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.264 -0.643 . . . . 71.43 109.264 176.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -70.58 -31.46 68.49 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 108.292 -1.003 . . . . 73.34 108.292 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.434 HD11 ' CE1' ' A' ' 28' ' ' PHE . 48.4 tp -66.82 -46.88 73.76 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.936 -0.575 . . . . 74.13 111.052 176.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.62 -34.33 75.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.359 0.6 . . . . 55.14 110.094 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -73.16 -34.82 66.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.366 -0.834 . . . . 72.05 109.632 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 41.8 t80 -66.28 -48.52 70.13 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.864 0.865 . . . . 75.34 110.231 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 pp -80.44 -3.07 48.43 Favored 'General case' 0 C--O 1.198 -1.616 0 CA-C-N 115.275 -0.875 . . . . 60.11 111.774 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -42.45 -60.82 2.66 Favored Glycine 0 CA--C 1.537 1.432 0 O-C-N 123.792 0.682 . . . . 64.14 113.573 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.45 -5.76 13.48 Favored 'Trans proline' 0 CA--C 1.551 1.328 0 C-N-CA 122.452 2.101 . . . . 74.13 112.998 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -116.51 22.47 12.75 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.128 -0.358 . . . . 64.42 110.454 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.67 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 18.4 t70 -65.9 120.07 66.13 Favored Pre-proline 0 C--O 1.256 1.434 0 N-CA-C 112.943 0.72 . . . . 74.21 112.943 -172.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 3.8 Cg_endo -104.92 -148.8 0.02 OUTLIER 'Trans proline' 0 CA--C 1.554 1.524 0 C-N-CA 124.252 3.301 . . . . 73.13 112.22 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -86.85 126.12 34.43 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 107.888 -1.152 . . . . 64.24 107.888 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.55 HD13 ' CB ' ' A' ' 68' ' ' PHE . 48.2 mt -107.34 113.1 42.71 Favored 'Isoleucine or valine' 0 C--O 1.172 -3.012 0 N-CA-C 106.86 -1.533 . . . . 72.45 106.86 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -99.2 135.18 40.98 Favored 'General case' 0 C--N 1.266 -3.051 0 O-C-N 121.669 -0.644 . . . . 74.43 109.703 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 74.9 t -133.54 113.61 19.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 108.714 -0.847 . . . . 74.43 108.714 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.414 ' OD1' ' HG2' ' A' ' 141' ' ' MET . 72.5 m-20 61.32 25.18 15.19 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 125.377 1.471 . . . . 72.22 111.695 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.8 2.12 58.53 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.856 -0.688 . . . . 43.54 112.627 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -113.4 135.49 53.81 Favored 'General case' 0 CA--C 1.492 -1.278 0 O-C-N 122.31 -0.524 . . . . 70.22 110.713 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.21 128.49 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 108.903 -0.777 . . . . 63.23 108.903 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -122.52 143.6 49.61 Favored 'General case' 0 C--O 1.282 2.766 0 N-CA-C 107.161 -1.422 . . . . 74.1 107.161 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.1 t -91.91 173.14 8.01 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.923 -1.14 . . . . 72.31 107.923 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.67 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 13.6 t -58.4 -32.46 68.64 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.698 0.399 . . . . 65.51 111.637 -176.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.5 m -60.82 -51.56 68.81 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.869 -0.605 . . . . 74.24 110.105 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.64 -49.36 75.49 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.532 -0.758 . . . . 61.54 110.441 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.55 ' CB ' HD13 ' A' ' 56' ' ' ILE . 56.9 t80 -52.9 -54.91 27.88 Favored 'General case' 0 CA--C 1.501 -0.939 0 O-C-N 123.676 0.61 . . . . 70.54 110.926 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.2 tp -53.06 -44.85 67.78 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 124.094 0.871 . . . . 72.21 111.782 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.528 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 76.3 mt-30 -58.07 -51.81 68.14 Favored 'General case' 0 N--CA 1.439 -1.014 0 O-C-N 123.257 0.348 . . . . 74.51 111.025 175.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.425 ' HB3' ' HB2' ' A' ' 76' ' ' LEU . 27.3 m-85 -62.47 -40.72 97.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.217 0.532 . . . . 71.31 110.735 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 2.6 t80 -57.86 -52.1 66.87 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.593 0.757 . . . . 71.23 110.309 177.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -73.23 -18.28 61.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.149 -0.478 . . . . 64.04 111.397 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 46.8 mt-30 -87.22 -11.5 49.59 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 120.167 -0.613 . . . . 75.4 111.773 175.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.52 42.14 6.62 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.509 -0.853 . . . . 74.42 112.821 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.442 HD23 ' HB2' ' A' ' 74' ' ' GLN . 4.3 mm? -88.03 -35.37 17.59 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 122.79 -0.241 . . . . 71.21 111.206 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -108.08 -2.81 19.23 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.219 -0.593 . . . . 74.44 112.297 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.565 ' HA ' ' OE2' ' A' ' 42' ' ' GLU 0.372 0.0 OUTLIER -60.19 -13.65 13.44 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 115.894 1.813 . . . . 72.41 115.894 -165.783 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.22 -12.91 62.08 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 116.113 -0.494 . . . . 71.33 111.169 174.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.7 tt -61.46 -27.09 68.32 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.438 1.095 . . . . 74.42 110.657 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.477 ' HB2' ' OD1' ' A' ' 40' ' ' ASN . 27.4 ttpp -55.02 -33.51 62.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.328 0.585 . . . . 75.34 111.321 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -105.33 14.56 28.69 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.443 -0.798 . . . . 73.12 111.032 -173.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -84.06 153.81 23.59 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.308 0.575 . . . . 61.12 112.433 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 103' ' ' TRP . 10.2 pt-20 -89.31 149.82 22.87 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.213 -1.402 . . . . 75.11 107.213 175.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -117.91 136.14 53.66 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 118.972 0.805 . . . . 73.3 112.002 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.86 110.22 21.89 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.827 -0.805 . . . . 54.22 108.827 174.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.4 tt -82.87 103.0 9.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.545 0.688 . . . . 61.54 111.703 -177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -116.33 89.68 3.16 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.691 -0.686 . . . . 54.53 109.806 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.8 t -104.0 149.28 7.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 107.71 -1.218 . . . . 54.41 107.71 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.8 p -65.28 -55.34 18.92 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.087 0.47 . . . . 60.43 110.811 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.47 -136.94 7.97 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 109.509 -1.437 . . . . 22.14 109.509 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -102.42 12.16 36.93 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.687 0.756 . . . . 64.22 110.324 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.1 t -82.28 139.68 17.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.454 -1.313 . . . . 73.43 107.454 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.432 ' HA ' ' NH1' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -130.9 102.54 6.1 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.127 -1.064 . . . . 44.22 108.127 177.61 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -136.5 -31.7 0.86 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.078 0.466 . . . . 52.43 111.547 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 129.53 47.03 0.16 Allowed Glycine 0 C--N 1.299 -1.476 0 N-CA-C 109.669 -1.373 . . . . 61.24 109.669 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 97' ' ' GLU . 1.1 mp0 -82.09 175.65 10.16 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 123.237 0.615 . . . . 73.51 110.641 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.59 144.5 18.28 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 110.852 -0.899 . . . . 73.24 110.852 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -109.99 140.4 44.05 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.628 -1.249 . . . . 75.43 107.628 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -131.59 101.19 5.4 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.769 -0.826 . . . . 73.11 108.769 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 83.4 mt -107.96 112.22 24.7 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.967 -0.753 . . . . 72.12 108.967 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.6 p -114.03 129.2 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-O 121.484 0.659 . . . . 62.04 111.996 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.579 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 31.4 m-90 -101.82 141.6 34.43 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.604 -1.18 . . . . 75.22 109.217 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.413 ' HB2' ' CG ' ' A' ' 84' ' ' GLU . 36.3 mtpt -118.56 125.46 49.87 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 107.549 -1.278 . . . . 73.1 107.549 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 42.8 t -79.33 -164.28 0.61 Allowed 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.917 -1.038 . . . . 53.12 110.311 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.52 151.98 40.82 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 112.862 0.689 . . . . 74.42 112.862 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.5 108.84 10.96 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.278 -1.379 . . . . 71.42 107.278 173.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -95.98 140.4 30.77 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 115.822 -0.626 . . . . 72.52 110.858 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -59.78 120.08 8.87 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 116.24 1.941 . . . . 75.13 116.24 -166.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 114' ' ' LYS . 18.7 t -154.0 105.82 2.77 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 104.881 -2.266 . . . . 54.44 104.881 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -76.31 12.64 1.14 Allowed 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 114.487 1.291 . . . . 64.43 114.487 -169.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -93.02 16.45 12.74 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.779 -0.575 . . . . 75.34 112.143 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.408 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 9.1 tt0 72.08 14.08 5.75 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 122.711 1.243 . . . . 73.45 109.614 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 110' ' ' SER . 2.8 pptp? -133.12 118.74 19.07 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 107.208 -1.404 . . . . 64.01 107.208 173.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.1 pt -93.59 168.55 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-N 115.553 -0.749 . . . . 70.4 109.131 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.424 ' HD2' ' OG ' ' A' ' 142' ' ' SER . 18.0 ptt180 -125.28 136.73 53.81 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 107.864 -1.162 . . . . 63.2 107.864 174.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.475 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 46.5 p90 -134.74 173.33 11.81 Favored 'General case' 0 C--N 1.269 -2.923 0 N-CA-C 107.536 -1.283 . . . . 74.42 107.536 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.435 ' H ' ' HB3' ' A' ' 105' ' ' SER . 2.1 m-20 -116.18 138.95 50.84 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 106.056 -1.831 . . . . 73.01 106.056 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.475 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 38.4 mt-10 -118.31 144.3 45.95 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.001 -0.68 . . . . 75.13 111.225 176.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -132.51 116.74 17.13 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.861 -1.163 . . . . 44.34 107.861 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -125.68 113.26 17.11 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 121.68 0.752 . . . . 72.12 111.987 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.86 128.65 41.77 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.791 -1.095 . . . . 72.44 110.036 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -109.55 117.93 35.27 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.316 -0.994 . . . . 63.4 108.316 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.5 mt -115.59 151.17 17.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 106.435 -1.691 . . . . 61.13 106.435 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.406 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -136.02 150.17 49.1 Favored 'General case' 0 C--O 1.27 2.144 0 C-N-CA 118.984 -1.086 . . . . 73.11 109.231 175.546 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.543 ' HE ' HG11 ' A' ' 21' ' ' VAL . 61.7 mtt180 -76.07 113.04 13.14 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 108.145 -1.057 . . . . 71.23 108.145 172.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -73.41 133.06 43.65 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 113.906 -1.497 . . . . 64.52 107.566 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -62.53 -15.46 50.73 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.152 0.581 . . . . 61.33 112.192 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -64.94 -16.8 63.75 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 124.001 0.921 . . . . 73.02 110.988 173.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.34 -6.35 30.24 Favored Glycine 0 CA--C 1.501 -0.791 0 N-CA-C 111.215 -0.754 . . . . 71.52 111.215 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.9 p -100.01 -172.34 2.21 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 123.33 0.652 . . . . 71.23 110.6 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.551 ' SG ' HD22 ' A' ' 24' ' ' LEU . 15.0 p -134.61 144.57 47.98 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.601 -1.259 . . . . 73.41 107.601 174.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.406 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 0.2 OUTLIER -155.23 155.2 33.41 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 119.292 -0.963 . . . . 71.42 108.889 -176.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.88 128.47 36.48 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.153 0.501 . . . . 64.43 109.652 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -87.12 -46.77 9.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.047 -0.723 . . . . 65.22 109.047 -176.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.9 p -175.01 152.4 1.48 Allowed 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 107.805 -1.183 . . . . 75.33 107.805 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.41 150.55 32.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.385 -1.339 . . . . 72.04 107.385 175.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -130.09 133.29 46.58 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 110.266 -0.272 . . . . 73.3 110.266 -177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 67.0 m-85 -117.57 127.26 53.8 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.609 -1.256 . . . . 75.23 107.609 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.418 HD12 ' HD2' ' A' ' 143' ' ' LYS . 6.0 pt -128.45 98.76 4.49 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.42 0 CA-C-O 122.395 1.093 . . . . 71.31 108.896 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.414 ' HG2' ' OD1' ' A' ' 59' ' ' ASN . 22.6 ptp -89.73 126.94 35.85 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.163 -1.381 . . . . 73.41 109.87 -175.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.424 ' OG ' ' HD2' ' A' ' 116' ' ' ARG . 32.2 t 73.74 73.97 0.12 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.42 -1.264 . . . . 65.5 110.593 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.418 ' HD2' HD12 ' A' ' 140' ' ' ILE . 85.6 tttt -113.78 135.96 53.38 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.19 -1.368 . . . . 61.42 107.451 177.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -134.69 143.1 47.02 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 109.715 -0.476 . . . . 65.32 109.715 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.83 130.53 24.31 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 109.107 -0.701 . . . . 61.32 109.107 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.94 132.28 44.05 Favored 'Trans proline' 0 C--O 1.246 0.924 0 C-N-CA 122.66 2.24 . . . . 73.55 111.094 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -93.61 168.06 11.27 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 108.164 -1.05 . . . . 73.21 108.164 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 38.5 t -135.23 98.98 2.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.505 -0.924 . . . . 73.12 108.505 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.888 0 CA-C-N 115.321 -0.854 . . . . 52.4 108.717 -179.013 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 112.565 0.58 . . . . 44.14 112.565 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 92.6 mtp -66.55 162.32 21.11 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.751 0.705 . . . . 63.12 110.764 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.11 -42.68 96.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.162 -0.681 . . . . 72.55 109.162 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 21' ' ' VAL . 8.5 p -62.39 -43.15 99.51 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.32 -0.855 . . . . 63.43 109.842 177.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -66.67 -34.9 78.9 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.018 -0.992 . . . . 53.44 111.413 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.69 -36.83 84.76 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.222 -1.029 . . . . 75.23 108.222 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -69.91 -38.23 76.2 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.372 -0.831 . . . . 74.54 109.853 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 17' ' ' THR . 89.3 t -59.16 -56.66 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 115.218 -0.901 . . . . 74.14 110.437 176.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -25.9 67.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.354 -0.384 . . . . 72.13 110.545 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.59 -50.44 48.91 Favored Glycine 0 C--O 1.25 1.128 0 N-CA-C 111.659 -0.576 . . . . 70.44 111.659 175.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.77 -37.74 76.48 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 108.613 -0.884 . . . . 52.21 108.613 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.58 -40.63 99.38 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.704 -0.68 . . . . 50.32 111.851 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -67.77 -46.03 73.22 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 120.457 -0.497 . . . . 60.31 110.409 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.23 -39.82 95.7 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 120.567 -0.453 . . . . 74.42 110.644 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -61.57 -52.54 64.01 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.604 0.762 . . . . 72.22 109.902 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.421 ' HA ' HD13 ' A' ' 29' ' ' ILE . 7.4 mm -67.52 -35.09 72.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 120.906 -0.318 . . . . 75.44 111.675 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -63.2 -46.24 87.94 Favored 'General case' 0 CA--C 1.495 -1.141 0 C-N-CA 122.425 0.29 . . . . 61.54 110.487 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.586 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 4.1 pp -69.65 -28.76 66.16 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 119.736 -0.786 . . . . 64.31 111.249 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.409 ' N ' HD12 ' A' ' 31' ' ' LEU . 52.9 t -71.76 -24.33 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-O 121.456 0.646 . . . . 74.31 110.084 174.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.9 p -107.23 19.29 20.56 Favored 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 121.598 -0.689 . . . . 73.1 111.261 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.586 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 64.7 mmtt -53.24 138.64 31.55 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 116.051 -0.522 . . . . 52.11 111.057 175.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -64.28 159.23 59.79 Favored Pre-proline 0 N--CA 1.435 -1.222 0 CA-C-N 115.003 -0.999 . . . . 74.31 109.675 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.5 -11.04 18.16 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 123.349 2.699 . . . . 73.34 111.502 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -68.0 -26.05 65.71 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.607 -1.179 . . . . 74.3 110.872 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.9 t -82.67 172.26 13.11 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.442 -1.318 . . . . 51.14 107.442 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.7 t -74.77 -54.29 14.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.485 -0.486 . . . . 54.45 111.131 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.498 ' O ' ' HB3' ' A' ' 43' ' ' HIS . 23.8 t30 -170.84 126.61 0.72 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.211 -0.45 . . . . 71.22 110.355 -173.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 p -61.0 -39.3 89.15 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 123.358 0.663 . . . . 71.43 111.624 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.44 -21.6 66.21 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.962 -0.563 . . . . 61.45 110.483 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.498 ' HB3' ' O ' ' A' ' 40' ' ' ASN . 42.7 t-80 -72.91 -48.87 33.41 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.354 -0.98 . . . . 74.3 108.354 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -64.19 -35.0 79.37 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.587 -1.188 . . . . 63.1 109.541 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.0 tp -66.88 -42.37 85.69 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 116.292 -0.413 . . . . 70.3 110.466 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.32 -32.13 73.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.455 0.645 . . . . 74.24 110.319 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -74.83 -35.75 62.4 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.536 -0.757 . . . . 71.21 110.25 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -68.37 -41.69 80.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.364 0.666 . . . . 72.05 110.718 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 pp -79.02 -8.44 58.94 Favored 'General case' 0 C--O 1.194 -1.838 0 CA-C-N 115.746 -0.661 . . . . 70.22 111.814 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -46.9 -55.67 8.2 Favored Glycine 0 CA--C 1.546 1.993 0 O-C-N 123.454 0.472 . . . . 53.31 114.017 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -78.0 -3.81 13.82 Favored 'Trans proline' 0 CA--C 1.55 1.32 0 C-N-CA 122.993 2.462 . . . . 64.11 112.474 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -129.46 28.31 5.21 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.984 -0.448 . . . . 74.14 110.21 -168.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -55.98 115.68 10.33 Favored Pre-proline 0 N--CA 1.475 0.818 0 O-C-N 124.042 0.839 . . . . 74.24 111.451 -175.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -108.96 -158.15 0.02 OUTLIER 'Trans proline' 0 CA--C 1.557 1.636 0 C-N-CA 123.721 2.947 . . . . 75.53 111.546 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -86.85 126.12 34.44 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.08 -1.081 . . . . 63.32 108.08 175.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.48 HD13 ' CB ' ' A' ' 68' ' ' PHE . 36.7 mt -112.18 107.06 22.0 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.412 0 N-CA-C 108.98 -0.748 . . . . 73.14 108.98 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -89.84 135.64 33.51 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 109.753 -0.462 . . . . 72.42 109.753 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.8 p -126.03 117.88 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 N-CA-C 107.371 -1.344 . . . . 64.04 107.371 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 62.77 20.8 12.38 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 123.956 0.902 . . . . 63.23 110.709 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.38 -5.34 58.82 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.38 -0.827 . . . . 63.55 112.489 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -99.82 126.18 45.87 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 109.026 -0.731 . . . . 73.42 109.026 -178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.88 126.41 31.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-O 121.54 0.686 . . . . 71.12 109.427 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.483 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 12.5 mm100 -122.33 152.45 40.11 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.077 -0.712 . . . . 71.3 109.077 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.6 t -87.64 169.15 12.39 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.327 -0.99 . . . . 74.55 108.327 175.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.426 ' HA ' HD12 ' A' ' 56' ' ' ILE . 13.2 t -58.03 -34.18 69.77 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.379 0.672 . . . . 73.12 111.33 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.0 m -61.58 -49.46 76.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.25 0.548 . . . . 73.34 109.784 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -60.83 -49.78 76.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.281 -0.872 . . . . 71.42 110.391 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.48 ' CB ' HD13 ' A' ' 56' ' ' ILE . 44.3 t80 -51.49 -56.07 15.38 Favored 'General case' 0 CA--C 1.5 -0.943 0 O-C-N 123.778 0.674 . . . . 74.33 110.415 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 69' ' ' LEU . 13.5 mt -49.77 -47.54 50.97 Favored 'General case' 0 CA--C 1.491 -1.3 0 O-C-N 124.079 0.862 . . . . 54.33 112.94 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -55.54 -51.42 67.12 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 123.703 0.627 . . . . 64.13 111.773 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -65.63 -37.3 86.18 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.555 0.693 . . . . 70.23 110.463 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 3.4 t80 -61.83 -53.6 53.69 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.183 -0.917 . . . . 64.12 111.197 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -74.62 -18.17 60.6 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 123.333 0.396 . . . . 64.21 111.123 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -75.3 -14.51 60.5 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.033 0.444 . . . . 63.53 111.285 171.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.43 18.01 29.66 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 120.749 -0.739 . . . . 60.43 113.577 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.6 mt -76.84 -44.65 31.46 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.469 -0.892 . . . . 75.34 112.019 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -89.3 -5.77 57.29 Favored 'General case' 0 C--O 1.203 -1.358 0 N-CA-C 113.384 0.883 . . . . 75.52 113.384 -174.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.286 0.0 OUTLIER -64.09 -12.4 38.9 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.727 1.38 . . . . 71.34 114.727 -175.277 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -80.81 -10.68 59.7 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.112 -0.495 . . . . 64.55 111.176 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.49 -15.56 60.39 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 122.76 0.424 . . . . 74.3 111.864 -176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -53.44 -30.42 40.4 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.265 0.555 . . . . 72.34 111.838 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -99.4 8.56 44.51 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 122.016 -0.427 . . . . 72.25 111.735 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.36 147.76 47.68 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.584 0.707 . . . . 50.32 111.675 -176.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -88.14 116.14 26.11 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.26 -0.882 . . . . 71.12 112.202 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.579 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 55.7 p90 -102.64 158.8 15.98 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.216 -1.772 . . . . 74.2 106.216 169.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -161.62 -151.28 0.21 Allowed 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.979 -1.489 . . . . 64.31 106.979 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.34 90.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-O 122.314 1.054 . . . . 74.33 108.969 174.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -79.62 125.14 29.24 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.609 -1.178 . . . . 74.41 108.533 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.9 m -78.71 139.5 18.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-O 121.762 0.792 . . . . 70.13 111.708 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 98' ' ' GLY . 48.6 m -150.61 -176.81 5.65 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.307 -1.368 . . . . 63.31 107.307 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -149.57 144.54 12.16 Favored Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 119.128 -1.511 . . . . 61.32 112.413 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.422 ' HA ' ' HB2' ' A' ' 97' ' ' GLU . 19.7 pttm -95.83 123.6 39.48 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.835 0.826 . . . . 71.21 110.892 177.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.494 HG12 ' H ' ' A' ' 95' ' ' GLU . 25.0 t -110.81 152.05 12.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 106.476 -1.676 . . . . 74.24 106.476 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -68.82 -11.58 60.59 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.223 0.535 . . . . 63.35 110.877 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.494 ' H ' HG12 ' A' ' 93' ' ' VAL . 37.7 tt0 -137.37 91.89 2.65 Favored 'General case' 0 N--CA 1.422 -1.875 0 CA-C-N 116.065 -0.516 . . . . 62.31 109.986 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 126' ' ' ARG . . . 75.34 70.1 1.31 Allowed Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 115.53 -0.759 . . . . 72.43 113.055 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.476 ' CG ' ' HB3' ' A' ' 126' ' ' ARG . 9.9 pt-20 -64.24 140.25 58.85 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.753 -0.462 . . . . 64.42 109.753 176.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 90' ' ' SER . . . -118.84 138.67 13.8 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 119.683 -1.246 . . . . 73.42 112.98 -173.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -108.44 129.83 55.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.281 -1.007 . . . . 70.41 108.281 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -108.25 98.96 8.43 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.961 -1.126 . . . . 72.44 107.961 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 3.2 mm? -92.8 100.82 13.23 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.853 -1.165 . . . . 71.32 107.853 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.1 p -116.81 122.18 69.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-O 122.415 1.102 . . . . 75.11 113.692 -176.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.579 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 29.7 m-90 -102.83 129.99 49.69 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 113.869 -1.514 . . . . 73.11 107.854 177.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.423 ' HG3' ' HG2' ' A' ' 119' ' ' GLU . 3.1 mppt? -114.41 125.7 54.14 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.105 -1.072 . . . . 65.21 108.105 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.9 p -79.08 -178.57 6.2 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.236 -0.586 . . . . 63.44 110.621 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.39 145.16 28.21 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 122.869 0.468 . . . . 73.22 111.111 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.486 ' HB1' HG21 ' A' ' 115' ' ' ILE . . . -96.72 127.4 42.67 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.879 -0.6 . . . . 64.15 110.007 -177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -114.56 127.42 55.78 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 109.146 -0.687 . . . . 64.32 109.146 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -82.8 106.13 14.39 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.732 -0.667 . . . . 73.3 110.432 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 51.1 m -75.6 155.02 36.32 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 115.027 -0.988 . . . . 74.31 109.17 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -65.54 -7.14 13.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 113.639 0.977 . . . . 62.14 113.639 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -87.15 -0.03 56.03 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.411 -0.589 . . . . 73.11 109.411 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 77.62 11.14 2.16 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.082 1.353 . . . . 70.51 108.922 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -98.03 158.82 15.32 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.692 -1.595 . . . . 50.34 106.692 175.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.486 HG21 ' HB1' ' A' ' 107' ' ' ALA . 1.6 mp -120.59 139.3 48.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 108.164 -1.05 . . . . 74.04 108.164 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.4 ' NH1' ' HA ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -118.54 146.84 44.25 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 123.29 0.369 . . . . 73.45 110.759 179.137 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.8 p90 -152.62 174.35 14.07 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.793 -1.558 . . . . 74.2 106.793 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -116.49 138.75 51.14 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.004 -1.85 . . . . 60.21 106.004 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.495 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 45.7 mt-10 -117.23 141.1 48.71 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 119.803 -0.759 . . . . 75.31 110.988 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -127.52 116.71 20.8 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.808 -1.182 . . . . 54.51 107.808 177.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 41.8 tt0 -125.5 114.94 19.45 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 121.162 0.506 . . . . 75.12 110.861 -177.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.98 134.3 39.16 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.732 -0.667 . . . . 55.22 109.49 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -111.28 118.57 36.25 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 123.396 0.679 . . . . 62.23 109.345 -175.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.2 mt -120.91 150.27 23.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.174 -1.417 . . . . 65.1 107.174 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -134.63 145.04 48.22 Favored 'General case' 0 C--O 1.266 1.924 0 C-N-CA 118.998 -1.081 . . . . 74.4 110.292 173.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.509 ' HB2' ' SG ' ' A' ' 132' ' ' CYS . 10.6 ttp180 -91.42 113.66 25.99 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 114.731 -1.122 . . . . 62.42 108.25 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 131' ' ' SER . 62.9 mtm180 -70.46 158.43 36.06 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.31 -1.314 . . . . 75.31 110.119 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -69.34 -15.07 63.25 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.875 0.845 . . . . 70.52 109.004 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -66.57 -17.76 64.99 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.068 -1.424 . . . . 63.01 108.918 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.72 -23.74 35.06 Favored Glycine 0 CA--C 1.504 -0.628 0 N-CA-C 111.315 -0.714 . . . . 54.51 111.315 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 36.6 t -88.49 133.82 34.03 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 115.07 -0.565 . . . . 72.22 110.33 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 126' ' ' ARG . 95.2 m -90.67 150.48 21.66 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 115.504 -0.771 . . . . 51.21 109.861 175.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 21.1 t90 -151.09 155.84 39.79 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.172 -1.047 . . . . 72.34 108.172 177.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.1 mt -65.85 117.62 8.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.196 -1.039 . . . . 73.33 108.196 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -75.37 -56.59 4.56 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.826 -1.546 . . . . 73.41 106.826 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 52.2 m -167.14 175.35 7.54 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.988 -1.486 . . . . 75.41 106.988 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.7 t -142.57 145.51 23.28 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 105.939 -1.874 . . . . 74.24 105.939 175.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -130.56 130.72 44.45 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-O 121.057 0.456 . . . . 71.21 109.773 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -115.58 126.97 54.89 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.985 -1.487 . . . . 73.44 106.985 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.7 pt -127.68 98.44 4.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 CA-C-O 122.304 1.049 . . . . 74.43 108.471 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 19.2 ptm -93.0 124.96 37.35 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 114.496 -1.229 . . . . 71.22 109.256 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.4 ' HA ' ' NH1' ' A' ' 116' ' ' ARG . 11.5 t 79.27 63.87 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.906 -1.497 . . . . 74.32 109.924 -176.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.495 ' HG2' ' OE1' ' A' ' 119' ' ' GLU . 23.4 tptm -98.31 136.47 38.44 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.139 -1.8 . . . . 71.21 106.139 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -136.46 143.94 44.12 Favored 'General case' 0 C--N 1.278 -2.513 0 C-N-CA 120.123 -0.631 . . . . 64.33 111.567 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.73 120.55 58.62 Favored Pre-proline 0 N--CA 1.424 -1.75 0 N-CA-C 106.819 -1.549 . . . . 73.4 106.819 173.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -56.04 141.21 87.07 Favored 'Trans proline' 0 C--O 1.257 1.429 0 C-N-CA 122.749 2.299 . . . . 62.43 111.38 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -62.16 145.11 54.34 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.633 -0.712 . . . . 72.41 110.141 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 31.0 m -80.82 128.62 38.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-O 120.996 0.427 . . . . 72.11 110.344 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.693 0 N-CA-C 107.611 -1.255 . . . . 51.43 107.611 177.781 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 . . . . . 0 CA--C 1.505 -0.757 0 N-CA-C 108.145 -1.058 . . . . 64.11 108.145 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.46 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 26.3 ttt -115.0 118.67 34.07 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.933 -1.136 . . . . 65.15 107.933 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.09 -44.43 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 113.47 0.915 . . . . 71.12 113.47 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.9 p -66.0 -40.63 91.33 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.154 0.502 . . . . 61.14 110.602 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 15' ' ' MET . 34.0 t70 -61.24 -44.95 96.43 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.238 -0.892 . . . . 73.14 110.298 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.62 -38.13 89.96 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-N 115.002 -0.999 . . . . 73.41 109.65 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.28 -47.69 63.85 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.346 -0.843 . . . . 74.53 109.816 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 m -71.95 -32.2 43.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 112.545 0.572 . . . . 72.25 112.545 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -72.0 -33.47 68.1 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.588 -0.893 . . . . 63.42 108.588 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.8 -37.59 92.43 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 110.823 -0.911 . . . . 72.13 110.823 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.5 tp -66.63 -50.1 64.09 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 124.544 1.138 . . . . 74.34 109.968 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.75 -44.3 98.11 Favored Glycine 0 C--O 1.245 0.841 0 N-CA-C 111.76 -0.536 . . . . 72.55 111.76 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -63.49 -42.61 98.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.692 -0.254 . . . . 73.55 110.46 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.72 -41.83 98.01 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 123.248 0.343 . . . . 72.14 110.806 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 33.5 t80 -62.05 -54.08 46.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.353 -0.84 . . . . 64.31 110.053 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 29' ' ' ILE . 9.8 mm -62.94 -39.37 84.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.406 -0.361 . . . . 55.32 111.774 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.29 -48.62 80.56 Favored 'General case' 0 C--O 1.198 -1.608 0 O-C-N 123.436 0.46 . . . . 73.15 110.782 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 41' ' ' SER . 4.0 pp -70.59 -25.0 62.86 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 119.734 -0.786 . . . . 74.35 112.055 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.7 t -70.9 -26.04 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.348 0.594 . . . . 70.35 109.896 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.5 p -119.77 28.16 8.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 122.156 0.979 . . . . 71.42 108.639 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.435 ' HB2' ' HA ' ' A' ' 31' ' ' LEU . 38.2 tptt -60.96 156.65 17.14 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.051 -1.431 . . . . 72.33 112.266 -175.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 5.2 p -52.62 141.75 34.13 Favored Pre-proline 0 N--CA 1.432 -1.328 0 C-N-CA 125.096 1.358 . . . . 52.15 112.307 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 35' ' ' SER . 31.4 Cg_exo -56.11 -18.7 24.09 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.825 3.017 . . . . 75.11 112.464 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -55.27 -27.83 49.26 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.604 -0.725 . . . . 70.25 110.158 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.2 p -111.24 102.77 11.16 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.862 -1.162 . . . . 71.11 107.862 174.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.3 -42.74 96.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 72.53 111.86 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -106.61 86.05 2.27 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 122.474 1.13 . . . . 74.31 110.504 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 36.8 m -68.6 -23.67 64.49 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.264 -1.335 . . . . 60.24 108.544 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.449 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 2.0 mp0 -61.38 -26.49 67.87 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 113.909 -1.496 . . . . 72.15 109.583 177.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -68.68 -42.43 77.85 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.443 -0.577 . . . . 73.44 109.443 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -69.07 -34.72 75.6 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 108.025 -1.102 . . . . 73.22 108.025 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 52.1 tp -66.22 -45.67 79.88 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 115.627 -0.715 . . . . 71.24 110.274 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.39 74.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.057 0.456 . . . . 72.1 110.949 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -75.24 -33.58 61.34 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 109.747 -0.464 . . . . 72.14 109.747 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 57.2 t80 -70.31 -46.31 64.49 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 123.286 0.634 . . . . 71.4 109.952 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 3.6 pp -84.24 -8.03 59.17 Favored 'General case' 0 C--O 1.194 -1.864 0 CA-C-N 115.654 -0.703 . . . . 73.42 112.146 -177.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -41.83 -57.49 3.42 Favored Glycine 0 CA--C 1.541 1.708 0 O-C-N 123.543 0.527 . . . . 70.44 113.574 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -85.48 -5.91 9.1 Favored 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 123.068 2.512 . . . . 72.34 112.768 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.481 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 16.0 m-70 -115.77 22.27 13.21 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.998 -0.439 . . . . 75.25 111.128 -172.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.502 ' CG ' ' HB ' ' A' ' 65' ' ' THR . 13.3 t70 -76.3 119.67 78.31 Favored Pre-proline 0 C--N 1.309 -1.173 0 O-C-N 123.337 0.398 . . . . 73.23 110.745 -174.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 9.9 Cg_endo -101.77 -150.33 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.431 0 C-N-CA 123.506 2.804 . . . . 62.31 111.993 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.67 118.64 24.52 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 107.711 -1.218 . . . . 72.15 107.711 172.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.484 HD13 ' HB2' ' A' ' 68' ' ' PHE . 52.9 mt -100.55 113.4 36.23 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.104 0 N-CA-C 107.753 -1.203 . . . . 64.13 107.753 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -100.34 112.37 24.71 Favored 'General case' 0 C--N 1.278 -2.534 0 O-C-N 121.048 -1.033 . . . . 74.12 111.578 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.453 HG22 ' HB2' ' A' ' 139' ' ' PHE . 70.4 t -115.11 117.69 56.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 108.793 -0.818 . . . . 73.03 108.793 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 60.34 21.7 11.22 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.503 1.127 . . . . 72.25 111.455 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.54 6.17 61.2 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.267 -0.878 . . . . 52.11 112.545 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -112.1 133.46 54.24 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.558 -0.534 . . . . 72.2 109.558 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.09 124.51 30.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 122.501 1.143 . . . . 72.25 109.392 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.401 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 66.6 mm-40 -117.92 136.96 53.14 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.589 -1.187 . . . . 54.32 107.966 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 t -93.43 174.78 7.03 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.266 -1.013 . . . . 71.14 108.266 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.502 ' HB ' ' CG ' ' A' ' 53' ' ' ASP . 8.8 t -51.24 -37.54 47.58 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 125.114 1.366 . . . . 60.34 111.529 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.4 m -62.84 -49.92 72.98 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.34 0.591 . . . . 75.23 110.135 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.48 -51.28 69.34 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.482 -0.781 . . . . 61.5 111.617 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.484 ' HB2' HD13 ' A' ' 56' ' ' ILE . 39.5 t80 -54.36 -55.45 28.41 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 123.22 0.325 . . . . 63.32 110.33 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -50.06 -44.62 51.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.852 -1.067 . . . . 71.22 110.737 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -58.23 -48.84 79.13 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.883 0.327 . . . . 72.04 111.883 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.485 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 33.1 m-85 -66.05 -37.89 86.98 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.615 0.722 . . . . 72.35 109.721 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -56.73 -54.16 49.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 123.965 0.906 . . . . 75.44 110.831 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -72.21 -22.02 61.32 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.317 -0.401 . . . . 74.42 111.608 -176.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -77.06 -16.44 59.25 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 112.457 0.54 . . . . 71.21 112.457 172.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.55 21.28 12.97 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.37 -0.919 . . . . 34.25 114.155 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.66 -54.76 6.23 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.504 0.668 . . . . 73.25 110.123 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.485 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 46.3 m-85 -83.22 5.7 22.03 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 115.898 -0.592 . . . . 64.23 112.057 -174.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.449 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 96.8 mttt -73.93 -14.11 61.0 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.843 0.83 . . . . 73.52 111.201 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -86.09 -19.08 30.74 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.095 -0.957 . . . . 55.52 108.705 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 80' ' ' LEU . 9.5 tt -77.76 -12.21 59.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.354 -0.839 . . . . 71.24 111.563 -171.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -74.1 -23.49 59.33 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.88 0.847 . . . . 71.3 109.182 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -96.5 13.61 27.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.857 -1.065 . . . . 70.15 110.131 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -81.48 147.27 29.8 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.736 -0.665 . . . . 65.14 111.563 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 103' ' ' TRP . 8.0 pt-20 -92.64 142.05 27.8 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.473 -0.785 . . . . 74.34 108.898 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.498 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 43.3 p90 -105.2 139.27 40.11 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.422 -0.511 . . . . 73.42 111.735 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -132.78 148.21 52.32 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.232 -0.895 . . . . 64.44 108.708 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.0 mm -89.78 118.43 35.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.019 -1.104 . . . . 73.1 108.019 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -86.61 153.73 21.56 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.753 -1.202 . . . . 62.43 107.753 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.6 m -70.17 80.4 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 122.592 1.186 . . . . 65.43 113.686 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.0 m -158.94 158.55 33.53 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.578 -1.638 . . . . 73.54 106.578 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 160.19 -99.21 0.18 Allowed Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 119.255 -1.45 . . . . 71.23 113.779 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.401 ' HA ' ' HB3' ' A' ' 97' ' ' GLU . 53.6 tptt -66.65 111.62 3.75 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 114.904 1.446 . . . . 73.34 114.904 -170.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' A' ' 97' ' ' GLU . 9.0 m -136.7 138.27 46.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 107.171 -1.418 . . . . 74.32 107.171 169.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -73.8 -7.24 51.42 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.607 0.965 . . . . 63.24 113.607 -172.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -87.8 -3.71 58.92 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.485 0.66 . . . . 72.43 110.217 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.74 100.24 1.13 Allowed Glycine 0 CA--C 1.487 -1.683 0 N-CA-C 107.844 -2.102 . . . . 70.3 107.844 -176.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.514 ' OE2' ' HD3' ' A' ' 126' ' ' ARG . 1.2 pm0 -60.17 141.38 56.03 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 113.767 1.025 . . . . 64.41 113.767 -173.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 125' ' ' TRP . . . -120.74 137.12 11.79 Favored Glycine 0 N--CA 1.411 -3.018 0 N-CA-C 109.475 -1.45 . . . . 62.31 109.475 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -108.06 140.36 41.35 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.747 -1.205 . . . . 72.14 107.747 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -125.05 99.08 5.95 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.91 -1.515 . . . . 54.41 106.91 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.5 mt -102.51 134.68 45.45 Favored 'General case' 0 C--N 1.274 -2.706 0 N-CA-C 107.984 -1.117 . . . . 74.35 107.984 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 9.8 p -123.89 125.23 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 119.414 -0.914 . . . . 65.2 112.861 -175.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.532 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 15.4 m-90 -101.06 148.8 24.64 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.629 -1.168 . . . . 74.11 109.6 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -118.61 120.9 38.83 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.415 -1.328 . . . . 75.34 107.415 172.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.447 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 35.2 t -72.32 176.78 4.98 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 123.977 0.798 . . . . 72.14 111.007 -176.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.29 162.02 23.68 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.905 -0.589 . . . . 75.24 110.435 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.46 108.84 4.47 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.739 0.78 . . . . 45.03 110.398 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -92.58 101.68 14.1 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.504 -1.295 . . . . 74.44 107.504 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.561 ' H ' ' HD3' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -59.14 119.46 7.36 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.498 -0.774 . . . . 73.25 110.345 176.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.8 t -103.03 161.29 13.89 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.115 -0.948 . . . . 72.34 109.822 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -61.57 -6.32 2.38 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.647 1.579 . . . . 74.24 114.3 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.532 ' HB2' ' HG2' ' A' ' 114' ' ' LYS . 0.5 OUTLIER -92.68 -4.66 52.89 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.6 -0.889 . . . . 71.12 108.6 179.297 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 68.69 42.07 1.52 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.454 1.121 . . . . 72.11 110.228 -171.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.532 ' HG2' ' HB2' ' A' ' 112' ' ' ASP . 18.2 pttp -129.22 158.0 40.27 Favored 'General case' 0 CA--C 1.487 -1.464 0 CA-C-N 113.912 -1.494 . . . . 63.35 107.369 173.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 26.1 pt -102.24 128.97 54.39 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.475 0 CA-C-O 121.113 0.482 . . . . 73.15 109.771 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.408 ' NH2' ' HA ' ' A' ' 142' ' ' SER . 0.8 OUTLIER -114.91 159.77 20.31 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 106.406 -1.702 . . . . 73.5 106.406 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 43.9 p90 -145.46 163.36 34.9 Favored 'General case' 0 C--N 1.265 -3.066 0 CA-C-O 121.464 0.649 . . . . 62.22 110.051 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 105' ' ' SER . 0.4 OUTLIER -102.62 136.9 41.6 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 106.206 -1.776 . . . . 64.11 106.206 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -114.21 141.14 47.91 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.487 -0.885 . . . . 70.41 108.974 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.66 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -123.2 117.49 25.46 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 115.472 -0.785 . . . . 62.34 111.307 -173.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -111.13 109.39 19.43 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.095 -1.076 . . . . 72.41 108.095 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.03 126.36 44.73 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 122.484 0.314 . . . . 70.33 110.48 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -103.69 119.3 38.62 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.584 -1.265 . . . . 74.41 107.584 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.438 HG22 ' SG ' ' A' ' 132' ' ' CYS . 50.2 mt -128.94 139.72 51.16 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 N-CA-C 106.315 -1.735 . . . . 75.22 106.315 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.429 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 0.2 OUTLIER -130.21 152.09 50.03 Favored 'General case' 0 C--O 1.256 1.428 0 C-N-CA 118.96 -1.096 . . . . 73.31 110.674 -177.733 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.514 ' HD3' ' OE2' ' A' ' 97' ' ' GLU . 45.6 ttp180 -74.81 114.49 13.31 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 105.965 -1.865 . . . . 61.43 105.965 174.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -81.43 145.48 30.75 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 108.271 -1.011 . . . . 75.0 108.271 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -66.4 -10.79 47.07 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 122.345 1.069 . . . . 75.35 110.12 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.78 -16.63 63.85 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.645 -1.161 . . . . 60.53 110.412 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.29 -23.43 20.68 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 111.482 -0.647 . . . . 72.1 111.482 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.0 t -100.47 -173.24 2.36 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.758 -0.83 . . . . 63.11 108.758 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.438 ' SG ' HG22 ' A' ' 124' ' ' ILE . 27.8 t -122.6 143.06 49.99 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.049 -1.834 . . . . 74.13 106.049 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.411 ' HE1' ' HA ' ' A' ' 52' ' ' HIS . 6.4 t90 -150.45 155.44 39.55 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 108.955 -0.757 . . . . 70.41 108.955 -172.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.59 130.75 42.64 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.938 0.399 . . . . 72.35 110.359 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -92.42 -43.29 9.29 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.746 -0.661 . . . . 71.01 109.646 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.5 t -179.41 151.33 0.47 Allowed 'General case' 0 C--O 1.194 -1.85 0 N-CA-C 106.582 -1.636 . . . . 71.23 106.582 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.2 m -134.95 152.37 32.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.832 -1.173 . . . . 74.51 107.832 173.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -128.64 133.64 48.31 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 122.72 0.408 . . . . 54.43 109.9 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.453 ' HB2' HG22 ' A' ' 58' ' ' VAL . 44.0 m-85 -121.98 112.4 18.24 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.185 -1.043 . . . . 71.22 108.185 176.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 17.2 pt -112.65 99.21 8.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 121.604 0.716 . . . . 60.51 111.926 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 52.2 mtt -86.78 94.65 9.59 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 106.415 -1.698 . . . . 74.51 106.415 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.408 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 66.5 m -162.74 -56.86 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.368 0.877 . . . . 75.43 113.368 -173.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -52.87 132.51 37.11 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.328 1.051 . . . . 72.24 112.744 -171.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -152.75 142.28 21.77 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.351 -0.841 . . . . 74.14 111.001 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.03 161.01 74.95 Favored Pre-proline 0 C--N 1.3 -1.571 0 O-C-N 124.036 0.835 . . . . 53.44 108.832 172.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.19 147.98 51.98 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.764 2.309 . . . . 60.31 111.712 176.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.449 ' HA ' ' HB3' ' A' ' 114' ' ' LYS . 6.1 p90 -61.87 160.12 12.67 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 113.089 0.774 . . . . 72.55 113.089 -176.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.5 p -101.93 148.74 7.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 108.242 -1.021 . . . . 74.42 108.242 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.962 0 N-CA-C 108.094 -1.076 . . . . 61.4 108.094 178.206 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 108.444 -0.947 . . . . 74.52 108.444 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.99 29.48 6.45 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.063 0.458 . . . . 70.53 111.284 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.78 -28.88 45.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 116.482 -0.326 . . . . 64.23 110.543 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.598 ' O ' HG23 ' A' ' 21' ' ' VAL . 1.4 p -63.87 -42.63 97.46 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.297 -0.41 . . . . 72.22 110.553 175.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.68 -38.49 91.17 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.841 0.856 . . . . 73.03 109.579 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.41 -37.12 84.49 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.265 -1.334 . . . . 71.21 108.182 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -73.12 -31.35 64.25 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.599 -0.728 . . . . 73.21 110.278 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 17' ' ' THR . 90.8 t -63.93 -50.19 78.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 109.688 -0.486 . . . . 71.2 109.688 175.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -30.21 66.71 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.398 -0.521 . . . . 64.24 110.438 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.43 -41.66 90.43 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 111.054 -0.818 . . . . 72.22 111.054 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 tp -63.04 -48.17 79.89 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 123.75 0.82 . . . . 74.44 109.146 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.95 -42.88 97.03 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.462 -0.79 . . . . 72.41 111.759 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -64.89 -44.33 89.98 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-O 119.773 -0.156 . . . . 74.45 111.194 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.35 -43.78 96.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.88 0.371 . . . . 61.12 110.251 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.463 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 26.7 t80 -62.39 -54.85 34.3 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 124.961 1.304 . . . . 73.44 110.113 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.2 mm -66.1 -34.06 67.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 112.24 0.459 . . . . 65.12 112.24 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.83 -39.15 73.16 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.572 -0.451 . . . . 71.45 110.043 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.63 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 4.1 pp -69.29 -30.25 68.3 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 119.556 -0.857 . . . . 65.14 110.846 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.7 t -72.08 -21.87 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 115.819 -0.628 . . . . 73.54 110.213 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.2 p -110.4 19.45 18.78 Favored 'General case' 0 C--O 1.248 0.991 0 O-C-N 121.455 -0.778 . . . . 74.3 111.887 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.63 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 70.6 mmtt -58.2 158.02 7.6 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-N 115.854 -0.612 . . . . 61.32 111.389 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.3 t -74.67 148.18 85.07 Favored Pre-proline 0 C--N 1.287 -2.11 0 N-CA-C 108.377 -0.971 . . . . 51.0 108.377 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -59.87 -6.03 4.28 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 123.858 3.039 . . . . 71.11 111.731 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.4 -27.48 67.48 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.009 0.924 . . . . 64.31 108.641 171.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.1 m -92.35 152.71 19.62 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 105.963 -1.866 . . . . 54.52 105.963 172.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.1 t -62.23 -53.21 50.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 113.208 0.818 . . . . 55.43 113.208 -174.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -158.08 125.4 5.07 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 119.618 -0.833 . . . . 72.33 112.204 -172.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -32.47 74.03 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 123.609 0.763 . . . . 75.32 112.14 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.04 -21.73 61.49 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.993 -0.549 . . . . 75.11 109.532 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -71.84 -42.35 67.05 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 107.42 -1.326 . . . . 71.51 107.42 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -66.16 -33.92 76.86 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.054 -0.976 . . . . 73.11 109.124 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.439 HD11 ' CE1' ' A' ' 28' ' ' PHE . 39.5 tp -69.91 -40.83 75.36 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.95 -0.568 . . . . 61.22 110.459 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.36 79.7 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.416 0.627 . . . . 73.21 109.915 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -69.59 -38.24 77.24 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.666 -1.152 . . . . 64.44 109.26 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.507 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 43.8 t80 -66.45 -45.31 80.21 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.353 -0.84 . . . . 71.42 110.308 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.3 pp -80.19 2.58 23.73 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.046 0.388 . . . . 71.33 112.046 -176.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -47.87 -62.52 4.09 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 111.729 -0.549 . . . . 42.35 111.729 173.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.507 ' HD2' ' O ' ' A' ' 48' ' ' PHE . 66.0 Cg_endo -79.99 -6.5 14.11 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.244 1.963 . . . . 72.3 112.363 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 92.4 m-70 -114.38 33.61 5.2 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 109.292 -0.632 . . . . 74.2 109.292 -176.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.436 ' CG ' HG21 ' A' ' 65' ' ' THR 0.267 13.5 t70 -53.76 99.03 0.19 Allowed Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 128.818 2.847 . . . . 74.01 111.516 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -113.06 -156.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 123.97 3.114 . . . . 74.13 113.089 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -92.75 127.87 38.41 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 107.608 -1.256 . . . . 74.33 107.608 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 65' ' ' THR . 43.2 mt -116.48 109.04 26.65 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 N-CA-C 109.046 -0.724 . . . . 61.24 109.046 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -91.18 138.89 31.24 Favored 'General case' 0 C--N 1.274 -2.698 0 O-C-N 122.176 -0.327 . . . . 64.31 110.487 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.76 120.07 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 N-CA-C 107.428 -1.323 . . . . 62.41 107.428 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 61.74 20.22 11.2 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.983 0.913 . . . . 72.43 110.636 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.41 3.67 58.55 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 115.922 -0.581 . . . . 73.55 113.208 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -111.67 132.39 54.64 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.021 -0.733 . . . . 72.13 109.021 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.77 126.15 34.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.689 0.757 . . . . 74.34 110.387 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -121.82 146.56 46.96 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.127 -1.434 . . . . 72.32 107.127 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -81.33 174.53 11.41 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.204 -0.598 . . . . 73.04 109.567 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.532 ' HA ' HD12 ' A' ' 56' ' ' ILE . 50.5 p -65.48 -33.92 77.07 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.528 1.131 . . . . 73.44 110.45 -176.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.526 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 25.0 m -62.53 -51.53 67.03 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.694 -1.139 . . . . 54.21 109.641 174.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.84 -48.51 79.56 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 123.628 0.771 . . . . 53.14 110.416 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CG ' HD13 ' A' ' 56' ' ' ILE . 31.6 t80 -49.87 -56.5 10.24 Favored 'General case' 0 CA--C 1.501 -0.931 0 O-C-N 123.751 0.657 . . . . 71.31 110.491 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -53.34 -42.95 67.29 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 124.517 1.135 . . . . 75.33 110.589 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.7 mm100 -61.75 -48.64 79.76 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 123.275 0.63 . . . . 73.12 111.234 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.462 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 34.3 m-85 -67.22 -40.27 86.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.314 0.578 . . . . 74.2 109.461 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -56.21 -51.31 68.55 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.765 -0.652 . . . . 72.43 110.653 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -72.05 -21.39 61.53 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 116.22 -0.446 . . . . 74.23 111.291 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -83.25 -2.5 55.76 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 120.793 -0.363 . . . . 75.52 111.889 173.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.09 12.09 50.48 Favored Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 120.632 -0.794 . . . . 34.44 114.136 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.83 -45.5 50.86 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 122.104 -0.645 . . . . 74.45 111.751 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 32.6 m-85 -97.08 0.83 49.25 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 113.819 1.044 . . . . 75.13 113.819 -175.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -67.74 -13.61 62.26 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.596 0.712 . . . . 64.33 111.374 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.424 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 8.4 mtpm? -72.25 -10.94 60.44 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.898 -0.592 . . . . 71.32 111.72 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.69 -7.28 59.58 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 121.067 0.461 . . . . 72.03 111.086 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.13 -26.39 64.87 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.469 0.652 . . . . 73.44 109.273 172.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -96.07 13.6 26.61 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.051 -0.522 . . . . 50.2 109.952 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -92.71 145.83 24.12 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.738 1.014 . . . . 64.23 113.738 -173.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -100.49 139.98 35.4 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.024 -1.843 . . . . 75.34 106.024 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.443 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 48.2 p90 -95.59 129.61 42.72 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.497 0.665 . . . . 70.1 112.222 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.61 103.33 14.15 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.184 -0.916 . . . . 73.34 108.612 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.3 tp -91.28 98.3 8.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 122.027 0.918 . . . . 71.02 110.226 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -90.05 170.34 10.42 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.731 -1.122 . . . . 64.52 109.228 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.7 p -70.49 106.31 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 121.631 0.729 . . . . 42.34 112.2 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.1 m -148.88 132.6 16.91 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.276 -0.875 . . . . 54.11 109.682 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 142.06 -47.12 0.84 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.143 -1.027 . . . . 71.21 113.318 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -83.38 83.8 7.74 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 113.878 1.066 . . . . 75.41 113.878 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.6 m -136.63 176.65 7.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.355 -1.72 . . . . 63.15 106.355 171.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -82.31 -59.43 2.55 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 113.09 0.774 . . . . 74.52 113.09 -176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -129.73 139.44 51.32 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.672 -0.492 . . . . 64.33 109.672 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.13 50.12 11.21 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 111.017 -0.833 . . . . 64.24 111.017 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -67.76 119.7 12.9 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.584 0.707 . . . . 72.44 111.235 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.28 148.79 17.52 Favored Glycine 0 N--CA 1.412 -2.935 0 CA-C-N 115.167 -0.924 . . . . 54.5 111.433 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -115.79 121.76 43.39 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.755 -1.202 . . . . 75.22 107.755 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.419 ' HE3' ' CD1' ' A' ' 123' ' ' TYR . 14.3 mptt -102.77 103.24 13.44 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 123.98 0.8 . . . . 74.13 108.952 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.25 125.1 48.86 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.161 -1.422 . . . . 64.24 107.161 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 15.3 t -124.4 134.64 66.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 119.796 -0.762 . . . . 71.24 110.492 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.443 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 18.8 m-90 -114.9 139.83 49.48 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.445 -0.946 . . . . 73.51 108.445 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.403 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 64.5 mttm -118.99 120.84 38.44 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.022 -1.103 . . . . 73.33 108.022 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 20.2 t -70.46 165.56 22.29 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.454 -0.943 . . . . 52.12 108.454 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.76 131.87 50.51 Favored 'General case' 0 C--O 1.239 0.515 0 O-C-N 123.249 0.343 . . . . 54.13 111.021 -176.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.88 129.75 36.64 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.094 0.473 . . . . 73.52 110.032 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -108.03 150.17 27.48 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.823 -1.547 . . . . 74.32 106.823 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -78.88 136.23 37.24 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 108.441 -0.948 . . . . 73.2 108.441 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.8 t -98.13 160.44 14.29 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.729 -0.841 . . . . 63.52 108.729 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -73.6 -14.11 61.13 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.69 0.757 . . . . 75.45 109.231 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -87.82 14.94 7.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.722 -0.672 . . . . 61.24 111.664 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 66.58 21.73 10.65 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.049 0.939 . . . . 73.1 111.8 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -114.53 -176.03 2.81 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.542 -1.281 . . . . 73.22 107.542 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 15.7 pt -121.55 153.04 25.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.832 -0.803 . . . . 75.02 108.832 172.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -133.92 142.61 47.8 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 123.23 0.612 . . . . 73.31 109.762 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.498 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 44.8 p90 -153.37 173.63 15.39 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.764 -0.828 . . . . 62.14 108.764 -176.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.4 ' H ' ' HB3' ' A' ' 105' ' ' SER . 8.1 m-20 -114.51 144.16 43.79 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.333 -1.358 . . . . 65.33 107.333 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.498 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 31.9 mt-10 -120.56 153.89 36.14 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 113.01 0.745 . . . . 72.33 113.01 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -137.07 120.93 17.52 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.731 -1.122 . . . . 75.1 108.939 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.418 ' HG3' HG22 ' A' ' 102' ' ' VAL . 88.6 tt0 -121.58 110.16 15.66 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.779 -0.823 . . . . 60.33 108.779 -176.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.57 133.94 41.45 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 122.933 0.493 . . . . 45.33 110.337 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.419 ' CD1' ' HE3' ' A' ' 100' ' ' LYS . 24.8 m-85 -113.53 116.85 30.19 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.703 -0.851 . . . . 75.35 108.703 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.9 mt -119.17 149.47 21.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.494 -1.669 . . . . 72.3 106.494 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -133.71 143.3 48.41 Favored 'General case' 0 C--O 1.265 1.898 0 C-N-CA 119.232 -0.987 . . . . 73.32 109.296 174.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -90.17 131.55 35.94 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 106.239 -1.763 . . . . 75.42 106.239 173.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.508 ' HD3' ' OG ' ' A' ' 131' ' ' SER . 54.4 mtp180 -85.39 144.58 27.94 Favored 'General case' 0 C--N 1.261 -3.242 0 N-CA-C 106.716 -1.587 . . . . 74.42 106.716 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -63.75 -10.57 20.42 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 114.651 1.352 . . . . 75.01 114.651 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -79.98 -14.17 58.78 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.726 -0.472 . . . . 73.35 109.726 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.88 -11.54 27.31 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.629 -0.796 . . . . 71.51 113.652 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.508 ' OG ' ' HD3' ' A' ' 127' ' ' ARG . 61.3 p -84.68 170.12 13.63 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 117.805 0.803 . . . . 73.04 109.72 175.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.564 ' SG ' ' HA ' ' A' ' 21' ' ' VAL . 13.7 p -138.02 142.3 40.39 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 108.395 -0.965 . . . . 62.21 108.395 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -150.08 155.66 40.27 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.291 -1.003 . . . . 73.21 108.291 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.9 mp -72.05 123.26 22.43 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.81 -0.441 . . . . 63.11 109.81 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -74.62 -52.91 10.44 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.149 -0.932 . . . . 74.32 109.009 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.4 t 179.52 156.91 0.58 Allowed 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 106.637 -1.616 . . . . 72.35 106.637 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.8 m -133.68 147.33 30.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 107.536 -1.283 . . . . 70.32 107.536 173.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -125.67 130.91 52.52 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-O 120.994 0.426 . . . . 65.05 109.979 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -110.23 135.85 50.34 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 107.878 -1.156 . . . . 72.22 107.878 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.528 ' HB ' ' CE ' ' A' ' 143' ' ' LYS . 12.3 pt -132.86 102.41 5.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 108.863 -0.792 . . . . 72.24 108.863 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 23.3 ptp -91.75 138.13 31.8 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.89 -0.724 . . . . 72.31 112.416 -173.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 35.3 m 59.34 77.97 0.29 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 113.456 -1.702 . . . . 74.33 114.08 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.528 ' CE ' ' HB ' ' A' ' 140' ' ' ILE . 5.9 mptp? -110.56 141.11 44.18 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.477 -1.238 . . . . 74.34 108.509 173.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -135.34 109.07 8.02 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.181 0.515 . . . . 41.43 109.997 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.77 159.09 34.11 Favored Pre-proline 0 C--N 1.294 -1.843 0 N-CA-C 109.208 -0.664 . . . . 75.02 109.208 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.81 129.79 35.85 Favored 'Trans proline' 0 CA--C 1.504 -0.982 0 C-N-CA 122.242 1.962 . . . . 74.52 111.102 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -139.32 131.15 27.59 Favored 'General case' 0 N--CA 1.392 -3.33 0 N-CA-C 107.847 -1.168 . . . . 73.4 107.847 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.4 m -92.28 122.45 43.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.544 0.687 . . . . 65.31 110.588 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.729 0 N-CA-C 107.633 -1.247 . . . . 74.34 107.633 178.94 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.491 -1.308 0 CA-C-O 121.137 0.494 . . . . 63.41 110.961 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.2 ttt -84.33 126.5 33.26 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 105.255 -2.128 . . . . 74.31 105.255 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.9 m -56.44 -26.39 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.454 0.909 . . . . 72.22 113.454 -173.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.639 ' O ' HG23 ' A' ' 21' ' ' VAL . 15.8 p -75.16 -22.77 57.87 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 112.195 0.443 . . . . 70.34 112.195 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.55 -35.55 60.64 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.351 -0.981 . . . . 71.52 108.351 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.91 -34.74 78.45 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.132 -1.394 . . . . 73.55 107.498 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 17' ' ' THR . 25.6 t70 -63.25 -43.28 98.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.433 -0.803 . . . . 74.5 109.669 177.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 17' ' ' THR . 57.7 t -61.04 -56.7 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 O-C-N 123.837 0.711 . . . . 64.21 111.077 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -64.14 -34.3 77.74 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.326 -0.55 . . . . 71.0 110.797 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.53 ' HA2' ' CE1' ' A' ' 26' ' ' TYR . . . -62.22 -51.45 56.55 Favored Glycine 0 C--O 1.256 1.519 0 CA-C-N 115.887 -0.597 . . . . 65.25 112.303 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 pp -70.63 -30.38 67.01 Favored 'General case' 0 C--O 1.21 -0.999 0 N-CA-C 108.48 -0.933 . . . . 70.43 108.48 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.14 -44.43 76.54 Favored Glycine 0 N--CA 1.424 -2.107 0 CA-C-N 115.729 -0.669 . . . . 51.54 111.849 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.53 ' CE1' ' HA2' ' A' ' 23' ' ' GLY . 2.9 p90 -74.59 -35.23 62.99 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 119.272 -0.971 . . . . 73.13 110.459 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -63.63 -46.76 84.22 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.351 -0.611 . . . . 52.22 109.351 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 33.0 t80 -61.58 -52.7 63.35 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 115.35 -0.841 . . . . 74.2 110.554 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 29' ' ' ILE . 9.3 mm -61.14 -39.03 81.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 112.643 0.609 . . . . 65.3 112.643 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -68.15 -40.21 82.45 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 119.697 -0.801 . . . . 74.43 110.365 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.615 ' HA ' ' HD3' ' A' ' 34' ' ' LYS . 4.0 pp -71.59 -26.77 62.74 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 119.134 -1.026 . . . . 73.42 112.311 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.2 t -70.72 -25.74 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 109.363 -0.606 . . . . 42.32 109.363 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.4 p -107.94 19.31 20.2 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.308 0.575 . . . . 73.51 110.226 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.615 ' HD3' ' HA ' ' A' ' 31' ' ' LEU . 17.8 tptt -61.83 143.21 56.68 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-N 115.196 -0.911 . . . . 72.4 109.446 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.6 m -55.53 141.58 63.37 Favored Pre-proline 0 C--N 1.309 -1.159 0 O-C-N 123.78 0.675 . . . . 74.55 112.216 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.53 -7.44 20.33 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.332 2.688 . . . . 74.01 112.883 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -79.63 -26.53 41.1 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.944 -0.571 . . . . 55.43 109.954 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.3 m -70.46 172.87 7.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.816 -0.809 . . . . 73.33 108.816 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.2 t -52.54 -53.69 18.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 112.255 0.465 . . . . 73.35 112.255 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 173.43 134.81 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.836 0.71 . . . . 74.13 109.243 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.7 m -58.11 -38.92 77.39 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.24 0.543 . . . . 73.31 110.283 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -68.43 -20.85 64.67 Favored 'General case' 0 C--O 1.204 -1.292 0 CA-C-N 115.153 -0.93 . . . . 64.5 110.135 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -67.16 -47.23 71.65 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.412 -0.959 . . . . 52.45 108.412 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 18.3 mm-40 -71.04 -34.38 71.2 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 114.744 -1.116 . . . . 52.22 109.52 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.1 tp -66.16 -45.87 79.43 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 120.961 -0.296 . . . . 74.31 110.656 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.401 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . . . -60.45 -34.14 73.56 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.57 0.7 . . . . 73.55 110.661 176.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -70.67 -39.56 73.49 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.379 -0.828 . . . . 75.2 109.902 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 62.4 t80 -68.04 -40.43 82.84 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 124.38 1.072 . . . . 73.23 110.565 -178.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.7 pp -83.13 0.94 42.88 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 115.689 -0.687 . . . . 72.35 110.864 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.45 -58.21 4.72 Favored Glycine 0 CA--C 1.536 1.378 0 O-C-N 123.965 0.791 . . . . 71.4 113.439 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.89 -6.3 12.3 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 121.922 1.748 . . . . 62.11 112.172 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 10.9 m170 -108.82 32.22 5.06 Favored 'General case' 0 C--O 1.213 -0.862 0 C-N-CA 123.417 0.687 . . . . 73.13 109.807 -175.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.421 ' CG ' HG21 ' A' ' 65' ' ' THR . 13.0 t70 -53.57 98.58 0.17 Allowed Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 127.515 2.326 . . . . 63.53 110.633 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -114.54 -147.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 124.48 3.453 . . . . 65.31 113.188 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -102.71 128.77 49.28 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 108.717 -0.846 . . . . 74.44 108.717 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.433 HG22 HG23 ' A' ' 58' ' ' VAL . 3.4 mp -107.91 111.71 37.06 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.369 0 N-CA-C 108.862 -0.792 . . . . 74.54 108.862 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -95.97 109.57 21.93 Favored 'General case' 0 C--O 1.18 -2.553 0 O-C-N 121.742 -0.599 . . . . 73.32 111.334 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 56' ' ' ILE . 70.6 t -109.14 114.34 46.64 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.539 0 N-CA-C 108.392 -0.966 . . . . 74.22 108.392 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 63.93 20.83 12.39 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.524 1.13 . . . . 75.42 110.311 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.93 -10.08 62.0 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 114.961 -1.018 . . . . 61.33 112.022 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -93.59 130.51 39.46 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 110.069 -0.345 . . . . 74.1 110.069 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.68 121.07 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-O 122.611 1.196 . . . . 73.34 109.163 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -115.22 137.88 51.55 Favored 'General case' 0 C--N 1.271 -2.811 0 N-CA-C 106.451 -1.685 . . . . 74.23 106.451 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 67' ' ' ALA . 15.2 t -77.1 168.21 20.46 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 108.606 -0.887 . . . . 41.32 108.606 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.421 HG21 ' CG ' ' A' ' 53' ' ' ASP . 46.9 p -63.76 -32.83 74.45 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 123.981 0.912 . . . . 75.54 110.472 -176.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -62.65 -46.84 86.37 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.221 -1.354 . . . . 73.43 109.888 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.451 ' H ' HG23 ' A' ' 64' ' ' THR . . . -64.96 -44.9 87.89 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 123.549 0.74 . . . . 64.43 110.469 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -53.58 -54.35 38.68 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 123.477 0.486 . . . . 74.21 110.137 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -52.15 -41.42 62.55 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 124.306 1.003 . . . . 54.41 110.643 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.491 ' HG2' ' NH2' ' A' ' 73' ' ' ARG . 48.5 mt-30 -60.26 -51.47 69.39 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.279 -0.419 . . . . 74.4 111.556 175.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -63.33 -32.98 74.55 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.981 0.896 . . . . 74.41 110.393 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -62.07 -53.51 54.52 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.419 -1.264 . . . . 62.24 111.169 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.491 ' NH2' ' HG2' ' A' ' 70' ' ' GLN . 26.1 ptt180 -71.29 -20.7 62.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.96 0.409 . . . . 73.45 110.561 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 56.3 mt-30 -76.88 -9.2 58.52 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.229 -0.442 . . . . 71.41 110.941 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.57 7.48 64.92 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.941 -0.647 . . . . 70.43 114.024 174.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.2 mt -65.92 -28.81 69.2 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 117.161 0.481 . . . . 75.4 112.273 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -99.18 12.63 35.6 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.529 -0.469 . . . . 74.2 111.912 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.435 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 30.1 mmmt -70.78 -17.34 62.78 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.388 0.613 . . . . 72.12 110.434 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -83.27 -22.51 33.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.83 -0.623 . . . . 34.01 110.001 175.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.0 tp -76.68 -6.72 53.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.854 -0.612 . . . . 73.23 111.453 -172.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 1.6 pptp? -76.76 -3.65 39.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.618 0.723 . . . . 75.31 110.687 177.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -100.93 10.83 40.65 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 115.295 -0.866 . . . . 75.43 110.147 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.714 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -76.14 130.07 37.74 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-O 121.406 0.622 . . . . 74.14 112.301 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -112.6 150.02 31.97 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.855 -1.066 . . . . 75.04 109.871 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -72.44 128.5 35.79 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 123.774 0.671 . . . . 72.15 111.041 -174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -129.86 137.99 50.73 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 116.148 -0.478 . . . . 75.32 110.01 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.8 pt -93.04 78.07 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.935 0.874 . . . . 63.53 113.158 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -97.08 160.65 14.22 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.548 -1.278 . . . . 74.55 107.548 175.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.5 m -62.75 139.14 21.62 Favored 'Isoleucine or valine' 0 C--O 1.25 1.112 0 N-CA-C 113.248 0.833 . . . . 74.41 113.248 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.9 m -81.59 -43.07 19.16 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.049 -0.978 . . . . 74.34 109.03 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.54 44.29 90.34 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.546 -0.752 . . . . 74.45 113.058 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -89.59 89.32 7.77 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.997 -0.372 . . . . 75.41 109.997 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.54 -52.15 17.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.835 -0.802 . . . . 74.43 108.835 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -157.71 133.89 9.5 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.228 -0.896 . . . . 71.34 108.698 175.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -179.15 -61.31 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.648 -1.612 . . . . 71.43 106.648 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.38 165.71 32.48 Favored Glycine 0 C--N 1.279 -2.633 0 N-CA-C 106.587 -2.605 . . . . 53.31 106.587 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -76.23 119.91 20.78 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 118.285 1.043 . . . . 73.21 108.842 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -165.25 -167.53 25.99 Favored Glycine 0 N--CA 1.417 -2.569 0 C-N-CA 119.718 -1.23 . . . . 62.13 112.568 -176.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.08 157.42 41.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 109.033 -0.729 . . . . 64.34 109.033 -174.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 57.9 tttm -147.41 100.13 3.22 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.93 -1.137 . . . . 74.54 107.93 174.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -110.31 158.88 17.94 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.766 -0.827 . . . . 54.0 108.766 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.2 p -134.51 140.56 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 121.667 0.746 . . . . 63.33 111.838 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.714 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 24.1 m-90 -116.15 127.69 55.03 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.689 -1.141 . . . . 74.25 108.172 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.431 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 66.3 mttm -105.9 131.96 52.58 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.147 -0.686 . . . . 74.22 109.147 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.2 t -75.01 -174.63 2.31 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.506 -0.924 . . . . 63.21 108.506 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.23 153.16 38.9 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.307 -0.627 . . . . 73.55 109.307 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.11 129.63 42.13 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 108.999 -0.741 . . . . 34.5 108.999 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -112.35 137.43 50.53 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.184 -1.043 . . . . 64.12 108.184 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -75.95 132.17 40.07 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.396 0.617 . . . . 72.15 110.91 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.7 t -92.04 161.77 14.64 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.099 -0.955 . . . . 71.45 109.183 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -60.69 -28.13 68.38 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.244 1.018 . . . . 73.01 111.224 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.462 ' OD2' ' HG2' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -88.77 15.76 7.82 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.378 -0.828 . . . . 64.24 112.856 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 73.0 10.07 5.34 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.032 0.933 . . . . 50.31 112.608 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.462 ' HG2' ' OD2' ' A' ' 112' ' ' ASP . 26.3 pttm -103.72 172.7 6.66 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.844 -1.169 . . . . 73.25 107.844 174.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 16.1 pt -114.44 140.37 35.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.733 -0.787 . . . . 71.32 111.765 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.61 133.15 54.99 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.982 -1.008 . . . . 75.55 109.083 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 2.8 p90 -129.15 174.06 9.91 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 108.772 -0.825 . . . . 73.11 108.772 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -110.5 135.56 50.98 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.963 -1.495 . . . . 74.33 106.963 176.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.468 ' HB2' HG13 ' A' ' 140' ' ' ILE . 46.0 mt-10 -116.83 156.53 27.11 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.919 -0.713 . . . . 52.13 111.89 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -135.87 117.53 14.97 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.923 -1.035 . . . . 71.31 108.415 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -112.79 112.31 23.71 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.845 -0.798 . . . . 75.52 108.845 -175.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -98.16 131.76 44.26 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.402 -0.519 . . . . 54.31 110.716 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -108.77 121.81 45.84 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 114.478 -1.237 . . . . 74.41 108.206 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.425 HG12 HD23 ' A' ' 134' ' ' LEU . 50.8 mt -124.3 137.12 58.26 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 N-CA-C 107.53 -1.285 . . . . 72.43 107.53 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -114.37 150.31 34.78 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.298 -1.742 . . . . 74.35 106.298 176.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -111.67 136.56 50.73 Favored 'General case' 0 N--CA 1.403 -2.817 0 C-N-CA 118.293 -1.363 . . . . 73.34 110.385 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.403 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 61.4 ttt180 -88.83 154.82 19.95 Favored 'General case' 0 C--N 1.258 -3.389 0 CA-C-N 112.912 -1.949 . . . . 74.22 109.366 -170.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -59.78 -26.62 65.87 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.466 0.706 . . . . 52.33 110.91 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.403 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 31.1 t70 -67.01 -16.22 64.23 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.43 -0.805 . . . . 72.25 110.773 175.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.62 -23.64 29.26 Favored Glycine 0 C--O 1.221 -0.683 0 O-C-N 121.921 -0.487 . . . . 74.41 112.111 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.9 t -73.0 140.47 47.35 Favored 'General case' 0 N--CA 1.42 -1.933 0 C-N-CA 123.483 0.713 . . . . 74.15 109.532 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 81.3 m -104.57 141.92 35.56 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.195 -1.039 . . . . 74.15 108.195 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -140.54 154.56 46.58 Favored 'General case' 0 N--CA 1.408 -2.56 0 N-CA-C 107.941 -1.133 . . . . 62.31 107.941 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.425 HD23 HG12 ' A' ' 124' ' ' ILE . 78.9 mt -67.9 116.14 8.21 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.25 -0.648 . . . . 60.25 109.25 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -80.84 -46.41 15.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 106.921 -1.511 . . . . 74.41 106.921 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.8 p -174.75 172.97 2.88 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.002 -0.999 . . . . 71.1 108.74 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.6 t -144.05 141.12 24.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 106.596 -1.631 . . . . 74.21 106.596 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -119.08 132.37 56.01 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 109.5 -0.555 . . . . 70.33 109.5 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.425 ' HB2' HG22 ' A' ' 58' ' ' VAL . 64.4 m-85 -115.28 131.72 56.84 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.604 -1.258 . . . . 64.41 107.604 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.468 HG13 ' HB2' ' A' ' 119' ' ' GLU . 4.5 pt -132.12 99.04 3.4 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 CA-C-O 121.71 0.767 . . . . 62.51 110.811 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 21.6 ptp -85.07 126.22 33.4 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.843 -1.071 . . . . 50.21 109.805 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.7 t 77.42 74.32 0.07 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.548 1.139 . . . . 61.24 112.016 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -113.12 128.7 56.56 Favored 'General case' 0 CA--C 1.47 -2.109 0 N-CA-C 107.167 -1.42 . . . . 74.33 107.167 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -119.3 128.06 53.79 Favored 'General case' 0 C--N 1.259 -3.349 0 CA-C-N 115.029 -0.987 . . . . 61.15 112.826 -171.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.75 133.03 33.21 Favored Pre-proline 0 N--CA 1.426 -1.654 0 N-CA-C 107.79 -1.189 . . . . 70.4 107.79 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.43 147.11 82.16 Favored 'Trans proline' 0 C--O 1.246 0.891 0 C-N-CA 122.23 1.953 . . . . 61.23 111.108 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -80.72 147.49 30.55 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 107.63 -1.248 . . . . 74.31 107.63 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.6 106.18 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 122.283 1.04 . . . . 63.41 112.554 -174.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.656 0 CA-C-N 114.589 -1.187 . . . . 65.42 108.709 -179.851 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 CA--C 1.5 -0.98 0 N-CA-C 109.763 -0.458 . . . . 71.52 109.763 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.469 ' H ' HD12 ' A' ' 19' ' ' LEU . 52.5 ttm 62.61 17.78 9.97 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.558 1.143 . . . . 74.12 110.715 -176.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.3 t -73.04 148.01 9.37 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.882 0 N-CA-C 105.344 -2.095 . . . . 64.54 105.344 175.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.4 p -45.59 -47.07 14.64 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.298 0.954 . . . . 64.53 113.431 -177.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 17.2 t70 -59.89 -45.45 92.46 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-O 122.083 0.944 . . . . 62.42 111.028 177.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.469 HD12 ' H ' ' A' ' 15' ' ' MET . 3.4 tm? -72.36 -33.83 67.54 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.865 -1.061 . . . . 72.11 108.39 -177.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -65.45 -47.43 76.18 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 124.751 1.22 . . . . 64.24 109.982 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.507 ' HA ' ' CD2' ' A' ' 24' ' ' LEU . 6.3 p -65.85 -43.06 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 112.327 0.491 . . . . 73.41 112.327 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 13.4 ptpt -71.25 -24.51 62.19 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 118.659 -1.216 . . . . 75.32 111.23 177.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.33 -56.49 10.09 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.782 -0.645 . . . . 71.44 112.323 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.507 ' CD2' ' HA ' ' A' ' 21' ' ' VAL . 1.7 pt? -70.09 -30.65 67.92 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 118.965 -1.094 . . . . 74.12 109.629 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.9 -42.17 98.47 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.664 -0.698 . . . . 51.1 111.92 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -69.03 -43.67 74.25 Favored 'General case' 0 C--O 1.208 -1.084 0 C-N-CA 119.795 -0.762 . . . . 75.33 110.759 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -57.75 -43.9 85.71 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.154 0.502 . . . . 70.3 110.1 -177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.501 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 26.5 t80 -62.3 -54.23 43.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.725 -1.125 . . . . 72.22 110.149 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.6 mm -63.42 -33.96 64.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 112.296 0.48 . . . . 65.13 112.296 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -68.82 -43.73 74.94 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 110.181 -0.303 . . . . 54.24 110.181 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.6 pp -68.19 -31.18 70.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.979 -0.688 . . . . 73.24 110.562 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.72 -27.49 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 116.06 -0.518 . . . . 62.43 110.103 175.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.8 p -107.51 19.83 19.7 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.485 0.659 . . . . 53.14 110.299 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 34' ' ' LYS . 20.5 tptt -77.26 158.14 30.41 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.749 -0.66 . . . . 65.13 109.62 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 m -56.39 131.3 76.25 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.474 0.71 . . . . 64.02 111.521 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.31 -7.11 20.04 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.614 2.876 . . . . 70.02 111.544 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.73 -19.58 65.78 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.26 1.424 . . . . 72.33 110.58 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -76.08 -176.56 3.55 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 107.92 -1.141 . . . . 71.45 107.92 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.64 -50.01 82.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 118.341 0.519 . . . . 74.55 111.575 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.3 t30 177.2 131.07 0.05 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.566 -0.531 . . . . 63.15 109.566 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.3 m -60.86 -35.19 75.94 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-O 121.44 0.638 . . . . 74.03 110.384 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -66.66 -20.75 66.06 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.923 -1.035 . . . . 74.4 110.946 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -67.68 -47.35 69.69 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 108.944 -0.761 . . . . 70.43 108.944 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -68.23 -34.32 76.02 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.084 -0.962 . . . . 73.35 108.741 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.4 HD11 ' CE2' ' A' ' 28' ' ' PHE . 36.1 tp -66.47 -44.68 82.06 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 116.129 -0.487 . . . . 54.12 110.42 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.77 -33.12 73.51 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.431 0.634 . . . . 32.24 110.408 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -77.12 -32.36 56.39 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.203 -0.908 . . . . 53.02 109.756 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -68.9 -47.31 66.11 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.772 -0.455 . . . . 73.22 109.772 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.6 pp -73.33 -2.56 22.6 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.766 -0.652 . . . . 65.13 112.363 -176.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -39.24 -67.44 0.59 Allowed Glycine 0 CA--C 1.538 1.487 0 O-C-N 123.908 0.755 . . . . 70.31 113.123 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.402 ' O ' ' HZ2' ' A' ' 133' ' ' TRP . 7.8 Cg_exo -78.78 -6.4 15.19 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.823 2.348 . . . . 64.53 113.002 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 70.1 m80 -110.5 24.73 12.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.704 -0.48 . . . . 75.2 109.704 -172.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.446 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 8.3 t70 -55.91 109.47 1.67 Allowed Pre-proline 0 C--O 1.244 0.811 0 C-N-CA 124.654 1.181 . . . . 75.31 111.965 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -112.98 -149.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 124.257 3.304 . . . . 73.32 110.577 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -92.12 119.16 31.52 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 107.986 -1.116 . . . . 74.43 107.986 172.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.475 HD13 ' CB ' ' A' ' 68' ' ' PHE . 67.5 mt -101.16 112.71 34.99 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.683 0 N-CA-C 106.552 -1.647 . . . . 74.53 106.552 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -98.09 133.24 42.81 Favored 'General case' 0 C--N 1.259 -3.357 0 C-N-CA 119.891 -0.724 . . . . 65.44 109.298 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.3 t -128.28 114.68 35.21 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 107.31 -1.367 . . . . 75.32 107.31 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 63.53 20.57 12.31 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.947 1.299 . . . . 75.24 110.473 -176.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.55 -3.24 65.59 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.672 -0.694 . . . . 43.01 112.286 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -98.48 133.14 43.28 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.934 -0.765 . . . . 64.44 108.934 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.401 HD13 ' N ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -73.63 125.41 32.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 122.152 0.977 . . . . 70.42 109.81 -175.863 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 58.9 mm-40 -124.65 148.02 48.18 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 115.044 -0.98 . . . . 63.3 108.727 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 t -95.14 172.21 8.26 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.517 -1.29 . . . . 74.45 107.517 173.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.446 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 9.1 t -54.06 -34.92 61.36 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 112.731 0.641 . . . . 73.52 112.731 -177.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.538 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 73.0 m -65.43 -48.31 73.2 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 120.869 -0.332 . . . . 74.14 110.696 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -59.12 -45.71 90.2 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 122.668 0.387 . . . . 75.5 110.16 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.475 ' CB ' HD13 ' A' ' 56' ' ' ILE . 56.7 t80 -54.21 -55.82 24.3 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 123.441 0.463 . . . . 75.54 110.032 174.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.86 -39.88 59.65 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.767 -1.106 . . . . 71.33 110.885 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.9 mm100 -63.81 -47.6 80.2 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 123.048 0.539 . . . . 64.4 111.375 177.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.43 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 31.7 m-85 -66.35 -32.67 74.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.816 0.817 . . . . 64.0 109.684 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -61.93 -56.02 23.54 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.008 -0.996 . . . . 52.33 110.617 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -69.16 -22.81 63.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.465 -0.334 . . . . 63.23 111.777 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 53.1 mt-30 -74.43 -16.1 60.88 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.164 0.507 . . . . 64.23 110.905 174.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.24 7.4 52.19 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.245 -0.978 . . . . 62.41 113.635 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.0 mt -70.72 -43.31 69.2 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.08 0.467 . . . . 72.03 110.641 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 32.3 m-85 -83.9 -4.45 58.7 Favored 'General case' 0 C--O 1.211 -0.945 0 C-N-CA 120.303 -0.559 . . . . 73.13 111.066 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.01 -14.44 61.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.673 0.749 . . . . 63.25 109.462 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -84.81 -29.02 25.73 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.58 -0.896 . . . . 74.55 108.58 175.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.519 ' HA ' ' OG ' ' A' ' 105' ' ' SER . 8.6 tt -84.45 -6.62 59.39 Favored 'General case' 0 C--O 1.2 -1.517 0 CA-C-N 114.835 -1.075 . . . . 73.3 110.919 -172.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -66.57 -10.96 50.65 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.608 0.718 . . . . 74.35 112.296 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -98.35 14.33 28.37 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.684 -0.689 . . . . 54.24 109.359 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.713 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -69.81 130.55 42.6 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 113.799 1.037 . . . . 65.31 113.799 -176.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -104.3 139.86 38.69 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.237 -1.347 . . . . 61.24 107.575 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.44 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 44.2 p90 -81.98 142.43 32.4 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.99 -0.684 . . . . 75.41 111.77 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.35 149.05 28.27 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 115.057 -0.974 . . . . 64.1 108.524 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 51.1 mm -79.23 124.49 37.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.433 -0.951 . . . . 74.4 108.433 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -146.8 140.9 26.15 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 106.027 -1.842 . . . . 74.13 106.027 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.303 28.0 m 45.79 96.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.794 1.638 . . . . 73.02 115.045 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.0 m -78.75 89.12 4.61 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 114.83 -1.077 . . . . 74.03 108.871 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.42 147.16 19.06 Favored Glycine 0 N--CA 1.424 -2.137 0 N-CA-C 110.344 -1.102 . . . . 43.45 110.344 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -113.07 -177.67 3.19 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.319 -0.552 . . . . 72.1 111.756 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.8 m -85.66 22.05 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 123.596 0.758 . . . . 55.11 112.052 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -51.49 16.11 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.825 0.676 . . . . 64.1 112.825 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -120.84 163.97 17.36 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.913 -0.403 . . . . 73.43 109.913 -175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 126' ' ' ARG . . . -79.49 91.97 1.29 Allowed Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 112.054 -0.418 . . . . 72.03 112.054 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -136.05 175.21 9.81 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.861 -1.163 . . . . 74.44 107.861 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -104.31 148.95 16.94 Favored Glycine 0 N--CA 1.427 -1.938 0 C-N-CA 120.242 -0.98 . . . . 54.41 112.524 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -106.87 145.32 32.31 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.142 -1.058 . . . . 63.31 108.142 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.12 100.24 6.86 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.875 -1.528 . . . . 70.24 106.875 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.6 mt -108.83 127.48 54.06 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 108.204 -1.036 . . . . 70.45 108.204 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 18.8 t -123.44 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 120.262 -0.575 . . . . 64.52 110.736 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.713 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 19.3 m-90 -111.06 145.15 39.02 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.402 -0.817 . . . . 71.3 109.093 176.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 83' ' ' ALA . 51.1 mttm -119.31 120.36 36.73 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.593 -0.892 . . . . 71.33 108.593 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.519 ' OG ' ' HA ' ' A' ' 80' ' ' LEU . 29.1 t -75.08 177.48 6.37 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 124.215 1.006 . . . . 64.04 111.399 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.0 139.31 54.99 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.879 -0.601 . . . . 62.31 109.608 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.499 ' HB1' ' HB ' ' A' ' 115' ' ' ILE . . . -82.74 120.92 26.21 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-N 115.922 -0.581 . . . . 73.21 109.696 -177.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -107.11 141.1 38.89 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.101 -1.074 . . . . 75.44 108.101 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.4 ttm-85 -78.35 118.12 20.23 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.547 -0.909 . . . . 73.4 108.547 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 99.3 p -91.31 -174.88 4.08 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.113 -0.949 . . . . 51.52 110.795 -173.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -82.94 -13.14 56.6 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.097 0.475 . . . . 75.25 110.344 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.419 ' HB2' ' HG2' ' A' ' 114' ' ' LYS . 19.1 m-20 -90.0 9.79 26.56 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.62 -0.718 . . . . 54.22 110.723 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 69.86 12.88 7.99 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.319 1.048 . . . . 73.32 112.152 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.419 ' HG2' ' HB2' ' A' ' 112' ' ' ASP . 26.1 pttm -111.57 165.45 12.0 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.034 -0.728 . . . . 61.33 109.034 176.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.499 ' HB ' ' HB1' ' A' ' 107' ' ' ALA . 21.2 pt -107.35 127.52 63.11 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 108.751 -0.833 . . . . 75.12 108.751 175.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 107' ' ' ALA . 41.6 ptt85 -112.62 159.31 19.0 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.237 -0.653 . . . . 74.05 109.237 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 36.9 p90 -136.13 173.97 11.13 Favored 'General case' 0 C--N 1.272 -2.784 0 N-CA-C 108.699 -0.852 . . . . 75.45 108.699 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.51 ' H ' ' HB3' ' A' ' 105' ' ' SER . 2.4 m-20 -112.08 136.8 50.98 Favored 'General case' 0 C--N 1.259 -3.339 0 N-CA-C 105.872 -1.899 . . . . 65.25 105.872 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.414 ' CD ' ' HD3' ' A' ' 143' ' ' LYS . 86.9 mt-10 -114.7 145.29 42.22 Favored 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 119.411 -0.915 . . . . 73.22 110.119 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -126.32 117.24 22.59 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 115.123 -0.944 . . . . 71.54 109.424 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -110.64 110.04 20.56 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.731 -0.84 . . . . 75.35 108.731 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.65 125.06 42.2 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 109.315 -0.624 . . . . 61.41 109.315 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -106.89 112.48 25.46 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.946 -1.131 . . . . 62.11 107.946 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 54.6 mt -110.74 146.84 15.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.283 0 N-CA-C 107.348 -1.353 . . . . 63.31 107.348 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.427 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.3 OUTLIER -129.24 150.5 50.59 Favored 'General case' 0 C--O 1.262 1.75 0 N-CA-C 108.028 -1.101 . . . . 72.21 108.028 177.016 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 40.3 ttp85 -85.45 112.57 21.01 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.408 -1.33 . . . . 73.52 107.408 176.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -67.41 150.43 48.94 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.852 -1.067 . . . . 73.41 109.132 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -57.82 -15.7 9.19 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.855 1.262 . . . . 71.4 111.411 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -81.06 -6.38 58.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.828 -0.624 . . . . 75.42 111.411 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.4 -25.25 15.97 Favored Glycine 0 CA--C 1.504 -0.597 0 N-CA-C 114.816 0.687 . . . . 52.34 114.816 172.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.5 m -103.79 166.56 10.34 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 109.399 -0.593 . . . . 73.23 109.399 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 63.9 m -98.66 154.7 17.76 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.866 -0.42 . . . . 52.23 109.866 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.427 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 25.0 t-105 -150.09 155.13 39.3 Favored 'General case' 0 N--CA 1.412 -2.368 0 N-CA-C 106.681 -1.6 . . . . 74.14 106.681 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.03 119.71 10.0 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.682 -0.488 . . . . 64.04 109.682 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -83.72 -53.8 5.37 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.693 -1.225 . . . . 71.51 107.693 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.6 m -164.62 157.42 16.85 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 106.396 -1.705 . . . . 71.34 106.396 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.95 154.8 31.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 107.472 -1.307 . . . . 72.1 107.472 173.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -130.55 137.35 49.65 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 110.112 -0.329 . . . . 71.31 110.112 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -120.63 118.02 29.05 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.873 -1.158 . . . . 61.53 107.873 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.5 pt -116.03 102.78 14.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-O 121.504 0.669 . . . . 73.51 110.851 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.8 mtp -96.33 92.45 6.34 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.802 -1.555 . . . . 64.31 106.802 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.4 m -177.23 -49.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 112.754 0.65 . . . . 70.53 112.754 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.414 ' HD3' ' CD ' ' A' ' 119' ' ' GLU . 86.6 tttt -50.09 137.79 16.94 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.986 0.914 . . . . 72.11 112.994 -172.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -152.91 161.75 42.15 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 112.516 0.561 . . . . 62.42 112.516 -173.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.73 156.95 67.6 Favored Pre-proline 0 C--N 1.312 -1.029 0 CA-C-N 114.591 -1.186 . . . . 61.11 107.915 170.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -55.7 147.41 60.48 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.869 2.379 . . . . 75.1 112.342 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -63.06 152.8 36.04 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 121.213 0.53 . . . . 72.05 111.403 -175.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.2 p -115.0 142.58 27.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.751 -0.659 . . . . 45.35 109.415 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.789 0 N-CA-C 107.227 -1.398 . . . . 60.51 107.227 176.55 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.5 -0.947 0 N-CA-C 108.327 -0.99 . . . . 71.14 108.327 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 55.3 ttm -91.11 -21.59 21.12 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.11 0.957 . . . . 52.25 109.718 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.1 m -85.2 67.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 114.235 -1.348 . . . . 61.12 109.364 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.0 p -64.44 -37.65 88.28 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.565 -1.198 . . . . 64.12 113.025 -171.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -63.03 -40.88 99.06 Favored 'General case' 0 C--O 1.249 1.071 0 CA-C-O 121.57 0.7 . . . . 62.53 110.489 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.55 -38.31 71.03 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.539 -0.911 . . . . 73.23 108.539 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.23 -45.37 69.96 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.372 -0.831 . . . . 74.35 111.259 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.3 m -70.39 -34.69 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 112.109 0.411 . . . . 52.15 112.109 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.537 ' HB3' ' HZ3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -69.7 -35.47 75.11 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 118.638 -1.225 . . . . 74.42 109.078 176.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.07 -40.79 83.05 Favored Glycine 0 C--O 1.216 -1.02 0 N-CA-C 111.327 -0.709 . . . . 74.4 111.327 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 tp -68.21 -47.98 66.42 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 123.465 0.706 . . . . 63.02 109.705 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.79 -41.04 99.01 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 115.645 -0.707 . . . . 72.41 111.718 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -67.82 -43.5 79.44 Favored 'General case' 0 C--O 1.198 -1.644 0 CA-C-O 118.879 -0.581 . . . . 74.45 111.085 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -57.96 -44.31 86.96 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 120.837 0.351 . . . . 72.32 110.082 -176.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -61.73 -54.56 40.9 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.633 -1.167 . . . . 74.25 110.438 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.6 mm -60.6 -35.84 66.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 112.49 0.552 . . . . 42.44 112.49 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.93 -47.76 73.66 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.102 -0.703 . . . . 71.04 109.102 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.536 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 4.1 pp -73.59 -19.13 60.96 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 119.985 -0.686 . . . . 63.22 112.099 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.1 t -74.86 -28.17 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.462 0.649 . . . . 71.01 109.527 173.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.8 p -106.13 14.32 27.85 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.829 0.823 . . . . 73.41 109.18 -176.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 21.5 tptp -39.66 124.25 1.65 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 127.163 2.185 . . . . 74.0 112.879 -176.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 m -53.49 146.91 22.21 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.707 1.203 . . . . 64.43 112.048 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.14 -7.76 16.47 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 123.598 2.865 . . . . 73.41 112.614 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.93 -26.95 68.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.321 -0.854 . . . . 75.35 110.276 175.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 p -101.81 167.79 9.85 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.861 -0.609 . . . . 72.11 110.675 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.4 t -62.96 -54.95 26.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 114.034 1.124 . . . . 71.35 114.034 -172.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -171.11 139.84 1.43 Allowed 'General case' 0 C--O 1.245 0.836 0 C-N-CA 119.195 -1.002 . . . . 64.1 110.654 -172.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.7 m -63.22 -42.94 99.34 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.004 0.521 . . . . 70.13 111.724 -172.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.453 ' HB2' ' CD2' ' A' ' 72' ' ' PHE . 1.6 mp0 -63.3 -20.6 65.62 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.031 -0.531 . . . . 61.03 111.466 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -69.86 -46.97 64.39 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.868 -0.79 . . . . 73.25 108.868 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -71.0 -31.95 68.62 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.87 -1.159 . . . . 73.13 107.87 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 54.3 tp -65.4 -46.59 79.42 Favored 'General case' 0 C--O 1.191 -2.012 0 CA-C-N 115.584 -0.735 . . . . 75.55 110.095 176.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 49' ' ' LEU . . . -62.37 -30.97 71.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.838 0.828 . . . . 65.42 110.494 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -73.25 -34.81 66.05 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.555 -1.202 . . . . 74.22 110.489 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.429 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 61.3 t80 -80.48 -26.92 37.96 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.458 1.123 . . . . 71.4 108.475 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.481 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 39.9 tp -69.79 -29.8 67.19 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 127.323 2.249 . . . . 53.11 111.509 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -38.47 -56.17 2.0 Allowed Glycine 0 CA--C 1.545 1.929 0 N-CA-C 115.628 1.011 . . . . 45.42 115.628 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 48' ' ' PHE . 8.2 Cg_exo -77.81 -5.83 15.6 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.153 1.902 . . . . 54.23 113.585 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -133.21 24.9 4.19 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.685 -0.634 . . . . 72.53 111.654 -169.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -56.17 107.32 0.86 Allowed Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 123.067 0.547 . . . . 73.44 111.823 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.424 ' HB2' ' HA ' ' A' ' 136' ' ' SER . 6.7 Cg_endo -109.51 -159.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 123.84 3.027 . . . . 72.23 112.228 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -86.73 131.16 34.21 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.226 -1.027 . . . . 44.43 108.226 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mp -108.86 112.75 41.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.763 -1.199 . . . . 75.34 107.763 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 138' ' ' LYS . 80.2 m-85 -92.88 133.7 35.82 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 108.502 -0.925 . . . . 75.53 108.502 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.3 t -131.84 117.09 32.81 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 108.101 -1.074 . . . . 62.5 108.101 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 60.78 29.44 19.01 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.373 1.045 . . . . 64.21 110.765 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.75 5.94 80.68 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.906 -1.043 . . . . 62.12 112.839 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -113.85 134.33 54.87 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 109.723 -0.473 . . . . 75.1 109.723 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.411 HD13 ' N ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -75.06 128.22 36.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.885 0.85 . . . . 75.41 110.284 -175.355 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.411 ' N ' HD13 ' A' ' 62' ' ' ILE . 50.8 mm-40 -126.37 144.32 50.86 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 106.921 -1.511 . . . . 63.2 106.921 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -87.08 174.3 8.74 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.281 -0.637 . . . . 74.14 109.281 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.7 t -56.7 -33.47 66.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.256 0.622 . . . . 70.1 111.378 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 60.9 m -67.21 -42.52 83.95 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.091 -0.504 . . . . 72.34 110.469 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -64.86 -47.92 76.15 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 122.766 0.426 . . . . 62.32 109.984 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -52.97 -53.56 48.04 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 123.552 0.533 . . . . 54.43 110.114 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.0 tp -49.72 -46.43 50.21 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 124.167 0.917 . . . . 70.25 111.537 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 66' ' ' THR . 54.6 mt-30 -59.46 -48.1 82.95 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 116.201 -0.454 . . . . 61.45 111.306 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -66.87 -35.28 79.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.243 0.544 . . . . 74.33 110.532 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.453 ' CD2' ' HB2' ' A' ' 42' ' ' GLU . 3.5 t80 -60.17 -51.91 67.57 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.554 -0.748 . . . . 75.51 110.649 175.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -75.33 -13.19 60.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.874 0.368 . . . . 70.22 111.372 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 27.9 mm-40 -82.1 -8.99 59.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.977 0.417 . . . . 71.34 111.412 170.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.82 26.31 50.19 Favored Glycine 0 N--CA 1.427 -1.903 0 CA-C-N 116.147 -0.479 . . . . 70.14 112.349 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.8 mt -78.36 -37.24 44.75 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.034 -0.667 . . . . 73.41 112.001 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -97.36 1.3 49.21 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.963 -0.695 . . . . 53.22 112.655 -175.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.301 0.0 OUTLIER -70.4 -16.88 63.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.177 1.177 . . . . 71.4 114.177 -173.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -89.53 -15.78 32.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.362 0.601 . . . . 74.41 111.543 171.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.3 tt -84.84 -14.82 46.76 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.568 -0.742 . . . . 62.02 110.262 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.84 -8.72 57.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.365 0.602 . . . . 64.44 111.748 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -92.72 13.52 19.91 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.616 -0.72 . . . . 62.51 109.524 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 105' ' ' SER . . . -79.99 154.44 28.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.282 -0.872 . . . . 71.23 113.352 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -107.79 143.79 35.87 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.523 -1.217 . . . . 72.23 109.256 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -95.58 120.11 35.25 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.236 0.541 . . . . 73.21 109.578 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.49 -179.94 4.17 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.915 -0.584 . . . . 72.14 109.943 -176.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.2 pp -61.26 130.7 25.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 CA-C-O 121.707 0.765 . . . . 63.54 112.621 177.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -106.27 81.82 1.67 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.382 -0.826 . . . . 71.25 109.151 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.0 t -75.49 -39.18 40.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.576 -0.898 . . . . 73.03 108.576 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.1 m -77.5 -5.61 50.62 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.973 -1.012 . . . . 63.12 111.259 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.04 64.49 4.22 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.819 -0.512 . . . . 51.55 111.819 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -112.18 111.15 21.83 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.421 0.629 . . . . 74.14 110.549 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.1 99.62 9.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.755 -0.832 . . . . 61.11 108.755 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -84.68 -26.88 27.45 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.547 0.689 . . . . 72.54 109.711 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -75.79 9.57 2.27 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.232 -0.895 . . . . 73.43 112.629 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.86 -125.35 1.73 Allowed Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.242 -1.543 . . . . 51.51 109.242 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -148.95 139.57 22.64 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.511 -0.551 . . . . 74.13 109.511 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.46 -164.64 33.94 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 110.261 -1.136 . . . . 70.33 110.261 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -128.55 136.3 50.55 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.454 -0.573 . . . . 73.45 109.454 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -122.71 98.9 6.12 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.008 -1.849 . . . . 75.34 106.008 170.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 mt -109.62 124.42 51.12 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 123.775 0.672 . . . . 74.22 109.889 -172.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 10.9 p -114.77 122.42 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-O 122.331 1.062 . . . . 55.12 112.474 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 -96.07 145.1 25.75 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.025 -1.443 . . . . 75.34 108.522 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -128.5 121.12 28.15 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.19 -1.411 . . . . 72.31 107.19 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 42.5 m -73.46 -174.29 1.63 Allowed 'General case' 0 C--O 1.253 1.282 0 C-N-CA 122.973 0.509 . . . . 73.25 112.018 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.9 161.11 19.06 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.713 -0.847 . . . . 72.14 108.713 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.514 ' HB1' HG21 ' A' ' 115' ' ' ILE . . . -100.08 136.67 39.62 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 120.83 -0.348 . . . . 74.35 111.832 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -113.56 112.46 23.59 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.542 -0.91 . . . . 65.14 108.542 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -77.46 108.63 10.76 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.637 -0.875 . . . . 62.22 108.637 176.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.2 t -93.22 154.63 17.92 Favored 'General case' 0 N--CA 1.414 -2.271 0 N-CA-C 108.183 -1.043 . . . . 74.23 108.183 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -71.83 0.37 9.24 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.346 0.594 . . . . 72.55 112.252 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -75.15 -4.7 40.28 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.101 0.96 . . . . 63.42 109.181 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 77.12 11.04 2.41 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 125.583 1.553 . . . . 72.45 111.68 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.428 ' HB3' ' CD1' ' A' ' 147' ' ' TYR . 25.0 pttm -125.96 157.85 36.74 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 115.521 -0.763 . . . . 73.32 109.039 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.514 HG21 ' HB1' ' A' ' 107' ' ' ALA . 2.0 mp -100.51 137.44 28.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 N-CA-C 107.891 -1.151 . . . . 71.03 107.891 -175.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.444 ' HG2' ' HB2' ' A' ' 144' ' ' ALA . 92.5 mtt180 -114.61 154.82 27.66 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.032 -0.729 . . . . 73.3 109.032 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.438 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 8.4 p90 -163.79 173.75 12.42 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.696 -1.224 . . . . 65.25 107.696 176.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -107.23 139.17 42.11 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.843 -1.169 . . . . 72.42 107.843 175.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.438 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 46.2 mt-10 -119.21 151.55 38.17 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 120.446 -0.502 . . . . 65.3 110.125 174.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -137.31 123.15 20.06 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 116.079 -0.51 . . . . 40.53 110.079 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -114.78 110.33 19.55 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.16 -0.682 . . . . 72.24 109.16 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.02 130.39 44.35 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 109.031 -0.729 . . . . 70.3 109.031 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -110.31 110.67 21.56 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.213 -1.032 . . . . 72.53 108.213 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.484 HG12 HD13 ' A' ' 134' ' ' LEU . 61.4 mt -115.28 137.16 49.7 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.674 0 N-CA-C 107.511 -1.292 . . . . 73.3 107.511 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.507 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.2 OUTLIER -122.27 147.95 45.6 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.007 -1.849 . . . . 71.12 106.007 177.335 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -117.06 133.53 55.88 Favored 'General case' 0 N--CA 1.398 -3.028 0 C-N-CA 117.553 -1.659 . . . . 74.44 109.725 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.465 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 73.4 ttt180 -82.56 144.69 30.19 Favored 'General case' 0 C--N 1.255 -3.533 0 CA-C-N 113.044 -1.889 . . . . 72.11 109.789 -172.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -49.4 -31.8 10.33 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.853 1.261 . . . . 74.12 112.423 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.465 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 6.9 m-20 -76.69 0.93 18.57 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.515 -0.766 . . . . 74.4 111.667 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.95 -1.48 56.54 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.335 -0.46 . . . . 45.02 112.619 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.4 m -85.5 101.46 12.67 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 122.623 -0.339 . . . . 74.51 111.521 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 42.0 t -80.78 120.74 25.05 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 105.57 -2.011 . . . . 74.03 105.57 173.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.507 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 5.9 t-105 -140.22 150.56 44.29 Favored 'General case' 0 N--CA 1.394 -3.245 0 C-N-CA 119.163 -1.015 . . . . 72.13 111.301 -170.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.484 HD13 HG12 ' A' ' 124' ' ' ILE . 3.4 mm? -68.75 116.6 9.44 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.053 -0.976 . . . . 72.4 109.057 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -83.72 -56.61 3.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.975 -0.75 . . . . 74.01 108.975 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.424 ' HA ' ' HB2' ' A' ' 54' ' ' PRO . 14.0 m -164.45 156.55 16.36 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 106.291 -1.744 . . . . 43.22 106.291 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.8 m -131.03 162.34 39.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.384 -1.339 . . . . 75.03 107.384 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 57' ' ' TYR . 78.7 tttt -142.28 136.97 30.3 Favored 'General case' 0 C--N 1.275 -2.641 0 C-N-CA 122.718 0.407 . . . . 35.02 110.071 -173.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -123.04 141.01 52.43 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.821 -0.807 . . . . 74.35 108.821 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.9 pt -132.18 98.36 3.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.788 -1.19 . . . . 72.2 107.788 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 68.8 mtm -89.55 130.38 35.88 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.213 -1.358 . . . . 74.32 111.138 -171.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.4 t 71.47 24.46 3.63 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 124.468 1.105 . . . . 71.33 110.303 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -75.26 144.72 42.39 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.891 -1.05 . . . . 54.32 108.381 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.444 ' HB2' ' HG2' ' A' ' 116' ' ' ARG . . . -127.03 175.09 8.37 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 121.373 0.606 . . . . 73.11 111.185 -175.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -112.89 129.31 24.61 Favored Pre-proline 0 C--N 1.289 -2.033 0 N-CA-C 107.258 -1.386 . . . . 40.51 107.258 175.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.42 129.15 22.17 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.736 2.291 . . . . 73.12 110.06 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.428 ' CD1' ' HB3' ' A' ' 114' ' ' LYS . 39.3 p90 -97.2 168.77 10.23 Favored 'General case' 0 N--CA 1.413 -2.289 0 CA-C-O 121.705 0.764 . . . . 74.23 112.088 -172.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.2 p -134.0 109.76 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.485 0 CA-C-N 114.569 -1.196 . . . . 71.3 108.689 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.289 -2.023 0 CA-C-N 114.99 -1.004 . . . . 44.12 108.728 -178.785 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 . . . . . 0 CA--C 1.484 -1.571 0 N-CA-C 108.909 -0.774 . . . . 74.03 108.909 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.7 ptp -80.86 91.86 6.03 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.289 1.042 . . . . 64.2 110.646 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.3 t -81.68 147.48 6.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 105.516 -2.031 . . . . 62.2 105.516 173.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.444 ' O ' HG13 ' A' ' 21' ' ' VAL . 6.7 m -56.63 -40.42 75.36 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 118.356 0.525 . . . . 72.1 109.782 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -64.66 -42.1 95.64 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 115.625 -0.716 . . . . 75.12 110.815 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.96 -40.43 96.4 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.68 -0.691 . . . . 52.31 109.454 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.15 -43.6 81.9 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.021 -0.536 . . . . 73.21 110.517 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 17' ' ' THR . 11.3 m -70.39 -38.73 75.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 120.334 -0.547 . . . . 75.41 112.104 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -28.0 50.37 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.662 -0.815 . . . . 71.15 110.581 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.75 -41.43 49.99 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 110.066 -1.214 . . . . 42.1 110.066 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.3 tp -68.12 -49.78 58.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.889 -0.782 . . . . 61.41 108.889 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.26 -38.72 95.0 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.516 -0.765 . . . . 33.21 112.447 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -71.95 -40.85 68.39 Favored 'General case' 0 C--O 1.195 -1.792 0 C-N-CA 120.426 -0.51 . . . . 72.2 110.571 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -62.32 -43.1 99.61 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.622 0.725 . . . . 73.43 110.049 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.427 ' CZ ' ' HH2' ' A' ' 103' ' ' TRP . 27.7 t80 -64.63 -54.63 28.78 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 113.946 -1.479 . . . . 74.42 110.157 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 29' ' ' ILE . 9.8 mm -65.49 -33.52 64.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 120.882 -0.327 . . . . 55.44 111.838 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -63.41 -48.82 76.24 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 110.067 -0.346 . . . . 64.32 110.067 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 32' ' ' VAL . 4.4 pp -68.55 -30.28 69.03 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.088 -0.645 . . . . 43.15 110.94 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.414 ' N ' HD12 ' A' ' 31' ' ' LEU . 66.0 t -70.58 -25.09 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 CA-C-O 121.201 0.524 . . . . 71.54 110.492 175.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.5 p -110.33 19.3 18.98 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.565 0.698 . . . . 74.11 110.226 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -55.78 142.86 33.14 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.949 -1.023 . . . . 74.31 110.328 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 m -62.92 153.99 78.1 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-N 115.435 -0.802 . . . . 63.23 110.694 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.16 -5.65 3.11 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 125.03 3.82 . . . . 64.25 113.043 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.6 -27.22 68.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.498 -0.774 . . . . 73.54 109.17 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -94.97 142.2 27.76 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 105.788 -1.93 . . . . 74.22 105.788 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.7 t -68.96 -46.07 79.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 120.606 -0.438 . . . . 44.11 111.927 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -145.01 119.29 9.54 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 119.406 -0.918 . . . . 64.34 112.552 -174.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.9 m -64.13 -35.96 82.49 Favored 'General case' 0 C--O 1.251 1.165 0 C-N-CA 123.714 0.806 . . . . 74.1 110.768 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.724 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 1.3 mp0 -65.8 -21.2 66.47 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.156 -0.929 . . . . 75.3 110.466 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -68.69 -43.02 76.94 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.607 -1.257 . . . . 72.22 107.607 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.43 -32.12 69.59 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.552 -1.204 . . . . 74.15 109.43 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.5 tp -67.78 -40.87 83.95 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 116.017 -0.538 . . . . 63.42 110.7 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.11 -36.62 84.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.622 0.725 . . . . 74.31 109.921 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -69.47 -37.6 77.35 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.985 -1.007 . . . . 72.32 109.44 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -65.55 -43.24 90.51 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.218 1.007 . . . . 74.12 110.727 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 pp -80.45 -2.49 46.02 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.822 -0.626 . . . . 61.52 111.214 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.2 -62.47 5.02 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 111.888 -0.485 . . . . 73.42 111.888 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -77.15 -5.57 15.88 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.45 2.1 . . . . 73.11 112.235 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -124.46 38.08 4.27 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.798 -0.445 . . . . 60.52 109.798 -172.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.553 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 34.4 t70 -54.52 106.03 0.61 Allowed Pre-proline 0 C--O 1.245 0.848 0 C-N-CA 125.23 1.412 . . . . 63.23 113.22 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -107.92 -157.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.101 0 C-N-CA 123.798 2.999 . . . . 74.53 110.548 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -98.97 123.66 43.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.665 -0.865 . . . . 52.53 108.665 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.445 HD13 ' CB ' ' A' ' 68' ' ' PHE . 46.6 mt -105.25 107.92 23.74 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.606 0 N-CA-C 107.868 -1.16 . . . . 61.22 107.868 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -96.75 138.82 33.73 Favored 'General case' 0 C--N 1.27 -2.888 0 O-C-N 121.737 -0.602 . . . . 75.23 110.26 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 p -128.24 117.92 46.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 107.16 -1.422 . . . . 74.1 107.16 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 60.8 20.82 10.95 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.705 -0.68 . . . . 74.1 111.571 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.27 1.17 56.89 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.817 -0.629 . . . . 61.04 112.866 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -108.74 130.84 55.37 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 117.397 0.598 . . . . 63.13 110.438 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.58 125.25 33.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 122.055 0.931 . . . . 74.41 110.256 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -120.56 140.53 51.36 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.44 -1.318 . . . . 70.21 107.44 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.0 t -85.66 173.52 10.06 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.701 -0.852 . . . . 71.42 108.701 176.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.553 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 9.7 t -52.62 -37.52 58.52 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.405 0.682 . . . . 64.52 111.57 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -70.03 -41.1 74.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.336 -0.393 . . . . 73.13 111.855 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.54 -47.34 76.19 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.229 -0.656 . . . . 44.31 109.229 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CB ' HD13 ' A' ' 56' ' ' ILE . 55.3 t80 -53.18 -54.33 37.57 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 115.667 -0.697 . . . . 71.23 110.118 174.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -50.13 -44.31 52.33 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 124.206 0.941 . . . . 33.23 110.867 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -60.41 -48.84 80.03 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 122.853 0.461 . . . . 62.13 111.531 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.47 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 32.6 m-85 -68.4 -36.78 79.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.678 0.752 . . . . 60.01 109.398 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -58.46 -54.56 45.7 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.102 -0.954 . . . . 73.2 110.948 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -66.07 -29.74 70.14 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.582 -0.281 . . . . 74.34 110.557 -176.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -77.71 -8.78 58.44 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 113.373 0.879 . . . . 44.42 113.373 178.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.419 ' HA2' ' HG3' ' A' ' 78' ' ' LYS . . . 100.13 11.35 42.84 Favored Glycine 0 C--N 1.315 -0.63 0 C-N-CA 120.31 -0.947 . . . . 60.31 114.944 173.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.14 -53.85 22.22 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 120.878 0.371 . . . . 73.14 111.974 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.47 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 40.5 m-85 -89.72 6.17 42.7 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 112.781 0.66 . . . . 74.35 112.781 -172.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.724 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 41.9 mtmt -66.16 -12.47 56.03 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.492 0.923 . . . . 75.34 113.492 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -77.64 -10.67 59.64 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.363 -0.835 . . . . 71.05 111.2 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.3 tp -68.3 -28.86 67.55 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.488 -0.56 . . . . 71.22 109.488 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.55 ' HB2' ' OE2' ' A' ' 42' ' ' GLU . 0.8 OUTLIER -65.83 -28.67 69.16 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.581 -0.736 . . . . 63.23 110.127 176.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -98.82 7.07 46.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.656 -0.702 . . . . 60.11 110.348 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.48 150.82 22.3 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.967 0.413 . . . . 45.51 110.612 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.09 134.11 47.9 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.674 -0.862 . . . . 70.11 108.674 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -85.71 144.25 27.9 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 113.55 0.944 . . . . 75.33 113.55 -174.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.74 95.13 3.08 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 105.545 -2.02 . . . . 72.0 105.545 173.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.407 ' O ' HD12 ' A' ' 87' ' ' ILE . 2.7 pp -84.51 140.74 15.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 112.687 0.625 . . . . 74.41 112.687 -174.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -131.63 93.94 3.43 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.893 0.854 . . . . 64.32 109.862 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -100.0 135.04 37.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 115.017 -0.992 . . . . 70.54 108.57 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.2 m -76.57 80.77 3.25 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.697 0.284 . . . . 74.41 111.069 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.48 -15.91 1.44 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 115.962 1.145 . . . . 71.42 115.962 174.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 86.9 tttt 64.03 44.12 4.81 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 106.321 -1.733 . . . . 74.55 106.321 -173.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.556 ' HB ' ' OE2' ' A' ' 95' ' ' GLU . 31.1 m -82.01 168.77 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 113.217 -1.811 . . . . 75.42 111.232 -176.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -95.38 -9.04 33.95 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 113.441 0.904 . . . . 74.0 113.441 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.556 ' OE2' ' HB ' ' A' ' 93' ' ' VAL . 2.4 pm0 -87.44 -176.12 5.49 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.03 -0.668 . . . . 62.15 111.324 177.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -83.01 72.47 2.84 Favored Glycine 0 N--CA 1.419 -2.491 0 N-CA-C 115.266 0.866 . . . . 73.55 115.266 -174.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -100.67 167.6 10.22 Favored 'General case' 0 C--O 1.256 1.44 0 N-CA-C 109.803 -0.443 . . . . 73.11 109.803 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -105.41 146.49 16.08 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 110.979 -0.848 . . . . 75.53 110.979 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -110.99 133.91 53.01 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.0 -1.111 . . . . 72.44 108.0 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -113.45 109.82 19.29 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 123.583 0.552 . . . . 74.35 109.872 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -97.42 108.73 21.51 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 105.675 -1.972 . . . . 61.44 105.675 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 3.9 t -115.11 150.24 17.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 119.776 -0.77 . . . . 75.03 110.187 -174.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.427 ' HH2' ' CZ ' ' A' ' 28' ' ' PHE . 25.2 m-90 -132.35 151.19 51.96 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.556 -0.905 . . . . 74.23 108.556 175.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.461 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 67.3 mttm -126.34 130.85 51.62 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.684 -1.599 . . . . 53.45 106.684 174.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.1 p -85.35 -166.83 1.62 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 110.288 -0.264 . . . . 63.21 110.288 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.41 128.46 36.77 Favored 'General case' 0 C--O 1.256 1.411 0 CA-C-O 121.223 0.535 . . . . 50.43 110.604 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -101.96 142.67 32.89 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.182 -0.917 . . . . 53.34 110.859 -177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -139.99 142.86 36.28 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.633 -1.617 . . . . 71.43 106.633 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.456 ' HG2' HG13 ' A' ' 115' ' ' ILE . 45.9 mtt180 -76.85 131.57 38.69 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-O 121.94 0.876 . . . . 71.03 112.4 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.4 m -95.49 169.18 10.23 Favored 'General case' 0 N--CA 1.405 -2.691 0 CA-C-N 113.816 -1.538 . . . . 62.42 109.292 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -72.61 -18.8 61.56 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.17 0.588 . . . . 72.14 111.461 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.442 ' HB2' ' HG2' ' A' ' 114' ' ' LYS . 24.9 m-20 -79.4 7.71 7.49 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.538 -0.301 . . . . 74.34 110.999 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 70.25 18.81 6.77 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.381 1.472 . . . . 75.44 109.451 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.442 ' HG2' ' HB2' ' A' ' 112' ' ' ASP . 65.2 pttt -108.84 173.31 6.38 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.586 -1.264 . . . . 73.44 107.586 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.456 HG13 ' HG2' ' A' ' 109' ' ' ARG . 1.1 mp -120.45 126.16 74.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 107.924 -1.139 . . . . 65.4 107.924 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.424 ' NH2' ' HA ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -97.38 142.03 29.74 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 120.397 -0.521 . . . . 63.43 110.51 -179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.456 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 1.6 p90 -153.85 173.29 16.1 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 107.147 -1.427 . . . . 74.21 107.147 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -113.02 135.33 53.9 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 106.022 -1.844 . . . . 63.32 106.022 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.461 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 44.0 mt-10 -115.07 148.77 38.49 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-O 121.69 0.757 . . . . 75.44 112.159 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -132.97 117.75 18.02 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-N 114.414 -1.266 . . . . 53.25 108.562 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.421 ' HG3' HG22 ' A' ' 102' ' ' VAL . 40.5 tt0 -121.38 110.91 16.67 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 109.1 -0.704 . . . . 75.34 109.1 -176.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -98.16 133.76 42.16 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.118 -0.492 . . . . 73.45 109.847 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -114.76 121.11 42.31 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 123.188 0.595 . . . . 72.53 110.198 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.5 mt -123.41 149.64 27.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.07 -1.826 . . . . 73.35 106.07 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.409 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.7 OUTLIER -132.19 145.21 51.19 Favored 'General case' 0 C--O 1.272 2.259 0 C-N-CA 119.066 -1.054 . . . . 73.33 109.157 173.492 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -83.66 119.9 25.33 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.473 -1.306 . . . . 65.54 107.473 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -89.59 133.06 34.79 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.481 -1.674 . . . . 64.23 106.481 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.29 -12.58 30.49 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.664 0.745 . . . . 75.15 111.228 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.8 -11.0 60.69 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.215 -0.902 . . . . 72.42 111.095 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.17 -12.9 28.79 Favored Glycine 0 CA--C 1.509 -0.344 0 C-N-CA 121.066 -0.588 . . . . 55.0 112.986 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.3 m -104.56 164.93 11.41 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 109.798 -0.445 . . . . 61.12 109.798 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.434 ' HB3' HG12 ' A' ' 21' ' ' VAL . 25.3 p -127.12 143.27 51.31 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.101 -1.444 . . . . 74.35 107.101 172.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.409 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 1.7 t90 -143.41 155.56 44.43 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.173 -1.011 . . . . 74.32 109.435 -176.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.7 mp -70.37 119.35 14.41 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 109.447 -0.575 . . . . 64.22 109.447 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -72.04 -50.5 27.97 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.562 -1.273 . . . . 62.21 107.562 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.8 p -177.19 177.42 1.23 Allowed 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.334 -1.303 . . . . 61.52 108.634 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.9 t -144.78 138.72 22.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 105.015 -2.217 . . . . 60.41 105.015 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -129.31 130.26 45.9 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-O 121.462 0.649 . . . . 74.42 109.847 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -110.42 133.57 53.15 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 107.791 -1.189 . . . . 71.43 107.791 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 10.1 pt -131.88 98.36 3.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 CA-C-O 122.078 0.942 . . . . 74.03 108.772 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 90.5 mtp -88.97 138.92 30.97 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.828 -1.078 . . . . 64.51 110.6 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.0 m 70.79 29.64 3.11 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 124.881 1.363 . . . . 73.34 112.795 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -87.04 170.0 11.92 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.365 -0.606 . . . . 73.24 109.365 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -154.14 159.9 41.66 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.247 -0.981 . . . . 75.1 111.849 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.24 126.79 28.21 Favored Pre-proline 0 C--N 1.296 -1.743 0 N-CA-C 106.736 -1.579 . . . . 75.32 106.736 173.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.08 158.4 41.9 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.819 1.679 . . . . 75.35 111.946 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -70.5 146.81 49.99 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.222 -1.029 . . . . 73.41 108.222 177.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.9 m -77.94 111.22 14.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.422 0.629 . . . . 73.43 110.271 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.519 0 N-CA-C 108.114 -1.069 . . . . 52.04 108.114 179.836 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 121.064 0.459 . . . . 44.34 111.078 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -108.41 121.92 45.94 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.428 -0.582 . . . . 70.45 109.428 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.7 p -60.07 -41.69 87.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 113.45 0.908 . . . . 72.3 113.45 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.444 ' OG1' ' HA2' ' A' ' 130' ' ' GLY . 1.7 m -76.87 -35.23 57.59 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.489 -0.485 . . . . 73.15 110.757 -176.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -62.67 -46.74 86.78 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.217 -1.031 . . . . 71.21 108.217 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.92 -36.69 84.06 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.784 -1.098 . . . . 64.0 110.027 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.36 -42.6 87.83 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.228 -0.442 . . . . 73.24 110.466 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 m -71.75 -41.88 70.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 112.387 0.514 . . . . 74.0 112.387 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -31.41 70.46 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.622 -0.831 . . . . 55.44 110.161 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.01 -57.32 8.8 Favored Glycine 0 N--CA 1.437 -1.263 0 O-C-N 123.805 0.69 . . . . 50.31 111.939 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.68 -33.08 73.36 Favored 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.086 -1.046 . . . . 71.4 110.231 -177.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.06 -39.68 96.51 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 120.925 -0.655 . . . . 70.23 111.971 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -67.15 -47.56 70.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.655 -0.498 . . . . 75.04 109.655 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.6 -41.93 98.14 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.558 -0.746 . . . . 75.53 110.28 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 45' ' ' LEU . 23.9 t80 -61.46 -53.15 60.2 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 124.912 1.285 . . . . 71.24 109.985 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 29' ' ' ILE . 9.8 mm -65.76 -32.66 59.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 112.152 0.427 . . . . 53.52 112.152 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.23 -47.0 72.1 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.371 -0.532 . . . . 51.41 110.622 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.77 -26.21 64.18 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.02 -0.672 . . . . 74.05 111.925 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.2 t -71.68 -24.42 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 CA-C-O 121.552 0.691 . . . . 52.11 110.538 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.6 p -107.31 9.83 29.88 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 121.618 -0.676 . . . . 73.03 110.595 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 34' ' ' LYS . 24.7 tptt -69.63 156.95 38.15 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.161 -0.927 . . . . 74.23 112.474 -174.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.0 m -63.31 154.31 78.95 Favored Pre-proline 0 N--CA 1.424 -1.765 0 CA-C-N 113.711 -1.586 . . . . 71.24 113.04 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -59.18 -5.17 2.69 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 125.182 3.921 . . . . 71.12 112.785 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -54.31 -26.8 31.49 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.93 0.892 . . . . 74.52 110.785 173.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.1 t -101.14 156.81 17.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 105.158 -2.164 . . . . 72.0 105.158 168.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -50.24 -41.63 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.831 0.741 . . . . 75.11 111.987 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -167.04 151.08 6.82 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.966 -1.124 . . . . 54.52 107.966 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.7 m -60.71 -32.16 71.41 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-O 121.461 0.648 . . . . 74.04 110.648 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' OE1' HD23 ' A' ' 45' ' ' LEU . 8.5 tp10 -64.55 -22.75 67.05 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.201 -0.909 . . . . 73.22 110.151 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -67.06 -45.78 76.35 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.78 0.8 . . . . 54.44 108.915 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -71.49 -33.49 69.3 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.409 -1.269 . . . . 74.05 109.151 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.513 HD11 ' CE2' ' A' ' 28' ' ' PHE . 34.4 tp -68.74 -43.88 74.97 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 116.17 -0.468 . . . . 72.13 110.37 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.51 -37.02 77.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.476 0.655 . . . . 74.34 110.195 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -69.49 -36.08 76.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.124 -0.944 . . . . 72.22 110.176 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -67.26 -46.56 73.32 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.667 -0.697 . . . . 75.33 110.285 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.2 pp -82.23 -2.39 52.28 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.356 -0.838 . . . . 60.55 111.338 -176.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.69 -62.5 4.82 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 112.306 -0.318 . . . . 75.34 112.306 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -79.47 -7.23 14.83 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 121.842 1.694 . . . . 74.21 112.151 176.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 77.3 m80 -114.17 35.19 4.26 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.041 -0.725 . . . . 72.12 109.041 -175.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.6 106.26 0.64 Allowed Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 125.28 1.432 . . . . 53.51 112.356 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -101.69 -164.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 123.243 2.629 . . . . 65.31 110.928 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -90.34 108.07 19.54 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 107.545 -1.28 . . . . 72.32 107.545 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.469 HD13 ' CB ' ' A' ' 68' ' ' PHE . 73.4 mt -92.48 107.91 19.58 Favored 'Isoleucine or valine' 0 C--O 1.162 -3.515 0 N-CA-C 108.744 -0.836 . . . . 73.03 108.744 -176.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -95.55 128.15 42.18 Favored 'General case' 0 C--N 1.268 -2.975 0 O-C-N 121.12 -0.988 . . . . 74.55 109.127 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.0 t -124.97 114.44 40.4 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 N-CA-C 107.959 -1.126 . . . . 74.54 107.959 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 62.01 20.94 11.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.56 -1.2 . . . . 74.33 110.591 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.63 -4.89 58.21 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 114.72 -1.127 . . . . 32.03 113.165 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -101.01 132.72 46.29 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 117.714 0.757 . . . . 72.44 109.376 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.59 129.25 36.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.874 0.845 . . . . 73.33 109.676 -177.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -126.9 152.83 46.56 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 124.78 1.232 . . . . 65.41 108.295 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.9 t -97.71 170.24 9.13 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.341 -0.985 . . . . 74.21 108.341 175.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.8 t -52.14 -38.43 57.52 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.285 0.634 . . . . 61.31 111.231 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -62.0 -49.2 76.99 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.175 0.59 . . . . 65.53 111.105 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.44 84.49 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.095 0.558 . . . . 73.25 110.314 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.469 ' CB ' HD13 ' A' ' 56' ' ' ILE . 56.6 t80 -53.68 -55.65 24.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.907 -0.588 . . . . 64.14 110.413 175.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -50.87 -42.44 58.92 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.07 -0.968 . . . . 61.34 110.572 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -60.28 -47.43 86.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 112.014 0.375 . . . . 73.23 112.014 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.427 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 39.8 m-85 -66.78 -32.7 74.16 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.495 0.664 . . . . 73.22 109.976 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -61.77 -52.61 63.53 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.47 -0.786 . . . . 62.23 110.91 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -71.17 -21.28 62.19 Favored 'General case' 0 C--O 1.224 -0.271 0 O-C-N 123.27 0.356 . . . . 74.41 110.904 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -71.57 -19.95 62.08 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.351 0.596 . . . . 62.53 110.108 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 78' ' ' LYS . . . 100.94 13.79 33.14 Favored Glycine 0 N--CA 1.422 -2.235 0 CA-C-N 115.492 -0.776 . . . . 63.04 113.299 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.0 mt -74.55 -44.56 50.48 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 117.427 0.614 . . . . 64.02 111.365 -177.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 45.0 m-85 -88.8 -4.58 58.46 Favored 'General case' 0 C--O 1.214 -0.814 0 N-CA-C 112.662 0.615 . . . . 74.11 112.662 -176.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -70.98 -15.57 62.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 119.392 -0.923 . . . . 70.23 112.304 -177.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -86.61 -21.57 26.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.631 -0.713 . . . . 75.31 110.281 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.1 tp -74.54 -14.76 60.84 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.915 0.864 . . . . 72.24 109.684 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -57.66 -25.65 60.53 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.598 -1.183 . . . . 52.45 112.295 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -92.95 11.94 25.58 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 111.997 0.369 . . . . 34.12 111.997 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.73 150.24 28.06 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.096 0.474 . . . . 74.55 111.627 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -99.5 132.41 44.86 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.504 -0.924 . . . . 64.33 108.504 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.56 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 51.1 p90 -95.25 143.94 26.24 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.924 -0.711 . . . . 74.15 112.311 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.89 163.37 34.31 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.694 -1.225 . . . . 63.34 107.694 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.6 pp -82.13 142.98 12.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 120.794 -0.363 . . . . 74.22 110.841 177.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.516 ' HB2' ' CG2' ' A' ' 102' ' ' VAL . 23.7 t-20 -90.79 153.43 20.25 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.653 -0.869 . . . . 72.14 108.653 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 p -51.43 -44.04 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 124.202 0.939 . . . . 74.12 110.745 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 m 50.76 42.65 27.79 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.238 1.015 . . . . 60.52 111.627 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -82.78 48.6 4.04 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.538 -0.755 . . . . 75.41 113.818 -174.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -101.34 167.8 9.94 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 106.908 -1.515 . . . . 63.42 106.908 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.3 m -78.38 95.38 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 121.818 0.818 . . . . 74.13 111.629 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.495 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.3 OUTLIER -92.06 116.58 29.06 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.842 -0.743 . . . . 73.41 110.868 177.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.49 -28.7 69.39 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.547 -1.206 . . . . 74.32 111.694 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -124.39 -88.03 0.78 Allowed Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 108.843 -1.703 . . . . 62.03 108.843 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -167.13 154.06 8.62 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 123.138 0.575 . . . . 71.24 110.184 175.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -153.88 141.67 8.48 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 108.853 -1.699 . . . . 75.31 108.853 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -108.56 150.99 26.72 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.459 -1.312 . . . . 70.13 107.459 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 39.4 ttpt -150.05 107.83 3.69 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-O 121.745 0.783 . . . . 54.11 109.41 176.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 72.8 mt -101.99 134.35 45.35 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 114.146 -1.388 . . . . 73.43 107.935 -177.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.516 ' CG2' ' HB2' ' A' ' 88' ' ' ASN . 6.1 t -120.01 128.97 75.97 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.182 0 C-N-CA 120.685 -0.406 . . . . 64.32 110.397 -176.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.56 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 18.8 m-90 -99.95 127.44 46.14 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 107.317 -1.364 . . . . 75.55 107.317 173.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -112.36 120.12 40.61 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 107.696 -1.224 . . . . 64.11 107.696 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.6 t -85.82 -176.29 5.95 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.194 -0.912 . . . . 75.3 110.483 -176.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.54 125.66 26.45 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 115.532 -0.758 . . . . 72.02 111.178 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.19 116.66 22.47 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.704 -1.135 . . . . 73.4 109.142 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -94.36 145.58 24.65 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.768 -0.827 . . . . 62.13 108.768 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -74.4 158.74 33.37 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.016 0.436 . . . . 64.01 111.491 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.3 t -142.12 147.46 36.75 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 106.292 -1.744 . . . . 65.11 106.292 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -71.85 -10.7 60.15 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.727 0.775 . . . . 75.15 111.872 -172.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.34 16.88 10.72 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.507 -0.77 . . . . 72.2 111.698 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 72.09 10.02 6.03 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.34 1.456 . . . . 74.2 113.158 173.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -108.6 178.82 4.37 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.88 -0.785 . . . . 73.13 108.88 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 9.5 pt -129.43 145.67 35.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 120.855 0.36 . . . . 73.34 111.633 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.503 ' HD3' ' HB2' ' A' ' 144' ' ' ALA . 35.0 mmt180 -105.68 109.5 21.48 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 124.464 1.105 . . . . 74.01 108.823 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.565 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 43.2 p90 -121.65 165.61 15.49 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.146 -1.057 . . . . 72.12 108.146 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -112.88 140.53 47.61 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.947 -1.501 . . . . 62.43 106.947 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.565 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 40.7 mt-10 -123.32 155.14 37.84 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 121.183 0.516 . . . . 52.15 111.031 175.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -141.61 117.29 10.35 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.771 -1.104 . . . . 62.41 108.039 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 7.9 pt-20 -125.23 111.99 15.89 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-O 121.718 0.771 . . . . 64.1 112.193 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.624 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -93.91 124.61 38.03 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.427 -1.261 . . . . 75.24 110.005 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.473 ' CE2' ' HD3' ' A' ' 100' ' ' LYS . 8.7 m-85 -103.07 129.34 49.85 Favored 'General case' 0 C--O 1.249 1.069 0 C-N-CA 124.622 1.169 . . . . 61.31 108.171 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 53.8 mt -131.46 144.28 38.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.697 -0.853 . . . . 63.35 108.697 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.427 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.5 OUTLIER -137.73 151.51 48.27 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 108.117 -1.068 . . . . 73.13 108.117 176.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 17.4 ptt180 -107.04 150.64 26.31 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.421 -0.912 . . . . 70.14 110.995 177.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.536 ' HB2' ' OD1' ' A' ' 129' ' ' ASP . 50.4 mtt180 -99.47 168.91 9.68 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.017 -0.992 . . . . 75.14 109.643 -172.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -80.97 -10.3 59.73 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.849 0.357 . . . . 64.25 110.617 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.536 ' OD1' ' HB2' ' A' ' 127' ' ' ARG . 11.4 p-10 -74.27 -16.04 60.96 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.058 0.456 . . . . 75.23 110.943 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.444 ' HA2' ' OG1' ' A' ' 17' ' ' THR . . . 112.08 -11.95 26.78 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 120.834 -0.698 . . . . 61.41 112.055 178.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.4 m -105.08 -177.33 3.33 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.687 0.756 . . . . 74.33 110.208 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 28.8 p -143.62 169.4 17.8 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 106.69 -1.596 . . . . 52.24 106.69 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.427 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 0.0 OUTLIER -159.28 155.81 27.61 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.125 -0.694 . . . . 72.25 109.125 -178.662 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.4 mp -70.07 123.38 21.42 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.555 -0.906 . . . . 65.23 108.555 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -72.71 -54.47 8.88 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.741 -1.207 . . . . 73.31 107.741 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.4 m -168.4 165.89 12.54 Favored 'General case' 0 C--O 1.201 -1.472 0 N-CA-C 106.066 -1.827 . . . . 71.33 106.066 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 122' ' ' ALA . 7.5 m -142.12 142.61 27.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 105.46 -2.052 . . . . 61.02 105.46 171.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -127.93 130.54 48.63 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 118.206 0.457 . . . . 75.34 110.439 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -115.25 128.91 56.45 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.901 -1.148 . . . . 74.2 107.901 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.6 pt -128.64 98.31 4.19 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.6 0 N-CA-C 108.07 -1.085 . . . . 72.41 108.07 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 74.7 mtm -87.27 128.36 35.17 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.631 -1.168 . . . . 64.44 111.71 -174.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.5 m 61.52 55.09 2.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 113.935 -1.484 . . . . 64.24 111.339 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -91.39 145.37 24.69 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 106.194 -1.78 . . . . 63.25 106.194 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.503 ' HB2' ' HD3' ' A' ' 116' ' ' ARG . . . -138.13 145.81 42.07 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 120.595 -0.442 . . . . 53.02 109.947 -177.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.52 134.14 23.77 Favored Pre-proline 0 N--CA 1.414 -2.239 0 N-CA-C 105.436 -2.061 . . . . 64.44 105.436 172.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -58.04 152.84 48.86 Favored 'Trans proline' 0 C--O 1.254 1.322 0 C-N-CA 122.041 1.827 . . . . 71.22 110.54 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -61.74 144.38 54.77 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 109.571 -0.529 . . . . 74.02 109.571 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.3 p -91.52 136.26 24.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 C-N-CA 120.348 -0.541 . . . . 62.1 110.114 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.5 0 N-CA-C 108.118 -1.068 . . . . 73.33 108.118 177.309 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 120.573 0.225 . . . . 60.1 110.525 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.7 mtt -92.32 155.76 17.72 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.306 -0.627 . . . . 75.12 109.306 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.6 t -78.32 136.22 24.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.492 -0.929 . . . . 72.44 108.492 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.449 ' O ' HG13 ' A' ' 21' ' ' VAL . 19.4 m -56.82 -39.36 74.05 Favored 'General case' 0 C--O 1.215 -0.751 0 C-N-CA 123.141 0.576 . . . . 65.31 110.9 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.52 -40.15 93.58 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.454 0.645 . . . . 73.32 111.387 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.52 -37.09 79.73 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.648 -0.871 . . . . 75.3 108.648 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -68.71 -42.41 77.73 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 115.873 -0.603 . . . . 61.31 110.627 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.699 HG12 ' SG ' ' A' ' 132' ' ' CYS . 13.2 m -69.92 -41.28 79.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.027 -0.533 . . . . 61.04 111.617 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.33 -24.94 50.73 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 118.907 -1.117 . . . . 53.44 110.018 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.07 -55.16 11.04 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 121.017 -0.611 . . . . 73.53 111.583 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.36 -35.26 71.07 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.244 -1.021 . . . . 75.35 108.244 -178.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.7 -43.57 97.69 Favored Glycine 0 N--CA 1.432 -1.583 0 O-C-N 123.936 0.772 . . . . 74.11 112.003 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -69.41 -42.07 75.57 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 120.841 -0.344 . . . . 71.43 110.82 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -63.16 -46.11 88.69 Favored 'General case' 0 C--O 1.253 1.262 0 N-CA-C 109.671 -0.492 . . . . 74.2 109.671 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.504 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 30.4 t80 -62.64 -53.12 59.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.923 -1.035 . . . . 64.34 110.61 177.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.476 HD13 ' HA ' ' A' ' 29' ' ' ILE . 6.8 mm -61.2 -38.86 80.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 111.974 0.361 . . . . 63.23 111.974 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.39 -49.76 76.3 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 123.155 0.284 . . . . 73.23 110.307 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.3 pp -67.99 -29.6 68.66 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 120.562 -0.455 . . . . 75.12 111.121 -176.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.2 t -72.53 -27.71 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.401 0.62 . . . . 61.25 110.264 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.6 p -111.05 22.56 15.14 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.701 0.763 . . . . 72.23 109.115 -177.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -63.4 136.51 57.68 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.27 -1.332 . . . . 74.24 109.116 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -57.59 153.91 27.54 Favored Pre-proline 0 N--CA 1.435 -1.177 0 O-C-N 124.14 0.9 . . . . 51.21 110.72 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.79 -7.32 4.29 Favored 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 124.239 3.293 . . . . 74.24 113.093 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.73 -27.54 68.79 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.346 -0.843 . . . . 75.34 109.04 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.2 t -94.86 123.25 38.22 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 105.387 -2.079 . . . . 74.03 105.387 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.8 t -57.92 -48.06 84.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 123.566 0.541 . . . . 71.31 112.299 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -141.12 114.53 8.77 Favored 'General case' 0 N--CA 1.417 -2.106 0 C-N-CA 118.12 -1.432 . . . . 73.32 111.785 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.0 m -60.53 -32.64 71.66 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 123.203 0.601 . . . . 72.22 110.686 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -24.24 67.38 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.105 0.962 . . . . 63.0 110.791 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -70.62 -42.84 70.38 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 108.425 -0.954 . . . . 73.11 108.425 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -71.79 -30.57 65.68 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 114.535 -1.211 . . . . 55.53 108.841 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.6 tp -70.13 -41.51 73.82 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.631 -0.713 . . . . 70.25 110.091 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.56 -34.76 77.58 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.607 0.718 . . . . 63.5 109.694 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -68.72 -39.25 80.5 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.885 -1.052 . . . . 75.33 109.675 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -67.78 -41.45 83.2 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.773 -0.649 . . . . 75.2 111.238 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.4 pp -82.06 -4.16 56.22 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.074 -0.512 . . . . 74.5 111.254 -177.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -47.07 -58.21 6.47 Favored Glycine 0 C--O 1.213 -1.189 0 O-C-N 123.742 0.652 . . . . 64.21 112.863 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.79 -3.35 9.03 Favored 'Trans proline' 0 CA--C 1.556 1.6 0 C-N-CA 123.811 3.007 . . . . 60.54 113.074 172.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 69.1 m-70 -125.5 38.11 4.24 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 122.878 0.471 . . . . 64.42 109.837 -167.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.412 ' CB ' HG21 ' A' ' 65' ' ' THR . 7.1 m-20 -53.65 107.46 0.86 Allowed Pre-proline 0 C--N 1.321 -0.673 0 C-N-CA 126.25 1.82 . . . . 62.44 112.806 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -100.66 -164.96 0.06 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 123.118 2.545 . . . . 64.51 111.054 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -98.69 119.52 37.57 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 107.302 -1.37 . . . . 70.42 107.302 174.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 65' ' ' THR . 72.1 mt -100.04 112.29 32.15 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.627 0 N-CA-C 109.102 -0.703 . . . . 72.11 109.102 -174.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -97.7 106.22 18.5 Favored 'General case' 0 C--N 1.283 -2.322 0 O-C-N 121.855 -0.528 . . . . 75.12 111.722 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.535 HG23 HG22 ' A' ' 56' ' ' ILE . 73.2 t -116.81 124.21 72.62 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 108.131 -1.063 . . . . 60.42 108.131 -175.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.0 m120 66.13 19.61 11.13 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 124.563 1.164 . . . . 72.51 109.291 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.81 11.85 78.56 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.567 -0.742 . . . . 74.41 111.291 -176.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -113.69 139.94 48.65 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 122.869 0.468 . . . . 71.41 110.196 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.21 125.5 35.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.997 0.903 . . . . 74.41 109.054 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -124.05 142.98 50.72 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.224 -1.028 . . . . 70.42 108.224 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 67' ' ' ALA . 4.9 t -82.05 170.09 15.95 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.156 -1.053 . . . . 64.42 108.156 173.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.541 ' HA ' HD12 ' A' ' 56' ' ' ILE . 64.3 p -65.64 -34.08 77.38 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 123.843 0.857 . . . . 73.14 110.357 -176.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.9 m -65.05 -40.57 94.96 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.428 -1.26 . . . . 60.02 110.307 175.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.449 ' H ' HG23 ' A' ' 64' ' ' THR . . . -65.42 -46.49 79.74 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 116.169 -0.469 . . . . 51.52 109.809 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.488 ' HB2' HD13 ' A' ' 56' ' ' ILE . 48.9 t80 -52.06 -54.86 25.15 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 123.459 0.474 . . . . 73.3 109.963 174.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -50.82 -41.5 57.51 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.412 1.07 . . . . 73.34 110.774 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 50.4 mt-30 -63.08 -48.16 79.83 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 116.311 -0.404 . . . . 63.42 111.82 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.484 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 40.0 m-85 -69.33 -30.17 68.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.831 0.824 . . . . 75.01 109.739 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -61.32 -51.84 67.16 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.883 -1.053 . . . . 75.42 110.432 175.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 12.4 ptm180 -71.56 -21.7 61.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.128 0.489 . . . . 52.14 110.401 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 96.1 mt-30 -77.49 -3.29 39.77 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.041 -0.527 . . . . 72.23 111.538 173.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.05 22.37 63.55 Favored Glycine 0 N--CA 1.438 -1.215 0 CA-C-N 116.315 -0.402 . . . . 73.43 113.262 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.2 mt -83.51 -41.4 18.02 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.02 -0.672 . . . . 61.21 111.066 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 22.9 m-85 -100.91 -6.88 24.04 Favored 'General case' 0 C--O 1.185 -2.335 0 C-N-CA 119.845 -0.742 . . . . 75.34 112.838 -178.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -12.72 36.42 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 122.009 0.909 . . . . 70.05 112.847 -175.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -82.2 -9.6 59.45 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.229 -0.896 . . . . 64.3 112.536 176.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 80' ' ' LEU . 3.2 tm? -77.9 -14.96 59.38 Favored 'General case' 0 C--O 1.208 -1.113 0 C-N-CA 123.26 0.624 . . . . 62.01 110.906 -175.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -53.31 -19.05 2.9 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 114.39 1.255 . . . . 75.23 114.39 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -100.01 10.86 40.61 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 120.977 0.418 . . . . 73.35 110.682 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.435 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -68.87 146.06 53.16 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.343 0.868 . . . . 53.2 113.343 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 103' ' ' TRP . 37.6 mt-10 -114.41 156.72 23.97 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.484 -1.235 . . . . 63.44 107.71 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.541 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 38.0 p90 -107.26 132.34 53.2 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.202 0.816 . . . . 71.11 113.202 -173.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.89 119.18 38.39 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.634 -1.247 . . . . 62.2 107.634 175.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.8 pt -82.83 113.53 22.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-O 121.898 0.856 . . . . 73.25 112.033 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -83.07 139.51 33.19 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.547 -0.908 . . . . 71.43 108.547 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 m -86.17 166.22 2.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 109.762 -0.458 . . . . 52.44 109.762 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -76.29 -36.34 58.41 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 120.761 0.315 . . . . 65.55 110.814 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.69 -65.25 3.73 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 116.006 -0.543 . . . . 51.52 112.145 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -144.29 132.07 21.31 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 106.992 -1.484 . . . . 71.01 106.992 -178.558 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.59 117.82 5.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 121.47 0.652 . . . . 75.22 110.05 175.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -126.77 141.12 51.92 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.577 -1.268 . . . . 52.34 107.577 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -69.87 136.01 50.2 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.276 -0.638 . . . . 63.14 109.276 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.48 54.3 0.58 Allowed Glycine 0 N--CA 1.427 -1.924 0 N-CA-C 106.952 -2.459 . . . . 64.21 106.952 -171.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -64.38 124.93 23.04 Favored 'General case' 0 CA--C 1.482 -1.649 0 CA-C-N 114.183 -1.009 . . . . 73.45 111.787 -173.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -158.99 161.57 32.04 Favored Glycine 1 N--CA 1.391 -4.32 0 CA-C-N 114.638 -1.165 . . . . 44.22 110.381 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -107.22 123.23 47.99 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.234 -1.024 . . . . 75.22 108.234 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -117.86 103.4 9.93 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.22 -1.03 . . . . 72.43 108.22 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 87.2 mt -124.63 158.16 33.75 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 110.092 -0.336 . . . . 75.54 110.092 -177.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 8.3 p -133.68 134.51 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.439 0.638 . . . . 62.4 111.954 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.541 ' NE1' ' HB3' ' A' ' 85' ' ' PHE . 14.6 m-90 -106.82 147.66 29.45 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 124.318 1.047 . . . . 74.33 109.5 177.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 83' ' ' ALA . 62.6 mttm -127.91 126.49 41.6 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.016 -0.735 . . . . 73.31 109.016 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.409 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 25.6 t -75.81 179.29 5.56 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 109.945 -0.391 . . . . 65.54 109.945 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.62 167.43 19.24 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 122.655 0.382 . . . . 32.1 110.21 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.26 110.86 1.76 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.474 0.654 . . . . 64.41 110.647 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -93.89 127.4 39.63 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.925 -1.139 . . . . 62.14 107.925 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -72.12 141.08 49.16 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.732 -0.667 . . . . 63.1 111.134 -177.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.2 m -131.96 150.11 52.25 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.522 -0.918 . . . . 70.51 108.522 -176.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -66.7 -9.35 35.45 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.548 0.689 . . . . 72.42 111.919 -176.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -92.25 -1.74 56.91 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.066 -0.97 . . . . 73.32 110.446 -178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 70.12 15.68 7.58 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.741 1.258 . . . . 64.32 110.264 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 0.1 OUTLIER -96.41 159.03 15.16 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 107.508 -1.293 . . . . 73.24 107.508 174.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 22.3 pt -109.16 130.77 61.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 109.019 -0.734 . . . . 64.25 109.019 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.487 ' HG2' ' HB2' ' A' ' 144' ' ' ALA . 47.8 mtm180 -121.6 171.3 8.93 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.383 -0.969 . . . . 65.04 108.383 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -163.08 173.58 13.34 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.551 -0.907 . . . . 75.13 108.551 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.409 ' H ' ' HB3' ' A' ' 105' ' ' SER . 7.1 m-20 -114.13 138.29 50.62 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.922 -1.51 . . . . 70.3 106.922 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.593 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 44.7 mt-10 -115.16 143.49 45.14 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.143 0.497 . . . . 75.32 109.927 175.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -129.43 120.94 26.33 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.724 -0.671 . . . . 74.45 110.877 -174.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 35.0 mt-10 -111.18 110.06 20.4 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.66 -0.496 . . . . 74.4 109.66 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.44 134.27 38.46 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 120.841 0.353 . . . . 62.41 110.401 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -118.5 120.17 36.72 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.437 1.095 . . . . 64.11 108.661 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.79 148.79 21.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 106.131 -1.803 . . . . 74.4 106.131 175.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -128.49 146.9 50.68 Favored 'General case' 0 C--O 1.262 1.742 0 C-N-CA 119.109 -1.036 . . . . 72.32 110.095 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -81.02 112.82 18.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.689 -1.226 . . . . 75.35 107.689 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.433 ' HD2' ' H ' ' A' ' 129' ' ' ASP . 0.4 OUTLIER -85.1 136.32 33.61 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 105.835 -1.913 . . . . 70.2 105.835 -175.863 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.98 -10.55 14.2 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-O 121.531 0.682 . . . . 63.42 111.889 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.433 ' H ' ' HD2' ' A' ' 127' ' ' ARG . 28.7 t70 -72.01 -16.04 62.05 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.552 0.692 . . . . 54.12 109.644 178.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.68 -11.7 27.75 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.599 -0.81 . . . . 64.04 113.493 175.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 24.4 t -105.18 169.39 8.47 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 107.254 -1.387 . . . . 65.22 107.254 176.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.699 ' SG ' HG12 ' A' ' 21' ' ' VAL . 14.9 p -119.19 145.22 46.2 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 107.634 -1.247 . . . . 72.15 107.634 173.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -140.66 155.68 46.44 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.738 -0.838 . . . . 72.32 108.738 -176.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.11 125.11 25.81 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.54 0.686 . . . . 62.31 110.256 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -81.04 -57.39 3.55 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.701 -1.136 . . . . 64.1 108.034 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.8 m -166.16 157.13 13.11 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.237 -1.394 . . . . 42.31 107.237 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.6 135.98 43.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 106.862 -1.532 . . . . 71.31 106.862 171.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -108.99 136.12 49.04 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 122.731 0.412 . . . . 62.23 110.136 -174.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.484 ' HB2' HG22 ' A' ' 58' ' ' VAL . 62.6 m-85 -120.95 113.98 20.88 Favored 'General case' 0 C--O 1.255 1.352 0 CA-C-O 121.344 0.593 . . . . 63.53 109.671 176.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 13.9 pt -110.7 97.79 6.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-O 122.532 1.158 . . . . 55.44 109.248 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 19.8 ptm -101.31 93.77 5.59 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.163 -1.38 . . . . 52.44 110.164 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.0 m 160.8 19.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 127.004 2.122 . . . . 52.44 111.65 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.593 ' HG2' ' OE1' ' A' ' 119' ' ' GLU . 50.3 tptt -80.67 136.1 36.14 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.079 -1.452 . . . . 72.51 107.079 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.487 ' HB2' ' HG2' ' A' ' 116' ' ' ARG . . . -155.55 142.28 18.87 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 112.714 0.635 . . . . 73.3 112.714 -174.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.67 158.87 32.91 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 107.593 -1.262 . . . . 54.35 107.593 172.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -49.42 135.32 32.59 Favored 'Trans proline' 0 C--N 1.358 1.026 0 C-N-CA 123.274 2.65 . . . . 74.33 112.626 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.45 ' HB3' ' HB3' ' A' ' 114' ' ' LYS . 50.0 p90 -61.5 155.61 21.52 Favored 'General case' 0 C--O 1.251 1.146 0 C-N-CA 123.697 0.799 . . . . 75.03 112.046 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 29.7 m -80.22 129.87 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 CA-C-N 115.738 -0.665 . . . . 53.53 109.32 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.284 -2.271 0 N-CA-C 106.287 -1.746 . . . . 45.01 106.287 177.748 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.444 ' HB3' HG12 ' A' ' 16' ' ' VAL . 5.6 m-20 . . . . . 0 CA--C 1.509 -0.622 0 N-CA-C 110.06 -0.348 . . . . 61.3 110.06 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 51.6 ttm -73.63 -27.29 61.19 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.623 0.725 . . . . 72.24 111.154 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.444 HG12 ' HB3' ' A' ' 14' ' ' ASP . 7.9 p -61.51 -33.2 56.01 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-N 114.571 -1.195 . . . . 70.35 110.663 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.587 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.2 m -68.02 -39.59 83.13 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.381 -0.6 . . . . 73.21 109.381 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.42 -35.22 73.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.916 -0.584 . . . . 73.12 110.019 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.96 -39.55 94.99 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.138 -1.06 . . . . 50.22 108.138 175.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.35 -42.11 84.06 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.146 -0.934 . . . . 73.43 109.893 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 17' ' ' THR . 58.8 t -65.22 -45.1 94.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.514 -0.766 . . . . 63.52 111.082 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -70.89 -25.95 63.01 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.732 -0.387 . . . . 71.24 110.28 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.83 -45.41 58.02 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.214 -1.154 . . . . 45.22 110.214 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.4 tp -62.89 -50.15 72.0 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 124.579 1.152 . . . . 71.4 109.791 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.23 -43.24 98.68 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.656 -0.702 . . . . 61.54 112.017 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -66.17 -39.6 89.86 Favored 'General case' 0 C--O 1.211 -0.928 0 CA-C-O 119.22 -0.419 . . . . 71.24 111.218 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -60.62 -46.41 90.39 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.829 -0.804 . . . . 45.11 108.829 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.497 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 38.5 t80 -61.64 -53.74 52.18 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 114.377 -1.283 . . . . 73.22 110.424 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 29' ' ' ILE . 12.9 mm -62.02 -36.17 72.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 112.464 0.542 . . . . 54.4 112.464 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.35 -41.16 81.08 Favored 'General case' 0 CA--C 1.491 -1.306 0 C-N-CA 120.333 -0.547 . . . . 73.21 109.864 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.673 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.8 pp -70.44 -28.03 64.72 Favored 'General case' 0 N--CA 1.421 -1.876 0 C-N-CA 119.498 -0.881 . . . . 74.34 111.761 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 28' ' ' PHE . 65.1 t -70.62 -24.58 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 121.315 0.579 . . . . 73.15 109.653 175.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.5 p -115.18 21.85 13.83 Favored 'General case' 0 C--O 1.244 0.773 0 O-C-N 122.071 -0.393 . . . . 71.25 111.296 -176.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.673 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 53.2 mmtt -44.24 149.34 0.37 Allowed 'General case' 0 C--O 1.245 0.843 0 N-CA-C 115.808 1.781 . . . . 64.11 115.808 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 m -60.7 154.23 58.32 Favored Pre-proline 0 N--CA 1.423 -1.782 0 CA-C-N 112.981 -1.918 . . . . 70.13 108.191 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.04 -8.9 8.84 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 123.5 2.8 . . . . 63.21 112.941 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.8 -27.35 64.82 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.567 0.699 . . . . 73.14 109.878 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.7 m -118.21 81.43 1.68 Allowed 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 107.817 -1.179 . . . . 72.04 107.817 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -81.21 -5.3 8.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-O 122.258 1.028 . . . . 61.54 110.091 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -115.67 78.14 1.15 Allowed 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 107.414 -1.328 . . . . 74.44 107.414 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.6 m -66.43 -25.54 66.79 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 113.979 -1.464 . . . . 74.44 110.906 -173.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.497 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 6.5 pm0 -68.5 -22.98 64.51 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.616 -0.72 . . . . 61.4 110.533 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -63.94 -49.87 70.91 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.573 -0.899 . . . . 73.13 108.573 176.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -65.26 -38.24 89.69 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.439 -1.255 . . . . 73.24 109.96 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.6 tp -65.25 -42.96 92.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 116.429 -0.351 . . . . 70.45 110.73 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.13 -32.33 73.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.296 0.569 . . . . 75.34 110.435 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -74.2 -36.78 64.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.439 -0.8 . . . . 43.45 109.496 178.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 68.4 t80 -67.97 -42.95 80.09 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.189 0.996 . . . . 75.31 111.04 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 pp -81.3 -5.34 57.7 Favored 'General case' 0 C--O 1.204 -1.316 0 CA-C-N 115.907 -0.588 . . . . 72.12 111.138 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.54 -54.4 6.54 Favored Glycine 0 CA--C 1.545 1.92 0 CA-C-N 115.895 -0.593 . . . . 53.14 113.781 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -85.41 -3.56 9.34 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 123.356 2.704 . . . . 50.31 112.941 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.414 ' HA ' ' HE1' ' A' ' 133' ' ' TRP . 92.0 m-70 -128.75 31.53 4.94 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.992 -0.443 . . . . 54.51 110.595 -168.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -56.0 111.91 3.72 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.132 0.973 . . . . 71.31 112.559 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -105.57 -159.68 0.03 OUTLIER 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 123.631 2.888 . . . . 65.21 111.367 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -89.16 124.11 34.04 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 108.189 -1.041 . . . . 74.52 108.189 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.483 HD13 ' CB ' ' A' ' 68' ' ' PHE . 59.6 mt -107.0 112.48 40.12 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.179 0 N-CA-C 107.447 -1.316 . . . . 52.41 107.447 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -98.18 136.14 38.82 Favored 'General case' 0 C--N 1.263 -3.166 0 O-C-N 121.468 -0.77 . . . . 70.11 109.108 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.0 t -132.38 117.34 31.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 107.286 -1.375 . . . . 62.33 107.286 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.5 m120 65.47 20.99 11.8 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.5 1.12 . . . . 74.43 109.893 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.59 3.25 84.09 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.903 -1.044 . . . . 75.22 111.454 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -99.97 130.91 46.19 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 108.14 -1.059 . . . . 72.52 108.14 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.51 124.28 23.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 122.325 1.06 . . . . 71.4 110.549 -176.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 61.7 mm-40 -123.55 143.06 50.43 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 107.315 -1.365 . . . . 43.41 107.315 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.1 t -87.42 171.3 10.66 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 109.023 -0.732 . . . . 61.55 109.023 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.409 ' HA ' HD12 ' A' ' 56' ' ' ILE . 5.3 t -53.83 -36.21 62.29 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.107 0.963 . . . . 74.44 111.426 177.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.497 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 16.4 m -61.91 -50.45 72.14 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 122.971 0.509 . . . . 75.34 110.35 178.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -58.37 -47.79 82.68 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 123.598 0.759 . . . . 61.15 110.744 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.483 ' CB ' HD13 ' A' ' 56' ' ' ILE . 60.5 t80 -54.38 -55.31 29.92 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 123.755 0.659 . . . . 73.34 110.267 176.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -51.98 -40.76 61.44 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.187 0.929 . . . . 71.4 110.512 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 66' ' ' THR . 48.1 mt-30 -62.19 -49.07 77.28 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 116.577 -0.283 . . . . 73.41 111.118 176.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.0 -36.56 84.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.649 0.738 . . . . 71.33 110.092 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -59.2 -54.65 44.5 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 124.303 1.041 . . . . 64.44 110.971 176.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 7.8 ptm180 -68.76 -24.5 64.45 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.371 -0.377 . . . . 71.03 110.58 -176.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -86.38 -0.48 56.03 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.304 0.483 . . . . 63.31 112.304 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.72 13.29 61.29 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 115.391 0.916 . . . . 52.31 115.391 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.77 -39.69 94.03 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 112.701 0.63 . . . . 74.15 112.701 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -89.75 -2.02 58.15 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.537 0.569 . . . . 72.03 112.537 -174.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.497 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 98.9 mttt -65.78 -14.62 61.72 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.732 0.641 . . . . 74.34 112.732 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -76.79 -37.66 55.4 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.373 0.606 . . . . 74.42 110.029 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.507 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.6 tt -88.88 5.56 43.3 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.031 -0.986 . . . . 74.23 110.85 -168.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -12.17 52.54 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.303 0.853 . . . . 75.11 113.303 -176.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.67 -36.51 51.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.574 0.702 . . . . 73.04 109.341 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 34.81 114.59 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 118.67 2.841 . . . . 60.12 118.67 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -113.77 123.39 49.72 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 113.847 -1.524 . . . . 74.41 107.537 173.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -83.61 138.04 33.54 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.252 -0.979 . . . . 75.54 112.301 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.11 115.37 30.15 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 106.737 -1.579 . . . . 61.23 106.737 175.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.1 pt -69.78 113.86 6.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-O 122.526 1.155 . . . . 72.44 113.949 -173.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -118.32 136.62 53.61 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 104.814 -2.291 . . . . 72.22 104.814 174.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.7 m -94.41 146.05 7.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 115.312 1.597 . . . . 72.43 115.312 -166.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.9 t -143.65 122.14 12.45 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 103.568 -2.753 . . . . 71.12 103.568 173.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.02 158.8 48.62 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 121.168 -0.539 . . . . 70.35 111.754 -176.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -81.77 45.08 0.87 Allowed 'General case' 0 C--O 1.253 1.259 0 CA-C-O 121.26 0.552 . . . . 52.42 110.075 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.69 124.73 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 CA-C-N 115.351 -0.841 . . . . 74.14 109.666 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -64.11 -22.88 67.11 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.449 -0.796 . . . . 71.45 111.44 -174.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -76.51 -25.97 54.75 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.019 0.438 . . . . 75.41 110.703 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.96 140.84 8.37 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.795 -0.639 . . . . 54.2 113.069 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -147.87 177.4 9.37 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.176 -1.416 . . . . 74.15 107.176 175.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 125' ' ' TRP . . . -80.93 152.78 33.54 Favored Glycine 0 N--CA 1.425 -2.034 0 C-N-CA 120.266 -0.969 . . . . 65.34 112.752 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -106.95 134.95 49.32 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.309 -1.367 . . . . 63.25 107.309 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.404 ' N ' ' HD2' ' A' ' 100' ' ' LYS . 7.7 mptt -124.21 102.59 7.78 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.433 -1.321 . . . . 70.34 107.433 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 96.0 mt -119.22 141.02 49.27 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 120.457 -0.497 . . . . 74.11 109.978 -176.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.537 HG22 ' HB3' ' A' ' 121' ' ' GLU . 20.3 t -122.9 135.39 63.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.941 -0.392 . . . . 73.13 109.941 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -120.38 141.42 50.11 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.38 -0.97 . . . . 75.41 108.38 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -114.96 144.33 43.75 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 109.304 -0.628 . . . . 73.14 109.304 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.508 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 22.9 t -68.96 166.23 18.37 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 124.165 0.986 . . . . 74.04 108.625 174.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.68 150.64 47.7 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.638 -0.875 . . . . 70.02 108.638 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.09 108.89 3.27 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.554 -0.535 . . . . 45.31 109.554 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -94.22 135.15 35.93 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.606 -0.725 . . . . 72.11 109.103 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -68.11 119.71 13.15 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 123.547 0.53 . . . . 60.42 109.895 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.1 t -96.19 162.45 13.52 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.05 -1.093 . . . . 74.12 108.05 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -62.57 -27.69 69.36 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.05 0.54 . . . . 72.5 111.716 -176.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.74 5.39 18.68 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.056 0.542 . . . . 63.54 110.615 -175.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 76.63 9.9 2.89 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.866 1.266 . . . . 72.25 109.953 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -96.69 174.7 6.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 109.045 -0.724 . . . . 63.04 109.045 177.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.518 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -113.96 133.54 59.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 109.547 -0.538 . . . . 73.21 109.547 178.18 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -115.01 155.44 26.96 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.688 -0.856 . . . . 70.2 108.688 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 46.2 p90 -156.04 149.38 24.63 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.633 -0.877 . . . . 74.24 108.633 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.508 ' H ' ' HB3' ' A' ' 105' ' ' SER . 3.5 m-20 -102.55 141.14 35.87 Favored 'General case' 0 C--N 1.264 -3.15 0 N-CA-C 106.653 -1.61 . . . . 65.54 106.653 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.507 ' CD ' ' HG3' ' A' ' 143' ' ' LYS . 93.5 mt-10 -114.94 141.39 48.02 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.484 -0.486 . . . . 65.13 110.005 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.72 121.77 31.19 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.838 -0.619 . . . . 71.51 109.565 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.537 ' HB3' HG22 ' A' ' 102' ' ' VAL . 14.5 pt-20 -123.77 115.33 21.2 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-O 121.626 0.726 . . . . 63.13 111.784 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.31 135.7 35.43 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.891 -1.049 . . . . 65.12 109.891 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -117.28 117.47 29.64 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.431 -0.951 . . . . 74.5 108.431 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.53 HG22 ' SG ' ' A' ' 132' ' ' CYS . 54.4 mt -119.76 128.87 75.92 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 N-CA-C 105.533 -2.025 . . . . 75.22 105.533 176.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.535 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 0.2 OUTLIER -110.89 145.18 38.74 Favored 'General case' 0 N--CA 1.425 -1.723 0 C-N-CA 117.373 -1.731 . . . . 74.42 110.536 -177.223 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -103.84 118.26 36.27 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 107.711 -1.218 . . . . 73.31 107.711 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -75.9 155.67 35.0 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.205 -1.361 . . . . 60.42 109.422 -174.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -60.12 -22.57 62.97 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.011 0.91 . . . . 72.22 110.106 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.69 -13.37 54.12 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.703 1.201 . . . . 72.1 111.336 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.77 -23.71 34.68 Favored Glycine 0 CA--C 1.498 -1.001 0 N-CA-C 111.22 -0.752 . . . . 54.25 111.22 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.0 p -78.37 159.58 28.28 Favored 'General case' 0 N--CA 1.408 -2.565 0 C-N-CA 124.06 0.944 . . . . 74.43 110.392 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.53 ' SG ' HG22 ' A' ' 124' ' ' ILE . 7.7 t -135.49 143.7 45.96 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 108.889 -0.782 . . . . 75.21 108.889 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.414 ' HE1' ' HA ' ' A' ' 52' ' ' HIS . 11.6 t90 -153.85 156.17 37.11 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.966 -1.124 . . . . 72.21 107.966 -176.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.0 mp -68.81 127.9 34.74 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.834 -0.432 . . . . 72.41 109.834 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -87.02 -52.26 5.54 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.902 0.858 . . . . 72.14 108.767 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.8 p -174.93 162.02 3.07 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.324 -1.307 . . . . 43.54 108.131 -175.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.6 m -137.08 144.44 32.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 N-CA-C 106.342 -1.725 . . . . 72.32 106.342 172.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -124.65 130.6 52.73 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 120.674 -0.41 . . . . 70.33 110.78 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -109.97 127.75 54.98 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.573 -1.269 . . . . 64.03 107.573 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.7 pt -126.82 99.01 5.12 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-O 121.932 0.872 . . . . 73.24 111.803 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -86.05 92.25 8.65 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 105.402 -2.073 . . . . 75.11 105.402 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.7 m -165.66 3.35 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.277 -0.42 . . . . 62.33 112.01 -176.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.507 ' HG3' ' CD ' ' A' ' 119' ' ' GLU . 28.1 mmtp -96.21 129.15 43.59 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 119.57 -0.852 . . . . 73.41 111.935 -176.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.18 109.03 0.29 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.448 -1.251 . . . . 71.51 109.476 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.36 138.47 81.2 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 109.045 -0.724 . . . . 74.35 109.045 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.24 140.56 71.97 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.591 2.194 . . . . 62.54 110.468 176.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -70.57 161.29 30.95 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.586 0.707 . . . . 74.12 111.559 -176.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.92 155.95 15.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 107.593 -1.262 . . . . 75.05 107.593 173.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.757 0 N-CA-C 108.623 -0.881 . . . . 75.2 108.623 -179.835 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 t70 . . . . . 0 CA--C 1.505 -0.788 0 CA-C-O 120.678 0.275 . . . . 64.44 110.457 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.5 mtt -95.17 107.69 19.79 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.873 -0.788 . . . . 74.23 108.873 175.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.9 t -76.16 140.2 17.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 105.569 -2.011 . . . . 63.54 105.569 173.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 21' ' ' VAL . 9.4 p -55.45 -42.97 74.97 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 118.594 0.634 . . . . 72.23 111.366 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.15 -37.91 89.17 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-O 121.726 0.774 . . . . 73.21 110.964 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.36 -33.32 72.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.918 -1.142 . . . . 73.22 107.918 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -69.98 -38.95 76.18 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.185 -0.916 . . . . 75.03 109.728 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 17' ' ' THR . 61.9 t -58.32 -53.89 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 123.507 0.504 . . . . 71.13 110.011 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.06 -32.78 74.2 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.874 -0.731 . . . . 64.32 111.413 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.86 -37.24 83.6 Favored Glycine 0 C--O 1.229 -0.161 0 N-CA-C 111.465 -0.654 . . . . 63.5 111.465 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.7 tp -65.45 -46.48 79.68 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 124.102 0.961 . . . . 71.12 108.663 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.46 -41.27 99.79 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.167 -0.924 . . . . 74.23 111.577 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -61.71 -42.28 98.74 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 122.731 0.412 . . . . 53.01 110.737 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -64.55 -47.71 77.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.356 0.598 . . . . 63.22 109.407 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 30.2 t80 -61.43 -51.59 68.09 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.309 -1.314 . . . . 61.24 110.42 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.3 mm -64.82 -32.28 57.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 116.24 -0.436 . . . . 52.14 111.687 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.31 -43.0 71.23 Favored 'General case' 0 CA--C 1.479 -1.784 0 C-N-CA 119.761 -0.775 . . . . 73.4 109.99 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 41' ' ' SER . 4.1 pp -70.53 -26.03 63.38 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 119.912 -0.715 . . . . 73.13 112.045 -178.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.0 t -70.25 -28.02 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 121.453 0.644 . . . . 52.32 109.777 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.9 p -114.21 23.66 12.67 Favored 'General case' 0 C--O 1.25 1.111 0 N-CA-C 109.148 -0.686 . . . . 54.02 109.148 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.617 ' HD3' ' HA ' ' A' ' 31' ' ' LEU . 27.4 tptt -52.8 137.56 31.48 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.342 -1.299 . . . . 72.1 111.684 -173.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.0 p -40.72 138.89 1.22 Allowed Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 125.411 1.484 . . . . 72.45 112.576 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -57.3 -15.22 18.06 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 123.545 2.83 . . . . 60.13 113.209 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.52 -27.94 68.96 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.921 0.867 . . . . 71.23 109.114 174.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.7 p -119.26 96.48 5.24 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 114.667 -1.151 . . . . 62.43 108.179 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.6 t -66.32 -50.03 71.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 113.348 0.87 . . . . 74.34 113.348 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.449 ' OD1' ' HB2' ' A' ' 43' ' ' HIS . 17.6 t-20 -89.72 80.76 6.51 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 123.111 1.434 . . . . 70.12 112.023 -171.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.68 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 15.8 m -67.2 -27.48 67.3 Favored 'General case' 0 C--O 1.255 1.374 0 CA-C-N 113.008 -1.906 . . . . 64.43 109.632 -175.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 42' ' ' GLU . 1.7 pm0 -68.52 -20.34 64.56 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 114.318 -1.31 . . . . 71.11 112.619 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.449 ' HB2' ' OD1' ' A' ' 40' ' ' ASN . 13.2 t60 -70.49 -38.46 74.35 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.19 -1.041 . . . . 72.14 108.19 175.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -66.57 -36.65 83.17 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.377 -0.972 . . . . 75.33 108.377 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.64 -43.18 97.54 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.671 -0.695 . . . . 74.45 110.722 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.01 79.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.31 0.576 . . . . 62.24 110.469 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -68.47 -39.12 81.52 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.443 -0.799 . . . . 63.41 109.698 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 79.7 t80 -69.4 -41.21 76.73 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 123.624 0.769 . . . . 73.31 111.084 -177.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.3 pp -79.52 -7.98 58.84 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-N 116.02 -0.536 . . . . 61.41 112.143 -176.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.05 -61.61 5.22 Favored Glycine 0 CA--C 1.541 1.687 0 C-N-CA 121.231 -0.509 . . . . 72.22 112.788 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -76.48 -4.92 15.61 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.118 2.545 . . . . 72.14 112.47 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.41 ' HB3' HD13 ' A' ' 134' ' ' LEU . 80.1 m-70 -122.61 29.95 6.68 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.889 -0.507 . . . . 74.03 110.646 -173.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.571 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 6.2 t70 -55.83 106.8 0.72 Allowed Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 125.207 1.403 . . . . 72.15 113.274 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 26.2 Cg_endo -107.33 -165.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 123.894 3.063 . . . . 50.21 112.803 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -87.85 115.58 25.41 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.077 -1.082 . . . . 72.51 108.077 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.407 HD13 ' HB2' ' A' ' 68' ' ' PHE . 53.4 mt -101.27 108.77 24.11 Favored 'Isoleucine or valine' 0 C--O 1.168 -3.217 0 N-CA-C 108.398 -0.964 . . . . 72.22 108.398 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -93.55 135.91 34.35 Favored 'General case' 0 C--N 1.272 -2.788 0 O-C-N 121.397 -0.814 . . . . 73.34 108.998 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.7 t -133.49 116.93 25.95 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.951 -1.129 . . . . 71.13 107.951 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 61.89 20.5 11.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.126 1.37 . . . . 61.54 110.931 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.6 4.72 60.51 Favored Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.26 -0.882 . . . . 75.23 112.822 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -107.45 134.77 49.99 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 108.096 -1.076 . . . . 71.34 108.096 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.11 127.88 38.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.523 0.678 . . . . 75.44 109.247 -178.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 61.9 mm-40 -122.01 150.12 42.53 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.005 -1.109 . . . . 73.41 108.005 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 t -97.86 174.09 6.76 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.414 -0.958 . . . . 75.24 108.414 176.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.571 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 8.9 t -53.77 -35.22 61.08 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 122.816 0.446 . . . . 74.41 111.058 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.543 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 10.7 m -58.73 -56.0 27.86 Favored 'General case' 0 C--O 1.212 -0.897 0 O-C-N 123.5 0.5 . . . . 63.53 110.014 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -58.96 -48.03 82.99 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 123.493 0.496 . . . . 74.44 111.014 -178.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.407 ' HB2' HD13 ' A' ' 56' ' ' ILE . 42.7 t80 -52.95 -56.86 12.85 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.464 0.478 . . . . 74.35 110.012 176.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -52.11 -42.87 63.63 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.716 -1.129 . . . . 73.14 110.857 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.8 mm100 -60.49 -48.77 80.32 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 122.797 0.439 . . . . 73.23 111.343 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.523 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 23.3 m-85 -66.41 -37.5 85.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.937 -0.764 . . . . 65.13 108.937 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -57.45 -53.37 58.89 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 123.762 0.825 . . . . 53.03 110.911 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -70.95 -19.2 62.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.118 0.485 . . . . 74.23 111.42 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -84.21 -9.91 58.14 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 112.972 0.731 . . . . 74.04 112.972 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.76 21.36 16.47 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 119.975 -1.107 . . . . 52.23 113.612 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.18 -49.7 9.19 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 122.255 -0.556 . . . . 44.13 110.78 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.523 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 62.4 m-85 -92.1 11.18 26.29 Favored 'General case' 0 C--O 1.193 -1.876 0 N-CA-C 113.333 0.864 . . . . 75.11 113.333 -175.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -12.35 59.96 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.391 0.885 . . . . 70.13 113.391 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -87.46 -10.05 52.92 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.648 -1.16 . . . . 64.11 111.779 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.7 tt -65.05 -26.24 68.17 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 122.505 0.322 . . . . 74.34 110.955 -173.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -60.86 -24.46 65.93 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.16 0.43 . . . . 72.1 112.16 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -105.16 13.65 30.35 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 112.108 0.41 . . . . 73.45 112.108 -178.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -70.17 126.46 29.75 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.414 0.626 . . . . 45.21 111.224 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -86.61 123.81 32.2 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.087 -0.96 . . . . 73.51 109.458 -177.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.468 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 39.7 p90 -87.45 135.31 33.39 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.238 0.542 . . . . 62.03 111.833 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.39 132.45 33.95 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 105.851 -1.907 . . . . 72.32 105.851 172.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.8 tp -83.79 74.32 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 122.706 1.241 . . . . 64.43 113.071 -173.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -89.27 99.95 12.84 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 104.406 -2.442 . . . . 65.12 104.406 170.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.3 p -112.98 97.46 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 113.912 1.079 . . . . 74.43 113.912 -173.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.0 m -83.37 -37.92 22.69 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 105.632 -1.988 . . . . 72.14 105.632 166.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.93 -115.76 4.82 Favored Glycine 0 CA--C 1.5 -0.849 0 CA-C-N 114.29 -1.323 . . . . 55.54 113.996 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -78.8 79.95 5.18 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.233 0.539 . . . . 72.44 111.807 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.8 m -120.07 110.69 29.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.04 -0.982 . . . . 70.1 108.484 173.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -91.84 79.71 5.3 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.106 -0.952 . . . . 72.12 109.49 -174.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.404 ' O ' ' HD2' ' A' ' 126' ' ' ARG . 8.7 tp10 -157.83 155.56 29.91 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.477 -1.238 . . . . 70.01 107.789 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.92 70.53 3.11 Favored Glycine 0 N--CA 1.429 -1.791 0 N-CA-C 110.718 -0.953 . . . . 72.11 110.718 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -127.43 177.03 7.01 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 122.549 0.34 . . . . 63.22 110.145 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 125' ' ' TRP . . . -100.0 148.89 18.63 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.649 -0.786 . . . . 70.43 113.214 -176.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -107.04 135.2 49.0 Favored 'General case' 0 C--O 1.25 1.111 0 N-CA-C 106.679 -1.6 . . . . 71.24 106.679 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -126.67 107.8 10.51 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.933 -0.766 . . . . 43.43 108.933 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.3 mt -114.57 138.14 51.0 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.082 -1.081 . . . . 73.4 108.082 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 11.8 p -127.26 137.69 57.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.572 0.701 . . . . 73.11 111.715 -177.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.576 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 17.4 m-90 -118.49 157.18 27.74 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.833 -1.076 . . . . 73.34 109.622 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.12 121.35 40.33 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.884 -1.895 . . . . 60.22 105.884 170.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.4 t -75.2 -166.91 0.55 Allowed 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 115.777 -0.647 . . . . 53.04 110.917 -174.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.41 124.1 19.31 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.979 -0.555 . . . . 75.12 112.359 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.77 124.42 28.59 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.396 -1.335 . . . . 74.52 107.396 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -131.26 136.19 47.98 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.934 -0.575 . . . . 74.42 110.233 -171.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.5 mtp85 -80.52 111.49 16.99 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.853 -0.795 . . . . 75.21 108.853 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.6 t -84.44 170.73 13.24 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.169 -0.923 . . . . 72.33 110.509 -174.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -67.73 -13.68 62.31 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.057 0.943 . . . . 71.42 110.489 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.585 ' HB2' ' HG2' ' A' ' 114' ' ' LYS . 6.0 m-20 -78.83 -5.94 54.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.041 -0.981 . . . . 71.24 110.285 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 69.44 19.22 7.66 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.898 1.279 . . . . 72.41 109.431 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.585 ' HG2' ' HB2' ' A' ' 112' ' ' ASP . 24.3 pttm -116.11 155.55 28.0 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.479 -0.934 . . . . 73.22 108.479 173.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 19.0 mt -90.8 132.92 34.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.22 -1.4 . . . . 72.01 107.22 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 56.6 ttm-85 -123.23 143.72 49.85 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.376 -0.972 . . . . 70.41 108.376 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 41.2 p90 -140.85 173.45 11.47 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.757 -0.831 . . . . 74.42 108.757 176.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.558 ' HB3' ' HA ' ' A' ' 141' ' ' MET . 2.7 p-10 -124.37 146.38 48.89 Favored 'General case' 0 C--N 1.249 -3.774 0 N-CA-C 108.82 -0.808 . . . . 74.22 108.82 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -113.78 147.88 37.53 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 119.725 -0.79 . . . . 75.31 109.786 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -131.45 120.22 22.71 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.345 -0.843 . . . . 64.45 111.274 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -110.83 118.1 35.22 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 108.207 -1.035 . . . . 74.43 108.207 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -106.15 134.66 48.94 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.664 -0.648 . . . . 55.35 110.146 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -119.82 118.75 31.62 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.171 -0.922 . . . . 63.45 110.818 -174.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.33 145.37 26.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 106.331 -1.729 . . . . 45.3 106.331 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.519 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 0.4 OUTLIER -123.58 140.06 53.38 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 117.751 -1.58 . . . . 75.11 108.924 174.871 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 95' ' ' GLU . 18.7 ttm180 -85.19 120.05 26.25 Favored 'General case' 0 N--CA 1.403 -2.811 0 N-CA-C 106.165 -1.791 . . . . 60.11 106.165 172.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.467 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 76.6 ttt180 -69.82 149.33 48.03 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.116 -1.438 . . . . 73.53 107.116 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.24 -20.35 58.53 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.697 0.76 . . . . 74.14 111.03 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.467 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 11.5 t70 -64.8 -18.13 64.83 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.507 1.123 . . . . 72.2 111.245 175.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.19 -21.28 33.72 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.192 -0.763 . . . . 55.11 111.192 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.0 m -78.2 171.33 15.2 Favored 'General case' 0 N--CA 1.419 -2.013 0 C-N-CA 123.562 0.745 . . . . 75.23 109.153 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.585 ' SG ' HG22 ' A' ' 21' ' ' VAL . 28.3 p -140.52 151.25 44.62 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 109.486 -0.561 . . . . 73.34 109.486 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.475 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 1.8 t90 -152.07 155.29 37.63 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.537 -1.283 . . . . 74.1 107.537 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.41 HD13 ' HB3' ' A' ' 52' ' ' HIS . 10.3 mp -68.82 123.87 22.14 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.349 0.595 . . . . 72.01 110.287 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -83.68 -50.6 8.02 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.135 -0.938 . . . . 74.41 108.563 -176.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 26.6 p -170.2 166.09 8.96 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 108.294 -1.002 . . . . 74.11 108.294 -177.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.2 t -143.52 143.37 24.45 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 N-CA-C 104.683 -2.34 . . . . 73.13 104.683 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -131.48 131.13 43.25 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 117.721 0.237 . . . . 74.4 110.866 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -118.17 130.54 56.16 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.147 -1.057 . . . . 64.53 108.147 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.5 pt -125.97 103.84 12.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-O 121.352 0.596 . . . . 75.21 111.438 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.558 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 52.8 mtt -95.85 94.85 7.88 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.064 -0.516 . . . . 55.24 109.611 -178.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.2 m -164.25 -46.38 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.018 -0.537 . . . . 62.52 110.672 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -45.44 131.58 8.32 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.644 1.578 . . . . 53.21 113.363 -173.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -159.52 157.49 30.07 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.393 -0.821 . . . . 63.32 109.788 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.59 159.2 53.11 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 108.274 -1.009 . . . . 65.33 108.274 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.05 147.73 32.93 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.994 2.463 . . . . 73.24 111.268 176.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.477 ' CB ' ' HB3' ' A' ' 114' ' ' LYS . 29.8 p90 -80.57 148.23 30.44 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-O 121.416 0.627 . . . . 74.21 112.143 -175.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.5 m -92.28 150.3 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 CA-C-N 114.978 -1.01 . . . . 61.34 108.336 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.466 0 N-CA-C 108.861 -0.792 . . . . 74.2 108.861 -179.91 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 CA--C 1.507 -0.682 0 N-CA-C 110.051 -0.352 . . . . 73.42 110.051 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.4 ttt 74.08 11.07 4.4 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 125.345 1.458 . . . . 75.25 110.683 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.1 p -64.62 -31.58 54.26 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.247 0 CA-C-N 115.209 -0.905 . . . . 74.23 109.764 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 130' ' ' GLY . 86.5 m -57.9 -46.71 84.52 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-O 121.46 0.648 . . . . 72.15 110.829 176.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -76.5 -35.35 58.4 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.541 -0.754 . . . . 73.31 110.758 -175.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.76 -37.34 81.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.518 -0.765 . . . . 73.34 108.941 178.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -66.65 -53.45 33.83 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 115.199 -0.91 . . . . 63.15 109.931 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.8 p -66.32 -32.99 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 116.033 -0.53 . . . . 65.51 112.39 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -33.89 62.88 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 119.045 -1.062 . . . . 63.0 110.045 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.29 -41.36 68.7 Favored Glycine 0 CA--C 1.496 -1.1 0 N-CA-C 110.605 -0.998 . . . . 41.03 110.605 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.7 tp -65.15 -50.8 64.59 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 123.778 0.831 . . . . 71.2 109.698 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.33 -42.18 97.26 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.61 -0.723 . . . . 61.15 112.258 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -74.02 -32.52 63.4 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 120.159 -0.616 . . . . 75.53 111.559 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.86 -44.04 97.19 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.069 -0.715 . . . . 64.22 109.069 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 23.0 t80 -62.08 -53.73 51.3 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.08 -1.418 . . . . 70.5 110.31 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.6 mm -61.09 -40.53 86.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.606 0.595 . . . . 73.21 112.606 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.5 -40.49 85.19 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 120.521 -0.471 . . . . 60.13 110.136 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.686 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.8 pp -71.54 -27.51 63.24 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 118.801 -1.16 . . . . 71.54 112.054 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.5 t -71.07 -21.65 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 121.27 0.557 . . . . 72.0 109.527 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.0 p -115.09 22.31 13.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 122.115 -0.366 . . . . 50.21 111.915 -177.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.686 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 61.0 mmtt -49.82 133.71 21.59 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 113.544 0.942 . . . . 60.13 113.544 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.5 m -55.21 150.39 21.88 Favored Pre-proline 0 C--N 1.302 -1.496 0 C-N-CA 125.537 1.535 . . . . 74.42 110.487 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -59.18 -12.77 17.05 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.658 2.905 . . . . 60.11 112.857 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.52 -27.42 69.14 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.072 0.939 . . . . 63.25 109.1 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.4 p -109.99 99.17 8.32 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 106.354 -1.721 . . . . 71.34 106.354 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.8 p -49.61 -37.88 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 116.657 2.095 . . . . 71.12 116.657 -168.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -132.49 110.54 10.57 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 118.153 -1.419 . . . . 73.0 113.149 -174.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.8 m -65.89 -35.77 81.56 Favored 'General case' 0 C--O 1.256 1.412 0 CA-C-O 121.823 0.821 . . . . 61.44 110.331 -175.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.568 ' OE2' ' HA ' ' A' ' 78' ' ' LYS . 1.5 mp0 -66.6 -21.3 66.13 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.243 -0.889 . . . . 64.22 110.586 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -68.62 -42.23 78.39 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 108.533 -0.914 . . . . 74.03 108.533 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.469 ' HG3' ' HG3' ' A' ' 34' ' ' LYS . 13.2 mm-40 -69.76 -35.01 74.57 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 108.098 -1.075 . . . . 72.34 108.098 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.0 tp -66.97 -42.97 84.25 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.896 -0.593 . . . . 63.31 110.801 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.99 -34.39 76.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.624 0.726 . . . . 70.53 110.366 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -76.35 -32.72 58.82 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.197 -0.91 . . . . 64.14 109.98 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.487 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 59.9 t80 -67.28 -47.7 69.86 Favored 'General case' 0 C--O 1.215 -0.744 0 C-N-CA 123.48 0.712 . . . . 63.4 109.991 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.443 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.5 pp -75.03 -4.14 36.65 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.766 -0.652 . . . . 74.44 111.107 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.61 -61.13 5.36 Favored Glycine 0 CA--C 1.526 0.755 0 O-C-N 123.644 0.59 . . . . 72.03 112.371 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 48' ' ' PHE . 93.5 Cg_endo -85.18 -6.5 9.3 Favored 'Trans proline' 0 CA--C 1.549 1.264 0 C-N-CA 122.214 1.942 . . . . 74.33 112.672 173.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 75.9 m80 -111.41 31.35 6.18 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.726 -0.472 . . . . 72.45 109.726 -175.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.412 ' OD2' ' HB ' ' A' ' 65' ' ' THR . 13.4 t70 -54.68 107.82 0.97 Allowed Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 124.679 1.192 . . . . 75.52 112.505 -177.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -108.7 -154.45 0.02 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.294 0 C-N-CA 123.602 2.868 . . . . 74.22 110.485 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -93.63 120.13 33.52 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 107.195 -1.409 . . . . 55.21 107.195 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.446 HD13 ' CB ' ' A' ' 68' ' ' PHE . 64.7 mt -101.56 110.38 28.25 Favored 'Isoleucine or valine' 0 C--O 1.168 -3.19 0 N-CA-C 108.038 -1.097 . . . . 74.13 108.038 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -96.77 138.62 34.05 Favored 'General case' 0 C--N 1.271 -2.839 0 O-C-N 121.304 -0.873 . . . . 75.33 109.304 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.5 t -133.07 114.44 21.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 107.502 -1.296 . . . . 74.33 107.502 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 63.19 21.02 12.63 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 124.794 1.237 . . . . 63.32 111.073 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.92 -1.16 59.41 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.329 -0.851 . . . . 71.42 112.39 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -103.96 135.27 45.79 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.417 -0.586 . . . . 61.31 109.417 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -76.97 129.2 37.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.671 0.748 . . . . 62.34 109.265 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.456 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 57.4 mm-40 -126.21 147.55 49.64 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 124.642 1.177 . . . . 73.43 108.227 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 t -92.63 174.56 7.2 Favored 'General case' 0 C--O 1.254 1.341 0 N-CA-C 108.232 -1.025 . . . . 71.42 108.232 175.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.412 ' HB ' ' OD2' ' A' ' 53' ' ' ASP . 8.8 t -54.8 -36.17 64.65 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.028 0.531 . . . . 71.24 111.058 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 35.8 m -65.92 -46.42 78.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 122.729 0.412 . . . . 74.14 111.194 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -63.88 -46.19 86.01 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.91 -0.404 . . . . 62.0 109.91 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.446 ' CB ' HD13 ' A' ' 56' ' ' ILE . 48.9 t80 -54.28 -54.94 33.41 Favored 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 123.656 0.597 . . . . 74.22 109.723 174.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 2.2 tm? -50.39 -44.36 54.87 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 124.424 1.078 . . . . 61.23 110.54 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.431 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 89.4 mt-30 -56.91 -52.11 66.45 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 123.101 0.56 . . . . 73.24 111.929 174.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -64.87 -36.53 84.66 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.704 0.764 . . . . 73.21 109.817 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -57.7 -55.99 27.72 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 124.612 1.165 . . . . 71.35 110.472 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 48.9 ptt85 -68.87 -23.93 64.28 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.358 -0.383 . . . . 74.51 111.597 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 54.8 mt-30 -78.99 -15.31 58.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 120.432 -0.507 . . . . 74.02 111.459 176.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.47 14.33 30.41 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.677 -0.773 . . . . 54.24 114.622 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.16 -42.54 79.91 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.437 0.532 . . . . 74.12 112.437 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -92.48 6.89 45.42 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.587 0.588 . . . . 75.2 112.587 -173.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.568 ' HA ' ' OE2' ' A' ' 42' ' ' GLU . 99.4 mttt -67.06 -13.96 62.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.222 0.534 . . . . 75.22 112.233 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -77.57 -27.24 51.39 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.083 -0.71 . . . . 54.11 109.083 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.461 ' O ' HD23 ' A' ' 80' ' ' LEU . 7.1 tt -71.63 -17.51 62.26 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.077 0.951 . . . . 60.53 109.662 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -68.04 -22.04 64.97 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.105 -0.498 . . . . 75.1 109.879 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -101.13 4.76 42.4 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.379 -0.601 . . . . 73.14 109.379 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 105' ' ' SER . . . -75.73 143.17 42.2 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.525 0.935 . . . . 60.12 113.525 -173.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 103' ' ' TRP . 49.4 mt-10 -89.14 139.37 30.54 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.12 -0.945 . . . . 74.5 109.175 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -76.25 106.04 7.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 104.465 -2.42 . . . . 65.34 104.465 167.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.68 101.12 4.52 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.448 0.642 . . . . 54.4 111.25 -173.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.6 mm -97.5 128.64 48.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 107.405 -1.331 . . . . 72.15 107.405 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -69.04 -46.66 67.34 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.221 -1.029 . . . . 61.2 108.221 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.9 p -167.74 136.02 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 107.718 -1.216 . . . . 74.44 107.718 176.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 m -87.64 -38.85 15.54 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.713 -0.847 . . . . 71.01 108.713 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.39 -145.74 37.95 Favored Glycine 0 N--CA 1.428 -1.846 0 CA-C-N 114.795 -1.093 . . . . 60.34 110.496 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -133.89 129.62 36.63 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 120.85 0.357 . . . . 74.11 110.147 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.7 t -89.44 118.01 33.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 106.143 -1.799 . . . . 63.52 106.143 174.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -73.28 -36.82 66.37 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 112.959 0.726 . . . . 64.31 112.959 -171.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -149.93 115.47 5.53 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.541 -0.463 . . . . 54.54 110.217 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.41 91.81 0.47 Allowed Glycine 0 CA--C 1.5 -0.875 0 N-CA-C 110.825 -0.91 . . . . 43.4 110.825 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -58.67 119.77 7.71 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 113.508 0.929 . . . . 64.01 113.508 -174.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.83 138.12 13.73 Favored Glycine 0 N--CA 1.406 -3.33 0 N-CA-C 107.556 -2.218 . . . . 33.33 107.556 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -111.14 127.0 55.43 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.583 -0.895 . . . . 71.41 108.583 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -123.2 98.63 5.96 Favored 'General case' 0 C--N 1.273 -2.736 0 N-CA-C 105.44 -2.059 . . . . 72.23 105.44 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 75.2 mt -109.75 138.84 45.53 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.034 -0.985 . . . . 53.53 108.897 -173.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 12.1 p -133.43 138.2 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-O 121.729 0.776 . . . . 72.33 111.839 -178.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.401 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 23.3 m-90 -113.77 143.71 44.19 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.392 -1.277 . . . . 74.11 107.661 176.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.425 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 21.8 mtpp -126.01 124.24 40.26 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.092 -1.447 . . . . 74.44 107.092 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 40.0 m -82.22 177.78 8.61 Favored 'General case' 0 C--N 1.281 -2.407 0 O-C-N 123.397 0.436 . . . . 52.41 111.012 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.34 126.22 25.35 Favored 'General case' 0 C--O 1.24 0.571 0 O-C-N 123.485 0.491 . . . . 71.12 110.787 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.472 ' HA ' ' HB3' ' A' ' 117' ' ' TRP . . . -76.99 142.89 39.77 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.035 -0.984 . . . . 72.02 110.375 -177.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -124.78 120.69 32.47 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.87 -1.159 . . . . 62.35 107.87 -176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -75.87 109.08 9.2 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.631 -0.877 . . . . 72.53 108.631 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 t -82.96 157.35 23.02 Favored 'General case' 0 N--CA 1.408 -2.532 0 CA-C-N 114.615 -1.175 . . . . 35.04 107.937 -172.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -76.74 3.69 11.2 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.859 0.838 . . . . 63.3 110.012 -177.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -87.86 5.56 39.72 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 124.952 1.301 . . . . 75.32 109.848 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 74.2 10.91 4.33 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.847 1.259 . . . . 73.31 110.698 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -129.02 165.44 21.15 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.308 -0.997 . . . . 72.31 108.308 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 115' ' ' ILE . 2.1 mp -104.91 136.2 39.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 108.193 -1.04 . . . . 74.11 108.193 -176.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.652 ' HG2' ' HB2' ' A' ' 144' ' ' ALA . 53.0 mtm180 -115.46 151.13 35.35 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.499 -0.556 . . . . 52.14 109.499 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 107' ' ' ALA . 10.2 p90 -160.49 174.06 14.63 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.918 -0.771 . . . . 73.13 108.918 177.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.437 ' CB ' ' HA ' ' A' ' 141' ' ' MET . 4.7 p-10 -113.01 134.65 54.41 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-O 121.199 0.523 . . . . 74.53 110.07 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.428 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 37.2 mt-10 -117.16 154.62 30.78 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.783 -1.099 . . . . 72.42 112.015 178.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.571 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -135.79 118.48 16.05 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.042 -0.981 . . . . 61.3 109.284 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 37.2 mt-10 -116.4 110.54 18.8 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.624 -0.51 . . . . 74.32 109.624 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.21 130.65 41.87 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 109.057 -0.72 . . . . 72.34 109.057 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -113.84 118.52 34.48 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.964 -0.754 . . . . 73.04 108.964 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.3 mt -118.95 152.69 21.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.388 -1.338 . . . . 74.51 107.388 178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -137.53 148.55 46.06 Favored 'General case' 0 C--O 1.275 2.417 0 C-N-CA 119.715 -0.794 . . . . 72.42 109.922 175.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -88.11 129.37 35.32 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.116 -0.947 . . . . 73.43 108.691 170.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.422 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 47.8 ttt180 -87.86 147.29 25.18 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-N 113.983 -1.462 . . . . 54.43 108.075 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -58.21 -28.27 64.66 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.855 0.462 . . . . 75.33 112.065 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.422 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 9.8 t70 -64.84 -16.87 63.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.148 -0.933 . . . . 74.52 111.702 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.401 ' O ' HG23 ' A' ' 17' ' ' THR . . . 98.6 6.8 56.24 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 119.849 -1.167 . . . . 63.11 111.283 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.404 ' OG ' ' HD3' ' A' ' 127' ' ' ARG . 0.4 OUTLIER -96.89 162.37 13.44 Favored 'General case' 0 N--CA 1.396 -3.151 0 N-CA-C 108.438 -0.949 . . . . 72.22 108.438 175.711 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 28.8 p -133.22 144.99 50.15 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 107.967 -1.123 . . . . 61.31 107.967 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.41 ' HE1' ' HA ' ' A' ' 52' ' ' HIS . 2.1 t90 -159.06 156.05 28.5 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 120.088 -0.645 . . . . 75.11 109.797 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.6 mp -69.23 127.01 31.54 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.268 0.556 . . . . 65.52 109.773 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -80.89 -56.12 4.34 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.806 -1.183 . . . . 75.43 107.806 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 10.9 m -166.5 162.27 16.67 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 105.931 -1.877 . . . . 65.3 105.931 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.7 m -137.55 149.84 25.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 106.394 -1.706 . . . . 74.23 106.394 171.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -134.4 130.71 37.26 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 117.686 0.221 . . . . 65.43 110.414 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -112.63 129.05 56.52 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 107.312 -1.366 . . . . 74.05 107.312 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 8.4 pt -129.0 98.3 4.08 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 CA-C-O 122.129 0.966 . . . . 60.32 109.048 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.437 ' HA ' ' CB ' ' A' ' 118' ' ' ASP . 23.3 ptp -92.83 138.31 31.6 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.013 -0.994 . . . . 72.24 110.205 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.5 t 81.26 29.02 0.17 Allowed 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.264 0.977 . . . . 72.42 109.812 176.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -73.42 146.03 45.35 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.282 -1.747 . . . . 75.1 106.282 173.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.652 ' HB2' ' HG2' ' A' ' 116' ' ' ARG . . . -135.38 150.37 49.9 Favored 'General case' 0 N--CA 1.418 -2.047 0 C-N-CA 120.221 -0.592 . . . . 73.51 111.688 -175.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.06 109.14 35.46 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 106.277 -1.749 . . . . 75.34 106.277 169.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.74 144.33 97.03 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.71 2.273 . . . . 71.02 111.898 -176.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -79.85 151.09 30.42 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 108.893 -0.78 . . . . 64.53 108.893 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 31.1 m -77.66 115.29 19.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-O 121.668 0.747 . . . . 74.34 111.328 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.644 0 N-CA-C 107.845 -1.168 . . . . 70.12 107.845 178.904 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 CA--C 1.504 -0.807 0 N-CA-C 111.921 0.341 . . . . 75.55 111.921 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.55 1.38 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 116.907 2.188 . . . . 71.51 116.907 -170.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.1 m -71.19 -43.48 74.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 118.772 0.715 . . . . 75.45 110.88 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.2 p -67.9 -41.54 82.55 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.38 -0.6 . . . . 74.24 109.38 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 9.6 m-20 -60.23 -43.46 96.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.488 -1.233 . . . . 71.13 111.21 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.4 -42.95 87.12 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.873 -0.788 . . . . 75.51 108.873 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.17 -48.81 78.4 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 115.86 -0.609 . . . . 73.34 111.411 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.0 p -69.38 -38.83 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 112.552 0.575 . . . . 64.41 112.552 -176.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 22.5 ptmt -75.76 -25.96 56.96 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 119.076 -1.05 . . . . 65.55 110.187 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.56 -57.74 5.82 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 120.64 -0.791 . . . . 71.11 111.262 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 pp -68.45 -35.91 78.26 Favored 'General case' 0 C--O 1.199 -1.559 0 N-CA-C 108.947 -0.76 . . . . 65.13 108.947 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.23 -43.67 96.69 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 116.231 -0.44 . . . . 70.34 112.036 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -63.83 -46.85 83.2 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.76 -0.459 . . . . 72.31 109.76 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -65.16 -41.27 94.85 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 116.051 -0.522 . . . . 71.24 110.247 -177.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -63.05 -53.59 51.39 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.418 -0.81 . . . . 74.42 110.481 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 29' ' ' ILE . 13.5 mm -64.23 -34.81 71.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.613 -0.267 . . . . 74.43 111.666 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -63.3 -48.59 77.43 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 116.34 -0.391 . . . . 72.24 110.144 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 pp -68.57 -29.35 67.88 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.288 -0.565 . . . . 62.51 111.84 -177.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.45 -28.54 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-O 121.471 0.653 . . . . 71.4 110.326 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.7 p -110.17 13.29 23.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.34 0.59 . . . . 34.34 110.566 -175.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 tptt -57.0 140.39 49.14 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.638 1.175 . . . . 74.31 111.928 -175.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.6 m -57.63 155.26 21.75 Favored Pre-proline 0 C--O 1.248 1.014 0 C-N-CA 124.183 0.993 . . . . 43.55 111.259 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.83 -5.99 5.39 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 124.82 3.68 . . . . 72.11 112.146 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -59.7 -26.42 65.59 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.463 -1.244 . . . . 64.44 110.589 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.2 p -92.43 167.72 11.78 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 107.358 -1.349 . . . . 72.43 107.358 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.62 -46.93 67.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 118.884 -1.126 . . . . 74.53 111.13 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -168.09 141.64 3.28 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.331 -0.989 . . . . 73.51 108.331 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.8 m -56.62 -41.29 76.84 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 123.186 0.594 . . . . 72.45 111.067 -177.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.444 ' HB2' ' CD2' ' A' ' 72' ' ' PHE . 6.9 mm-40 -67.83 -20.06 65.12 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.947 -1.024 . . . . 54.3 111.383 -176.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -69.99 -48.26 58.91 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 108.26 -1.015 . . . . 72.3 108.26 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -69.32 -32.07 70.96 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 114.2 -1.364 . . . . 74.52 108.518 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.4 tp -67.04 -45.06 78.6 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.526 -0.761 . . . . 73.14 110.117 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.85 -34.94 75.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.293 0.568 . . . . 50.1 110.214 177.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -69.14 -40.29 78.33 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.103 -0.953 . . . . 70.25 109.215 177.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -68.48 -42.58 78.47 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 123.498 0.719 . . . . 62.14 110.594 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.472 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 3.3 pp -84.41 0.66 48.64 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.877 -0.601 . . . . 63.12 110.964 -176.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.32 -61.59 7.05 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 111.303 -0.719 . . . . 63.1 111.303 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -77.2 -5.09 15.47 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.868 2.379 . . . . 75.11 112.034 175.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 62.9 m-70 -121.47 36.55 4.58 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.698 -0.482 . . . . 61.02 109.698 -174.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -55.7 106.56 0.69 Allowed Pre-proline 0 N--CA 1.48 1.051 0 O-C-N 124.706 1.254 . . . . 64.0 111.892 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -99.95 -177.37 0.19 Allowed 'Trans proline' 0 N--CA 1.422 -2.697 0 C-N-CA 122.661 2.241 . . . . 72.53 109.979 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -84.22 107.46 16.54 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 107.254 -1.388 . . . . 72.54 107.254 174.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.65 HD13 ' HB2' ' A' ' 68' ' ' PHE . 71.7 mt -92.41 105.95 17.27 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.161 0 N-CA-C 107.39 -1.337 . . . . 63.32 107.39 -175.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -98.9 105.9 18.09 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 122.029 -0.42 . . . . 72.12 111.312 -175.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 70.3 t -107.97 113.1 42.89 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.649 0 N-CA-C 108.02 -1.104 . . . . 73.01 108.02 -177.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 56.63 26.3 11.02 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 124.536 1.148 . . . . 71.43 111.034 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.75 14.3 61.42 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.438 -0.801 . . . . 75.54 112.614 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -112.3 130.35 55.97 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.519 -0.919 . . . . 63.12 108.519 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.88 125.97 38.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 121.833 0.825 . . . . 74.32 109.183 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.454 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 47.9 mm-40 -124.44 147.84 48.03 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.719 -1.215 . . . . 75.43 107.719 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.1 t -101.24 173.73 6.32 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.793 -1.188 . . . . 60.12 107.793 174.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -46.23 -39.88 10.55 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.809 1.244 . . . . 62.43 112.09 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.466 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 27.6 m -64.43 -52.74 56.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 122.651 0.38 . . . . 72.42 110.489 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -60.95 -45.82 93.2 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.036 -0.529 . . . . 64.31 110.809 -178.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.65 ' HB2' HD13 ' A' ' 56' ' ' ILE . 46.5 t80 -52.22 -56.4 14.89 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.232 0.539 . . . . 75.44 109.796 175.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -49.77 -43.3 48.09 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 114.194 -1.367 . . . . 64.12 111.12 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.492 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 15.7 mm100 -62.75 -46.68 86.94 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 122.892 0.477 . . . . 71.0 111.222 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.498 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 51.6 m-85 -66.45 -37.58 85.46 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.332 0.587 . . . . 75.23 109.664 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.444 ' CD2' ' HB2' ' A' ' 42' ' ' GLU . 3.9 t80 -57.19 -51.83 67.77 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.022 -0.536 . . . . 70.44 110.96 175.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 12.8 ptm180 -69.47 -23.33 63.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.334 0.588 . . . . 75.35 110.68 -176.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -81.01 -6.12 58.4 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.653 0.612 . . . . 72.05 112.653 175.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.8 17.37 30.67 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.175 -0.536 . . . . 24.11 114.032 175.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.45 -60.29 2.42 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 122.47 -0.429 . . . . 45.22 111.874 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.498 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 56.5 m-85 -83.31 -7.43 59.59 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 113.455 0.909 . . . . 70.33 113.455 -171.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -15.81 63.82 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.469 -0.892 . . . . 62.34 111.561 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -88.37 -17.01 31.46 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.123 0.487 . . . . 75.21 109.689 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 80' ' ' LEU . 3.3 tm? -84.59 -17.36 38.99 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 115.64 -0.709 . . . . 73.35 109.381 -174.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.47 3.27 13.83 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.721 0.772 . . . . 75.45 111.086 -176.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -104.64 2.93 31.08 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.422 -0.955 . . . . 64.14 108.422 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -74.56 153.13 39.17 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.126 -0.943 . . . . 61.12 113.248 -175.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -99.48 135.45 40.87 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.382 -1.281 . . . . 71.12 108.385 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -76.93 118.83 19.91 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.506 -0.553 . . . . 75.41 109.506 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.22 161.37 15.05 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.587 0.708 . . . . 75.13 110.77 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.6 tp -108.53 141.34 24.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.378 -0.971 . . . . 64.4 108.378 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -125.02 103.3 7.94 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.49 -0.93 . . . . 64.31 108.49 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.5 p -68.9 -21.07 25.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.295 0.569 . . . . 74.33 111.237 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 t -96.97 20.38 11.26 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 122.142 0.972 . . . . 74.43 108.664 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.45 157.7 52.86 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 110.477 -1.049 . . . . 72.42 110.477 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -95.46 143.18 27.01 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.508 -0.477 . . . . 73.03 111.381 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.2 m -126.4 156.49 37.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.294 -1.373 . . . . 34.32 107.294 174.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.09 172.86 16.85 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.82 -0.437 . . . . 52.11 109.82 -171.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -54.03 -34.36 59.77 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.431 0.692 . . . . 75.23 112.563 -177.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.14 102.84 2.95 Favored Glycine 0 N--CA 1.425 -2.089 0 N-CA-C 106.126 -2.79 . . . . 73.33 106.126 170.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -58.76 119.86 7.91 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.022 0.439 . . . . 62.04 111.265 -172.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -138.74 156.41 24.21 Favored Glycine 0 N--CA 1.409 -3.116 0 C-N-CA 120.412 -0.899 . . . . 73.54 111.587 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -116.7 157.0 26.14 Favored 'General case' 0 C--O 1.261 1.671 0 N-CA-C 108.119 -1.067 . . . . 74.45 108.119 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -125.46 101.8 7.1 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 105.833 -1.914 . . . . 72.43 105.833 171.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.2 mt -99.16 112.43 24.58 Favored 'General case' 0 C--N 1.261 -3.253 0 N-CA-C 106.923 -1.51 . . . . 72.15 106.923 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 8.5 p -115.6 132.0 66.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.486 0.66 . . . . 75.44 112.035 -174.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.401 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 24.3 m-90 -106.34 140.86 38.6 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.051 -0.977 . . . . 75.42 109.245 176.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -118.63 121.24 39.71 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.063 -1.088 . . . . 74.12 108.063 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.461 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 45.1 t -80.26 -168.13 1.57 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.313 -0.858 . . . . 43.0 110.827 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.26 141.72 53.68 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 113.426 0.899 . . . . 74.52 113.426 -174.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.07 98.47 9.32 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.863 -1.162 . . . . 61.43 107.863 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -93.42 110.41 21.97 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 114.098 -1.41 . . . . 73.5 107.561 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -64.03 132.41 50.52 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 114.948 1.462 . . . . 75.02 114.948 -172.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.7 t -113.98 132.99 55.78 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 106.382 -1.71 . . . . 74.32 106.382 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -69.89 6.73 1.1 Allowed 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 113.005 0.743 . . . . 71.3 113.005 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -96.13 25.56 4.78 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 122.158 -0.339 . . . . 64.43 110.454 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 70.54 23.23 4.83 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.236 1.014 . . . . 64.35 111.12 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 20.8 pttp -137.03 171.11 14.99 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.238 0.542 . . . . 65.32 111.462 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.448 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -127.54 151.4 34.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.135 -1.431 . . . . 64.15 107.135 176.504 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -114.83 158.33 22.07 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 106.528 -1.656 . . . . 74.25 106.528 176.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.423 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 39.1 p90 -148.76 164.88 33.09 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 108.019 -1.104 . . . . 75.51 108.019 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.461 ' H ' ' HB3' ' A' ' 105' ' ' SER . 1.5 m-20 -106.55 134.19 50.06 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 105.57 -2.011 . . . . 72.22 105.57 176.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.434 ' HB2' HG13 ' A' ' 140' ' ' ILE . 34.9 mt-10 -114.87 154.12 29.23 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 119.482 -0.887 . . . . 75.44 111.727 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -139.32 116.85 11.36 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.878 -1.055 . . . . 53.22 108.999 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -111.98 109.66 19.54 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.058 -0.719 . . . . 71.53 109.058 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.54 118.25 33.62 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 121.136 0.493 . . . . 32.35 109.751 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -100.82 113.55 26.57 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.198 -1.408 . . . . 70.45 107.198 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 54.4 mt -118.31 143.62 28.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.42 -1.326 . . . . 63.31 107.42 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.25 147.57 51.1 Favored 'General case' 0 C--O 1.262 1.725 0 C-N-CA 119.098 -1.041 . . . . 61.22 110.752 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.577 ' HG2' ' SG ' ' A' ' 132' ' ' CYS . 29.1 mtp180 -89.91 116.86 28.29 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.073 -1.421 . . . . 73.22 109.17 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -80.96 145.21 31.35 Favored 'General case' 0 C--N 1.273 -2.725 0 CA-C-N 113.79 -1.55 . . . . 74.21 111.049 -170.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -72.59 -10.71 60.13 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 107.813 -1.18 . . . . 64.05 107.813 174.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.95 -17.72 64.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.006 -0.997 . . . . 72.0 109.589 173.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 101.89 -6.67 54.54 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.508 -0.637 . . . . 42.41 111.508 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.9 m -103.88 -179.62 4.0 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.141 -0.688 . . . . 65.52 109.141 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.577 ' SG ' ' HG2' ' A' ' 126' ' ' ARG . 74.0 m -131.49 142.14 49.91 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.611 -1.255 . . . . 73.53 107.611 175.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -149.78 154.89 39.19 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 119.718 -0.793 . . . . 74.52 109.879 -176.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.23 122.35 22.68 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.861 -0.792 . . . . 70.43 108.861 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -76.34 -52.8 9.2 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.209 -1.034 . . . . 74.3 108.209 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.7 m -167.88 154.53 7.86 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.479 -1.674 . . . . 64.45 106.479 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.39 139.41 41.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.469 -1.308 . . . . 62.44 107.469 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 33.9 ttmt -114.39 139.19 49.69 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 109.965 -0.383 . . . . 64.34 109.965 -175.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 66.2 m-85 -125.4 121.44 33.85 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.78 -1.192 . . . . 72.11 107.78 174.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.51 ' HB ' ' CD ' ' A' ' 143' ' ' LYS . 9.5 pt -128.83 97.61 3.75 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 CA-C-O 122.16 0.981 . . . . 73.13 109.109 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -87.95 137.04 32.68 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.925 -1.034 . . . . 72.22 111.33 -177.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.482 ' O ' ' HE3' ' A' ' 143' ' ' LYS . 41.4 t 71.27 49.19 0.33 Allowed 'General case' 0 C--N 1.321 -0.668 0 O-C-N 124.657 1.223 . . . . 75.41 111.403 175.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.51 ' CD ' ' HB ' ' A' ' 140' ' ' ILE . 0.3 OUTLIER -101.86 145.81 28.69 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.422 -0.955 . . . . 72.3 108.422 175.436 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -149.84 139.07 21.28 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.308 -0.627 . . . . 74.21 109.308 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.92 153.16 49.34 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 109.062 -0.718 . . . . 74.43 109.062 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.62 132.49 52.45 Favored 'Trans proline' 0 C--O 1.247 0.963 0 C-N-CA 122.519 2.146 . . . . 74.41 109.997 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.454 ' HB3' ' HB3' ' A' ' 114' ' ' LYS . 54.9 p90 -67.71 153.92 42.64 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 121.201 0.524 . . . . 63.12 112.01 -173.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.73 127.1 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 CA-C-N 115.575 -0.739 . . . . 71.1 110.273 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.465 0 N-CA-C 107.78 -1.192 . . . . 70.41 107.78 178.412 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.407 ' HB3' HG12 ' A' ' 16' ' ' VAL . 1.3 m-20 . . . . . 0 CA--C 1.501 -0.905 0 N-CA-C 109.029 -0.73 . . . . 61.33 109.029 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.9 ttt -94.56 -6.82 42.76 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.673 0.749 . . . . 72.5 111.21 -174.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.407 HG12 ' HB3' ' A' ' 14' ' ' ASP . 14.2 p -65.92 -20.32 27.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 114.965 -1.016 . . . . 75.15 110.326 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.455 ' O ' HG13 ' A' ' 21' ' ' VAL . 18.9 p -64.57 -39.69 94.19 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.351 -0.84 . . . . 74.43 111.288 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -68.21 -34.94 77.19 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.94 0.876 . . . . 74.13 109.104 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -70.41 -39.49 74.43 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.864 -1.062 . . . . 74.13 108.901 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.57 -45.01 84.94 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.859 -0.61 . . . . 72.54 109.916 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.496 HG12 ' SG ' ' A' ' 132' ' ' CYS . 17.9 m -69.49 -37.89 75.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.167 -0.47 . . . . 43.32 112.015 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HB3' ' HZ3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -72.5 -33.5 66.99 Favored 'General case' 0 C--O 1.211 -0.954 0 C-N-CA 118.629 -1.228 . . . . 74.24 109.961 178.519 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.83 -41.93 61.96 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.241 -0.743 . . . . 72.22 111.241 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.0 tp -69.65 -50.4 44.55 Favored 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 124.047 0.939 . . . . 71.11 109.173 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.05 -42.22 99.72 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.967 -0.56 . . . . 43.12 111.872 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -65.32 -44.2 88.61 Favored 'General case' 0 C--O 1.187 -2.218 0 CA-C-O 118.791 -0.623 . . . . 72.13 110.872 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.02 -38.63 91.95 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.116 0.96 . . . . 63.51 110.252 -174.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.572 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 24.1 t80 -64.45 -55.18 22.52 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.698 -1.592 . . . . 75.02 110.081 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 29' ' ' ILE . 16.0 mm -67.03 -30.56 49.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.074 -0.512 . . . . 71.42 111.007 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.34 -48.44 77.96 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.596 0.758 . . . . 73.14 110.142 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.4 pp -69.14 -28.49 66.49 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 119.944 -0.702 . . . . 64.41 110.048 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 68.8 t -73.21 -22.19 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 CA-C-O 121.219 0.533 . . . . 71.44 110.929 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.4 p -107.5 15.69 24.57 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.415 -0.803 . . . . 74.44 111.858 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.525 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 32.4 mmmt -57.05 162.22 2.64 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 113.543 0.942 . . . . 74.14 113.543 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.442 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 12.2 p -70.33 169.54 13.35 Favored Pre-proline 0 N--CA 1.435 -1.197 0 C-N-CA 125.469 1.508 . . . . 64.21 111.8 -177.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 35' ' ' SER . 19.0 Cg_endo -64.42 -7.46 14.27 Favored 'Trans proline' 0 C--N 1.363 1.317 0 C-N-CA 123.09 2.527 . . . . 75.34 112.09 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -73.92 -27.32 60.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.662 -0.699 . . . . 64.52 109.886 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.6 m -82.73 113.08 20.15 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.62 -0.718 . . . . 74.52 109.312 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.1 -32.91 56.04 Favored 'Isoleucine or valine' 0 C--O 1.25 1.124 0 N-CA-C 113.331 0.863 . . . . 71.14 113.331 -174.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -151.06 94.04 2.0 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.428 -0.909 . . . . 74.21 109.921 -174.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.3 m -67.35 -30.17 69.91 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.699 0.762 . . . . 54.23 109.766 -175.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' ' 42' ' ' GLU . 1.4 pm0 -71.84 -20.03 61.88 Favored 'General case' 0 N--CA 1.414 -2.269 0 CA-C-N 115.15 -0.932 . . . . 75.15 112.008 177.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -69.76 -45.37 68.21 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.692 -1.225 . . . . 73.44 107.692 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.13 -26.82 65.08 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.004 -0.998 . . . . 65.25 110.177 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.559 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 51.2 tp -70.18 -47.09 63.09 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.554 -0.748 . . . . 73.22 109.636 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.48 -27.01 68.99 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 121.528 0.68 . . . . 61.13 110.083 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -73.95 -38.8 64.13 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.878 -1.055 . . . . 72.4 109.64 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -70.11 -51.64 29.98 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.562 -0.745 . . . . 54.24 110.419 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 4.0 pp -82.12 -8.03 59.64 Favored 'General case' 0 C--O 1.196 -1.754 0 CA-C-N 115.382 -0.826 . . . . 72.25 111.824 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -43.64 -60.19 3.4 Favored Glycine 0 N--CA 1.477 1.374 0 O-C-N 123.672 0.607 . . . . 71.23 114.264 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.11 -6.3 16.49 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.506 2.137 . . . . 73.4 112.04 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -110.42 19.78 18.43 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.008 -0.738 . . . . 73.33 109.008 -175.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.663 ' CG ' ' HB ' ' A' ' 65' ' ' THR . 27.2 t70 -56.7 109.94 2.04 Favored Pre-proline 0 C--O 1.245 0.857 0 C-N-CA 125.163 1.385 . . . . 71.04 113.744 -176.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 17.3 Cg_endo -106.54 -152.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.637 0 C-N-CA 123.929 3.086 . . . . 63.11 110.502 178.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -81.99 124.03 29.41 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.551 -0.907 . . . . 72.53 108.551 176.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.51 HD13 ' CB ' ' A' ' 68' ' ' PHE . 39.7 mt -108.22 109.2 27.38 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.396 0 N-CA-C 107.219 -1.4 . . . . 60.42 107.219 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -96.07 138.88 33.05 Favored 'General case' 0 C--N 1.263 -3.182 0 O-C-N 121.601 -0.687 . . . . 75.41 109.678 -177.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 3.6 p -133.29 122.76 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 N-CA-C 107.298 -1.371 . . . . 71.03 107.298 174.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 62.69 20.72 12.27 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.612 0.72 . . . . 74.24 110.865 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.59 7.38 64.98 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.652 -0.704 . . . . 64.02 112.572 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -113.78 135.52 53.86 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.908 -0.405 . . . . 54.03 109.908 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.53 126.52 37.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-O 121.708 0.766 . . . . 73.54 110.187 -175.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.448 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 10.5 mm100 -122.68 148.19 45.58 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.46 -0.941 . . . . 73.13 108.46 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.2 t -100.43 175.71 5.6 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.953 -1.128 . . . . 53.02 107.953 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.663 ' HB ' ' CG ' ' A' ' 53' ' ' ASP . 9.3 t -52.17 -34.05 43.33 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 123.28 0.632 . . . . 72.14 112.261 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 m -59.41 -54.15 49.95 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-O 121.123 0.487 . . . . 71.42 109.946 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -65.45 -47.51 75.91 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-N 115.005 -0.998 . . . . 51.15 110.967 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.51 ' CB ' HD13 ' A' ' 56' ' ' ILE . 51.0 t80 -54.46 -54.29 42.83 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.661 0.384 . . . . 73.44 111.169 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 2.8 tm? -54.16 -42.49 69.67 Favored 'General case' 0 C--O 1.244 0.801 0 O-C-N 124.206 0.941 . . . . 71.51 110.384 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.422 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 73.3 mt-30 -57.93 -53.61 56.3 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 116.552 -0.294 . . . . 65.52 111.115 174.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.499 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 28.5 m-85 -63.05 -32.54 73.93 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.657 0.742 . . . . 75.04 110.723 -176.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -61.64 -55.27 32.42 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.204 -0.907 . . . . 73.32 110.354 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 12.4 ptp180 -70.64 -22.52 62.5 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 120.798 0.332 . . . . 73.34 111.391 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 54.4 mt-30 -71.39 -20.12 62.18 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.161 -0.472 . . . . 53.4 110.807 174.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.62 24.96 12.56 Favored Glycine 0 N--CA 1.415 -2.758 0 C-N-CA 120.103 -1.046 . . . . 60.25 113.278 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.6 mt -88.44 -46.75 8.88 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.692 -0.803 . . . . 74.33 110.593 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 22.1 m-85 -89.87 10.86 22.14 Favored 'General case' 0 C--O 1.21 -0.99 0 O-C-N 121.913 -0.492 . . . . 64.55 112.258 -177.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -71.67 -11.71 60.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.754 1.02 . . . . 71.21 113.754 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -82.47 -10.17 59.13 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 122.056 -0.403 . . . . 71.34 111.012 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 80' ' ' LEU . 3.3 tm? -59.32 -29.59 67.74 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.515 0.509 . . . . 71.22 110.602 -174.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.479 ' C ' ' HD3' ' A' ' 81' ' ' LYS . 12.1 tmtt? -58.97 -41.72 88.2 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.442 -0.345 . . . . 71.34 111.445 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -98.68 13.15 33.16 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 120.802 0.334 . . . . 52.32 111.856 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 105' ' ' SER . . . -81.02 131.66 35.32 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.101 -1.074 . . . . 63.34 108.101 175.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -104.12 130.72 51.84 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.593 -0.443 . . . . 72.42 110.305 -174.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 103' ' ' TRP . 50.8 p90 -70.52 122.29 19.42 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.619 0.724 . . . . 63.41 112.028 -177.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.47 95.89 7.96 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 107.044 -1.465 . . . . 72.14 107.044 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.1 tp -72.66 84.14 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 122.615 1.198 . . . . 73.11 111.233 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -88.39 -43.71 11.29 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.159 -1.382 . . . . 74.13 107.481 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.522 HG22 ' H ' ' A' ' 91' ' ' GLY . 13.2 p -152.22 147.82 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.083 -1.821 . . . . 61.54 106.083 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.4 m -90.31 -19.3 24.22 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.525 0.679 . . . . 72.33 110.006 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.522 ' H ' HG22 ' A' ' 89' ' ' VAL . . . 140.83 -122.41 2.12 Favored Glycine 0 N--CA 1.424 -2.103 0 N-CA-C 110.795 -0.922 . . . . 64.22 110.795 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -150.45 147.8 27.97 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.545 -0.539 . . . . 73.21 109.545 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.471 HG22 ' H ' ' A' ' 94' ' ' LYS . 10.7 p -146.51 -179.25 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 104.222 -2.511 . . . . 72.52 104.222 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.471 ' H ' HG22 ' A' ' 93' ' ' VAL . 59.4 tttp 78.92 -44.3 0.35 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.405 1.082 . . . . 70.54 111.199 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -141.14 92.92 2.53 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 107.986 -1.116 . . . . 73.33 107.986 176.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.56 107.25 0.7 Allowed Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 111.254 -0.739 . . . . 61.34 111.254 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -75.84 118.54 18.74 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 108.509 -0.923 . . . . 64.13 108.509 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -149.22 141.08 8.6 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.468 -1.053 . . . . 54.12 110.468 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -121.03 136.52 54.97 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.3 -0.63 . . . . 75.31 109.3 -177.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.473 ' HD3' ' HA2' ' A' ' 91' ' ' GLY . 13.5 mptt -124.97 107.55 10.96 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.869 0.731 . . . . 74.45 109.155 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -106.48 117.14 33.28 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.713 -1.217 . . . . 73.4 107.713 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 8.2 p -120.35 125.07 73.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 122.037 0.923 . . . . 64.03 112.522 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 25.8 m-90 -105.73 147.23 28.8 Favored 'General case' 0 CA--C 1.472 -2.034 0 CA-C-N 114.613 -1.176 . . . . 75.12 109.356 178.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -121.64 123.66 42.45 Favored 'General case' 0 N--CA 1.403 -2.82 0 N-CA-C 105.713 -1.958 . . . . 74.32 105.713 172.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 39.2 m -71.95 177.95 4.01 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.897 -0.592 . . . . 50.03 110.082 -177.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.86 120.85 8.61 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-O 121.1 0.476 . . . . 61.34 110.97 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.2 135.47 38.5 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 114.51 -1.223 . . . . 75.32 110.749 -176.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -124.64 123.46 40.09 Favored 'General case' 0 C--O 1.255 1.348 0 N-CA-C 108.494 -0.928 . . . . 74.24 108.494 -175.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -72.55 158.35 35.85 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 123.989 0.915 . . . . 61.45 111.463 -173.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.7 t -137.86 154.84 49.44 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.579 -0.897 . . . . 72.41 108.579 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -66.73 -14.81 62.99 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.694 0.627 . . . . 63.23 112.694 -174.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.409 ' HB2' ' HG2' ' A' ' 114' ' ' LYS . 11.1 m-20 -80.38 -0.26 36.17 Favored 'General case' 0 C--O 1.2 -1.5 0 CA-C-O 119.478 -0.296 . . . . 61.14 111.282 177.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 75.82 10.48 3.28 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.415 1.086 . . . . 73.13 109.533 -173.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.409 ' HG2' ' HB2' ' A' ' 112' ' ' ASP . 25.6 pttm -95.11 162.62 13.64 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.914 -1.513 . . . . 73.32 106.914 176.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.4 mp -133.14 140.15 47.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 N-CA-C 106.216 -1.772 . . . . 74.25 106.216 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 144' ' ' ALA . 0.0 OUTLIER -121.96 143.84 49.23 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.379 -0.528 . . . . 62.35 111.79 177.523 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -144.95 173.92 11.47 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 106.978 -1.49 . . . . 73.42 106.978 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -107.71 141.28 39.48 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 106.384 -1.71 . . . . 61.42 106.384 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.439 ' HB2' HG13 ' A' ' 140' ' ' ILE . 93.3 mt-10 -114.97 144.55 43.41 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 119.784 -0.766 . . . . 74.31 110.485 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -133.76 117.26 16.71 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.537 -0.756 . . . . 73.12 109.109 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -115.9 110.3 18.81 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 109.281 -0.637 . . . . 62.25 109.281 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.12 125.5 46.24 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.377 -0.601 . . . . 61.23 109.377 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -111.45 121.08 44.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.75 -0.833 . . . . 74.42 108.75 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.2 mt -120.42 153.32 23.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 108.537 -0.912 . . . . 72.41 108.537 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -141.25 152.12 44.28 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 108.553 -0.906 . . . . 74.14 108.553 174.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.429 ' HD3' ' HB ' ' A' ' 17' ' ' THR . 41.9 ttm180 -80.8 115.29 20.22 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.605 -0.887 . . . . 74.1 108.605 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -79.05 140.87 37.81 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.803 -1.925 . . . . 74.52 105.803 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -64.83 -14.71 60.23 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.327 0.584 . . . . 73.11 111.874 -170.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.8 -16.46 63.1 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 124.557 1.143 . . . . 72.33 111.314 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.408 ' HA2' HG22 ' A' ' 17' ' ' THR . . . 105.67 -8.86 43.87 Favored Glycine 0 CA--C 1.5 -0.851 0 C-N-CA 121.073 -0.584 . . . . 63.4 111.805 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.9 t -104.7 130.14 52.79 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 106.547 -1.649 . . . . 71.14 106.547 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.496 ' SG ' HG12 ' A' ' 21' ' ' VAL . 12.0 t -83.79 134.81 34.71 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.522 -1.288 . . . . 73.33 107.522 177.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -133.12 154.53 50.51 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.093 -0.706 . . . . 73.22 109.093 -173.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.0 mp -75.14 128.82 36.38 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 120.875 0.369 . . . . 74.11 110.472 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -72.46 -56.39 5.48 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.068 -1.086 . . . . 73.21 108.068 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.7 m -172.62 157.73 3.93 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.799 -1.556 . . . . 64.23 106.799 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.7 m -131.73 149.3 32.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 107.543 -1.281 . . . . 54.34 107.543 172.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -131.61 131.96 43.66 Favored 'General case' 0 C--N 1.266 -3.046 0 C-N-CA 123.107 0.563 . . . . 74.41 110.121 -172.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 72.8 m-85 -121.93 129.02 52.18 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.348 -0.982 . . . . 74.1 108.348 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.439 HG13 ' HB2' ' A' ' 119' ' ' GLU . 6.0 pt -131.74 99.12 3.59 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-O 122.162 0.982 . . . . 63.23 109.142 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 58.4 mtm -85.44 133.64 34.1 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.653 -1.158 . . . . 73.42 110.836 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . 0.267 51.3 p 62.61 73.15 0.47 Allowed 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 125.953 1.701 . . . . 74.44 113.222 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -113.83 131.26 56.31 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 114.433 -1.258 . . . . 73.11 108.106 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 116' ' ' ARG . . . -112.11 149.69 31.79 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.752 -0.658 . . . . 45.44 112.508 -173.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.58 105.85 52.0 Favored Pre-proline 0 N--CA 1.429 -1.486 0 N-CA-C 107.057 -1.46 . . . . 74.23 107.057 169.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.51 147.83 77.63 Favored 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 122.609 2.206 . . . . 74.44 111.302 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -70.77 156.03 40.03 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 116.287 -0.415 . . . . 71.22 110.54 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 28.7 m -93.64 135.09 29.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.95 -0.568 . . . . 75.44 109.99 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.43 0 N-CA-C 108.728 -0.842 . . . . 65.44 108.728 179.966 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 CA--C 1.507 -0.676 0 N-CA-C 109.431 -0.581 . . . . 74.0 109.431 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.6 ttt 69.02 15.83 8.77 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.576 1.15 . . . . 75.14 110.2 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.5 t -73.45 129.78 36.07 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 N-CA-C 107.308 -1.367 . . . . 64.34 107.308 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.6 m -33.23 -63.95 0.22 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 126.0 1.72 . . . . 73.01 115.632 -170.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -72.75 -40.4 66.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.907 0.384 . . . . 70.14 111.827 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.51 -38.21 77.49 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.241 -0.652 . . . . 74.14 109.241 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.96 -45.51 74.02 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.715 -0.675 . . . . 74.41 110.214 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.52 ' HB ' ' SG ' ' A' ' 132' ' ' CYS . 14.6 p -65.84 -42.74 92.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 112.25 0.463 . . . . 75.44 112.25 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 -28.61 60.73 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 118.673 -1.211 . . . . 61.12 110.772 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.24 -44.84 63.92 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.415 -0.811 . . . . 54.22 111.874 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.46 -34.85 70.58 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 108.905 -0.776 . . . . 71.24 108.905 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.98 -40.94 99.92 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 111.244 -0.742 . . . . 51.23 111.244 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -69.62 -44.98 69.57 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 120.991 -0.284 . . . . 71.53 110.259 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.42 -42.6 99.0 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.687 0.395 . . . . 73.04 110.539 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.434 ' CE1' HD11 ' A' ' 45' ' ' LEU . 18.0 t80 -62.46 -54.59 37.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.238 -0.892 . . . . 73.54 110.016 177.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.3 mm -63.31 -35.78 73.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 112.149 0.426 . . . . 73.14 112.149 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -62.85 -48.95 76.81 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 119.409 -0.329 . . . . 34.22 110.568 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 pp -67.6 -30.79 70.48 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.348 -0.541 . . . . 71.41 111.315 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.34 -24.01 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-O 121.484 0.659 . . . . 61.43 110.912 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.5 p -115.5 14.22 16.59 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 121.504 -0.748 . . . . 64.02 110.59 -176.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -81.54 145.3 30.75 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.762 -0.654 . . . . 71.41 111.861 -173.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.5 m -51.2 160.36 0.91 Allowed Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 126.421 1.889 . . . . 61.32 113.113 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.06 -6.83 6.88 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 124.289 3.326 . . . . 65.31 112.897 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -61.46 -27.03 68.28 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.277 -1.009 . . . . 72.14 108.277 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.4 m -96.7 123.31 40.34 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 103.778 -2.675 . . . . 73.45 103.778 168.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.7 t -49.92 -53.07 11.75 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 113.301 0.852 . . . . 71.21 113.301 -170.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 43' ' ' HIS . 50.3 t-20 -147.64 127.82 13.81 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.29 -1.004 . . . . 64.3 108.29 -176.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.3 m -59.47 -36.51 76.13 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.602 0.564 . . . . 64.42 109.848 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -73.83 -21.17 60.22 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.153 -0.93 . . . . 72.31 110.268 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 40' ' ' ASN . 10.0 t60 -76.77 -43.33 37.37 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.483 -1.303 . . . . 64.33 107.483 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -63.07 -35.34 79.91 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.597 -0.89 . . . . 75.43 108.597 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.434 HD11 ' CE1' ' A' ' 28' ' ' PHE . 35.2 tp -68.2 -44.34 76.04 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.639 -0.71 . . . . 75.42 110.097 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.83 -31.5 71.75 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.355 0.598 . . . . 64.32 110.529 177.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -71.72 -40.52 69.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.909 -1.041 . . . . 72.53 109.627 177.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -69.3 -44.32 72.0 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.028 -0.533 . . . . 74.15 110.511 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.1 pp -80.75 -2.03 45.3 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.95 -0.568 . . . . 53.32 111.052 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.26 -60.47 6.69 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 119.926 -0.374 . . . . 74.24 112.906 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.51 -6.4 12.67 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.114 1.876 . . . . 74.4 111.904 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -118.52 38.26 3.8 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.773 -0.454 . . . . 72.32 109.773 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -55.78 105.89 0.59 Allowed Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 124.627 1.171 . . . . 73.41 112.815 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -98.89 -168.93 0.1 Allowed 'Trans proline' 0 N--CA 1.43 -2.216 0 C-N-CA 122.825 2.35 . . . . 73.45 111.177 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -91.66 104.74 17.17 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.782 -1.192 . . . . 74.33 107.782 176.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.504 HD13 ' HB2' ' A' ' 68' ' ' PHE . 67.6 mt -89.65 106.85 17.49 Favored 'Isoleucine or valine' 0 C--O 1.18 -2.59 0 CA-C-N 115.391 -0.822 . . . . 72.42 109.054 -175.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -96.23 107.68 20.05 Favored 'General case' 0 C--N 1.276 -2.608 0 O-C-N 121.55 -0.719 . . . . 71.22 111.815 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 139' ' ' PHE . 70.0 t -108.3 111.59 36.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 108.398 -0.964 . . . . 73.32 108.398 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 63.25 21.15 12.68 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.624 -1.171 . . . . 71.33 110.329 -177.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.49 -5.45 62.54 Favored Glycine 0 N--CA 1.437 -1.237 0 CA-C-N 114.87 -1.059 . . . . 64.43 111.967 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -95.7 125.68 40.45 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 109.592 -0.521 . . . . 75.13 109.592 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.2 127.21 35.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.643 0.735 . . . . 64.44 109.54 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.432 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 48.3 mm-40 -128.41 150.94 49.9 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.949 -1.13 . . . . 73.14 107.949 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -101.57 172.9 6.68 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.283 -1.006 . . . . 73.54 108.283 172.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -45.53 -40.46 8.62 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 125.179 1.392 . . . . 51.02 112.231 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.6 m -65.4 -44.67 86.71 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.124 0.487 . . . . 53.25 111.358 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -67.64 -44.94 76.73 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.697 -0.483 . . . . 71.1 109.697 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.504 ' HB2' HD13 ' A' ' 56' ' ' ILE . 48.3 t80 -53.62 -56.2 19.3 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.206 0.602 . . . . 73.2 109.863 175.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -49.95 -43.8 50.21 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.276 -1.329 . . . . 71.53 110.765 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -60.22 -47.5 85.69 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 111.9 0.333 . . . . 70.24 111.9 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.474 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 33.7 m-85 -66.94 -36.37 82.08 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.514 0.674 . . . . 65.2 110.008 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -57.85 -54.8 42.87 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.543 -0.753 . . . . 72.51 110.637 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -66.83 -29.67 69.66 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.519 -0.31 . . . . 75.52 110.69 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -73.67 -15.35 61.24 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 112.273 0.472 . . . . 44.42 112.273 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.48 13.78 25.42 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 119.931 -1.128 . . . . 54.22 114.544 175.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.38 -56.56 4.89 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.183 0.516 . . . . 71.41 110.96 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.474 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 43.1 m-85 -83.52 -5.31 59.13 Favored 'General case' 0 C--O 1.21 -0.995 0 N-CA-C 112.911 0.708 . . . . 73.23 112.911 -172.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -14.19 61.8 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.095 -1.042 . . . . 63.43 111.795 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -85.33 -16.59 39.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.169 0.509 . . . . 62.35 110.377 175.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 80' ' ' LEU . 3.2 tm? -89.32 -15.73 32.74 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 108.109 -1.071 . . . . 73.11 108.109 -178.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.502 ' C ' ' HD3' ' A' ' 81' ' ' LYS . 11.2 tmtt? -52.18 -41.74 62.89 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.969 0.908 . . . . 64.31 111.963 -177.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -88.46 14.61 9.36 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.561 0.696 . . . . 74.35 111.686 -174.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.52 150.92 47.57 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.989 0.737 . . . . 64.24 112.989 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -106.26 136.14 46.51 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.524 -1.287 . . . . 64.54 107.524 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.645 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 53.0 p90 -99.15 140.33 33.48 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.545 0.943 . . . . 61.12 113.545 -175.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.03 124.18 45.12 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 106.914 -1.513 . . . . 63.53 106.914 175.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.5 tt -77.13 98.51 2.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 122.184 0.992 . . . . 74.31 111.136 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -82.65 127.3 33.26 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.605 -1.628 . . . . 74.15 106.605 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.8 106.98 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.2 0.524 . . . . 62.43 112.124 -173.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 m -90.12 170.05 10.64 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.926 -1.139 . . . . 52.41 107.926 176.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.482 ' HA3' ' OE1' ' A' ' 97' ' ' GLU . . . -79.65 139.12 21.18 Favored Glycine 0 N--CA 1.428 -1.872 0 C-N-CA 120.249 -0.977 . . . . 72.21 111.705 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -74.54 -50.52 17.77 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.595 -0.52 . . . . 65.41 109.595 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.1 t -138.82 93.3 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-N 116.21 -0.45 . . . . 75.3 110.915 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 97' ' ' GLU . 35.4 mtmm -139.6 134.22 31.8 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.012 -0.736 . . . . 73.41 109.012 170.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.72 -0.73 19.08 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 112.873 0.694 . . . . 71.32 112.873 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.7 98.01 0.14 Allowed Glycine 0 N--CA 1.428 -1.879 0 C-N-CA 120.449 -0.881 . . . . 35.22 111.656 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.482 ' OE1' ' HA3' ' A' ' 91' ' ' GLY . 10.0 pt-20 -156.53 175.25 14.28 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.753 -0.462 . . . . 72.34 109.753 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -116.7 139.56 15.27 Favored Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 109.456 -1.458 . . . . 73.4 109.456 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -106.34 150.43 25.99 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.2 -1.778 . . . . 73.22 106.2 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.476 ' HE2' ' CE2' ' A' ' 123' ' ' TYR . 35.9 ttmt -136.23 129.79 32.11 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.465 -0.568 . . . . 74.11 109.465 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.5 mt -126.79 127.1 44.49 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.259 -1.386 . . . . 61.04 107.259 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.5 p -125.64 127.03 71.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 113.302 0.852 . . . . 62.51 113.302 -174.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.645 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 20.4 m-90 -104.16 151.03 23.81 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.642 -1.163 . . . . 75.43 108.523 178.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -135.79 133.54 38.01 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.908 -2.256 . . . . 75.43 104.908 176.175 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.7 p -68.62 171.78 7.17 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 118.09 0.405 . . . . 73.31 110.346 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.72 121.03 10.04 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.827 -0.434 . . . . 61.45 109.827 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.419 ' HB1' ' CG2' ' A' ' 115' ' ' ILE . . . -67.29 135.12 52.83 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 124.045 0.841 . . . . 42.13 111.063 -174.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -131.08 136.02 48.05 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.906 -1.146 . . . . 71.14 107.906 -175.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -84.6 130.15 34.76 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.575 -0.85 . . . . 73.11 110.711 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.466 ' HB3' ' OD2' ' A' ' 112' ' ' ASP . 38.5 t -88.5 177.42 6.8 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.373 -0.83 . . . . 72.14 111.088 -174.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -77.08 -15.31 59.62 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 122.142 0.972 . . . . 71.04 110.648 -175.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.66 ' OD2' ' HG2' ' A' ' 114' ' ' LYS . 1.1 p30 -87.87 1.17 54.69 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.299 -1.319 . . . . 75.43 110.537 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 78.44 9.88 1.98 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.287 1.835 . . . . 73.33 112.493 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.66 ' HG2' ' OD2' ' A' ' 112' ' ' ASP . 57.3 pttt -108.33 173.89 6.12 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.354 -0.841 . . . . 72.44 109.26 175.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.419 ' CG2' ' HB1' ' A' ' 107' ' ' ALA . 1.2 mp -107.02 132.65 53.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.92 -0.771 . . . . 63.03 108.92 -174.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.08 154.77 29.35 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 109.171 -0.677 . . . . 73.21 109.171 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 6.4 p90 -161.17 173.89 14.45 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 124.572 1.149 . . . . 73.31 108.223 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -113.14 137.61 51.18 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.153 -1.795 . . . . 75.52 106.153 176.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -115.01 151.92 33.35 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 119.947 -0.701 . . . . 74.23 111.71 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -139.6 117.49 11.7 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.03 -0.986 . . . . 75.44 108.52 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -123.98 112.35 17.08 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.572 0.701 . . . . 75.42 110.324 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -93.78 133.38 37.22 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.372 -0.831 . . . . 75.44 109.925 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.476 ' CE2' ' HE2' ' A' ' 100' ' ' LYS . 35.9 m-85 -115.9 122.82 46.46 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 124.153 0.908 . . . . 64.32 108.617 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.408 HG12 ' HG ' ' A' ' 134' ' ' LEU . 62.5 mt -120.84 141.59 40.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.281 -1.748 . . . . 73.55 106.281 176.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -130.17 150.8 51.26 Favored 'General case' 0 C--O 1.268 2.045 0 C-N-CA 117.417 -1.713 . . . . 71.41 112.853 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.431 ' HD3' ' SG ' ' A' ' 132' ' ' CYS . 4.6 tpp180 -75.28 104.67 5.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 104.633 -2.358 . . . . 74.33 104.633 174.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 131' ' ' SER . 57.0 ttt180 -85.45 139.73 31.28 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.417 -0.81 . . . . 63.45 110.69 -168.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -59.77 -10.41 3.78 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.961 1.304 . . . . 70.31 112.641 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.445 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 10.3 t70 -78.41 -16.39 57.67 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 123.882 0.873 . . . . 74.13 110.604 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.06 -5.85 50.44 Favored Glycine 0 C--O 1.24 0.525 0 N-CA-C 111.042 -0.823 . . . . 63.22 111.042 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 127' ' ' ARG . 12.0 p -103.86 169.85 8.27 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 109.66 -0.496 . . . . 74.43 109.66 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.52 ' SG ' ' HB ' ' A' ' 21' ' ' VAL . 68.8 m -121.67 125.27 46.27 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 106.891 -1.522 . . . . 64.32 106.891 174.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -140.82 155.39 46.38 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.516 -0.873 . . . . 71.1 109.533 -169.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.408 ' HG ' HG12 ' A' ' 124' ' ' ILE . 9.0 mp -67.55 125.95 27.79 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 109.093 -0.706 . . . . 73.11 109.093 176.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -83.34 -53.65 5.58 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 108.897 -0.779 . . . . 74.4 108.897 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.0 m -166.71 161.45 15.64 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.874 -1.528 . . . . 73.23 106.874 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.1 m -141.28 139.59 32.68 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 105.751 -1.944 . . . . 54.22 105.751 172.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 32.4 ttmt -115.15 132.12 56.71 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 110.196 -0.298 . . . . 74.04 110.196 -176.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.455 ' HB2' HG22 ' A' ' 58' ' ' VAL . 64.7 m-85 -118.53 122.42 42.63 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 107.517 -1.29 . . . . 73.23 107.517 175.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.446 ' HB ' ' HD3' ' A' ' 143' ' ' LYS . 9.3 pt -126.24 98.57 4.98 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.551 0 CA-C-O 122.079 0.943 . . . . 75.15 109.112 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.4 mtm -85.89 127.47 34.6 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.293 -1.321 . . . . 71.42 111.213 -174.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 70.7 m 71.64 75.43 0.17 Allowed 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 113.794 -1.548 . . . . 74.2 114.145 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.446 ' HD3' ' HB ' ' A' ' 140' ' ' ILE . 1.5 mptm? -116.13 152.66 33.22 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.249 -1.341 . . . . 72.51 107.547 172.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -136.4 158.65 43.94 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 120.775 -0.37 . . . . 73.22 110.488 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 114' ' ' LYS . . . -107.96 130.06 23.3 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 108.299 -1.0 . . . . 73.23 108.299 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.3 133.17 47.84 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.935 2.423 . . . . 71.12 112.43 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -87.25 169.82 11.98 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.49 -0.777 . . . . 75.35 109.41 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.0 p -125.18 139.03 52.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.981 -0.748 . . . . 74.43 108.981 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.28 0 N-CA-C 108.3 -1.0 . . . . 72.42 108.3 177.848 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 . . . . . 0 CA--C 1.509 -0.613 0 CA-C-O 120.462 0.172 . . . . 73.13 111.198 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.426 ' HA ' HD12 ' A' ' 19' ' ' LEU . 67.0 mtt -127.22 102.03 6.75 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.298 0.571 . . . . 60.45 111.474 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 t -89.68 165.85 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 106.492 -1.67 . . . . 53.44 106.492 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.3 p -40.09 -66.56 0.3 Allowed 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 115.226 1.565 . . . . 73.12 115.226 -173.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.53 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 8.4 m-20 -68.91 -27.27 65.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.131 0.491 . . . . 75.13 111.901 -176.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 15' ' ' MET . 3.0 tm? -70.38 -40.61 73.86 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.934 -1.136 . . . . 64.52 107.934 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -61.66 -51.63 67.63 Favored 'General case' 0 CA--C 1.496 -1.132 0 C-N-CA 124.159 0.984 . . . . 74.52 109.982 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 18' ' ' ASP . 7.3 p -64.88 -42.74 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.358 -0.837 . . . . 64.24 112.893 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 17.3 ptpt -74.48 -24.73 59.06 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 118.622 -1.231 . . . . 71.35 111.745 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.47 -54.45 12.89 Favored Glycine 0 N--CA 1.428 -1.867 0 C-N-CA 120.633 -0.794 . . . . 62.05 111.166 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.79 -36.04 72.84 Favored 'General case' 0 C--O 1.213 -0.864 0 N-CA-C 109.159 -0.682 . . . . 52.54 109.159 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.52 -43.08 98.63 Favored Glycine 0 C--O 1.254 1.359 0 CA-C-N 116.213 -0.448 . . . . 61.54 112.57 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -73.32 -39.5 65.23 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 119.56 -0.856 . . . . 74.31 109.8 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.51 -39.32 94.11 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.028 0.442 . . . . 75.12 110.334 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.413 ' CE2' HD11 ' A' ' 45' ' ' LEU . 31.7 t80 -61.31 -53.17 60.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.293 -0.867 . . . . 70.05 109.623 176.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.7 mm -64.43 -33.76 64.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 112.202 0.445 . . . . 63.44 112.202 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.86 -52.12 66.4 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 122.588 0.355 . . . . 54.42 110.614 175.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.81 -26.32 64.2 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 120.347 -0.541 . . . . 71.41 111.538 -176.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.7 t -70.75 -26.08 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 CA-C-O 120.983 0.421 . . . . 71.5 110.698 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.4 p -109.75 14.99 23.05 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.855 0.836 . . . . 71.02 109.895 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -62.29 147.95 46.52 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 114.306 -1.316 . . . . 62.44 111.203 -176.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.7 p -54.64 158.35 4.38 Favored Pre-proline 0 C--N 1.313 -0.983 0 C-N-CA 125.196 1.398 . . . . 75.42 113.282 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.38 -7.01 18.95 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.917 2.411 . . . . 73.3 111.13 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.33 -27.67 67.54 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.317 -0.856 . . . . 71.25 109.777 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 p -100.78 143.39 31.0 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.536 -1.283 . . . . 74.11 107.536 173.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.9 p -51.32 -52.58 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.887 1.069 . . . . 71.42 113.887 -173.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -150.82 136.73 18.25 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 122.381 0.272 . . . . 62.12 110.454 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.419 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 19.6 m -67.98 -33.66 75.06 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 122.337 1.065 . . . . 72.43 108.778 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -70.06 -20.32 63.23 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.427 -1.26 . . . . 53.31 111.408 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -69.95 -46.75 64.61 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 107.646 -1.242 . . . . 72.03 107.646 177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.29 -34.15 77.35 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.818 -1.083 . . . . 74.23 109.076 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.413 HD11 ' CE2' ' A' ' 28' ' ' PHE . 44.1 tp -66.28 -41.73 89.44 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.808 -0.633 . . . . 63.3 110.651 177.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.53 -35.9 80.9 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.326 0.584 . . . . 51.32 110.437 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -72.99 -35.94 66.97 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.939 -1.028 . . . . 72.43 110.157 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -68.5 -43.03 77.71 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 116.045 -0.525 . . . . 75.24 109.846 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.2 pp -77.79 -2.11 34.78 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.942 -0.572 . . . . 63.03 111.281 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.71 -63.84 2.35 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 123.746 0.654 . . . . 70.32 112.766 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -82.73 -8.56 11.25 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.849 1.699 . . . . 75.13 111.935 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 45.8 m-70 -100.45 27.94 5.4 Favored 'General case' 0 C--O 1.213 -0.863 0 N-CA-C 109.014 -0.736 . . . . 73.34 109.014 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.473 ' HA ' HG21 ' A' ' 65' ' ' THR . 10.2 t70 -52.44 100.77 0.24 Allowed Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 127.844 2.457 . . . . 61.15 111.661 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -114.17 -154.91 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 124.22 3.28 . . . . 73.44 112.131 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -94.06 123.74 37.63 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.149 -1.056 . . . . 73.22 108.149 176.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 65' ' ' THR . 74.3 mt -109.46 112.97 42.82 Favored 'Isoleucine or valine' 0 C--O 1.177 -2.711 0 N-CA-C 108.734 -0.839 . . . . 71.45 108.734 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.54 138.52 33.1 Favored 'General case' 0 C--N 1.269 -2.924 0 N-CA-C 108.825 -0.805 . . . . 72.11 108.825 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.4 t -132.58 112.69 19.4 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 107.906 -1.146 . . . . 72.52 107.906 176.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 63.7 20.39 12.2 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.914 1.285 . . . . 73.45 111.068 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.11 2.25 58.13 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.748 -0.66 . . . . 25.04 112.222 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -108.17 132.76 53.29 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.896 -0.779 . . . . 73.5 108.896 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.401 HD13 ' N ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -78.77 127.9 38.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 121.699 0.761 . . . . 71.22 109.658 -175.354 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.401 ' N ' HD13 ' A' ' 62' ' ' ILE . 50.3 mm-40 -126.81 149.19 49.81 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.388 -1.338 . . . . 71.4 107.388 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.1 t -87.38 173.52 9.09 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.313 -0.625 . . . . 64.14 109.313 174.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.49 ' HA ' HD12 ' A' ' 56' ' ' ILE . 18.5 p -61.4 -38.31 86.63 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 125.361 1.464 . . . . 72.31 110.543 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 m -59.62 -46.65 88.36 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.518 -1.219 . . . . 53.43 110.584 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.24 -47.26 83.17 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.066 0.546 . . . . 73.12 109.994 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.476 ' CB ' HD13 ' A' ' 56' ' ' ILE . 38.4 t80 -51.24 -55.95 15.43 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 123.759 0.662 . . . . 70.54 110.371 174.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -51.07 -45.34 61.37 Favored 'General case' 0 C--O 1.245 0.834 0 O-C-N 124.315 1.01 . . . . 74.04 110.826 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 46.7 mt-30 -58.75 -50.9 72.21 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 116.133 -0.485 . . . . 71.14 111.861 175.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.477 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 38.4 m-85 -65.76 -35.53 80.98 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.495 0.664 . . . . 73.44 109.989 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -57.23 -53.34 59.24 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.55 -0.75 . . . . 71.32 110.748 176.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -72.13 -22.0 61.39 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 120.832 0.348 . . . . 72.34 111.293 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 92.3 mm-40 -76.29 -11.21 59.87 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 116.226 -0.443 . . . . 63.21 112.133 174.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.21 27.23 11.07 Favored Glycine 0 N--CA 1.428 -1.837 0 C-N-CA 120.209 -0.996 . . . . 65.14 113.081 177.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.402 HD23 ' HB2' ' A' ' 74' ' ' GLN . 3.8 mm? -85.67 -53.02 5.41 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.108 0.48 . . . . 74.3 110.654 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 35.1 m-85 -91.72 6.51 45.64 Favored 'General case' 0 C--O 1.208 -1.086 0 N-CA-C 113.167 0.803 . . . . 74.23 113.167 -173.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -11.97 30.04 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.262 0.838 . . . . 72.51 113.262 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -75.48 -11.28 60.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.081 -0.509 . . . . 65.42 111.232 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 tt -69.63 -25.6 64.02 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.585 0.707 . . . . 72.24 109.296 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.419 ' HG2' ' H ' ' A' ' 41' ' ' SER . 4.2 tmtp? -62.71 -32.84 74.02 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 124.559 1.143 . . . . 70.23 109.481 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -105.79 4.62 30.06 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.633 0.73 . . . . 73.23 110.457 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -79.36 146.09 33.05 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.66 0.615 . . . . 73.33 112.66 -173.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -102.53 133.81 46.9 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.741 -0.663 . . . . 73.12 109.29 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -89.38 151.84 21.83 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 113.288 0.848 . . . . 63.31 113.288 -173.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -142.05 134.9 28.62 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.018 -1.104 . . . . 73.12 108.018 174.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.2 tt -101.54 133.12 45.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 109.347 -0.612 . . . . 74.03 109.347 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -99.83 87.72 3.6 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.944 -0.703 . . . . 74.33 111.181 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.8 m -77.61 148.47 6.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.018 -0.992 . . . . 74.32 109.234 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.5 t 69.24 16.78 8.42 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.159 0.984 . . . . 63.43 108.627 -176.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.74 -34.16 77.36 Favored Glycine 0 C--N 1.344 0.979 0 CA-C-N 115.219 -0.901 . . . . 73.04 111.596 -178.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 96' ' ' GLY . 46.2 tptt -140.82 115.57 9.62 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.466 -1.309 . . . . 65.33 107.466 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.6 m -104.66 2.88 10.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-O 121.105 0.479 . . . . 73.13 111.458 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -95.06 -178.57 4.52 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.976 -0.556 . . . . 62.24 110.694 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.28 -20.27 65.32 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.628 1.171 . . . . 72.32 112.84 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 92' ' ' LYS . . . -73.96 87.91 0.66 Allowed Glycine 0 N--CA 1.428 -1.856 0 N-CA-C 111.446 -0.661 . . . . 51.51 111.446 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -58.92 118.55 5.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.678 -0.49 . . . . 75.14 109.678 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 124' ' ' ILE . . . -149.77 138.65 6.9 Favored Glycine 0 N--CA 1.412 -2.921 0 N-CA-C 109.836 -1.305 . . . . 72.2 109.836 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -114.52 124.18 51.25 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.096 -1.446 . . . . 71.42 107.096 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -117.82 101.6 8.43 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 107.705 -1.221 . . . . 64.4 107.705 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -109.87 133.27 53.34 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.657 -1.156 . . . . 61.13 108.171 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 12.9 p -126.9 135.69 62.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-O 121.324 0.583 . . . . 72.22 110.771 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.414 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 27.9 m-90 -108.88 132.03 54.44 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.456 -0.942 . . . . 73.02 108.456 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -109.09 121.37 45.0 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.62 -1.252 . . . . 72.15 107.62 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.7 t -70.92 -171.75 0.58 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.368 -0.833 . . . . 72.23 111.368 -176.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.63 134.6 43.69 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.681 -0.69 . . . . 70.1 109.306 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -87.7 125.95 34.69 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 115.628 -0.715 . . . . 73.11 109.496 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -102.7 142.38 33.95 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 106.928 -1.508 . . . . 63.32 106.928 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -84.04 130.81 34.86 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.321 -0.552 . . . . 72.14 111.447 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.6 t -106.79 161.17 14.92 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.745 -0.835 . . . . 64.34 108.745 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -80.86 11.93 3.6 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.559 0.695 . . . . 74.44 112.365 -175.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -110.03 13.44 23.31 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 122.144 0.974 . . . . 75.44 109.011 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 68.17 10.46 7.84 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.148 1.379 . . . . 51.2 112.207 -178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 25.4 pttm -110.36 174.56 5.81 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.623 -0.88 . . . . 64.04 108.623 174.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.459 HG13 ' CE3' ' A' ' 117' ' ' TRP . 13.8 pt -113.22 157.04 14.04 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 CA-C-O 121.721 0.772 . . . . 54.11 111.483 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.432 ' NE ' ' HA ' ' A' ' 142' ' ' SER . 10.0 tpt180 -108.04 118.16 36.02 Favored 'General case' 0 C--N 1.28 -2.428 0 C-N-CA 125.121 1.369 . . . . 73.31 107.943 176.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CE3' HG13 ' A' ' 115' ' ' ILE . 40.1 p90 -133.46 174.29 10.57 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.79 -0.818 . . . . 74.04 108.79 176.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -132.53 147.0 52.35 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 105.59 -2.004 . . . . 72.54 105.59 176.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -125.27 155.26 40.42 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-O 121.138 0.495 . . . . 71.11 112.028 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -134.68 117.55 16.18 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.529 -0.76 . . . . 74.13 109.351 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -111.36 110.82 21.46 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 123.357 0.663 . . . . 75.42 109.842 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.14 131.48 45.15 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 109.039 -0.726 . . . . 73.0 109.039 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -115.93 114.65 24.94 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.568 -0.901 . . . . 73.04 108.568 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.407 ' O ' ' HA2' ' A' ' 98' ' ' GLY . 59.0 mt -112.83 143.71 21.97 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.694 0 N-CA-C 106.643 -1.614 . . . . 50.12 106.643 176.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -127.43 148.41 50.29 Favored 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 118.668 -1.213 . . . . 65.24 109.006 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.468 ' NH2' HG11 ' A' ' 21' ' ' VAL . 19.4 ttm180 -90.09 115.01 27.03 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 106.007 -1.849 . . . . 74.35 106.007 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 23.2 ttp85 -67.55 144.26 55.71 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.484 -1.302 . . . . 74.2 107.484 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -63.54 -10.31 17.45 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.139 0.792 . . . . 71.4 113.139 -172.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -71.33 -16.82 62.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.115 -0.493 . . . . 73.05 110.269 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.37 -19.24 27.03 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 115.874 -0.603 . . . . 73.43 112.54 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.0 m -91.51 152.23 20.42 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 106.897 -1.52 . . . . 50.32 106.897 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.405 ' SG ' HG22 ' A' ' 124' ' ' ILE . 22.4 t -111.03 153.26 25.86 Favored 'General case' 0 C--N 1.271 -2.834 0 C-N-CA 121.11 -0.236 . . . . 62.11 110.411 -174.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -157.72 155.92 30.76 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.429 -0.952 . . . . 73.34 108.429 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.7 mp -67.18 130.31 42.7 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 110.193 -0.299 . . . . 74.24 110.193 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -82.27 -59.94 2.38 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.286 -1.376 . . . . 75.54 107.286 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.6 m -167.62 160.82 13.19 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.358 -1.719 . . . . 73.34 106.358 -176.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.51 152.19 34.73 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 N-CA-C 106.42 -1.696 . . . . 74.35 106.42 171.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -136.96 130.38 31.44 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-O 120.954 0.406 . . . . 72.54 109.932 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -110.78 143.17 41.74 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.362 -0.977 . . . . 71.11 108.362 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.515 HD12 ' HE3' ' A' ' 143' ' ' LYS . 2.4 pt -138.25 98.28 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-O 121.774 0.797 . . . . 73.33 109.341 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 22.1 ptp -93.14 136.89 32.99 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-N 115.095 -0.957 . . . . 71.21 108.742 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.432 ' HA ' ' NE ' ' A' ' 116' ' ' ARG . 23.1 t 81.39 73.92 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 O-C-N 125.017 1.448 . . . . 72.33 110.536 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.515 ' HE3' HD12 ' A' ' 140' ' ' ILE . 53.1 mmtt -112.98 138.45 49.83 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 114.39 -1.277 . . . . 63.3 109.125 175.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -152.53 152.82 32.35 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.533 -1.212 . . . . 51.31 108.154 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.69 158.28 68.44 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 107.413 -1.328 . . . . 61.14 107.413 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -49.64 129.35 23.38 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 122.413 2.076 . . . . 73.41 110.366 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 114' ' ' LYS . 6.6 p90 -63.54 156.26 26.96 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 113.159 0.799 . . . . 74.32 113.159 -171.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 19.7 m -129.09 150.51 34.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 115.063 -0.972 . . . . 74.3 108.584 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.286 -2.156 0 N-CA-C 108.14 -1.059 . . . . 70.53 108.14 178.381 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 109.388 -0.597 . . . . 44.23 109.388 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.1 mtt -91.57 119.32 31.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.414 -0.958 . . . . 72.1 108.414 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.32 -40.49 81.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 121.724 0.774 . . . . 73.43 109.767 -177.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 130' ' ' GLY . 18.0 p -73.38 -25.79 60.72 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.463 -1.244 . . . . 64.42 112.645 -176.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -77.62 -39.67 44.55 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-O 122.326 1.06 . . . . 62.55 108.713 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.58 -34.21 71.94 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.1 -1.409 . . . . 62.21 107.481 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.01 -49.96 70.39 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 114.759 -1.11 . . . . 72.51 110.559 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.62 -43.08 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 112.216 0.45 . . . . 72.14 112.216 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HB2' ' HE3' ' A' ' 22' ' ' LYS . 21.1 ptmt -70.47 -31.76 69.03 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 118.069 -1.452 . . . . 60.22 111.512 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.91 -37.13 83.25 Favored Glycine 0 C--O 1.218 -0.861 0 N-CA-C 110.641 -0.984 . . . . 62.21 110.641 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp -65.53 -50.02 66.78 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 124.348 1.059 . . . . 63.54 109.165 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.85 -36.82 93.91 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.475 -0.784 . . . . 72.33 112.228 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -69.98 -41.18 74.78 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 110.665 -0.124 . . . . 71.44 110.665 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.75 -40.2 96.5 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.81 0.814 . . . . 72.45 109.555 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.484 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 14.0 t80 -62.11 -55.32 30.12 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.068 -1.424 . . . . 73.44 109.705 176.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.3 mm -63.43 -35.19 71.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.98 -0.555 . . . . 73.33 111.89 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.29 -44.77 86.91 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 121.109 -0.236 . . . . 74.25 111.011 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.3 pp -70.63 -27.58 64.17 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.378 -0.929 . . . . 71.05 110.567 -178.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 28' ' ' PHE . 79.1 t -73.6 -21.03 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 CA-C-O 121.173 0.511 . . . . 72.5 110.411 176.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.5 p -114.46 18.15 16.99 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.619 0.723 . . . . 71.24 110.131 -177.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 34' ' ' LYS . 25.1 tptt -72.31 161.78 30.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.13 -0.941 . . . . 65.35 110.252 -176.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 m -48.06 144.94 5.38 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 124.463 1.105 . . . . 74.14 113.317 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.81 -7.74 15.77 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.56 2.84 . . . . 71.12 112.962 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -66.98 -26.57 66.87 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.163 0.506 . . . . 73.41 109.91 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.2 m -75.53 106.25 6.99 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.898 -1.149 . . . . 74.22 107.898 176.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.6 t -53.98 -52.7 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.097 -0.956 . . . . 75.34 113.075 -173.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -129.05 105.36 8.14 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.923 -0.711 . . . . 63.42 110.668 -175.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.1 t -65.92 -33.31 75.54 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 115.776 -0.647 . . . . 54.11 109.728 -175.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.29 -23.35 67.01 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.414 -0.812 . . . . 54.41 110.131 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.43 ' HA ' ' CZ ' ' A' ' 72' ' ' PHE . 52.8 t-80 -71.68 -45.48 61.78 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 109.84 -0.43 . . . . 60.12 109.84 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -69.72 -31.79 69.99 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.22 -1.03 . . . . 73.22 108.22 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.421 HD11 ' CE2' ' A' ' 28' ' ' PHE . 45.1 tp -67.1 -45.03 78.49 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.273 -0.876 . . . . 63.13 110.595 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.58 -32.0 73.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.244 0.545 . . . . 54.35 110.613 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -72.77 -37.05 67.76 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.901 -0.778 . . . . 73.31 108.901 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -63.41 -44.29 95.06 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.827 0.851 . . . . 75.44 111.073 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 pp -84.69 6.78 22.82 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 115.873 -0.603 . . . . 53.45 111.846 -177.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -47.73 -57.28 7.73 Favored Glycine 0 CA--C 1.548 2.139 0 CA-C-N 116.254 -0.43 . . . . 70.51 112.792 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -76.98 -3.43 13.76 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 123.101 2.534 . . . . 70.43 112.645 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -125.86 28.35 6.17 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.197 -0.314 . . . . 74.12 111.469 -169.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.469 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 25.4 m-20 -56.58 113.73 6.52 Favored Pre-proline 0 C--O 1.24 0.588 0 O-C-N 123.771 0.669 . . . . 64.12 111.544 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.463 ' HB2' ' HA ' ' A' ' 136' ' ' SER . 45.5 Cg_endo -101.45 -164.59 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 123.011 2.474 . . . . 70.11 112.058 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -90.8 125.06 35.6 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 106.986 -1.487 . . . . 72.4 106.986 173.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 mp -103.41 114.3 42.63 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.173 0 C-N-CA 119.024 -1.07 . . . . 74.13 109.298 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 138' ' ' LYS . 32.4 m-85 -96.83 132.03 42.97 Favored 'General case' 0 C--N 1.271 -2.812 0 N-CA-C 108.981 -0.748 . . . . 72.04 108.981 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 53.7 t -129.53 112.95 25.94 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 107.691 -1.226 . . . . 63.22 107.691 176.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 62.61 22.22 13.18 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.111 -0.95 . . . . 73.23 110.867 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.01 -2.41 66.08 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.076 -0.965 . . . . 24.23 112.185 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -98.37 126.87 44.05 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.292 -1.003 . . . . 65.15 108.292 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -76.81 127.83 37.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.924 0.868 . . . . 70.4 108.89 -177.335 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.424 ' N ' HD13 ' A' ' 62' ' ' ILE . 63.4 mm-40 -117.6 137.67 52.46 Favored 'General case' 0 C--O 1.284 2.881 0 N-CA-C 106.752 -1.573 . . . . 74.11 106.752 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -75.3 174.62 9.28 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 115.895 -0.593 . . . . 73.31 109.407 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.469 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 78.6 p -60.68 -40.67 93.02 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 124.14 0.976 . . . . 43.43 109.807 -175.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 91.3 m -65.48 -45.03 85.22 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 114.563 -1.198 . . . . 65.42 110.696 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.06 -48.33 82.0 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 122.753 0.421 . . . . 64.24 110.389 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -52.66 -54.17 37.04 Favored 'General case' 0 CA--C 1.498 -1.045 0 O-C-N 123.445 0.466 . . . . 74.11 109.913 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.1 tp -51.43 -42.65 61.65 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.958 -1.019 . . . . 64.11 112.152 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.2 mm100 -63.55 -49.19 74.41 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 116.122 -0.49 . . . . 60.41 111.413 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -65.17 -34.13 77.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.535 0.683 . . . . 62.4 109.94 -178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 2.7 t80 -59.41 -53.78 54.21 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.379 -0.828 . . . . 75.51 110.474 175.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -73.89 -15.24 61.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.86 0.362 . . . . 73.12 111.629 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 55.3 mt-30 -87.8 -5.08 58.8 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 116.197 -0.456 . . . . 75.04 112.144 175.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.53 28.39 27.23 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.485 -0.864 . . . . 53.21 113.589 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.84 -45.34 18.87 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 117.286 0.543 . . . . 63.44 111.462 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -94.46 5.58 51.38 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.796 0.665 . . . . 64.11 112.796 -171.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -14.77 63.15 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.046 0.758 . . . . 63.0 113.046 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -78.12 -29.08 48.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.325 0.583 . . . . 70.44 110.112 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.1 mt -78.11 -8.21 57.96 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.399 -0.818 . . . . 63.23 111.378 -174.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -68.2 -31.6 71.24 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.483 0.659 . . . . 75.22 109.344 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -98.81 13.87 30.85 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.858 0.837 . . . . 71.52 110.286 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.31 148.97 31.91 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.869 -0.605 . . . . 73.13 110.763 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -100.6 138.62 37.42 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.344 -0.613 . . . . 61.52 109.344 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -75.3 135.7 40.9 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.185 0.516 . . . . 75.01 111.139 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -117.18 92.85 3.97 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.611 -0.885 . . . . 72.13 108.611 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.3 pt -87.63 87.05 2.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-O 122.262 1.03 . . . . 71.54 112.064 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -80.32 -84.87 0.09 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.732 -1.122 . . . . 62.44 109.696 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.66 86.35 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 105.344 -2.095 . . . . 74.51 105.344 171.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.5 m -67.35 -48.67 66.8 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.215 -1.357 . . . . 73.12 111.344 -175.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -108.93 115.1 4.23 Favored Glycine 0 N--CA 1.424 -2.143 0 C-N-CA 120.032 -1.08 . . . . 71.23 111.972 -176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -80.79 101.95 9.67 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.389 -0.597 . . . . 74.42 109.389 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.9 102.22 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-O 122.025 0.917 . . . . 73.55 110.632 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -160.16 167.92 26.61 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.642 -1.985 . . . . 63.2 105.642 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -71.4 114.51 9.54 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.544 -1.65 . . . . 72.22 106.544 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.64 78.35 1.38 Allowed Glycine 0 N--CA 1.421 -2.344 0 N-CA-C 107.399 -2.28 . . . . 60.43 107.399 -170.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.23 136.6 48.09 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 112.638 0.607 . . . . 61.12 112.638 -174.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -133.91 138.17 9.88 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 108.72 -1.752 . . . . 52.34 108.72 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.422 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 21.8 m-85 -120.06 129.4 54.2 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.347 -0.983 . . . . 71.14 108.347 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.422 ' HD2' ' C ' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -119.39 103.77 9.77 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.121 -0.696 . . . . 74.23 109.121 179.484 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.33 121.26 43.52 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.04 -1.096 . . . . 62.21 108.04 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 10.0 p -120.16 132.5 69.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.665 0.745 . . . . 71.33 112.269 -177.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 30.5 m-90 -109.82 130.47 55.52 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.677 -1.147 . . . . 72.3 107.946 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -115.87 128.65 55.97 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.042 -0.725 . . . . 73.04 109.042 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.471 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 34.6 t -81.51 174.74 11.14 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.217 -0.901 . . . . 73.53 109.594 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.99 136.71 58.17 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 123.623 0.577 . . . . 52.13 110.624 -178.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.401 ' HB1' ' CG2' ' A' ' 115' ' ' ILE . . . -71.27 136.13 47.79 Favored 'General case' 0 N--CA 1.435 -1.183 0 O-C-N 123.799 0.687 . . . . 62.54 109.623 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -114.8 134.87 54.77 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.453 -0.573 . . . . 62.21 109.453 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -74.41 106.82 6.2 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.884 -1.154 . . . . 72.35 107.884 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.4 t -96.39 133.09 41.22 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 107.67 -1.233 . . . . 75.32 107.67 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -74.87 11.59 1.04 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 114.595 1.332 . . . . 65.12 114.595 -174.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.71 -1.58 57.35 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 106.297 -1.742 . . . . 75.33 106.297 172.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.516 ' O ' ' HB3' ' A' ' 147' ' ' TYR . 23.8 tt0 79.34 17.96 0.82 Allowed 'General case' 0 C--N 1.347 0.459 0 C-N-CA 126.797 2.039 . . . . 74.33 110.156 -176.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 22.8 pttm -109.88 179.04 4.23 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.014 -1.106 . . . . 73.34 108.014 174.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.401 ' CG2' ' HB1' ' A' ' 107' ' ' ALA . 27.2 mt -122.45 134.95 64.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.22 -1.03 . . . . 74.53 108.22 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.473 ' HG2' ' HB2' ' A' ' 144' ' ' ALA . 49.4 mtm180 -114.08 140.46 48.46 Favored 'General case' 0 C--O 1.2 -1.516 0 N-CA-C 109.325 -0.62 . . . . 74.12 109.325 -178.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 17.9 p90 -147.47 160.26 42.79 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.24 -1.022 . . . . 64.21 108.24 174.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.471 ' H ' ' HB3' ' A' ' 105' ' ' SER . 3.7 m-20 -102.83 133.18 48.32 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 107.83 -1.174 . . . . 62.14 107.83 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.405 ' HB2' HG13 ' A' ' 140' ' ' ILE . 50.0 mt-10 -115.51 141.73 47.67 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 120.582 -0.447 . . . . 65.25 110.277 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -127.25 116.74 21.04 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.504 -1.295 . . . . 72.31 107.504 176.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -123.16 111.39 16.46 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.27 -0.641 . . . . 74.44 109.27 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.6 133.86 36.49 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 123.119 0.567 . . . . 71.42 109.642 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -111.96 115.33 28.78 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.189 -1.041 . . . . 75.32 108.189 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.4 mt -113.9 147.04 17.7 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.497 0 N-CA-C 106.994 -1.484 . . . . 70.2 106.994 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.444 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -131.73 150.37 52.18 Favored 'General case' 0 C--O 1.266 1.945 0 C-N-CA 118.722 -1.191 . . . . 74.34 109.333 176.492 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -100.92 116.58 33.11 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 106.219 -1.771 . . . . 61.33 106.219 174.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.459 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 63.5 ttt180 -69.3 155.15 40.89 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.389 -0.823 . . . . 71.41 109.455 -176.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -51.85 -31.53 28.13 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.638 0.775 . . . . 64.35 111.552 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.459 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 3.9 m-20 -71.42 -5.63 34.21 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 124.512 1.125 . . . . 62.31 111.271 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.494 ' O ' ' HB ' ' A' ' 17' ' ' THR . . . 94.07 -23.95 29.03 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.46 -0.656 . . . . 62.04 111.46 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.4 m -65.73 124.56 22.76 Favored 'General case' 0 N--CA 1.425 -1.675 0 C-N-CA 124.014 0.925 . . . . 70.14 109.868 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 7.1 t -103.26 142.24 34.52 Favored 'General case' 0 C--N 1.27 -2.864 0 N-CA-C 108.666 -0.864 . . . . 64.51 108.666 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.444 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 2.1 t90 -156.53 155.61 32.24 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.8 -1.185 . . . . 71.44 107.8 -173.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.37 127.55 33.11 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.577 -0.527 . . . . 64.35 109.577 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -83.28 -55.57 4.26 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.006 -1.109 . . . . 63.33 108.006 -176.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.463 ' HA ' ' HB2' ' A' ' 54' ' ' PRO . 34.0 m -167.08 164.72 15.86 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.698 -1.593 . . . . 52.12 106.698 -177.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.95 149.49 22.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 106.263 -1.754 . . . . 70.24 106.263 172.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 57' ' ' TYR . 39.4 ttmt -129.51 130.79 46.25 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 120.843 0.354 . . . . 74.44 110.414 -177.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 53.7 m-85 -113.43 127.24 56.04 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.535 -1.283 . . . . 71.2 107.535 177.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.405 HG13 ' HB2' ' A' ' 119' ' ' GLU . 6.9 pt -129.58 98.72 4.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-O 122.273 1.035 . . . . 74.51 109.427 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 74.8 mtm -84.46 131.7 34.64 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.529 -1.214 . . . . 72.31 110.762 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 74.5 m 68.84 37.79 2.26 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.512 1.133 . . . . 70.42 111.943 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -66.31 130.24 42.55 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 103.314 -2.847 . . . . 64.45 103.314 173.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.473 ' HB2' ' HG2' ' A' ' 116' ' ' ARG . . . -134.44 145.74 49.15 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 114.732 1.382 . . . . 61.41 114.732 -167.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 114' ' ' LYS . . . -101.62 126.1 35.26 Favored Pre-proline 0 N--CA 1.43 -1.441 0 N-CA-C 107.052 -1.462 . . . . 71.22 107.052 172.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -72.82 160.35 46.34 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.565 2.177 . . . . 61.22 111.948 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.516 ' HB3' ' O ' ' A' ' 113' ' ' GLN . 37.2 p90 -68.06 159.88 29.97 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.793 -0.639 . . . . 71.24 110.326 177.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.4 m -97.89 96.78 5.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 122.165 0.983 . . . . 53.32 112.18 -177.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.958 0 N-CA-C 108.355 -0.979 . . . . 51.13 108.355 179.181 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 t70 . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 121.033 0.444 . . . . 72.33 110.8 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.433 HD22 ' HD2' ' A' ' 22' ' ' LYS . 3.1 tm? -65.31 -38.46 90.26 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 107.582 -1.266 . . . . 73.41 107.582 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -71.31 -35.02 71.11 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.543 -0.753 . . . . 72.34 110.028 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.495 HG13 ' SG ' ' A' ' 132' ' ' CYS . 90.2 t -62.65 -55.9 20.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.868 -0.605 . . . . 74.45 110.696 176.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.433 ' HD2' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -71.76 -25.65 62.12 Favored 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 120.431 -0.508 . . . . 74.24 111.633 -178.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.48 -42.17 89.43 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.198 -1.161 . . . . 65.12 110.198 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.88 -53.49 49.63 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 123.658 0.783 . . . . 65.35 109.786 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.19 -44.89 88.87 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 115.427 -0.806 . . . . 75.45 112.536 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -66.46 -40.1 89.21 Favored 'General case' 0 C--O 1.206 -1.192 0 CA-C-O 119.423 -0.323 . . . . 75.13 111.549 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.6 -40.41 92.63 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.483 0.659 . . . . 54.21 110.102 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.501 ' CE2' HD11 ' A' ' 45' ' ' LEU . 13.6 t80 -61.79 -53.52 54.81 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.414 -1.266 . . . . 70.34 109.783 176.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 29' ' ' ILE . 14.4 mm -64.17 -35.89 75.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 116.328 -0.396 . . . . 64.41 111.502 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.73 -52.36 66.03 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.28 0.632 . . . . 53.13 110.109 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.5 pp -67.73 -29.32 68.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 120.58 -0.448 . . . . 75.1 111.338 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.17 -31.84 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.119 0.485 . . . . 63.22 110.602 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 p -108.09 17.17 22.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.668 0.747 . . . . 73.22 110.466 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.427 ' HB2' ' HA ' ' A' ' 31' ' ' LEU . 8.3 tptm -74.04 171.26 13.82 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-N 114.523 -1.217 . . . . 61.15 111.708 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.5 m -43.94 138.56 3.23 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.357 1.863 . . . . 72.12 113.768 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.16 -7.18 16.12 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.794 2.329 . . . . 74.32 109.889 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.21 -28.02 68.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.04 -1.436 . . . . 73.42 110.736 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.7 p -94.3 158.23 15.67 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.872 -0.604 . . . . 74.23 110.089 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.5 HG22 ' OD1' ' A' ' 40' ' ' ASN . 9.2 p -50.55 -53.02 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 114.77 1.396 . . . . 45.31 114.77 -172.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.5 ' OD1' HG22 ' A' ' 39' ' ' VAL . 14.5 m120 -159.21 135.55 9.1 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 118.184 0.447 . . . . 73.13 110.548 -176.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.0 m -66.19 -31.28 72.02 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.667 -1.234 . . . . 73.13 107.667 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.471 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 1.8 mp0 -63.4 -25.61 68.37 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.731 -1.577 . . . . 74.44 109.624 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -71.02 -46.17 62.63 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.489 -0.93 . . . . 73.02 108.489 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -67.57 -31.66 71.89 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.016 -0.993 . . . . 71.11 109.424 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.501 HD11 ' CE2' ' A' ' 28' ' ' PHE . 42.6 tp -68.2 -45.06 74.39 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.763 -0.653 . . . . 74.54 110.358 177.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.37 -36.62 78.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.831 0.824 . . . . 70.45 109.844 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -75.62 -27.72 58.56 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.499 -1.228 . . . . 74.31 110.384 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -74.72 -44.59 49.19 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.477 -0.564 . . . . 74.43 109.477 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 3.9 pp -79.59 -2.62 43.3 Favored 'General case' 0 C--O 1.199 -1.562 0 CA-C-N 115.824 -0.626 . . . . 61.24 112.422 -174.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -51.89 -61.77 6.2 Favored Glycine 0 CA--C 1.544 1.853 0 C-N-CA 121.494 -0.384 . . . . 63.1 112.235 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -77.04 -5.42 15.83 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.236 2.624 . . . . 70.41 112.178 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.497 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 55.8 m-70 -119.0 29.5 7.67 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.837 -0.801 . . . . 54.24 108.837 -175.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -55.91 107.67 0.96 Allowed Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 124.859 1.264 . . . . 71.24 112.871 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.508 ' HB3' ' HB3' ' A' ' 134' ' ' LEU . 75.0 Cg_endo -98.93 -173.81 0.15 Allowed 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 123.273 2.649 . . . . 73.3 111.13 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -86.08 101.98 13.43 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 107.306 -1.368 . . . . 73.2 107.306 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 68' ' ' PHE . 65.1 mt -87.15 105.69 15.35 Favored 'Isoleucine or valine' 0 C--O 1.172 -3.007 0 N-CA-C 109.251 -0.648 . . . . 75.35 109.251 -175.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -94.02 106.88 18.84 Favored 'General case' 0 C--N 1.276 -2.61 0 O-C-N 121.314 -0.866 . . . . 64.03 111.459 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.454 HG23 HG22 ' A' ' 56' ' ' ILE . 54.2 t -108.45 113.19 43.29 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.939 0 N-CA-C 108.23 -1.026 . . . . 51.22 108.23 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 62.04 21.28 12.24 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.96 -1.473 . . . . 52.32 110.599 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.47 2.98 56.52 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.564 -0.744 . . . . 61.42 113.357 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -112.85 135.21 53.87 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 117.758 0.779 . . . . 74.44 110.509 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.01 126.35 34.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.949 0.88 . . . . 64.52 109.376 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.535 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 59.0 mm-40 -126.13 149.45 48.94 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.164 -1.421 . . . . 75.13 107.164 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.8 t -97.95 173.56 7.01 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.355 -0.98 . . . . 71.22 108.355 173.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.6 t -42.25 -42.89 3.22 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.144 1.378 . . . . 62.25 112.479 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.5 m -69.35 -42.36 75.37 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.377 -0.374 . . . . 54.23 111.978 -176.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -65.08 -45.99 82.98 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.656 -0.498 . . . . 63.25 109.656 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' HB2' HD13 ' A' ' 56' ' ' ILE . 41.2 t80 -52.75 -55.21 24.46 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 109.108 -0.701 . . . . 73.4 109.108 174.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -48.34 -44.19 34.07 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.3 -1.318 . . . . 73.15 110.963 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 45.2 mt-30 -61.55 -46.49 89.7 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 112.029 0.381 . . . . 63.03 112.029 177.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.528 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 57.6 m-85 -68.62 -36.25 78.41 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.421 0.629 . . . . 71.21 109.315 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -57.99 -51.57 69.1 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.621 -0.718 . . . . 55.43 111.084 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 34.1 ptt180 -66.85 -30.93 71.24 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.705 -0.48 . . . . 72.14 109.705 -176.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -74.86 -10.09 59.17 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.779 -0.646 . . . . 72.01 112.212 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.36 6.84 47.17 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 114.77 0.668 . . . . 54.43 114.77 174.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.457 ' HB3' ' SD ' ' A' ' 141' ' ' MET . 3.5 mm? -68.15 -48.77 64.44 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.659 0.614 . . . . 34.24 112.659 -176.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.528 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 45.5 m-85 -90.8 12.74 18.34 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 113.273 0.842 . . . . 73.53 113.273 -173.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.471 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 51.7 mtmt -66.97 -14.22 62.64 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.634 0.605 . . . . 74.44 112.634 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -79.96 -13.01 59.67 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 123.218 0.607 . . . . 54.21 110.695 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.5 tt -60.78 -28.17 68.54 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.583 0.586 . . . . 72.31 112.583 -174.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.13 4.57 46.93 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 117.623 -1.631 . . . . 74.23 111.409 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -105.85 10.07 32.64 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.265 -1.384 . . . . 55.44 107.265 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -91.71 153.08 19.89 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 113.805 -1.543 . . . . 74.41 113.15 -174.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 104' ' ' LYS . 13.6 pt-20 -95.09 133.23 39.13 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.64 -1.164 . . . . 73.34 110.143 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.619 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 43.2 p90 . . . . . 0 C--N 1.31 -1.113 0 N-CA-C 108.763 -0.829 . . . . 62.34 108.763 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 . . . . . 0 CA--C 1.508 -0.659 0 CA-C-O 121.602 0.715 . . . . 70.32 112.842 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -150.75 138.76 6.83 Favored Glycine 0 N--CA 1.414 -2.768 0 N-CA-C 109.695 -1.362 . . . . 55.52 109.695 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -123.63 143.63 50.11 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.687 -1.598 . . . . 72.52 106.687 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 19.6 pttp -136.02 98.98 4.02 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-O 122.104 0.954 . . . . 71.12 109.257 173.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.88 125.43 34.0 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.349 -1.296 . . . . 63.52 108.253 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 10.0 p -117.11 136.74 53.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 C-N-CA 119.866 -0.734 . . . . 61.23 111.414 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.619 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 27.0 m-90 -115.58 140.29 49.31 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.506 -1.225 . . . . 71.21 107.711 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 97.4 mttt -116.87 120.99 40.19 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.985 -1.487 . . . . 74.24 106.985 172.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.429 ' HB2' ' H ' ' A' ' 118' ' ' ASP . 46.3 m . . . . . 0 C--N 1.306 -1.311 0 N-CA-C 108.218 -1.03 . . . . 73.13 108.218 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 21.7 p90 . . . . . 0 N--CA 1.445 -0.693 0 N-CA-C 108.938 -0.764 . . . . 73.12 108.938 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.429 ' H ' ' HB2' ' A' ' 105' ' ' SER . 5.6 m-20 -118.59 138.39 52.6 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 105.651 -1.981 . . . . 62.32 105.651 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.454 ' HB2' HG13 ' A' ' 140' ' ' ILE . 47.6 mt-10 -114.57 142.08 46.91 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.722 -0.791 . . . . 75.01 110.533 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -133.9 117.15 16.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.739 -0.664 . . . . 73.22 110.042 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -116.45 110.89 19.23 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 122.94 0.496 . . . . 71.03 110.366 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -97.74 113.75 25.59 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 110.152 -0.314 . . . . 74.31 110.152 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -97.84 119.8 37.09 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.455 -0.942 . . . . 74.51 108.455 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.499 HG12 HD13 ' A' ' 134' ' ' LEU . 59.6 mt -118.54 144.88 25.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 106.953 -1.499 . . . . 41.0 106.953 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.503 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.6 OUTLIER -119.97 146.0 46.24 Favored 'General case' 0 C--O 1.267 2.008 0 C-N-CA 118.485 -1.286 . . . . 63.33 107.604 174.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -93.0 106.02 18.04 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 106.607 -1.627 . . . . 75.24 106.607 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.449 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 65.1 ttt180 -58.44 145.69 37.71 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 113.67 -1.605 . . . . 72.32 108.195 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 128' ' ' LYS . 37.5 ttmt -61.51 -18.21 58.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.694 0.759 . . . . 65.42 110.8 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.449 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 7.4 t70 -65.07 -17.86 64.82 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.562 1.145 . . . . 74.34 110.953 173.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.92 -16.66 36.18 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 121.38 -0.438 . . . . 64.03 112.677 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.0 p -92.8 176.98 6.24 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 109.51 -0.552 . . . . 42.41 109.51 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.495 ' SG ' HG13 ' A' ' 21' ' ' VAL . 30.4 p -131.16 143.7 50.82 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 109.705 -0.48 . . . . 54.33 109.705 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.503 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 2.0 t90 -139.27 155.01 48.04 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.809 -0.811 . . . . 65.53 108.809 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 2.7 mm? -67.89 111.35 4.3 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.071 -0.968 . . . . 71.54 108.676 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -76.44 -60.41 2.35 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.718 -1.215 . . . . 62.03 107.718 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.8 m -161.31 150.5 16.43 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.136 -1.801 . . . . 73.01 106.136 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.0 m -133.35 135.83 55.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 107.001 -1.481 . . . . 71.14 107.001 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -115.79 131.29 56.98 Favored 'General case' 0 C--N 1.274 -2.716 0 CA-C-O 120.644 0.259 . . . . 73.41 110.8 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.416 ' HB2' HG22 ' A' ' 58' ' ' VAL . 78.2 m-85 -119.66 126.23 50.64 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.915 -1.143 . . . . 71.53 107.915 176.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.454 HG13 ' HB2' ' A' ' 119' ' ' GLU . 3.8 pt -126.29 98.65 5.02 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 N-CA-C 107.94 -1.133 . . . . 63.44 107.94 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.457 ' SD ' ' HB3' ' A' ' 76' ' ' LEU . 63.1 mtm -87.91 127.98 35.36 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.01 -1.45 . . . . 71.15 112.039 -171.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.1 m 64.19 77.33 0.32 Allowed 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 113.332 -1.758 . . . . 41.01 112.654 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt . . . . . 0 N--CA 1.418 -2.068 0 CA-C-N 112.981 -1.918 . . . . 60.44 108.566 177.69 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 27.7 t70 . . . . . 0 C--O 1.241 0.612 0 CA-C-O 121.811 0.815 . . . . 74.24 109.403 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.2 -35.82 80.41 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.141 -0.936 . . . . 71.53 108.946 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -64.34 -49.25 72.45 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.725 -0.67 . . . . 71.21 110.052 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.71 -45.55 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.038 -0.528 . . . . 74.35 112.341 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 18.3 ptpt -72.27 -26.09 61.85 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 118.632 -1.227 . . . . 72.54 111.128 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.64 -55.1 12.45 Favored Glycine 0 C--O 1.262 1.876 0 N-CA-C 111.386 -0.685 . . . . 65.23 111.386 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 pp -66.75 -38.98 87.7 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 108.518 -0.919 . . . . 74.14 108.518 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.12 -42.84 99.92 Favored Glycine 0 CA--C 1.497 -1.074 0 CA-C-N 116.025 -0.534 . . . . 72.21 111.986 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -64.62 -45.77 85.46 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-O 119.533 -0.27 . . . . 75.14 110.424 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.18 -38.61 88.45 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 120.456 -0.498 . . . . 75.23 110.771 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.49 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 24.7 t80 -62.48 -54.62 37.31 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.522 1.129 . . . . 70.01 110.123 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 29' ' ' ILE . 12.6 mm -65.58 -33.14 61.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 116.358 -0.383 . . . . 25.4 111.134 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.76 -49.11 77.68 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.109 -0.496 . . . . 74.04 110.774 175.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.5 pp -67.76 -31.22 70.98 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 120.671 -0.412 . . . . 74.05 110.836 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.5 t -69.97 -21.87 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-O 121.308 0.575 . . . . 62.21 110.651 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.7 p -110.51 13.06 22.77 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.754 -0.591 . . . . 73.11 111.334 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -62.91 144.24 56.91 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.615 -0.721 . . . . 61.5 112.167 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.3 m -66.05 155.14 88.03 Favored Pre-proline 0 C--N 1.299 -1.594 0 CA-C-N 114.86 -1.064 . . . . 50.55 110.971 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.97 -6.49 4.92 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 124.389 3.393 . . . . 74.31 113.259 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.8 -27.84 68.56 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.884 -0.598 . . . . 71.5 110.193 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.6 m -72.46 158.8 35.05 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.431 -0.951 . . . . 62.45 108.431 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.544 HG23 ' OD1' ' A' ' 40' ' ' ASN . 32.0 m -63.89 -37.6 80.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 C-N-CA 119.503 -0.879 . . . . 61.31 110.634 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.636 ' HB2' ' OE1' ' A' ' 42' ' ' GLU . 12.1 p-10 178.92 137.94 0.09 Allowed 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.563 1.145 . . . . 63.14 110.661 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.3 m -63.55 -37.37 87.07 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-O 122.34 1.067 . . . . 74.4 109.639 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.636 ' OE1' ' HB2' ' A' ' 40' ' ' ASN . 1.2 pm0 -67.58 -20.5 65.39 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 114.317 -1.31 . . . . 65.14 112.191 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.561 ' HB2' ' OD1' ' A' ' 40' ' ' ASN . 54.8 t-80 -67.43 -49.03 65.52 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 108.877 -0.786 . . . . 51.24 108.877 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -66.99 -33.84 76.45 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.317 -1.311 . . . . 63.43 109.058 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.423 HD11 ' CE1' ' A' ' 28' ' ' PHE . 51.8 tp -66.56 -46.42 76.09 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 116.281 -0.418 . . . . 71.52 110.708 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.73 -35.32 76.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.188 0.518 . . . . 74.45 110.418 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -76.95 -29.97 55.84 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.436 -0.802 . . . . 72.35 109.699 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -68.27 -42.96 78.79 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 123.248 0.619 . . . . 73.0 110.019 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 pp -85.44 0.72 51.41 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.821 -0.627 . . . . 72.33 111.323 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -52.61 -57.95 12.6 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-N 116.383 -0.372 . . . . 74.41 112.423 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -76.85 -4.1 14.54 Favored 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.438 2.759 . . . . 72.24 112.525 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.413 ' HA ' ' HE1' ' A' ' 133' ' ' TRP . 71.1 m-70 -125.13 45.07 2.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.372 -0.376 . . . . 75.34 110.006 -173.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -54.97 104.98 0.46 Allowed Pre-proline 0 N--CA 1.492 1.666 0 C-N-CA 124.833 1.253 . . . . 75.45 113.179 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -97.9 177.16 0.47 Allowed 'Trans proline' 0 N--CA 1.431 -2.164 0 C-N-CA 123.13 2.553 . . . . 71.34 110.268 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.92 105.34 11.13 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.919 -1.141 . . . . 73.34 107.919 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.467 HD13 ' CB ' ' A' ' 68' ' ' PHE . 68.9 mt -93.06 106.54 18.05 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.404 0 N-CA-C 108.879 -0.786 . . . . 62.42 108.879 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -95.82 112.9 24.52 Favored 'General case' 0 C--N 1.265 -3.092 0 O-C-N 121.718 -0.614 . . . . 62.3 110.398 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 3.6 p -108.57 118.49 56.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 C-N-CA 118.81 -1.156 . . . . 64.43 108.129 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.408 ' HA ' HG22 ' A' ' 140' ' ' ILE . 63.9 m-20 59.74 20.34 9.1 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.643 -1.162 . . . . 75.45 111.106 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.53 7.84 53.29 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 115.158 -0.928 . . . . 25.54 114.144 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -116.64 132.94 56.55 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 117.666 0.733 . . . . 62.44 110.862 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.1 127.05 36.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 121.481 0.658 . . . . 73.24 110.222 -176.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.466 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 50.0 mm-40 -126.95 151.17 48.87 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.793 -1.188 . . . . 74.44 107.793 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.6 t -93.77 173.11 7.84 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.457 -0.942 . . . . 75.41 108.457 174.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.0 t -49.22 -39.45 30.02 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 124.605 1.162 . . . . 52.4 111.64 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.2 m -65.21 -47.86 75.4 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 122.918 0.487 . . . . 74.2 111.108 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.466 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -64.51 -47.6 78.28 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 122.745 0.418 . . . . 34.12 110.129 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.467 ' CB ' HD13 ' A' ' 56' ' ' ILE . 51.4 t80 -52.81 -55.17 24.89 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 116.177 -0.465 . . . . 74.21 110.271 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -51.35 -42.09 61.05 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.042 -0.981 . . . . 62.44 110.857 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -62.66 -49.7 74.12 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 116.299 -0.41 . . . . 75.53 111.683 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.434 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 24.8 m-85 -65.82 -33.4 75.78 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.794 0.807 . . . . 71.52 109.27 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.546 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 4.1 t80 -57.85 -53.18 61.13 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.02 -0.991 . . . . 63.03 110.841 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -74.73 -20.63 59.76 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.15 0.5 . . . . 75.12 110.671 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.424 ' HB2' HD23 ' A' ' 76' ' ' LEU . 55.3 mt-30 -76.18 -8.25 56.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.901 -0.591 . . . . 70.42 111.051 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.16 10.07 57.6 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 120.539 -0.838 . . . . 74.13 114.266 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 74' ' ' GLN . 3.5 mm? -68.32 -50.53 52.83 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 116.868 0.334 . . . . 62.13 110.442 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.434 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 36.5 m-85 -99.31 10.08 42.12 Favored 'General case' 0 C--O 1.204 -1.326 0 N-CA-C 112.819 0.674 . . . . 73.44 112.819 -173.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.301 62.8 pttt -70.48 -10.62 59.65 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 114.221 1.193 . . . . 74.35 114.221 -176.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -83.33 -10.55 58.42 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.196 -0.456 . . . . 75.35 110.485 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.44 -15.93 63.71 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 112.578 0.584 . . . . 60.11 112.578 -172.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -11.16 40.54 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.931 -0.481 . . . . 61.42 112.122 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -99.76 14.06 31.55 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 122.65 0.38 . . . . 73.32 111.23 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.505 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -58.71 129.22 41.06 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.008 0.744 . . . . 65.02 113.008 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -100.67 127.01 47.23 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.497 -1.668 . . . . 72.05 106.497 173.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 73.7 t80 . . . . . 0 C--N 1.304 -1.403 0 C-N-CA 120.749 -0.38 . . . . 75.15 110.526 -178.371 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 . . . . . 0 C--O 1.247 0.93 0 CA-C-O 121.009 0.433 . . . . 73.45 111.058 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.54 138.35 14.91 Favored Glycine 0 N--CA 1.423 -2.226 0 N-CA-C 108.628 -1.789 . . . . 71.21 108.628 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -112.67 146.3 38.93 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 117.11 0.455 . . . . 74.52 109.931 -176.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -124.89 97.59 5.33 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.164 -1.421 . . . . 64.22 107.164 172.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.64 107.99 20.53 Favored 'General case' 0 C--N 1.259 -3.363 0 N-CA-C 106.383 -1.71 . . . . 73.41 106.383 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.2 p -115.89 135.27 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 CA-C-O 121.897 0.856 . . . . 73.34 112.258 -174.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.505 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 30.5 m-90 -119.28 155.43 31.81 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.285 -1.325 . . . . 72.34 109.94 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -129.03 125.25 36.91 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 104.485 -2.413 . . . . 73.13 104.485 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 80.6 p . . . . . 0 C--N 1.3 -1.576 0 CA-C-N 118.296 0.498 . . . . 65.33 110.644 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.505 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 22.1 p90 . . . . . 0 C--O 1.2 -1.536 0 N-CA-C 106.822 -1.548 . . . . 65.31 106.822 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -116.28 141.3 48.34 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 106.332 -1.729 . . . . 74.2 106.332 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.505 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 42.4 mt-10 -115.33 147.04 40.94 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 119.701 -0.8 . . . . 65.03 112.567 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.604 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -139.37 117.88 12.16 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.169 -0.923 . . . . 63.41 110.185 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.57 109.57 17.98 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.697 -0.853 . . . . 72.02 108.697 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.65 123.02 37.84 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 109.527 -0.546 . . . . 74.32 109.527 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -103.31 112.18 24.94 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.764 -1.199 . . . . 75.33 107.764 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.4 mt -117.3 150.92 19.24 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 N-CA-C 106.744 -1.576 . . . . 60.23 106.744 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -136.16 143.06 44.26 Favored 'General case' 0 C--O 1.275 2.414 0 N-CA-C 108.226 -1.028 . . . . 73.23 108.226 172.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -91.53 100.98 13.63 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 106.793 -1.558 . . . . 72.01 106.793 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -68.03 132.89 48.08 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 114.765 -1.107 . . . . 75.22 109.258 -171.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -66.16 -10.57 42.46 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 123.75 0.82 . . . . 74.42 111.417 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -74.6 -8.0 54.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.055 -0.52 . . . . 72.24 111.023 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.22 -8.78 28.95 Favored Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.707 -0.759 . . . . 72.51 113.932 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.9 m -104.16 138.78 40.15 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.414 -0.587 . . . . 70.13 109.414 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 44.7 t -98.33 132.65 43.63 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 107.037 -1.468 . . . . 74.31 107.037 170.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.413 ' HE1' ' HA ' ' A' ' 52' ' ' HIS . 1.6 t90 -146.0 154.78 42.27 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 118.389 -1.324 . . . . 73.44 110.642 -176.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.22 125.67 29.59 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.99 -1.115 . . . . 74.31 107.99 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -80.79 -53.99 6.0 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.408 -0.96 . . . . 64.21 108.408 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.4 m -162.48 158.48 23.76 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 105.266 -2.124 . . . . 70.34 105.266 -175.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.7 m -143.06 138.4 27.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 107.296 -1.372 . . . . 52.51 107.296 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -112.82 136.33 52.57 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 109.786 -0.45 . . . . 65.31 109.786 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 71.8 m-85 -125.04 122.94 38.69 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 107.72 -1.215 . . . . 61.34 107.72 175.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.408 HG22 ' HA ' ' A' ' 59' ' ' ASN . 5.2 pt -127.14 98.81 4.9 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 N-CA-C 107.946 -1.131 . . . . 74.44 107.946 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 23.4 ptm -86.63 143.09 27.8 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.481 -1.236 . . . . 74.33 110.564 -173.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.8 m 67.62 35.23 4.17 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.569 1.168 . . . . 74.15 109.287 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 26.1 tptp . . . . . 0 N--CA 1.408 -2.54 0 CA-C-N 113.082 -1.872 . . . . 71.31 109.258 179.075 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 . . . . . 0 CA--C 1.507 -0.695 0 CA-C-O 121.007 0.432 . . . . 73.04 110.178 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.99 -43.86 97.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.559 -0.746 . . . . 64.23 109.434 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.04 -42.93 99.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.843 -0.617 . . . . 54.3 111.622 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.543 HG11 ' HE ' ' A' ' 126' ' ' ARG . 26.6 m -74.46 -39.79 48.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 119.352 -0.939 . . . . 71.44 112.698 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -72.38 -28.03 62.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 119.052 -1.059 . . . . 75.31 109.787 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.03 -42.55 43.94 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 110.533 -1.027 . . . . 52.13 110.533 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.551 HD22 ' SG ' ' A' ' 132' ' ' CYS . 17.9 tp -64.84 -50.37 66.94 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.025 -0.731 . . . . 73.35 109.025 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.59 -39.05 94.58 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.347 -0.842 . . . . 71.4 112.232 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -68.63 -42.13 78.49 Favored 'General case' 0 C--O 1.204 -1.292 0 C-N-CA 121.051 -0.26 . . . . 75.23 110.565 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.461 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 7.9 t70 -63.56 -41.46 98.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.777 0.799 . . . . 74.0 109.234 -176.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.434 ' CE1' HD11 ' A' ' 45' ' ' LEU . 33.4 t80 -63.88 -55.03 25.76 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.362 -1.744 . . . . 64.14 110.163 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 29' ' ' ILE . 11.9 mm -64.41 -32.89 59.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 111.693 0.257 . . . . 71.05 111.693 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.41 -52.8 63.06 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 122.786 0.434 . . . . 75.33 110.192 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 27' ' ' ASP . 3.7 pp -71.97 -24.4 61.59 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 119.629 -0.828 . . . . 72.33 112.162 -176.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.2 t -71.08 -25.31 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.094 0.473 . . . . 73.34 109.972 174.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.6 p -108.17 13.38 25.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.251 0.548 . . . . 73.24 110.281 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -62.67 148.35 46.71 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 115.423 -0.808 . . . . 72.01 110.834 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.6 m -51.37 143.11 19.36 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 125.763 1.625 . . . . 64.51 114.175 -175.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.39 -6.39 17.41 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 124.452 3.434 . . . . 53.1 113.338 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -62.99 -25.84 68.58 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.643 0.735 . . . . 52.31 110.134 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 t -81.46 172.18 13.83 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.233 -1.025 . . . . 75.53 108.233 175.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -56.52 -45.65 82.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 C-N-CA 122.51 0.324 . . . . 74.41 110.776 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.568 ' ND2' ' HB3' ' A' ' 42' ' ' GLU . 39.2 t30 178.16 139.06 0.09 Allowed 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.873 -1.158 . . . . 73.4 107.873 -177.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 m -61.85 -26.66 68.27 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 122.571 1.177 . . . . 62.5 110.688 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.568 ' HB3' ' ND2' ' A' ' 40' ' ' ASN . 38.1 tt0 -64.67 -23.48 67.27 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 125.099 1.36 . . . . 55.44 109.897 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 72' ' ' PHE . 48.2 t-80 -65.05 -46.12 82.54 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.264 -0.643 . . . . 71.43 109.264 176.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -70.58 -31.46 68.49 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 108.292 -1.003 . . . . 73.34 108.292 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.434 HD11 ' CE1' ' A' ' 28' ' ' PHE . 48.4 tp -66.82 -46.88 73.76 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.936 -0.575 . . . . 74.13 111.052 176.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.62 -34.33 75.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.359 0.6 . . . . 55.14 110.094 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -73.16 -34.82 66.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.366 -0.834 . . . . 72.05 109.632 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 41.8 t80 -66.28 -48.52 70.13 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.864 0.865 . . . . 75.34 110.231 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 pp -80.44 -3.07 48.43 Favored 'General case' 0 C--O 1.198 -1.616 0 CA-C-N 115.275 -0.875 . . . . 60.11 111.774 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -42.45 -60.82 2.66 Favored Glycine 0 CA--C 1.537 1.432 0 O-C-N 123.792 0.682 . . . . 64.14 113.573 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.45 -5.76 13.48 Favored 'Trans proline' 0 CA--C 1.551 1.328 0 C-N-CA 122.452 2.101 . . . . 74.13 112.998 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -116.51 22.47 12.75 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.128 -0.358 . . . . 64.42 110.454 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.67 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 18.4 t70 -65.9 120.07 66.13 Favored Pre-proline 0 C--O 1.256 1.434 0 N-CA-C 112.943 0.72 . . . . 74.21 112.943 -172.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 3.8 Cg_endo -104.92 -148.8 0.02 OUTLIER 'Trans proline' 0 CA--C 1.554 1.524 0 C-N-CA 124.252 3.301 . . . . 73.13 112.22 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -86.85 126.12 34.43 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 107.888 -1.152 . . . . 64.24 107.888 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.55 HD13 ' CB ' ' A' ' 68' ' ' PHE . 48.2 mt -107.34 113.1 42.71 Favored 'Isoleucine or valine' 0 C--O 1.172 -3.012 0 N-CA-C 106.86 -1.533 . . . . 72.45 106.86 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -99.2 135.18 40.98 Favored 'General case' 0 C--N 1.266 -3.051 0 O-C-N 121.669 -0.644 . . . . 74.43 109.703 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 74.9 t -133.54 113.61 19.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 108.714 -0.847 . . . . 74.43 108.714 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.414 ' OD1' ' HG2' ' A' ' 141' ' ' MET . 72.5 m-20 61.32 25.18 15.19 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 125.377 1.471 . . . . 72.22 111.695 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.8 2.12 58.53 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.856 -0.688 . . . . 43.54 112.627 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -113.4 135.49 53.81 Favored 'General case' 0 CA--C 1.492 -1.278 0 O-C-N 122.31 -0.524 . . . . 70.22 110.713 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.21 128.49 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 108.903 -0.777 . . . . 63.23 108.903 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -122.52 143.6 49.61 Favored 'General case' 0 C--O 1.282 2.766 0 N-CA-C 107.161 -1.422 . . . . 74.1 107.161 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.1 t -91.91 173.14 8.01 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.923 -1.14 . . . . 72.31 107.923 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.67 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 13.6 t -58.4 -32.46 68.64 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.698 0.399 . . . . 65.51 111.637 -176.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.5 m -60.82 -51.56 68.81 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.869 -0.605 . . . . 74.24 110.105 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.64 -49.36 75.49 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.532 -0.758 . . . . 61.54 110.441 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.55 ' CB ' HD13 ' A' ' 56' ' ' ILE . 56.9 t80 -52.9 -54.91 27.88 Favored 'General case' 0 CA--C 1.501 -0.939 0 O-C-N 123.676 0.61 . . . . 70.54 110.926 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.2 tp -53.06 -44.85 67.78 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 124.094 0.871 . . . . 72.21 111.782 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.528 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 76.3 mt-30 -58.07 -51.81 68.14 Favored 'General case' 0 N--CA 1.439 -1.014 0 O-C-N 123.257 0.348 . . . . 74.51 111.025 175.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.425 ' HB3' ' HB2' ' A' ' 76' ' ' LEU . 27.3 m-85 -62.47 -40.72 97.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.217 0.532 . . . . 71.31 110.735 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 2.6 t80 -57.86 -52.1 66.87 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.593 0.757 . . . . 71.23 110.309 177.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -73.23 -18.28 61.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.149 -0.478 . . . . 64.04 111.397 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 46.8 mt-30 -87.22 -11.5 49.59 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 120.167 -0.613 . . . . 75.4 111.773 175.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.52 42.14 6.62 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.509 -0.853 . . . . 74.42 112.821 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.442 HD23 ' HB2' ' A' ' 74' ' ' GLN . 4.3 mm? -88.03 -35.37 17.59 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 122.79 -0.241 . . . . 71.21 111.206 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -108.08 -2.81 19.23 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.219 -0.593 . . . . 74.44 112.297 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.565 ' HA ' ' OE2' ' A' ' 42' ' ' GLU 0.372 0.0 OUTLIER -60.19 -13.65 13.44 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 115.894 1.813 . . . . 72.41 115.894 -165.783 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.22 -12.91 62.08 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 116.113 -0.494 . . . . 71.33 111.169 174.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.7 tt -61.46 -27.09 68.32 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.438 1.095 . . . . 74.42 110.657 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.477 ' HB2' ' OD1' ' A' ' 40' ' ' ASN . 27.4 ttpp -55.02 -33.51 62.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.328 0.585 . . . . 75.34 111.321 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -105.33 14.56 28.69 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.443 -0.798 . . . . 73.12 111.032 -173.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -84.06 153.81 23.59 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.308 0.575 . . . . 61.12 112.433 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 103' ' ' TRP . 10.2 pt-20 -89.31 149.82 22.87 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.213 -1.402 . . . . 75.11 107.213 175.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.5 p90 . . . . . 0 C--N 1.316 -0.869 0 CA-C-N 118.972 0.805 . . . . 73.3 112.002 -177.335 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--O 1.247 0.974 0 CA-C-O 120.974 0.416 . . . . 73.51 110.641 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.59 144.5 18.28 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 110.852 -0.899 . . . . 73.24 110.852 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -109.99 140.4 44.05 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.628 -1.249 . . . . 75.43 107.628 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -131.59 101.19 5.4 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.769 -0.826 . . . . 73.11 108.769 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 83.4 mt -107.96 112.22 24.7 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.967 -0.753 . . . . 72.12 108.967 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.6 p -114.03 129.2 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-O 121.484 0.659 . . . . 62.04 111.996 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.579 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 31.4 m-90 -101.82 141.6 34.43 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.604 -1.18 . . . . 75.22 109.217 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.413 ' HB2' ' CG ' ' A' ' 84' ' ' GLU . 36.3 mtpt -118.56 125.46 49.87 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 107.549 -1.278 . . . . 73.1 107.549 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 42.8 t . . . . . 0 C--N 1.27 -2.862 0 CA-C-N 114.917 -1.038 . . . . 53.12 110.311 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.475 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 46.5 p90 . . . . . 0 N--CA 1.42 -1.945 0 N-CA-C 107.536 -1.283 . . . . 74.42 107.536 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.435 ' H ' ' HB3' ' A' ' 105' ' ' SER . 2.1 m-20 -116.18 138.95 50.84 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 106.056 -1.831 . . . . 73.01 106.056 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.475 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 38.4 mt-10 -118.31 144.3 45.95 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.001 -0.68 . . . . 75.13 111.225 176.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -132.51 116.74 17.13 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.861 -1.163 . . . . 44.34 107.861 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -125.68 113.26 17.11 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 121.68 0.752 . . . . 72.12 111.987 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.86 128.65 41.77 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.791 -1.095 . . . . 72.44 110.036 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -109.55 117.93 35.27 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.316 -0.994 . . . . 63.4 108.316 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.5 mt -115.59 151.17 17.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 106.435 -1.691 . . . . 61.13 106.435 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.406 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -136.02 150.17 49.1 Favored 'General case' 0 C--O 1.27 2.144 0 C-N-CA 118.984 -1.086 . . . . 73.11 109.231 175.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.543 ' HE ' HG11 ' A' ' 21' ' ' VAL . 61.7 mtt180 -76.07 113.04 13.14 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 108.145 -1.057 . . . . 71.23 108.145 172.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -73.41 133.06 43.65 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 113.906 -1.497 . . . . 64.52 107.566 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -62.53 -15.46 50.73 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.152 0.581 . . . . 61.33 112.192 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -64.94 -16.8 63.75 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 124.001 0.921 . . . . 73.02 110.988 173.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.34 -6.35 30.24 Favored Glycine 0 CA--C 1.501 -0.791 0 N-CA-C 111.215 -0.754 . . . . 71.52 111.215 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.9 p -100.01 -172.34 2.21 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 123.33 0.652 . . . . 71.23 110.6 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.551 ' SG ' HD22 ' A' ' 24' ' ' LEU . 15.0 p -134.61 144.57 47.98 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.601 -1.259 . . . . 73.41 107.601 174.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.406 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 0.2 OUTLIER -155.23 155.2 33.41 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 119.292 -0.963 . . . . 71.42 108.889 -176.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.88 128.47 36.48 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.153 0.501 . . . . 64.43 109.652 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -87.12 -46.77 9.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.047 -0.723 . . . . 65.22 109.047 -176.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.9 p -175.01 152.4 1.48 Allowed 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 107.805 -1.183 . . . . 75.33 107.805 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.41 150.55 32.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.385 -1.339 . . . . 72.04 107.385 175.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -130.09 133.29 46.58 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 110.266 -0.272 . . . . 73.3 110.266 -177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 67.0 m-85 -117.57 127.26 53.8 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.609 -1.256 . . . . 75.23 107.609 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.418 HD12 ' HD2' ' A' ' 143' ' ' LYS . 6.0 pt -128.45 98.76 4.49 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.42 0 CA-C-O 122.395 1.093 . . . . 71.31 108.896 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.414 ' HG2' ' OD1' ' A' ' 59' ' ' ASN . 22.6 ptp -89.73 126.94 35.85 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.163 -1.381 . . . . 73.41 109.87 -175.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.2 t 73.74 73.97 0.12 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.42 -1.264 . . . . 65.5 110.593 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.418 ' HD2' HD12 ' A' ' 140' ' ' ILE . 85.6 tttt . . . . . 0 C--N 1.294 -1.838 0 CA-C-N 114.19 -1.368 . . . . 61.42 107.451 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 C--O 1.236 0.347 0 CA-C-O 121.24 0.543 . . . . 53.44 111.413 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.69 -36.83 84.76 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.222 -1.029 . . . . 75.23 108.222 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -69.91 -38.23 76.2 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.372 -0.831 . . . . 74.54 109.853 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 89.3 t -59.16 -56.66 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 115.218 -0.901 . . . . 74.14 110.437 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -25.9 67.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.354 -0.384 . . . . 72.13 110.545 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.59 -50.44 48.91 Favored Glycine 0 C--O 1.25 1.128 0 N-CA-C 111.659 -0.576 . . . . 70.44 111.659 175.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.77 -37.74 76.48 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 108.613 -0.884 . . . . 52.21 108.613 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.58 -40.63 99.38 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.704 -0.68 . . . . 50.32 111.851 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -67.77 -46.03 73.22 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 120.457 -0.497 . . . . 60.31 110.409 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.23 -39.82 95.7 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 120.567 -0.453 . . . . 74.42 110.644 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -61.57 -52.54 64.01 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.604 0.762 . . . . 72.22 109.902 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.421 ' HA ' HD13 ' A' ' 29' ' ' ILE . 7.4 mm -67.52 -35.09 72.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 120.906 -0.318 . . . . 75.44 111.675 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -63.2 -46.24 87.94 Favored 'General case' 0 CA--C 1.495 -1.141 0 C-N-CA 122.425 0.29 . . . . 61.54 110.487 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.586 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 4.1 pp -69.65 -28.76 66.16 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 119.736 -0.786 . . . . 64.31 111.249 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.409 ' N ' HD12 ' A' ' 31' ' ' LEU . 52.9 t -71.76 -24.33 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-O 121.456 0.646 . . . . 74.31 110.084 174.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.9 p -107.23 19.29 20.56 Favored 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 121.598 -0.689 . . . . 73.1 111.261 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.586 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 64.7 mmtt -53.24 138.64 31.55 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 116.051 -0.522 . . . . 52.11 111.057 175.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -64.28 159.23 59.79 Favored Pre-proline 0 N--CA 1.435 -1.222 0 CA-C-N 115.003 -0.999 . . . . 74.31 109.675 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.5 -11.04 18.16 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 123.349 2.699 . . . . 73.34 111.502 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -68.0 -26.05 65.71 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.607 -1.179 . . . . 74.3 110.872 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.9 t -82.67 172.26 13.11 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.442 -1.318 . . . . 51.14 107.442 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.7 t -74.77 -54.29 14.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.485 -0.486 . . . . 54.45 111.131 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.498 ' O ' ' HB3' ' A' ' 43' ' ' HIS . 23.8 t30 -170.84 126.61 0.72 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.211 -0.45 . . . . 71.22 110.355 -173.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 p -61.0 -39.3 89.15 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 123.358 0.663 . . . . 71.43 111.624 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.44 -21.6 66.21 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.962 -0.563 . . . . 61.45 110.483 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.498 ' HB3' ' O ' ' A' ' 40' ' ' ASN . 42.7 t-80 -72.91 -48.87 33.41 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.354 -0.98 . . . . 74.3 108.354 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -64.19 -35.0 79.37 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.587 -1.188 . . . . 63.1 109.541 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.0 tp -66.88 -42.37 85.69 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 116.292 -0.413 . . . . 70.3 110.466 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.32 -32.13 73.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.455 0.645 . . . . 74.24 110.319 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -74.83 -35.75 62.4 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.536 -0.757 . . . . 71.21 110.25 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -68.37 -41.69 80.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.364 0.666 . . . . 72.05 110.718 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 pp -79.02 -8.44 58.94 Favored 'General case' 0 C--O 1.194 -1.838 0 CA-C-N 115.746 -0.661 . . . . 70.22 111.814 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -46.9 -55.67 8.2 Favored Glycine 0 CA--C 1.546 1.993 0 O-C-N 123.454 0.472 . . . . 53.31 114.017 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -78.0 -3.81 13.82 Favored 'Trans proline' 0 CA--C 1.55 1.32 0 C-N-CA 122.993 2.462 . . . . 64.11 112.474 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -129.46 28.31 5.21 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.984 -0.448 . . . . 74.14 110.21 -168.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -55.98 115.68 10.33 Favored Pre-proline 0 N--CA 1.475 0.818 0 O-C-N 124.042 0.839 . . . . 74.24 111.451 -175.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -108.96 -158.15 0.02 OUTLIER 'Trans proline' 0 CA--C 1.557 1.636 0 C-N-CA 123.721 2.947 . . . . 75.53 111.546 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -86.85 126.12 34.44 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.08 -1.081 . . . . 63.32 108.08 175.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.48 HD13 ' CB ' ' A' ' 68' ' ' PHE . 36.7 mt -112.18 107.06 22.0 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.412 0 N-CA-C 108.98 -0.748 . . . . 73.14 108.98 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -89.84 135.64 33.51 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 109.753 -0.462 . . . . 72.42 109.753 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.8 p -126.03 117.88 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 N-CA-C 107.371 -1.344 . . . . 64.04 107.371 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 62.77 20.8 12.38 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 123.956 0.902 . . . . 63.23 110.709 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.38 -5.34 58.82 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.38 -0.827 . . . . 63.55 112.489 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -99.82 126.18 45.87 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 109.026 -0.731 . . . . 73.42 109.026 -178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.88 126.41 31.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-O 121.54 0.686 . . . . 71.12 109.427 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.483 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 63.1 mm-40 -122.33 152.45 40.11 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.077 -0.712 . . . . 71.3 109.077 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.6 t -87.64 169.15 12.39 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.327 -0.99 . . . . 74.55 108.327 175.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.426 ' HA ' HD12 ' A' ' 56' ' ' ILE . 13.2 t -58.03 -34.18 69.77 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.379 0.672 . . . . 73.12 111.33 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.0 m -61.58 -49.46 76.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.25 0.548 . . . . 73.34 109.784 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -60.83 -49.78 76.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.281 -0.872 . . . . 71.42 110.391 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.48 ' CB ' HD13 ' A' ' 56' ' ' ILE . 44.3 t80 -51.49 -56.07 15.38 Favored 'General case' 0 CA--C 1.5 -0.943 0 O-C-N 123.778 0.674 . . . . 74.33 110.415 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 69' ' ' LEU . 13.5 mt -49.77 -47.54 50.97 Favored 'General case' 0 CA--C 1.491 -1.3 0 O-C-N 124.079 0.862 . . . . 54.33 112.94 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -55.54 -51.42 67.12 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 123.703 0.627 . . . . 64.13 111.773 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -65.63 -37.3 86.18 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.555 0.693 . . . . 70.23 110.463 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 3.4 t80 -61.83 -53.6 53.69 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.183 -0.917 . . . . 64.12 111.197 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -74.62 -18.17 60.6 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 123.333 0.396 . . . . 64.21 111.123 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -75.3 -14.51 60.5 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.033 0.444 . . . . 63.53 111.285 171.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.43 18.01 29.66 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 120.749 -0.739 . . . . 60.43 113.577 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.6 mt -76.84 -44.65 31.46 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.469 -0.892 . . . . 75.34 112.019 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -89.3 -5.77 57.29 Favored 'General case' 0 C--O 1.203 -1.358 0 N-CA-C 113.384 0.883 . . . . 75.52 113.384 -174.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.286 0.0 OUTLIER -64.09 -12.4 38.9 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.727 1.38 . . . . 71.34 114.727 -175.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -80.81 -10.68 59.7 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.112 -0.495 . . . . 64.55 111.176 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.49 -15.56 60.39 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 122.76 0.424 . . . . 74.3 111.864 -176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -53.44 -30.42 40.4 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.265 0.555 . . . . 72.34 111.838 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -99.4 8.56 44.51 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 122.016 -0.427 . . . . 72.25 111.735 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.36 147.76 47.68 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.584 0.707 . . . . 50.32 111.675 -176.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -88.14 116.14 26.11 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.26 -0.882 . . . . 71.12 112.202 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.579 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 55.7 p90 . . . . . 0 C--N 1.302 -1.467 0 N-CA-C 106.216 -1.772 . . . . 74.2 106.216 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.476 ' CG ' ' HB3' ' A' ' 126' ' ' ARG . 9.9 pt-20 . . . . . 0 C--O 1.234 0.283 0 N-CA-C 109.753 -0.462 . . . . 64.42 109.753 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -118.84 138.67 13.8 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 119.683 -1.246 . . . . 73.42 112.98 -173.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -108.44 129.83 55.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.281 -1.007 . . . . 70.41 108.281 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -108.25 98.96 8.43 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.961 -1.126 . . . . 72.44 107.961 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 3.2 mm? -92.8 100.82 13.23 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.853 -1.165 . . . . 71.32 107.853 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.1 p -116.81 122.18 69.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-O 122.415 1.102 . . . . 75.11 113.692 -176.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.579 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 29.7 m-90 -102.83 129.99 49.69 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 113.869 -1.514 . . . . 73.11 107.854 177.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.423 ' HG3' ' HG2' ' A' ' 119' ' ' GLU . 3.1 mppt? -114.41 125.7 54.14 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.105 -1.072 . . . . 65.21 108.105 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.9 p . . . . . 0 C--N 1.308 -1.213 0 C-N-CA 120.236 -0.586 . . . . 63.44 110.621 -179.132 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.8 p90 . . . . . 0 N--CA 1.436 -1.127 0 N-CA-C 106.793 -1.558 . . . . 74.2 106.793 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -116.49 138.75 51.14 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.004 -1.85 . . . . 60.21 106.004 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.495 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 45.7 mt-10 -117.23 141.1 48.71 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 119.803 -0.759 . . . . 75.31 110.988 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -127.52 116.71 20.8 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.808 -1.182 . . . . 54.51 107.808 177.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 41.8 tt0 -125.5 114.94 19.45 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 121.162 0.506 . . . . 75.12 110.861 -177.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.98 134.3 39.16 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.732 -0.667 . . . . 55.22 109.49 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -111.28 118.57 36.25 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 123.396 0.679 . . . . 62.23 109.345 -175.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.2 mt -120.91 150.27 23.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.174 -1.417 . . . . 65.1 107.174 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -134.63 145.04 48.22 Favored 'General case' 0 C--O 1.266 1.924 0 C-N-CA 118.998 -1.081 . . . . 74.4 110.292 173.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.509 ' HB2' ' SG ' ' A' ' 132' ' ' CYS . 10.6 ttp180 -91.42 113.66 25.99 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 114.731 -1.122 . . . . 62.42 108.25 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 131' ' ' SER . 62.9 mtm180 -70.46 158.43 36.06 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.31 -1.314 . . . . 75.31 110.119 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -69.34 -15.07 63.25 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.875 0.845 . . . . 70.52 109.004 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -66.57 -17.76 64.99 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.068 -1.424 . . . . 63.01 108.918 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.72 -23.74 35.06 Favored Glycine 0 CA--C 1.504 -0.628 0 N-CA-C 111.315 -0.714 . . . . 54.51 111.315 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 36.6 t -88.49 133.82 34.03 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 115.07 -0.565 . . . . 72.22 110.33 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 126' ' ' ARG . 95.2 m -90.67 150.48 21.66 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 115.504 -0.771 . . . . 51.21 109.861 175.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 21.1 t90 -151.09 155.84 39.79 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.172 -1.047 . . . . 72.34 108.172 177.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.1 mt -65.85 117.62 8.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.196 -1.039 . . . . 73.33 108.196 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -75.37 -56.59 4.56 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.826 -1.546 . . . . 73.41 106.826 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 52.2 m -167.14 175.35 7.54 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.988 -1.486 . . . . 75.41 106.988 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.7 t -142.57 145.51 23.28 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 105.939 -1.874 . . . . 74.24 105.939 175.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -130.56 130.72 44.45 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-O 121.057 0.456 . . . . 71.21 109.773 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -115.58 126.97 54.89 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.985 -1.487 . . . . 73.44 106.985 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.7 pt -127.68 98.44 4.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 CA-C-O 122.304 1.049 . . . . 74.43 108.471 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 19.2 ptm -93.0 124.96 37.35 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 114.496 -1.229 . . . . 71.22 109.256 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.5 t 79.27 63.87 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.906 -1.497 . . . . 74.32 109.924 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.495 ' HG2' ' OE1' ' A' ' 119' ' ' GLU . 23.4 tptm . . . . . 0 C--N 1.295 -1.778 0 N-CA-C 106.139 -1.8 . . . . 71.21 106.139 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.0 t70 . . . . . 0 CA--C 1.506 -0.747 0 CA-C-O 121.109 0.48 . . . . 73.14 110.298 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.62 -38.13 89.96 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-N 115.002 -0.999 . . . . 73.41 109.65 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.28 -47.69 63.85 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.346 -0.843 . . . . 74.53 109.816 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 m -71.95 -32.2 43.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 112.545 0.572 . . . . 72.25 112.545 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -72.0 -33.47 68.1 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.588 -0.893 . . . . 63.42 108.588 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.8 -37.59 92.43 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 110.823 -0.911 . . . . 72.13 110.823 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.5 tp -66.63 -50.1 64.09 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 124.544 1.138 . . . . 74.34 109.968 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.75 -44.3 98.11 Favored Glycine 0 C--O 1.245 0.841 0 N-CA-C 111.76 -0.536 . . . . 72.55 111.76 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -63.49 -42.61 98.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.692 -0.254 . . . . 73.55 110.46 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.72 -41.83 98.01 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 123.248 0.343 . . . . 72.14 110.806 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 33.5 t80 -62.05 -54.08 46.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.353 -0.84 . . . . 64.31 110.053 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 29' ' ' ILE . 9.8 mm -62.94 -39.37 84.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.406 -0.361 . . . . 55.32 111.774 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.29 -48.62 80.56 Favored 'General case' 0 C--O 1.198 -1.608 0 O-C-N 123.436 0.46 . . . . 73.15 110.782 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 41' ' ' SER . 4.0 pp -70.59 -25.0 62.86 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 119.734 -0.786 . . . . 74.35 112.055 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.7 t -70.9 -26.04 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.348 0.594 . . . . 70.35 109.896 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.5 p -119.77 28.16 8.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 122.156 0.979 . . . . 71.42 108.639 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.435 ' HB2' ' HA ' ' A' ' 31' ' ' LEU . 38.2 tptt -60.96 156.65 17.14 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.051 -1.431 . . . . 72.33 112.266 -175.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 5.2 p -52.62 141.75 34.13 Favored Pre-proline 0 N--CA 1.432 -1.328 0 C-N-CA 125.096 1.358 . . . . 52.15 112.307 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 35' ' ' SER . 31.4 Cg_exo -56.11 -18.7 24.09 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.825 3.017 . . . . 75.11 112.464 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -55.27 -27.83 49.26 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.604 -0.725 . . . . 70.25 110.158 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.2 p -111.24 102.77 11.16 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.862 -1.162 . . . . 71.11 107.862 174.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.3 -42.74 96.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 72.53 111.86 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -106.61 86.05 2.27 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 122.474 1.13 . . . . 74.31 110.504 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 36.8 m -68.6 -23.67 64.49 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.264 -1.335 . . . . 60.24 108.544 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.449 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 2.0 mp0 -61.38 -26.49 67.87 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 113.909 -1.496 . . . . 72.15 109.583 177.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -68.68 -42.43 77.85 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.443 -0.577 . . . . 73.44 109.443 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -69.07 -34.72 75.6 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 108.025 -1.102 . . . . 73.22 108.025 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 52.1 tp -66.22 -45.67 79.88 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 115.627 -0.715 . . . . 71.24 110.274 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.39 74.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.057 0.456 . . . . 72.1 110.949 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -75.24 -33.58 61.34 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 109.747 -0.464 . . . . 72.14 109.747 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 57.2 t80 -70.31 -46.31 64.49 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 123.286 0.634 . . . . 71.4 109.952 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 3.6 pp -84.24 -8.03 59.17 Favored 'General case' 0 C--O 1.194 -1.864 0 CA-C-N 115.654 -0.703 . . . . 73.42 112.146 -177.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -41.83 -57.49 3.42 Favored Glycine 0 CA--C 1.541 1.708 0 O-C-N 123.543 0.527 . . . . 70.44 113.574 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -85.48 -5.91 9.1 Favored 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 123.068 2.512 . . . . 72.34 112.768 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.481 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 16.0 m-70 -115.77 22.27 13.21 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.998 -0.439 . . . . 75.25 111.128 -172.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.502 ' CG ' ' HB ' ' A' ' 65' ' ' THR . 13.3 t70 -76.3 119.67 78.31 Favored Pre-proline 0 C--N 1.309 -1.173 0 O-C-N 123.337 0.398 . . . . 73.23 110.745 -174.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 9.9 Cg_endo -101.77 -150.33 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.431 0 C-N-CA 123.506 2.804 . . . . 62.31 111.993 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.67 118.64 24.52 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 107.711 -1.218 . . . . 72.15 107.711 172.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.484 HD13 ' HB2' ' A' ' 68' ' ' PHE . 52.9 mt -100.55 113.4 36.23 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.104 0 N-CA-C 107.753 -1.203 . . . . 64.13 107.753 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -100.34 112.37 24.71 Favored 'General case' 0 C--N 1.278 -2.534 0 O-C-N 121.048 -1.033 . . . . 74.12 111.578 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.453 HG22 ' HB2' ' A' ' 139' ' ' PHE . 70.4 t -115.11 117.69 56.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 108.793 -0.818 . . . . 73.03 108.793 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 60.34 21.7 11.22 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.503 1.127 . . . . 72.25 111.455 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.54 6.17 61.2 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.267 -0.878 . . . . 52.11 112.545 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -112.1 133.46 54.24 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.558 -0.534 . . . . 72.2 109.558 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.09 124.51 30.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 122.501 1.143 . . . . 72.25 109.392 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.401 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 66.6 mm-40 -117.92 136.96 53.14 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.589 -1.187 . . . . 54.32 107.966 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 t -93.43 174.78 7.03 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.266 -1.013 . . . . 71.14 108.266 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.502 ' HB ' ' CG ' ' A' ' 53' ' ' ASP . 8.8 t -51.24 -37.54 47.58 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 125.114 1.366 . . . . 60.34 111.529 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.4 m -62.84 -49.92 72.98 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.34 0.591 . . . . 75.23 110.135 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.48 -51.28 69.34 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.482 -0.781 . . . . 61.5 111.617 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.484 ' HB2' HD13 ' A' ' 56' ' ' ILE . 39.5 t80 -54.36 -55.45 28.41 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 123.22 0.325 . . . . 63.32 110.33 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -50.06 -44.62 51.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.852 -1.067 . . . . 71.22 110.737 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -58.23 -48.84 79.13 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.883 0.327 . . . . 72.04 111.883 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.485 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 33.1 m-85 -66.05 -37.89 86.98 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.615 0.722 . . . . 72.35 109.721 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -56.73 -54.16 49.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 123.965 0.906 . . . . 75.44 110.831 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -72.21 -22.02 61.32 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.317 -0.401 . . . . 74.42 111.608 -176.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -77.06 -16.44 59.25 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 112.457 0.54 . . . . 71.21 112.457 172.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.55 21.28 12.97 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.37 -0.919 . . . . 34.25 114.155 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.66 -54.76 6.23 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.504 0.668 . . . . 73.25 110.123 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.485 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 46.3 m-85 -83.22 5.7 22.03 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 115.898 -0.592 . . . . 64.23 112.057 -174.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.449 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 96.8 mttt -73.93 -14.11 61.0 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.843 0.83 . . . . 73.52 111.201 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -86.09 -19.08 30.74 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.095 -0.957 . . . . 55.52 108.705 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 80' ' ' LEU . 9.5 tt -77.76 -12.21 59.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.354 -0.839 . . . . 71.24 111.563 -171.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -74.1 -23.49 59.33 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.88 0.847 . . . . 71.3 109.182 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -96.5 13.61 27.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.857 -1.065 . . . . 70.15 110.131 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -81.48 147.27 29.8 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.736 -0.665 . . . . 65.14 111.563 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 103' ' ' TRP . 8.0 pt-20 -92.64 142.05 27.8 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.473 -0.785 . . . . 74.34 108.898 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.498 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 43.3 p90 . . . . . 0 C--N 1.307 -1.269 0 C-N-CA 120.422 -0.511 . . . . 73.42 111.735 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.514 ' OE2' ' HD3' ' A' ' 126' ' ' ARG . 1.2 pm0 . . . . . 0 CA--C 1.504 -0.805 0 N-CA-C 113.767 1.025 . . . . 64.41 113.767 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 125' ' ' TRP . . . -120.74 137.12 11.79 Favored Glycine 0 N--CA 1.411 -3.018 0 N-CA-C 109.475 -1.45 . . . . 62.31 109.475 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -108.06 140.36 41.35 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.747 -1.205 . . . . 72.14 107.747 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -125.05 99.08 5.95 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.91 -1.515 . . . . 54.41 106.91 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.5 mt -102.51 134.68 45.45 Favored 'General case' 0 C--N 1.274 -2.706 0 N-CA-C 107.984 -1.117 . . . . 74.35 107.984 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 9.8 p -123.89 125.23 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 119.414 -0.914 . . . . 65.2 112.861 -175.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.532 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 15.4 m-90 -101.06 148.8 24.64 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.629 -1.168 . . . . 74.11 109.6 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -118.61 120.9 38.83 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.415 -1.328 . . . . 75.34 107.415 172.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.447 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 35.2 t . . . . . 0 C--N 1.298 -1.667 0 O-C-N 123.977 0.798 . . . . 72.14 111.007 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 43.9 p90 . . . . . 0 N--CA 1.413 -2.293 0 CA-C-O 121.464 0.649 . . . . 62.22 110.051 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 105' ' ' SER . 0.4 OUTLIER -102.62 136.9 41.6 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 106.206 -1.776 . . . . 64.11 106.206 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -114.21 141.14 47.91 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.487 -0.885 . . . . 70.41 108.974 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.66 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -123.2 117.49 25.46 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 115.472 -0.785 . . . . 62.34 111.307 -173.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -111.13 109.39 19.43 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.095 -1.076 . . . . 72.41 108.095 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.03 126.36 44.73 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 122.484 0.314 . . . . 70.33 110.48 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -103.69 119.3 38.62 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.584 -1.265 . . . . 74.41 107.584 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.438 HG22 ' SG ' ' A' ' 132' ' ' CYS . 50.2 mt -128.94 139.72 51.16 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 N-CA-C 106.315 -1.735 . . . . 75.22 106.315 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.429 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 0.2 OUTLIER -130.21 152.09 50.03 Favored 'General case' 0 C--O 1.256 1.428 0 C-N-CA 118.96 -1.096 . . . . 73.31 110.674 -177.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.514 ' HD3' ' OE2' ' A' ' 97' ' ' GLU . 45.6 ttp180 -74.81 114.49 13.31 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 105.965 -1.865 . . . . 61.43 105.965 174.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -81.43 145.48 30.75 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 108.271 -1.011 . . . . 75.0 108.271 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -66.4 -10.79 47.07 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 122.345 1.069 . . . . 75.35 110.12 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.78 -16.63 63.85 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.645 -1.161 . . . . 60.53 110.412 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.29 -23.43 20.68 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 111.482 -0.647 . . . . 72.1 111.482 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.0 t -100.47 -173.24 2.36 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.758 -0.83 . . . . 63.11 108.758 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.438 ' SG ' HG22 ' A' ' 124' ' ' ILE . 27.8 t -122.6 143.06 49.99 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.049 -1.834 . . . . 74.13 106.049 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.411 ' HE1' ' HA ' ' A' ' 52' ' ' HIS . 6.4 t90 -150.45 155.44 39.55 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 108.955 -0.757 . . . . 70.41 108.955 -172.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.59 130.75 42.64 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.938 0.399 . . . . 72.35 110.359 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -92.42 -43.29 9.29 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.746 -0.661 . . . . 71.01 109.646 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.5 t -179.41 151.33 0.47 Allowed 'General case' 0 C--O 1.194 -1.85 0 N-CA-C 106.582 -1.636 . . . . 71.23 106.582 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.2 m -134.95 152.37 32.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.832 -1.173 . . . . 74.51 107.832 173.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -128.64 133.64 48.31 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 122.72 0.408 . . . . 54.43 109.9 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.453 ' HB2' HG22 ' A' ' 58' ' ' VAL . 44.0 m-85 -121.98 112.4 18.24 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.185 -1.043 . . . . 71.22 108.185 176.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 17.2 pt -112.65 99.21 8.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 121.604 0.716 . . . . 60.51 111.926 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 52.2 mtt -86.78 94.65 9.59 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 106.415 -1.698 . . . . 74.51 106.415 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.5 m -162.74 -56.86 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.368 0.877 . . . . 75.43 113.368 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 N--CA 1.471 0.603 0 C-N-CA 124.328 1.051 . . . . 72.24 112.744 -171.101 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 121.663 0.744 . . . . 73.03 109.579 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.41 -37.12 84.49 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.265 -1.334 . . . . 71.21 108.182 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -73.12 -31.35 64.25 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.599 -0.728 . . . . 73.21 110.278 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.564 ' HA ' ' SG ' ' A' ' 132' ' ' CYS . 90.8 t -63.93 -50.19 78.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 109.688 -0.486 . . . . 71.2 109.688 175.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -30.21 66.71 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.398 -0.521 . . . . 64.24 110.438 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.43 -41.66 90.43 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 111.054 -0.818 . . . . 72.22 111.054 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 tp -63.04 -48.17 79.89 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 123.75 0.82 . . . . 74.44 109.146 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.95 -42.88 97.03 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.462 -0.79 . . . . 72.41 111.759 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -64.89 -44.33 89.98 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-O 119.773 -0.156 . . . . 74.45 111.194 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.35 -43.78 96.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.88 0.371 . . . . 61.12 110.251 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.463 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 26.7 t80 -62.39 -54.85 34.3 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 124.961 1.304 . . . . 73.44 110.113 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.2 mm -66.1 -34.06 67.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 112.24 0.459 . . . . 65.12 112.24 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.83 -39.15 73.16 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.572 -0.451 . . . . 71.45 110.043 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.63 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 4.1 pp -69.29 -30.25 68.3 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 119.556 -0.857 . . . . 65.14 110.846 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.7 t -72.08 -21.87 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 115.819 -0.628 . . . . 73.54 110.213 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.2 p -110.4 19.45 18.78 Favored 'General case' 0 C--O 1.248 0.991 0 O-C-N 121.455 -0.778 . . . . 74.3 111.887 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.63 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 70.6 mmtt -58.2 158.02 7.6 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-N 115.854 -0.612 . . . . 61.32 111.389 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.3 t -74.67 148.18 85.07 Favored Pre-proline 0 C--N 1.287 -2.11 0 N-CA-C 108.377 -0.971 . . . . 51.0 108.377 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -59.87 -6.03 4.28 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 123.858 3.039 . . . . 71.11 111.731 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.4 -27.48 67.48 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.009 0.924 . . . . 64.31 108.641 171.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.1 m -92.35 152.71 19.62 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 105.963 -1.866 . . . . 54.52 105.963 172.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.1 t -62.23 -53.21 50.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 113.208 0.818 . . . . 55.43 113.208 -174.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -158.08 125.4 5.07 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 119.618 -0.833 . . . . 72.33 112.204 -172.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -32.47 74.03 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 123.609 0.763 . . . . 75.32 112.14 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.04 -21.73 61.49 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.993 -0.549 . . . . 75.11 109.532 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -71.84 -42.35 67.05 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 107.42 -1.326 . . . . 71.51 107.42 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -66.16 -33.92 76.86 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.054 -0.976 . . . . 73.11 109.124 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.439 HD11 ' CE1' ' A' ' 28' ' ' PHE . 39.5 tp -69.91 -40.83 75.36 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.95 -0.568 . . . . 61.22 110.459 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.36 79.7 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.416 0.627 . . . . 73.21 109.915 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -69.59 -38.24 77.24 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.666 -1.152 . . . . 64.44 109.26 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.507 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 43.8 t80 -66.45 -45.31 80.21 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.353 -0.84 . . . . 71.42 110.308 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.3 pp -80.19 2.58 23.73 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.046 0.388 . . . . 71.33 112.046 -176.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -47.87 -62.52 4.09 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 111.729 -0.549 . . . . 42.35 111.729 173.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.507 ' HD2' ' O ' ' A' ' 48' ' ' PHE . 66.0 Cg_endo -79.99 -6.5 14.11 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.244 1.963 . . . . 72.3 112.363 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 92.4 m-70 -114.38 33.61 5.2 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 109.292 -0.632 . . . . 74.2 109.292 -176.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.436 ' CG ' HG21 ' A' ' 65' ' ' THR 0.267 13.5 t70 -53.76 99.03 0.19 Allowed Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 128.818 2.847 . . . . 74.01 111.516 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -113.06 -156.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 123.97 3.114 . . . . 74.13 113.089 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -92.75 127.87 38.41 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 107.608 -1.256 . . . . 74.33 107.608 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 65' ' ' THR . 43.2 mt -116.48 109.04 26.65 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 N-CA-C 109.046 -0.724 . . . . 61.24 109.046 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -91.18 138.89 31.24 Favored 'General case' 0 C--N 1.274 -2.698 0 O-C-N 122.176 -0.327 . . . . 64.31 110.487 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.76 120.07 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 N-CA-C 107.428 -1.323 . . . . 62.41 107.428 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 61.74 20.22 11.2 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.983 0.913 . . . . 72.43 110.636 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.41 3.67 58.55 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 115.922 -0.581 . . . . 73.55 113.208 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -111.67 132.39 54.64 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.021 -0.733 . . . . 72.13 109.021 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.77 126.15 34.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.689 0.757 . . . . 74.34 110.387 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -121.82 146.56 46.96 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.127 -1.434 . . . . 72.32 107.127 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -81.33 174.53 11.41 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.204 -0.598 . . . . 73.04 109.567 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.532 ' HA ' HD12 ' A' ' 56' ' ' ILE . 50.5 p -65.48 -33.92 77.07 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.528 1.131 . . . . 73.44 110.45 -176.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.526 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 25.0 m -62.53 -51.53 67.03 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.694 -1.139 . . . . 54.21 109.641 174.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.84 -48.51 79.56 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 123.628 0.771 . . . . 53.14 110.416 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CG ' HD13 ' A' ' 56' ' ' ILE . 31.6 t80 -49.87 -56.5 10.24 Favored 'General case' 0 CA--C 1.501 -0.931 0 O-C-N 123.751 0.657 . . . . 71.31 110.491 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -53.34 -42.95 67.29 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 124.517 1.135 . . . . 75.33 110.589 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.7 mm100 -61.75 -48.64 79.76 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 123.275 0.63 . . . . 73.12 111.234 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.462 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 34.3 m-85 -67.22 -40.27 86.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.314 0.578 . . . . 74.2 109.461 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -56.21 -51.31 68.55 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.765 -0.652 . . . . 72.43 110.653 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -72.05 -21.39 61.53 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 116.22 -0.446 . . . . 74.23 111.291 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -83.25 -2.5 55.76 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 120.793 -0.363 . . . . 75.52 111.889 173.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.09 12.09 50.48 Favored Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 120.632 -0.794 . . . . 34.44 114.136 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.83 -45.5 50.86 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 122.104 -0.645 . . . . 74.45 111.751 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 32.6 m-85 -97.08 0.83 49.25 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 113.819 1.044 . . . . 75.13 113.819 -175.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -67.74 -13.61 62.26 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.596 0.712 . . . . 64.33 111.374 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.424 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 8.4 mtpm? -72.25 -10.94 60.44 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.898 -0.592 . . . . 71.32 111.72 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.69 -7.28 59.58 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 121.067 0.461 . . . . 72.03 111.086 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.13 -26.39 64.87 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.469 0.652 . . . . 73.44 109.273 172.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -96.07 13.6 26.61 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.051 -0.522 . . . . 50.2 109.952 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -92.71 145.83 24.12 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.738 1.014 . . . . 64.23 113.738 -173.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -100.49 139.98 35.4 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.024 -1.843 . . . . 75.34 106.024 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.443 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 48.2 p90 . . . . . 0 C--N 1.308 -1.223 0 CA-C-O 121.497 0.665 . . . . 70.1 112.222 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 N--CA 1.444 -0.771 0 CA-C-O 121.584 0.707 . . . . 72.44 111.235 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.28 148.79 17.52 Favored Glycine 0 N--CA 1.412 -2.935 0 CA-C-N 115.167 -0.924 . . . . 54.5 111.433 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -115.79 121.76 43.39 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.755 -1.202 . . . . 75.22 107.755 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.419 ' HE3' ' CD1' ' A' ' 123' ' ' TYR . 14.3 mptt -102.77 103.24 13.44 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 123.98 0.8 . . . . 74.13 108.952 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.25 125.1 48.86 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.161 -1.422 . . . . 64.24 107.161 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 15.3 t -124.4 134.64 66.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 119.796 -0.762 . . . . 71.24 110.492 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.443 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 18.8 m-90 -114.9 139.83 49.48 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.445 -0.946 . . . . 73.51 108.445 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.403 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 64.5 mttm -118.99 120.84 38.44 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.022 -1.103 . . . . 73.33 108.022 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 20.2 t . . . . . 0 C--N 1.308 -1.239 0 N-CA-C 108.454 -0.943 . . . . 52.12 108.454 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.498 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 44.8 p90 . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 108.764 -0.828 . . . . 62.14 108.764 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.4 ' H ' ' HB3' ' A' ' 105' ' ' SER . 8.1 m-20 -114.51 144.16 43.79 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.333 -1.358 . . . . 65.33 107.333 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.498 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 31.9 mt-10 -120.56 153.89 36.14 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 113.01 0.745 . . . . 72.33 113.01 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -137.07 120.93 17.52 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.731 -1.122 . . . . 75.1 108.939 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.418 ' HG3' HG22 ' A' ' 102' ' ' VAL . 88.6 tt0 -121.58 110.16 15.66 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.779 -0.823 . . . . 60.33 108.779 -176.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.57 133.94 41.45 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 122.933 0.493 . . . . 45.33 110.337 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.419 ' CD1' ' HE3' ' A' ' 100' ' ' LYS . 24.8 m-85 -113.53 116.85 30.19 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.703 -0.851 . . . . 75.35 108.703 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.9 mt -119.17 149.47 21.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.494 -1.669 . . . . 72.3 106.494 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -133.71 143.3 48.41 Favored 'General case' 0 C--O 1.265 1.898 0 C-N-CA 119.232 -0.987 . . . . 73.32 109.296 174.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -90.17 131.55 35.94 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 106.239 -1.763 . . . . 75.42 106.239 173.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.508 ' HD3' ' OG ' ' A' ' 131' ' ' SER . 54.4 mtp180 -85.39 144.58 27.94 Favored 'General case' 0 C--N 1.261 -3.242 0 N-CA-C 106.716 -1.587 . . . . 74.42 106.716 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -63.75 -10.57 20.42 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 114.651 1.352 . . . . 75.01 114.651 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -79.98 -14.17 58.78 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.726 -0.472 . . . . 73.35 109.726 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.88 -11.54 27.31 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.629 -0.796 . . . . 71.51 113.652 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.508 ' OG ' ' HD3' ' A' ' 127' ' ' ARG . 61.3 p -84.68 170.12 13.63 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 117.805 0.803 . . . . 73.04 109.72 175.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.564 ' SG ' ' HA ' ' A' ' 21' ' ' VAL . 13.7 p -138.02 142.3 40.39 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 108.395 -0.965 . . . . 62.21 108.395 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -150.08 155.66 40.27 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.291 -1.003 . . . . 73.21 108.291 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.9 mp -72.05 123.26 22.43 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.81 -0.441 . . . . 63.11 109.81 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -74.62 -52.91 10.44 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.149 -0.932 . . . . 74.32 109.009 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.4 t 179.52 156.91 0.58 Allowed 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 106.637 -1.616 . . . . 72.35 106.637 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.8 m -133.68 147.33 30.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 107.536 -1.283 . . . . 70.32 107.536 173.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -125.67 130.91 52.52 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-O 120.994 0.426 . . . . 65.05 109.979 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -110.23 135.85 50.34 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 107.878 -1.156 . . . . 72.22 107.878 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.528 ' HB ' ' CE ' ' A' ' 143' ' ' LYS . 12.3 pt -132.86 102.41 5.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 108.863 -0.792 . . . . 72.24 108.863 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 23.3 ptp -91.75 138.13 31.8 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.89 -0.724 . . . . 72.31 112.416 -173.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 35.3 m 59.34 77.97 0.29 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 113.456 -1.702 . . . . 74.33 114.08 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.528 ' CE ' ' HB ' ' A' ' 140' ' ' ILE . 5.9 mptp? . . . . . 0 C--N 1.3 -1.57 0 CA-C-N 114.477 -1.238 . . . . 74.34 108.509 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 C--O 1.24 0.588 0 N-CA-C 108.351 -0.981 . . . . 71.52 108.351 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.91 -34.74 78.45 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.132 -1.394 . . . . 73.55 107.498 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.25 -43.28 98.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.433 -0.803 . . . . 74.5 109.669 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.04 -56.7 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 O-C-N 123.837 0.711 . . . . 64.21 111.077 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -64.14 -34.3 77.74 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.326 -0.55 . . . . 71.0 110.797 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.53 ' HA2' ' CE1' ' A' ' 26' ' ' TYR . . . -62.22 -51.45 56.55 Favored Glycine 0 C--O 1.256 1.519 0 CA-C-N 115.887 -0.597 . . . . 65.25 112.303 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 pp -70.63 -30.38 67.01 Favored 'General case' 0 C--O 1.21 -0.999 0 N-CA-C 108.48 -0.933 . . . . 70.43 108.48 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.14 -44.43 76.54 Favored Glycine 0 N--CA 1.424 -2.107 0 CA-C-N 115.729 -0.669 . . . . 51.54 111.849 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.53 ' CE1' ' HA2' ' A' ' 23' ' ' GLY . 2.9 p90 -74.59 -35.23 62.99 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 119.272 -0.971 . . . . 73.13 110.459 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -63.63 -46.76 84.22 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.351 -0.611 . . . . 52.22 109.351 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 33.0 t80 -61.58 -52.7 63.35 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 115.35 -0.841 . . . . 74.2 110.554 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 29' ' ' ILE . 9.3 mm -61.14 -39.03 81.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 112.643 0.609 . . . . 65.3 112.643 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -68.15 -40.21 82.45 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 119.697 -0.801 . . . . 74.43 110.365 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.615 ' HA ' ' HD3' ' A' ' 34' ' ' LYS . 4.0 pp -71.59 -26.77 62.74 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 119.134 -1.026 . . . . 73.42 112.311 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.2 t -70.72 -25.74 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 109.363 -0.606 . . . . 42.32 109.363 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.4 p -107.94 19.31 20.2 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.308 0.575 . . . . 73.51 110.226 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.615 ' HD3' ' HA ' ' A' ' 31' ' ' LEU . 17.8 tptt -61.83 143.21 56.68 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-N 115.196 -0.911 . . . . 72.4 109.446 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.6 m -55.53 141.58 63.37 Favored Pre-proline 0 C--N 1.309 -1.159 0 O-C-N 123.78 0.675 . . . . 74.55 112.216 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.53 -7.44 20.33 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.332 2.688 . . . . 74.01 112.883 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -79.63 -26.53 41.1 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.944 -0.571 . . . . 55.43 109.954 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.3 m -70.46 172.87 7.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.816 -0.809 . . . . 73.33 108.816 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.2 t -52.54 -53.69 18.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 112.255 0.465 . . . . 73.35 112.255 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.53 ' ND2' ' HB3' ' A' ' 42' ' ' GLU . 33.4 t30 173.43 134.81 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.836 0.71 . . . . 74.13 109.243 -175.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.7 m -58.11 -38.92 77.39 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.24 0.543 . . . . 73.31 110.283 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.53 ' HB3' ' ND2' ' A' ' 40' ' ' ASN . 8.7 tp10 -68.43 -20.85 64.67 Favored 'General case' 0 C--O 1.204 -1.292 0 CA-C-N 115.153 -0.93 . . . . 64.5 110.135 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -67.16 -47.23 71.65 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.412 -0.959 . . . . 52.45 108.412 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 18.3 mm-40 -71.04 -34.38 71.2 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 114.744 -1.116 . . . . 52.22 109.52 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.1 tp -66.16 -45.87 79.43 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 120.961 -0.296 . . . . 74.31 110.656 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.401 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . . . -60.45 -34.14 73.56 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.57 0.7 . . . . 73.55 110.661 176.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -70.67 -39.56 73.49 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.379 -0.828 . . . . 75.2 109.902 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 62.4 t80 -68.04 -40.43 82.84 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 124.38 1.072 . . . . 73.23 110.565 -178.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.7 pp -83.13 0.94 42.88 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 115.689 -0.687 . . . . 72.35 110.864 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.45 -58.21 4.72 Favored Glycine 0 CA--C 1.536 1.378 0 O-C-N 123.965 0.791 . . . . 71.4 113.439 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.89 -6.3 12.3 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 121.922 1.748 . . . . 62.11 112.172 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 10.9 m170 -108.82 32.22 5.06 Favored 'General case' 0 C--O 1.213 -0.862 0 C-N-CA 123.417 0.687 . . . . 73.13 109.807 -175.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.421 ' CG ' HG21 ' A' ' 65' ' ' THR . 13.0 t70 -53.57 98.58 0.17 Allowed Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 127.515 2.326 . . . . 63.53 110.633 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -114.54 -147.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 124.48 3.453 . . . . 65.31 113.188 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -102.71 128.77 49.28 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 108.717 -0.846 . . . . 74.44 108.717 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.433 HG22 HG23 ' A' ' 58' ' ' VAL . 3.4 mp -107.91 111.71 37.06 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.369 0 N-CA-C 108.862 -0.792 . . . . 74.54 108.862 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -95.97 109.57 21.93 Favored 'General case' 0 C--O 1.18 -2.553 0 O-C-N 121.742 -0.599 . . . . 73.32 111.334 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 56' ' ' ILE . 70.6 t -109.14 114.34 46.64 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.539 0 N-CA-C 108.392 -0.966 . . . . 74.22 108.392 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 63.93 20.83 12.39 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.524 1.13 . . . . 75.42 110.311 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.93 -10.08 62.0 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 114.961 -1.018 . . . . 61.33 112.022 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -93.59 130.51 39.46 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 110.069 -0.345 . . . . 74.1 110.069 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.68 121.07 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-O 122.611 1.196 . . . . 73.34 109.163 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -115.22 137.88 51.55 Favored 'General case' 0 C--N 1.271 -2.811 0 N-CA-C 106.451 -1.685 . . . . 74.23 106.451 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 67' ' ' ALA . 15.2 t -77.1 168.21 20.46 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 108.606 -0.887 . . . . 41.32 108.606 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.421 HG21 ' CG ' ' A' ' 53' ' ' ASP . 46.9 p -63.76 -32.83 74.45 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 123.981 0.912 . . . . 75.54 110.472 -176.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -62.65 -46.84 86.37 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.221 -1.354 . . . . 73.43 109.888 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.451 ' H ' HG23 ' A' ' 64' ' ' THR . . . -64.96 -44.9 87.89 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 123.549 0.74 . . . . 64.43 110.469 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -53.58 -54.35 38.68 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 123.477 0.486 . . . . 74.21 110.137 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -52.15 -41.42 62.55 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 124.306 1.003 . . . . 54.41 110.643 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.491 ' HG2' ' NH2' ' A' ' 73' ' ' ARG . 46.2 mt-30 -60.26 -51.47 69.39 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.279 -0.419 . . . . 74.4 111.556 175.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -63.33 -32.98 74.55 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.981 0.896 . . . . 74.41 110.393 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -62.07 -53.51 54.52 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.419 -1.264 . . . . 62.24 111.169 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.491 ' NH2' ' HG2' ' A' ' 70' ' ' GLN . 26.1 ptt180 -71.29 -20.7 62.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.96 0.409 . . . . 73.45 110.561 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 56.3 mt-30 -76.88 -9.2 58.52 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.229 -0.442 . . . . 71.41 110.941 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.57 7.48 64.92 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.941 -0.647 . . . . 70.43 114.024 174.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.2 mt -65.92 -28.81 69.2 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 117.161 0.481 . . . . 75.4 112.273 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -99.18 12.63 35.6 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.529 -0.469 . . . . 74.2 111.912 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.435 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 30.1 mmmt -70.78 -17.34 62.78 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.388 0.613 . . . . 72.12 110.434 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -83.27 -22.51 33.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.83 -0.623 . . . . 34.01 110.001 175.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.0 tp -76.68 -6.72 53.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.854 -0.612 . . . . 73.23 111.453 -172.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 1.6 pptp? -76.76 -3.65 39.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.618 0.723 . . . . 75.31 110.687 177.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -100.93 10.83 40.65 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 115.295 -0.866 . . . . 75.43 110.147 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.714 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -76.14 130.07 37.74 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-O 121.406 0.622 . . . . 74.14 112.301 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -112.6 150.02 31.97 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.855 -1.066 . . . . 75.04 109.871 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.6 t80 . . . . . 0 C--N 1.307 -1.278 0 O-C-N 123.774 0.671 . . . . 72.15 111.041 -174.991 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 . . . . . 0 N--CA 1.437 -1.079 0 N-CA-C 108.842 -0.799 . . . . 73.21 108.842 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -165.25 -167.53 25.99 Favored Glycine 0 N--CA 1.417 -2.569 0 C-N-CA 119.718 -1.23 . . . . 62.13 112.568 -176.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.08 157.42 41.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 109.033 -0.729 . . . . 64.34 109.033 -174.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 57.9 tttm -147.41 100.13 3.22 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.93 -1.137 . . . . 74.54 107.93 174.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -110.31 158.88 17.94 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.766 -0.827 . . . . 54.0 108.766 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.2 p -134.51 140.56 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 121.667 0.746 . . . . 63.33 111.838 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.714 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 24.1 m-90 -116.15 127.69 55.03 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.689 -1.141 . . . . 74.25 108.172 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.431 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 66.3 mttm -105.9 131.96 52.58 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.147 -0.686 . . . . 74.22 109.147 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 C--N 1.299 -1.615 0 N-CA-C 108.506 -0.924 . . . . 63.21 108.506 176.412 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 2.8 p90 . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 108.772 -0.825 . . . . 73.11 108.772 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -110.5 135.56 50.98 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.963 -1.495 . . . . 74.33 106.963 176.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.468 ' HB2' HG13 ' A' ' 140' ' ' ILE . 46.0 mt-10 -116.83 156.53 27.11 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.919 -0.713 . . . . 52.13 111.89 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -135.87 117.53 14.97 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.923 -1.035 . . . . 71.31 108.415 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -112.79 112.31 23.71 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.845 -0.798 . . . . 75.52 108.845 -175.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -98.16 131.76 44.26 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.402 -0.519 . . . . 54.31 110.716 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -108.77 121.81 45.84 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 114.478 -1.237 . . . . 74.41 108.206 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.425 HG12 HD23 ' A' ' 134' ' ' LEU . 50.8 mt -124.3 137.12 58.26 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 N-CA-C 107.53 -1.285 . . . . 72.43 107.53 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -114.37 150.31 34.78 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.298 -1.742 . . . . 74.35 106.298 176.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -111.67 136.56 50.73 Favored 'General case' 0 N--CA 1.403 -2.817 0 C-N-CA 118.293 -1.363 . . . . 73.34 110.385 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.403 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 61.4 ttt180 -88.83 154.82 19.95 Favored 'General case' 0 C--N 1.258 -3.389 0 CA-C-N 112.912 -1.949 . . . . 74.22 109.366 -170.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -59.78 -26.62 65.87 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.466 0.706 . . . . 52.33 110.91 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.403 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 31.1 t70 -67.01 -16.22 64.23 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.43 -0.805 . . . . 72.25 110.773 175.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.62 -23.64 29.26 Favored Glycine 0 C--O 1.221 -0.683 0 O-C-N 121.921 -0.487 . . . . 74.41 112.111 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.9 t -73.0 140.47 47.35 Favored 'General case' 0 N--CA 1.42 -1.933 0 C-N-CA 123.483 0.713 . . . . 74.15 109.532 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 81.3 m -104.57 141.92 35.56 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.195 -1.039 . . . . 74.15 108.195 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -140.54 154.56 46.58 Favored 'General case' 0 N--CA 1.408 -2.56 0 N-CA-C 107.941 -1.133 . . . . 62.31 107.941 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.425 HD23 HG12 ' A' ' 124' ' ' ILE . 78.9 mt -67.9 116.14 8.21 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.25 -0.648 . . . . 60.25 109.25 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -80.84 -46.41 15.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 106.921 -1.511 . . . . 74.41 106.921 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.8 p -174.75 172.97 2.88 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.002 -0.999 . . . . 71.1 108.74 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.6 t -144.05 141.12 24.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 106.596 -1.631 . . . . 74.21 106.596 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -119.08 132.37 56.01 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 109.5 -0.555 . . . . 70.33 109.5 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.425 ' HB2' HG22 ' A' ' 58' ' ' VAL . 64.4 m-85 -115.28 131.72 56.84 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.604 -1.258 . . . . 64.41 107.604 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.468 HG13 ' HB2' ' A' ' 119' ' ' GLU . 4.5 pt -132.12 99.04 3.4 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 CA-C-O 121.71 0.767 . . . . 62.51 110.811 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 21.6 ptp -85.07 126.22 33.4 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.843 -1.071 . . . . 50.21 109.805 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.7 t 77.42 74.32 0.07 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.548 1.139 . . . . 61.24 112.016 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt . . . . . 0 CA--C 1.47 -2.109 0 N-CA-C 107.167 -1.42 . . . . 74.33 107.167 171.459 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 17.2 t70 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 122.083 0.944 . . . . 62.42 111.028 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.36 -33.83 67.54 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.865 -1.061 . . . . 72.11 108.39 -177.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -65.45 -47.43 76.18 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 124.751 1.22 . . . . 64.24 109.982 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.507 ' HA ' ' CD2' ' A' ' 24' ' ' LEU . 6.3 p -65.85 -43.06 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 112.327 0.491 . . . . 73.41 112.327 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 13.4 ptpt -71.25 -24.51 62.19 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 118.659 -1.216 . . . . 75.32 111.23 177.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.33 -56.49 10.09 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.782 -0.645 . . . . 71.44 112.323 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.507 ' CD2' ' HA ' ' A' ' 21' ' ' VAL . 1.7 pt? -70.09 -30.65 67.92 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 118.965 -1.094 . . . . 74.12 109.629 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.9 -42.17 98.47 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.664 -0.698 . . . . 51.1 111.92 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -69.03 -43.67 74.25 Favored 'General case' 0 C--O 1.208 -1.084 0 C-N-CA 119.795 -0.762 . . . . 75.33 110.759 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -57.75 -43.9 85.71 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.154 0.502 . . . . 70.3 110.1 -177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.501 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 26.5 t80 -62.3 -54.23 43.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.725 -1.125 . . . . 72.22 110.149 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.6 mm -63.42 -33.96 64.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 112.296 0.48 . . . . 65.13 112.296 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -68.82 -43.73 74.94 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 110.181 -0.303 . . . . 54.24 110.181 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.6 pp -68.19 -31.18 70.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.979 -0.688 . . . . 73.24 110.562 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.72 -27.49 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 116.06 -0.518 . . . . 62.43 110.103 175.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.8 p -107.51 19.83 19.7 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.485 0.659 . . . . 53.14 110.299 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 34' ' ' LYS . 20.5 tptt -77.26 158.14 30.41 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.749 -0.66 . . . . 65.13 109.62 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 m -56.39 131.3 76.25 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.474 0.71 . . . . 64.02 111.521 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.31 -7.11 20.04 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.614 2.876 . . . . 70.02 111.544 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.73 -19.58 65.78 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.26 1.424 . . . . 72.33 110.58 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -76.08 -176.56 3.55 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 107.92 -1.141 . . . . 71.45 107.92 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.64 -50.01 82.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 118.341 0.519 . . . . 74.55 111.575 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.3 t30 177.2 131.07 0.05 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.566 -0.531 . . . . 63.15 109.566 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.3 m -60.86 -35.19 75.94 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-O 121.44 0.638 . . . . 74.03 110.384 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -66.66 -20.75 66.06 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.923 -1.035 . . . . 74.4 110.946 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -67.68 -47.35 69.69 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 108.944 -0.761 . . . . 70.43 108.944 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -68.23 -34.32 76.02 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.084 -0.962 . . . . 73.35 108.741 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.4 HD11 ' CE2' ' A' ' 28' ' ' PHE . 36.1 tp -66.47 -44.68 82.06 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 116.129 -0.487 . . . . 54.12 110.42 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.77 -33.12 73.51 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.431 0.634 . . . . 32.24 110.408 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -77.12 -32.36 56.39 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.203 -0.908 . . . . 53.02 109.756 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -68.9 -47.31 66.11 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.772 -0.455 . . . . 73.22 109.772 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.6 pp -73.33 -2.56 22.6 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.766 -0.652 . . . . 65.13 112.363 -176.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -39.24 -67.44 0.59 Allowed Glycine 0 CA--C 1.538 1.487 0 O-C-N 123.908 0.755 . . . . 70.31 113.123 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.402 ' O ' ' HZ2' ' A' ' 133' ' ' TRP . 7.8 Cg_exo -78.78 -6.4 15.19 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.823 2.348 . . . . 64.53 113.002 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 86.2 m-70 -110.5 24.73 12.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.704 -0.48 . . . . 75.2 109.704 -172.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.446 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 8.3 t70 -55.91 109.47 1.67 Allowed Pre-proline 0 C--O 1.244 0.811 0 C-N-CA 124.654 1.181 . . . . 75.31 111.965 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -112.98 -149.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 124.257 3.304 . . . . 73.32 110.577 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -92.12 119.16 31.52 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 107.986 -1.116 . . . . 74.43 107.986 172.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.475 HD13 ' CB ' ' A' ' 68' ' ' PHE . 67.5 mt -101.16 112.71 34.99 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.683 0 N-CA-C 106.552 -1.647 . . . . 74.53 106.552 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -98.09 133.24 42.81 Favored 'General case' 0 C--N 1.259 -3.357 0 C-N-CA 119.891 -0.724 . . . . 65.44 109.298 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.3 t -128.28 114.68 35.21 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 107.31 -1.367 . . . . 75.32 107.31 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 63.53 20.57 12.31 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.947 1.299 . . . . 75.24 110.473 -176.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.55 -3.24 65.59 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.672 -0.694 . . . . 43.01 112.286 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -98.48 133.14 43.28 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.934 -0.765 . . . . 64.44 108.934 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.401 HD13 ' N ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -73.63 125.41 32.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 122.152 0.977 . . . . 70.42 109.81 -175.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 58.9 mm-40 -124.65 148.02 48.18 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 115.044 -0.98 . . . . 63.3 108.727 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 t -95.14 172.21 8.26 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.517 -1.29 . . . . 74.45 107.517 173.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.446 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 9.1 t -54.06 -34.92 61.36 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 112.731 0.641 . . . . 73.52 112.731 -177.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.538 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 73.0 m -65.43 -48.31 73.2 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 120.869 -0.332 . . . . 74.14 110.696 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -59.12 -45.71 90.2 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 122.668 0.387 . . . . 75.5 110.16 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.475 ' CB ' HD13 ' A' ' 56' ' ' ILE . 56.7 t80 -54.21 -55.82 24.3 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 123.441 0.463 . . . . 75.54 110.032 174.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.86 -39.88 59.65 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.767 -1.106 . . . . 71.33 110.885 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.9 mm100 -63.81 -47.6 80.2 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 123.048 0.539 . . . . 64.4 111.375 177.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.43 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 31.7 m-85 -66.35 -32.67 74.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.816 0.817 . . . . 64.0 109.684 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -61.93 -56.02 23.54 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.008 -0.996 . . . . 52.33 110.617 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -69.16 -22.81 63.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.465 -0.334 . . . . 63.23 111.777 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 53.1 mt-30 -74.43 -16.1 60.88 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.164 0.507 . . . . 64.23 110.905 174.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.24 7.4 52.19 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.245 -0.978 . . . . 62.41 113.635 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.0 mt -70.72 -43.31 69.2 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.08 0.467 . . . . 72.03 110.641 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 32.3 m-85 -83.9 -4.45 58.7 Favored 'General case' 0 C--O 1.211 -0.945 0 C-N-CA 120.303 -0.559 . . . . 73.13 111.066 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.01 -14.44 61.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.673 0.749 . . . . 63.25 109.462 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -84.81 -29.02 25.73 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.58 -0.896 . . . . 74.55 108.58 175.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.519 ' HA ' ' OG ' ' A' ' 105' ' ' SER . 8.6 tt -84.45 -6.62 59.39 Favored 'General case' 0 C--O 1.2 -1.517 0 CA-C-N 114.835 -1.075 . . . . 73.3 110.919 -172.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -66.57 -10.96 50.65 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.608 0.718 . . . . 74.35 112.296 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -98.35 14.33 28.37 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.684 -0.689 . . . . 54.24 109.359 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.713 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -69.81 130.55 42.6 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 113.799 1.037 . . . . 65.31 113.799 -176.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -104.3 139.86 38.69 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.237 -1.347 . . . . 61.24 107.575 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.44 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 44.2 p90 . . . . . 0 C--N 1.309 -1.185 0 C-N-CA 119.99 -0.684 . . . . 75.41 111.77 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 N--CA 1.434 -1.226 0 N-CA-C 107.861 -1.163 . . . . 74.44 107.861 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -104.31 148.95 16.94 Favored Glycine 0 N--CA 1.427 -1.938 0 C-N-CA 120.242 -0.98 . . . . 54.41 112.524 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -106.87 145.32 32.31 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.142 -1.058 . . . . 63.31 108.142 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.12 100.24 6.86 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.875 -1.528 . . . . 70.24 106.875 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.6 mt -108.83 127.48 54.06 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 108.204 -1.036 . . . . 70.45 108.204 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 18.8 t -123.44 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 120.262 -0.575 . . . . 64.52 110.736 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.713 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 19.3 m-90 -111.06 145.15 39.02 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.402 -0.817 . . . . 71.3 109.093 176.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 83' ' ' ALA . 51.1 mttm -119.31 120.36 36.73 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.593 -0.892 . . . . 71.33 108.593 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.519 ' OG ' ' HA ' ' A' ' 80' ' ' LEU . 29.1 t . . . . . 0 C--N 1.298 -1.654 0 C-N-CA 124.215 1.006 . . . . 64.04 111.399 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 36.9 p90 . . . . . 0 N--CA 1.408 -2.565 0 N-CA-C 108.699 -0.852 . . . . 75.45 108.699 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.51 ' H ' ' HB3' ' A' ' 105' ' ' SER . 2.4 m-20 -112.08 136.8 50.98 Favored 'General case' 0 C--N 1.259 -3.339 0 N-CA-C 105.872 -1.899 . . . . 65.25 105.872 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.414 ' CD ' ' HD3' ' A' ' 143' ' ' LYS . 86.9 mt-10 -114.7 145.29 42.22 Favored 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 119.411 -0.915 . . . . 73.22 110.119 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -126.32 117.24 22.59 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 115.123 -0.944 . . . . 71.54 109.424 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -110.64 110.04 20.56 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.731 -0.84 . . . . 75.35 108.731 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.65 125.06 42.2 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 109.315 -0.624 . . . . 61.41 109.315 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -106.89 112.48 25.46 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.946 -1.131 . . . . 62.11 107.946 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 54.6 mt -110.74 146.84 15.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.283 0 N-CA-C 107.348 -1.353 . . . . 63.31 107.348 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.427 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.3 OUTLIER -129.24 150.5 50.59 Favored 'General case' 0 C--O 1.262 1.75 0 N-CA-C 108.028 -1.101 . . . . 72.21 108.028 177.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 40.3 ttp85 -85.45 112.57 21.01 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.408 -1.33 . . . . 73.52 107.408 176.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -67.41 150.43 48.94 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.852 -1.067 . . . . 73.41 109.132 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -57.82 -15.7 9.19 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.855 1.262 . . . . 71.4 111.411 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -81.06 -6.38 58.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.828 -0.624 . . . . 75.42 111.411 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.4 -25.25 15.97 Favored Glycine 0 CA--C 1.504 -0.597 0 N-CA-C 114.816 0.687 . . . . 52.34 114.816 172.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.5 m -103.79 166.56 10.34 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 109.399 -0.593 . . . . 73.23 109.399 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 63.9 m -98.66 154.7 17.76 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.866 -0.42 . . . . 52.23 109.866 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.427 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 25.0 t-105 -150.09 155.13 39.3 Favored 'General case' 0 N--CA 1.412 -2.368 0 N-CA-C 106.681 -1.6 . . . . 74.14 106.681 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.03 119.71 10.0 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.682 -0.488 . . . . 64.04 109.682 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -83.72 -53.8 5.37 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.693 -1.225 . . . . 71.51 107.693 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.6 m -164.62 157.42 16.85 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 106.396 -1.705 . . . . 71.34 106.396 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.95 154.8 31.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 107.472 -1.307 . . . . 72.1 107.472 173.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -130.55 137.35 49.65 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 110.112 -0.329 . . . . 71.31 110.112 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -120.63 118.02 29.05 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.873 -1.158 . . . . 61.53 107.873 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.5 pt -116.03 102.78 14.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-O 121.504 0.669 . . . . 73.51 110.851 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.8 mtp -96.33 92.45 6.34 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.802 -1.555 . . . . 64.31 106.802 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.4 m -177.23 -49.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 112.754 0.65 . . . . 70.53 112.754 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.414 ' HD3' ' CD ' ' A' ' 119' ' ' GLU . 86.6 tttt . . . . . 0 N--CA 1.485 1.313 0 C-N-CA 123.986 0.914 . . . . 72.11 112.994 -172.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.4 t70 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 121.57 0.7 . . . . 62.53 110.489 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.55 -38.31 71.03 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.539 -0.911 . . . . 73.23 108.539 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.23 -45.37 69.96 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.372 -0.831 . . . . 74.35 111.259 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.3 m -70.39 -34.69 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 112.109 0.411 . . . . 52.15 112.109 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.537 ' HZ3' ' HB3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -69.7 -35.47 75.11 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 118.638 -1.225 . . . . 74.42 109.078 176.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.07 -40.79 83.05 Favored Glycine 0 C--O 1.216 -1.02 0 N-CA-C 111.327 -0.709 . . . . 74.4 111.327 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 tp -68.21 -47.98 66.42 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 123.465 0.706 . . . . 63.02 109.705 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.79 -41.04 99.01 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 115.645 -0.707 . . . . 72.41 111.718 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -67.82 -43.5 79.44 Favored 'General case' 0 C--O 1.198 -1.644 0 CA-C-O 118.879 -0.581 . . . . 74.45 111.085 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -57.96 -44.31 86.96 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 120.837 0.351 . . . . 72.32 110.082 -176.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -61.73 -54.56 40.9 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.633 -1.167 . . . . 74.25 110.438 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.6 mm -60.6 -35.84 66.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 112.49 0.552 . . . . 42.44 112.49 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.93 -47.76 73.66 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.102 -0.703 . . . . 71.04 109.102 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.536 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 4.1 pp -73.59 -19.13 60.96 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 119.985 -0.686 . . . . 63.22 112.099 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.1 t -74.86 -28.17 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.462 0.649 . . . . 71.01 109.527 173.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.8 p -106.13 14.32 27.85 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.829 0.823 . . . . 73.41 109.18 -176.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 21.5 tptp -39.66 124.25 1.65 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 127.163 2.185 . . . . 74.0 112.879 -176.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 m -53.49 146.91 22.21 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.707 1.203 . . . . 64.43 112.048 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.14 -7.76 16.47 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 123.598 2.865 . . . . 73.41 112.614 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.93 -26.95 68.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.321 -0.854 . . . . 75.35 110.276 175.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 p -101.81 167.79 9.85 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.861 -0.609 . . . . 72.11 110.675 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.4 t -62.96 -54.95 26.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 114.034 1.124 . . . . 71.35 114.034 -172.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -171.11 139.84 1.43 Allowed 'General case' 0 C--O 1.245 0.836 0 C-N-CA 119.195 -1.002 . . . . 64.1 110.654 -172.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.7 m -63.22 -42.94 99.34 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.004 0.521 . . . . 70.13 111.724 -172.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.453 ' HB2' ' CD2' ' A' ' 72' ' ' PHE . 1.6 mp0 -63.3 -20.6 65.62 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.031 -0.531 . . . . 61.03 111.466 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -69.86 -46.97 64.39 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.868 -0.79 . . . . 73.25 108.868 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -71.0 -31.95 68.62 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.87 -1.159 . . . . 73.13 107.87 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 54.3 tp -65.4 -46.59 79.42 Favored 'General case' 0 C--O 1.191 -2.012 0 CA-C-N 115.584 -0.735 . . . . 75.55 110.095 176.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 49' ' ' LEU . . . -62.37 -30.97 71.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.838 0.828 . . . . 65.42 110.494 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -73.25 -34.81 66.05 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.555 -1.202 . . . . 74.22 110.489 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.429 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 61.3 t80 -80.48 -26.92 37.96 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.458 1.123 . . . . 71.4 108.475 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.481 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 39.9 tp -69.79 -29.8 67.19 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 127.323 2.249 . . . . 53.11 111.509 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -38.47 -56.17 2.0 Allowed Glycine 0 CA--C 1.545 1.929 0 N-CA-C 115.628 1.011 . . . . 45.42 115.628 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 48' ' ' PHE . 8.2 Cg_exo -77.81 -5.83 15.6 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.153 1.902 . . . . 54.23 113.585 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -133.21 24.9 4.19 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.685 -0.634 . . . . 72.53 111.654 -169.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -56.17 107.32 0.86 Allowed Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 123.067 0.547 . . . . 73.44 111.823 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.424 ' HB2' ' HA ' ' A' ' 136' ' ' SER . 6.7 Cg_endo -109.51 -159.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 123.84 3.027 . . . . 72.23 112.228 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -86.73 131.16 34.21 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.226 -1.027 . . . . 44.43 108.226 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mp -108.86 112.75 41.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.763 -1.199 . . . . 75.34 107.763 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 138' ' ' LYS . 80.2 m-85 -92.88 133.7 35.82 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 108.502 -0.925 . . . . 75.53 108.502 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.3 t -131.84 117.09 32.81 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 108.101 -1.074 . . . . 62.5 108.101 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 60.78 29.44 19.01 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.373 1.045 . . . . 64.21 110.765 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.75 5.94 80.68 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.906 -1.043 . . . . 62.12 112.839 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -113.85 134.33 54.87 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 109.723 -0.473 . . . . 75.1 109.723 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.411 HD13 ' N ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -75.06 128.22 36.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.885 0.85 . . . . 75.41 110.284 -175.355 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.411 ' N ' HD13 ' A' ' 62' ' ' ILE . 50.8 mm-40 -126.37 144.32 50.86 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 106.921 -1.511 . . . . 63.2 106.921 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -87.08 174.3 8.74 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.281 -0.637 . . . . 74.14 109.281 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.7 t -56.7 -33.47 66.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.256 0.622 . . . . 70.1 111.378 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 60.9 m -67.21 -42.52 83.95 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.091 -0.504 . . . . 72.34 110.469 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -64.86 -47.92 76.15 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 122.766 0.426 . . . . 62.32 109.984 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -52.97 -53.56 48.04 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 123.552 0.533 . . . . 54.43 110.114 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.0 tp -49.72 -46.43 50.21 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 124.167 0.917 . . . . 70.25 111.537 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 66' ' ' THR . 49.0 mt-30 -59.46 -48.1 82.95 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 116.201 -0.454 . . . . 61.45 111.306 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -66.87 -35.28 79.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.243 0.544 . . . . 74.33 110.532 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.453 ' CD2' ' HB2' ' A' ' 42' ' ' GLU . 3.5 t80 -60.17 -51.91 67.57 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.554 -0.748 . . . . 75.51 110.649 175.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -75.33 -13.19 60.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.874 0.368 . . . . 70.22 111.372 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 27.9 mm-40 -82.1 -8.99 59.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.977 0.417 . . . . 71.34 111.412 170.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.82 26.31 50.19 Favored Glycine 0 N--CA 1.427 -1.903 0 CA-C-N 116.147 -0.479 . . . . 70.14 112.349 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.8 mt -78.36 -37.24 44.75 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.034 -0.667 . . . . 73.41 112.001 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -97.36 1.3 49.21 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.963 -0.695 . . . . 53.22 112.655 -175.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.301 0.0 OUTLIER -70.4 -16.88 63.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.177 1.177 . . . . 71.4 114.177 -173.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -89.53 -15.78 32.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.362 0.601 . . . . 74.41 111.543 171.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.3 tt -84.84 -14.82 46.76 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.568 -0.742 . . . . 62.02 110.262 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.84 -8.72 57.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.365 0.602 . . . . 64.44 111.748 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -92.72 13.52 19.91 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.616 -0.72 . . . . 62.51 109.524 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 105' ' ' SER . . . -79.99 154.44 28.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.282 -0.872 . . . . 71.23 113.352 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -107.79 143.79 35.87 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.523 -1.217 . . . . 72.23 109.256 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.0 p90 . . . . . 0 C--N 1.298 -1.643 0 CA-C-O 121.236 0.541 . . . . 73.21 109.578 176.286 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 . . . . . 0 N--CA 1.432 -1.34 0 N-CA-C 109.511 -0.551 . . . . 74.13 109.511 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.46 -164.64 33.94 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 110.261 -1.136 . . . . 70.33 110.261 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -128.55 136.3 50.55 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.454 -0.573 . . . . 73.45 109.454 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -122.71 98.9 6.12 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.008 -1.849 . . . . 75.34 106.008 170.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 mt -109.62 124.42 51.12 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 123.775 0.672 . . . . 74.22 109.889 -172.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 10.9 p -114.77 122.42 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-O 122.331 1.062 . . . . 55.12 112.474 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 -96.07 145.1 25.75 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.025 -1.443 . . . . 75.34 108.522 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -128.5 121.12 28.15 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.19 -1.411 . . . . 72.31 107.19 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 42.5 m . . . . . 0 C--O 1.253 1.282 0 C-N-CA 122.973 0.509 . . . . 73.25 112.018 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.438 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 8.4 p90 . . . . . 0 N--CA 1.436 -1.143 0 N-CA-C 107.696 -1.224 . . . . 65.25 107.696 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -107.23 139.17 42.11 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.843 -1.169 . . . . 72.42 107.843 175.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.438 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 46.2 mt-10 -119.21 151.55 38.17 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 120.446 -0.502 . . . . 65.3 110.125 174.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -137.31 123.15 20.06 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 116.079 -0.51 . . . . 40.53 110.079 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -114.78 110.33 19.55 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.16 -0.682 . . . . 72.24 109.16 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.02 130.39 44.35 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 109.031 -0.729 . . . . 70.3 109.031 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -110.31 110.67 21.56 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.213 -1.032 . . . . 72.53 108.213 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.484 HG12 HD13 ' A' ' 134' ' ' LEU . 61.4 mt -115.28 137.16 49.7 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.674 0 N-CA-C 107.511 -1.292 . . . . 73.3 107.511 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.507 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.2 OUTLIER -122.27 147.95 45.6 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.007 -1.849 . . . . 71.12 106.007 177.335 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -117.06 133.53 55.88 Favored 'General case' 0 N--CA 1.398 -3.028 0 C-N-CA 117.553 -1.659 . . . . 74.44 109.725 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.465 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 73.4 ttt180 -82.56 144.69 30.19 Favored 'General case' 0 C--N 1.255 -3.533 0 CA-C-N 113.044 -1.889 . . . . 72.11 109.789 -172.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -49.4 -31.8 10.33 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.853 1.261 . . . . 74.12 112.423 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.465 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 6.9 m-20 -76.69 0.93 18.57 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.515 -0.766 . . . . 74.4 111.667 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.95 -1.48 56.54 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.335 -0.46 . . . . 45.02 112.619 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.4 m -85.5 101.46 12.67 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 122.623 -0.339 . . . . 74.51 111.521 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 42.0 t -80.78 120.74 25.05 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 105.57 -2.011 . . . . 74.03 105.57 173.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.507 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 5.9 t-105 -140.22 150.56 44.29 Favored 'General case' 0 N--CA 1.394 -3.245 0 C-N-CA 119.163 -1.015 . . . . 72.13 111.301 -170.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.484 HD13 HG12 ' A' ' 124' ' ' ILE . 3.4 mm? -68.75 116.6 9.44 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.053 -0.976 . . . . 72.4 109.057 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -83.72 -56.61 3.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.975 -0.75 . . . . 74.01 108.975 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.424 ' HA ' ' HB2' ' A' ' 54' ' ' PRO . 14.0 m -164.45 156.55 16.36 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 106.291 -1.744 . . . . 43.22 106.291 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.8 m -131.03 162.34 39.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.384 -1.339 . . . . 75.03 107.384 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 57' ' ' TYR . 78.7 tttt -142.28 136.97 30.3 Favored 'General case' 0 C--N 1.275 -2.641 0 C-N-CA 122.718 0.407 . . . . 35.02 110.071 -173.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -123.04 141.01 52.43 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.821 -0.807 . . . . 74.35 108.821 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.9 pt -132.18 98.36 3.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.788 -1.19 . . . . 72.2 107.788 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 68.8 mtm -89.55 130.38 35.88 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.213 -1.358 . . . . 74.32 111.138 -171.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.4 t 71.47 24.46 3.63 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 124.468 1.105 . . . . 71.33 110.303 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? . . . . . 0 N--CA 1.426 -1.641 0 CA-C-N 114.891 -1.05 . . . . 54.32 108.381 178.732 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 . . . . . 0 CA--C 1.507 -0.676 0 CA-C-O 120.969 0.414 . . . . 75.12 110.815 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.96 -40.43 96.4 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.68 -0.691 . . . . 52.31 109.454 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.15 -43.6 81.9 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.021 -0.536 . . . . 73.21 110.517 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.434 HG12 ' HB3' ' A' ' 132' ' ' CYS . 11.3 m -70.39 -38.73 75.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 120.334 -0.547 . . . . 75.41 112.104 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -28.0 50.37 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.662 -0.815 . . . . 71.15 110.581 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.75 -41.43 49.99 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 110.066 -1.214 . . . . 42.1 110.066 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.3 tp -68.12 -49.78 58.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.889 -0.782 . . . . 61.41 108.889 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.26 -38.72 95.0 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.516 -0.765 . . . . 33.21 112.447 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -71.95 -40.85 68.39 Favored 'General case' 0 C--O 1.195 -1.792 0 C-N-CA 120.426 -0.51 . . . . 72.2 110.571 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -62.32 -43.1 99.61 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.622 0.725 . . . . 73.43 110.049 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.427 ' CZ ' ' HH2' ' A' ' 103' ' ' TRP . 27.7 t80 -64.63 -54.63 28.78 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 113.946 -1.479 . . . . 74.42 110.157 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 29' ' ' ILE . 9.8 mm -65.49 -33.52 64.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 120.882 -0.327 . . . . 55.44 111.838 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -63.41 -48.82 76.24 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 110.067 -0.346 . . . . 64.32 110.067 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 32' ' ' VAL . 4.4 pp -68.55 -30.28 69.03 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.088 -0.645 . . . . 43.15 110.94 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.414 ' N ' HD12 ' A' ' 31' ' ' LEU . 66.0 t -70.58 -25.09 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 CA-C-O 121.201 0.524 . . . . 71.54 110.492 175.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.5 p -110.33 19.3 18.98 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.565 0.698 . . . . 74.11 110.226 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -55.78 142.86 33.14 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.949 -1.023 . . . . 74.31 110.328 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 m -62.92 153.99 78.1 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-N 115.435 -0.802 . . . . 63.23 110.694 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.16 -5.65 3.11 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 125.03 3.82 . . . . 64.25 113.043 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.6 -27.22 68.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.498 -0.774 . . . . 73.54 109.17 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -94.97 142.2 27.76 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 105.788 -1.93 . . . . 74.22 105.788 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.7 t -68.96 -46.07 79.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 120.606 -0.438 . . . . 44.11 111.927 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -145.01 119.29 9.54 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 119.406 -0.918 . . . . 64.34 112.552 -174.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.9 m -64.13 -35.96 82.49 Favored 'General case' 0 C--O 1.251 1.165 0 C-N-CA 123.714 0.806 . . . . 74.1 110.768 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.724 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 1.3 mp0 -65.8 -21.2 66.47 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.156 -0.929 . . . . 75.3 110.466 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -68.69 -43.02 76.94 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.607 -1.257 . . . . 72.22 107.607 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.43 -32.12 69.59 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.552 -1.204 . . . . 74.15 109.43 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.5 tp -67.78 -40.87 83.95 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 116.017 -0.538 . . . . 63.42 110.7 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.11 -36.62 84.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.622 0.725 . . . . 74.31 109.921 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -69.47 -37.6 77.35 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.985 -1.007 . . . . 72.32 109.44 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -65.55 -43.24 90.51 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.218 1.007 . . . . 74.12 110.727 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 pp -80.45 -2.49 46.02 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.822 -0.626 . . . . 61.52 111.214 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.2 -62.47 5.02 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 111.888 -0.485 . . . . 73.42 111.888 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -77.15 -5.57 15.88 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.45 2.1 . . . . 73.11 112.235 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -124.46 38.08 4.27 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.798 -0.445 . . . . 60.52 109.798 -172.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.553 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 34.4 t70 -54.52 106.03 0.61 Allowed Pre-proline 0 C--O 1.245 0.848 0 C-N-CA 125.23 1.412 . . . . 63.23 113.22 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -107.92 -157.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.101 0 C-N-CA 123.798 2.999 . . . . 74.53 110.548 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -98.97 123.66 43.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.665 -0.865 . . . . 52.53 108.665 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.445 HD13 ' CB ' ' A' ' 68' ' ' PHE . 46.6 mt -105.25 107.92 23.74 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.606 0 N-CA-C 107.868 -1.16 . . . . 61.22 107.868 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -96.75 138.82 33.73 Favored 'General case' 0 C--N 1.27 -2.888 0 O-C-N 121.737 -0.602 . . . . 75.23 110.26 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 p -128.24 117.92 46.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 107.16 -1.422 . . . . 74.1 107.16 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 60.8 20.82 10.95 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.705 -0.68 . . . . 74.1 111.571 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.27 1.17 56.89 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.817 -0.629 . . . . 61.04 112.866 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -108.74 130.84 55.37 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 117.397 0.598 . . . . 63.13 110.438 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.58 125.25 33.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 122.055 0.931 . . . . 74.41 110.256 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -120.56 140.53 51.36 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.44 -1.318 . . . . 70.21 107.44 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.0 t -85.66 173.52 10.06 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.701 -0.852 . . . . 71.42 108.701 176.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.553 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 9.7 t -52.62 -37.52 58.52 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.405 0.682 . . . . 64.52 111.57 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -70.03 -41.1 74.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.336 -0.393 . . . . 73.13 111.855 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.54 -47.34 76.19 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.229 -0.656 . . . . 44.31 109.229 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CB ' HD13 ' A' ' 56' ' ' ILE . 55.3 t80 -53.18 -54.33 37.57 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 115.667 -0.697 . . . . 71.23 110.118 174.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -50.13 -44.31 52.33 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 124.206 0.941 . . . . 33.23 110.867 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -60.41 -48.84 80.03 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 122.853 0.461 . . . . 62.13 111.531 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.47 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 32.6 m-85 -68.4 -36.78 79.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.678 0.752 . . . . 60.01 109.398 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -58.46 -54.56 45.7 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.102 -0.954 . . . . 73.2 110.948 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -66.07 -29.74 70.14 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.582 -0.281 . . . . 74.34 110.557 -176.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.522 ' HA ' HE21 ' A' ' 74' ' ' GLN . 0.0 OUTLIER -77.71 -8.78 58.44 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 113.373 0.879 . . . . 44.42 113.373 178.007 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.419 ' HA2' ' HG3' ' A' ' 78' ' ' LYS . . . 100.13 11.35 42.84 Favored Glycine 0 C--N 1.315 -0.63 0 C-N-CA 120.31 -0.947 . . . . 60.31 114.944 173.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.14 -53.85 22.22 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 120.878 0.371 . . . . 73.14 111.974 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.47 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 40.5 m-85 -89.72 6.17 42.7 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 112.781 0.66 . . . . 74.35 112.781 -172.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.724 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 41.9 mtmt -66.16 -12.47 56.03 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.492 0.923 . . . . 75.34 113.492 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -77.64 -10.67 59.64 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.363 -0.835 . . . . 71.05 111.2 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.3 tp -68.3 -28.86 67.55 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.488 -0.56 . . . . 71.22 109.488 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.55 ' HB2' ' OE2' ' A' ' 42' ' ' GLU . 0.8 OUTLIER -65.83 -28.67 69.16 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.581 -0.736 . . . . 63.23 110.127 176.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -98.82 7.07 46.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.656 -0.702 . . . . 60.11 110.348 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.48 150.82 22.3 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.967 0.413 . . . . 45.51 110.612 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.09 134.11 47.9 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.674 -0.862 . . . . 70.11 108.674 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 48.7 p90 . . . . . 0 C--N 1.302 -1.479 0 N-CA-C 113.55 0.944 . . . . 75.33 113.55 -174.013 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 . . . . . 0 C--O 1.256 1.44 0 N-CA-C 109.803 -0.443 . . . . 73.11 109.803 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -105.41 146.49 16.08 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 110.979 -0.848 . . . . 75.53 110.979 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -110.99 133.91 53.01 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.0 -1.111 . . . . 72.44 108.0 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -113.45 109.82 19.29 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 123.583 0.552 . . . . 74.35 109.872 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -97.42 108.73 21.51 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 105.675 -1.972 . . . . 61.44 105.675 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 3.9 t -115.11 150.24 17.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 119.776 -0.77 . . . . 75.03 110.187 -174.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.427 ' HH2' ' CZ ' ' A' ' 28' ' ' PHE . 25.2 m-90 -132.35 151.19 51.96 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.556 -0.905 . . . . 74.23 108.556 175.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.461 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 67.3 mttm -126.34 130.85 51.62 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.684 -1.599 . . . . 53.45 106.684 174.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.1 p . . . . . 0 C--N 1.3 -1.577 0 N-CA-C 110.288 -0.264 . . . . 63.21 110.288 -179.616 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.456 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 1.6 p90 . . . . . 0 N--CA 1.422 -1.83 0 N-CA-C 107.147 -1.427 . . . . 74.21 107.147 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -113.02 135.33 53.9 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 106.022 -1.844 . . . . 63.32 106.022 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.461 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 44.0 mt-10 -115.07 148.77 38.49 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-O 121.69 0.757 . . . . 75.44 112.159 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -132.97 117.75 18.02 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-N 114.414 -1.266 . . . . 53.25 108.562 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.421 ' HG3' HG22 ' A' ' 102' ' ' VAL . 40.5 tt0 -121.38 110.91 16.67 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 109.1 -0.704 . . . . 75.34 109.1 -176.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -98.16 133.76 42.16 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.118 -0.492 . . . . 73.45 109.847 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -114.76 121.11 42.31 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 123.188 0.595 . . . . 72.53 110.198 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.5 mt -123.41 149.64 27.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.07 -1.826 . . . . 73.35 106.07 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.409 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.7 OUTLIER -132.19 145.21 51.19 Favored 'General case' 0 C--O 1.272 2.259 0 C-N-CA 119.066 -1.054 . . . . 73.33 109.157 173.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -83.66 119.9 25.33 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.473 -1.306 . . . . 65.54 107.473 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -89.59 133.06 34.79 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.481 -1.674 . . . . 64.23 106.481 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.29 -12.58 30.49 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.664 0.745 . . . . 75.15 111.228 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.8 -11.0 60.69 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.215 -0.902 . . . . 72.42 111.095 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.17 -12.9 28.79 Favored Glycine 0 CA--C 1.509 -0.344 0 C-N-CA 121.066 -0.588 . . . . 55.0 112.986 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.3 m -104.56 164.93 11.41 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 109.798 -0.445 . . . . 61.12 109.798 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.434 ' HB3' HG12 ' A' ' 21' ' ' VAL . 25.3 p -127.12 143.27 51.31 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.101 -1.444 . . . . 74.35 107.101 172.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.409 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 1.7 t90 -143.41 155.56 44.43 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.173 -1.011 . . . . 74.32 109.435 -176.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.7 mp -70.37 119.35 14.41 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 109.447 -0.575 . . . . 64.22 109.447 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -72.04 -50.5 27.97 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.562 -1.273 . . . . 62.21 107.562 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.8 p -177.19 177.42 1.23 Allowed 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.334 -1.303 . . . . 61.52 108.634 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.9 t -144.78 138.72 22.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 105.015 -2.217 . . . . 60.41 105.015 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -129.31 130.26 45.9 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-O 121.462 0.649 . . . . 74.42 109.847 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -110.42 133.57 53.15 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 107.791 -1.189 . . . . 71.43 107.791 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 10.1 pt -131.88 98.36 3.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 CA-C-O 122.078 0.942 . . . . 74.03 108.772 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 90.5 mtp -88.97 138.92 30.97 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.828 -1.078 . . . . 64.51 110.6 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.0 m 70.79 29.64 3.11 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 124.881 1.363 . . . . 73.34 112.795 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.1 mptt . . . . . 0 C--N 1.306 -1.305 0 N-CA-C 109.365 -0.606 . . . . 73.24 109.365 177.452 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 C--O 1.242 0.667 0 N-CA-C 108.217 -1.031 . . . . 71.21 108.217 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.92 -36.69 84.06 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.784 -1.098 . . . . 64.0 110.027 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.36 -42.6 87.83 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.228 -0.442 . . . . 73.24 110.466 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 m -71.75 -41.88 70.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 112.387 0.514 . . . . 74.0 112.387 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -31.41 70.46 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.622 -0.831 . . . . 55.44 110.161 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.01 -57.32 8.8 Favored Glycine 0 N--CA 1.437 -1.263 0 O-C-N 123.805 0.69 . . . . 50.31 111.939 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.68 -33.08 73.36 Favored 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.086 -1.046 . . . . 71.4 110.231 -177.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.06 -39.68 96.51 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 120.925 -0.655 . . . . 70.23 111.971 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -67.15 -47.56 70.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.655 -0.498 . . . . 75.04 109.655 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.6 -41.93 98.14 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.558 -0.746 . . . . 75.53 110.28 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 45' ' ' LEU . 23.9 t80 -61.46 -53.15 60.2 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 124.912 1.285 . . . . 71.24 109.985 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 29' ' ' ILE . 9.8 mm -65.76 -32.66 59.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 112.152 0.427 . . . . 53.52 112.152 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.23 -47.0 72.1 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.371 -0.532 . . . . 51.41 110.622 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.77 -26.21 64.18 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.02 -0.672 . . . . 74.05 111.925 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.2 t -71.68 -24.42 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 CA-C-O 121.552 0.691 . . . . 52.11 110.538 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.6 p -107.31 9.83 29.88 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 121.618 -0.676 . . . . 73.03 110.595 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 34' ' ' LYS . 24.7 tptt -69.63 156.95 38.15 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.161 -0.927 . . . . 74.23 112.474 -174.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.0 m -63.31 154.31 78.95 Favored Pre-proline 0 N--CA 1.424 -1.765 0 CA-C-N 113.711 -1.586 . . . . 71.24 113.04 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -59.18 -5.17 2.69 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 125.182 3.921 . . . . 71.12 112.785 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -54.31 -26.8 31.49 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.93 0.892 . . . . 74.52 110.785 173.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.1 t -101.14 156.81 17.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 105.158 -2.164 . . . . 72.0 105.158 168.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -50.24 -41.63 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.831 0.741 . . . . 75.11 111.987 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -167.04 151.08 6.82 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.966 -1.124 . . . . 54.52 107.966 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.7 m -60.71 -32.16 71.41 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-O 121.461 0.648 . . . . 74.04 110.648 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' OE1' HD23 ' A' ' 45' ' ' LEU . 8.5 tp10 -64.55 -22.75 67.05 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.201 -0.909 . . . . 73.22 110.151 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -67.06 -45.78 76.35 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.78 0.8 . . . . 54.44 108.915 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -71.49 -33.49 69.3 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.409 -1.269 . . . . 74.05 109.151 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.513 HD11 ' CE2' ' A' ' 28' ' ' PHE . 34.4 tp -68.74 -43.88 74.97 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 116.17 -0.468 . . . . 72.13 110.37 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.51 -37.02 77.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.476 0.655 . . . . 74.34 110.195 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -69.49 -36.08 76.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.124 -0.944 . . . . 72.22 110.176 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -67.26 -46.56 73.32 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.667 -0.697 . . . . 75.33 110.285 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.2 pp -82.23 -2.39 52.28 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.356 -0.838 . . . . 60.55 111.338 -176.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.69 -62.5 4.82 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 112.306 -0.318 . . . . 75.34 112.306 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -79.47 -7.23 14.83 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 121.842 1.694 . . . . 74.21 112.151 176.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 73.9 m-70 -114.17 35.19 4.26 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.041 -0.725 . . . . 72.12 109.041 -175.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.6 106.26 0.64 Allowed Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 125.28 1.432 . . . . 53.51 112.356 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -101.69 -164.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 123.243 2.629 . . . . 65.31 110.928 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -90.34 108.07 19.54 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 107.545 -1.28 . . . . 72.32 107.545 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.469 HD13 ' CB ' ' A' ' 68' ' ' PHE . 73.4 mt -92.48 107.91 19.58 Favored 'Isoleucine or valine' 0 C--O 1.162 -3.515 0 N-CA-C 108.744 -0.836 . . . . 73.03 108.744 -176.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -95.55 128.15 42.18 Favored 'General case' 0 C--N 1.268 -2.975 0 O-C-N 121.12 -0.988 . . . . 74.55 109.127 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.0 t -124.97 114.44 40.4 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 N-CA-C 107.959 -1.126 . . . . 74.54 107.959 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 62.01 20.94 11.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.56 -1.2 . . . . 74.33 110.591 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.63 -4.89 58.21 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 114.72 -1.127 . . . . 32.03 113.165 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -101.01 132.72 46.29 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 117.714 0.757 . . . . 72.44 109.376 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.59 129.25 36.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.874 0.845 . . . . 73.33 109.676 -177.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -126.9 152.83 46.56 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 124.78 1.232 . . . . 65.41 108.295 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.9 t -97.71 170.24 9.13 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.341 -0.985 . . . . 74.21 108.341 175.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.8 t -52.14 -38.43 57.52 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.285 0.634 . . . . 61.31 111.231 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -62.0 -49.2 76.99 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.175 0.59 . . . . 65.53 111.105 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.44 84.49 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.095 0.558 . . . . 73.25 110.314 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.469 ' CB ' HD13 ' A' ' 56' ' ' ILE . 56.6 t80 -53.68 -55.65 24.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.907 -0.588 . . . . 64.14 110.413 175.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -50.87 -42.44 58.92 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.07 -0.968 . . . . 61.34 110.572 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -60.28 -47.43 86.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 112.014 0.375 . . . . 73.23 112.014 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.427 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 39.8 m-85 -66.78 -32.7 74.16 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.495 0.664 . . . . 73.22 109.976 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -61.77 -52.61 63.53 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.47 -0.786 . . . . 62.23 110.91 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -71.17 -21.28 62.19 Favored 'General case' 0 C--O 1.224 -0.271 0 O-C-N 123.27 0.356 . . . . 74.41 110.904 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -71.57 -19.95 62.08 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.351 0.596 . . . . 62.53 110.108 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 78' ' ' LYS . . . 100.94 13.79 33.14 Favored Glycine 0 N--CA 1.422 -2.235 0 CA-C-N 115.492 -0.776 . . . . 63.04 113.299 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.0 mt -74.55 -44.56 50.48 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 117.427 0.614 . . . . 64.02 111.365 -177.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 45.0 m-85 -88.8 -4.58 58.46 Favored 'General case' 0 C--O 1.214 -0.814 0 N-CA-C 112.662 0.615 . . . . 74.11 112.662 -176.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -70.98 -15.57 62.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 119.392 -0.923 . . . . 70.23 112.304 -177.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -86.61 -21.57 26.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.631 -0.713 . . . . 75.31 110.281 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.1 tp -74.54 -14.76 60.84 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.915 0.864 . . . . 72.24 109.684 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -57.66 -25.65 60.53 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.598 -1.183 . . . . 52.45 112.295 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -92.95 11.94 25.58 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 111.997 0.369 . . . . 34.12 111.997 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.73 150.24 28.06 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.096 0.474 . . . . 74.55 111.627 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -99.5 132.41 44.86 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.504 -0.924 . . . . 64.33 108.504 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.56 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 51.1 p90 . . . . . 0 C--N 1.319 -0.759 0 C-N-CA 119.924 -0.711 . . . . 74.15 112.311 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.435 -1.184 0 N-CA-C 110.184 -0.302 . . . . 71.24 110.184 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -153.88 141.67 8.48 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 108.853 -1.699 . . . . 75.31 108.853 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -108.56 150.99 26.72 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.459 -1.312 . . . . 70.13 107.459 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 39.4 ttpt -150.05 107.83 3.69 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-O 121.745 0.783 . . . . 54.11 109.41 176.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 72.8 mt -101.99 134.35 45.35 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 114.146 -1.388 . . . . 73.43 107.935 -177.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 6.1 t -120.01 128.97 75.97 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.182 0 C-N-CA 120.685 -0.406 . . . . 64.32 110.397 -176.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.56 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 18.8 m-90 -99.95 127.44 46.14 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 107.317 -1.364 . . . . 75.55 107.317 173.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -112.36 120.12 40.61 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 107.696 -1.224 . . . . 64.11 107.696 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 C--N 1.301 -1.54 0 CA-C-N 115.194 -0.912 . . . . 75.3 110.483 -176.057 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.565 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 43.2 p90 . . . . . 0 C--O 1.211 -0.936 0 N-CA-C 108.146 -1.057 . . . . 72.12 108.146 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -112.88 140.53 47.61 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.947 -1.501 . . . . 62.43 106.947 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.565 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 40.7 mt-10 -123.32 155.14 37.84 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 121.183 0.516 . . . . 52.15 111.031 175.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -141.61 117.29 10.35 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.771 -1.104 . . . . 62.41 108.039 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 7.9 pt-20 -125.23 111.99 15.89 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-O 121.718 0.771 . . . . 64.1 112.193 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.624 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -93.91 124.61 38.03 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.427 -1.261 . . . . 75.24 110.005 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.473 ' CE2' ' HD3' ' A' ' 100' ' ' LYS . 8.7 m-85 -103.07 129.34 49.85 Favored 'General case' 0 C--O 1.249 1.069 0 C-N-CA 124.622 1.169 . . . . 61.31 108.171 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 53.8 mt -131.46 144.28 38.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.697 -0.853 . . . . 63.35 108.697 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.427 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.5 OUTLIER -137.73 151.51 48.27 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 108.117 -1.068 . . . . 73.13 108.117 176.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 17.4 ptt180 -107.04 150.64 26.31 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.421 -0.912 . . . . 70.14 110.995 177.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.536 ' HB2' ' OD1' ' A' ' 129' ' ' ASP . 50.4 mtt180 -99.47 168.91 9.68 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.017 -0.992 . . . . 75.14 109.643 -172.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -80.97 -10.3 59.73 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.849 0.357 . . . . 64.25 110.617 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.536 ' OD1' ' HB2' ' A' ' 127' ' ' ARG . 11.4 p-10 -74.27 -16.04 60.96 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.058 0.456 . . . . 75.23 110.943 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.08 -11.95 26.78 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 120.834 -0.698 . . . . 61.41 112.055 178.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.4 m -105.08 -177.33 3.33 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.687 0.756 . . . . 74.33 110.208 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 28.8 p -143.62 169.4 17.8 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 106.69 -1.596 . . . . 52.24 106.69 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.427 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 0.0 OUTLIER -159.28 155.81 27.61 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.125 -0.694 . . . . 72.25 109.125 -178.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.4 mp -70.07 123.38 21.42 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.555 -0.906 . . . . 65.23 108.555 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -72.71 -54.47 8.88 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.741 -1.207 . . . . 73.31 107.741 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.4 m -168.4 165.89 12.54 Favored 'General case' 0 C--O 1.201 -1.472 0 N-CA-C 106.066 -1.827 . . . . 71.33 106.066 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 122' ' ' ALA . 7.5 m -142.12 142.61 27.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 105.46 -2.052 . . . . 61.02 105.46 171.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -127.93 130.54 48.63 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 118.206 0.457 . . . . 75.34 110.439 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -115.25 128.91 56.45 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.901 -1.148 . . . . 74.2 107.901 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.6 pt -128.64 98.31 4.19 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.6 0 N-CA-C 108.07 -1.085 . . . . 72.41 108.07 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 74.7 mtm -87.27 128.36 35.17 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.631 -1.168 . . . . 64.44 111.71 -174.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.5 m 61.52 55.09 2.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 113.935 -1.484 . . . . 64.24 111.339 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 37.3 tptt . . . . . 0 N--CA 1.412 -2.343 0 N-CA-C 106.194 -1.78 . . . . 63.25 106.194 179.362 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.4 t70 . . . . . 0 C--O 1.242 0.707 0 CA-C-O 121.454 0.645 . . . . 73.32 111.387 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.52 -37.09 79.73 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.648 -0.871 . . . . 75.3 108.648 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -68.71 -42.41 77.73 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 115.873 -0.603 . . . . 61.31 110.627 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.699 HG12 ' SG ' ' A' ' 132' ' ' CYS . 13.2 m -69.92 -41.28 79.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.027 -0.533 . . . . 61.04 111.617 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.33 -24.94 50.73 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 118.907 -1.117 . . . . 53.44 110.018 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.07 -55.16 11.04 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 121.017 -0.611 . . . . 73.53 111.583 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.36 -35.26 71.07 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.244 -1.021 . . . . 75.35 108.244 -178.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.7 -43.57 97.69 Favored Glycine 0 N--CA 1.432 -1.583 0 O-C-N 123.936 0.772 . . . . 74.11 112.003 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -69.41 -42.07 75.57 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 120.841 -0.344 . . . . 71.43 110.82 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -63.16 -46.11 88.69 Favored 'General case' 0 C--O 1.253 1.262 0 N-CA-C 109.671 -0.492 . . . . 74.2 109.671 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.504 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 30.4 t80 -62.64 -53.12 59.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.923 -1.035 . . . . 64.34 110.61 177.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.476 HD13 ' HA ' ' A' ' 29' ' ' ILE . 6.8 mm -61.2 -38.86 80.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 111.974 0.361 . . . . 63.23 111.974 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.39 -49.76 76.3 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 123.155 0.284 . . . . 73.23 110.307 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.3 pp -67.99 -29.6 68.66 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 120.562 -0.455 . . . . 75.12 111.121 -176.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.2 t -72.53 -27.71 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.401 0.62 . . . . 61.25 110.264 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.6 p -111.05 22.56 15.14 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.701 0.763 . . . . 72.23 109.115 -177.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -63.4 136.51 57.68 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.27 -1.332 . . . . 74.24 109.116 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -57.59 153.91 27.54 Favored Pre-proline 0 N--CA 1.435 -1.177 0 O-C-N 124.14 0.9 . . . . 51.21 110.72 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.79 -7.32 4.29 Favored 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 124.239 3.293 . . . . 74.24 113.093 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.73 -27.54 68.79 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.346 -0.843 . . . . 75.34 109.04 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.2 t -94.86 123.25 38.22 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 105.387 -2.079 . . . . 74.03 105.387 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.8 t -57.92 -48.06 84.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 123.566 0.541 . . . . 71.31 112.299 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -141.12 114.53 8.77 Favored 'General case' 0 N--CA 1.417 -2.106 0 C-N-CA 118.12 -1.432 . . . . 73.32 111.785 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.0 m -60.53 -32.64 71.66 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 123.203 0.601 . . . . 72.22 110.686 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -24.24 67.38 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.105 0.962 . . . . 63.0 110.791 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -70.62 -42.84 70.38 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 108.425 -0.954 . . . . 73.11 108.425 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -71.79 -30.57 65.68 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 114.535 -1.211 . . . . 55.53 108.841 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.6 tp -70.13 -41.51 73.82 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.631 -0.713 . . . . 70.25 110.091 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.56 -34.76 77.58 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.607 0.718 . . . . 63.5 109.694 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -68.72 -39.25 80.5 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.885 -1.052 . . . . 75.33 109.675 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -67.78 -41.45 83.2 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.773 -0.649 . . . . 75.2 111.238 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.4 pp -82.06 -4.16 56.22 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.074 -0.512 . . . . 74.5 111.254 -177.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -47.07 -58.21 6.47 Favored Glycine 0 C--O 1.213 -1.189 0 O-C-N 123.742 0.652 . . . . 64.21 112.863 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.79 -3.35 9.03 Favored 'Trans proline' 0 CA--C 1.556 1.6 0 C-N-CA 123.811 3.007 . . . . 60.54 113.074 172.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 69.1 m-70 -125.5 38.11 4.24 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 122.878 0.471 . . . . 64.42 109.837 -167.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.412 ' CB ' HG21 ' A' ' 65' ' ' THR . 7.1 m-20 -53.65 107.46 0.86 Allowed Pre-proline 0 C--N 1.321 -0.673 0 C-N-CA 126.25 1.82 . . . . 62.44 112.806 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -100.66 -164.96 0.06 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 123.118 2.545 . . . . 64.51 111.054 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -98.69 119.52 37.57 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 107.302 -1.37 . . . . 70.42 107.302 174.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 65' ' ' THR . 72.1 mt -100.04 112.29 32.15 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.627 0 N-CA-C 109.102 -0.703 . . . . 72.11 109.102 -174.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -97.7 106.22 18.5 Favored 'General case' 0 C--N 1.283 -2.322 0 O-C-N 121.855 -0.528 . . . . 75.12 111.722 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.535 HG23 HG22 ' A' ' 56' ' ' ILE . 73.2 t -116.81 124.21 72.62 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 108.131 -1.063 . . . . 60.42 108.131 -175.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.0 m120 66.13 19.61 11.13 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 124.563 1.164 . . . . 72.51 109.291 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.81 11.85 78.56 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.567 -0.742 . . . . 74.41 111.291 -176.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -113.69 139.94 48.65 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 122.869 0.468 . . . . 71.41 110.196 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.21 125.5 35.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.997 0.903 . . . . 74.41 109.054 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -124.05 142.98 50.72 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.224 -1.028 . . . . 70.42 108.224 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 67' ' ' ALA . 4.9 t -82.05 170.09 15.95 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.156 -1.053 . . . . 64.42 108.156 173.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.541 ' HA ' HD12 ' A' ' 56' ' ' ILE . 64.3 p -65.64 -34.08 77.38 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 123.843 0.857 . . . . 73.14 110.357 -176.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.9 m -65.05 -40.57 94.96 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.428 -1.26 . . . . 60.02 110.307 175.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.449 ' H ' HG23 ' A' ' 64' ' ' THR . . . -65.42 -46.49 79.74 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 116.169 -0.469 . . . . 51.52 109.809 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.488 ' HB2' HD13 ' A' ' 56' ' ' ILE . 48.9 t80 -52.06 -54.86 25.15 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 123.459 0.474 . . . . 73.3 109.963 174.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -50.82 -41.5 57.51 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.412 1.07 . . . . 73.34 110.774 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 45.8 mt-30 -63.08 -48.16 79.83 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 116.311 -0.404 . . . . 63.42 111.82 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.484 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 40.0 m-85 -69.33 -30.17 68.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.831 0.824 . . . . 75.01 109.739 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -61.32 -51.84 67.16 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.883 -1.053 . . . . 75.42 110.432 175.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 12.4 ptm180 -71.56 -21.7 61.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.128 0.489 . . . . 52.14 110.401 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 96.1 mt-30 -77.49 -3.29 39.77 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.041 -0.527 . . . . 72.23 111.538 173.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.05 22.37 63.55 Favored Glycine 0 N--CA 1.438 -1.215 0 CA-C-N 116.315 -0.402 . . . . 73.43 113.262 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.2 mt -83.51 -41.4 18.02 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.02 -0.672 . . . . 61.21 111.066 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 22.9 m-85 -100.91 -6.88 24.04 Favored 'General case' 0 C--O 1.185 -2.335 0 C-N-CA 119.845 -0.742 . . . . 75.34 112.838 -178.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -12.72 36.42 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 122.009 0.909 . . . . 70.05 112.847 -175.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -82.2 -9.6 59.45 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.229 -0.896 . . . . 64.3 112.536 176.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 80' ' ' LEU . 3.2 tm? -77.9 -14.96 59.38 Favored 'General case' 0 C--O 1.208 -1.113 0 C-N-CA 123.26 0.624 . . . . 62.01 110.906 -175.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -53.31 -19.05 2.9 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 114.39 1.255 . . . . 75.23 114.39 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -100.01 10.86 40.61 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 120.977 0.418 . . . . 73.35 110.682 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.435 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -68.87 146.06 53.16 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.343 0.868 . . . . 53.2 113.343 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 103' ' ' TRP . 37.6 mt-10 -114.41 156.72 23.97 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.484 -1.235 . . . . 63.44 107.71 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.541 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 38.0 p90 . . . . . 0 C--N 1.309 -1.194 0 N-CA-C 113.202 0.816 . . . . 71.11 113.202 -173.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 . . . . . 0 CA--C 1.482 -1.649 0 CA-C-O 121.361 0.6 . . . . 73.45 111.787 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -158.99 161.57 32.04 Favored Glycine 1 N--CA 1.391 -4.32 0 CA-C-N 114.638 -1.165 . . . . 44.22 110.381 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -107.22 123.23 47.99 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.234 -1.024 . . . . 75.22 108.234 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -117.86 103.4 9.93 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.22 -1.03 . . . . 72.43 108.22 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 87.2 mt -124.63 158.16 33.75 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 110.092 -0.336 . . . . 75.54 110.092 -177.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 8.3 p -133.68 134.51 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.439 0.638 . . . . 62.4 111.954 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.541 ' NE1' ' HB3' ' A' ' 85' ' ' PHE . 14.6 m-90 -106.82 147.66 29.45 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 124.318 1.047 . . . . 74.33 109.5 177.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 83' ' ' ALA . 62.6 mttm -127.91 126.49 41.6 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.016 -0.735 . . . . 73.31 109.016 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.409 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 25.6 t . . . . . 0 CA--C 1.553 1.081 0 N-CA-C 109.945 -0.391 . . . . 65.54 109.945 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 46.8 p90 . . . . . 0 N--CA 1.43 -1.436 0 N-CA-C 108.551 -0.907 . . . . 75.13 108.551 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.409 ' H ' ' HB3' ' A' ' 105' ' ' SER . 7.1 m-20 -114.13 138.29 50.62 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.922 -1.51 . . . . 70.3 106.922 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.593 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 44.7 mt-10 -115.16 143.49 45.14 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.143 0.497 . . . . 75.32 109.927 175.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -129.43 120.94 26.33 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.724 -0.671 . . . . 74.45 110.877 -174.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 35.0 mt-10 -111.18 110.06 20.4 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.66 -0.496 . . . . 74.4 109.66 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.44 134.27 38.46 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 120.841 0.353 . . . . 62.41 110.401 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -118.5 120.17 36.72 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.437 1.095 . . . . 64.11 108.661 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.79 148.79 21.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 106.131 -1.803 . . . . 74.4 106.131 175.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -128.49 146.9 50.68 Favored 'General case' 0 C--O 1.262 1.742 0 C-N-CA 119.109 -1.036 . . . . 72.32 110.095 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -81.02 112.82 18.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.689 -1.226 . . . . 75.35 107.689 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.433 ' HD2' ' H ' ' A' ' 129' ' ' ASP . 0.4 OUTLIER -85.1 136.32 33.61 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 105.835 -1.913 . . . . 70.2 105.835 -175.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.98 -10.55 14.2 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-O 121.531 0.682 . . . . 63.42 111.889 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.433 ' H ' ' HD2' ' A' ' 127' ' ' ARG . 28.7 t70 -72.01 -16.04 62.05 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.552 0.692 . . . . 54.12 109.644 178.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.68 -11.7 27.75 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.599 -0.81 . . . . 64.04 113.493 175.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 24.4 t -105.18 169.39 8.47 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 107.254 -1.387 . . . . 65.22 107.254 176.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.699 ' SG ' HG12 ' A' ' 21' ' ' VAL . 14.9 p -119.19 145.22 46.2 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 107.634 -1.247 . . . . 72.15 107.634 173.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -140.66 155.68 46.44 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.738 -0.838 . . . . 72.32 108.738 -176.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.11 125.11 25.81 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.54 0.686 . . . . 62.31 110.256 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -81.04 -57.39 3.55 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.701 -1.136 . . . . 64.1 108.034 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.8 m -166.16 157.13 13.11 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.237 -1.394 . . . . 42.31 107.237 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.6 135.98 43.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 106.862 -1.532 . . . . 71.31 106.862 171.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -108.99 136.12 49.04 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 122.731 0.412 . . . . 62.23 110.136 -174.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.484 ' HB2' HG22 ' A' ' 58' ' ' VAL . 62.6 m-85 -120.95 113.98 20.88 Favored 'General case' 0 C--O 1.255 1.352 0 CA-C-O 121.344 0.593 . . . . 63.53 109.671 176.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 13.9 pt -110.7 97.79 6.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-O 122.532 1.158 . . . . 55.44 109.248 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 19.8 ptm -101.31 93.77 5.59 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.163 -1.38 . . . . 52.44 110.164 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.0 m 160.8 19.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 127.004 2.122 . . . . 52.44 111.65 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.593 ' HG2' ' OE1' ' A' ' 119' ' ' GLU . 50.3 tptt . . . . . 0 C--N 1.319 -0.753 0 N-CA-C 107.079 -1.452 . . . . 72.51 107.079 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 t70 . . . . . 0 CA--C 1.511 -0.528 0 CA-C-O 121.162 0.506 . . . . 73.12 110.019 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.96 -39.55 94.99 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.138 -1.06 . . . . 50.22 108.138 175.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.35 -42.11 84.06 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.146 -0.934 . . . . 73.43 109.893 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.22 -45.1 94.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.514 -0.766 . . . . 63.52 111.082 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -70.89 -25.95 63.01 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.732 -0.387 . . . . 71.24 110.28 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.83 -45.41 58.02 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.214 -1.154 . . . . 45.22 110.214 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.4 tp -62.89 -50.15 72.0 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 124.579 1.152 . . . . 71.4 109.791 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.23 -43.24 98.68 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.656 -0.702 . . . . 61.54 112.017 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -66.17 -39.6 89.86 Favored 'General case' 0 C--O 1.211 -0.928 0 CA-C-O 119.22 -0.419 . . . . 71.24 111.218 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -60.62 -46.41 90.39 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.829 -0.804 . . . . 45.11 108.829 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.497 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 38.5 t80 -61.64 -53.74 52.18 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 114.377 -1.283 . . . . 73.22 110.424 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 29' ' ' ILE . 12.9 mm -62.02 -36.17 72.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 112.464 0.542 . . . . 54.4 112.464 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.35 -41.16 81.08 Favored 'General case' 0 CA--C 1.491 -1.306 0 C-N-CA 120.333 -0.547 . . . . 73.21 109.864 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.673 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.8 pp -70.44 -28.03 64.72 Favored 'General case' 0 N--CA 1.421 -1.876 0 C-N-CA 119.498 -0.881 . . . . 74.34 111.761 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 28' ' ' PHE . 65.1 t -70.62 -24.58 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 121.315 0.579 . . . . 73.15 109.653 175.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.5 p -115.18 21.85 13.83 Favored 'General case' 0 C--O 1.244 0.773 0 O-C-N 122.071 -0.393 . . . . 71.25 111.296 -176.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.673 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 53.2 mmtt -44.24 149.34 0.37 Allowed 'General case' 0 C--O 1.245 0.843 0 N-CA-C 115.808 1.781 . . . . 64.11 115.808 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 m -60.7 154.23 58.32 Favored Pre-proline 0 N--CA 1.423 -1.782 0 CA-C-N 112.981 -1.918 . . . . 70.13 108.191 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.04 -8.9 8.84 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 123.5 2.8 . . . . 63.21 112.941 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.8 -27.35 64.82 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.567 0.699 . . . . 73.14 109.878 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.7 m -118.21 81.43 1.68 Allowed 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 107.817 -1.179 . . . . 72.04 107.817 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -81.21 -5.3 8.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-O 122.258 1.028 . . . . 61.54 110.091 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -115.67 78.14 1.15 Allowed 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 107.414 -1.328 . . . . 74.44 107.414 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.6 m -66.43 -25.54 66.79 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 113.979 -1.464 . . . . 74.44 110.906 -173.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.497 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 6.5 pm0 -68.5 -22.98 64.51 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.616 -0.72 . . . . 61.4 110.533 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -63.94 -49.87 70.91 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.573 -0.899 . . . . 73.13 108.573 176.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -65.26 -38.24 89.69 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.439 -1.255 . . . . 73.24 109.96 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.6 tp -65.25 -42.96 92.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 116.429 -0.351 . . . . 70.45 110.73 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.13 -32.33 73.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.296 0.569 . . . . 75.34 110.435 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -74.2 -36.78 64.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.439 -0.8 . . . . 43.45 109.496 178.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 68.4 t80 -67.97 -42.95 80.09 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.189 0.996 . . . . 75.31 111.04 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 pp -81.3 -5.34 57.7 Favored 'General case' 0 C--O 1.204 -1.316 0 CA-C-N 115.907 -0.588 . . . . 72.12 111.138 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.54 -54.4 6.54 Favored Glycine 0 CA--C 1.545 1.92 0 CA-C-N 115.895 -0.593 . . . . 53.14 113.781 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -85.41 -3.56 9.34 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 123.356 2.704 . . . . 50.31 112.941 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.414 ' HA ' ' HE1' ' A' ' 133' ' ' TRP . 92.0 m-70 -128.75 31.53 4.94 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.992 -0.443 . . . . 54.51 110.595 -168.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -56.0 111.91 3.72 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.132 0.973 . . . . 71.31 112.559 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -105.57 -159.68 0.03 OUTLIER 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 123.631 2.888 . . . . 65.21 111.367 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -89.16 124.11 34.04 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 108.189 -1.041 . . . . 74.52 108.189 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.483 HD13 ' CB ' ' A' ' 68' ' ' PHE . 59.6 mt -107.0 112.48 40.12 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.179 0 N-CA-C 107.447 -1.316 . . . . 52.41 107.447 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -98.18 136.14 38.82 Favored 'General case' 0 C--N 1.263 -3.166 0 O-C-N 121.468 -0.77 . . . . 70.11 109.108 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.416 HG12 HD22 ' A' ' 59' ' ' ASN . 55.0 t -132.38 117.34 31.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 107.286 -1.375 . . . . 62.33 107.286 177.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.416 HD22 HG12 ' A' ' 58' ' ' VAL . 54.7 m-80 65.47 20.99 11.8 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.5 1.12 . . . . 74.43 109.893 -174.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.59 3.25 84.09 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.903 -1.044 . . . . 75.22 111.454 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -99.97 130.91 46.19 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 108.14 -1.059 . . . . 72.52 108.14 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.51 124.28 23.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 122.325 1.06 . . . . 71.4 110.549 -176.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 61.7 mm-40 -123.55 143.06 50.43 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 107.315 -1.365 . . . . 43.41 107.315 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.1 t -87.42 171.3 10.66 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 109.023 -0.732 . . . . 61.55 109.023 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.409 ' HA ' HD12 ' A' ' 56' ' ' ILE . 5.3 t -53.83 -36.21 62.29 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.107 0.963 . . . . 74.44 111.426 177.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.497 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 16.4 m -61.91 -50.45 72.14 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 122.971 0.509 . . . . 75.34 110.35 178.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -58.37 -47.79 82.68 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 123.598 0.759 . . . . 61.15 110.744 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.483 ' CB ' HD13 ' A' ' 56' ' ' ILE . 60.5 t80 -54.38 -55.31 29.92 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 123.755 0.659 . . . . 73.34 110.267 176.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -51.98 -40.76 61.44 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.187 0.929 . . . . 71.4 110.512 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 66' ' ' THR . 44.9 mt-30 -62.19 -49.07 77.28 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 116.577 -0.283 . . . . 73.41 111.118 176.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.0 -36.56 84.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.649 0.738 . . . . 71.33 110.092 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -59.2 -54.65 44.5 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 124.303 1.041 . . . . 64.44 110.971 176.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 7.8 ptm180 -68.76 -24.5 64.45 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.371 -0.377 . . . . 71.03 110.58 -176.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -86.38 -0.48 56.03 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.304 0.483 . . . . 63.31 112.304 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.72 13.29 61.29 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 115.391 0.916 . . . . 52.31 115.391 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.77 -39.69 94.03 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 112.701 0.63 . . . . 74.15 112.701 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -89.75 -2.02 58.15 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.537 0.569 . . . . 72.03 112.537 -174.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.497 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 98.9 mttt -65.78 -14.62 61.72 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.732 0.641 . . . . 74.34 112.732 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -76.79 -37.66 55.4 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.373 0.606 . . . . 74.42 110.029 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.507 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.6 tt -88.88 5.56 43.3 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.031 -0.986 . . . . 74.23 110.85 -168.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -12.17 52.54 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.303 0.853 . . . . 75.11 113.303 -176.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.67 -36.51 51.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.574 0.702 . . . . 73.04 109.341 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 34.81 114.59 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 118.67 2.841 . . . . 60.12 118.67 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -113.77 123.39 49.72 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 113.847 -1.524 . . . . 74.41 107.537 173.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.8 p90 . . . . . 0 C--N 1.296 -1.736 0 C-N-CA 119.252 -0.979 . . . . 75.54 112.301 -176.759 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 N--CA 1.442 -0.855 0 N-CA-C 107.176 -1.416 . . . . 74.15 107.176 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 125' ' ' TRP . . . -80.93 152.78 33.54 Favored Glycine 0 N--CA 1.425 -2.034 0 C-N-CA 120.266 -0.969 . . . . 65.34 112.752 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -106.95 134.95 49.32 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.309 -1.367 . . . . 63.25 107.309 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.404 ' N ' ' HD2' ' A' ' 100' ' ' LYS . 7.7 mptt -124.21 102.59 7.78 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.433 -1.321 . . . . 70.34 107.433 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 96.0 mt -119.22 141.02 49.27 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 120.457 -0.497 . . . . 74.11 109.978 -176.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.537 HG22 ' HB3' ' A' ' 121' ' ' GLU . 20.3 t -122.9 135.39 63.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.941 -0.392 . . . . 73.13 109.941 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -120.38 141.42 50.11 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.38 -0.97 . . . . 75.41 108.38 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -114.96 144.33 43.75 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 109.304 -0.628 . . . . 73.14 109.304 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.508 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 22.9 t . . . . . 0 C--N 1.293 -1.869 0 C-N-CA 124.165 0.986 . . . . 74.04 108.625 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 46.2 p90 . . . . . 0 N--CA 1.425 -1.709 0 N-CA-C 108.633 -0.877 . . . . 74.24 108.633 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.508 ' H ' ' HB3' ' A' ' 105' ' ' SER . 3.5 m-20 -102.55 141.14 35.87 Favored 'General case' 0 C--N 1.264 -3.15 0 N-CA-C 106.653 -1.61 . . . . 65.54 106.653 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.507 ' CD ' ' HG3' ' A' ' 143' ' ' LYS . 93.5 mt-10 -114.94 141.39 48.02 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.484 -0.486 . . . . 65.13 110.005 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.72 121.77 31.19 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.838 -0.619 . . . . 71.51 109.565 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.537 ' HB3' HG22 ' A' ' 102' ' ' VAL . 14.5 pt-20 -123.77 115.33 21.2 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-O 121.626 0.726 . . . . 63.13 111.784 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.31 135.7 35.43 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.891 -1.049 . . . . 65.12 109.891 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -117.28 117.47 29.64 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.431 -0.951 . . . . 74.5 108.431 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.53 HG22 ' SG ' ' A' ' 132' ' ' CYS . 54.4 mt -119.76 128.87 75.92 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 N-CA-C 105.533 -2.025 . . . . 75.22 105.533 176.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.535 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 0.2 OUTLIER -110.89 145.18 38.74 Favored 'General case' 0 N--CA 1.425 -1.723 0 C-N-CA 117.373 -1.731 . . . . 74.42 110.536 -177.223 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -103.84 118.26 36.27 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 107.711 -1.218 . . . . 73.31 107.711 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -75.9 155.67 35.0 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.205 -1.361 . . . . 60.42 109.422 -174.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -60.12 -22.57 62.97 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.011 0.91 . . . . 72.22 110.106 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.69 -13.37 54.12 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.703 1.201 . . . . 72.1 111.336 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.77 -23.71 34.68 Favored Glycine 0 CA--C 1.498 -1.001 0 N-CA-C 111.22 -0.752 . . . . 54.25 111.22 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.0 p -78.37 159.58 28.28 Favored 'General case' 0 N--CA 1.408 -2.565 0 C-N-CA 124.06 0.944 . . . . 74.43 110.392 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.53 ' SG ' HG22 ' A' ' 124' ' ' ILE . 7.7 t -135.49 143.7 45.96 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 108.889 -0.782 . . . . 75.21 108.889 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.414 ' HE1' ' HA ' ' A' ' 52' ' ' HIS . 11.6 t90 -153.85 156.17 37.11 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.966 -1.124 . . . . 72.21 107.966 -176.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.0 mp -68.81 127.9 34.74 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.834 -0.432 . . . . 72.41 109.834 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -87.02 -52.26 5.54 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.902 0.858 . . . . 72.14 108.767 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.8 p -174.93 162.02 3.07 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.324 -1.307 . . . . 43.54 108.131 -175.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.6 m -137.08 144.44 32.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 N-CA-C 106.342 -1.725 . . . . 72.32 106.342 172.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -124.65 130.6 52.73 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 120.674 -0.41 . . . . 70.33 110.78 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -109.97 127.75 54.98 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.573 -1.269 . . . . 64.03 107.573 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.7 pt -126.82 99.01 5.12 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-O 121.932 0.872 . . . . 73.24 111.803 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -86.05 92.25 8.65 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 105.402 -2.073 . . . . 75.11 105.402 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.7 m -165.66 3.35 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.277 -0.42 . . . . 62.33 112.01 -176.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.507 ' HG3' ' CD ' ' A' ' 119' ' ' GLU . 28.1 mmtp . . . . . 0 CA--C 1.489 -1.383 0 C-N-CA 119.57 -0.852 . . . . 73.41 111.935 -176.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 t70 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 121.726 0.774 . . . . 73.21 110.964 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.36 -33.32 72.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.918 -1.142 . . . . 73.22 107.918 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -69.98 -38.95 76.18 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.185 -0.916 . . . . 75.03 109.728 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.585 HG22 ' SG ' ' A' ' 132' ' ' CYS . 61.9 t -58.32 -53.89 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 123.507 0.504 . . . . 71.13 110.011 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.06 -32.78 74.2 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.874 -0.731 . . . . 64.32 111.413 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.86 -37.24 83.6 Favored Glycine 0 C--O 1.229 -0.161 0 N-CA-C 111.465 -0.654 . . . . 63.5 111.465 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.7 tp -65.45 -46.48 79.68 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 124.102 0.961 . . . . 71.12 108.663 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.46 -41.27 99.79 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.167 -0.924 . . . . 74.23 111.577 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -61.71 -42.28 98.74 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 122.731 0.412 . . . . 53.01 110.737 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -64.55 -47.71 77.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.356 0.598 . . . . 63.22 109.407 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 30.2 t80 -61.43 -51.59 68.09 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.309 -1.314 . . . . 61.24 110.42 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.3 mm -64.82 -32.28 57.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 116.24 -0.436 . . . . 52.14 111.687 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.31 -43.0 71.23 Favored 'General case' 0 CA--C 1.479 -1.784 0 C-N-CA 119.761 -0.775 . . . . 73.4 109.99 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 41' ' ' SER . 4.1 pp -70.53 -26.03 63.38 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 119.912 -0.715 . . . . 73.13 112.045 -178.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.0 t -70.25 -28.02 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 121.453 0.644 . . . . 52.32 109.777 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.9 p -114.21 23.66 12.67 Favored 'General case' 0 C--O 1.25 1.111 0 N-CA-C 109.148 -0.686 . . . . 54.02 109.148 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.617 ' HD3' ' HA ' ' A' ' 31' ' ' LEU . 27.4 tptt -52.8 137.56 31.48 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.342 -1.299 . . . . 72.1 111.684 -173.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.0 p -40.72 138.89 1.22 Allowed Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 125.411 1.484 . . . . 72.45 112.576 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -57.3 -15.22 18.06 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 123.545 2.83 . . . . 60.13 113.209 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.52 -27.94 68.96 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.921 0.867 . . . . 71.23 109.114 174.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.7 p -119.26 96.48 5.24 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 114.667 -1.151 . . . . 62.43 108.179 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.6 t -66.32 -50.03 71.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 113.348 0.87 . . . . 74.34 113.348 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.449 ' OD1' ' HB2' ' A' ' 43' ' ' HIS . 17.6 t-20 -89.72 80.76 6.51 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 123.111 1.434 . . . . 70.12 112.023 -171.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.68 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 15.8 m -67.2 -27.48 67.3 Favored 'General case' 0 C--O 1.255 1.374 0 CA-C-N 113.008 -1.906 . . . . 64.43 109.632 -175.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 42' ' ' GLU . 1.7 pm0 -68.52 -20.34 64.56 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 114.318 -1.31 . . . . 71.11 112.619 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.449 ' HB2' ' OD1' ' A' ' 40' ' ' ASN . 13.2 t60 -70.49 -38.46 74.35 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.19 -1.041 . . . . 72.14 108.19 175.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -66.57 -36.65 83.17 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.377 -0.972 . . . . 75.33 108.377 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.64 -43.18 97.54 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.671 -0.695 . . . . 74.45 110.722 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.01 79.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.31 0.576 . . . . 62.24 110.469 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -68.47 -39.12 81.52 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.443 -0.799 . . . . 63.41 109.698 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 79.7 t80 -69.4 -41.21 76.73 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 123.624 0.769 . . . . 73.31 111.084 -177.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.3 pp -79.52 -7.98 58.84 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-N 116.02 -0.536 . . . . 61.41 112.143 -176.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.05 -61.61 5.22 Favored Glycine 0 CA--C 1.541 1.687 0 C-N-CA 121.231 -0.509 . . . . 72.22 112.788 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -76.48 -4.92 15.61 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.118 2.545 . . . . 72.14 112.47 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.41 ' HB3' HD13 ' A' ' 134' ' ' LEU . 80.1 m-70 -122.61 29.95 6.68 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.889 -0.507 . . . . 74.03 110.646 -173.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.571 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 6.2 t70 -55.83 106.8 0.72 Allowed Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 125.207 1.403 . . . . 72.15 113.274 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 26.2 Cg_endo -107.33 -165.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 123.894 3.063 . . . . 50.21 112.803 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -87.85 115.58 25.41 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.077 -1.082 . . . . 72.51 108.077 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.407 HD13 ' HB2' ' A' ' 68' ' ' PHE . 53.4 mt -101.27 108.77 24.11 Favored 'Isoleucine or valine' 0 C--O 1.168 -3.217 0 N-CA-C 108.398 -0.964 . . . . 72.22 108.398 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -93.55 135.91 34.35 Favored 'General case' 0 C--N 1.272 -2.788 0 O-C-N 121.397 -0.814 . . . . 73.34 108.998 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.7 t -133.49 116.93 25.95 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.951 -1.129 . . . . 71.13 107.951 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 61.89 20.5 11.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.126 1.37 . . . . 61.54 110.931 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.6 4.72 60.51 Favored Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.26 -0.882 . . . . 75.23 112.822 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -107.45 134.77 49.99 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 108.096 -1.076 . . . . 71.34 108.096 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.11 127.88 38.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.523 0.678 . . . . 75.44 109.247 -178.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 61.9 mm-40 -122.01 150.12 42.53 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.005 -1.109 . . . . 73.41 108.005 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 t -97.86 174.09 6.76 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.414 -0.958 . . . . 75.24 108.414 176.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.571 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 8.9 t -53.77 -35.22 61.08 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 122.816 0.446 . . . . 74.41 111.058 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.543 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 10.7 m -58.73 -56.0 27.86 Favored 'General case' 0 C--O 1.212 -0.897 0 O-C-N 123.5 0.5 . . . . 63.53 110.014 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -58.96 -48.03 82.99 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 123.493 0.496 . . . . 74.44 111.014 -178.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.407 ' HB2' HD13 ' A' ' 56' ' ' ILE . 42.7 t80 -52.95 -56.86 12.85 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.464 0.478 . . . . 74.35 110.012 176.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -52.11 -42.87 63.63 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.716 -1.129 . . . . 73.14 110.857 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.8 mm100 -60.49 -48.77 80.32 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 122.797 0.439 . . . . 73.23 111.343 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.523 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 23.3 m-85 -66.41 -37.5 85.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.937 -0.764 . . . . 65.13 108.937 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -57.45 -53.37 58.89 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 123.762 0.825 . . . . 53.03 110.911 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -70.95 -19.2 62.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.118 0.485 . . . . 74.23 111.42 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -84.21 -9.91 58.14 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 112.972 0.731 . . . . 74.04 112.972 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.76 21.36 16.47 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 119.975 -1.107 . . . . 52.23 113.612 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.18 -49.7 9.19 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 122.255 -0.556 . . . . 44.13 110.78 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.523 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 62.4 m-85 -92.1 11.18 26.29 Favored 'General case' 0 C--O 1.193 -1.876 0 N-CA-C 113.333 0.864 . . . . 75.11 113.333 -175.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -12.35 59.96 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.391 0.885 . . . . 70.13 113.391 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -87.46 -10.05 52.92 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.648 -1.16 . . . . 64.11 111.779 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.7 tt -65.05 -26.24 68.17 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 122.505 0.322 . . . . 74.34 110.955 -173.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -60.86 -24.46 65.93 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.16 0.43 . . . . 72.1 112.16 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -105.16 13.65 30.35 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 112.108 0.41 . . . . 73.45 112.108 -178.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -70.17 126.46 29.75 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.414 0.626 . . . . 45.21 111.224 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -86.61 123.81 32.2 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.087 -0.96 . . . . 73.51 109.458 -177.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.468 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 39.7 p90 . . . . . 0 C--N 1.294 -1.827 0 CA-C-O 121.238 0.542 . . . . 62.03 111.833 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 110.145 -0.317 . . . . 63.22 110.145 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 125' ' ' TRP . . . -100.0 148.89 18.63 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.649 -0.786 . . . . 70.43 113.214 -176.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -107.04 135.2 49.0 Favored 'General case' 0 C--O 1.25 1.111 0 N-CA-C 106.679 -1.6 . . . . 71.24 106.679 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -126.67 107.8 10.51 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.933 -0.766 . . . . 43.43 108.933 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.3 mt -114.57 138.14 51.0 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.082 -1.081 . . . . 73.4 108.082 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 11.8 p -127.26 137.69 57.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.572 0.701 . . . . 73.11 111.715 -177.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.576 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 17.4 m-90 -118.49 157.18 27.74 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.833 -1.076 . . . . 73.34 109.622 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.12 121.35 40.33 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.884 -1.895 . . . . 60.22 105.884 170.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.4 t . . . . . 0 C--N 1.279 -2.483 0 CA-C-N 115.777 -0.647 . . . . 53.04 110.917 -174.6 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 41.2 p90 . . . . . 0 N--CA 1.416 -2.165 0 N-CA-C 108.757 -0.831 . . . . 74.42 108.757 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.558 ' HB3' ' HA ' ' A' ' 141' ' ' MET . 2.7 p-10 -124.37 146.38 48.89 Favored 'General case' 0 C--N 1.249 -3.774 0 N-CA-C 108.82 -0.808 . . . . 74.22 108.82 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -113.78 147.88 37.53 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 119.725 -0.79 . . . . 75.31 109.786 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -131.45 120.22 22.71 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.345 -0.843 . . . . 64.45 111.274 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -110.83 118.1 35.22 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 108.207 -1.035 . . . . 74.43 108.207 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -106.15 134.66 48.94 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.664 -0.648 . . . . 55.35 110.146 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -119.82 118.75 31.62 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.171 -0.922 . . . . 63.45 110.818 -174.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.33 145.37 26.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 106.331 -1.729 . . . . 45.3 106.331 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.519 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 0.4 OUTLIER -123.58 140.06 53.38 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 117.751 -1.58 . . . . 75.11 108.924 174.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -85.19 120.05 26.25 Favored 'General case' 0 N--CA 1.403 -2.811 0 N-CA-C 106.165 -1.791 . . . . 60.11 106.165 172.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.467 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 76.6 ttt180 -69.82 149.33 48.03 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.116 -1.438 . . . . 73.53 107.116 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.24 -20.35 58.53 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.697 0.76 . . . . 74.14 111.03 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.467 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 11.5 t70 -64.8 -18.13 64.83 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.507 1.123 . . . . 72.2 111.245 175.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.19 -21.28 33.72 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.192 -0.763 . . . . 55.11 111.192 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.0 m -78.2 171.33 15.2 Favored 'General case' 0 N--CA 1.419 -2.013 0 C-N-CA 123.562 0.745 . . . . 75.23 109.153 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.585 ' SG ' HG22 ' A' ' 21' ' ' VAL . 28.3 p -140.52 151.25 44.62 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 109.486 -0.561 . . . . 73.34 109.486 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.475 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 1.8 t90 -152.07 155.29 37.63 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.537 -1.283 . . . . 74.1 107.537 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.41 HD13 ' HB3' ' A' ' 52' ' ' HIS . 10.3 mp -68.82 123.87 22.14 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.349 0.595 . . . . 72.01 110.287 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -83.68 -50.6 8.02 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.135 -0.938 . . . . 74.41 108.563 -176.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 26.6 p -170.2 166.09 8.96 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 108.294 -1.002 . . . . 74.11 108.294 -177.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.2 t -143.52 143.37 24.45 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 N-CA-C 104.683 -2.34 . . . . 73.13 104.683 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -131.48 131.13 43.25 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 117.721 0.237 . . . . 74.4 110.866 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -118.17 130.54 56.16 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.147 -1.057 . . . . 64.53 108.147 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.5 pt -125.97 103.84 12.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-O 121.352 0.596 . . . . 75.21 111.438 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.558 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 52.8 mtt -95.85 94.85 7.88 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.064 -0.516 . . . . 55.24 109.611 -178.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.2 m -164.25 -46.38 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.018 -0.537 . . . . 62.52 110.672 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.9 tptm . . . . . 0 N--CA 1.475 0.787 0 C-N-CA 125.644 1.578 . . . . 53.21 113.363 -173.182 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.0 t70 . . . . . 0 N--CA 1.444 -0.759 0 CA-C-O 121.134 0.492 . . . . 73.31 110.758 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.76 -37.34 81.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.518 -0.765 . . . . 73.34 108.941 178.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -66.65 -53.45 33.83 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 115.199 -0.91 . . . . 63.15 109.931 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.8 p -66.32 -32.99 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 116.033 -0.53 . . . . 65.51 112.39 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -33.89 62.88 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 119.045 -1.062 . . . . 63.0 110.045 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.29 -41.36 68.7 Favored Glycine 0 CA--C 1.496 -1.1 0 N-CA-C 110.605 -0.998 . . . . 41.03 110.605 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.7 tp -65.15 -50.8 64.59 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 123.778 0.831 . . . . 71.2 109.698 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.33 -42.18 97.26 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.61 -0.723 . . . . 61.15 112.258 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -74.02 -32.52 63.4 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 120.159 -0.616 . . . . 75.53 111.559 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.86 -44.04 97.19 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.069 -0.715 . . . . 64.22 109.069 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 23.0 t80 -62.08 -53.73 51.3 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.08 -1.418 . . . . 70.5 110.31 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.6 mm -61.09 -40.53 86.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.606 0.595 . . . . 73.21 112.606 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.5 -40.49 85.19 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 120.521 -0.471 . . . . 60.13 110.136 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.686 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.8 pp -71.54 -27.51 63.24 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 118.801 -1.16 . . . . 71.54 112.054 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.5 t -71.07 -21.65 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 121.27 0.557 . . . . 72.0 109.527 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.0 p -115.09 22.31 13.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 122.115 -0.366 . . . . 50.21 111.915 -177.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.686 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 61.0 mmtt -49.82 133.71 21.59 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 113.544 0.942 . . . . 60.13 113.544 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.5 m -55.21 150.39 21.88 Favored Pre-proline 0 C--N 1.302 -1.496 0 C-N-CA 125.537 1.535 . . . . 74.42 110.487 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -59.18 -12.77 17.05 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.658 2.905 . . . . 60.11 112.857 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.52 -27.42 69.14 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.072 0.939 . . . . 63.25 109.1 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.4 p -109.99 99.17 8.32 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 106.354 -1.721 . . . . 71.34 106.354 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.8 p -49.61 -37.88 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 116.657 2.095 . . . . 71.12 116.657 -168.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -132.49 110.54 10.57 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 118.153 -1.419 . . . . 73.0 113.149 -174.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.8 m -65.89 -35.77 81.56 Favored 'General case' 0 C--O 1.256 1.412 0 CA-C-O 121.823 0.821 . . . . 61.44 110.331 -175.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.568 ' OE2' ' HA ' ' A' ' 78' ' ' LYS . 1.5 mp0 -66.6 -21.3 66.13 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.243 -0.889 . . . . 64.22 110.586 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -68.62 -42.23 78.39 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 108.533 -0.914 . . . . 74.03 108.533 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.469 ' HG3' ' HG3' ' A' ' 34' ' ' LYS . 13.2 mm-40 -69.76 -35.01 74.57 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 108.098 -1.075 . . . . 72.34 108.098 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.0 tp -66.97 -42.97 84.25 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.896 -0.593 . . . . 63.31 110.801 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.99 -34.39 76.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.624 0.726 . . . . 70.53 110.366 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -76.35 -32.72 58.82 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.197 -0.91 . . . . 64.14 109.98 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.487 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 59.9 t80 -67.28 -47.7 69.86 Favored 'General case' 0 C--O 1.215 -0.744 0 C-N-CA 123.48 0.712 . . . . 63.4 109.991 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.443 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.5 pp -75.03 -4.14 36.65 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.766 -0.652 . . . . 74.44 111.107 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.61 -61.13 5.36 Favored Glycine 0 CA--C 1.526 0.755 0 O-C-N 123.644 0.59 . . . . 72.03 112.371 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 48' ' ' PHE . 93.5 Cg_endo -85.18 -6.5 9.3 Favored 'Trans proline' 0 CA--C 1.549 1.264 0 C-N-CA 122.214 1.942 . . . . 74.33 112.672 173.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.451 ' HD2' ' O ' ' A' ' 48' ' ' PHE . 91.3 m-70 -111.41 31.35 6.18 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.726 -0.472 . . . . 72.45 109.726 -175.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.412 ' OD2' ' HB ' ' A' ' 65' ' ' THR . 13.4 t70 -54.68 107.82 0.97 Allowed Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 124.679 1.192 . . . . 75.52 112.505 -177.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -108.7 -154.45 0.02 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.294 0 C-N-CA 123.602 2.868 . . . . 74.22 110.485 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -93.63 120.13 33.52 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 107.195 -1.409 . . . . 55.21 107.195 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.446 HD13 ' CB ' ' A' ' 68' ' ' PHE . 64.7 mt -101.56 110.38 28.25 Favored 'Isoleucine or valine' 0 C--O 1.168 -3.19 0 N-CA-C 108.038 -1.097 . . . . 74.13 108.038 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -96.77 138.62 34.05 Favored 'General case' 0 C--N 1.271 -2.839 0 O-C-N 121.304 -0.873 . . . . 75.33 109.304 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.5 t -133.07 114.44 21.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 107.502 -1.296 . . . . 74.33 107.502 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 63.19 21.02 12.63 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 124.794 1.237 . . . . 63.32 111.073 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.92 -1.16 59.41 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.329 -0.851 . . . . 71.42 112.39 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -103.96 135.27 45.79 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.417 -0.586 . . . . 61.31 109.417 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -76.97 129.2 37.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.671 0.748 . . . . 62.34 109.265 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.456 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 57.4 mm-40 -126.21 147.55 49.64 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 124.642 1.177 . . . . 73.43 108.227 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 t -92.63 174.56 7.2 Favored 'General case' 0 C--O 1.254 1.341 0 N-CA-C 108.232 -1.025 . . . . 71.42 108.232 175.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.412 ' HB ' ' OD2' ' A' ' 53' ' ' ASP . 8.8 t -54.8 -36.17 64.65 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.028 0.531 . . . . 71.24 111.058 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 35.8 m -65.92 -46.42 78.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 122.729 0.412 . . . . 74.14 111.194 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -63.88 -46.19 86.01 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.91 -0.404 . . . . 62.0 109.91 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.446 ' CB ' HD13 ' A' ' 56' ' ' ILE . 48.9 t80 -54.28 -54.94 33.41 Favored 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 123.656 0.597 . . . . 74.22 109.723 174.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 2.2 tm? -50.39 -44.36 54.87 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 124.424 1.078 . . . . 61.23 110.54 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.431 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 26.8 mt-30 -56.91 -52.11 66.45 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 123.101 0.56 . . . . 73.24 111.929 174.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -64.87 -36.53 84.66 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.704 0.764 . . . . 73.21 109.817 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -57.7 -55.99 27.72 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 124.612 1.165 . . . . 71.35 110.472 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 48.9 ptt85 -68.87 -23.93 64.28 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.358 -0.383 . . . . 74.51 111.597 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 54.8 mt-30 -78.99 -15.31 58.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 120.432 -0.507 . . . . 74.02 111.459 176.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.47 14.33 30.41 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.677 -0.773 . . . . 54.24 114.622 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.16 -42.54 79.91 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.437 0.532 . . . . 74.12 112.437 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -92.48 6.89 45.42 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.587 0.588 . . . . 75.2 112.587 -173.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.568 ' HA ' ' OE2' ' A' ' 42' ' ' GLU . 99.4 mttt -67.06 -13.96 62.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.222 0.534 . . . . 75.22 112.233 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -77.57 -27.24 51.39 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.083 -0.71 . . . . 54.11 109.083 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.461 ' O ' HD23 ' A' ' 80' ' ' LEU . 7.1 tt -71.63 -17.51 62.26 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.077 0.951 . . . . 60.53 109.662 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -68.04 -22.04 64.97 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.105 -0.498 . . . . 75.1 109.879 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -101.13 4.76 42.4 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.379 -0.601 . . . . 73.14 109.379 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 105' ' ' SER . . . -75.73 143.17 42.2 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.525 0.935 . . . . 60.12 113.525 -173.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 103' ' ' TRP . 49.4 mt-10 -89.14 139.37 30.54 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.12 -0.945 . . . . 74.5 109.175 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.5 t80 . . . . . 0 N--CA 1.43 -1.469 0 N-CA-C 104.465 -2.42 . . . . 65.34 104.465 167.953 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 . . . . . 0 CA--C 1.508 -0.643 0 N-CA-C 113.508 0.929 . . . . 64.01 113.508 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.83 138.12 13.73 Favored Glycine 0 N--CA 1.406 -3.33 0 N-CA-C 107.556 -2.218 . . . . 33.33 107.556 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -111.14 127.0 55.43 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.583 -0.895 . . . . 71.41 108.583 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -123.2 98.63 5.96 Favored 'General case' 0 C--N 1.273 -2.736 0 N-CA-C 105.44 -2.059 . . . . 72.23 105.44 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 75.2 mt -109.75 138.84 45.53 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.034 -0.985 . . . . 53.53 108.897 -173.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 12.1 p -133.43 138.2 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-O 121.729 0.776 . . . . 72.33 111.839 -178.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.401 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 23.3 m-90 -113.77 143.71 44.19 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.392 -1.277 . . . . 74.11 107.661 176.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.425 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 21.8 mtpp -126.01 124.24 40.26 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.092 -1.447 . . . . 74.44 107.092 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 40.0 m . . . . . 0 C--N 1.281 -2.407 0 O-C-N 123.397 0.436 . . . . 52.41 111.012 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.428 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 10.2 p90 . . . . . 0 N--CA 1.439 -1.017 0 N-CA-C 108.918 -0.771 . . . . 73.13 108.918 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.437 ' CB ' ' HA ' ' A' ' 141' ' ' MET . 4.7 p-10 -113.01 134.65 54.41 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-O 121.199 0.523 . . . . 74.53 110.07 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.428 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 37.2 mt-10 -117.16 154.62 30.78 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.783 -1.099 . . . . 72.42 112.015 178.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.571 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -135.79 118.48 16.05 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.042 -0.981 . . . . 61.3 109.284 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 37.2 mt-10 -116.4 110.54 18.8 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.624 -0.51 . . . . 74.32 109.624 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.21 130.65 41.87 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 109.057 -0.72 . . . . 72.34 109.057 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -113.84 118.52 34.48 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.964 -0.754 . . . . 73.04 108.964 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.3 mt -118.95 152.69 21.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.388 -1.338 . . . . 74.51 107.388 178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -137.53 148.55 46.06 Favored 'General case' 0 C--O 1.275 2.417 0 C-N-CA 119.715 -0.794 . . . . 72.42 109.922 175.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -88.11 129.37 35.32 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.116 -0.947 . . . . 73.43 108.691 170.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.422 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 47.8 ttt180 -87.86 147.29 25.18 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-N 113.983 -1.462 . . . . 54.43 108.075 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -58.21 -28.27 64.66 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.855 0.462 . . . . 75.33 112.065 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.422 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 9.8 t70 -64.84 -16.87 63.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.148 -0.933 . . . . 74.52 111.702 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.6 6.8 56.24 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 119.849 -1.167 . . . . 63.11 111.283 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.404 ' OG ' ' HD3' ' A' ' 127' ' ' ARG . 0.4 OUTLIER -96.89 162.37 13.44 Favored 'General case' 0 N--CA 1.396 -3.151 0 N-CA-C 108.438 -0.949 . . . . 72.22 108.438 175.711 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 28.8 p -133.22 144.99 50.15 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 107.967 -1.123 . . . . 61.31 107.967 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.41 ' HE1' ' HA ' ' A' ' 52' ' ' HIS . 2.1 t90 -159.06 156.05 28.5 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 120.088 -0.645 . . . . 75.11 109.797 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.6 mp -69.23 127.01 31.54 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.268 0.556 . . . . 65.52 109.773 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -80.89 -56.12 4.34 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.806 -1.183 . . . . 75.43 107.806 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 10.9 m -166.5 162.27 16.67 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 105.931 -1.877 . . . . 65.3 105.931 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.7 m -137.55 149.84 25.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 106.394 -1.706 . . . . 74.23 106.394 171.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -134.4 130.71 37.26 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 117.686 0.221 . . . . 65.43 110.414 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -112.63 129.05 56.52 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 107.312 -1.366 . . . . 74.05 107.312 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 8.4 pt -129.0 98.3 4.08 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 CA-C-O 122.129 0.966 . . . . 60.32 109.048 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.437 ' HA ' ' CB ' ' A' ' 118' ' ' ASP . 23.3 ptp -92.83 138.31 31.6 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.013 -0.994 . . . . 72.24 110.205 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.5 t 81.26 29.02 0.17 Allowed 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.264 0.977 . . . . 72.42 109.812 176.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 80.4 tttt . . . . . 0 N--CA 1.439 -1.009 0 N-CA-C 106.282 -1.747 . . . . 75.1 106.282 173.557 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 9.6 m-20 . . . . . 0 CA--C 1.508 -0.664 0 CA-C-O 120.533 0.206 . . . . 71.13 111.21 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.4 -42.95 87.12 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.873 -0.788 . . . . 75.51 108.873 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.17 -48.81 78.4 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 115.86 -0.609 . . . . 73.34 111.411 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.0 p -69.38 -38.83 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 112.552 0.575 . . . . 64.41 112.552 -176.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 22.5 ptmt -75.76 -25.96 56.96 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 119.076 -1.05 . . . . 65.55 110.187 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.56 -57.74 5.82 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 120.64 -0.791 . . . . 71.11 111.262 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 pp -68.45 -35.91 78.26 Favored 'General case' 0 C--O 1.199 -1.559 0 N-CA-C 108.947 -0.76 . . . . 65.13 108.947 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.23 -43.67 96.69 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 116.231 -0.44 . . . . 70.34 112.036 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -63.83 -46.85 83.2 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.76 -0.459 . . . . 72.31 109.76 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -65.16 -41.27 94.85 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 116.051 -0.522 . . . . 71.24 110.247 -177.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -63.05 -53.59 51.39 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.418 -0.81 . . . . 74.42 110.481 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 29' ' ' ILE . 13.5 mm -64.23 -34.81 71.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.613 -0.267 . . . . 74.43 111.666 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -63.3 -48.59 77.43 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 116.34 -0.391 . . . . 72.24 110.144 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 pp -68.57 -29.35 67.88 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.288 -0.565 . . . . 62.51 111.84 -177.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.45 -28.54 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-O 121.471 0.653 . . . . 71.4 110.326 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.7 p -110.17 13.29 23.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.34 0.59 . . . . 34.34 110.566 -175.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 tptt -57.0 140.39 49.14 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.638 1.175 . . . . 74.31 111.928 -175.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.6 m -57.63 155.26 21.75 Favored Pre-proline 0 C--O 1.248 1.014 0 C-N-CA 124.183 0.993 . . . . 43.55 111.259 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.83 -5.99 5.39 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 124.82 3.68 . . . . 72.11 112.146 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -59.7 -26.42 65.59 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.463 -1.244 . . . . 64.44 110.589 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.2 p -92.43 167.72 11.78 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 107.358 -1.349 . . . . 72.43 107.358 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.62 -46.93 67.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 118.884 -1.126 . . . . 74.53 111.13 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -168.09 141.64 3.28 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.331 -0.989 . . . . 73.51 108.331 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.8 m -56.62 -41.29 76.84 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 123.186 0.594 . . . . 72.45 111.067 -177.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' HB2' ' CD2' ' A' ' 72' ' ' PHE . 6.9 mm-40 -67.83 -20.06 65.12 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.947 -1.024 . . . . 54.3 111.383 -176.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -69.99 -48.26 58.91 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 108.26 -1.015 . . . . 72.3 108.26 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -69.32 -32.07 70.96 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 114.2 -1.364 . . . . 74.52 108.518 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.4 tp -67.04 -45.06 78.6 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.526 -0.761 . . . . 73.14 110.117 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.85 -34.94 75.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.293 0.568 . . . . 50.1 110.214 177.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -69.14 -40.29 78.33 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.103 -0.953 . . . . 70.25 109.215 177.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -68.48 -42.58 78.47 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 123.498 0.719 . . . . 62.14 110.594 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.472 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 3.3 pp -84.41 0.66 48.64 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.877 -0.601 . . . . 63.12 110.964 -176.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.32 -61.59 7.05 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 111.303 -0.719 . . . . 63.1 111.303 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -77.2 -5.09 15.47 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.868 2.379 . . . . 75.11 112.034 175.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 62.9 m-70 -121.47 36.55 4.58 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.698 -0.482 . . . . 61.02 109.698 -174.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -55.7 106.56 0.69 Allowed Pre-proline 0 N--CA 1.48 1.051 0 O-C-N 124.706 1.254 . . . . 64.0 111.892 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -99.95 -177.37 0.19 Allowed 'Trans proline' 0 N--CA 1.422 -2.697 0 C-N-CA 122.661 2.241 . . . . 72.53 109.979 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -84.22 107.46 16.54 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 107.254 -1.388 . . . . 72.54 107.254 174.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.65 HD13 ' HB2' ' A' ' 68' ' ' PHE . 71.7 mt -92.41 105.95 17.27 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.161 0 N-CA-C 107.39 -1.337 . . . . 63.32 107.39 -175.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -98.9 105.9 18.09 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 122.029 -0.42 . . . . 72.12 111.312 -175.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 70.3 t -107.97 113.1 42.89 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.649 0 N-CA-C 108.02 -1.104 . . . . 73.01 108.02 -177.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 56.63 26.3 11.02 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 124.536 1.148 . . . . 71.43 111.034 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.75 14.3 61.42 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.438 -0.801 . . . . 75.54 112.614 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -112.3 130.35 55.97 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.519 -0.919 . . . . 63.12 108.519 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.88 125.97 38.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 121.833 0.825 . . . . 74.32 109.183 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.454 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 47.9 mm-40 -124.44 147.84 48.03 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.719 -1.215 . . . . 75.43 107.719 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.1 t -101.24 173.73 6.32 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.793 -1.188 . . . . 60.12 107.793 174.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -46.23 -39.88 10.55 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.809 1.244 . . . . 62.43 112.09 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.466 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 27.6 m -64.43 -52.74 56.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 122.651 0.38 . . . . 72.42 110.489 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -60.95 -45.82 93.2 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.036 -0.529 . . . . 64.31 110.809 -178.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.65 ' HB2' HD13 ' A' ' 56' ' ' ILE . 46.5 t80 -52.22 -56.4 14.89 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.232 0.539 . . . . 75.44 109.796 175.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -49.77 -43.3 48.09 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 114.194 -1.367 . . . . 64.12 111.12 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.492 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 15.7 mm100 -62.75 -46.68 86.94 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 122.892 0.477 . . . . 71.0 111.222 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.498 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 51.6 m-85 -66.45 -37.58 85.46 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.332 0.587 . . . . 75.23 109.664 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.444 ' CD2' ' HB2' ' A' ' 42' ' ' GLU . 3.9 t80 -57.19 -51.83 67.77 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.022 -0.536 . . . . 70.44 110.96 175.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 12.8 ptm180 -69.47 -23.33 63.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.334 0.588 . . . . 75.35 110.68 -176.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -81.01 -6.12 58.4 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.653 0.612 . . . . 72.05 112.653 175.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.8 17.37 30.67 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.175 -0.536 . . . . 24.11 114.032 175.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.45 -60.29 2.42 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 122.47 -0.429 . . . . 45.22 111.874 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.498 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 56.5 m-85 -83.31 -7.43 59.59 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 113.455 0.909 . . . . 70.33 113.455 -171.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -15.81 63.82 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.469 -0.892 . . . . 62.34 111.561 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -88.37 -17.01 31.46 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.123 0.487 . . . . 75.21 109.689 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 80' ' ' LEU . 3.3 tm? -84.59 -17.36 38.99 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 115.64 -0.709 . . . . 73.35 109.381 -174.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.47 3.27 13.83 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.721 0.772 . . . . 75.45 111.086 -176.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -104.64 2.93 31.08 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.422 -0.955 . . . . 64.14 108.422 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -74.56 153.13 39.17 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.126 -0.943 . . . . 61.12 113.248 -175.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -99.48 135.45 40.87 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.382 -1.281 . . . . 71.12 108.385 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 25.2 p90 . . . . . 0 C--N 1.307 -1.252 0 N-CA-C 109.506 -0.553 . . . . 75.41 109.506 177.188 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 CA--C 1.509 -0.627 0 CA-C-O 121.022 0.439 . . . . 62.04 111.265 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -138.74 156.41 24.21 Favored Glycine 0 N--CA 1.409 -3.116 0 C-N-CA 120.412 -0.899 . . . . 73.54 111.587 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -116.7 157.0 26.14 Favored 'General case' 0 C--O 1.261 1.671 0 N-CA-C 108.119 -1.067 . . . . 74.45 108.119 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -125.46 101.8 7.1 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 105.833 -1.914 . . . . 72.43 105.833 171.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.2 mt -99.16 112.43 24.58 Favored 'General case' 0 C--N 1.261 -3.253 0 N-CA-C 106.923 -1.51 . . . . 72.15 106.923 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 8.5 p -115.6 132.0 66.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.486 0.66 . . . . 75.44 112.035 -174.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.401 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 24.3 m-90 -106.34 140.86 38.6 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.051 -0.977 . . . . 75.42 109.245 176.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -118.63 121.24 39.71 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.063 -1.088 . . . . 74.12 108.063 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.461 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 45.1 t . . . . . 0 C--N 1.292 -1.931 0 CA-C-N 115.313 -0.858 . . . . 43.0 110.827 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.423 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 39.1 p90 . . . . . 0 N--CA 1.418 -2.069 0 N-CA-C 108.019 -1.104 . . . . 75.51 108.019 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.461 ' H ' ' HB3' ' A' ' 105' ' ' SER . 1.5 m-20 -106.55 134.19 50.06 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 105.57 -2.011 . . . . 72.22 105.57 176.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.434 ' HB2' HG13 ' A' ' 140' ' ' ILE . 34.9 mt-10 -114.87 154.12 29.23 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 119.482 -0.887 . . . . 75.44 111.727 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -139.32 116.85 11.36 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.878 -1.055 . . . . 53.22 108.999 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -111.98 109.66 19.54 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.058 -0.719 . . . . 71.53 109.058 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.54 118.25 33.62 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 121.136 0.493 . . . . 32.35 109.751 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -100.82 113.55 26.57 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.198 -1.408 . . . . 70.45 107.198 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 54.4 mt -118.31 143.62 28.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.42 -1.326 . . . . 63.31 107.42 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.25 147.57 51.1 Favored 'General case' 0 C--O 1.262 1.725 0 C-N-CA 119.098 -1.041 . . . . 61.22 110.752 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.577 ' HG2' ' SG ' ' A' ' 132' ' ' CYS . 29.1 mtp180 -89.91 116.86 28.29 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.073 -1.421 . . . . 73.22 109.17 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -80.96 145.21 31.35 Favored 'General case' 0 C--N 1.273 -2.725 0 CA-C-N 113.79 -1.55 . . . . 74.21 111.049 -170.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -72.59 -10.71 60.13 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 107.813 -1.18 . . . . 64.05 107.813 174.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.95 -17.72 64.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.006 -0.997 . . . . 72.0 109.589 173.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 101.89 -6.67 54.54 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.508 -0.637 . . . . 42.41 111.508 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.9 m -103.88 -179.62 4.0 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.141 -0.688 . . . . 65.52 109.141 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.577 ' SG ' ' HG2' ' A' ' 126' ' ' ARG . 74.0 m -131.49 142.14 49.91 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.611 -1.255 . . . . 73.53 107.611 175.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -149.78 154.89 39.19 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 119.718 -0.793 . . . . 74.52 109.879 -176.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.23 122.35 22.68 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.861 -0.792 . . . . 70.43 108.861 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -76.34 -52.8 9.2 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.209 -1.034 . . . . 74.3 108.209 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.7 m -167.88 154.53 7.86 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.479 -1.674 . . . . 64.45 106.479 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.39 139.41 41.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.469 -1.308 . . . . 62.44 107.469 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 33.9 ttmt -114.39 139.19 49.69 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 109.965 -0.383 . . . . 64.34 109.965 -175.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 66.2 m-85 -125.4 121.44 33.85 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.78 -1.192 . . . . 72.11 107.78 174.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.51 ' HB ' ' CD ' ' A' ' 143' ' ' LYS . 9.5 pt -128.83 97.61 3.75 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 CA-C-O 122.16 0.981 . . . . 73.13 109.109 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -87.95 137.04 32.68 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.925 -1.034 . . . . 72.22 111.33 -177.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.482 ' O ' ' HE3' ' A' ' 143' ' ' LYS . 41.4 t 71.27 49.19 0.33 Allowed 'General case' 0 C--N 1.321 -0.668 0 O-C-N 124.657 1.223 . . . . 75.41 111.403 175.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.51 ' CD ' ' HB ' ' A' ' 140' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.623 0 N-CA-C 108.422 -0.955 . . . . 72.3 108.422 175.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 t70 . . . . . 0 C--O 1.244 0.804 0 CA-C-O 121.94 0.876 . . . . 74.13 109.104 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -70.41 -39.49 74.43 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.864 -1.062 . . . . 74.13 108.901 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.57 -45.01 84.94 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.859 -0.61 . . . . 72.54 109.916 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.496 HG12 ' SG ' ' A' ' 132' ' ' CYS . 17.9 m -69.49 -37.89 75.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.167 -0.47 . . . . 43.32 112.015 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HB3' ' HZ3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -72.5 -33.5 66.99 Favored 'General case' 0 C--O 1.211 -0.954 0 C-N-CA 118.629 -1.228 . . . . 74.24 109.961 178.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.83 -41.93 61.96 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.241 -0.743 . . . . 72.22 111.241 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.0 tp -69.65 -50.4 44.55 Favored 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 124.047 0.939 . . . . 71.11 109.173 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.05 -42.22 99.72 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.967 -0.56 . . . . 43.12 111.872 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -65.32 -44.2 88.61 Favored 'General case' 0 C--O 1.187 -2.218 0 CA-C-O 118.791 -0.623 . . . . 72.13 110.872 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.02 -38.63 91.95 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.116 0.96 . . . . 63.51 110.252 -174.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.572 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 24.1 t80 -64.45 -55.18 22.52 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.698 -1.592 . . . . 75.02 110.081 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 29' ' ' ILE . 16.0 mm -67.03 -30.56 49.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.074 -0.512 . . . . 71.42 111.007 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.34 -48.44 77.96 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.596 0.758 . . . . 73.14 110.142 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.4 pp -69.14 -28.49 66.49 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 119.944 -0.702 . . . . 64.41 110.048 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 68.8 t -73.21 -22.19 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 CA-C-O 121.219 0.533 . . . . 71.44 110.929 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.4 p -107.5 15.69 24.57 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.415 -0.803 . . . . 74.44 111.858 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.525 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 32.4 mmmt -57.05 162.22 2.64 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 113.543 0.942 . . . . 74.14 113.543 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.442 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 12.2 p -70.33 169.54 13.35 Favored Pre-proline 0 N--CA 1.435 -1.197 0 C-N-CA 125.469 1.508 . . . . 64.21 111.8 -177.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 35' ' ' SER . 19.0 Cg_endo -64.42 -7.46 14.27 Favored 'Trans proline' 0 C--N 1.363 1.317 0 C-N-CA 123.09 2.527 . . . . 75.34 112.09 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -73.92 -27.32 60.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.662 -0.699 . . . . 64.52 109.886 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.6 m -82.73 113.08 20.15 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.62 -0.718 . . . . 74.52 109.312 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.1 -32.91 56.04 Favored 'Isoleucine or valine' 0 C--O 1.25 1.124 0 N-CA-C 113.331 0.863 . . . . 71.14 113.331 -174.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -151.06 94.04 2.0 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.428 -0.909 . . . . 74.21 109.921 -174.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.3 m -67.35 -30.17 69.91 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.699 0.762 . . . . 54.23 109.766 -175.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' ' 42' ' ' GLU . 1.4 pm0 -71.84 -20.03 61.88 Favored 'General case' 0 N--CA 1.414 -2.269 0 CA-C-N 115.15 -0.932 . . . . 75.15 112.008 177.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -69.76 -45.37 68.21 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.692 -1.225 . . . . 73.44 107.692 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.13 -26.82 65.08 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.004 -0.998 . . . . 65.25 110.177 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.559 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 51.2 tp -70.18 -47.09 63.09 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.554 -0.748 . . . . 73.22 109.636 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.48 -27.01 68.99 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 121.528 0.68 . . . . 61.13 110.083 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -73.95 -38.8 64.13 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.878 -1.055 . . . . 72.4 109.64 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -70.11 -51.64 29.98 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.562 -0.745 . . . . 54.24 110.419 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 4.0 pp -82.12 -8.03 59.64 Favored 'General case' 0 C--O 1.196 -1.754 0 CA-C-N 115.382 -0.826 . . . . 72.25 111.824 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -43.64 -60.19 3.4 Favored Glycine 0 N--CA 1.477 1.374 0 O-C-N 123.672 0.607 . . . . 71.23 114.264 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.11 -6.3 16.49 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.506 2.137 . . . . 73.4 112.04 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -110.42 19.78 18.43 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.008 -0.738 . . . . 73.33 109.008 -175.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.663 ' CG ' ' HB ' ' A' ' 65' ' ' THR . 27.2 t70 -56.7 109.94 2.04 Favored Pre-proline 0 C--O 1.245 0.857 0 C-N-CA 125.163 1.385 . . . . 71.04 113.744 -176.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 17.3 Cg_endo -106.54 -152.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.637 0 C-N-CA 123.929 3.086 . . . . 63.11 110.502 178.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -81.99 124.03 29.41 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.551 -0.907 . . . . 72.53 108.551 176.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.51 HD13 ' CB ' ' A' ' 68' ' ' PHE . 39.7 mt -108.22 109.2 27.38 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.396 0 N-CA-C 107.219 -1.4 . . . . 60.42 107.219 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -96.07 138.88 33.05 Favored 'General case' 0 C--N 1.263 -3.182 0 O-C-N 121.601 -0.687 . . . . 75.41 109.678 -177.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 3.6 p -133.29 122.76 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 N-CA-C 107.298 -1.371 . . . . 71.03 107.298 174.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 62.69 20.72 12.27 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.612 0.72 . . . . 74.24 110.865 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.59 7.38 64.98 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.652 -0.704 . . . . 64.02 112.572 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -113.78 135.52 53.86 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.908 -0.405 . . . . 54.03 109.908 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.53 126.52 37.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-O 121.708 0.766 . . . . 73.54 110.187 -175.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.448 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 51.9 mm-40 -122.68 148.19 45.58 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.46 -0.941 . . . . 73.13 108.46 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.2 t -100.43 175.71 5.6 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.953 -1.128 . . . . 53.02 107.953 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.663 ' HB ' ' CG ' ' A' ' 53' ' ' ASP . 9.3 t -52.17 -34.05 43.33 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 123.28 0.632 . . . . 72.14 112.261 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 m -59.41 -54.15 49.95 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-O 121.123 0.487 . . . . 71.42 109.946 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -65.45 -47.51 75.91 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-N 115.005 -0.998 . . . . 51.15 110.967 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.51 ' CB ' HD13 ' A' ' 56' ' ' ILE . 51.0 t80 -54.46 -54.29 42.83 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.661 0.384 . . . . 73.44 111.169 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 2.8 tm? -54.16 -42.49 69.67 Favored 'General case' 0 C--O 1.244 0.801 0 O-C-N 124.206 0.941 . . . . 71.51 110.384 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.422 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 73.3 mt-30 -57.93 -53.61 56.3 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 116.552 -0.294 . . . . 65.52 111.115 174.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.499 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 28.5 m-85 -63.05 -32.54 73.93 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.657 0.742 . . . . 75.04 110.723 -176.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -61.64 -55.27 32.42 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.204 -0.907 . . . . 73.32 110.354 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 12.4 ptp180 -70.64 -22.52 62.5 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 120.798 0.332 . . . . 73.34 111.391 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 54.4 mt-30 -71.39 -20.12 62.18 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.161 -0.472 . . . . 53.4 110.807 174.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.62 24.96 12.56 Favored Glycine 0 N--CA 1.415 -2.758 0 C-N-CA 120.103 -1.046 . . . . 60.25 113.278 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.6 mt -88.44 -46.75 8.88 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.692 -0.803 . . . . 74.33 110.593 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 22.1 m-85 -89.87 10.86 22.14 Favored 'General case' 0 C--O 1.21 -0.99 0 O-C-N 121.913 -0.492 . . . . 64.55 112.258 -177.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -71.67 -11.71 60.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.754 1.02 . . . . 71.21 113.754 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -82.47 -10.17 59.13 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 122.056 -0.403 . . . . 71.34 111.012 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 80' ' ' LEU . 3.3 tm? -59.32 -29.59 67.74 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.515 0.509 . . . . 71.22 110.602 -174.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.479 ' C ' ' HD3' ' A' ' 81' ' ' LYS . 12.1 tmtt? -58.97 -41.72 88.2 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.442 -0.345 . . . . 71.34 111.445 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -98.68 13.15 33.16 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 120.802 0.334 . . . . 52.32 111.856 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 105' ' ' SER . . . -81.02 131.66 35.32 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.101 -1.074 . . . . 63.34 108.101 175.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -104.12 130.72 51.84 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.593 -0.443 . . . . 72.42 110.305 -174.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 103' ' ' TRP . 50.8 p90 . . . . . 0 N--CA 1.439 -1.009 0 CA-C-O 121.619 0.724 . . . . 63.41 112.028 -177.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 . . . . . 0 C--O 1.249 1.061 0 N-CA-C 108.509 -0.923 . . . . 64.13 108.509 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -149.22 141.08 8.6 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.468 -1.053 . . . . 54.12 110.468 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -121.03 136.52 54.97 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.3 -0.63 . . . . 75.31 109.3 -177.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -124.97 107.55 10.96 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.869 0.731 . . . . 74.45 109.155 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -106.48 117.14 33.28 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.713 -1.217 . . . . 73.4 107.713 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 8.2 p -120.35 125.07 73.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 122.037 0.923 . . . . 64.03 112.522 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 25.8 m-90 -105.73 147.23 28.8 Favored 'General case' 0 CA--C 1.472 -2.034 0 CA-C-N 114.613 -1.176 . . . . 75.12 109.356 178.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -121.64 123.66 42.45 Favored 'General case' 0 N--CA 1.403 -2.82 0 N-CA-C 105.713 -1.958 . . . . 74.32 105.713 172.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 39.2 m . . . . . 0 C--N 1.292 -1.896 0 CA-C-N 115.897 -0.592 . . . . 50.03 110.082 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 16.4 p90 . . . . . 0 N--CA 1.434 -1.242 0 N-CA-C 106.978 -1.49 . . . . 73.42 106.978 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -107.71 141.28 39.48 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 106.384 -1.71 . . . . 61.42 106.384 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.439 ' HB2' HG13 ' A' ' 140' ' ' ILE . 93.3 mt-10 -114.97 144.55 43.41 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 119.784 -0.766 . . . . 74.31 110.485 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -133.76 117.26 16.71 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.537 -0.756 . . . . 73.12 109.109 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -115.9 110.3 18.81 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 109.281 -0.637 . . . . 62.25 109.281 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.12 125.5 46.24 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.377 -0.601 . . . . 61.23 109.377 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -111.45 121.08 44.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.75 -0.833 . . . . 74.42 108.75 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.2 mt -120.42 153.32 23.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 108.537 -0.912 . . . . 72.41 108.537 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -141.25 152.12 44.28 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 108.553 -0.906 . . . . 74.14 108.553 174.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -80.8 115.29 20.22 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.605 -0.887 . . . . 74.1 108.605 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -79.05 140.87 37.81 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.803 -1.925 . . . . 74.52 105.803 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -64.83 -14.71 60.23 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.327 0.584 . . . . 73.11 111.874 -170.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.8 -16.46 63.1 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 124.557 1.143 . . . . 72.33 111.314 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.67 -8.86 43.87 Favored Glycine 0 CA--C 1.5 -0.851 0 C-N-CA 121.073 -0.584 . . . . 63.4 111.805 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.9 t -104.7 130.14 52.79 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 106.547 -1.649 . . . . 71.14 106.547 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.496 ' SG ' HG12 ' A' ' 21' ' ' VAL . 12.0 t -83.79 134.81 34.71 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.522 -1.288 . . . . 73.33 107.522 177.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -133.12 154.53 50.51 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.093 -0.706 . . . . 73.22 109.093 -173.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.0 mp -75.14 128.82 36.38 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 120.875 0.369 . . . . 74.11 110.472 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -72.46 -56.39 5.48 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.068 -1.086 . . . . 73.21 108.068 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.7 m -172.62 157.73 3.93 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.799 -1.556 . . . . 64.23 106.799 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.7 m -131.73 149.3 32.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 107.543 -1.281 . . . . 54.34 107.543 172.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -131.61 131.96 43.66 Favored 'General case' 0 C--N 1.266 -3.046 0 C-N-CA 123.107 0.563 . . . . 74.41 110.121 -172.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 72.8 m-85 -121.93 129.02 52.18 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.348 -0.982 . . . . 74.1 108.348 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.439 HG13 ' HB2' ' A' ' 119' ' ' GLU . 6.0 pt -131.74 99.12 3.59 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-O 122.162 0.982 . . . . 63.23 109.142 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 58.4 mtm -85.44 133.64 34.1 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.653 -1.158 . . . . 73.42 110.836 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . 0.267 51.3 p 62.61 73.15 0.47 Allowed 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 125.953 1.701 . . . . 74.44 113.222 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 47.1 tttm . . . . . 0 N--CA 1.423 -1.801 0 CA-C-N 114.433 -1.258 . . . . 73.11 108.106 177.333 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 120.907 0.384 . . . . 70.14 111.827 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.51 -38.21 77.49 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.241 -0.652 . . . . 74.14 109.241 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.96 -45.51 74.02 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.715 -0.675 . . . . 74.41 110.214 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.52 ' HB ' ' SG ' ' A' ' 132' ' ' CYS . 14.6 p -65.84 -42.74 92.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 112.25 0.463 . . . . 75.44 112.25 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 -28.61 60.73 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 118.673 -1.211 . . . . 61.12 110.772 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.24 -44.84 63.92 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.415 -0.811 . . . . 54.22 111.874 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.46 -34.85 70.58 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 108.905 -0.776 . . . . 71.24 108.905 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.98 -40.94 99.92 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 111.244 -0.742 . . . . 51.23 111.244 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -69.62 -44.98 69.57 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 120.991 -0.284 . . . . 71.53 110.259 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.42 -42.6 99.0 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.687 0.395 . . . . 73.04 110.539 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.434 ' CE1' HD11 ' A' ' 45' ' ' LEU . 18.0 t80 -62.46 -54.59 37.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.238 -0.892 . . . . 73.54 110.016 177.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.3 mm -63.31 -35.78 73.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 112.149 0.426 . . . . 73.14 112.149 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -62.85 -48.95 76.81 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 119.409 -0.329 . . . . 34.22 110.568 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 pp -67.6 -30.79 70.48 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.348 -0.541 . . . . 71.41 111.315 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.34 -24.01 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-O 121.484 0.659 . . . . 61.43 110.912 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.5 p -115.5 14.22 16.59 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 121.504 -0.748 . . . . 64.02 110.59 -176.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -81.54 145.3 30.75 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.762 -0.654 . . . . 71.41 111.861 -173.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.5 m -51.2 160.36 0.91 Allowed Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 126.421 1.889 . . . . 61.32 113.113 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.06 -6.83 6.88 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 124.289 3.326 . . . . 65.31 112.897 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -61.46 -27.03 68.28 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.277 -1.009 . . . . 72.14 108.277 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.4 m -96.7 123.31 40.34 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 103.778 -2.675 . . . . 73.45 103.778 168.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.7 t -49.92 -53.07 11.75 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 113.301 0.852 . . . . 71.21 113.301 -170.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 43' ' ' HIS . 50.3 t-20 -147.64 127.82 13.81 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.29 -1.004 . . . . 64.3 108.29 -176.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.3 m -59.47 -36.51 76.13 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.602 0.564 . . . . 64.42 109.848 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -73.83 -21.17 60.22 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.153 -0.93 . . . . 72.31 110.268 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 40' ' ' ASN . 10.0 t60 -76.77 -43.33 37.37 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.483 -1.303 . . . . 64.33 107.483 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -63.07 -35.34 79.91 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.597 -0.89 . . . . 75.43 108.597 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.434 HD11 ' CE1' ' A' ' 28' ' ' PHE . 35.2 tp -68.2 -44.34 76.04 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.639 -0.71 . . . . 75.42 110.097 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.83 -31.5 71.75 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.355 0.598 . . . . 64.32 110.529 177.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -71.72 -40.52 69.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.909 -1.041 . . . . 72.53 109.627 177.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -69.3 -44.32 72.0 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.028 -0.533 . . . . 74.15 110.511 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.1 pp -80.75 -2.03 45.3 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.95 -0.568 . . . . 53.32 111.052 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.26 -60.47 6.69 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 119.926 -0.374 . . . . 74.24 112.906 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.51 -6.4 12.67 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.114 1.876 . . . . 74.4 111.904 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -118.52 38.26 3.8 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.773 -0.454 . . . . 72.32 109.773 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -55.78 105.89 0.59 Allowed Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 124.627 1.171 . . . . 73.41 112.815 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -98.89 -168.93 0.1 Allowed 'Trans proline' 0 N--CA 1.43 -2.216 0 C-N-CA 122.825 2.35 . . . . 73.45 111.177 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -91.66 104.74 17.17 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.782 -1.192 . . . . 74.33 107.782 176.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.504 HD13 ' HB2' ' A' ' 68' ' ' PHE . 67.6 mt -89.65 106.85 17.49 Favored 'Isoleucine or valine' 0 C--O 1.18 -2.59 0 CA-C-N 115.391 -0.822 . . . . 72.42 109.054 -175.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -96.23 107.68 20.05 Favored 'General case' 0 C--N 1.276 -2.608 0 O-C-N 121.55 -0.719 . . . . 71.22 111.815 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 139' ' ' PHE . 70.0 t -108.3 111.59 36.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 108.398 -0.964 . . . . 73.32 108.398 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 63.25 21.15 12.68 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.624 -1.171 . . . . 71.33 110.329 -177.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.49 -5.45 62.54 Favored Glycine 0 N--CA 1.437 -1.237 0 CA-C-N 114.87 -1.059 . . . . 64.43 111.967 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -95.7 125.68 40.45 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 109.592 -0.521 . . . . 75.13 109.592 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.2 127.21 35.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.643 0.735 . . . . 64.44 109.54 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.432 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 48.3 mm-40 -128.41 150.94 49.9 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.949 -1.13 . . . . 73.14 107.949 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -101.57 172.9 6.68 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.283 -1.006 . . . . 73.54 108.283 172.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -45.53 -40.46 8.62 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 125.179 1.392 . . . . 51.02 112.231 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.6 m -65.4 -44.67 86.71 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.124 0.487 . . . . 53.25 111.358 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -67.64 -44.94 76.73 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.697 -0.483 . . . . 71.1 109.697 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.504 ' HB2' HD13 ' A' ' 56' ' ' ILE . 48.3 t80 -53.62 -56.2 19.3 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.206 0.602 . . . . 73.2 109.863 175.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -49.95 -43.8 50.21 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.276 -1.329 . . . . 71.53 110.765 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -60.22 -47.5 85.69 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 111.9 0.333 . . . . 70.24 111.9 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.474 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 33.7 m-85 -66.94 -36.37 82.08 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.514 0.674 . . . . 65.2 110.008 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -57.85 -54.8 42.87 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.543 -0.753 . . . . 72.51 110.637 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -66.83 -29.67 69.66 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.519 -0.31 . . . . 75.52 110.69 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -73.67 -15.35 61.24 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 112.273 0.472 . . . . 44.42 112.273 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.48 13.78 25.42 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 119.931 -1.128 . . . . 54.22 114.544 175.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.38 -56.56 4.89 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.183 0.516 . . . . 71.41 110.96 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.474 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 43.1 m-85 -83.52 -5.31 59.13 Favored 'General case' 0 C--O 1.21 -0.995 0 N-CA-C 112.911 0.708 . . . . 73.23 112.911 -172.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -14.19 61.8 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.095 -1.042 . . . . 63.43 111.795 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -85.33 -16.59 39.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.169 0.509 . . . . 62.35 110.377 175.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 80' ' ' LEU . 3.2 tm? -89.32 -15.73 32.74 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 108.109 -1.071 . . . . 73.11 108.109 -178.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.502 ' C ' ' HD3' ' A' ' 81' ' ' LYS . 11.2 tmtt? -52.18 -41.74 62.89 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.969 0.908 . . . . 64.31 111.963 -177.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -88.46 14.61 9.36 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.561 0.696 . . . . 74.35 111.686 -174.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.52 150.92 47.57 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.989 0.737 . . . . 64.24 112.989 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -106.26 136.14 46.51 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.524 -1.287 . . . . 64.54 107.524 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.645 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 53.0 p90 . . . . . 0 C--N 1.315 -0.925 0 N-CA-C 113.545 0.943 . . . . 61.12 113.545 -175.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 C--O 1.247 0.95 0 N-CA-C 109.753 -0.462 . . . . 72.34 109.753 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -116.7 139.56 15.27 Favored Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 109.456 -1.458 . . . . 73.4 109.456 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -106.34 150.43 25.99 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.2 -1.778 . . . . 73.22 106.2 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.476 ' HE2' ' CE2' ' A' ' 123' ' ' TYR . 35.9 ttmt -136.23 129.79 32.11 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.465 -0.568 . . . . 74.11 109.465 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.5 mt -126.79 127.1 44.49 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.259 -1.386 . . . . 61.04 107.259 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.5 p -125.64 127.03 71.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 113.302 0.852 . . . . 62.51 113.302 -174.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.645 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 20.4 m-90 -104.16 151.03 23.81 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.642 -1.163 . . . . 75.43 108.523 178.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -135.79 133.54 38.01 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.908 -2.256 . . . . 75.43 104.908 176.175 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.7 p . . . . . 0 C--N 1.306 -1.317 0 CA-C-N 118.09 0.405 . . . . 73.31 110.346 179.016 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 6.4 p90 . . . . . 0 N--CA 1.442 -0.863 0 N-CA-C 108.223 -1.029 . . . . 73.31 108.223 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -113.14 137.61 51.18 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.153 -1.795 . . . . 75.52 106.153 176.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -115.01 151.92 33.35 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 119.947 -0.701 . . . . 74.23 111.71 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -139.6 117.49 11.7 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.03 -0.986 . . . . 75.44 108.52 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -123.98 112.35 17.08 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.572 0.701 . . . . 75.42 110.324 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -93.78 133.38 37.22 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.372 -0.831 . . . . 75.44 109.925 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.476 ' CE2' ' HE2' ' A' ' 100' ' ' LYS . 35.9 m-85 -115.9 122.82 46.46 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 124.153 0.908 . . . . 64.32 108.617 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.408 HG12 ' HG ' ' A' ' 134' ' ' LEU . 62.5 mt -120.84 141.59 40.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.281 -1.748 . . . . 73.55 106.281 176.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -130.17 150.8 51.26 Favored 'General case' 0 C--O 1.268 2.045 0 C-N-CA 117.417 -1.713 . . . . 71.41 112.853 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.431 ' HD3' ' SG ' ' A' ' 132' ' ' CYS . 4.6 tpp180 -75.28 104.67 5.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 104.633 -2.358 . . . . 74.33 104.633 174.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 131' ' ' SER . 57.0 ttt180 -85.45 139.73 31.28 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.417 -0.81 . . . . 63.45 110.69 -168.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -59.77 -10.41 3.78 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.961 1.304 . . . . 70.31 112.641 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.445 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 10.3 t70 -78.41 -16.39 57.67 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 123.882 0.873 . . . . 74.13 110.604 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.06 -5.85 50.44 Favored Glycine 0 C--O 1.24 0.525 0 N-CA-C 111.042 -0.823 . . . . 63.22 111.042 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 127' ' ' ARG . 12.0 p -103.86 169.85 8.27 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 109.66 -0.496 . . . . 74.43 109.66 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.52 ' SG ' ' HB ' ' A' ' 21' ' ' VAL . 68.8 m -121.67 125.27 46.27 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 106.891 -1.522 . . . . 64.32 106.891 174.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -140.82 155.39 46.38 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.516 -0.873 . . . . 71.1 109.533 -169.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.408 ' HG ' HG12 ' A' ' 124' ' ' ILE . 9.0 mp -67.55 125.95 27.79 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 109.093 -0.706 . . . . 73.11 109.093 176.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -83.34 -53.65 5.58 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 108.897 -0.779 . . . . 74.4 108.897 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.0 m -166.71 161.45 15.64 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.874 -1.528 . . . . 73.23 106.874 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.1 m -141.28 139.59 32.68 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 105.751 -1.944 . . . . 54.22 105.751 172.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 32.4 ttmt -115.15 132.12 56.71 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 110.196 -0.298 . . . . 74.04 110.196 -176.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.455 ' HB2' HG22 ' A' ' 58' ' ' VAL . 64.7 m-85 -118.53 122.42 42.63 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 107.517 -1.29 . . . . 73.23 107.517 175.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.446 ' HB ' ' HD3' ' A' ' 143' ' ' LYS . 9.3 pt -126.24 98.57 4.98 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.551 0 CA-C-O 122.079 0.943 . . . . 75.15 109.112 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.4 mtm -85.89 127.47 34.6 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.293 -1.321 . . . . 71.42 111.213 -174.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 70.7 m 71.64 75.43 0.17 Allowed 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 113.794 -1.548 . . . . 74.2 114.145 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.446 ' HD3' ' HB ' ' A' ' 140' ' ' ILE . 1.5 mptm? . . . . . 0 C--N 1.301 -1.515 0 CA-C-N 114.249 -1.341 . . . . 72.51 107.547 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.53 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 8.4 m-20 . . . . . 0 CA--C 1.518 -0.282 0 CA-C-O 121.131 0.491 . . . . 75.13 111.901 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.38 -40.61 73.86 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.934 -1.136 . . . . 64.52 107.934 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -61.66 -51.63 67.63 Favored 'General case' 0 CA--C 1.496 -1.132 0 C-N-CA 124.159 0.984 . . . . 74.52 109.982 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 18' ' ' ASP . 7.3 p -64.88 -42.74 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.358 -0.837 . . . . 64.24 112.893 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 17.3 ptpt -74.48 -24.73 59.06 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 118.622 -1.231 . . . . 71.35 111.745 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.47 -54.45 12.89 Favored Glycine 0 N--CA 1.428 -1.867 0 C-N-CA 120.633 -0.794 . . . . 62.05 111.166 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.79 -36.04 72.84 Favored 'General case' 0 C--O 1.213 -0.864 0 N-CA-C 109.159 -0.682 . . . . 52.54 109.159 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.52 -43.08 98.63 Favored Glycine 0 C--O 1.254 1.359 0 CA-C-N 116.213 -0.448 . . . . 61.54 112.57 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -73.32 -39.5 65.23 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 119.56 -0.856 . . . . 74.31 109.8 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.51 -39.32 94.11 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.028 0.442 . . . . 75.12 110.334 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.413 ' CE2' HD11 ' A' ' 45' ' ' LEU . 31.7 t80 -61.31 -53.17 60.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.293 -0.867 . . . . 70.05 109.623 176.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.7 mm -64.43 -33.76 64.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 112.202 0.445 . . . . 63.44 112.202 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.86 -52.12 66.4 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 122.588 0.355 . . . . 54.42 110.614 175.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.81 -26.32 64.2 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 120.347 -0.541 . . . . 71.41 111.538 -176.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.7 t -70.75 -26.08 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 CA-C-O 120.983 0.421 . . . . 71.5 110.698 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.4 p -109.75 14.99 23.05 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.855 0.836 . . . . 71.02 109.895 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -62.29 147.95 46.52 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 114.306 -1.316 . . . . 62.44 111.203 -176.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.7 p -54.64 158.35 4.38 Favored Pre-proline 0 C--N 1.313 -0.983 0 C-N-CA 125.196 1.398 . . . . 75.42 113.282 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.38 -7.01 18.95 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.917 2.411 . . . . 73.3 111.13 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.33 -27.67 67.54 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.317 -0.856 . . . . 71.25 109.777 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 p -100.78 143.39 31.0 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.536 -1.283 . . . . 74.11 107.536 173.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.9 p -51.32 -52.58 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.887 1.069 . . . . 71.42 113.887 -173.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -150.82 136.73 18.25 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 122.381 0.272 . . . . 62.12 110.454 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.419 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 19.6 m -67.98 -33.66 75.06 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 122.337 1.065 . . . . 72.43 108.778 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -70.06 -20.32 63.23 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.427 -1.26 . . . . 53.31 111.408 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -69.95 -46.75 64.61 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 107.646 -1.242 . . . . 72.03 107.646 177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.29 -34.15 77.35 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.818 -1.083 . . . . 74.23 109.076 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.413 HD11 ' CE2' ' A' ' 28' ' ' PHE . 44.1 tp -66.28 -41.73 89.44 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.808 -0.633 . . . . 63.3 110.651 177.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.53 -35.9 80.9 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.326 0.584 . . . . 51.32 110.437 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -72.99 -35.94 66.97 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.939 -1.028 . . . . 72.43 110.157 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -68.5 -43.03 77.71 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 116.045 -0.525 . . . . 75.24 109.846 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.2 pp -77.79 -2.11 34.78 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.942 -0.572 . . . . 63.03 111.281 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.71 -63.84 2.35 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 123.746 0.654 . . . . 70.32 112.766 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -82.73 -8.56 11.25 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.849 1.699 . . . . 75.13 111.935 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 45.8 m-70 -100.45 27.94 5.4 Favored 'General case' 0 C--O 1.213 -0.863 0 N-CA-C 109.014 -0.736 . . . . 73.34 109.014 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.473 ' HA ' HG21 ' A' ' 65' ' ' THR . 10.2 t70 -52.44 100.77 0.24 Allowed Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 127.844 2.457 . . . . 61.15 111.661 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -114.17 -154.91 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 124.22 3.28 . . . . 73.44 112.131 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -94.06 123.74 37.63 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.149 -1.056 . . . . 73.22 108.149 176.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 65' ' ' THR . 74.3 mt -109.46 112.97 42.82 Favored 'Isoleucine or valine' 0 C--O 1.177 -2.711 0 N-CA-C 108.734 -0.839 . . . . 71.45 108.734 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.54 138.52 33.1 Favored 'General case' 0 C--N 1.269 -2.924 0 N-CA-C 108.825 -0.805 . . . . 72.11 108.825 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.4 t -132.58 112.69 19.4 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 107.906 -1.146 . . . . 72.52 107.906 176.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 63.7 20.39 12.2 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.914 1.285 . . . . 73.45 111.068 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.11 2.25 58.13 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.748 -0.66 . . . . 25.04 112.222 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -108.17 132.76 53.29 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.896 -0.779 . . . . 73.5 108.896 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.401 HD13 ' N ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -78.77 127.9 38.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 121.699 0.761 . . . . 71.22 109.658 -175.354 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.401 ' N ' HD13 ' A' ' 62' ' ' ILE . 50.3 mm-40 -126.81 149.19 49.81 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.388 -1.338 . . . . 71.4 107.388 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.1 t -87.38 173.52 9.09 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.313 -0.625 . . . . 64.14 109.313 174.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.49 ' HA ' HD12 ' A' ' 56' ' ' ILE . 18.5 p -61.4 -38.31 86.63 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 125.361 1.464 . . . . 72.31 110.543 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 m -59.62 -46.65 88.36 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.518 -1.219 . . . . 53.43 110.584 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.24 -47.26 83.17 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.066 0.546 . . . . 73.12 109.994 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.476 ' CB ' HD13 ' A' ' 56' ' ' ILE . 38.4 t80 -51.24 -55.95 15.43 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 123.759 0.662 . . . . 70.54 110.371 174.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -51.07 -45.34 61.37 Favored 'General case' 0 C--O 1.245 0.834 0 O-C-N 124.315 1.01 . . . . 74.04 110.826 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 46.7 mt-30 -58.75 -50.9 72.21 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 116.133 -0.485 . . . . 71.14 111.861 175.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.477 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 38.4 m-85 -65.76 -35.53 80.98 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.495 0.664 . . . . 73.44 109.989 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -57.23 -53.34 59.24 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.55 -0.75 . . . . 71.32 110.748 176.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -72.13 -22.0 61.39 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 120.832 0.348 . . . . 72.34 111.293 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 16.5 mm100 -76.29 -11.21 59.87 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 116.226 -0.443 . . . . 63.21 112.133 174.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.21 27.23 11.07 Favored Glycine 0 N--CA 1.428 -1.837 0 C-N-CA 120.209 -0.996 . . . . 65.14 113.081 177.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.402 HD23 ' HB2' ' A' ' 74' ' ' GLN . 3.8 mm? -85.67 -53.02 5.41 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.108 0.48 . . . . 74.3 110.654 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 35.1 m-85 -91.72 6.51 45.64 Favored 'General case' 0 C--O 1.208 -1.086 0 N-CA-C 113.167 0.803 . . . . 74.23 113.167 -173.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -11.97 30.04 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.262 0.838 . . . . 72.51 113.262 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -75.48 -11.28 60.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.081 -0.509 . . . . 65.42 111.232 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 tt -69.63 -25.6 64.02 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.585 0.707 . . . . 72.24 109.296 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.419 ' HG2' ' H ' ' A' ' 41' ' ' SER . 4.2 tmtp? -62.71 -32.84 74.02 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 124.559 1.143 . . . . 70.23 109.481 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -105.79 4.62 30.06 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.633 0.73 . . . . 73.23 110.457 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -79.36 146.09 33.05 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.66 0.615 . . . . 73.33 112.66 -173.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -102.53 133.81 46.9 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.741 -0.663 . . . . 73.12 109.29 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 47.5 p90 . . . . . 0 C--N 1.311 -1.106 0 N-CA-C 113.288 0.848 . . . . 63.31 113.288 -173.546 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 . . . . . 0 N--CA 1.443 -0.788 0 N-CA-C 109.678 -0.49 . . . . 75.14 109.678 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 124' ' ' ILE . . . -149.77 138.65 6.9 Favored Glycine 0 N--CA 1.412 -2.921 0 N-CA-C 109.836 -1.305 . . . . 72.2 109.836 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -114.52 124.18 51.25 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.096 -1.446 . . . . 71.42 107.096 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -117.82 101.6 8.43 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 107.705 -1.221 . . . . 64.4 107.705 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -109.87 133.27 53.34 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.657 -1.156 . . . . 61.13 108.171 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 12.9 p -126.9 135.69 62.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-O 121.324 0.583 . . . . 72.22 110.771 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.414 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 27.9 m-90 -108.88 132.03 54.44 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.456 -0.942 . . . . 73.02 108.456 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -109.09 121.37 45.0 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.62 -1.252 . . . . 72.15 107.62 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.7 t . . . . . 0 C--N 1.299 -1.59 0 CA-C-N 115.368 -0.833 . . . . 72.23 111.368 -176.491 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 40.1 p90 . . . . . 0 N--CA 1.43 -1.45 0 N-CA-C 108.79 -0.818 . . . . 74.04 108.79 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -132.53 147.0 52.35 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 105.59 -2.004 . . . . 72.54 105.59 176.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -125.27 155.26 40.42 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-O 121.138 0.495 . . . . 71.11 112.028 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -134.68 117.55 16.18 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.529 -0.76 . . . . 74.13 109.351 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -111.36 110.82 21.46 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 123.357 0.663 . . . . 75.42 109.842 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.14 131.48 45.15 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 109.039 -0.726 . . . . 73.0 109.039 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -115.93 114.65 24.94 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.568 -0.901 . . . . 73.04 108.568 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.407 ' O ' ' HA2' ' A' ' 98' ' ' GLY . 59.0 mt -112.83 143.71 21.97 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.694 0 N-CA-C 106.643 -1.614 . . . . 50.12 106.643 176.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -127.43 148.41 50.29 Favored 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 118.668 -1.213 . . . . 65.24 109.006 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.468 ' NH2' HG11 ' A' ' 21' ' ' VAL . 19.4 ttm180 -90.09 115.01 27.03 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 106.007 -1.849 . . . . 74.35 106.007 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 23.2 ttp85 -67.55 144.26 55.71 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.484 -1.302 . . . . 74.2 107.484 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -63.54 -10.31 17.45 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.139 0.792 . . . . 71.4 113.139 -172.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -71.33 -16.82 62.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.115 -0.493 . . . . 73.05 110.269 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.37 -19.24 27.03 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 115.874 -0.603 . . . . 73.43 112.54 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.0 m -91.51 152.23 20.42 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 106.897 -1.52 . . . . 50.32 106.897 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.405 ' SG ' HG22 ' A' ' 124' ' ' ILE . 22.4 t -111.03 153.26 25.86 Favored 'General case' 0 C--N 1.271 -2.834 0 C-N-CA 121.11 -0.236 . . . . 62.11 110.411 -174.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -157.72 155.92 30.76 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.429 -0.952 . . . . 73.34 108.429 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.7 mp -67.18 130.31 42.7 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 110.193 -0.299 . . . . 74.24 110.193 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -82.27 -59.94 2.38 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.286 -1.376 . . . . 75.54 107.286 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.6 m -167.62 160.82 13.19 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.358 -1.719 . . . . 73.34 106.358 -176.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.51 152.19 34.73 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 N-CA-C 106.42 -1.696 . . . . 74.35 106.42 171.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -136.96 130.38 31.44 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-O 120.954 0.406 . . . . 72.54 109.932 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -110.78 143.17 41.74 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.362 -0.977 . . . . 71.11 108.362 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.515 HD12 ' HE3' ' A' ' 143' ' ' LYS . 2.4 pt -138.25 98.28 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-O 121.774 0.797 . . . . 73.33 109.341 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 22.1 ptp -93.14 136.89 32.99 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-N 115.095 -0.957 . . . . 71.21 108.742 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.1 t 81.39 73.92 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 O-C-N 125.017 1.448 . . . . 72.33 110.536 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.515 ' HE3' HD12 ' A' ' 140' ' ' ILE . 53.1 mmtt . . . . . 0 N--CA 1.415 -2.204 0 CA-C-N 114.39 -1.277 . . . . 63.3 109.125 175.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 C--O 1.252 1.234 0 CA-C-O 122.326 1.06 . . . . 62.55 108.713 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.58 -34.21 71.94 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.1 -1.409 . . . . 62.21 107.481 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.01 -49.96 70.39 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 114.759 -1.11 . . . . 72.51 110.559 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.62 -43.08 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 112.216 0.45 . . . . 72.14 112.216 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HB2' ' HE3' ' A' ' 22' ' ' LYS . 21.1 ptmt -70.47 -31.76 69.03 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 118.069 -1.452 . . . . 60.22 111.512 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.91 -37.13 83.25 Favored Glycine 0 C--O 1.218 -0.861 0 N-CA-C 110.641 -0.984 . . . . 62.21 110.641 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp -65.53 -50.02 66.78 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 124.348 1.059 . . . . 63.54 109.165 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.85 -36.82 93.91 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.475 -0.784 . . . . 72.33 112.228 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -69.98 -41.18 74.78 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 110.665 -0.124 . . . . 71.44 110.665 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.75 -40.2 96.5 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.81 0.814 . . . . 72.45 109.555 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.484 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 14.0 t80 -62.11 -55.32 30.12 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.068 -1.424 . . . . 73.44 109.705 176.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.3 mm -63.43 -35.19 71.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.98 -0.555 . . . . 73.33 111.89 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.29 -44.77 86.91 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 121.109 -0.236 . . . . 74.25 111.011 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.3 pp -70.63 -27.58 64.17 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.378 -0.929 . . . . 71.05 110.567 -178.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 28' ' ' PHE . 79.1 t -73.6 -21.03 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 CA-C-O 121.173 0.511 . . . . 72.5 110.411 176.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.5 p -114.46 18.15 16.99 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.619 0.723 . . . . 71.24 110.131 -177.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 34' ' ' LYS . 25.1 tptt -72.31 161.78 30.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.13 -0.941 . . . . 65.35 110.252 -176.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 m -48.06 144.94 5.38 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 124.463 1.105 . . . . 74.14 113.317 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.81 -7.74 15.77 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.56 2.84 . . . . 71.12 112.962 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -66.98 -26.57 66.87 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.163 0.506 . . . . 73.41 109.91 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.2 m -75.53 106.25 6.99 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.898 -1.149 . . . . 74.22 107.898 176.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.6 t -53.98 -52.7 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.097 -0.956 . . . . 75.34 113.075 -173.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -129.05 105.36 8.14 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.923 -0.711 . . . . 63.42 110.668 -175.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.1 t -65.92 -33.31 75.54 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 115.776 -0.647 . . . . 54.11 109.728 -175.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.29 -23.35 67.01 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.414 -0.812 . . . . 54.41 110.131 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.43 ' HA ' ' CZ ' ' A' ' 72' ' ' PHE . 52.8 t-80 -71.68 -45.48 61.78 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 109.84 -0.43 . . . . 60.12 109.84 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -69.72 -31.79 69.99 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.22 -1.03 . . . . 73.22 108.22 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.421 HD11 ' CE2' ' A' ' 28' ' ' PHE . 45.1 tp -67.1 -45.03 78.49 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.273 -0.876 . . . . 63.13 110.595 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.58 -32.0 73.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.244 0.545 . . . . 54.35 110.613 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -72.77 -37.05 67.76 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.901 -0.778 . . . . 73.31 108.901 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -63.41 -44.29 95.06 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.827 0.851 . . . . 75.44 111.073 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 pp -84.69 6.78 22.82 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 115.873 -0.603 . . . . 53.45 111.846 -177.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -47.73 -57.28 7.73 Favored Glycine 0 CA--C 1.548 2.139 0 CA-C-N 116.254 -0.43 . . . . 70.51 112.792 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -76.98 -3.43 13.76 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 123.101 2.534 . . . . 70.43 112.645 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -125.86 28.35 6.17 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.197 -0.314 . . . . 74.12 111.469 -169.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.469 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 25.4 m-20 -56.58 113.73 6.52 Favored Pre-proline 0 C--O 1.24 0.588 0 O-C-N 123.771 0.669 . . . . 64.12 111.544 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.463 ' HB2' ' HA ' ' A' ' 136' ' ' SER . 45.5 Cg_endo -101.45 -164.59 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 123.011 2.474 . . . . 70.11 112.058 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -90.8 125.06 35.6 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 106.986 -1.487 . . . . 72.4 106.986 173.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 mp -103.41 114.3 42.63 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.173 0 C-N-CA 119.024 -1.07 . . . . 74.13 109.298 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 138' ' ' LYS . 32.4 m-85 -96.83 132.03 42.97 Favored 'General case' 0 C--N 1.271 -2.812 0 N-CA-C 108.981 -0.748 . . . . 72.04 108.981 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 53.7 t -129.53 112.95 25.94 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 107.691 -1.226 . . . . 63.22 107.691 176.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 62.61 22.22 13.18 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.111 -0.95 . . . . 73.23 110.867 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.01 -2.41 66.08 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.076 -0.965 . . . . 24.23 112.185 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -98.37 126.87 44.05 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.292 -1.003 . . . . 65.15 108.292 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -76.81 127.83 37.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.924 0.868 . . . . 70.4 108.89 -177.335 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.424 ' N ' HD13 ' A' ' 62' ' ' ILE . 63.4 mm-40 -117.6 137.67 52.46 Favored 'General case' 0 C--O 1.284 2.881 0 N-CA-C 106.752 -1.573 . . . . 74.11 106.752 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -75.3 174.62 9.28 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 115.895 -0.593 . . . . 73.31 109.407 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.469 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 78.6 p -60.68 -40.67 93.02 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 124.14 0.976 . . . . 43.43 109.807 -175.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 91.3 m -65.48 -45.03 85.22 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 114.563 -1.198 . . . . 65.42 110.696 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.06 -48.33 82.0 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 122.753 0.421 . . . . 64.24 110.389 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -52.66 -54.17 37.04 Favored 'General case' 0 CA--C 1.498 -1.045 0 O-C-N 123.445 0.466 . . . . 74.11 109.913 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.1 tp -51.43 -42.65 61.65 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.958 -1.019 . . . . 64.11 112.152 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.2 mm100 -63.55 -49.19 74.41 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 116.122 -0.49 . . . . 60.41 111.413 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -65.17 -34.13 77.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.535 0.683 . . . . 62.4 109.94 -178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 2.7 t80 -59.41 -53.78 54.21 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.379 -0.828 . . . . 75.51 110.474 175.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -73.89 -15.24 61.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.86 0.362 . . . . 73.12 111.629 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 55.3 mt-30 -87.8 -5.08 58.8 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 116.197 -0.456 . . . . 75.04 112.144 175.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.53 28.39 27.23 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.485 -0.864 . . . . 53.21 113.589 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.84 -45.34 18.87 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 117.286 0.543 . . . . 63.44 111.462 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -94.46 5.58 51.38 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.796 0.665 . . . . 64.11 112.796 -171.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -14.77 63.15 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.046 0.758 . . . . 63.0 113.046 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -78.12 -29.08 48.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.325 0.583 . . . . 70.44 110.112 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.1 mt -78.11 -8.21 57.96 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.399 -0.818 . . . . 63.23 111.378 -174.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -68.2 -31.6 71.24 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.483 0.659 . . . . 75.22 109.344 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -98.81 13.87 30.85 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.858 0.837 . . . . 71.52 110.286 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.31 148.97 31.91 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.869 -0.605 . . . . 73.13 110.763 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -100.6 138.62 37.42 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.344 -0.613 . . . . 61.52 109.344 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 45.4 p90 . . . . . 0 C--N 1.299 -1.601 0 CA-C-O 121.185 0.516 . . . . 75.01 111.139 179.296 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 C--O 1.246 0.886 0 N-CA-C 112.638 0.607 . . . . 61.12 112.638 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -133.91 138.17 9.88 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 108.72 -1.752 . . . . 52.34 108.72 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.422 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 21.8 m-85 -120.06 129.4 54.2 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.347 -0.983 . . . . 71.14 108.347 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.422 ' HD2' ' C ' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -119.39 103.77 9.77 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.121 -0.696 . . . . 74.23 109.121 179.484 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.33 121.26 43.52 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.04 -1.096 . . . . 62.21 108.04 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 10.0 p -120.16 132.5 69.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.665 0.745 . . . . 71.33 112.269 -177.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 30.5 m-90 -109.82 130.47 55.52 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.677 -1.147 . . . . 72.3 107.946 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -115.87 128.65 55.97 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.042 -0.725 . . . . 73.04 109.042 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.471 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 34.6 t . . . . . 0 C--N 1.286 -2.157 0 CA-C-N 115.217 -0.901 . . . . 73.53 109.594 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 17.9 p90 . . . . . 0 C--O 1.208 -1.098 0 N-CA-C 108.24 -1.022 . . . . 64.21 108.24 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.471 ' H ' ' HB3' ' A' ' 105' ' ' SER . 3.7 m-20 -102.83 133.18 48.32 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 107.83 -1.174 . . . . 62.14 107.83 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.405 ' HB2' HG13 ' A' ' 140' ' ' ILE . 50.0 mt-10 -115.51 141.73 47.67 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 120.582 -0.447 . . . . 65.25 110.277 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -127.25 116.74 21.04 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.504 -1.295 . . . . 72.31 107.504 176.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -123.16 111.39 16.46 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.27 -0.641 . . . . 74.44 109.27 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.6 133.86 36.49 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 123.119 0.567 . . . . 71.42 109.642 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -111.96 115.33 28.78 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.189 -1.041 . . . . 75.32 108.189 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.4 mt -113.9 147.04 17.7 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.497 0 N-CA-C 106.994 -1.484 . . . . 70.2 106.994 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.444 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -131.73 150.37 52.18 Favored 'General case' 0 C--O 1.266 1.945 0 C-N-CA 118.722 -1.191 . . . . 74.34 109.333 176.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -100.92 116.58 33.11 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 106.219 -1.771 . . . . 61.33 106.219 174.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.459 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 63.5 ttt180 -69.3 155.15 40.89 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.389 -0.823 . . . . 71.41 109.455 -176.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -51.85 -31.53 28.13 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.638 0.775 . . . . 64.35 111.552 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.459 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 3.9 m-20 -71.42 -5.63 34.21 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 124.512 1.125 . . . . 62.31 111.271 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 94.07 -23.95 29.03 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.46 -0.656 . . . . 62.04 111.46 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.4 m -65.73 124.56 22.76 Favored 'General case' 0 N--CA 1.425 -1.675 0 C-N-CA 124.014 0.925 . . . . 70.14 109.868 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 7.1 t -103.26 142.24 34.52 Favored 'General case' 0 C--N 1.27 -2.864 0 N-CA-C 108.666 -0.864 . . . . 64.51 108.666 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.444 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 2.1 t90 -156.53 155.61 32.24 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.8 -1.185 . . . . 71.44 107.8 -173.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.37 127.55 33.11 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.577 -0.527 . . . . 64.35 109.577 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -83.28 -55.57 4.26 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.006 -1.109 . . . . 63.33 108.006 -176.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.463 ' HA ' ' HB2' ' A' ' 54' ' ' PRO . 34.0 m -167.08 164.72 15.86 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.698 -1.593 . . . . 52.12 106.698 -177.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.95 149.49 22.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 106.263 -1.754 . . . . 70.24 106.263 172.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 57' ' ' TYR . 39.4 ttmt -129.51 130.79 46.25 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 120.843 0.354 . . . . 74.44 110.414 -177.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 53.7 m-85 -113.43 127.24 56.04 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.535 -1.283 . . . . 71.2 107.535 177.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.405 HG13 ' HB2' ' A' ' 119' ' ' GLU . 6.9 pt -129.58 98.72 4.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-O 122.273 1.035 . . . . 74.51 109.427 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 74.8 mtm -84.46 131.7 34.64 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.529 -1.214 . . . . 72.31 110.762 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 74.5 m 68.84 37.79 2.26 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.512 1.133 . . . . 70.42 111.943 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? . . . . . 0 N--CA 1.436 -1.137 0 N-CA-C 103.314 -2.847 . . . . 64.45 103.314 173.102 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.5 t70 . . . . . 0 CA--C 1.497 -1.079 0 N-CA-C 106.735 -1.58 . . . . 64.05 106.735 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.9 mtt -75.88 78.04 2.79 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.228 0.537 . . . . 74.4 111.177 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.4 m -88.09 -178.25 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.158 -0.928 . . . . 75.23 109.369 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 21' ' ' VAL . 16.7 p -60.41 -47.79 84.56 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 113.46 0.911 . . . . 70.15 113.46 -176.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.11 -34.14 77.38 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.033 0.444 . . . . 72.33 110.8 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.433 HD22 ' HD2' ' A' ' 22' ' ' LYS . 3.1 tm? -65.31 -38.46 90.26 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 107.582 -1.266 . . . . 73.41 107.582 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -71.31 -35.02 71.11 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.543 -0.753 . . . . 72.34 110.028 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 17' ' ' THR . 90.2 t -62.65 -55.9 20.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.868 -0.605 . . . . 74.45 110.696 176.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.433 ' HD2' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -71.76 -25.65 62.12 Favored 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 120.431 -0.508 . . . . 74.24 111.633 -178.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.48 -42.17 89.43 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 110.198 -1.161 . . . . 65.12 110.198 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.5 tt -63.88 -53.49 49.63 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 123.658 0.783 . . . . 65.35 109.786 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.19 -44.89 88.87 Favored Glycine 0 C--N 1.314 -0.681 0 CA-C-N 115.427 -0.806 . . . . 75.45 112.536 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -66.46 -40.1 89.21 Favored 'General case' 0 C--O 1.206 -1.192 0 CA-C-O 119.423 -0.323 . . . . 75.13 111.549 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.6 -40.41 92.63 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.483 0.659 . . . . 54.21 110.102 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.501 ' CE2' HD11 ' A' ' 45' ' ' LEU . 13.6 t80 -61.79 -53.52 54.81 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.414 -1.266 . . . . 70.34 109.783 176.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 29' ' ' ILE . 14.4 mm -64.17 -35.89 75.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 116.328 -0.396 . . . . 64.41 111.502 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.73 -52.36 66.03 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.28 0.632 . . . . 53.13 110.109 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.5 pp -67.73 -29.32 68.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 120.58 -0.448 . . . . 75.1 111.338 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.17 -31.84 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.119 0.485 . . . . 63.22 110.602 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 p -108.09 17.17 22.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.668 0.747 . . . . 73.22 110.466 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.427 ' HB2' ' HA ' ' A' ' 31' ' ' LEU . 8.3 tptm -74.04 171.26 13.82 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-N 114.523 -1.217 . . . . 61.15 111.708 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.5 m -43.94 138.56 3.23 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.357 1.863 . . . . 72.12 113.768 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.16 -7.18 16.12 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.794 2.329 . . . . 74.32 109.889 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.21 -28.02 68.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.04 -1.436 . . . . 73.42 110.736 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.7 p -94.3 158.23 15.67 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.872 -0.604 . . . . 74.23 110.089 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.5 HG22 ' OD1' ' A' ' 40' ' ' ASN . 9.2 p -50.55 -53.02 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 114.77 1.396 . . . . 45.31 114.77 -172.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.5 ' OD1' HG22 ' A' ' 39' ' ' VAL . 14.5 m120 -159.21 135.55 9.1 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 118.184 0.447 . . . . 73.13 110.548 -176.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.0 m -66.19 -31.28 72.02 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.667 -1.234 . . . . 73.13 107.667 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.471 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 1.8 mp0 -63.4 -25.61 68.37 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 113.731 -1.577 . . . . 74.44 109.624 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -71.02 -46.17 62.63 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.489 -0.93 . . . . 73.02 108.489 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -67.57 -31.66 71.89 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.016 -0.993 . . . . 71.11 109.424 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.501 HD11 ' CE2' ' A' ' 28' ' ' PHE . 42.6 tp -68.2 -45.06 74.39 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.763 -0.653 . . . . 74.54 110.358 177.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.37 -36.62 78.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.831 0.824 . . . . 70.45 109.844 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -75.62 -27.72 58.56 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.499 -1.228 . . . . 74.31 110.384 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -74.72 -44.59 49.19 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.477 -0.564 . . . . 74.43 109.477 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 3.9 pp -79.59 -2.62 43.3 Favored 'General case' 0 C--O 1.199 -1.562 0 CA-C-N 115.824 -0.626 . . . . 61.24 112.422 -174.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -51.89 -61.77 6.2 Favored Glycine 0 CA--C 1.544 1.853 0 C-N-CA 121.494 -0.384 . . . . 63.1 112.235 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -77.04 -5.42 15.83 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.236 2.624 . . . . 70.41 112.178 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.497 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 55.8 m-70 -119.0 29.5 7.67 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.837 -0.801 . . . . 54.24 108.837 -175.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -55.91 107.67 0.96 Allowed Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 124.859 1.264 . . . . 71.24 112.871 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.508 ' HB3' ' HB3' ' A' ' 134' ' ' LEU . 75.0 Cg_endo -98.93 -173.81 0.15 Allowed 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 123.273 2.649 . . . . 73.3 111.13 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -86.08 101.98 13.43 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 107.306 -1.368 . . . . 73.2 107.306 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 68' ' ' PHE . 65.1 mt -87.15 105.69 15.35 Favored 'Isoleucine or valine' 0 C--O 1.172 -3.007 0 N-CA-C 109.251 -0.648 . . . . 75.35 109.251 -175.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -94.02 106.88 18.84 Favored 'General case' 0 C--N 1.276 -2.61 0 O-C-N 121.314 -0.866 . . . . 64.03 111.459 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.454 HG23 HG22 ' A' ' 56' ' ' ILE . 54.2 t -108.45 113.19 43.29 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.939 0 N-CA-C 108.23 -1.026 . . . . 51.22 108.23 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 62.04 21.28 12.24 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.96 -1.473 . . . . 52.32 110.599 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.47 2.98 56.52 Favored Glycine 0 N--CA 1.439 -1.102 0 CA-C-N 115.564 -0.744 . . . . 61.42 113.357 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -112.85 135.21 53.87 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-N 117.758 0.779 . . . . 74.44 110.509 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.01 126.35 34.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.949 0.88 . . . . 64.52 109.376 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.535 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 59.0 mm-40 -126.13 149.45 48.94 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.164 -1.421 . . . . 75.13 107.164 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.8 t -97.95 173.56 7.01 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.355 -0.98 . . . . 71.22 108.355 173.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.6 t -42.25 -42.89 3.22 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.144 1.378 . . . . 62.25 112.479 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.5 m -69.35 -42.36 75.37 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.377 -0.374 . . . . 54.23 111.978 -176.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -65.08 -45.99 82.98 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.656 -0.498 . . . . 63.25 109.656 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' HB2' HD13 ' A' ' 56' ' ' ILE . 41.2 t80 -52.75 -55.21 24.46 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 109.108 -0.701 . . . . 73.4 109.108 174.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -48.34 -44.19 34.07 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.3 -1.318 . . . . 73.15 110.963 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 45.2 mt-30 -61.55 -46.49 89.7 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 112.029 0.381 . . . . 63.03 112.029 177.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.528 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 57.6 m-85 -68.62 -36.25 78.41 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.421 0.629 . . . . 71.21 109.315 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -57.99 -51.57 69.1 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.621 -0.718 . . . . 55.43 111.084 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 34.1 ptt180 -66.85 -30.93 71.24 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.705 -0.48 . . . . 72.14 109.705 -176.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -74.86 -10.09 59.17 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.779 -0.646 . . . . 72.01 112.212 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.36 6.84 47.17 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 114.77 0.668 . . . . 54.43 114.77 174.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.457 ' HB3' ' SD ' ' A' ' 141' ' ' MET . 3.5 mm? -68.15 -48.77 64.44 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.659 0.614 . . . . 34.24 112.659 -176.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.528 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 45.5 m-85 -90.8 12.74 18.34 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 113.273 0.842 . . . . 73.53 113.273 -173.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.471 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 51.7 mtmt -66.97 -14.22 62.64 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.634 0.605 . . . . 74.44 112.634 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -79.96 -13.01 59.67 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 123.218 0.607 . . . . 54.21 110.695 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.5 tt -60.78 -28.17 68.54 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.583 0.586 . . . . 72.31 112.583 -174.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.13 4.57 46.93 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 117.623 -1.631 . . . . 74.23 111.409 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -105.85 10.07 32.64 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.265 -1.384 . . . . 55.44 107.265 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -91.71 153.08 19.89 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 113.805 -1.543 . . . . 74.41 113.15 -174.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 104' ' ' LYS . 13.6 pt-20 -95.09 133.23 39.13 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.64 -1.164 . . . . 73.34 110.143 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.619 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 43.2 p90 -130.7 156.0 45.67 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.763 -0.829 . . . . 62.34 108.763 176.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -146.7 -178.15 6.03 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.673 -0.862 . . . . 61.43 108.673 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.2 tp -77.75 113.66 17.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.249 0.547 . . . . 73.34 109.671 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.411 HD21 HG12 ' A' ' 102' ' ' VAL . 18.2 m120 -86.3 158.55 19.65 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 122.157 -0.339 . . . . 63.22 110.259 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.35 133.82 31.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.624 0.726 . . . . 45.2 112.444 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.5 m -154.31 21.71 0.49 Allowed 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.047 0.939 . . . . 73.35 108.476 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.77 -38.39 42.53 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.786 -0.643 . . . . 62.31 113.389 -174.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -85.41 89.44 7.68 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 120.551 -0.46 . . . . 64.44 110.625 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.39 114.97 26.24 Favored 'Isoleucine or valine' 0 C--O 1.248 1.015 0 N-CA-C 108.368 -0.975 . . . . 75.24 108.368 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.574 ' HG3' ' H ' ' A' ' 95' ' ' GLU . 44.3 pttt -103.36 -73.51 0.66 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 113.757 1.021 . . . . 71.55 113.757 -172.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.574 ' H ' ' HG3' ' A' ' 94' ' ' LYS . 34.8 tt0 170.22 102.85 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 126.503 1.921 . . . . 63.13 106.394 -172.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.82 74.81 1.11 Allowed Glycine 0 C--O 1.242 0.642 0 N-CA-C 108.594 -1.803 . . . . 74.23 108.594 -174.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -76.89 171.46 14.72 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.602 0.715 . . . . 70.32 112.842 -171.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -150.75 138.76 6.83 Favored Glycine 0 N--CA 1.414 -2.768 0 N-CA-C 109.695 -1.362 . . . . 55.52 109.695 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -123.63 143.63 50.11 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.687 -1.598 . . . . 72.52 106.687 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 19.6 pttp -136.02 98.98 4.02 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-O 122.104 0.954 . . . . 71.12 109.257 173.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.88 125.43 34.0 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.349 -1.296 . . . . 63.52 108.253 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 10.0 p -117.11 136.74 53.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 C-N-CA 119.866 -0.734 . . . . 61.23 111.414 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.619 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 27.0 m-90 -115.58 140.29 49.31 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.506 -1.225 . . . . 71.21 107.711 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 97.4 mttt -116.87 120.99 40.19 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.985 -1.487 . . . . 74.24 106.985 172.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.429 ' HB2' ' H ' ' A' ' 118' ' ' ASP . 46.3 m -64.18 150.71 45.21 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.218 -1.03 . . . . 73.13 108.218 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.39 119.62 5.88 Favored 'General case' 0 CA--C 1.49 -1.351 0 O-C-N 123.892 0.745 . . . . 70.11 111.018 -174.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.516 ' HB1' ' CG2' ' A' ' 115' ' ' ILE . . . -64.09 130.89 45.77 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 113.487 -1.688 . . . . 53.12 109.862 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -113.52 137.53 51.43 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.963 -0.562 . . . . 71.3 109.834 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -58.44 117.97 5.06 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 122.095 0.95 . . . . 73.44 111.666 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 114' ' ' LYS . 19.8 m -109.96 -165.26 0.99 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.068 -0.969 . . . . 74.41 111.448 -174.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -84.42 -59.6 2.33 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 114.373 1.249 . . . . 62.03 114.373 -171.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -86.44 36.75 0.71 Allowed 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 114.18 1.178 . . . . 54.34 114.18 -165.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 67.43 10.53 7.81 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 122.567 1.175 . . . . 73.44 111.36 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 110' ' ' SER . 20.3 pttp -115.91 167.91 10.53 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.135 -1.431 . . . . 61.23 107.135 173.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.516 ' CG2' ' HB1' ' A' ' 107' ' ' ALA . 0.7 OUTLIER -120.88 149.71 23.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 C-N-CA 120.056 -0.658 . . . . 74.31 109.382 -169.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -98.84 131.16 45.16 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.975 -0.75 . . . . 73.21 108.975 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 21.7 p90 -147.08 170.05 17.98 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.938 -0.764 . . . . 73.12 108.938 176.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.429 ' H ' ' HB2' ' A' ' 105' ' ' SER . 5.6 m-20 -118.59 138.39 52.6 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 105.651 -1.981 . . . . 62.32 105.651 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.454 ' HB2' HG13 ' A' ' 140' ' ' ILE . 47.6 mt-10 -114.57 142.08 46.91 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.722 -0.791 . . . . 75.01 110.533 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -133.9 117.15 16.45 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.739 -0.664 . . . . 73.22 110.042 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -116.45 110.89 19.23 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 122.94 0.496 . . . . 71.03 110.366 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -97.74 113.75 25.59 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 110.152 -0.314 . . . . 74.31 110.152 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -97.84 119.8 37.09 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.455 -0.942 . . . . 74.51 108.455 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.499 HG12 HD13 ' A' ' 134' ' ' LEU . 59.6 mt -118.54 144.88 25.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 106.953 -1.499 . . . . 41.0 106.953 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.503 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.6 OUTLIER -119.97 146.0 46.24 Favored 'General case' 0 C--O 1.267 2.008 0 C-N-CA 118.485 -1.286 . . . . 63.33 107.604 174.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -93.0 106.02 18.04 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 106.607 -1.627 . . . . 75.24 106.607 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.449 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 65.1 ttt180 -58.44 145.69 37.71 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 113.67 -1.605 . . . . 72.32 108.195 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 128' ' ' LYS . 37.5 ttmt -61.51 -18.21 58.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.694 0.759 . . . . 65.42 110.8 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.449 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 7.4 t70 -65.07 -17.86 64.82 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.562 1.145 . . . . 74.34 110.953 173.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.92 -16.66 36.18 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 121.38 -0.438 . . . . 64.03 112.677 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.0 p -92.8 176.98 6.24 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 109.51 -0.552 . . . . 42.41 109.51 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.495 ' SG ' HG13 ' A' ' 21' ' ' VAL . 30.4 p -131.16 143.7 50.82 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 109.705 -0.48 . . . . 54.33 109.705 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.503 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 2.0 t90 -139.27 155.01 48.04 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.809 -0.811 . . . . 65.53 108.809 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . 2.7 mm? -67.89 111.35 4.3 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.071 -0.968 . . . . 71.54 108.676 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -76.44 -60.41 2.35 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.718 -1.215 . . . . 62.03 107.718 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.8 m -161.31 150.5 16.43 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.136 -1.801 . . . . 73.01 106.136 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.0 m -133.35 135.83 55.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 107.001 -1.481 . . . . 71.14 107.001 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -115.79 131.29 56.98 Favored 'General case' 0 C--N 1.274 -2.716 0 CA-C-O 120.644 0.259 . . . . 73.41 110.8 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.416 ' HB2' HG22 ' A' ' 58' ' ' VAL . 78.2 m-85 -119.66 126.23 50.64 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 107.915 -1.143 . . . . 71.53 107.915 176.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.454 HG13 ' HB2' ' A' ' 119' ' ' GLU . 3.8 pt -126.29 98.65 5.02 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 N-CA-C 107.94 -1.133 . . . . 63.44 107.94 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.457 ' SD ' ' HB3' ' A' ' 76' ' ' LEU . 63.1 mtm -87.91 127.98 35.36 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.01 -1.45 . . . . 71.15 112.039 -171.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.1 m 64.19 77.33 0.32 Allowed 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 113.332 -1.758 . . . . 41.01 112.654 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -118.85 177.01 5.01 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 112.981 -1.918 . . . . 60.44 108.566 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -160.55 175.2 12.98 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 106.84 -1.541 . . . . 72.31 106.84 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -135.9 147.07 59.52 Favored Pre-proline 0 C--N 1.288 -2.073 0 N-CA-C 106.537 -1.653 . . . . 74.24 106.537 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -61.13 129.62 29.28 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.028 1.818 . . . . 74.41 109.946 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -81.26 146.75 30.27 Favored 'General case' 0 N--CA 1.413 -2.301 0 N-CA-C 108.863 -0.791 . . . . 74.22 108.863 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 19.1 m -87.59 120.82 37.35 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-O 121.112 0.482 . . . . 70.42 110.767 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.806 0 N-CA-C 108.435 -0.95 . . . . 33.4 108.435 177.927 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.0 t70 . . . . . 0 N--CA 1.464 0.227 0 N-CA-C 107.37 -1.344 . . . . 71.15 107.37 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.2 mmt -80.95 92.13 6.12 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.38 -0.6 . . . . 73.25 109.38 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.9 m -61.77 -30.89 49.39 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.048 0 CA-C-N 115.55 -0.75 . . . . 75.44 110.562 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.4 m -67.32 -38.04 84.28 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 123.746 0.818 . . . . 33.11 110.254 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 27.7 t70 -75.8 -39.01 57.66 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.272 -0.877 . . . . 74.24 109.403 -177.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.2 -35.82 80.41 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.141 -0.936 . . . . 71.53 108.946 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -64.34 -49.25 72.45 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.725 -0.67 . . . . 71.21 110.052 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.71 -45.55 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 116.038 -0.528 . . . . 74.35 112.341 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 18.3 ptpt -72.27 -26.09 61.85 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 118.632 -1.227 . . . . 72.54 111.128 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.64 -55.1 12.45 Favored Glycine 0 C--O 1.262 1.876 0 N-CA-C 111.386 -0.685 . . . . 65.23 111.386 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 pp -66.75 -38.98 87.7 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 108.518 -0.919 . . . . 74.14 108.518 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.12 -42.84 99.92 Favored Glycine 0 CA--C 1.497 -1.074 0 CA-C-N 116.025 -0.534 . . . . 72.21 111.986 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -64.62 -45.77 85.46 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-O 119.533 -0.27 . . . . 75.14 110.424 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.18 -38.61 88.45 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 120.456 -0.498 . . . . 75.23 110.771 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.49 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 24.7 t80 -62.48 -54.62 37.31 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.522 1.129 . . . . 70.01 110.123 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 29' ' ' ILE . 12.6 mm -65.58 -33.14 61.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 116.358 -0.383 . . . . 25.4 111.134 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.76 -49.11 77.68 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.109 -0.496 . . . . 74.04 110.774 175.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.5 pp -67.76 -31.22 70.98 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 120.671 -0.412 . . . . 74.05 110.836 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.5 t -69.97 -21.87 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-O 121.308 0.575 . . . . 62.21 110.651 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.7 p -110.51 13.06 22.77 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 121.754 -0.591 . . . . 73.11 111.334 -177.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -62.91 144.24 56.91 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.615 -0.721 . . . . 61.5 112.167 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.3 m -66.05 155.14 88.03 Favored Pre-proline 0 C--N 1.299 -1.594 0 CA-C-N 114.86 -1.064 . . . . 50.55 110.971 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.97 -6.49 4.92 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 124.389 3.393 . . . . 74.31 113.259 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.8 -27.84 68.56 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.884 -0.598 . . . . 71.5 110.193 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.6 m -72.46 158.8 35.05 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.431 -0.951 . . . . 62.45 108.431 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.544 HG23 ' OD1' ' A' ' 40' ' ' ASN . 32.0 m -63.89 -37.6 80.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 C-N-CA 119.503 -0.879 . . . . 61.31 110.634 -177.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.636 ' HB2' ' OE1' ' A' ' 42' ' ' GLU . 12.1 p-10 178.92 137.94 0.09 Allowed 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.563 1.145 . . . . 63.14 110.661 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.3 m -63.55 -37.37 87.07 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-O 122.34 1.067 . . . . 74.4 109.639 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.636 ' OE1' ' HB2' ' A' ' 40' ' ' ASN . 1.2 pm0 -67.58 -20.5 65.39 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 114.317 -1.31 . . . . 65.14 112.191 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.561 ' HB2' ' OD1' ' A' ' 40' ' ' ASN . 54.8 t-80 -67.43 -49.03 65.52 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 108.877 -0.786 . . . . 51.24 108.877 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -66.99 -33.84 76.45 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.317 -1.311 . . . . 63.43 109.058 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.423 HD11 ' CE1' ' A' ' 28' ' ' PHE . 51.8 tp -66.56 -46.42 76.09 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 116.281 -0.418 . . . . 71.52 110.708 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.73 -35.32 76.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.188 0.518 . . . . 74.45 110.418 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -76.95 -29.97 55.84 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.436 -0.802 . . . . 72.35 109.699 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -68.27 -42.96 78.79 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 123.248 0.619 . . . . 73.0 110.019 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 pp -85.44 0.72 51.41 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.821 -0.627 . . . . 72.33 111.323 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -52.61 -57.95 12.6 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-N 116.383 -0.372 . . . . 74.41 112.423 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -76.85 -4.1 14.54 Favored 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.438 2.759 . . . . 72.24 112.525 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.413 ' HA ' ' HE1' ' A' ' 133' ' ' TRP . 71.1 m-70 -125.13 45.07 2.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.372 -0.376 . . . . 75.34 110.006 -173.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -54.97 104.98 0.46 Allowed Pre-proline 0 N--CA 1.492 1.666 0 C-N-CA 124.833 1.253 . . . . 75.45 113.179 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -97.9 177.16 0.47 Allowed 'Trans proline' 0 N--CA 1.431 -2.164 0 C-N-CA 123.13 2.553 . . . . 71.34 110.268 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.92 105.34 11.13 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.919 -1.141 . . . . 73.34 107.919 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.467 HD13 ' CB ' ' A' ' 68' ' ' PHE . 68.9 mt -93.06 106.54 18.05 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.404 0 N-CA-C 108.879 -0.786 . . . . 62.42 108.879 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -95.82 112.9 24.52 Favored 'General case' 0 C--N 1.265 -3.092 0 O-C-N 121.718 -0.614 . . . . 62.3 110.398 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 3.6 p -108.57 118.49 56.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 C-N-CA 118.81 -1.156 . . . . 64.43 108.129 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.408 ' HA ' HG22 ' A' ' 140' ' ' ILE . 63.9 m-20 59.74 20.34 9.1 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.643 -1.162 . . . . 75.45 111.106 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.53 7.84 53.29 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 115.158 -0.928 . . . . 25.54 114.144 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -116.64 132.94 56.55 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 117.666 0.733 . . . . 62.44 110.862 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.1 127.05 36.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 121.481 0.658 . . . . 73.24 110.222 -176.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.466 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 50.0 mm-40 -126.95 151.17 48.87 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.793 -1.188 . . . . 74.44 107.793 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.6 t -93.77 173.11 7.84 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.457 -0.942 . . . . 75.41 108.457 174.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.0 t -49.22 -39.45 30.02 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 124.605 1.162 . . . . 52.4 111.64 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.2 m -65.21 -47.86 75.4 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 122.918 0.487 . . . . 74.2 111.108 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.466 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -64.51 -47.6 78.28 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 122.745 0.418 . . . . 34.12 110.129 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.467 ' CB ' HD13 ' A' ' 56' ' ' ILE . 51.4 t80 -52.81 -55.17 24.89 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 116.177 -0.465 . . . . 74.21 110.271 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -51.35 -42.09 61.05 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.042 -0.981 . . . . 62.44 110.857 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -62.66 -49.7 74.12 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 116.299 -0.41 . . . . 75.53 111.683 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.434 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 24.8 m-85 -65.82 -33.4 75.78 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.794 0.807 . . . . 71.52 109.27 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.546 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 4.1 t80 -57.85 -53.18 61.13 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.02 -0.991 . . . . 63.03 110.841 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -74.73 -20.63 59.76 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.15 0.5 . . . . 75.12 110.671 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.424 ' HB2' HD23 ' A' ' 76' ' ' LEU . 55.3 mt-30 -76.18 -8.25 56.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.901 -0.591 . . . . 70.42 111.051 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.16 10.07 57.6 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 120.539 -0.838 . . . . 74.13 114.266 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 74' ' ' GLN . 3.5 mm? -68.32 -50.53 52.83 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 116.868 0.334 . . . . 62.13 110.442 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.434 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 36.5 m-85 -99.31 10.08 42.12 Favored 'General case' 0 C--O 1.204 -1.326 0 N-CA-C 112.819 0.674 . . . . 73.44 112.819 -173.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.301 62.8 pttt -70.48 -10.62 59.65 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 114.221 1.193 . . . . 74.35 114.221 -176.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -83.33 -10.55 58.42 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.196 -0.456 . . . . 75.35 110.485 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.44 -15.93 63.71 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 112.578 0.584 . . . . 60.11 112.578 -172.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -11.16 40.54 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.931 -0.481 . . . . 61.42 112.122 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -99.76 14.06 31.55 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 122.65 0.38 . . . . 73.32 111.23 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.505 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -58.71 129.22 41.06 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.008 0.744 . . . . 65.02 113.008 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -100.67 127.01 47.23 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.497 -1.668 . . . . 72.05 106.497 173.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -82.2 125.12 30.55 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 120.749 -0.38 . . . . 75.15 110.526 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.469 ' HB3' HG13 ' A' ' 102' ' ' VAL . . . -88.94 113.5 24.54 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.167 -1.42 . . . . 60.02 107.167 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.2 tt -47.74 107.75 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 114.337 1.236 . . . . 74.52 114.337 -173.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -87.58 117.71 26.57 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 106.507 -1.664 . . . . 55.04 106.507 173.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.45 97.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.855 0.836 . . . . 53.44 109.993 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p -113.09 6.05 17.4 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 114.757 -1.111 . . . . 34.21 110.375 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.34 85.55 0.72 Allowed Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 114.715 -1.13 . . . . 62.3 110.661 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -173.3 172.36 3.81 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 124.441 1.096 . . . . 63.05 108.44 -175.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.7 t -81.06 118.18 28.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.053 -1.092 . . . . 71.04 108.053 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -116.68 123.74 48.0 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.622 -0.717 . . . . 72.43 109.556 -174.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.4 ' HA ' ' NH2' ' A' ' 126' ' ' ARG . 10.0 pt-20 -116.13 -44.07 2.93 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.376 -0.53 . . . . 75.24 110.316 173.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -145.61 61.81 0.47 Allowed Glycine 0 C--N 1.308 -0.986 0 N-CA-C 110.176 -1.17 . . . . 65.45 110.176 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -96.65 163.53 12.98 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 121.009 0.433 . . . . 73.45 111.058 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.54 138.35 14.91 Favored Glycine 0 N--CA 1.423 -2.226 0 N-CA-C 108.628 -1.789 . . . . 71.21 108.628 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -112.67 146.3 38.93 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 117.11 0.455 . . . . 74.52 109.931 -176.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -124.89 97.59 5.33 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.164 -1.421 . . . . 64.22 107.164 172.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.64 107.99 20.53 Favored 'General case' 0 C--N 1.259 -3.363 0 N-CA-C 106.383 -1.71 . . . . 73.41 106.383 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.2 p -115.89 135.27 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 CA-C-O 121.897 0.856 . . . . 73.34 112.258 -174.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.505 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 30.5 m-90 -119.28 155.43 31.81 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.285 -1.325 . . . . 72.34 109.94 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -129.03 125.25 36.91 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 104.485 -2.413 . . . . 73.13 104.485 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 80.6 p -75.65 -170.47 1.29 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 118.296 0.498 . . . . 65.33 110.644 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.32 117.33 5.96 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.438 0.637 . . . . 64.13 109.894 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.68 139.79 32.56 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.327 -1.306 . . . . 73.31 109.189 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -126.55 114.76 18.53 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.312 -0.625 . . . . 73.02 109.312 -176.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -66.35 133.45 50.53 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 120.169 -0.612 . . . . 75.0 109.412 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.9 m -104.88 164.57 11.68 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.137 -0.938 . . . . 74.44 109.386 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -68.06 -19.79 64.91 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.334 0.588 . . . . 61.53 111.012 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.76 -1.03 29.3 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.902 -0.59 . . . . 73.52 109.917 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 75.37 10.56 3.54 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.318 1.447 . . . . 52.24 109.355 -176.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -92.14 164.6 13.52 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.859 -1.534 . . . . 73.12 106.859 174.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.1 mp -127.38 137.84 56.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 106.506 -1.664 . . . . 74.41 106.506 175.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -115.64 137.84 51.67 Favored 'General case' 0 C--N 1.292 -1.925 0 O-C-N 123.411 0.444 . . . . 74.43 110.331 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.505 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 22.1 p90 -149.41 174.6 12.28 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.822 -1.548 . . . . 65.31 106.822 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -116.28 141.3 48.34 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 106.332 -1.729 . . . . 74.2 106.332 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.505 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 42.4 mt-10 -115.33 147.04 40.94 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 119.701 -0.8 . . . . 65.03 112.567 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.604 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -139.37 117.88 12.16 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.169 -0.923 . . . . 63.41 110.185 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.57 109.57 17.98 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.697 -0.853 . . . . 72.02 108.697 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.65 123.02 37.84 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 109.527 -0.546 . . . . 74.32 109.527 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -103.31 112.18 24.94 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.764 -1.199 . . . . 75.33 107.764 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.4 mt -117.3 150.92 19.24 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 N-CA-C 106.744 -1.576 . . . . 60.23 106.744 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -136.16 143.06 44.26 Favored 'General case' 0 C--O 1.275 2.414 0 N-CA-C 108.226 -1.028 . . . . 73.23 108.226 172.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.4 ' NH2' ' HA ' ' A' ' 95' ' ' GLU . 19.9 ttp180 -91.53 100.98 13.63 Favored 'General case' 0 N--CA 1.405 -2.679 0 N-CA-C 106.793 -1.558 . . . . 72.01 106.793 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -68.03 132.89 48.08 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 114.765 -1.107 . . . . 75.22 109.258 -171.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -66.16 -10.57 42.46 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 123.75 0.82 . . . . 74.42 111.417 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -74.6 -8.0 54.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.055 -0.52 . . . . 72.24 111.023 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.22 -8.78 28.95 Favored Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.707 -0.759 . . . . 72.51 113.932 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.9 m -104.16 138.78 40.15 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.414 -0.587 . . . . 70.13 109.414 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 44.7 t -98.33 132.65 43.63 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 107.037 -1.468 . . . . 74.31 107.037 170.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.413 ' HE1' ' HA ' ' A' ' 52' ' ' HIS . 1.6 t90 -146.0 154.78 42.27 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 118.389 -1.324 . . . . 73.44 110.642 -176.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.22 125.67 29.59 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.99 -1.115 . . . . 74.31 107.99 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -80.79 -53.99 6.0 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.408 -0.96 . . . . 64.21 108.408 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.4 m -162.48 158.48 23.76 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 105.266 -2.124 . . . . 70.34 105.266 -175.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.7 m -143.06 138.4 27.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 107.296 -1.372 . . . . 52.51 107.296 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -112.82 136.33 52.57 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 109.786 -0.45 . . . . 65.31 109.786 -177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 71.8 m-85 -125.04 122.94 38.69 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 107.72 -1.215 . . . . 61.34 107.72 175.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.408 HG22 ' HA ' ' A' ' 59' ' ' ASN . 5.2 pt -127.14 98.81 4.9 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 N-CA-C 107.946 -1.131 . . . . 74.44 107.946 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 23.4 ptm -86.63 143.09 27.8 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.481 -1.236 . . . . 74.33 110.564 -173.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.8 m 67.62 35.23 4.17 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.569 1.168 . . . . 74.15 109.287 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -71.07 127.69 33.44 Favored 'General case' 0 N--CA 1.408 -2.54 0 CA-C-N 113.082 -1.872 . . . . 71.31 109.258 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -147.44 168.78 21.0 Favored 'General case' 0 C--N 1.268 -2.966 0 CA-C-N 114.313 -1.312 . . . . 55.44 108.578 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -123.03 158.86 56.38 Favored Pre-proline 0 C--N 1.279 -2.47 0 N-CA-C 106.247 -1.76 . . . . 71.34 106.247 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.81 130.9 42.84 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.809 1.673 . . . . 73.54 109.246 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -61.65 139.14 58.32 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.326 0.584 . . . . 75.42 111.45 -174.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.8 m -90.11 151.04 3.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 108.414 -0.958 . . . . 61.32 108.414 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.654 0 N-CA-C 108.762 -0.829 . . . . 50.11 108.762 -179.189 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 120.826 0.346 . . . . 64.15 111.436 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -75.24 8.89 2.35 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 112.615 0.598 . . . . 51.42 112.615 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.7 m -65.43 -40.15 87.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 110.194 -0.298 . . . . 73.51 110.194 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.4 m -72.13 -29.18 63.81 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.405 0.622 . . . . 73.11 109.507 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -69.76 -46.43 65.83 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 116.153 -0.476 . . . . 73.04 110.178 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.99 -43.86 97.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.559 -0.746 . . . . 64.23 109.434 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.04 -42.93 99.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.843 -0.617 . . . . 54.3 111.622 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.543 HG11 ' HE ' ' A' ' 126' ' ' ARG . 26.6 m -74.46 -39.79 48.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 119.352 -0.939 . . . . 71.44 112.698 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -72.38 -28.03 62.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 119.052 -1.059 . . . . 75.31 109.787 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.03 -42.55 43.94 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 110.533 -1.027 . . . . 52.13 110.533 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.551 HD22 ' SG ' ' A' ' 132' ' ' CYS . 17.9 tp -64.84 -50.37 66.94 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.025 -0.731 . . . . 73.35 109.025 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.59 -39.05 94.58 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.347 -0.842 . . . . 71.4 112.232 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -68.63 -42.13 78.49 Favored 'General case' 0 C--O 1.204 -1.292 0 C-N-CA 121.051 -0.26 . . . . 75.23 110.565 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.461 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 7.9 t70 -63.56 -41.46 98.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.777 0.799 . . . . 74.0 109.234 -176.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.434 ' CE1' HD11 ' A' ' 45' ' ' LEU . 33.4 t80 -63.88 -55.03 25.76 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.362 -1.744 . . . . 64.14 110.163 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 29' ' ' ILE . 11.9 mm -64.41 -32.89 59.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 111.693 0.257 . . . . 71.05 111.693 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.41 -52.8 63.06 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 122.786 0.434 . . . . 75.33 110.192 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 27' ' ' ASP . 3.7 pp -71.97 -24.4 61.59 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 119.629 -0.828 . . . . 72.33 112.162 -176.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.2 t -71.08 -25.31 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.094 0.473 . . . . 73.34 109.972 174.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.6 p -108.17 13.38 25.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.251 0.548 . . . . 73.24 110.281 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -62.67 148.35 46.71 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 115.423 -0.808 . . . . 72.01 110.834 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.6 m -51.37 143.11 19.36 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 125.763 1.625 . . . . 64.51 114.175 -175.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.39 -6.39 17.41 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 124.452 3.434 . . . . 53.1 113.338 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -62.99 -25.84 68.58 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.643 0.735 . . . . 52.31 110.134 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 t -81.46 172.18 13.83 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.233 -1.025 . . . . 75.53 108.233 175.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -56.52 -45.65 82.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 C-N-CA 122.51 0.324 . . . . 74.41 110.776 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.568 ' ND2' ' HB3' ' A' ' 42' ' ' GLU . 39.2 t30 178.16 139.06 0.09 Allowed 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.873 -1.158 . . . . 73.4 107.873 -177.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.4 m -61.85 -26.66 68.27 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 122.571 1.177 . . . . 62.5 110.688 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.568 ' HB3' ' ND2' ' A' ' 40' ' ' ASN . 38.1 tt0 -64.67 -23.48 67.27 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 125.099 1.36 . . . . 55.44 109.897 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 72' ' ' PHE . 48.2 t-80 -65.05 -46.12 82.54 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.264 -0.643 . . . . 71.43 109.264 176.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -70.58 -31.46 68.49 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 108.292 -1.003 . . . . 73.34 108.292 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.434 HD11 ' CE1' ' A' ' 28' ' ' PHE . 48.4 tp -66.82 -46.88 73.76 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.936 -0.575 . . . . 74.13 111.052 176.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.62 -34.33 75.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.359 0.6 . . . . 55.14 110.094 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -73.16 -34.82 66.27 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.366 -0.834 . . . . 72.05 109.632 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 41.8 t80 -66.28 -48.52 70.13 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.864 0.865 . . . . 75.34 110.231 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 pp -80.44 -3.07 48.43 Favored 'General case' 0 C--O 1.198 -1.616 0 CA-C-N 115.275 -0.875 . . . . 60.11 111.774 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -42.45 -60.82 2.66 Favored Glycine 0 CA--C 1.537 1.432 0 O-C-N 123.792 0.682 . . . . 64.14 113.573 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.45 -5.76 13.48 Favored 'Trans proline' 0 CA--C 1.551 1.328 0 C-N-CA 122.452 2.101 . . . . 74.13 112.998 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -116.51 22.47 12.75 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.128 -0.358 . . . . 64.42 110.454 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.67 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 18.4 t70 -65.9 120.07 66.13 Favored Pre-proline 0 C--O 1.256 1.434 0 N-CA-C 112.943 0.72 . . . . 74.21 112.943 -172.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 3.8 Cg_endo -104.92 -148.8 0.02 OUTLIER 'Trans proline' 0 CA--C 1.554 1.524 0 C-N-CA 124.252 3.301 . . . . 73.13 112.22 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -86.85 126.12 34.43 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 107.888 -1.152 . . . . 64.24 107.888 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.55 HD13 ' CB ' ' A' ' 68' ' ' PHE . 48.2 mt -107.34 113.1 42.71 Favored 'Isoleucine or valine' 0 C--O 1.172 -3.012 0 N-CA-C 106.86 -1.533 . . . . 72.45 106.86 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -99.2 135.18 40.98 Favored 'General case' 0 C--N 1.266 -3.051 0 O-C-N 121.669 -0.644 . . . . 74.43 109.703 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 74.9 t -133.54 113.61 19.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 108.714 -0.847 . . . . 74.43 108.714 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.414 ' OD1' ' HG2' ' A' ' 141' ' ' MET . 72.5 m-20 61.32 25.18 15.19 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 125.377 1.471 . . . . 72.22 111.695 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.8 2.12 58.53 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.856 -0.688 . . . . 43.54 112.627 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -113.4 135.49 53.81 Favored 'General case' 0 CA--C 1.492 -1.278 0 O-C-N 122.31 -0.524 . . . . 70.22 110.713 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.21 128.49 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 108.903 -0.777 . . . . 63.23 108.903 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -122.52 143.6 49.61 Favored 'General case' 0 C--O 1.282 2.766 0 N-CA-C 107.161 -1.422 . . . . 74.1 107.161 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.1 t -91.91 173.14 8.01 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.923 -1.14 . . . . 72.31 107.923 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.67 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 13.6 t -58.4 -32.46 68.64 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.698 0.399 . . . . 65.51 111.637 -176.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.5 m -60.82 -51.56 68.81 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.869 -0.605 . . . . 74.24 110.105 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.64 -49.36 75.49 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.532 -0.758 . . . . 61.54 110.441 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.55 ' CB ' HD13 ' A' ' 56' ' ' ILE . 56.9 t80 -52.9 -54.91 27.88 Favored 'General case' 0 CA--C 1.501 -0.939 0 O-C-N 123.676 0.61 . . . . 70.54 110.926 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.2 tp -53.06 -44.85 67.78 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 124.094 0.871 . . . . 72.21 111.782 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.528 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 76.3 mt-30 -58.07 -51.81 68.14 Favored 'General case' 0 N--CA 1.439 -1.014 0 O-C-N 123.257 0.348 . . . . 74.51 111.025 175.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.425 ' HB3' ' HB2' ' A' ' 76' ' ' LEU . 27.3 m-85 -62.47 -40.72 97.57 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.217 0.532 . . . . 71.31 110.735 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 2.6 t80 -57.86 -52.1 66.87 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.593 0.757 . . . . 71.23 110.309 177.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -73.23 -18.28 61.26 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.149 -0.478 . . . . 64.04 111.397 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 46.8 mt-30 -87.22 -11.5 49.59 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 120.167 -0.613 . . . . 75.4 111.773 175.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.52 42.14 6.62 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.509 -0.853 . . . . 74.42 112.821 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.442 HD23 ' HB2' ' A' ' 74' ' ' GLN . 4.3 mm? -88.03 -35.37 17.59 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 122.79 -0.241 . . . . 71.21 111.206 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -108.08 -2.81 19.23 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.219 -0.593 . . . . 74.44 112.297 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.565 ' HA ' ' OE2' ' A' ' 42' ' ' GLU 0.372 0.0 OUTLIER -60.19 -13.65 13.44 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 115.894 1.813 . . . . 72.41 115.894 -165.783 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.22 -12.91 62.08 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 116.113 -0.494 . . . . 71.33 111.169 174.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.7 tt -61.46 -27.09 68.32 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.438 1.095 . . . . 74.42 110.657 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.477 ' HB2' ' OD1' ' A' ' 40' ' ' ASN . 27.4 ttpp -55.02 -33.51 62.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.328 0.585 . . . . 75.34 111.321 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -105.33 14.56 28.69 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.443 -0.798 . . . . 73.12 111.032 -173.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -84.06 153.81 23.59 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.308 0.575 . . . . 61.12 112.433 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 103' ' ' TRP . 10.2 pt-20 -89.31 149.82 22.87 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.213 -1.402 . . . . 75.11 107.213 175.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -117.91 136.14 53.66 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 118.972 0.805 . . . . 73.3 112.002 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.86 110.22 21.89 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.827 -0.805 . . . . 54.22 108.827 174.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.4 tt -82.87 103.0 9.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.545 0.688 . . . . 61.54 111.703 -177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -116.33 89.68 3.16 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.691 -0.686 . . . . 54.53 109.806 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 53.8 t -104.0 149.28 7.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 107.71 -1.218 . . . . 54.41 107.71 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.8 p -65.28 -55.34 18.92 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.087 0.47 . . . . 60.43 110.811 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.47 -136.94 7.97 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 109.509 -1.437 . . . . 22.14 109.509 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -102.42 12.16 36.93 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.687 0.756 . . . . 64.22 110.324 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.1 t -82.28 139.68 17.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.454 -1.313 . . . . 73.43 107.454 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.432 ' HA ' ' NH1' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -130.9 102.54 6.1 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.127 -1.064 . . . . 44.22 108.127 177.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -136.5 -31.7 0.86 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.078 0.466 . . . . 52.43 111.547 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 129.53 47.03 0.16 Allowed Glycine 0 C--N 1.299 -1.476 0 N-CA-C 109.669 -1.373 . . . . 61.24 109.669 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 97' ' ' GLU . 1.1 mp0 -82.09 175.65 10.16 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 123.237 0.615 . . . . 73.51 110.641 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.59 144.5 18.28 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 110.852 -0.899 . . . . 73.24 110.852 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -109.99 140.4 44.05 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.628 -1.249 . . . . 75.43 107.628 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -131.59 101.19 5.4 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.769 -0.826 . . . . 73.11 108.769 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 83.4 mt -107.96 112.22 24.7 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.967 -0.753 . . . . 72.12 108.967 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.6 p -114.03 129.2 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-O 121.484 0.659 . . . . 62.04 111.996 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.579 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 31.4 m-90 -101.82 141.6 34.43 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.604 -1.18 . . . . 75.22 109.217 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.413 ' HB2' ' CG ' ' A' ' 84' ' ' GLU . 36.3 mtpt -118.56 125.46 49.87 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 107.549 -1.278 . . . . 73.1 107.549 176.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 42.8 t -79.33 -164.28 0.61 Allowed 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.917 -1.038 . . . . 53.12 110.311 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.52 151.98 40.82 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 112.862 0.689 . . . . 74.42 112.862 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.5 108.84 10.96 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 107.278 -1.379 . . . . 71.42 107.278 173.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -95.98 140.4 30.77 Favored 'General case' 0 C--N 1.277 -2.575 0 CA-C-N 115.822 -0.626 . . . . 72.52 110.858 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -59.78 120.08 8.87 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 116.24 1.941 . . . . 75.13 116.24 -166.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 114' ' ' LYS . 18.7 t -154.0 105.82 2.77 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 104.881 -2.266 . . . . 54.44 104.881 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -76.31 12.64 1.14 Allowed 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 114.487 1.291 . . . . 64.43 114.487 -169.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -93.02 16.45 12.74 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.779 -0.575 . . . . 75.34 112.143 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.408 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 9.1 tt0 72.08 14.08 5.75 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 122.711 1.243 . . . . 73.45 109.614 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 110' ' ' SER . 2.8 pptp? -133.12 118.74 19.07 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 107.208 -1.404 . . . . 64.01 107.208 173.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.1 pt -93.59 168.55 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-N 115.553 -0.749 . . . . 70.4 109.131 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.424 ' HD2' ' OG ' ' A' ' 142' ' ' SER . 18.0 ptt180 -125.28 136.73 53.81 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 107.864 -1.162 . . . . 63.2 107.864 174.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.475 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 46.5 p90 -134.74 173.33 11.81 Favored 'General case' 0 C--N 1.269 -2.923 0 N-CA-C 107.536 -1.283 . . . . 74.42 107.536 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.435 ' H ' ' HB3' ' A' ' 105' ' ' SER . 2.1 m-20 -116.18 138.95 50.84 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 106.056 -1.831 . . . . 73.01 106.056 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.475 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 38.4 mt-10 -118.31 144.3 45.95 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.001 -0.68 . . . . 75.13 111.225 176.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -132.51 116.74 17.13 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.861 -1.163 . . . . 44.34 107.861 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -125.68 113.26 17.11 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 121.68 0.752 . . . . 72.12 111.987 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.86 128.65 41.77 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.791 -1.095 . . . . 72.44 110.036 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -109.55 117.93 35.27 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.316 -0.994 . . . . 63.4 108.316 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.5 mt -115.59 151.17 17.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 106.435 -1.691 . . . . 61.13 106.435 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.406 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -136.02 150.17 49.1 Favored 'General case' 0 C--O 1.27 2.144 0 C-N-CA 118.984 -1.086 . . . . 73.11 109.231 175.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.543 ' HE ' HG11 ' A' ' 21' ' ' VAL . 61.7 mtt180 -76.07 113.04 13.14 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 108.145 -1.057 . . . . 71.23 108.145 172.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -73.41 133.06 43.65 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 113.906 -1.497 . . . . 64.52 107.566 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -62.53 -15.46 50.73 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.152 0.581 . . . . 61.33 112.192 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -64.94 -16.8 63.75 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 124.001 0.921 . . . . 73.02 110.988 173.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.34 -6.35 30.24 Favored Glycine 0 CA--C 1.501 -0.791 0 N-CA-C 111.215 -0.754 . . . . 71.52 111.215 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.9 p -100.01 -172.34 2.21 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 123.33 0.652 . . . . 71.23 110.6 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.551 ' SG ' HD22 ' A' ' 24' ' ' LEU . 15.0 p -134.61 144.57 47.98 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.601 -1.259 . . . . 73.41 107.601 174.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.406 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 0.2 OUTLIER -155.23 155.2 33.41 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 119.292 -0.963 . . . . 71.42 108.889 -176.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.88 128.47 36.48 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.153 0.501 . . . . 64.43 109.652 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -87.12 -46.77 9.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.047 -0.723 . . . . 65.22 109.047 -176.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.9 p -175.01 152.4 1.48 Allowed 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 107.805 -1.183 . . . . 75.33 107.805 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.41 150.55 32.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 107.385 -1.339 . . . . 72.04 107.385 175.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -130.09 133.29 46.58 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 110.266 -0.272 . . . . 73.3 110.266 -177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 67.0 m-85 -117.57 127.26 53.8 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.609 -1.256 . . . . 75.23 107.609 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.418 HD12 ' HD2' ' A' ' 143' ' ' LYS . 6.0 pt -128.45 98.76 4.49 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.42 0 CA-C-O 122.395 1.093 . . . . 71.31 108.896 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.414 ' HG2' ' OD1' ' A' ' 59' ' ' ASN . 22.6 ptp -89.73 126.94 35.85 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.163 -1.381 . . . . 73.41 109.87 -175.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.424 ' OG ' ' HD2' ' A' ' 116' ' ' ARG . 32.2 t 73.74 73.97 0.12 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.42 -1.264 . . . . 65.5 110.593 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.418 ' HD2' HD12 ' A' ' 140' ' ' ILE . 85.6 tttt -113.78 135.96 53.38 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.19 -1.368 . . . . 61.42 107.451 177.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -134.69 143.1 47.02 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 109.715 -0.476 . . . . 65.32 109.715 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.83 130.53 24.31 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 109.107 -0.701 . . . . 61.32 109.107 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.94 132.28 44.05 Favored 'Trans proline' 0 C--O 1.246 0.924 0 C-N-CA 122.66 2.24 . . . . 73.55 111.094 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -93.61 168.06 11.27 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 108.164 -1.05 . . . . 73.21 108.164 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 38.5 t -135.23 98.98 2.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.505 -0.924 . . . . 73.12 108.505 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.888 0 CA-C-N 115.321 -0.854 . . . . 52.4 108.717 -179.013 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 112.565 0.58 . . . . 44.14 112.565 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 92.6 mtp -66.55 162.32 21.11 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.751 0.705 . . . . 63.12 110.764 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.11 -42.68 96.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.162 -0.681 . . . . 72.55 109.162 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 21' ' ' VAL . 8.5 p -62.39 -43.15 99.51 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.32 -0.855 . . . . 63.43 109.842 177.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -66.67 -34.9 78.9 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.018 -0.992 . . . . 53.44 111.413 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.69 -36.83 84.76 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.222 -1.029 . . . . 75.23 108.222 175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -69.91 -38.23 76.2 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.372 -0.831 . . . . 74.54 109.853 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 17' ' ' THR . 89.3 t -59.16 -56.66 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 115.218 -0.901 . . . . 74.14 110.437 176.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -25.9 67.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.354 -0.384 . . . . 72.13 110.545 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.59 -50.44 48.91 Favored Glycine 0 C--O 1.25 1.128 0 N-CA-C 111.659 -0.576 . . . . 70.44 111.659 175.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.77 -37.74 76.48 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 108.613 -0.884 . . . . 52.21 108.613 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.58 -40.63 99.38 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.704 -0.68 . . . . 50.32 111.851 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -67.77 -46.03 73.22 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 120.457 -0.497 . . . . 60.31 110.409 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.23 -39.82 95.7 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 120.567 -0.453 . . . . 74.42 110.644 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -61.57 -52.54 64.01 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.604 0.762 . . . . 72.22 109.902 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.421 ' HA ' HD13 ' A' ' 29' ' ' ILE . 7.4 mm -67.52 -35.09 72.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 120.906 -0.318 . . . . 75.44 111.675 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -63.2 -46.24 87.94 Favored 'General case' 0 CA--C 1.495 -1.141 0 C-N-CA 122.425 0.29 . . . . 61.54 110.487 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.586 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 4.1 pp -69.65 -28.76 66.16 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 119.736 -0.786 . . . . 64.31 111.249 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.409 ' N ' HD12 ' A' ' 31' ' ' LEU . 52.9 t -71.76 -24.33 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-O 121.456 0.646 . . . . 74.31 110.084 174.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.9 p -107.23 19.29 20.56 Favored 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 121.598 -0.689 . . . . 73.1 111.261 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.586 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 64.7 mmtt -53.24 138.64 31.55 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 116.051 -0.522 . . . . 52.11 111.057 175.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -64.28 159.23 59.79 Favored Pre-proline 0 N--CA 1.435 -1.222 0 CA-C-N 115.003 -0.999 . . . . 74.31 109.675 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.5 -11.04 18.16 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 123.349 2.699 . . . . 73.34 111.502 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -68.0 -26.05 65.71 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.607 -1.179 . . . . 74.3 110.872 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.9 t -82.67 172.26 13.11 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.442 -1.318 . . . . 51.14 107.442 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.7 t -74.77 -54.29 14.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.485 -0.486 . . . . 54.45 111.131 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.498 ' O ' ' HB3' ' A' ' 43' ' ' HIS . 23.8 t30 -170.84 126.61 0.72 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.211 -0.45 . . . . 71.22 110.355 -173.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 p -61.0 -39.3 89.15 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 123.358 0.663 . . . . 71.43 111.624 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.44 -21.6 66.21 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.962 -0.563 . . . . 61.45 110.483 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.498 ' HB3' ' O ' ' A' ' 40' ' ' ASN . 42.7 t-80 -72.91 -48.87 33.41 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.354 -0.98 . . . . 74.3 108.354 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -64.19 -35.0 79.37 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.587 -1.188 . . . . 63.1 109.541 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.0 tp -66.88 -42.37 85.69 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 116.292 -0.413 . . . . 70.3 110.466 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.32 -32.13 73.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.455 0.645 . . . . 74.24 110.319 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -74.83 -35.75 62.4 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.536 -0.757 . . . . 71.21 110.25 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -68.37 -41.69 80.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.364 0.666 . . . . 72.05 110.718 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 pp -79.02 -8.44 58.94 Favored 'General case' 0 C--O 1.194 -1.838 0 CA-C-N 115.746 -0.661 . . . . 70.22 111.814 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -46.9 -55.67 8.2 Favored Glycine 0 CA--C 1.546 1.993 0 O-C-N 123.454 0.472 . . . . 53.31 114.017 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -78.0 -3.81 13.82 Favored 'Trans proline' 0 CA--C 1.55 1.32 0 C-N-CA 122.993 2.462 . . . . 64.11 112.474 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -129.46 28.31 5.21 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.984 -0.448 . . . . 74.14 110.21 -168.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -55.98 115.68 10.33 Favored Pre-proline 0 N--CA 1.475 0.818 0 O-C-N 124.042 0.839 . . . . 74.24 111.451 -175.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -108.96 -158.15 0.02 OUTLIER 'Trans proline' 0 CA--C 1.557 1.636 0 C-N-CA 123.721 2.947 . . . . 75.53 111.546 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -86.85 126.12 34.44 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 108.08 -1.081 . . . . 63.32 108.08 175.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.48 HD13 ' CB ' ' A' ' 68' ' ' PHE . 36.7 mt -112.18 107.06 22.0 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.412 0 N-CA-C 108.98 -0.748 . . . . 73.14 108.98 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -89.84 135.64 33.51 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 109.753 -0.462 . . . . 72.42 109.753 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.8 p -126.03 117.88 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 N-CA-C 107.371 -1.344 . . . . 64.04 107.371 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 62.77 20.8 12.38 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 123.956 0.902 . . . . 63.23 110.709 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.38 -5.34 58.82 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.38 -0.827 . . . . 63.55 112.489 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -99.82 126.18 45.87 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 109.026 -0.731 . . . . 73.42 109.026 -178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.88 126.41 31.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-O 121.54 0.686 . . . . 71.12 109.427 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.483 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 63.1 mm-40 -122.33 152.45 40.11 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.077 -0.712 . . . . 71.3 109.077 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.6 t -87.64 169.15 12.39 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.327 -0.99 . . . . 74.55 108.327 175.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.426 ' HA ' HD12 ' A' ' 56' ' ' ILE . 13.2 t -58.03 -34.18 69.77 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.379 0.672 . . . . 73.12 111.33 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.0 m -61.58 -49.46 76.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.25 0.548 . . . . 73.34 109.784 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -60.83 -49.78 76.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.281 -0.872 . . . . 71.42 110.391 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.48 ' CB ' HD13 ' A' ' 56' ' ' ILE . 44.3 t80 -51.49 -56.07 15.38 Favored 'General case' 0 CA--C 1.5 -0.943 0 O-C-N 123.778 0.674 . . . . 74.33 110.415 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 69' ' ' LEU . 13.5 mt -49.77 -47.54 50.97 Favored 'General case' 0 CA--C 1.491 -1.3 0 O-C-N 124.079 0.862 . . . . 54.33 112.94 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -55.54 -51.42 67.12 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 123.703 0.627 . . . . 64.13 111.773 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -65.63 -37.3 86.18 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.555 0.693 . . . . 70.23 110.463 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 3.4 t80 -61.83 -53.6 53.69 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.183 -0.917 . . . . 64.12 111.197 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -74.62 -18.17 60.6 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 123.333 0.396 . . . . 64.21 111.123 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -75.3 -14.51 60.5 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.033 0.444 . . . . 63.53 111.285 171.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.43 18.01 29.66 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 120.749 -0.739 . . . . 60.43 113.577 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.6 mt -76.84 -44.65 31.46 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.469 -0.892 . . . . 75.34 112.019 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -89.3 -5.77 57.29 Favored 'General case' 0 C--O 1.203 -1.358 0 N-CA-C 113.384 0.883 . . . . 75.52 113.384 -174.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.286 0.0 OUTLIER -64.09 -12.4 38.9 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.727 1.38 . . . . 71.34 114.727 -175.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -80.81 -10.68 59.7 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.112 -0.495 . . . . 64.55 111.176 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.49 -15.56 60.39 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 122.76 0.424 . . . . 74.3 111.864 -176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -53.44 -30.42 40.4 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.265 0.555 . . . . 72.34 111.838 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -99.4 8.56 44.51 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 122.016 -0.427 . . . . 72.25 111.735 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.36 147.76 47.68 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.584 0.707 . . . . 50.32 111.675 -176.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -88.14 116.14 26.11 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.26 -0.882 . . . . 71.12 112.202 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.579 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 55.7 p90 -102.64 158.8 15.98 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.216 -1.772 . . . . 74.2 106.216 169.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -161.62 -151.28 0.21 Allowed 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.979 -1.489 . . . . 64.31 106.979 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.8 tp -77.34 90.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-O 122.314 1.054 . . . . 74.33 108.969 174.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -79.62 125.14 29.24 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.609 -1.178 . . . . 74.41 108.533 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.9 m -78.71 139.5 18.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-O 121.762 0.792 . . . . 70.13 111.708 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 98' ' ' GLY . 48.6 m -150.61 -176.81 5.65 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.307 -1.368 . . . . 63.31 107.307 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -149.57 144.54 12.16 Favored Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 119.128 -1.511 . . . . 61.32 112.413 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.422 ' HA ' ' HB2' ' A' ' 97' ' ' GLU . 19.7 pttm -95.83 123.6 39.48 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.835 0.826 . . . . 71.21 110.892 177.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.494 HG12 ' H ' ' A' ' 95' ' ' GLU . 25.0 t -110.81 152.05 12.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 106.476 -1.676 . . . . 74.24 106.476 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -68.82 -11.58 60.59 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.223 0.535 . . . . 63.35 110.877 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.494 ' H ' HG12 ' A' ' 93' ' ' VAL . 37.7 tt0 -137.37 91.89 2.65 Favored 'General case' 0 N--CA 1.422 -1.875 0 CA-C-N 116.065 -0.516 . . . . 62.31 109.986 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 126' ' ' ARG . . . 75.34 70.1 1.31 Allowed Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 115.53 -0.759 . . . . 72.43 113.055 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.476 ' CG ' ' HB3' ' A' ' 126' ' ' ARG . 9.9 pt-20 -64.24 140.25 58.85 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.753 -0.462 . . . . 64.42 109.753 176.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 90' ' ' SER . . . -118.84 138.67 13.8 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 119.683 -1.246 . . . . 73.42 112.98 -173.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -108.44 129.83 55.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.281 -1.007 . . . . 70.41 108.281 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -108.25 98.96 8.43 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.961 -1.126 . . . . 72.44 107.961 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 3.2 mm? -92.8 100.82 13.23 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.853 -1.165 . . . . 71.32 107.853 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.1 p -116.81 122.18 69.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-O 122.415 1.102 . . . . 75.11 113.692 -176.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.579 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 29.7 m-90 -102.83 129.99 49.69 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 113.869 -1.514 . . . . 73.11 107.854 177.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.423 ' HG3' ' HG2' ' A' ' 119' ' ' GLU . 3.1 mppt? -114.41 125.7 54.14 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.105 -1.072 . . . . 65.21 108.105 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.9 p -79.08 -178.57 6.2 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.236 -0.586 . . . . 63.44 110.621 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.39 145.16 28.21 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 122.869 0.468 . . . . 73.22 111.111 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.486 ' HB1' HG21 ' A' ' 115' ' ' ILE . . . -96.72 127.4 42.67 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.879 -0.6 . . . . 64.15 110.007 -177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -114.56 127.42 55.78 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 109.146 -0.687 . . . . 64.32 109.146 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -82.8 106.13 14.39 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.732 -0.667 . . . . 73.3 110.432 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 51.1 m -75.6 155.02 36.32 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 115.027 -0.988 . . . . 74.31 109.17 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -65.54 -7.14 13.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 113.639 0.977 . . . . 62.14 113.639 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -87.15 -0.03 56.03 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.411 -0.589 . . . . 73.11 109.411 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 77.62 11.14 2.16 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.082 1.353 . . . . 70.51 108.922 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -98.03 158.82 15.32 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.692 -1.595 . . . . 50.34 106.692 175.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.486 HG21 ' HB1' ' A' ' 107' ' ' ALA . 1.6 mp -120.59 139.3 48.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 108.164 -1.05 . . . . 74.04 108.164 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.4 ' NH1' ' HA ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -118.54 146.84 44.25 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 123.29 0.369 . . . . 73.45 110.759 179.137 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.8 p90 -152.62 174.35 14.07 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.793 -1.558 . . . . 74.2 106.793 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -116.49 138.75 51.14 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.004 -1.85 . . . . 60.21 106.004 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.495 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 45.7 mt-10 -117.23 141.1 48.71 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 119.803 -0.759 . . . . 75.31 110.988 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -127.52 116.71 20.8 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.808 -1.182 . . . . 54.51 107.808 177.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 41.8 tt0 -125.5 114.94 19.45 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 121.162 0.506 . . . . 75.12 110.861 -177.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.98 134.3 39.16 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.732 -0.667 . . . . 55.22 109.49 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -111.28 118.57 36.25 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 123.396 0.679 . . . . 62.23 109.345 -175.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.2 mt -120.91 150.27 23.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 107.174 -1.417 . . . . 65.1 107.174 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -134.63 145.04 48.22 Favored 'General case' 0 C--O 1.266 1.924 0 C-N-CA 118.998 -1.081 . . . . 74.4 110.292 173.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.509 ' HB2' ' SG ' ' A' ' 132' ' ' CYS . 10.6 ttp180 -91.42 113.66 25.99 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 114.731 -1.122 . . . . 62.42 108.25 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 131' ' ' SER . 62.9 mtm180 -70.46 158.43 36.06 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.31 -1.314 . . . . 75.31 110.119 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -69.34 -15.07 63.25 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.875 0.845 . . . . 70.52 109.004 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -66.57 -17.76 64.99 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.068 -1.424 . . . . 63.01 108.918 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.72 -23.74 35.06 Favored Glycine 0 CA--C 1.504 -0.628 0 N-CA-C 111.315 -0.714 . . . . 54.51 111.315 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 36.6 t -88.49 133.82 34.03 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 115.07 -0.565 . . . . 72.22 110.33 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 126' ' ' ARG . 95.2 m -90.67 150.48 21.66 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 115.504 -0.771 . . . . 51.21 109.861 175.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 21.1 t90 -151.09 155.84 39.79 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.172 -1.047 . . . . 72.34 108.172 177.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.1 mt -65.85 117.62 8.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.196 -1.039 . . . . 73.33 108.196 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -75.37 -56.59 4.56 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.826 -1.546 . . . . 73.41 106.826 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 52.2 m -167.14 175.35 7.54 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.988 -1.486 . . . . 75.41 106.988 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.7 t -142.57 145.51 23.28 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 105.939 -1.874 . . . . 74.24 105.939 175.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -130.56 130.72 44.45 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-O 121.057 0.456 . . . . 71.21 109.773 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -115.58 126.97 54.89 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.985 -1.487 . . . . 73.44 106.985 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.7 pt -127.68 98.44 4.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 CA-C-O 122.304 1.049 . . . . 74.43 108.471 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 19.2 ptm -93.0 124.96 37.35 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 114.496 -1.229 . . . . 71.22 109.256 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.4 ' HA ' ' NH1' ' A' ' 116' ' ' ARG . 11.5 t 79.27 63.87 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.906 -1.497 . . . . 74.32 109.924 -176.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.495 ' HG2' ' OE1' ' A' ' 119' ' ' GLU . 23.4 tptm -98.31 136.47 38.44 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.139 -1.8 . . . . 71.21 106.139 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -136.46 143.94 44.12 Favored 'General case' 0 C--N 1.278 -2.513 0 C-N-CA 120.123 -0.631 . . . . 64.33 111.567 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.73 120.55 58.62 Favored Pre-proline 0 N--CA 1.424 -1.75 0 N-CA-C 106.819 -1.549 . . . . 73.4 106.819 173.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -56.04 141.21 87.07 Favored 'Trans proline' 0 C--O 1.257 1.429 0 C-N-CA 122.749 2.299 . . . . 62.43 111.38 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -62.16 145.11 54.34 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.633 -0.712 . . . . 72.41 110.141 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 31.0 m -80.82 128.62 38.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-O 120.996 0.427 . . . . 72.11 110.344 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.693 0 N-CA-C 107.611 -1.255 . . . . 51.43 107.611 177.781 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 . . . . . 0 CA--C 1.505 -0.757 0 N-CA-C 108.145 -1.058 . . . . 64.11 108.145 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.46 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 26.3 ttt -115.0 118.67 34.07 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.933 -1.136 . . . . 65.15 107.933 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.09 -44.43 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 113.47 0.915 . . . . 71.12 113.47 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.9 p -66.0 -40.63 91.33 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.154 0.502 . . . . 61.14 110.602 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 15' ' ' MET . 34.0 t70 -61.24 -44.95 96.43 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.238 -0.892 . . . . 73.14 110.298 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.62 -38.13 89.96 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-N 115.002 -0.999 . . . . 73.41 109.65 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.28 -47.69 63.85 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.346 -0.843 . . . . 74.53 109.816 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 m -71.95 -32.2 43.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 112.545 0.572 . . . . 72.25 112.545 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -72.0 -33.47 68.1 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.588 -0.893 . . . . 63.42 108.588 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.8 -37.59 92.43 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 110.823 -0.911 . . . . 72.13 110.823 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.5 tp -66.63 -50.1 64.09 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 124.544 1.138 . . . . 74.34 109.968 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.75 -44.3 98.11 Favored Glycine 0 C--O 1.245 0.841 0 N-CA-C 111.76 -0.536 . . . . 72.55 111.76 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -63.49 -42.61 98.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.692 -0.254 . . . . 73.55 110.46 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.72 -41.83 98.01 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 123.248 0.343 . . . . 72.14 110.806 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 33.5 t80 -62.05 -54.08 46.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.353 -0.84 . . . . 64.31 110.053 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 29' ' ' ILE . 9.8 mm -62.94 -39.37 84.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.406 -0.361 . . . . 55.32 111.774 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.29 -48.62 80.56 Favored 'General case' 0 C--O 1.198 -1.608 0 O-C-N 123.436 0.46 . . . . 73.15 110.782 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 41' ' ' SER . 4.0 pp -70.59 -25.0 62.86 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 119.734 -0.786 . . . . 74.35 112.055 -177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.7 t -70.9 -26.04 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.348 0.594 . . . . 70.35 109.896 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.5 p -119.77 28.16 8.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 122.156 0.979 . . . . 71.42 108.639 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.435 ' HB2' ' HA ' ' A' ' 31' ' ' LEU . 38.2 tptt -60.96 156.65 17.14 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.051 -1.431 . . . . 72.33 112.266 -175.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 5.2 p -52.62 141.75 34.13 Favored Pre-proline 0 N--CA 1.432 -1.328 0 C-N-CA 125.096 1.358 . . . . 52.15 112.307 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 35' ' ' SER . 31.4 Cg_exo -56.11 -18.7 24.09 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.825 3.017 . . . . 75.11 112.464 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -55.27 -27.83 49.26 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.604 -0.725 . . . . 70.25 110.158 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.2 p -111.24 102.77 11.16 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.862 -1.162 . . . . 71.11 107.862 174.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.3 -42.74 96.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 72.53 111.86 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -106.61 86.05 2.27 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 122.474 1.13 . . . . 74.31 110.504 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 36.8 m -68.6 -23.67 64.49 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.264 -1.335 . . . . 60.24 108.544 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.449 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 2.0 mp0 -61.38 -26.49 67.87 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 113.909 -1.496 . . . . 72.15 109.583 177.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -68.68 -42.43 77.85 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.443 -0.577 . . . . 73.44 109.443 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -69.07 -34.72 75.6 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 108.025 -1.102 . . . . 73.22 108.025 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 52.1 tp -66.22 -45.67 79.88 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 115.627 -0.715 . . . . 71.24 110.274 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.39 74.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.057 0.456 . . . . 72.1 110.949 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -75.24 -33.58 61.34 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 109.747 -0.464 . . . . 72.14 109.747 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 57.2 t80 -70.31 -46.31 64.49 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 123.286 0.634 . . . . 71.4 109.952 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 3.6 pp -84.24 -8.03 59.17 Favored 'General case' 0 C--O 1.194 -1.864 0 CA-C-N 115.654 -0.703 . . . . 73.42 112.146 -177.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -41.83 -57.49 3.42 Favored Glycine 0 CA--C 1.541 1.708 0 O-C-N 123.543 0.527 . . . . 70.44 113.574 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -85.48 -5.91 9.1 Favored 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 123.068 2.512 . . . . 72.34 112.768 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.481 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 16.0 m-70 -115.77 22.27 13.21 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.998 -0.439 . . . . 75.25 111.128 -172.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.502 ' CG ' ' HB ' ' A' ' 65' ' ' THR . 13.3 t70 -76.3 119.67 78.31 Favored Pre-proline 0 C--N 1.309 -1.173 0 O-C-N 123.337 0.398 . . . . 73.23 110.745 -174.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 9.9 Cg_endo -101.77 -150.33 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.431 0 C-N-CA 123.506 2.804 . . . . 62.31 111.993 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.67 118.64 24.52 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 107.711 -1.218 . . . . 72.15 107.711 172.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.484 HD13 ' HB2' ' A' ' 68' ' ' PHE . 52.9 mt -100.55 113.4 36.23 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.104 0 N-CA-C 107.753 -1.203 . . . . 64.13 107.753 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -100.34 112.37 24.71 Favored 'General case' 0 C--N 1.278 -2.534 0 O-C-N 121.048 -1.033 . . . . 74.12 111.578 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.453 HG22 ' HB2' ' A' ' 139' ' ' PHE . 70.4 t -115.11 117.69 56.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 108.793 -0.818 . . . . 73.03 108.793 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 60.34 21.7 11.22 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.503 1.127 . . . . 72.25 111.455 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.54 6.17 61.2 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.267 -0.878 . . . . 52.11 112.545 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -112.1 133.46 54.24 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.558 -0.534 . . . . 72.2 109.558 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.09 124.51 30.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 122.501 1.143 . . . . 72.25 109.392 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.401 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 66.6 mm-40 -117.92 136.96 53.14 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.589 -1.187 . . . . 54.32 107.966 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 t -93.43 174.78 7.03 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.266 -1.013 . . . . 71.14 108.266 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.502 ' HB ' ' CG ' ' A' ' 53' ' ' ASP . 8.8 t -51.24 -37.54 47.58 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 125.114 1.366 . . . . 60.34 111.529 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.4 m -62.84 -49.92 72.98 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.34 0.591 . . . . 75.23 110.135 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.48 -51.28 69.34 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.482 -0.781 . . . . 61.5 111.617 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.484 ' HB2' HD13 ' A' ' 56' ' ' ILE . 39.5 t80 -54.36 -55.45 28.41 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 123.22 0.325 . . . . 63.32 110.33 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -50.06 -44.62 51.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.852 -1.067 . . . . 71.22 110.737 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -58.23 -48.84 79.13 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 111.883 0.327 . . . . 72.04 111.883 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.485 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 33.1 m-85 -66.05 -37.89 86.98 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.615 0.722 . . . . 72.35 109.721 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -56.73 -54.16 49.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 123.965 0.906 . . . . 75.44 110.831 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -72.21 -22.02 61.32 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.317 -0.401 . . . . 74.42 111.608 -176.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -77.06 -16.44 59.25 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 112.457 0.54 . . . . 71.21 112.457 172.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.55 21.28 12.97 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.37 -0.919 . . . . 34.25 114.155 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.66 -54.76 6.23 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.504 0.668 . . . . 73.25 110.123 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.485 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 46.3 m-85 -83.22 5.7 22.03 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 115.898 -0.592 . . . . 64.23 112.057 -174.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.449 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 96.8 mttt -73.93 -14.11 61.0 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.843 0.83 . . . . 73.52 111.201 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -86.09 -19.08 30.74 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.095 -0.957 . . . . 55.52 108.705 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 80' ' ' LEU . 9.5 tt -77.76 -12.21 59.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.354 -0.839 . . . . 71.24 111.563 -171.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -74.1 -23.49 59.33 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.88 0.847 . . . . 71.3 109.182 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -96.5 13.61 27.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.857 -1.065 . . . . 70.15 110.131 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -81.48 147.27 29.8 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.736 -0.665 . . . . 65.14 111.563 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 103' ' ' TRP . 8.0 pt-20 -92.64 142.05 27.8 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.473 -0.785 . . . . 74.34 108.898 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.498 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 43.3 p90 -105.2 139.27 40.11 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.422 -0.511 . . . . 73.42 111.735 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -132.78 148.21 52.32 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.232 -0.895 . . . . 64.44 108.708 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.0 mm -89.78 118.43 35.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.019 -1.104 . . . . 73.1 108.019 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -86.61 153.73 21.56 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.753 -1.202 . . . . 62.43 107.753 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.6 m -70.17 80.4 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 122.592 1.186 . . . . 65.43 113.686 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.0 m -158.94 158.55 33.53 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.578 -1.638 . . . . 73.54 106.578 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 160.19 -99.21 0.18 Allowed Glycine 0 N--CA 1.418 -2.56 0 C-N-CA 119.255 -1.45 . . . . 71.23 113.779 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.401 ' HA ' ' HB3' ' A' ' 97' ' ' GLU . 53.6 tptt -66.65 111.62 3.75 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 114.904 1.446 . . . . 73.34 114.904 -170.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' A' ' 97' ' ' GLU . 9.0 m -136.7 138.27 46.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 107.171 -1.418 . . . . 74.32 107.171 169.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -73.8 -7.24 51.42 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.607 0.965 . . . . 63.24 113.607 -172.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -87.8 -3.71 58.92 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.485 0.66 . . . . 72.43 110.217 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.74 100.24 1.13 Allowed Glycine 0 CA--C 1.487 -1.683 0 N-CA-C 107.844 -2.102 . . . . 70.3 107.844 -176.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.514 ' OE2' ' HD3' ' A' ' 126' ' ' ARG . 1.2 pm0 -60.17 141.38 56.03 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 113.767 1.025 . . . . 64.41 113.767 -173.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 125' ' ' TRP . . . -120.74 137.12 11.79 Favored Glycine 0 N--CA 1.411 -3.018 0 N-CA-C 109.475 -1.45 . . . . 62.31 109.475 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -108.06 140.36 41.35 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.747 -1.205 . . . . 72.14 107.747 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -125.05 99.08 5.95 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.91 -1.515 . . . . 54.41 106.91 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.5 mt -102.51 134.68 45.45 Favored 'General case' 0 C--N 1.274 -2.706 0 N-CA-C 107.984 -1.117 . . . . 74.35 107.984 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 9.8 p -123.89 125.23 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 119.414 -0.914 . . . . 65.2 112.861 -175.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.532 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 15.4 m-90 -101.06 148.8 24.64 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.629 -1.168 . . . . 74.11 109.6 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -118.61 120.9 38.83 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.415 -1.328 . . . . 75.34 107.415 172.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.447 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 35.2 t -72.32 176.78 4.98 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 123.977 0.798 . . . . 72.14 111.007 -176.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.29 162.02 23.68 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.905 -0.589 . . . . 75.24 110.435 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.46 108.84 4.47 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.739 0.78 . . . . 45.03 110.398 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -92.58 101.68 14.1 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.504 -1.295 . . . . 74.44 107.504 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.561 ' H ' ' HD3' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -59.14 119.46 7.36 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.498 -0.774 . . . . 73.25 110.345 176.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.8 t -103.03 161.29 13.89 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.115 -0.948 . . . . 72.34 109.822 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -61.57 -6.32 2.38 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.647 1.579 . . . . 74.24 114.3 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.532 ' HB2' ' HG2' ' A' ' 114' ' ' LYS . 0.5 OUTLIER -92.68 -4.66 52.89 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.6 -0.889 . . . . 71.12 108.6 179.297 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 68.69 42.07 1.52 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.454 1.121 . . . . 72.11 110.228 -171.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.532 ' HG2' ' HB2' ' A' ' 112' ' ' ASP . 18.2 pttp -129.22 158.0 40.27 Favored 'General case' 0 CA--C 1.487 -1.464 0 CA-C-N 113.912 -1.494 . . . . 63.35 107.369 173.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 26.1 pt -102.24 128.97 54.39 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.475 0 CA-C-O 121.113 0.482 . . . . 73.15 109.771 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.408 ' NH2' ' HA ' ' A' ' 142' ' ' SER . 0.8 OUTLIER -114.91 159.77 20.31 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 106.406 -1.702 . . . . 73.5 106.406 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 43.9 p90 -145.46 163.36 34.9 Favored 'General case' 0 C--N 1.265 -3.066 0 CA-C-O 121.464 0.649 . . . . 62.22 110.051 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 105' ' ' SER . 0.4 OUTLIER -102.62 136.9 41.6 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 106.206 -1.776 . . . . 64.11 106.206 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -114.21 141.14 47.91 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.487 -0.885 . . . . 70.41 108.974 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.66 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -123.2 117.49 25.46 Favored 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 115.472 -0.785 . . . . 62.34 111.307 -173.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -111.13 109.39 19.43 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.095 -1.076 . . . . 72.41 108.095 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.03 126.36 44.73 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 122.484 0.314 . . . . 70.33 110.48 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -103.69 119.3 38.62 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.584 -1.265 . . . . 74.41 107.584 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.438 HG22 ' SG ' ' A' ' 132' ' ' CYS . 50.2 mt -128.94 139.72 51.16 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 N-CA-C 106.315 -1.735 . . . . 75.22 106.315 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.429 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 0.2 OUTLIER -130.21 152.09 50.03 Favored 'General case' 0 C--O 1.256 1.428 0 C-N-CA 118.96 -1.096 . . . . 73.31 110.674 -177.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.514 ' HD3' ' OE2' ' A' ' 97' ' ' GLU . 45.6 ttp180 -74.81 114.49 13.31 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 105.965 -1.865 . . . . 61.43 105.965 174.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -81.43 145.48 30.75 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 108.271 -1.011 . . . . 75.0 108.271 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -66.4 -10.79 47.07 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 122.345 1.069 . . . . 75.35 110.12 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.78 -16.63 63.85 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.645 -1.161 . . . . 60.53 110.412 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.29 -23.43 20.68 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 111.482 -0.647 . . . . 72.1 111.482 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.0 t -100.47 -173.24 2.36 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.758 -0.83 . . . . 63.11 108.758 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.438 ' SG ' HG22 ' A' ' 124' ' ' ILE . 27.8 t -122.6 143.06 49.99 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.049 -1.834 . . . . 74.13 106.049 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.411 ' HE1' ' HA ' ' A' ' 52' ' ' HIS . 6.4 t90 -150.45 155.44 39.55 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 108.955 -0.757 . . . . 70.41 108.955 -172.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.59 130.75 42.64 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.938 0.399 . . . . 72.35 110.359 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -92.42 -43.29 9.29 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.746 -0.661 . . . . 71.01 109.646 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.5 t -179.41 151.33 0.47 Allowed 'General case' 0 C--O 1.194 -1.85 0 N-CA-C 106.582 -1.636 . . . . 71.23 106.582 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.2 m -134.95 152.37 32.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.832 -1.173 . . . . 74.51 107.832 173.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -128.64 133.64 48.31 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 122.72 0.408 . . . . 54.43 109.9 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.453 ' HB2' HG22 ' A' ' 58' ' ' VAL . 44.0 m-85 -121.98 112.4 18.24 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.185 -1.043 . . . . 71.22 108.185 176.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 17.2 pt -112.65 99.21 8.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 121.604 0.716 . . . . 60.51 111.926 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 52.2 mtt -86.78 94.65 9.59 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 106.415 -1.698 . . . . 74.51 106.415 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.408 ' HA ' ' NH2' ' A' ' 116' ' ' ARG . 66.5 m -162.74 -56.86 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.368 0.877 . . . . 75.43 113.368 -173.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -52.87 132.51 37.11 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.328 1.051 . . . . 72.24 112.744 -171.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -152.75 142.28 21.77 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.351 -0.841 . . . . 74.14 111.001 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.03 161.01 74.95 Favored Pre-proline 0 C--N 1.3 -1.571 0 O-C-N 124.036 0.835 . . . . 53.44 108.832 172.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.19 147.98 51.98 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.764 2.309 . . . . 60.31 111.712 176.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.449 ' HA ' ' HB3' ' A' ' 114' ' ' LYS . 6.1 p90 -61.87 160.12 12.67 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 113.089 0.774 . . . . 72.55 113.089 -176.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.5 p -101.93 148.74 7.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 108.242 -1.021 . . . . 74.42 108.242 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.962 0 N-CA-C 108.094 -1.076 . . . . 61.4 108.094 178.206 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 108.444 -0.947 . . . . 74.52 108.444 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.99 29.48 6.45 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.063 0.458 . . . . 70.53 111.284 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.7 t -63.78 -28.88 45.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 116.482 -0.326 . . . . 64.23 110.543 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.598 ' O ' HG23 ' A' ' 21' ' ' VAL . 1.4 p -63.87 -42.63 97.46 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 116.297 -0.41 . . . . 72.22 110.553 175.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.68 -38.49 91.17 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.841 0.856 . . . . 73.03 109.579 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.41 -37.12 84.49 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.265 -1.334 . . . . 71.21 108.182 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -73.12 -31.35 64.25 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.599 -0.728 . . . . 73.21 110.278 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 17' ' ' THR . 90.8 t -63.93 -50.19 78.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 109.688 -0.486 . . . . 71.2 109.688 175.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -30.21 66.71 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.398 -0.521 . . . . 64.24 110.438 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.43 -41.66 90.43 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 111.054 -0.818 . . . . 72.22 111.054 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 tp -63.04 -48.17 79.89 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 123.75 0.82 . . . . 74.44 109.146 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.95 -42.88 97.03 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.462 -0.79 . . . . 72.41 111.759 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -64.89 -44.33 89.98 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-O 119.773 -0.156 . . . . 74.45 111.194 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.35 -43.78 96.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.88 0.371 . . . . 61.12 110.251 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.463 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 26.7 t80 -62.39 -54.85 34.3 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 124.961 1.304 . . . . 73.44 110.113 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.2 mm -66.1 -34.06 67.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 112.24 0.459 . . . . 65.12 112.24 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.83 -39.15 73.16 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.572 -0.451 . . . . 71.45 110.043 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.63 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 4.1 pp -69.29 -30.25 68.3 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 119.556 -0.857 . . . . 65.14 110.846 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.7 t -72.08 -21.87 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 115.819 -0.628 . . . . 73.54 110.213 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.2 p -110.4 19.45 18.78 Favored 'General case' 0 C--O 1.248 0.991 0 O-C-N 121.455 -0.778 . . . . 74.3 111.887 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.63 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 70.6 mmtt -58.2 158.02 7.6 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-N 115.854 -0.612 . . . . 61.32 111.389 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.3 t -74.67 148.18 85.07 Favored Pre-proline 0 C--N 1.287 -2.11 0 N-CA-C 108.377 -0.971 . . . . 51.0 108.377 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -59.87 -6.03 4.28 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 123.858 3.039 . . . . 71.11 111.731 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.4 -27.48 67.48 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.009 0.924 . . . . 64.31 108.641 171.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.1 m -92.35 152.71 19.62 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 105.963 -1.866 . . . . 54.52 105.963 172.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.1 t -62.23 -53.21 50.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 113.208 0.818 . . . . 55.43 113.208 -174.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -158.08 125.4 5.07 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 119.618 -0.833 . . . . 72.33 112.204 -172.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -32.47 74.03 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 123.609 0.763 . . . . 75.32 112.14 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.04 -21.73 61.49 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.993 -0.549 . . . . 75.11 109.532 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -71.84 -42.35 67.05 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 107.42 -1.326 . . . . 71.51 107.42 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -66.16 -33.92 76.86 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.054 -0.976 . . . . 73.11 109.124 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.439 HD11 ' CE1' ' A' ' 28' ' ' PHE . 39.5 tp -69.91 -40.83 75.36 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.95 -0.568 . . . . 61.22 110.459 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.36 79.7 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.416 0.627 . . . . 73.21 109.915 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -69.59 -38.24 77.24 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.666 -1.152 . . . . 64.44 109.26 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.507 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 43.8 t80 -66.45 -45.31 80.21 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.353 -0.84 . . . . 71.42 110.308 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.3 pp -80.19 2.58 23.73 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.046 0.388 . . . . 71.33 112.046 -176.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -47.87 -62.52 4.09 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 111.729 -0.549 . . . . 42.35 111.729 173.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.507 ' HD2' ' O ' ' A' ' 48' ' ' PHE . 66.0 Cg_endo -79.99 -6.5 14.11 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.244 1.963 . . . . 72.3 112.363 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 92.4 m-70 -114.38 33.61 5.2 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 109.292 -0.632 . . . . 74.2 109.292 -176.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.436 ' CG ' HG21 ' A' ' 65' ' ' THR 0.267 13.5 t70 -53.76 99.03 0.19 Allowed Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 128.818 2.847 . . . . 74.01 111.516 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -113.06 -156.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 123.97 3.114 . . . . 74.13 113.089 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -92.75 127.87 38.41 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 107.608 -1.256 . . . . 74.33 107.608 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 65' ' ' THR . 43.2 mt -116.48 109.04 26.65 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 N-CA-C 109.046 -0.724 . . . . 61.24 109.046 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -91.18 138.89 31.24 Favored 'General case' 0 C--N 1.274 -2.698 0 O-C-N 122.176 -0.327 . . . . 64.31 110.487 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.76 120.07 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 N-CA-C 107.428 -1.323 . . . . 62.41 107.428 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 61.74 20.22 11.2 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.983 0.913 . . . . 72.43 110.636 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.41 3.67 58.55 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 115.922 -0.581 . . . . 73.55 113.208 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -111.67 132.39 54.64 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.021 -0.733 . . . . 72.13 109.021 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.77 126.15 34.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.689 0.757 . . . . 74.34 110.387 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -121.82 146.56 46.96 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.127 -1.434 . . . . 72.32 107.127 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -81.33 174.53 11.41 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.204 -0.598 . . . . 73.04 109.567 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.532 ' HA ' HD12 ' A' ' 56' ' ' ILE . 50.5 p -65.48 -33.92 77.07 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.528 1.131 . . . . 73.44 110.45 -176.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.526 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 25.0 m -62.53 -51.53 67.03 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.694 -1.139 . . . . 54.21 109.641 174.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.84 -48.51 79.56 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 123.628 0.771 . . . . 53.14 110.416 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CG ' HD13 ' A' ' 56' ' ' ILE . 31.6 t80 -49.87 -56.5 10.24 Favored 'General case' 0 CA--C 1.501 -0.931 0 O-C-N 123.751 0.657 . . . . 71.31 110.491 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -53.34 -42.95 67.29 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 124.517 1.135 . . . . 75.33 110.589 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.7 mm100 -61.75 -48.64 79.76 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 123.275 0.63 . . . . 73.12 111.234 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.462 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 34.3 m-85 -67.22 -40.27 86.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.314 0.578 . . . . 74.2 109.461 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -56.21 -51.31 68.55 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.765 -0.652 . . . . 72.43 110.653 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -72.05 -21.39 61.53 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 116.22 -0.446 . . . . 74.23 111.291 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -83.25 -2.5 55.76 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 120.793 -0.363 . . . . 75.52 111.889 173.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.09 12.09 50.48 Favored Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 120.632 -0.794 . . . . 34.44 114.136 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.83 -45.5 50.86 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 122.104 -0.645 . . . . 74.45 111.751 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 32.6 m-85 -97.08 0.83 49.25 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 113.819 1.044 . . . . 75.13 113.819 -175.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -67.74 -13.61 62.26 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.596 0.712 . . . . 64.33 111.374 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.424 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 8.4 mtpm? -72.25 -10.94 60.44 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.898 -0.592 . . . . 71.32 111.72 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.69 -7.28 59.58 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 121.067 0.461 . . . . 72.03 111.086 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.13 -26.39 64.87 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.469 0.652 . . . . 73.44 109.273 172.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -96.07 13.6 26.61 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.051 -0.522 . . . . 50.2 109.952 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -92.71 145.83 24.12 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.738 1.014 . . . . 64.23 113.738 -173.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -100.49 139.98 35.4 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.024 -1.843 . . . . 75.34 106.024 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.443 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 48.2 p90 -95.59 129.61 42.72 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.497 0.665 . . . . 70.1 112.222 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.61 103.33 14.15 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.184 -0.916 . . . . 73.34 108.612 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.3 tp -91.28 98.3 8.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 122.027 0.918 . . . . 71.02 110.226 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -90.05 170.34 10.42 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.731 -1.122 . . . . 64.52 109.228 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.7 p -70.49 106.31 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 121.631 0.729 . . . . 42.34 112.2 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.1 m -148.88 132.6 16.91 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.276 -0.875 . . . . 54.11 109.682 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 142.06 -47.12 0.84 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.143 -1.027 . . . . 71.21 113.318 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -83.38 83.8 7.74 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 113.878 1.066 . . . . 75.41 113.878 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.6 m -136.63 176.65 7.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.355 -1.72 . . . . 63.15 106.355 171.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -82.31 -59.43 2.55 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 113.09 0.774 . . . . 74.52 113.09 -176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -129.73 139.44 51.32 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.672 -0.492 . . . . 64.33 109.672 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.13 50.12 11.21 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 111.017 -0.833 . . . . 64.24 111.017 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -67.76 119.7 12.9 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.584 0.707 . . . . 72.44 111.235 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -110.28 148.79 17.52 Favored Glycine 0 N--CA 1.412 -2.935 0 CA-C-N 115.167 -0.924 . . . . 54.5 111.433 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -115.79 121.76 43.39 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.755 -1.202 . . . . 75.22 107.755 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.419 ' HE3' ' CD1' ' A' ' 123' ' ' TYR . 14.3 mptt -102.77 103.24 13.44 Favored 'General case' 0 C--N 1.313 -1.018 0 O-C-N 123.98 0.8 . . . . 74.13 108.952 174.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.25 125.1 48.86 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.161 -1.422 . . . . 64.24 107.161 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 15.3 t -124.4 134.64 66.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 119.796 -0.762 . . . . 71.24 110.492 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.443 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 18.8 m-90 -114.9 139.83 49.48 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.445 -0.946 . . . . 73.51 108.445 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.403 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 64.5 mttm -118.99 120.84 38.44 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.022 -1.103 . . . . 73.33 108.022 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 20.2 t -70.46 165.56 22.29 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.454 -0.943 . . . . 52.12 108.454 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.76 131.87 50.51 Favored 'General case' 0 C--O 1.239 0.515 0 O-C-N 123.249 0.343 . . . . 54.13 111.021 -176.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.88 129.75 36.64 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.094 0.473 . . . . 73.52 110.032 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -108.03 150.17 27.48 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.823 -1.547 . . . . 74.32 106.823 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -78.88 136.23 37.24 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 108.441 -0.948 . . . . 73.2 108.441 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.8 t -98.13 160.44 14.29 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.729 -0.841 . . . . 63.52 108.729 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -73.6 -14.11 61.13 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.69 0.757 . . . . 75.45 109.231 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -87.82 14.94 7.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.722 -0.672 . . . . 61.24 111.664 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 66.58 21.73 10.65 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.049 0.939 . . . . 73.1 111.8 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -114.53 -176.03 2.81 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.542 -1.281 . . . . 73.22 107.542 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 15.7 pt -121.55 153.04 25.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.832 -0.803 . . . . 75.02 108.832 172.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -133.92 142.61 47.8 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 123.23 0.612 . . . . 73.31 109.762 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.498 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 44.8 p90 -153.37 173.63 15.39 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.764 -0.828 . . . . 62.14 108.764 -176.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.4 ' H ' ' HB3' ' A' ' 105' ' ' SER . 8.1 m-20 -114.51 144.16 43.79 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.333 -1.358 . . . . 65.33 107.333 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.498 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 31.9 mt-10 -120.56 153.89 36.14 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 113.01 0.745 . . . . 72.33 113.01 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -137.07 120.93 17.52 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.731 -1.122 . . . . 75.1 108.939 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.418 ' HG3' HG22 ' A' ' 102' ' ' VAL . 88.6 tt0 -121.58 110.16 15.66 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.779 -0.823 . . . . 60.33 108.779 -176.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.57 133.94 41.45 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 122.933 0.493 . . . . 45.33 110.337 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.419 ' CD1' ' HE3' ' A' ' 100' ' ' LYS . 24.8 m-85 -113.53 116.85 30.19 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.703 -0.851 . . . . 75.35 108.703 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.9 mt -119.17 149.47 21.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.494 -1.669 . . . . 72.3 106.494 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -133.71 143.3 48.41 Favored 'General case' 0 C--O 1.265 1.898 0 C-N-CA 119.232 -0.987 . . . . 73.32 109.296 174.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -90.17 131.55 35.94 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 106.239 -1.763 . . . . 75.42 106.239 173.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.508 ' HD3' ' OG ' ' A' ' 131' ' ' SER . 54.4 mtp180 -85.39 144.58 27.94 Favored 'General case' 0 C--N 1.261 -3.242 0 N-CA-C 106.716 -1.587 . . . . 74.42 106.716 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -63.75 -10.57 20.42 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 114.651 1.352 . . . . 75.01 114.651 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -79.98 -14.17 58.78 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.726 -0.472 . . . . 73.35 109.726 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.88 -11.54 27.31 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.629 -0.796 . . . . 71.51 113.652 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.508 ' OG ' ' HD3' ' A' ' 127' ' ' ARG . 61.3 p -84.68 170.12 13.63 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 117.805 0.803 . . . . 73.04 109.72 175.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.564 ' SG ' ' HA ' ' A' ' 21' ' ' VAL . 13.7 p -138.02 142.3 40.39 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 108.395 -0.965 . . . . 62.21 108.395 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -150.08 155.66 40.27 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.291 -1.003 . . . . 73.21 108.291 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.9 mp -72.05 123.26 22.43 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.81 -0.441 . . . . 63.11 109.81 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -74.62 -52.91 10.44 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.149 -0.932 . . . . 74.32 109.009 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.4 t 179.52 156.91 0.58 Allowed 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 106.637 -1.616 . . . . 72.35 106.637 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.8 m -133.68 147.33 30.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 107.536 -1.283 . . . . 70.32 107.536 173.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -125.67 130.91 52.52 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-O 120.994 0.426 . . . . 65.05 109.979 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -110.23 135.85 50.34 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 107.878 -1.156 . . . . 72.22 107.878 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.528 ' HB ' ' CE ' ' A' ' 143' ' ' LYS . 12.3 pt -132.86 102.41 5.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 108.863 -0.792 . . . . 72.24 108.863 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 23.3 ptp -91.75 138.13 31.8 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.89 -0.724 . . . . 72.31 112.416 -173.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 35.3 m 59.34 77.97 0.29 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 113.456 -1.702 . . . . 74.33 114.08 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.528 ' CE ' ' HB ' ' A' ' 140' ' ' ILE . 5.9 mptp? -110.56 141.11 44.18 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.477 -1.238 . . . . 74.34 108.509 173.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -135.34 109.07 8.02 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.181 0.515 . . . . 41.43 109.997 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.77 159.09 34.11 Favored Pre-proline 0 C--N 1.294 -1.843 0 N-CA-C 109.208 -0.664 . . . . 75.02 109.208 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.81 129.79 35.85 Favored 'Trans proline' 0 CA--C 1.504 -0.982 0 C-N-CA 122.242 1.962 . . . . 74.52 111.102 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -139.32 131.15 27.59 Favored 'General case' 0 N--CA 1.392 -3.33 0 N-CA-C 107.847 -1.168 . . . . 73.4 107.847 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.4 m -92.28 122.45 43.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.544 0.687 . . . . 65.31 110.588 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.729 0 N-CA-C 107.633 -1.247 . . . . 74.34 107.633 178.94 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.491 -1.308 0 CA-C-O 121.137 0.494 . . . . 63.41 110.961 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.2 ttt -84.33 126.5 33.26 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 105.255 -2.128 . . . . 74.31 105.255 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.9 m -56.44 -26.39 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.454 0.909 . . . . 72.22 113.454 -173.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.639 ' O ' HG23 ' A' ' 21' ' ' VAL . 15.8 p -75.16 -22.77 57.87 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 112.195 0.443 . . . . 70.34 112.195 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.55 -35.55 60.64 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.351 -0.981 . . . . 71.52 108.351 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.91 -34.74 78.45 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.132 -1.394 . . . . 73.55 107.498 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 17' ' ' THR . 25.6 t70 -63.25 -43.28 98.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.433 -0.803 . . . . 74.5 109.669 177.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 17' ' ' THR . 57.7 t -61.04 -56.7 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 O-C-N 123.837 0.711 . . . . 64.21 111.077 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -64.14 -34.3 77.74 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.326 -0.55 . . . . 71.0 110.797 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.53 ' HA2' ' CE1' ' A' ' 26' ' ' TYR . . . -62.22 -51.45 56.55 Favored Glycine 0 C--O 1.256 1.519 0 CA-C-N 115.887 -0.597 . . . . 65.25 112.303 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 pp -70.63 -30.38 67.01 Favored 'General case' 0 C--O 1.21 -0.999 0 N-CA-C 108.48 -0.933 . . . . 70.43 108.48 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.14 -44.43 76.54 Favored Glycine 0 N--CA 1.424 -2.107 0 CA-C-N 115.729 -0.669 . . . . 51.54 111.849 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.53 ' CE1' ' HA2' ' A' ' 23' ' ' GLY . 2.9 p90 -74.59 -35.23 62.99 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 119.272 -0.971 . . . . 73.13 110.459 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -63.63 -46.76 84.22 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.351 -0.611 . . . . 52.22 109.351 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 33.0 t80 -61.58 -52.7 63.35 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 115.35 -0.841 . . . . 74.2 110.554 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 29' ' ' ILE . 9.3 mm -61.14 -39.03 81.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 112.643 0.609 . . . . 65.3 112.643 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -68.15 -40.21 82.45 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 119.697 -0.801 . . . . 74.43 110.365 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.615 ' HA ' ' HD3' ' A' ' 34' ' ' LYS . 4.0 pp -71.59 -26.77 62.74 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 119.134 -1.026 . . . . 73.42 112.311 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.2 t -70.72 -25.74 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 109.363 -0.606 . . . . 42.32 109.363 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.4 p -107.94 19.31 20.2 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.308 0.575 . . . . 73.51 110.226 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.615 ' HD3' ' HA ' ' A' ' 31' ' ' LEU . 17.8 tptt -61.83 143.21 56.68 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-N 115.196 -0.911 . . . . 72.4 109.446 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.6 m -55.53 141.58 63.37 Favored Pre-proline 0 C--N 1.309 -1.159 0 O-C-N 123.78 0.675 . . . . 74.55 112.216 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.53 -7.44 20.33 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.332 2.688 . . . . 74.01 112.883 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -79.63 -26.53 41.1 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.944 -0.571 . . . . 55.43 109.954 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.3 m -70.46 172.87 7.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.816 -0.809 . . . . 73.33 108.816 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.2 t -52.54 -53.69 18.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 112.255 0.465 . . . . 73.35 112.255 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.53 ' ND2' ' HB3' ' A' ' 42' ' ' GLU . 33.4 t30 173.43 134.81 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.836 0.71 . . . . 74.13 109.243 -175.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.7 m -58.11 -38.92 77.39 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.24 0.543 . . . . 73.31 110.283 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.53 ' HB3' ' ND2' ' A' ' 40' ' ' ASN . 8.7 tp10 -68.43 -20.85 64.67 Favored 'General case' 0 C--O 1.204 -1.292 0 CA-C-N 115.153 -0.93 . . . . 64.5 110.135 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -67.16 -47.23 71.65 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.412 -0.959 . . . . 52.45 108.412 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 18.3 mm-40 -71.04 -34.38 71.2 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 114.744 -1.116 . . . . 52.22 109.52 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.1 tp -66.16 -45.87 79.43 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 120.961 -0.296 . . . . 74.31 110.656 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.401 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . . . -60.45 -34.14 73.56 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.57 0.7 . . . . 73.55 110.661 176.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -70.67 -39.56 73.49 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.379 -0.828 . . . . 75.2 109.902 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 62.4 t80 -68.04 -40.43 82.84 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 124.38 1.072 . . . . 73.23 110.565 -178.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.7 pp -83.13 0.94 42.88 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 115.689 -0.687 . . . . 72.35 110.864 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.45 -58.21 4.72 Favored Glycine 0 CA--C 1.536 1.378 0 O-C-N 123.965 0.791 . . . . 71.4 113.439 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.89 -6.3 12.3 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 121.922 1.748 . . . . 62.11 112.172 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 10.9 m170 -108.82 32.22 5.06 Favored 'General case' 0 C--O 1.213 -0.862 0 C-N-CA 123.417 0.687 . . . . 73.13 109.807 -175.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.421 ' CG ' HG21 ' A' ' 65' ' ' THR . 13.0 t70 -53.57 98.58 0.17 Allowed Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 127.515 2.326 . . . . 63.53 110.633 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -114.54 -147.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 124.48 3.453 . . . . 65.31 113.188 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -102.71 128.77 49.28 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 108.717 -0.846 . . . . 74.44 108.717 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.433 HG22 HG23 ' A' ' 58' ' ' VAL . 3.4 mp -107.91 111.71 37.06 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.369 0 N-CA-C 108.862 -0.792 . . . . 74.54 108.862 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -95.97 109.57 21.93 Favored 'General case' 0 C--O 1.18 -2.553 0 O-C-N 121.742 -0.599 . . . . 73.32 111.334 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 56' ' ' ILE . 70.6 t -109.14 114.34 46.64 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.539 0 N-CA-C 108.392 -0.966 . . . . 74.22 108.392 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 63.93 20.83 12.39 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.524 1.13 . . . . 75.42 110.311 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.93 -10.08 62.0 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 114.961 -1.018 . . . . 61.33 112.022 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -93.59 130.51 39.46 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 110.069 -0.345 . . . . 74.1 110.069 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.68 121.07 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-O 122.611 1.196 . . . . 73.34 109.163 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -115.22 137.88 51.55 Favored 'General case' 0 C--N 1.271 -2.811 0 N-CA-C 106.451 -1.685 . . . . 74.23 106.451 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 67' ' ' ALA . 15.2 t -77.1 168.21 20.46 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 108.606 -0.887 . . . . 41.32 108.606 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.421 HG21 ' CG ' ' A' ' 53' ' ' ASP . 46.9 p -63.76 -32.83 74.45 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 123.981 0.912 . . . . 75.54 110.472 -176.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -62.65 -46.84 86.37 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.221 -1.354 . . . . 73.43 109.888 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.451 ' H ' HG23 ' A' ' 64' ' ' THR . . . -64.96 -44.9 87.89 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 123.549 0.74 . . . . 64.43 110.469 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -53.58 -54.35 38.68 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 123.477 0.486 . . . . 74.21 110.137 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -52.15 -41.42 62.55 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 124.306 1.003 . . . . 54.41 110.643 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.491 ' HG2' ' NH2' ' A' ' 73' ' ' ARG . 46.2 mt-30 -60.26 -51.47 69.39 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.279 -0.419 . . . . 74.4 111.556 175.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -63.33 -32.98 74.55 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.981 0.896 . . . . 74.41 110.393 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -62.07 -53.51 54.52 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.419 -1.264 . . . . 62.24 111.169 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.491 ' NH2' ' HG2' ' A' ' 70' ' ' GLN . 26.1 ptt180 -71.29 -20.7 62.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.96 0.409 . . . . 73.45 110.561 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 56.3 mt-30 -76.88 -9.2 58.52 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.229 -0.442 . . . . 71.41 110.941 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.57 7.48 64.92 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.941 -0.647 . . . . 70.43 114.024 174.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.2 mt -65.92 -28.81 69.2 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 117.161 0.481 . . . . 75.4 112.273 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -99.18 12.63 35.6 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.529 -0.469 . . . . 74.2 111.912 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.435 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 30.1 mmmt -70.78 -17.34 62.78 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.388 0.613 . . . . 72.12 110.434 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -83.27 -22.51 33.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.83 -0.623 . . . . 34.01 110.001 175.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.0 tp -76.68 -6.72 53.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.854 -0.612 . . . . 73.23 111.453 -172.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 1.6 pptp? -76.76 -3.65 39.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.618 0.723 . . . . 75.31 110.687 177.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -100.93 10.83 40.65 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 115.295 -0.866 . . . . 75.43 110.147 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.714 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -76.14 130.07 37.74 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-O 121.406 0.622 . . . . 74.14 112.301 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -112.6 150.02 31.97 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.855 -1.066 . . . . 75.04 109.871 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -72.44 128.5 35.79 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 123.774 0.671 . . . . 72.15 111.041 -174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -129.86 137.99 50.73 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 116.148 -0.478 . . . . 75.32 110.01 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.8 pt -93.04 78.07 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.935 0.874 . . . . 63.53 113.158 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -97.08 160.65 14.22 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.548 -1.278 . . . . 74.55 107.548 175.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.5 m -62.75 139.14 21.62 Favored 'Isoleucine or valine' 0 C--O 1.25 1.112 0 N-CA-C 113.248 0.833 . . . . 74.41 113.248 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.9 m -81.59 -43.07 19.16 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.049 -0.978 . . . . 74.34 109.03 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.54 44.29 90.34 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.546 -0.752 . . . . 74.45 113.058 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -89.59 89.32 7.77 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.997 -0.372 . . . . 75.41 109.997 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.54 -52.15 17.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.835 -0.802 . . . . 74.43 108.835 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -157.71 133.89 9.5 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.228 -0.896 . . . . 71.34 108.698 175.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -179.15 -61.31 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.648 -1.612 . . . . 71.43 106.648 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.38 165.71 32.48 Favored Glycine 0 C--N 1.279 -2.633 0 N-CA-C 106.587 -2.605 . . . . 53.31 106.587 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -76.23 119.91 20.78 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 118.285 1.043 . . . . 73.21 108.842 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -165.25 -167.53 25.99 Favored Glycine 0 N--CA 1.417 -2.569 0 C-N-CA 119.718 -1.23 . . . . 62.13 112.568 -176.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.08 157.42 41.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 109.033 -0.729 . . . . 64.34 109.033 -174.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 57.9 tttm -147.41 100.13 3.22 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.93 -1.137 . . . . 74.54 107.93 174.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -110.31 158.88 17.94 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.766 -0.827 . . . . 54.0 108.766 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.2 p -134.51 140.56 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 121.667 0.746 . . . . 63.33 111.838 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.714 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 24.1 m-90 -116.15 127.69 55.03 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.689 -1.141 . . . . 74.25 108.172 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.431 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 66.3 mttm -105.9 131.96 52.58 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.147 -0.686 . . . . 74.22 109.147 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.2 t -75.01 -174.63 2.31 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.506 -0.924 . . . . 63.21 108.506 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.23 153.16 38.9 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.307 -0.627 . . . . 73.55 109.307 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.11 129.63 42.13 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 108.999 -0.741 . . . . 34.5 108.999 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -112.35 137.43 50.53 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.184 -1.043 . . . . 64.12 108.184 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -75.95 132.17 40.07 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.396 0.617 . . . . 72.15 110.91 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.7 t -92.04 161.77 14.64 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.099 -0.955 . . . . 71.45 109.183 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -60.69 -28.13 68.38 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.244 1.018 . . . . 73.01 111.224 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.462 ' OD2' ' HG2' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -88.77 15.76 7.82 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.378 -0.828 . . . . 64.24 112.856 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 73.0 10.07 5.34 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.032 0.933 . . . . 50.31 112.608 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.462 ' HG2' ' OD2' ' A' ' 112' ' ' ASP . 26.3 pttm -103.72 172.7 6.66 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.844 -1.169 . . . . 73.25 107.844 174.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 16.1 pt -114.44 140.37 35.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.733 -0.787 . . . . 71.32 111.765 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.61 133.15 54.99 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.982 -1.008 . . . . 75.55 109.083 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 2.8 p90 -129.15 174.06 9.91 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 108.772 -0.825 . . . . 73.11 108.772 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -110.5 135.56 50.98 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.963 -1.495 . . . . 74.33 106.963 176.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.468 ' HB2' HG13 ' A' ' 140' ' ' ILE . 46.0 mt-10 -116.83 156.53 27.11 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.919 -0.713 . . . . 52.13 111.89 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -135.87 117.53 14.97 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.923 -1.035 . . . . 71.31 108.415 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -112.79 112.31 23.71 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.845 -0.798 . . . . 75.52 108.845 -175.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -98.16 131.76 44.26 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.402 -0.519 . . . . 54.31 110.716 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -108.77 121.81 45.84 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 114.478 -1.237 . . . . 74.41 108.206 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.425 HG12 HD23 ' A' ' 134' ' ' LEU . 50.8 mt -124.3 137.12 58.26 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 N-CA-C 107.53 -1.285 . . . . 72.43 107.53 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -114.37 150.31 34.78 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.298 -1.742 . . . . 74.35 106.298 176.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -111.67 136.56 50.73 Favored 'General case' 0 N--CA 1.403 -2.817 0 C-N-CA 118.293 -1.363 . . . . 73.34 110.385 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.403 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 61.4 ttt180 -88.83 154.82 19.95 Favored 'General case' 0 C--N 1.258 -3.389 0 CA-C-N 112.912 -1.949 . . . . 74.22 109.366 -170.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -59.78 -26.62 65.87 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.466 0.706 . . . . 52.33 110.91 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.403 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 31.1 t70 -67.01 -16.22 64.23 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.43 -0.805 . . . . 72.25 110.773 175.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.62 -23.64 29.26 Favored Glycine 0 C--O 1.221 -0.683 0 O-C-N 121.921 -0.487 . . . . 74.41 112.111 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.9 t -73.0 140.47 47.35 Favored 'General case' 0 N--CA 1.42 -1.933 0 C-N-CA 123.483 0.713 . . . . 74.15 109.532 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 81.3 m -104.57 141.92 35.56 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.195 -1.039 . . . . 74.15 108.195 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -140.54 154.56 46.58 Favored 'General case' 0 N--CA 1.408 -2.56 0 N-CA-C 107.941 -1.133 . . . . 62.31 107.941 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.425 HD23 HG12 ' A' ' 124' ' ' ILE . 78.9 mt -67.9 116.14 8.21 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.25 -0.648 . . . . 60.25 109.25 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -80.84 -46.41 15.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 106.921 -1.511 . . . . 74.41 106.921 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.8 p -174.75 172.97 2.88 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.002 -0.999 . . . . 71.1 108.74 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.6 t -144.05 141.12 24.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 106.596 -1.631 . . . . 74.21 106.596 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -119.08 132.37 56.01 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 109.5 -0.555 . . . . 70.33 109.5 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.425 ' HB2' HG22 ' A' ' 58' ' ' VAL . 64.4 m-85 -115.28 131.72 56.84 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.604 -1.258 . . . . 64.41 107.604 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.468 HG13 ' HB2' ' A' ' 119' ' ' GLU . 4.5 pt -132.12 99.04 3.4 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 CA-C-O 121.71 0.767 . . . . 62.51 110.811 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 21.6 ptp -85.07 126.22 33.4 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.843 -1.071 . . . . 50.21 109.805 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.7 t 77.42 74.32 0.07 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.548 1.139 . . . . 61.24 112.016 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -113.12 128.7 56.56 Favored 'General case' 0 CA--C 1.47 -2.109 0 N-CA-C 107.167 -1.42 . . . . 74.33 107.167 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -119.3 128.06 53.79 Favored 'General case' 0 C--N 1.259 -3.349 0 CA-C-N 115.029 -0.987 . . . . 61.15 112.826 -171.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.75 133.03 33.21 Favored Pre-proline 0 N--CA 1.426 -1.654 0 N-CA-C 107.79 -1.189 . . . . 70.4 107.79 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.43 147.11 82.16 Favored 'Trans proline' 0 C--O 1.246 0.891 0 C-N-CA 122.23 1.953 . . . . 61.23 111.108 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -80.72 147.49 30.55 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 107.63 -1.248 . . . . 74.31 107.63 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.6 106.18 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 122.283 1.04 . . . . 63.41 112.554 -174.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.656 0 CA-C-N 114.589 -1.187 . . . . 65.42 108.709 -179.851 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 CA--C 1.5 -0.98 0 N-CA-C 109.763 -0.458 . . . . 71.52 109.763 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.469 ' H ' HD12 ' A' ' 19' ' ' LEU . 52.5 ttm 62.61 17.78 9.97 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.558 1.143 . . . . 74.12 110.715 -176.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.3 t -73.04 148.01 9.37 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.882 0 N-CA-C 105.344 -2.095 . . . . 64.54 105.344 175.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.4 p -45.59 -47.07 14.64 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.298 0.954 . . . . 64.53 113.431 -177.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 17.2 t70 -59.89 -45.45 92.46 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-O 122.083 0.944 . . . . 62.42 111.028 177.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.469 HD12 ' H ' ' A' ' 15' ' ' MET . 3.4 tm? -72.36 -33.83 67.54 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.865 -1.061 . . . . 72.11 108.39 -177.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -65.45 -47.43 76.18 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 124.751 1.22 . . . . 64.24 109.982 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.507 ' HA ' ' CD2' ' A' ' 24' ' ' LEU . 6.3 p -65.85 -43.06 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 112.327 0.491 . . . . 73.41 112.327 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 13.4 ptpt -71.25 -24.51 62.19 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 118.659 -1.216 . . . . 75.32 111.23 177.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.33 -56.49 10.09 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.782 -0.645 . . . . 71.44 112.323 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.507 ' CD2' ' HA ' ' A' ' 21' ' ' VAL . 1.7 pt? -70.09 -30.65 67.92 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 118.965 -1.094 . . . . 74.12 109.629 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.9 -42.17 98.47 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.664 -0.698 . . . . 51.1 111.92 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -69.03 -43.67 74.25 Favored 'General case' 0 C--O 1.208 -1.084 0 C-N-CA 119.795 -0.762 . . . . 75.33 110.759 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -57.75 -43.9 85.71 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.154 0.502 . . . . 70.3 110.1 -177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.501 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 26.5 t80 -62.3 -54.23 43.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.725 -1.125 . . . . 72.22 110.149 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.6 mm -63.42 -33.96 64.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 112.296 0.48 . . . . 65.13 112.296 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -68.82 -43.73 74.94 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 110.181 -0.303 . . . . 54.24 110.181 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.6 pp -68.19 -31.18 70.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.979 -0.688 . . . . 73.24 110.562 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.72 -27.49 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 116.06 -0.518 . . . . 62.43 110.103 175.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.8 p -107.51 19.83 19.7 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.485 0.659 . . . . 53.14 110.299 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 34' ' ' LYS . 20.5 tptt -77.26 158.14 30.41 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.749 -0.66 . . . . 65.13 109.62 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 m -56.39 131.3 76.25 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.474 0.71 . . . . 64.02 111.521 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.31 -7.11 20.04 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.614 2.876 . . . . 70.02 111.544 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.73 -19.58 65.78 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.26 1.424 . . . . 72.33 110.58 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.1 t -76.08 -176.56 3.55 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 107.92 -1.141 . . . . 71.45 107.92 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.64 -50.01 82.16 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 118.341 0.519 . . . . 74.55 111.575 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.3 t30 177.2 131.07 0.05 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.566 -0.531 . . . . 63.15 109.566 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.3 m -60.86 -35.19 75.94 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-O 121.44 0.638 . . . . 74.03 110.384 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -66.66 -20.75 66.06 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.923 -1.035 . . . . 74.4 110.946 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -67.68 -47.35 69.69 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 108.944 -0.761 . . . . 70.43 108.944 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -68.23 -34.32 76.02 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.084 -0.962 . . . . 73.35 108.741 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.4 HD11 ' CE2' ' A' ' 28' ' ' PHE . 36.1 tp -66.47 -44.68 82.06 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 116.129 -0.487 . . . . 54.12 110.42 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.77 -33.12 73.51 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.431 0.634 . . . . 32.24 110.408 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -77.12 -32.36 56.39 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.203 -0.908 . . . . 53.02 109.756 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -68.9 -47.31 66.11 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.772 -0.455 . . . . 73.22 109.772 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.6 pp -73.33 -2.56 22.6 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.766 -0.652 . . . . 65.13 112.363 -176.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -39.24 -67.44 0.59 Allowed Glycine 0 CA--C 1.538 1.487 0 O-C-N 123.908 0.755 . . . . 70.31 113.123 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.402 ' O ' ' HZ2' ' A' ' 133' ' ' TRP . 7.8 Cg_exo -78.78 -6.4 15.19 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.823 2.348 . . . . 64.53 113.002 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 86.2 m-70 -110.5 24.73 12.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.704 -0.48 . . . . 75.2 109.704 -172.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.446 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 8.3 t70 -55.91 109.47 1.67 Allowed Pre-proline 0 C--O 1.244 0.811 0 C-N-CA 124.654 1.181 . . . . 75.31 111.965 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -112.98 -149.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.634 0 C-N-CA 124.257 3.304 . . . . 73.32 110.577 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -92.12 119.16 31.52 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 107.986 -1.116 . . . . 74.43 107.986 172.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.475 HD13 ' CB ' ' A' ' 68' ' ' PHE . 67.5 mt -101.16 112.71 34.99 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.683 0 N-CA-C 106.552 -1.647 . . . . 74.53 106.552 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -98.09 133.24 42.81 Favored 'General case' 0 C--N 1.259 -3.357 0 C-N-CA 119.891 -0.724 . . . . 65.44 109.298 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.3 t -128.28 114.68 35.21 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 107.31 -1.367 . . . . 75.32 107.31 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 63.53 20.57 12.31 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.947 1.299 . . . . 75.24 110.473 -176.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.55 -3.24 65.59 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.672 -0.694 . . . . 43.01 112.286 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -98.48 133.14 43.28 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.934 -0.765 . . . . 64.44 108.934 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.401 HD13 ' N ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -73.63 125.41 32.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 122.152 0.977 . . . . 70.42 109.81 -175.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 58.9 mm-40 -124.65 148.02 48.18 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 115.044 -0.98 . . . . 63.3 108.727 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 t -95.14 172.21 8.26 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.517 -1.29 . . . . 74.45 107.517 173.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.446 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 9.1 t -54.06 -34.92 61.36 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 112.731 0.641 . . . . 73.52 112.731 -177.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.538 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 73.0 m -65.43 -48.31 73.2 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 120.869 -0.332 . . . . 74.14 110.696 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -59.12 -45.71 90.2 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 122.668 0.387 . . . . 75.5 110.16 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.475 ' CB ' HD13 ' A' ' 56' ' ' ILE . 56.7 t80 -54.21 -55.82 24.3 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 123.441 0.463 . . . . 75.54 110.032 174.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.86 -39.88 59.65 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.767 -1.106 . . . . 71.33 110.885 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.9 mm100 -63.81 -47.6 80.2 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 123.048 0.539 . . . . 64.4 111.375 177.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.43 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 31.7 m-85 -66.35 -32.67 74.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.816 0.817 . . . . 64.0 109.684 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -61.93 -56.02 23.54 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.008 -0.996 . . . . 52.33 110.617 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -69.16 -22.81 63.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.465 -0.334 . . . . 63.23 111.777 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 53.1 mt-30 -74.43 -16.1 60.88 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.164 0.507 . . . . 64.23 110.905 174.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.24 7.4 52.19 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.245 -0.978 . . . . 62.41 113.635 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.0 mt -70.72 -43.31 69.2 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.08 0.467 . . . . 72.03 110.641 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 32.3 m-85 -83.9 -4.45 58.7 Favored 'General case' 0 C--O 1.211 -0.945 0 C-N-CA 120.303 -0.559 . . . . 73.13 111.066 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.01 -14.44 61.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.673 0.749 . . . . 63.25 109.462 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -84.81 -29.02 25.73 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.58 -0.896 . . . . 74.55 108.58 175.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.519 ' HA ' ' OG ' ' A' ' 105' ' ' SER . 8.6 tt -84.45 -6.62 59.39 Favored 'General case' 0 C--O 1.2 -1.517 0 CA-C-N 114.835 -1.075 . . . . 73.3 110.919 -172.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -66.57 -10.96 50.65 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.608 0.718 . . . . 74.35 112.296 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -98.35 14.33 28.37 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.684 -0.689 . . . . 54.24 109.359 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.713 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -69.81 130.55 42.6 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 113.799 1.037 . . . . 65.31 113.799 -176.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -104.3 139.86 38.69 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.237 -1.347 . . . . 61.24 107.575 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.44 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 44.2 p90 -81.98 142.43 32.4 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.99 -0.684 . . . . 75.41 111.77 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.35 149.05 28.27 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 115.057 -0.974 . . . . 64.1 108.524 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 51.1 mm -79.23 124.49 37.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.433 -0.951 . . . . 74.4 108.433 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -146.8 140.9 26.15 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 106.027 -1.842 . . . . 74.13 106.027 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.303 28.0 m 45.79 96.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.794 1.638 . . . . 73.02 115.045 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.0 m -78.75 89.12 4.61 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 114.83 -1.077 . . . . 74.03 108.871 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.42 147.16 19.06 Favored Glycine 0 N--CA 1.424 -2.137 0 N-CA-C 110.344 -1.102 . . . . 43.45 110.344 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -113.07 -177.67 3.19 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.319 -0.552 . . . . 72.1 111.756 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.8 m -85.66 22.05 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 123.596 0.758 . . . . 55.11 112.052 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -51.49 16.11 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.825 0.676 . . . . 64.1 112.825 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -120.84 163.97 17.36 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.913 -0.403 . . . . 73.43 109.913 -175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 126' ' ' ARG . . . -79.49 91.97 1.29 Allowed Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 112.054 -0.418 . . . . 72.03 112.054 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -136.05 175.21 9.81 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.861 -1.163 . . . . 74.44 107.861 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -104.31 148.95 16.94 Favored Glycine 0 N--CA 1.427 -1.938 0 C-N-CA 120.242 -0.98 . . . . 54.41 112.524 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -106.87 145.32 32.31 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.142 -1.058 . . . . 63.31 108.142 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.12 100.24 6.86 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.875 -1.528 . . . . 70.24 106.875 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.6 mt -108.83 127.48 54.06 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 108.204 -1.036 . . . . 70.45 108.204 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 18.8 t -123.44 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 120.262 -0.575 . . . . 64.52 110.736 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.713 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 19.3 m-90 -111.06 145.15 39.02 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.402 -0.817 . . . . 71.3 109.093 176.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 83' ' ' ALA . 51.1 mttm -119.31 120.36 36.73 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.593 -0.892 . . . . 71.33 108.593 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.519 ' OG ' ' HA ' ' A' ' 80' ' ' LEU . 29.1 t -75.08 177.48 6.37 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 124.215 1.006 . . . . 64.04 111.399 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.0 139.31 54.99 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.879 -0.601 . . . . 62.31 109.608 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.499 ' HB1' ' HB ' ' A' ' 115' ' ' ILE . . . -82.74 120.92 26.21 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-N 115.922 -0.581 . . . . 73.21 109.696 -177.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -107.11 141.1 38.89 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.101 -1.074 . . . . 75.44 108.101 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.4 ttm-85 -78.35 118.12 20.23 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.547 -0.909 . . . . 73.4 108.547 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 99.3 p -91.31 -174.88 4.08 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.113 -0.949 . . . . 51.52 110.795 -173.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -82.94 -13.14 56.6 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.097 0.475 . . . . 75.25 110.344 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.419 ' HB2' ' HG2' ' A' ' 114' ' ' LYS . 19.1 m-20 -90.0 9.79 26.56 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.62 -0.718 . . . . 54.22 110.723 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 69.86 12.88 7.99 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.319 1.048 . . . . 73.32 112.152 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.419 ' HG2' ' HB2' ' A' ' 112' ' ' ASP . 26.1 pttm -111.57 165.45 12.0 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.034 -0.728 . . . . 61.33 109.034 176.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.499 ' HB ' ' HB1' ' A' ' 107' ' ' ALA . 21.2 pt -107.35 127.52 63.11 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 108.751 -0.833 . . . . 75.12 108.751 175.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 107' ' ' ALA . 41.6 ptt85 -112.62 159.31 19.0 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.237 -0.653 . . . . 74.05 109.237 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 36.9 p90 -136.13 173.97 11.13 Favored 'General case' 0 C--N 1.272 -2.784 0 N-CA-C 108.699 -0.852 . . . . 75.45 108.699 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.51 ' H ' ' HB3' ' A' ' 105' ' ' SER . 2.4 m-20 -112.08 136.8 50.98 Favored 'General case' 0 C--N 1.259 -3.339 0 N-CA-C 105.872 -1.899 . . . . 65.25 105.872 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.414 ' CD ' ' HD3' ' A' ' 143' ' ' LYS . 86.9 mt-10 -114.7 145.29 42.22 Favored 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 119.411 -0.915 . . . . 73.22 110.119 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -126.32 117.24 22.59 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 115.123 -0.944 . . . . 71.54 109.424 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -110.64 110.04 20.56 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.731 -0.84 . . . . 75.35 108.731 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.65 125.06 42.2 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 109.315 -0.624 . . . . 61.41 109.315 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -106.89 112.48 25.46 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.946 -1.131 . . . . 62.11 107.946 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 54.6 mt -110.74 146.84 15.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.283 0 N-CA-C 107.348 -1.353 . . . . 63.31 107.348 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.427 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.3 OUTLIER -129.24 150.5 50.59 Favored 'General case' 0 C--O 1.262 1.75 0 N-CA-C 108.028 -1.101 . . . . 72.21 108.028 177.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 40.3 ttp85 -85.45 112.57 21.01 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.408 -1.33 . . . . 73.52 107.408 176.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -67.41 150.43 48.94 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.852 -1.067 . . . . 73.41 109.132 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -57.82 -15.7 9.19 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.855 1.262 . . . . 71.4 111.411 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -81.06 -6.38 58.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.828 -0.624 . . . . 75.42 111.411 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.4 -25.25 15.97 Favored Glycine 0 CA--C 1.504 -0.597 0 N-CA-C 114.816 0.687 . . . . 52.34 114.816 172.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.5 m -103.79 166.56 10.34 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 109.399 -0.593 . . . . 73.23 109.399 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 63.9 m -98.66 154.7 17.76 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.866 -0.42 . . . . 52.23 109.866 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.427 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 25.0 t-105 -150.09 155.13 39.3 Favored 'General case' 0 N--CA 1.412 -2.368 0 N-CA-C 106.681 -1.6 . . . . 74.14 106.681 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.03 119.71 10.0 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.682 -0.488 . . . . 64.04 109.682 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -83.72 -53.8 5.37 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.693 -1.225 . . . . 71.51 107.693 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.6 m -164.62 157.42 16.85 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 106.396 -1.705 . . . . 71.34 106.396 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.95 154.8 31.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 107.472 -1.307 . . . . 72.1 107.472 173.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -130.55 137.35 49.65 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 110.112 -0.329 . . . . 71.31 110.112 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -120.63 118.02 29.05 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.873 -1.158 . . . . 61.53 107.873 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.5 pt -116.03 102.78 14.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-O 121.504 0.669 . . . . 73.51 110.851 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.8 mtp -96.33 92.45 6.34 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.802 -1.555 . . . . 64.31 106.802 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.4 m -177.23 -49.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 112.754 0.65 . . . . 70.53 112.754 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.414 ' HD3' ' CD ' ' A' ' 119' ' ' GLU . 86.6 tttt -50.09 137.79 16.94 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.986 0.914 . . . . 72.11 112.994 -172.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -152.91 161.75 42.15 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 112.516 0.561 . . . . 62.42 112.516 -173.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.73 156.95 67.6 Favored Pre-proline 0 C--N 1.312 -1.029 0 CA-C-N 114.591 -1.186 . . . . 61.11 107.915 170.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -55.7 147.41 60.48 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.869 2.379 . . . . 75.1 112.342 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -63.06 152.8 36.04 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 121.213 0.53 . . . . 72.05 111.403 -175.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.2 p -115.0 142.58 27.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.751 -0.659 . . . . 45.35 109.415 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.789 0 N-CA-C 107.227 -1.398 . . . . 60.51 107.227 176.55 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.5 -0.947 0 N-CA-C 108.327 -0.99 . . . . 71.14 108.327 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 55.3 ttm -91.11 -21.59 21.12 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.11 0.957 . . . . 52.25 109.718 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.1 m -85.2 67.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 114.235 -1.348 . . . . 61.12 109.364 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.0 p -64.44 -37.65 88.28 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.565 -1.198 . . . . 64.12 113.025 -171.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -63.03 -40.88 99.06 Favored 'General case' 0 C--O 1.249 1.071 0 CA-C-O 121.57 0.7 . . . . 62.53 110.489 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.55 -38.31 71.03 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.539 -0.911 . . . . 73.23 108.539 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.23 -45.37 69.96 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.372 -0.831 . . . . 74.35 111.259 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.3 m -70.39 -34.69 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 112.109 0.411 . . . . 52.15 112.109 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.537 ' HB3' ' HZ3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -69.7 -35.47 75.11 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 118.638 -1.225 . . . . 74.42 109.078 176.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.07 -40.79 83.05 Favored Glycine 0 C--O 1.216 -1.02 0 N-CA-C 111.327 -0.709 . . . . 74.4 111.327 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 tp -68.21 -47.98 66.42 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 123.465 0.706 . . . . 63.02 109.705 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.79 -41.04 99.01 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 115.645 -0.707 . . . . 72.41 111.718 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -67.82 -43.5 79.44 Favored 'General case' 0 C--O 1.198 -1.644 0 CA-C-O 118.879 -0.581 . . . . 74.45 111.085 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -57.96 -44.31 86.96 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 120.837 0.351 . . . . 72.32 110.082 -176.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -61.73 -54.56 40.9 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.633 -1.167 . . . . 74.25 110.438 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.6 mm -60.6 -35.84 66.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 112.49 0.552 . . . . 42.44 112.49 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.93 -47.76 73.66 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.102 -0.703 . . . . 71.04 109.102 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.536 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 4.1 pp -73.59 -19.13 60.96 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 119.985 -0.686 . . . . 63.22 112.099 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.1 t -74.86 -28.17 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.462 0.649 . . . . 71.01 109.527 173.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.8 p -106.13 14.32 27.85 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.829 0.823 . . . . 73.41 109.18 -176.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 21.5 tptp -39.66 124.25 1.65 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 127.163 2.185 . . . . 74.0 112.879 -176.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 m -53.49 146.91 22.21 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.707 1.203 . . . . 64.43 112.048 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.14 -7.76 16.47 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 123.598 2.865 . . . . 73.41 112.614 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.93 -26.95 68.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.321 -0.854 . . . . 75.35 110.276 175.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 p -101.81 167.79 9.85 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.861 -0.609 . . . . 72.11 110.675 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.4 t -62.96 -54.95 26.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 114.034 1.124 . . . . 71.35 114.034 -172.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -171.11 139.84 1.43 Allowed 'General case' 0 C--O 1.245 0.836 0 C-N-CA 119.195 -1.002 . . . . 64.1 110.654 -172.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.7 m -63.22 -42.94 99.34 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.004 0.521 . . . . 70.13 111.724 -172.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.453 ' HB2' ' CD2' ' A' ' 72' ' ' PHE . 1.6 mp0 -63.3 -20.6 65.62 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.031 -0.531 . . . . 61.03 111.466 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -69.86 -46.97 64.39 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.868 -0.79 . . . . 73.25 108.868 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -71.0 -31.95 68.62 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.87 -1.159 . . . . 73.13 107.87 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 54.3 tp -65.4 -46.59 79.42 Favored 'General case' 0 C--O 1.191 -2.012 0 CA-C-N 115.584 -0.735 . . . . 75.55 110.095 176.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 49' ' ' LEU . . . -62.37 -30.97 71.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.838 0.828 . . . . 65.42 110.494 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -73.25 -34.81 66.05 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.555 -1.202 . . . . 74.22 110.489 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.429 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 61.3 t80 -80.48 -26.92 37.96 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.458 1.123 . . . . 71.4 108.475 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.481 ' HB3' ' O ' ' A' ' 46' ' ' ALA . 39.9 tp -69.79 -29.8 67.19 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 127.323 2.249 . . . . 53.11 111.509 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -38.47 -56.17 2.0 Allowed Glycine 0 CA--C 1.545 1.929 0 N-CA-C 115.628 1.011 . . . . 45.42 115.628 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 48' ' ' PHE . 8.2 Cg_exo -77.81 -5.83 15.6 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.153 1.902 . . . . 54.23 113.585 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -133.21 24.9 4.19 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.685 -0.634 . . . . 72.53 111.654 -169.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -56.17 107.32 0.86 Allowed Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 123.067 0.547 . . . . 73.44 111.823 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.424 ' HB2' ' HA ' ' A' ' 136' ' ' SER . 6.7 Cg_endo -109.51 -159.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 123.84 3.027 . . . . 72.23 112.228 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -86.73 131.16 34.21 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.226 -1.027 . . . . 44.43 108.226 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mp -108.86 112.75 41.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.763 -1.199 . . . . 75.34 107.763 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 138' ' ' LYS . 80.2 m-85 -92.88 133.7 35.82 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 108.502 -0.925 . . . . 75.53 108.502 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.3 t -131.84 117.09 32.81 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 108.101 -1.074 . . . . 62.5 108.101 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 60.78 29.44 19.01 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.373 1.045 . . . . 64.21 110.765 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.75 5.94 80.68 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.906 -1.043 . . . . 62.12 112.839 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -113.85 134.33 54.87 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 109.723 -0.473 . . . . 75.1 109.723 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.411 HD13 ' N ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -75.06 128.22 36.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.885 0.85 . . . . 75.41 110.284 -175.355 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.411 ' N ' HD13 ' A' ' 62' ' ' ILE . 50.8 mm-40 -126.37 144.32 50.86 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 106.921 -1.511 . . . . 63.2 106.921 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -87.08 174.3 8.74 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.281 -0.637 . . . . 74.14 109.281 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.7 t -56.7 -33.47 66.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.256 0.622 . . . . 70.1 111.378 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 60.9 m -67.21 -42.52 83.95 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.091 -0.504 . . . . 72.34 110.469 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -64.86 -47.92 76.15 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 122.766 0.426 . . . . 62.32 109.984 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -52.97 -53.56 48.04 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 123.552 0.533 . . . . 54.43 110.114 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.0 tp -49.72 -46.43 50.21 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 124.167 0.917 . . . . 70.25 111.537 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 66' ' ' THR . 49.0 mt-30 -59.46 -48.1 82.95 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 116.201 -0.454 . . . . 61.45 111.306 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -66.87 -35.28 79.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.243 0.544 . . . . 74.33 110.532 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.453 ' CD2' ' HB2' ' A' ' 42' ' ' GLU . 3.5 t80 -60.17 -51.91 67.57 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.554 -0.748 . . . . 75.51 110.649 175.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -75.33 -13.19 60.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.874 0.368 . . . . 70.22 111.372 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 27.9 mm-40 -82.1 -8.99 59.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.977 0.417 . . . . 71.34 111.412 170.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.82 26.31 50.19 Favored Glycine 0 N--CA 1.427 -1.903 0 CA-C-N 116.147 -0.479 . . . . 70.14 112.349 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.8 mt -78.36 -37.24 44.75 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.034 -0.667 . . . . 73.41 112.001 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -97.36 1.3 49.21 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.963 -0.695 . . . . 53.22 112.655 -175.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.301 0.0 OUTLIER -70.4 -16.88 63.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.177 1.177 . . . . 71.4 114.177 -173.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -89.53 -15.78 32.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.362 0.601 . . . . 74.41 111.543 171.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.3 tt -84.84 -14.82 46.76 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.568 -0.742 . . . . 62.02 110.262 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.84 -8.72 57.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.365 0.602 . . . . 64.44 111.748 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -92.72 13.52 19.91 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.616 -0.72 . . . . 62.51 109.524 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 105' ' ' SER . . . -79.99 154.44 28.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.282 -0.872 . . . . 71.23 113.352 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -107.79 143.79 35.87 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.523 -1.217 . . . . 72.23 109.256 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -95.58 120.11 35.25 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.236 0.541 . . . . 73.21 109.578 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.49 -179.94 4.17 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.915 -0.584 . . . . 72.14 109.943 -176.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.2 pp -61.26 130.7 25.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 CA-C-O 121.707 0.765 . . . . 63.54 112.621 177.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -106.27 81.82 1.67 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.382 -0.826 . . . . 71.25 109.151 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.0 t -75.49 -39.18 40.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.576 -0.898 . . . . 73.03 108.576 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.1 m -77.5 -5.61 50.62 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.973 -1.012 . . . . 63.12 111.259 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.04 64.49 4.22 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.819 -0.512 . . . . 51.55 111.819 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -112.18 111.15 21.83 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.421 0.629 . . . . 74.14 110.549 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.1 99.62 9.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.755 -0.832 . . . . 61.11 108.755 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -84.68 -26.88 27.45 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.547 0.689 . . . . 72.54 109.711 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -75.79 9.57 2.27 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.232 -0.895 . . . . 73.43 112.629 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.86 -125.35 1.73 Allowed Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.242 -1.543 . . . . 51.51 109.242 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -148.95 139.57 22.64 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.511 -0.551 . . . . 74.13 109.511 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.46 -164.64 33.94 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 110.261 -1.136 . . . . 70.33 110.261 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -128.55 136.3 50.55 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.454 -0.573 . . . . 73.45 109.454 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -122.71 98.9 6.12 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.008 -1.849 . . . . 75.34 106.008 170.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 mt -109.62 124.42 51.12 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 123.775 0.672 . . . . 74.22 109.889 -172.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 10.9 p -114.77 122.42 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-O 122.331 1.062 . . . . 55.12 112.474 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 -96.07 145.1 25.75 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.025 -1.443 . . . . 75.34 108.522 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -128.5 121.12 28.15 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.19 -1.411 . . . . 72.31 107.19 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 42.5 m -73.46 -174.29 1.63 Allowed 'General case' 0 C--O 1.253 1.282 0 C-N-CA 122.973 0.509 . . . . 73.25 112.018 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.9 161.11 19.06 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.713 -0.847 . . . . 72.14 108.713 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.514 ' HB1' HG21 ' A' ' 115' ' ' ILE . . . -100.08 136.67 39.62 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 120.83 -0.348 . . . . 74.35 111.832 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -113.56 112.46 23.59 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.542 -0.91 . . . . 65.14 108.542 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -77.46 108.63 10.76 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.637 -0.875 . . . . 62.22 108.637 176.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.2 t -93.22 154.63 17.92 Favored 'General case' 0 N--CA 1.414 -2.271 0 N-CA-C 108.183 -1.043 . . . . 74.23 108.183 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -71.83 0.37 9.24 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.346 0.594 . . . . 72.55 112.252 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -75.15 -4.7 40.28 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.101 0.96 . . . . 63.42 109.181 175.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 77.12 11.04 2.41 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 125.583 1.553 . . . . 72.45 111.68 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.428 ' HB3' ' CD1' ' A' ' 147' ' ' TYR . 25.0 pttm -125.96 157.85 36.74 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 115.521 -0.763 . . . . 73.32 109.039 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.514 HG21 ' HB1' ' A' ' 107' ' ' ALA . 2.0 mp -100.51 137.44 28.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 N-CA-C 107.891 -1.151 . . . . 71.03 107.891 -175.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.444 ' HG2' ' HB2' ' A' ' 144' ' ' ALA . 92.5 mtt180 -114.61 154.82 27.66 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.032 -0.729 . . . . 73.3 109.032 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.438 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 8.4 p90 -163.79 173.75 12.42 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.696 -1.224 . . . . 65.25 107.696 176.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -107.23 139.17 42.11 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.843 -1.169 . . . . 72.42 107.843 175.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.438 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 46.2 mt-10 -119.21 151.55 38.17 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 120.446 -0.502 . . . . 65.3 110.125 174.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -137.31 123.15 20.06 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 116.079 -0.51 . . . . 40.53 110.079 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -114.78 110.33 19.55 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.16 -0.682 . . . . 72.24 109.16 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.02 130.39 44.35 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 109.031 -0.729 . . . . 70.3 109.031 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -110.31 110.67 21.56 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.213 -1.032 . . . . 72.53 108.213 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.484 HG12 HD13 ' A' ' 134' ' ' LEU . 61.4 mt -115.28 137.16 49.7 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.674 0 N-CA-C 107.511 -1.292 . . . . 73.3 107.511 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.507 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.2 OUTLIER -122.27 147.95 45.6 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.007 -1.849 . . . . 71.12 106.007 177.335 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -117.06 133.53 55.88 Favored 'General case' 0 N--CA 1.398 -3.028 0 C-N-CA 117.553 -1.659 . . . . 74.44 109.725 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.465 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 73.4 ttt180 -82.56 144.69 30.19 Favored 'General case' 0 C--N 1.255 -3.533 0 CA-C-N 113.044 -1.889 . . . . 72.11 109.789 -172.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -49.4 -31.8 10.33 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.853 1.261 . . . . 74.12 112.423 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.465 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 6.9 m-20 -76.69 0.93 18.57 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.515 -0.766 . . . . 74.4 111.667 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.95 -1.48 56.54 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.335 -0.46 . . . . 45.02 112.619 177.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.4 m -85.5 101.46 12.67 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 122.623 -0.339 . . . . 74.51 111.521 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 42.0 t -80.78 120.74 25.05 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 105.57 -2.011 . . . . 74.03 105.57 173.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.507 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 5.9 t-105 -140.22 150.56 44.29 Favored 'General case' 0 N--CA 1.394 -3.245 0 C-N-CA 119.163 -1.015 . . . . 72.13 111.301 -170.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.484 HD13 HG12 ' A' ' 124' ' ' ILE . 3.4 mm? -68.75 116.6 9.44 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.053 -0.976 . . . . 72.4 109.057 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -83.72 -56.61 3.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.975 -0.75 . . . . 74.01 108.975 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.424 ' HA ' ' HB2' ' A' ' 54' ' ' PRO . 14.0 m -164.45 156.55 16.36 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 106.291 -1.744 . . . . 43.22 106.291 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.8 m -131.03 162.34 39.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.384 -1.339 . . . . 75.03 107.384 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 57' ' ' TYR . 78.7 tttt -142.28 136.97 30.3 Favored 'General case' 0 C--N 1.275 -2.641 0 C-N-CA 122.718 0.407 . . . . 35.02 110.071 -173.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -123.04 141.01 52.43 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.821 -0.807 . . . . 74.35 108.821 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.9 pt -132.18 98.36 3.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.788 -1.19 . . . . 72.2 107.788 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 68.8 mtm -89.55 130.38 35.88 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.213 -1.358 . . . . 74.32 111.138 -171.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.4 t 71.47 24.46 3.63 Favored 'General case' 0 C--O 1.243 0.715 0 O-C-N 124.468 1.105 . . . . 71.33 110.303 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -75.26 144.72 42.39 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 114.891 -1.05 . . . . 54.32 108.381 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.444 ' HB2' ' HG2' ' A' ' 116' ' ' ARG . . . -127.03 175.09 8.37 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 121.373 0.606 . . . . 73.11 111.185 -175.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -112.89 129.31 24.61 Favored Pre-proline 0 C--N 1.289 -2.033 0 N-CA-C 107.258 -1.386 . . . . 40.51 107.258 175.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.42 129.15 22.17 Favored 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.736 2.291 . . . . 73.12 110.06 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.428 ' CD1' ' HB3' ' A' ' 114' ' ' LYS . 39.3 p90 -97.2 168.77 10.23 Favored 'General case' 0 N--CA 1.413 -2.289 0 CA-C-O 121.705 0.764 . . . . 74.23 112.088 -172.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.2 p -134.0 109.76 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.485 0 CA-C-N 114.569 -1.196 . . . . 71.3 108.689 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.289 -2.023 0 CA-C-N 114.99 -1.004 . . . . 44.12 108.728 -178.785 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 . . . . . 0 CA--C 1.484 -1.571 0 N-CA-C 108.909 -0.774 . . . . 74.03 108.909 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.7 ptp -80.86 91.86 6.03 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.289 1.042 . . . . 64.2 110.646 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.3 t -81.68 147.48 6.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 105.516 -2.031 . . . . 62.2 105.516 173.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.444 ' O ' HG13 ' A' ' 21' ' ' VAL . 6.7 m -56.63 -40.42 75.36 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 118.356 0.525 . . . . 72.1 109.782 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -64.66 -42.1 95.64 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 115.625 -0.716 . . . . 75.12 110.815 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.96 -40.43 96.4 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.68 -0.691 . . . . 52.31 109.454 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.15 -43.6 81.9 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.021 -0.536 . . . . 73.21 110.517 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 17' ' ' THR . 11.3 m -70.39 -38.73 75.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 120.334 -0.547 . . . . 75.41 112.104 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -28.0 50.37 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.662 -0.815 . . . . 71.15 110.581 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.75 -41.43 49.99 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 110.066 -1.214 . . . . 42.1 110.066 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.3 tp -68.12 -49.78 58.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.889 -0.782 . . . . 61.41 108.889 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.26 -38.72 95.0 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.516 -0.765 . . . . 33.21 112.447 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -71.95 -40.85 68.39 Favored 'General case' 0 C--O 1.195 -1.792 0 C-N-CA 120.426 -0.51 . . . . 72.2 110.571 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -62.32 -43.1 99.61 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.622 0.725 . . . . 73.43 110.049 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.427 ' CZ ' ' HH2' ' A' ' 103' ' ' TRP . 27.7 t80 -64.63 -54.63 28.78 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 113.946 -1.479 . . . . 74.42 110.157 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 29' ' ' ILE . 9.8 mm -65.49 -33.52 64.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 120.882 -0.327 . . . . 55.44 111.838 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -63.41 -48.82 76.24 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 110.067 -0.346 . . . . 64.32 110.067 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 32' ' ' VAL . 4.4 pp -68.55 -30.28 69.03 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.088 -0.645 . . . . 43.15 110.94 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.414 ' N ' HD12 ' A' ' 31' ' ' LEU . 66.0 t -70.58 -25.09 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 CA-C-O 121.201 0.524 . . . . 71.54 110.492 175.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.5 p -110.33 19.3 18.98 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.565 0.698 . . . . 74.11 110.226 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -55.78 142.86 33.14 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.949 -1.023 . . . . 74.31 110.328 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 m -62.92 153.99 78.1 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-N 115.435 -0.802 . . . . 63.23 110.694 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.16 -5.65 3.11 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 125.03 3.82 . . . . 64.25 113.043 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.6 -27.22 68.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.498 -0.774 . . . . 73.54 109.17 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -94.97 142.2 27.76 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 105.788 -1.93 . . . . 74.22 105.788 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.7 t -68.96 -46.07 79.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 120.606 -0.438 . . . . 44.11 111.927 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -145.01 119.29 9.54 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 119.406 -0.918 . . . . 64.34 112.552 -174.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.9 m -64.13 -35.96 82.49 Favored 'General case' 0 C--O 1.251 1.165 0 C-N-CA 123.714 0.806 . . . . 74.1 110.768 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.724 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 1.3 mp0 -65.8 -21.2 66.47 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.156 -0.929 . . . . 75.3 110.466 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -68.69 -43.02 76.94 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.607 -1.257 . . . . 72.22 107.607 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.43 -32.12 69.59 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.552 -1.204 . . . . 74.15 109.43 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.5 tp -67.78 -40.87 83.95 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 116.017 -0.538 . . . . 63.42 110.7 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.11 -36.62 84.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.622 0.725 . . . . 74.31 109.921 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -69.47 -37.6 77.35 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.985 -1.007 . . . . 72.32 109.44 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -65.55 -43.24 90.51 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.218 1.007 . . . . 74.12 110.727 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 pp -80.45 -2.49 46.02 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.822 -0.626 . . . . 61.52 111.214 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.2 -62.47 5.02 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 111.888 -0.485 . . . . 73.42 111.888 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -77.15 -5.57 15.88 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.45 2.1 . . . . 73.11 112.235 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -124.46 38.08 4.27 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.798 -0.445 . . . . 60.52 109.798 -172.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.553 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 34.4 t70 -54.52 106.03 0.61 Allowed Pre-proline 0 C--O 1.245 0.848 0 C-N-CA 125.23 1.412 . . . . 63.23 113.22 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -107.92 -157.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.101 0 C-N-CA 123.798 2.999 . . . . 74.53 110.548 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -98.97 123.66 43.41 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.665 -0.865 . . . . 52.53 108.665 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.445 HD13 ' CB ' ' A' ' 68' ' ' PHE . 46.6 mt -105.25 107.92 23.74 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.606 0 N-CA-C 107.868 -1.16 . . . . 61.22 107.868 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -96.75 138.82 33.73 Favored 'General case' 0 C--N 1.27 -2.888 0 O-C-N 121.737 -0.602 . . . . 75.23 110.26 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 p -128.24 117.92 46.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 107.16 -1.422 . . . . 74.1 107.16 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 60.8 20.82 10.95 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.705 -0.68 . . . . 74.1 111.571 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.27 1.17 56.89 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.817 -0.629 . . . . 61.04 112.866 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -108.74 130.84 55.37 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 117.397 0.598 . . . . 63.13 110.438 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.58 125.25 33.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 122.055 0.931 . . . . 74.41 110.256 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -120.56 140.53 51.36 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.44 -1.318 . . . . 70.21 107.44 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.0 t -85.66 173.52 10.06 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.701 -0.852 . . . . 71.42 108.701 176.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.553 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 9.7 t -52.62 -37.52 58.52 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.405 0.682 . . . . 64.52 111.57 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -70.03 -41.1 74.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.336 -0.393 . . . . 73.13 111.855 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.54 -47.34 76.19 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.229 -0.656 . . . . 44.31 109.229 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CB ' HD13 ' A' ' 56' ' ' ILE . 55.3 t80 -53.18 -54.33 37.57 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 115.667 -0.697 . . . . 71.23 110.118 174.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -50.13 -44.31 52.33 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 124.206 0.941 . . . . 33.23 110.867 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -60.41 -48.84 80.03 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 122.853 0.461 . . . . 62.13 111.531 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.47 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 32.6 m-85 -68.4 -36.78 79.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.678 0.752 . . . . 60.01 109.398 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -58.46 -54.56 45.7 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.102 -0.954 . . . . 73.2 110.948 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -66.07 -29.74 70.14 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.582 -0.281 . . . . 74.34 110.557 -176.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.522 ' HA ' HE21 ' A' ' 74' ' ' GLN . 0.0 OUTLIER -77.71 -8.78 58.44 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 113.373 0.879 . . . . 44.42 113.373 178.007 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.419 ' HA2' ' HG3' ' A' ' 78' ' ' LYS . . . 100.13 11.35 42.84 Favored Glycine 0 C--N 1.315 -0.63 0 C-N-CA 120.31 -0.947 . . . . 60.31 114.944 173.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.14 -53.85 22.22 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 120.878 0.371 . . . . 73.14 111.974 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.47 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 40.5 m-85 -89.72 6.17 42.7 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 112.781 0.66 . . . . 74.35 112.781 -172.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.724 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 41.9 mtmt -66.16 -12.47 56.03 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.492 0.923 . . . . 75.34 113.492 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -77.64 -10.67 59.64 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.363 -0.835 . . . . 71.05 111.2 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.3 tp -68.3 -28.86 67.55 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.488 -0.56 . . . . 71.22 109.488 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.55 ' HB2' ' OE2' ' A' ' 42' ' ' GLU . 0.8 OUTLIER -65.83 -28.67 69.16 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.581 -0.736 . . . . 63.23 110.127 176.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -98.82 7.07 46.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.656 -0.702 . . . . 60.11 110.348 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.48 150.82 22.3 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.967 0.413 . . . . 45.51 110.612 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.09 134.11 47.9 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.674 -0.862 . . . . 70.11 108.674 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -85.71 144.25 27.9 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 113.55 0.944 . . . . 75.33 113.55 -174.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.74 95.13 3.08 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 105.545 -2.02 . . . . 72.0 105.545 173.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.407 ' O ' HD12 ' A' ' 87' ' ' ILE . 2.7 pp -84.51 140.74 15.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 112.687 0.625 . . . . 74.41 112.687 -174.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -131.63 93.94 3.43 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.893 0.854 . . . . 64.32 109.862 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -100.0 135.04 37.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 115.017 -0.992 . . . . 70.54 108.57 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.2 m -76.57 80.77 3.25 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.697 0.284 . . . . 74.41 111.069 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.48 -15.91 1.44 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 115.962 1.145 . . . . 71.42 115.962 174.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 86.9 tttt 64.03 44.12 4.81 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 106.321 -1.733 . . . . 74.55 106.321 -173.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.556 ' HB ' ' OE2' ' A' ' 95' ' ' GLU . 31.1 m -82.01 168.77 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 113.217 -1.811 . . . . 75.42 111.232 -176.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -95.38 -9.04 33.95 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 113.441 0.904 . . . . 74.0 113.441 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.556 ' OE2' ' HB ' ' A' ' 93' ' ' VAL . 2.4 pm0 -87.44 -176.12 5.49 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.03 -0.668 . . . . 62.15 111.324 177.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -83.01 72.47 2.84 Favored Glycine 0 N--CA 1.419 -2.491 0 N-CA-C 115.266 0.866 . . . . 73.55 115.266 -174.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -100.67 167.6 10.22 Favored 'General case' 0 C--O 1.256 1.44 0 N-CA-C 109.803 -0.443 . . . . 73.11 109.803 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -105.41 146.49 16.08 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 110.979 -0.848 . . . . 75.53 110.979 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -110.99 133.91 53.01 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.0 -1.111 . . . . 72.44 108.0 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -113.45 109.82 19.29 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 123.583 0.552 . . . . 74.35 109.872 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -97.42 108.73 21.51 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 105.675 -1.972 . . . . 61.44 105.675 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 3.9 t -115.11 150.24 17.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 C-N-CA 119.776 -0.77 . . . . 75.03 110.187 -174.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.427 ' HH2' ' CZ ' ' A' ' 28' ' ' PHE . 25.2 m-90 -132.35 151.19 51.96 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.556 -0.905 . . . . 74.23 108.556 175.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.461 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 67.3 mttm -126.34 130.85 51.62 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.684 -1.599 . . . . 53.45 106.684 174.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.1 p -85.35 -166.83 1.62 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 110.288 -0.264 . . . . 63.21 110.288 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.41 128.46 36.77 Favored 'General case' 0 C--O 1.256 1.411 0 CA-C-O 121.223 0.535 . . . . 50.43 110.604 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -101.96 142.67 32.89 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.182 -0.917 . . . . 53.34 110.859 -177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -139.99 142.86 36.28 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.633 -1.617 . . . . 71.43 106.633 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.456 ' HG2' HG13 ' A' ' 115' ' ' ILE . 45.9 mtt180 -76.85 131.57 38.69 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-O 121.94 0.876 . . . . 71.03 112.4 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.4 m -95.49 169.18 10.23 Favored 'General case' 0 N--CA 1.405 -2.691 0 CA-C-N 113.816 -1.538 . . . . 62.42 109.292 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -72.61 -18.8 61.56 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.17 0.588 . . . . 72.14 111.461 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.442 ' HB2' ' HG2' ' A' ' 114' ' ' LYS . 24.9 m-20 -79.4 7.71 7.49 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.538 -0.301 . . . . 74.34 110.999 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 70.25 18.81 6.77 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.381 1.472 . . . . 75.44 109.451 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.442 ' HG2' ' HB2' ' A' ' 112' ' ' ASP . 65.2 pttt -108.84 173.31 6.38 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.586 -1.264 . . . . 73.44 107.586 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.456 HG13 ' HG2' ' A' ' 109' ' ' ARG . 1.1 mp -120.45 126.16 74.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 107.924 -1.139 . . . . 65.4 107.924 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.424 ' NH2' ' HA ' ' A' ' 117' ' ' TRP . 0.0 OUTLIER -97.38 142.03 29.74 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 120.397 -0.521 . . . . 63.43 110.51 -179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.456 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 1.6 p90 -153.85 173.29 16.1 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 107.147 -1.427 . . . . 74.21 107.147 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -113.02 135.33 53.9 Favored 'General case' 0 C--N 1.274 -2.676 0 N-CA-C 106.022 -1.844 . . . . 63.32 106.022 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.461 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 44.0 mt-10 -115.07 148.77 38.49 Favored 'General case' 0 C--N 1.274 -2.691 0 CA-C-O 121.69 0.757 . . . . 75.44 112.159 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -132.97 117.75 18.02 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-N 114.414 -1.266 . . . . 53.25 108.562 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.421 ' HG3' HG22 ' A' ' 102' ' ' VAL . 40.5 tt0 -121.38 110.91 16.67 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 109.1 -0.704 . . . . 75.34 109.1 -176.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -98.16 133.76 42.16 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 116.118 -0.492 . . . . 73.45 109.847 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -114.76 121.11 42.31 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 123.188 0.595 . . . . 72.53 110.198 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.5 mt -123.41 149.64 27.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.07 -1.826 . . . . 73.35 106.07 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.409 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.7 OUTLIER -132.19 145.21 51.19 Favored 'General case' 0 C--O 1.272 2.259 0 C-N-CA 119.066 -1.054 . . . . 73.33 109.157 173.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -83.66 119.9 25.33 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.473 -1.306 . . . . 65.54 107.473 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -89.59 133.06 34.79 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.481 -1.674 . . . . 64.23 106.481 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -63.29 -12.58 30.49 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.664 0.745 . . . . 75.15 111.228 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.8 -11.0 60.69 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.215 -0.902 . . . . 72.42 111.095 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.17 -12.9 28.79 Favored Glycine 0 CA--C 1.509 -0.344 0 C-N-CA 121.066 -0.588 . . . . 55.0 112.986 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.3 m -104.56 164.93 11.41 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 109.798 -0.445 . . . . 61.12 109.798 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.434 ' HB3' HG12 ' A' ' 21' ' ' VAL . 25.3 p -127.12 143.27 51.31 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.101 -1.444 . . . . 74.35 107.101 172.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.409 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 1.7 t90 -143.41 155.56 44.43 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.173 -1.011 . . . . 74.32 109.435 -176.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.7 mp -70.37 119.35 14.41 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 109.447 -0.575 . . . . 64.22 109.447 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -72.04 -50.5 27.97 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.562 -1.273 . . . . 62.21 107.562 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.8 p -177.19 177.42 1.23 Allowed 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.334 -1.303 . . . . 61.52 108.634 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.9 t -144.78 138.72 22.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 105.015 -2.217 . . . . 60.41 105.015 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -129.31 130.26 45.9 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-O 121.462 0.649 . . . . 74.42 109.847 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -110.42 133.57 53.15 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 107.791 -1.189 . . . . 71.43 107.791 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 10.1 pt -131.88 98.36 3.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 CA-C-O 122.078 0.942 . . . . 74.03 108.772 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 90.5 mtp -88.97 138.92 30.97 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.828 -1.078 . . . . 64.51 110.6 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.0 m 70.79 29.64 3.11 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 124.881 1.363 . . . . 73.34 112.795 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -87.04 170.0 11.92 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.365 -0.606 . . . . 73.24 109.365 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -154.14 159.9 41.66 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.247 -0.981 . . . . 75.1 111.849 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.24 126.79 28.21 Favored Pre-proline 0 C--N 1.296 -1.743 0 N-CA-C 106.736 -1.579 . . . . 75.32 106.736 173.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.08 158.4 41.9 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.819 1.679 . . . . 75.35 111.946 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -70.5 146.81 49.99 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.222 -1.029 . . . . 73.41 108.222 177.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.9 m -77.94 111.22 14.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.422 0.629 . . . . 73.43 110.271 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.519 0 N-CA-C 108.114 -1.069 . . . . 52.04 108.114 179.836 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 121.064 0.459 . . . . 44.34 111.078 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -108.41 121.92 45.94 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.428 -0.582 . . . . 70.45 109.428 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.7 p -60.07 -41.69 87.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 113.45 0.908 . . . . 72.3 113.45 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.444 ' OG1' ' HA2' ' A' ' 130' ' ' GLY . 1.7 m -76.87 -35.23 57.59 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.489 -0.485 . . . . 73.15 110.757 -176.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -62.67 -46.74 86.78 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.217 -1.031 . . . . 71.21 108.217 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.92 -36.69 84.06 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.784 -1.098 . . . . 64.0 110.027 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.36 -42.6 87.83 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.228 -0.442 . . . . 73.24 110.466 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 m -71.75 -41.88 70.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 112.387 0.514 . . . . 74.0 112.387 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -31.41 70.46 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.622 -0.831 . . . . 55.44 110.161 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.01 -57.32 8.8 Favored Glycine 0 N--CA 1.437 -1.263 0 O-C-N 123.805 0.69 . . . . 50.31 111.939 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.68 -33.08 73.36 Favored 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.086 -1.046 . . . . 71.4 110.231 -177.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.06 -39.68 96.51 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 120.925 -0.655 . . . . 70.23 111.971 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -67.15 -47.56 70.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.655 -0.498 . . . . 75.04 109.655 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.6 -41.93 98.14 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.558 -0.746 . . . . 75.53 110.28 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 45' ' ' LEU . 23.9 t80 -61.46 -53.15 60.2 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 124.912 1.285 . . . . 71.24 109.985 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 29' ' ' ILE . 9.8 mm -65.76 -32.66 59.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 112.152 0.427 . . . . 53.52 112.152 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.23 -47.0 72.1 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.371 -0.532 . . . . 51.41 110.622 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.77 -26.21 64.18 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.02 -0.672 . . . . 74.05 111.925 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.2 t -71.68 -24.42 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 CA-C-O 121.552 0.691 . . . . 52.11 110.538 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.6 p -107.31 9.83 29.88 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 121.618 -0.676 . . . . 73.03 110.595 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 34' ' ' LYS . 24.7 tptt -69.63 156.95 38.15 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.161 -0.927 . . . . 74.23 112.474 -174.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.0 m -63.31 154.31 78.95 Favored Pre-proline 0 N--CA 1.424 -1.765 0 CA-C-N 113.711 -1.586 . . . . 71.24 113.04 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -59.18 -5.17 2.69 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 125.182 3.921 . . . . 71.12 112.785 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -54.31 -26.8 31.49 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.93 0.892 . . . . 74.52 110.785 173.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.1 t -101.14 156.81 17.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 105.158 -2.164 . . . . 72.0 105.158 168.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -50.24 -41.63 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.831 0.741 . . . . 75.11 111.987 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -167.04 151.08 6.82 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.966 -1.124 . . . . 54.52 107.966 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.7 m -60.71 -32.16 71.41 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-O 121.461 0.648 . . . . 74.04 110.648 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' OE1' HD23 ' A' ' 45' ' ' LEU . 8.5 tp10 -64.55 -22.75 67.05 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.201 -0.909 . . . . 73.22 110.151 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -67.06 -45.78 76.35 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.78 0.8 . . . . 54.44 108.915 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -71.49 -33.49 69.3 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.409 -1.269 . . . . 74.05 109.151 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.513 HD11 ' CE2' ' A' ' 28' ' ' PHE . 34.4 tp -68.74 -43.88 74.97 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 116.17 -0.468 . . . . 72.13 110.37 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.51 -37.02 77.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.476 0.655 . . . . 74.34 110.195 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -69.49 -36.08 76.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.124 -0.944 . . . . 72.22 110.176 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -67.26 -46.56 73.32 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.667 -0.697 . . . . 75.33 110.285 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.2 pp -82.23 -2.39 52.28 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.356 -0.838 . . . . 60.55 111.338 -176.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.69 -62.5 4.82 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 112.306 -0.318 . . . . 75.34 112.306 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -79.47 -7.23 14.83 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 121.842 1.694 . . . . 74.21 112.151 176.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 73.9 m-70 -114.17 35.19 4.26 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.041 -0.725 . . . . 72.12 109.041 -175.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.6 106.26 0.64 Allowed Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 125.28 1.432 . . . . 53.51 112.356 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -101.69 -164.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 123.243 2.629 . . . . 65.31 110.928 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -90.34 108.07 19.54 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 107.545 -1.28 . . . . 72.32 107.545 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.469 HD13 ' CB ' ' A' ' 68' ' ' PHE . 73.4 mt -92.48 107.91 19.58 Favored 'Isoleucine or valine' 0 C--O 1.162 -3.515 0 N-CA-C 108.744 -0.836 . . . . 73.03 108.744 -176.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -95.55 128.15 42.18 Favored 'General case' 0 C--N 1.268 -2.975 0 O-C-N 121.12 -0.988 . . . . 74.55 109.127 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.0 t -124.97 114.44 40.4 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 N-CA-C 107.959 -1.126 . . . . 74.54 107.959 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 62.01 20.94 11.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.56 -1.2 . . . . 74.33 110.591 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.63 -4.89 58.21 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 114.72 -1.127 . . . . 32.03 113.165 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -101.01 132.72 46.29 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 117.714 0.757 . . . . 72.44 109.376 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.59 129.25 36.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 121.874 0.845 . . . . 73.33 109.676 -177.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -126.9 152.83 46.56 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 124.78 1.232 . . . . 65.41 108.295 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.9 t -97.71 170.24 9.13 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.341 -0.985 . . . . 74.21 108.341 175.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.8 t -52.14 -38.43 57.52 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.285 0.634 . . . . 61.31 111.231 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -62.0 -49.2 76.99 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.175 0.59 . . . . 65.53 111.105 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.44 84.49 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.095 0.558 . . . . 73.25 110.314 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.469 ' CB ' HD13 ' A' ' 56' ' ' ILE . 56.6 t80 -53.68 -55.65 24.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.907 -0.588 . . . . 64.14 110.413 175.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -50.87 -42.44 58.92 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.07 -0.968 . . . . 61.34 110.572 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -60.28 -47.43 86.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 112.014 0.375 . . . . 73.23 112.014 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.427 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 39.8 m-85 -66.78 -32.7 74.16 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.495 0.664 . . . . 73.22 109.976 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -61.77 -52.61 63.53 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.47 -0.786 . . . . 62.23 110.91 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -71.17 -21.28 62.19 Favored 'General case' 0 C--O 1.224 -0.271 0 O-C-N 123.27 0.356 . . . . 74.41 110.904 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -71.57 -19.95 62.08 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.351 0.596 . . . . 62.53 110.108 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 78' ' ' LYS . . . 100.94 13.79 33.14 Favored Glycine 0 N--CA 1.422 -2.235 0 CA-C-N 115.492 -0.776 . . . . 63.04 113.299 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.0 mt -74.55 -44.56 50.48 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 117.427 0.614 . . . . 64.02 111.365 -177.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 45.0 m-85 -88.8 -4.58 58.46 Favored 'General case' 0 C--O 1.214 -0.814 0 N-CA-C 112.662 0.615 . . . . 74.11 112.662 -176.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -70.98 -15.57 62.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 119.392 -0.923 . . . . 70.23 112.304 -177.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -86.61 -21.57 26.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.631 -0.713 . . . . 75.31 110.281 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.1 tp -74.54 -14.76 60.84 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.915 0.864 . . . . 72.24 109.684 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -57.66 -25.65 60.53 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.598 -1.183 . . . . 52.45 112.295 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -92.95 11.94 25.58 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 111.997 0.369 . . . . 34.12 111.997 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.73 150.24 28.06 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.096 0.474 . . . . 74.55 111.627 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -99.5 132.41 44.86 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.504 -0.924 . . . . 64.33 108.504 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.56 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 51.1 p90 -95.25 143.94 26.24 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.924 -0.711 . . . . 74.15 112.311 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.89 163.37 34.31 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.694 -1.225 . . . . 63.34 107.694 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.6 pp -82.13 142.98 12.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 120.794 -0.363 . . . . 74.22 110.841 177.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.516 ' HB2' ' CG2' ' A' ' 102' ' ' VAL . 23.7 t-20 -90.79 153.43 20.25 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.653 -0.869 . . . . 72.14 108.653 178.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 p -51.43 -44.04 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 124.202 0.939 . . . . 74.12 110.745 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 m 50.76 42.65 27.79 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.238 1.015 . . . . 60.52 111.627 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -82.78 48.6 4.04 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.538 -0.755 . . . . 75.41 113.818 -174.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -101.34 167.8 9.94 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 106.908 -1.515 . . . . 63.42 106.908 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.3 m -78.38 95.38 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 121.818 0.818 . . . . 74.13 111.629 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.495 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.3 OUTLIER -92.06 116.58 29.06 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.842 -0.743 . . . . 73.41 110.868 177.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.49 -28.7 69.39 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.547 -1.206 . . . . 74.32 111.694 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -124.39 -88.03 0.78 Allowed Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 108.843 -1.703 . . . . 62.03 108.843 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -167.13 154.06 8.62 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 123.138 0.575 . . . . 71.24 110.184 175.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -153.88 141.67 8.48 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 108.853 -1.699 . . . . 75.31 108.853 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -108.56 150.99 26.72 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.459 -1.312 . . . . 70.13 107.459 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 39.4 ttpt -150.05 107.83 3.69 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-O 121.745 0.783 . . . . 54.11 109.41 176.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 72.8 mt -101.99 134.35 45.35 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 114.146 -1.388 . . . . 73.43 107.935 -177.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.516 ' CG2' ' HB2' ' A' ' 88' ' ' ASN . 6.1 t -120.01 128.97 75.97 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.182 0 C-N-CA 120.685 -0.406 . . . . 64.32 110.397 -176.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.56 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 18.8 m-90 -99.95 127.44 46.14 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 107.317 -1.364 . . . . 75.55 107.317 173.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -112.36 120.12 40.61 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 107.696 -1.224 . . . . 64.11 107.696 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.6 t -85.82 -176.29 5.95 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.194 -0.912 . . . . 75.3 110.483 -176.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.54 125.66 26.45 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 115.532 -0.758 . . . . 72.02 111.178 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.19 116.66 22.47 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.704 -1.135 . . . . 73.4 109.142 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -94.36 145.58 24.65 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.768 -0.827 . . . . 62.13 108.768 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -74.4 158.74 33.37 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.016 0.436 . . . . 64.01 111.491 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.3 t -142.12 147.46 36.75 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 106.292 -1.744 . . . . 65.11 106.292 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -71.85 -10.7 60.15 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.727 0.775 . . . . 75.15 111.872 -172.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.34 16.88 10.72 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.507 -0.77 . . . . 72.2 111.698 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 72.09 10.02 6.03 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.34 1.456 . . . . 74.2 113.158 173.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -108.6 178.82 4.37 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.88 -0.785 . . . . 73.13 108.88 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 9.5 pt -129.43 145.67 35.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 120.855 0.36 . . . . 73.34 111.633 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.503 ' HD3' ' HB2' ' A' ' 144' ' ' ALA . 35.0 mmt180 -105.68 109.5 21.48 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 124.464 1.105 . . . . 74.01 108.823 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.565 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 43.2 p90 -121.65 165.61 15.49 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.146 -1.057 . . . . 72.12 108.146 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -112.88 140.53 47.61 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.947 -1.501 . . . . 62.43 106.947 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.565 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 40.7 mt-10 -123.32 155.14 37.84 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-O 121.183 0.516 . . . . 52.15 111.031 175.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -141.61 117.29 10.35 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 114.771 -1.104 . . . . 62.41 108.039 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 7.9 pt-20 -125.23 111.99 15.89 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-O 121.718 0.771 . . . . 64.1 112.193 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.624 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -93.91 124.61 38.03 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.427 -1.261 . . . . 75.24 110.005 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.473 ' CE2' ' HD3' ' A' ' 100' ' ' LYS . 8.7 m-85 -103.07 129.34 49.85 Favored 'General case' 0 C--O 1.249 1.069 0 C-N-CA 124.622 1.169 . . . . 61.31 108.171 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 53.8 mt -131.46 144.28 38.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.697 -0.853 . . . . 63.35 108.697 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.427 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.5 OUTLIER -137.73 151.51 48.27 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 108.117 -1.068 . . . . 73.13 108.117 176.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 17.4 ptt180 -107.04 150.64 26.31 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.421 -0.912 . . . . 70.14 110.995 177.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.536 ' HB2' ' OD1' ' A' ' 129' ' ' ASP . 50.4 mtt180 -99.47 168.91 9.68 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.017 -0.992 . . . . 75.14 109.643 -172.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -80.97 -10.3 59.73 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.849 0.357 . . . . 64.25 110.617 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.536 ' OD1' ' HB2' ' A' ' 127' ' ' ARG . 11.4 p-10 -74.27 -16.04 60.96 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.058 0.456 . . . . 75.23 110.943 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.444 ' HA2' ' OG1' ' A' ' 17' ' ' THR . . . 112.08 -11.95 26.78 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 120.834 -0.698 . . . . 61.41 112.055 178.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.4 m -105.08 -177.33 3.33 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.687 0.756 . . . . 74.33 110.208 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 28.8 p -143.62 169.4 17.8 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 106.69 -1.596 . . . . 52.24 106.69 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.427 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 0.0 OUTLIER -159.28 155.81 27.61 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.125 -0.694 . . . . 72.25 109.125 -178.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.4 mp -70.07 123.38 21.42 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.555 -0.906 . . . . 65.23 108.555 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -72.71 -54.47 8.88 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.741 -1.207 . . . . 73.31 107.741 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.4 m -168.4 165.89 12.54 Favored 'General case' 0 C--O 1.201 -1.472 0 N-CA-C 106.066 -1.827 . . . . 71.33 106.066 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 122' ' ' ALA . 7.5 m -142.12 142.61 27.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 105.46 -2.052 . . . . 61.02 105.46 171.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -127.93 130.54 48.63 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 118.206 0.457 . . . . 75.34 110.439 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -115.25 128.91 56.45 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.901 -1.148 . . . . 74.2 107.901 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.6 pt -128.64 98.31 4.19 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.6 0 N-CA-C 108.07 -1.085 . . . . 72.41 108.07 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 74.7 mtm -87.27 128.36 35.17 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.631 -1.168 . . . . 64.44 111.71 -174.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.5 m 61.52 55.09 2.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 113.935 -1.484 . . . . 64.24 111.339 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -91.39 145.37 24.69 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 106.194 -1.78 . . . . 63.25 106.194 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.503 ' HB2' ' HD3' ' A' ' 116' ' ' ARG . . . -138.13 145.81 42.07 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 120.595 -0.442 . . . . 53.02 109.947 -177.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.52 134.14 23.77 Favored Pre-proline 0 N--CA 1.414 -2.239 0 N-CA-C 105.436 -2.061 . . . . 64.44 105.436 172.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -58.04 152.84 48.86 Favored 'Trans proline' 0 C--O 1.254 1.322 0 C-N-CA 122.041 1.827 . . . . 71.22 110.54 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -61.74 144.38 54.77 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 109.571 -0.529 . . . . 74.02 109.571 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.3 p -91.52 136.26 24.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 C-N-CA 120.348 -0.541 . . . . 62.1 110.114 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.5 0 N-CA-C 108.118 -1.068 . . . . 73.33 108.118 177.309 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 120.573 0.225 . . . . 60.1 110.525 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.7 mtt -92.32 155.76 17.72 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.306 -0.627 . . . . 75.12 109.306 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.6 t -78.32 136.22 24.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.492 -0.929 . . . . 72.44 108.492 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.449 ' O ' HG13 ' A' ' 21' ' ' VAL . 19.4 m -56.82 -39.36 74.05 Favored 'General case' 0 C--O 1.215 -0.751 0 C-N-CA 123.141 0.576 . . . . 65.31 110.9 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.52 -40.15 93.58 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.454 0.645 . . . . 73.32 111.387 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.52 -37.09 79.73 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.648 -0.871 . . . . 75.3 108.648 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -68.71 -42.41 77.73 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 115.873 -0.603 . . . . 61.31 110.627 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.699 HG12 ' SG ' ' A' ' 132' ' ' CYS . 13.2 m -69.92 -41.28 79.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.027 -0.533 . . . . 61.04 111.617 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.33 -24.94 50.73 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 118.907 -1.117 . . . . 53.44 110.018 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.07 -55.16 11.04 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 121.017 -0.611 . . . . 73.53 111.583 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.36 -35.26 71.07 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.244 -1.021 . . . . 75.35 108.244 -178.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.7 -43.57 97.69 Favored Glycine 0 N--CA 1.432 -1.583 0 O-C-N 123.936 0.772 . . . . 74.11 112.003 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -69.41 -42.07 75.57 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 120.841 -0.344 . . . . 71.43 110.82 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -63.16 -46.11 88.69 Favored 'General case' 0 C--O 1.253 1.262 0 N-CA-C 109.671 -0.492 . . . . 74.2 109.671 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.504 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 30.4 t80 -62.64 -53.12 59.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.923 -1.035 . . . . 64.34 110.61 177.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.476 HD13 ' HA ' ' A' ' 29' ' ' ILE . 6.8 mm -61.2 -38.86 80.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 111.974 0.361 . . . . 63.23 111.974 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.39 -49.76 76.3 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 123.155 0.284 . . . . 73.23 110.307 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.3 pp -67.99 -29.6 68.66 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 120.562 -0.455 . . . . 75.12 111.121 -176.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.2 t -72.53 -27.71 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.401 0.62 . . . . 61.25 110.264 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.6 p -111.05 22.56 15.14 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.701 0.763 . . . . 72.23 109.115 -177.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -63.4 136.51 57.68 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.27 -1.332 . . . . 74.24 109.116 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -57.59 153.91 27.54 Favored Pre-proline 0 N--CA 1.435 -1.177 0 O-C-N 124.14 0.9 . . . . 51.21 110.72 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.79 -7.32 4.29 Favored 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 124.239 3.293 . . . . 74.24 113.093 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.73 -27.54 68.79 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.346 -0.843 . . . . 75.34 109.04 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.2 t -94.86 123.25 38.22 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 105.387 -2.079 . . . . 74.03 105.387 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.8 t -57.92 -48.06 84.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 O-C-N 123.566 0.541 . . . . 71.31 112.299 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -141.12 114.53 8.77 Favored 'General case' 0 N--CA 1.417 -2.106 0 C-N-CA 118.12 -1.432 . . . . 73.32 111.785 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.0 m -60.53 -32.64 71.66 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 123.203 0.601 . . . . 72.22 110.686 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -24.24 67.38 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.105 0.962 . . . . 63.0 110.791 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -70.62 -42.84 70.38 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 108.425 -0.954 . . . . 73.11 108.425 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -71.79 -30.57 65.68 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 114.535 -1.211 . . . . 55.53 108.841 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.6 tp -70.13 -41.51 73.82 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.631 -0.713 . . . . 70.25 110.091 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.56 -34.76 77.58 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.607 0.718 . . . . 63.5 109.694 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -68.72 -39.25 80.5 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.885 -1.052 . . . . 75.33 109.675 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -67.78 -41.45 83.2 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.773 -0.649 . . . . 75.2 111.238 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.4 pp -82.06 -4.16 56.22 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.074 -0.512 . . . . 74.5 111.254 -177.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -47.07 -58.21 6.47 Favored Glycine 0 C--O 1.213 -1.189 0 O-C-N 123.742 0.652 . . . . 64.21 112.863 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.79 -3.35 9.03 Favored 'Trans proline' 0 CA--C 1.556 1.6 0 C-N-CA 123.811 3.007 . . . . 60.54 113.074 172.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 69.1 m-70 -125.5 38.11 4.24 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 122.878 0.471 . . . . 64.42 109.837 -167.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.412 ' CB ' HG21 ' A' ' 65' ' ' THR . 7.1 m-20 -53.65 107.46 0.86 Allowed Pre-proline 0 C--N 1.321 -0.673 0 C-N-CA 126.25 1.82 . . . . 62.44 112.806 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -100.66 -164.96 0.06 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 123.118 2.545 . . . . 64.51 111.054 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -98.69 119.52 37.57 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 107.302 -1.37 . . . . 70.42 107.302 174.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 65' ' ' THR . 72.1 mt -100.04 112.29 32.15 Favored 'Isoleucine or valine' 0 C--O 1.179 -2.627 0 N-CA-C 109.102 -0.703 . . . . 72.11 109.102 -174.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -97.7 106.22 18.5 Favored 'General case' 0 C--N 1.283 -2.322 0 O-C-N 121.855 -0.528 . . . . 75.12 111.722 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.535 HG23 HG22 ' A' ' 56' ' ' ILE . 73.2 t -116.81 124.21 72.62 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 108.131 -1.063 . . . . 60.42 108.131 -175.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.0 m120 66.13 19.61 11.13 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 124.563 1.164 . . . . 72.51 109.291 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.81 11.85 78.56 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.567 -0.742 . . . . 74.41 111.291 -176.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -113.69 139.94 48.65 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 122.869 0.468 . . . . 71.41 110.196 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.21 125.5 35.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.997 0.903 . . . . 74.41 109.054 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -124.05 142.98 50.72 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 108.224 -1.028 . . . . 70.42 108.224 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 67' ' ' ALA . 4.9 t -82.05 170.09 15.95 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.156 -1.053 . . . . 64.42 108.156 173.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.541 ' HA ' HD12 ' A' ' 56' ' ' ILE . 64.3 p -65.64 -34.08 77.38 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 123.843 0.857 . . . . 73.14 110.357 -176.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.9 m -65.05 -40.57 94.96 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.428 -1.26 . . . . 60.02 110.307 175.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.449 ' H ' HG23 ' A' ' 64' ' ' THR . . . -65.42 -46.49 79.74 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 116.169 -0.469 . . . . 51.52 109.809 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.488 ' HB2' HD13 ' A' ' 56' ' ' ILE . 48.9 t80 -52.06 -54.86 25.15 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 123.459 0.474 . . . . 73.3 109.963 174.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -50.82 -41.5 57.51 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.412 1.07 . . . . 73.34 110.774 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 45.8 mt-30 -63.08 -48.16 79.83 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 116.311 -0.404 . . . . 63.42 111.82 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.484 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 40.0 m-85 -69.33 -30.17 68.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.831 0.824 . . . . 75.01 109.739 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -61.32 -51.84 67.16 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.883 -1.053 . . . . 75.42 110.432 175.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 12.4 ptm180 -71.56 -21.7 61.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.128 0.489 . . . . 52.14 110.401 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 96.1 mt-30 -77.49 -3.29 39.77 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.041 -0.527 . . . . 72.23 111.538 173.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.05 22.37 63.55 Favored Glycine 0 N--CA 1.438 -1.215 0 CA-C-N 116.315 -0.402 . . . . 73.43 113.262 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.2 mt -83.51 -41.4 18.02 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.02 -0.672 . . . . 61.21 111.066 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 22.9 m-85 -100.91 -6.88 24.04 Favored 'General case' 0 C--O 1.185 -2.335 0 C-N-CA 119.845 -0.742 . . . . 75.34 112.838 -178.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -12.72 36.42 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 122.009 0.909 . . . . 70.05 112.847 -175.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -82.2 -9.6 59.45 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.229 -0.896 . . . . 64.3 112.536 176.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 80' ' ' LEU . 3.2 tm? -77.9 -14.96 59.38 Favored 'General case' 0 C--O 1.208 -1.113 0 C-N-CA 123.26 0.624 . . . . 62.01 110.906 -175.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -53.31 -19.05 2.9 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 114.39 1.255 . . . . 75.23 114.39 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -100.01 10.86 40.61 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 120.977 0.418 . . . . 73.35 110.682 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.435 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -68.87 146.06 53.16 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.343 0.868 . . . . 53.2 113.343 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 103' ' ' TRP . 37.6 mt-10 -114.41 156.72 23.97 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.484 -1.235 . . . . 63.44 107.71 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.541 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 38.0 p90 -107.26 132.34 53.2 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.202 0.816 . . . . 71.11 113.202 -173.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.89 119.18 38.39 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.634 -1.247 . . . . 62.2 107.634 175.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.8 pt -82.83 113.53 22.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-O 121.898 0.856 . . . . 73.25 112.033 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -83.07 139.51 33.19 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.547 -0.908 . . . . 71.43 108.547 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 m -86.17 166.22 2.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 109.762 -0.458 . . . . 52.44 109.762 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -76.29 -36.34 58.41 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 120.761 0.315 . . . . 65.55 110.814 -177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.69 -65.25 3.73 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 116.006 -0.543 . . . . 51.52 112.145 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -144.29 132.07 21.31 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 106.992 -1.484 . . . . 71.01 106.992 -178.558 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.59 117.82 5.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 121.47 0.652 . . . . 75.22 110.05 175.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -126.77 141.12 51.92 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.577 -1.268 . . . . 52.34 107.577 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -69.87 136.01 50.2 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.276 -0.638 . . . . 63.14 109.276 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.48 54.3 0.58 Allowed Glycine 0 N--CA 1.427 -1.924 0 N-CA-C 106.952 -2.459 . . . . 64.21 106.952 -171.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -64.38 124.93 23.04 Favored 'General case' 0 CA--C 1.482 -1.649 0 CA-C-N 114.183 -1.009 . . . . 73.45 111.787 -173.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -158.99 161.57 32.04 Favored Glycine 1 N--CA 1.391 -4.32 0 CA-C-N 114.638 -1.165 . . . . 44.22 110.381 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -107.22 123.23 47.99 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.234 -1.024 . . . . 75.22 108.234 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -117.86 103.4 9.93 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.22 -1.03 . . . . 72.43 108.22 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 87.2 mt -124.63 158.16 33.75 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 110.092 -0.336 . . . . 75.54 110.092 -177.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 8.3 p -133.68 134.51 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.439 0.638 . . . . 62.4 111.954 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.541 ' NE1' ' HB3' ' A' ' 85' ' ' PHE . 14.6 m-90 -106.82 147.66 29.45 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 124.318 1.047 . . . . 74.33 109.5 177.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 83' ' ' ALA . 62.6 mttm -127.91 126.49 41.6 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.016 -0.735 . . . . 73.31 109.016 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.409 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 25.6 t -75.81 179.29 5.56 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 109.945 -0.391 . . . . 65.54 109.945 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.62 167.43 19.24 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 122.655 0.382 . . . . 32.1 110.21 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.26 110.86 1.76 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.474 0.654 . . . . 64.41 110.647 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -93.89 127.4 39.63 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.925 -1.139 . . . . 62.14 107.925 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -72.12 141.08 49.16 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.732 -0.667 . . . . 63.1 111.134 -177.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.2 m -131.96 150.11 52.25 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.522 -0.918 . . . . 70.51 108.522 -176.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -66.7 -9.35 35.45 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.548 0.689 . . . . 72.42 111.919 -176.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -92.25 -1.74 56.91 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.066 -0.97 . . . . 73.32 110.446 -178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 70.12 15.68 7.58 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.741 1.258 . . . . 64.32 110.264 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 0.1 OUTLIER -96.41 159.03 15.16 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 107.508 -1.293 . . . . 73.24 107.508 174.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 22.3 pt -109.16 130.77 61.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 109.019 -0.734 . . . . 64.25 109.019 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.487 ' HG2' ' HB2' ' A' ' 144' ' ' ALA . 47.8 mtm180 -121.6 171.3 8.93 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.383 -0.969 . . . . 65.04 108.383 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -163.08 173.58 13.34 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.551 -0.907 . . . . 75.13 108.551 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.409 ' H ' ' HB3' ' A' ' 105' ' ' SER . 7.1 m-20 -114.13 138.29 50.62 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.922 -1.51 . . . . 70.3 106.922 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.593 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 44.7 mt-10 -115.16 143.49 45.14 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.143 0.497 . . . . 75.32 109.927 175.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -129.43 120.94 26.33 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.724 -0.671 . . . . 74.45 110.877 -174.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 35.0 mt-10 -111.18 110.06 20.4 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.66 -0.496 . . . . 74.4 109.66 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.44 134.27 38.46 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 120.841 0.353 . . . . 62.41 110.401 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -118.5 120.17 36.72 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.437 1.095 . . . . 64.11 108.661 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.79 148.79 21.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 106.131 -1.803 . . . . 74.4 106.131 175.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -128.49 146.9 50.68 Favored 'General case' 0 C--O 1.262 1.742 0 C-N-CA 119.109 -1.036 . . . . 72.32 110.095 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -81.02 112.82 18.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.689 -1.226 . . . . 75.35 107.689 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.433 ' HD2' ' H ' ' A' ' 129' ' ' ASP . 0.4 OUTLIER -85.1 136.32 33.61 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 105.835 -1.913 . . . . 70.2 105.835 -175.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.98 -10.55 14.2 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-O 121.531 0.682 . . . . 63.42 111.889 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.433 ' H ' ' HD2' ' A' ' 127' ' ' ARG . 28.7 t70 -72.01 -16.04 62.05 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.552 0.692 . . . . 54.12 109.644 178.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.68 -11.7 27.75 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.599 -0.81 . . . . 64.04 113.493 175.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 24.4 t -105.18 169.39 8.47 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 107.254 -1.387 . . . . 65.22 107.254 176.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.699 ' SG ' HG12 ' A' ' 21' ' ' VAL . 14.9 p -119.19 145.22 46.2 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 107.634 -1.247 . . . . 72.15 107.634 173.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -140.66 155.68 46.44 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.738 -0.838 . . . . 72.32 108.738 -176.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.11 125.11 25.81 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.54 0.686 . . . . 62.31 110.256 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -81.04 -57.39 3.55 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 114.701 -1.136 . . . . 64.1 108.034 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.8 m -166.16 157.13 13.11 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.237 -1.394 . . . . 42.31 107.237 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.6 135.98 43.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 106.862 -1.532 . . . . 71.31 106.862 171.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -108.99 136.12 49.04 Favored 'General case' 0 C--N 1.276 -2.622 0 C-N-CA 122.731 0.412 . . . . 62.23 110.136 -174.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.484 ' HB2' HG22 ' A' ' 58' ' ' VAL . 62.6 m-85 -120.95 113.98 20.88 Favored 'General case' 0 C--O 1.255 1.352 0 CA-C-O 121.344 0.593 . . . . 63.53 109.671 176.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 13.9 pt -110.7 97.79 6.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-O 122.532 1.158 . . . . 55.44 109.248 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 19.8 ptm -101.31 93.77 5.59 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.163 -1.38 . . . . 52.44 110.164 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.0 m 160.8 19.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 127.004 2.122 . . . . 52.44 111.65 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.593 ' HG2' ' OE1' ' A' ' 119' ' ' GLU . 50.3 tptt -80.67 136.1 36.14 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.079 -1.452 . . . . 72.51 107.079 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.487 ' HB2' ' HG2' ' A' ' 116' ' ' ARG . . . -155.55 142.28 18.87 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 112.714 0.635 . . . . 73.3 112.714 -174.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.67 158.87 32.91 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 107.593 -1.262 . . . . 54.35 107.593 172.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -49.42 135.32 32.59 Favored 'Trans proline' 0 C--N 1.358 1.026 0 C-N-CA 123.274 2.65 . . . . 74.33 112.626 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.45 ' HB3' ' HB3' ' A' ' 114' ' ' LYS . 50.0 p90 -61.5 155.61 21.52 Favored 'General case' 0 C--O 1.251 1.146 0 C-N-CA 123.697 0.799 . . . . 75.03 112.046 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 29.7 m -80.22 129.87 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 CA-C-N 115.738 -0.665 . . . . 53.53 109.32 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.284 -2.271 0 N-CA-C 106.287 -1.746 . . . . 45.01 106.287 177.748 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.444 ' HB3' HG12 ' A' ' 16' ' ' VAL . 5.6 m-20 . . . . . 0 CA--C 1.509 -0.622 0 N-CA-C 110.06 -0.348 . . . . 61.3 110.06 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 51.6 ttm -73.63 -27.29 61.19 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.623 0.725 . . . . 72.24 111.154 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.444 HG12 ' HB3' ' A' ' 14' ' ' ASP . 7.9 p -61.51 -33.2 56.01 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-N 114.571 -1.195 . . . . 70.35 110.663 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.587 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.2 m -68.02 -39.59 83.13 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.381 -0.6 . . . . 73.21 109.381 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.42 -35.22 73.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.916 -0.584 . . . . 73.12 110.019 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.96 -39.55 94.99 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.138 -1.06 . . . . 50.22 108.138 175.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.35 -42.11 84.06 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.146 -0.934 . . . . 73.43 109.893 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 17' ' ' THR . 58.8 t -65.22 -45.1 94.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.514 -0.766 . . . . 63.52 111.082 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -70.89 -25.95 63.01 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.732 -0.387 . . . . 71.24 110.28 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.83 -45.41 58.02 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.214 -1.154 . . . . 45.22 110.214 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.4 tp -62.89 -50.15 72.0 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 124.579 1.152 . . . . 71.4 109.791 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.23 -43.24 98.68 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.656 -0.702 . . . . 61.54 112.017 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -66.17 -39.6 89.86 Favored 'General case' 0 C--O 1.211 -0.928 0 CA-C-O 119.22 -0.419 . . . . 71.24 111.218 178.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -60.62 -46.41 90.39 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.829 -0.804 . . . . 45.11 108.829 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.497 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 38.5 t80 -61.64 -53.74 52.18 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 114.377 -1.283 . . . . 73.22 110.424 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 29' ' ' ILE . 12.9 mm -62.02 -36.17 72.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 112.464 0.542 . . . . 54.4 112.464 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.35 -41.16 81.08 Favored 'General case' 0 CA--C 1.491 -1.306 0 C-N-CA 120.333 -0.547 . . . . 73.21 109.864 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.673 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.8 pp -70.44 -28.03 64.72 Favored 'General case' 0 N--CA 1.421 -1.876 0 C-N-CA 119.498 -0.881 . . . . 74.34 111.761 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 28' ' ' PHE . 65.1 t -70.62 -24.58 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 121.315 0.579 . . . . 73.15 109.653 175.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.5 p -115.18 21.85 13.83 Favored 'General case' 0 C--O 1.244 0.773 0 O-C-N 122.071 -0.393 . . . . 71.25 111.296 -176.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.673 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 53.2 mmtt -44.24 149.34 0.37 Allowed 'General case' 0 C--O 1.245 0.843 0 N-CA-C 115.808 1.781 . . . . 64.11 115.808 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 m -60.7 154.23 58.32 Favored Pre-proline 0 N--CA 1.423 -1.782 0 CA-C-N 112.981 -1.918 . . . . 70.13 108.191 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.04 -8.9 8.84 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 123.5 2.8 . . . . 63.21 112.941 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.8 -27.35 64.82 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.567 0.699 . . . . 73.14 109.878 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.7 m -118.21 81.43 1.68 Allowed 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 107.817 -1.179 . . . . 72.04 107.817 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -81.21 -5.3 8.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-O 122.258 1.028 . . . . 61.54 110.091 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -115.67 78.14 1.15 Allowed 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 107.414 -1.328 . . . . 74.44 107.414 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.6 m -66.43 -25.54 66.79 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 113.979 -1.464 . . . . 74.44 110.906 -173.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.497 ' OE1' ' HA ' ' A' ' 78' ' ' LYS . 6.5 pm0 -68.5 -22.98 64.51 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 115.616 -0.72 . . . . 61.4 110.533 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -63.94 -49.87 70.91 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.573 -0.899 . . . . 73.13 108.573 176.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -65.26 -38.24 89.69 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.439 -1.255 . . . . 73.24 109.96 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.6 tp -65.25 -42.96 92.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 116.429 -0.351 . . . . 70.45 110.73 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.13 -32.33 73.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.296 0.569 . . . . 75.34 110.435 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -74.2 -36.78 64.01 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.439 -0.8 . . . . 43.45 109.496 178.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 68.4 t80 -67.97 -42.95 80.09 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.189 0.996 . . . . 75.31 111.04 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 pp -81.3 -5.34 57.7 Favored 'General case' 0 C--O 1.204 -1.316 0 CA-C-N 115.907 -0.588 . . . . 72.12 111.138 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.54 -54.4 6.54 Favored Glycine 0 CA--C 1.545 1.92 0 CA-C-N 115.895 -0.593 . . . . 53.14 113.781 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -85.41 -3.56 9.34 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 123.356 2.704 . . . . 50.31 112.941 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.414 ' HA ' ' HE1' ' A' ' 133' ' ' TRP . 92.0 m-70 -128.75 31.53 4.94 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.992 -0.443 . . . . 54.51 110.595 -168.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -56.0 111.91 3.72 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.132 0.973 . . . . 71.31 112.559 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -105.57 -159.68 0.03 OUTLIER 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 123.631 2.888 . . . . 65.21 111.367 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -89.16 124.11 34.04 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 108.189 -1.041 . . . . 74.52 108.189 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.483 HD13 ' CB ' ' A' ' 68' ' ' PHE . 59.6 mt -107.0 112.48 40.12 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.179 0 N-CA-C 107.447 -1.316 . . . . 52.41 107.447 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -98.18 136.14 38.82 Favored 'General case' 0 C--N 1.263 -3.166 0 O-C-N 121.468 -0.77 . . . . 70.11 109.108 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.416 HG12 HD22 ' A' ' 59' ' ' ASN . 55.0 t -132.38 117.34 31.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 107.286 -1.375 . . . . 62.33 107.286 177.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.416 HD22 HG12 ' A' ' 58' ' ' VAL . 54.7 m-80 65.47 20.99 11.8 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.5 1.12 . . . . 74.43 109.893 -174.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.59 3.25 84.09 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.903 -1.044 . . . . 75.22 111.454 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -99.97 130.91 46.19 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 108.14 -1.059 . . . . 72.52 108.14 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.51 124.28 23.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 122.325 1.06 . . . . 71.4 110.549 -176.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 61.7 mm-40 -123.55 143.06 50.43 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 107.315 -1.365 . . . . 43.41 107.315 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.1 t -87.42 171.3 10.66 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 109.023 -0.732 . . . . 61.55 109.023 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.409 ' HA ' HD12 ' A' ' 56' ' ' ILE . 5.3 t -53.83 -36.21 62.29 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.107 0.963 . . . . 74.44 111.426 177.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.497 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 16.4 m -61.91 -50.45 72.14 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 122.971 0.509 . . . . 75.34 110.35 178.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -58.37 -47.79 82.68 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 123.598 0.759 . . . . 61.15 110.744 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.483 ' CB ' HD13 ' A' ' 56' ' ' ILE . 60.5 t80 -54.38 -55.31 29.92 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 123.755 0.659 . . . . 73.34 110.267 176.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -51.98 -40.76 61.44 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.187 0.929 . . . . 71.4 110.512 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 66' ' ' THR . 44.9 mt-30 -62.19 -49.07 77.28 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 116.577 -0.283 . . . . 73.41 111.118 176.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.0 -36.56 84.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.649 0.738 . . . . 71.33 110.092 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -59.2 -54.65 44.5 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 124.303 1.041 . . . . 64.44 110.971 176.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 7.8 ptm180 -68.76 -24.5 64.45 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.371 -0.377 . . . . 71.03 110.58 -176.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -86.38 -0.48 56.03 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.304 0.483 . . . . 63.31 112.304 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.72 13.29 61.29 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 115.391 0.916 . . . . 52.31 115.391 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.77 -39.69 94.03 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 112.701 0.63 . . . . 74.15 112.701 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -89.75 -2.02 58.15 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.537 0.569 . . . . 72.03 112.537 -174.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.497 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 98.9 mttt -65.78 -14.62 61.72 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.732 0.641 . . . . 74.34 112.732 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -76.79 -37.66 55.4 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.373 0.606 . . . . 74.42 110.029 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.507 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.6 tt -88.88 5.56 43.3 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.031 -0.986 . . . . 74.23 110.85 -168.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -12.17 52.54 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.303 0.853 . . . . 75.11 113.303 -176.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.67 -36.51 51.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.574 0.702 . . . . 73.04 109.341 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 34.81 114.59 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 118.67 2.841 . . . . 60.12 118.67 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -113.77 123.39 49.72 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 113.847 -1.524 . . . . 74.41 107.537 173.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -83.61 138.04 33.54 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.252 -0.979 . . . . 75.54 112.301 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.11 115.37 30.15 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 106.737 -1.579 . . . . 61.23 106.737 175.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.1 pt -69.78 113.86 6.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-O 122.526 1.155 . . . . 72.44 113.949 -173.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -118.32 136.62 53.61 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 104.814 -2.291 . . . . 72.22 104.814 174.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.7 m -94.41 146.05 7.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 115.312 1.597 . . . . 72.43 115.312 -166.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.9 t -143.65 122.14 12.45 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 103.568 -2.753 . . . . 71.12 103.568 173.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.02 158.8 48.62 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 121.168 -0.539 . . . . 70.35 111.754 -176.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -81.77 45.08 0.87 Allowed 'General case' 0 C--O 1.253 1.259 0 CA-C-O 121.26 0.552 . . . . 52.42 110.075 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.69 124.73 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 CA-C-N 115.351 -0.841 . . . . 74.14 109.666 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -64.11 -22.88 67.11 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.449 -0.796 . . . . 71.45 111.44 -174.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -76.51 -25.97 54.75 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.019 0.438 . . . . 75.41 110.703 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.96 140.84 8.37 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.795 -0.639 . . . . 54.2 113.069 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -147.87 177.4 9.37 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.176 -1.416 . . . . 74.15 107.176 175.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 125' ' ' TRP . . . -80.93 152.78 33.54 Favored Glycine 0 N--CA 1.425 -2.034 0 C-N-CA 120.266 -0.969 . . . . 65.34 112.752 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -106.95 134.95 49.32 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.309 -1.367 . . . . 63.25 107.309 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.404 ' N ' ' HD2' ' A' ' 100' ' ' LYS . 7.7 mptt -124.21 102.59 7.78 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.433 -1.321 . . . . 70.34 107.433 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 96.0 mt -119.22 141.02 49.27 Favored 'General case' 0 C--N 1.282 -2.352 0 C-N-CA 120.457 -0.497 . . . . 74.11 109.978 -176.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.537 HG22 ' HB3' ' A' ' 121' ' ' GLU . 20.3 t -122.9 135.39 63.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.941 -0.392 . . . . 73.13 109.941 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -120.38 141.42 50.11 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.38 -0.97 . . . . 75.41 108.38 175.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -114.96 144.33 43.75 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 109.304 -0.628 . . . . 73.14 109.304 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.508 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 22.9 t -68.96 166.23 18.37 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 124.165 0.986 . . . . 74.04 108.625 174.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.68 150.64 47.7 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.638 -0.875 . . . . 70.02 108.638 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.09 108.89 3.27 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.554 -0.535 . . . . 45.31 109.554 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -94.22 135.15 35.93 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.606 -0.725 . . . . 72.11 109.103 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -68.11 119.71 13.15 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 123.547 0.53 . . . . 60.42 109.895 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.1 t -96.19 162.45 13.52 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.05 -1.093 . . . . 74.12 108.05 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -62.57 -27.69 69.36 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.05 0.54 . . . . 72.5 111.716 -176.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.74 5.39 18.68 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.056 0.542 . . . . 63.54 110.615 -175.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 76.63 9.9 2.89 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.866 1.266 . . . . 72.25 109.953 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -96.69 174.7 6.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 109.045 -0.724 . . . . 63.04 109.045 177.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.518 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -113.96 133.54 59.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 109.547 -0.538 . . . . 73.21 109.547 178.18 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -115.01 155.44 26.96 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.688 -0.856 . . . . 70.2 108.688 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 46.2 p90 -156.04 149.38 24.63 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.633 -0.877 . . . . 74.24 108.633 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.508 ' H ' ' HB3' ' A' ' 105' ' ' SER . 3.5 m-20 -102.55 141.14 35.87 Favored 'General case' 0 C--N 1.264 -3.15 0 N-CA-C 106.653 -1.61 . . . . 65.54 106.653 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.507 ' CD ' ' HG3' ' A' ' 143' ' ' LYS . 93.5 mt-10 -114.94 141.39 48.02 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.484 -0.486 . . . . 65.13 110.005 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.72 121.77 31.19 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.838 -0.619 . . . . 71.51 109.565 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.537 ' HB3' HG22 ' A' ' 102' ' ' VAL . 14.5 pt-20 -123.77 115.33 21.2 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-O 121.626 0.726 . . . . 63.13 111.784 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.31 135.7 35.43 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.891 -1.049 . . . . 65.12 109.891 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -117.28 117.47 29.64 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.431 -0.951 . . . . 74.5 108.431 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.53 HG22 ' SG ' ' A' ' 132' ' ' CYS . 54.4 mt -119.76 128.87 75.92 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 N-CA-C 105.533 -2.025 . . . . 75.22 105.533 176.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.535 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 0.2 OUTLIER -110.89 145.18 38.74 Favored 'General case' 0 N--CA 1.425 -1.723 0 C-N-CA 117.373 -1.731 . . . . 74.42 110.536 -177.223 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -103.84 118.26 36.27 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 107.711 -1.218 . . . . 73.31 107.711 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -75.9 155.67 35.0 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.205 -1.361 . . . . 60.42 109.422 -174.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -60.12 -22.57 62.97 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.011 0.91 . . . . 72.22 110.106 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.69 -13.37 54.12 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.703 1.201 . . . . 72.1 111.336 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.77 -23.71 34.68 Favored Glycine 0 CA--C 1.498 -1.001 0 N-CA-C 111.22 -0.752 . . . . 54.25 111.22 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.0 p -78.37 159.58 28.28 Favored 'General case' 0 N--CA 1.408 -2.565 0 C-N-CA 124.06 0.944 . . . . 74.43 110.392 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.53 ' SG ' HG22 ' A' ' 124' ' ' ILE . 7.7 t -135.49 143.7 45.96 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 108.889 -0.782 . . . . 75.21 108.889 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.414 ' HE1' ' HA ' ' A' ' 52' ' ' HIS . 11.6 t90 -153.85 156.17 37.11 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.966 -1.124 . . . . 72.21 107.966 -176.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.0 mp -68.81 127.9 34.74 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.834 -0.432 . . . . 72.41 109.834 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -87.02 -52.26 5.54 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.902 0.858 . . . . 72.14 108.767 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 27.8 p -174.93 162.02 3.07 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 114.324 -1.307 . . . . 43.54 108.131 -175.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.6 m -137.08 144.44 32.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 N-CA-C 106.342 -1.725 . . . . 72.32 106.342 172.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -124.65 130.6 52.73 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 120.674 -0.41 . . . . 70.33 110.78 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -109.97 127.75 54.98 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.573 -1.269 . . . . 64.03 107.573 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.7 pt -126.82 99.01 5.12 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-O 121.932 0.872 . . . . 73.24 111.803 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -86.05 92.25 8.65 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 105.402 -2.073 . . . . 75.11 105.402 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.7 m -165.66 3.35 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.277 -0.42 . . . . 62.33 112.01 -176.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.507 ' HG3' ' CD ' ' A' ' 119' ' ' GLU . 28.1 mmtp -96.21 129.15 43.59 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 119.57 -0.852 . . . . 73.41 111.935 -176.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.18 109.03 0.29 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.448 -1.251 . . . . 71.51 109.476 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.36 138.47 81.2 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 109.045 -0.724 . . . . 74.35 109.045 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.24 140.56 71.97 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.591 2.194 . . . . 62.54 110.468 176.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -70.57 161.29 30.95 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.586 0.707 . . . . 74.12 111.559 -176.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.92 155.95 15.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 107.593 -1.262 . . . . 75.05 107.593 173.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.757 0 N-CA-C 108.623 -0.881 . . . . 75.2 108.623 -179.835 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 t70 . . . . . 0 CA--C 1.505 -0.788 0 CA-C-O 120.678 0.275 . . . . 64.44 110.457 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.5 mtt -95.17 107.69 19.79 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.873 -0.788 . . . . 74.23 108.873 175.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.9 t -76.16 140.2 17.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 105.569 -2.011 . . . . 63.54 105.569 173.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 21' ' ' VAL . 9.4 p -55.45 -42.97 74.97 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 118.594 0.634 . . . . 72.23 111.366 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.15 -37.91 89.17 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-O 121.726 0.774 . . . . 73.21 110.964 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.36 -33.32 72.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.918 -1.142 . . . . 73.22 107.918 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -69.98 -38.95 76.18 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.185 -0.916 . . . . 75.03 109.728 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 17' ' ' THR . 61.9 t -58.32 -53.89 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 123.507 0.504 . . . . 71.13 110.011 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.06 -32.78 74.2 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.874 -0.731 . . . . 64.32 111.413 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.86 -37.24 83.6 Favored Glycine 0 C--O 1.229 -0.161 0 N-CA-C 111.465 -0.654 . . . . 63.5 111.465 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.7 tp -65.45 -46.48 79.68 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 124.102 0.961 . . . . 71.12 108.663 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.46 -41.27 99.79 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.167 -0.924 . . . . 74.23 111.577 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -61.71 -42.28 98.74 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 122.731 0.412 . . . . 53.01 110.737 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -64.55 -47.71 77.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.356 0.598 . . . . 63.22 109.407 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 30.2 t80 -61.43 -51.59 68.09 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.309 -1.314 . . . . 61.24 110.42 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.3 mm -64.82 -32.28 57.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 116.24 -0.436 . . . . 52.14 111.687 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.31 -43.0 71.23 Favored 'General case' 0 CA--C 1.479 -1.784 0 C-N-CA 119.761 -0.775 . . . . 73.4 109.99 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 41' ' ' SER . 4.1 pp -70.53 -26.03 63.38 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 119.912 -0.715 . . . . 73.13 112.045 -178.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.0 t -70.25 -28.02 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 121.453 0.644 . . . . 52.32 109.777 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.9 p -114.21 23.66 12.67 Favored 'General case' 0 C--O 1.25 1.111 0 N-CA-C 109.148 -0.686 . . . . 54.02 109.148 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.617 ' HD3' ' HA ' ' A' ' 31' ' ' LEU . 27.4 tptt -52.8 137.56 31.48 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.342 -1.299 . . . . 72.1 111.684 -173.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.0 p -40.72 138.89 1.22 Allowed Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 125.411 1.484 . . . . 72.45 112.576 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -57.3 -15.22 18.06 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 123.545 2.83 . . . . 60.13 113.209 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.52 -27.94 68.96 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.921 0.867 . . . . 71.23 109.114 174.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.7 p -119.26 96.48 5.24 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 114.667 -1.151 . . . . 62.43 108.179 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.6 t -66.32 -50.03 71.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 113.348 0.87 . . . . 74.34 113.348 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.449 ' OD1' ' HB2' ' A' ' 43' ' ' HIS . 17.6 t-20 -89.72 80.76 6.51 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 123.111 1.434 . . . . 70.12 112.023 -171.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.68 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 15.8 m -67.2 -27.48 67.3 Favored 'General case' 0 C--O 1.255 1.374 0 CA-C-N 113.008 -1.906 . . . . 64.43 109.632 -175.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 42' ' ' GLU . 1.7 pm0 -68.52 -20.34 64.56 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 114.318 -1.31 . . . . 71.11 112.619 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.449 ' HB2' ' OD1' ' A' ' 40' ' ' ASN . 13.2 t60 -70.49 -38.46 74.35 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.19 -1.041 . . . . 72.14 108.19 175.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -66.57 -36.65 83.17 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.377 -0.972 . . . . 75.33 108.377 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.64 -43.18 97.54 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.671 -0.695 . . . . 74.45 110.722 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.01 79.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.31 0.576 . . . . 62.24 110.469 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -68.47 -39.12 81.52 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.443 -0.799 . . . . 63.41 109.698 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 28' ' ' PHE . 79.7 t80 -69.4 -41.21 76.73 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 123.624 0.769 . . . . 73.31 111.084 -177.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.3 pp -79.52 -7.98 58.84 Favored 'General case' 0 C--O 1.205 -1.244 0 CA-C-N 116.02 -0.536 . . . . 61.41 112.143 -176.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.05 -61.61 5.22 Favored Glycine 0 CA--C 1.541 1.687 0 C-N-CA 121.231 -0.509 . . . . 72.22 112.788 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -76.48 -4.92 15.61 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.118 2.545 . . . . 72.14 112.47 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.41 ' HB3' HD13 ' A' ' 134' ' ' LEU . 80.1 m-70 -122.61 29.95 6.68 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.889 -0.507 . . . . 74.03 110.646 -173.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.571 ' OD1' ' HB ' ' A' ' 65' ' ' THR . 6.2 t70 -55.83 106.8 0.72 Allowed Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 125.207 1.403 . . . . 72.15 113.274 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 26.2 Cg_endo -107.33 -165.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 123.894 3.063 . . . . 50.21 112.803 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -87.85 115.58 25.41 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.077 -1.082 . . . . 72.51 108.077 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.407 HD13 ' HB2' ' A' ' 68' ' ' PHE . 53.4 mt -101.27 108.77 24.11 Favored 'Isoleucine or valine' 0 C--O 1.168 -3.217 0 N-CA-C 108.398 -0.964 . . . . 72.22 108.398 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -93.55 135.91 34.35 Favored 'General case' 0 C--N 1.272 -2.788 0 O-C-N 121.397 -0.814 . . . . 73.34 108.998 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.7 t -133.49 116.93 25.95 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 107.951 -1.129 . . . . 71.13 107.951 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 61.89 20.5 11.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.126 1.37 . . . . 61.54 110.931 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.6 4.72 60.51 Favored Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.26 -0.882 . . . . 75.23 112.822 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -107.45 134.77 49.99 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 108.096 -1.076 . . . . 71.34 108.096 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.11 127.88 38.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.523 0.678 . . . . 75.44 109.247 -178.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 61.9 mm-40 -122.01 150.12 42.53 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.005 -1.109 . . . . 73.41 108.005 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 t -97.86 174.09 6.76 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.414 -0.958 . . . . 75.24 108.414 176.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.571 ' HB ' ' OD1' ' A' ' 53' ' ' ASP . 8.9 t -53.77 -35.22 61.08 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 122.816 0.446 . . . . 74.41 111.058 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.543 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 10.7 m -58.73 -56.0 27.86 Favored 'General case' 0 C--O 1.212 -0.897 0 O-C-N 123.5 0.5 . . . . 63.53 110.014 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -58.96 -48.03 82.99 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 123.493 0.496 . . . . 74.44 111.014 -178.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.407 ' HB2' HD13 ' A' ' 56' ' ' ILE . 42.7 t80 -52.95 -56.86 12.85 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.464 0.478 . . . . 74.35 110.012 176.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -52.11 -42.87 63.63 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.716 -1.129 . . . . 73.14 110.857 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.8 mm100 -60.49 -48.77 80.32 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 122.797 0.439 . . . . 73.23 111.343 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.523 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 23.3 m-85 -66.41 -37.5 85.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.937 -0.764 . . . . 65.13 108.937 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -57.45 -53.37 58.89 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 123.762 0.825 . . . . 53.03 110.911 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -70.95 -19.2 62.59 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.118 0.485 . . . . 74.23 111.42 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -84.21 -9.91 58.14 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 112.972 0.731 . . . . 74.04 112.972 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.76 21.36 16.47 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 119.975 -1.107 . . . . 52.23 113.612 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.18 -49.7 9.19 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 122.255 -0.556 . . . . 44.13 110.78 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.523 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 62.4 m-85 -92.1 11.18 26.29 Favored 'General case' 0 C--O 1.193 -1.876 0 N-CA-C 113.333 0.864 . . . . 75.11 113.333 -175.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -12.35 59.96 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.391 0.885 . . . . 70.13 113.391 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -87.46 -10.05 52.92 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.648 -1.16 . . . . 64.11 111.779 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.7 tt -65.05 -26.24 68.17 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 122.505 0.322 . . . . 74.34 110.955 -173.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -60.86 -24.46 65.93 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.16 0.43 . . . . 72.1 112.16 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -105.16 13.65 30.35 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 112.108 0.41 . . . . 73.45 112.108 -178.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -70.17 126.46 29.75 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.414 0.626 . . . . 45.21 111.224 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -86.61 123.81 32.2 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.087 -0.96 . . . . 73.51 109.458 -177.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.468 ' HB3' ' NE1' ' A' ' 103' ' ' TRP . 39.7 p90 -87.45 135.31 33.39 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.238 0.542 . . . . 62.03 111.833 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.39 132.45 33.95 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 105.851 -1.907 . . . . 72.32 105.851 172.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.8 tp -83.79 74.32 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 122.706 1.241 . . . . 64.43 113.071 -173.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -89.27 99.95 12.84 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 104.406 -2.442 . . . . 65.12 104.406 170.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.3 p -112.98 97.46 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 113.912 1.079 . . . . 74.43 113.912 -173.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.0 m -83.37 -37.92 22.69 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 105.632 -1.988 . . . . 72.14 105.632 166.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.93 -115.76 4.82 Favored Glycine 0 CA--C 1.5 -0.849 0 CA-C-N 114.29 -1.323 . . . . 55.54 113.996 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -78.8 79.95 5.18 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.233 0.539 . . . . 72.44 111.807 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.8 m -120.07 110.69 29.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.04 -0.982 . . . . 70.1 108.484 173.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -91.84 79.71 5.3 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.106 -0.952 . . . . 72.12 109.49 -174.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.404 ' O ' ' HD2' ' A' ' 126' ' ' ARG . 8.7 tp10 -157.83 155.56 29.91 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.477 -1.238 . . . . 70.01 107.789 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.92 70.53 3.11 Favored Glycine 0 N--CA 1.429 -1.791 0 N-CA-C 110.718 -0.953 . . . . 72.11 110.718 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -127.43 177.03 7.01 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 122.549 0.34 . . . . 63.22 110.145 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 125' ' ' TRP . . . -100.0 148.89 18.63 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.649 -0.786 . . . . 70.43 113.214 -176.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -107.04 135.2 49.0 Favored 'General case' 0 C--O 1.25 1.111 0 N-CA-C 106.679 -1.6 . . . . 71.24 106.679 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -126.67 107.8 10.51 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.933 -0.766 . . . . 43.43 108.933 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.3 mt -114.57 138.14 51.0 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.082 -1.081 . . . . 73.4 108.082 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 11.8 p -127.26 137.69 57.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.572 0.701 . . . . 73.11 111.715 -177.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.576 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 17.4 m-90 -118.49 157.18 27.74 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.833 -1.076 . . . . 73.34 109.622 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.12 121.35 40.33 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.884 -1.895 . . . . 60.22 105.884 170.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.4 t -75.2 -166.91 0.55 Allowed 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 115.777 -0.647 . . . . 53.04 110.917 -174.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.41 124.1 19.31 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.979 -0.555 . . . . 75.12 112.359 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.77 124.42 28.59 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.396 -1.335 . . . . 74.52 107.396 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -131.26 136.19 47.98 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.934 -0.575 . . . . 74.42 110.233 -171.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.5 mtp85 -80.52 111.49 16.99 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.853 -0.795 . . . . 75.21 108.853 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.6 t -84.44 170.73 13.24 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.169 -0.923 . . . . 72.33 110.509 -174.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -67.73 -13.68 62.31 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.057 0.943 . . . . 71.42 110.489 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.585 ' HB2' ' HG2' ' A' ' 114' ' ' LYS . 6.0 m-20 -78.83 -5.94 54.74 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.041 -0.981 . . . . 71.24 110.285 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 69.44 19.22 7.66 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.898 1.279 . . . . 72.41 109.431 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.585 ' HG2' ' HB2' ' A' ' 112' ' ' ASP . 24.3 pttm -116.11 155.55 28.0 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.479 -0.934 . . . . 73.22 108.479 173.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 19.0 mt -90.8 132.92 34.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 107.22 -1.4 . . . . 72.01 107.22 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 56.6 ttm-85 -123.23 143.72 49.85 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.376 -0.972 . . . . 70.41 108.376 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 41.2 p90 -140.85 173.45 11.47 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.757 -0.831 . . . . 74.42 108.757 176.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.558 ' HB3' ' HA ' ' A' ' 141' ' ' MET . 2.7 p-10 -124.37 146.38 48.89 Favored 'General case' 0 C--N 1.249 -3.774 0 N-CA-C 108.82 -0.808 . . . . 74.22 108.82 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -113.78 147.88 37.53 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 119.725 -0.79 . . . . 75.31 109.786 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -131.45 120.22 22.71 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.345 -0.843 . . . . 64.45 111.274 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -110.83 118.1 35.22 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 108.207 -1.035 . . . . 74.43 108.207 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -106.15 134.66 48.94 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.664 -0.648 . . . . 55.35 110.146 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -119.82 118.75 31.62 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.171 -0.922 . . . . 63.45 110.818 -174.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.33 145.37 26.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 106.331 -1.729 . . . . 45.3 106.331 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.519 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 0.4 OUTLIER -123.58 140.06 53.38 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 117.751 -1.58 . . . . 75.11 108.924 174.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 95' ' ' GLU . 18.7 ttm180 -85.19 120.05 26.25 Favored 'General case' 0 N--CA 1.403 -2.811 0 N-CA-C 106.165 -1.791 . . . . 60.11 106.165 172.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.467 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 76.6 ttt180 -69.82 149.33 48.03 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.116 -1.438 . . . . 73.53 107.116 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.24 -20.35 58.53 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.697 0.76 . . . . 74.14 111.03 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.467 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 11.5 t70 -64.8 -18.13 64.83 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.507 1.123 . . . . 72.2 111.245 175.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.19 -21.28 33.72 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.192 -0.763 . . . . 55.11 111.192 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.0 m -78.2 171.33 15.2 Favored 'General case' 0 N--CA 1.419 -2.013 0 C-N-CA 123.562 0.745 . . . . 75.23 109.153 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.585 ' SG ' HG22 ' A' ' 21' ' ' VAL . 28.3 p -140.52 151.25 44.62 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 109.486 -0.561 . . . . 73.34 109.486 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.475 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 1.8 t90 -152.07 155.29 37.63 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.537 -1.283 . . . . 74.1 107.537 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.41 HD13 ' HB3' ' A' ' 52' ' ' HIS . 10.3 mp -68.82 123.87 22.14 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.349 0.595 . . . . 72.01 110.287 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -83.68 -50.6 8.02 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.135 -0.938 . . . . 74.41 108.563 -176.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 26.6 p -170.2 166.09 8.96 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 108.294 -1.002 . . . . 74.11 108.294 -177.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.2 t -143.52 143.37 24.45 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 N-CA-C 104.683 -2.34 . . . . 73.13 104.683 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -131.48 131.13 43.25 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 117.721 0.237 . . . . 74.4 110.866 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -118.17 130.54 56.16 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.147 -1.057 . . . . 64.53 108.147 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.5 pt -125.97 103.84 12.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-O 121.352 0.596 . . . . 75.21 111.438 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.558 ' HA ' ' HB3' ' A' ' 118' ' ' ASP . 52.8 mtt -95.85 94.85 7.88 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.064 -0.516 . . . . 55.24 109.611 -178.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.2 m -164.25 -46.38 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.018 -0.537 . . . . 62.52 110.672 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -45.44 131.58 8.32 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.644 1.578 . . . . 53.21 113.363 -173.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -159.52 157.49 30.07 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.393 -0.821 . . . . 63.32 109.788 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.59 159.2 53.11 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 108.274 -1.009 . . . . 65.33 108.274 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.05 147.73 32.93 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.994 2.463 . . . . 73.24 111.268 176.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.477 ' CB ' ' HB3' ' A' ' 114' ' ' LYS . 29.8 p90 -80.57 148.23 30.44 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-O 121.416 0.627 . . . . 74.21 112.143 -175.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.5 m -92.28 150.3 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 CA-C-N 114.978 -1.01 . . . . 61.34 108.336 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.466 0 N-CA-C 108.861 -0.792 . . . . 74.2 108.861 -179.91 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 CA--C 1.507 -0.682 0 N-CA-C 110.051 -0.352 . . . . 73.42 110.051 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.4 ttt 74.08 11.07 4.4 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 125.345 1.458 . . . . 75.25 110.683 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.1 p -64.62 -31.58 54.26 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.247 0 CA-C-N 115.209 -0.905 . . . . 74.23 109.764 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 130' ' ' GLY . 86.5 m -57.9 -46.71 84.52 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-O 121.46 0.648 . . . . 72.15 110.829 176.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -76.5 -35.35 58.4 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.541 -0.754 . . . . 73.31 110.758 -175.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.76 -37.34 81.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.518 -0.765 . . . . 73.34 108.941 178.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -66.65 -53.45 33.83 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 115.199 -0.91 . . . . 63.15 109.931 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.8 p -66.32 -32.99 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 116.033 -0.53 . . . . 65.51 112.39 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -33.89 62.88 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 119.045 -1.062 . . . . 63.0 110.045 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.29 -41.36 68.7 Favored Glycine 0 CA--C 1.496 -1.1 0 N-CA-C 110.605 -0.998 . . . . 41.03 110.605 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.7 tp -65.15 -50.8 64.59 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 123.778 0.831 . . . . 71.2 109.698 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.33 -42.18 97.26 Favored Glycine 0 N--CA 1.439 -1.156 0 CA-C-N 115.61 -0.723 . . . . 61.15 112.258 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -74.02 -32.52 63.4 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 120.159 -0.616 . . . . 75.53 111.559 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.86 -44.04 97.19 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.069 -0.715 . . . . 64.22 109.069 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 23.0 t80 -62.08 -53.73 51.3 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.08 -1.418 . . . . 70.5 110.31 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.6 mm -61.09 -40.53 86.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.606 0.595 . . . . 73.21 112.606 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.5 -40.49 85.19 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 120.521 -0.471 . . . . 60.13 110.136 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.686 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.8 pp -71.54 -27.51 63.24 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 118.801 -1.16 . . . . 71.54 112.054 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.5 t -71.07 -21.65 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 121.27 0.557 . . . . 72.0 109.527 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.0 p -115.09 22.31 13.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 122.115 -0.366 . . . . 50.21 111.915 -177.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.686 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 61.0 mmtt -49.82 133.71 21.59 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 113.544 0.942 . . . . 60.13 113.544 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.5 m -55.21 150.39 21.88 Favored Pre-proline 0 C--N 1.302 -1.496 0 C-N-CA 125.537 1.535 . . . . 74.42 110.487 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -59.18 -12.77 17.05 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.658 2.905 . . . . 60.11 112.857 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.52 -27.42 69.14 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.072 0.939 . . . . 63.25 109.1 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.4 p -109.99 99.17 8.32 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 106.354 -1.721 . . . . 71.34 106.354 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.8 p -49.61 -37.88 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 116.657 2.095 . . . . 71.12 116.657 -168.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -132.49 110.54 10.57 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 118.153 -1.419 . . . . 73.0 113.149 -174.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.8 m -65.89 -35.77 81.56 Favored 'General case' 0 C--O 1.256 1.412 0 CA-C-O 121.823 0.821 . . . . 61.44 110.331 -175.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.568 ' OE2' ' HA ' ' A' ' 78' ' ' LYS . 1.5 mp0 -66.6 -21.3 66.13 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.243 -0.889 . . . . 64.22 110.586 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -68.62 -42.23 78.39 Favored 'General case' 0 CA--C 1.5 -0.981 0 N-CA-C 108.533 -0.914 . . . . 74.03 108.533 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.469 ' HG3' ' HG3' ' A' ' 34' ' ' LYS . 13.2 mm-40 -69.76 -35.01 74.57 Favored 'General case' 0 N--CA 1.414 -2.252 0 N-CA-C 108.098 -1.075 . . . . 72.34 108.098 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.0 tp -66.97 -42.97 84.25 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.896 -0.593 . . . . 63.31 110.801 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.99 -34.39 76.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.624 0.726 . . . . 70.53 110.366 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -76.35 -32.72 58.82 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.197 -0.91 . . . . 64.14 109.98 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.487 ' O ' ' HD2' ' A' ' 51' ' ' PRO . 59.9 t80 -67.28 -47.7 69.86 Favored 'General case' 0 C--O 1.215 -0.744 0 C-N-CA 123.48 0.712 . . . . 63.4 109.991 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.443 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.5 pp -75.03 -4.14 36.65 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.766 -0.652 . . . . 74.44 111.107 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.61 -61.13 5.36 Favored Glycine 0 CA--C 1.526 0.755 0 O-C-N 123.644 0.59 . . . . 72.03 112.371 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 48' ' ' PHE . 93.5 Cg_endo -85.18 -6.5 9.3 Favored 'Trans proline' 0 CA--C 1.549 1.264 0 C-N-CA 122.214 1.942 . . . . 74.33 112.672 173.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.451 ' HD2' ' O ' ' A' ' 48' ' ' PHE . 91.3 m-70 -111.41 31.35 6.18 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.726 -0.472 . . . . 72.45 109.726 -175.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.412 ' OD2' ' HB ' ' A' ' 65' ' ' THR . 13.4 t70 -54.68 107.82 0.97 Allowed Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 124.679 1.192 . . . . 75.52 112.505 -177.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -108.7 -154.45 0.02 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.294 0 C-N-CA 123.602 2.868 . . . . 74.22 110.485 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -93.63 120.13 33.52 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 107.195 -1.409 . . . . 55.21 107.195 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.446 HD13 ' CB ' ' A' ' 68' ' ' PHE . 64.7 mt -101.56 110.38 28.25 Favored 'Isoleucine or valine' 0 C--O 1.168 -3.19 0 N-CA-C 108.038 -1.097 . . . . 74.13 108.038 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -96.77 138.62 34.05 Favored 'General case' 0 C--N 1.271 -2.839 0 O-C-N 121.304 -0.873 . . . . 75.33 109.304 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.5 t -133.07 114.44 21.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 N-CA-C 107.502 -1.296 . . . . 74.33 107.502 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 63.19 21.02 12.63 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 124.794 1.237 . . . . 63.32 111.073 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.92 -1.16 59.41 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.329 -0.851 . . . . 71.42 112.39 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -103.96 135.27 45.79 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.417 -0.586 . . . . 61.31 109.417 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -76.97 129.2 37.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.671 0.748 . . . . 62.34 109.265 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.456 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 57.4 mm-40 -126.21 147.55 49.64 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 124.642 1.177 . . . . 73.43 108.227 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 t -92.63 174.56 7.2 Favored 'General case' 0 C--O 1.254 1.341 0 N-CA-C 108.232 -1.025 . . . . 71.42 108.232 175.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.412 ' HB ' ' OD2' ' A' ' 53' ' ' ASP . 8.8 t -54.8 -36.17 64.65 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.028 0.531 . . . . 71.24 111.058 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 35.8 m -65.92 -46.42 78.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 122.729 0.412 . . . . 74.14 111.194 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -63.88 -46.19 86.01 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.91 -0.404 . . . . 62.0 109.91 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.446 ' CB ' HD13 ' A' ' 56' ' ' ILE . 48.9 t80 -54.28 -54.94 33.41 Favored 'General case' 0 CA--C 1.505 -0.771 0 O-C-N 123.656 0.597 . . . . 74.22 109.723 174.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 2.2 tm? -50.39 -44.36 54.87 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 124.424 1.078 . . . . 61.23 110.54 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.431 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 26.8 mt-30 -56.91 -52.11 66.45 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 123.101 0.56 . . . . 73.24 111.929 174.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -64.87 -36.53 84.66 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.704 0.764 . . . . 73.21 109.817 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -57.7 -55.99 27.72 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 124.612 1.165 . . . . 71.35 110.472 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 48.9 ptt85 -68.87 -23.93 64.28 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.358 -0.383 . . . . 74.51 111.597 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 54.8 mt-30 -78.99 -15.31 58.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 120.432 -0.507 . . . . 74.02 111.459 176.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.47 14.33 30.41 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.677 -0.773 . . . . 54.24 114.622 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.16 -42.54 79.91 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.437 0.532 . . . . 74.12 112.437 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -92.48 6.89 45.42 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.587 0.588 . . . . 75.2 112.587 -173.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.568 ' HA ' ' OE2' ' A' ' 42' ' ' GLU . 99.4 mttt -67.06 -13.96 62.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.222 0.534 . . . . 75.22 112.233 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -77.57 -27.24 51.39 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.083 -0.71 . . . . 54.11 109.083 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.461 ' O ' HD23 ' A' ' 80' ' ' LEU . 7.1 tt -71.63 -17.51 62.26 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.077 0.951 . . . . 60.53 109.662 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -68.04 -22.04 64.97 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.105 -0.498 . . . . 75.1 109.879 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -101.13 4.76 42.4 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.379 -0.601 . . . . 73.14 109.379 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 105' ' ' SER . . . -75.73 143.17 42.2 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.525 0.935 . . . . 60.12 113.525 -173.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 103' ' ' TRP . 49.4 mt-10 -89.14 139.37 30.54 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.12 -0.945 . . . . 74.5 109.175 175.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -76.25 106.04 7.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 104.465 -2.42 . . . . 65.34 104.465 167.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -136.68 101.12 4.52 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.448 0.642 . . . . 54.4 111.25 -173.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.6 mm -97.5 128.64 48.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 107.405 -1.331 . . . . 72.15 107.405 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -69.04 -46.66 67.34 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.221 -1.029 . . . . 61.2 108.221 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.9 p -167.74 136.02 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 107.718 -1.216 . . . . 74.44 107.718 176.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 m -87.64 -38.85 15.54 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.713 -0.847 . . . . 71.01 108.713 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.39 -145.74 37.95 Favored Glycine 0 N--CA 1.428 -1.846 0 CA-C-N 114.795 -1.093 . . . . 60.34 110.496 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -133.89 129.62 36.63 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 120.85 0.357 . . . . 74.11 110.147 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.7 t -89.44 118.01 33.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 106.143 -1.799 . . . . 63.52 106.143 174.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -73.28 -36.82 66.37 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 112.959 0.726 . . . . 64.31 112.959 -171.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -149.93 115.47 5.53 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.541 -0.463 . . . . 54.54 110.217 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.41 91.81 0.47 Allowed Glycine 0 CA--C 1.5 -0.875 0 N-CA-C 110.825 -0.91 . . . . 43.4 110.825 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -58.67 119.77 7.71 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 113.508 0.929 . . . . 64.01 113.508 -174.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -117.83 138.12 13.73 Favored Glycine 0 N--CA 1.406 -3.33 0 N-CA-C 107.556 -2.218 . . . . 33.33 107.556 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -111.14 127.0 55.43 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.583 -0.895 . . . . 71.41 108.583 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -123.2 98.63 5.96 Favored 'General case' 0 C--N 1.273 -2.736 0 N-CA-C 105.44 -2.059 . . . . 72.23 105.44 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 121' ' ' GLU . 75.2 mt -109.75 138.84 45.53 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.034 -0.985 . . . . 53.53 108.897 -173.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 12.1 p -133.43 138.2 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-O 121.729 0.776 . . . . 72.33 111.839 -178.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.401 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 23.3 m-90 -113.77 143.71 44.19 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.392 -1.277 . . . . 74.11 107.661 176.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.425 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 21.8 mtpp -126.01 124.24 40.26 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.092 -1.447 . . . . 74.44 107.092 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 40.0 m -82.22 177.78 8.61 Favored 'General case' 0 C--N 1.281 -2.407 0 O-C-N 123.397 0.436 . . . . 52.41 111.012 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.34 126.22 25.35 Favored 'General case' 0 C--O 1.24 0.571 0 O-C-N 123.485 0.491 . . . . 71.12 110.787 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.472 ' HA ' ' HB3' ' A' ' 117' ' ' TRP . . . -76.99 142.89 39.77 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.035 -0.984 . . . . 72.02 110.375 -177.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -124.78 120.69 32.47 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.87 -1.159 . . . . 62.35 107.87 -176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -75.87 109.08 9.2 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.631 -0.877 . . . . 72.53 108.631 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 t -82.96 157.35 23.02 Favored 'General case' 0 N--CA 1.408 -2.532 0 CA-C-N 114.615 -1.175 . . . . 35.04 107.937 -172.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -76.74 3.69 11.2 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.859 0.838 . . . . 63.3 110.012 -177.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -87.86 5.56 39.72 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 124.952 1.301 . . . . 75.32 109.848 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 74.2 10.91 4.33 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.847 1.259 . . . . 73.31 110.698 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -129.02 165.44 21.15 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.308 -0.997 . . . . 72.31 108.308 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 115' ' ' ILE . 2.1 mp -104.91 136.2 39.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 108.193 -1.04 . . . . 74.11 108.193 -176.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.652 ' HG2' ' HB2' ' A' ' 144' ' ' ALA . 53.0 mtm180 -115.46 151.13 35.35 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.499 -0.556 . . . . 52.14 109.499 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 107' ' ' ALA . 10.2 p90 -160.49 174.06 14.63 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.918 -0.771 . . . . 73.13 108.918 177.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.437 ' CB ' ' HA ' ' A' ' 141' ' ' MET . 4.7 p-10 -113.01 134.65 54.41 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-O 121.199 0.523 . . . . 74.53 110.07 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.428 ' HG3' ' CD1' ' A' ' 117' ' ' TRP . 37.2 mt-10 -117.16 154.62 30.78 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.783 -1.099 . . . . 72.42 112.015 178.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.571 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -135.79 118.48 16.05 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.042 -0.981 . . . . 61.3 109.284 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 37.2 mt-10 -116.4 110.54 18.8 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.624 -0.51 . . . . 74.32 109.624 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.21 130.65 41.87 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 109.057 -0.72 . . . . 72.34 109.057 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -113.84 118.52 34.48 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.964 -0.754 . . . . 73.04 108.964 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.3 mt -118.95 152.69 21.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.388 -1.338 . . . . 74.51 107.388 178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -137.53 148.55 46.06 Favored 'General case' 0 C--O 1.275 2.417 0 C-N-CA 119.715 -0.794 . . . . 72.42 109.922 175.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -88.11 129.37 35.32 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.116 -0.947 . . . . 73.43 108.691 170.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.422 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 47.8 ttt180 -87.86 147.29 25.18 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-N 113.983 -1.462 . . . . 54.43 108.075 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -58.21 -28.27 64.66 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.855 0.462 . . . . 75.33 112.065 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.422 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 9.8 t70 -64.84 -16.87 63.71 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.148 -0.933 . . . . 74.52 111.702 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.401 ' O ' HG23 ' A' ' 17' ' ' THR . . . 98.6 6.8 56.24 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 119.849 -1.167 . . . . 63.11 111.283 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.404 ' OG ' ' HD3' ' A' ' 127' ' ' ARG . 0.4 OUTLIER -96.89 162.37 13.44 Favored 'General case' 0 N--CA 1.396 -3.151 0 N-CA-C 108.438 -0.949 . . . . 72.22 108.438 175.711 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 28.8 p -133.22 144.99 50.15 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 107.967 -1.123 . . . . 61.31 107.967 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.41 ' HE1' ' HA ' ' A' ' 52' ' ' HIS . 2.1 t90 -159.06 156.05 28.5 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 120.088 -0.645 . . . . 75.11 109.797 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.6 mp -69.23 127.01 31.54 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.268 0.556 . . . . 65.52 109.773 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -80.89 -56.12 4.34 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 107.806 -1.183 . . . . 75.43 107.806 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 10.9 m -166.5 162.27 16.67 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 105.931 -1.877 . . . . 65.3 105.931 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.7 m -137.55 149.84 25.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 106.394 -1.706 . . . . 74.23 106.394 171.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -134.4 130.71 37.26 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 117.686 0.221 . . . . 65.43 110.414 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -112.63 129.05 56.52 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 107.312 -1.366 . . . . 74.05 107.312 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 8.4 pt -129.0 98.3 4.08 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 CA-C-O 122.129 0.966 . . . . 60.32 109.048 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.437 ' HA ' ' CB ' ' A' ' 118' ' ' ASP . 23.3 ptp -92.83 138.31 31.6 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.013 -0.994 . . . . 72.24 110.205 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.5 t 81.26 29.02 0.17 Allowed 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.264 0.977 . . . . 72.42 109.812 176.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -73.42 146.03 45.35 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.282 -1.747 . . . . 75.1 106.282 173.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.652 ' HB2' ' HG2' ' A' ' 116' ' ' ARG . . . -135.38 150.37 49.9 Favored 'General case' 0 N--CA 1.418 -2.047 0 C-N-CA 120.221 -0.592 . . . . 73.51 111.688 -175.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.06 109.14 35.46 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 106.277 -1.749 . . . . 75.34 106.277 169.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.74 144.33 97.03 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.71 2.273 . . . . 71.02 111.898 -176.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -79.85 151.09 30.42 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 108.893 -0.78 . . . . 64.53 108.893 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 31.1 m -77.66 115.29 19.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-O 121.668 0.747 . . . . 74.34 111.328 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.644 0 N-CA-C 107.845 -1.168 . . . . 70.12 107.845 178.904 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 CA--C 1.504 -0.807 0 N-CA-C 111.921 0.341 . . . . 75.55 111.921 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.55 1.38 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 116.907 2.188 . . . . 71.51 116.907 -170.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.1 m -71.19 -43.48 74.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 118.772 0.715 . . . . 75.45 110.88 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.2 p -67.9 -41.54 82.55 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.38 -0.6 . . . . 74.24 109.38 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 9.6 m-20 -60.23 -43.46 96.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.488 -1.233 . . . . 71.13 111.21 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.4 -42.95 87.12 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.873 -0.788 . . . . 75.51 108.873 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.17 -48.81 78.4 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 115.86 -0.609 . . . . 73.34 111.411 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.0 p -69.38 -38.83 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 112.552 0.575 . . . . 64.41 112.552 -176.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 22.5 ptmt -75.76 -25.96 56.96 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 119.076 -1.05 . . . . 65.55 110.187 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.56 -57.74 5.82 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 120.64 -0.791 . . . . 71.11 111.262 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.4 pp -68.45 -35.91 78.26 Favored 'General case' 0 C--O 1.199 -1.559 0 N-CA-C 108.947 -0.76 . . . . 65.13 108.947 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.23 -43.67 96.69 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 116.231 -0.44 . . . . 70.34 112.036 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -63.83 -46.85 83.2 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.76 -0.459 . . . . 72.31 109.76 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -65.16 -41.27 94.85 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 116.051 -0.522 . . . . 71.24 110.247 -177.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -63.05 -53.59 51.39 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.418 -0.81 . . . . 74.42 110.481 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 29' ' ' ILE . 13.5 mm -64.23 -34.81 71.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.613 -0.267 . . . . 74.43 111.666 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -63.3 -48.59 77.43 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 116.34 -0.391 . . . . 72.24 110.144 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 pp -68.57 -29.35 67.88 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.288 -0.565 . . . . 62.51 111.84 -177.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.45 -28.54 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-O 121.471 0.653 . . . . 71.4 110.326 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.7 p -110.17 13.29 23.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.34 0.59 . . . . 34.34 110.566 -175.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 tptt -57.0 140.39 49.14 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.638 1.175 . . . . 74.31 111.928 -175.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.6 m -57.63 155.26 21.75 Favored Pre-proline 0 C--O 1.248 1.014 0 C-N-CA 124.183 0.993 . . . . 43.55 111.259 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.83 -5.99 5.39 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 124.82 3.68 . . . . 72.11 112.146 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -59.7 -26.42 65.59 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.463 -1.244 . . . . 64.44 110.589 172.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.2 p -92.43 167.72 11.78 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 107.358 -1.349 . . . . 72.43 107.358 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.62 -46.93 67.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 118.884 -1.126 . . . . 74.53 111.13 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -168.09 141.64 3.28 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.331 -0.989 . . . . 73.51 108.331 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.8 m -56.62 -41.29 76.84 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 123.186 0.594 . . . . 72.45 111.067 -177.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.444 ' HB2' ' CD2' ' A' ' 72' ' ' PHE . 6.9 mm-40 -67.83 -20.06 65.12 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.947 -1.024 . . . . 54.3 111.383 -176.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -69.99 -48.26 58.91 Favored 'General case' 0 C--O 1.25 1.084 0 N-CA-C 108.26 -1.015 . . . . 72.3 108.26 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -69.32 -32.07 70.96 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 114.2 -1.364 . . . . 74.52 108.518 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.4 tp -67.04 -45.06 78.6 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.526 -0.761 . . . . 73.14 110.117 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.85 -34.94 75.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.293 0.568 . . . . 50.1 110.214 177.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -69.14 -40.29 78.33 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.103 -0.953 . . . . 70.25 109.215 177.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -68.48 -42.58 78.47 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 123.498 0.719 . . . . 62.14 110.594 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.472 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 3.3 pp -84.41 0.66 48.64 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.877 -0.601 . . . . 63.12 110.964 -176.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.32 -61.59 7.05 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 111.303 -0.719 . . . . 63.1 111.303 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -77.2 -5.09 15.47 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.868 2.379 . . . . 75.11 112.034 175.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 62.9 m-70 -121.47 36.55 4.58 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.698 -0.482 . . . . 61.02 109.698 -174.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -55.7 106.56 0.69 Allowed Pre-proline 0 N--CA 1.48 1.051 0 O-C-N 124.706 1.254 . . . . 64.0 111.892 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -99.95 -177.37 0.19 Allowed 'Trans proline' 0 N--CA 1.422 -2.697 0 C-N-CA 122.661 2.241 . . . . 72.53 109.979 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -84.22 107.46 16.54 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 107.254 -1.388 . . . . 72.54 107.254 174.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.65 HD13 ' HB2' ' A' ' 68' ' ' PHE . 71.7 mt -92.41 105.95 17.27 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.161 0 N-CA-C 107.39 -1.337 . . . . 63.32 107.39 -175.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -98.9 105.9 18.09 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 122.029 -0.42 . . . . 72.12 111.312 -175.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 70.3 t -107.97 113.1 42.89 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.649 0 N-CA-C 108.02 -1.104 . . . . 73.01 108.02 -177.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 56.63 26.3 11.02 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 124.536 1.148 . . . . 71.43 111.034 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.75 14.3 61.42 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.438 -0.801 . . . . 75.54 112.614 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -112.3 130.35 55.97 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.519 -0.919 . . . . 63.12 108.519 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.88 125.97 38.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 121.833 0.825 . . . . 74.32 109.183 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.454 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 47.9 mm-40 -124.44 147.84 48.03 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.719 -1.215 . . . . 75.43 107.719 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.1 t -101.24 173.73 6.32 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.793 -1.188 . . . . 60.12 107.793 174.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -46.23 -39.88 10.55 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.809 1.244 . . . . 62.43 112.09 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.466 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 27.6 m -64.43 -52.74 56.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 122.651 0.38 . . . . 72.42 110.489 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -60.95 -45.82 93.2 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.036 -0.529 . . . . 64.31 110.809 -178.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.65 ' HB2' HD13 ' A' ' 56' ' ' ILE . 46.5 t80 -52.22 -56.4 14.89 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.232 0.539 . . . . 75.44 109.796 175.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -49.77 -43.3 48.09 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 114.194 -1.367 . . . . 64.12 111.12 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.492 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 15.7 mm100 -62.75 -46.68 86.94 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 122.892 0.477 . . . . 71.0 111.222 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.498 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 51.6 m-85 -66.45 -37.58 85.46 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.332 0.587 . . . . 75.23 109.664 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.444 ' CD2' ' HB2' ' A' ' 42' ' ' GLU . 3.9 t80 -57.19 -51.83 67.77 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.022 -0.536 . . . . 70.44 110.96 175.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 12.8 ptm180 -69.47 -23.33 63.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.334 0.588 . . . . 75.35 110.68 -176.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -81.01 -6.12 58.4 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.653 0.612 . . . . 72.05 112.653 175.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.8 17.37 30.67 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.175 -0.536 . . . . 24.11 114.032 175.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.45 -60.29 2.42 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 122.47 -0.429 . . . . 45.22 111.874 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.498 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 56.5 m-85 -83.31 -7.43 59.59 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 113.455 0.909 . . . . 70.33 113.455 -171.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -15.81 63.82 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.469 -0.892 . . . . 62.34 111.561 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -88.37 -17.01 31.46 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.123 0.487 . . . . 75.21 109.689 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 80' ' ' LEU . 3.3 tm? -84.59 -17.36 38.99 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 115.64 -0.709 . . . . 73.35 109.381 -174.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.47 3.27 13.83 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.721 0.772 . . . . 75.45 111.086 -176.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -104.64 2.93 31.08 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.422 -0.955 . . . . 64.14 108.422 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -74.56 153.13 39.17 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.126 -0.943 . . . . 61.12 113.248 -175.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -99.48 135.45 40.87 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.382 -1.281 . . . . 71.12 108.385 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -76.93 118.83 19.91 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.506 -0.553 . . . . 75.41 109.506 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.22 161.37 15.05 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.587 0.708 . . . . 75.13 110.77 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.6 tp -108.53 141.34 24.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.378 -0.971 . . . . 64.4 108.378 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -125.02 103.3 7.94 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.49 -0.93 . . . . 64.31 108.49 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.5 p -68.9 -21.07 25.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.295 0.569 . . . . 74.33 111.237 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 t -96.97 20.38 11.26 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 122.142 0.972 . . . . 74.43 108.664 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.45 157.7 52.86 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 110.477 -1.049 . . . . 72.42 110.477 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -95.46 143.18 27.01 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.508 -0.477 . . . . 73.03 111.381 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.2 m -126.4 156.49 37.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.294 -1.373 . . . . 34.32 107.294 174.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.09 172.86 16.85 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.82 -0.437 . . . . 52.11 109.82 -171.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -54.03 -34.36 59.77 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.431 0.692 . . . . 75.23 112.563 -177.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.14 102.84 2.95 Favored Glycine 0 N--CA 1.425 -2.089 0 N-CA-C 106.126 -2.79 . . . . 73.33 106.126 170.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -58.76 119.86 7.91 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.022 0.439 . . . . 62.04 111.265 -172.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -138.74 156.41 24.21 Favored Glycine 0 N--CA 1.409 -3.116 0 C-N-CA 120.412 -0.899 . . . . 73.54 111.587 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -116.7 157.0 26.14 Favored 'General case' 0 C--O 1.261 1.671 0 N-CA-C 108.119 -1.067 . . . . 74.45 108.119 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -125.46 101.8 7.1 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 105.833 -1.914 . . . . 72.43 105.833 171.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.2 mt -99.16 112.43 24.58 Favored 'General case' 0 C--N 1.261 -3.253 0 N-CA-C 106.923 -1.51 . . . . 72.15 106.923 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 8.5 p -115.6 132.0 66.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.486 0.66 . . . . 75.44 112.035 -174.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.401 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 24.3 m-90 -106.34 140.86 38.6 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.051 -0.977 . . . . 75.42 109.245 176.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -118.63 121.24 39.71 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.063 -1.088 . . . . 74.12 108.063 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.461 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 45.1 t -80.26 -168.13 1.57 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.313 -0.858 . . . . 43.0 110.827 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.26 141.72 53.68 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 113.426 0.899 . . . . 74.52 113.426 -174.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.07 98.47 9.32 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.863 -1.162 . . . . 61.43 107.863 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -93.42 110.41 21.97 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 114.098 -1.41 . . . . 73.5 107.561 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -64.03 132.41 50.52 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 114.948 1.462 . . . . 75.02 114.948 -172.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.7 t -113.98 132.99 55.78 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 106.382 -1.71 . . . . 74.32 106.382 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -69.89 6.73 1.1 Allowed 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 113.005 0.743 . . . . 71.3 113.005 -176.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -96.13 25.56 4.78 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 122.158 -0.339 . . . . 64.43 110.454 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 70.54 23.23 4.83 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.236 1.014 . . . . 64.35 111.12 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 20.8 pttp -137.03 171.11 14.99 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.238 0.542 . . . . 65.32 111.462 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.448 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -127.54 151.4 34.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.135 -1.431 . . . . 64.15 107.135 176.504 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -114.83 158.33 22.07 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 106.528 -1.656 . . . . 74.25 106.528 176.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.423 ' CD1' ' HG3' ' A' ' 119' ' ' GLU . 39.1 p90 -148.76 164.88 33.09 Favored 'General case' 0 C--N 1.268 -2.944 0 N-CA-C 108.019 -1.104 . . . . 75.51 108.019 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.461 ' H ' ' HB3' ' A' ' 105' ' ' SER . 1.5 m-20 -106.55 134.19 50.06 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 105.57 -2.011 . . . . 72.22 105.57 176.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.434 ' HB2' HG13 ' A' ' 140' ' ' ILE . 34.9 mt-10 -114.87 154.12 29.23 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 119.482 -0.887 . . . . 75.44 111.727 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -139.32 116.85 11.36 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.878 -1.055 . . . . 53.22 108.999 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -111.98 109.66 19.54 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.058 -0.719 . . . . 71.53 109.058 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.54 118.25 33.62 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 121.136 0.493 . . . . 32.35 109.751 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -100.82 113.55 26.57 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.198 -1.408 . . . . 70.45 107.198 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 54.4 mt -118.31 143.62 28.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.42 -1.326 . . . . 63.31 107.42 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.25 147.57 51.1 Favored 'General case' 0 C--O 1.262 1.725 0 C-N-CA 119.098 -1.041 . . . . 61.22 110.752 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.577 ' HG2' ' SG ' ' A' ' 132' ' ' CYS . 29.1 mtp180 -89.91 116.86 28.29 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.073 -1.421 . . . . 73.22 109.17 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -80.96 145.21 31.35 Favored 'General case' 0 C--N 1.273 -2.725 0 CA-C-N 113.79 -1.55 . . . . 74.21 111.049 -170.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -72.59 -10.71 60.13 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 107.813 -1.18 . . . . 64.05 107.813 174.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -67.95 -17.72 64.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.006 -0.997 . . . . 72.0 109.589 173.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 101.89 -6.67 54.54 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.508 -0.637 . . . . 42.41 111.508 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.9 m -103.88 -179.62 4.0 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 109.141 -0.688 . . . . 65.52 109.141 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.577 ' SG ' ' HG2' ' A' ' 126' ' ' ARG . 74.0 m -131.49 142.14 49.91 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.611 -1.255 . . . . 73.53 107.611 175.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -149.78 154.89 39.19 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 119.718 -0.793 . . . . 74.52 109.879 -176.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.23 122.35 22.68 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.861 -0.792 . . . . 70.43 108.861 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -76.34 -52.8 9.2 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.209 -1.034 . . . . 74.3 108.209 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 38.7 m -167.88 154.53 7.86 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.479 -1.674 . . . . 64.45 106.479 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.39 139.41 41.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.469 -1.308 . . . . 62.44 107.469 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 33.9 ttmt -114.39 139.19 49.69 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 109.965 -0.383 . . . . 64.34 109.965 -175.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 66.2 m-85 -125.4 121.44 33.85 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.78 -1.192 . . . . 72.11 107.78 174.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.51 ' HB ' ' CD ' ' A' ' 143' ' ' LYS . 9.5 pt -128.83 97.61 3.75 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 CA-C-O 122.16 0.981 . . . . 73.13 109.109 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -87.95 137.04 32.68 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.925 -1.034 . . . . 72.22 111.33 -177.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.482 ' O ' ' HE3' ' A' ' 143' ' ' LYS . 41.4 t 71.27 49.19 0.33 Allowed 'General case' 0 C--N 1.321 -0.668 0 O-C-N 124.657 1.223 . . . . 75.41 111.403 175.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.51 ' CD ' ' HB ' ' A' ' 140' ' ' ILE . 0.3 OUTLIER -101.86 145.81 28.69 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.422 -0.955 . . . . 72.3 108.422 175.436 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -149.84 139.07 21.28 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.308 -0.627 . . . . 74.21 109.308 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.92 153.16 49.34 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 109.062 -0.718 . . . . 74.43 109.062 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.62 132.49 52.45 Favored 'Trans proline' 0 C--O 1.247 0.963 0 C-N-CA 122.519 2.146 . . . . 74.41 109.997 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.454 ' HB3' ' HB3' ' A' ' 114' ' ' LYS . 54.9 p90 -67.71 153.92 42.64 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 121.201 0.524 . . . . 63.12 112.01 -173.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.73 127.1 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 CA-C-N 115.575 -0.739 . . . . 71.1 110.273 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.465 0 N-CA-C 107.78 -1.192 . . . . 70.41 107.78 178.412 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.407 ' HB3' HG12 ' A' ' 16' ' ' VAL . 1.3 m-20 . . . . . 0 CA--C 1.501 -0.905 0 N-CA-C 109.029 -0.73 . . . . 61.33 109.029 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.9 ttt -94.56 -6.82 42.76 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.673 0.749 . . . . 72.5 111.21 -174.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.407 HG12 ' HB3' ' A' ' 14' ' ' ASP . 14.2 p -65.92 -20.32 27.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 114.965 -1.016 . . . . 75.15 110.326 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.455 ' O ' HG13 ' A' ' 21' ' ' VAL . 18.9 p -64.57 -39.69 94.19 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.351 -0.84 . . . . 74.43 111.288 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -68.21 -34.94 77.19 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.94 0.876 . . . . 74.13 109.104 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -70.41 -39.49 74.43 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.864 -1.062 . . . . 74.13 108.901 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.57 -45.01 84.94 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.859 -0.61 . . . . 72.54 109.916 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.496 HG12 ' SG ' ' A' ' 132' ' ' CYS . 17.9 m -69.49 -37.89 75.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.167 -0.47 . . . . 43.32 112.015 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HB3' ' HZ3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -72.5 -33.5 66.99 Favored 'General case' 0 C--O 1.211 -0.954 0 C-N-CA 118.629 -1.228 . . . . 74.24 109.961 178.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.83 -41.93 61.96 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.241 -0.743 . . . . 72.22 111.241 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.0 tp -69.65 -50.4 44.55 Favored 'General case' 0 N--CA 1.426 -1.668 0 C-N-CA 124.047 0.939 . . . . 71.11 109.173 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.05 -42.22 99.72 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.967 -0.56 . . . . 43.12 111.872 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -65.32 -44.2 88.61 Favored 'General case' 0 C--O 1.187 -2.218 0 CA-C-O 118.791 -0.623 . . . . 72.13 110.872 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.02 -38.63 91.95 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.116 0.96 . . . . 63.51 110.252 -174.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.572 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 24.1 t80 -64.45 -55.18 22.52 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.698 -1.592 . . . . 75.02 110.081 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 29' ' ' ILE . 16.0 mm -67.03 -30.56 49.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.074 -0.512 . . . . 71.42 111.007 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.34 -48.44 77.96 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 123.596 0.758 . . . . 73.14 110.142 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.4 pp -69.14 -28.49 66.49 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 119.944 -0.702 . . . . 64.41 110.048 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 68.8 t -73.21 -22.19 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 CA-C-O 121.219 0.533 . . . . 71.44 110.929 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.4 p -107.5 15.69 24.57 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.415 -0.803 . . . . 74.44 111.858 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.525 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 32.4 mmmt -57.05 162.22 2.64 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 113.543 0.942 . . . . 74.14 113.543 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.442 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 12.2 p -70.33 169.54 13.35 Favored Pre-proline 0 N--CA 1.435 -1.197 0 C-N-CA 125.469 1.508 . . . . 64.21 111.8 -177.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 35' ' ' SER . 19.0 Cg_endo -64.42 -7.46 14.27 Favored 'Trans proline' 0 C--N 1.363 1.317 0 C-N-CA 123.09 2.527 . . . . 75.34 112.09 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -73.92 -27.32 60.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.662 -0.699 . . . . 64.52 109.886 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.6 m -82.73 113.08 20.15 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.62 -0.718 . . . . 74.52 109.312 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.1 -32.91 56.04 Favored 'Isoleucine or valine' 0 C--O 1.25 1.124 0 N-CA-C 113.331 0.863 . . . . 71.14 113.331 -174.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -151.06 94.04 2.0 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.428 -0.909 . . . . 74.21 109.921 -174.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.3 m -67.35 -30.17 69.91 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.699 0.762 . . . . 54.23 109.766 -175.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' ' 42' ' ' GLU . 1.4 pm0 -71.84 -20.03 61.88 Favored 'General case' 0 N--CA 1.414 -2.269 0 CA-C-N 115.15 -0.932 . . . . 75.15 112.008 177.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -69.76 -45.37 68.21 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.692 -1.225 . . . . 73.44 107.692 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.13 -26.82 65.08 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.004 -0.998 . . . . 65.25 110.177 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.559 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 51.2 tp -70.18 -47.09 63.09 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.554 -0.748 . . . . 73.22 109.636 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.48 -27.01 68.99 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 121.528 0.68 . . . . 61.13 110.083 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -73.95 -38.8 64.13 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.878 -1.055 . . . . 72.4 109.64 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -70.11 -51.64 29.98 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.562 -0.745 . . . . 54.24 110.419 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 4.0 pp -82.12 -8.03 59.64 Favored 'General case' 0 C--O 1.196 -1.754 0 CA-C-N 115.382 -0.826 . . . . 72.25 111.824 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -43.64 -60.19 3.4 Favored Glycine 0 N--CA 1.477 1.374 0 O-C-N 123.672 0.607 . . . . 71.23 114.264 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.11 -6.3 16.49 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.506 2.137 . . . . 73.4 112.04 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -110.42 19.78 18.43 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.008 -0.738 . . . . 73.33 109.008 -175.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.663 ' CG ' ' HB ' ' A' ' 65' ' ' THR . 27.2 t70 -56.7 109.94 2.04 Favored Pre-proline 0 C--O 1.245 0.857 0 C-N-CA 125.163 1.385 . . . . 71.04 113.744 -176.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 53' ' ' ASP . 17.3 Cg_endo -106.54 -152.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.637 0 C-N-CA 123.929 3.086 . . . . 63.11 110.502 178.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -81.99 124.03 29.41 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.551 -0.907 . . . . 72.53 108.551 176.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.51 HD13 ' CB ' ' A' ' 68' ' ' PHE . 39.7 mt -108.22 109.2 27.38 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.396 0 N-CA-C 107.219 -1.4 . . . . 60.42 107.219 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -96.07 138.88 33.05 Favored 'General case' 0 C--N 1.263 -3.182 0 O-C-N 121.601 -0.687 . . . . 75.41 109.678 -177.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 3.6 p -133.29 122.76 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.035 0 N-CA-C 107.298 -1.371 . . . . 71.03 107.298 174.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 62.69 20.72 12.27 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.612 0.72 . . . . 74.24 110.865 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.59 7.38 64.98 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.652 -0.704 . . . . 64.02 112.572 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -113.78 135.52 53.86 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.908 -0.405 . . . . 54.03 109.908 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.53 126.52 37.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-O 121.708 0.766 . . . . 73.54 110.187 -175.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.448 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 51.9 mm-40 -122.68 148.19 45.58 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.46 -0.941 . . . . 73.13 108.46 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.2 t -100.43 175.71 5.6 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.953 -1.128 . . . . 53.02 107.953 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.663 ' HB ' ' CG ' ' A' ' 53' ' ' ASP . 9.3 t -52.17 -34.05 43.33 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 123.28 0.632 . . . . 72.14 112.261 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 m -59.41 -54.15 49.95 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-O 121.123 0.487 . . . . 71.42 109.946 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -65.45 -47.51 75.91 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-N 115.005 -0.998 . . . . 51.15 110.967 -178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.51 ' CB ' HD13 ' A' ' 56' ' ' ILE . 51.0 t80 -54.46 -54.29 42.83 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.661 0.384 . . . . 73.44 111.169 177.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 2.8 tm? -54.16 -42.49 69.67 Favored 'General case' 0 C--O 1.244 0.801 0 O-C-N 124.206 0.941 . . . . 71.51 110.384 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.422 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 73.3 mt-30 -57.93 -53.61 56.3 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 116.552 -0.294 . . . . 65.52 111.115 174.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.499 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 28.5 m-85 -63.05 -32.54 73.93 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.657 0.742 . . . . 75.04 110.723 -176.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -61.64 -55.27 32.42 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.204 -0.907 . . . . 73.32 110.354 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 12.4 ptp180 -70.64 -22.52 62.5 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 120.798 0.332 . . . . 73.34 111.391 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 54.4 mt-30 -71.39 -20.12 62.18 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.161 -0.472 . . . . 53.4 110.807 174.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.62 24.96 12.56 Favored Glycine 0 N--CA 1.415 -2.758 0 C-N-CA 120.103 -1.046 . . . . 60.25 113.278 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.6 mt -88.44 -46.75 8.88 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.692 -0.803 . . . . 74.33 110.593 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 71' ' ' PHE . 22.1 m-85 -89.87 10.86 22.14 Favored 'General case' 0 C--O 1.21 -0.99 0 O-C-N 121.913 -0.492 . . . . 64.55 112.258 -177.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -71.67 -11.71 60.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.754 1.02 . . . . 71.21 113.754 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -82.47 -10.17 59.13 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 122.056 -0.403 . . . . 71.34 111.012 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 80' ' ' LEU . 3.3 tm? -59.32 -29.59 67.74 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.515 0.509 . . . . 71.22 110.602 -174.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.479 ' C ' ' HD3' ' A' ' 81' ' ' LYS . 12.1 tmtt? -58.97 -41.72 88.2 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.442 -0.345 . . . . 71.34 111.445 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -98.68 13.15 33.16 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 120.802 0.334 . . . . 52.32 111.856 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 105' ' ' SER . . . -81.02 131.66 35.32 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.101 -1.074 . . . . 63.34 108.101 175.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -104.12 130.72 51.84 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.593 -0.443 . . . . 72.42 110.305 -174.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 103' ' ' TRP . 50.8 p90 -70.52 122.29 19.42 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.619 0.724 . . . . 63.41 112.028 -177.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.47 95.89 7.96 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 107.044 -1.465 . . . . 72.14 107.044 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.1 tp -72.66 84.14 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 122.615 1.198 . . . . 73.11 111.233 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -88.39 -43.71 11.29 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.159 -1.382 . . . . 74.13 107.481 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.522 HG22 ' H ' ' A' ' 91' ' ' GLY . 13.2 p -152.22 147.82 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.083 -1.821 . . . . 61.54 106.083 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.4 m -90.31 -19.3 24.22 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.525 0.679 . . . . 72.33 110.006 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.522 ' H ' HG22 ' A' ' 89' ' ' VAL . . . 140.83 -122.41 2.12 Favored Glycine 0 N--CA 1.424 -2.103 0 N-CA-C 110.795 -0.922 . . . . 64.22 110.795 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -150.45 147.8 27.97 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.545 -0.539 . . . . 73.21 109.545 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.471 HG22 ' H ' ' A' ' 94' ' ' LYS . 10.7 p -146.51 -179.25 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 104.222 -2.511 . . . . 72.52 104.222 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.471 ' H ' HG22 ' A' ' 93' ' ' VAL . 59.4 tttp 78.92 -44.3 0.35 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.405 1.082 . . . . 70.54 111.199 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -141.14 92.92 2.53 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 107.986 -1.116 . . . . 73.33 107.986 176.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.56 107.25 0.7 Allowed Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 111.254 -0.739 . . . . 61.34 111.254 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -75.84 118.54 18.74 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 108.509 -0.923 . . . . 64.13 108.509 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -149.22 141.08 8.6 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 110.468 -1.053 . . . . 54.12 110.468 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -121.03 136.52 54.97 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.3 -0.63 . . . . 75.31 109.3 -177.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.473 ' HD3' ' HA2' ' A' ' 91' ' ' GLY . 13.5 mptt -124.97 107.55 10.96 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.869 0.731 . . . . 74.45 109.155 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -106.48 117.14 33.28 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.713 -1.217 . . . . 73.4 107.713 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 8.2 p -120.35 125.07 73.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 122.037 0.923 . . . . 64.03 112.522 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 25.8 m-90 -105.73 147.23 28.8 Favored 'General case' 0 CA--C 1.472 -2.034 0 CA-C-N 114.613 -1.176 . . . . 75.12 109.356 178.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -121.64 123.66 42.45 Favored 'General case' 0 N--CA 1.403 -2.82 0 N-CA-C 105.713 -1.958 . . . . 74.32 105.713 172.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 83' ' ' ALA . 39.2 m -71.95 177.95 4.01 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.897 -0.592 . . . . 50.03 110.082 -177.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.86 120.85 8.61 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-O 121.1 0.476 . . . . 61.34 110.97 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.2 135.47 38.5 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 114.51 -1.223 . . . . 75.32 110.749 -176.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -124.64 123.46 40.09 Favored 'General case' 0 C--O 1.255 1.348 0 N-CA-C 108.494 -0.928 . . . . 74.24 108.494 -175.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -72.55 158.35 35.85 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 123.989 0.915 . . . . 61.45 111.463 -173.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.7 t -137.86 154.84 49.44 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.579 -0.897 . . . . 72.41 108.579 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -66.73 -14.81 62.99 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.694 0.627 . . . . 63.23 112.694 -174.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.409 ' HB2' ' HG2' ' A' ' 114' ' ' LYS . 11.1 m-20 -80.38 -0.26 36.17 Favored 'General case' 0 C--O 1.2 -1.5 0 CA-C-O 119.478 -0.296 . . . . 61.14 111.282 177.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 75.82 10.48 3.28 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.415 1.086 . . . . 73.13 109.533 -173.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.409 ' HG2' ' HB2' ' A' ' 112' ' ' ASP . 25.6 pttm -95.11 162.62 13.64 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.914 -1.513 . . . . 73.32 106.914 176.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.4 mp -133.14 140.15 47.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 N-CA-C 106.216 -1.772 . . . . 74.25 106.216 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 144' ' ' ALA . 0.0 OUTLIER -121.96 143.84 49.23 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.379 -0.528 . . . . 62.35 111.79 177.523 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -144.95 173.92 11.47 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 106.978 -1.49 . . . . 73.42 106.978 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -107.71 141.28 39.48 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 106.384 -1.71 . . . . 61.42 106.384 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.439 ' HB2' HG13 ' A' ' 140' ' ' ILE . 93.3 mt-10 -114.97 144.55 43.41 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 119.784 -0.766 . . . . 74.31 110.485 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -133.76 117.26 16.71 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.537 -0.756 . . . . 73.12 109.109 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -115.9 110.3 18.81 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 109.281 -0.637 . . . . 62.25 109.281 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.12 125.5 46.24 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.377 -0.601 . . . . 61.23 109.377 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -111.45 121.08 44.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.75 -0.833 . . . . 74.42 108.75 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.2 mt -120.42 153.32 23.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 108.537 -0.912 . . . . 72.41 108.537 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -141.25 152.12 44.28 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 108.553 -0.906 . . . . 74.14 108.553 174.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.429 ' HD3' ' HB ' ' A' ' 17' ' ' THR . 41.9 ttm180 -80.8 115.29 20.22 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.605 -0.887 . . . . 74.1 108.605 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -79.05 140.87 37.81 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.803 -1.925 . . . . 74.52 105.803 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -64.83 -14.71 60.23 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.327 0.584 . . . . 73.11 111.874 -170.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.8 -16.46 63.1 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 124.557 1.143 . . . . 72.33 111.314 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.408 ' HA2' HG22 ' A' ' 17' ' ' THR . . . 105.67 -8.86 43.87 Favored Glycine 0 CA--C 1.5 -0.851 0 C-N-CA 121.073 -0.584 . . . . 63.4 111.805 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.9 t -104.7 130.14 52.79 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 106.547 -1.649 . . . . 71.14 106.547 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.496 ' SG ' HG12 ' A' ' 21' ' ' VAL . 12.0 t -83.79 134.81 34.71 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.522 -1.288 . . . . 73.33 107.522 177.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -133.12 154.53 50.51 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.093 -0.706 . . . . 73.22 109.093 -173.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.0 mp -75.14 128.82 36.38 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 120.875 0.369 . . . . 74.11 110.472 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -72.46 -56.39 5.48 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.068 -1.086 . . . . 73.21 108.068 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.7 m -172.62 157.73 3.93 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.799 -1.556 . . . . 64.23 106.799 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.7 m -131.73 149.3 32.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 107.543 -1.281 . . . . 54.34 107.543 172.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -131.61 131.96 43.66 Favored 'General case' 0 C--N 1.266 -3.046 0 C-N-CA 123.107 0.563 . . . . 74.41 110.121 -172.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 72.8 m-85 -121.93 129.02 52.18 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.348 -0.982 . . . . 74.1 108.348 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.439 HG13 ' HB2' ' A' ' 119' ' ' GLU . 6.0 pt -131.74 99.12 3.59 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-O 122.162 0.982 . . . . 63.23 109.142 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 58.4 mtm -85.44 133.64 34.1 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.653 -1.158 . . . . 73.42 110.836 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . 0.267 51.3 p 62.61 73.15 0.47 Allowed 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 125.953 1.701 . . . . 74.44 113.222 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -113.83 131.26 56.31 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 114.433 -1.258 . . . . 73.11 108.106 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 116' ' ' ARG . . . -112.11 149.69 31.79 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.752 -0.658 . . . . 45.44 112.508 -173.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.58 105.85 52.0 Favored Pre-proline 0 N--CA 1.429 -1.486 0 N-CA-C 107.057 -1.46 . . . . 74.23 107.057 169.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.51 147.83 77.63 Favored 'Trans proline' 0 C--O 1.249 1.029 0 C-N-CA 122.609 2.206 . . . . 74.44 111.302 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -70.77 156.03 40.03 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 116.287 -0.415 . . . . 71.22 110.54 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 28.7 m -93.64 135.09 29.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.95 -0.568 . . . . 75.44 109.99 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.43 0 N-CA-C 108.728 -0.842 . . . . 65.44 108.728 179.966 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 CA--C 1.507 -0.676 0 N-CA-C 109.431 -0.581 . . . . 74.0 109.431 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.6 ttt 69.02 15.83 8.77 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.576 1.15 . . . . 75.14 110.2 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.5 t -73.45 129.78 36.07 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 N-CA-C 107.308 -1.367 . . . . 64.34 107.308 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.6 m -33.23 -63.95 0.22 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 126.0 1.72 . . . . 73.01 115.632 -170.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -72.75 -40.4 66.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.907 0.384 . . . . 70.14 111.827 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.51 -38.21 77.49 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.241 -0.652 . . . . 74.14 109.241 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.96 -45.51 74.02 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.715 -0.675 . . . . 74.41 110.214 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.52 ' HB ' ' SG ' ' A' ' 132' ' ' CYS . 14.6 p -65.84 -42.74 92.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 112.25 0.463 . . . . 75.44 112.25 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 -28.61 60.73 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 118.673 -1.211 . . . . 61.12 110.772 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.24 -44.84 63.92 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.415 -0.811 . . . . 54.22 111.874 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.46 -34.85 70.58 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 108.905 -0.776 . . . . 71.24 108.905 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.98 -40.94 99.92 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 111.244 -0.742 . . . . 51.23 111.244 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -69.62 -44.98 69.57 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 120.991 -0.284 . . . . 71.53 110.259 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.42 -42.6 99.0 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.687 0.395 . . . . 73.04 110.539 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.434 ' CE1' HD11 ' A' ' 45' ' ' LEU . 18.0 t80 -62.46 -54.59 37.77 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.238 -0.892 . . . . 73.54 110.016 177.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.3 mm -63.31 -35.78 73.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 112.149 0.426 . . . . 73.14 112.149 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -62.85 -48.95 76.81 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 119.409 -0.329 . . . . 34.22 110.568 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 pp -67.6 -30.79 70.48 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.348 -0.541 . . . . 71.41 111.315 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.34 -24.01 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-O 121.484 0.659 . . . . 61.43 110.912 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.5 p -115.5 14.22 16.59 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 121.504 -0.748 . . . . 64.02 110.59 -176.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -81.54 145.3 30.75 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.762 -0.654 . . . . 71.41 111.861 -173.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.5 m -51.2 160.36 0.91 Allowed Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 126.421 1.889 . . . . 61.32 113.113 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.06 -6.83 6.88 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 124.289 3.326 . . . . 65.31 112.897 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -61.46 -27.03 68.28 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.277 -1.009 . . . . 72.14 108.277 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.4 m -96.7 123.31 40.34 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 103.778 -2.675 . . . . 73.45 103.778 168.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.7 t -49.92 -53.07 11.75 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 N-CA-C 113.301 0.852 . . . . 71.21 113.301 -170.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 43' ' ' HIS . 50.3 t-20 -147.64 127.82 13.81 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.29 -1.004 . . . . 64.3 108.29 -176.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.3 m -59.47 -36.51 76.13 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.602 0.564 . . . . 64.42 109.848 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -73.83 -21.17 60.22 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.153 -0.93 . . . . 72.31 110.268 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 40' ' ' ASN . 10.0 t60 -76.77 -43.33 37.37 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.483 -1.303 . . . . 64.33 107.483 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -63.07 -35.34 79.91 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.597 -0.89 . . . . 75.43 108.597 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.434 HD11 ' CE1' ' A' ' 28' ' ' PHE . 35.2 tp -68.2 -44.34 76.04 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.639 -0.71 . . . . 75.42 110.097 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.83 -31.5 71.75 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.355 0.598 . . . . 64.32 110.529 177.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -71.72 -40.52 69.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.909 -1.041 . . . . 72.53 109.627 177.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -69.3 -44.32 72.0 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.028 -0.533 . . . . 74.15 110.511 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.1 pp -80.75 -2.03 45.3 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.95 -0.568 . . . . 53.32 111.052 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.26 -60.47 6.69 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 119.926 -0.374 . . . . 74.24 112.906 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.51 -6.4 12.67 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.114 1.876 . . . . 74.4 111.904 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -118.52 38.26 3.8 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.773 -0.454 . . . . 72.32 109.773 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -55.78 105.89 0.59 Allowed Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 124.627 1.171 . . . . 73.41 112.815 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -98.89 -168.93 0.1 Allowed 'Trans proline' 0 N--CA 1.43 -2.216 0 C-N-CA 122.825 2.35 . . . . 73.45 111.177 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -91.66 104.74 17.17 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.782 -1.192 . . . . 74.33 107.782 176.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.504 HD13 ' HB2' ' A' ' 68' ' ' PHE . 67.6 mt -89.65 106.85 17.49 Favored 'Isoleucine or valine' 0 C--O 1.18 -2.59 0 CA-C-N 115.391 -0.822 . . . . 72.42 109.054 -175.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -96.23 107.68 20.05 Favored 'General case' 0 C--N 1.276 -2.608 0 O-C-N 121.55 -0.719 . . . . 71.22 111.815 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 139' ' ' PHE . 70.0 t -108.3 111.59 36.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 108.398 -0.964 . . . . 73.32 108.398 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 63.25 21.15 12.68 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.624 -1.171 . . . . 71.33 110.329 -177.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.49 -5.45 62.54 Favored Glycine 0 N--CA 1.437 -1.237 0 CA-C-N 114.87 -1.059 . . . . 64.43 111.967 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -95.7 125.68 40.45 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 109.592 -0.521 . . . . 75.13 109.592 -177.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.2 127.21 35.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.643 0.735 . . . . 64.44 109.54 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.432 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 48.3 mm-40 -128.41 150.94 49.9 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.949 -1.13 . . . . 73.14 107.949 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -101.57 172.9 6.68 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.283 -1.006 . . . . 73.54 108.283 172.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -45.53 -40.46 8.62 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 125.179 1.392 . . . . 51.02 112.231 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.6 m -65.4 -44.67 86.71 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.124 0.487 . . . . 53.25 111.358 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 63' ' ' GLN . . . -67.64 -44.94 76.73 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.697 -0.483 . . . . 71.1 109.697 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.504 ' HB2' HD13 ' A' ' 56' ' ' ILE . 48.3 t80 -53.62 -56.2 19.3 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.206 0.602 . . . . 73.2 109.863 175.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -49.95 -43.8 50.21 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.276 -1.329 . . . . 71.53 110.765 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -60.22 -47.5 85.69 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 111.9 0.333 . . . . 70.24 111.9 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.474 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 33.7 m-85 -66.94 -36.37 82.08 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.514 0.674 . . . . 65.2 110.008 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -57.85 -54.8 42.87 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.543 -0.753 . . . . 72.51 110.637 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -66.83 -29.67 69.66 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.519 -0.31 . . . . 75.52 110.69 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -73.67 -15.35 61.24 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 112.273 0.472 . . . . 44.42 112.273 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.48 13.78 25.42 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 119.931 -1.128 . . . . 54.22 114.544 175.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.38 -56.56 4.89 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.183 0.516 . . . . 71.41 110.96 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.474 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 43.1 m-85 -83.52 -5.31 59.13 Favored 'General case' 0 C--O 1.21 -0.995 0 N-CA-C 112.911 0.708 . . . . 73.23 112.911 -172.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -14.19 61.8 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.095 -1.042 . . . . 63.43 111.795 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -85.33 -16.59 39.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.169 0.509 . . . . 62.35 110.377 175.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 80' ' ' LEU . 3.2 tm? -89.32 -15.73 32.74 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 108.109 -1.071 . . . . 73.11 108.109 -178.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.502 ' C ' ' HD3' ' A' ' 81' ' ' LYS . 11.2 tmtt? -52.18 -41.74 62.89 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.969 0.908 . . . . 64.31 111.963 -177.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -88.46 14.61 9.36 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.561 0.696 . . . . 74.35 111.686 -174.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.52 150.92 47.57 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.989 0.737 . . . . 64.24 112.989 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -106.26 136.14 46.51 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.524 -1.287 . . . . 64.54 107.524 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.645 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 53.0 p90 -99.15 140.33 33.48 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.545 0.943 . . . . 61.12 113.545 -175.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.03 124.18 45.12 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 106.914 -1.513 . . . . 63.53 106.914 175.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.5 tt -77.13 98.51 2.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 122.184 0.992 . . . . 74.31 111.136 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -82.65 127.3 33.26 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.605 -1.628 . . . . 74.15 106.605 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.8 106.98 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.2 0.524 . . . . 62.43 112.124 -173.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 m -90.12 170.05 10.64 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.926 -1.139 . . . . 52.41 107.926 176.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.482 ' HA3' ' OE1' ' A' ' 97' ' ' GLU . . . -79.65 139.12 21.18 Favored Glycine 0 N--CA 1.428 -1.872 0 C-N-CA 120.249 -0.977 . . . . 72.21 111.705 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -74.54 -50.52 17.77 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.595 -0.52 . . . . 65.41 109.595 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.1 t -138.82 93.3 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-N 116.21 -0.45 . . . . 75.3 110.915 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 97' ' ' GLU . 35.4 mtmm -139.6 134.22 31.8 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.012 -0.736 . . . . 73.41 109.012 170.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.72 -0.73 19.08 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 112.873 0.694 . . . . 71.32 112.873 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.7 98.01 0.14 Allowed Glycine 0 N--CA 1.428 -1.879 0 C-N-CA 120.449 -0.881 . . . . 35.22 111.656 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.482 ' OE1' ' HA3' ' A' ' 91' ' ' GLY . 10.0 pt-20 -156.53 175.25 14.28 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.753 -0.462 . . . . 72.34 109.753 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -116.7 139.56 15.27 Favored Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 109.456 -1.458 . . . . 73.4 109.456 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -106.34 150.43 25.99 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.2 -1.778 . . . . 73.22 106.2 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.476 ' HE2' ' CE2' ' A' ' 123' ' ' TYR . 35.9 ttmt -136.23 129.79 32.11 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.465 -0.568 . . . . 74.11 109.465 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.5 mt -126.79 127.1 44.49 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.259 -1.386 . . . . 61.04 107.259 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 7.5 p -125.64 127.03 71.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 113.302 0.852 . . . . 62.51 113.302 -174.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.645 ' CD1' ' HB3' ' A' ' 85' ' ' PHE . 20.4 m-90 -104.16 151.03 23.81 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.642 -1.163 . . . . 75.43 108.523 178.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -135.79 133.54 38.01 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.908 -2.256 . . . . 75.43 104.908 176.175 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.7 p -68.62 171.78 7.17 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 118.09 0.405 . . . . 73.31 110.346 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.72 121.03 10.04 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.827 -0.434 . . . . 61.45 109.827 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.419 ' HB1' ' CG2' ' A' ' 115' ' ' ILE . . . -67.29 135.12 52.83 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 124.045 0.841 . . . . 42.13 111.063 -174.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -131.08 136.02 48.05 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.906 -1.146 . . . . 71.14 107.906 -175.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -84.6 130.15 34.76 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.575 -0.85 . . . . 73.11 110.711 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.466 ' HB3' ' OD2' ' A' ' 112' ' ' ASP . 38.5 t -88.5 177.42 6.8 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.373 -0.83 . . . . 72.14 111.088 -174.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -77.08 -15.31 59.62 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 122.142 0.972 . . . . 71.04 110.648 -175.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.66 ' OD2' ' HG2' ' A' ' 114' ' ' LYS . 1.1 p30 -87.87 1.17 54.69 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.299 -1.319 . . . . 75.43 110.537 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 78.44 9.88 1.98 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.287 1.835 . . . . 73.33 112.493 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.66 ' HG2' ' OD2' ' A' ' 112' ' ' ASP . 57.3 pttt -108.33 173.89 6.12 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.354 -0.841 . . . . 72.44 109.26 175.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.419 ' CG2' ' HB1' ' A' ' 107' ' ' ALA . 1.2 mp -107.02 132.65 53.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.92 -0.771 . . . . 63.03 108.92 -174.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.08 154.77 29.35 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 109.171 -0.677 . . . . 73.21 109.171 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 6.4 p90 -161.17 173.89 14.45 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 124.572 1.149 . . . . 73.31 108.223 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -113.14 137.61 51.18 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.153 -1.795 . . . . 75.52 106.153 176.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -115.01 151.92 33.35 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 119.947 -0.701 . . . . 74.23 111.71 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -139.6 117.49 11.7 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.03 -0.986 . . . . 75.44 108.52 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -123.98 112.35 17.08 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.572 0.701 . . . . 75.42 110.324 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 100' ' ' LYS . . . -93.78 133.38 37.22 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.372 -0.831 . . . . 75.44 109.925 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.476 ' CE2' ' HE2' ' A' ' 100' ' ' LYS . 35.9 m-85 -115.9 122.82 46.46 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 124.153 0.908 . . . . 64.32 108.617 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.408 HG12 ' HG ' ' A' ' 134' ' ' LEU . 62.5 mt -120.84 141.59 40.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.281 -1.748 . . . . 73.55 106.281 176.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -130.17 150.8 51.26 Favored 'General case' 0 C--O 1.268 2.045 0 C-N-CA 117.417 -1.713 . . . . 71.41 112.853 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.431 ' HD3' ' SG ' ' A' ' 132' ' ' CYS . 4.6 tpp180 -75.28 104.67 5.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 104.633 -2.358 . . . . 74.33 104.633 174.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 131' ' ' SER . 57.0 ttt180 -85.45 139.73 31.28 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.417 -0.81 . . . . 63.45 110.69 -168.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -59.77 -10.41 3.78 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.961 1.304 . . . . 70.31 112.641 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.445 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 10.3 t70 -78.41 -16.39 57.67 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 123.882 0.873 . . . . 74.13 110.604 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.06 -5.85 50.44 Favored Glycine 0 C--O 1.24 0.525 0 N-CA-C 111.042 -0.823 . . . . 63.22 111.042 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 127' ' ' ARG . 12.0 p -103.86 169.85 8.27 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 109.66 -0.496 . . . . 74.43 109.66 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.52 ' SG ' ' HB ' ' A' ' 21' ' ' VAL . 68.8 m -121.67 125.27 46.27 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 106.891 -1.522 . . . . 64.32 106.891 174.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -140.82 155.39 46.38 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.516 -0.873 . . . . 71.1 109.533 -169.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.408 ' HG ' HG12 ' A' ' 124' ' ' ILE . 9.0 mp -67.55 125.95 27.79 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 109.093 -0.706 . . . . 73.11 109.093 176.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -83.34 -53.65 5.58 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 108.897 -0.779 . . . . 74.4 108.897 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.0 m -166.71 161.45 15.64 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.874 -1.528 . . . . 73.23 106.874 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.1 m -141.28 139.59 32.68 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 105.751 -1.944 . . . . 54.22 105.751 172.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 120' ' ' ALA . 32.4 ttmt -115.15 132.12 56.71 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 110.196 -0.298 . . . . 74.04 110.196 -176.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.455 ' HB2' HG22 ' A' ' 58' ' ' VAL . 64.7 m-85 -118.53 122.42 42.63 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 107.517 -1.29 . . . . 73.23 107.517 175.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.446 ' HB ' ' HD3' ' A' ' 143' ' ' LYS . 9.3 pt -126.24 98.57 4.98 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.551 0 CA-C-O 122.079 0.943 . . . . 75.15 109.112 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.4 mtm -85.89 127.47 34.6 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.293 -1.321 . . . . 71.42 111.213 -174.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 70.7 m 71.64 75.43 0.17 Allowed 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 113.794 -1.548 . . . . 74.2 114.145 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.446 ' HD3' ' HB ' ' A' ' 140' ' ' ILE . 1.5 mptm? -116.13 152.66 33.22 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.249 -1.341 . . . . 72.51 107.547 172.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -136.4 158.65 43.94 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 120.775 -0.37 . . . . 73.22 110.488 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 114' ' ' LYS . . . -107.96 130.06 23.3 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 108.299 -1.0 . . . . 73.23 108.299 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.3 133.17 47.84 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.935 2.423 . . . . 71.12 112.43 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -87.25 169.82 11.98 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.49 -0.777 . . . . 75.35 109.41 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.0 p -125.18 139.03 52.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.981 -0.748 . . . . 74.43 108.981 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.28 0 N-CA-C 108.3 -1.0 . . . . 72.42 108.3 177.848 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 . . . . . 0 CA--C 1.509 -0.613 0 CA-C-O 120.462 0.172 . . . . 73.13 111.198 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.426 ' HA ' HD12 ' A' ' 19' ' ' LEU . 67.0 mtt -127.22 102.03 6.75 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.298 0.571 . . . . 60.45 111.474 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 t -89.68 165.85 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 106.492 -1.67 . . . . 53.44 106.492 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.3 p -40.09 -66.56 0.3 Allowed 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 115.226 1.565 . . . . 73.12 115.226 -173.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.53 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 8.4 m-20 -68.91 -27.27 65.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.131 0.491 . . . . 75.13 111.901 -176.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 15' ' ' MET . 3.0 tm? -70.38 -40.61 73.86 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.934 -1.136 . . . . 64.52 107.934 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -61.66 -51.63 67.63 Favored 'General case' 0 CA--C 1.496 -1.132 0 C-N-CA 124.159 0.984 . . . . 74.52 109.982 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 18' ' ' ASP . 7.3 p -64.88 -42.74 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.358 -0.837 . . . . 64.24 112.893 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 18' ' ' ASP . 17.3 ptpt -74.48 -24.73 59.06 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 118.622 -1.231 . . . . 71.35 111.745 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.47 -54.45 12.89 Favored Glycine 0 N--CA 1.428 -1.867 0 C-N-CA 120.633 -0.794 . . . . 62.05 111.166 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.79 -36.04 72.84 Favored 'General case' 0 C--O 1.213 -0.864 0 N-CA-C 109.159 -0.682 . . . . 52.54 109.159 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.52 -43.08 98.63 Favored Glycine 0 C--O 1.254 1.359 0 CA-C-N 116.213 -0.448 . . . . 61.54 112.57 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -73.32 -39.5 65.23 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 119.56 -0.856 . . . . 74.31 109.8 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.51 -39.32 94.11 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.028 0.442 . . . . 75.12 110.334 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.413 ' CE2' HD11 ' A' ' 45' ' ' LEU . 31.7 t80 -61.31 -53.17 60.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.293 -0.867 . . . . 70.05 109.623 176.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.7 mm -64.43 -33.76 64.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 112.202 0.445 . . . . 63.44 112.202 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.86 -52.12 66.4 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 122.588 0.355 . . . . 54.42 110.614 175.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.81 -26.32 64.2 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 120.347 -0.541 . . . . 71.41 111.538 -176.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.7 t -70.75 -26.08 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 CA-C-O 120.983 0.421 . . . . 71.5 110.698 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.4 p -109.75 14.99 23.05 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-O 121.855 0.836 . . . . 71.02 109.895 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -62.29 147.95 46.52 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 114.306 -1.316 . . . . 62.44 111.203 -176.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.7 p -54.64 158.35 4.38 Favored Pre-proline 0 C--N 1.313 -0.983 0 C-N-CA 125.196 1.398 . . . . 75.42 113.282 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.38 -7.01 18.95 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.917 2.411 . . . . 73.3 111.13 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.33 -27.67 67.54 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.317 -0.856 . . . . 71.25 109.777 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 p -100.78 143.39 31.0 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.536 -1.283 . . . . 74.11 107.536 173.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.9 p -51.32 -52.58 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.887 1.069 . . . . 71.42 113.887 -173.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -150.82 136.73 18.25 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 122.381 0.272 . . . . 62.12 110.454 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.419 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 19.6 m -67.98 -33.66 75.06 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 122.337 1.065 . . . . 72.43 108.778 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -70.06 -20.32 63.23 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.427 -1.26 . . . . 53.31 111.408 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -69.95 -46.75 64.61 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 107.646 -1.242 . . . . 72.03 107.646 177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.29 -34.15 77.35 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 114.818 -1.083 . . . . 74.23 109.076 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.413 HD11 ' CE2' ' A' ' 28' ' ' PHE . 44.1 tp -66.28 -41.73 89.44 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.808 -0.633 . . . . 63.3 110.651 177.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.53 -35.9 80.9 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.326 0.584 . . . . 51.32 110.437 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -72.99 -35.94 66.97 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.939 -1.028 . . . . 72.43 110.157 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -68.5 -43.03 77.71 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 116.045 -0.525 . . . . 75.24 109.846 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 52' ' ' HIS . 4.2 pp -77.79 -2.11 34.78 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.942 -0.572 . . . . 63.03 111.281 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.71 -63.84 2.35 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 123.746 0.654 . . . . 70.32 112.766 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -82.73 -8.56 11.25 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.849 1.699 . . . . 75.13 111.935 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 49' ' ' LEU . 45.8 m-70 -100.45 27.94 5.4 Favored 'General case' 0 C--O 1.213 -0.863 0 N-CA-C 109.014 -0.736 . . . . 73.34 109.014 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.473 ' HA ' HG21 ' A' ' 65' ' ' THR . 10.2 t70 -52.44 100.77 0.24 Allowed Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 127.844 2.457 . . . . 61.15 111.661 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -114.17 -154.91 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 124.22 3.28 . . . . 73.44 112.131 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -94.06 123.74 37.63 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.149 -1.056 . . . . 73.22 108.149 176.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 65' ' ' THR . 74.3 mt -109.46 112.97 42.82 Favored 'Isoleucine or valine' 0 C--O 1.177 -2.711 0 N-CA-C 108.734 -0.839 . . . . 71.45 108.734 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.54 138.52 33.1 Favored 'General case' 0 C--N 1.269 -2.924 0 N-CA-C 108.825 -0.805 . . . . 72.11 108.825 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 54.4 t -132.58 112.69 19.4 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 107.906 -1.146 . . . . 72.52 107.906 176.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 63.7 20.39 12.2 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.914 1.285 . . . . 73.45 111.068 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.11 2.25 58.13 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.748 -0.66 . . . . 25.04 112.222 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -108.17 132.76 53.29 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.896 -0.779 . . . . 73.5 108.896 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.401 HD13 ' N ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -78.77 127.9 38.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 121.699 0.761 . . . . 71.22 109.658 -175.354 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.401 ' N ' HD13 ' A' ' 62' ' ' ILE . 50.3 mm-40 -126.81 149.19 49.81 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.388 -1.338 . . . . 71.4 107.388 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.1 t -87.38 173.52 9.09 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.313 -0.625 . . . . 64.14 109.313 174.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.49 ' HA ' HD12 ' A' ' 56' ' ' ILE . 18.5 p -61.4 -38.31 86.63 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 125.361 1.464 . . . . 72.31 110.543 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 m -59.62 -46.65 88.36 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.518 -1.219 . . . . 53.43 110.584 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.24 -47.26 83.17 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.066 0.546 . . . . 73.12 109.994 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.476 ' CB ' HD13 ' A' ' 56' ' ' ILE . 38.4 t80 -51.24 -55.95 15.43 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 123.759 0.662 . . . . 70.54 110.371 174.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -51.07 -45.34 61.37 Favored 'General case' 0 C--O 1.245 0.834 0 O-C-N 124.315 1.01 . . . . 74.04 110.826 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 46.7 mt-30 -58.75 -50.9 72.21 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 116.133 -0.485 . . . . 71.14 111.861 175.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.477 ' HB2' ' CE1' ' A' ' 77' ' ' PHE . 38.4 m-85 -65.76 -35.53 80.98 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.495 0.664 . . . . 73.44 109.989 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -57.23 -53.34 59.24 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.55 -0.75 . . . . 71.32 110.748 176.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -72.13 -22.0 61.39 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 120.832 0.348 . . . . 72.34 111.293 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 70' ' ' GLN . 16.5 mm100 -76.29 -11.21 59.87 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 116.226 -0.443 . . . . 63.21 112.133 174.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.21 27.23 11.07 Favored Glycine 0 N--CA 1.428 -1.837 0 C-N-CA 120.209 -0.996 . . . . 65.14 113.081 177.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.402 HD23 ' HB2' ' A' ' 74' ' ' GLN . 3.8 mm? -85.67 -53.02 5.41 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.108 0.48 . . . . 74.3 110.654 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 71' ' ' PHE . 35.1 m-85 -91.72 6.51 45.64 Favored 'General case' 0 C--O 1.208 -1.086 0 N-CA-C 113.167 0.803 . . . . 74.23 113.167 -173.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -11.97 30.04 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.262 0.838 . . . . 72.51 113.262 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -75.48 -11.28 60.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.081 -0.509 . . . . 65.42 111.232 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 tt -69.63 -25.6 64.02 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.585 0.707 . . . . 72.24 109.296 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.419 ' HG2' ' H ' ' A' ' 41' ' ' SER . 4.2 tmtp? -62.71 -32.84 74.02 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 124.559 1.143 . . . . 70.23 109.481 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -105.79 4.62 30.06 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.633 0.73 . . . . 73.23 110.457 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.414 ' HB1' ' HB3' ' A' ' 103' ' ' TRP . . . -79.36 146.09 33.05 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.66 0.615 . . . . 73.33 112.66 -173.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -102.53 133.81 46.9 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.741 -0.663 . . . . 73.12 109.29 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -89.38 151.84 21.83 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 113.288 0.848 . . . . 63.31 113.288 -173.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -142.05 134.9 28.62 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.018 -1.104 . . . . 73.12 108.018 174.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.2 tt -101.54 133.12 45.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 109.347 -0.612 . . . . 74.03 109.347 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -99.83 87.72 3.6 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.944 -0.703 . . . . 74.33 111.181 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.8 m -77.61 148.47 6.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.018 -0.992 . . . . 74.32 109.234 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.5 t 69.24 16.78 8.42 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.159 0.984 . . . . 63.43 108.627 -176.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.74 -34.16 77.36 Favored Glycine 0 C--N 1.344 0.979 0 CA-C-N 115.219 -0.901 . . . . 73.04 111.596 -178.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 96' ' ' GLY . 46.2 tptt -140.82 115.57 9.62 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.466 -1.309 . . . . 65.33 107.466 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.6 m -104.66 2.88 10.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-O 121.105 0.479 . . . . 73.13 111.458 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -95.06 -178.57 4.52 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.976 -0.556 . . . . 62.24 110.694 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.28 -20.27 65.32 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.628 1.171 . . . . 72.32 112.84 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 92' ' ' LYS . . . -73.96 87.91 0.66 Allowed Glycine 0 N--CA 1.428 -1.856 0 N-CA-C 111.446 -0.661 . . . . 51.51 111.446 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -58.92 118.55 5.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.678 -0.49 . . . . 75.14 109.678 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 124' ' ' ILE . . . -149.77 138.65 6.9 Favored Glycine 0 N--CA 1.412 -2.921 0 N-CA-C 109.836 -1.305 . . . . 72.2 109.836 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -114.52 124.18 51.25 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.096 -1.446 . . . . 71.42 107.096 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -117.82 101.6 8.43 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 107.705 -1.221 . . . . 64.4 107.705 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -109.87 133.27 53.34 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.657 -1.156 . . . . 61.13 108.171 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 12.9 p -126.9 135.69 62.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-O 121.324 0.583 . . . . 72.22 110.771 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.414 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 27.9 m-90 -108.88 132.03 54.44 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.456 -0.942 . . . . 73.02 108.456 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -109.09 121.37 45.0 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.62 -1.252 . . . . 72.15 107.62 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.7 t -70.92 -171.75 0.58 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.368 -0.833 . . . . 72.23 111.368 -176.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.63 134.6 43.69 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.681 -0.69 . . . . 70.1 109.306 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -87.7 125.95 34.69 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 115.628 -0.715 . . . . 73.11 109.496 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -102.7 142.38 33.95 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 106.928 -1.508 . . . . 63.32 106.928 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -84.04 130.81 34.86 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.321 -0.552 . . . . 72.14 111.447 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.6 t -106.79 161.17 14.92 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.745 -0.835 . . . . 64.34 108.745 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -80.86 11.93 3.6 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.559 0.695 . . . . 74.44 112.365 -175.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -110.03 13.44 23.31 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 122.144 0.974 . . . . 75.44 109.011 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 68.17 10.46 7.84 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.148 1.379 . . . . 51.2 112.207 -178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 147' ' ' TYR . 25.4 pttm -110.36 174.56 5.81 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.623 -0.88 . . . . 64.04 108.623 174.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.459 HG13 ' CE3' ' A' ' 117' ' ' TRP . 13.8 pt -113.22 157.04 14.04 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 CA-C-O 121.721 0.772 . . . . 54.11 111.483 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.432 ' NE ' ' HA ' ' A' ' 142' ' ' SER . 10.0 tpt180 -108.04 118.16 36.02 Favored 'General case' 0 C--N 1.28 -2.428 0 C-N-CA 125.121 1.369 . . . . 73.31 107.943 176.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.459 ' CE3' HG13 ' A' ' 115' ' ' ILE . 40.1 p90 -133.46 174.29 10.57 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.79 -0.818 . . . . 74.04 108.79 176.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -132.53 147.0 52.35 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 105.59 -2.004 . . . . 72.54 105.59 176.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -125.27 155.26 40.42 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-O 121.138 0.495 . . . . 71.11 112.028 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -134.68 117.55 16.18 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.529 -0.76 . . . . 74.13 109.351 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -111.36 110.82 21.46 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 123.357 0.663 . . . . 75.42 109.842 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.14 131.48 45.15 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 109.039 -0.726 . . . . 73.0 109.039 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -115.93 114.65 24.94 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.568 -0.901 . . . . 73.04 108.568 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.407 ' O ' ' HA2' ' A' ' 98' ' ' GLY . 59.0 mt -112.83 143.71 21.97 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.694 0 N-CA-C 106.643 -1.614 . . . . 50.12 106.643 176.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -127.43 148.41 50.29 Favored 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 118.668 -1.213 . . . . 65.24 109.006 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.468 ' NH2' HG11 ' A' ' 21' ' ' VAL . 19.4 ttm180 -90.09 115.01 27.03 Favored 'General case' 0 N--CA 1.415 -2.177 0 N-CA-C 106.007 -1.849 . . . . 74.35 106.007 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 23.2 ttp85 -67.55 144.26 55.71 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 107.484 -1.302 . . . . 74.2 107.484 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -63.54 -10.31 17.45 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 113.139 0.792 . . . . 71.4 113.139 -172.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -71.33 -16.82 62.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.115 -0.493 . . . . 73.05 110.269 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.37 -19.24 27.03 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 115.874 -0.603 . . . . 73.43 112.54 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.0 m -91.51 152.23 20.42 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 106.897 -1.52 . . . . 50.32 106.897 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.405 ' SG ' HG22 ' A' ' 124' ' ' ILE . 22.4 t -111.03 153.26 25.86 Favored 'General case' 0 C--N 1.271 -2.834 0 C-N-CA 121.11 -0.236 . . . . 62.11 110.411 -174.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -157.72 155.92 30.76 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.429 -0.952 . . . . 73.34 108.429 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.7 mp -67.18 130.31 42.7 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 110.193 -0.299 . . . . 74.24 110.193 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -82.27 -59.94 2.38 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.286 -1.376 . . . . 75.54 107.286 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.6 m -167.62 160.82 13.19 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.358 -1.719 . . . . 73.34 106.358 -176.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.51 152.19 34.73 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 N-CA-C 106.42 -1.696 . . . . 74.35 106.42 171.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -136.96 130.38 31.44 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-O 120.954 0.406 . . . . 72.54 109.932 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -110.78 143.17 41.74 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.362 -0.977 . . . . 71.11 108.362 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.515 HD12 ' HE3' ' A' ' 143' ' ' LYS . 2.4 pt -138.25 98.28 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-O 121.774 0.797 . . . . 73.33 109.341 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 22.1 ptp -93.14 136.89 32.99 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-N 115.095 -0.957 . . . . 71.21 108.742 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.432 ' HA ' ' NE ' ' A' ' 116' ' ' ARG . 23.1 t 81.39 73.92 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 O-C-N 125.017 1.448 . . . . 72.33 110.536 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.515 ' HE3' HD12 ' A' ' 140' ' ' ILE . 53.1 mmtt -112.98 138.45 49.83 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 114.39 -1.277 . . . . 63.3 109.125 175.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -152.53 152.82 32.35 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.533 -1.212 . . . . 51.31 108.154 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -126.69 158.28 68.44 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 107.413 -1.328 . . . . 61.14 107.413 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -49.64 129.35 23.38 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 122.413 2.076 . . . . 73.41 110.366 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 114' ' ' LYS . 6.6 p90 -63.54 156.26 26.96 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 113.159 0.799 . . . . 74.32 113.159 -171.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 19.7 m -129.09 150.51 34.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 115.063 -0.972 . . . . 74.3 108.584 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.286 -2.156 0 N-CA-C 108.14 -1.059 . . . . 70.53 108.14 178.381 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 109.388 -0.597 . . . . 44.23 109.388 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.1 mtt -91.57 119.32 31.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.414 -0.958 . . . . 72.1 108.414 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.32 -40.49 81.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 121.724 0.774 . . . . 73.43 109.767 -177.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 130' ' ' GLY . 18.0 p -73.38 -25.79 60.72 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.463 -1.244 . . . . 64.42 112.645 -176.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -77.62 -39.67 44.55 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-O 122.326 1.06 . . . . 62.55 108.713 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.58 -34.21 71.94 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.1 -1.409 . . . . 62.21 107.481 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.01 -49.96 70.39 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-N 114.759 -1.11 . . . . 72.51 110.559 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.62 -43.08 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 112.216 0.45 . . . . 72.14 112.216 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HB2' ' HE3' ' A' ' 22' ' ' LYS . 21.1 ptmt -70.47 -31.76 69.03 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 118.069 -1.452 . . . . 60.22 111.512 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.91 -37.13 83.25 Favored Glycine 0 C--O 1.218 -0.861 0 N-CA-C 110.641 -0.984 . . . . 62.21 110.641 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp -65.53 -50.02 66.78 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 124.348 1.059 . . . . 63.54 109.165 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.85 -36.82 93.91 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.475 -0.784 . . . . 72.33 112.228 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -69.98 -41.18 74.78 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 110.665 -0.124 . . . . 71.44 110.665 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.75 -40.2 96.5 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.81 0.814 . . . . 72.45 109.555 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.484 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 14.0 t80 -62.11 -55.32 30.12 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.068 -1.424 . . . . 73.44 109.705 176.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.3 mm -63.43 -35.19 71.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.98 -0.555 . . . . 73.33 111.89 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.29 -44.77 86.91 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 121.109 -0.236 . . . . 74.25 111.011 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 28' ' ' PHE . 4.3 pp -70.63 -27.58 64.17 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 119.378 -0.929 . . . . 71.05 110.567 -178.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 28' ' ' PHE . 79.1 t -73.6 -21.03 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 CA-C-O 121.173 0.511 . . . . 72.5 110.411 176.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.5 p -114.46 18.15 16.99 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.619 0.723 . . . . 71.24 110.131 -177.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 34' ' ' LYS . 25.1 tptt -72.31 161.78 30.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.13 -0.941 . . . . 65.35 110.252 -176.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 m -48.06 144.94 5.38 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 124.463 1.105 . . . . 74.14 113.317 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.81 -7.74 15.77 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.56 2.84 . . . . 71.12 112.962 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -66.98 -26.57 66.87 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.163 0.506 . . . . 73.41 109.91 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.2 m -75.53 106.25 6.99 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.898 -1.149 . . . . 74.22 107.898 176.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.6 t -53.98 -52.7 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.097 -0.956 . . . . 75.34 113.075 -173.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -129.05 105.36 8.14 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.923 -0.711 . . . . 63.42 110.668 -175.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.1 t -65.92 -33.31 75.54 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 115.776 -0.647 . . . . 54.11 109.728 -175.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.29 -23.35 67.01 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.414 -0.812 . . . . 54.41 110.131 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.43 ' HA ' ' CZ ' ' A' ' 72' ' ' PHE . 52.8 t-80 -71.68 -45.48 61.78 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 109.84 -0.43 . . . . 60.12 109.84 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -69.72 -31.79 69.99 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.22 -1.03 . . . . 73.22 108.22 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.421 HD11 ' CE2' ' A' ' 28' ' ' PHE . 45.1 tp -67.1 -45.03 78.49 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.273 -0.876 . . . . 63.13 110.595 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.58 -32.0 73.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.244 0.545 . . . . 54.35 110.613 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -72.77 -37.05 67.76 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.901 -0.778 . . . . 73.31 108.901 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -63.41 -44.29 95.06 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.827 0.851 . . . . 75.44 111.073 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 pp -84.69 6.78 22.82 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 115.873 -0.603 . . . . 53.45 111.846 -177.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -47.73 -57.28 7.73 Favored Glycine 0 CA--C 1.548 2.139 0 CA-C-N 116.254 -0.43 . . . . 70.51 112.792 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -76.98 -3.43 13.76 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 123.101 2.534 . . . . 70.43 112.645 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -125.86 28.35 6.17 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.197 -0.314 . . . . 74.12 111.469 -169.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.469 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 25.4 m-20 -56.58 113.73 6.52 Favored Pre-proline 0 C--O 1.24 0.588 0 O-C-N 123.771 0.669 . . . . 64.12 111.544 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.463 ' HB2' ' HA ' ' A' ' 136' ' ' SER . 45.5 Cg_endo -101.45 -164.59 0.05 OUTLIER 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 123.011 2.474 . . . . 70.11 112.058 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -90.8 125.06 35.6 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 106.986 -1.487 . . . . 72.4 106.986 173.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 mp -103.41 114.3 42.63 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.173 0 C-N-CA 119.024 -1.07 . . . . 74.13 109.298 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 138' ' ' LYS . 32.4 m-85 -96.83 132.03 42.97 Favored 'General case' 0 C--N 1.271 -2.812 0 N-CA-C 108.981 -0.748 . . . . 72.04 108.981 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 139' ' ' PHE . 53.7 t -129.53 112.95 25.94 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 107.691 -1.226 . . . . 63.22 107.691 176.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 62.61 22.22 13.18 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.111 -0.95 . . . . 73.23 110.867 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.01 -2.41 66.08 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.076 -0.965 . . . . 24.23 112.185 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -98.37 126.87 44.05 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.292 -1.003 . . . . 65.15 108.292 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -76.81 127.83 37.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.924 0.868 . . . . 70.4 108.89 -177.335 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.424 ' N ' HD13 ' A' ' 62' ' ' ILE . 63.4 mm-40 -117.6 137.67 52.46 Favored 'General case' 0 C--O 1.284 2.881 0 N-CA-C 106.752 -1.573 . . . . 74.11 106.752 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -75.3 174.62 9.28 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 115.895 -0.593 . . . . 73.31 109.407 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.469 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 78.6 p -60.68 -40.67 93.02 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 124.14 0.976 . . . . 43.43 109.807 -175.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 91.3 m -65.48 -45.03 85.22 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 114.563 -1.198 . . . . 65.42 110.696 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.06 -48.33 82.0 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 122.753 0.421 . . . . 64.24 110.389 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -52.66 -54.17 37.04 Favored 'General case' 0 CA--C 1.498 -1.045 0 O-C-N 123.445 0.466 . . . . 74.11 109.913 174.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.1 tp -51.43 -42.65 61.65 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.958 -1.019 . . . . 64.11 112.152 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 66' ' ' THR . 15.2 mm100 -63.55 -49.19 74.41 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 116.122 -0.49 . . . . 60.41 111.413 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -65.17 -34.13 77.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.535 0.683 . . . . 62.4 109.94 -178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 43' ' ' HIS . 2.7 t80 -59.41 -53.78 54.21 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.379 -0.828 . . . . 75.51 110.474 175.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -73.89 -15.24 61.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.86 0.362 . . . . 73.12 111.629 -175.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 70' ' ' GLN . 55.3 mt-30 -87.8 -5.08 58.8 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 116.197 -0.456 . . . . 75.04 112.144 175.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.53 28.39 27.23 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.485 -0.864 . . . . 53.21 113.589 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.84 -45.34 18.87 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 117.286 0.543 . . . . 63.44 111.462 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -94.46 5.58 51.38 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.796 0.665 . . . . 64.11 112.796 -171.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -14.77 63.15 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.046 0.758 . . . . 63.0 113.046 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -78.12 -29.08 48.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.325 0.583 . . . . 70.44 110.112 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.1 mt -78.11 -8.21 57.96 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.399 -0.818 . . . . 63.23 111.378 -174.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -68.2 -31.6 71.24 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.483 0.659 . . . . 75.22 109.344 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -98.81 13.87 30.85 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.858 0.837 . . . . 71.52 110.286 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.31 148.97 31.91 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.869 -0.605 . . . . 73.13 110.763 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -100.6 138.62 37.42 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.344 -0.613 . . . . 61.52 109.344 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -75.3 135.7 40.9 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.185 0.516 . . . . 75.01 111.139 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -117.18 92.85 3.97 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.611 -0.885 . . . . 72.13 108.611 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.3 pt -87.63 87.05 2.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-O 122.262 1.03 . . . . 71.54 112.064 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -80.32 -84.87 0.09 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.732 -1.122 . . . . 62.44 109.696 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.66 86.35 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 105.344 -2.095 . . . . 74.51 105.344 171.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.5 m -67.35 -48.67 66.8 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.215 -1.357 . . . . 73.12 111.344 -175.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -108.93 115.1 4.23 Favored Glycine 0 N--CA 1.424 -2.143 0 C-N-CA 120.032 -1.08 . . . . 71.23 111.972 -176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -80.79 101.95 9.67 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.389 -0.597 . . . . 74.42 109.389 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.9 102.22 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-O 122.025 0.917 . . . . 73.55 110.632 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -160.16 167.92 26.61 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.642 -1.985 . . . . 63.2 105.642 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -71.4 114.51 9.54 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.544 -1.65 . . . . 72.22 106.544 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.64 78.35 1.38 Allowed Glycine 0 N--CA 1.421 -2.344 0 N-CA-C 107.399 -2.28 . . . . 60.43 107.399 -170.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.23 136.6 48.09 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 112.638 0.607 . . . . 61.12 112.638 -174.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -133.91 138.17 9.88 Favored Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 108.72 -1.752 . . . . 52.34 108.72 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.422 ' C ' ' HD2' ' A' ' 100' ' ' LYS . 21.8 m-85 -120.06 129.4 54.2 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.347 -0.983 . . . . 71.14 108.347 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.422 ' HD2' ' C ' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -119.39 103.77 9.77 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.121 -0.696 . . . . 74.23 109.121 179.484 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.33 121.26 43.52 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.04 -1.096 . . . . 62.21 108.04 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 10.0 p -120.16 132.5 69.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.665 0.745 . . . . 71.33 112.269 -177.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 30.5 m-90 -109.82 130.47 55.52 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.677 -1.147 . . . . 72.3 107.946 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -115.87 128.65 55.97 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.042 -0.725 . . . . 73.04 109.042 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.471 ' HB3' ' H ' ' A' ' 118' ' ' ASP . 34.6 t -81.51 174.74 11.14 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.217 -0.901 . . . . 73.53 109.594 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.99 136.71 58.17 Favored 'General case' 0 CA--C 1.502 -0.882 0 O-C-N 123.623 0.577 . . . . 52.13 110.624 -178.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.401 ' HB1' ' CG2' ' A' ' 115' ' ' ILE . . . -71.27 136.13 47.79 Favored 'General case' 0 N--CA 1.435 -1.183 0 O-C-N 123.799 0.687 . . . . 62.54 109.623 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -114.8 134.87 54.77 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.453 -0.573 . . . . 62.21 109.453 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -74.41 106.82 6.2 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.884 -1.154 . . . . 72.35 107.884 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.4 t -96.39 133.09 41.22 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 107.67 -1.233 . . . . 75.32 107.67 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -74.87 11.59 1.04 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 114.595 1.332 . . . . 65.12 114.595 -174.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.71 -1.58 57.35 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 106.297 -1.742 . . . . 75.33 106.297 172.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.516 ' O ' ' HB3' ' A' ' 147' ' ' TYR . 23.8 tt0 79.34 17.96 0.82 Allowed 'General case' 0 C--N 1.347 0.459 0 C-N-CA 126.797 2.039 . . . . 74.33 110.156 -176.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 22.8 pttm -109.88 179.04 4.23 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.014 -1.106 . . . . 73.34 108.014 174.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.401 ' CG2' ' HB1' ' A' ' 107' ' ' ALA . 27.2 mt -122.45 134.95 64.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.22 -1.03 . . . . 74.53 108.22 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.473 ' HG2' ' HB2' ' A' ' 144' ' ' ALA . 49.4 mtm180 -114.08 140.46 48.46 Favored 'General case' 0 C--O 1.2 -1.516 0 N-CA-C 109.325 -0.62 . . . . 74.12 109.325 -178.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 17.9 p90 -147.47 160.26 42.79 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.24 -1.022 . . . . 64.21 108.24 174.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.471 ' H ' ' HB3' ' A' ' 105' ' ' SER . 3.7 m-20 -102.83 133.18 48.32 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 107.83 -1.174 . . . . 62.14 107.83 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.405 ' HB2' HG13 ' A' ' 140' ' ' ILE . 50.0 mt-10 -115.51 141.73 47.67 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 120.582 -0.447 . . . . 65.25 110.277 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 102' ' ' VAL . . . -127.25 116.74 21.04 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.504 -1.295 . . . . 72.31 107.504 176.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -123.16 111.39 16.46 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.27 -0.641 . . . . 74.44 109.27 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.6 133.86 36.49 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 123.119 0.567 . . . . 71.42 109.642 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -111.96 115.33 28.78 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.189 -1.041 . . . . 75.32 108.189 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.4 mt -113.9 147.04 17.7 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.497 0 N-CA-C 106.994 -1.484 . . . . 70.2 106.994 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.444 ' CZ3' ' HB3' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -131.73 150.37 52.18 Favored 'General case' 0 C--O 1.266 1.945 0 C-N-CA 118.722 -1.191 . . . . 74.34 109.333 176.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -100.92 116.58 33.11 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 106.219 -1.771 . . . . 61.33 106.219 174.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.459 ' HG2' ' H ' ' A' ' 129' ' ' ASP . 63.5 ttt180 -69.3 155.15 40.89 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.389 -0.823 . . . . 71.41 109.455 -176.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -51.85 -31.53 28.13 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.638 0.775 . . . . 64.35 111.552 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.459 ' H ' ' HG2' ' A' ' 127' ' ' ARG . 3.9 m-20 -71.42 -5.63 34.21 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 124.512 1.125 . . . . 62.31 111.271 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.494 ' O ' ' HB ' ' A' ' 17' ' ' THR . . . 94.07 -23.95 29.03 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.46 -0.656 . . . . 62.04 111.46 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.4 m -65.73 124.56 22.76 Favored 'General case' 0 N--CA 1.425 -1.675 0 C-N-CA 124.014 0.925 . . . . 70.14 109.868 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 7.1 t -103.26 142.24 34.52 Favored 'General case' 0 C--N 1.27 -2.864 0 N-CA-C 108.666 -0.864 . . . . 64.51 108.666 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.444 ' HB3' ' CZ3' ' A' ' 125' ' ' TRP . 2.1 t90 -156.53 155.61 32.24 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.8 -1.185 . . . . 71.44 107.8 -173.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.37 127.55 33.11 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.577 -0.527 . . . . 64.35 109.577 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -83.28 -55.57 4.26 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 108.006 -1.109 . . . . 63.33 108.006 -176.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.463 ' HA ' ' HB2' ' A' ' 54' ' ' PRO . 34.0 m -167.08 164.72 15.86 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.698 -1.593 . . . . 52.12 106.698 -177.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.95 149.49 22.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 106.263 -1.754 . . . . 70.24 106.263 172.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 57' ' ' TYR . 39.4 ttmt -129.51 130.79 46.25 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-O 120.843 0.354 . . . . 74.44 110.414 -177.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 53.7 m-85 -113.43 127.24 56.04 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.535 -1.283 . . . . 71.2 107.535 177.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.405 HG13 ' HB2' ' A' ' 119' ' ' GLU . 6.9 pt -129.58 98.72 4.13 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-O 122.273 1.035 . . . . 74.51 109.427 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 74.8 mtm -84.46 131.7 34.64 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.529 -1.214 . . . . 72.31 110.762 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 74.5 m 68.84 37.79 2.26 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.512 1.133 . . . . 70.42 111.943 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -66.31 130.24 42.55 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 103.314 -2.847 . . . . 64.45 103.314 173.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.473 ' HB2' ' HG2' ' A' ' 116' ' ' ARG . . . -134.44 145.74 49.15 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 114.732 1.382 . . . . 61.41 114.732 -167.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 114' ' ' LYS . . . -101.62 126.1 35.26 Favored Pre-proline 0 N--CA 1.43 -1.441 0 N-CA-C 107.052 -1.462 . . . . 71.22 107.052 172.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -72.82 160.35 46.34 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.565 2.177 . . . . 61.22 111.948 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.516 ' HB3' ' O ' ' A' ' 113' ' ' GLN . 37.2 p90 -68.06 159.88 29.97 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.793 -0.639 . . . . 71.24 110.326 177.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.4 m -97.89 96.78 5.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-O 122.165 0.983 . . . . 53.32 112.18 -177.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.958 0 N-CA-C 108.355 -0.979 . . . . 51.13 108.355 179.181 . . . . . . . . 0 0 . 1 stop_ save_